PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Pan, J; Qian, Y; Zhou, XD; Lu, H; Ramacciotti, E; Zhang, LJ				Pan, Jing; Qian, Yi; Zhou, Xiaodong; Lu, Hong; Ramacciotti, Eduardo; Zhang, Lijuan			Chemically Oversulfated Glycosaminoglycans Are Potent Modulators of Contact System Activation and Different Cell Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; ADVERSE CLINICAL EVENTS; CHONDROITIN SULFATE-E; CONTAMINATED HEPARIN; FACTOR-XII; MITOGENIC ACTIVITY; PLASMA KALLIKREIN; CRYSTAL-STRUCTURE; DERMATAN SULFATE; HIGH-AFFINITY	Contaminated heparin was associated with adverse reactions by activating the contact system. Chemically oversulfated/modified glycosaminoglycans (GAGs) consisting of heparan sulfate, dermatan sulfate, and chondroitin sulfate have been identified as heparin contaminants. Current studies demonstrated that each component of oversulfated GAGs was comparable with oversulfated chondroitin sulfate in activating the contact system. By testing a series of unrelated negatively charged compounds, we found that the contact system recognized negative charges rather than specific chemical structures. We further tested how oversulfated GAGs and contaminated heparins affect different cell signaling pathways. Our data showed that chemically oversulfated GAGs and contaminated heparin had higher activity than the parent compounds and authentic heparin, indicative of sulfation-dominant and GAG sequence-dependent activities in BaF cell-based models of fibroblast growth factor/fibroblast growth factor receptor, glial cell line-derived neurotrophic factor/c-Ret, and hepatocyte growth factor/c-Met signaling. In summary, these data indicate that contaminated heparins intended for blood anticoagulation not only activated the contact system but also modified different GAG-dependent cell signaling pathways.	[Pan, Jing; Qian, Yi; Zhou, Xiaodong; Lu, Hong; Zhang, Lijuan] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Ramacciotti, Eduardo] Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA; [Ramacciotti, Eduardo] Univ Michigan, Ctr Cardiovasc, Vasc Surg Sect, Jobst Vasc Surg Res Lab, Ann Arbor, MI 48109 USA	Washington University (WUSTL); Loyola University Chicago; University of Michigan System; University of Michigan	Zhang, LJ (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	ljzhang@wustl.edu	Zhou, Xiaodong/B-4017-2011	Ramacciotti, Eduardo/0000-0002-5735-1333	National Institutes of Health [R01GM069968]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM069968 (to L.Z.).	Ashikari- Hada S, 2005, J BIOL CHEM, V280, P31508, DOI 10.1074/jbc.M414581200; Barnett MW, 2002, J CELL SCI, V115, P4495, DOI 10.1242/jcs.00114; Bischof D, 2006, BLOOD, V107, P3235, DOI 10.1182/blood-2005-01-0256; Blossom DB, 2008, NEW ENGL J MED, V359, P2674, DOI 10.1056/NEJMoa0806450; Clark A, 2008, MOL IMMUNOL, V45, P3125, DOI 10.1016/j.molimm.2008.03.008; Colman R, 2006, HEMOSTASIS THROMBOSI, P107; Conrad H. E., 1998, HEPARIN BINDING PROT; Davies JA, 2003, GROWTH FACTORS, V21, P109, DOI 10.1080/08977190310001621005; Dougher AM, 1997, GROWTH FACTORS, V14, P257, DOI 10.3109/08977199709021524; Fareed J, 2008, SEMIN THROMB HEMOST, V34, P58, DOI 10.1055/s-2008-1066025; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; GAO GX, 1995, EMBO J, V14, P2183, DOI 10.1002/j.1460-2075.1995.tb07212.x; Gilstad CW, 2003, CURR OPIN HEMATOL, V10, P419, DOI 10.1097/00062752-200311000-00004; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Guerrini M, 2009, P NATL ACAD SCI USA, V106, P16956, DOI 10.1073/pnas.0906861106; HOJIMA Y, 1984, BLOOD, V63, P1453; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; JENNY NS, 2006, HEMOSTASIS THROMBOSI, P193; Keire DA, 2010, J PHARMACEUT BIOMED, V51, P921, DOI 10.1016/j.jpba.2009.10.017; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Krufka A, 1996, BIOCHEMISTRY-US, V35, P11131, DOI 10.1021/bi960125+; Lyon M, 2004, J BIOL CHEM, V279, P43560, DOI 10.1074/jbc.M408510200; Lyon M, 1998, J BIOL CHEM, V273, P271, DOI 10.1074/jbc.273.1.271; Maas C, 2008, J CLIN INVEST, V118, P3208, DOI [10.1172/JC135424, 10.1172/JCI35424]; McDowell LM, 2006, J BIOL CHEM, V281, P6924, DOI 10.1074/jbc.M512932200; MCKEE J, 2010, J CLIN PHARM; Meth MJ, 2006, DRUG SAFETY, V29, P133, DOI 10.2165/00002018-200629020-00003; Mullins ES, 2009, BLOOD, V113, P696, DOI 10.1182/blood-2008-07-169003; NAGASAWA K, 1986, CARBOHYD RES, V158, P183, DOI 10.1016/0008-6215(86)84016-2; NAGGI A, 1987, BIOCHEM PHARMACOL, V36, P1895, DOI 10.1016/0006-2952(87)90485-0; Onodera H, 1999, NEPHROL DIAL TRANSPL, V14, P1604, DOI 10.1093/ndt/14.6.1604; PAN J, 2010, GLYCOBIOL INSIGHTS, V2, P1; Pan J, 2010, NAT BIOTECHNOL, V28, P203, DOI 10.1038/nbt0310-203; Parkash V, 2008, J BIOL CHEM, V283, P35164, DOI 10.1074/jbc.M802543200; Peek M, 2002, J BIOL CHEM, V277, P47804, DOI 10.1074/jbc.M209778200; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Qian Y, 2010, CLIN APPL THROMB-HEM, V16, P251, DOI 10.1177/1076029610362072; Qian Y, 2010, CLIN APPL THROMB-HEM, V16, P261, DOI 10.1177/1076029610362073; Rolny C, 2002, J BIOL CHEM, V277, P19315, DOI 10.1074/jbc.M111805200; Rubin JB, 2002, DEVELOPMENT, V129, P2223; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Saito A, 2007, BBA-GEN SUBJECTS, V1770, P241, DOI 10.1016/j.bbagen.2006.10.015; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schmaier AH, 2007, J THROMB HAEMOST, V5, P2323, DOI 10.1111/j.1538-7836.2007.02770.x; Schmaier AH, 2008, INT IMMUNOPHARMACOL, V8, P161, DOI 10.1016/j.intimp.2007.08.022; Schwall RH, 1996, J CELL BIOL, V133, P709, DOI 10.1083/jcb.133.3.709; SHIMADA T, 1985, THROMB RES, V38, P21, DOI 10.1016/0049-3848(85)90004-0; SHIMADA T, 1985, J BIOCHEM-TOKYO, V97, P429, DOI 10.1093/oxfordjournals.jbchem.a135077; SHIMOMURA T, 1993, J BIOL CHEM, V268, P22927; Thompson RW, 1990, GROWTH FACTORS, V3, P221, DOI 10.3109/08977199009043906; Toida T, 1999, INT J BIOL MACROMOL, V26, P233, DOI 10.1016/S0141-8130(99)00088-4; UCHIYAMA H, 1991, J BIOL CHEM, V266, P6756; VANDERGRAAF F, 1983, J CLIN INVEST, V71, P149, DOI 10.1172/JCI110743; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; ZIONCHECK TF, 1995, J BIOL CHEM, V270, P16871, DOI 10.1074/jbc.270.28.16871	56	50	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22964	22973		10.1074/jbc.M109.063735	http://dx.doi.org/10.1074/jbc.M109.063735			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20418371	hybrid, Green Published			2022-12-25	WOS:000279999900031
J	Chen, Z; Medina, F; Liu, MY; Thomas, C; Sprang, SR; Sternweis, PC				Chen, Zhe; Medina, Frank; Liu, Mu-Ya; Thomas, Celestine; Sprang, Stephen R.; Sternweis, Paul C.			Activated RhoA Binds to the Pleckstrin Homology (PH) Domain of PDZ-RhoGEF, a Potential Site for Autoregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; PLASMA-MEMBRANE RECRUITMENT; CRYSTAL-STRUCTURE; P115 RHOGEF; RECOGNITION; COMPLEX; GTPASES; DETERMINANTS; G-ALPHA(12); P115RHOGEF	Guanine nucleotide exchange factors (GEFs) catalyze exchange of GDP for GTP by stabilizing the nucleotide-free state of the small GTPases through their Dbl homology/pleckstrin homology (DH.PH) domains. Unconventionally, PDZ-RhoGEF (PRG), a member of the RGS-RhoGEFs, binds tightly to both nucleotide-free and activated RhoA (RhoA.GTP). We have characterized the interaction between PRG and activated RhoA and determined the structure of the PRG-DH.PH-RhoA.GTP gamma S (guanosine 5'-O-[gamma-thio]triphosphate) complex. The interface bears striking similarity to a GTPase-effector interface and involves the switch regions in RhoA and a hydrophobic patch in PRG-PH that is conserved among all Lbc RhoGEFs. The two surfaces that bind activated and nucleotide-free RhoA on PRG-DH.PH do not overlap, and a ternary complex of PRG-DH.PH bound to both forms of RhoA can be isolated by size-exclusion chromatography. This novel interaction between activated RhoA and PH could play a key role in regulation of RhoGEF activity in vivo.	[Chen, Zhe; Medina, Frank; Liu, Mu-Ya; Sternweis, Paul C.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Thomas, Celestine; Sprang, Stephen R.] Univ Montana, Div Biol Sci, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Montana System; University of Montana	Chen, Z (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	Zhe.Chen@utsouthwestern.edu; Paul.Sternweis@utsouthwestern.edu		Chen, Zhe/0000-0002-1668-4051	National Institutes of Health [GM31954, DK46371]; Robert A. Welch Foundation [I-1262]; Alfred and Mabel Gilman Chair in Molecular Pharmacology; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046371, R01DK046371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Alfred and Mabel Gilman Chair in Molecular Pharmacology; United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31954 (to P. C. S.) and DK46371 (to S. R. S.). This work was also supported by the Robert A. Welch Foundation Grant I-1262 (to P. C. S.) and a grant from the Alfred and Mabel Gilman Chair in Molecular Pharmacology (to P. C. S.).; We thank Jana Hadas and Stephen Gutowski for superb technical assistance and Diana Tomchick for assistance with data collection. Results shown in this report are derived from work performed at the Argonne National Laboratory, Structural Biology Center, at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Aittaleb M, 2009, CELL SIGNAL, V21, P1569, DOI 10.1016/j.cellsig.2009.06.003; Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baumeister MA, 2003, J BIOL CHEM, V278, P11457, DOI 10.1074/jbc.M211901200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharyya R, 2003, BIOCHEM J, V371, P709, DOI 10.1042/BJ20021897; Bhattacharyya R, 2000, J BIOL CHEM, V275, P14992, DOI 10.1074/jbc.M000415200; Bhattacharyya R, 2009, CELL SIGNAL, V21, P996, DOI 10.1016/j.cellsig.2009.02.010; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Chen Z, 2008, STRUCTURE, V16, P1532, DOI 10.1016/j.str.2008.07.009; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; Cierpicki T, 2009, PROTEIN SCI, V18, P2067, DOI 10.1002/pro.219; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; Eisenhaure TM, 2003, J BIOL CHEM, V278, P30975, DOI 10.1074/jbc.M303277200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rossman KL, 2003, J BIOL CHEM, V278, P18393, DOI 10.1074/jbc.M300127200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Taya S, 2001, J CELL BIOL, V155, P809, DOI 10.1083/jcb.200106139; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; Zheng MY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-36	46	36	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21070	21081		10.1074/jbc.M110.122549	http://dx.doi.org/10.1074/jbc.M110.122549			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430886	Green Published, hybrid			2022-12-25	WOS:000279228600070
J	Gupta, K; Diamond, T; Hwang, Y; Bushman, F; Van Duyne, GD				Gupta, Kushol; Diamond, Tracy; Hwang, Young; Bushman, Frederic; Van Duyne, Gregory D.			Structural Properties of HIV Integrase.Lens Epithelium-derived Growth Factor Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 INTEGRASE; RETROVIRAL DNA INTEGRATION; BINDING DOMAIN; CRYSTAL-STRUCTURE; TERMINAL DOMAINS; IN-VITRO; LEDGF/P75; PROTEINS; IDENTIFICATION; SCATTERING	Integrase (IN) is the catalytic component of the preintegration complex, a large nucleoprotein assembly critical for the integration of the retroviral genome into a host chromosome. Although partial crystal structures of human immunodeficiency virus IN alone and its complex with the integrase binding domain of the host factor PSIP1/lens epithelium-derived growth factor (LEDGF)/p75 are available, many questions remain regarding the properties and structures of LEDGF-bound IN oligomers. Using analytical ultracentrifugation, multiangle light scattering, and small angle x-ray scattering, we have established the oligomeric state, stoichiometry, and molecular shapes of IN center dot LEDGF complexes in solution. Analyses of intact IN tetramers bound to two different LEDGF truncations allow for placement of the integrase binding domain by difference analysis. Modeling of the small angle x-ray scattering envelopes using existing structural data suggests domain arrangements in the IN oligomers that support and extend existing biochemical data for IN center dot LEDGF complexes and lend new insights into the quaternary structure of LEDGF-bound IN tetramers. These IN oligomers may be involved in stages of the viral life cycle other than integration, including assembly, budding, and early replication.	Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19105 USA; Howard Hughes Med Inst, Philadelphia, PA 19105 USA; [Diamond, Tracy; Hwang, Young; Bushman, Frederic] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Van Duyne, GD (corresponding author), Univ Penn, Howard Hughes Med Inst, Sch Med, Dept Biochem & Biophys, 809C Stellar Chance Bldg,422 Curie Blvd, Philadelphia, PA 19104 USA.	vanduyne@mail.med.upenn.edu	Gupta, Kushol/GOE-5620-2022	Gupta, Kushol/0000-0002-7006-2667; Bushman, Frederic/0000-0003-4740-4056	National Institutes of Health [AI52845, AI082020, RR-01646]; University of Pennsylvania Center for AIDS Research; Penn Genome Frontiers Institute; Pennsylvania Department of Health; Swarthmore College; amfAR Mathilde Krim Fellowship in Basic Biomedical Research [106994-43-RFNT]; National Science Foundation [DMR 0225180]; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources, National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052845, R01AI082020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Center for AIDS Research; Penn Genome Frontiers Institute; Pennsylvania Department of Health; Swarthmore College; amfAR Mathilde Krim Fellowship in Basic Biomedical Research; National Science Foundation(National Science Foundation (NSF)); Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI52845 and AI082020. This work was also supported by the University of Pennsylvania Center for AIDS Research, the Penn Genome Frontiers Institute, and a grant from the Pennsylvania Department of Health.; Supported by a Swarthmore College Postdoctoral Teaching Fellowship and the amfAR Mathilde Krim Fellowship in Basic Biomedical Research 106994-43-RFNT.; We are grateful to Marc Ruff for supplying the model coordinates derived from the cryo-EM studies by his group; Richard Gillilan (Cornell University High Energy Synchrotron Source), Hiro Tsuruta (Stanford Synchrotron Radiation Light Source), and Lin Yang (National Synchrotron Light Source) for their technical expertise and support; and G. V. and F. B. laboratory members for helpful discussions. Cornell University High Energy Synchrotron Source is supported by National Science Foundation Grant DMR 0225180, and the MacCHESS facility is supported by National Institutes of Health Grant RR-01646. Financial support for the National Synchrotron Light Source comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and from the National Center for Research Resources, National Institutes of Health. The Stanford Synchrotron Radiation Light Source is a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences.	Alian A, 2009, P NATL ACAD SCI USA, V106, P8192, DOI 10.1073/pnas.0811919106; Bao KK, 2003, J BIOL CHEM, V278, P1323, DOI 10.1074/jbc.C200550200; Baranova S, 2007, NUCLEIC ACIDS RES, V35, P975, DOI 10.1093/nar/gkl1111; Bera S, 2009, J MOL BIOL, V389, P183, DOI 10.1016/j.jmb.2009.04.007; Berthoux L, 2007, VIROLOGY, V364, P227, DOI 10.1016/j.virol.2007.02.029; Birmanns S, 2007, J STRUCT BIOL, V157, P271, DOI 10.1016/j.jsb.2006.08.008; Bosserman MA, 2007, BIOCHEMISTRY-US, V46, P11231, DOI 10.1021/bi700197a; Briones MS, 2010, J VIROL, V84, P5181, DOI 10.1128/JVI.02382-09; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Busschots K, 2005, J BIOL CHEM, V280, P17841, DOI 10.1074/jbc.M411681200; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; CARTEAU S, 1993, ARCH BIOCHEM BIOPHYS, V300, P756, DOI 10.1006/abbi.1993.1105; Chen AP, 2006, J BIOL CHEM, V281, P4173, DOI 10.1074/jbc.M510628200; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Ciuffi A, 2006, HUM GENE THER, V17, P960, DOI 10.1089/hum.2006.17.960; Craigie R, 2002, MOBILE DNA, P613; DAMASCHUN G, 1992, EUR BIOPHYS J BIOPHY, V20, P355; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Deprez E, 2001, P NATL ACAD SCI USA, V98, P10090, DOI 10.1073/pnas.181024498; Diamond TL, 2005, J VIROL, V79, P15376, DOI 10.1128/JVI.79.24.15376-15387.2005; Dolan J, 2009, J MOL BIOL, V385, P568, DOI 10.1016/j.jmb.2008.10.083; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Engelman A, 1999, ADV VIRUS RES, V52, P411, DOI 10.1016/S0065-3527(08)60309-7; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Havlir DV, 2008, NEW ENGL J MED, V359, P416, DOI 10.1056/NEJMe0804289; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Lutzke RAP, 1998, J VIROL, V72, P4841, DOI 10.1128/JVI.72.6.4841-4848.1998; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Nishitsuji H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007825; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; SHERMAN PA, 1990, P NATL ACAD SCI USA, V87, P5119, DOI 10.1073/pnas.87.13.5119; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Van Duyne GD, 2008, RSC BIOMOL SCI, P303, DOI 10.1039/9781847558268-00303; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Vogt V.M., 1997, RETROVIRUSES, P263; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wang LD, 2005, BIOCHEM BIOPH RES CO, V337, P313, DOI 10.1016/j.bbrc.2005.08.274; WOERNER AM, 1993, NUCLEIC ACIDS RES, V21, P3507, DOI 10.1093/nar/21.15.3507; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Yoder KE, 2000, J VIROL, V74, P11191, DOI 10.1128/JVI.74.23.11191-11200.2000	75	20	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20303	20315		10.1074/jbc.M110.114413	http://dx.doi.org/10.1074/jbc.M110.114413			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20406807	Green Published, hybrid			2022-12-25	WOS:000279012000065
J	Amente, S; Bertoni, A; Morano, A; Lania, L; Avvedimento, EV; Majello, B				Amente, S.; Bertoni, A.; Morano, A.; Lania, L.; Avvedimento, E. V.; Majello, B.			LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription	ONCOGENE			English	Article						Myc; LSD1; transcription; histone; methylation; oxidative burst	AP-ENDONUCLEASE APE1/REF-1; C-MYC; BINDING; ACTIVATION; LSD1; ACETYLATION; MECHANISM; COFACTOR; GLYCOSYLASE; RECRUITS	Myc is a transcription factor that significantly contributes to cancer progression by modulating the expression of important genes through binding to a DNA sequence, CACGTG, called E-box. We find that on Myc binding to chromatin, the lysine-demethylating enzyme, LSD1, triggers a transient demethylation of lysine 4 in the histone H3. In addition, we demonstrate that Myc binds and recruits LSD1 to the E-box chromatin and the formation of this complex is stimulated by cAMP-PKA. Demethylation by LSD1 produces H2O2, which locally oxidizes guanine and induces the recruitment of 8-oxoguanine-DNA glycosylase (OGG1) and of the nuclease Ape1 on the E-box chromatin. Inhibition of oxidation or silencing of LSD1, OGG1 or Ape1 significantly reduce transcription and inhibit mRNA accumulation of Myc-target genes. Collectively, these data highlight the role of transient LSD1-mediated demethylation of H3K4 leading to local DNA oxidation as driving force in the assembly of the Myc-induced transcription initiation complex. Oncogene (2010) 29, 3691-3702; doi: 10.1038/onc.2010.120; published online 26 April 2010	[Amente, S.; Lania, L.; Majello, B.] Univ Naples Federico II, Dept Struct & Funct Biol, I-80126 Naples, Italy; [Amente, S.; Lania, L.; Avvedimento, E. V.] Naples Oncogenom Ctr CEINGE, Naples, Italy; [Bertoni, A.; Morano, A.; Avvedimento, E. V.] L Califano Univ Naples Federico II, Dept Biol Cellular & Mol Pathol, Naples, Italy	University of Naples Federico II; University of Naples Federico II	Majello, B (corresponding author), Univ Naples Federico II, Dept Struct & Funct Biol, Via Cinthia, I-80126 Naples, Italy.	majello@unina.it	Amente, Stefano/AAU-7605-2020; Morano, Annalisa/K-6955-2012	Amente, Stefano/0000-0003-0612-6096; Morano, Annalisa/0000-0002-5609-4742; Majello, Barbara/0000-0003-2789-3585	Italian Association for Cancer Research (AIRC)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	We thank R Dalla Favera for critical reading of the paper and A Fusco for stimulating discussions and support. This work was supported by grants from the Italian Association for Cancer Research (AIRC) and by a core grant to NOGEC (AIRC). SA is a recipient of a postdoctoral fellowship from AIRC.	Anand R, 2007, J BIOL CHEM, V282, P35425, DOI 10.1074/jbc.R700027200; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Bhakat KK, 2003, METHOD ENZYMOL, V371, P292; Bhakat KK, 2003, EMBO J, V22, P6299, DOI 10.1093/emboj/cdg595; Chattopadhyay R, 2008, MOL CELL BIOL, V28, P7066, DOI 10.1128/MCB.00244-08; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cowling VH, 2006, SEMIN CANCER BIOL, V16, P242, DOI 10.1016/j.semcancer.2006.08.001; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Forneris F, 2008, TRENDS BIOCHEM SCI, V33, P181, DOI 10.1016/j.tibs.2008.01.003; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Gargano B, 2007, CELL CYCLE, V6, P2031, DOI 10.4161/cc.6.16.4554; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Kirmizis A, 2009, NAT STRUCT MOL BIOL, V16, P449, DOI 10.1038/nsmb.1569; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Mantha AK, 2008, J MOL BIOL, V379, P28, DOI 10.1016/j.jmb.2008.03.052; Martinato F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003650; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2007, NAT STRUCT MOL BIOL, V14, P252, DOI 10.1038/nsmb0407-252; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Schlosser I, 2005, ONCOGENE, V24, P520, DOI 10.1038/sj.onc.1208198; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sidorenko VS, 2007, DNA REPAIR, V6, P317, DOI 10.1016/j.dnarep.2006.10.022; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Wu KJ, 2002, ONCOGENE, V21, P7872, DOI 10.1038/sj.onc.1205986; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	41	127	132	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 24	2010	29	25					3691	3702		10.1038/onc.2010.120	http://dx.doi.org/10.1038/onc.2010.120			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	615CG	20418916				2022-12-25	WOS:000279108600009
J	Madar-Balakirski, N; Tempel-Brami, C; Kalchenko, V; Brenner, O; Varon, D; Scherz, A; Salomon, Y				Madar-Balakirski, Noa; Tempel-Brami, Catherine; Kalchenko, Vyacheslav; Brenner, Ori; Varon, David; Scherz, Avigdor; Salomon, Yoram			Permanent Occlusion of Feeding Arteries and Draining Veins in Solid Mouse Tumors by Vascular Targeted Photodynamic Therapy (VTP) with Tookad	PLOS ONE			English	Article							NITRIC-OXIDE; SYSTEMIC HYPOXIA; MELANOMA TUMORS; PROSTATE-CANCER; BLOOD-VESSELS; PD-BACTERIOPHEOPHORBIDE; OXYGEN-CONSUMPTION; ANGIOGENESIS; RAT; PHOTOSENSITIZER	Background: Antiangiogenic and anti-vascular therapies present intriguing alternatives to cancer therapy. However, despite promising preclinical results and significant delays in tumor progression, none have demonstrated long-term curative features to date. Here, we show that a single treatment session of Tookad-based vascular targeted photodynamic therapy (VTP) promotes permanent arrest of tumor blood supply by rapid occlusion of the tumor feeding arteries (FA) and draining veins (DV), leading to tumor necrosis and eradication within 24-48 h. Methodology/Principal Findings: A mouse earlobe MADB106 tumor model was subjected to Tookad-VTP and monitored by three complementary, non-invasive online imaging techniques: Fluorescent intravital microscopy, Dynamic Light Scattering Imaging and photosensitized MRI. Tookad-VTP led to prompt tumor FA vasodilatation (a mean volume increase of 70%) with a transient increase (60%) in blood-flow rate. Rapid vasoconstriction, simultaneous blood clotting, vessel permeabilization and a sharp decline in the flow rates then followed, culminating in FA occlusion at 63.2 sec+/-1.5SEM. This blockage was deemed irreversible after 10 minutes of VTP treatment. A decrease in DV blood flow was demonstrated, with a slight lag from FA response, accompanied by frequent changes in flow direction before reaching a complete standstill. In contrast, neighboring, healthy tissue vessels of similar sizes remained intact and functional after Tookad-VTP. Conclusion/Significance: Tookad-VTP selectively targets the tumor feeding and draining vessels. To the best of our knowledge, this is the first mono-therapeutic modality that primarily aims at the larger tumor vessels and leads to high cure rates, both in the preclinical and clinical arenas.	[Madar-Balakirski, Noa; Tempel-Brami, Catherine; Salomon, Yoram] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Kalchenko, Vyacheslav; Brenner, Ori] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Scherz, Avigdor] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Varon, David] Hadassah Hebrew Univ, Med Ctr, Dept Hematol, Jerusalem, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Hebrew University of Jerusalem; Hadassah University Medical Center	Madar-Balakirski, N (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	yoram.salomon@weizmann.ac.il	Kalchenko, Vyacheslav/F-2924-2012	Kalchenko, Vyacheslav/0000-0002-3166-7049	STEBA Biotech, France	STEBA Biotech, France	This study was funded solely by STEBA Biotech, France. YS and AS are the incumbents of the Tillie and Charles Lubin Professorial Chair in Biochemical Endocrinology, and the Robert and Yaddele Sklare Professorial Chair in Biochemistry, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashur I, 2009, J PHYS CHEM A, V113, P8027, DOI 10.1021/jp900580e; BAATZ H, 1995, INT J MICROCIRC, V15, P85, DOI 10.1159/000178955; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Berdugo M, 2008, INVEST OPHTH VIS SCI, V49, P1633, DOI 10.1167/iovs.07-0767; Brandis A, 2005, PHOTOCHEM PHOTOBIOL, V81, P983, DOI 10.1562/2004-12-01-RA-389R1.1; Bryan PT, 1999, J PHYSIOL-LONDON, V514, P163, DOI 10.1111/j.1469-7793.1999.163af.x; CHAPLIN DJ, 1987, CANCER RES, V47, P597; Chen B, 2006, CLIN CANCER RES, V12, P917, DOI 10.1158/1078-0432.CCR-05-1673; Chen B, 2008, INT J CANCER, V123, P695, DOI 10.1002/ijc.23538; Chen B, 2006, CRIT REV EUKAR GENE, V16, P279, DOI 10.1615/CritRevEukarGeneExpr.v16.i4.10; Cooney MM, 2006, NAT CLIN PRACT ONCOL, V3, P682, DOI 10.1038/ncponc0663; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dolmans DEJGJ, 2002, CANCER RES, V62, P2151; Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x; DVORAK HF, 1988, AM J PATHOL, V133, P95; Eberhard A, 2000, CANCER RES, V60, P1388; Edmunds NJ, 2001, J PHYSIOL-LONDON, V532, P251, DOI 10.1111/j.1469-7793.2001.0251g.x; Eggener SE, 2008, THESCIENTIFICWORLDJO, V8, P963, DOI 10.1100/tsw.2008.127; Fleshker S, 2008, PHOTOCHEM PHOTOBIOL, V84, P1231, DOI 10.1111/j.1751-1097.2008.00340.x; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; GERTNER MRW, 2003, CAPCURE SCI RETREAT; Gross S, 2003, NAT MED, V9, P1327, DOI 10.1038/nm940; Hathcock JJ, 2006, ARTERIOSCL THROM VAS, V26, P1729, DOI 10.1161/01.ATV.0000229658.76797.30; He C, 2008, PHARM RES-DORDR, V25, P1873, DOI 10.1007/s11095-008-9604-5; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jung O, 2007, ARTERIOSCL THROM VAS, V27, P470, DOI 10.1161/01.ATV.0000254823.15843.1f; Kalchenko V, 2007, J MICROSC-OXFORD, V228, P118, DOI 10.1111/j.1365-2818.2007.01832.x; Kawamura Y, 2009, J ATHEROSCLER THROMB, V16, P807; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; Koudinova NV, 2003, INT J CANCER, V104, P782, DOI 10.1002/ijc.11002; Lepor Herbert, 2008, Rev Urol, V10, P254; MARSHALL JM, 1988, J PHYSIOL-LONDON, V407, P385, DOI 10.1113/jphysiol.1988.sp017422; Mazor O, 2005, PHOTOCHEM PHOTOBIOL, V81, P342, DOI 10.1562/2004-06-14-RA-199.1; Moncada S., 2006, V176, P213; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moore CM, 2009, NAT CLIN PRACT UROL, V6, P18, DOI 10.1038/ncpuro1274; Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929; Scherz A., 2003, U.S. Patent, Patent No. [6569846, 6,569,846]; SCHERZ A, 2004, Patent No. 04045492; Takaya T, 2007, ARTERIOSCL THROM VAS, V27, P1632, DOI 10.1161/ATVBAHA.107.142182; Tempel-Brami C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001191; Tozer GM, 2004, SEMIN RADIAT ONCOL, V14, P222, DOI 10.1016/j.semradonc.2004.04.009; Tozer GM, 2005, ADV DRUG DELIVER REV, V57, P135, DOI 10.1016/j.addr.2004.07.015; Trachtenberg J, 2007, J UROLOGY, V178, P1974, DOI 10.1016/j.juro.2007.07.036; TRACHTENBERG J, 2008, BJU INT; Vakrat-Haglili Y, 2005, J AM CHEM SOC, V127, P6487, DOI 10.1021/ja046210j; Zangari M, 2003, SEMIN THROMB HEMOST, V29, P275; Zilberstein J, 1997, PHOTOCHEM PHOTOBIOL, V65, P1012, DOI 10.1111/j.1751-1097.1997.tb07962.x; Zilberstein J, 2001, PHOTOCHEM PHOTOBIOL, V73, P257, DOI 10.1562/0031-8655(2001)073<0257:ATOSMT>2.0.CO;2	50	53	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10282	10.1371/journal.pone.0010282	http://dx.doi.org/10.1371/journal.pone.0010282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421983	Green Published, gold, Green Submitted			2022-12-25	WOS:000276952600006
J	Willberg, CB; Garrison, KE; Jones, RB; Meiklejohn, DJ; Spotts, G; Liegler, TJ; Ostrowski, MA; Karlsson, AC; Hecht, FM; Nixon, DF				Willberg, Christian B.; Garrison, Keith E.; Jones, R. Brad; Meiklejohn, Duncan J.; Spotts, Gerald; Liegler, Teri J.; Ostrowski, Mario A.; Karlsson, Annika C.; Hecht, Frederick M.; Nixon, Douglas F.			Rapid Progressing Allele HLA-B35 Px Restricted Anti-HIV-1 CD8+T Cells Recognize Vestigial CTL Epitopes	PLOS ONE			English	Article							T-LYMPHOCYTE RESPONSES; HIV-1 GENOTYPING KIT; MHC CLASS-I; HIV-1-INFECTED INDIVIDUALS; HLA-B; AIDS; INFECTION; ANTIGEN; IDENTIFICATION; IMMUNIZATION	Background: The HLA-B*35-Px allele has been associated with rapid disease progression in HIV-1 infection, in contrast to the HLA-B*35-Py allele. Methodology/Principal Findings: Immune responses to two HLA-B*35 restricted HIV-1 specific CTL epitopes and their variants were followed longitudinally during early HIV-1 infection in 16 HLA-B*35+ individuals. Subjects expressing HLA-B*35-Px alleles showed no difference in response to the consensus epitopes compared to individuals with HLA-B*35-Py alleles. Surprisingly, all the HLA-B*35-Px+ individuals responded to epitope-variants even in the absence of a consensus response. Sequencing of the viral population revealed no evidence of variant virus in any of the individuals. Conclusions/Significance: This demonstrates a novel phenomenon that distinguishes individuals with the HLA-B*35-Px rapid progressing allele and those with the HLA-B*35-Py slower progressing allele.	[Willberg, Christian B.; Garrison, Keith E.; Meiklejohn, Duncan J.; Nixon, Douglas F.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA; [Jones, R. Brad; Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Spotts, Gerald; Liegler, Teri J.; Hecht, Frederick M.] Univ Calif San Francisco, Dept Med, Div HIV AIDS, San Francisco, CA USA; [Karlsson, Annika C.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Solna, Sweden; [Karlsson, Annika C.] Swedish Inst Infect Dis Control, Dept Virol, Solna, Sweden	University of California System; University of California San Francisco; University of Toronto; University of California System; University of California San Francisco; Karolinska Institutet; Swedish Institute for Infectious Disease Control	Willberg, CB (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA.	douglas.nixon@ucsf.edu	Karlsson, Annika/R-2255-2016; Nixon, Douglas/AAU-5734-2020	Karlsson, Annika/0000-0002-2028-8393; Nixon, Douglas/0000-0002-2801-1786; Willberg, Christian/0000-0001-5299-9344; Hecht, Frederick/0000-0002-5782-1171	AIDS Research Institute (ARI); National Institutes of Health (NIH) [AI056988, AI71713, AI65241, AI62333, AI41531]; Swedish Agency for International Development Cooperation-SIDA [2005001756]; Swedish Research Council [K2007-56X-20345-01-3]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI071713, R01AI062333, U01AI041531, R01AI056988, R21AI065241] Funding Source: NIH RePORTER	AIDS Research Institute (ARI); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Agency for International Development Cooperation-SIDA; Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the University of California San Francisco (UCSF) AIDS Biology Program of the AIDS Research Institute (ARI), National Institutes of Health (NIH) grants AI056988, AI71713, AI65241, AI62333, AI41531, and the Swedish Agency for International Development Cooperation-SIDA (2005001756), and the Swedish Research Council (K2007-56X-20345-01-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741; BARBER LD, 1995, CURR BIOL, V5, P179, DOI 10.1016/S0960-9822(95)00039-X; Brown ME, 2007, J IMMUNOTHER, V30, P350, DOI 10.1097/CJI.0b013e31802b5005; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 2002, AIDS, V16, pS105, DOI 10.1097/00002030-200216004-00015; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Dyall R, 1998, J EXP MED, V188, P1553, DOI 10.1084/jem.188.9.1553; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Gold JS, 2003, J IMMUNOL, V170, P5188, DOI 10.4049/jimmunol.170.10.5188; Grant RM, 2003, J CLIN MICROBIOL, V41, P1586, DOI 10.1128/JCM.41.4.1586-1593.2003; Hecht FM, 2002, AIDS, V16, P1119, DOI 10.1097/00002030-200205240-00005; Jin X, 2002, J VIROL, V76, P12603, DOI 10.1128/JVI.76.24.12603-12610.2002; Karlsson AC, 2003, J IMMUNOL METHODS, V283, P141, DOI 10.1016/j.jim.2003.09.001; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kuritzkes DR, 2003, J CLIN MICROBIOL, V41, P1594, DOI 10.1128/JCM.41.4.1594-1599.2003; Larsson M, 1999, AIDS, V13, P767, DOI 10.1097/00002030-199905070-00005; Menendez-Arias L, 1998, VIRAL IMMUNOL, V11, P167, DOI 10.1089/vim.1998.11.167; Nicholson LB, 2000, INT IMMUNOL, V12, P205, DOI 10.1093/intimm/12.2.205; Sandberg JK, 2003, J IMMUNOL, V170, P4403, DOI 10.4049/jimmunol.170.8.4403; Scherer A, 2004, P NATL ACAD SCI USA, V101, P12266, DOI 10.1073/pnas.0404091101; Sipsas NV, 1997, J CLIN INVEST, V99, P752, DOI 10.1172/JCI119221; Turnbull EL, 2006, J IMMUNOL, V176, P6130, DOI 10.4049/jimmunol.176.10.6130	23	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10249	10.1371/journal.pone.0010249	http://dx.doi.org/10.1371/journal.pone.0010249			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422053	Green Published, Green Submitted, gold			2022-12-25	WOS:000276952500014
J	Viel, S; Vaugoyeau, M; Assaiante, C				Viel, Sebastien; Vaugoyeau, Marianne; Assaiante, Christine			Postural Adaptation of the Spatial Reference Frames to Microgravity: Back to the Egocentric Reference Frame	PLOS ONE			English	Article							VOLUNTARY HEAD STABILIZATION; OSCILLATORY TRUNK MOVEMENTS; ORIENTATION; INTEGRATION; SPACE; WEIGHTLESSNESS; READAPTATION; PERCEPTION; CHILDREN; DEFICITS	Background: In order to test how gravitational information would affect the choice of stable reference frame used to control posture and voluntary movement, we have analysed the forearm stabilisation during sit to stand movement under microgravity condition obtained during parabolic flights. In this study, we hypothesised that in response to the transient loss of graviceptive information, the postural adaptation might involve the use of several strategies of segmental stabilisation, depending on the subject's perceptual typology (dependence - independence with respect to the visual field). More precisely, we expected a continuum of postural strategies across subjects with 1) at one extreme the maintaining of an egocentric reference frame and 2) at the other the re-activation of childhood strategies consisting in adopting an egocentric reference frame. Methodology/Principal Findings: To check this point, a forearm stabilisation task combined with a sit to stand movement was performed with eyes closed by 11 subjects during parabolic flight campaigns. Kinematic data were collected during 1-g and 0-g periods. The postural adaptation to microgravity's constraint may be described as a continuum of strategies ranging from the use of an exo-to an egocentric reference frame for segmental stabilisation. At one extremity, the subjects used systematically an exocentric frame to control each of their body segments independently, as under normogravity conditions. At the other, the segmental stabilisation strategies consist in systematically adopting an egocentric reference frame to control their forearm's stabilisation. A strong correlation between the mode of segmental stabilisation used and the perceptual typology ( dependence - independence with respect to the visual field) of the subjects was reported. Conclusion: The results of this study show different subjects' typologies from those that use the forearm orientation in a mainly exocentric reference frame to those that use the forearm orientation in a mainly egocentric reference frame.	[Viel, Sebastien] Univ Aix Marseille 1, Grp DPA, UMR 6149, Marseille, France; CNRS, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Viel, S (corresponding author), Univ Aix Marseille 1, Grp DPA, UMR 6149, Marseille, France.	christine.assaiante@univ-provence.fr			Centre National d'Etudes Spatiales (CNES); CNRS (Centre National de la recherche Scientifique)	Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); CNRS (Centre National de la recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Centre National d'Etudes Spatiales (CNES) and the CNRS (Centre National de la recherche Scientifique). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amblard B, 1997, EXP BRAIN RES, V114, P214, DOI 10.1007/PL00005630; Amblard B, 2001, EXP BRAIN RES, V137, P170, DOI 10.1007/s002210000621; Amblard B, 1995, ACTA ASTRONAUT, V36, P415, DOI 10.1016/0094-5765(95)00126-3; Assaiante C, 1998, NEUROSCI BIOBEHAV R, V22, P527, DOI 10.1016/S0149-7634(97)00040-7; Assaiante C, 1997, J VESTIBUL RES-EQUIL, V7, P145, DOI 10.1016/S0957-4271(96)00168-1; ASSAIANTE C, 1993, EXP BRAIN RES, V93, P499; Assaiante Christine, 2005, Neural Plasticity, V12, P109, DOI 10.1155/NP.2005.109; Baroni G, 2001, J APPL PHYSIOL, V90, P205, DOI 10.1152/jappl.2001.90.1.205; BETH H, 1971, PERCEPT PSYCHOPHYS, V9, P353; Borel L, 2002, BRAIN, V125, P880, DOI 10.1093/brain/awf085; CHEUNG BSK, 1990, EXP BRAIN RES, V81, P391; CLEMENT G, 1984, EXP BRAIN RES, V57, P61; Clement G, 2007, NEUROSCI LETT, V413, P150, DOI 10.1016/j.neulet.2006.11.047; FRIEDERICI AD, 1990, PERCEPT PSYCHOPHYS, V47, P253, DOI 10.3758/BF03205000; Guerraz M, 2001, BRAIN, V124, P1646, DOI 10.1093/brain/124.8.1646; Gurfinkel V, 1988, STANCE MOTION FACTS, P185; Isableu B, 1997, EXP BRAIN RES, V114, P584, DOI 10.1007/PL00005667; Isableu B, 2003, EXP BRAIN RES, V150, P208, DOI 10.1007/s00221-003-1446-0; Isableu B, 2006, EXP BRAIN RES, V174, P763, DOI 10.1007/s00221-006-0630-4; Kluzik J, 2005, EXP BRAIN RES, V162, P474, DOI 10.1007/s00221-004-2124-6; Lackner J R, 1993, J Vestib Res, V3, P361; Lackner JR, 2000, EXP BRAIN RES, V130, P2, DOI 10.1007/s002210050002; Massion Jean, 1994, Current Opinion in Neurobiology, V4, P877, DOI 10.1016/0959-4388(94)90137-6; Mergner T, 1998, BRAIN RES REV, V28, P118, DOI 10.1016/S0165-0173(98)00032-0; MONEY KE, 1991, J CLIN PHARMACOL, V31, P1007, DOI 10.1002/j.1552-4604.1991.tb03664.x; Mouchnino L, 1996, J NEUROPHYSIOL, V76, P1212, DOI 10.1152/jn.1996.76.2.1212; NYBORG H, 1979, PERCEPT MOTOR SKILL, V48, P67, DOI 10.2466/pms.1979.48.1.67; OLTMAN PK, 1968, PERCEPT MOTOR SKILL, V26, P503, DOI 10.2466/pms.1968.26.2.503; Paillard J., 1991, BRAIN SPACE, P81; Paillard J., 1974, S ASS PSYCH SCI LANG, P7; Pozzo T, 1998, BRAIN RES REV, V28, P92, DOI 10.1016/S0165-0173(98)00030-7; Roncesvalles MN, 2005, J MOTOR BEHAV, V37, P404, DOI 10.3200/JMBR.37.5.404-416; Schmitz C, 1999, EXP BRAIN RES, V126, P200, DOI 10.1007/s002210050729; Vaugoyeau M, 2007, NEUROSCIENCE, V146, P852, DOI 10.1016/j.neuroscience.2007.01.052; VAUGOYEAU M, 2007, SIT SATND BACK STAND; VAUGOYEAU M, 2005, GAIT POSTURE, V21, pS31; Vaugoyeau M, 2009, ACTA ASTRONAUT, V65, P347, DOI 10.1016/j.actaastro.2009.03.016; Vernazza-Martin S, 2000, J NEUROPHYSIOL, V83, P453, DOI 10.1152/jn.2000.83.1.453; Viel S, 2009, MOTOR CONTROL, V13, P25, DOI 10.1123/mcj.13.1.25; White O, 2005, EXP BRAIN RES, V163, P324, DOI 10.1007/s00221-004-2175-8; YOUNG LR, 1984, SCIENCE, V225, P205, DOI 10.1126/science.6610215; YOUNG LR, 1986, EXP BRAIN RES, V64, P291; Zoccolotti P, 1997, PERCEPTION, V26, P1485, DOI 10.1068/p261485	43	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10259	10.1371/journal.pone.0010259	http://dx.doi.org/10.1371/journal.pone.0010259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422038	gold, Green Submitted, Green Published			2022-12-25	WOS:000276854300015
J	Xu, J; Zhou, JY; Wei, WZ; Wu, GS				Xu, Jing; Zhou, Jun-Ying; Wei, Wei-Zen; Wu, Gen Sheng			Activation of the Akt Survival Pathway Contributes to TRAIL Resistance in Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED APOPTOSIS; DOWN-REGULATION; CISPLATIN RESISTANCE; CARCINOMA CELLS; LEUKEMIA-CELLS; INDUCED DEATH; PROLIFERATION; RECEPTOR; BREAST	The mechanism of tumor necrosis factor-related apoptosis-inducing ligand ( TRAIL) resistance in cancer cells is not fully understood. Here, we show that the Akt survival pathway plays an important role in TRAIL resistance in human cancer cells. Specifically, we found that TRAIL treatment activates the Akt survival pathway and that inhibition of this pathway by the PI3K inhibitor LY294002 or knockdown of Akt sensitizes resistant cancer cells to TRAIL. Since Akt is negatively regulated by the tumor suppressor PTEN, we examined the TRAIL sensitivity in PTEN knockdown mouse prostate epithelial cells and found that PTEN(-/-) cells are more resistant than PTEN(+/+) cells while the sensitivity of PTEN(+/-) cells fell in between. Further, we showed that overexpression of a mutant PTEN confers TRAIL resistance in PTEN(+/+) cells, supporting a role of PTEN in TRAIL sensitivity. In TRAIL resistant breast T47D cells, overexpression of the mutant PTEN further increased their resistance to TRAIL. Taken together, our data indicate that inactivation of functional PTEN and the consequent activation of the Akt pathway prevents TRAIL-induced apoptosis, leading to TRAIL resistance. Therefore, our results suggest that TRAIL resistance can be overcome by targeting PTEN or the Akt survival pathway in cancer cells.	[Xu, Jing; Zhou, Jun-Ying; Wu, Gen Sheng] Wayne State Univ, Sch Med, Dept Pathol, Program Mol Biol & Genet,Karmanos Canc Inst, Detroit, MI 48201 USA; [Wei, Wei-Zen] Wayne State Univ, Sch Med, Dept Immunol & Microbiol, Program Breast Canc,Karmanos Canc Inst, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Xu, J (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Program Mol Biol & Genet,Karmanos Canc Inst, Detroit, MI 48201 USA.	wug@karmanos.org			NIH/NCI [R01 CA100073]; Department of Defense Breast Cancer Program [W81XWH-07-1-05-21]; NATIONAL CANCER INSTITUTE [R01CA100073] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Breast Cancer Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH/NCI grant R01 CA100073 and Department of Defense Breast Cancer Program W81XWH-07-1-05-21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7; Berquin IM, 2007, J CLIN INVEST, V117, P1866, DOI 10.1172/JCI31494; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Burns TF, 2001, J BIOL CHEM, V276, P37879; Cuello M, 2001, GYNECOL ONCOL, V81, P380, DOI 10.1006/gyno.2001.6194; Cuello M, 2001, CANCER RES, V61, P4892; Dida F, 2008, EXP HEMATOL, V36, P1343, DOI 10.1016/j.exphem.2008.04.011; Ehrhardt H, 2003, ONCOGENE, V22, P3842, DOI 10.1038/sj.onc.1206520; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hietakangas V, 2003, MOL CELL BIOL, V23, P1278, DOI 10.1128/MCB.23.4.1278-1291.2003; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kandasamy K, 2002, CANCER RES, V62, P4929; Keane MM, 1999, CANCER RES, V59, P734; Kim MJ, 2009, BIOCHEM PHARMACOL, V78, P573, DOI 10.1016/j.bcp.2009.05.016; Lane D, 2007, INT J CANCER, V121, P1227, DOI 10.1002/ijc.22840; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Nesterov A, 2001, J BIOL CHEM, V276, P10767, DOI 10.1074/jbc.M005196200; Plastaras JP, 2008, CANCER BIOL THER, V7, P2047, DOI 10.4161/cbt.7.12.7570; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; Secchiero P, 2004, CELL MOL LIFE SCI, V61, P1965, DOI 10.1007/s00018-004-4197-6; Song JJ, 2010, CELL SIGNAL, V22, P377, DOI 10.1016/j.cellsig.2009.10.007; Song JH, 2007, CANCER RES, V67, P6946, DOI 10.1158/0008-5472.CAN-06-3896; Sun SY, 2001, BIOCHEM BIOPH RES CO, V280, P788, DOI 10.1006/bbrc.2000.4218; Trauzold A, 2001, ONCOGENE, V20, P4258, DOI 10.1038/sj.onc.1204559; Wang J, 2009, CELL CYCLE, V8, P3191, DOI 10.4161/cc.8.19.9751; Wang ZQ, 2006, CANCER RES, V66, P8870, DOI 10.1158/0008-5472.CAN-06-1280; Wu GS, 2009, CANCER LETT, V285, P1, DOI 10.1016/j.canlet.2009.02.029; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Xu J, 2007, CANCER RES, V67, P1203, DOI 10.1158/0008-5472.CAN-06-2310	31	65	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10226	10.1371/journal.pone.0010226	http://dx.doi.org/10.1371/journal.pone.0010226			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419107	Green Published, gold, Green Submitted			2022-12-25	WOS:000276853800016
J	Ting, C; Rajji, TK; Ismail, Z; Tang-Wai, DF; Apanasiewicz, N; Miranda, D; Mamo, D; Mulsant, BH				Ting, Christina; Rajji, Tarek K.; Ismail, Zahinoor; Tang-Wai, David F.; Apanasiewicz, Nina; Miranda, Dielle; Mamo, David; Mulsant, Benoit H.			Differentiating the Cognitive Profile of Schizophrenia from That of Alzheimer Disease and Depression in Late Life	PLOS ONE			English	Article							LATE-ONSET SCHIZOPHRENIA; NEUROPSYCHOLOGICAL DEFICITS; DEMENTIA	Background: To compare the cognitive profile of older patients with schizophrenia to those with other neuropsychiatric disorders assessed in a hospital-based memory clinic. Methods: Demographic, clinical, and cognitive data of all patients referred to the memory clinic at the Centre for Addiction and Mental Health between April 1, 2006 and August 15, 2008 were reviewed. We then identified four groups of older patients with: (1) late-life schizophrenia (LLS) and no dementia or depression (DEP); (2) Alzheimer's disease (AD); (3) DEP and no dementia or LLS; (4) normal cognition (NC) and no DEP or LLS. Results: The four groups did not differ in demographic data except that patients with AD were about 12 years older than those with LLS. However, they differed on cognitive tests even after controlling for age. Patients with LLS were impaired on most cognitive tests in comparison with patients with NC but not on recalling newly learned verbal information at a short delay. They experienced equivalent performance on learning new verbal information in comparison with patients with AD, but better performance on all other tests of memory, including the ability to recall newly learned verbal information. Finally, they were more impaired than patients with DEP in overall memory. Conclusions: Patients with LLS have a different cognitive profile than patients with AD or DEP. Particularly, memory impairment in LLS seems to be more pronounced in learning than recall. These findings suggest that cognitive and psychosocial interventions designed to compensate for learning deficits may be beneficial in LLS.	[Ting, Christina; Rajji, Tarek K.; Ismail, Zahinoor; Tang-Wai, David F.; Apanasiewicz, Nina; Miranda, Dielle; Mamo, David; Mulsant, Benoit H.] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON, Canada; [Rajji, Tarek K.; Ismail, Zahinoor; Mamo, David; Mulsant, Benoit H.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Ismail, Zahinoor] Univ Calgary, Dept Psychiat, Calgary, AB, Canada; [Tang-Wai, David F.] Univ Toronto, Div Neurol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Calgary; University of Toronto	Ting, C (corresponding author), Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON, Canada.	Tarek_Rajji@camh.net	Rajji, Tarek K/K-1543-2015		Canadian Institutes of Health [CIHR180087]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research Fellowship Award to Dr. Rajji (CIHR180087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P5; Butters MA, 2000, AM J PSYCHIAT, V157, P1949, DOI 10.1176/appi.ajp.157.12.1949; Davidson M, 1996, AM J PSYCHIAT, V153, P1274; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Freedman M., 1994, CLOCK DRAWING NEUROP, pVI; Friedman JI, 2001, AM J PSYCHIAT, V158, P1441, DOI 10.1176/appi.ajp.158.9.1441; Golden C. J., 1979, LURIA NEBRASKA NEURO; Green MF, 2004, BIOL PSYCHIAT, V56, P301, DOI 10.1016/j.biopsych.2004.06.023; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; HEATON R, 1994, ARCH GEN PSYCHIAT, V51, P469; Heaton RK, 2001, ARCH GEN PSYCHIAT, V58, P24, DOI 10.1001/archpsyc.58.1.24; JESTE DV, 1995, AM J PSYCHIAT, V152, P722; Kaplan E, 1983, BOSTON DIAGNOSTIC AP; Kongs SK, 2000, WISCONSIN CARD SORTI; Mattis S, 1988, DEMENTIA RATING SCAL; McBride T, 2002, SCHIZOPHR RES, V55, P217, DOI 10.1016/S0920-9964(01)00232-8; McGurk SR, 2000, SCHIZOPHR RES, V42, P47, DOI 10.1016/S0920-9964(99)00097-3; NADLER JD, 1993, ARCH CLIN NEUROPSYCH, V8, P449, DOI 10.1016/0887-6177(93)90008-O; Palmer BW, 2003, J NEUROPSYCH CLIN N, V15, P45, DOI 10.1176/appi.neuropsych.15.1.45; Paulsen J S, 1995, J Int Neuropsychol Soc, V1, P88; Rajji TK, 2008, SCHIZOPHR RES, V102, P122, DOI 10.1016/j.schres.2008.03.015; Reitan R.M., 1993, HALSTEAD REITAN NEUR	23	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10151	10.1371/journal.pone.0010151	http://dx.doi.org/10.1371/journal.pone.0010151			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405043	Green Published, gold, Green Submitted			2022-12-25	WOS:000276705900024
J	Golden, E; Emiliano, A; Maudsley, S; Windham, BG; Carlson, OD; Egan, JM; Driscoll, I; Ferrucci, L; Martin, B; Mattson, MP				Golden, Erin; Emiliano, Ana; Maudsley, Stuart; Windham, B. Gwen; Carlson, Olga D.; Egan, Josephine M.; Driscoll, Ira; Ferrucci, Luigi; Martin, Bronwen; Mattson, Mark P.			Circulating Brain-Derived Neurotrophic Factor and Indices of Metabolic and Cardiovascular Health: Data from the Baltimore Longitudinal Study of Aging	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; BODY-MASS INDEX; PLASMA-CONCENTRATIONS; FUNCTIONAL MODULES; SURVIVAL FACTOR; HUMAN PLATELETS; SEVERE OBESITY; FACTOR BDNF; IN-VITRO; PROTEIN	Background: Besides its well-established role in nerve cell survival and adaptive plasticity, brain-derived neurotrophic factor (BDNF) is also involved in energy homeostasis and cardiovascular regulation. Although BDNF is present in the systemic circulation, it is unknown whether plasma BDNF correlates with circulating markers of dysregulated metabolism and an adverse cardiovascular profile. Methodology/Principal Findings: To determine whether circulating BDNF correlates with indices of metabolic and cardiovascular health, we measured plasma BDNF levels in 496 middle-age and elderly subjects (mean age similar to 70), in the Baltimore Longitudinal Study of Aging. Linear regression analysis revealed that plasma BDNF is associated with risk factors for cardiovascular disease and metabolic syndrome, regardless of age. In females, BDNF was positively correlated with BMI, fat mass, diastolic blood pressure, total cholesterol, and LDL-cholesterol, and inversely correlated with folate. In males, BDNF was positively correlated with diastolic blood pressure, triglycerides, free thiiodo-thyronine (FT3), and bioavailable testosterone, and inversely correlated with sex-hormone binding globulin, and adiponectin. Conclusion/Significance: Plasma BDNF significantly correlates with multiple risk factors for metabolic syndrome and cardiovascular dysfunction. Whether BDNF contributes to the pathogenesis of these disorders or functions in adaptive responses to cellular stress (as occurs in the brain) remains to be determined.	[Golden, Erin; Mattson, Mark P.] NIA, Cellular & Mol Neurosci Sect, Intramural Res Program, Baltimore, MD 21224 USA; [Emiliano, Ana; Martin, Bronwen] NIA, Metab Unit, Intramural Res Program, Baltimore, MD 21224 USA; [Maudsley, Stuart] NIA, Receptor Pharmacol Unit, Intramural Res Program, Baltimore, MD 21224 USA; [Windham, B. Gwen; Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Clin Res Branch, Intramural Res Program, Baltimore, MD 21224 USA; [Carlson, Olga D.; Egan, Josephine M.] NIA, Diabet Sect, Intramural Res Program, Baltimore, MD 21224 USA; [Driscoll, Ira] NIA, Lab Personal & Cognit, Intramural Res Program, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Golden, E (corresponding author), NIA, Cellular & Mol Neurosci Sect, Intramural Res Program, Baltimore, MD 21224 USA.	martinbro@mail.nih.gov	Maudsley, Stuart/AAV-9929-2021; Maudsley, Stuart/Q-4782-2019; Mattson, Mark P/F-6038-2012	Maudsley, Stuart/0000-0002-1868-184X; Martin, Bronwen/0000-0002-9185-6925	Intramural Research Program of the National Institutes of Health (NIH) [5 T32 DK007751-09]; National Institute on Aging; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000325, ZIAAG000214, ZIAAG000917, ZIAAG000015, ZIAAG000319, ZIAAG000915, ZIAAG000916, ZIAAG000318] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported entirely by the Intramural Research Program of the National Institutes of Health (NIH), National Institute on Aging. Ana Emiliano was supported by grant number NIH 5 T32 DK007751-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barde Y A, 1994, Prog Clin Biol Res, V390, P45; Bariohay B, 2005, ENDOCRINOLOGY, V146, P5612, DOI 10.1210/en.2005-0419; Brady R, 1999, J NEUROSCI, V19, P2131; Byerly MS, 2009, AM J PHYSIOL-REG I, V296, pR1180, DOI 10.1152/ajpregu.90813.2008; Cai DQ, 2006, PHYSIOL GENOMICS, V24, P191, DOI 10.1152/physiolgenomics.00165.2005; Caldwell JD, 2009, HORM METAB RES, V41, P173, DOI 10.1055/s-0028-1093351; Crunkhorn S, 2008, THYROID, V18, P227, DOI 10.1089/thy.2007.0249; Dhillo WS, 2007, THYROID, V17, P433, DOI 10.1089/thy.2007.0018; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; Ejiri J, 2005, CIRCULATION, V112, P2114, DOI 10.1161/CIRCULATIONAHA.104.476903; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flint AJ, 2006, INT J EPIDEMIOL, V35, P187, DOI 10.1093/ije/dyi298; Franzosi MG, 2006, LANCET, V368, P624, DOI 10.1016/S0140-6736(06)69222-2; Fujinami A, 2008, CLIN BIOCHEM, V41, P812, DOI 10.1016/j.clinbiochem.2008.03.003; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Hu R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-20; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ishii S, 2003, NEUROENDOCRINOLOGY, V78, P321, DOI 10.1159/000074885; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Klebanov L, 2006, STAT APPL GENET MOL, V5; Klee GG, 1996, CLIN CHEM, V42, P155; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; Krabbe KS, 2009, J AM GERIATR SOC, V57, P1447, DOI 10.1111/j.1532-5415.2009.02345.x; Kragelund C, 2005, LANCET, V366, P1589, DOI 10.1016/S0140-6736(05)67642-8; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Lapice E, 2009, DIABETES CARE, V32, P1734, DOI 10.2337/dc09-0176; Lindenberger U, 2008, FRONT NEUROSCI-SWITZ, V2, P234, DOI 10.3389/neuro.01.039.2008; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Manni L, 2005, INT J CARDIOL, V102, P169, DOI 10.1016/j.ijcard.2004.10.041; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Matthews VB, 2009, DIABETOLOGIA, V52, P1409, DOI 10.1007/s00125-009-1364-1; Mattson MP, 2004, AGEING RES REV, V3, P445, DOI 10.1016/j.arr.2004.08.001; Merhi ZO, 2009, FERTIL STERIL, V91, P1544, DOI 10.1016/j.fertnstert.2008.09.032; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; Nedvidkova J, 2005, PHYSIOL RES, V54, P133, DOI 10.33549/physiolres.930600; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Rosenbaum M, 1996, J CLIN ENDOCR METAB, V81, P3424, DOI 10.1210/jc.81.9.3424; Schadt EE, 2009, NAT REV DRUG DISCOV, V8, P286, DOI 10.1038/nrd2826; Seifer DB, 2002, J CLIN ENDOCR METAB, V87, P655, DOI 10.1210/jc.87.2.655; SHOCK NW, 1984, NORMAL HUMAN AGING B, V84, P2450; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Spirin V, 2006, P NATL ACAD SCI USA, V103, P8774, DOI 10.1073/pnas.0510258103; Stranahan AM, 2009, HIPPOCAMPUS, V19, P951, DOI 10.1002/hipo.20577; TREMBLAY RR, 1974, CONTRACEPTION, V10, P599, DOI 10.1016/0010-7824(74)90099-7; VERMEULEN A, 1971, J CLIN ENDOCR METAB, V33, P759, DOI 10.1210/jcem-33-5-759; von Mering C, 2003, P NATL ACAD SCI USA, V100, P15428, DOI 10.1073/pnas.2136809100; Wang H, 2002, NEUROSCIENCE, V112, P967, DOI 10.1016/S0306-4522(02)00085-4; Wellens RI, 1996, OBES RES, V4, P35, DOI 10.1002/j.1550-8528.1996.tb00510.x; YAMAMOTO H, 1990, J NEUROSCI, V10, P3469; Yeap BB, 2009, NAT CLIN PRACT ENDOC, V5, P113, DOI 10.1038/ncpendmet1050; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336	60	153	154	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10099	10.1371/journal.pone.0010099	http://dx.doi.org/10.1371/journal.pone.0010099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404913	Green Submitted, gold, Green Published			2022-12-25	WOS:000276482100015
J	Weth, O; Weth, C; Bartkuhn, M; Leers, J; Uhle, F; Renkawitz, R				Weth, Oliver; Weth, Christine; Bartkuhn, Marek; Leers, Joerg; Uhle, Florian; Renkawitz, Rainer			Modular Insulators: Genome Wide Search for Composite CTCF/Thyroid Hormone Receptor Binding Sites	PLOS ONE			English	Article							IMPRINTING CONTROL REGION; ENHANCER-BLOCKING ACTIVITY; C-MYC GENE; CTCF-BINDING; THYROID-HORMONE; PROTEIN CTCF; RESPONSE ELEMENTS; CHROMATIN INSULATOR; BREAST-CANCER; METHYLATION	The conserved 11 zinc-finger protein CTCF is involved in several transcriptional mechanisms, including insulation and enhancer blocking. We had previously identified two composite elements consisting of a CTCF and a TR binding site at the chicken lysozyme and the human c-myc genes. Using these it has been demonstrated that thyroid hormone mediates the relief of enhancer blocking even though CTCF remains bound to its binding site. Here we wished to determine whether CTCF and TR combined sites are representative of a general feature of the genome, and whether such sites are functional in regulating enhancer blocking. Genome wide analysis revealed that about 18% of the CTCF regions harbored at least one of the four different palindromic or repeated sequence arrangements typical for the binding of TR homodimers or TR/RXR heterodimers. Functional analysis of 10 different composite elements of thyroid hormone responsive genes was performed using episomal constructs. The episomal system allowed recapitulating CTCF mediated enhancer blocking function to be dependent on poly (ADP)-ribose modification and to mediate histone deacetylation. Furthermore, thyroid hormone sensitive enhancer blocking could be shown for one of these new composite elements. Remarkably, not only did the regulation of enhancer blocking require functional TR binding, but also the basal enhancer blocking activity of CTCF was dependent on the binding of the unliganded TR. Thus, a number of composite CTCF/TR binding sites may represent a subset of other modular CTCF composite sites, such as groups of multiple CTCF sites or of CTCF/Oct4, CTCF/Kaiso or CTCF/Yy1 combinations.	[Weth, Oliver; Weth, Christine; Bartkuhn, Marek; Leers, Joerg; Uhle, Florian; Renkawitz, Rainer] Univ Giessen, Inst Genet, Giessen, Germany	Justus Liebig University Giessen	Weth, O (corresponding author), Univ Giessen, Inst Genet, Giessen, Germany.	rainer.renkawitz@gen.bio.uni-giessen.de	Uhle, Florian/G-8649-2012; Uhle, Florian/Q-6191-2019	Bartkuhn, Marek/0000-0001-6872-9082	DFG	DFG(German Research Foundation (DFG))	This work was supported by grants from the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Burgess-Beusse B, 2002, P NATL ACAD SCI USA, V99, P16433, DOI 10.1073/pnas.162342499; Burke LJ, 2005, EMBO J, V24, P3291, DOI 10.1038/sj.emboj.7600793; Chan CS, 2008, CANCER RES, V68, P9041, DOI 10.1158/0008-5472.CAN-08-2632; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; De K, 2004, J ENDOCRINOL, V182, P303, DOI 10.1677/joe.0.1820303; Defossez PA, 2005, J BIOL CHEM, V280, P43017, DOI 10.1074/jbc.M510802200; DESVERGNE B, 1994, MOL CELL ENDOCRINOL, V100, P125, DOI 10.1016/0303-7207(94)90291-7; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Eckey M, 2007, MOL CELL BIOL, V27, P3557, DOI 10.1128/MCB.01106-06; Feng X, 2001, J BIOL CHEM, V276, P15066, DOI 10.1074/jbc.M011027200; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Jackson DA, 2003, NUCLEIC ACIDS RES, V31, P1180, DOI 10.1093/nar/gkg217; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kanduri C, 2002, J BIOL CHEM, V277, P18106, DOI 10.1074/jbc.M200031200; Kanduri M, 2002, MOL CELL BIOL, V22, P3339, DOI 10.1128/MCB.22.10.3339-3344.2002; Kim J, 2008, EPIGENETICS-US, V3, P115, DOI 10.4161/epi.3.3.6176; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; LEBEL JM, 1994, P NATL ACAD SCI USA, V91, P2644, DOI 10.1073/pnas.91.7.2644; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Li LP, 2007, BIOINFORMATICS, V23, P1188, DOI 10.1093/bioinformatics/btm080; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lutz M, 2003, EMBO J, V22, P1579, DOI 10.1093/emboj/cdg147; Lutz M, 2000, NUCLEIC ACIDS RES, V28, P1707, DOI 10.1093/nar/28.8.1707; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Majumder P, 2006, J BIOL CHEM, V281, P18435, DOI 10.1074/jbc.M601298200; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; NEGRE N, PLOS GENET, V6; Pant V, 2004, MOL CELL BIOL, V24, P3497, DOI 10.1128/MCB.24.8.3497-3504.2004; PARK EA, 1995, BIOCHEM J, V309, P913, DOI 10.1042/bj3090913; Parnell TJ, 2000, EMBO J, V19, P5864, DOI 10.1093/emboj/19.21.5864; Perez-Juste G, 2000, J BIOL CHEM, V275, P1307, DOI 10.1074/jbc.275.2.1307; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101; SHULEMOVICH K, 1995, NUCLEIC ACIDS RES, V23, P811, DOI 10.1093/nar/23.5.811; Szabo PE, 2006, CYTOGENET GENOME RES, V113, P238, DOI 10.1159/000090838; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Szabo PE, 2004, MOL CELL BIOL, V24, P4858, DOI 10.1128/MCB.24.11.4858-4868.2004; Szabo PE, 2004, MOL CELL BIOL, V24, P4791, DOI 10.1128/MCB.24.11.4791-4800.2004; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Tanimoto K, 2003, MOL CELL BIOL, V23, P8946, DOI 10.1128/MCB.23.24.8946-8952.2003; Torrano V, 2006, J CELL SCI, V119, P1746, DOI 10.1242/jcs.02890; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Zhao H, 2004, NUCLEIC ACIDS RES, V32, P4903, DOI 10.1093/nar/gkh832; ZLATANOVA J, 2009, CELL MOL LIFE SCI; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	64	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10119	10.1371/journal.pone.0010119	http://dx.doi.org/10.1371/journal.pone.0010119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404925	gold, Green Published, Green Submitted			2022-12-25	WOS:000276482100025
J	Rathinakumar, R; Wimley, WC				Rathinakumar, Ramesh; Wimley, William C.			High-throughput discovery of broad-spectrum peptide antibiotics	FASEB JOURNAL			English	Article						antimicrobial peptide; combinatorial chemistry; high-throughput screening; membrane permeabilization	RATIONAL COMBINATORIAL DESIGN; PORE-FORMING PEPTIDES; ANTIMICROBIAL PEPTIDES; DEFENSINS; MEMBRANES	Membrane-permeabilizing peptide antibiotics are an underutilized weapon in the battle against drug-resistant microorganisms. This is true, in part, because of the bottleneck caused by the lack of explicit design principles and the paucity of simple high-throughput methods for selection. In this work, we characterize the requirements for broad-spectrum antimicrobial activity by membrane permeabilization and find that different microbial membranes have very different susceptibilities to permeabilization by individual antimicrobial peptides. Broad-spectrum activity requires only that an AMP have at least a small amount of membrane-permeabilizing activity against multiple classes of microbes, a feature that we show to be rare in a peptide library containing many members with species-specific activity. We compare biological and vesicle-based high-throughput strategies for selecting such broad-spectrum AMPs from combinatorial peptide libraries and demonstrate that a simple in vitro, lipid vesicle-based high-throughput screen is the most effective strategy for rapid discovery of novel, broad-spectrum antimicrobial peptides.-Rathinakumar, R., Wimley, W. C. High-throughput discovery of broad-spectrum peptide antibiotics. FASEB J. 24, 3232-3238 (2010). www.fasebj.org	[Rathinakumar, Ramesh; Wimley, William C.] Tulane Univ, Hlth Sci Ctr, Dept Biochem, New Orleans, LA 70112 USA	Tulane University	Wimley, WC (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Biochem SL43, New Orleans, LA 70112 USA.	wwimley@tulane.edu			U.S. National Institutes of Health [GM060000]; Louisiana Board of Regents Support Fund [RC/EEP-05(2007-10)]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060000] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents Support Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Christopher Bishop for peptide synthesis and purification and William F. Walkenhorst and Paulo F. Almeida for critically reading the manuscript. This work was supported by U.S. National Institutes of Health grant GM060000 and by Louisiana Board of Regents Support Fund grant RC/EEP-05(2007-10).	Almeida PF, 2009, BIOCHEMISTRY-US, V48, P8083, DOI 10.1021/bi900914g; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Bechinger B, 2009, CURR OPIN COLLOID IN, V14, P349, DOI 10.1016/j.cocis.2009.02.004; Easton DM, 2009, TRENDS BIOTECHNOL, V27, P582, DOI 10.1016/j.tibtech.2009.07.004; Gardy JL, 2009, TRENDS IMMUNOL, V30, P249, DOI 10.1016/j.it.2009.03.009; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hong RW, 2003, ANTIMICROB AGENTS CH, V47, P1, DOI 10.1128/AAC.47.1.1-6.2003; Imura Y, 2008, BIOPHYS J, V95, P5757, DOI 10.1529/biophysj.108.133488; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Pittet D, 2008, J HOSP INFECT, V68, P285, DOI 10.1016/j.jhin.2007.12.013; Rathinakumar R, 2008, J AM CHEM SOC, V130, P9849, DOI 10.1021/ja8017863; Rathinakumar R, 2009, J AM CHEM SOC, V131, P7609, DOI 10.1021/ja8093247; Rausch JM, 2005, P NATL ACAD SCI USA, V102, P10511, DOI 10.1073/pnas.0502013102; Rausch JM, 2001, ANAL BIOCHEM, V293, P258, DOI 10.1006/abio.2001.5137; Rausch JM, 2007, BIOCHEMISTRY-US, V46, P12124, DOI 10.1021/bi700978h; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; VANABEL RJ, 1995, INT J PEPT PROT RES, V45, P401; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101	22	48	50	1	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3232	3238		10.1096/fj.10-157040	http://dx.doi.org/10.1096/fj.10-157040			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20410445	Green Published			2022-12-25	WOS:000281446400012
J	Vercruysse, T; Pardon, E; Vanstreels, E; Steyaert, J; Daelemans, D				Vercruysse, Thomas; Pardon, Els; Vanstreels, Els; Steyaert, Jan; Daelemans, Dirk			An Intrabody Based on a Llama Single-domain Antibody Targeting the N-terminal alpha-Helical Multimerization Domain of HIV-1 Rev Prevents Viral Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 REPLICATION; PFIZER MONKEY VIRUS; NUCLEAR EXPORT; FUNCTIONAL-ANALYSIS; STRUCTURAL MODEL; TRANS-ACTIVATOR; PROTEIN; BINDING; RNA; INHIBITION	The human immunodeficiency virus, type 1 (HIV-1)-encoded Rev protein is essential for the expression of late viral mRNAs. Rev forms a large organized multimeric protein-protein complex on the Rev response element of these viral mRNA species and transports them from the nucleus to the cytoplasm, exploiting the CRM1-mediated cellular machinery. Here we report the selection of a nanobody, derived from a llama heavy-chain only antibody, that efficiently blocks the assembly of Rev multimers. The nanobody inhibits HIV-1 replication in cells and specifically suppresses the Rev-dependent expression of partially spliced and unspliced HIV-1 RNA. In HIV-susceptible cells, this nanobody thus has potential as an effective anti-HIV agent using genetic immunization strategies. Its binding site was mapped to Rev residues Lys-20 and Tyr-23 located in the N-terminal alpha-helical multimerization domain. In the presence of this nanobody, we observed an accumulation of dimeric Rev species, supporting a head-to-head/tail-to-tail molecular model for Rev assembly. The results indicate that the oligomeric assembly of Rev follows an ordered stepwise process and identify a new epitope within Rev that could guide strategies for the development of novel HIV inhibitors.	[Vercruysse, Thomas; Vanstreels, Els; Daelemans, Dirk] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel VIB, Struct Biol Brussels Lab, B-1050 Brussels, Belgium; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel VIB, Dept Mol & Cell Interact, B-1050 Brussels, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Daelemans, D (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Minderbroedersstr 10, B-3000 Louvain, Belgium.	dirk.daelemans@rega.kuleuven.be	Vanstreels, Els/I-2366-2018; steyaert, jan/GQP-7811-2022; Vercruysse, Thomas/AAK-8879-2020; Steyaert, Jan/H-4662-2011; Daelemans, Dirk/P-7923-2017	Vanstreels, Els/0000-0002-7814-8035; Steyaert, Jan/0000-0002-3825-874X; Daelemans, Dirk/0000-0001-7092-1153; Vercruysse, Thomas/0000-0002-8649-777X; Pardon, Els/0000-0002-2466-0172	Fonds voor Weteschappelijk Onderzoek-Vlaanderen [1.5.104.07, 1.5.165.10]; Belgian Government [I.A.P. P6/19]; K.U. Leuven Impulsfinanciering	Fonds voor Weteschappelijk Onderzoek-Vlaanderen; Belgian Government; K.U. Leuven Impulsfinanciering	This work was supported by "Fonds voor Weteschappelijk Onderzoek-Vlaanderen" Grants 1.5.104.07 and 1.5.165.10, the Belgian Government under the framework of the Interuniversity Attraction Poles (I.A.P. P6/19), the "Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie," and the "K.U. Leuven Impulsfinanciering."	AUER M, 1994, BIOCHEMISTRY-US, V33, P2988, DOI 10.1021/bi00176a031; Bayer TS, 2005, RNA, V11, P1848, DOI 10.1261/rna.2167605; BEVEC D, 1992, P NATL ACAD SCI USA, V89, P9870, DOI 10.1073/pnas.89.20.9870; Blanco FJ, 2001, J MOL BIOL, V313, P845, DOI 10.1006/jmbi.2001.5067; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; COCHRANE AW, 1990, J VIROL, V64, P881, DOI 10.1128/JVI.64.2.881-885.1990; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Daelemans D, 2005, MOL CELL BIOL, V25, P728, DOI 10.1128/MCB.25.2.728-739.2005; Daelemans D, 2004, J BIOL CHEM, V279, P50167, DOI 10.1074/jbc.M407713200; Daelemans D, 2002, P NATL ACAD SCI USA, V99, P14440, DOI 10.1073/pnas.212285299; DALY TJ, 1989, NATURE, V342, P816, DOI 10.1038/342816a0; Daugherty MD, 2008, MOL CELL, V31, P824, DOI 10.1016/j.molcel.2008.07.016; DAYTON ET, 1989, SCIENCE, V246, P1625, DOI 10.1126/science.2688093; DUAN LX, 1994, P NATL ACAD SCI USA, V91, P5075, DOI 10.1073/pnas.91.11.5075; Fang JH, 2004, VIROLOGY, V330, P471, DOI 10.1016/j.virol.2004.09.039; FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495; Fischer PM, 2004, TRENDS PHARMACOL SCI, V25, P343, DOI 10.1016/j.tips.2004.04.011; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; FISHER AG, 1985, NATURE, V316, P262, DOI 10.1038/316262a0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P343, DOI 10.1089/aid.1994.10.343; HADZOPOULOUCLADARAS M, 1989, J VIROL, V63, P1265, DOI 10.1128/JVI.63.3.1265-1274.1989; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; HOPE TJ, 1990, J VIROL, V64, P5360, DOI 10.1128/JVI.64.11.5360-5366.1990; Jain C, 2001, MOL CELL, V7, P603, DOI 10.1016/S1097-2765(01)00207-6; KALLAND KH, 1994, MOL CELL BIOL, V14, P7436, DOI 10.1128/MCB.14.11.7436; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; Kubota S, 1998, ONCOGENE, V16, P1851, DOI 10.1038/sj.onc.1201738; Lam AY, 2009, J STRUCT BIOL, V166, P8, DOI 10.1016/j.jsb.2008.11.008; MADORE SJ, 1994, VIROLOGY, V202, P186, DOI 10.1006/viro.1994.1334; MALIM MH, 1991, CELL, V65, P241, DOI 10.1016/0092-8674(91)90158-U; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; MANN DA, 1994, J MOL BIOL, V241, P193, DOI 10.1006/jmbi.1994.1488; McNally JG, 2008, METHOD CELL BIOL, V85, P329, DOI 10.1016/S0091-679X(08)85014-5; MEYER BE, 1994, GENE DEV, V8, P1538, DOI 10.1101/gad.8.13.1538; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Pasternak AO, 2008, J CLIN MICROBIOL, V46, P2206, DOI 10.1128/JCM.00055-08; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; POMERANTZ RJ, 1992, J VIROL, V66, P1809, DOI 10.1128/JVI.66.3.1809-1813.1992; Pond SJK, 2009, P NATL ACAD SCI USA, V106, P1404, DOI 10.1073/pnas.0807388106; Smith CA, 2000, MOL CELL, V6, P1067, DOI 10.1016/S1097-2765(00)00105-2; SONIGO P, 1986, CELL, V45, P375, DOI 10.1016/0092-8674(86)90323-5; TAN RY, 1993, CELL, V73, P1031, DOI 10.1016/0092-8674(93)90280-4; Thomas SL, 1998, J VIROL, V72, P2935, DOI 10.1128/JVI.72.4.2935-2944.1998; TILEY LS, 1992, P NATL ACAD SCI USA, V89, P758, DOI 10.1073/pnas.89.2.758; Van Neck T, 2008, BIOORGAN MED CHEM, V16, P9487, DOI 10.1016/j.bmc.2008.09.051; Watts NR, 1998, J STRUCT BIOL, V121, P41, DOI 10.1006/jsbi.1998.3964; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; ZOLOTUKHIN AS, 1994, J VIROL, V68, P7944, DOI 10.1128/JVI.68.12.7944-7952.1994	56	54	60	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21768	21780		10.1074/jbc.M110.112490	http://dx.doi.org/10.1074/jbc.M110.112490			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20406803	Green Published, hybrid			2022-12-25	WOS:000279516100062
J	Fayyad-Kazan, H; Rouas, R; Merimi, M; El Zein, N; Lewalle, P; Jebbawi, F; Mourtada, M; Badran, H; Ezzeddine, M; Salaun, B; Romero, P; Burny, A; Martiat, P; Badran, B				Fayyad-Kazan, Hussein; Rouas, Redouane; Merimi, Makram; El Zein, Nabil; Lewalle, Philippe; Jebbawi, Fadi; Mourtada, Mohamad; Badran, Hussein; Ezzeddine, Mohamad; Salaun, Bruno; Romero, Pedro; Burny, Arsene; Martiat, Philippe; Badran, Bassam			Valproate Treatment of Human Cord Blood CD4-positive Effector T Cells Confers on Them the Molecular Profile (MicroRNA Signature and FOXP3 Expression) of Natural Regulatory CD4-positive Cells through Inhibition of Histone Deacetylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; CHROMATIN-STRUCTURE; TRICHOSTATIN-A; IN-VIVO; ACID; DIFFERENTIATION; INDUCTION; APOPTOSIS; TARGET; GROWTH	Regulatory T cells (Tregs) play a key role in immune system homeostasis and tolerance to antigens, thereby preventing autoimmunity, and may be partly responsible for the lack of an appropriate immune response against tumor cells. Although not sufficient, a high expression of forkhead box P3 (FOXP3) is necessary for their suppressive function. Recent reports have shown that histones deacetylase inhibitors increased FOXP3 expression in T cells. We therefore decided to investigate in non-Tregs CD4-positive cells, the mechanisms by which an aspecific opening of the chromatin could lead to an increased FOXP3 expression. We focused on binding of potentially activating transcription factors to the promoter region of FOXP3 and on modifications in the five miRs constituting the Tregs signature. Valproate treatment induced binding of Ets-1 and Ets-2 to the FOXP3 promoter and acted positively on its expression, by increasing the acetylation of histone H4 lysines. Valproate treatment also induced the acquisition of the miRs Tregs signature. To elucidate whether the changes in the miRs expression could be due to the increased FOXP3 expression, we transduced these non-Tregs with a FOXP3 lentiviral expression vector, and found no changes in miRs expression. Therefore, the modification in their miRs expression profile is not due to an increased expression of FOXP3 but directly results from histones deacetylase inhibition. Rather, the increased FOXP3 expression results from the additive effects of Ets factors binding and the change in expression level of miR-21 and miR-31. We conclude that valproate treatment of human non-Tregs confers on them a molecular profile similar to that of their regulatory counterpart.	[Martiat, Philippe] Univ Libre Bruxelles, Dept Expt Hematol, Inst Jules Bordet, Lab Expt Hematol, B-1000 Brussels, Belgium; [Mourtada, Mohamad; Ezzeddine, Mohamad; Badran, Bassam] Lebanese Univ, Fac Sci, Dept Biochem, Immunol Lab, Hadath Beirut 657314, Lebanon; [Salaun, Bruno; Romero, Pedro] Ludwig Inst Canc Res, Div Clin Oncoimmunol, Lausanne Branch, CH-1005 Lausanne, Switzerland	Institut Jules Bordet; Universite Libre de Bruxelles; Lebanese University; Ludwig Institute for Cancer Research	Martiat, P (corresponding author), Univ Libre Bruxelles, Dept Expt Hematol, Inst Jules Bordet, Lab Expt Hematol, 121 Blvd Waterloo, B-1000 Brussels, Belgium.	pmartiat@ulb.ac.be	Romero, Pedro/S-6015-2017; Jebbawi, Fadi/AAD-6063-2020	Romero, Pedro/0000-0002-9688-2882; Fayyad-Kazan, Hussein/0000-0002-3465-4630; el zein, nabil/0000-0002-8596-5359	Belgian Fonds National de la Recherche Scientifique (Televie); MEDIC Foundation; International Brachet Stiftung; les Amis de l'Institut Bordet; Van Buuren and Hoguet Foundations; Lebanese University; Lambeau-Marteaux Foundation.	Belgian Fonds National de la Recherche Scientifique (Televie)(Fonds de la Recherche Scientifique - FNRS); MEDIC Foundation; International Brachet Stiftung; les Amis de l'Institut Bordet; Van Buuren and Hoguet Foundations; Lebanese University; Lambeau-Marteaux Foundation.	This work was supported in part by grants from the Belgian Fonds National de la Recherche Scientifique (Televie), the MEDIC Foundation, The International Brachet Stiftung, les Amis de l'Institut Bordet, the Van Buuren and Hoguet Foundations, the Lebanese University, and the Lambeau-Marteaux Foundation.	Abbas-Terki T, 2002, HUM GENE THER, V13, P2197, DOI 10.1089/104303402320987888; Achachi A, 2005, P NATL ACAD SCI USA, V102, P10309, DOI 10.1073/pnas.0504248102; Acharya MR, 2005, MOL PHARMACOL, V68, P917, DOI 10.1124/mol.105.014167; Arinze IJ, 2003, J BIOL CHEM, V278, P17785, DOI 10.1074/jbc.M209430200; Bacchetta R, 2007, J ALLERGY CLIN IMMUN, V120, P227, DOI 10.1016/j.jaci.2007.06.023; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Chatila TA, 2005, J ALLERGY CLIN IMMUN, V116, P949, DOI 10.1016/j.jaci.2005.08.047; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cinatl J, 1997, ANTI-CANCER DRUG, V8, P958, DOI 10.1097/00001813-199711000-00007; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Colter DC, 2005, MATRIX BIOL, V24, P185, DOI 10.1016/j.matbio.2005.04.001; Costello JF, 2003, FRONT BIOSCI, V8, pS175, DOI 10.2741/1027; Dejaco C, 2006, IMMUNOLOGY, V117, P289, DOI 10.1111/j.1365-2567.2005.02317.x; Detich N, 2003, J BIOL CHEM, V278, P27586, DOI 10.1074/jbc.M303740200; Drucker L, 2006, CARCINOGENESIS, V27, P197, DOI 10.1093/carcin/bgi209; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Herold C, 2002, J HEPATOL, V36, P233, DOI 10.1016/S0168-8278(01)00257-4; Holmen N, 2007, NEUROGASTROENT MOTIL, V19, P119, DOI 10.1111/j.1365-2982.2006.00878.x; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Kim YB, 1999, ANN NY ACAD SCI, V886, P200, DOI 10.1111/j.1749-6632.1999.tb09416.x; Lucas JL, 2009, CELL IMMUNOL, V257, P97, DOI 10.1016/j.cellimm.2009.03.004; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Marchion DC, 2005, CANCER RES, V65, P3815, DOI 10.1158/0008-5472.CAN-04-2478; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Munster PN, 2001, CANCER RES, V61, P8492; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nguyen LT, 2007, ARTHRITIS RHEUM-US, V56, P509, DOI 10.1002/art.22272; Olsen CM, 2004, MOL CELL ENDOCRINOL, V213, P173, DOI 10.1016/j.mce.2003.10.032; Park HB, 2004, INT IMMUNOL, V16, P1203, DOI 10.1093/intimm/dxh123; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Qiu L, 1999, BRIT J CANCER, V80, P1252, DOI 10.1038/sj.bjc.6690493; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sakajiri S, 2005, EXP HEMATOL, V33, P53, DOI 10.1016/j.exphem.2004.09.008; Sands SA, 2000, NEUROPSYCHOPHARMACOL, V22, P27, DOI 10.1016/S0893-133X(99)00072-X; Schramm C, 2004, INT IMMUNOL, V16, P1241, DOI 10.1093/intimm/dxh126; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sugiyama H, 2005, J IMMUNOL, V174, P164, DOI 10.4049/jimmunol.174.1.164; Suzuki T, 2000, INT J CANCER, V88, P992, DOI 10.1002/1097-0215(20001215)88:6<992::AID-IJC24>3.0.CO;2-9; Tang R, 2004, LEUKEMIA, V18, P1246, DOI 10.1038/sj.leu.2403390; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Verhagen J, 2006, J ALLERGY CLIN IMMUN, V117, P176, DOI 10.1016/j.jaci.2005.10.040; Yamashita Y, 2003, INT J CANCER, V103, P572, DOI 10.1002/ijc.10699; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	56	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20481	20491		10.1074/jbc.M110.119628	http://dx.doi.org/10.1074/jbc.M110.119628			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20427269	hybrid, Green Published			2022-12-25	WOS:000279228600008
J	Krautwald, S; Ziegler, E; Rolver, L; Linkermann, A; Keyser, KA; Steen, P; Wollert, KC; Korf-Klingebiel, M; Kunzendorf, U				Krautwald, Stefan; Ziegler, Ekkehard; Roelver, Lars; Linkermann, Andreas; Keyser, Kirsten A.; Steen, Philip; Wollert, Kai C.; Korf-Klingebiel, Mortimer; Kunzendorf, Ulrich			Effective Blockage of Both the Extrinsic and Intrinsic Pathways of Apoptosis in Mice by TAT-crmA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-ISCHEMIA; CASPASE INHIBITOR; IN-VIVO; DEATH; FAS; HEART; PROTEIN; TRANSDUCTION; REPERFUSION; ACTIVATION	Evidence accumulates that in clinically relevant cell death, both the intrinsic and extrinsic apoptotic pathway synergistically contribute to organ failure. In search for an inhibitor of apoptosis that provides effective blockage of these pathways, we analyzed viral proteins that evolved to protect the infected host cells. In particular, the cowpox virus protein crmA has been demonstrated to be capable of blocking key caspases of both pro-apoptotic pathways. To deliver crmA into eukaryotic cells, we fused the TAT protein transduction domain of HIV to the N terminus of crmA. In vitro, the TAT-crmA fusion protein was efficiently translocated into target cells and inhibited apoptosis mediated through caspase-8, caspase-9, and caspase-3 after stimulation with alpha-Fas, etoposide, doxorubicin, or staurosporine. The extrinsic apoptotic pathway was investigated following alpha-Fas stimulation. In vivo 90% of TAT-crmA-treated animals survived an otherwise lethal dose of alpha-Fas and showed protection from Fas-induced organ failure. To examine the intrinsic apoptotic pathway, we investigated the survival of mice treated with an otherwise lethal dose of doxorubicin. Whereas all control mice died within 31 days, 40% of mice that concomitantly received intraperitoneal injections of TAT-crmA survived. To test the ability to comprehensively block both the intrinsic and extrinsic apoptotic pathway in a clinically relevant setting, we employed a murine cardiac ischemia-reperfusion model. TAT-crmA reduced infarction size by 40% and preserved left ventricular function. In summary, these results provide a proof of principle for the inhibition of apoptosis with TAT-crmA, which might provide a new treatment option for ischemia-reperfusion injuries.	[Kunzendorf, Ulrich] Univ Kiel, Div Nephrol & Hypertens, D-24105 Kiel, Germany; [Wollert, Kai C.; Korf-Klingebiel, Mortimer] Hannover Med Sch, Dept Cardiol & Angiol, D-30625 Hannover, Germany	University of Kiel; Hannover Medical School	Kunzendorf, U (corresponding author), Univ Kiel, Div Nephrol & Hypertens, Schittenhelmstr 12, D-24105 Kiel, Germany.	kunzendorf@nephro.uni-kiel.de	Kunzendorf, Ulrich/A-8257-2010; Linkermann, Andreas/AAB-8308-2020; Krautwald, Stefan/J-9984-2016; Linkermann, Andreas/H-3551-2012	Linkermann, Andreas/0000-0001-6287-9725; Krautwald, Stefan/0000-0001-7768-2132; Linkermann, Andreas/0000-0001-6287-9725				Bhuiyan MS, 2008, CARDIOVASC THER, V26, P10, DOI 10.1111/j.1527-3466.2008.00039.x; BRAUNWALD E, 1989, CIRCULATION, V79, P441, DOI 10.1161/01.CIR.79.2.441; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; Gomez L, 2005, AM J PHYSIOL-HEART C, V289, pH2153, DOI 10.1152/ajpheart.00165.2005; Gustafsson AB, 2008, CARDIOVASC RES, V77, P334, DOI 10.1093/cvr/cvm005; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kilic E, 2007, BRAIN RES, V1185, P293, DOI 10.1016/j.brainres.2007.09.031; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Krautwald S, 2004, J BIOL CHEM, V279, P44005, DOI 10.1074/jbc.M401327200; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Li YW, 2004, CIRC RES, V95, P627, DOI 10.1161/01.RES.0000141528.54850.bd; Martin-Villalba A, 2001, CELL DEATH DIFFER, V8, P679, DOI 10.1038/sj.cdd.4400882; Meldrum DR, 1998, AM J PHYSIOL-REG I, V274, pR577, DOI 10.1152/ajpregu.1998.274.3.R577; MIURA M, 1995, P NATL ACAD SCI USA, V92, P8318, DOI 10.1073/pnas.92.18.8318; Nogae S, 1998, J AM SOC NEPHROL, V9, P620; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Rabuffetti M, 2000, J NEUROSCI, V20, P4398, DOI 10.1523/JNEUROSCI.20-12-04398.2000; Rudiger HA, 2002, GASTROENTEROLOGY, V122, P202, DOI 10.1053/gast.2002.30304; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Shelton SN, 2009, J BIOL CHEM, V284, P11247, DOI 10.1074/jbc.M809392200; Suliman HB, 2007, J CLIN INVEST, V117, P3730, DOI 10.1172/JCI32967; Sung JH, 2007, NEUROSCIENCE, V149, P804, DOI 10.1016/j.neuroscience.2007.07.030; TANAKA M, 1994, CIRC RES, V75, P426, DOI 10.1161/01.RES.75.3.426; TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255; Toro A, 2006, J CLIN INVEST, V116, P2717, DOI 10.1172/JCI25052; Wiessner C, 2000, CELL MOL BIOL, V46, P53	31	27	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19997	20005		10.1074/jbc.M110.122127	http://dx.doi.org/10.1074/jbc.M110.122127			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427266	Green Published, hybrid			2022-12-25	WOS:000279012000033
J	Voorhees, JL; Brooks, CL				Voorhees, Jeffery L.; Brooks, Charles L.			Obligate Ordered Binding of Human Lactogenic Cytokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GROWTH-HORMONE; HUMAN PLACENTAL-LACTOGEN; HUMAN PROLACTIN; RECEPTOR-BINDING; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; DISULFIDE BONDS; NB2 CELLS; PROTEIN; SITES	Class 1 cytokines bind two receptors to create an active heterotrimeric complex. It has been argued that ligand binding to their receptors is an ordered process, but a structural mechanism describing this process has not been determined. We have previously described an obligate ordered binding mechanism for the human prolactin/prolactin receptor heterotrimeric complex. In this work we expand this conceptual understanding of ordered binding to include three human lactogenic hormones: prolactin, growth hormone, and placental lactogen. We independently blocked either of the two receptor binding sites of each hormone and used surface plasmon resonance to measure human prolactin receptor binding kinetics and stoichiometries to the remaining binding surface. When site 1 of any of the three hormones was blocked, site 2 could not bind the receptor. But blocking site 2 did not affect receptor binding at site 1, indicating a requirement for receptor binding to site 1 before site 2 binding. In addition we noted variable responses to the presence of zinc in hormone-receptor interaction. Finally, we performed Forster resonance energy transfer (FRET) analyses where receptor binding at subsaturating stoichiometries induced changes in FRET signaling, indicative of binding-induced changes in hormone conformation, whereas at receptor: hormone ratios in excess of 2:1 no additional changes in FRET signaling were observed. These results strongly support a conformationally mediated obligate-ordered receptor binding for each of the three lactogenic hormones.	[Voorhees, Jeffery L.; Brooks, Charles L.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Voorhees, Jeffery L.] Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Brooks, Charles L.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Brooks, Charles L.] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Brooks, CL (corresponding author), Ohio State Univ, Ohio State Biochem Program, 1925 Coffey Rd, Columbus, OH 43210 USA.	brooks.8@osu.edu			National Institutes of Health [R01-DK72275]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK72275.	Bernat B, 2003, P NATL ACAD SCI USA, V100, P952, DOI 10.1073/pnas.0235023100; BEWLEY TA, 1969, INT J PROT RES, V1, P117; Chen WY, 1999, CLIN CANCER RES, V5, P3583; CUNNINGHAM BC, 1990, SCIENCE, V250, P1709, DOI 10.1126/science.2270485; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DATTANI MT, 1995, J BIOL CHEM, V270, P9222, DOI 10.1074/jbc.270.16.9222; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DONEEN BA, 1979, BIOCHEMISTRY-US, V18, P4851, DOI 10.1021/bi00589a013; Duda KM, 2003, PROTEIN ENG, V16, P531, DOI 10.1093/protein/gzg067; Duda KM, 2003, J BIOL CHEM, V278, P22734, DOI 10.1074/jbc.M212550200; Duda KM, 1999, FEBS LETT, V449, P120, DOI 10.1016/S0014-5793(99)00416-0; FORSYTH IA, 1986, J DAIRY SCI, V69, P886, DOI 10.3168/jds.S0022-0302(86)80479-9; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; GOFFIN V, 1994, J BIOL CHEM, V269, P32598; HOOPER KP, 1993, J BIOL CHEM, V268, P22347; Huising MO, 2006, J ENDOCRINOL, V189, P1, DOI 10.1677/joe.1.06591; Jomain JB, 2007, J BIOL CHEM, V282, P33118, DOI 10.1074/jbc.M704364200; Keeler C, 2003, J MOL BIOL, V328, P1105, DOI 10.1016/S0022-2836(03)00367-X; Kinet S, 1999, J BIOL CHEM, V274, P26033, DOI 10.1074/jbc.274.37.26033; Kossiakoff AA, 2004, ADV PROTEIN CHEM, V68, P147; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LEBRUN JJ, 1994, J BIOL CHEM, V269, P14021; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LOWMAN HB, 1991, J BIOL CHEM, V266, P10982; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Permyakov EA, 1997, FEBS LETT, V405, P273, DOI 10.1016/S0014-5793(97)00203-2; Peterson FC, 1999, PROTEIN EXPRES PURIF, V15, P16, DOI 10.1006/prep.1998.0984; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5467; Schiffer C, 2002, J MOL BIOL, V316, P277, DOI 10.1006/jmbi.2001.5348; Sivaprasad U, 2004, BIOCHEMISTRY-US, V43, P13755, DOI 10.1021/bi049333p; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; Svensson LA, 2008, J BIOL CHEM, V283, P19085, DOI 10.1074/jbc.M801202200; Teilum K, 2005, J MOL BIOL, V351, P810, DOI 10.1016/j.jmb.2005.06.042; UIVAPRASAD U, 2003, THESIS OHIO STATE U; Walsh STR, 2006, J MOL BIOL, V358, P773, DOI 10.1016/j.jmb.2006.02.038; Walsh STR, 2004, P NATL ACAD SCI USA, V101, P17078, DOI 10.1073/pnas.0403336101; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03	39	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20022	20030		10.1074/jbc.M109.084988	http://dx.doi.org/10.1074/jbc.M109.084988			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427283	Green Published, hybrid			2022-12-25	WOS:000279012000036
J	Cornea, RL; Nitu, FR; Samso, M; Thomas, DD; Fruen, BR				Cornea, Razvan L.; Nitu, Florentin R.; Samso, Montserrat; Thomas, David D.; Fruen, Bradley R.			Mapping the Ryanodine Receptor FK506-binding Protein Subunit Using Fluorescence Resonance Energy Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; POLYMORPHIC VENTRICULAR-TACHYCARDIA; FK-506 BINDING-PROTEIN; SKELETAL-MUSCLE; FKBP12.6 BINDING; CALMODULIN; VISUALIZATION; LOCATIONS; INSIGHTS; REGION	The 12-kDa FK506-binding proteins (FKBP12 and FKBP12.6) are regulatory subunits of ryanodine receptor (RyR) Ca2+ release channels. To investigate the structural basis of FKBP interactions with the RyR1 and RyR2 isoforms, we used site-directed fluorescent labeling of FKBP12.6, ligand binding measurements, and fluorescence resonance energy transfer (FRET). Single-cysteine substitutions were introduced at five positions distributed over the surface of FKBP12.6. Fluorescent labeling at position 14, 32, 49, or 85 did not affect high affinity binding to the RyR1. By comparison, fluorescent labeling at position 41 reduced the affinity of FKBP12.6 binding by 10-fold. Each of the five fluorescent FKBPs retained the ability to inhibit [3H]ryanodine binding to the RyR1, although the maximal extent of inhibition was reduced by half when the label was attached at position 32. The orientation of FKBP12.6 bound to the RyR1 and RyR2 was examined by measuring FRET from the different labeling positions on FKBP12.6 to an acceptor attached within the RyR calmodulin subunit. FRET was dependent on the position of fluorophore attachment on FKBP12.6; however, for any given position, the distance separating donors and acceptors bound to RyR1 versus RyR2 did not differ significantly. Our results show that FKBP12.6 binds to RyR1 and RyR2 in the same orientation and suggest new insights into the discrete structural domains responsible for channel binding and inhibition. FRET mapping of RyR-bound FKBP12.6 is consistent with the predictions of a previous cryoelectron microscopy study and strongly supports the proposed structural model	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Samso, Montserrat] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Brigham & Women's Hospital	Fruen, BR (corresponding author), 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	fruen001@umn.edu	Thomas, David D/B-4257-2012	Nitu, Florentin/0000-0001-9768-6333; Samso, Montserrat/0000-0002-2788-3283; Thomas, David D./0000-0002-8822-2040; Cornea, Razvan/0000-0001-5739-0992	National Institutes of Health [R01HL076433, R01GM27906, R01HL092097]; BWH Biomedical Research Institute Fund to Sustain Research Excellence; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092097, R01HL076433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027906] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BWH Biomedical Research Institute Fund to Sustain Research Excellence; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL076433 (to B.R.F.) and R01GM27906 (to D.D.T.).This work was also supported by a subcontract (to R.L.C.) from National Institutes of Health Grant R01HL092097 (to D.M.Bers, University of California, Davis, CA) and the BWH Biomedical Research Institute Fund to Sustain Research Excellence (to M.S.).	Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Aracena P, 2005, ANTIOXID REDOX SIGN, V7, P870, DOI 10.1089/ars.2005.7.870; Barg S, 1997, AM J PHYSIOL-CELL PH, V272, pC1726, DOI 10.1152/ajpcell.1997.272.5.C1726; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Bers DM, 2004, J MOL CELL CARDIOL, V37, P417, DOI 10.1016/j.yjmcc.2004.05.026; Bers Donald M, 2006, Biochem J, V396, pe1; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Cornea RL, 2009, P NATL ACAD SCI USA, V106, P6128, DOI 10.1073/pnas.0813010106; CRYAN J, 1991, BIOCHEM BIOPH RES CO, V180, P846, DOI 10.1016/S0006-291X(05)81142-8; Deivanayagam CCS, 2000, ACTA CRYSTALLOGR D, V56, P266, DOI 10.1107/S0907444999016571; Fruen BR, 2005, BIOCHEMISTRY-US, V44, P278, DOI 10.1021/bi048246u; Fruen BR, 2003, BIOCHEMISTRY-US, V42, P2740, DOI 10.1021/bi0267689; GUO T, 2010, CIRC RES IN PRESS; Hamilton SL, 2009, J BIOL CHEM, V284, P4047, DOI 10.1074/jbc.R800054200; HAUGLAND R, 2005, HDB GUIDE FLUORESCEN, P23; HOLZMAN TF, 1991, J BIOL CHEM, V266, P2474; Huang FN, 2006, P NATL ACAD SCI USA, V103, P3456, DOI 10.1073/pnas.0511282103; Lee EH, 2004, J BIOL CHEM, V279, P26481, DOI 10.1074/jbc.M309574200; Lehnart SE, 2004, CIRCULATION, V109, P3208, DOI 10.1161/01.CIR.0000132472.98675.EC; Liu N, 2006, CIRC RES, V99, P292, DOI 10.1161/01.RES.0000235869.50747.e1; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; MAYRLEITNER M, 1994, CELL CALCIUM, V15, P99, DOI 10.1016/0143-4160(94)90048-5; Meng X, 2007, J BIOL CHEM, V282, P25929, DOI 10.1074/jbc.M704474200; PARK ST, 1992, J BIOL CHEM, V267, P3316; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qi Y, 1998, J BIOL CHEM, V273, P34813, DOI 10.1074/jbc.273.52.34813; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; Seidler T, 2007, CIRC RES, V101, P1020, DOI 10.1161/CIRCRESAHA.107.154609; Serysheva II, 2008, P NATL ACAD SCI USA, V105, P9610, DOI 10.1073/pnas.0803189105; Sharma MR, 2006, BIOPHYS J, V90, P164, DOI 10.1529/biophysj.105.063503; Wagenknecht T, 1997, J BIOL CHEM, V272, P32463, DOI 10.1074/jbc.272.51.32463; Wagenknecht T, 2002, FRONT BIOSCI, V7, pD1464, DOI 10.2741/wagen; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Xiao JM, 2007, J BIOL CHEM, V282, P34828, DOI 10.1074/jbc.M707423200; Xin HB, 1999, J BIOL CHEM, V274, P15315, DOI 10.1074/jbc.274.22.15315; Zissimofolilos S, 2009, BIOCHEM J, V419, P273, DOI 10.1042/BJ20082324; Zissimopoulos S, 2007, J BIOL CHEM, V282, P6976, DOI 10.1074/jbc.M607590200	39	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19219	19226		10.1074/jbc.M109.066944	http://dx.doi.org/10.1074/jbc.M109.066944			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404344	Green Published, hybrid			2022-12-25	WOS:000278727800031
J	Tapia, VE; Nicolaescu, E; McDonald, CB; Musi, V; Oka, T; Inayoshi, Y; Satteson, AC; Mazack, V; Humbert, J; Gaffney, CJ; Beullens, M; Schwartz, CE; Landgraf, C; Volkmer, R; Pastore, A; Farooq, A; Bollen, M; Sudol, M				Tapia, Victor E.; Nicolaescu, Emilia; McDonald, Caleb B.; Musi, Valeria; Oka, Tsutomu; Inayoshi, Yujin; Satteson, Adam C.; Mazack, Virginia; Humbert, Jasper; Gaffney, Christian J.; Beullens, Monique; Schwartz, Charles E.; Landgraf, Christiane; Volkmer, Rudolf; Pastore, Annalisa; Farooq, Amjad; Bollen, Mathieu; Sudol, Marius			Y65C Missense Mutation in the WW Domain of the Golabi-Ito-Hall Syndrome Protein PQBP1 Affects Its Binding Activity and Deregulates Pre-mRNA Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYGLUTAMINE TRACT-BINDING; LINKED MENTAL-RETARDATION; CARBOXYL-TERMINAL DOMAIN; YES-ASSOCIATED PROTEIN; RENPENNING SYNDROME; POLYMERASE-II; GENE PQBP1; TRANSCRIPTION; MECHANISM; LIGAND	The PQBP1 (polyglutamine tract-binding protein 1) gene encodes a nuclear protein that regulates pre-mRNA splicing and transcription. Mutations in the PQBP1 gene were reported in several X chromosome-linked mental retardation disorders including Golabi-Ito-Hall syndrome. The missense mutation that causes this syndrome is unique among other PQBP1 mutations reported to date because it maps within a functional domain of PQBP1, known as the WW domain. The mutation substitutes tyrosine 65 with cysteine and is located within the conserved core of aromatic amino acids of the domain. We show here that the binding property of the Y65C-mutated WW domain and the full-length mutant protein toward its cognate proline-rich ligands was diminished. Furthermore, in Golabi-Ito-Hall-derived lymphoblasts we showed that the complex between PQBP1-Y65C and WBP11 (WW domain-binding protein 11) splicing factor was compromised. In these cells a substantial decrease in pre-mRNA splicing efficiency was detected. Our study points to the critical role of the WW domain in the function of the PQBP1 protein and provides an insight into the molecular mechanism that underlies the X chromosome-linked mental retardation entities classified globally as Renpenning syndrome.	[Tapia, Victor E.; Landgraf, Christiane; Volkmer, Rudolf] Charite, Inst Med Immunol, D-10115 Berlin, Germany; [Nicolaescu, Emilia; Beullens, Monique; Bollen, Mathieu] Univ Louvain, Dept Mol Cell Biol, B-3000 Louvain, Belgium; [McDonald, Caleb B.; Farooq, Amjad] Univ Miami, Dept Biochem & Mol Biol, Leonard Miller Sch Med, Miami, FL 33136 USA; [McDonald, Caleb B.; Farooq, Amjad] Univ Miami, Leonard Miller Sch Med, UMSylvester Braman Family Breast Canc Inst, Miami, FL 33136 USA; [Musi, Valeria; Pastore, Annalisa] Natl Inst Med Res, Dept Mol Struct, London NW7 1AA, England; [Oka, Tsutomu; Inayoshi, Yujin; Satteson, Adam C.; Mazack, Virginia; Humbert, Jasper; Gaffney, Christian J.; Sudol, Marius] Weis Ctr Res, Lab Signal Transduct & Prote Profiling, Danville, PA 17822 USA; [Schwartz, Charles E.] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; [Sudol, Marius] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Miami; University of Miami; MRC National Institute for Medical Research; Greenwood Genetic Center; Icahn School of Medicine at Mount Sinai	Sudol, M (corresponding author), Weis Ctr Res, Geisinger Clin, Lab 202, 100 N Acad Ave, Danville, PA 17822 USA.	msudol1@geisinger.edu	Farooq, Amjad/B-5084-2012	Volkmer, Rudolf/0000-0003-4710-1143	National Institutes of Health [T32-CA119929, R01-GM083897, HD26202]; NICHD; Deutsche Forschungsgemeinschaft [SFB 449]; UMSylvester Braman Family Breast Cancer Institute; Medical Research Council [U117584256]; Concerted Research Action and the Fund for Scientific Research-Flanders [G.0670.09N, KAN1.5.101.07]; Geisinger Clinic; Medical Research Council [MC_U117533887, MC_U117584256] Funding Source: researchfish; MRC [MC_U117584256, MC_U117533887] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA119929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UMSylvester Braman Family Breast Cancer Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Concerted Research Action and the Fund for Scientific Research-Flanders(FWO); Geisinger Clinic; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32-CA119929 (to C. B. M.), R01-GM083897 (to A. F.), and HD26202, NICHD (to C. E. S.). This work was also supported by Deutsche Forschungsgemeinschaft Grant SFB 449 (to V. T.), by the UMSylvester Braman Family Breast Cancer Institute (to A. F.), by Medical Research Council Grant U117584256 (to A. P.), by Concerted Research Action and the Fund for Scientific Research-Flanders Grants G.0670.09N and KAN1.5.101.07 (to M. B.), and by the Geisinger Clinic (to M. S.).	Bienkiewicz EA, 2000, J MOL BIOL, V297, P119, DOI 10.1006/jmbi.2000.3545; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chang A, 2000, J BIOL CHEM, V275, P20562, DOI 10.1074/jbc.M002479200; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cossee M, 2006, EUR J HUM GENET, V14, P418, DOI 10.1038/sj.ejhg.5201593; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Enokido Y, 2002, BIOCHEM BIOPH RES CO, V294, P268, DOI 10.1016/S0006-291X(02)00477-1; Fairbrother W, 2008, BIOESSAYS, V30, P1, DOI 10.1002/bies.20696; Fernandez-Escamilla AM, 2006, PROTEIN SCI, V15, P2278, DOI 10.1110/ps.062186506; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Gavva NR, 1997, J BIOL CHEM, V272, P24105, DOI 10.1074/jbc.272.39.24105; Gibson TJ, 2009, TRENDS BIOCHEM SCI, V34, P471, DOI 10.1016/j.tibs.2009.06.007; Gregersen N, 2000, J INHERIT METAB DIS, V23, P441, DOI 10.1023/A:1005663728291; Guo F, 2007, MOL BIOTECHNOL, V36, P38, DOI 10.1007/s12033-007-0018-0; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Ito H, 2009, HUM MOL GENET, V18, P4239, DOI 10.1093/hmg/ddp378; Jager M, 2009, PROTEIN SCI, V18, P1806, DOI 10.1002/pro.172; Jiang Y, 2008, INT J BIOCHEM CELL B, V40, P776, DOI 10.1016/j.biocel.2007.10.022; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Kalscheuer VM, 2003, NAT GENET, V35, P313, DOI 10.1038/ng1264; Kato Y, 2004, J BIOL CHEM, V279, P31833, DOI 10.1074/jbc.M404719200; Kleefstra T, 2004, CLIN GENET, V66, P318, DOI 10.1111/j.1399-0004.2004.00308.x; Koepf EK, 1999, BIOCHEMISTRY-US, V38, P14338, DOI 10.1021/bi991105l; Komuro A, 1999, NUCLEIC ACIDS RES, V27, P1957, DOI 10.1093/nar/27.9.1957; Komuro A, 1999, J BIOL CHEM, V274, P36513, DOI 10.1074/jbc.274.51.36513; Lappalainen K, 2008, PROTEINS, V72, P779, DOI 10.1002/prot.21970; Lenski C, 2004, AM J HUM GENET, V74, P777, DOI 10.1086/383205; Llorian M, 2005, J BIOL CHEM, V280, P38862, DOI 10.1074/jbc.M509185200; Llorian M, 2004, BIOCHEM J, V378, P229, DOI 10.1042/BJ20030950; Lubs H, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037556; Macias MJ, 2000, NAT STRUCT BIOL, V7, P375, DOI 10.1038/75144; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Martinez-Garay I, 2007, EUR J HUM GENET, V15, P29, DOI 10.1038/sj.ejhg.5201717; Musante L, 2010, HUM MUTAT, V31, P90, DOI 10.1002/humu.21146; Nasim MT, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf108; Nicolaescu E, 2008, EUR J CELL BIOL, V87, P817, DOI 10.1016/j.ejcb.2008.05.001; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Okazawa H, 2001, BRAIN RES BULL, V56, P273, DOI 10.1016/S0361-9230(01)00579-2; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Okuda T, 2003, HUM MOL GENET, V12, P711, DOI 10.1093/hmg/ddg084; Petrovich M, 2006, J MOL BIOL, V360, P865, DOI 10.1016/j.jmb.2006.05.050; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Stevenson RE, 2005, AM J MED GENET A, V134A, P415, DOI 10.1002/ajmg.a.30664; Strickland E H, 1974, CRC Crit Rev Biochem, V2, P113, DOI 10.3109/10409237409105445; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; SUDOL M, 2005, WW DOMAIN MODULAR PR, P59; Tsuji S, 1999, Adv Neurol, V79, P399; Volkmer R, 2009, CHEMBIOCHEM, V10, P1431, DOI 10.1002/cbic.200900078; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Waragai M, 2000, BIOCHEM BIOPH RES CO, V273, P592, DOI 10.1006/bbrc.2000.2992; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xu D, 2002, DEV CELL, V2, P251, DOI 10.1016/S1534-5807(02)00132-6; Yoshimura N, 2006, FEBS LETT, V580, P2335, DOI 10.1016/j.febslet.2006.03.056; Yu JH, 2009, DEV DYNAM, V238, P2471, DOI 10.1002/dvdy.22063; Zhang YZ, 2000, GENE, V257, P33, DOI 10.1016/S0378-1119(00)00372-3	61	45	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19391	19401		10.1074/jbc.M109.084525	http://dx.doi.org/10.1074/jbc.M109.084525			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410308	hybrid, Green Published			2022-12-25	WOS:000278727800050
J	Illuzzi, G; Bernacchioni, C; Aureli, M; Prioni, S; Frera, G; Donati, C; Valsecchi, M; Chigorno, V; Bruni, P; Sonnino, S; Prinetti, A				Illuzzi, Giuditta; Bernacchioni, Caterina; Aureli, Massimo; Prioni, Simona; Frera, Gianluca; Donati, Chiara; Valsecchi, Manuela; Chigorno, Vanna; Bruni, Paola; Sonnino, Sandro; Prinetti, Alessandro			Sphingosine Kinase Mediates Resistance to the Synthetic Retinoid N-(4-Hydroxyphenyl)retinamide in Human Ovarian Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; GLUCOSYLCERAMIDE SYNTHASE; SPHINGOLIPID METABOLISM; SPHINGOSINE-1-PHOSPHATE RECEPTOR; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; P-GLYCOPROTEIN; EXPRESSION; CERAMIDE; FENRETINIDE	A2780 human ovarian carcinoma cells respond to treatment with the synthetic retinoid N-(4-hydroxyphenyl) retinamide (HPR) with the production of dihydroceramide and with a concomitant reduction of cell proliferation and induction of apoptosis. The derived HPR-resistant clonal cell line, A2780/HPR, is less responsive to HPR in terms of dihydroceramide generation. In this report, we show that the production of sphingosine 1-phosphate (S1P) is significantly higher in A2780/HPR versus A2780 cells due to an increased sphingosine kinase (SK) activity and SK-1 mRNA and protein levels. Treatment of A2780 and A2780/HPR cells with a potent and highly selective pharmacological SK inhibitor effectively reduced S1P production and resulted in a marked reduction of cell proliferation. Moreover, A2780/HPR cells treated with a SK inhibitor were sensitized to the cytotoxic effect of HPR, due to an increased dihydroceramide production. On the other hand, the ectopic expression of SK-1 in A2780 cells was sufficient to induce HPR resistance in these cells. Challenge of A2780 and A2780/HPR cells with agonists and antagonists of S1P receptors had no effects on their sensitivity to the drug, suggesting that the role of SK in HPR resistance in these cells is not mediated by the S1P receptors. These data clearly demonstrate a role for SK in determining resistance to HPR in ovarian carcinoma cells, due to its effect in the regulation of intracellular ceramide/S1P ratio, which is critical in the control of cell death and proliferation.	[Illuzzi, Giuditta; Aureli, Massimo; Prioni, Simona; Frera, Gianluca; Valsecchi, Manuela; Chigorno, Vanna; Sonnino, Sandro; Prinetti, Alessandro] Univ Milan, Dipartimento Chim Biochim Biotecnol & Med, Ctr Excellence Neurodegenerat Dis, I-20090 Milan, Italy; [Bernacchioni, Caterina; Donati, Chiara; Bruni, Paola] Univ Florence, Dept Biochem Sci, I-50134 Florence, Italy	University of Milan; University of Florence	Prinetti, A (corresponding author), Univ Milan, Dipartimento Chim Biochim Biotecnol & Med, Ctr Excellence Neurodegenerat Dis, Via Fratelli Cervi 93, I-20090 Milan, Italy.	alessandro.prinetti@unimi.it	Sonnino, Sandro/R-4154-2017; Prinetti, Alessandro/R-4206-2017; Bruni, Paola/A-1151-2008; Frera, Gianluca/N-2904-2017; Aureli, Massimo/G-3876-2014; donati, chiara/AAN-2682-2021	Sonnino, Sandro/0000-0001-8180-5908; Prinetti, Alessandro/0000-0003-0252-2593; Aureli, Massimo/0000-0003-1916-2440; donati, chiara/0000-0003-2224-4199; Bernacchioni, Caterina/0000-0002-1023-0067; Bruni, Paola/0000-0002-1151-3413	Mizutani Foundation for Glycoscience [070002]; Associazione Italiana per la Ricerca sul Cancro [2007]	Mizutani Foundation for Glycoscience; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Mizutani Foundation for Glycoscience Grant 070002 (to A. P.) and Associazione Italiana per la Ricerca sul Cancro Grant 2007 (to S. S.).	Akao Y, 2006, BIOCHEM BIOPH RES CO, V342, P1284, DOI 10.1016/j.bbrc.2006.02.070; Appierto V, 2001, BRIT J CANCER, V84, P1528, DOI 10.1054/bjoc.2001.1826; Bassi R, 2006, GLIA, V53, P621, DOI 10.1002/glia.20324; Bonanni B, 2007, EXPERT REV ANTICANC, V7, P423, DOI 10.1586/14737140.7.4.423; Cornish-Bowden A, 1998, CARBOHYD RES, V312, P167; Donati C, 2007, FEBS LETT, V581, P4384, DOI 10.1016/j.febslet.2007.08.007; Fieber CB, 2006, EXP CELL RES, V312, P1164, DOI 10.1016/j.yexcr.2006.01.022; Gouaze V, 2004, MOL CANCER THER, V3, P633; Gouaze-Andersson V, 2006, BBA-BIOMEMBRANES, V1758, P2096, DOI 10.1016/j.bbamem.2006.08.012; Guillermet-Guibert J, 2009, MOL CANCER THER, V8, P809, DOI 10.1158/1535-7163.MCT-08-1096; Hail N, 2006, APOPTOSIS, V11, P1677, DOI 10.1007/s10495-006-9289-3; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Liu YY, 2004, J LIPID RES, V45, P933, DOI 10.1194/jlr.M300486-JLR200; Liu YY, 1999, J BIOL CHEM, V274, P1140, DOI 10.1074/jbc.274.2.1140; Liu YY, 2001, FASEB J, V15, P719, DOI 10.1096/fj.00-0223com; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Merrill AH, 2009, J LIPID RES, V50, pS97, DOI 10.1194/jlr.R800073-JLR200; Murate T, 2001, J HISTOCHEM CYTOCHEM, V49, P845, DOI 10.1177/002215540104900705; Nemoto S, 2009, J BIOL CHEM, V284, P10422, DOI 10.1074/jbc.M900735200; Olivera A, 2003, J BIOL CHEM, V278, P46452, DOI 10.1074/jbc.M308749200; OLIVERA A, 1994, ANAL BIOCHEM, V223, P306, DOI 10.1006/abio.1994.1589; Pchejetski D, 2008, MOL CANCER THER, V7, P1836, DOI 10.1158/1535-7163.MCT-07-2322; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Prinetti A, 2003, J BIOL CHEM, V278, P5574, DOI 10.1074/jbc.M207269200; Riboni L, 2000, METHOD ENZYMOL, V311, P656; Schnitzer SE, 2009, MOL CANCER RES, V7, P393, DOI 10.1158/1541-7786.MCR-08-0156; Spiegl-Kreinecker S, 2002, J NEURO-ONCOL, V57, P27, DOI 10.1023/A:1015735815111; Vadas M, 2008, BBA-MOL CELL BIOL L, V1781, P442, DOI 10.1016/j.bbalip.2008.06.007; VALSECCHI M, 2010, J LIPID RES IN PRESS; Valsecchi M, 2007, J LIPID RES, V48, P417, DOI 10.1194/jlr.M600344-JLR200; Wamhoff BR, 2008, ARTERIOSCL THROM VAS, V28, P1454, DOI 10.1161/ATVBAHA.107.159392; Wang H, 2008, MOL CANCER THER, V7, P2967, DOI 10.1158/1535-7163.MCT-08-0549; Wang HT, 2003, UROLOGY, V61, P1047, DOI 10.1016/S0090-4295(02)02511-6; Wang HT, 2001, CANCER RES, V61, P5102; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	40	41	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18594	18602		10.1074/jbc.M109.072801	http://dx.doi.org/10.1074/jbc.M109.072801			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20404323	hybrid, Green Published			2022-12-25	WOS:000278453900053
J	Wong, A				Wong, Albert			Quantitative Modeling of the High-Throughput Production and In Vivo Kinetics of (Drug-Encapsulating) Liposomes	PLOS ONE			English	Article							EGF	In developing liposomes for in vivo use, it is important to design the liposomes to have optimal in vivo kinetics, and it is also necessary to identify optimal high-throughput production conditions for these liposomes. Previous work has not definitively established the general relationship between liposomes' configuration and composition, and their in vivo kinetics. Also, no straightforward method exists to calculate optimal liposome high-throughput production conditions for specific liposome compositions. This work presents first-principles quantitative correlations describing liposomes' in vivo drug leakage and vascular mass transfer kinetics. This work further presents a simple quantitative model relating specific liposome compositions to ideal high-throughput production parameters. The results have implications for the identification of promising liposome compositions via high-throughput screening methodologies, as well as the design and optimization of high-throughput reactors for liposome production.	Yale Univ, Program Biol & Biomed Sci, New Haven, CT 06520 USA	Yale University	Wong, A (corresponding author), Yale Univ, Program Biol & Biomed Sci, New Haven, CT 06520 USA.	albert.wong@yale.edu			MIT Office of the Provost; MIT Portugal	MIT Office of the Provost; MIT Portugal	This work was supported by funding from the MIT Office of the Provost and the MIT Portugal Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carneiro AL, 2004, PROG COLL POL SCI S, V128, P273, DOI 10.1007/b97107; COLTON CK, 1971, AICHE J, V17, P773, DOI 10.1002/aic.690170404; Deen, 1998, ANAL TRANSPORT PHENO; Ishida O, 2001, PHARMACEUT RES, V18, P1042, DOI 10.1023/A:1010960900254; Johnston MJW, 2006, BBA-BIOMEMBRANES, V1758, P55, DOI 10.1016/j.bbamem.2006.01.009; Kullberg EB, 2002, BIOCONJUGATE CHEM, V13, P737, DOI 10.1021/bc0100713; ROSS SM, 1974, J FLUID MECH, V63, P157, DOI 10.1017/S0022112074001066; Scott Fogler H., 2006, ELEMENTS CHEM REACTI; Semple SC, 2005, J PHARMACOL EXP THER, V312, P1020, DOI 10.1124/jpet.104.078113; Suita T, 1997, ANAL SCI, V13, P577, DOI 10.2116/analsci.13.577; Wong A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007391	11	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10280	10.1371/journal.pone.0010280	http://dx.doi.org/10.1371/journal.pone.0010280			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428243	Green Published, Green Submitted, gold			2022-12-25	WOS:000277079300005
J	Deng, S; Yang, XJ; Lassus, H; Liang, S; Kaur, S; Ye, QR; Li, CS; Wang, LP; Roby, KF; Orsulic, S; Connolly, DC; Zhang, YC; Montone, K; Butzow, R; Coukos, G; Zhang, L				Deng, Shan; Yang, Xiaojun; Lassus, Heini; Liang, Shun; Kaur, Sippy; Ye, Qunrui; Li, Chunsheng; Wang, Li-Ping; Roby, Katherine F.; Orsulic, Sandra; Connolly, Denise C.; Zhang, Youcheng; Montone, Kathleen; Butzow, Ralf; Coukos, George; Zhang, Lin			Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; BREAST-CANCER; PROGENITOR CELLS; OVARIAN-CANCER; PHENOTYPIC CHARACTERIZATION; IN-VIVO; IDENTIFICATION; CHEMOTHERAPY; TUMORIGENESIS; ASSOCIATION	Aldehyde dehydrogenase isoform 1 (ALDH1) has been proved useful for the identification of cancer stem cells. However, our knowledge of the expression and activity of ALDH1 in common epithelial cancers and their corresponding normal tissues is still largely absent. Therefore, we characterized ALDH1 expression in 24 types of normal tissues and a large collection of epithelial tumor specimens (six cancer types, n = 792) by immunohistochemical staining. Using the ALDEFUOR assay, ALDH1 activity was also examined in 16 primary tumor specimens and 43 established epithelial cancer cell lines. In addition, an ovarian cancer transgenic mouse model and 7 murine ovarian cancer cell lines were analyzed. We found that the expression levels and patterns of ALDH1 in epithelial cancers are remarkably distinct, and they correlate with their corresponding normal tissues. ALDH1 protein expression levels are positively correlated with ALDH1 enzymatic activity measured by ALDEFLUOR assay. Long-term in vitro culture doesn't significantly affect ALDH1 activity in epithelial tumor cells. Consistent with research on other cancers, we found that high ALDH1 expression is significantly associated with poor clinical outcomes in serous ovarian cancer patients (n = 439, p = 0.0036). Finally, ALDH(br) tumor cells exhibit cancer stem cell properties and are resistant to chemotherapy. As a novel cancer stem cell marker, ALDH1 can be used for tumors whose corresponding normal tissues express ALDH1 in relatively restricted or limited levels such as breast, lung, ovarian or colon cancer.	[Deng, Shan; Yang, Xiaojun; Liang, Shun; Ye, Qunrui; Li, Chunsheng; Coukos, George; Zhang, Lin] Univ Penn, Ctr Res Early Detect & Cure Ovarian Canc, Philadelphia, PA 19104 USA; [Coukos, George; Zhang, Lin] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Coukos, George] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Wang, Li-Ping; Montone, Kathleen] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Deng, Shan] Chinese Acad Med Sci, Peking Union Med Coll, Dept Obstet & Gynecol, Beijing 100037, Peoples R China; [Yang, Xiaojun; Zhang, Youcheng] Lanzhou Univ, Hosp 2, Dept Gen Surg, Lanzhou 730000, Peoples R China; [Lassus, Heini; Kaur, Sippy; Butzow, Ralf] Univ Helsinki, Dept Obstet & Gynecol & Pathol, Helsinki, Finland; [Lassus, Heini; Kaur, Sippy; Butzow, Ralf] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Roby, Katherine F.] Univ Kansas, Ctr Reprod Sci, Kansas City, KS USA; [Orsulic, Sandra] Cedars Sinai Med Ctr, Womens Canc Res Inst, Los Angeles, CA 90048 USA; [Connolly, Denise C.] Fox Chase Canc Ctr, Womens Canc Program, Philadelphia, PA 19111 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Lanzhou University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Kansas; Cedars Sinai Medical Center; Fox Chase Cancer Center	Deng, S (corresponding author), Univ Penn, Ctr Res Early Detect & Cure Ovarian Canc, Philadelphia, PA 19104 USA.	linzhang@mail.med.upenn.edu	Zhang, Lin/K-8478-2012; Coukos, George/ABG-7389-2020; Li, chunsheng/G-4418-2011	Coukos, George/0000-0001-8813-7367; Lassus, Heini/0000-0003-0598-5147	Breast Cancer Alliance; Ovarian Cancer Research Found; Mary Kay Ash Charitable Foundation; National Cancer Institute [R01CA142776, P50-CA83638-7951]; US Department of Defense [W81XWH-10-1-0082]; NATIONAL CANCER INSTITUTE [P50CA083638, R01CA142776] Funding Source: NIH RePORTER	Breast Cancer Alliance; Ovarian Cancer Research Found; Mary Kay Ash Charitable Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Breast Cancer Alliance (LZ), the Ovarian Cancer Research Found (Liz Tilberis Scholar, LZ), the Mary Kay Ash Charitable Foundation (LZ), National Cancer Institute (R01CA142776 and Ovarian Cancer SPORE P50-CA83638-7951 project 3, LZ), and US Department of Defense (W81XWH-10-1-0082, LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; BURGER PE, 2009, STEM CELLS; Carpentino JE, 2009, CANCER RES, V69, P8208, DOI 10.1158/0008-5472.CAN-09-1132; Chang B, 2009, MODERN PATHOL, V22, P817, DOI 10.1038/modpathol.2009.35; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Connolly DC, 2003, CANCER RES, V63, P1389; Corti S, 2006, STEM CELLS, V24, P975, DOI 10.1634/stemcells.2005-0217; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dontu G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2130; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Gentry T, 2007, CYTOTHERAPY, V9, P259, DOI 10.1080/14653240701218516; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee JT, 2007, J CELL PHYSIOL, V213, P603, DOI 10.1002/jcp.21252; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Morimoto K, 2009, CANCER SCI, V100, P1062, DOI 10.1111/j.1349-7006.2009.01151.x; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Su Y, 2010, CANCER EPIDEM BIOMAR, V19, P327, DOI 10.1158/1055-9965.EPI-09-0865; Szotek PP, 2008, P NATL ACAD SCI USA, V105, P12469, DOI 10.1073/pnas.0805012105; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Vlashi E, 2009, JNCI-J NATL CANCER I, V101, P350, DOI 10.1093/jnci/djn509; Wang L, 2010, INT J CANC; Ward RJ, 2007, ANNU REV PATHOL-MECH, V2, P175, DOI 10.1146/annurev.pathol.2.010506.091847; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; Zhang L, 2002, AM J PATHOL, V161, P2295, DOI 10.1016/S0002-9440(10)64505-1	53	313	330	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10277	10.1371/journal.pone.0010277	http://dx.doi.org/10.1371/journal.pone.0010277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422001	Green Submitted, Green Published, gold			2022-12-25	WOS:000276952500022
J	Rozhdestvenskaya, AS; Totolian, AA; Dmitriev, AV				Rozhdestvenskaya, Anastasia S.; Totolian, Artem A.; Dmitriev, Alexander V.			Inactivation of DNA-Binding Response Regulator Sak189 Abrogates beta-Antigen Expression and Affects Virulence of Streptococcus agalactiae	PLOS ONE			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; GROUP-B STREPTOCOCCI; COMPLETE GENOME SEQUENCE; CLONALLY RELATED GROUPS; WALL-SPANNING DOMAIN; STRAIN R6; BAC GENE; SYSTEM; PROTEIN; PNEUMONIAE	Background: Streptococcus agalactiae is able to colonize numerous tissues employing different mechanisms of gene regulation, particularly via two-component regulatory systems. These systems sense the environmental stimuli and regulate expression of the genes including virulence genes. Recently, the novel two-component regulatory system Sak188/Sak189 was identified. In S. agalactiae genome, it was adjacent to the bac gene encoding for beta-antigen, an important virulence factor. Methodology/Principal Findings: In this study, the sak188 and sak189 genes were inactivated, and the functional role of Sak188/Sak189 two-component system in regulation of the beta-antigen expression was investigated. It was demonstrated that both transcription of bac gene and expression of encoded beta-antigen were controlled by Sak189 response regulator, but not Sak188 histidine kinase. It was also found that the regulation occurred at transcriptional level. Finally, insertional inactivation of sak189 gene, but not sak188 gene, significantly affected virulent properties of S. agalactiae. Conclusions/Significance: Sak189 response regulator is necessary for activation of bac gene transcription. It also controls the virulent properties of S. agalactiae. Given that the primary functional role of Sak188/Sak189 two-component systems is a control of bac gene transcription, this system can be annotated as BgrR/S ( bac gene regulatory system).	[Rozhdestvenskaya, Anastasia S.; Totolian, Artem A.; Dmitriev, Alexander V.] Russian Acad Med Sci, Inst Expt Med, Dept Mol Microbiol, St Petersburg, Russia	Institute of Experimental Medicine; Russian Academy of Medical Sciences	Rozhdestvenskaya, AS (corresponding author), Russian Acad Med Sci, Inst Expt Med, Dept Mol Microbiol, St Petersburg, Russia.	admitriev10@yandex.ru	Dmitriev, Alexander/C-9407-2012; Totolian, Artem/J-4218-2014	Totolian, Artem/0000-0002-3310-9294				Areschoug T, 2002, J BIOL CHEM, V277, P12642, DOI 10.1074/jbc.M112072200; Berner R, 2002, PEDIATR RES, V51, P106, DOI 10.1203/00006450-200201000-00019; BRADY LJ, 1989, INFECT IMMUN, V57, P1573, DOI 10.1128/IAI.57.5.1573-1581.1989; Dmitriev A, 2006, FOLIA MICROBIOL, V51, P229, DOI 10.1007/BF02932127; Dmitriev A, 2002, FEMS MICROBIOL LETT, V208, P93, DOI 10.1111/j.1574-6968.2002.tb11066.x; Dmitriev A, 1999, FOLIA MICROBIOL, V44, P449, DOI 10.1007/BF02903721; Dogan B, 2005, J CLIN MICROBIOL, V43, P5899, DOI 10.1128/JCM.43.12.5899-5906.2005; Dopazo J, 2001, MICROB DRUG RESIST, V7, P99, DOI 10.1089/10766290152044995; Facklam RR, 1991, MANUAL CLIN MICROBIO, P238; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; GRUBB A, 1982, INT ARCH ALLER A IMM, V67, P369, DOI 10.1159/000233049; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Hynes W, 2009, MICROB PATHOGENESIS, V47, P308, DOI 10.1016/j.micpath.2009.09.008; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; JERLSTROM PG, 1991, MOL MICROBIOL, V5, P843, DOI 10.1111/j.1365-2958.1991.tb00757.x; Jiang SM, 2008, J BACTERIOL, V190, P1956, DOI 10.1128/JB.01677-07; Jiang SM, 2005, J BACTERIOL, V187, P1105, DOI 10.1128/JB.187.3.1105-1113.2005; Johnson DR., 1996, LAB DIAGNOSIS GROUP; Keefe GP, 1997, CAN VET J, V38, P429; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; Kong FR, 2006, J MED MICROBIOL, V55, P829, DOI 10.1099/jmm.0.46307-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; LEONTEVA GF, 2005, ZH MIKROBIOL EPIDEMI, V2, P35; Ma Z, 2007, J BACTERIOL, V189, P2497, DOI 10.1128/JB.01429-06; Maniatis T., 1982, MOL CLONING LAB MANU; Murdoch C, 2002, J INFECT DIS, V186, P1253, DOI 10.1086/344527; Nagano N, 2006, MICROBIOL-SGM, V152, P771, DOI 10.1099/mic.0.28535-0; Nagano N, 2002, INFECT IMMUN, V70, P4643, DOI 10.1128/IAI.70.8.4643-4649.2002; Panda B, 2009, J MATERN-FETAL NEO M, V22, P111, DOI 10.1080/14767050802488212; Poyart C, 2001, J BACTERIOL, V183, P6324, DOI 10.1128/JB.183.21.6324-6334.2001; Rogasch K, 2006, J BACTERIOL, V188, P7742, DOI 10.1128/JB.00555-06; Spellerberg B, 2002, INFECT IMMUN, V70, P2434, DOI 10.1128/IAI.70.5.2434-2440.2002; Standish AJ, 2005, P NATL ACAD SCI USA, V102, P7701, DOI 10.1073/pnas.0409377102; Standish AJ, 2007, J BACTERIOL, V189, P5591, DOI 10.1128/JB.00335-07; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Towbin H, 1992, Biotechnology, V24, P145	44	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10212	10.1371/journal.pone.0010212	http://dx.doi.org/10.1371/journal.pone.0010212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419089	Green Submitted, Green Published, gold			2022-12-25	WOS:000276853800009
J	Lanni, C; Nardinocchi, L; Puca, R; Stanga, S; Uberti, D; Memo, M; Govoni, S; D'Orazi, G; Racchi, M				Lanni, Cristina; Nardinocchi, Lavinia; Puca, Rosa; Stanga, Serena; Uberti, Daniela; Memo, Maurizio; Govoni, Stefano; D'Orazi, Gabriella; Racchi, Marco			Homeodomain Interacting Protein Kinase 2: A Target for Alzheimer's Beta Amyloid Leading to Misfolded p53 and Inappropriate Cell Survival	PLOS ONE			English	Article							PRECURSOR PROTEIN; DISEASE PATIENTS; HYPOXIC RESPONSE; HIPK2; APOPTOSIS; FIBROBLASTS; PHOSPHORYLATION; CONFORMATION; DOXORUBICIN; SECRETION	Background: Homeodomain interacting protein kinase 2 (HIPK2) is an evolutionary conserved serine/threonine whose activity is fundamental in maintaining wild-type p53 function, thereby controlling the destiny of cells when to DNA damaging agents. We recently reported an altered conformational state of p53 in tissues from patients Alzheimer's Disease (AD) that led to an impaired and dysfunctional response to stressors. Methodology/Principal Findings: Here we examined the molecular mechanisms underlying the impairment of p53 in two cellular models, HEK-293 cells overexpressing the amyloid precursor protein and fibroblasts from AD starting from recent findings showing that p53 conformation may be regulated by HIPK2. We demonstrated that amyloid 1-40 induces HIPK2 degradation and alters HIPK2 binding activity to DNA, in turn regulating the conformational state and vulnerability to a noxious stimulus. Expression of HIPK2 was analysed by western experiments, whereas HIPK2 DNA binding was examined by chromatin immunoprecipitation analysis. In particular, evaluated the recruitment of HIPK2 onto some target promoters, including hypoxia inducible factor-1 alpha and 2A. Conclusions/Significance: These results support the existence of a novel amyloid-based pathogenetic mechanism in potentially leading to the survival of injured dysfunctional cells.	[Lanni, Cristina; Stanga, Serena; Govoni, Stefano; Racchi, Marco] Univ Pavia, Ctr Excellence Appl Biol, Dept Expt & Appl Pharmacol, I-27100 Pavia, Italy; [Nardinocchi, Lavinia; Puca, Rosa; D'Orazi, Gabriella] Natl Canc Inst Regina Elena, Dept Expt Oncol, Mol Oncogenesis Lab, Rome, Italy; [Nardinocchi, Lavinia; Puca, Rosa; D'Orazi, Gabriella] Univ G DAnnunzio, Dept Oncol & Neurosci, Chieti, Italy; [Uberti, Daniela; Memo, Maurizio] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy	University of Pavia; G d'Annunzio University of Chieti-Pescara; University of Brescia	Lanni, C (corresponding author), Univ Pavia, Ctr Excellence Appl Biol, Dept Expt & Appl Pharmacol, Via Palestro 3, I-27100 Pavia, Italy.	cristina.lanni@unipv.it	Stanga, Serena/AAP-1558-2020; Govoni, Stefano/K-2965-2015; Racchi, Marco/G-6104-2018; Memo, Maurizio/C-2555-2011; Memo, Maurizio/AAK-7197-2020; Uberti, Daniela/K-1551-2019; Lanni, Cristina/AAI-2182-2020; D'Orazi, Gabriella/T-2792-2019	Govoni, Stefano/0000-0002-7243-6837; Racchi, Marco/0000-0002-7185-7808; D'Orazi, Gabriella/0000-0001-6876-9105; LANNI, CRISTINA/0000-0002-3061-4738; Stanga, Serena/0000-0003-1454-0713; UBERTI, Daniela Letizia/0000-0002-5926-9122; MEMO, Maurizio/0000-0002-7543-0289	Ministry of University and Research (MIUR) [2007HJCCSF]; CARIPLO; Fondo Ateneo Ricerca (University of Pavia); Associazione Italiana per la Ricerca sul Cancro (AIRC); Fondazione Italina per la Ricerca sul cancro (FIRC)	Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); CARIPLO(Fondazione Cariplo); Fondo Ateneo Ricerca (University of Pavia); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Italina per la Ricerca sul cancro (FIRC)	This work was supported by the contribution of grants from the Ministry of University and Research (MIUR, Grant #2007HJCCSF to S. G.), CARIPLO to M. R., Fondo Ateneo Ricerca (University of Pavia to C. L., M. R. and S. G.) and from Associazione Italiana per la Ricerca sul Cancro (AIRC) (to G.D.O.). R. P. has been supported by a Fellowship from Fondazione Italina per la Ricerca sul cancro (FIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamaschi S, 1995, NEUROSCI LETT, V201, P1, DOI 10.1016/0304-3940(95)12168-4; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Calzado MA, 2007, CELL CYCLE, V6, P139, DOI 10.4161/cc.6.2.3788; Calzado MA, 2009, CELL CYCLE, V8, P1659, DOI 10.4161/cc.8.11.8597; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Doxakis E, 2004, CURR BIOL, V14, P1761, DOI 10.1016/j.cub.2004.09.050; Gasparini L, 1998, FASEB J, V12, P17, DOI 10.1096/fasebj.12.1.17; GOVONI S, 1993, NEUROLOGY, V43, P2581, DOI 10.1212/WNL.43.12.2581; HAINAUT P, 1993, CANCER RES, V53, P4469; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Lanni C, 2008, MOL PSYCHIATR, V13, P641, DOI 10.1038/sj.mp.4002060; Lanni C, 2004, EUR J BIOCHEM, V271, P3068, DOI 10.1111/j.1432-1033.2004.04240.x; Lanni C, 2007, J ALZHEIMERS DIS, V12, P93; Li H, 2009, NEUROBIOL AGING, V30, P2010, DOI 10.1016/j.neurobiolaging.2008.02.015; Meplan C, 2000, BIOCHEM PHARMACOL, V59, P25, DOI 10.1016/S0006-2952(99)00297-X; Nardinocchi L, 2010, CELL CYCLE, V9, P1270, DOI 10.4161/cc.9.7.11125; Nardinocchi L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006819; Nardinocchi L, 2009, BBA-MOL CELL RES, V1793, P368, DOI 10.1016/j.bbamcr.2008.10.013; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Puca R, 2008, CANCER RES, V68, P3707, DOI 10.1158/0008-5472.CAN-07-6776; Puca R, 2009, EXP CELL RES, V315, P67, DOI 10.1016/j.yexcr.2008.10.018; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Ryu J, 2008, BIOCHEMISTRY-US, V47, P5328, DOI 10.1021/bi800012e; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Uberti D, 2002, J CELL SCI, V115, P3131; Uberti D, 2007, J NEUROCHEM, V103, P322, DOI 10.1111/j.1471-4159.2007.04757.x; Uberti D, 2006, NEUROBIOL AGING, V27, P1193, DOI 10.1016/j.neurobiolaging.2005.06.013; Verdile G, 2004, PHARMACOL RES, V50, P397, DOI 10.1016/j.phrs.2003.12.028; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Wiggins AK, 2004, J CELL BIOL, V167, P257, DOI 10.1083/jcb.200406131; Zhang JS, 2007, NAT NEUROSCI, V10, P77, DOI 10.1038/nn1816	35	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10171	10.1371/journal.pone.0010171	http://dx.doi.org/10.1371/journal.pone.0010171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418953	gold, Green Published, Green Submitted			2022-12-25	WOS:000276706800013
J	Gjesing, AP; Larsen, LH; Torekov, SS; Hainerova, IA; Kapur, R; Johansen, A; Albrechtsen, A; Boj, S; Holst, B; Harper, A; Urhammer, SA; Borch-Johnsen, K; Pisinger, C; Echwald, SM; Eiberg, H; Astrup, A; Lebl, J; Ferrer, J; Schwartz, TW; Hansen, T; Pedersen, O				Gjesing, Anette P.; Larsen, Lesli H.; Torekov, Signe S.; Hainerova, Irena Aldhoon; Kapur, Rahul; Johansen, Anders; Albrechtsen, Anders; Boj, Sylvia; Holst, Birgitte; Harper, Angela; Urhammer, Soren A.; Borch-Johnsen, Knut; Pisinger, Charlotta; Echwald, Soren M.; Eiberg, Hans; Astrup, Arne; Lebl, Jan; Ferrer, Jorge; Schwartz, Thue W.; Hansen, Torben; Pedersen, Oluf			Family and Population-Based Studies of Variation within the Ghrelin Receptor Locus in Relation to Measures of Obesity	PLOS ONE			English	Article							HORMONE SECRETAGOGUE RECEPTOR; FOOD-INTAKE; GENE; ASSOCIATION; LINKAGE	Background: The growth hormone secretagogue receptor (GHSR) is mediating hunger sensation when stimulated by its natural ligand ghrelin. In the present study, we tested the hypothesis that common and rare variation in the GHSR locus are related to increased prevalence of obesity and overweight among Whites. Methodology/Principal Findings: In a population-based study sample of 15,854 unrelated, middle-aged Danes, seven variants were genotyped to capture common variation in an 11 kbp region including GHSR. These were investigated for their individual and haplotypic association with obesity. None of these analyses revealed consistent association with measures of obesity. A -151C/T promoter mutation in the GHSR was found in two unrelated obese patients. One family presented with complete co-segregation, but the other with incomplete co-segregation. The mutation resulted in an increased transcriptional activity (p < 0.02) and introduction of a specific binding for Sp-1-like nuclear extracts relative to the wild type. The -151C/T mutation was genotyped in the 15,854 Danes with a minor allele frequency of 0.01%. No association with obesity in carriers (mean BMI: 27 +/- 4 kg/m(2)) versus non-carriers (mean BMI: 28 +/- 5 kg/m(2)) (p > 0.05) could be shown. Conclusions/Significance: In a population-based study sample of 15,854 Danes no association between GHSR genotypes and measures of obesity and overweight was found. Also, analyses of GHSR haplotypes lack consistent associations with obesity related traits. A rare functional GHSR promoter mutation variant was identified, yet there was no consistent relationship with obesity in neither family- nor population-based studies.	[Gjesing, Anette P.; Torekov, Signe S.; Kapur, Rahul; Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Larsen, Lesli H.; Johansen, Anders; Albrechtsen, Anders; Borch-Johnsen, Knut; Echwald, Soren M.; Hansen, Torben; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Larsen, Lesli H.; Astrup, Arne] Univ Copenhagen, Inst Human Nutr, Copenhagen, Denmark; [Hainerova, Irena Aldhoon] Charles Univ Prague, Dept Paediat, Prague, Czech Republic; [Hainerova, Irena Aldhoon] Charles Univ Prague, Ctr Res Diabet Metab & Nutr, Fac Med 3, Prague, Czech Republic; [Boj, Sylvia; Ferrer, Jorge] Inst Invest Biomed August Pi & Sunyer, Hosp Clin Barcelona, Endocrinol Unit, Barcelona, Spain; [Holst, Birgitte; Schwartz, Thue W.] Univ Copenhagen, Panum Inst, Dept Pharmacol, Mol Pharmacol Lab, DK-2200 Copenhagen, Denmark; [Harper, Angela] Royal Vet & Agr Univ, Inst Human Nutr, Copenhagen, Denmark; [Urhammer, Soren A.] Hvidovre Univ Hosp, Dept Endocrinol, DK-2650 Hvidovre, Denmark; [Pisinger, Charlotta] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Echwald, Soren M.] Exiqon, Vedbaek, Denmark; [Eiberg, Hans] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark; [Pisinger, Charlotta; Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Borch-Johnsen, Knut; Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark; [Lebl, Jan] Charles Univ Prague, Dept Pediat, Fac Med 2, Prague, Czech Republic	Novo Nordisk; Hagedorn Research Institute; Steno Diabetes Center; University of Copenhagen; Charles University Prague; Charles University Prague; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Aarhus University; University of Southern Denmark; Charles University Prague	Gjesing, AP (corresponding author), Hagedorn Res Inst, Gentofte, Denmark.	apri@hagedorn.dk	Pedersen, Oluf/AAG-8015-2020; Lebl, Jan/D-9563-2017; Gjesing, Anette/ACC-7521-2022; Pedersen, Oluf/Z-1731-2019; Albrechtsen, Anders/K-4281-2013; Palmer, David/E-6824-2010; Larsen, Lesli H/D-2252-2011; Ferrer, Jorge/A-3176-2012; Astrup, Arne/B-1407-2015	Lebl, Jan/0000-0002-3365-5375; Gjesing, Anette/0000-0003-4580-1576; Pedersen, Oluf/0000-0002-3321-3972; Albrechtsen, Anders/0000-0001-7306-031X; Larsen, Lesli H/0000-0001-8827-7992; Ferrer, Jorge/0000-0002-5959-5729; Holst, Birgitte/0000-0001-7432-097X; Schwartz, Thue W./0000-0002-0261-6904; Torekov, Signe/0000-0001-6779-0252; Pisinger, Charlotta/0000-0002-7970-3168; Astrup, Arne/0000-0001-8968-8996	University of Copenhagen; Danish Diabetes Association; European Union [LSHM-CT-2005-018734]; Danish Medical Research Council; Danish Agency for Science Technology and Innovation [271-06-0539]; Czech Research Project of MSM [0021620814]; Novo Nordisk	University of Copenhagen; Danish Diabetes Association; European Union(European Commission); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Agency for Science Technology and Innovation; Czech Research Project of MSM; Novo Nordisk(Novo Nordisk)	The study is part of the DanORC project (http://www.danorc.dk) and was additionally supported by the University of Copenhagen, the Danish Diabetes Association, the European Union (HEPADIP, grant no. LSHM-CT-2005-018734), the Danish Medical Research Council, the Danish Agency for Science Technology and Innovation (grant no. 271-06-0539), the Czech Research Project of MSM No. 0021620814 and a European Society of Paediatric Endocrinology (ESPE) research fellowship sponsored by Novo Nordisk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa A, 2003, GUT, V52, P947, DOI 10.1136/gut.52.7.947; Baessler A, 2005, DIABETES, V54, P259, DOI 10.2337/diabetes.54.1.259; Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; Gil-Campos M, 2006, BRIT J NUTR, V96, P201, DOI 10.1079/BJN20061787; Gueorguiev M, 2009, OBESITY, V17, P745, DOI 10.1038/oby.2008.589; Hoist B, 2006, J CLIN INVEST, V116, P637, DOI 10.1172/JCI27999; Holst B, 2004, TRENDS PHARMACOL SCI, V25, P113, DOI 10.1016/j.tips.2004.01.010; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Klausen B, 1997, AM J CLIN NUTR, V65, P895; Kobzova J., 2004, Central European Journal of Public Health, V12, P126; Kojima M, 2002, CURR OPIN PHARMACOL, V2, P665, DOI 10.1016/S1471-4892(02)00220-5; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; MOLLER A, 1974, METHODS ENZYMATIC AN; Pantel J, 2006, J CLIN INVEST, V116, P760, DOI 10.1172/JCI25303; Perusse L, 2005, OBES RES, V13, P381, DOI 10.1038/oby.2005.50; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Shuto Y, 2002, J CLIN INVEST, V109, P1429, DOI 10.1172/JCI0213300; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8	19	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10084	10.1371/journal.pone.0010084	http://dx.doi.org/10.1371/journal.pone.0010084			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404923	Green Published, gold, Green Submitted			2022-12-25	WOS:000276482100010
J	Lalou, C; Scamuffa, N; Mourah, S; Plassa, F; Podgorniak, MP; Soufir, N; Dumaz, N; Calvo, F; Basset-Seguin, N; Khatib, AM				Lalou, Claude; Scamuffa, Nathalie; Mourah, Samia; Plassa, Francois; Podgorniak, Marie-Pierre; Soufir, Nadem; Dumaz, Nicolas; Calvo, Fabien; Basset-Seguin, Nicole; Khatib, Abdel-Majid			Inhibition of the Proprotein Convertases Represses the Invasiveness of Human Primary Melanoma Cells with Altered p53, CDKN2A and N-Ras Genes	PLOS ONE			English	Article							SUPPRESSOR PROTEIN P53; TUMOR-SUPPRESSOR; IN-VITRO; PLASMINOGEN-ACTIVATOR; UROKINASE EXPRESSION; REGRESSIVE MELANOMA; GLIOMA INVASION; CANCER-CELLS; GROWTH; RECEPTOR	Background: Altered tumor suppressor p53 and/or CDKN2A as well as Ras genes are frequently found in primary and metastatic melanomas. These alterations were found to be responsible for acquisition of invasive and metastatic potential through their defective regulatory control of metalloproteinases and urokinase genes. Methodology/Principal Findings: Using primary human melanoma M10 cells with altered p53, CDKN2A and N-Ras genes, we found that inhibition of the proprotein convertases (PCs), enzymes involved in the proteolytic activation of various cancer-related protein precursors resulted in significantly reduced invasiveness. Analysis of M10 cells and their gastric and lymph node derived metastatic cells revealed the presence of all the PCs found in the secretory pathway. Expression of the general PCs inhibitor alpha 1-PDX in these cells in a stable manner (M10/PDX) had no effect on the mRNA expression levels of these PCs. Whereas, in vitro digestion assays and cell transfection experiments, revealed that M10/PDX cells display reduced PCs activity and are unable to process the PCs substrates proIGF-1R and proPDGF-A. These cells showed reduced migration and invasion that paralleled decreased gelatinase MMP-2 activity and increased expression and secretion of tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2. Furthermore, these cells showed decreased levels of urokinase-type plasminogen activator receptor (uPAR) and increased levels of plasminogen activator inhibitor-1 (PAI-1). Conclusions: Taken together, these data suggest that inhibition of PCs activity results in decreased invasiveness of primary human melanoma cells despite their altered p53, CDKN2A and N-Ras genes, suggesting that PCs may serve as novel therapeutic targets in melanoma.	[Lalou, Claude; Scamuffa, Nathalie; Mourah, Samia; Podgorniak, Marie-Pierre; Calvo, Fabien; Basset-Seguin, Nicole; Khatib, Abdel-Majid] Univ Paris 07, Hop St Louis, INSERM, Inst Genet Mol,UMRS940,Equipe Avenir, Paris, France; [Plassa, Francois] Hop St Louis, Biochim Lab, Paris, France; [Soufir, Nadem] Hop Bichat Claude Bernard, Lab Biochim Hormonale & Genet, F-75877 Paris, France; [Dumaz, Nicolas] Hop St Louis, INSERM, U976, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Lalou, C (corresponding author), Univ Paris 07, Hop St Louis, INSERM, Inst Genet Mol,UMRS940,Equipe Avenir, Paris, France.	Majid.Khatib@inserm.fr	KHATIB, Abdel-Majid/A-9948-2015; Dumaz, Nicolas/B-5907-2008	KHATIB, Abdel-Majid/0000-0001-6957-0384; Dumaz, Nicolas/0000-0003-3511-2160; LALOU, Claude/0000-0002-5271-7439; calvo, fabien/0000-0002-0298-7633	Institut National du Cancer (INCA); Socite Francaise de Dermatologie (SFD)	Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Socite Francaise de Dermatologie (SFD)	This work was supported by Institut National du Cancer (INCA) to A. M. K. and by Socite Francaise de Dermatologie (SFD) to N. B. S. and A. M. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2002, ONCOGENE, V21, P87, DOI 10.1038/sj.onc.1204999; Barnhill RL, 2008, AM J SURG PATHOL, V32, P36, DOI 10.1097/PAS.0b013e3181573aaf; Bartkova J, 1996, CANCER RES, V56, P5475; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bassi DE, 2001, P NATL ACAD SCI USA, V98, P10326, DOI 10.1073/pnas.191199198; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Bontemps Y, 2007, MED RES REV, V27, P631, DOI 10.1002/med.20072; Carcelain G, 1997, INT J CANCER, V72, P241, DOI 10.1002/(SICI)1097-0215(19970717)72:2<241::AID-IJC7>3.0.CO;2-R; Chintala SK, 1997, ONCOGENE, V15, P2049, DOI 10.1038/sj.onc.1201382; Cohen M, 2008, HUM REPROD, V23, P2273, DOI 10.1093/humrep/den264; DELBALDO C, 1994, CANCER RES, V54, P4547; Eskandarpour M, 2009, INT J CANCER, V124, P16, DOI 10.1002/ijc.23876; Fenrick R, 2000, MOL CELL BIOL, V20, P5828, DOI 10.1128/MCB.20.16.5828-5839.2000; FERRADINI L, 1993, J CLIN INVEST, V91, P1183, DOI 10.1172/JCI116278; Fujita M, 1999, MELANOMA RES, V9, P279, DOI 10.1097/00008390-199906000-00010; Gondi Christopher S., 2009, V487, P267, DOI 10.1007/978-1-60327-547-7_13; Gu ML, 1996, INFECT IMMUN, V64, P524, DOI 10.1128/IAI.64.2.524-527.1996; Khatib AM, 2005, J MOL MED, V83, P856, DOI 10.1007/s00109-005-0692-y; Khatib AM, 2002, AM J PATHOL, V160, P1921, DOI 10.1016/S0002-9440(10)61140-6; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; La Porta CAM, 2007, CURR MED CHEM, V14, P387; Lapierre M, 2007, CANCER RES, V67, P9030, DOI 10.1158/0008-5472.CAN-07-0807; Li W, 2006, PATHOLOGY, V38, P287, DOI 10.1080/00313020600817951; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; Page RE, 2007, CELL ONCOL, V29, P289; Scamuffa N, 2008, J CLIN INVEST, V118, P352, DOI 10.1172/JCI32040; Shetty P, 2008, AM J RESP CELL MOL, V39, P364, DOI 10.1165/rcmb.2007-0406OC; Shetty S, 2008, J BIOL CHEM, V283, P19570, DOI 10.1074/jbc.M710268200; Siegfried G, 2003, CANCER RES, V63, P1458; STETLERSTEVENSON WG, 1989, J BIOL CHEM, V264, P17374; Sun YB, 1999, J BIOL CHEM, V274, P11535, DOI 10.1074/jbc.274.17.11535; Tsao H, 2000, CANCER RES, V60, P1800; Tzimas GN, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-149; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang CH, 2006, J CELL PHYSIOL, V208, P246, DOI 10.1002/jcp.20660; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Yan CH, 2002, J BIOL CHEM, V277, P10804, DOI 10.1074/jbc.M112069200; Zhao Y, 2008, GLIA, V56, P917, DOI 10.1002/glia.20667	39	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e9992	10.1371/journal.pone.0009992	http://dx.doi.org/10.1371/journal.pone.0009992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404912	Green Published, Green Submitted, gold			2022-12-25	WOS:000276482100001
J	Fanelli, F; Seeber, M				Fanelli, Francesca; Seeber, Michele			Structural insights into retinitis pigmentosa from unfolding simulations of rhodopsin mutants	FASEB JOURNAL			English	Article						GPCR; in silico mutagenesis; protein structure network; retinal diseases; steered molecular dynamics	PROTEIN-COUPLED RECEPTORS; MOLECULAR-DYNAMICS SIMULATIONS; MEMBRANE-PROTEINS; BOVINE RHODOPSIN; TRANSMEMBRANE DOMAIN; INTRADISCAL DOMAIN; CRYSTAL-STRUCTURE; POINT MUTANTS; MUTATIONS; GENE	Disease-causing missense mutations in membrane proteins, such as rhodopsin mutations associated with the autosomal dominant form of retinitis pigmentosa (ADRP), are often linked to defects in folding and/or trafficking. The mechanical unfolding of wild-type rhodopsin was compared with that of 20 selected ADRP-linked mutants more or less defective in folding and retinal binding. Rhodopsin fold is characterized by networks of amino acids in the retinal and G-protein binding sites likely to play a role in the stability and function of the protein. The distribution of highly connected nodes in the network reflects the existence of a diffuse intramolecular communication inside and between the 2 poles of the helix bundle, which makes pathogenic mutations share similar phenotypes irrespective of topological and physicochemical differences between them. Because of this communication, the ADRP-linked rhodopsin mutations share a more or less marked ability to impair selected hubs in the protein structure network. The extent of this structural effect relates to the severity of the biochemical defect caused by mutation. The investigative strategy employed in this study is likely to apply to all structurally known membrane proteins particularly susceptible to misassembly-causing mutations.-Fanelli, F., Seeber, M. Structural insights into retinitis pigmentosa from unfolding simulations of rhodopsin mutants. FASEB J. 24, 3196-3209 (2010). www.fasebj.org	[Fanelli, Francesca] Dulbecco Telethon Inst, I-41100 Modena, Italy; Univ Modena, Dept Chem, I-41100 Modena, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Universita di Modena e Reggio Emilia	Fanelli, F (corresponding author), Dulbecco Telethon Inst, Via Campi 183, I-41100 Modena, Italy.	fanelli@unimo.it	Seeber, Michele/AAJ-8036-2021; Fanelli, Francesca/O-8807-2014	Fanelli, Francesca/0000-0002-7620-6895; Seeber, Michele/0000-0003-4666-8834	Telethon-Italy [S00068TELU]	Telethon-Italy(Fondazione Telethon)	The authors are grateful to Angelo Felline for his contribution to the PSN analysis code and for computing the normalization factor for retinal. The authors also thank Emanuele Paci and Amedeo Caflisch for helpful discussions. This study was supported by Telethon-Italy grant S00068TELU (to F. F.). The employment of the PyMOL 0.99rc6 software for the achievement of all drawings is acknowledged.	Andres A, 2003, BIOCHEM BIOPH RES CO, V303, P294, DOI 10.1016/S0006-291X(03)00328-0; Bosch L, 2003, J BIOL CHEM, V278, P20203, DOI 10.1074/jbc.M301319200; Breikers G, 2002, BIOCHEM BIOPH RES CO, V297, P847, DOI 10.1016/S0006-291X(02)02308-2; Briscoe AD, 2004, GENE, V332, P107, DOI 10.1016/j.gene.2004.02.037; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BUNGE S, 1993, GENOMICS, V17, P230, DOI 10.1006/geno.1993.1309; Dryja TP, 2000, INVEST OPHTH VIS SCI, V41, P3124; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; Edwards SW, 2000, TRENDS PHARMACOL SCI, V21, P304, DOI 10.1016/S0165-6147(00)01513-3; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Fanelli F, 2005, CHEM REV, V105, P3297, DOI 10.1021/cr000095n; Felline A, 2009, J CHEM THEORY COMPUT, V5, P2472, DOI 10.1021/ct900145u; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; FUCHS S, 1994, HUM MOL GENET, V3, P1203, DOI 10.1093/hmg/3.7.1203; Hwa J, 1997, P NATL ACAD SCI USA, V94, P10571, DOI 10.1073/pnas.94.20.10571; Hwa J, 1999, P NATL ACAD SCI USA, V96, P1932, DOI 10.1073/pnas.96.5.1932; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; INGLEHEARN CF, 1992, HUM MOL GENET, V1, P41, DOI 10.1093/hmg/1.1.41; Janz JM, 2003, J BIOL CHEM, V278, P16982, DOI 10.1074/jbc.M210567200; Kanna N, 1999, J MOL BIOL, V292, P441, DOI 10.1006/jmbi.1999.3058; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kedrov A, 2007, ANNU REV BIOPH BIOM, V36, P233, DOI 10.1146/annurev.biophys.36.040306.132640; KEEN TJ, 1994, HUM MOL GENET, V3, P367, DOI 10.1093/hmg/3.2.367; Kennan A, 2005, TRENDS GENET, V21, P103, DOI 10.1016/j.tig.2004.12.001; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Liu X, 1996, P NATL ACAD SCI USA, V93, P4554, DOI 10.1073/pnas.93.10.4554; MACKE JP, 1993, AM J HUM GENET, V53, P80; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Rader AJ, 2004, P NATL ACAD SCI USA, V101, P7246, DOI 10.1073/pnas.0401429101; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Reeves PJ, 1999, P NATL ACAD SCI USA, V96, P1927, DOI 10.1073/pnas.96.5.1927; RICHARDS JE, 1995, OPHTHALMOLOGY, V102, P669, DOI 10.1016/S0161-6420(95)30972-4; RODRIGUEZ JA, 1994, AM J HUM GENET S, V53, pA239; Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348; Sapra KT, 2008, LANGMUIR, V24, P1330, DOI 10.1021/la702299z; Sapra KT, 2006, J MOL BIOL, V358, P255, DOI 10.1016/j.jmb.2006.02.008; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Seeber M, 2007, BIOINFORMATICS, V23, P2625, DOI 10.1093/bioinformatics/btm378; Seeber M, 2006, BIOPHYS J, V91, P3276, DOI 10.1529/biophysj.106.088591; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; SOUIED E, 1994, HUM MOL GENET, V3, P1433, DOI 10.1093/hmg/3.8.1433; Stojanovic A, 2003, J BIOL CHEM, V278, P39020, DOI 10.1074/jbc.M303625200; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; SUNG CH, 1993, J BIOL CHEM, V268, P26645; VAITHINATHAN R, 1994, GENOMICS, V21, P461, DOI 10.1006/geno.1994.1301; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Vishveshwara S., 2002, J THEOR COMPUT CHEM, V1, P187, DOI DOI 10.1142/S0219633602000117; Vishveshwara S, 2009, CURR PROTEIN PEPT SC, V10, P146, DOI 10.2174/138920309787847590	55	31	31	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2010	24	9					3196	3209		10.1096/fj.09-151084	http://dx.doi.org/10.1096/fj.09-151084			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20395457				2022-12-25	WOS:000281446400009
J	Bate, C; Tayebi, M; Williams, A				Bate, Clive; Tayebi, Mourad; Williams, Alun			Glycosylphosphatidylinositol Anchor Analogues Sequester Cholesterol and Reduce Prion Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; PHOSPHOLIPASE A(2); INTRACELLULAR TRAFFICKING; NEUROBLASTOMA-CELLS; SIGNAL-TRANSDUCTION; DEPENDENT RETENTION; SCRAPIE; PROTEIN; DISEASE; PRP	A hallmark of prion diseases is the conversion of the host-encoded prion protein (PrPC where C is cellular) into an alternatively folded, disease-related isoform (PrPSc, where Sc is scrapie), the accumulation of which is associated with synapse degeneration and ultimately neuronal death. The formation of PrPSc is dependent upon the presence of PrPC in specific, cholesterol-sensitive membrane microdomains, commonly called lipid rafts. PrPC is targeted to these lipid rafts because it is attached to membranes via a glycosylphosphatidylinositol anchor. Here, we show that treatment of prion-infected neuronal cell lines (ScN2a, ScGT1, or SMB cells) with synthetic glycosylphosphatidylinositol analogues, glucosamine-phosphatidylinositol (glucosamine-PI) or glucosamine 2-O-methyl inositol octadecyl phosphate, reduced the PrPSc content of these cells in a dose-dependent manner. In addition, ScGT1 cells treated with glucosamine-PI did not transmit infection following intracerebral injection to mice. Treatment with glucosamine-PI increased the cholesterol content of ScGT1 cell membranes and reduced activation of cytoplasmic phospholipase A(2) (PLA(2)), consistent with the hypothesis that the composition of cell membranes affects key PLA(2)-dependent signaling pathways involved in PrPSc formation. The effect of glucosamine-PI on PrPSc formation was also reversed by the addition of platelet-activating factor. Glucosamine-PI caused the displacement of PrPC from lipid rafts and reduced expression of PrPC at the cell surface, putative sites for PrPSc formation. We propose that treatment with glucosamine-PI modifies local micro-environments that control PrPC expression and activation of PLA(2) and subsequently inhibits PrPSc formation.	[Bate, Clive; Tayebi, Mourad; Williams, Alun] Royal Vet Coll, Dept Pathol & Infect Dis, N Mymms AL9 7TA, Herts, England	University of London; University of London Royal Veterinary College	Bate, C (corresponding author), Royal Vet Coll, Dept Pathol & Infect Dis, Hawkshead Lane, N Mymms AL9 7TA, Herts, England.	c.bate@rvc.ac.uk	TAYEBI, MOURAD/F-7404-2010	TAYEBI, MOURAD/0000-0001-8664-6918	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission FP6-NeuroPrion-Network of Excellence.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Bate C, 2004, J GEN VIROL, V85, P3797, DOI 10.1099/vir.0.80366-0; Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; Bate C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-8; Beranger F, 2002, J BIOL CHEM, V277, P38972, DOI 10.1074/jbc.M205110200; BERGELSON LD, 1985, FEBS LETT, V190, P305, DOI 10.1016/0014-5793(85)81306-5; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CAUGHEY B, 1990, J VIROL, V64, P1093, DOI 10.1128/JVI.64.3.1093-1101.1990; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Chatterjee S, 2001, EMBO J, V20, P1583, DOI 10.1093/emboj/20.7.1583; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; de Figueiredo P, 1998, P NATL ACAD SCI USA, V95, P8642, DOI 10.1073/pnas.95.15.8642; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; FELISTE R, 1989, ATHEROSCLEROSIS, V78, P151, DOI 10.1016/0021-9150(89)90219-0; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Frick W, 1998, BIOCHEMISTRY-US, V37, P13421, DOI 10.1021/bi9806201; Gilch S, 2006, MOL CELL NEUROSCI, V31, P346, DOI 10.1016/j.mcn.2005.10.008; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; GOCZE PM, 1992, ENDOCRINOLOGY, V131, P2972, DOI 10.1210/en.131.6.2972; Hagiwara K, 2007, BIOL PHARM BULL, V30, P835, DOI 10.1248/bpb.30.835; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; Ikezawa H, 2002, BIOL PHARM BULL, V25, P409, DOI 10.1248/bpb.25.409; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; Kempster S, 2007, NEUROREPORT, V18, P479, DOI 10.1097/WNR.0b013e328058678d; Leblanc P, 2006, EMBO J, V25, P2674, DOI 10.1038/sj.emboj.7601162; Legler DF, 2004, FASEB J, V18, P73, DOI 10.1096/fj.03-1338fje; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; MAJOR S, 2004, NAT REV MOL CELL BIO, V5, P110; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mayor S, 1998, EMBO J, V17, P4626, DOI 10.1093/emboj/17.16.4626; Mok SWF, 2006, BIOCHEM BIOPH RES CO, V348, P697, DOI 10.1016/j.bbrc.2006.07.123; Nicholson TB, 2006, J CELL BIOL, V175, P647, DOI 10.1083/jcb.200605001; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Schroeder F, 2001, EXP BIOL MED, V226, P873, DOI 10.1177/153537020122601002; SHUKLA SD, 1992, FASEB J, V6, P2296, DOI 10.1096/fasebj.6.6.1312046; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sotgia F, 2002, MOL CELL BIOL, V22, P3905, DOI 10.1128/MCB.22.11.3905-3926.2002; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Vijaykumar M, 2001, J BIOL CHEM, V276, P6909, DOI 10.1074/jbc.C100007200; Wadsworth JDF, 2006, BRAIN, V129, P1557, DOI 10.1093/brain/awl076; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457	56	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22017	22026		10.1074/jbc.M110.108548	http://dx.doi.org/10.1074/jbc.M110.108548			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20427265	Green Published, hybrid			2022-12-25	WOS:000279702200014
J	Hale, SJ; Lovell, SC; de Keyzer, J; Stirling, CJ				Hale, Sarah J.; Lovell, Simon C.; de Keyzer, Jeanine; Stirling, Colin J.			Interactions between Kar2p and Its Nucleotide Exchange Factors Sil1p and Lhs1p Are Mechanistically Distinct	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARINESCO-SJOGREN-SYNDROME; REGULATED PROTEIN ORP150; MOLECULAR CHAPERONE; HSP70 CHAPERONES; ENDOPLASMIC-RETICULUM; INTERDOMAIN LINKER; HSP110 CHAPERONES; STRUCTURAL BASIS; YEAST ER; TRANSLOCATION	Kar2p, an essential Hsp70 chaperone in the endoplasmic reticulum of Saccharomyces cerevisiae, facilitates the transport and folding of nascent polypeptides within the endoplasmic reticulum lumen. The chaperone activity of Kar2p is regulated by its intrinsic ATPase activity that can be stimulated by two different nucleotide exchange factors, namely Sil1p and Lhs1p. Here, we demonstrate that the binding requirements for Lhs1p are complex, requiring both the nucleotide binding domain plus the linker domain of Kar2p. In contrast, the IIB domain of Kar2p is sufficient for binding of Sil1p, and point mutations within IIB specifically blocked Sil1p-dependent activation while remaining competent for activation by Lhs1p. Taken together, these results demonstrate that the interactions between Kar2p and its two nucleotide exchange factors can be functionally resolved and are thus mechanistically distinct.	[Stirling, Colin J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [de Keyzer, Jeanine] Univ Groningen, Dept Microbiol, Groningen Biomol Sci & Biotechnol Inst, NL-9751 NN Haren, Netherlands	University of Manchester; University of Groningen	Stirling, CJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	colin.stirling@manchester.ac.uk		Lovell, Simon/0000-0002-4092-8458	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust.	Andreasson C, 2008, P NATL ACAD SCI USA, V105, P16519, DOI 10.1073/pnas.0804187105; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Anttonen AK, 2005, NAT GENET, V37, P1309, DOI 10.1038/ng1677; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; Craven RA, 1996, EMBO J, V15, P2640, DOI 10.1002/j.1460-2075.1996.tb00624.x; de Keyzer J, 2009, J BIOL CHEM, V284, P31564, DOI 10.1074/jbc.M109.055160; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Huang P, 2005, NAT STRUCT MOL BIOL, V12, P497, DOI 10.1038/nsmb942; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Kabani M, 2002, FEBS LETT, V531, P339, DOI 10.1016/S0014-5793(02)03570-6; KAMATHLOEB AS, 1995, J BIOL CHEM, V270, P30051; KASSENBROCK CK, 1989, EMBO J, V8, P1461, DOI 10.1002/j.1460-2075.1989.tb03529.x; Kuwabara K, 1996, J BIOL CHEM, V271, P5025; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McClellan AJ, 1998, MOL BIOL CELL, V9, P3533, DOI 10.1091/mbc.9.12.3533; McLellan CA, 2003, J BIOL CHEM, V278, P19017, DOI 10.1074/jbc.M301109200; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Ozawa K, 1999, J BIOL CHEM, V274, P6397, DOI 10.1074/jbc.274.10.6397; Park J, 2003, BIOCHEMISTRY-US, V42, P14893, DOI 10.1021/bi030122e; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Senderek J, 2005, NAT GENET, V37, P1312, DOI 10.1038/ng1678; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; SIMONS JF, 1995, J CELL BIOL, V130, P41, DOI 10.1083/jcb.130.1.41; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Tamatani M, 2001, NAT MED, V7, P317, DOI 10.1038/85463; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200	38	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21600	21606		10.1074/jbc.M110.111211	http://dx.doi.org/10.1074/jbc.M110.111211			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20430899	Green Published, hybrid			2022-12-25	WOS:000279516100046
J	Kang, HJ; Bin Hong, Y; Kim, HJ; Bae, I				Kang, Hyo Jin; Bin Hong, Young; Kim, Hee Jeong; Bae, Insoo			CR6-interacting Factor 1 (CRIF1) Regulates NF-E2-related Factor 2 (NRF2) Protein Stability by Proteasome-mediated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT-RESPONSE ELEMENT; GADD45 FAMILY PROTEINS; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; GENE-EXPRESSION; HEME OXYGENASE-1; CELL-CYCLE; INDUCTION; KEAP1; ACTIVATION	Free radicals generated by oxidative stress cause damage that can contribute to numerous chronic diseases. Mammalian cells respond to this damage by increased transcription of cytoprotective phase II genes, which are regulated by NRF2. Previously, it has been shown that NRF2 protein levels increase after oxidative stress because its negative regulator, KEAP1, loses its ability to bind NRF2 and cause its proteasome-mediated degradation during oxidative stress. Here, we show that CRIF1, a protein previously known as cell cycle regulator and transcription cofactor, is also able to negatively regulate NRF2 protein stability. However, in contrast to KEAP1, which regulates NRF2 stability only under normal reducing conditions, CRIF1 regulates NRF2 stability and its target gene expression under both reducing and oxidative stress conditions. Thus, CRIF1-NRF2 interactions and their consequences are redox-independent. In addition, we found that CRIF1, unlike KEAP1 (which only interacts with N-terminal region of NRF2), physically interacts with both Nand C-terminal regions of NRF2 and promotes NRF2 ubiquitination and subsequent proteasome-mediated NRF2 protein degradation.	[Kang, Hyo Jin; Bin Hong, Young; Kim, Hee Jeong; Bae, Insoo] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Bae, Insoo] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Radiat Med, Washington, DC 20057 USA; [Bae, Insoo] Dankook Univ, WCU, Res Ctr Nanobiomed Sci, Anseo Dong 330714, Cheonan, South Korea	Georgetown University; Georgetown University; Dankook University	Bae, I (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, 3970 Reservoir Rd NW, Washington, DC 20057 USA.	ib42@georgetown.edu			United States Department of Defense [DAMD17-02-1-0525]; American Cancer Society [IRG 97-152-13]; Susan G. Komen for the Cure [BCTR119906]; Ministry of Education, Science and Technology [R31-10069]	United States Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	Supported by the United States Department of Defense Breast Cancer Program Idea Award DAMD17-02-1-0525, American Cancer Society Grant IRG 97-152-13, Susan G. Komen for the Cure Grant BCTR119906, and by Grant R31-10069 (WCU Program) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology. To whom correspondence should be addressed: Dept. of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Rd., NW, Washington, D. C. 20057. Tel.: 202-687-5267; E-mail: ib42@georgetown.edu.	ALAM J, 1994, J BIOL CHEM, V269, P25049; Rubiolo JA, 2008, EUR J PHARMACOL, V591, P66, DOI 10.1016/j.ejphar.2008.06.067; Aoki Y, 2001, TOXICOL APPL PHARM, V173, P154, DOI 10.1006/taap.2001.9176; Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Chung HK, 2003, J BIOL CHEM, V278, P28079, DOI 10.1074/jbc.M212835200; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Dhakshinamoorthy S, 2002, ONCOGENE, V21, P5301, DOI 10.1038/sj.onc.1205642; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kang ES, 2007, FREE RADICAL BIO MED, V43, P535, DOI 10.1016/j.freeradbiomed.2007.05.006; Kang HJ, 2006, J BIOL CHEM, V281, P13047, DOI 10.1074/jbc.M513033200; Kang HJ, 2006, J BIOL CHEM, V281, P14654, DOI 10.1074/jbc.M601613200; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Kovacic P, 2001, CURR MED CHEM, V8, P773, DOI 10.2174/0929867013373084; Kwon MC, 2008, EMBO J, V27, P642, DOI 10.1038/sj.emboj.7601986; Kwon MC, 2009, J BIOL CHEM, V284, P33634, DOI 10.1074/jbc.M109.059840; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Nakamura Y, 2003, BIOCHEMISTRY-US, V42, P4300, DOI 10.1021/bi0340090; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Osburn WO, 2006, ARCH BIOCHEM BIOPHYS, V454, P7, DOI 10.1016/j.abb.2006.08.005; Park KC, 2005, MOL ENDOCRINOL, V19, P12, DOI 10.1210/me.2004-0107; Patel R, 2008, FREE RADICAL BIO MED, V44, P1897, DOI 10.1016/j.freeradbiomed.2008.02.006; Sankaranarayanan K, 2004, J BIOL CHEM, V279, P50810, DOI 10.1074/jbc.M404984200; Sekhar KR, 2002, ONCOGENE, V21, P6829, DOI 10.1038/sj.onc.1205905; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Stacy DR, 2006, HEAD NECK-J SCI SPEC, V28, P813, DOI 10.1002/hed.20430; Suh JH, 2008, MOL ENDOCRINOL, V22, P33, DOI 10.1210/me.2007-0194; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Yi YW, 2000, BIOCHEM BIOPH RES CO, V272, P193; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	39	56	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21258	21268		10.1074/jbc.M109.084590	http://dx.doi.org/10.1074/jbc.M109.084590			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20427290	Green Published, hybrid			2022-12-25	WOS:000279516100011
J	Charbonneau, NL; Jordan, CD; Keene, DR; Lee-Arteaga, S; Dietz, HC; Rifkin, DB; Ramirez, F; Sakai, LY				Charbonneau, Noe L.; Jordan, C. Diana; Keene, Douglas R.; Lee-Arteaga, Sui; Dietz, Harry C.; Rifkin, Daniel B.; Ramirez, Francesco; Sakai, Lynn Y.			Microfibril Structure Masks Fibrillin-2 in Postnatal Tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR MICROFIBRILS; MARFAN-SYNDROME; EXPRESSION; ORGANIZATION; COMPONENT; DOMAIN; IDENTIFICATION; PROTEINS; BONE	Fibrillin microfibrils are polymeric structures present in connective tissues. The importance of fibrillin microfibrils to connective tissue function has been demonstrated by the multiple genetic disorders caused by mutations in fibrillins and in microfibril-associated molecules. However, knowledge of microfibril structure is limited, largely due to their insolubility. Most previous studies have focused on how fibrillin-1 is organized within microfibril polymers. In this study, an immunochemical approach was used to circumvent the insolubility of microfibrils to determine the role of fibrillin-2 in postnatal microfibril structure. Results obtained from studies of wild type and fibrillin-1 null tissues, using monoclonal and polyclonal antibodies with defined epitopes, demonstrated that N-terminal fibrillin-2 epitopes are masked in postnatal microfibrils and can be revealed by enzymatic digestion or by genetic ablation of Fbn1. From these studies, we conclude that fetal fibrillin polymers form an inner core within postnatal microfibrils and that microfibril structure evolves as growth and development proceed into the postnatal period. Furthermore, documentation of a novel cryptic site present in EGF4 in fibrillin-1 underscores the molecular complexity and tissue-specific differences in microfibril structure.	[Charbonneau, Noe L.; Keene, Douglas R.; Sakai, Lynn Y.] Shriners Hosp Children, Portland, OR 97239 USA; [Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Jordan, C. Diana] Univ Washington, Med Ctr, Dept Pathol, Seattle, WA 98195 USA; [Lee-Arteaga, Sui; Ramirez, Francesco] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Dietz, Harry C.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Rifkin, Daniel B.] NYU, Langone Med Ctr, Dept Cell Biol, New York, NY 10016 USA	Oregon Health & Science University; University of Washington; University of Washington Seattle; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; New York University; NYU Langone Medical Center	Sakai, LY (corresponding author), Shriners Hosp Children, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	lys@shcc.org			National Institutes of Health [P01 AR049698, AR042044]; Shriners Hospitals for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042044, P01AR049698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AR049698 ( to F. R., D. B. R., H. C. D., and L. Y. S.) and AR042044 ( to F. R.). This work was also supported by Shriners Hospitals for Children ( to D. R. K. and to L. Y. S.).	Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Baldock C, 2001, J CELL BIOL, V152, P1045, DOI 10.1083/jcb.152.5.1045; Baldock C, 2006, P NATL ACAD SCI USA, V103, P11922, DOI 10.1073/pnas.0601609103; Boregowda R, 2008, MATRIX BIOL, V27, P661, DOI 10.1016/j.matbio.2008.09.579; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Charbonneau NL, 2003, J BIOL CHEM, V278, P2740, DOI 10.1074/jbc.M209201200; Corson GM, 2004, GENOMICS, V83, P461, DOI 10.1016/j.ygeno.2003.08.023; GALLAGHER BC, 1993, DEV DYNAM, V196, P70, DOI 10.1002/aja.1001960109; Hanssen E, 2004, J BIOL CHEM, V279, P29185, DOI 10.1074/jbc.M313672200; Hirai M, 2007, EMBO J, V26, P3283, DOI 10.1038/sj.emboj.7601768; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; Jensen SA, 2009, STRUCTURE, V17, P759, DOI 10.1016/j.str.2009.03.014; KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P441, DOI 10.1177/39.4.2005373; KIELTY CM, 1995, J CELL SCI, V108, P1317; KIELTY CM, 1994, J CELL BIOL, V124, P997, DOI 10.1083/jcb.124.6.997; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; Lee SSJ, 2004, STRUCTURE, V12, P717, DOI 10.1016/j.str.2004.02.023; LOW FN, 1962, ANAT REC, V142, P131, DOI 10.1002/ar.1091420205; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; SAKAI LY, 1994, METHOD ENZYMOL, V245, P29; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Weinbaum JS, 2008, J BIOL CHEM, V283, P25533, DOI 10.1074/jbc.M709962200; Werneck CC, 2004, J BIOL CHEM, V279, P23045, DOI 10.1074/jbc.M402656200; ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	28	39	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20242	20251		10.1074/jbc.M109.087031	http://dx.doi.org/10.1074/jbc.M109.087031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20404337	hybrid, Green Published			2022-12-25	WOS:000279012000059
J	Liu, HY; Enyeart, JA; Enyeart, JJ				Liu, Haiyan; Enyeart, Judith A.; Enyeart, John J.			ACTH Induces Ca(v)3.2 Current and mRNA by cAMP-dependent and cAMP-independent Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL-CORTICAL CELLS; NONINACTIVATING K+ CURRENT; STEROID HYDROXYLASE GENES; ADRENOCORTICOTROPIC HORMONE; CYCLIC-AMP; TRANSCRIPTIONAL REGULATION; NONHYDROLYTIC BINDING; CORTISOL PRODUCTION; FASCICULATA CELLS; ZONA-FASCICULATA	Bovine adrenal zona fasciculata (AZF) cells express Ca(v)3.2 T-type Ca2+ channels that function pivotally in adrenocorticotropic hormone (ACTH)-stimulated cortisol secretion. The regulation of Ca(v)3.2 expression in AZF cells by ACTH, cAMP analogs, and their metabolites was studied using Northern blot and patch clamp recording. Exposing AZF cells to ACTH for 3-6 days markedly enhanced the expression of Ca(v)3.2 current. The increase in Ca(v)3.2 current was preceded by an increase in corresponding CACNA1H mRNA. O-Nitrophenyl, sulfenyl-adrenocorticotropin, which produces a minimal increase in cAMP, also enhanced Ca(v)3.2 current. cAMP analogs, including 8-bromoadenosine cAMP (600 mu M) and 6-benzoyladenosine cAMP (300 mu M) induced CACNA1H mRNA, but not Ca(v)3.2 current. In contrast, 8-(4-chlorophenylthio) (8CPT)-cAMP (10-50 mu M) enhanced CACNA1H mRNA and Ca(v)3.2 current, whereas nonhydrolyzable Sp-8CPT-cAMP failed to increase either Ca(v)3.2 current or mRNA. Metabolites of 8CPT-cAMP, including 8CPT-adenosine and 8CPT-adenine, increased Ca(v)3.2 current and mRNA with a potency and effectiveness similar to the parent compound. The Epac activator 8CPT-2'-O-methyl-cAMP and its metabolites 8CPT-2'-OMe-5'-AMP and 8CPT-2'O-methyl-adenosine increased CACNA1H mRNA and Ca(v)3.2 current; Sp-8CPT-2'-O-methyl-cAMP increased neither Ca(v)3.2 current nor mRNA. These results reveal an interesting dichotomy between ACTH and cAMP with regard to regulation of CACNA1H mRNA and Ca2+ current. Specifically, ACTH induces expression of CACNA1H mRNA and Ca(v)3.2 current in AZF cells by mechanisms that depend at most only partly on cAMP. In contrast, cAMP enhances expression of CACNA1H mRNA but not the corresponding Ca2+ current. Surprisingly, chlorophenylthio-cAMP analogs stimulate the expression of Ca(v)3.2 current indirectly through metabolites. ACTH and the metabolites may induce Ca(v)3.2 expression by the same, unidentified mechanism.	[Liu, Haiyan; Enyeart, Judith A.; Enyeart, John J.] Ohio State Univ, Coll Med & Publ Hlth, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Enyeart, JJ (corresponding author), Ohio State Univ, Coll Med & Publ Hlth, Dept Neurosci, 5196 Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.	enyeart.1@osu.edu			National Institutes of Health [R01-DK47875]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK47875 (to J.J.E.).	BARBARA JG, 1995, J PHYSIOL-LONDON, V488, P609, DOI 10.1113/jphysiol.1995.sp020994; Becker AJ, 2008, J NEUROSCI, V28, P13341, DOI 10.1523/JNEUROSCI.1421-08.2008; Borland G, 2009, BRIT J PHARMACOL, V158, P70, DOI 10.1111/j.1476-5381.2008.00087.x; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Enyeart JA, 2000, J BIOL CHEM, V275, P34640, DOI 10.1074/jbc.M004214200; Enyeart JA, 2003, MOL PHARMACOL, V64, P132, DOI 10.1124/mol.64.1.132; Enyeart JJ, 1997, J GEN PHYSIOL, V110, P679, DOI 10.1085/jgp.110.6.679; Enyeart JJ, 2002, J BIOL CHEM, V277, P49186, DOI 10.1074/jbc.M207233200; ENYEART JJ, 1993, MOL ENDOCRINOL, V7, P1031, DOI 10.1210/me.7.8.1031; Enyeart JJ, 1996, J GEN PHYSIOL, V108, P251, DOI 10.1085/jgp.108.4.251; Enyeart JJ, 1998, ENDOCR RES, V24, P325, DOI 10.3109/07435809809032612; Enyeart JA, 2010, MOL PHARMACOL, V77, P469, DOI 10.1124/mol.109.061861; Enyeart JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006088; Fujita T, 2002, J BIOL CHEM, V277, P22191, DOI 10.1074/jbc.M110364200; GRAHAMES.DG, 1967, J BIOL CHEM, V242, P5535; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYNES RC, 1957, J BIOL CHEM, V225, P115; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Iacovelli L, 2001, MOL PHARMACOL, V60, P924, DOI 10.1124/mol.60.5.924; Ivins JK, 2004, J NEUROSCI, V24, P1212, DOI 10.1523/JNEUROSCI.4689-03.2004; Jagodic MM, 2007, J NEUROSCI, V27, P3305, DOI 10.1523/JNEUROSCI.4866-06.2007; JOHN ME, 1986, P NATL ACAD SCI USA, V83, P4715, DOI 10.1073/pnas.83.13.4715; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Laxman S, 2006, P NATL ACAD SCI USA, V103, P19194, DOI 10.1073/pnas.0608971103; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Liu HY, 2008, J GEN PHYSIOL, V132, P279, DOI 10.1085/jgp.200810003; MLINAR B, 1993, J BIOL CHEM, V268, P8640; MLINAR B, 1993, J GEN PHYSIOL, V102, P217, DOI 10.1085/jgp.102.2.217; MOYLE WR, 1973, J BIOL CHEM, V248, P2409; Novara M, 2004, J PHYSIOL-LONDON, V558, P433, DOI 10.1113/jphysiol.2004.061184; Omura M, 2007, ENDOCR J, V54, P585, DOI 10.1507/endocrj.K07-015; Parker KL, 1995, VITAM HORM, V51, P339, DOI 10.1016/S0083-6729(08)61044-4; PENHOAT A, 1989, P NATL ACAD SCI USA, V86, P4978, DOI 10.1073/pnas.86.13.4978; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; PRICE NC, 1999, FUNDAMENTALS ENZYMOL, P450; QUINTON PM, 1992, NATURE, V360, P79, DOI 10.1038/360079a0; RAIKHINSTEIN M, 1994, BBA-MOL CELL RES, V1220, P329, DOI 10.1016/0167-4889(94)90157-0; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; RICHARDSON MC, 1973, BIOCHEM J, V136, P993, DOI 10.1042/bj1360993; SALA GB, 1979, J BIOL CHEM, V254, P3861; SIMPSON ER, 1988, ANNU REV PHYSIOL, V50, P427, DOI 10.1146/annurev.ph.50.030188.002235; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Su H, 2002, J NEUROSCI, V22, P3645; WATERMAN MR, 1994, J BIOL CHEM, V269, P27783; WATERMAN MR, 1989, RECENT PROG HORM RES, V45, P533; Yamazaki T, 1998, ENDOCRINOLOGY, V139, P4765, DOI 10.1210/en.139.12.4765; Zazopoulos E, 1997, NATURE, V390, P311, DOI 10.1038/36899	53	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20040	20050		10.1074/jbc.M110.104190	http://dx.doi.org/10.1074/jbc.M110.104190			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20424171	Green Published, hybrid			2022-12-25	WOS:000279012000038
J	Yamashita, Y; Yuan, J; Suetake, I; Suzuki, H; Ishikawa, Y; Choi, YL; Ueno, T; Soda, M; Hamada, T; Haruta, H; Takada, S; Miyazaki, Y; Kiyoi, H; Ito, E; Naoe, T; Tomonaga, M; Toyota, M; Tajima, S; Iwama, A; Mano, H				Yamashita, Y.; Yuan, J.; Suetake, I.; Suzuki, H.; Ishikawa, Y.; Choi, Y. L.; Ueno, T.; Soda, M.; Hamada, T.; Haruta, H.; Takada, S.; Miyazaki, Y.; Kiyoi, H.; Ito, E.; Naoe, T.; Tomonaga, M.; Toyota, M.; Tajima, S.; Iwama, A.; Mano, H.			Array-based genomic resequencing of human leukemia	ONCOGENE			English	Article						resequencing; AML; JAK3; DNMT3A	ACUTE MYELOID-LEUKEMIA; ACUTE MEGAKARYOBLASTIC LEUKEMIA; DNA METHYLTRANSFERASES DNMT3A; ACUTE MYELOGENOUS LEUKEMIA; HEMATOPOIETIC STEM; ACTIVATING MUTATION; JAK3 MUTATIONS; DOWN-SYNDROME; CELLS; METHYLATION	To identify oncogenes in leukemias, we performed large-scale resequencing of the leukemia genome using DNA sequence arrays that determine similar to 9 Mbp of sequence corresponding to the exons or exon-intron boundaries of 5648 protein-coding genes. Hybridization of genomic DNA from CD34-positive blasts of acute myeloid leukemia (n = 19) or myeloproliferative disorder (n = 1) with the arrays identified 9148 nonsynonymous nucleotide changes. Subsequent analysis showed that most of these changes were also present in the genomic DNA of the paired controls, with 11 somatic changes identified only in the leukemic blasts. One of these latter changes results in a Met-to-Ile substitution at amino-acid position 511 of Janus kinase 3 (JAK3), and the JAK3(M511I) protein exhibited transforming potential both in vitro and in vivo. Further screening for JAK3 mutations showed novel and known transforming changes in a total of 9 out of 286 cases of leukemia. Our experiments also showed a somatic change responsible for an Arg-to-His substitution at amino-acid position 882 of DNA methyltransferase 3A, which resulted in a loss of DNA methylation activity of >50%. Our data have thus shown a unique profile of gene mutations in human leukemia. Oncogene (2010) 29, 3723-3731; doi: 10.1038/onc.2010.117; published online 19 April 2010	[Yamashita, Y.; Choi, Y. L.; Ueno, T.; Soda, M.; Hamada, T.; Haruta, H.; Takada, S.; Mano, H.] Jichi Med Univ, Div Funct Genom, Shimotsukeshi, Tochigi 3290498, Japan; [Yuan, J.; Iwama, A.] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan; [Suetake, I.; Tajima, S.] Osaka Univ, Inst Prot Res, Lab Epigenet, Osaka, Japan; [Suzuki, H.] Sapporo Med Univ, Dept Internal Med 1, Sapporo, Hokkaido, Japan; [Ishikawa, Y.] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan; [Choi, Y. L.; Mano, H.] Univ Tokyo, Grad Sch Med, Dept Med Genom, Tokyo, Japan; [Miyazaki, Y.; Tomonaga, M.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med & Hematol, Nagasaki 852, Japan; [Kiyoi, H.] Nagoya Univ, Sch Med, Dept Infect Dis, Nagoya, Aichi 466, Japan; [Ito, E.] Hirosaki Univ, Grad Sch Med, Dept Paediat, Aomori, Japan; [Toyota, M.] Sapporo Med Univ, Dept Biochem, Sapporo, Hokkaido, Japan; [Iwama, A.; Mano, H.] Japan Sci & Technol Agcy, CREST, Saitama, Japan	Jichi Medical University; Chiba University; Osaka University; Sapporo Medical University; Nagoya University; University of Tokyo; Nagasaki University; Nagoya University; Hirosaki University; Sapporo Medical University; Japan Science & Technology Agency (JST)	Mano, H (corresponding author), Jichi Med Univ, Div Funct Genom, 3311-1 Yakushiji, Shimotsukeshi, Tochigi 3290498, Japan.	hmano@jichi.ac.jp	Naoe, Tomoki/I-1888-2012; Suetake, Isao/D-4326-2009; Suetake, Isao/G-3144-2013	Suetake, Isao/0000-0002-1246-8474; Takada, Shuji/0000-0002-9406-4683	Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22300326] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank D Cox, KA Frazer, DG Ballinger, J Montgomery, H Tao, C Chen, L Stuve, J Kwon, J Sheehan and Y Zhan for discussion on the wafer experiments, as well as JN Ihle, T Kitamura and SB Baylin for human JAK3 cDNA, the pMX plasmid and human DNMT3A cDNA, respectively. This study was supported in part by a grant for Third-Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor, and Welfare of Japan, and by a grant for Scientific Research on Priority Areas 'Applied Genomics' from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Choi YL, 2007, LEUKEMIA RES, V31, P203, DOI 10.1016/j.leukres.2006.05.006; Ehrlich M, 2003, CLIN IMMUNOL, V109, P17, DOI 10.1016/S1521-6616(03)00201-8; El-Osta A, 2004, LEUKEMIA, V18, P233, DOI 10.1038/sj.leu.2403218; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Imanishi D, 2007, BLOOD, V110, P2231, DOI 10.1182/blood-2007-02-071423; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kiyoi H, 2007, LEUKEMIA, V21, P574, DOI 10.1038/sj.leu.2404527; Koinuma K, 2005, CARCINOGENESIS, V26, P2078, DOI 10.1093/carcin/bgi184; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; KUBONISHI I, 1983, International Journal of Cell Cloning, V1, P105; Kwong YL, 1996, CANCER GENET CYTOGEN, V88, P151, DOI 10.1016/0165-4608(95)00282-0; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Miyamoto T, 1996, BLOOD, V87, P4789, DOI 10.1182/blood.V87.11.4789.bloodjournal87114789; Nimer SD, 2004, ONCOGENE, V23, P4249, DOI 10.1038/sj.onc.1207673; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Onishi M, 1996, EXP HEMATOL, V24, P324; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Sato T, 2008, BRIT J HAEMATOL, V141, P681, DOI 10.1111/j.1365-2141.2008.07081.x; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schwonzen M, 2007, LEUKEMIA RES, V31, P113, DOI 10.1016/j.leukres.2006.03.022; Shimada A, 2006, BLOOD, V107, P1806, DOI 10.1182/blood-2005-08-3408; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Suetake I, 2003, J BIOCHEM, V133, P737, DOI 10.1093/jb/mvg095; Tallman Martin S, 2008, Hematology Am Soc Hematol Educ Program, P391, DOI 10.1182/asheducation-2008.1.391; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wong S, 2001, ONCOGENE, V20, P5644, DOI 10.1038/sj.onc.1204638; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434	36	196	208	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 24	2010	29	25					3723	3731		10.1038/onc.2010.117	http://dx.doi.org/10.1038/onc.2010.117			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	615CG	20400977				2022-12-25	WOS:000279108600012
J	Cross, PC; Heisey, DM; Scurlock, BM; Edwards, WH; Ebinger, MR; Brennan, A				Cross, Paul C.; Heisey, Dennis M.; Scurlock, Brandon M.; Edwards, William H.; Ebinger, Michael R.; Brennan, Angela			Mapping Brucellosis Increases Relative to Elk Density Using Hierarchical Bayesian Models	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; ROCKY-MOUNTAIN ELK; TIME-SERIES; TRANSMISSION; WILDLIFE; MANAGEMENT; REGRESSION; EPIDEMIC; SURVIVAL; CLIMATE	The relationship between host density and parasite transmission is central to the effectiveness of many disease management strategies. Few studies, however, have empirically estimated this relationship particularly in large mammals. We applied hierarchical Bayesian methods to a 19-year dataset of over 6400 brucellosis tests of adult female elk (Cervus elaphus) in northwestern Wyoming. Management captures that occurred from January to March were over two times more likely to be seropositive than hunted elk that were killed in September to December, while accounting for site and year effects. Areas with supplemental feeding grounds for elk had higher seroprevalence in 1991 than other regions, but by 2009 many areas distant from the feeding grounds were of comparable seroprevalence. The increases in brucellosis seroprevalence were correlated with elk densities at the elk management unit, or hunt area, scale (mean 2070 km(2); range = [95-10237]). The data, however, could not differentiate among linear and non-linear effects of host density. Therefore, control efforts that focus on reducing elk densities at a broad spatial scale were only weakly supported. Additional research on how a few, large groups within a region may be driving disease dynamics is needed for more targeted and effective management interventions. Brucellosis appears to be expanding its range into new regions and elk populations, which is likely to further complicate the United States brucellosis eradication program. This study is an example of how the dynamics of host populations can affect their ability to serve as disease reservoirs.	[Cross, Paul C.] US Geol Survey, No Rocky Mt Sci Ctr, Bozeman, MT USA; [Heisey, Dennis M.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Scurlock, Brandon M.] Wyoming Game & Fish Dept, Pinedale, WY USA; [Edwards, William H.] Wyoming Game & Fish Dept, Laramie, WY USA; [Ebinger, Michael R.] Montana State Univ, Big Sky Inst, Bozeman, MT 59717 USA; [Brennan, Angela] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Cross, PC (corresponding author), US Geol Survey, No Rocky Mt Sci Ctr, Bozeman, MT USA.	pcross@usgs.gov	Cross, Paul/K-6987-2012	Cross, Paul/0000-0001-8045-5213; Brennan, Angela/0000-0003-4360-0738	Wyoming Game and Fish Department; United States Geological Survey	Wyoming Game and Fish Department; United States Geological Survey(United States Geological Survey)	Wyoming Game and Fish Department (http://gf.state.wy.us) and the United States Geological Survey (http://www.usgs.gov) provided funding for this study. The funding agencies did not influence the authors' study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Barber-Meyer SM, 2007, AM MIDL NAT, V158, P369, DOI 10.1674/0003-0031(2007)158[369:SOSPAB]2.0.CO;2; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; BERNARDINELLI L, 1995, STAT MED, V14, P2433, DOI 10.1002/sim.4780142112; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Bienen L, 2006, FRONT ECOL ENVIRON, V4, P319, DOI 10.1890/1540-9295(2006)4[319:AAEATB]2.0.CO;2; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Caley P, 1998, WILDLIFE RES, V25, P383, DOI 10.1071/WR97029; CAROFF M, 1984, EUR J BIOCHEM, V139, P195, DOI 10.1111/j.1432-1033.1984.tb07994.x; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cheville NF, 1998, BRUCELLOSIS GREATER; Conner MM, 2007, ECOL APPL, V17, P140, DOI 10.1890/1051-0761(2007)017[0140:AMAFEM]2.0.CO;2; Creel S, 2009, J ANIM ECOL, V78, P1291, DOI 10.1111/j.1365-2656.2009.01581.x; Cross PC, 2010, ECOL APPL, V20, P278, DOI 10.1890/08-2062.1; Cross PC, 2007, ECOL APPL, V17, P957, DOI 10.1890/06-1603; Cross Paul C., 2009, P9, DOI 10.1007/978-4-431-77134-0_2; Davis S, 2008, NATURE, V454, P634, DOI 10.1038/nature07053; Eberly LE, 2000, STAT MED, V19, P2279, DOI 10.1002/1097-0258(20000915/30)19:17/18<2279::AID-SIM569>3.0.CO;2-R; Farnsworth ML, 2006, ECOL APPL, V16, P1026, DOI 10.1890/1051-0761(2006)016[1026:LCWDTM]2.0.CO;2; Fuller JA, 2007, J WILDLIFE MANAGE, V71, P2365, DOI 10.2193/2006-201; GALEY F, 2005, WYOMING BRUCELLOSIS; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 2004, BAYESIAN DATA ANAL; GILKS WR, 1994, STATISTICIAN, V43, P169, DOI 10.2307/2348941; Gourdon F, 1999, EMERG INFECT DIS, V5, P719, DOI 10.3201/eid0505.990516; HEISEY DM, ECOLOGICAL IN PRESS; Hudson PJ, 2001, ECOLOGY WILDLIFE DIS; Joly DO, 2005, J ANIM ECOL, V74, P543, DOI 10.1111/j.1365-2656.2005.00953.x; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; KING R. O. C., 1940, Australian Veterinary Journal, V16, P117, DOI 10.1111/j.1751-0813.1940.tb01297.x; Klepac P, 2009, P ROY SOC B-BIOL SCI, V276, P2469, DOI 10.1098/rspb.2009.0175; Knorr-Held L, 2003, J R STAT SOC C-APPL, V52, P169, DOI 10.1111/1467-9876.00396; LLOYD M, 1967, J ANIM ECOL, V36, P1, DOI 10.2307/3012; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; LUBBENHUSIN RE, 1926, J AM VET MED ASSOC, V69, P467; Maichak EJ, 2009, J WILDLIFE DIS, V45, P398, DOI 10.7589/0090-3558-45.2.398; *MT DEP LIV, 2008, PREL EP REP; Osnas EE, 2009, ECOL APPL, V19, P1311, DOI 10.1890/08-0578.1; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; R Development Core Team, 2009, R FDN STAT COMP; Reeve A. F., 2003, ELK POPULATIONS WYOM; Rhyan JC, 2009, J WILDLIFE DIS, V45, P729, DOI 10.7589/0090-3558-45.3.729; Robison C. D., 1994, CONSERVATION GERM PL; *ROCK MOUNT ELK FD, 2009, ELK POP REFL SUCC RM; SCURLOCK BM, 2010, J WILDLIFE IN PRESS; Smith MJ, 2009, P NATL ACAD SCI USA, V106, P7905, DOI 10.1073/pnas.0809145106; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Thomsen Axel, 1943, JOUR COMP PATH AND THERAP, V53, P199, DOI 10.1016/S0368-1742(43)80019-9; Thorne E. Tom, 2001, P372, DOI 10.1002/9780470344880.ch22; THORNE ET, 1978, J WILDLIFE DIS, V14, P280, DOI 10.7589/0090-3558-14.3.280; Van Houten CK, 2003, J WILDLIFE DIS, V39, P316, DOI 10.7589/0090-3558-39.2.316; Wakefield J, 2007, BIOSTATISTICS, V8, P158, DOI 10.1093/biostatistics/kxl008; Woodroffe R, 2009, J ANIM ECOL, V78, P818, DOI 10.1111/j.1365-2656.2009.01545.x; Wyoming Game and Fish Department, 2007, ANN BIG GAM HERD UN	54	36	37	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10322	10.1371/journal.pone.0010322	http://dx.doi.org/10.1371/journal.pone.0010322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428240	Green Published, gold, Green Submitted			2022-12-25	WOS:000277079300012
J	Skoglund, P; Hoglund, J				Skoglund, Pontus; Hoglund, Jacob			Sequence Polymorphism in Candidate Genes for Differences in Winter Plumage between Scottish and Scandinavian Willow Grouse (Lagopus lagopus)	PLOS ONE			English	Article							EVOLUTION; COLOR; MUTATION; MC1R; PIGMENTATION; MELANISM; GENETICS	Background: Population variation in the degree of seasonal polymorphism is rare in birds, and the genetic basis of this phenomenon remains largely undescribed. Both sexes of Scandinavian and Scottish Willow grouse (Lagopus lagopus) display marked differences in their winter phenotypes, with Scottish grouse retaining a pigmented plumage year-round and Scandinavian Willow grouse molting to a white morph during winter. A widely studied pathway implicated in vertebrate pigmentation is the melanin system, for which functional variation has been characterised in many taxa. Methodology/Principal Findings: We sequenced coding regions from four genes involved in melanin pigmentation (DCT, MC1R, TYR and TYRP1), and an additional control involved in the melanocortin pathway (AGRP), to investigate the genetic basis of winter plumage in Lagopus. Despite the well documented role of the melanin system in animal coloration, we found no plumage-associated polymorphism or evidence for selection in a total of similar to 2.6 kb analysed sequence. Conclusions/Significance: Our results indicate that the genetic basis of alternating between pigmented and unpigmented seasonal phenotypes is more likely explained by regulatory changes controlling the expression of these or other loci in the physiological pathway leading to pigmentation.	[Skoglund, Pontus; Hoglund, Jacob] Uppsala Univ, Dept Populat Biol & Conservat Biol, Uppsala, Sweden	Uppsala University	Skoglund, P (corresponding author), Uppsala Univ, Dept Evolutionary Biol, Uppsala, Sweden.	pontus.skoglund@ebc.uu.se		Skoglund, Pontus/0000-0002-3021-5913; Hoglund, Jacob/0000-0002-5840-779X	Swedish Research Council [2008:5418]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by a grant from the Swedish Research Council (No. 2008:5418; http://vr.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baiao PC, 2007, J HERED, V98, P287, DOI 10.1093/jhered/esm030; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Berlin S, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-89; CHEVIRON ZA, 2006, P R SOC B, V287, P1613; CRAMP S, HDB BIRDS EUROPE MID, V2, P695; Dalen L, 2007, P NATL ACAD SCI USA, V104, P6726, DOI 10.1073/pnas.0701341104; Doucet SM, 2004, P ROY SOC B-BIOL SCI, V271, P1663, DOI 10.1098/rspb.2004.2779; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fay JC, 2000, GENETICS, V155, P1405; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Johnsen A, 2007, MOL ECOL, V16, P4867, DOI 10.1111/j.1365-294X.2007.03552.x; Kelly JK, 1997, GENETICS, V146, P1197; Kerje S, 2003, ANIM GENET, V34, P241, DOI 10.1046/j.1365-2052.2003.00991.x; KETTLEWELL HBD, 1956, PROC R SOC SER B-BIO, V145, P297, DOI 10.1098/rspb.1956.0037; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; MacDougall-Shackleton EA, 2003, MOL BIOL EVOL, V20, P1675, DOI 10.1093/molbev/msg186; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Mundy NI, 2004, SCIENCE, V303, P1870, DOI 10.1126/science.1093834; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Nadeau NJ, 2007, P ROY SOC B-BIOL SCI, V274, P1807, DOI 10.1098/rspb.2007.0174; NADEAU NJ, 2007, ANIM GENET, V37, P1; Piertney SB, 2010, GENETICA, V138, P419, DOI 10.1007/s10709-008-9322-2; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; TAJIMA F, 1989, GENETICS, V123, P585; Theron E, 2001, CURR BIOL, V11, P550, DOI 10.1016/S0960-9822(01)00158-0; Vage DI, 2005, PEPTIDES, V26, P1814, DOI 10.1016/j.peptides.2004.11.040; WRIGHT S, 1951, ANN EUGENIC, V15, P323	32	15	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10334	10.1371/journal.pone.0010334	http://dx.doi.org/10.1371/journal.pone.0010334			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428241	gold, Green Published, Green Submitted			2022-12-25	WOS:000277079300018
J	Stokes, EJ; Strindberg, S; Bakabana, PC; Elkan, PW; Iyenguet, FC; Madzoke, B; Malanda, GAF; Mowawa, BS; Moukoumbou, C; Ouakabadio, FK; Rainey, HJ				Stokes, Emma J.; Strindberg, Samantha; Bakabana, Parfait C.; Elkan, Paul W.; Iyenguet, Fortune C.; Madzoke, Bola; Malanda, Guy Aime F.; Mowawa, Brice S.; Moukoumbou, Calixte; Ouakabadio, Franck K.; Rainey, Hugo J.			Monitoring Great Ape and Elephant Abundance at Large Spatial Scales: Measuring Effectiveness of a Conservation Landscape	PLOS ONE			English	Article							LOXODONTA-AFRICANA-CYCLOTIS; WESTERN LOWLAND GORILLAS; LOGGING CONCESSION; FOREST ELEPHANTS; SPECIES APPROACH; PROTECTED AREAS; SWAMP FOREST; CONGO; CHIMPANZEES; MANAGEMENT	Protected areas are fundamental to biodiversity conservation, but there is growing recognition of the need to extend beyond protected areas to meet the ecological requirements of species at larger scales. Landscape-scale conservation requires an evaluation of management impact on biodiversity under different land-use strategies; this is challenging and there exist few empirical studies. In a conservation landscape in northern Republic of Congo we demonstrate the application of a large-scale monitoring program designed to evaluate the impact of conservation interventions on three globally threatened species: western gorillas, chimpanzees and forest elephants, under three land-use types: integral protection, commercial logging, and community-based natural resource management. We applied distance-sampling methods to examine species abundance across different land-use types under varying degrees of management and human disturbance. We found no clear trends in abundance between land-use types. However, units with interventions designed to reduce poaching and protect habitats irrespective of land-use type - harboured all three species at consistently higher abundance than a neighbouring logging concession undergoing no wildlife management. We applied Generalized-Additive Models to evaluate a priori predictions of species response to different landscape processes. Our results indicate that, given adequate protection from poaching, elephants and gorillas can profit from herbaceous vegetation in recently logged forests and maintain access to ecologically important resources located outside of protected areas. However, proximity to the single integrally protected area in the landscape maintained an overriding positive influence on elephant abundance, and logging roads - even subject to anti-poaching controls - were exploited by elephant poachers and had a major negative influence on elephant distribution. Chimpanzees show a clear preference for unlogged or more mature forests and human disturbance had a negative influence on chimpanzee abundance, in spite of anti-poaching interventions. We caution against the pitfalls of missing and confounded co-variables in model-based estimation approaches and highlight the importance of spatial scale in the response of different species to landscape processes. We stress the importance of a stratified design-based approach to monitoring species status in response to conservation interventions and advocate a holistic framework for landscape-scale monitoring that includes smaller-scale targeted research and punctual assessment of threats.	[Stokes, Emma J.; Strindberg, Samantha; Elkan, Paul W.; Rainey, Hugo J.] Wildlife Conservat Soc, Global Conservat Program, New York, NY USA; [Bakabana, Parfait C.; Iyenguet, Fortune C.; Madzoke, Bola; Malanda, Guy Aime F.; Ouakabadio, Franck K.] Wildlife Conservat Soc, Congo Program, Brazzaville, Rep Congo; [Mowawa, Brice S.] Minist Econ Forestiere, Brazzaville, Rep Congo	Wildlife Conservation Society	Stokes, EJ (corresponding author), Wildlife Conservat Soc, Global Conservat Program, New York, NY USA.	estokes@wcs.org	Rainey, Hugo/I-6047-2012		United States Fish and Wildlife Service; United States Agency for International Development; Wildlife Conservation Society	United States Fish and Wildlife Service(US Fish & Wildlife Service); United States Agency for International Development(United States Agency for International Development (USAID)); Wildlife Conservation Society	This work was funded by the United States Fish and Wildlife Service Great Ape and African Elephant Conservation Funds (http://www.fws.gov/international/DIC/species/species.html) with additional support from the United States Agency for International Development, Central African Regional Program for the Environment (http://carpe.umd.edu), and the Wildlife Conservation Society's Global Conservation Program (http://www.wcs.org). The views expressed here do not necessarily represent those of the US government or its agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, ESTIMATION ANIMAL AB; Arnhem E, 2008, FOLIA PRIMATOL, V79, P1, DOI 10.1159/000107664; Balcomb SR, 2000, AM J PRIMATOL, V51, P197, DOI 10.1002/1098-2345(200007)51:3&lt;197::AID-AJP4&gt;3.0.CO;2-C; BARNES R, 1987, TECHNICAL B AFRICAN, P1; BARNES RFW, 1991, AFR J ECOL, V29, P54, DOI 10.1111/j.1365-2028.1991.tb00820.x; BARNES RFW, 1995, J TROP ECOL, V11, P27, DOI 10.1017/S0266467400008361; Barnes RFW, 2001, AFR J ECOL, V39, P1, DOI 10.1046/j.1365-2028.2001.00266.x; Barrows CW, 2007, NAT AREA J, V27, P194, DOI 10.3375/0885-8608(2007)27[194:BMABTG]2.0.CO;2; Blake S, 2004, BIOTROPICA, V36, P392, DOI 10.1646/03215; Blake S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003546; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Blom A, 2004, BIODIVERS CONSERV, V13, P2661, DOI 10.1007/s10531-004-2138-1; Bradley BJ, 2008, J ZOOL, V275, P333, DOI 10.1111/j.1469-7998.2008.00431.x; Brandon K, 2002, MAKING PARKS WORK: STRATEGIES FOR PRESERVING TROPICAL NATURE, P443; Breuer T, 2007, PACHYDERM, P43; Buckland S.T., 2001, pi; BUCKLAND ST, 1984, BIOMETRICS, V40, P811, DOI 10.2307/2530926; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; Clark CJ, 2009, CONSERV BIOL, V23, P1281, DOI 10.1111/j.1523-1739.2009.01243.x; Congo Basin Forest Partnership, 2006, FOR CONG BAS STAT FO; Coppolillo P, 2004, BIOL CONSERV, V115, P419, DOI 10.1016/S0006-3207(03)00159-9; Danielsen F, 2003, ORYX, V37, P407, DOI 10.1017/S0030605303000735; DeFries R, 2007, ECOL APPL, V17, P1031, DOI 10.1890/05-1111; Di Stefano J, 2003, FUNCT ECOL, V17, P707, DOI 10.1046/j.1365-2435.2003.00782.x; Didier KA, 2009, ORYX, V43, P476, DOI 10.1017/S0030605309000945; Dixon PM, 1998, ECOL APPL, V8, P225, DOI 10.1890/1051-0761(1998)008[0225:MTIER]2.0.CO;2; Dupain J, 2004, ORYX, V38, P209, DOI 10.1017/S0030605304000365; Elkan Paul W., 2006, P393; FAY JM, 1991, AFR J ECOL, V29, P177, DOI 10.1111/j.1365-2028.1991.tb01000.x; FAY JM, 1989, INT J PRIMATOL, V10, P477, DOI 10.1007/BF02736372; FAY JM, 1992, AM J PRIMATOL, V27, P275, DOI 10.1002/ajp.1350270405; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Field SA, 2005, J WILDLIFE MANAGE, V69, P473, DOI 10.2193/0022-541X(2005)069[0473:OAOMEU]2.0.CO;2; Gardner TA, 2007, CONSERV BIOL, V21, P1516, DOI 10.1111/j.1523-1739.2007.00794.x; GERRODETTE T, 1987, ECOLOGY, V68, P1364, DOI 10.2307/1939220; Grossmann F, 2008, DEV PRIMATOL-PROG PR, P189, DOI 10.1007/978-0-387-74787-3_11; Guschanski K, 2009, BIOL CONSERV, V142, P290, DOI 10.1016/j.biocon.2008.10.024; Kamdem-Toham A, 2003, SCIENCE, V299, P346, DOI 10.1126/science.299.5605.346; Kano Takayoshi, 1994, African Study Monographs, V15, P143; Kapos V, 2009, ORYX, V43, P336, DOI 10.1017/S0030605309990275; Klaus G, 1998, J TROP ECOL, V14, P829, DOI 10.1017/S0266467498000595; Kuehl HS, 2007, ECOL APPL, V17, P2403, DOI 10.1890/06-0934.1; Kuehl HS, 2009, BIOL CONSERV, V142, P1500, DOI 10.1016/j.biocon.2009.02.032; Laing SE, 2003, J APPL ECOL, V40, P1102, DOI 10.1111/j.1365-2664.2003.00861.x; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Legg CJ, 2006, J ENVIRON MANAGE, V78, P194, DOI 10.1016/j.jenvman.2005.04.016; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Lyons JE, 2008, J WILDLIFE MANAGE, V72, P1683, DOI 10.2193/2008-141; Magliocca F, 2002, AM J PRIMATOL, V57, P67, DOI 10.1002/ajp.10034; Manley PN, 2004, ECOL APPL, V14, P296, DOI 10.1890/02-5249; Matthews A, 2004, PRIMATES, V45, P15, DOI 10.1007/s10329-003-0058-4; Morgan D, 2006, INT J PRIMATOL, V27, P147, DOI 10.1007/s10764-005-9013-0; Morgan D., 2007, BEST PRACTICE GUIDEL, P32; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Plumptre AJ, 2000, J APPL ECOL, V37, P356, DOI 10.1046/j.1365-2664.2000.00499.x; Plumptre Andrew J., 2001, P71; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; Poulsen JR, 2009, CONSERV BIOL, V23, P1597, DOI 10.1111/j.1523-1739.2009.01251.x; Poulsen JR, 2007, CONSERV SCI PRACT, V2, P140; Poulsen JR, 2004, INT J PRIMATOL, V25, P285, DOI 10.1023/B:IJOP.0000019153.50161.58; Pullin AS, 2009, BIOL CONSERV, V142, P931, DOI 10.1016/j.biocon.2009.01.010; R Core Team, 2022, R LANG ENV STAT COMP; Rainey HJ, 2010, ORYX, V44, P124, DOI 10.1017/S003060530999010X; Robinson JG, 1999, SCIENCE, V284, P595, DOI 10.1126/science.284.5414.595; Rosenzweig M. L., 2003, WIN WIN ECOLOGY EART; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sanderson EW, 2002, LANDSCAPE URBAN PLAN, V58, P41, DOI 10.1016/S0169-2046(01)00231-6; Sanz C, 2007, J APPL ECOL, V44, P263, DOI 10.1111/j.1365-2664.2007.01278.x; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; TCHAMBA MN, 1992, MAMMALIA, V56, P155; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; *TROP FOR TRUST, 2008, CIBS TOT FSC CERT AR; TURNER MG, 1995, ECOL APPL, V5, P12, DOI 10.2307/1942046; Tutin C., 2005, REGIONAL ACTION PLAN; TUTIN CEG, 1984, AM J PRIMATOL, V6, P313, DOI 10.1002/ajp.1350060403; TUTIN CEG, 1995, INT J PRIMATOL, V16, P53, DOI 10.1007/BF02700153; Vogel G, 2008, SCIENCE, V321, P756, DOI 10.1126/science.321.5890.756b; Walsh PD, 2005, ECOL APPL, V15, P1342, DOI 10.1890/03-5283; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Walters C, 1986, ADAPTIVE MANAGEMENT; WHITE F, 1981, VEGETATION AFRICA; White Lee J.T., 2001, P449; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI 10.1046/j.1523-1739.2000.99102.x; Wood S., 2006, GEN ADDITIVE MODELS, DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	86	112	114	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10294	10.1371/journal.pone.0010294	http://dx.doi.org/10.1371/journal.pone.0010294			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428233	Green Submitted, Green Published, gold			2022-12-25	WOS:000277079300006
J	Posey, KL; Liu, PM; Wang, HR; Veerisetty, AC; Alcorn, JL; Hecht, JT				Posey, Karen L.; Liu, Peiman; Wang, Huiqiu R.; Veerisetty, Alka C.; Alcorn, Joseph L.; Hecht, Jacqueline T.			RNAi Reduces Expression and Intracellular Retention of Mutant Cartilage Oligomeric Matrix Protein	PLOS ONE			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; SMALL INTERFERING RNA; SHORT HAIRPIN RNAS; ENDOPLASMIC-RETICULUM; IN-VIVO; ARTICULAR-CARTILAGE; COMP MUTATIONS; IX COLLAGEN; CELL-DEATH; PSEUDOACHONDROPLASIA	Mutations in cartilage oligomeric matrix protein (COMP), a large extracellular glycoprotein expressed in musculoskeletal tissues, cause two skeletal dysplasias, pseudoachondroplasia and multiple epiphyseal dysplasia. These mutations lead to massive intracellular retention of COMP, chondrocyte death and loss of growth plate chondrocytes that are necessary for linear growth. In contrast, COMP null mice have only minor growth plate abnormalities, normal growth and longevity. This suggests that reducing mutant and wild-type COMP expression in chondrocytes may prevent the toxic cellular phenotype causing the skeletal dysplasias. We tested this hypothesis using RNA interference to reduce steady state levels of COMP mRNA. A panel of shRNAs directed against COMP was tested. One shRNA (3B) reduced endogenous and recombinant COMP mRNA dramatically, regardless of expression levels. The activity of the shRNA against COMP mRNA was maintained for up to 10 weeks. We also demonstrate that this treatment reduced ER stress. Moreover, we show that reducing steady state levels of COMP mRNA alleviates intracellular retention of other extracellular matrix proteins associated with the pseudoachondroplasia cellular pathology. These findings are a proof of principle and the foundation for the development of a therapeutic intervention based on reduction of COMP expression.	[Posey, Karen L.; Liu, Peiman; Wang, Huiqiu R.; Veerisetty, Alka C.; Alcorn, Joseph L.; Hecht, Jacqueline T.] Univ Texas Houston, Sch Med, Dept Pediat, Houston, TX 77030 USA; [Hecht, Jacqueline T.] Shriners Hosp Children, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Posey, KL (corresponding author), Univ Texas Houston, Sch Med, Dept Pediat, Houston, TX 77030 USA.	Karen.Posey@uth.tmc.edu		, karen/0000-0003-1234-6087	Department of Pediatrics at the University of Texas Medical School at Houston; Shriners Hospital	Department of Pediatrics at the University of Texas Medical School at Houston; Shriners Hospital	This research was funded by a grant from the Department of Pediatrics at the University of Texas Medical School at Houston to Karen Posey and a grant from Shriners Hospital to Jacqueline Hecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J. C., 1995, THROMBOSPONDIN GENE; Andersson MLE, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-98; Bahi A, 2005, J NEUROCHEM, V92, P1243, DOI 10.1111/j.1471-4159.2004.02961.x; Briggs MD, 1998, AM J HUM GENET, V62, P311, DOI 10.1086/301713; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Campbell Tessa N, 2004, Genet Mol Res, V3, P282; Cashman SM, 2006, INVEST OPHTH VIS SCI, V47, P3496, DOI 10.1167/iovs.05-1610; Chen TLL, 2008, J CELL BIOCHEM, V103, P778, DOI 10.1002/jcb.21445; Christoph T, 2007, NEUROCHEM INT, V50, P281, DOI 10.1016/j.neuint.2006.08.017; Clark AG, 1999, ARTHRITIS RHEUM, V42, P2356, DOI 10.1002/1529-0131(199911)42:11<2356::AID-ANR14>3.0.CO;2-R; COOPER RR, 1973, J BONE JOINT SURG AM, VA 55, P475, DOI 10.2106/00004623-197355030-00003; Davidson BL, 2005, METHOD ENZYMOL, V392, P145, DOI 10.1016/S0076-6879(04)92009-5; Deere M, 1999, AM J MED GENET, V85, P486, DOI 10.1002/(SICI)1096-8628(19990827)85:5<486::AID-AJMG10>3.0.CO;2-O; Deere M, 1998, AM J MED GENET, V80, P510, DOI 10.1002/(SICI)1096-8628(19981228)80:5<510::AID-AJMG14>3.0.CO;2-F; Diab M, 1996, BIOCHEM J, V314, P327, DOI 10.1042/bj3140327; Diaz-Font A, 2006, BLOOD CELL MOL DIS, V37, P197, DOI 10.1016/j.bcmd.2006.07.002; DICESARE PE, 1995, J ORTHOPAED RES, V13, P422, DOI 10.1002/jor.1100130316; DICESARE PE, 1994, EUR J BIOCHEM, V223, P927, DOI 10.1111/j.1432-1033.1994.tb19070.x; Eter N, 2006, BIODRUGS, V20, P167, DOI 10.2165/00063030-200620030-00004; Fang C, 2000, J ORTHOPAED RES, V18, P593, DOI 10.1002/jor.1100180412; Fang C, 2001, J ORTHOPAED RES, V19, P634, DOI 10.1016/S0736-0266(00)00039-5; Gonzalez-Alegre P, 2005, J NEUROSCI, V25, P10502, DOI 10.1523/JNEUROSCI.3016-05.2005; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hashimoto Y, 2003, AM J PATHOL, V163, P101, DOI 10.1016/S0002-9440(10)63634-6; Hecht JT, 1998, MATRIX BIOL, V17, P269, DOI 10.1016/S0945-053X(98)90080-4; Hecht JT, 2005, MATRIX BIOL, V23, P525, DOI 10.1016/j.matbio.2004.09.006; Hecht JT, 2004, J ORTHOP RES, V22, P759, DOI 10.1016/j.orthres.2003.11.010; Hecht JT, 1998, MATRIX BIOL, V17, P625, DOI 10.1016/S0945-053X(98)90113-5; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; Hecht JT, 2001, MATRIX BIOL, V20, P251, DOI 10.1016/S0945-053X(01)00136-6; Kappel S, 2006, NUCLEIC ACIDS RES, V34, P4527, DOI 10.1093/nar/gkl628; Karen LP, 2004, INT J BIOCHEM CELL B, V36, P1005, DOI 10.1016/j.biocel.2004.01.011; Kim SS, 2010, MOL THER, V18, P370, DOI 10.1038/mt.2009.271; King KB, 2003, J CELL BIOCHEM, V89, P992, DOI 10.1002/jcb.10571; Kleerekoper Q, 2002, J BIOL CHEM, V277, P10581, DOI 10.1074/jbc.M109944200; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Koelling S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1922; Lopez-Fraga M., 2008, Infectious Disorders - Drug Targets, V8, P262; Merritt TM, 2007, AM J PATHOL, V170, P293, DOI 10.2353/ajpath.2007.060530; Merritt TM, 2006, J ORTHOP RES, V24, P700, DOI 10.1002/jor.20100; Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093; Perkins GL, 2005, DIFFERENTIATION, V73, P199, DOI 10.1111/j.1432-0436.2005.00024.x; Pfeifer A, 2006, J CLIN INVEST, V116, P3204, DOI 10.1172/JCI29236; Posey KL, 2008, AM J PATHOL, V172, P1664, DOI 10.2353/ajpath.2008.071094; Posey KL, 2005, MATRIX BIOL, V24, P539, DOI 10.1016/j.matbio.2005.07.007; Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852; Takahashi Y, 2008, GENE THER, V15, P572, DOI 10.1038/sj.gt.3303103; Takanashi M, 2009, GENE THER, V16, P982, DOI 10.1038/gt.2009.66; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Takeshita Fumitaka, 2009, V487, P83, DOI 10.1007/978-1-60327-547-7_4; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; Unger S, 2001, AM J MED GENET, V106, P244, DOI 10.1002/ajmg.10234; Vorhies JS, 2007, BIOL-TARGETS THER, V1, P367; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Xia CF, 2009, MOL PHARMACEUT, V6, P747, DOI 10.1021/mp800194y; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yoo JY, 2007, MOL THER, V15, P295, DOI 10.1038/sj.mt.6300023; ZAMORAAVILA DE, 2009, CANC GENE THER	59	10	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10302	10.1371/journal.pone.0010302	http://dx.doi.org/10.1371/journal.pone.0010302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421976	Green Submitted, Green Published, gold			2022-12-25	WOS:000276952600019
J	Baber, I; Keita, M; Sogoba, N; Konate, M; Diallo, M; Doumbia, S; Traore, SF; Ribeiro, JMC; Manoukis, NC				Baber, Ibrahima; Keita, Moussa; Sogoba, Nafomon; Konate, Mamadou; Diallo, M'Bouye; Doumbia, Seydou; Traore, Sekou F.; Ribeiro, Jose M. C.; Manoukis, Nicholas C.			Population Size and Migration of Anopheles gambiae in the Bancoumana Region of Mali and Their Significance for Efficient Vector Control	PLOS ONE			English	Article							MALARIA TRANSMISSION; DRY SEASON; COMPLEX MOSQUITOS; CHROMOSOMAL FORMS; SUDAN SAVANNA; DISPERSAL; IDENTIFICATION; SURVIVAL; VILLAGE; ECOLOGY	We present results of two intensive mark-release-recapture surveys conducted during the wet and dry seasons of 2008 in the villages of Fourda and Kenieroba, Mali. The former is a small fishing village by the Niger River with a moderate to high densities of Anopheles gambiae Giles s.s. (Diptera: Culicidae) throughout the year, while the latter is a large agricultural community 2 km inland that experiences strong seasonal fluctuation in An. gambiae densities. We estimate the population size of female An. gambiae in Fourda to be in less than 3,000 during the dry season. We found evidence of large population size and migration from Fourda in Kenieroba during the wet season, but very low numbers and no sign of migrants during the dry season. We suggest that malaria vector control measures aimed at adult mosquitoes might be made more efficient in this region and other seasonal riparian habitats by targeting disruption of mosquito populations by the river during the dry season. This would decrease the size of an already small population, and would be likely to delay the explosive growth in vector numbers in the larger inland villages as rainfall increases.	[Baber, Ibrahima; Keita, Moussa; Sogoba, Nafomon; Konate, Mamadou; Diallo, M'Bouye; Doumbia, Seydou; Traore, Sekou F.] Univ Mali, Fac Med Pharm & Odontostomatol, Malaria Res & Training Ctr, Bamako, Mali; [Ribeiro, Jose M. C.; Manoukis, Nicholas C.] NIAID, Sect Vector Biol, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA	University of Bamako; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Baber, I (corresponding author), Univ Mali, Fac Med Pharm & Odontostomatol, Malaria Res & Training Ctr, Bamako, Mali.	manoukisn@niaid.nih.gov	Manoukis, Nicholas C./V-9063-2019	Manoukis, Nicholas C./0000-0001-5062-7256; Ribeiro, Jose/0000-0002-9107-0818	National Institutes of Allergies and Infectious Diseases (NIAID); National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001062] Funding Source: NIH RePORTER	National Institutes of Allergies and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the intramural program of the National Institutes of Allergies and Infectious Diseases (NIAID), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, MOSQUITO ECOLOGY FIE; BARTMANN RM, 1987, J WILDLIFE MANAGE, V51, P41, DOI 10.2307/3801626; Bates M., 1949, NATURAL HIST MOSQUIT; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Charlwood JD, 2000, AM J TROP MED HYG, V62, P726, DOI 10.4269/ajtmh.2000.62.726; Costantini C, 1996, MED VET ENTOMOL, V10, P203, DOI 10.1111/j.1365-2915.1996.tb00733.x; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; Dingle H., 1996, MIGRATION; Diuk-Wasser MA, 2005, AM J TROP MED HYG, V72, P725, DOI 10.4269/ajtmh.2005.72.725; Dolo A, 2003, Bull Soc Pathol Exot, V96, P308; Dolo A, 2003, Bull Soc Pathol Exot, V96, P287; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Feachem RGA, 2007, JAMA-J AM MED ASSOC, V297, P2281, DOI 10.1001/jama.297.20.2281; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; GILLIES M. T., 1961, BULL ENT RES, V52, P99, DOI 10.1017/S0007485300055309; GILLIES MT, 1965, B ENTOMOL RES, V56, P237, DOI 10.1017/S0007485300056339; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Jawara M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-156; Killeen GF, 2004, AM J TROP MED HYG, V71, P87, DOI 10.4269/ajtmh.2004.71.2_suppl.0700087; Killeen GF, 2003, LANCET INFECT DIS, V3, P297, DOI 10.1016/S1473-3099(03)00611-X; Kulkarni MA, 2006, J MED ENTOMOL, V43, P580, DOI 10.1603/0022-2585(2006)43[580:EEOMVA]2.0.CO;2; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; OMER SM, 1970, B WORLD HEALTH ORGAN, V42, P319; Ribeiro JMC, 1996, B WORLD HEALTH ORGAN, V74, P299; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Service MW, 1997, J MED ENTOMOL, V34, P579, DOI 10.1093/jmedent/34.6.579; Sogoba N, 2007, AM J TROP MED HYG, V77, P82, DOI 10.4269/ajtmh.2007.77.82; TAYLOR CE, 2007, ECOLOGICAL ASPECTS A, P133; Toure YT, 1998, MED VET ENTOMOL, V12, P74, DOI 10.1046/j.1365-2915.1998.00071.x; Toure YT, 1998, AM J TROP MED HYG, V59, P481, DOI 10.4269/ajtmh.1998.59.481; WARBURG A, 2002, ESTIVATION ANOPHELES; White GC, 1996, WILDLIFE SOC B, V24, P50	36	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10270	10.1371/journal.pone.0010270	http://dx.doi.org/10.1371/journal.pone.0010270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422013	gold, Green Published, Green Submitted			2022-12-25	WOS:000276952500025
J	Malmendal, A; Underhaug, J; Otzen, DE; Nielsen, NC				Malmendal, Anders; Underhaug, Jarl; Otzen, Daniel E.; Nielsen, Niels C.			Fast Mapping of Global Protein Folding States by Multivariate NMR: A GPS for Proteins	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; MOLTEN GLOBULE STATE; ALPHA-LACTALBUMIN; FIBRIL FORMATION; SPECTROSCOPY; LYSOZYME; PH	To obtain insight into the functions of proteins and their specific roles, it is important to establish efficient procedures for exploring the states that encapsulate their conformational space. Global Protein folding State mapping by multivariate NMR (GPS NMR) is a powerful high-throughput method that provides such an overview. GPS NMR exploits the unique ability of NMR to simultaneously record signals from individual hydrogen atoms in complex macromolecular systems and of multivariate analysis to describe spectral variations from these by a few variables for establishment of, and positioning in, protein-folding state maps. The method is fast, sensitive, and robust, and it works without isotope-labelling. The unique capabilities of GPS NMR to identify different folding states and to compare different unfolding processes are demonstrated by mapping of the equilibrium folding space of bovine alpha-lactalbumin in the presence of the anionic surfactant sodium dodecyl sulfate, SDS, and compare these with other surfactants, acid, denaturants and heat.	[Malmendal, Anders; Underhaug, Jarl; Otzen, Daniel E.; Nielsen, Niels C.] Aarhus Univ, Interdisciplinary Nanosci Ctr, Ctr Insoluble Prot Struct, Aarhus, Denmark; [Malmendal, Anders; Underhaug, Jarl; Nielsen, Niels C.] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark; [Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Malmendal, A (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr, Ctr Insoluble Prot Struct, Aarhus, Denmark.	anders@chem.au.dk; ncn@inano.dk	Malmendal, Anders/S-2014-2019; Malmendal, Anders/F-1198-2017	Malmendal, Anders/0000-0002-8413-9717; Malmendal, Anders/0000-0002-8413-9717; Underhaug, Jarl/0000-0003-0346-3986; Nielsen, Niels Chr./0000-0003-2978-4366; Otzen, Daniel/0000-0002-2918-8989	Danish National Research Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond)	The research was funded by the Danish National Research Foundation (http://www.dg.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDRESCU AT, 1993, BIOCHEMISTRY-US, V32, P1707, DOI 10.1021/bi00058a003; ALEXANDRESCU AT, 1994, J MOL BIOL, V235, P587, DOI 10.1006/jmbi.1994.1015; Aloy P, 2004, NAT BIOTECHNOL, V22, P1317, DOI 10.1038/nbt1018; BALARAM P, 1973, BIOCHEMISTRY-US, V12, P4695, DOI 10.1021/bi00747a024; Balbach J, 1996, SCIENCE, V274, P1161, DOI 10.1126/science.274.5290.1161; BALBACH J, 1995, NAT STRUCT BIOL, V2, P865, DOI 10.1038/nsb1095-865; Berglund A, 2005, J MAGN RESON, V172, P24, DOI 10.1016/j.jmr.2004.09.010; Chaudhuri TK, 1999, J MOL BIOL, V285, P1179, DOI 10.1006/jmbi.1998.2362; Chiti F, 2000, EMBO J, V19, P1441, DOI 10.1093/emboj/19.7.1441; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; DOMBI GW, 1985, BIOCHEM J, V228, P551, DOI 10.1042/bj2280551; Forge V, 1999, J MOL BIOL, V288, P673, DOI 10.1006/jmbi.1999.2687; Halskau O, 2005, J MOL BIOL, V349, P1072, DOI 10.1016/j.jmb.2005.04.020; HAMADA S, 1993, J PROTEIN CHEM, V12, P477, DOI 10.1007/BF01025048; IKEGUCHI M, 1986, J BIOCHEM-TOKYO, V99, P1191, DOI 10.1093/oxfordjournals.jbchem.a135582; KLEFHABER T, 1995, NATURE, V375, P513; KUWAJIMA K, 1976, J MOL BIOL, V106, P359, DOI 10.1016/0022-2836(76)90091-7; Kuwajima K, 1996, FASEB J, V10, P102, DOI 10.1096/fasebj.10.1.8566530; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Moosavi-Movahedi AA, 2007, COLLOID SURFACE B, V60, P55, DOI 10.1016/j.colsurfb.2007.05.018; Otzen DE, 2009, J COLLOID INTERF SCI, V329, P273, DOI 10.1016/j.jcis.2008.10.021; Perlo J, 2007, SCIENCE, V315, P1110, DOI 10.1126/science.1135499; Pertinhez TA, 2002, FEBS LETT, V529, P193, DOI 10.1016/S0014-5793(02)03333-1; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sakurai K, 2007, P NATL ACAD SCI USA, V104, P15346, DOI 10.1073/pnas.0702112104; Schanda P, 2007, P NATL ACAD SCI USA, V104, P11257, DOI 10.1073/pnas.0702069104; Schlepckow K, 2008, J MOL BIOL, V378, P686, DOI 10.1016/j.jmb.2008.02.033; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u	32	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10262	10.1371/journal.pone.0010262	http://dx.doi.org/10.1371/journal.pone.0010262			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20421996	Green Published, gold			2022-12-25	WOS:000276952500017
J	Tong, ZQ; Luo, WH; Wang, YQ; Yang, F; Han, Y; Li, H; Luo, HJ; Duan, B; Xu, TL; Maoying, QL; Tan, HY; Wang, J; Zhao, HM; Liu, FY; Wan, Y				Tong, Zhiqian; Luo, Wenhong; Wang, Yanqing; Yang, Fei; Han, Ying; Li, Hui; Luo, Hongjun; Duan, Bo; Xu, Tianle; Maoying, Qiliang; Tan, Huangying; Wang, Jun; Zhao, Hongmei; Liu, Fengyu; Wan, You			Tumor Tissue-Derived Formaldehyde and Acidic Microenvironment Synergistically Induce Bone Cancer Pain	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; COMPLETE FREUNDS-ADJUVANT; ISOLATED RAT HEPATOCYTES; HUMAN OSTEOBLASTIC CELLS; BREAST-CANCER; CAPSAICIN RECEPTOR; ION-CHANNEL; GLUTATHIONE; EXPRESSION; MELATONIN	Background: There is current interest in understanding the molecular mechanisms of tumor-induced bone pain. Accumulated evidence shows that endogenous formaldehyde concentrations are elevated in the blood or urine of patients with breast, prostate or bladder cancer. These cancers are frequently associated with cancer pain especially after bone metastasis. It is well known that transient receptor potential vanilloid receptor 1 (TRPV1) participates in cancer pain. The present study aims to demonstrate that the tumor tissue-derived endogenous formaldehyde induces bone cancer pain via TRPV1 activation under tumor acidic environment. Methodology/Principal Findings: Endogenous formaldehyde concentration increased significantly in the cultured breast cancer cell lines in vitro, in the bone marrow of breast MRMT-1 bone cancer pain model in rats and in tissues from breast cancer and lung cancer patients in vivo. Low concentrations (1 similar to 5 mM) of formaldehyde induced pain responses in rat via TRPV1 and this pain response could be significantly enhanced by pH 6.0 (mimicking the acidic tumor microenvironment). Formaldehyde at low concentrations (1 mM to 100 mM) induced a concentration-dependent increase of [Ca2+]i in the freshly isolated rat dorsal root ganglion neurons and TRPV1-transfected CHO cells. Furthermore, electrophysiological experiments showed that low concentration formaldehyde-elicited TRPV1 currents could be significantly potentiated by low pH (6.0). TRPV1 antagonists and formaldehyde scavengers attenuated bone cancer pain responses. Conclusions/Significance: Our data suggest that cancer tissues directly secrete endogenous formaldehyde, and this formaldehyde at low concentration induces metastatic bone cancer pain through TRPV1 activation especially under tumor acidic environment.	[Tong, Zhiqian; Yang, Fei; Han, Ying; Liu, Fengyu; Wan, You] Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China; [Luo, Wenhong; Li, Hui; Luo, Hongjun] Shantou Univ, Coll Med, Cent Lab, Shantou, Peoples R China; [Wang, Yanqing; Maoying, Qiliang] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Dept Integrat Med & Neurobiol, Shanghai 200433, Peoples R China; [Duan, Bo; Xu, Tianle] Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China; [Duan, Bo; Xu, Tianle] Chinese Acad Sci, Natl Key Lab Neurosci, Shanghai, Peoples R China; [Tan, Huangying] China Japan Friendship Hosp, Dept TCM Oncol, Beijing, Peoples R China; [Wang, Jun] Peking Univ, Peoples Hosp, Dept Thorat Surg, Beijing, Peoples R China; [Wan, You] Minist Publ Hlth, Minist Educ, Key Lab Neurosci, Beijing, Peoples R China	Peking University; Shantou University; Fudan University; Chinese Academy of Sciences; Chinese Academy of Sciences; China-Japan Friendship Hospital; Peking University	Tong, ZQ (corresponding author), Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China.	tzq88666883@sina.com; ywan@hsc.pku.edu.cn	Wan, You/M-5279-2019	Wan, You/0000-0001-6110-7192	National Natural Science Foundation of China [30700206, 30800332]; Ministry of Education of China [B07001]; National Basic Research Program of the Ministry of Science and Technology of China [2007CB512501]; Key Project of Chinese Ministry of Education [109003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); National Basic Research Program of the Ministry of Science and Technology of China; Key Project of Chinese Ministry of Education(Ministry of Education, China)	This research was supported by grants from the National Natural Science Foundation of China (30700206, 30800332), the 111 Project of the Ministry of Education of China (B07001), the National Basic Research Program of the Ministry of Science and Technology of China (2007CB512501) and Beijing Outstanding Ph.D. Program Mentor Grant, Key Project of Chinese Ministry of Education (109003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Audinot V, 2008, BIOCHEM PHARMACOL, V75, P2007, DOI 10.1016/j.bcp.2008.02.022; Ayar A, 2001, NEUROSCI LETT, V313, P73, DOI 10.1016/S0304-3940(01)02188-7; Balendiran GK, 2004, CELL BIOCHEM FUNCT, V22, P343, DOI 10.1002/cbf.1149; Barber RD, 1998, J MOL BIOL, V280, P775, DOI 10.1006/jmbi.1998.1900; Bode AM, 2009, CANCER RES, V69, P905, DOI 10.1158/0008-5472.CAN-08-3263; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Choi JY, 2003, PHARMACOGENETICS, V13, P67, DOI 10.1097/00008571-200302000-00002; Chuang HH, 2009, P NATL ACAD SCI USA, V106, P20097, DOI 10.1073/pnas.0902675106; Delaisse Jean-Marie, 1992, P289; Ebeler SE, 1997, J CHROMATOGR B, V702, P211, DOI 10.1016/S0378-4347(97)00369-1; Fujita F, 2008, J CLIN INVEST, V118, P4049, DOI 10.1172/JCI35957; Ghilardi JR, 2005, J NEUROSCI, V25, P3126, DOI 10.1523/JNEUROSCI.3815-04.2005; Gopinath Preethi, 2005, BMC Womens Health, V5, P2, DOI 10.1186/1472-6874-5-2; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; Gronvall JLE, 1998, LIFE SCI, V63, P759, DOI 10.1016/S0024-3205(98)00331-2; Hartel M, 2006, GUT, V55, P519, DOI 10.1136/gut.2005.073205; Heck HD, 2004, REGUL TOXICOL PHARM, V40, P92, DOI 10.1016/j.yrtph.2004.05.001; Hedberg JJ, 2000, AM J PATHOL, V157, P1745, DOI 10.1016/S0002-9440(10)64811-0; Ho YC, 2007, J BIOMED MATER RES B, V83B, P340, DOI 10.1002/jbm.b.30801; Huang FM, 2005, J BIOMED MATER RES B, V74B, P768, DOI 10.1002/jbm.b.30283; Kanai Y, 2006, J PHARM PHARMACOL, V58, P489, DOI 10.1211/jpp.58.4.0008; KU RH, 1984, CHEM-BIOL INTERACT, V51, P25, DOI 10.1016/0009-2797(84)90017-6; Lazzeri M, 2005, EUR UROL, V48, P691, DOI 10.1016/j.eururo.2005.05.018; LIZCANO JM, 1991, BIOCHEM PHARMACOL, V42, P263, DOI 10.1016/0006-2952(91)90712-E; Luo H, 2004, NEUROREPORT, V15, P655, DOI 10.1097/00001756-200403220-00016; Luo WH, 2001, J CHROMATOGR B, V753, P253, DOI 10.1016/S0378-4347(00)00552-1; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Mantyh PW, 2002, NAT REV CANCER, V2, P201, DOI 10.1038/nrc747; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Medhurst SJ, 2002, PAIN, V96, P129, DOI 10.1016/S0304-3959(01)00437-7; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Nagae M, 2007, J BONE MINER METAB, V25, P99, DOI 10.1007/s00774-006-0734-8; Niiyama Y, 2007, NEUROSCIENCE, V148, P560, DOI 10.1016/j.neuroscience.2007.05.049; Perissin L, 2004, PAIN, V110, P250, DOI 10.1016/j.pain.2004.03.039; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Ray M, 2004, Indian J Med Sci, V58, P122; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Retfalvi T, 1998, ACTA BIOL HUNG, V49, P375; Rozylo TK, 2000, BIOMED CHROMATOGR, V14, P173, DOI 10.1002/1099-0801(200005)14:3<173::AID-BMC957>3.0.CO;2-O; Sabino Mary Ann C, 2005, J Support Oncol, V3, P15; Saiko P, 2008, MUTAT RES-REV MUTAT, V658, P68, DOI 10.1016/j.mrrev.2007.08.004; Santos ARS, 1997, NEUROSCI LETT, V235, P73, DOI 10.1016/S0304-3940(97)00722-2; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shin CY, 2003, MOL CELL NEUROSCI, V24, P57, DOI 10.1016/S1044-7431(03)00121-0; Shinoda M, 2008, J PAIN, V9, P687, DOI 10.1016/j.jpain.2008.02.007; Spanel P, 1999, RAPID COMMUN MASS SP, V13, P1354, DOI 10.1002/(SICI)1097-0231(19990730)13:14<1354::AID-RCM641>3.0.CO;2-J; STAAB CA, 2008, BIOCHEM J, P493; Szallasi A, 1999, PHARMACOL REV, V51, P159; Szende B, 1998, ACTA BIOL HUNG, V49, P323; Szende B, 2000, EXP MOL MED, V32, P88, DOI 10.1038/emm.2000.16; Teng S, 2001, CHEM-BIOL INTERACT, V130, P285, DOI 10.1016/S0009-2797(00)00272-6; Terry MB, 2006, CARCINOGENESIS, V27, P840, DOI 10.1093/carcin/bgi285; THORNDIKE J, 1977, CANCER RES, V37, P1125; Tian Li-Juan, 2009, Shengli Xuebao, V61, P404; Torres-Lopez JE, 2002, LIFE SCI, V70, P1669, DOI 10.1016/S0024-3205(02)01491-1; Tortorici S, 2007, BRIT DENT J, V203, P511, DOI 10.1038/bdj.2007.995; Travis RC, 2004, JNCI-J NATL CANCER I, V96, P475, DOI 10.1093/jnci/djh077; Trevisani M, 2002, NAT NEUROSCI, V5, P546, DOI 10.1038/nn852; TREZL L, 1983, BIOCHEM J, V214, P289, DOI 10.1042/bj2140289; Tu HY, 2004, J NEUROSCI RES, V76, P713, DOI 10.1002/jnr.20109; Tu YJ, 2004, PAIN, V109, P340, DOI 10.1016/j.pain.2004.01.027; Tyihak E, 2001, CELL PROLIFERAT, V34, P135, DOI 10.1046/j.1365-2184.2001.00206.x; Ugawa S, 2002, J CLIN INVEST, V110, P1185, DOI 10.1172/JCI200215709; Walker K, 2002, PAIN, V100, P219, DOI 10.1016/S0304-3959(02)00040-4; Wang MY, 2009, CANCER RES, V69, P7170, DOI 10.1158/0008-5472.CAN-09-1571; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Yeh CC, 2006, CELL BIOCHEM FUNCT, V24, P555, DOI 10.1002/cbf.1275; Yu L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-61; Yu PH, 1997, NEUROCHEM RES, V22, P615, DOI 10.1023/A:1022478221421; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	71	85	93	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10234	10.1371/journal.pone.0010234	http://dx.doi.org/10.1371/journal.pone.0010234			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422007	Green Published, Green Submitted, gold			2022-12-25	WOS:000276952500011
J	Chan, CEZ; Lim, APC; Chan, AHY; MacAry, PA; Hanson, BJ				Chan, Conrad En Zuo; Lim, Angeline Pei Chiew; Chan, Annie Hoi Yi; MacAry, Paul A.; Hanson, Brendon John			Optimized Expression of Full-Length IgG1 Antibody in a Common E. coli Strain	PLOS ONE			English	Article							ESCHERICHIA-COLI; CARBOHYDRATE STRUCTURE; EFFECTOR FUNCTIONS; GLYCOSYLATION; CYTOPLASM; FRAGMENT; MUTANTS; LEVEL; CELLS	Multi-polypeptide proteins such as antibodies are difficult to express in prokaryotic systems such as E. coli due to the complexity of protein folding plus secretion. Thus far, proprietary strains or fermenter cultures have been required for appreciable yields. Previous studies have shown that expression of heterologous proteins in E. coli can be enhanced by the reduction of protein translation rates. In this paper, we demonstrate that useful quantities of full-length IgG can be expressed and purified from the common E. coli laboratory strain HB2151 in standard shaking culture using a simple strategy of reduced inducer concentration combined with delayed induction times to modulate translation rates. Purified IgG had only marginally reduced avidity compared to mammalian derived IgG. This indicates that this technique can be used to derive antibodies of potentially equal utility as those expressed in mammalian cell culture, particularly for applications where effector functions mediated by the glycosylated residues in the Fragment Crystallizable (Fc) portion of the immunoglobulin are not required.	[Chan, Conrad En Zuo; Lim, Angeline Pei Chiew; Chan, Annie Hoi Yi; Hanson, Brendon John] DSO Natl Labs, Def Med & Environm Res Inst, Med Countermeasures Biol Lab, Singapore, Singapore; [Chan, Conrad En Zuo; MacAry, Paul A.] Natl Univ Singapore, Program Immunol, Dept Microbiol, Singapore 117548, Singapore	National University of Singapore	Chan, CEZ (corresponding author), DSO Natl Labs, Def Med & Environm Res Inst, Med Countermeasures Biol Lab, Singapore, Singapore.	hbrendon@dso.org.sg		MacAry, Paul/0000-0002-1139-8996				Chadd HE, 2001, CURR OPIN BIOTECH, V12, P188, DOI 10.1016/S0958-1669(00)00198-1; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Jefferis R, 2005, BIOTECHNOL PROGR, V21, P11, DOI 10.1021/bp040016j; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Levy R, 2001, PROTEIN EXPRES PURIF, V23, P338, DOI 10.1006/prep.2001.1520; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mazor Y, 2007, NAT BIOTECHNOL, V25, P563, DOI 10.1038/nbt1296; Presta LG, 2006, ADV DRUG DELIVER REV, V58, P640, DOI 10.1016/j.addr.2006.01.026; Simmons LC, 1996, NAT BIOTECHNOL, V14, P629, DOI 10.1038/nbt0596-629; Simmons LC, 2002, J IMMUNOL METHODS, V263, P133, DOI 10.1016/S0022-1759(02)00036-4; SKERRA A, 1994, GENE, V151, P131, DOI 10.1016/0378-1119(94)90643-2; TAO MH, 1989, J IMMUNOL, V143, P2595; Venturi M, 2002, J MOL BIOL, V315, P1, DOI 10.1006/jmbi.2001.5221; WALKER MR, 1989, BIOCHEM J, V259, P347, DOI 10.1042/bj2590347; Wright A, 1998, J IMMUNOL, V160, P3393; WRIGHT A, 1994, J EXP MED, V180, P1087, DOI 10.1084/jem.180.3.1087	16	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10261	10.1371/journal.pone.0010261	http://dx.doi.org/10.1371/journal.pone.0010261			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422027	Green Published, Green Submitted, gold			2022-12-25	WOS:000276854300017
J	Li, N; McMurry, T; Berg, A; Wang, Z; Berceli, SA; Wu, RL				Li, Ning; McMurry, Timothy; Berg, Arthur; Wang, Zhong; Berceli, Scott A.; Wu, Rongling			Functional Clustering of Periodic Transcriptional Profiles through ARMA(p,q)	PLOS ONE			English	Article							COVARIANCE-MATRIX; LONGITUDINAL DATA; EXPRESSED GENES; MODEL; SERIES; PATTERNS	Background: Gene clustering of periodic transcriptional profiles provides an opportunity to shed light on a variety of biological processes, but this technique relies critically upon the robust modeling of longitudinal covariance structure over time. Methodology: We propose a statistical method for functional clustering of periodic gene expression by modeling the covariance matrix of serial measurements through a general autoregressive moving-average process of order (p,q), the so-called ARMA(p,q). We derive a sophisticated EM algorithm to estimate the proportions of each gene cluster, the Fourier series parameters that define gene-specific differences in periodic expression trajectories, and the ARMA parameters that model the covariance structure within a mixture model framework. The orders p and q of the ARMA process that provide the best fit are identified by model selection criteria. Conclusions: Through simulated data we show that whenever it is necessary, employment of sophisticated covariance structures such as ARMA is crucial in order to obtain unbiased estimates of the mean structure parameters and increased precision of estimation. The methods were implemented on recently published time-course gene expression data in yeast and the procedure was shown to effectively identify interesting periodic clusters in the dataset. The new approach will provide a powerful tool for understanding biological functions on a genomic scale.	[Li, Ning] Univ Florida, Dept Epidemiol & Biostat, Gainesville, FL 32610 USA; [McMurry, Timothy] Depaul Univ, Dept Math Sci, Chicago, IL 60604 USA; [Berg, Arthur; Wang, Zhong; Wu, Rongling] Penn State Univ, Coll Med, Div Biostat, Hershey, PA USA; [Berg, Arthur; Wu, Rongling] Beijing Forestry Univ, Ctr Computat Biol, Beijing, Peoples R China; [Berceli, Scott A.] Univ Florida, Dept Surg, Gainesville, FL USA	State University System of Florida; University of Florida; DePaul University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Beijing Forestry University; State University System of Florida; University of Florida	Li, N (corresponding author), Univ Florida, Dept Epidemiol & Biostat, Gainesville, FL 32610 USA.	rwu@hes.hmc.psu.edu	Wang, Zhong/C-3737-2014	Berceli, Scott/0000-0003-2257-0111; Berg, Arthur/0000-0002-4097-7348	National Science Foundation (NSF) [00060643]; Changjiang Scholarship Award at Beijing Forestry University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095508] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Changjiang Scholarship Award at Beijing Forestry University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Science Foundation (NSF) grant (00060643) and the Changjiang Scholarship Award at Beijing Forestry University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ATTINGER EO, 1966, BIOPHYS J, V6, P291, DOI 10.1016/S0006-3495(66)86657-2; Begum Esmot ara, 2006, J Circadian Rhythms, V4, P11, DOI 10.1186/1740-3391-4-11; Box G.E.P., 1976, TIME SERIES ANAL FOR; Brockwell P.J., 1991, TIME SERIES THEORY M; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; FAN J, 2008, J ROYAL STAT SOC B; Fan JQ, 2007, J AM STAT ASSOC, V102, P632, DOI 10.1198/016214507000000095; Fan JQ, 2008, J ECONOMETRICS, V147, P186, DOI 10.1016/j.jeconom.2008.09.017; Fraley C., 2009, MCLUST MODEL BASED C; Frank O, 1926, Z BIOL-MUNICH, V85, P91; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; Haddad JN, 2004, J TIME SER ANAL, V25, P443, DOI 10.1111/j.1467-9892.2004.01454.x; Inoue L. Y., 2007, BIOSTATISTICS; KIM B, 2008, GENETICS; Kim BR, 2006, CURR GENOMICS, V7, P197, DOI 10.2174/138920206777780229; LAKINTHOMAS P, 2004, CIRCADIAN RHYTHMS MI; Luan Y, 2004, BIOINFORMATICS, V20, P332, DOI 10.1093/bioinformatics/btg413; Luan YH, 2003, BIOINFORMATICS, V19, P474, DOI 10.1093/bioinformatics/btg014; Ma P, 2006, NUCLEIC ACIDS RES, V34, P1261, DOI 10.1093/nar/gkl013; Mager DE, 2007, J PHARMACOL EXP THER, V321, P423, DOI 10.1124/jpet.106.113183; MCLACHLAN G, 2000, WILEY SER PROB STAT, P1; MCMURRY T, 2009, GENEARMA SIMULATE MO; MITCHISON J, 2003, INT REV CYTOL, P166; Ng SK, 2006, BIOINFORMATICS, V22, P1745, DOI 10.1093/bioinformatics/btl165; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Pandit SM, 1983, TIME SERIES SYSTEM A; Park T, 2003, BIOINFORMATICS, V19, P694, DOI 10.1093/bioinformatics/btg068; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Rovery C, 2005, ANN NY ACAD SCI, V1063, P79, DOI 10.1196/annals.1355.011; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; Zeng DL, 2005, LIFETIME DATA ANAL, V11, P151, DOI 10.1007/s10985-004-0381-0	35	51	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e9894	10.1371/journal.pone.0009894	http://dx.doi.org/10.1371/journal.pone.0009894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419127	gold, Green Submitted, Green Published			2022-12-25	WOS:000276743500005
J	Maher, MT; Mo, RG; Flozak, AS; Peled, ON; Gottardi, CJ				Maher, Meghan T.; Mo, Rigen; Flozak, Annette S.; Peled, Ofra N.; Gottardi, Cara J.			beta-Catenin Phosphorylated at Serine 45 Is Spatially Uncoupled from beta-Catenin Phosphorylated in the GSK3 Domain: Implications for Signaling	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; NUCLEAR-LOCALIZATION; ALPHA-CATENIN; TRANSCRIPTIONAL ACTIVITY; PLASMA-MEMBRANE; XENOPUS EMBRYOS; COMPLEX; ADHESION; CELL; APC	C. elegans and Drosophila generate distinct signaling and adhesive forms of beta-catenin at the level of gene expression. Whether vertebrates, which rely on a single beta-catenin gene, generate unique adhesive and signaling forms at the level of protein modification remains unresolved. We show that beta-catenin unphosphorylated at serine 37 (S37) and threonine 41 (T41), commonly referred to as transcriptionally Active beta-Catenin (ABC), is a minor nuclear-enriched monomeric form of beta-catenin in SW480 cells, which express low levels of E-cadherin. Despite earlier indications, the superior signaling activity of ABC is not due to reduced cadherin binding, as ABC is readily incorporated into cadherin contacts in E-cadherin-restored cells. beta-catenin phosphorylated at serine 45 (S45) or threonine 41 (T41) (T41/S45) or along the GSK3 regulatory cassette S33, S37 or T41 (S33/37/T41), however, is largely unable to associate with cadherins. b-catenin phosphorylated at T41/S45 and unphosphorylated at S37 and T41 is predominantly nuclear, while beta-catenin phosphorylated at S33/37/T41 is mostly cytoplasmic, suggesting that beta-catenin hypophosphorylated at S37 and T41 may be more active in transcription due to its enhanced nuclear accumulation. Evidence that phosphorylation at T41/S45 can be spatially separated from phosphorylations at S33/37/T41 suggests that these phosphorylations may not always be coupled, raising the possibility that phosphorylation at S45 serves a distinct nuclear function.	[Maher, Meghan T.; Mo, Rigen; Flozak, Annette S.; Gottardi, Cara J.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Maher, Meghan T.] Northwestern Univ, Integrated Grad Program Life Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Peled, Ofra N.] Natl Louis Univ, Dept Biol Sci, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; National Louis University	Maher, MT (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA.	c-gottardi@northwestern.edu	Gottardi, Cara J./AAU-4691-2021	Gottardi, Cara J./0000-0003-0912-7617	National Institutes of Health (NIH) [T32 GM08061]; American Heart Association [09PRE2261197]; Malkin Family Scholars Award; American Recovery and Reinvestment Act [NIH GM076561]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076561, T32GM008061] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Malkin Family Scholars Award; American Recovery and Reinvestment Act; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MTM was supported by National Institutes of Health (NIH) T32 GM08061, an American Heart Association Pre-doctoral Award (#09PRE2261197), a Malkin Family Scholars Award and an American Recovery and Reinvestment Act supplement awarded to CJG (NIH GM076561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Cox RT, 1999, GENETICS, V153, P319; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; FLOZAK AS, J BIOL CHEM, V285, P3157; Giannini AL, 2000, J BIOL CHEM, V275, P21883, DOI 10.1074/jbc.M001929200; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Gottardi CJ, 2004, AM J PHYSIOL-CELL PH, V286, pC747, DOI 10.1152/ajpcell.00433.2003; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; GOTTARDI CJ, 1995, AM J PHYSIOL, V268, P285; Guger KA, 2000, DEV BIOL, V223, P441, DOI 10.1006/dbio.2000.9770; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hatsell S, 2003, J BIOL CHEM, V278, P37745, DOI 10.1074/jbc.M301346200; Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Maher MT, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-5; Malik HS, 1997, P NATL ACAD SCI USA, V94, P13738, DOI 10.1073/pnas.94.25.13738; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Polakis P, 1999, ADV EXP MED BIOL, V470, P23; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Sayat R, 2008, EXP CELL RES, V314, P2774, DOI 10.1016/j.yexcr.2008.05.017; Sehgal RNM, 1997, J CELL BIOL, V139, P1033, DOI 10.1083/jcb.139.4.1033; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tolwinski NS, 2001, DEVELOPMENT, V128, P2107; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wahl JK, 2003, J BIOL CHEM, V278, P17269, DOI 10.1074/jbc.M211452200; Wiechens N, 2001, CURR BIOL, V11, P18, DOI 10.1016/S0960-9822(00)00045-2; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zhang Z, 2006, P NATL ACAD SCI USA, V103, P1422, DOI 10.1073/pnas.0510516103	48	68	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10184	10.1371/journal.pone.0010184	http://dx.doi.org/10.1371/journal.pone.0010184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419129	Green Published, gold, Green Submitted			2022-12-25	WOS:000276743500001
J	Schwarzinger, M; Flicoteaux, R; Cortarenoda, S; Obadia, Y; Moatti, JP				Schwarzinger, Michael; Flicoteaux, Remi; Cortarenoda, Sebastien; Obadia, Yolande; Moatti, Jean-Paul			Low Acceptability of A/H1N1 Pandemic Vaccination in French Adult Population: Did Public Health Policy Fuel Public Dissonance?	PLOS ONE			English	Article							HUMAN AVIAN INFLUENZA; PERCEPTIONS; IMMUNIZATION; WILLINGNESS; INFORMATION; KNOWLEDGE; ATTITUDES; BEHAVIOR; RATES	Background: In July 2009, French public health authorities embarked in a mass vaccination campaign against A/H1N1 2009 pandemic-influenza. We explored the attitudes and behaviors of the general population toward pandemic vaccination. Methodology/Principal Findings: We conducted a cross-sectional online survey among 2,253 French representative adults aged 18 to 64 from November 17 to 25, 2009 (completion rate: 93.8%). The main outcome was the acceptability of A/H1N1 vaccination as defined by previous receipt or intention to get vaccinated ("Yes, certainly", "Yes, probably"). Overall 17.0% (CI 95%, 15.5% to 18.7%) of respondents accepted A/H1N1 vaccination. Independent factors associated with acceptability included: male sex (p = .0001); older age (p = .002); highest or lowest level of education (p = .016); non-clerical occupation (p = .011); having only one child (p = .008); and having received seasonal flu vaccination in prior 3 years (p,.0001). Acceptability was also significantly higher among pregnant women (37.9%) and other at risk groups with chronic diseases (34.8%) (p = .002). Only 35.5% of respondents perceived A/H1N1 influenza illness as a severe disease and 12.7% had experienced A/H1N1 cases in their close relationships with higher acceptability (p,.0001 and p = .006, respectively). In comparison to 26.0% respondents who did not consult their primary care physician, acceptability was significantly higher among 8.0% respondents who were formally advised to get vaccinated, and lower among 63.7% respondents who were not advised to get vaccinated (respectively: 15.8%, 59.5% and 11.7%- p,.0001). Among respondents who refused vaccination, 71.2% expressed concerns about vaccine safety. Conclusions/Significance: Our survey occurred one week before the peak of the pandemic in France. We found that alarming public health messages aiming at increasing the perception of risk severity were counteracted by daily personal experience which did not confirm the threat, while vaccine safety was a major issue. This dissonance may have been amplified by having not involved primary care physicians in the mass vaccination campaign.	[Schwarzinger, Michael; Cortarenoda, Sebastien; Obadia, Yolande; Moatti, Jean-Paul] INSERM, Econ & Social Sci U912, Marseille, France; [Schwarzinger, Michael; Cortarenoda, Sebastien; Obadia, Yolande; Moatti, Jean-Paul] Univ Aix Marseille, IRD, UMR S912, Marseille, France; [Schwarzinger, Michael; Flicoteaux, Remi; Cortarenoda, Sebastien; Obadia, Yolande] So Hlth Reg Observ, ORS PACA, Marseille, France; [Flicoteaux, Remi] Univ Paris 07, Lab Pathol Infect, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Cite	Schwarzinger, M (corresponding author), INSERM, Econ & Social Sci U912, Marseille, France.	michael.schwarzinger@inserm.fr	Schwarzinger, Michael/F-7367-2011	Schwarzinger, Michael/0000-0002-0573-6856; Cortaredona, Sebastien/0000-0003-3523-7158	French National Research Institute for Microbiology and Infectious Diseases; French Institute for Prevention and Education for Health	French National Research Institute for Microbiology and Infectious Diseases; French Institute for Prevention and Education for Health	The study was funded by the French National Research Institute for Microbiology and Infectious Diseases (Institut de Microbiologie et Maladies Infectieuses/IMMI; http://extranet.inserm.fr/instituts-thematiques/microbiologie-et-maladies-infectieuses/organisation-de-l-institut) as well as the French Institute for Prevention and Education for Health (Institut National de Prevention et d Education pour la Sante/INPES; http://www.inpes.sante.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AG FRANC SEC SAN, 2010, AFSSAPS B, V16; [Anonymous], WHO REC PAND H1N1 20; Baker L, 2003, JAMA-J AM MED ASSOC, V289, P2400, DOI 10.1001/jama.289.18.2400; Barr M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-117; BIGOT R, 2008, DIFFUSION TECHNOL IN; Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Blank PR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-272; Breakwell G.M., 2007, PSYCHOL RISK; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Chowell G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008164; CUMMINGS KM, 1979, MED CARE, V17, P639, DOI 10.1097/00005650-197906000-00008; *DE NOS CORR, 2010, AVEC 60 SA POP VACC; Di Giuseppe G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-36; Eastwood K, 2010, MED J AUSTRALIA, V192, P33, DOI 10.5694/j.1326-5377.2010.tb03399.x; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; FIELDING N, 2008, SAGE HDB ONLINE; Frank E, 2000, ARCH FAM MED, V9, P359, DOI 10.1001/archfami.9.4.359; *HAUT CONS SANT PU, 2009, AV REC PRIOR SAN UT; Henrich N, 2009, Emerg Health Threats J, V2, pe8, DOI 10.3134/ehtj.09.008; Hollmeyer HG, 2009, VACCINE, V27, P3935, DOI 10.1016/j.vaccine.2009.03.056; *INST NATL STAT, 2006, RES REC POP 2006; *INST VEILL SAN, 2009, B EP GRIPP A H1N1; *INST VEILL SAN, 2010, B EP GRIPP A H1N1; *INT RES INFL, 2009, MMWR-MORBID MORTAL W, V59, P44; Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032; Kmietowicz Z, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3815; Kreuter F, 2008, PUBLIC OPIN QUART, V72, P847, DOI 10.1093/poq/nfn063; LANOE J, 2005, TAT SANTE FRANCE 200; Lau JTF, 2008, INFECTION, V36, P434, DOI [10.1007/s15010-008-7277-y, 10.1007/s15010-008-7277-Y]; Lau JTF, 2007, AM J INFECT CONTROL, V35, P38, DOI 10.1016/j.ajic.2006.07.010; Lau JTF, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4164; LEPPIN A, 2006, EMERG INFECT DIS, V12, P29; Maurer J, 2009, J HEALTH ECON, V28, P704, DOI 10.1016/j.jhealeco.2009.01.005; *MIN INT, 2009, POINT TAP CAMP VACC; Nichol KL, 2001, ARCH INTERN MED, V161, P2702, DOI 10.1001/archinte.161.22.2702; Quinn SC, 2009, BIOSECUR BIOTERROR, V7, P275, DOI 10.1089/bsp.2009.0041; Rubin G., 2009, BMJ-BRIT MED J, V339, P2651, DOI DOI 10.1136/BMJ.B2651; Schwarzinger M, 2010, VACCINE, V28, P2743, DOI 10.1016/j.vaccine.2010.01.027; Sencer DJ, 2006, EMERG INFECT DIS, V12, P29; Sypsa V., 2009, EURO SURVEILL; Tuppin P, 2009, MED MALADIES INFECT, V39, P780, DOI 10.1016/j.medmal.2009.08.013; Voeten HACM, 2009, INT J BEHAV MED, V16, P49, DOI 10.1007/s12529-008-9006-4; Young ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003552	43	161	161	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10199	10.1371/journal.pone.0010199	http://dx.doi.org/10.1371/journal.pone.0010199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20421908	Green Published, gold			2022-12-25	WOS:000276743500019
J	Geething, NC; To, W; Spink, BJ; Scholle, MD; Wang, CW; Yin, Y; Yao, Y; Schellenberger, V; Cleland, JL; Stemmer, WPC; Silverman, J				Geething, Nathan C.; To, Wayne; Spink, Benjamin J.; Scholle, Michael D.; Wang, Chia-wei; Yin, Yong; Yao, Yi; Schellenberger, Volker; Cleland, Jeffrey L.; Stemmer, Willem P. C.; Silverman, Joshua			Gcg-XTEN: An Improved Glucagon Capable of Preventing Hypoglycemia without Increasing Baseline Blood Glucose	PLOS ONE			English	Article							DIABETES-MELLITUS; TYPE-1; ADOLESCENTS; CHILDREN; THERAPY; IMPACT	Objective: While the majority of current diabetes treatments focus on reducing blood glucose levels, hypoglycemia represents a significant risk associated with insulin treatment. Glucagon plays a major regulatory role in controlling hypoglycemia in vivo, but its short half-life and hyperglycemic effects prevent its therapeutic use for non-acute applications. The goal of this study was to identify a modified form of glucagon suitable for prophylactic treatment of hypoglycemia without increasing baseline blood glucose levels. Methodology/Principal Findings: Through application of the XTEN technology, we report the construction of a glucagon fusion protein with an extended exposure profile (Gcg-XTEN). The in vivo half-life of the construct was tuned to support nightly dosing through design and testing in cynomolgus monkeys. Efficacy of the construct was assessed in beagle dogs using an insulin challenge to induce hypoglycemia. Dose ranging of Gcg-XTEN in fasted beagle dogs demonstrated that the compound was biologically active with a pharmacodynamic profile consistent with the designed half-life. Prophylactic administration of 0.6 nmol/kg Gcg-XTEN to dogs conferred resistance to a hypoglycemic challenge at 6 hours post-dose without affecting baseline blood glucose levels. Consistent with the designed pharmacokinetic profile, hypoglycemia resistance was not observed at 12 hours post-dose. Importantly, the solubility and stability of the glucagon peptide were also significantly improved by fusion to XTEN. Conclusions/Significance: The data show that Gcg-XTEN is effective in preventing hypoglycemia without the associated hyperglycemia expected for unmodified glucagon. While the plasma clearance of this Gcg-XTEN has been optimized for overnight dosing, specifically for the treatment of nocturnal hypoglycemia, constructs with significantly longer exposure profiles are feasible. Such constructs may have multiple applications such as allowing for more aggressive insulin treatment regimens, treating hypoglycemia due to insulin-secreting tumors, providing synergistic efficacy in combination therapies with long-acting GLP1 analogs, and as an appetite suppressant for treatment of obesity. The improved physical properties of the Gcg-XTEN molecule may also allow for novel delivery systems not currently possible with native glucagon.	[Geething, Nathan C.; To, Wayne; Spink, Benjamin J.; Scholle, Michael D.; Wang, Chia-wei; Yin, Yong; Yao, Yi; Schellenberger, Volker; Stemmer, Willem P. C.; Silverman, Joshua] Amunix Inc, Mountain View, CA USA; [Cleland, Jeffrey L.] Versartis Inc, Mountain View, CA USA		Geething, NC (corresponding author), Amunix Inc, Mountain View, CA USA.	jsilverman@amunix.com	Wang, Chia Wei/GXF-9984-2022		National Institute of General Medical Sciences [R44GM079873]; Amunix, Inc.; Versartis, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM079873] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Amunix, Inc.; Versartis, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project described was supported by Award Number R44GM079873 from the National Institute of General Medical Sciences. In addition, the project was supported by funding from Amunix, Inc. and Versartis, Inc., and was conducted by employees of both companies. Employees of the funding companies had a primary role in the design, data collection and analysis, decision to publish, and preparation of the manuscript.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Bode BW, 2005, DIABETES CARE, V28, P2361, DOI 10.2337/diacare.28.10.2361; Bray GA, 2000, P NUTR SOC, V59, P373, DOI 10.1017/S0029665100000422; Bulsara MK, 2004, DIABETES CARE, V27, P2293, DOI 10.2337/diacare.27.10.2293; CRYER PE, 1983, DIABETES CARE, V6, P95, DOI 10.2337/diacare.6.1.95; Davis EA, 1998, ARCH DIS CHILD, V78, P111, DOI 10.1136/adc.78.2.111; Davis EA, 1997, DIABETES CARE, V20, P22, DOI 10.2337/diacare.20.1.22; DAVIS MR, 1991, J CLIN ENDOCR METAB, V73, P995, DOI 10.1210/jcem-73-5-995; DAY JW, 2009, NAT CHEM BIOL; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; EDELMAN SV, AM DIAB ASS ANN M CH; *EL LILL INC, 2009, GLUC PACK INS; Fanelli CG, 2006, NUTR METAB CARDIOVAS, V16, pS28, DOI 10.1016/j.numecd.2005.10.018; Kim D, 2007, DIABETES CARE, V30, P1487, DOI 10.2337/dc06-2375; Lawson ML, 1999, DIABETES CARE, V22, pB35; Radan I, 2004, ACTA DIABETOL, V41, P33, DOI 10.1007/s00592-004-0141-3; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; Schultes B, 2007, PLOS MED, V4, P361, DOI 10.1371/jourmal.pmed.0040069; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tu E, 2008, MED J AUSTRALIA, V188, P699, DOI 10.5694/j.1326-5377.2008.tb01849.x; Wiltshire EJ, 2006, J PAEDIATR CHILD H, V42, P758, DOI 10.1111/j.1440-1754.2006.00973.x; Zick R, 2007, DIABETES TECHNOL THE, V9, P483, DOI 10.1089/dia.2007.0230	22	39	53	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10175	10.1371/journal.pone.0010175	http://dx.doi.org/10.1371/journal.pone.0010175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418955	gold, Green Submitted, Green Published			2022-12-25	WOS:000276706800015
J	Xu, XL; Jiang, M; Wang, YH; Smith, T; Baumgarten, CM; Wood, MA; Tseng, GN				Xu, Xulin; Jiang, Min; Wang, Yuhong; Smith, Timothy; Baumgarten, Clive M.; Wood, Mark A.; Tseng, Gea-Ny			Long-Term Fish Oil Supplementation Induces Cardiac Electrical Remodeling by Changing Channel Protein Expression in the Rabbit Model	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; RAT VENTRICULAR MYOCYTES; SODIUM-CHANNEL; NA+ CHANNELS; CURRENTS; ARRHYTHMIAS; MODULATION; ADULT; HEART; BLOCK	Clinical trials and epidemiological studies have suggested that dietary fish oil (FO) supplementation can provide an antiarrhythmic benefit in some patient populations. The underlying mechanisms are not entirely clear. We wanted to understand how FO supplementation (for 4 weeks) affected the action potential configuration/duration of ventricular myocytes, and the ionic mechanism(s)/molecular basis for these effects. The experiments were conducted on adult rabbits, a widely used animal model for cardiac electrophysiology and pathophysiology. We used gas chromatography - mass spectroscopy to confirm that FO feeding produced a marked increase in the content of n-3 polyunsaturated fatty acids in the phospholipids of rabbit hearts. Left ventricular myocytes were used in current and voltage clamp experiments to monitor action potentials and ionic currents, respectively. Action potentials of myocytes from FO-fed rabbits exhibited much more positive plateau voltages and prolonged durations. These changes could be explained by an increase in the L-type Ca current (I(CaL)) and a decrease in the transient outward current (I(to)) in these myocytes. FO feeding did not change the delayed rectifier or inward rectifier current. Immunoblot experiments showed that the FO-feeding induced changes in I(CaL) and I(to) were associated with corresponding changes in the protein levels of major pore-forming subunits of these channels: increase in Cav1.2 and decrease in Kv4.2 and Kv1.4. There was no change in other channel subunits (Cav1.1, Kv4.3, KChIP2, and ERG1). We conclude that long-term fish oil supplementation can impact on cardiac electrical activity at least partially by changing channel subunit expression in cardiac myocytes.	[Xu, Xulin; Jiang, Min; Wang, Yuhong; Baumgarten, Clive M.; Tseng, Gea-Ny] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23284 USA; [Smith, Timothy] Univ Richmond, Dept Chem, Richmond, VA 23173 USA; [Baumgarten, Clive M.; Wood, Mark A.] Virginia Commonwealth Univ, Med Coll Virginia, Dept Internal Med, Div Cardiol, Richmond, VA 23298 USA	Virginia Commonwealth University; University of Richmond; Virginia Commonwealth University	Xu, XL (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23284 USA.	gtseng@vcu.edu			National Center for Complementary and Alternative Medicine [R21 AT0044601]; National Heart, Lung, and Blood Institute of the National Institutes of Health [RO1 HL67840]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067840] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by R21 AT0044601 from the National Center for Complementary and Alternative Medicine, and RO1 HL67840 from the National Heart, Lung, and Blood Institute of the National Institutes of Health ( to G.N.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogdanov KY, 1998, AM J PHYSIOL-HEART C, V274, pH571, DOI 10.1152/ajpheart.1998.274.2.H571; Bruno MJ, 2007, P NATL ACAD SCI USA, V104, P9638, DOI 10.1073/pnas.0701015104; CHRISTIE WW, 1989, GAS CHROMATOGRAPHY L, P5; Dujardin KS, 2008, AM J PHYSIOL-HEART C, V295, pH1414, DOI 10.1152/ajpheart.01219.2007; Edwards IJ, 2008, PPAR RES, V2008, DOI 10.1155/2008/358052; FOLCH J, 1957, J BIOL CHEM, V226, P497; Jia Y, 2006, CIRC RES, V98, P386, DOI 10.1161/01.RES.0000201956.86258.e1; London B, 2007, CIRCULATION, V116, pE320, DOI 10.1161/CIRCULATIONAHA.107.712984; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; O'Rourke B, 1999, CIRC RES, V84, P562, DOI 10.1161/01.RES.84.5.562; Pepe S, 2005, EXP GERONTOL, V40, P369, DOI 10.1016/j.exger.2005.03.005; Rose J, 2005, AM J PHYSIOL-HEART C, V288, pH2077, DOI 10.1152/ajpheart.00526.2003; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; Verkerk AO, 2006, CARDIOVASC RES, V70, P509, DOI 10.1016/j.cardiores.2006.02.022; Wassall SR, 2004, CHEM PHYS LIPIDS, V132, P79, DOI 10.1016/j.chemphyslip.2004.09.007; Wickenden AD, 1999, CELL PHYSIOL BIOCHEM, V9, P11, DOI 10.1159/000016299; Xiao YF, 2005, J MEMBRANE BIOL, V206, P141, DOI 10.1007/S00232-005-0786-Z; Xiao YF, 2001, P NATL ACAD SCI USA, V98, P3606, DOI 10.1073/pnas.061003798; Xiao YF, 1997, P NATL ACAD SCI USA, V94, P4182, DOI 10.1073/pnas.94.8.4182; XIAO YF, 1995, P NATL ACAD SCI USA, V92, P11000, DOI 10.1073/pnas.92.24.11000	20	6	6	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10140	10.1371/journal.pone.0010140	http://dx.doi.org/10.1371/journal.pone.0010140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405051	Green Submitted, Green Published, gold			2022-12-25	WOS:000276706300004
J	Dange, M; Colman, RF				Dange, Mayura; Colman, Roberta F.			Each Conserved Active Site Tyr in the Three Subunits of Human Isocitrate Dehydrogenase Has a Different Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIG-HEART; ESCHERICHIA-COLI; GAMMA-SUBUNITS; BETA-SUBUNIT; NAD; IDENTIFICATION; RESOLUTION; BINDING; INSIGHTS; COMPLEX	The human NAD-dependent isocitrate dehydrogenase (IDH) is a heterotetrameric mitochondrial enzyme with 2 alpha:1 beta:1 gamma subunit ratio. The three subunits share 40-52% identity in amino acid sequence and each includes a tyrosine in a comparable position: alpha Y126, beta Y137, and gamma Y135. To study the role of the corresponding tyrosines of each of the subunits of human NAD-IDH, the tyrosines were mutated (one subunit at a time) to Ser, Phe, or Glu. Enzymes were expressed with one mutant and two wildtype subunits. The results of characterization of the mutant enzymes suggest that beta Y137 is involved in NAD binding and allosteric activation by ADP. The alpha Y126 is required for catalytic activity and likely acts as a general acid in the reaction. The gamma Y135 is also required for catalytic activity and may be involved in proper folding of the enzyme. The corresponding tyrosines in the three dissimilar subunits of NAD-IDH thus have distinctive functions.	[Dange, Mayura; Colman, Roberta F.] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA	University of Delaware	Colman, RF (corresponding author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.	rfcolman@udel.edu			National Institutes of Health [HL67774]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL67774.	Bzymek KP, 2007, BIOCHEMISTRY-US, V46, P5391, DOI 10.1021/bi700061t; Ceccarelli C, 2002, J BIOL CHEM, V277, P43454, DOI 10.1074/jbc.M207306200; Cherbavaz DB, 2000, J MOL BIOL, V295, P377, DOI 10.1006/jmbi.1999.3195; COHEN PF, 1972, BIOCHEMISTRY-US, V11, P1501, DOI 10.1021/bi00758a027; EHRLICH RS, 1981, J BIOL CHEM, V256, P1276; EHRLICH RS, 1982, J BIOL CHEM, V257, P4769; EHRLICH RS, 1981, J BIOL CHEM, V256, P560; Hartong DT, 2008, NAT GENET, V40, P1230, DOI 10.1038/ng.223; HUANG YC, 1990, BIOCHEMISTRY-US, V29, P8266, DOI 10.1021/bi00488a010; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; Kim TK, 2003, J BIOL CHEM, V278, P49323, DOI 10.1074/jbc.M303781200; Kim YO, 1999, J BIOL CHEM, V274, P36866, DOI 10.1074/jbc.274.52.36866; LEE ME, 1995, BIOCHEMISTRY-US, V34, P378, DOI 10.1021/bi00001a046; RAMACHANDRAN N, 1980, J BIOL CHEM, V255, P8859; RAMACHANDRAN N, 1978, P NATL ACAD SCI USA, V75, P252, DOI 10.1073/pnas.75.1.252; SOUNDAR S, 1993, J BIOL CHEM, V268, P5264; Soundar S, 2003, J BIOL CHEM, V278, P52146, DOI 10.1074/jbc.M306178200; Soundar S, 2006, J BIOL CHEM, V281, P21073, DOI 10.1074/jbc.M602956200; STODDARD BL, 1993, BIOCHEMISTRY-US, V32, P9310, DOI 10.1021/bi00087a008; STODDARD BL, 1993, BIOCHEMISTRY-US, V32, P9317, DOI 10.1021/bi00087a009	20	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20520	20525		10.1074/jbc.M110.115386	http://dx.doi.org/10.1074/jbc.M110.115386			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20435888	Green Published, hybrid			2022-12-25	WOS:000279228600013
J	McLean, S; Bowman, LAH; Sanguinetti, G; Read, RC; Poole, RK				McLean, Samantha; Bowman, Lesley A. H.; Sanguinetti, Guido; Read, Robert C.; Poole, Robert K.			Peroxynitrite Toxicity in Escherichia coli K12 Elicits Expression of Oxidative Stress Responses and Protein Nitration and Nitrosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; TYROSINE NITRATION; S-NITROSYLATION; MYCOBACTERIUM-TUBERCULOSIS; METHIONINE BIOSYNTHESIS; HYDROGEN-PEROXIDE; CARBON-DIOXIDE; YTFE PROTEIN; COLI; SUPEROXIDE	Peroxynitrite is formed in macrophages by the diffusion-limited reaction of superoxide and nitric oxide. This highly reactive species is thought to contribute to bacterial killing by interaction with diverse targets and nitration of protein tyrosines. This work presents for the first time a comprehensive analysis of transcriptional responses to peroxynitrite under tightly controlled chemostat growth conditions. Up-regulation of the cysteine biosynthesis pathway and an increase in S-nitrosothiol levels suggest S-nitrosylation to be a consequence of peroxynitrite exposure. Genes involved in the assembly/repair of iron-sulfur clusters also show enhanced transcription. Unexpectedly, arginine biosynthesis gene transcription levels were also elevated after treatment with peroxynitrite. Analysis of the negative regulator for these genes, ArgR, showed that post-translational nitration of tyrosine residues within this protein is responsible for its degradation in vitro. Further up-regulation was seen in oxidative stress response genes, including katG and ahpCF. However, genes known to be up-regulated by nitric oxide and nitrosating agents (e.g. hmp and norVW) were unaffected. Probabilistic modeling of the transcriptomic data identified five altered transcription factors in response to peroxynitrite exposure, including OxyR and ArgR. Hydrogen peroxide can be present as a contaminant in commercially available peroxynitrite preparations. Transcriptomic analysis of cells treated with hydrogen peroxide alone also revealed up-regulation of oxidative stress response genes but not of many other genes that are up-regulated by peroxynitrite. Thus, the cellular responses to peroxynitrite and hydrogen peroxide are distinct.	[McLean, Samantha; Bowman, Lesley A. H.; Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Sanguinetti, Guido] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [Read, Robert C.] Univ Sheffield, Sch Med, Royal Hallamshire Hosp, Acad Unit Infect & Immun, Sheffield S10 2RX, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	McLean, S (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	S.McLean@Sheffield.ac.uk		Bowman, Lesley/0000-0001-6838-7174; Read, Robert/0000-0002-4297-6728	Biotechnology and Biological Sciences Research Council (United Kingdom); Biotechnology and Biological Sciences Research Council [BB/E015883/1] Funding Source: researchfish; BBSRC [BB/E015883/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (United Kingdom).	Alvarez MN, 2004, ARCH BIOCHEM BIOPHYS, V432, P222, DOI 10.1016/j.abb.2004.09.015; Ascenzi P, 2006, BIOCHEM BIOPH RES CO, V351, P528, DOI 10.1016/j.bbrc.2006.10.060; Bartesaghi S, 2007, AMINO ACIDS, V32, P501, DOI 10.1007/s00726-006-0425-8; Bartesaghi S, 2006, BIOCHEMISTRY-US, V45, P6813, DOI 10.1021/bi060363x; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beltran B, 2000, BRIT J PHARMACOL, V129, P953, DOI 10.1038/sj.bjp.0703147; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNELLI L, 1995, ARCH BIOCHEM BIOPHYS, V316, P327, DOI 10.1006/abbi.1995.1044; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Curry-McCoy TV, 2009, BBA-GEN SUBJECTS, V1790, P778, DOI 10.1016/j.bbagen.2009.04.008; Davidge KS, 2009, J BIOL CHEM, V284, P4516, DOI 10.1074/jbc.M808210200; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; FLORIS R, 1993, EUR J BIOCHEM, V215, P767, DOI 10.1111/j.1432-1033.1993.tb18091.x; Gebicka L, 2009, J INORG BIOCHEM, V103, P1375, DOI 10.1016/j.jinorgbio.2009.07.011; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hurst JK, 1997, CHEM RES TOXICOL, V10, P802, DOI 10.1021/tx970008v; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; Ischiropoulos H, 2009, ARCH BIOCHEM BIOPHYS, V484, P117, DOI 10.1016/j.abb.2008.10.034; Justino MC, 2007, J BIOL CHEM, V282, P10352, DOI 10.1074/jbc.M610656200; Kohr MJ, 2009, NITRIC OXIDE-BIOL CH, V20, P217, DOI 10.1016/j.niox.2009.01.003; Laver JR, 2008, METHOD ENZYMOL, V436, P113, DOI 10.1016/S0076-6879(08)36007-8; Lee JB, 1998, J AM CHEM SOC, V120, P6053, DOI 10.1021/ja9801036; LYMAR SV, 1995, J AM CHEM SOC, V117, P8867, DOI 10.1021/ja00139a027; Master SS, 2002, MICROBIOL-SGM, V148, P3139, DOI 10.1099/00221287-148-10-3139; McLean S, 2010, FEBS LETT, V584, P1628, DOI 10.1016/j.febslet.2010.03.029; Pfeiffer S, 1997, J BIOL CHEM, V272, P3465, DOI 10.1074/jbc.272.6.3465; Pullan ST, 2007, J BACTERIOL, V189, P1845, DOI 10.1128/JB.01354-06; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Radi R., 2000, BIOL CHEM PEROXYNITR, P57; Saha A, 1998, FREE RADICAL BIO MED, V24, P653, DOI 10.1016/S0891-5849(97)00365-1; Sahoo R, 2009, BIOCHEM BIOPH RES CO, V385, P507, DOI 10.1016/j.bbrc.2009.05.062; SALGO MG, 1995, ARCH BIOCHEM BIOPHYS, V322, P500, DOI 10.1006/abbi.1995.1493; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Szwajkajzer D, 2001, J MOL BIOL, V312, P949, DOI 10.1006/jmbi.2001.4941; Todorovic S, 2008, J BIOL INORG CHEM, V13, P765, DOI 10.1007/s00775-008-0362-y; Trujillo M, 2008, ANTIOXID REDOX SIGN, V10, P1607, DOI 10.1089/ars.2008.2060; Wengenack NL, 1999, BIOCHEM BIOPH RES CO, V256, P485, DOI 10.1006/bbrc.1999.0358; Zhang HW, 1997, ARCH BIOCHEM BIOPHYS, V339, P183, DOI 10.1006/abbi.1996.9863; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001; ZHU L, 1992, ARCH BIOCHEM BIOPHYS, V298, P452, DOI 10.1016/0003-9861(92)90434-X	45	53	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20724	20731		10.1074/jbc.M109.085506	http://dx.doi.org/10.1074/jbc.M109.085506			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20427277	hybrid, Green Published			2022-12-25	WOS:000279228600036
J	Hartman, IZ; Liu, PS; Zehmer, JK; Luby-Phelps, K; Jo, Y; Anderson, RGW; Debose-Boyd, RA				Hartman, Isamu Z.; Liu, Pingsheng; Zehmer, John K.; Luby-Phelps, Katherine; Jo, Youngah; Anderson, Richard G. W.; Debose-Boyd, Russell A.			Sterol-induced Dislocation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase from Endoplasmic Reticulum Membranes into the Cytosol through a Subcellular Compartment Resembling Lipid Droplets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG-COA REDUCTASE; DIFFERENTIATION-RELATED PROTEIN; PROTEASOMAL DEGRADATION; UBIQUITIN LIGASE; APOLIPOPROTEIN-B; MESSENGER-RNA; BINDING; ER; INSIG-1; CELLS	Sterol-induced binding to Insigs in the endoplasmic reticulum ( ER) allows for ubiquitination of 3-hydroxy-3-methylglutaryl coenzyme A reductase, the rate-limiting enzyme in cholesterol synthesis. This ubiquitination marks reductase for recognition by the ATPase VCP/p97, which mediates extraction and delivery of reductase from ER membranes to cytosolic 26 S proteasomes for degradation. Here, we report that reductase becomes dislocated from ER membranes into the cytosol of sterol-treated cells. This dislocation exhibits an absolute requirement for the actions of Insigs and VCP/p97. Reductase also appears in a buoyant fraction of sterol-treated cells that co-purifies with lipid droplets, cytosolic organelles traditionally regarded as storage depots for neutral lipids such as triglycerides and cholesteryl esters. Genetic, biochemical, and localization studies suggest a model in which reductase is dislodged into the cytosol from an ER subdomain closely associated with lipid droplets.	[Debose-Boyd, Russell A.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Hartman, Isamu Z.; Jo, Youngah; Debose-Boyd, Russell A.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Liu, Pingsheng; Zehmer, John K.; Luby-Phelps, Katherine; Anderson, Richard G. W.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Debose-Boyd, RA (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	russell.debose-boyd@utsouthwestern.edu	Liu, Pingsheng/B-7124-2012	Luby-Phelps, Katherine/0000-0002-8378-1409	National Institutes of Health [HL20948]; Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL20948. This work was also supported by the Perot Family Foundation.	Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Brasaemle DL, 2006, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB0315S29; BROWN MS, 1978, J BIOL CHEM, V253, P1121; BROWN MS, 1980, J LIPID RES, V21, P505; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Lee JN, 2006, P NATL ACAD SCI USA, V103, P4958, DOI 10.1073/pnas.0600422103; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Leichner GS, 2009, MOL BIOL CELL, V20, P3330, DOI 10.1091/mbc.E08-09-0953; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; LISCUM L, 1983, P NATL ACAD SCI-BIOL, V80, P7165, DOI 10.1073/pnas.80.23.7165; LISCUM L, 1985, J BIOL CHEM, V260, P522; LISCUM L, 1983, J BIOL CHEM, V258, P8450; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Masuda Y, 2006, J LIPID RES, V47, P87, DOI 10.1194/jlr.M500170-JLR200; MCGOOKEY DJ, 1983, J CELL BIOL, V97, P1156, DOI 10.1083/jcb.97.4.1156; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; NAKANISHI M, 1988, J BIOL CHEM, V263, P8929; NOVIKOFF AB, 1980, J CELL BIOL, V87, P180, DOI 10.1083/jcb.87.1.180; Ohsaki Y, 2008, J CELL SCI, V121, P2415, DOI 10.1242/jcs.025452; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; OMURA S, 1986, J ANTIBIOT, V39, P1211, DOI 10.7164/antibiotics.39.1211; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; ROBBINS PW, 1984, J BIOL CHEM, V259, P7577; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; VanSlyke JK, 2002, J CELL BIOL, V157, P381, DOI 10.1083/jcb.200111045; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vij N, 2008, J CELL MOL MED, V12, P2511, DOI 10.1111/j.1582-4934.2008.00462.x; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; YANG JX, 1995, J BIOL CHEM, V270, P12152, DOI 10.1074/jbc.270.20.12152; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zehmer JK, 2008, J CELL SCI, V121, P1852, DOI 10.1242/jcs.012013	52	67	71	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19288	19298		10.1074/jbc.M110.134213	http://dx.doi.org/10.1074/jbc.M110.134213			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20406816	hybrid, Green Published			2022-12-25	WOS:000278727800038
J	Lou, Y; Shanklin, J				Lou, Ying; Shanklin, John			Evidence That the Yeast Desaturase Ole1p Exists as a Dimer in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARRIER-PROTEIN-DESATURASE; FATTY-ACID DESATURASE; STEAROYL-COA DESATURASE; ACYL-LIPID DESATURASE; HISTIDINE-RESIDUES; MEMBRANE TOPOLOGY; CRYSTAL-STRUCTURE; ENZYME; SITE; PURIFICATION	Desaturase enzymes are composed of two classes, the structurally well characterized soluble class found predominantly in the plastids of higher plants and the more widely distributed but poorly structurally defined integral membrane class. Despite their distinct evolutionary origins, the two classes both require an iron cofactor and molecular oxygen for activity and are inhibited by azide and cyanide, suggesting strong mechanistic similarities. The fact that the soluble desaturase is active as a homodimer prompted us test the hypothesis that an archetypal integral membrane desaturase from Saccharomyces cerevisiae, the Delta(9)-acyl-Co-A desaturase Ole1p, also exhibits a dimeric organization. Ole1p was chosen because it is one of the best characterized integral membrane desaturase and because it retains activity when fused with epitope tags. FLAG-Ole1p was detected by Western blotting of immunoprecipitates in which anti-Myc antibodies were used for capture from yeast extracts co-expressing Ole1p-Myc and Ole1p-FLAG. Interaction was confirmed by two independent bimolecular complementation assays (i.e. the split ubiquitin system and the split luciferase system). Co-expression of active and inactive Ole1p subunits resulted in an similar to 75% suppression of the accumulation of palmitoleic acid, demonstrating that the physiologically active form of Ole1p in vivo is the dimer in which both protomers must be functional.	[Lou, Ying; Shanklin, John] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Shanklin, J (corresponding author), Brookhaven Natl Lab, Dept Biol, Bldg 463,50 Bell Ave, Upton, NY 11973 USA.	shanklin@bnl.gov		Shanklin, John/0000-0002-6774-8043	Office of Basic Energy Sciences of the United States Department of Energy; Bayer Corp	Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); Bayer Corp	This work was supported by the Office of Basic Energy Sciences of the United States Department of Energy and by the Bayer Corp.	AVELANGEMACHEREL MH, 1995, FEBS LETT, V361, P111, DOI 10.1016/0014-5793(95)00163-4; Behrouzian B, 2002, CURR OPIN CHEM BIOL, V6, P577, DOI 10.1016/S1367-5931(02)00365-4; BLOCH K, 1969, ACCOUNTS CHEM RES, V2, P193, DOI 10.1021/ar50019a001; Broadwater JA, 1998, BIOCHEMISTRY-US, V37, P14664, DOI 10.1021/bi981839i; Buist PH, 2004, NAT PROD REP, V21, P249, DOI 10.1039/b302094k; Chapman KD, 2001, J AM OIL CHEM SOC, V78, P941, DOI 10.1007/s11746-001-0368-y; Chapman KD, 2008, CROP SCI, V48, P1470, DOI 10.2135/cropsci2007.11.0618; Davydov R, 2005, BIOCHEMISTRY-US, V44, P1309, DOI 10.1021/bi048599t; Diaz AR, 2002, J BIOL CHEM, V277, P48099, DOI 10.1074/jbc.M208960200; Fox BG, 2004, ACCOUNTS CHEM RES, V37, P421, DOI 10.1021/ar030186h; Fujikawa Y, 2007, PLANT J, V52, P185, DOI 10.1111/j.1365-313X.2007.03214.x; Guy JE, 2007, J BIOL CHEM, V282, P19863, DOI 10.1074/jbc.M702520200; Haas JA, 2002, BIOCHEMISTRY-US, V41, P14472, DOI 10.1021/bi020340s; Kachroo A, 2007, PLANT MOL BIOL, V63, P257, DOI 10.1007/s11103-006-9086-y; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; LINDQVIST Y, 2001, DELTA 9 STEAROYL ACY, P725; Man WC, 2006, J BIOL CHEM, V281, P1251, DOI 10.1074/jbc.M508733200; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; Massoud TF, 2004, FASEB J, V18, P1105, DOI 10.1096/fj.03-1128fje; MITCHELL AG, 1995, J BIOL CHEM, V270, P29766; Moche M, 2003, J BIOL CHEM, V278, P25072, DOI 10.1074/jbc.M301662200; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; SCHMIDT H, 1994, PLANT MOL BIOL, V26, P631, DOI 10.1007/BF00013749; SHANKLIN J, 1991, P NATL ACAD SCI USA, V88, P2510, DOI 10.1073/pnas.88.6.2510; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Shanklin J, 1997, P NATL ACAD SCI USA, V94, P2981, DOI 10.1073/pnas.94.7.2981; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; STUKEY JE, 1990, J BIOL CHEM, V265, P20144	32	15	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19384	19390		10.1074/jbc.M110.125377	http://dx.doi.org/10.1074/jbc.M110.125377			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20406812	Green Published, hybrid			2022-12-25	WOS:000278727800049
J	Pierard, V; Guiguen, A; Colin, L; Wijmeersch, G; Vanhulle, C; Van Driessche, B; Dekoninck, A; Blazkova, J; Cardona, C; Merimi, M; Vierendeel, V; Calomme, C; Nguyen, TLA; Nuttinck, M; Twizere, JC; Kettmann, R; Portetelle, D; Burny, A; Hirsch, I; Rohr, O; Van Lint, C				Pierard, Valerie; Guiguen, Allan; Colin, Laurence; Wijmeersch, Gaelle; Vanhulle, Caroline; Van Driessche, Benoit; Dekoninck, Ann; Blazkova, Jana; Cardona, Christelle; Merimi, Makram; Vierendeel, Valerie; Calomme, Claire; Nguyen, Thi Lien-Anh; Nuttinck, Michele; Twizere, Jean-Claude; Kettmann, Richard; Portetelle, Daniel; Burny, Arsene; Hirsch, Ivan; Rohr, Olivier; Van Lint, Carine			DNA Cytosine Methylation in the Bovine Leukemia Virus Promoter Is Associated with Latency in a Lymphoma-derived B-cell Line POTENTIAL INVOLVEMENT OF DIRECT INHIBITION OF cAMP-RESPONSIVE ELEMENT (CRE)-BINDING PROTEIN/CRE MODULATOR/ACTIVATION TRANSCRIPTION FACTOR BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG TERMINAL REPEAT; VIRAL GENE-EXPRESSION; PERIPHERAL-BLOOD LYMPHOCYTES; IN-VIVO; HTLV-1 TAX; BINDING PROTEIN; TRANSCRIPTIONAL ACTIVATION; PERSISTENT LYMPHOCYTOSIS; CPG METHYLATION; PROVIRAL DNA	Bovine leukemia virus (BLV) proviral latency represents a viral strategy to escape the host immune system and allow tumor development. Besides the previously demonstrated role of histone deacetylation in the epigenetic repression of BLV expression, we showed here that BLV promoter activity was induced by several DNA methylation inhibitors (such as 5-aza-2'-deoxycytidine) and that overexpressed DNMT1 and DNMT3A, but not DNMT3B, down-regulated BLV promoter activity. Importantly, cytosine hypermethylation in the 5'-long terminal repeat (LTR) U3 and R regions was associated with true latency in the lymphoma-derived B-cell line L267 but not with defective latency in YR2 cells. Moreover, the virus-encoded transactivator Tax(BLV) decreased DNA methyltransferase expression levels, which could explain the lower level of cytosine methylation observed in the L267(LTaxSN) 5'-LTR compared with the L267 5'-LTR. Interestingly, DNA methylation inhibitors and Tax(BLV) synergistically activated BLV promoter transcriptional activity in a cAMP-responsive element (CRE)-dependent manner. Mechanistically, methylation at the -154 or -129 CpG position (relative to the transcription start site) impaired in vitro binding of CRE-binding protein (CREB) transcription factors to their respective CRE sites. Methylation at -129 CpG alone was sufficient to decrease BLV promoter-driven reporter gene expression by 2-fold. We demonstrated in vivo the recruitment of CREB/CRE modulator (CREM) and to a lesser extent activating transcription factor-1 (ATF-1) to the hypomethylated CRE region of the YR2 5'-LTR, whereas we detected no CREB/CREM/ATF recruitment to the hypermethylated corresponding region in the L267 cells. Altogether, these findings suggest that site-specific DNA methylation of the BLV promoter represses viral transcription by directly inhibiting transcription factor binding, thereby contributing to true proviral latency.	[Rohr, Olivier] Univ Strasbourg, Inst Univ Technol Louis Pasteur Schiltigheim, F-67300 Schiltigheim, France; [Pierard, Valerie; Guiguen, Allan; Colin, Laurence; Wijmeersch, Gaelle; Vanhulle, Caroline; Van Driessche, Benoit; Dekoninck, Ann; Cardona, Christelle; Vierendeel, Valerie; Calomme, Claire; Nguyen, Thi Lien-Anh; Van Lint, Carine] Univ Libre Bruxelles, IBMM, Mol Virol Lab, B-6041 Gosselies, Belgium; [Blazkova, Jana; Hirsch, Ivan] Univ Mediterranee, Inst J Paoli I Calmettes, INSERM, Inst Cancerol Marseille,UMR 599, F-13009 Marseille, France; [Merimi, Makram] Univ Libre Bruxelles, Inst Jules Bordet, Lab Expt Hematol, B-1000 Brussels, Belgium; [Nuttinck, Michele; Twizere, Jean-Claude; Kettmann, Richard; Portetelle, Daniel; Burny, Arsene] Fac Univ Sci Agron Gembloux, Dept Biol Mol, B-5030 Gembloux, Belgium	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite Libre de Bruxelles; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Institut Jules Bordet; Universite Libre de Bruxelles; University of Liege	Rohr, O (corresponding author), Univ Strasbourg, Inst Univ Technol Louis Pasteur Schiltigheim, 1 Allee Athenes, F-67300 Schiltigheim, France.	olivier.rohr@iutlpa.u-strasbg.fr; cvlint@ulb.ac.be	Hirsch, Ivan/J-7726-2015; Twizere, Jean-Claude/AAG-3706-2019	Hirsch, Ivan/0000-0003-1701-1438; TWIZERE, Jean-Claude/0000-0002-8683-705X; Colin, Laurence/0000-0002-8544-7746; ROHR, Olivier/0000-0001-8992-2025	Belgian Fund for Scientific Research (FRS-FNRS, Belgium); Televie Program; "Action de Recherche Concertee du Ministere de la Communaute Francaise" (Universite Libre de Bruxelles) [04/09-309]; Internationale Brachet Stiftung; CGRI-INSERM Cooperation; Region Wallonne-Commission Europeenne FEDER (Fonds Europeen de Developpment Regionale); "Fortis Banque Assurance," ANRS, Sidaction; French Ministry of Research; Theyskens-Mineur Foundation; "Centre National des Oeuvres Universitaires et Scolaires" and by Sidaction (France)	Belgian Fund for Scientific Research (FRS-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Televie Program; "Action de Recherche Concertee du Ministere de la Communaute Francaise" (Universite Libre de Bruxelles); Internationale Brachet Stiftung; CGRI-INSERM Cooperation; Region Wallonne-Commission Europeenne FEDER (Fonds Europeen de Developpment Regionale); "Fortis Banque Assurance," ANRS, Sidaction; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Theyskens-Mineur Foundation; "Centre National des Oeuvres Universitaires et Scolaires" and by Sidaction (France)	This work was supported by grants from the Belgian Fund for Scientific Research (FRS-FNRS, Belgium), the Televie Program, the "Action de Recherche Concertee du Ministere de la Communaute Francaise" (Universite Libre de Bruxelles, ARC Program 04/09-309), the Internationale Brachet Stiftung, the CGRI-INSERM Cooperation, the Region Wallonne-Commission Europeenne FEDER (Fonds Europeen de Developpment Regionale), the "Fortis Banque Assurance," ANRS, Sidaction, the French Ministry of Research, and the Theyskens-Mineur Foundation.; Doctoral fellows of the FNRS-Televie Program.; Supported by the "Centre National des Oeuvres Universitaires et Scolaires" and by Sidaction (France). Present address: Inst. of Molecular Genetics, Academy of Sciences of the Czech Republic, 16637 Prague, Czech Republic.	Achachi A, 2005, P NATL ACAD SCI USA, V102, P10309, DOI 10.1073/pnas.0504248102; Adam E, 1996, J VIROL, V70, P1990, DOI 10.1128/JVI.70.3.1990-1999.1996; ADAM E, 1994, J VIROL, V68, P5845, DOI 10.1128/JVI.68.9.5845-5853.1994; Bhende PM, 2005, J VIROL, V79, P7338, DOI 10.1128/JVI.79.12.7338-7348.2005; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; BLOOM JC, 1979, BLOOD, V53, P899; BLOOM JC, 1980, CANCER RES, V40, P2240; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenner C, 2006, CURR TOP MICROBIOL, V301, P45; BURNY A, 1987, CANCER SURV, V6, P139; Burny A., 1980, Viral oncology, P231; BURNY A, 1994, BOVINE LEUKEMIA VIRU, P213; Calomme C, 2004, J VIROL, V78, P13848, DOI 10.1128/JVI.78.24.13848-13864.2004; Calomme C, 2002, J BIOL CHEM, V277, P8775, DOI 10.1074/jbc.M107441200; Dekoninck A, 2003, ONCOGENE, V22, P2882, DOI 10.1038/sj.onc.1206392; DERSE D, 1987, J VIROL, V61, P2462, DOI 10.1128/JVI.61.8.2462-2471.1987; Dickerson SJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000356; Ego T, 2005, ONCOGENE, V24, P1914, DOI 10.1038/sj.onc.1208394; Ego T, 2002, ONCOGENE, V21, P7241, DOI 10.1038/sj.onc.1205701; FERRER JF, 1979, J AM VET MED ASSOC, V175, P1281; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Gillet N, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-18; GUPTA P, 1982, SCIENCE, V215, P405, DOI 10.1126/science.6276975; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; HERSCHLAG D, 1993, GENE DEV, V7, P173, DOI 10.1101/gad.7.2.173; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; JENSEN WA, 1992, J VIROL, V66, P4427, DOI 10.1128/JVI.66.7.4427-4433.1992; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Kamoi K, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-5; KASHMIRI SVS, 1985, BIOCHEM BIOPH RES CO, V129, P126, DOI 10.1016/0006-291X(85)91412-3; Kauder SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000495; Kerkhofs P, 1996, J VIROL, V70, P2170, DOI 10.1128/JVI.70.4.2170-2177.1996; KETTMANN R, 1980, P NATL ACAD SCI-BIOL, V77, P2577, DOI 10.1073/pnas.77.5.2577; KETTMANN R, 1982, P NATL ACAD SCI-BIOL, V79, P2465, DOI 10.1073/pnas.79.8.2465; KETTMANN R, 1985, J VIROL, V54, P899, DOI 10.1128/JVI.54.3.899-901.1985; Kiermer V, 1998, J VIROL, V72, P5526, DOI 10.1128/JVI.72.7.5526-5534.1998; Koiwa T, 2002, J VIROL, V76, P9389, DOI 10.1128/JVI.76.18.9389-9397.2002; LAGARIAS DM, 1989, J VIROL, V63, P2099, DOI 10.1128/JVI.63.5.2099-2107.1989; Latham T, 2008, CELL TISSUE RES, V331, P31, DOI 10.1007/s00441-007-0537-9; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Matsuoka M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-71; Merezak C, 2002, J VIROL, V76, P5034, DOI 10.1128/JVI.76.10.5034-5042.2002; Merimi M, 2007, J VIROL, V81, P5929, DOI 10.1128/JVI.02606-06; Merimi M, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-51; Nguyen TLA, 2007, J BIOL CHEM, V282, P20854, DOI 10.1074/jbc.M703060200; Nguyen TLA, 2004, J BIOL CHEM, V279, P35025, DOI 10.1074/jbc.M404081200; Niermann GL, 1997, VIROLOGY, V239, P249, DOI 10.1006/viro.1997.8868; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Park IY, 2007, GASTROENTEROLOGY, V132, P1476, DOI 10.1053/j.gastro.2007.01.034; PORTETELLE D, 1989, J VIROL METHODS, V23, P211, DOI 10.1016/0166-0934(89)90135-3; SAGGIORO D, 1990, CANCER RES, V50, P4968; StanfieldOakley SA, 1996, J MOL BIOL, V256, P503, DOI 10.1006/jmbi.1996.0104; Tajima S, 2003, J VIROL, V77, P4423, DOI 10.1128/JVI.77.7.4423-4430.2003; Takeda S, 2004, INT J CANCER, V109, P559, DOI 10.1002/ijc.20007; Taniguchi Y, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-64; UNK I, 1994, NUCLEIC ACIDS RES, V22, P4872; Van den Broeke A, 1999, J VIROL, V73, P1054, DOI 10.1128/JVI.73.2.1054-1065.1999; Van Den Broeke Anne, 1997, P2127; van der Vlag J, 2000, J BIOL CHEM, V275, P697, DOI 10.1074/jbc.275.1.697; VANDENBROEKE A, 1988, P NATL ACAD SCI USA, V85, P9263, DOI 10.1073/pnas.85.23.9263; VANLINT C, 1994, J VIROL, V68, P2632, DOI 10.1128/JVI.68.4.2632-2648.1994; Villanueva R, 2006, ONCOL REP, V16, P581; WILLEMS L, 1992, J VIROL, V66, P766, DOI 10.1128/JVI.66.2.766-772.1992; Willems L, 1987, Haematol Blood Transfus, V31, P482; WILLEMS L, 1993, J VIROL, V67, P4078, DOI 10.1128/JVI.67.7.4078-4085.1993; Willems L, 2000, AIDS RES HUM RETROV, V16, P1787, DOI 10.1089/08892220050193326; WILLEMS L, 1999, CURRENT TOP VIROL, V1, P139; Xiao JQ, 1998, J VIROL, V72, P5994, DOI 10.1128/JVI.72.7.5994-6003.1998	72	22	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19434	19449		10.1074/jbc.M110.107607	http://dx.doi.org/10.1074/jbc.M110.107607			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20413592	Green Published, hybrid			2022-12-25	WOS:000278727800054
J	Rudolph, B; Gebendorfer, KM; Buchner, J; Winter, J				Rudolph, Birgit; Gebendorfer, Katharina M.; Buchner, Johannes; Winter, Jeannette			Evolution of Escherichia coli for Growth at High Temperatures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK; MOLECULAR CHAPERONES; ENDOSYMBIOTIC BACTERIA; DELETERIOUS MUTATIONS; ELEVATED-TEMPERATURES; STATIONARY-PHASE; PROTEIN; STRESS; GROEL; AGGREGATION	Evolution depends on the acquisition of genomic mutations that increase cellular fitness. Here, we evolved Escherichia coli MG1655 cells to grow at extreme temperatures. We obtained a maximum growth temperature of 48.5 degrees C, which was not increased further upon continuous cultivation at this temperature for >600 generations. Despite a permanently induced heat shock response in thermoresistant cells, only exquisitely high GroEL/GroES levels are essential for growth at 48.5 degrees C. They depend on the presence of lysyl-tRNA-synthetase, LysU, because deletion of lysU rendered thermoresistant cells thermosensitive. Our data suggest that GroEL/GroES are especially required for the folding of mutated proteins generated during evolution. GroEL/GroES therefore appear as mediators of evolution of extremely heat-resistant E. coli cells.	[Rudolph, Birgit; Gebendorfer, Katharina M.; Buchner, Johannes; Winter, Jeannette] Tech Univ Munich, Dept Chem, CiPSM, D-85747 Garching, Germany	Technical University of Munich	Winter, J (corresponding author), Tech Univ Munich, Dept Chem, CiPSM, Lichtenbergstr 4, D-85747 Garching, Germany.	jeannette.winter@ch.tum.de	Buchner, Johannes/A-2651-2010	Buchner, Johannes/0000-0003-1282-7737	Elitenetzwerk Bayern; Fonds der chemischen Industrie and Sonderforschungsbereich [594]; Deutsche Forschungsgemeinschaft	Elitenetzwerk Bayern; Fonds der chemischen Industrie and Sonderforschungsbereich; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Elitenetzwerk Bayern (to K. M. G.), the Fonds der chemischen Industrie and Sonderforschungsbereich 594 (to J.B.), and the Emmy-Noether program of the Deutsche Forschungsgemeinschaft (to J.W.).	BARDWELL JCA, 1988, J BACTERIOL, V170, P2977, DOI 10.1128/jb.170.7.2977-2983.1988; Barth E, 2009, MICROBIOL-SGM, V155, P1680, DOI 10.1099/mic.0.026021-0; Beissinger M, 1999, J MOL BIOL, V289, P1075, DOI 10.1006/jmbi.1999.2780; BREVET A, 1989, P NATL ACAD SCI USA, V86, P8275, DOI 10.1073/pnas.86.21.8275; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cullum AJ, 2001, EVOLUTION, V55, P2194; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Grallert H, 1999, J BIOL CHEM, V274, P20171, DOI 10.1074/jbc.274.29.20171; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; Gur E, 2002, MOL MICROBIOL, V46, P1391, DOI 10.1046/j.1365-2958.2002.03257.x; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hinault MP, 2006, J MOL NEUROSCI, V30, P249, DOI 10.1385/JMN:30:3:249; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; JOHNSTONE DB, 1991, EMBO J, V10, P3897, DOI 10.1002/j.1460-2075.1991.tb04959.x; Kandror O, 1997, P NATL ACAD SCI USA, V94, P4978, DOI 10.1073/pnas.94.10.4978; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; LANGE R, 1991, J BACTERIOL, V173, P4474, DOI 10.1128/JB.173.14.4474-4481.1991; LEE PC, 1983, P NATL ACAD SCI-BIOL, V80, P7496, DOI 10.1073/pnas.80.24.7496; LILIE H, 1995, P NATL ACAD SCI USA, V92, P8100, DOI 10.1073/pnas.92.18.8100; Loewe L, 2003, SCIENCE, V302, P1558, DOI 10.1126/science.1087911; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; Matic I, 2004, RES MICROBIOL, V155, P337, DOI 10.1016/j.resmic.2004.01.010; McKenzie GJ, 2001, CURR OPIN MICROBIOL, V4, P586, DOI 10.1016/S1369-5274(00)00255-1; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Mordukhova EA, 2008, APPL ENVIRON MICROB, V74, P7660, DOI 10.1128/AEM.00654-08; Niwa T, 2009, P NATL ACAD SCI USA, V106, P4201, DOI 10.1073/pnas.0811922106; PARSELL DA, 1989, GENE DEV, V3, P1226, DOI 10.1101/gad.3.8.1226; Riehle MM, 2001, P NATL ACAD SCI USA, V98, P525, DOI 10.1073/pnas.021448998; RON EZ, 1971, J BACTERIOL, V107, P391, DOI 10.1128/JB.107.2.391-396.1971; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schafer H, 2001, ELECTROPHORESIS, V22, P2955, DOI 10.1002/1522-2683(200108)22:14<2955::AID-ELPS2955>3.0.CO;2-U; Tanner JA, 2006, BIOCHEMISTRY-US, V45, P3095, DOI 10.1021/bi052529k; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Todd MJ, 1996, P NATL ACAD SCI USA, V93, P4030, DOI 10.1073/pnas.93.9.4030; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; VANBOGELEN RA, 1987, GENE DEV, V1, P525, DOI 10.1101/gad.1.6.525; vandeVossenberg JLCM, 1995, MOL MICROBIOL, V18, P925, DOI 10.1111/j.1365-2958.1995.18050925.x; Walter S, 2002, ANGEW CHEM INT EDIT, V41, P1098, DOI 10.1002/1521-3773(20020402)41:7<1098::AID-ANIE1098>3.0.CO;2-9; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027	43	92	95	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19029	19034		10.1074/jbc.M110.103374	http://dx.doi.org/10.1074/jbc.M110.103374			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20406805	Green Published, hybrid			2022-12-25	WOS:000278727800011
J	Hou, J; Aerts, J; den Hamer, B; van IJcken, W; den Bakker, M; Riegman, P; van der Leest, C; van der Spek, P; Foekens, JA; Hoogsteden, HC; Grosveld, F; Philipsen, S				Hou, Jun; Aerts, Joachim; den Hamer, Bianca; van IJcken, Wilfred; den Bakker, Michael; Riegman, Peter; van der Leest, Cor; van der Spek, Peter; Foekens, John A.; Hoogsteden, Henk C.; Grosveld, Frank; Philipsen, Sjaak			Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CANCER; ADENOCARCINOMA; MICROARRAYS; IDENTIFICATION; SIGNATURE; PROFILES; EGFR	Background: Current clinical therapy of non-small cell lung cancer depends on histo-pathological classification. This approach poorly predicts clinical outcome for individual patients. Gene expression profiling holds promise to improve clinical stratification, thus paving the way for individualized therapy. Methodology and Principal Findings: A genome-wide gene expression analysis was performed on a cohort of 91 patients. We used 91 tumor-and 65 adjacent normal lung tissue samples. We defined sets of predictor genes (probe sets) with the expression profiles. The power of predictor genes was evaluated using an independent cohort of 96 non-small cell lung cancer-and 6 normal lung samples. We identified a tumor signature of 5 genes that aggregates the 156 tumor and normal samples into the expected groups. We also identified a histology signature of 75 genes, which classifies the samples in the major histological subtypes of non-small cell lung cancer. Correlation analysis identified 17 genes which showed the best association with post-surgery survival time. This signature was used for stratification of all patients in two risk groups. Kaplan-Meier survival curves show that the two groups display a significant difference in post-surgery survival time (p = 5.6E-6). The performance of the signatures was validated using a patient cohort of similar size (Duke University, n = 96). Compared to previously published prognostic signatures for NSCLC, the 17 gene signature performed well on these two cohorts. Conclusions: The gene signatures identified are promising tools for histo-pathological classification of non-small cell lung cancer, and may improve the prediction of clinical outcome.	[Hou, Jun; den Hamer, Bianca; Foekens, John A.; Grosveld, Frank; Philipsen, Sjaak] Erasmus Univ, Med Ctr, Canc Genom Ctr, Rotterdam, Netherlands; [van IJcken, Wilfred] Erasmus Univ, Med Ctr, Ctr Biom, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Hou, J (corresponding author), Erasmus Univ, Med Ctr, Canc Genom Ctr, Rotterdam, Netherlands.	j.philipsen@erasmusmc.nl	van ijcken, willem/N-9805-2018; Riegman, Peter/GLS-0041-2022; Aerts, Joachim GJV/I-7885-2018; Hou, Jun/AGJ-0692-2022	van ijcken, willem/0000-0002-0421-8301; 	Netherlands Genomics Initiative	Netherlands Genomics Initiative	Netherlands Genomics Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, AM J RESP CRIT CARE, V156, P320; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; COX DR, 1972, J R STAT SOC B, V34, P187; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Fujii T, 2002, CANCER RES, V62, P3340; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Jarvinen AK, 2004, GENOMICS, V83, P1164, DOI 10.1016/j.ygeno.2004.01.004; Jones MH, 2004, LANCET, V363, P775, DOI 10.1016/S0140-6736(04)15693-6; Kikuchi T, 2003, ONCOGENE, V22, P2192, DOI 10.1038/sj.onc.1206288; Kobayashi K, 2004, ONCOGENE, V23, P3089, DOI 10.1038/sj.onc.1207433; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Meche A, 2009, ROM J MORPHOL EMBRYO, V50, P217; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Potti A, 2006, NEW ENGL J MED, V355, P570, DOI 10.1056/NEJMoa060467; Press OA, 2008, CANCER RES, V68, P3037, DOI 10.1158/0008-5472.CAN-07-2718; Roepman P, 2009, CLIN CANCER RES, V15, P284, DOI 10.1158/1078-0432.CCR-08-1258; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Skrzypski M, 2008, CLIN CANCER RES, V14, P4794, DOI 10.1158/1078-0432.CCR-08-0576; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yao RS, 2002, ONCOGENE, V21, P5814, DOI 10.1038/sj.onc.1205422	32	563	581	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10312	10.1371/journal.pone.0010312	http://dx.doi.org/10.1371/journal.pone.0010312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421987	Green Published, gold			2022-12-25	WOS:000276952600025
J	Kang, KS; Wang, P; Yamabe, N; Fukui, M; Jay, T; Zhu, BT				Kang, Ki Sung; Wang, Pan; Yamabe, Noriko; Fukui, Masayuki; Jay, Taylor; Zhu, Bao Ting			Docosahexaenoic Acid Induces Apoptosis in MCF-7 Cells In Vitro and In Vivo via Reactive Oxygen Species Formation and Caspase 8 Activation	PLOS ONE			English	Article							BREAST-CANCER CELLS; POLYUNSATURATED FATTY-ACIDS; FISH-OIL; LIPID-PEROXIDATION; PROLIFERATION; GROWTH; N-3; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION; ANTHRACYCLINES	Background: The present study sought to further investigate the in vitro and in vivo anticancer effects of a representative omega-3 fatty acid, docosahexaenoic acid (DHA), with a focus on assessing the induction of oxidative stress and apoptosis as an important mechanism for its anticancer actions. Methodology/Principal Findings: In vitro studies showed that DHA strongly reduces the viability and DNA synthesis of MCF-7 human breast cancer cells in culture, and also promotes cell death via apoptosis. Mechanistically, accumulation of reactive oxygen species and activation of caspase 8 contribute critically to the induction of apoptotic cell death. Co-presence of antioxidants or selective inhibition or knockdown of caspase 8 each effectively abrogates the cytotoxic effect of DHA. Using athymic nude mice as an in vivo model, we found that feeding animals the 5% fish oil-supplemented diet for 6 weeks significantly reduces the growth of MCF-7 human breast cancer cells in vivo through inhibition of cancer cell proliferation as well as promotion of cell death. Using 3-nitrotyrosine as a parameter, we confirmed that the fish oil-supplemented diet significantly increases oxidative stress in tumor cells in vivo. Analysis of fatty acid content in plasma and tissues showed that feeding animals a 5% fish oil diet increases the levels of DHA and eicosapentaenoic acid in both normal and tumorous mammary tissues by 329% and 300%, respectively. Conclusions/Significance: DHA can strongly induce apoptosis in human MCF-7 breast cancer cells both in vitro and in vivo. The induction of apoptosis in these cells is selectively mediated via caspase 8 activation. These observations call for further studies to assess the effectiveness of fish oil as a dietary supplement in the prevention and treatment of human breast cancer.	[Kang, Ki Sung; Wang, Pan; Yamabe, Noriko; Fukui, Masayuki; Jay, Taylor; Zhu, Bao Ting] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Kang, KS (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	BTZhu@kumc.edu		Jay, Taylor/0000-0003-3878-7059	National Institutes of Health [ES015242]; National Center for Research Resources, NIH [P20RR021940]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported, in part, by a grant from the National Institutes of Health (ES015242). Some of the analytical and imaging instruments employed in this study are part of the Centers of Biomedical Research Excellence core facility that is supported by the NIH Grant P20RR021940 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTI M, 1992, GASTROENTEROLOGY, V103, P883, DOI 10.1016/0016-5085(92)90021-P; Arita K, 2001, BIOCHEM PHARMACOL, V62, P821, DOI 10.1016/S0006-2952(01)00723-7; Bagga D, 2002, NUTR CANCER, V42, P180, DOI 10.1207/S15327914NC422_5; BARTRAM HP, 1993, GASTROENTEROLOGY, V105, P1317, DOI 10.1016/0016-5085(93)90135-Y; BEGIN ME, 1986, JNCI-J NATL CANCER I, V77, P1053; Bougnoux P, 2009, BRIT J CANCER, V101, P1978, DOI 10.1038/sj.bjc.6605441; Calviello G, 1999, LIPIDS, V34, P599, DOI 10.1007/s11745-999-0404-6; CHAJES V, 1995, BREAST CANCER RES TR, V34, P199, DOI 10.1007/BF00689711; Chamras H, 2002, J NUTR BIOCHEM, V13, P711, DOI 10.1016/S0955-2863(02)00230-9; Cognault S, 2000, NUTR CANCER, V36, P33, DOI 10.1207/S15327914NC3601_6; Colas S, 2005, NUTR CANCER, V51, P178, DOI 10.1207/s15327914nc5102_8; Connolly JM, 1999, NUTR CANCER, V35, P44, DOI 10.1207/S1532791444-49; Day TW, 2008, BIOCHEM PHARMACOL, V76, P1694, DOI 10.1016/j.bcp.2008.09.007; Ding WQ, 2004, MOL CANCER THER, V3, P1109; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gago-Dominguez M, 2005, CANCER EPIDEM BIOMAR, V14, P2829, DOI 10.1158/1055-9965.EPI-05-0015; Gajate C, 2009, BIOCHEM BIOPH RES CO, V380, P780, DOI 10.1016/j.bbrc.2009.01.147; Hammamieh R, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-138; Hardman WE, 2002, J NUTR, V132, p3508S, DOI 10.1093/jn/132.11.3508S; Hardman WE, 1999, BRIT J CANCER, V81, P440, DOI 10.1038/sj.bjc.6690713; Hardman WE, 1997, BRIT J CANCER, V76, P347, DOI 10.1038/bjc.1997.389; KAIZER L, 1989, NUTR CANCER, V12, P61, DOI 10.1080/01635588909514002; Koh YH, 1997, J BIOCHEM MOL BIOL, V30, P188; Lin YH, 2007, J LIPID RES, V48, P2709, DOI 10.1194/jlr.M700369-JLR200; MORRISON WR, 1964, J LIPID RES, V5, P600; Noguchi M, 1997, BRIT J CANCER, V75, P348, DOI 10.1038/bjc.1997.57; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rose DP, 1999, PHARMACOL THERAPEUT, V83, P217, DOI 10.1016/S0163-7258(99)00026-1; Rose DP, 1996, CLIN CANCER RES, V2, P1751; Sauer LA, 2005, J NUTR, V135, P2124, DOI 10.1093/jn/135.9.2124; Siddiqui RA, 2001, BBA-MOL CELL RES, V1499, P265, DOI 10.1016/S0167-4889(00)00128-2; SPECTOR AA, 1987, CANCER RES, V47, P4529; Sun H, 2008, CANCER RES, V68, P2912, DOI 10.1158/0008-5472.CAN-07-2305; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vibet S, 2008, FREE RADICAL BIO MED, V44, P1483, DOI 10.1016/j.freeradbiomed.2008.01.009; WELSCH CW, 1995, FREE RADICAL BIO MED, V18, P757, DOI 10.1016/0891-5849(94)00187-O; Wu M, 2005, INT J CANCER, V117, P340, DOI 10.1002/ijc.21238; Ye YN, 2005, CARCINOGENESIS, V26, P827, DOI 10.1093/carcin/bgi012; Zamboni WC, 1998, J NATL CANCER I, V90, P505, DOI 10.1093/jnci/90.7.505	41	149	151	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10296	10.1371/journal.pone.0010296	http://dx.doi.org/10.1371/journal.pone.0010296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421971	Green Submitted, Green Published, gold			2022-12-25	WOS:000276952600013
J	Ligresti, A; De Petrocellis, L; de la Ossa, DHP; Aberturas, R; Cristino, L; Moriello, AS; Finizio, A; Gil, ME; Torres, AI; Molpeceres, J; Di Marzo, V				Ligresti, Alessia; De Petrocellis, Luciano; Hernan Perez de la Ossa, Dolores; Aberturas, Rosario; Cristino, Luigia; Moriello, Aniello Schiano; Finizio, Andrea; Esther Gil, Ma; Torres, Ana-Isabel; Molpeceres, Jesus; Di Marzo, Vincenzo			Exploiting Nanotechnologies and TRPV1 Channels to Investigate the Putative Anandamide Membrane Transporter	PLOS ONE			English	Article							TYPE-1 CANNABINOID RECEPTORS; PHASE-CONTRAST MICROSCOPY; CELLULAR UPTAKE; INHIBITORS; NANOPARTICLES; TEMPERATURE; HYDROLYSIS; CELLS; PALMITOYLETHANOLAMIDE; INACTIVATION	Background: Considerable efforts have been made to characterize the pathways regulating the extracellular levels of the endocannabinoid anandamide. However, none of such pathways has been so argued as the existence of a carrier-mediated transport of anandamide across the membrane. Apart from the lack of molecular evidence for such a carrier, the main reasons of this controversy lie in the methodologies currently used to study anandamide cellular uptake. Furthermore, the main evidence in favor of the existence of an "anandamide transporter" relies on synthetic inhibitors of this process, the selectivity of which has been questioned. Methodology/Principal Findings: We used the cytosolic binding site for anandamide on TRPV1 channels as a biosensor to detect anandamide entry into cells, and exploited nanotechnologies to study anandamide membrane transport into intact TRPV1-overexpressing HEK-293 cells. Both fluorescence and digital holographic (DH) quantitative phase microscopy were used to study TRPV1 activation. Poly-epsilon-caprolactone nanoparticles (PCL-NPs) were used to incorporate anandamide, which could thus enter the cell and activate TRPV1 channels bypassing any possible specific protein(s) involved in the uptake process. We reasoned that in the absence of such protein(s), pharmacological tools previously shown to inhibit the "anandamide transporter" would affect in the same way the uptake of anandamide and PCL-NP-anandamide, and hence the activation of TRPV1. However, when masked into PCL-NPs, anandamide cellular uptake became much less sensitive to these agents, although it maintained the same pharmacokinetics and pharmacodynamics as that of "free" anandamide. Conclusions: We found here that several agents previously reported to inhibit anandamide cellular uptake lose their efficacy when anandamide is prevented from interacting directly with plasma membrane proteins, thus arguing in favor of the specificity of such agents for the putative "anandamide transporter", and of the existence of such mechanism.	[Ligresti, Alessia; Di Marzo, Vincenzo] CNR, Inst Biomol Chem, Pozzuoli, Italy; [Ligresti, Alessia; De Petrocellis, Luciano; Cristino, Luigia; Moriello, Aniello Schiano; Di Marzo, Vincenzo] Endocannabinoid Res Grp, Pozzuoli, Italy; [Ligresti, Alessia; De Petrocellis, Luciano; Cristino, Luigia; Moriello, Aniello Schiano; Di Marzo, Vincenzo] Endocannabinoid Res Grp, Naples, Italy; [De Petrocellis, Luciano; Cristino, Luigia; Moriello, Aniello Schiano; Finizio, Andrea] CNR, Inst Cybernet, Pozzuoli, Italy; [Hernan Perez de la Ossa, Dolores; Esther Gil, Ma; Torres, Ana-Isabel] Univ Complutense, Dept Pharm & Pharmaceut Technol, Sch Pharm, E-28040 Madrid, Spain; [Aberturas, Rosario; Molpeceres, Jesus] Alcala Univ, Dept Pharm & Pharmaceut Technol, Sch Pharm, Madrid, Spain	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Cibernetica "Eduardo Caianiello" (ICIB-CNR); Complutense University of Madrid; Universidad de Alcala	Ligresti, A (corresponding author), CNR, Inst Biomol Chem, Pozzuoli, Italy.	vdimarzo@icmib.na.cnr.it	Ligresti, Alessia/B-7564-2015; Di Marzo, Vincenzo/AAD-7742-2019; Torres-SuÃrez, Ana Isabel/AAR-9320-2020; /Y-9512-2019; Torres-Suárez, Ana I/N-4666-2013; Cristino, Luigia/AAE-3934-2020; del Rosario Aberturas, María/AAA-9014-2019	Ligresti, Alessia/0000-0003-1787-3900; Di Marzo, Vincenzo/0000-0002-1490-3070; Torres-SuÃrez, Ana Isabel/0000-0003-2468-6177; /0000-0003-4201-0795; Torres-Suárez, Ana I/0000-0003-2468-6177; Cristino, Luigia/0000-0002-0182-4699; del Rosario Aberturas, María/0000-0001-7875-6009; GIL-ALEGRE, MARIA ESTHER/0000-0002-8313-8261	Consiglio Nazionale delle Ricerche	Consiglio Nazionale delle Ricerche(Consiglio Nazionale delle Ricerche (CNR))	This study was partly funded by the Consiglio Nazionale delle Ricerche. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bari M, 2005, J BIOL CHEM, V280, P12212, DOI 10.1074/jbc.M411642200; Bari M, 2008, NEUROPHARMACOLOGY, V54, P45, DOI 10.1016/j.neuropharm.2007.06.030; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Bisogno T, 1997, J BIOL CHEM, V272, P3315, DOI 10.1074/jbc.272.6.3315; Bojesen IN, 2005, J LIPID RES, V46, P1652, DOI 10.1194/jlr.M400498-JLR200; Bojesen IN, 2006, J LIPID RES, V47, P561, DOI 10.1194/jlr.M500411-JLR200; Chawla JS, 2002, INT J PHARM, V249, P127, DOI 10.1016/S0378-5173(02)00483-0; Cuche E, 1999, OPT LETT, V24, P291, DOI 10.1364/OL.24.000291; Dausend J, 2008, MACROMOL BIOSCI, V8, P1135, DOI 10.1002/mabi.200800123; Davda J, 2002, INT J PHARM, V233, P51, DOI 10.1016/S0378-5173(01)00923-1; de Lago E, 2004, EUR J PHARMACOL, V484, P249, DOI 10.1016/j.ejphar.2003.11.027; De Petrocellis L, 2001, FEBS LETT, V506, P253, DOI 10.1016/S0014-5793(01)02934-9; De Petrocellis L, 2001, J BIOL CHEM, V276, P12856, DOI 10.1074/jbc.M008555200; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 1998, FEBS LETT, V436, P449, DOI 10.1016/S0014-5793(98)01175-2; Di Pasquale E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004989; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Fegley D, 2004, P NATL ACAD SCI USA, V101, P8756, DOI 10.1073/pnas.0400997101; Ferraro P, 2006, OPT LETT, V31, P1405, DOI 10.1364/OL.31.001405; Fowler CJ, 2004, EUR J PHARMACOL, V492, P1, DOI 10.1016/j.ejphar.2004.03.048; GARRETT ER, 1974, J PHARM SCI-US, V63, P1056, DOI 10.1002/jps.2600630705; Hajos N, 2004, EUR J NEUROSCI, V19, P2991, DOI 10.1111/j.0953-816X.2004.03433.x; Hillard CJ, 2007, J MOL NEUROSCI, V33, P18, DOI 10.1007/s12031-007-0045-0; Hillard CJ, 2003, BRIT J PHARMACOL, V140, P802, DOI 10.1038/sj.bjp.0705468; Jeong K, 2007, OPT EXPRESS, V15, P14057, DOI 10.1364/OE.15.014057; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kaczocha M, 2006, J BIOL CHEM, V281, P9066, DOI 10.1074/jbc.M509721200; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Karlsson M, 2004, EUR J PHARM SCI, V22, P181, DOI 10.1016/j.ejps.2004.03.009; Ligresti A, 2004, BIOCHEM J, V380, P265, DOI 10.1042/BJ20031812; Lopez-Rodriguez ML, 2003, EUR J MED CHEM, V38, P403, DOI 10.1016/S0223-5234(03)00045-X; Maccarrone M, 2000, J BIOL CHEM, V275, P13484, DOI 10.1074/jbc.275.18.13484; Mailander V, 2009, BIOMACROMOLECULES, V10, P2379, DOI 10.1021/bm900266r; Maione S, 2008, BRIT J PHARMACOL, V155, P775, DOI 10.1038/bjp.2008.308; Mann CJ, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-21; Mann CJ, 2005, OPT EXPRESS, V13, P8693, DOI 10.1364/OPEX.13.008693; MICCIO L, 2007, SPIE P, V6631; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Ortar G, 2003, BIOCHEM PHARMACOL, V65, P1473, DOI 10.1016/S0006-2952(03)00109-6; Ortega-Gutierrez S, 2004, BIOCHEMISTRY-US, V43, P8184, DOI 10.1021/bi049395f; Rappaz B, 2009, BLOOD CELL MOL DIS, V42, P228, DOI 10.1016/j.bcmd.2009.01.018; Thors L, 2006, BRIT J PHARMACOL, V149, P73, DOI 10.1038/sj.bjp.0706831; Thors L, 2007, BRIT J PHARMACOL, V152, P744, DOI 10.1038/sj.bjp.0707401; Vasir JK, 2007, ADV DRUG DELIVER REV, V59, P718, DOI 10.1016/j.addr.2007.06.003	45	30	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10239	10.1371/journal.pone.0010239	http://dx.doi.org/10.1371/journal.pone.0010239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20422025	gold, Green Published, Green Submitted			2022-12-25	WOS:000276952600002
J	Chanut-Delalande, H; Jung, AC; Baer, MM; Lin, L; Payre, F; Affolter, M				Chanut-Delalande, Helene; Jung, Alain C.; Baer, Magdalena M.; Lin, Li; Payre, Francois; Affolter, Markus			The Hrs/Stam Complex Acts as a Positive and Negative Regulator of RTK Signaling during Drosophila Development	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASES; GROWTH-FACTOR RECEPTOR; TRACHEAL CELL-MIGRATION; DOWN-REGULATION; BRANCHING MORPHOGENESIS; ENDOSOMAL TRAFFICKING; ESCRT MACHINERY; MOSAIC ANALYSIS; EGF-RECEPTOR; HRS	Background: Endocytosis is a key regulatory step of diverse signalling pathways, including receptor tyrosine kinase (RTK) signalling. Hrs and Stam constitute the ESCRT-0 complex that controls the initial selection of ubiquitinated proteins, which will subsequently be degraded in lysosomes. It has been well established ex vivo and during Drosophila embryogenesis that Hrs promotes EGFR down regulation. We have recently isolated the first mutations of stam in flies and shown that Stam is required for air sac morphogenesis, a larval respiratory structure whose formation critically depends on finely tuned levels of FGFR activity. This suggest that Stam, putatively within the ESCRT-0 complex, modulates FGF signalling, a possibility that has not been examined in Drosophila yet. Principal Findings: Here, we assessed the role of the Hrs/Stam complex in the regulation of signalling activity during Drosophila development. We show that stam and hrs are required for efficient FGFR signalling in the tracheal system, both during cell migration in the air sac primordium and during the formation of fine cytoplasmic extensions in terminal cells. We find that stam and hrs mutant cells display altered FGFR/Btl localisation, likely contributing to impaired signalling levels. Electron microscopy analyses indicate that endosome maturation is impaired at distinct steps by hrs and stam mutations. These somewhat unexpected results prompted us to further explore the function of stam and hrs in EGFR signalling. We show that while stam and hrs together downregulate EGFR signalling in the embryo, they are required for full activation of EGFR signalling during wing development. Conclusions/Significance: Our study shows that the ESCRT-0 complex differentially regulates RTK signalling, either positively or negatively depending on tissues and developmental stages, further highlighting the importance of endocytosis in modulating signalling pathways during development.	[Chanut-Delalande, Helene; Jung, Alain C.; Baer, Magdalena M.; Lin, Li; Affolter, Markus] Univ Basel, Biozentrum, Abt Zellbiol, Basel, Switzerland; [Chanut-Delalande, Helene; Payre, Francois] Univ Toulouse 3, Ctr Biol Dev, UPS, Univ Toulouse, F-31062 Toulouse, France; [Chanut-Delalande, Helene; Payre, Francois] Ctr Dev Biol, CNRS, UMR5547, Toulouse, France	University of Basel; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Chanut-Delalande, H (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, Basel, Switzerland.	chanut@cict.fr; markus.affolter@unibas.ch	Jung, Alain/AAC-6598-2019; Jung, Alain/X-5384-2019	Jung, Alain/0000-0002-4049-4151; Affolter, Markus/0000-0002-5171-0016; CHANUT-DELALANDE, Helene/0000-0002-1720-2069; PAYRE, Francois/0000-0002-8144-6711; Baer, Magdalena/0000-0003-3315-0921	Swiss National Science Foundation; Kantons Basel-Stadt and Basel-Land; European Commission; Association pour la Recherche contre le Cancer n [1111]; ANR Programme Blanc Netoshape	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kantons Basel-Stadt and Basel-Land; European Commission(European CommissionEuropean Commission Joint Research Centre); Association pour la Recherche contre le Cancer n; ANR Programme Blanc Netoshape(French National Research Agency (ANR))	Studies done in the laboratory of Markus Affolter are supported by research grants from the Swiss National Science Foundation, the Kantons Basel-Stadt and Basel-Land, and the European Commission via the FP6 Network of Excellence "Cells into organs''. Experiments performed in Francois Payre laboratory are supported by Association pour la Recherche contre le Cancer n degrees 1111 and ANR Programme Blanc Netoshape. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0; Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Belleudi F, 2007, TRAFFIC, V8, P1854, DOI 10.1111/j.1600-0854.2007.00651.x; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Cabernard C, 2005, DEV CELL, V9, P831, DOI 10.1016/j.devcel.2005.10.008; Centanin L, 2008, DEV CELL, V14, P547, DOI 10.1016/j.devcel.2008.01.020; Chanut-Delalande H, 2007, GENETICS, V176, P2177, DOI 10.1534/genetics.107.073890; Dammai V, 2003, GENE DEV, V17, P2812, DOI 10.1101/gad.1096903; Devergne O, 2007, J CELL SCI, V120, P3457, DOI 10.1242/jcs.005926; Fischer JA, 2006, ANNU REV CELL DEV BI, V22, P181, DOI 10.1146/annurev.cellbio.22.010605.093205; Gabay L, 1997, DEVELOPMENT, V124, P3535; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Golembo M, 1996, DEVELOPMENT, V122, P223; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Kanazawa C, 2003, BIOCHEM BIOPH RES CO, V309, P848, DOI 10.1016/j.bbrc.2003.08.078; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim MS, 2006, BIOCHEM BIOPH RES CO, V351, P612, DOI 10.1016/j.bbrc.2006.10.068; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; Miura GI, 2008, DEVELOPMENT, V135, P1913, DOI 10.1242/dev.017202; Prag G, 2007, DEV CELL, V12, P973, DOI 10.1016/j.devcel.2007.04.013; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Reich A, 2002, EMBO J, V21, P4287, DOI 10.1093/emboj/cdf439; Row PE, 2005, BIOCHEM J, V389, P629, DOI 10.1042/BJ20050067; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Sato M, 2008, DEV BIOL, V318, P247, DOI 10.1016/j.ydbio.2008.03.025; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Vecchione A, 2007, PROTEOMICS, V7, P4565, DOI 10.1002/pmic.200700615; WEAVER M, 2008, SCIENCE; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087	49	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10245	10.1371/journal.pone.0010245	http://dx.doi.org/10.1371/journal.pone.0010245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422006	Green Published, Green Submitted, gold			2022-12-25	WOS:000276952500013
J	Boles, BR; Thoendel, M; Roth, AJ; Horswill, AR				Boles, Blaise R.; Thoendel, Matthew; Roth, Aleeza J.; Horswill, Alexander R.			Identification of Genes Involved in Polysaccharide-Independent Staphylococcus aureus Biofilm Formation	PLOS ONE			English	Article							EXTRACELLULAR DNA; STREPTOCOCCUS-PNEUMONIAE; METHICILLIN RESISTANCE; PROTEOLYTIC ACTIVITY; BINDING PROTEINS; EXPRESSION; RELEASE; SYSTEM; AUTOLYSIS; SUSCEPTIBILITY	Staphylococcus aureus is a potent biofilm former on host tissue and medical implants, and biofilm growth is a critical virulence determinant for chronic infections. Recent studies suggest that many clinical isolates form polysaccharide-independent biofilms. However, a systematic screen for defective mutants has not been performed to identify factors important for biofilm formation in these strains. We created a library of 14,880 mariner transposon mutants in a S. aureus strain that generates a proteinaceous and extracellular DNA based biofilm matrix. The library was screened for biofilm defects and 31 transposon mutants conferred a reproducible phenotype. In the pool, 16 mutants overproduced extracellular proteases and the protease inhibitor alpha(2)-macroglobulin restored biofilm capacity to 13 of these mutants. The other 15 mutants in the pool displayed normal protease levels and had defects in genes involved in autolysis, osmoregulation, or uncharacterized membrane proteins. Two transposon mutants of interest in the GraRS two-component system and a putative inositol monophosphatase were confirmed in a flow cell biofilm model, genetically complemented, and further verified in a community-associated methicillin-resistant S. aureus (CA-MRSA) isolate. Collectively, our screen for biofilm defective mutants identified novel loci involved in S. aureus biofilm formation and underscored the importance of extracellular protease activity and autolysis in biofilm development.	[Boles, Blaise R.; Thoendel, Matthew; Roth, Aleeza J.; Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Horswill, AR (corresponding author), Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	alex-horswill@uiowa.edu			National Institute of Allergy and Infectious Diseases [AI083211]; American Heart Association [0825877G]; National Science Foundation [DBI-0647982]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI081748, P01AI083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by PO1 award AI083211 (Project 3 to A. R. H.) from the National Institute of Allergy and Infectious Diseases. B. R. B. was supported by an American Heart Association Postdoctoral Training Grant (0825877G). A.J.R. was supported by grant DBI-0647982 (REU in Microbiology at The University of Iowa) from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; BISWAS R, 2006, FEMS MICROBIOL LETT, V268, P259; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; Conrady DG, 2008, P NATL ACAD SCI USA, V105, P19456, DOI 10.1073/pnas.0807717105; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Costerton JW, 2005, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000175128.44966.d9; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Fan X, 2007, J BIOL CHEM, V282, P35143, DOI 10.1074/jbc.M706296200; Fournier B, 2000, J BACTERIOL, V182, P3955, DOI 10.1128/JB.182.14.3955-3964.2000; Guiton PS, 2009, INFECT IMMUN, V77, P3626, DOI 10.1128/IAI.00219-09; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; HEINS JN, 1967, J BIOL CHEM, V242, P1016; Herbert S, 2007, PLOS PATHOG, V3, P981, DOI 10.1371/journal.ppat.0030102; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Huber B, 2002, MOL MICROBIOL, V46, P411, DOI 10.1046/j.1365-2958.2002.03182.x; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Kapfhammer D, 2005, APPL ENVIRON MICROB, V71, P3840, DOI 10.1128/AEM.71.7.3840-3847.2005; Komatsuzawa H, 1999, ANTIMICROB AGENTS CH, V43, P2121, DOI 10.1128/AAC.43.9.2121; Komatsuzawa H, 1997, ANTIMICROB AGENTS CH, V41, P2355, DOI 10.1128/AAC.41.11.2355; Kraus D, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-85; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lauderdale KJ, 2010, J ORTHOP RES, V28, P55, DOI 10.1002/jor.20943; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; Li M, 2007, MOL MICROBIOL, V66, P1136, DOI 10.1111/j.1365-2958.2007.05986.x; Malone CL, 2007, APPL ENVIRON MICROB, V73, P6036, DOI 10.1128/AEM.00912-07; Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Marti M, 2010, MICROBES INFECT, V12, P55, DOI 10.1016/j.micinf.2009.10.005; Meehl M, 2007, ANTIMICROB AGENTS CH, V51, P2679, DOI 10.1128/AAC.00209-07; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; O'Neill AJ, 2004, J ANTIMICROB CHEMOTH, V54, P1127, DOI 10.1093/jac/dkh476; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Quoc PHT, 2007, INFECT IMMUN, V75, P1079, DOI 10.1128/IAI.01143-06; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Roberts Mary F., 2006, V39, P103; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Trotonda MP, 2005, J BACTERIOL, V187, P5790, DOI 10.1128/JB.187.16.5790-5798.2005; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487	56	250	255	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10146	10.1371/journal.pone.0010146	http://dx.doi.org/10.1371/journal.pone.0010146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418950	gold, Green Published, Green Submitted			2022-12-25	WOS:000276706800009
J	Tay, HG; Ng, YW; Manser, E				Tay, Hwee Goon; Ng, Yuen Wai; Manser, Ed			A Vertebrate-Specific Chp-PAK-PIX Pathway Maintains E-Cadherin at Adherens Junctions during Zebrafish Epiboly	PLOS ONE			English	Article							CELL-CELL ADHESION; CONVERGENT EXTENSION MOVEMENTS; NUCLEOTIDE EXCHANGE FACTOR; RHO-FAMILY GTPASES; EPITHELIAL-MESENCHYMAL TRANSITIONS; ACTIN CYTOSKELETON; SIGNALING PATHWAY; EMBRYONIC-DEVELOPMENT; P21-ACTIVATED KINASE; DISTINCT ROLES	Background: In early vertebrate development, embryonic tissues modulate cell adhesiveness and acto-myosin contractility to correctly orchestrate the complex processes of gastrulation. E-cadherin (E-cadh) is the earliest expressed cadherin and is needed in the mesendodermal progenitors for efficient migration [1,2]. Regulatory mechanisms involving directed E-cadh trafficking have been invoked downstream of Wnt11/5 signaling [3]. This non-canonical Wnt pathway regulates RhoA-ROK/DAAM1 to control the acto-myosin network. However, in this context nothing is known of the intracellular signals that participate in the correct localization of E-cadh, other than a need for Rab5c signaling [3]. Methodology/Principal Findings: By studying loss of Chp induced by morpholino-oligonucleotide injection in zebrafish, we find that the vertebrate atypical Rho-GTPase Chp is essential for the proper disposition of cells in the early embryo. The underlying defect is not leading edge F-actin assembly ( prominent in the cells of the envelope layer), but rather the failure to localize E-cadh and beta-catenin at the adherens junctions. Loss of Chp results in delayed epiboly that can be rescued by mRNA co-injection, and phenocopies zebrafish E-cadh mutants [4,5]. This new signaling pathway involves activation of an effector kinase PAK, and involvement of the adaptor PAK-interacting exchange factor PIX. Loss of signaling by any of the three components results in similar underlying defects, which is most prominent in the epithelial-like envelope layer. Conclusions/Significance: Our current study uncovers a developmental pathway involving Chp/PAK/PIX signaling, which helps co-ordinate E-cadh disposition to promote proper cell adhesiveness, and coordinate movements of the three major cell layers in epiboly. Our data shows that without Chp signaling, E-cadh shifts to intracellular vesicles rather than the adhesive contacts needed for directed cell movement. These events may mirror the requirement for PAK2 signaling essential for the proper formation of the blood-brain barrier [6,7].	[Tay, Hwee Goon; Manser, Ed] IMB, RGS Rho GTPases Stem Cells Grp, Singapore, Singapore; [Ng, Yuen Wai; Manser, Ed] IMCB, SGSK, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Tay, HG (corresponding author), IMB, RGS Rho GTPases Stem Cells Grp, Singapore, Singapore.	ed.manser@imb.a-star.edu.sg	Manser, Edward/ABD-2301-2020		Agency for Science, Technology and Research (A-STAR)	Agency for Science, Technology and Research (A-STAR)(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology and Research (A-STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2001, MOL BIOL CELL, V12, P847, DOI 10.1091/mbc.12.4.847; Aronheim A, 1998, CURR BIOL, V8, P1125, DOI 10.1016/S0960-9822(98)70468-3; Babb SG, 2004, DEV DYNAM, V230, P263, DOI 10.1002/dvdy.20057; Bahri SM, 2009, DEV BIOL, V325, P15, DOI 10.1016/j.ydbio.2008.09.001; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Buchner DA, 2007, P NATL ACAD SCI USA, V104, P13996, DOI 10.1073/pnas.0700947104; Chenette EJ, 2005, J BIOL CHEM, V280, P13784, DOI 10.1074/jbc.M411300200; Cheng JC, 2004, DEV DYNAM, V231, P313, DOI 10.1002/dvdy.20144; Chihara T, 2003, DEVELOPMENT, V130, P1419, DOI 10.1242/dev.00361; Choi SC, 2002, DEV BIOL, V244, P342, DOI 10.1006/dbio.2002.0602; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Djiane A, 2000, DEVELOPMENT, V127, P3091; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Guemar L, 2007, DEV BIOL, V310, P113, DOI 10.1016/j.ydbio.2007.07.031; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Harden N, 1999, J CELL SCI, V112, P273; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Hsu HJ, 2006, NATURE, V439, P480, DOI 10.1038/nature04436; Hubsman MW, 2007, BIOCHEM J, V404, P487, DOI 10.1042/BJ20061696; Kane DA, 2005, DEVELOPMENT, V132, P1105, DOI 10.1242/dev.01668; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kardash E., NAT CELL BIOL, V12, P47; KARDASH E, NAT CELL BIOL, V12, P41; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kim GH, 2005, DEV DYNAM, V232, P958, DOI 10.1002/dvdy.20262; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinoshita N, 2008, MOL BIOL CELL, V19, P2289, DOI 10.1091/mbc.E07-12-1286; Koh CG, 2001, J CELL SCI, V114, P4239; Kuroda S, 1997, BIOCHEM BIOPH RES CO, V240, P430, DOI 10.1006/bbrc.1997.7675; Lai SL, 2005, MOL REPROD DEV, V71, P186, DOI 10.1002/mrd.20290; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Leskow FC, 2006, P NATL ACAD SCI USA, V103, P5373, DOI 10.1073/pnas.0508585103; Lin F, 2009, J CELL BIOL, V184, P909, DOI 10.1083/jcb.200805148; Liu J, 2007, P NATL ACAD SCI USA, V104, P13990, DOI 10.1073/pnas.0700825104; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Lozano E, 2008, J CELL SCI, V121, P933, DOI 10.1242/jcs.016121; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Missy K, 2008, MOL CELL BIOL, V28, P3776, DOI 10.1128/MCB.00507-07; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Montero JA, 2004, TRENDS CELL BIOL, V14, P620, DOI 10.1016/j.tcb.2004.09.008; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Munoz-Descalzo S, 2007, INT J DEV BIOL, V51, P379, DOI 10.1387/ijdb.062250sm; Nakagawa M, 2001, J CELL SCI, V114, P1829; Nandadasa S, 2009, DEVELOPMENT, V136, P1327, DOI 10.1242/dev.031203; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Notarnicola C, 2008, DEV DYNAM, V237, P1165, DOI 10.1002/dvdy.21507; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Pirraglia C, 2006, DEV BIOL, V290, P435, DOI 10.1016/j.ydbio.2005.12.005; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Salas-Vidal E, 2005, GENOMICS, V86, P25, DOI 10.1016/j.ygeno.2005.03.010; Shimizu T, 2005, MECH DEVELOP, V122, P747, DOI 10.1016/j.mod.2005.03.008; Shin EY, 2006, J BIOL CHEM, V281, P35954, DOI 10.1074/jbc.M602399200; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; SOLNICAKREZEL L, 1994, DEVELOPMENT, V120, P2443; Stappenbeck TS, 2000, DEVELOPMENT, V127, P2629; STRAHLE U, 1993, DEVELOPMENT, V119, P909; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Ulrich F, 2003, DEVELOPMENT, V130, P5375, DOI 10.1242/dev.00758; Ulrich Florian, 2008, V440, P371, DOI 10.1007/978-1-59745-178-9_27; Warga RM, 2007, DEV BIOL, V310, P211, DOI 10.1016/j.ydbio.2007.06.023; Weis WI, 2006, J BIOL CHEM, V281, P35593, DOI 10.1074/jbc.R600027200; Wherlock M, 2002, J CELL SCI, V115, P239; Williams MJ, 2005, BRAIN RES, V1058, P62, DOI 10.1016/j.brainres.2005.07.078; Yagi R, 2007, EMBO J, V26, P1234, DOI 10.1038/sj.emboj.7601595; Zalik SE, 1999, BIOCHEM CELL BIOL, V77, P527, DOI 10.1139/bcb-77-6-527; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035	90	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10125	10.1371/journal.pone.0010125	http://dx.doi.org/10.1371/journal.pone.0010125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405038	gold, Green Published, Green Submitted			2022-12-25	WOS:000276705900009
J	Ibrahim, M; Al Masri, A; Navaratnarajah, M; Siedlecka, U; Soppa, GK; Moshkov, A; Abou Al-Saud, S; Gorelik, J; Yacoub, MH; Terracciano, CMN				Ibrahim, Michael; Al Masri, Abeer; Navaratnarajah, Manoraj; Siedlecka, Urszula; Soppa, Gopal K.; Moshkov, Alexey; Abou Al-Saud, Sara; Gorelik, Julia; Yacoub, Magdi H.; Terracciano, Cesare M. N.			Prolonged mechanical unloading affects cardiomyocyte excitation-contraction coupling, transverse-tubule structure, and the cell surface	FASEB JOURNAL			English	Article						Ca2+-induced Ca2+ release; scanning ion conductance microscope; confocal microscope	VENTRICULAR ASSIST DEVICE; SCANNING ION-CONDUCTANCE; T-TUBULES; REDUCED SYNCHRONY; CA2+ RELEASE; HEART-TRANSPLANTATION; FAILING HUMAN; CALCIUM; RECOVERY; MYOCYTES	Prolonged mechanical unloading (UN) of the heart is associated with detrimental changes to the structure and function of cardiomyocytes. The mechanisms underlying these changes are unknown. In this study, we report the influence of UN on excitation-contraction coupling, Ca2+-induce Ca2+ release (CICR) in particular, and transverse (t)-tubule structure. UN was induced in male Lewis rat hearts by heterotopic abdominal heart transplantation. Left ventricular cardiomyocytes were isolated from the transplanted hearts after 4 wk and studied using whole-cell patch clamping, confocal microscopy, and scanning ion conductance microscopy (SICM). Recipient hearts were used as control (C). UN reduced the volume of cardiomyocytes by 56.5% compared with C (UN, n = 90; C, n = 59; P<0.001). The variance of time-to-peak of the Ca2+ transients was significantly increased in unloaded cardiomyocytes (UN 227.4+/-24.9 ms(2), n = 42 vs. C 157.8+/-18.0 ms(2), n = 40; P<0.05). UN did not alter the action potential morphology or whole-cell L-type Ca2+ current compared with C, but caused a significantly higher Ca2+ spark frequency (UN 3.718+/-0.85 events/100 mu m/s, n = 47 vs. C 0.908+/-0.186 events/100 mu m/s, n = 45; P<0.05). Confocal studies showed irregular distribution of the t tubules (power of the normal t-tubule frequency: UN 8.13+/-1.12x10(5), n = 57 vs. C 20.60+/-3.174x10(5), n = 56; P<0.001) and SICM studies revealed a profound disruption to the openings of the t tubules and the cell surface in unloaded cardiomyocytes. We show that UN leads to a functional uncoupling of the CICR process and identify disruption of the t-tubule-sarcoplasmic reticulum interaction as a possible mechanism.-Ibrahim, M., Al Masri, A., Navaratnarajah, M., Siedlecka, U., Soppa, G. K., Moshkov, A., Abou Al-Saud, S., Gorelik, J., Yacoub, M. H., Terracciano, C. M. N. Prolonged mechanical unloading affects cardiomyocyte excitation-contraction coupling, transverse-tubule structure, and the cell surface. FASEB J. 24, 3321-3329 (2010). www.fasebj.org	[Ibrahim, Michael; Navaratnarajah, Manoraj; Siedlecka, Urszula; Soppa, Gopal K.; Moshkov, Alexey; Abou Al-Saud, Sara; Gorelik, Julia; Yacoub, Magdi H.; Terracciano, Cesare M. N.] Univ London Imperial Coll Sci Technol & Med, Harefield Heart Sci Ctr & Cardiovasc Sci, London, England; [Al Masri, Abeer; Abou Al-Saud, Sara] King Saud Univ, Coll Med, King Fahad Cardiac Ctr, Riyadh 11461, Saudi Arabia	Imperial College London; King Saud University	Terracciano, CMN (corresponding author), Harefield Hosp, Harefield Heart Sci Ctr, Harefield UB9 6JH, Middx, England.	c.terracciano@imperial.ac.uk	Moshkov, Alexey/AAO-9902-2020; Moshkov, Alexey/C-2825-2014; Al-Masri, Abeer/AAL-3389-2020	Moshkov, Alexey/0000-0002-1858-6738; Moshkov, Alexey/0000-0002-1858-6738; Gorelik, Julia/0000-0003-1148-9158; Al-Masri, Abeer/0000-0002-3981-2132	British Heart Foundation [FS/09/025/27468]	British Heart Foundation(British Heart Foundation)	This work was supported by a British Heart Foundation M.B.-Ph.D. studentship to M. I. (FS/09/025/27468).	BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; BERS DM, 1991, EXCITATION CONTRACTI; Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063; Brette F, 2003, CIRC RES, V92, P1182, DOI 10.1161/01.RES.0000074908.17214.FD; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Dandel M, 2005, CIRCULATION, V112, pI37, DOI 10.1161/CIRCULATIONAHA.104.525352; DUBELL WH, 1991, J PHYSIOL-LONDON, V436, P347, DOI 10.1113/jphysiol.1991.sp018554; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; Gorelik J, 2006, CARDIOVASC RES, V72, P422, DOI 10.1016/j.cardiores.2006.09.009; Gu YC, 2002, FASEB J, V16, P748, DOI 10.1096/fj.01-1024fje; He JQ, 2001, CARDIOVASC RES, V49, P298, DOI 10.1016/S0008-6363(00)00256-X; Heinzel FR, 2008, CIRC RES, V102, P338, DOI 10.1161/CIRCRESAHA.107.160085; Ito K, 2003, CIRCULATION, V107, P1176, DOI 10.1161/01.CIR.0000051463.72137.96; Korchev YE, 2000, BIOPHYS J, V78, P2675, DOI 10.1016/S0006-3495(00)76811-1; Korchev YE, 1997, J MICROSC-OXFORD, V188, P17, DOI 10.1046/j.1365-2818.1997.2430801.x; Lenaerts I, 2009, CIRC RES, V105, P876, DOI 10.1161/CIRCRESAHA.109.206276; Louch WE, 2004, CARDIOVASC RES, V62, P63, DOI 10.1016/j.cardiores.2003.12.031; Louch WE, 2006, J PHYSIOL-LONDON, V574, P519, DOI 10.1113/jphysiol.2006.107227; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Mancini DM, 1998, CIRCULATION, V98, P2383, DOI 10.1161/01.CIR.98.22.2383; Maybaum S, 2007, CIRCULATION, V115, P2497, DOI 10.1161/CIRCULATIONAHA.106.633180; Meethal SV, 2007, CELL CALCIUM, V41, P123, DOI 10.1016/j.ceca.2006.05.006; Mohapatra B, 2010, J HEART LUNG TRANSPL, V29, P98, DOI 10.1016/j.healun.2009.06.030; Novak P, 2009, NAT METHODS, V6, P279, DOI [10.1038/NMETH.1306, 10.1038/nmeth.1306]; Ogletree ML, 2010, J HEART LUNG TRANSPL, V29, P554, DOI 10.1016/j.healun.2009.10.015; ONO K, 1969, J THORAC CARDIOV SUR, V57, P225, DOI 10.1016/S0022-5223(19)42744-X; Orchard C, 2008, CARDIOVASC RES, V77, P237, DOI 10.1093/cvr/cvm002; Oriyanhan W, 2007, J HEART LUNG TRANSPL, V26, P16, DOI 10.1016/j.healun.2006.10.016; Protasi F, 1996, DEV BIOL, V173, P265, DOI 10.1006/dbio.1996.0022; Ritter M, 2000, J MOL CELL CARDIOL, V32, P577, DOI 10.1006/jmcc.2000.1101; Siedlecka U, 2008, AM J PHYSIOL-HEART C, V295, pH1917, DOI 10.1152/ajpheart.00258.2008; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Soppa GKR, 2008, J HEART LUNG TRANSPL, V27, P882, DOI 10.1016/j.healun.2008.05.005; Soppa GKR, 2008, CURR OPIN CARDIOL, V23, P206, DOI 10.1097/HCO.0b013e3282fc7010; Soppa GKR, 2008, CARDIOVASC RES, V77, P695, DOI 10.1093/cvr/cvm106; Stagg MA, 2008, CIRC RES, V103, P855, DOI 10.1161/CIRCRESAHA.108.176461; STERN MD, 1992, FASEB J, V6, P3092, DOI 10.1096/fasebj.6.12.1325933; STERN MD, 1992, BIOPHYS J, V63, P497, DOI 10.1016/S0006-3495(92)81615-6; Stolen TO, 2009, CIRC RES, V105, P527, DOI 10.1161/CIRCRESAHA.109.199810; SUN XH, 1995, J CELL BIOL, V129, P659, DOI 10.1083/jcb.129.3.659; Swift F, 2008, CARDIOVASC RES, V78, P71, DOI 10.1093/cvr/cvn013; TERRACCIANO CM, 2010, ANN REV MED, V61; Terracciano CMN, 2004, CIRCULATION, V109, P2263, DOI 10.1161/01.CIR.0000129233.51320.92; Wang SQ, 2004, CIRC RES, V94, P1011, DOI 10.1161/01.RES.0000125883.68447.A1; Xydas S, 2006, J HEART LUNG TRANSPL, V25, P7, DOI 10.1016/j.healun.2005.08.001; Yacoub MH, 2001, EUR HEART J, V22, P534, DOI 10.1053/euhj.2001.2613; Yacoub MH, 2001, TRANSPL P, V33, P2762, DOI 10.1016/S0041-1345(01)02183-2; Zafeiridis A, 1998, CIRCULATION, V98, P656, DOI 10.1161/01.CIR.98.7.656; Zhang RL, 2009, HUM MOL GENET, V18, P4130, DOI 10.1093/hmg/ddp362	51	57	59	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3321	3329		10.1096/fj.10-156638	http://dx.doi.org/10.1096/fj.10-156638			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20430793	Green Published			2022-12-25	WOS:000281446400020
J	Wang, DY; Govindaiah, G; Liu, RJ; De Arcangelis, V; Cox, CL; Xiang, YK				Wang, Dayong; Govindaiah, G.; Liu, Ruijie; De Arcangelis, Vania; Cox, Charles L.; Xiang, Yang K.			Binding of amyloid beta peptide to beta(2) adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity	FASEB JOURNAL			English	Article						Alzheimer's disease; cAMP; EPSC; FRET; GluR1	PROTEIN-KINASE-A; ALZHEIMERS-DISEASE; ELECTROPHYSIOLOGICAL CHANGES; GLUTAMATE RECEPTORS; MOUSE MODEL; CAMP; OLIGOMERS; NEURONS; BETA(2)-ADRENOCEPTOR; NEUROTOXICITY	Progressive decrease in neuronal function is an established feature of Alzheimer's disease (AD). Previous studies have shown that amyloid beta (A beta) peptide induces acute increase in spontaneous synaptic activity accompanied by neurotoxicity, and A beta induces excitotoxic neuronal death by increasing calcium influx mediated by hyperactive alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors. An in vivo study has revealed subpopulations of hyperactive neurons near A beta plaques in mutant amyloid precursor protein (APP)-transgenic animal model of Alzheimer's disease (AD) that can be normalized by an AMPA receptor antagonist. In the present study, we aim to determine whether soluble A beta acutely induces hyperactivity of AMPA receptors by a mechanism involving beta(2) adrenergic receptor (beta(2)AR). We found that the soluble A beta binds to beta(2)AR, and the extracellular N terminus of beta(2)AR is critical for the binding. The binding is required to induce G-protein/cAMP/protein kinase A (PKA) signaling, which controls PKA-dependent phosphorylation of GluR1 and beta(2)AR, and AMPA receptor-mediated excitatory postsynaptic currents (EPSCs). beta(2)AR and GluR1 also form a complex comprising postsynaptic density protein 95 (PSD95), PKA and its anchor AKAP150, and protein phosphotase 2A (PP2A). Both the third intracellular (i3) loop and C terminus of beta(2)AR are required for the beta(2)AR/AMPA receptor complex. A beta acutely induces PKA phosphorylation of GluR1 in the complex without affecting the association between two receptors. The present study reveals that non-neurotransmitter A beta has a binding capacity to beta(2)AR and induces PKA-dependent hyperactivity in AMPA receptors.-Wang, D., Govindaiah, G., Liu, R., De Arcangelis, V., Cox, C. L., Xiang, Y. K. Binding of amyloid beta peptide to beta(2) adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity. FASEB J. 24, 3511-3521 (2010). www.fasebj.org	[Wang, Dayong; Govindaiah, G.; Liu, Ruijie; De Arcangelis, Vania; Xiang, Yang K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Cox, Charles L.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Cox, Charles L.; Xiang, Yang K.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Xiang, YK (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, 407 S Goodwin Ave, Urbana, IL 61801 USA.	kevinyx@illinois.edu	LIU, ruijie/K-7376-2012	Wang, Dayong/0000-0002-2086-1663; liu, ruijie/0000-0002-2468-0579; Cox, Charles/0000-0002-1179-7014	National Eye Institute [EY014024]; National Institute of Heart, Blood, and Lung [HL082846]; National Alliance for Research on Schizophrenia and Depression; Illinois Department of Public Health; NATIONAL EYE INSTITUTE [R01EY014024, R56EY014024] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082846] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Heart, Blood, and Lung; National Alliance for Research on Schizophrenia and Depression(NARSAD); Illinois Department of Public Health; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Dennis J. Selkoe (Harvard Medical School, Cambridge, MA, USA) for kindly providing the 7PA2-transgenic CHO cell line and the plasmid, and Dr. Richard Clark (University of Texas Medical Center, Houston, TX, USA) for anti-beta<INF>2</INF>AR S261/262 antibody. The authors thank Dr. Venkata R. P. Ratnala (Departments of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA) for performing the [<SUP>35</SUP>S] GTP gamma S binding assay. The authors thank Mr. Mingwei Ding, Branden Skarpiak, Elaine Wu, and other members of the Y.K.X. laboratory for assistance. This work was supported by National Eye Institute grant EY014024 (C. L. C.) and National Institute of Heart, Blood, and Lung grant HL082846 (Y.K.X.). D. W. is a recipient of a National Alliance for Research on Schizophrenia and Depression award and an Illinois Department of Public Health grant.	AbdAlla S, 2009, J BIOL CHEM, V284, P6554, DOI 10.1074/jbc.M807746200; Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Chen CJ, 2003, J NEUROCHEM, V85, P443, DOI 10.1046/j.1471-4159.2003.01691.x; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; Echeverria V, 2005, NEUROSCIENCE, V135, P1193, DOI 10.1016/j.neuroscience.2005.06.057; Englund H, 2007, DEMENT GERIATR COGN, V24, P369, DOI 10.1159/000109215; Francis P T, 2009, Curr Mol Pharmacol, V2, P77; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gallardo G, 2008, NAT NEUROSCI, V11, P301, DOI 10.1038/nn2058; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Govindaiah G, 2006, J NEUROSCI, V26, P13443, DOI 10.1523/JNEUROSCI.3578-06.2006; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hoogendijk W J, 2001, Tijdschr Gerontol Geriatr, V32, P17; Hoogendijk WJG, 1999, ANN NEUROL, V45, P82, DOI 10.1002/1531-8249(199901)45:1<82::AID-ART14>3.0.CO;2-T; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Igbavboa U, 2006, NEUROSCIENCE, V142, P655, DOI 10.1016/j.neuroscience.2006.06.056; Iijima-Ando K, 2008, J BIOL CHEM, V283, P19066, DOI 10.1074/jbc.M710509200; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kornischka J, 2007, FORTSCHR NEUROL PSYC, V75, P199, DOI 10.1055/s-2006-944295; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Liu RJ, 2009, J BIOL CHEM, V284, P32279, DOI 10.1074/jbc.M109.021428; Louzada PR, 2001, NEUROSCI LETT, V301, P59, DOI 10.1016/S0304-3940(01)01585-3; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Parameshwaran K, 2008, EXP NEUROL, V210, P7, DOI 10.1016/j.expneurol.2007.10.008; Pettit DL, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-01-j0003.2001; Rosenberg PB, 2008, AM J GERIAT PSYCHIAT, V16, P883, DOI 10.1097/JGP.0b013e318181276a; RussoNeustadt A, 1997, J NEUROSCI, V17, P5573; Satoh Y, 2001, NEUROSCI LETT, V302, P97, DOI 10.1016/S0304-3940(01)01665-2; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Tao JC, 2003, EMBO J, V22, P6419, DOI 10.1093/emboj/cdg628; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tong LQ, 2001, J BIOL CHEM, V276, P17301, DOI 10.1074/jbc.M010450200; Vekovischeva OY, 2007, PHARMACOL BIOCHEM BE, V87, P241, DOI 10.1016/j.pbb.2007.04.020; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang DY, 2007, NEUROPSYCHOPHARMACOL, V32, P1261, DOI 10.1038/sj.npp.1301256; Wang Y, 2008, J BIOL CHEM, V283, P1799, DOI 10.1074/jbc.M705747200; Wang YY, 2007, MOL PHARMACOL, V72, P429, DOI 10.1124/mol.107.037747; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Xiang Y, 2005, P NATL ACAD SCI USA, V102, P909, DOI 10.1073/pnas.0405263102; Ye CP, 2004, NEUROSCI LETT, V366, P320, DOI 10.1016/j.neulet.2004.05.060; Yu JT, 2008, BRAIN RES, V1210, P216, DOI 10.1016/j.brainres.2008.03.019; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140	60	62	65	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3511	3521		10.1096/fj.10-156661	http://dx.doi.org/10.1096/fj.10-156661			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20395454	Green Published			2022-12-25	WOS:000281446400038
J	Western, PS; van den Bergen, JA; Miles, DC; Sinclair, AH				Western, Patrick S.; van den Bergen, Jocelyn A.; Miles, Denise C.; Sinclair, Andrew H.			Male fetal germ cell differentiation involves complex repression of the regulatory network controlling pluripotency	FASEB JOURNAL			English	Article						Oct4; Nanog; Sox2; mitotic arrest; methylation	GENE-EXPRESSION; SELF-RENEWAL; STEM-CELLS; SOX2; NANOG; OCT4; MEIOSIS	Mammalian germ cells are derived from the pluripotent epiblast and share features with pluripotent stem cells, including the expression of key genes that regulate developmental potency. The core genes Oct4, Sox2, and Nanog that regulate pluripotency in stem cells also perform important roles in regulating germ cell development and potentially in occurrence of germ line tumors in humans. Despite this, our understanding of the regulation of these genes during germ cell development remains limited. In this study we examine the regulation of pluripotency in the mouse fetal germ line. We show that male-specific methylation occurs in key functional elements of the Nanog and Sox2 promoters, and these genes are suppressed during early male germ cell differentiation. Furthermore, Oct4 translation is suppressed post-transcriptionally as germ cells differentiate down the male lineage and enter mitotic arrest. Combined, our data strongly support the conclusion that repression of the core machinery regulating pluripotency is a robust and early event involved in the differentiation of the male germ cell lineage. We hypothesize that active repression of pluripotency is required for fetal male germ cell differentiation and that failure of this mechanism may render germ cells susceptible to tumor formation.-Western, P. S., van den Bergen, J. A., Miles, D. C., Sinclair, A. H. Male fetal germ cell differentiation involves complex repression of the regulatory network controlling pluripotency. FASEB J. 24, 3026-3035 (2010). www.fasebj.org	[Western, Patrick S.] Univ Melbourne, Royal Childrens Hosp, ARC Ctr Excellence Biotechnol & Dev, Murdoch Childrens Res Inst,Dept Paediat, Melbourne, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Western, PS (corresponding author), Univ Melbourne, Royal Childrens Hosp, ARC Ctr Excellence Biotechnol & Dev, Murdoch Childrens Res Inst,Dept Paediat, Flemington Rd, Melbourne, Vic 3052, Australia.	patrick.western@mcri.edu.au	Sinclair, Andrew H/A-3598-2010	Sinclair, Andrew H/0000-0003-2741-7992; Western, Patrick/0000-0002-7587-8227	Australian Research Council Centre of Excellence for Biotechnology and Development	Australian Research Council Centre of Excellence for Biotechnology and Development(Australian Research Council)	The authors thank Prof. George Enders (University of Kansas Medical Center, Kansas City, KS, USA) for the GCNA antibody, Dr. Nick Wong for advice on bisulfite sequencing, Dr. Matt Burton for FACS sorting, and Christine Hall and the MCRI animal staff for animal care. The authors also thank Dr. Stefan White for critical comments on the manuscript. This project was supported through the Australian Research Council Centre of Excellence for Biotechnology and Development. Authors' contributions were as follows: P.S.W.: conception and design, collection and assembly of data, data analysis and interpretation, manuscript preparation, final approval of manuscript. J.A.V.: conception and design, collection and assembly of data, data analysis and interpretation, manuscript preparation, final approval of manuscript. D.C.M.: conception and design, collection and assembly of data, data analysis and interpretation, final approval of manuscript. A.H.S.: conception and design, financial support, final approval of manuscript.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Bullejos M, 2004, MOL REPROD DEV, V68, P422, DOI 10.1002/mrd.20105; Catena R, 2004, J BIOL CHEM, V279, P41846, DOI 10.1074/jbc.M405514200; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hata K, 2002, DEVELOPMENT, V129, P1983; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; Kossack N, 2009, STEM CELLS, V27, P138, DOI 10.1634/stemcells.2008-0439; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Maldonado-Saldivia J, 2007, STEM CELLS, V25, P19, DOI 10.1634/stemcells.2006-0269; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Miles DC, 2010, CELL CYCLE, V9, P408, DOI 10.4161/cc.9.2.10691; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Rajpert-De Meyts E, 2003, APMIS, V111; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shinohara T, 2003, BIOL REPROD, V68, P1064, DOI 10.1095/biolreprod.102.009977; Spiller CM, 2010, BIOL REPROD, V82, P433, DOI 10.1095/biolreprod.109.078691; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Tanaka SS, 2000, GENE DEV, V14, P841; van den Bergen JA, 2009, BIOL REPROD, V81, P362, DOI 10.1095/biolreprod.109.076224; Voorhoeve PM, 2007, ADV EXP MED BIOL, V604, P17, DOI 10.1007/978-0-387-69116-9_2; Western P, 2005, STEM CELLS, V23, P1436, DOI 10.1634/stemcells.2005-0146; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595	41	56	59	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					3026	3035		10.1096/fj.09-151555	http://dx.doi.org/10.1096/fj.09-151555			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20395456				2022-12-25	WOS:000285005400040
J	Narala, VR; Adapala, RK; Suresh, MV; Brock, TG; Peters-Golden, M; Reddy, RC				Narala, Venkata R.; Adapala, Ravi K.; Suresh, Madathilparambil V.; Brock, Thomas G.; Peters-Golden, Marc; Reddy, Raju C.			Leukotriene B-4 Is a Physiologically Relevant Endogenous Peroxisome Proliferator-activated Receptor-alpha Agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMORPHONUCLEAR LEUKOCYTES; PPAR-ALPHA; LIGAND; INFLAMMATION; METABOLISM; IDENTIFICATION; BIOSYNTHESIS; EICOSANOIDS	Peroxisome proliferator-activated receptors (PPARs) are nuclear transcription factors that play central roles in metabolism and inflammation. Although a variety of compounds have been shown to activate PPARs, identification of physiologically relevant ligands has proven difficult. In silico studies of lipid derivatives reported here identify specific 5-lipoxygenase products as candidate physiologically relevant PPAR-alpha activators. Subsequent studies show both in vitro and in a murine model of inflammation that 5-lipoxygenase stimulation induces PPAR-alpha signaling and that this results specifically from production of the inflammatory mediator and chemoattractant leukotriene B-4 (LTB4). Activation of PPAR-alpha is a direct effect of intracellularly generated LTB4 binding to the nuclear receptor and not of secreted LTB4 acting via its cell-surface receptors. Activation of PPAR-alpha reduces secretion of LTB4 by stimulating degradation of this fatty acid derivative. We also show that the LTB4 precursors leukotriene A(4) (LTA(4)) and 5-hydroperoxyeicosatetrenoic acid (5-HPETE) activate PPAR-alpha but have no significant endogenous effect independent of conversion to LTB4. We conclude that LTB4 is a physiologically relevant PPAR-alpha activator in cells of the immune system. This, together with previous findings, demonstrates that different types of lipids serve as endogenous PPAR-alpha ligands, with the relevant ligand varying between functionally different cell types. Our results also support the suggestion that regulation of inflammation may involve balancing proinflammatory effects of LTB4, exerted through cell-surface receptors, and anti-inflammatory effects exerted through PPAR-alpha activation.	[Narala, Venkata R.; Adapala, Ravi K.; Suresh, Madathilparambil V.; Brock, Thomas G.; Peters-Golden, Marc; Reddy, Raju C.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Reddy, RC (corresponding author), 109 Zina Pitcher Pl,4062 BSRB, Ann Arbor, MI 48109 USA.	rajuc@umich.edu	Narala, Venkata Ramireddy/W-5197-2018; Reddy, Raju C/GLR-5338-2022; Adapala, Ravi kumar/AAD-1282-2020; madathilparambil, suresh/L-6791-2019	Reddy, Raju C/0000-0001-7079-1520; Adapala, Ravi kumar/0000-0002-4082-5301; Narala, Venkata/0000-0001-6672-4165	National Institutes of Health [HL093196]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL093196.	Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Christmas P, 2006, J BIOL CHEM, V281, P7189, DOI 10.1074/jbc.M513101200; CLAESSON HE, 1981, BIOCHEM BIOPH RES CO, V99, P1230, DOI 10.1016/0006-291X(81)90751-8; Crooks SW, 1998, INT J BIOCHEM CELL B, V30, P173, DOI 10.1016/S1357-2725(97)00123-4; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Fiedler J, 2001, J PHARMACOL EXP THER, V299, P691; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Kalsotra A, 2007, ARCH BIOCHEM BIOPHYS, V461, P104, DOI 10.1016/j.abb.2007.02.027; Kozak KR, 2002, J BIOL CHEM, V277, P23278, DOI 10.1074/jbc.M201084200; LEIER I, 1992, EUR J BIOCHEM, V209, P281, DOI 10.1111/j.1432-1033.1992.tb17287.x; Lin QO, 1999, BIOCHEMISTRY-US, V38, P185, DOI 10.1021/bi9816094; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Ng VY, 2007, DRUG METAB DISPOS, V35, P1126, DOI 10.1124/dmd.106.013839; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833; Tzameli I, 2004, J BIOL CHEM, V279, P36093, DOI 10.1074/jbc.M405346200; Woerly G, 2003, J EXP MED, V198, P411, DOI 10.1084/jem.20021384; WONG A, 1991, BIOCHEMISTRY-US, V30, P9346, DOI 10.1021/bi00102a030; Youssef J, 2004, J BIOMED BIOTECHNOL, P156, DOI 10.1155/S1110724304308065; Vincent ZA, 2007, BBA-MOL CELL BIOL L, V1771, P915, DOI 10.1016/j.bbalip.2007.01.007	24	91	92	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22067	22074		10.1074/jbc.M109.085118	http://dx.doi.org/10.1074/jbc.M109.085118			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20400503	Green Published, hybrid			2022-12-25	WOS:000279702200019
J	Rosental, N; Kanner, BI				Rosental, Noa; Kanner, Baruch I.			A Conserved Methionine Residue Controls the Substrate Selectivity of a Neuronal Glutamate Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; RAT-BRAIN; NEUROTRANSMITTER TRANSPORTERS; INDIVIDUAL SUBUNITS; ANION CONDUCTANCE; MEMBRANE-VESICLES; CRYSTAL-STRUCTURE; CHLORIDE CHANNEL; REENTRANT LOOP; GLT-1	Glutamate transporters located in the brain maintain low synaptic concentrations of the neurotransmitter by coupling its flux to that of sodium and other cations. In the binding pocket of the archeal homologue Glt(Ph), a conserved methionine residue has been implicated in the binding of the benzyl moiety of the non-transportable substrate analogue threo-beta-benzyloxyaspartate. To determine whether the corresponding methionine residue of the neuronal glutamate transporter EAAC1, Met-367, fulfills a similar role, M367L, M367C, and M367S mutants were expressed in HeLa cells and Xenopus laevis oocytes to monitor radioactive transport and transport currents, respectively. The apparent affinity of the Met-367 mutants for D-aspartate and L-glutamate, but not for L-aspartate, was 10-20-fold reduced as compared with wild type. Unlike wild type, the magnitude of I-max was different for each of the three substrates. D-Glutamate, which is also a transportable substrate of EAAC1, did not elicit any detectable response with M367C and M367S but acted as a nontransportable substrate analogue in M367L. In the mutants, substrates inhibited the anion conductance as opposed to the stimulation observed with wild type. Remarkably, the apparent affinity of the blocker D, L-threo-beta-benzyloxyaspartate in the mutants was similar to that of wild type EAAC1. Our results are consistent with the idea that the side chain of Met-367 fulfills a steric role in the positioning of the substrate in the binding pocket in a step subsequent to its initial binding.	[Rosental, Noa; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, POB 12272, IL-91120 Jerusalem, Israel.	kannerb@cc.huji.ac.il			National Institutes of Health [NS16708]; United States-Israel Binational Science Foundation [2007051]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS16708. This work was also supported by United States-Israel Binational Science Foundation Grant 2007051.	Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Menaker D, 2006, J NEUROCHEM, V99, P20, DOI 10.1111/j.1471-4159.2006.04003.x; Otis TS, 2000, J NEUROSCI, V20, P2749; Otis TS, 1998, J NEUROSCI, V18, P7099; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	47	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21241	21248		10.1074/jbc.M109.087163	http://dx.doi.org/10.1074/jbc.M109.087163			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20424168	Green Published, hybrid			2022-12-25	WOS:000279516100009
J	Wang, XNH; Zhang, LP; Mitch, WE; LeDoux, JM; Hu, JP; Du, J				Wang, Xiaonan H.; Zhang, Liping; Mitch, William E.; LeDoux, Joseph M.; Hu, Junping; Du, Jie			Caspase-3 Cleaves Specific 19 S Proteasome Subunits in Skeletal Muscle Stimulating Proteasome Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; PROTEOLYTIC PATHWAY; PROTEIN-DEGRADATION; UBIQUITIN LIGASES; SUBSTRATE ENTRY; 20S PROTEASOME; 26S PROTEASOME; ATROPHY; ACTIVATION; EXPRESSION	With muscle wasting, caspase-3 activation and the ubiquitin-proteasome system act synergistically to increase the degradation of muscle proteins. Whether proteasome activity is also elevated in response to catabolic conditions is unknown. We find that caspase-3 increases proteasome activity in myotubes but not in myoblasts. This difference is related to the cleavage of specific 19 S proteasome subunits. In mouse muscle or myotubes, caspase-3 cleaves Rpt2 and Rpt6 increasing proteasome activity. In myoblasts, caspase-3 cleaves Rpt5 to decrease proteasome activity. To confirm the caspase-3 dependence, caspase-3 cleavage sites in Rpt2, Rpt6, or Rpt5 were mutated. This prevented the cleavage of these subunits by caspase-3 as well as the changes in proteasome activity. During differentiation of myoblasts to myotubes, there is an obligatory, transient increase in caspase-3 activity, accompanied by a corresponding increase in proteasome activity and cleavage of Rpt2 and Rpt6. Therefore, differentiation changes the proteasome type from sensitivity of Rpt5 to caspase-3 in myoblasts to sensitivity of Rpt2 and Rpt6 in myotubes. This novel mechanism identifies a feed-forward amplification that augments muscle proteolysis in catabolic conditions. Indeed, we found that in mice with a muscle wasting condition, chronic kidney disease, there was cleavage of subunits Rpt2 and Rpt6 and stimulation of proteasome activity.	[Wang, Xiaonan H.; Hu, Junping] Emory Univ, Div Renal, Atlanta, GA 30322 USA; [Zhang, Liping; Mitch, William E.; Du, Jie] Baylor Coll Med, Div Nephrol, Houston, TX 77030 USA; [LeDoux, Joseph M.] Georgia Tech & Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA	Emory University; Baylor College of Medicine; University System of Georgia; Georgia Institute of Technology	Wang, XNH (corresponding author), 1639 Pierce Dr,WMB 338, Atlanta, GA 30322 USA.	xwang03@emory.edu; jiedu@yahoo.com	Hu, Junping/J-2019-2014; Hu, Junping/F-3404-2013		National Institutes of Health [NIH R37 DK37175, P50 DK64233, R01HL70762]; University Research Committee of Emory University; Satellite Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064233, R37DK037175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Research Committee of Emory University; Satellite Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Grants NIH R37 DK37175 and P50 DK64233 (to W. E. M.) and R01HL70762 (to J.D.). This work was also supported by the University Research Committee of Emory University and a Norman S. Coplon extramural research grant from Satellite Health (to X. H. W. and L.Z.).	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bailey JL, 2006, J AM SOC NEPHROL, V17, P1388, DOI 10.1681/ASN.2004100842; Bailey JL, 1996, J CLIN INVEST, V97, P1447, DOI 10.1172/JCI118566; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Fabunmi RP, 2000, J BIOL CHEM, V275, P409, DOI 10.1074/jbc.275.1.409; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; HU J, 2010, J AM SOC NE IN PRESS; Isozaki Y, 1996, P NATL ACAD SCI USA, V93, P1967, DOI 10.1073/pnas.93.5.1967; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Mansoor O, 1996, P NATL ACAD SCI USA, V93, P2714, DOI 10.1073/pnas.93.7.2714; Minetti CASA, 1998, J BIOL CHEM, V273, P25329, DOI 10.1074/jbc.273.39.25329; Mitch WE, 1999, AM J PHYSIOL-CELL PH, V276, pC1132, DOI 10.1152/ajpcell.1999.276.5.C1132; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Price SR, 1996, J CLIN INVEST, V98, P1703, DOI 10.1172/JCI118968; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sun XM, 2004, MOL CELL, V14, P81, DOI 10.1016/S1097-2765(04)00156-X; Tiao G, 1997, J CLIN INVEST, V99, P163, DOI 10.1172/JCI119143; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang XH, 2007, GENE THER, V14, P711, DOI 10.1038/sj.gt.3302927; Wang XN, 2006, ENDOCRINOLOGY, V147, P4160, DOI 10.1210/en.2006-0251; Wang XNH, 2009, KIDNEY INT, V76, P751, DOI 10.1038/ki.2009.260; Williams A, 1999, SURGERY, V126, P744, DOI 10.1067/msy.2099.99888; YANG Y, 1992, P NATL ACAD SCI USA, V89, P4928, DOI 10.1073/pnas.89.11.4928; Zhou Q, 2007, ENDOCRINOLOGY, V148, P5696, DOI 10.1210/en.2007-0183	46	57	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21249	21257		10.1074/jbc.M109.041707	http://dx.doi.org/10.1074/jbc.M109.041707			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20424172	hybrid, Green Published			2022-12-25	WOS:000279516100010
J	Bai, JP; Surguchev, A; Ogando, Y; Song, L; Bian, SM; Santos-Sacchi, J; Navaratnam, D				Bai, Jun-Ping; Surguchev, Alexei; Ogando, Yudelca; Song, Lei; Bian, Shumin; Santos-Sacchi, Joseph; Navaratnam, Dhasakumar			Prestin Surface Expression and Activity Are Augmented by Interaction with MAP1S, a Microtubule-associated Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR CELL; TRANSCRIPTION FACTOR SIGMA(F); MOTILITY-RELATED CHARGE; TRANSPORTER DTDST GENE; SULFATE TRANSPORTER; STAS DOMAIN; VOLTAGE-DEPENDENCE; MOTOR PROTEIN; GUINEA-PIG; MEMBRANE	Prestin is a member of the SLC26 family of anion transporters that is responsible for outer hair cell (OHC) electromotility. Measures of voltage-evoked charge density (Q(sp)) of prestin indicated that the protein is highly expressed in OHCs, with single cells expressing up to 10 million molecules within the lateral membrane. In contrast, charge density measures in transfected cells indicated that they express, at best, only a fifth as many proteins on their surface. We sought to determine whether associations with other OHC-specific proteins could account for this difference. Using a yeast two-hybrid technique, we found microtubule-associated protein 1S (MAP1S) bound to prestin. The interaction was limited to the STAS domain of prestin and the region connecting the heavy and light chain of MAP1S. Using reciprocal immunoprecipitation and Forster resonance energy transfer, we confirmed these interactions. Furthermore, co-expression of prestin with MAP1S resulted in a 2.7-fold increase in Q(sp) in single cells that was paralleled by a 2.8-fold increase in protein surface expression, indicating that the interactions are physiological. Quantitative PCR data showed gradients in the expression of prestin and MAP1S across the tonotopic axis that may partially contribute to a previously observed 6-fold increase in Q(sp) in high frequency hair cells. These data highlight the importance of protein partner effects on prestin.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Santos-Sacchi, Joseph; Navaratnam, Dhasakumar] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Surguchev, Alexei; Song, Lei; Bian, Shumin; Santos-Sacchi, Joseph; Navaratnam, Dhasakumar] Yale Univ, Sch Med, Dept Surg Otolaryngol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University	Navaratnam, D (corresponding author), LCI 703,310 Cedar St, New Haven, CT 06510 USA.	Dhasakumar.Navaratnam@Yale.Edu			National Institutes of Health, NIDCD [DC 007894, DC 000273, DC 0081130]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008130, R01DC000273, R01DC007894] Funding Source: NIH RePORTER	National Institutes of Health, NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC 007894, DC 000273, and DC 0081130 from NIDCD.	Abe T, 2007, J MEMBRANE BIOL, V215, P49, DOI 10.1007/s00232-007-9004-5; Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Ashmore J. F., 1989, MECH HEARING, P107; Bai JP, 2006, NEUROSCI LETT, V404, P270, DOI 10.1016/j.neulet.2006.05.062; Bai JP, 2009, BIOPHYS J, V96, P3179, DOI 10.1016/j.bpj.2008.12.3948; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; Blot Vincent, 2008, V457, P347, DOI 10.1007/978-1-59745-261-8-26; Chang MH, 2009, J BIOL CHEM, V284, P28306, DOI 10.1074/jbc.M109.001669; Clarkson J, 2003, BIOCHEM J, V372, P113, DOI 10.1042/BJ20021748; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; DIEDERICH B, 1994, GENE DEV, V8, P2653, DOI 10.1101/gad.8.21.2653; Dorwart MR, 2008, J BIOL CHEM, V283, P8711, DOI 10.1074/jbc.M704328200; Eriksson M, 2007, BIOCHEM BIOPH RES CO, V361, P127, DOI 10.1016/j.bbrc.2007.06.179; GALE JE, 1994, P ROY SOC B-BIOL SCI, V255, P243, DOI 10.1098/rspb.1994.0035; Gale JE, 1997, PFLUG ARCH EUR J PHY, V434, P267, DOI 10.1007/s004240050395; HUANG GJ, 1993, BIOPHYS J, V65, P2228, DOI 10.1016/S0006-3495(93)81248-7; IWASA KH, 1993, BIOPHYS J, V65, P492, DOI 10.1016/S0006-3495(93)81053-1; Iwasa KH, 2001, BIOPHYS J, V81, P2495, DOI 10.1016/S0006-3495(01)75895-X; KAKEHATA S, 1995, BIOPHYS J, V68, P2190, DOI 10.1016/S0006-3495(95)80401-7; Karniski LP, 2004, HUM MOL GENET, V13, P2165, DOI 10.1093/hmg/ddh242; Karniski LP, 2001, HUM MOL GENET, V10, P1485, DOI 10.1093/hmg/10.14.1485; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Kovacs H, 1998, P NATL ACAD SCI USA, V95, P5067, DOI 10.1073/pnas.95.9.5067; Kroos L, 1999, MOL MICROBIOL, V31, P1285, DOI 10.1046/j.1365-2958.1999.01214.x; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Liu LY, 2005, BIOCHEM BIOPH RES CO, V332, P670, DOI 10.1016/j.bbrc.2005.05.006; Liu LY, 2005, CANCER RES, V65, P4191, DOI 10.1158/0008-5472.CAN-04-3865; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; Murray JW, 2003, ADV DRUG DELIVER REV, V55, P1385, DOI 10.1016/j.addr.2003.07.008; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Navaratnam Dhasakumar S., 2009, V493, P257, DOI 10.1007/978-1-59745-523-7_15; Navaratnam DS, 1997, NEURON, V19, P1077, DOI 10.1016/S0896-6273(00)80398-0; Orban-Nemeth Z, 2005, J BIOL CHEM, V280, P2257, DOI 10.1074/jbc.M408984200; Pattnaik B, 2000, J NEUROSCI, V20, P6789, DOI 10.1523/JNEUROSCI.20-18-06789.2000; Pocklington A. J., 2006, Briefings in Functional Genomics & Proteomics, V5, P66, DOI 10.1093/bfgp/ell013; Pocklington AJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100041; Rouached H, 2005, J BIOL CHEM, V280, P15976, DOI 10.1074/jbc.M501635200; Santos-Sacchi J, 2006, J NEUROSCI, V26, P3992, DOI 10.1523/JNEUROSCI.4548-05.2006; Santos-Sacchi J, 2004, BIOPHYS J, V87, P714, DOI 10.1529/biophysj.103.033993; SANTOS-SACCHI J, 1993, BIOPHYS J, V65, P2217, DOI 10.1016/S0006-3495(93)81247-5; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2001, J PHYSIOL-LONDON, V531, P661, DOI 10.1111/j.1469-7793.2001.0661h.x; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Santos-Sacchi J, 1998, NEUROSCI LETT, V256, P155, DOI 10.1016/S0304-3940(98)00788-5; Scherer MP, 2005, BIOPHYS J, V88, pL27, DOI 10.1529/biophysj.105.059782; Seavers PR, 2001, STRUCTURE, V9, P605, DOI 10.1016/S0969-2126(01)00623-2; Shibagaki N, 2004, J BIOL CHEM, V279, P30791, DOI 10.1074/jbc.M403248200; Shibagaki N, 2006, J BIOL CHEM, V281, P22964, DOI 10.1074/jbc.M603462200; Song MS, 2005, J BIOL CHEM, V280, P3920, DOI 10.1074/jbc.M409115200; Taylor JP, 2002, J CLIN ENDOCR METAB, V87, P1778, DOI 10.1210/jc.87.4.1778; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Wong EYM, 2004, BIOL REPROD, V70, P775, DOI 10.1095/biolreprod.103.018531; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2002, AUDIOL NEURO-OTOL, V7, P9, DOI 10.1159/000046855; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777	55	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20834	20843		10.1074/jbc.M110.117853	http://dx.doi.org/10.1074/jbc.M110.117853			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20418376	Green Published, hybrid			2022-12-25	WOS:000279228600047
J	Lefurgy, ST; Rodriguez, SB; Park, CS; Cahill, S; Silverman, RB; Leyh, TS				Lefurgy, Scott T.; Rodriguez, Sofia B.; Park, Chan Sun; Cahill, Sean; Silverman, Richard B.; Leyh, Thomas S.			Probing Ligand-binding Pockets of the Mevalonate Pathway Enzymes from Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; ISOPRENOID BIOSYNTHESIS; INHIBITION; DECARBOXYLASE; MECHANISM; KINASE; EVOLUTION; CARRIAGE; COMPLEX	Diphosphomevalonate (Mev.pp) is the founding member of a new class of potential antibiotics targeting the Streptococcus pneumoniae mevalonate (Mev) pathway. We have synthesized a series of Mev.pp analogues designed to simultaneously block two steps in this pathway, through allosteric inhibition of mevalonate kinase (MK) and, for five of the analogues, by mechanism-based inactivation of diphosphomevalonate decarboxylase (DPM-DC). The analogue series expands the C-3-methyl group of Mev.pp with hydrocarbons of varying size, shape, and chemical and physical properties. Previously, we established the feasibility of a prodrug strategy in which unphosphorylated Mev analogues could be enzymatically converted to the active Mev.pp forms by the endogenous MK and phosphomevalonate kinase. We now report the kinetic parameters for the turnover of non-, mono-, and diphosphorylated analogues as substrates and inhibitors of the three mevalonate pathway enzymes. The inhibition of MK by Mev.pp analogues revealed that the allosteric site is selective for compact, electron-rich C-3-subsitutents. The lack of reactivity of analogues with DPM-DC provided evidence, counter to the existing model, for a decarboxylation transition state that is concerted rather than dissociative. The Mev pathway is composed of three structurally and functionally conserved enzymes that catalyze consecutive steps in a metabolic pathway. The current work reveals that these enzymes exhibit significant differences in specificity toward R-group substitution at C-3 and that these patterns are explained well by changes in the volume of the C-3 R-group-binding pockets of the enzymes.	Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Cahill, Sean] Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Park, Chan Sun; Silverman, Richard B.] Northwestern Univ, Dept Chem, Dept Biochem Mol Biol & Cell Biol, Ctr Mol Innovat & Drug Discovery, Evanston, IL 60208 USA; [Park, Chan Sun; Silverman, Richard B.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Northwestern University; Northwestern University	Leyh, TS (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	thomas.leyh@einstein.yu.edu			National Institutes of Health [AI 068989]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI 068989.	Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P16461, DOI 10.1021/bi048075t; Andreassi JL, 2007, PROTEIN SCI, V16, P983, DOI 10.1110/ps.072755707; Andreassi JL, 2009, BIOCHEMISTRY-US, V48, P6461, DOI 10.1021/bi900537u; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; Byres E, 2007, J MOL BIOL, V371, P540, DOI 10.1016/j.jmb.2007.05.094; Camoretti-Mercado B, 2009, TRANSL RES, V154, P165, DOI 10.1016/j.trsl.2009.06.008; CLELAND WW, 1967, ADV ENZYMOL RAMB, V29, P1; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P173, DOI 10.1016/0926-6569(63)90226-8; CORNFORTH RH, 1960, NATURE, V185, P923, DOI 10.1038/185923a0; DAVIS AM, 1999, ANGEW CHEM INT EDIT, V122, P736; del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DHEPAGANON S, 1994, BIOCHEMISTRY-US, V33, P13355, DOI 10.1021/bi00249a023; Fritz G, 2009, CURR CANCER DRUG TAR, V9, P626, DOI 10.2174/156800909789057033; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUNTHER H, 1997, NMR SPECTROSCOPY BAS; HART H, 1959, J AM CHEM SOC, V81, P320, DOI 10.1021/ja01511a016; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; Kawaguchi S, 1997, J BIOCHEM-TOKYO, V122, P55; Kudoh T, 2010, BIOORGAN MED CHEM, V18, P1124, DOI 10.1016/j.bmc.2009.12.050; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; LIEBMAN JF, 1976, CHEM REV, V76, P311, DOI 10.1021/cr60301a002; LONDON JW, 1977, ANAL CHEM, V49, P1716, DOI 10.1021/ac50020a021; Lyn RK, 2009, VIROLOGY, V394, P130, DOI 10.1016/j.virol.2009.08.022; Mandel J, 1964, STAT ANAL EXPT DATA, P131; MCCLURE WR, 1969, BIOCHEMISTRY-US, V8, P2782, DOI 10.1021/bi00835a014; Obaro S, 2002, J MED MICROBIOL, V51, P98, DOI 10.1099/0022-1317-51-2-98; Pilloff D, 2003, J BIOL CHEM, V278, P4510, DOI 10.1074/jbc.M210551200; Qiu YG, 2006, BBA-GEN SUBJECTS, V1760, P1080, DOI 10.1016/j.bbagen.2006.03.009; REARDON JE, 1987, BIOCHEMISTRY-US, V26, P4717, DOI 10.1021/bi00389a018; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; SUCKLING CJ, 1988, ANGEW CHEM INT EDIT, V27, P537, DOI 10.1002/anie.198805371; TCHEN TT, 1958, J BIOL CHEM, V233, P1100; Van Bambeke F, 2007, DRUGS, V67, P2355, DOI 10.2165/00003495-200767160-00005; Wilding EI, 2000, J BACTERIOL, V182, P4319, DOI 10.1128/JB.182.15.4319-4327.2000; Wolfenden R, 1999, BIOORGAN MED CHEM, V7, P647, DOI 10.1016/S0968-0896(98)00247-8; Ye J, 2003, P NATL ACAD SCI USA, V100, P15865, DOI 10.1073/pnas.2237238100; Zeki AA, 2009, AM J RESP CRIT CARE, V180, P731, DOI 10.1164/rccm.200901-0018OC	40	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20654	20663		10.1074/jbc.M109.098350	http://dx.doi.org/10.1074/jbc.M109.098350			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20404339	hybrid, Green Published			2022-12-25	WOS:000279228600029
J	Subramaniam, S; Mealer, RG; Sixt, KM; Barrow, RK; Usiello, A; Snyder, SH				Subramaniam, Srinivasa; Mealer, Robert G.; Sixt, Katherine M.; Barrow, Roxanne K.; Usiello, Alessandro; Snyder, Solomon H.			Rhes, a Physiologic Regulator of Sumoylation, Enhances Cross-sumoylation between the Basic Sumoylation Enzymes E1 and Ubc9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; GTP-BINDING PROTEIN; HUNTINGTONS-DISEASE; SUMO MODIFICATION; AUTOUBIQUITINATION; SYSTEM; GENES; MICE	We recently reported that the small G-protein Rhes has the properties of a SUMO-E3 ligase and mediates mutant huntingtin (mHtt) cytotoxicity. We now demonstrate that Rhes is a physiologic regulator of sumoylation, which is markedly reduced in the corpus striatum of Rhes-deleted mice. Sumoylation involves activation and transfer of small ubiquitin-like modifier (SUMO) from the thioester of E1 to the thioester of Ubc9 (E2) and final transfer to lysines on target proteins, which is enhanced by E3s. We show that E1 transfers SUMO from its thioester directly to lysine residues on Ubc9, forming isopeptide linkages. Conversely, sumoylation on E1 requires transfer of SUMO from the thioester of Ubc9. Thus, the process regarded as "autosumoylation" reflects intermolecular transfer between E1 and Ubc9, which we designate "cross-sumoylation." Rhes binds directly to both E1 and Ubc9, enhancing cross-sumoylation as well as thioester transfer from E1 to Ubc9.	[Subramaniam, Srinivasa; Mealer, Robert G.; Sixt, Katherine M.; Barrow, Roxanne K.; Snyder, Solomon H.] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Subramaniam, Srinivasa; Mealer, Robert G.; Sixt, Katherine M.; Barrow, Roxanne K.; Snyder, Solomon H.] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Usiello, Alessandro] CEINGE Biotecnol Avanzate, I-80145 Naples, Italy; [Usiello, Alessandro] Univ Del Molise, Dept Hlth Sci, I-86100 Campobasso, Italy	Johns Hopkins University; Johns Hopkins University; CEINGE Biotecnologie Avanzate; University of Molise	Snyder, SH (corresponding author), Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Dept Pharmacol & Mol Sci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu	usiello, alessandro/B-2368-2012	Usiello, Alessandro/0000-0001-9203-853X	National Institutes of Health through the United States Public Health Service [MH18501];  [DA00074]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018501, R01MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000074] Funding Source: NIH RePORTER	National Institutes of Health through the United States Public Health Service; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant MH18501 (to S.H.S.) through the United States Public Health Service. This work was also supported a Research Scientist Award DA00074 (to S.H.S.).	ALKHODAIRY F, 1995, J CELL SCI, V108, P475; ARNOLD JE, 1990, BIOCHEM J, V267, P751, DOI 10.1042/bj2670751; Baek SH, 2006, CELL CYCLE, V5, P1492, DOI 10.4161/cc.5.14.3008; BANERJEE A, 1993, J BIOL CHEM, V268, P5668; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Errico F, 2008, MOL CELL NEUROSCI, V37, P335, DOI 10.1016/j.mcn.2007.10.007; Falk JD, 1999, J NEUROSCI RES, V57, P782, DOI 10.1002/(SICI)1097-4547(19990915)57:6<782::AID-JNR3>3.0.CO;2-9; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; GUSELLA JF, 1995, CURR OPIN NEUROBIOL, V5, P656, DOI 10.1016/0959-4388(95)80072-7; Harrison LM, 2006, NEUROSCIENCE, V137, P483, DOI 10.1016/j.neuroscience.2005.08.017; Hayashi T, 2002, EXP CELL RES, V280, P212, DOI 10.1006/excr.2002.5634; Hsiao HH, 2009, MOL CELL PROTEOMICS, V8, P2664, DOI 10.1074/mcp.M900087-MCP200; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Liu YL, 2008, BIOL PSYCHIAT, V64, P789, DOI 10.1016/j.biopsych.2008.04.035; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; PTAK C, 1994, J BIOL CHEM, V269, P26539; Quintero GC, 2008, NEUROREPORT, V19, P1563, DOI 10.1097/WNR.0b013e3283118434; Scaglione KM, 2007, MOL CELL BIOL, V27, P5860, DOI 10.1128/MCB.01555-06; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Shayeghi M, 1997, NUCLEIC ACIDS RES, V25, P1162, DOI 10.1093/nar/25.6.1162; Spano D, 2004, MOL CELL BIOL, V24, P5788, DOI 10.1128/MCB.24.13.5788-5796.2004; St Croix B, 2000, SCIENCE, V289, P1197; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Thapliyal A, 2008, AM J PHYSIOL-CELL PH, V295, pC1417, DOI 10.1152/ajpcell.00341.2008; Tong H, 1997, J BIOL CHEM, V272, P21381, DOI 10.1074/jbc.272.34.21381; Vargiu P, 2004, ONCOGENE, V23, P559, DOI 10.1038/sj.onc.1207161; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	32	58	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20428	20432		10.1074/jbc.C110.127191	http://dx.doi.org/10.1074/jbc.C110.127191			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20424159	hybrid, Green Published			2022-12-25	WOS:000279228600002
J	Zhu, XF; van Pee, KH; Naismith, JH				Zhu, Xiaofeng; van Pee, Karl-Heinz; Naismith, James H.			The Ternary Complex of PrnB (the Second Enzyme in the Pyrrolnitrin Biosynthesis Pathway), Tryptophan, and Cyanide Yields New Mechanistic Insights into the Indolamine Dioxygenase Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-FLUORESCENS; DEPENDENT HALOGENASES; HEME; 2,3-DIOXYGENASE; CHLORINATION; INTERMEDIATE; CHEMISTRY; GENES; O-2	Pyrrolnitrin (3-chloro-4-(2'-nitro-3'-chlorophenyl)pyrrole) is a broad-spectrum antifungal compound isolated from Pseudomonas pyrrocinia. Four enzymes (PrnA, PrnB, PrnC, and PrnD) are required for pyrrolnitrin biosynthesis from tryptophan. PrnB rearranges the indole ring of 7-Cl-L-tryptophan and eliminates the carboxylate group. PrnB shows robust activity in vivo, but in vitro activity for PrnB under defined conditions remains undetected. The structure of PrnB establishes that the enzyme belongs to the heme b-dependent indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO) family. We report the cyanide complex of PrnB and two ternary complexes with both L-tryptophan or 7-Cl-L-tryptophan and cyanide. The latter two complexes are essentially identical and mimic the likely catalytic ternary complex that occurs during turnover. In the cyanide ternary complexes, a loop previously disordered becomes ordered, contributing to the binding of substrates. The conformations of the bound tryptophan substrates are changed from that seen previously in the binary complexes. In L-tryptophan ternary complex, the indole ring now adopts the same orientation as seen in the PrnB binary complexes with other tryptophan substrates. The amide and carboxylate group of the substrate are orientated in a new conformation. Tyr(321) and Ser(332) play a key role in binding these groups. The structures suggest that catalysis requires an L-configured substrate. Isothermal titration calorimetry data suggest D-tryptophan does not bind after cyanide (or oxygen) coordinates with the distal (or sixth) site of heme. This is the first ternary complex with a tryptophan substrate of a member of the tryptophan dioxygenase superfamily and has mechanistic implications.	[Zhu, Xiaofeng; Naismith, James H.] Univ St Andrews, St Andrews KY16 9ST, Fife, Scotland; [van Pee, Karl-Heinz] Tech Univ Dresden, D-01062 Dresden, Germany	University of St Andrews; Technische Universitat Dresden	Naismith, JH (corresponding author), Univ St Andrews, Biomed Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland.	naismith@st-and.ac.uk	Naismith, James Henderson/AAB-8614-2020; Naismith, James Henderson/H-3408-2012	Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061	Biotechnology and Biological Sciences Research Council UK; Biotechnology and Biological Sciences Research Council [BB/C000080/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council UK.	ARIMA K, 1964, AGR BIOL CHEM TOKYO, V28, P575, DOI 10.1080/00021369.1964.10858275; Bolognesi M, 1999, BIOPHYS J, V77, P1093, DOI 10.1016/S0006-3495(99)76959-6; CHANG CJ, 1981, J ANTIBIOT, V34, P555, DOI 10.7164/antibiotics.34.555; Chauhan N, 2009, J AM CHEM SOC, V131, P4186, DOI 10.1021/ja808326g; Chung LW, 2008, J AM CHEM SOC, V130, P12299, DOI 10.1021/ja803107w; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Davydov RM, 2010, J AM CHEM SOC, V132, P5494, DOI 10.1021/ja100518z; De Laurentis W, 2007, BIOCHEMISTRY-US, V46, P12393, DOI 10.1021/bi7012189; De Laurentis W, 2006, ACTA CRYSTALLOGR F, V62, P1134, DOI 10.1107/S1744309106041649; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flecks S, 2008, ANGEW CHEM INT EDIT, V47, P9533, DOI 10.1002/anie.200802466; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Hammer PE, 1997, APPL ENVIRON MICROB, V63, P2147, DOI 10.1128/AEM.63.6.2147-2154.1997; Hammer PE, 1999, FEMS MICROBIOL LETT, V180, P39, DOI 10.1111/j.1574-6968.1999.tb08775.x; Hohaus K, 1997, ANGEW CHEM INT EDIT, V36, P2012, DOI 10.1002/anie.199720121; Kirner S, 1998, J BACTERIOL, V180, P1939, DOI 10.1128/JB.180.7.1939-1943.1998; Lee JK, 2006, J BACTERIOL, V188, P6179, DOI 10.1128/JB.00259-06; Lewis-Ballester A, 2009, P NATL ACAD SCI USA, V106, P17371, DOI 10.1073/pnas.0906655106; Littlejohn TK, 2000, PROTEIN EXPRES PURIF, V19, P22, DOI 10.1006/prep.2000.1214; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; Sugishima M, 2003, BIOCHEMISTRY-US, V42, P9898, DOI 10.1021/bi027268i; Thackray SJ, 2008, BIOCHEM SOC T, V36, P1120, DOI 10.1042/BST0361120; van Pee KH, 2000, NAT PROD REP, V17, P157, DOI 10.1039/a902138h; Yeh E, 2007, BIOCHEMISTRY-US, V46, P1284, DOI 10.1021/bi0621213; Yeh E, 2006, BIOCHEMISTRY-US, V45, P7904, DOI 10.1021/bi060607d; Zhu XF, 2009, J MOL BIOL, V391, P74, DOI 10.1016/j.jmb.2009.06.008	30	25	28	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21126	21133		10.1074/jbc.M110.120485	http://dx.doi.org/10.1074/jbc.M110.120485			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20421301	hybrid, Green Published			2022-12-25	WOS:000279228600075
J	Falandry, C; Fourel, G; Galy, V; Ristriani, T; Horard, B; Bensimon, E; Salles, G; Gilson, E; Magdinier, F				Falandry, Claire; Fourel, Genevieve; Galy, Vincent; Ristriani, Tutik; Horard, Beatrice; Bensimon, Elsa; Salles, Gilles; Gilson, Eric; Magdinier, Frederique			CLLD8/KMT1F Is a Lysine Methyltransferase That Is Important for Chromosome Segregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3 METHYLATION; PERICENTRIC HETEROCHROMATIN; CHROMATIN; PROTEIN; GENE; TRANSCRIPTION; SETDB1; CELLS; HP1; TRIMETHYLATION	Proteins bearing a SET domain have been shown to methylate lysine residues in histones and contribute to chromatin architecture. Methylation of histone H3 at lysine 9 (H3K9) has emerged as an important player in the formation of heterochromatin, chromatin condensation, and transcriptional repression. Here, we have characterized a previously undescribed member of the histone H3K9 methyltransferase family named CLLD8 (or SETDB2 or KMT1F). This protein contributes to the trimethylation of both interspersed repetitive elements and centromere-associated repeats and participates in the recruitment of heterochromatin protein 1 to centromeres. Consistently, depletion in CLLD8/KMT1F coincides with a loss of CENP proteins and delayed mitosis, suggesting that this protein participates in chromosome condensation and segregation. Altogether, our results provide evidence that CLLD8/KMT1F is recruited to heterochromatin regions and contributes in vivo to the deposition of trimethyl marks in concert with SUV39H1/KMT1A.	[Salles, Gilles; Gilson, Eric] Univ Lyon 1, Ecole Normale Super Lyon, Fac Med Lyon Sud, CNRS,UMR 5239,IFR 128,Lab Biol Mol Cellule, F-69600 Oullins, France; [Falandry, Claire; Horard, Beatrice; Bensimon, Elsa; Salles, Gilles; Magdinier, Frederique] Univ Lyon, F-69622 Lyon, France; [Falandry, Claire; Fourel, Genevieve; Ristriani, Tutik; Gilson, Eric] Univ Lyon 1, Ecole Normale Super Lyon, Lab Biol Mol Cellule, CNRS,UMR 5239,IFR128, F-69364 Lyon 07, France; [Falandry, Claire] Hosp Civils Lyon, Ctr Hosp Lyon Sud, F-69495 Pierre Benite, France; [Galy, Vincent] Univ Paris 06, CNRS, UMR 7622, Dev Biol Lab, F-75252 Paris 05, France; [Gilson, Eric] Ctr Hosp Univ Nice, Dept Med Genet, Archet Hosp 2, F-06107 Nice, France; [Gilson, Eric] Univ Nice Sophia Antipolis, Fac Med, Lab Biol & Pathol Genomes, INSERM,U988,CNRS 6267, F-06107 Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Gilson, E (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, Fac Med Lyon Sud, CNRS,UMR 5239,IFR 128,Lab Biol Mol Cellule, F-69600 Oullins, France.	Eric.Gilson@ens-lyon.fr; Frederique.Magdinier@univmed.fr	FALANDRY, Claire/H-6055-2012; Salles, Gilles/Z-2336-2019; Magdinier, Frederique/I-4735-2016; Falandry, Claire/AAI-5736-2021	FALANDRY, Claire/0000-0001-7267-4723; Salles, Gilles/0000-0002-9541-8666; Magdinier, Frederique/0000-0002-0159-9559; Falandry, Claire/0000-0001-7267-4723	La Ligue Nationale contre le Cancer (Comite de la Drome and Comite du Rhone); l'Association pour la Recherche sur le Cancer (Programme National et Programme Alliance des Recherches sur le Cancer); Canceropole Rhone-Alpes; European Economic Community; French Minister of Research; La Fondation pour la Recherche Medicale; La Ligue Contre le Cancer	La Ligue Nationale contre le Cancer (Comite de la Drome and Comite du Rhone); l'Association pour la Recherche sur le Cancer (Programme National et Programme Alliance des Recherches sur le Cancer); Canceropole Rhone-Alpes; European Economic Community; French Minister of Research; La Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); La Ligue Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from La Ligue Nationale contre le Cancer (Comite de la Drome and Comite du Rhone, to G.F.; and Equipe Labelisee, to E. G.), l'Association pour la Recherche sur le Cancer (Programme National et Programme Alliance des Recherches sur le Cancer), Canceropole Rhone-Alpes, "RISCRAD, an FP6 program from European Economic Community (to E. G.), and an Action Concertee Incitative grant from the French Minister of Research (to G. F.).; Recipient of a fellowship from La Fondation pour la Recherche Medicale.; Recipient of a fellowship from La Ligue Contre le Cancer.	Ainsztein AM, 1998, J CELL BIOL, V143, P1763, DOI 10.1083/jcb.143.7.1763; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Bannister AJ, 2004, METHOD ENZYMOL, V376, P269; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Ekwall K, 1996, J CELL SCI, V109, P2637; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Harte PJ, 1999, CYTOGENET CELL GENET, V84, P83, DOI 10.1159/000015220; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Kourmouli N, 2005, BIOCHEM BIOPH RES CO, V337, P901, DOI 10.1016/j.bbrc.2005.09.132; Lee J, 2008, HUM MOL GENET, V17, P1774, DOI 10.1093/hmg/ddn067; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Mabuchi H, 2001, CANCER RES, V61, P2870; Magdinier F, 2004, J BIOL CHEM, V279, P25381, DOI 10.1074/jbc.M403121200; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Ryu H, 2006, P NATL ACAD SCI USA, V103, P19176, DOI 10.1073/pnas.0606373103; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; SMALL JV, 1981, J CELL BIOL, V91, P695, DOI 10.1083/jcb.91.3.695; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Van Duyne R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-40; Waring PM, 1997, CURR TOP MICROBIOL, V220, P1; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981; Wu R, 2005, MOL BIOL CELL, V16, P2872, DOI 10.1091/mbc.e04-11-0997; Yang L, 2002, ONCOGENE, V21, P148, DOI 10.1038/sj.onc.1204998	34	58	61	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20234	20241		10.1074/jbc.M109.052399	http://dx.doi.org/10.1074/jbc.M109.052399			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20404330	Green Published, hybrid			2022-12-25	WOS:000279012000058
J	Li, DQ; Ohshiro, K; Khan, MN; Kumar, R				Li, Da-Qiang; Ohshiro, Kazufumi; Khan, Mudassar N.; Kumar, Rakesh			Requirement of MTA1 in ATR-mediated DNA Damage Checkpoint Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; DOUBLE-STRAND BREAKS; HISTONE H2AX; ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; FISSION YEAST; TRANSCRIPTIONAL REPRESSION; REPLICATION CHECKPOINT; GENOMIC INSTABILITY; UV-RADIATION	MTA1 (metastasis-associated protein 1), an integral component of the nucleosome remodeling and deacetylase complex, has recently been implicated in the ionizing radiation-induced DNA damage response. However, whether MTA1 also participates in the UV-induced DNA damage checkpoint pathway remains unknown. In response to UV radiation, ATR (ataxia teleangiectasia- and Rad3-related) is the major kinase activated that orchestrates cell cycle progression with DNA repair machinery by phosphorylating and activating a number of downstream substrates, such as Chk1 (checkpoint kinase 1) and H2AX (histone 2A variant X). Here, we report that UV radiation stabilizes MTA1 in an ATR-dependent manner and increases MTA1 binding to ATR. On the other hand, depletion of MTA1 compromises the ATR-mediated Chk1 activation following UV treatment, accompanied by a marked down-regulation of Chk1 and its interacting partner Claspin, an adaptor protein that is required for the phosphorylation and activation of Chk1 by ATR. Furthermore, MTA1 deficiency decreases the induction of phosphorylated H2AX (referred to as gamma-H2AX) and gamma-H2AX focus formation after UV treatment. Consequently, depletion of MTA1 results in a defect in the G(2)-M checkpoint and increases cellular sensitivity to UV-induced DNA damage. Thus, MTA1 is required for the activation of the ATR-Claspin-Chk1 and ATR-H2AX pathways following UV treatment, and the noted abrogation of the DNA damage checkpoint in the MTA1-depleted cells may be, at least in part, a consequence of dysregulation of the expression of these two pathways. These findings suggest that, in addition to its role in the repair of double strand breaks caused by ionizing radiation, MTA1 also participates in the UV-induced ATR-mediated DNA damage checkpoint pathway.	[Li, Da-Qiang; Ohshiro, Kazufumi; Khan, Mudassar N.; Kumar, Rakesh] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Kumar, Rakesh] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	George Washington University; University of Texas System; UTMD Anderson Cancer Center	Kumar, R (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803	National Institutes of Health [CA98823, CA98823-S1]; NATIONAL CANCER INSTITUTE [R01CA098823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA98823 and CA98823-S1 (to R.K.).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; ALKHODAIRY F, 1992, EMBO J, V11, P1343, DOI 10.1002/j.1460-2075.1992.tb05179.x; ALKHODAIRY F, 1994, MOL BIOL CELL, V5, P147, DOI 10.1091/mbc.5.2.147; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Balasenthil S, 2007, CANCER RES, V67, P7132, DOI 10.1158/0008-5472.CAN-07-0750; BALIGA BS, 1969, J BIOL CHEM, V244, P4480; Bao Yunhe, 2007, Cell, V129, P632, DOI 10.1016/j.cell.2007.04.018; Bao YH, 2007, CURR OPIN GENET DEV, V17, P126, DOI 10.1016/j.gde.2007.02.010; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Burd CJ, 2008, J BIOL CHEM, V283, P34976, DOI 10.1074/jbc.M805383200; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chen YH, 2004, DNA REPAIR, V3, P1025, DOI 10.1016/j.dnarep.2004.03.003; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; Chini C, 2006, ONCOGENE, V25, P4165, DOI 10.1038/sj.onc.1209447; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cooper SJ, 2007, CURR CANCER DRUG TAR, V7, P325, DOI 10.2174/156800907780809714; de Gruijl FR, 1999, EUR J CANCER, V35, P2003, DOI 10.1016/S0959-8049(99)00283-X; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Feng Q, 2003, CURR TOP MICROBIOL, V274, P269; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Freire R, 2006, CELL CYCLE, V5, P2831, DOI 10.4161/cc.5.24.3559; Fujita N, 2004, MOL ENDOCRINOL, V18, P2937, DOI 10.1210/me.2004-0258; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; HERRLICH P, 1994, ADV ENZYME REGUL, V34, P381, DOI 10.1016/0065-2571(94)90024-8; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Li DQ, 2010, J BIOL CHEM, V285, P10044, DOI 10.1074/jbc.M109.079095; Li DQ, 2009, J BIOL CHEM, V284, P34545, DOI 10.1074/jbc.M109.056499; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; LI DQ, 2010, CELL CYCLE IN PRESS, V9; Lindsey-Boltz LA, 2009, J BIOL CHEM, V284, P33107, DOI 10.1074/jbc.M109.064485; Liu QH, 2000, GENE DEV, V14, P1448; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Lopez-Girona A, 2001, P NATL ACAD SCI USA, V98, P11289, DOI 10.1073/pnas.191557598; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Molli PR, 2008, ONCOGENE, V27, P1971, DOI 10.1038/sj.onc.1210839; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nghiem P, 2002, J BIOL CHEM, V277, P4428, DOI 10.1074/jbc.M106113200; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; O'Malley BW, 2009, CANCER RES, V69, P8217, DOI 10.1158/0008-5472.CAN-09-2223; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; PARKER RC, 1977, P NATL ACAD SCI USA, V74, P851, DOI 10.1073/pnas.74.3.851; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Schmidt DR, 1999, BIOCHEMISTRY-US, V38, P14711, DOI 10.1021/bi991614n; SCHROTER H, 1985, EMBO J, V4, P3867, DOI 10.1002/j.1460-2075.1985.tb04159.x; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Takai H, 2000, GENE DEV, V14, P1439; TOH Y, 1994, J BIOL CHEM, V269, P22958; Tse AN, 2004, CANCER RES, V64, P6635, DOI 10.1158/0008-5472.CAN-04-0841; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Wang X, 2003, J BIOL CHEM, V278, P30869, DOI 10.1074/jbc.M301876200; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	78	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19802	19812		10.1074/jbc.M109.085258	http://dx.doi.org/10.1074/jbc.M109.085258			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427275	hybrid, Green Published			2022-12-25	WOS:000279012000013
J	Loukin, S; Su, ZW; Zhou, XL; Kung, C				Loukin, Stephen; Su, Zhenwei; Zhou, Xinliang; Kung, Ching			Forward Genetic Analysis Reveals Multiple Gating Mechanisms of TRPV4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-EVOKED ACTIVATION; OF-FUNCTION MUTATIONS; YEAST K+ CHANNEL; CATION CHANNEL; MOLECULAR DETERMINANTS; VR-OAC; HELIX; ARCHITECTURE; VOLTAGE; DOMAIN	TRPV4 is a polymodal cation channel gain-of-function (GOF) allele which causes skeletal dysplasia in humans. To better understand its gating, we screened for additional GOF alleles based on their ability to block yeast proliferation. Repeatedly, only a limited number of such growth-blocking mutations were isolated. Expressed in oocytes, wild-type channels can be strongly activated by either hypotonicity or exposure to the potent agonist 4 alpha PDD, although the GOF channels behaved as if they were fully prestimulated as well as lacking a previously uncharacterized voltage-dependent inactivation. Five of six mutations occurred at or near the inner ends of the predicted core helices, giving further direct evidence that this region indeed forms the main intracellular gate in TRP channels. Surprisingly, both wild-type channels as well as these GOF channels maintain strong steady-state outward rectification that is not due to a Ca2+ block, as has been proposed elsewhere. We conclude that TRPV4 contains an additional voltage-dependent gating mechanism in series with the main intracellular gate.	[Loukin, Stephen; Su, Zhenwei; Zhou, Xinliang; Kung, Ching] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Kung, Ching] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Loukin, S (corresponding author), 1525 Linden Dr, Madison, WI 53706 USA.	shloukin@wisc.edu	Su, Zhenwei/C-3185-2018	Su, Zhenwei/0000-0002-5591-418X	National Institutes of Health [GM047856]; Vilas Trust of the University of Wisconsin, Madison	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vilas Trust of the University of Wisconsin, Madison	This work was supported, in whole or in part, by National Institutes of Health Grant GM047856 and the Vilas Trust of the University of Wisconsin, Madison.	Auer-Grumbach M, 2010, NAT GENET, V42, P160, DOI 10.1038/ng.508; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; GOLDIN AL, 1992, METHODS ENZYMOLOGY; Guler AD, 2002, J NEUROSCI, V22, P6408; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Liedtke W, 2008, ANN NY ACAD SCI, V1144, P42, DOI 10.1196/annals.1418.012; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Loukin SH, 1999, BIOPHYS J, V77, P3060, DOI 10.1016/S0006-3495(99)77137-7; Loukin SH, 1997, EMBO J, V16, P4817, DOI 10.1093/emboj/16.16.4817; Loukin SH, 2009, FEBS LETT, V583, P754, DOI 10.1016/j.febslet.2009.01.027; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Nilius B, 2003, PFLUG ARCH EUR J PHY, V446, P298, DOI 10.1007/s00424-003-1028-9; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Sherman F, 1991, GUIDE YEAST GENETICS; Smith PL, 2006, J BIOL CHEM, V281, P29897, DOI 10.1074/jbc.M605394200; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Su ZW, 2007, P NATL ACAD SCI USA, V104, P19607, DOI 10.1073/pnas.0708584104; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Voets T, 2004, J BIOL CHEM, V279, P15223, DOI 10.1074/jbc.M312076200; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Zhou XL, 2007, P NATL ACAD SCI USA, V104, P15555, DOI 10.1073/pnas.0704039104	39	29	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19884	19890		10.1074/jbc.M110.113936	http://dx.doi.org/10.1074/jbc.M110.113936			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20424166	Green Published, hybrid			2022-12-25	WOS:000279012000021
J	Prakash, H; Albrecht, M; Becker, D; Kuhlmann, T; Rudel, T				Prakash, Hridayesh; Albrecht, Marco; Becker, Daniel; Kuhlmann, Tanja; Rudel, Thomas			Deficiency of XIAP Leads to Sensitization for Chlamydophila pneumoniae Pulmonary Infection and Dysregulation of Innate Immune Response in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; NEGATIVE BACTERIAL-INFECTION; CHLAMYDIA-PNEUMONIAE; APOPTOSIS RESISTANCE; DROSOPHILA INHIBITOR; CYTOKINE PRODUCTION; NITRIC-OXIDE; CELLS; PROTEIN	Obligate intracellular Chlamydophila pneumoniae induce apoptosis resistance in host cells to escape eradication by immune effector cells. Apoptosis resistance depends on the increased expression and stabilization of cellular inhibitor of apoptosis proteins (cIAPs) and X-linked inhibitor of apoptosis protein (XIAP). Here we investigated the role of XIAP in experimental pulmonary infection of mice with C. pneumoniae. XIAP knock out (KO) mice were sensitized for C. pneumoniae infection compared with wild type mice. XIAP was involved in lipopolysaccharide (LPS)-induced production of nitric oxide (NO) and endotoxin shock. Hyper-secretion of tumor necrosis factor-alpha and lower NO in LPS-treated KO mouse macrophages revealed its regulatory role in inflammatory responses. Unexpectedly, activating stimuli like LPS, tumor necrosis factor-alpha, or interferon-gamma very efficiently induced apoptotic cell death in KO macrophages but not in wild type macrophages. Cell survival transcription factor nuclear factor kappa B (NF-kappa B) p65 levels were reduced in lungs and pulmonary macrophages of infected KO mice. Furthermore, a reduced CD8 T cell population and their increased sensitivity for concanavalin A and chlamydial HSP60 stimulation revealed a defect in CD8 T cells in XIAP KO mice. These data demonstrated a role of XIAP for the integrity of both innate and cellular immune responses during C. pneumoniae infection.	[Albrecht, Marco; Rudel, Thomas] Univ Wurzburg, Dept Microbiol, Bioctr, D-97074 Wurzburg, Germany; [Prakash, Hridayesh; Becker, Daniel; Rudel, Thomas] Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany; [Kuhlmann, Tanja] Univ Hosp Muenster, Inst Neuropathol, D-48149 Munster, Germany	University of Wurzburg; Max Planck Society; University of Munster	Rudel, T (corresponding author), Univ Wurzburg, Dept Microbiol, Bioctr, Hubland, D-97074 Wurzburg, Germany.	thomas.rudel@biozentrum.uni-wuerzburg.de	Hridayesh, Prakash/W-9478-2019	Hridayesh, Prakash/0000-0001-5269-2481	Sixth Research Framework Program [LSHB-CT-2004-005276]	Sixth Research Framework Program	This work was supported by Sixth Research Framework Program Grant LSHB-CT-2004-005276 ( to T. R.).	Arno G, 2005, BRIT J BIOMED SCI, V62, P155, DOI 10.1080/09674845.2005.11732703; Bauler LD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000142; Bivas-Benita M, 2005, EUR J PHARM BIOPHARM, V61, P214, DOI 10.1016/j.ejpb.2005.04.009; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Byrne GI, 2004, NAT REV MICROBIOL, V2, P802, DOI 10.1038/nrmicro1007; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Conway DJ, 1997, INFECT IMMUN, V65, P1003, DOI 10.1128/IAI.65.3.1003-1006.1997; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; EDELSON PJ, 1976, J EXP MED, V144, P1581, DOI 10.1084/jem.144.6.1581; FIERS W, 1991, FEBS LETT, V285, P199, DOI 10.1016/0014-5793(91)80803-B; Fischer SF, 2001, INFECT IMMUN, V69, P7121, DOI 10.1128/IAI.69.11.7121-7129.2001; Gesellchen V, 2005, EMBO REP, V6, P979, DOI 10.1038/sj.embor.7400530; Hacker G, 2006, MED MICROBIOL IMMUN, V195, P11, DOI 10.1007/s00430-005-0239-4; HAHN DL, 2002, FRONT BIOSCI, V7, P66; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Heinemann M, 1996, INFECT IMMUN, V64, P4872, DOI 10.1128/IAI.64.11.4872-4875.1996; HOLTMANN H, 1990, INFECT IMMUN, V58, P3168, DOI 10.1128/IAI.58.10.3168-3172.1990; Huh JR, 2007, J BIOL CHEM, V282, P2056, DOI 10.1074/jbc.M608051200; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Kleino A, 2005, EMBO J, V24, P3423, DOI 10.1038/sj.emboj.7600807; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Kragsbjerg P, 1998, RESPIRATION, V65, P299, DOI 10.1159/000029280; Leulier F, 2006, MOL CELL BIOL, V26, P7821, DOI 10.1128/MCB.00548-06; LY IA, 1974, J IMMUNOL METHODS, V5, P239, DOI 10.1016/0022-1759(74)90108-2; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Netea MG, 2002, EUR J IMMUNOL, V32, P1188, DOI 10.1002/1521-4141(200204)32:4<1188::AID-IMMU1188>3.3.CO;2-1; Paland N, 2008, J BIOL CHEM, V283, P6438, DOI 10.1074/jbc.M708422200; Paland N, 2006, CELL MICROBIOL, V8, P1643, DOI 10.1111/j.1462-5822.2006.00739.x; Prakash H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006519; Rajalingam K, 2001, INFECT IMMUN, V69, P7880, DOI 10.1128/IAI.69.12.7880-7888.2001; Rajalingam K, 2006, PLOS PATHOG, V2, P1013, DOI 10.1371/journal.ppat.0020114; Rajalingam K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003102; Rottenberg ME, 1999, J IMMUNOL, V162, P2829; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Sharma M, 2009, FEMS IMMUNOL MED MIC, V55, P154, DOI 10.1111/j.1574-695X.2008.00515.x; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Tvinnereim A, 2007, J IMMUNOL, V179, P3947, DOI 10.4049/jimmunol.179.6.3947; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Winsauer G, 2008, CELL SIGNAL, V20, P2107, DOI 10.1016/j.cellsig.2008.08.004; Zhao Haizhen, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P630	46	31	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20291	20302		10.1074/jbc.M109.096297	http://dx.doi.org/10.1074/jbc.M109.096297			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427267	Green Published, hybrid			2022-12-25	WOS:000279012000064
J	Sayed, D; He, MZ; Hong, C; Gao, SM; Rane, S; Yang, Z; Abdellatif, M				Sayed, Danish; He, Minzhen; Hong, Chull; Gao, Shumin; Rane, Shweta; Yang, Zhi; Abdellatif, Maha			MicroRNA-21 Is a Downstream Effector of AKT That Mediates Its Antiapoptotic Effects via Suppression of Fas Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN HYPERSENSITIVITY; CARDIAC-HYPERTROPHY; HEART-FAILURE; EXPRESSION SIGNATURE; TENSIN HOMOLOG; BREAST-CANCER; FEEDBACK LOOP; UP-REGULATION; PTEN; GENE	MicroRNA-21 (miR-21) is highly up-regulated during hypertrophic and cancerous cell growth. In contrast, we found that it declines in cardiac myocytes upon exposure to hypoxia. Thus, the objective was to explore its role during hypoxia. We show that miR-21 not only regulates phosphatase and tensin homologue deleted on chromosome 10 (PTEN), but also targets Fas ligand (FasL). During prolonged hypoxia, down-regulation of miR-21 proved necessary and sufficient for enhancing expression of both proteins. We demonstrate here for the first time that miR-21 is positively regulated via an AKT-dependent pathway, which is depressed during prolonged hypoxia. Accordingly, hypoxia-induced down-regulation of miR-21 and up-regulation of FasL and PTEN were reversed by activated AKT and reproduced by a dominant negative mutant, wortmannin, or PTEN. Moreover, the antiapoptotic function of AKT partly required miR-21, which was sufficient for inhibition of caspase-8 activity and mitochondrial damage. In consensus, overexpression of miR-21 in a transgenic mouse heart resulted in suppression of ischemia-induced up-regulation of PTEN and FasL expression, an increase in phospho-AKT, a smaller infarct size, and ameliorated heart failure. Thus, we have identified a unique aspect of the function of AKT by which it inhibits apoptosis through miR-21-dependent suppression of FasL.	[Sayed, Danish; He, Minzhen; Hong, Chull; Gao, Shumin; Rane, Shweta; Yang, Zhi; Abdellatif, Maha] Univ Med & Dent New Jersey, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Abdellatif, M (corresponding author), Univ Med & Dent New Jersey, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA.	abdellma@umdnj.edu	Sayed, Danish/B-9047-2012; Yang, Zhi/B-8629-2012		National Institutes of Health [2R01 HL057970, R01 HL081381]; Dept. of Cell Biology and Molecular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057970, R01HL081381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Cell Biology and Molecular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01 HL057970 and R01 HL081381 ( to M. A.).; We thank Dr. Stephen F. Vatner, Chairman of the Dept. of Cell Biology and Molecular Medicine for his support.	ABDELLATIF M, 1994, J BIOL CHEM, V269, P15423; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Chen HH, 2009, BRIT J ORAL MAX SURG, V47, P14, DOI 10.1016/j.bjoms.2008.06.008; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fukazawa T, 1999, ONCOGENE, V18, P2189, DOI 10.1038/sj.onc.1202561; Gibson S, 1999, J BIOL CHEM, V274, P17612, DOI 10.1074/jbc.274.25.17612; Graham FL, 1991, METHOD MOL BIOL, P109; Hlobilkova Alice, 2003, Biomedical Papers (Olomouc), V147, P19; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Jiang L, 2003, EUR HEART J, V24, P742, DOI 10.1016/S0195-668X(02)00655-3; Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005; Lee P, 2003, AM J PHYSIOL-HEART C, V284, pH456, DOI 10.1152/ajpheart.00777.2002; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Li Y, 2009, BRAIN RES, V1286, P13, DOI 10.1016/j.brainres.2009.06.053; Li YW, 2004, CIRC RES, V95, P627, DOI 10.1161/01.RES.0000141528.54850.bd; Li YX, 2006, AM J PHYSIOL-HEART C, V290, pH2116, DOI 10.1152/ajpheart.00551.2005; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Mocanu MM, 2007, BRIT J PHARMACOL, V150, P833, DOI 10.1038/sj.bjp.0707155; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Rane S, 2010, CELL SIGNAL, V22, P1054, DOI 10.1016/j.cellsig.2010.02.008; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Ruan HM, 2009, J MOL CELL CARDIOL, V46, P193, DOI 10.1016/j.yjmcc.2008.10.021; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Setsuta K, 2004, CIRC J, V68, P747, DOI 10.1253/circj.68.747; Shilkrut M, 2003, J MOL CELL CARDIOL, V35, P1229, DOI 10.1016/S0022-2828(03)00232-3; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Stiles BL, 2006, MOL CELL BIOL, V26, P2772, DOI 10.1128/MCB.26.7.2772-2781.2006; Suhara T, 2002, MOL CELL BIOL, V22, P680, DOI 10.1128/MCB.22.2.680-691.2002; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Wong JT, 2007, DIABETOLOGIA, V50, P395, DOI 10.1007/s00125-006-0531-x; Woodard J, 2008, CLIN CANCER RES, V14, P4640, DOI 10.1158/1078-0432.CCR-07-5232; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yin C, 2009, CIRC RES, V104, P572, DOI 10.1161/CIRCRESAHA.108.193250; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	47	264	284	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20281	20290		10.1074/jbc.M110.109207	http://dx.doi.org/10.1074/jbc.M110.109207			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20404348	Green Published, hybrid			2022-12-25	WOS:000279012000063
J	Torres-Quiroz, F; Garcia-Marques, S; Coria, R; Randez-Gil, F; Prieto, JA				Torres-Quiroz, Francisco; Garcia-Marques, Sara; Coria, Roberto; Randez-Gil, Francisca; Prieto, Jose A.			The Activity of Yeast Hog1 MAPK Is Required during Endoplasmic Reticulum Stress Induced by Tunicamycin Exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN-RESPONSE; NATURALLY-OCCURRING OSMOLYTES; SACCHAROMYCES-CEREVISIAE; HIGH-OSMOLARITY; KINASE PATHWAY; TYROSINE PHOSPHATASES; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTOR; OSMOTIC-STRESS; MESSENGER-RNA	Accumulation of unfolded proteins in the endoplasmic reticulum (ER) triggers the so-called unfolded protein response (UPR), a conserved signaling pathway that drives the transcription of genes such as chaperones and folding enzymes. Nevertheless, the activity of the UPR accounts only for a part of the gene expression program activated upon ER stress. Moreover, the mechanism(s) for how cells adapt and survive to this stress are largely unknown. Here, we show that the yeast high osmolarity glycerol (HOG) pathway plays a role in ER stress resistance. Strains lacking the MAPK Hog1p displayed sensitivity to tunicamycin or beta-mercaptoethanol, whereas hyperactivation of the pathway enhanced their resistance. However, these effects were not due to Hog1p-mediated regulation of the UPR. Northern blot analysis demonstrated that Hog1p controls the tunicamycin-induced transcriptional change of GPD1 and that wild-type cells exposed to the drug accumulated glycerol in a Hog1p-dependent manner. Consistent with this, deletion of genes involved in glycerol synthesis caused increased sensitivity to tunicamycin, whereas overexpression of GPD1 provided higher tolerance to both wildtype and hog1 Delta mutant cells. Quite remarkably, these effects were mediated by the basal activity of the MAPK because tunicamycin exposure does not trigger the phosphorylation of Hog1p or its nuclear import. Hence, our results describe new aspects of the yeast response to ER stress and identify additional functions of glycerol and the Hog1p MAPK to provide stress resistance.	[Garcia-Marques, Sara; Randez-Gil, Francisca; Prieto, Jose A.] Consejo Super Invest Cient, Inst Agroquim & Tecnol Alimentos, Dept Biotechnol, E-46100 Valencia, Spain; [Torres-Quiroz, Francisco; Coria, Roberto] Univ Nacl Autonoma Mexico, Dept Mol Genet, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Universidad Nacional Autonoma de Mexico	Prieto, JA (corresponding author), Consejo Super Invest Cient, Inst Agroquim & Tecnol Alimentos, Dept Biotechnol, POB 73, E-46100 Valencia, Spain.	prieto@iata.csic.es	Torres-Quiroz, Francisco/L-4643-2019; Prieto, Jose A/H-4646-2012; Randez-Gil, Francisca/H-2868-2012; Torres-Quiroz, Francisco/E-3704-2012	Torres-Quiroz, Francisco/0000-0002-3073-8546; Prieto, Jose A/0000-0001-9677-0023; Randez-Gil, Francisca/0000-0001-8217-3156; 	Ministry of Science and Technology of Spain [AGL2007-65498-C02-01]; Instituto de Fisiologia Celular, Universidad Nacional Autonoma de Mexico CONACyT [80343]	Ministry of Science and Technology of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Fisiologia Celular, Universidad Nacional Autonoma de Mexico CONACyT	This work was supported by the Comision Interministerial de Ciencia y Tecnologia project (AGL2007-65498-C02-01) from the Ministry of Science and Technology of Spain. This work was also supported in part by Instituto de Fisiologia Celular, Universidad Nacional Autonoma de Mexico CONACyT Grant 80343.	Aguilera J, 2005, MOL MICROBIOL, V56, P228, DOI 10.1111/j.1365-2958.2005.04533.x; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Bahn YS, 2008, EUKARYOT CELL, V7, P2017, DOI 10.1128/EC.00323-08; Bell M, 2003, J BIOL CHEM, V278, P14603, DOI 10.1074/jbc.C300006200; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Bolen D W, 2001, Methods Mol Biol, V168, P17; Bolen DW, 2008, ANNU REV BIOCHEM, V77, P339, DOI 10.1146/annurev.biochem.77.061306.131357; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chapman R, 1998, ANNU REV CELL DEV BI, V14, P459, DOI 10.1146/annurev.cellbio.14.1.459; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; CIRIACY M, 1975, MOL GEN GENET, V138, P157, DOI 10.1007/BF02428119; Cohen TJ, 2008, EUKARYOT CELL, V7, P1191, DOI 10.1128/EC.00059-08; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Dihazi H, 2004, J BIOL CHEM, V279, P23961, DOI 10.1074/jbc.M312974200; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Gacto M, 2003, INT MICROBIOL, V6, P211, DOI 10.1007/s10123-003-0136-x; Garcia-Rodriguez LJ, 2000, J BACTERIOL, V182, P2428, DOI 10.1128/JB.182.9.2428-2437.2000; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Hohmann S, 2009, FEBS LETT, V583, P4025, DOI 10.1016/j.febslet.2009.10.069; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jacoby T, 1997, J BIOL CHEM, V272, P17749, DOI 10.1074/jbc.272.28.17749; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kim S, 2007, FEBS LETT, V581, P1209, DOI 10.1016/j.febslet.2007.02.032; Krysan Damian J, 2009, Commun Integr Biol, V2, P233; Kumar R, 2009, ARCH BIOCHEM BIOPHYS, V491, P1, DOI 10.1016/j.abb.2009.09.007; Lawrence CL, 2004, MOL CELL BIOL, V24, P3307, DOI 10.1128/MCB.24.8.3307-3323.2004; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Mattison CP, 2000, GENE DEV, V14, P1229; MORI K, 1993, CELL, V74, P743; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Panadero J, 2006, J BIOL CHEM, V281, P4638, DOI 10.1074/jbc.M512736200; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; PLATT T, 1972, EXPT MOL GENETICS, P352; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Rassow J, 1997, TRENDS CELL BIOL, V7, P129, DOI 10.1016/S0962-8924(96)10056-8; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Reynolds TB, 1998, J CELL BIOL, V143, P935, DOI 10.1083/jcb.143.4.935; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; SCHLENSTEDT G, 1995, J CELL BIOL, V129, P979, DOI 10.1083/jcb.129.4.979; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sherman F., 1986, METHODS YEAST GENETI; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Thorsen M, 2006, MOL BIOL CELL, V17, P4400, DOI 10.1091/mbc.E06-04-0315; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Westfall PJ, 2006, EUKARYOT CELL, V5, P1215, DOI 10.1128/EC.00037-06; Winkler A, 2002, EUKARYOT CELL, V1, P163, DOI 10.1128/EC.1.2.163-173.2002; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	75	45	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20088	20096		10.1074/jbc.M109.063578	http://dx.doi.org/10.1074/jbc.M109.063578			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20430884	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000279012000043
J	Biesiadecki, BJ; Tachampa, K; Yuan, C; Jin, JP; de Tombe, PP; Solaro, RJ				Biesiadecki, Brandon J.; Tachampa, Kittipong; Yuan, Chao; Jin, Jian-Ping; de Tombe, Pieter P.; Solaro, R. John			Removal of the Cardiac Troponin I N-terminal Extension Improves Cardiac Function in Aged Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC HEART-FAILURE; BINDING-PROTEIN-C; RAT HEARTS; PHOSPHORYLATION; KINASE; MUSCLE; DYSFUNCTION; KINETICS; MUTATION; MUTANT	The cardiac troponin I (cTnI) isoform contains a unique N-terminal extension that functions to modulate activation of cardiac myofilaments. During cardiac remodeling restricted proteolysis of cTnI removes this cardiac specific N-terminal modulatory extension to alter myofilament regulation. We have demonstrated expression of the N-terminal-deleted cTnI (cTnI-ND) in the heart decreased the development of the cardiomyopathy like phenotype in a beta-adrenergic-deficient transgenic mouse model. To investigate the potential beneficial effects of cTnI-ND on the development of naturally occurring cardiac dysfunction, we measured the hemodynamic and biochemical effects of cTnI-ND transgenic expression in the aged heart. Echocardiographic measurements demonstrate cTnI-ND transgenic mice exhibit increased systolic and diastolic functions at 16 months of age compared with age-matched controls. This improvement likely results from decreased Ca2+ sensitivity and increased cross-bridge kinetics as observed in skinned papillary bundles from young transgenic mice prior to the effects of aging. Hearts of cTnI-ND transgenic mice further exhibited decreased beta myosin heavy chain expression compared to age matched non-transgenic mice as well as altered cTnI phosphorylation. Finally, we demonstrated cTnI-ND expressed in the heart is not phosphorylated indicating the cTnI N-terminal is necessary for the higher level phosphorylation of cTnI. Taken together, our data suggest the regulated proteolysis of cTnI during cardiac stress to remove the unique cardiac N-terminal extension functions to improve cardiac contractility at the myofilament level and improve overall cardiac function.	[Tachampa, Kittipong; Yuan, Chao; de Tombe, Pieter P.; Solaro, R. John] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Tachampa, Kittipong; Yuan, Chao; de Tombe, Pieter P.; Solaro, R. John] Univ Illinois, Coll Med, Cardiovasc Res Ctr, Chicago, IL 60612 USA; Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Jin, Jian-Ping] Wayne State Univ, Dept Physiol, Sch Med, Detroit, MI 48201 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Wayne State University	Biesiadecki, BJ (corresponding author), 404 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	biesiadecki.1@osu.edu	Jin, Jian-Ping/AAD-1149-2020; Tachampa, Kittipong/AAK-3634-2020	Jin, JP/0000-0001-9932-1063; Tachampa, Kittipong/0000-0002-2011-3542	National Institutes of Health [HL091056, HL078773, HL75494, HL62426, HL22231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL091056, R00HL091056, P01HL062426, R01HL078773, R01HL022231, R37HL022231, R01HL075494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL091056, HL078773, HL75494, HL62426 Project 4, HL22231, and HL62426 Project 1.	Abbott MB, 2001, BIOCHEMISTRY-US, V40, P5992, DOI 10.1021/bi0100642; Barbato JC, 2005, J BIOL CHEM, V280, P6602, DOI 10.1074/jbc.M408525200; Biesiadecki BJ, 2004, J BIOL CHEM, V279, P13825, DOI 10.1074/jbc.M314225200; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; Chandra M, 2005, AM J PHYSIOL-HEART C, V289, pH2112, DOI 10.1152/ajpheart.00571.2005; Chong SM, 2009, J MOL EVOL, V68, P448, DOI 10.1007/s00239-009-9202-0; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; DETOMBE PP, 1995, CIRC RES, V76, P734, DOI 10.1161/01.RES.76.5.734; Dong WJ, 1997, BIOCHEMISTRY-US, V36, P6754, DOI 10.1021/bi9622276; Feng HZ, 2008, J BIOL CHEM, V283, P33384, DOI 10.1074/jbc.M803302200; Finley N, 1999, FEBS LETT, V453, P107, DOI 10.1016/S0014-5793(99)00693-6; Heller WT, 2003, BIOCHEMISTRY-US, V42, P7790, DOI 10.1021/bi0341509; Hinton RB, 2008, AM J PHYSIOL-HEART C, V294, pH2480, DOI 10.1152/ajpheart.91431.2007; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Hunlich M, 2005, J MOL CELL CARDIOL, V38, P119, DOI 10.1016/j.yjmcc.2004.10.005; Javadpour MM, 2003, J CLIN INVEST, V112, P768, DOI 10.1172/JC1200315967; JIN JP, 1990, HYBRIDOMA, V9, P597, DOI 10.1089/hyb.1990.9.597; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; McConnell BK, 2009, J BIOL CHEM, V284, P1583, DOI 10.1074/jbc.M806321200; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Osadchii OE, 2007, HEART FAIL REV, V12, P66, DOI 10.1007/s10741-007-9007-4; PACKER M, 1995, EUR HEART J, V16, P4, DOI 10.1093/eurheartj/16.suppl_F.4; Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715; Rajan S, 2007, CIRC RES, V101, P205, DOI 10.1161/CIRCRESAHA.107.148379; Reddy AK, 2007, J GERONTOL A-BIOL, V62, P1319, DOI 10.1093/gerona/62.12.1319; Royer A, 2005, CIRCULATION, V111, P1738, DOI 10.1161/01.CIR.0000160853.19867.61; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2008, FASEB J, V22, P1246, DOI 10.1096/fj.07-9458com; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Scruggs SB, 2006, J MOL CELL CARDIOL, V40, P465, DOI 10.1016/j.yjmcc.2005.12.009; SOLARO RJ, 1976, NATURE, V262, P615, DOI 10.1038/262615a0; STRANG KT, 1994, CIRC RES, V74, P542, DOI 10.1161/01.RES.74.3.542; Tachampa K, 2008, J BIOL CHEM, V283, P15114, DOI 10.1074/jbc.M801636200; Tachampa K, 2009, BIOPHYS J, V96, p502A, DOI 10.1016/j.bpj.2008.12.2589; VanEyk JE, 1997, J BIOL CHEM, V272, P10529; Ward DG, 2002, J BIOL CHEM, V277, P41795, DOI 10.1074/jbc.M206744200; WATTANAPERMPOOL J, 1995, J MOL CELL CARDIOL, V27, P1383, DOI 10.1006/jmcc.1995.0131; Yu ZB, 2001, J BIOL CHEM, V276, P15753, DOI 10.1074/jbc.M011048200; Yuan C, 2008, AM J PHYSIOL-HEART C, V295, pH647, DOI 10.1152/ajpheart.00357.2008; Yuan C, 2006, PROTEOMICS, V6, P4176, DOI 10.1002/pmic.200500894	41	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19688	19698		10.1074/jbc.M109.086892	http://dx.doi.org/10.1074/jbc.M109.086892			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410305	Green Published, hybrid			2022-12-25	WOS:000278727800077
J	Sanchez-Tillo, E; Lazaro, A; Torrent, R; Cuatrecasas, M; Vaquero, EC; Castells, A; Engel, P; Postigo, A				Sanchez-Tillo, E.; Lazaro, A.; Torrent, R.; Cuatrecasas, M.; Vaquero, E. C.; Castells, A.; Engel, P.; Postigo, A.			ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1	ONCOGENE			English	Article						BRG1; E-cadherin; epithelial-mesenchymal transition (EMT); ZEB1	EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTIONAL REPRESSOR; MIR-200 FAMILY; BETA-CATENIN; CANCER-CELLS; PROMOTES METASTASIS; COLORECTAL-CANCER; GENE-EXPRESSION; INVASION FRONT; STEM-CELLS	Loss of E-cadherin is a key initial step in the transdifferentiation of epithelial cells to a mesenchymal phenotype, which occurs when tumor epithelial cells invade into surrounding tissues. Expression of the nuclear factor ZEB1 induces an epithelial-to-mesenchymal transition and confers a metastatic phenotype on carcinomas by repressing the E-cadherin gene at the transcriptional level. In this study, we show that ZEB1 interacts with the SWI/SNF chromatin-remodeling protein BRG1 to regulate E-cadherin independently of CtBP, its traditional corepressor. Blocking the interaction between ZEB1 and BRG1 induces expression of E-cadherin and downregulation of the mesenchymal marker vimentin. ZEB1 and BRG1 colocalize in E-cadherin-negative cells from cancer lines and in the stroma of normal colon. Colocalization of ZEB1 and BRG1 in epithelial cells is only found in those de-differentiated cells characterized by nuclear beta-catenin staining at the invasive edge of the tumor. Our results identify ZEB1/BRG1 as a new transcriptional mechanism regulating E-cadherin expression and epithelial-to-mesenchymal transdifferentiation that may be involved during the initial stages of tumor invasion. Oncogene (2010) 29, 3490-3500; doi:10.1038/onc.2010.102; published online 26 April 2010	[Sanchez-Tillo, E.; Postigo, A.] IDIBAPS, Dept Hematol & Oncol, Grp Transcript Regulat, Barcelona 08036, Spain; [Lazaro, A.; Engel, P.] Univ Barcelona, Sch Med, Dept Cellular Biol & Pathol, Immunol Unit, Barcelona, Spain; [Torrent, R.] Univ Pompeu Fabra, Master Program Biotechnol, Barcelona, Spain; [Cuatrecasas, M.] Hosp Clin Barcelona, Dept Pathol, Barcelona, Spain; [Vaquero, E. C.; Castells, A.] IDIBAPS, CIBEREHD, Hosp Clin, Dept Gastroenterol, Barcelona 08036, Spain; [Postigo, A.] ICREA, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Pompeu Fabra University; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA	Postigo, A (corresponding author), IDIBAPS, Dept Hematol & Oncol, Grp Transcript Regulat, Barcelona 08036, Spain.	idib412@clinic.ub.es	Cuatrecasas, Miriam/C-9156-2019; Castells, Antoni/ABC-1002-2021; Engel, Pablo/R-5907-2019	Cuatrecasas, Miriam/0000-0003-3063-0110; Castells, Antoni/0000-0001-8431-2033; Engel, Pablo/0000-0001-8410-252X; Vaquero, Eva C./0000-0003-0098-5295; Postigo, Antonio/0000-0003-4605-2634	Caixa Foundation [BM-06570]; Spanish Ministry of Science and Innovation (MICINN) [BFU2007-60302]; Olga Torres Foundation [FOT-0902]; ICREA Funding Source: Custom	Caixa Foundation(La Caixa Foundation); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Olga Torres Foundation; ICREA(ICREA)	We also thank M Morales (Department Physiological Sciences) and staff from the Technical Science Services at the University of Barcelona for their help in confocal analysis, M Rickman (IDIBAPS) and the Pathology Department at the Hospital Clinic of Barcelona for technical advice and M Parrizas (IDIBAPS) for helpful recommendations on ChIP assays. We are also grateful to R Gasa (IDIBAPS) for critical reading of the paper and J Moore for help with English editing. We apologize to those researchers whose work was cited indirectly through reviews because of space limitations. Initial work in this study was supported by a grant from La Caixa Foundation (BM-06570) to AP. At later stages, this project was funded by the Spanish Ministry of Science and Innovation (MICINN) (BFU2007-60302) and Olga Torres Foundation (FOT-0902) to AP. EST's salary was partly funded by Grant BM-06570.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Baldus SE, 2004, CLIN CANCER RES, V10, P2790, DOI 10.1158/1078-0432.CCR-03-0163; Banine F, 2005, CANCER RES, V65, P3542, DOI 10.1158/0008-5472.CAN-04-3554; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Brabletz T, 1998, PATHOL RES PRACT, V194, P701, DOI 10.1016/S0344-0338(98)80129-5; Brabletz T, 2002, VIRCHOWS ARCH, V441, P1, DOI 10.1007/s00428-002-0642-9; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Burkhart BA, 2005, J BIOL CHEM, V280, P6349, DOI 10.1074/jbc.M411147200; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Furusawa T, 1999, MOL CELL BIOL, V19, P8581; Glaros S, 2008, CANCER RES, V68, P3689, DOI 10.1158/0008-5472.CAN-07-6652; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Medina PP, 2008, EPIGENETICS-US, V3, P64, DOI 10.4161/epi.3.2.6153; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peter ME, 2010, CELL STEM CELL, V6, P4, DOI 10.1016/j.stem.2009.12.006; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Postigo AA, 1999, MOL CELL BIOL, V19, P7961; Postigo AA, 1999, MOL CELL BIOL, V19, P7255; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Postigo AA, 2003, EMBO J, V22, P2443, DOI 10.1093/emboj/cdg225; Postigo AA, 1997, EMBO J, V16, P3924, DOI 10.1093/emboj/16.13.3924; Postigo AA, 1997, EMBO J, V16, P3935, DOI 10.1093/emboj/16.13.3935; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Postigo AA, 2000, P NATL ACAD SCI USA, V97, P6391, DOI 10.1073/pnas.97.12.6391; Rasband W., 2006, IMAGEJ; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sentani K, 2001, PATHOBIOLOGY, V69, P315, DOI 10.1159/000064638; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Sun A, 2007, PROSTATE, V67, P203, DOI 10.1002/pros.20521; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; van Grunsven LA, 2003, J BIOL CHEM, V278, P26135, DOI 10.1074/jbc.M300597200; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Verstappen G, 2008, HUM MOL GENET, V17, P1175, DOI 10.1093/hmg/ddn007; Waldmann J, 2009, ANN SURG ONCOL, V16, P1997, DOI 10.1245/s10434-009-0480-y; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yarnamichi N, 2007, CANCER RES, V67, P10727, DOI 10.1158/0008-5472.CAN-07-2601; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X	59	321	335	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 17	2010	29	24					3490	3500		10.1038/onc.2010.102	http://dx.doi.org/10.1038/onc.2010.102			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	611QN	20418909				2022-12-25	WOS:000278835400004
J	Mazauric, MH; Dirick, L; Purushothaman, SK; Bjork, GR; Lapeyre, B				Mazauric, Marie-Helene; Dirick, Leon; Purushothaman, Suresh K.; Bjoerk, Glenn R.; Lapeyre, Bruno			Trm112p Is a 15-kDa Zinc Finger Protein Essential for the Activity of Two tRNA and One Protein Methyltransferases in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; TRANSCRIPTION FACTOR IIIA; RELEASE FACTOR ERF1; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNAS; RSC; TRANSLATION; EXPRESSION; GENES; TERMINATION	The degenerate base at position 34 of the tRNA anticodon is the target of numerous modification enzymes. In Saccharomyces cerevisiae, five tRNAs exhibit a complex modification of uridine 34 (mcm(5)U(34) and mcm(5)s(2)U(34)), the formation of which requires at least 25 different proteins. The addition of the last methyl group is catalyzed by the methyltransferase Trm9p. Trm9p interacts with Trm112p, a 15-kDa protein with a zinc finger domain. Trm112p is essential for the activity of Trm11p, another tRNA methyltransferase, and for Mtq2p, an enzyme that methylates the translation termination factor eRF1/Sup45. Here, we report that Trm112p is required in vivo for the formation of mcm(5)U(34) and mcm(5)s(2)U(34). When produced in Escherichia coli, Trm112p forms a complex with Trm9p, which renders the latter soluble. This recombinant complex catalyzes the formation of mcm(5)U(34) on tRNA in vitro but not mcm(5)s(2)U(34). An mtq2-0 trm9-0 strain exhibits a synthetic growth defect, thus revealing the existence of an unexpected link between tRNA anticodon modification and termination of translation. Trm112p is associated with other partners involved in ribosome biogenesis and chromatin remodeling, suggesting that it has additional roles in the cell.	[Lapeyre, Bruno] Univ Montpellier 1 & 2, CRBM, CNRS, F-34293 Montpellier, France; [Dirick, Leon] Univ Montpellier 1 & 2, Inst Genet Mol, F-34293 Montpellier, France; [Bjoerk, Glenn R.] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Umea University	Lapeyre, B (corresponding author), Univ Montpellier 1 & 2, CRBM, CNRS, 1919 Route Mende, F-34293 Montpellier, France.	bruno.lapeyre@crbm.cnrs.fr	Björk, Glenn/AAE-8219-2022		CNRS; Association pour la Recherche sur le Cancer [ARC3793]; Swedish Science Research Council [BU-2930]; Carl Tryggers Foundation	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Swedish Science Research Council; Carl Tryggers Foundation	This work was supported by the CNRS and Grant ARC3793 from the Association pour la Recherche sur le Cancer (to B. L.) and by grants from Swedish Science Research Council Project BU-2930 and the Carl Tryggers Foundation (to G. R. B.).	Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; Alexandrov A, 2002, RNA, V8, P1253, DOI 10.1017/S1355838202024019; Anderson J, 1998, GENE DEV, V12, P3650, DOI 10.1101/gad.12.23.3650; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; BUTLER AR, 1994, MOL CELL BIOL, V14, P6306, DOI 10.1128/MCB.14.9.6306; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Campsteijn C, 2007, PLOS GENET, V3, P947, DOI 10.1371/journal.pgen.0030092; Cao YX, 1997, MOL CELL BIOL, V17, P3323, DOI 10.1128/MCB.17.6.3323; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Colley A, 2000, MOL CELL BIOL, V20, P7238, DOI 10.1128/MCB.20.19.7238-7246.2000; Colomina N, 2008, J BIOL CHEM, V283, P28670, DOI 10.1074/jbc.M804604200; COMPTON SJ, 1985, ANAL BIOCHEM, V151, P369, DOI 10.1016/0003-2697(85)90190-3; CROSS FR, 1991, CELL, V65, P875, DOI 10.1016/0092-8674(91)90394-E; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; FELICI F, 1989, MOL CELL BIOL, V9, P3260, DOI 10.1128/MCB.9.8.3260; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GEHRKE CW, 1982, J CHROMATOGR, V230, P297, DOI 10.1016/S0378-4347(00)80479-X; GEHRKE CW, 1990, CHROMATOGRAPHY MOD A, pA3; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GROSJEAN H, 2005, MODIFICATION EDITING, P1; Guthrie C., 1991, METHODS ENZYMOLOGY G, V194; Hasegawa Y, 2008, RNA, V14, P2333, DOI 10.1261/rna.1016508; Heurgue-Hamard V, 2005, J BIOL CHEM, V280, P2439, DOI 10.1074/jbc.M407252200; Heurgue-Hamard V, 2006, J BIOL CHEM, V281, P36140, DOI 10.1074/jbc.M608571200; Hsu JM, 2003, MOL CELL BIOL, V23, P3202, DOI 10.1128/MCB.23.9.3202-3215.2003; Hu ZB, 2010, PLANT J, V61, P600, DOI 10.1111/j.1365-313X.2009.04085.x; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; Huang JA, 2004, CELL CYCLE, V3, P973; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Kalhor HR, 2003, MOL CELL BIOL, V23, P9283, DOI 10.1128/MCB.23.24.9283-9292.2003; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Lu J, 2005, RNA, V11, P1648, DOI 10.1261/rna.2172105; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MONIER R, 1960, BIOCHIM BIOPHYS ACTA, V43, P1, DOI 10.1016/0006-3002(60)90399-1; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; OKADA K, 2009, NUCL ACIDS S SER, V53, P303, DOI DOI 10.1093/NASS/NRP152; Pearson CG, 2004, NAT REV MOL CELL BIO, V5, P481, DOI 10.1038/nrm1402; Polevoda B, 2006, J BIOL CHEM, V281, P2562, DOI 10.1074/jbc.M507651200; Purushothaman SK, 2005, MOL CELL BIOL, V25, P4359, DOI 10.1128/MCB.25.11.4359-4370.2005; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Searles MA, 2000, J MOL BIOL, V301, P47, DOI 10.1006/jmbi.2000.3946; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Studte P, 2008, MOL MICROBIOL, V69, P1266, DOI 10.1111/j.1365-2958.2008.06358.x; Trobro S, 2007, MOL CELL, V27, P758, DOI 10.1016/j.molcel.2007.06.032; Urbonavicius J, 2002, J BACTERIOL, V184, P5348, DOI 10.1128/JB.184.19.5348-5357.2002; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhouravleva GA, 2006, MOL BIOL+, V40, P724	55	47	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18505	18515		10.1074/jbc.M110.113100	http://dx.doi.org/10.1074/jbc.M110.113100			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400505	hybrid, Green Published			2022-12-25	WOS:000278453900044
J	Shi, QA; Banks, EA; Yu, XS; Gu, SM; Lauer, J; Fields, GB; Jiang, JX				Shi, Qian; Banks, Eric A.; Yu, X. Sean; Gu, Sumin; Lauer, Janelle; Fields, Gregg B.; Jiang, Jean X.			Amino Acid Residue Val(362) Plays a Critical Role in Maintaining the Structure of C Terminus of Connexin 50 and in Lens Epithelial-fiber Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; GAP-JUNCTION COMMUNICATION; INTERCELLULAR COMMUNICATION; BINDING DOMAIN; SWISS-MODEL; CHICK LENS; MICE; EYE; CATARACTOGENESIS; MICROPHTHALMIA	We have previously shown that connexin (Cx) 50, unlike the other two lens connexins, Cx43 and Cx46, promotes chicken lens epithelial-fiber differentiation in a channel-independent manner. Here, we show that deletion of the PEST motif at the C terminus (CT) domain of Cx50 attenuates the stimulatory effect of Cx50 on lens fiber differentiation. Valine 362, a residue located within the PEST domain, is functionally involved. The structure of the Cx50 CT predicted by molecular modeling revealed four alpha-helices and Val(362) was found to be located in the middle of the 3rd helix. Replacement of Val(362) with amino acid residues that disrupt the alpha-helical structure predicted by molecular modeling, such as arginine, glutamate, or phenylalanine, attenuated the stimulatory effects of Cx50 on lens differentiation, whereas replacement with threonine, isoleucine, leucine, or proline, which maintain the structure preserved the function of Cx50. Circular dichroism (CD) studies supported the structural predictions and showed that the substitution with Glu, but not Thr or Pro, disrupted the alpha-helix, which appears to be the structural feature important for lens epithelial-fiber differentiation. Together, our results suggest that Val(362) is important for maintaining the helical structure and is crucial for the role of Cx50 in promoting lens epithelial-fiber differentiation.	[Shi, Qian; Banks, Eric A.; Yu, X. Sean; Gu, Sumin; Lauer, Janelle; Fields, Gregg B.; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Jiang, JX (corresponding author), 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu	Shi, Qian/C-5962-2013	Jiang, Jean/0000-0002-2185-5716	National Institutes of Health [EY12085]; Welch Foundation [AQ-1507]; NATIONAL EYE INSTITUTE [R29EY012085, R01EY012085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY12085 and Welch Foundation Grant AQ-1507.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Banks EA, 2007, J CELL SCI, V120, P3602, DOI 10.1242/jcs.000935; BRUZZONE R, 2001, METHOD MOL BIOL, V154, P159; COX M, 1993, BIOCHEMISTRY-US, V32, P6032, DOI 10.1021/bi00074a014; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; Dunia I, 2006, EUR J CELL BIOL, V85, P729, DOI 10.1016/j.ejcb.2006.03.006; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Fort AG, 2009, BIOPOLYMERS, V92, P173, DOI 10.1002/bip.21166; Frishman D, 1996, PROTEIN ENG, V9, P133, DOI 10.1093/protein/9.2.133; GEOURJON C, 1994, PROTEIN ENG, V7, P157, DOI 10.1093/protein/7.2.157; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Gong X, 2007, J MEMBRANE BIOL, V218, P9, DOI 10.1007/s00232-007-9033-0; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Gu SM, 2003, INVEST OPHTH VIS SCI, V44, P2103, DOI 10.1167/iovs.02-1045; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Hirst-Jensen BJ, 2007, J BIOL CHEM, V282, P5801, DOI 10.1074/jbc.M605233200; Jiang JX, 1998, INVEST OPHTH VIS SCI, V39, P537; JIANG JX, 1994, MOL BIOL CELL, V5, P363, DOI 10.1091/mbc.5.3.363; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y; Nielsen PA, 2003, MOL BIOL CELL, V14, P2470, DOI 10.1091/mbc.E02-10-0637; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rong P, 2002, DEVELOPMENT, V129, P167; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sorgen PL, 2004, BIOPHYS J, V87, P574, DOI 10.1529/biophysj.103.039230; Tholozan FMD, 2007, INT J BIOCHEM CELL B, V39, P1754, DOI 10.1016/j.biocel.2007.06.021; Wallace P, 1998, GENE, V211, P19, DOI 10.1016/S0378-1119(98)00117-6; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yin XY, 2000, J BIOL CHEM, V275, P6850, DOI 10.1074/jbc.275.10.6850; Yin XY, 2001, J BIOL CHEM, V276, P34567, DOI 10.1074/jbc.M106073200; Zhang YW, 2003, J BIOL CHEM, V278, P44852, DOI 10.1074/jbc.M305072200; Zhang YW, 2003, CANCER RES, V63, P1623; Zhou L, 2002, MOL VIS, V8, P143; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200	39	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18415	18422		10.1074/jbc.M110.107052	http://dx.doi.org/10.1074/jbc.M110.107052			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20395299	Green Published, hybrid			2022-12-25	WOS:000278453900035
J	Kuroda, M; Katano, H; Nakajima, N; Tobiume, M; Ainai, A; Sekizuka, T; Hasegawa, H; Tashiro, M; Sasaki, Y; Arakawa, Y; Hata, S; Watanabe, M; Sata, T				Kuroda, Makoto; Katano, Harutaka; Nakajima, Noriko; Tobiume, Minoru; Ainai, Akira; Sekizuka, Tsuyoshi; Hasegawa, Hideki; Tashiro, Masato; Sasaki, Yuko; Arakawa, Yoshichika; Hata, Satoru; Watanabe, Masahide; Sata, Tetsutaro			Characterization of Quasispecies of Pandemic 2009 Influenza A Virus (A/H1N1/2009) by De Novo Sequencing Using a Next-Generation DNA Sequencer	PLOS ONE			English	Article							ANTIGENIC STRUCTURE; HEMAGGLUTININ; H1N1; INFECTIONS; SPECIMENS	Pandemic 2009 influenza A virus (A/H1N1/2009) has emerged globally. In this study, we performed a comprehensive detection of potential pathogens by de novo sequencing using a next-generation DNA sequencer on total RNAs extracted from an autopsy lung of a patient who died of viral pneumonia with A/H1N1/2009. Among a total of 9.4x10(6) 40-mer short reads, more than 98% appeared to be human, while 0.85% were identified as A/H1N1/2009 (A/Nagano/RC1-L/2009(H1N1)). Suspected bacterial reads such as Streptococcus pneumoniae and other oral bacteria flora were very low at 0.005%, and a significant bacterial infection was not histologically observed. De novo assembly and read mapping analysis of A/Nagano/RC1-L/2009(H1N1) showed more than x 200 coverage on average, and revealed nucleotide heterogeneity on hemagglutinin as quasispecies, specifically at two amino acids (Gly(172)Glu and Gly(239)Asn of HA) located on the Sa and Ca2 antigenic sites, respectively. Gly239 and Asn239 on antigenic site Ca2 appeared to be minor amino acids compared with the highly distributed Asp239 in H1N1 HAs. This study demonstrated that de novo sequencing can comprehensively detect pathogens, and such in-depth investigation facilitates the identification of influenza A viral heterogeneity. To better characterize the A/H1N1/2009 virus, unbiased comprehensive techniques will be indispensable for the primary investigations of emerging infectious diseases.	[Kuroda, Makoto; Sekizuka, Tsuyoshi] Natl Inst Infect Dis, Pathogen Genom Ctr, Lab Bacterial Genom, Tokyo, Japan; [Katano, Harutaka; Nakajima, Noriko; Tobiume, Minoru; Ainai, Akira; Sata, Tetsutaro] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Hasegawa, Hideki; Tashiro, Masato] Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo, Japan; [Sasaki, Yuko; Arakawa, Yoshichika] Natl Inst Infect Dis, Dept Bacterial Pathogenesis & Infect Control, Tokyo, Japan; [Hata, Satoru] Nagano Red Cross Hosp, Dept Clin Lab, Nagano, Japan; [Watanabe, Masahide] Nagano Red Cross Hosp, Dept Pathol, Nagano, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Nagano Red Cross Hospital; Nagano Red Cross Hospital	Kuroda, M (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Lab Bacterial Genom, Tokyo, Japan.	makokuro@nih.go.jp	Hasegawa, Hideki/C-7978-2014; Arakawa, Yoshichika/P-5997-2015	Katano, Harutaka/0000-0002-5332-4434; Sekizuka, Tsuyoshi/0000-0002-1302-5472	Ministry of Health, Labour, and Welfare, Japan	Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants for Research on Emerging and Re-emerging Infectious Diseases (H20 and 21 Shinko-Ippan-6), from the Ministry of Health, Labour, and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Air G M, 1987, Contrib Microbiol Immunol, V8, P20; Bao H, 2009, BIOINFORMATICS, V25, P1554, DOI 10.1093/bioinformatics/btp255; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mitra S, 2009, BIOINFORMATICS, V25, P1849, DOI 10.1093/bioinformatics/btp341; Nakajima N, 2010, JPN J INFECT DIS, V63, P67; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Ramakrishnan MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007105; Shen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007789; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Soundararajan V, 2009, NAT BIOTECHNOL, V27, P510, DOI 10.1038/nbt0609-510; Squires B, 2008, NUCLEIC ACIDS RES, V36, pD497, DOI 10.1093/nar/gkm905; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	29	91	96	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10256	10.1371/journal.pone.0010256	http://dx.doi.org/10.1371/journal.pone.0010256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428231	Green Submitted, Green Published, gold			2022-12-25	WOS:000277079300002
J	Medic, S; Ziman, M				Medic, Sandra; Ziman, Mel			PAX3 Expression in Normal Skin Melanocytes and Melanocytic Lesions (Naevi and Melanomas)	PLOS ONE			English	Article							TUMOR ALVEOLAR RHABDOMYOSARCOMA; DOWNSTREAM TARGET GENES; CELL ADHESION MOLECULE; STEM-CELLS; TRANSCRIPTION FACTORS; BCL-XL; MICROARRAY ANALYSIS; MALIGNANT-MELANOMA; FATE DETERMINATION; DIFFERENTIATION	Background: Cutaneous Malignant Melanoma is an aggressive form of skin cancer, arising in cutaneous melanocytes. The transcription factor PAX3 regulates melanocyte specification from neural crest cells during development but expression in differentiated melanocytes is uncertain. By contrast it is frequently found in melanomas and naevi and is a marker for melanoma staging and detection. In this study we analysed the expression of PAX3 across the spectrum of melanocytic cells, from normal melanocytes to cells of benign and malignant lesions to better assess its function in these various tissues. Pax3 and PAX3 (italicized) refer to the mouse and human gene, respectively; whereas Pax3 and PAX3 (non-italicized) refer to the corresponding mouse and human protein. Methodology and Principal Findings: PAX3 expression was analysed by immunohistochemistry and qRT-PCR. Immunofluorescence was used for co-expression with differentiation, migration and survival markers. As expected PAX3 expression was observed in naevi and melanoma cells. It was also found in melanocytes of normal skin where it coexpressed with melanocyte markers, MITF and MLANA. Co-expression with its downstream target, antiapoptotic factor BCL2L1 confirms PAX3 as a cell survival regulator. PAX3 was also co-expressed with melanoma cell migration marker MCAM in dermal naevi and melanoma cell nests, but this downstream target of PAX3 was not present in normal epidermal melanocytes, suggesting differential roles for PAX3 in normal epidermal melanocytes and melanoma cells. Most interestingly, a proportion of PAX3-positive epidermal melanocytes in normal skin show HES1 and Ki67 co-expression, indicating their less differentiated proliferative phenotype. Conclusions and Significance: Our results suggest that a previously identified role for PAX3, that of regulator of an undifferentiated plastic state, may operate in melanocytes of normal skin. This role, possibly required for cellular response to environmental stimuli, may contribute to formation and development of melanocytic lesions in which PAX3 expression is prominent.	[Medic, Sandra; Ziman, Mel] Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Perth, WA, Australia; [Ziman, Mel] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia	Edith Cowan University; University of Western Australia	Medic, S (corresponding author), Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Perth, WA, Australia.	m.ziman@ecu.edu.au		Ziman, Mel/0000-0001-7527-3538	Cancer Council of Western Australia	Cancer Council of Western Australia(Cancer Council Western Australia)	This project was partially funded by the Cancer Council of Western Australia (http://www.cancerwa.asn.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambler CA, 2007, DEV DYNAM, V236, P1595, DOI 10.1002/dvdy.21151; Aubin-Houzelstein G, 2008, J INVEST DERMATOL, V128, P2686, DOI 10.1038/jid.2008.120; Bang AG, 1997, DEVELOPMENT, V124, P2075; Barber TD, 1999, GENE, V237, P311, DOI 10.1016/S0378-1119(99)00339-X; Bardin N, 2001, BLOOD, V98, P3677, DOI 10.1182/blood.V98.13.3677; Barr FG, 1999, CANCER RES, V59, P5443; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Bernasconi M, 1996, P NATL ACAD SCI USA, V93, P13164, DOI 10.1073/pnas.93.23.13164; Blake JA, 2005, DEV GROWTH DIFFER, V47, P627; Blake JA, 2008, DEV DYNAM, V237, P2791, DOI 10.1002/dvdy.21711; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Borycki AG, 1999, DEVELOPMENT, V126, P1665; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Cook AL, 2005, EXP CELL RES, V308, P222, DOI 10.1016/j.yexcr.2005.04.019; DENTON KJ, 1992, J PATHOL, V167, P187, DOI 10.1002/path.1711670205; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; Frost V, 2008, CRIT REV BIOCHEM MOL, V43, P371, DOI [10.1080/10409230802486208, 10.1080/10409230802486208 ]; Galibert MD, 1999, J BIOL CHEM, V274, P26894, DOI 10.1074/jbc.274.38.26894; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Gershon TR, 2005, NEOPLASIA, V7, P575, DOI 10.1593/neo.04637; Ghazizadeh S, 2005, J INVEST DERMATOL, V124, P367, DOI 10.1111/j.0022-202X.2004.23599.x; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; He S., 2010, J INVEST DERMATOL; He SJ, 2005, MOL CANCER THER, V4, P996, DOI 10.1158/1535-7163.MCT-04-0252; Heere-Ress E, 2002, INT J CANCER, V99, P29, DOI 10.1002/ijc.10248; Himoudi N, 2007, CANCER IMMUNOL IMMUN, V56, P1381, DOI 10.1007/s00262-007-0294-3; Hornyak TJ, 2001, MECH DEVELOP, V101, P47, DOI 10.1016/S0925-4773(00)00569-4; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Johnson JP, 1997, INT J CANCER, V73, P769; Koyanagi K, 2005, CLIN CHEM, V51, P981, DOI 10.1373/clinchem.2004.045096; KRAJEWSKI S, 1994, CANCER RES, V54, P5501; Kraus A, 1997, MELANOMA RES, V7, pS75; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; LEHMANN JM, 1987, CANCER RES, V47, P841; Leiter U, 2000, ARCH DERMATOL RES, V292, P225, DOI 10.1007/s004030050479; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; LUCA M, 1993, MELANOMA RES, V3, P35, DOI 10.1097/00008390-199304000-00006; Lyle S, 1998, J CELL SCI, V111, P3179; Margue CM, 2000, ONCOGENE, V19, P2921, DOI 10.1038/sj.onc.1203607; Matsuzaki Y, 2005, J IMMUNOTHER, V28, P10, DOI 10.1097/00002371-200501000-00002; Mayanil CSK, 2001, J BIOL CHEM, V276, P49299, DOI 10.1074/jbc.M107933200; Medic S, 2009, CRIT REV BIOCHEM MOL, V44, P85, DOI 10.1080/10409230902755056; Melnikova VO, 2006, PIGM CELL RES, V19, P395, DOI 10.1111/j.1600-0749.2006.00331.x; Meulemans D, 2004, DEV CELL, V7, P291, DOI 10.1016/j.devcel.2004.08.007; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Olie RA, 2002, J INVEST DERMATOL, V118, P505, DOI 10.1046/j.0022-202x.2001.01677.x; Osawa M, 2005, DEVELOPMENT, V132, P5589, DOI 10.1242/dev.02161; Pacifico MD, 2005, PLAST RECONSTR SURG, V115, P367, DOI 10.1097/01.PRS.0000148417.86768.C9; Pearl RA, 2008, J PLAST RECONSTR AES, V61, P265, DOI 10.1016/j.bjps.2007.04.010; Plummer RS, 2008, MODERN PATHOL, V21, P525, DOI 10.1038/modpathol.3801019; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Rodeberg DA, 2006, INT J CANCER, V119, P126, DOI 10.1002/ijc.21817; Scholl FA, 2001, CANCER RES, V61, P823; SHAPIRO DN, 1993, CANCER RES, V53, P5108; Shih IM, 1997, CANCER RES, V57, P3835; SHIH IM, 1994, CANCER RES, V54, P2514; Takeuchi H, 2004, J CLIN ONCOL, V22, P2671, DOI 10.1200/JCO.2004.12.009; Venters SJ, 2004, DEV DYNAM, V229, P591, DOI 10.1002/dvdy.20016; Wang QY, 2007, INT J CANCER, V120, P1223, DOI 10.1002/ijc.22316; Wang QY, 2008, J CELL MOL MED, V12, P2281, DOI 10.1111/j.1582-4934.2008.00427.x; Xie SH, 1997, CANCER RES, V57, P2295; Yamamoto N, 2003, CURR BIOL, V13, P333, DOI 10.1016/S0960-9822(03)00081-2; Yang G, 2008, MOL CELL, V32, P554, DOI 10.1016/j.molcel.2008.11.002; Zhuang LQ, 2007, MODERN PATHOL, V20, P416, DOI 10.1038/modpathol.3800750; Ziman M, 2006, MOLECULAR AND CELLULAR PATHOLOGY OF CANCER PROGRESSION AND PROGNOSIS, P235	70	47	51	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e9977	10.1371/journal.pone.0009977	http://dx.doi.org/10.1371/journal.pone.0009977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421967	Green Published, gold			2022-12-25	WOS:000276952600001
J	Ohshima, Y; Yajima, I; Takeda, K; Iida, M; Kumasaka, M; Matsumoto, Y; Kato, M				Ohshima, Yuichiro; Yajima, Ichiro; Takeda, Kozue; Iida, Machiko; Kumasaka, Mayuko; Matsumoto, Yoshinari; Kato, Masashi			c-RET Molecule in Malignant Melanoma from Oncogenic RET-Carrying Transgenic Mice and Human Cell Lines	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; TYROSINE KINASES; MOUSE MODEL; CANCER; PROGRESSION; EXPRESSION; MUTATION; DISEASE; SUPERACTIVATION; PROLIFERATION	Malignant melanoma is one of the most aggressive cancers and its incidence worldwide has been increasing at a greater rate than that of any other cancer. We previously reported that constitutively activated RFP-RET-carrying transgenic mice (RET-mice) spontaneously develop malignant melanoma. In this study, we showed that expression levels of intrinsic c-Ret, glial cell line-derived neurotrophic factor (Gdnf) and Gdnf receptor alpha 1 (Gfra1) transcripts in malignant melanomas from RET-transgenic mice were significantly upregulated compared with those in benign melanocytic tumors. These results suggest that not only introduced oncogenic RET but also intrinsic c-Ret/Gdnf are involved in murine melanomagenesis in RET-mice. We then showed that c-RET and GDNF transcript expression levels in human malignant melanoma cell lines (HM3KO and MNT-1) were higher than those in primary cultured normal human epithelial melanocytes (NHEM), while GFRa1 transcript expression levels were comparable among NHEM, HM3KO and MNT-1. We next showed c-RET and GFRa1 protein expression in HM3KO cells and GDNF-mediated increased levels of their phosphorylated c-RET tyrosine kinase and signal transduction molecules (ERK and AKT) sited potentially downstream of c-RET. Taken together with the finding of augmented proliferation of HM3KO cells after GDNF stimulation, our results suggest that GDNF-mediated c-RET kinase activation is associated with the pathogenesis of malignant melanoma.	[Ohshima, Yuichiro; Yajima, Ichiro; Takeda, Kozue; Iida, Machiko; Kumasaka, Mayuko; Kato, Masashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Units Environm Hlth Sci, Kasugai, Aichi 487, Japan; [Ohshima, Yuichiro; Matsumoto, Yoshinari] Aichi Med Univ, Sch Med, Dept Dermatol, Nagakute, Aichi 48011, Japan	Chubu University; Aichi Medical University	Ohshima, Y (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Units Environm Hlth Sci, Kasugai, Aichi 487, Japan.	katomasa@isc.chubu.ac.jp	KATO, Masashi/I-7250-2014; YAJIMA, Ichiro/I-7467-2014		Ministry of Education, Culture, Sports, Science and Technology (MEXT) [19390168, 20406003]; MEXT [S0801055]; Japan Society for the Promotion of Science (JSPS) [20790775, 20790821, 20700370]; ROHTO Award; Uehara Memorial Foundation; Chubu University	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ROHTO Award; Uehara Memorial Foundation(Uehara Memorial Foundation); Chubu University	This study was supported in part by Grants-in-Aid for Scientific Research (B) (No. 19390168 and 20406003) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), COE Project for Private Universities (No. S0801055) from MEXT, Grant-in-Aid for Young Scientists (B) (No. 20790775, 20790821, 20700370) from the Japan Society for the Promotion of Science (JSPS), the ROHTO Award, the Uehara Memorial Foundation and Chubu University grants A and C. MEXT: http://www.mext.go.jp. JSPS:http://www.jsps.go.jp. ROHTO Award: no web sites. Uehara Memorial Foundation: http://www.ueharazaidan. com/. Chubu University grants:http://www.chubu.ac.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Drosten M, 2006, NAT CLIN PRACT ONCOL, V3, P564, DOI 10.1038/ncponc0610; EASTY DJ, 1995, INT J CANCER, V60, P129, DOI 10.1002/ijc.2910600119; Emionite L, 2003, ANTICANCER RES, V23, P13; Esseghir S, 2007, CANCER RES, V67, P11732, DOI 10.1158/0008-5472.CAN-07-2343; Garnis C, 2005, ONCOGENE, V24, P4806, DOI 10.1038/sj.onc.1208643; Hasselblatt M, 2009, CANCER RES, V69, P2219, DOI 10.1158/0008-5472.CAN-08-3176; Hussein MR, 2005, J CLIN PATHOL, V58, P453, DOI 10.1136/jcp.2004.019422; Iwahashi N, 2002, CANCER, V94, P167, DOI 10.1002/cncr.10169; Jijiwa M, 2004, MOL CELL BIOL, V24, P8026, DOI 10.1128/MCB.24.18.8026-8036.2004; KATO M, 1994, CELL IMMUNOL, V159, P15, DOI 10.1006/cimm.1994.1291; Kato M, 2004, CANCER RES, V64, P801, DOI 10.1158/0008-5472.CAN-03-2532; Kato M, 2003, P NATL ACAD SCI USA, V100, P6398, DOI 10.1073/pnas.1132162100; Kato M, 2002, CANCER RES, V62, P2414; Kato M, 1998, ONCOGENE, V17, P1885, DOI 10.1038/sj.onc.1202077; Kato M, 2000, MOL BIOL CELL, V11, P93, DOI 10.1091/mbc.11.1.93; Kato M, 2007, J INVEST DERMATOL, V127, P1244, DOI 10.1038/sj.jid.5700659; Kato M, 2000, ANTIOXID REDOX SIGN, V2, P841, DOI 10.1089/ars.2000.2.4-841; KUMASAKA YM, 2010, CANC RES IN PRESS; Mologni L, 2006, J MOL ENDOCRINOL, V37, P199, DOI 10.1677/jme.1.01999; Narita N, 2009, ONCOGENE, V28, P3058, DOI 10.1038/onc.2009.164; Oka M, 1996, J CELL PHYSIOL, V167, P406, DOI 10.1002/(SICI)1097-4652(199606)167:3<406::AID-JCP4>3.3.CO;2-A; Peterson S, 2004, ONCOGENE, V23, P213, DOI 10.1038/sj.onc.1206980; Takahashi M, 1999, HUM MUTAT, V13, P331, DOI 10.1002/(SICI)1098-1004(1999)13:4<331::AID-HUMU11>3.3.CO;2-R; Takahashi M, 2001, CYTOKINE GROWTH F R, V12, P361, DOI 10.1016/S1359-6101(01)00012-0; Trupp M, 1999, J BIOL CHEM, V274, P20885, DOI 10.1074/jbc.274.30.20885; Yajima I, 2009, J DERMATOL SCI, V55, P68, DOI 10.1016/j.jdermsci.2009.02.010; Zeng Q, 2008, J INT MED RES, V36, P656, DOI 10.1177/147323000803600406	27	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10279	10.1371/journal.pone.0010279	http://dx.doi.org/10.1371/journal.pone.0010279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422010	Green Submitted, Green Published, gold			2022-12-25	WOS:000276952500023
J	Oshikawa, J; Urao, N; Kim, HW; Kaplan, N; Razvi, M; McKinney, R; Poole, LB; Fukai, T; Ushio-Fukai, M				Oshikawa, Jin; Urao, Norifumi; Kim, Ha Won; Kaplan, Nihal; Razvi, Masooma; McKinney, Ronald; Poole, Leslie B.; Fukai, Tohru; Ushio-Fukai, Masuko			Extracellular SOD-Derived H2O2 Promotes VEGF Signaling in Caveolae/Lipid Rafts and Post-Ischemic Angiogenesis in Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROTEIN-TYROSINE PHOSPHATASES; SULFENIC ACID FORMATION; SUPEROXIDE-DISMUTASE; HEPARAN-SULFATE; ANGIOTENSIN-II; NAD(P)H OXIDASE; CELL MIGRATION; NADPH OXIDASE; ACTIVATION	Reactive oxygen species (ROS), in particular, H2O2, is essential for full activation of VEGF receptor2 (VEGFR2) signaling involved in endothelial cell (EC) proliferation and migration. Extracellular superoxide dismutase (ecSOD) is a major secreted extracellular enzyme that catalyzes the dismutation of superoxide to H2O2, and anchors to EC surface through heparin-binding domain (HBD). Mice lacking ecSOD show impaired postnatal angiogenesis. However, it is unknown whether ecSOD-derived H2O2 regulates VEGF signaling. Here we show that gene transfer of ecSOD, but not ecSOD lacking HBD (ecSOD-Delta HBD), increases H2O2 levels in adductor muscle of mice, and promotes angiogenesis after hindlimb ischemia. Mice lacking ecSOD show reduction of H2O2 in non-ischemic and ischemic limbs. In vitro, overexpression of ecSOD, but not ecSOD-Delta HBD, in cultured medium in ECs enhances VEGF-induced tyrosine phosphorylation of VEGFR2 (VEGFR2-pY), which is prevented by short-term pretreatment with catalase that scavenges extracellular H2O2. Either exogenous H2O2 (<500 mu M), which is diffusible, or nitric oxide donor has no effect on VEGF-induced VEGFR2-pY. These suggest that ecSOD binding to ECs via HBD is required for localized generation of extracellular H2O2 to regulate VEGFR2-pY. Mechanistically, VEGF-induced VEGFR2-pY in caveolae/lipid rafts, but non-lipid rafts, is enhanced by ecSOD, which localizes at lipid rafts via HBD. One of the targets of ROS is protein tyrosine phosphatases (PTPs). ecSOD induces oxidation and inactivation of both PTP1B and DEP1, which negatively regulates VEGFR2-pY, in caveolae/lipid rafts, but not non-lipid rafts. Disruption of caveolae/lipid rafts, or PTPs inhibitor orthovanadate, or siRNAs for PTP1B and DEP1 enhances VEGF-induced VEGFR2-pY, which prevents ecSOD-induced effect. Functionally, ecSOD promotes VEGF-stimulated EC migration and proliferation. In summary, extracellular H2O2 generated by ecSOD localized at caveolae/lipid rafts via HBD promotes VEGFR2 signaling via oxidative inactivation of PTPs in these microdomains. Thus, ecSOD is a potential therapeutic target for angiogenesis-dependent cardiovascular diseases.	[Oshikawa, Jin; Urao, Norifumi; Kaplan, Nihal; Razvi, Masooma; McKinney, Ronald; Ushio-Fukai, Masuko] Univ Chicago, Dept Pharmacol, Ctr Lung & Vasc Biol, Chicago, IL 60637 USA; [Kim, Ha Won; McKinney, Ronald; Fukai, Tohru] Univ Chicago, Dept Med & Pharmacol, Chicago, IL 60637 USA; [Oshikawa, Jin; Urao, Norifumi; Kim, Ha Won; Kaplan, Nihal; Razvi, Masooma; McKinney, Ronald; Fukai, Tohru; Ushio-Fukai, Masuko] Univ Chicago, Cardiovasc Res Ctr, Chicago, IL 60637 USA; [Poole, Leslie B.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27103 USA	University of Chicago; University of Chicago; University of Chicago; Wake Forest University; Wake Forest Baptist Medical Center	Oshikawa, J (corresponding author), Univ Chicago, Dept Pharmacol, Ctr Lung & Vasc Biol, Chicago, IL 60637 USA.	mfukai@uic.edu	Urao, Norifumi/O-7313-2015	Urao, Norifumi/0000-0001-9750-8406; Poole, Leslie/0000-0003-0334-7328; Kim, Ha Won/0000-0001-6272-4248	National Institutes of Health (NIH) [R01, 077524, HL077524-S1, HL070187, 126659]; American Heart Association (AHA) [0755805Z]; AHA National Center Research Program (NCRP) Innovative Research [0970336N]; AHA Post-doctoral Fellowship [09POST2250151]; Ruth L. Kirschstein-National Service Research [T32]; Uehara Memorial Foundation; Naito Foundation; NATIONAL CANCER INSTITUTE [R33CA126659] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077524, R01HL070187] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); AHA National Center Research Program (NCRP) Innovative Research; AHA Post-doctoral Fellowship(American Heart Association); Ruth L. Kirschstein-National Service Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by National Institutes of Health (NIH) R01 Heart and Lung (HL) 077524 and HL077524-S1 (to M.U.-F.), HL070187 (to T.F.) and Cancer (CA) 126659 (to L.B.P.), American Heart Association (AHA) Grant-In-Aid 0755805Z (to M.U.-F.) and AHA National Center Research Program (NCRP) Innovative Research Grant 0970336N (to M.U.-F), AHA Post-doctoral Fellowship 09POST2250151 (to N.U.), Ruth L. Kirschstein-National Service Research Award (Kirschstein-NRSA) T32 Training Grant (to N.K. and M.R.), Uehara Memorial Foundation and Naito Foundation (to J.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baljinnyam E, 2009, AM J PHYSIOL-CELL PH, V297, pC802, DOI 10.1152/ajpcell.00129.2009; Buczek-Thomas JA, 2002, J CELL PHYSIOL, V192, P294, DOI 10.1002/jcp.10135; Caselli A, 2002, BIOCHEM BIOPH RES CO, V296, P692, DOI 10.1016/S0006-291X(02)00928-2; Chaiswing L, 2008, CANCER RES, V68, P5820, DOI 10.1158/0008-5472.CAN-08-0162; Chaiswing L, 2018, ANTIOXID REDOX SIGN, V29, P1237, DOI 10.1089/ars.2017.7485; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Chu Y, 2003, CIRC RES, V92, P461, DOI 10.1161/01.RES.0000057755.02845.F9; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Finkel T, 1999, J LEUKOCYTE BIOL, V65, P337, DOI 10.1002/jlb.65.3.337; Fukai T, 2002, CARDIOVASC RES, V55, P239, DOI 10.1016/S0008-6363(02)00328-0; Fukai T, 1998, J CLIN INVEST, V101, P2101, DOI 10.1172/JCI2105; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; GO YM, 2009, FREE RADIC BIOL MED; Gonzalez-Pacheco FR, 2006, AM J PHYSIOL-HEART C, V291, pH1395, DOI 10.1152/ajpheart.01277.2005; GRAZIA LM, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Hink HU, 2002, ARTERIOSCL THROM VAS, V22, P1402, DOI 10.1161/01.ATV.0000027524.86752.02; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; Ikeda S, 2005, ARTERIOSCL THROM VAS, V25, P2295, DOI 10.1161/01.ATV.0000187472.55437.af; Insel PA, 2009, CURR OPIN NEPHROL HY, V18, P50, DOI 10.1097/MNH.0b013e3283186f82; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jung O, 2007, ARTERIOSCL THROM VAS, V27, P470, DOI 10.1161/01.ATV.0000254823.15843.1f; Juul K, 2004, CIRCULATION, V109, P59, DOI 10.1161/01.CIR.0000105720.28086.6C; Kim HW, 2007, CIRC RES, V101, P409, DOI 10.1161/CIRCRESAHA.107.153791; Labrecque L, 2003, MOL BIOL CELL, V14, P334, DOI 10.1091/mbc.E02-07-0379; Lamalice L, 2004, ONCOGENE, V23, P434, DOI 10.1038/sj.onc.1207034; Laurila JP, 2009, MOL THER, V17, P448, DOI 10.1038/mt.2008.282; MARKLUND SL, 1990, BIOCHEM J, V266, P213, DOI 10.1042/bj2660213; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Mavromatis K, 2000, ARTERIOSCL THROM VAS, V20, P1889, DOI 10.1161/01.ATV.20.8.1889; Michalek RD, 2007, J IMMUNOL, V179, P6456, DOI 10.4049/jimmunol.179.10.6456; Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080; Oshikawa J, 2004, P NATL ACAD SCI USA, V101, P12670, DOI 10.1073/pnas.0402053101; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Poole LB, 2007, BIOCONJUGATE CHEM, V18, P2004, DOI 10.1021/bc700257a; Qin ZY, 2008, HYPERTENSION, V52, P945, DOI 10.1161/HYPERTENSIONAHA.108.116467; Rhee S G, 2000, Sci STKE, V2000, ppe1; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Souchard JP, 1998, FREE RADICAL RES, V29, P441, DOI 10.1080/10715769800300491; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tkachenko E, 2002, J BIOL CHEM, V277, P19946, DOI 10.1074/jbc.M200841200; Tojo T, 2005, CIRCULATION, V111, P2347, DOI 10.1161/01.CIR.0000164261.62586.14; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Urao N, 2008, CIRC RES, V103, P212, DOI 10.1161/CIRCRESAHA.108.176230; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; Ushio-Fukai M, 2001, J BIOL CHEM, V276, P48269, DOI 10.1074/jbc.M105901200; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI [10.1089/ars.2008.2333, 10.1089/ARS.2008.2333]; Wheeler MD, 2003, MOL CANCER RES, V1, P871; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60	51	119	121	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10189	10.1371/journal.pone.0010189	http://dx.doi.org/10.1371/journal.pone.0010189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422004	Green Published, Green Submitted, gold			2022-12-25	WOS:000276952500006
J	Yamaji, S; Saegusa, J; Ieguchi, K; Fujita, M; Takada, YK; Takada, Y				Yamaji, Satoshi; Saegusa, Jun; Ieguchi, Katsuaki; Fujita, Masaaki; Takada, Yoko K.; Takada, Yoshikazu			A Novel Fibroblast Growth Factor-1 (FGF1) Mutant that Acts as an FGF Antagonist	PLOS ONE			English	Article							TYROSINE PHOSPHATASE; INDUCED ANGIOGENESIS; KINASE-ACTIVITY; CYCLIN D1; RECEPTOR; ACTIVATION; INTEGRINS; SHP-2; PHOSPHORYLATION; ALPHA-V-BETA-3	Background: Crosstalk between integrins and FGF receptors has been implicated in FGF signaling, but the specifics of the crosstalk are unclear. We recently discovered that 1) FGF1 directly binds to integrin alpha v beta 3, 2) the integrin-binding site and FGF receptor (FGFR) binding site are distinct, and 3) the integrin-binding-defective FGF1 mutant (R50E) is defective in inducing FGF signaling although R50E still binds to FGFR and heparin and induces transient ERK1/2 activation. Principal Findings: We tested if excess R50E affect DNA synthesis and cell survival induced by WT FGF1 in BaF3 mouse proB cells expressing human FGFR1. R50E suppressed DNA synthesis and cell proliferation induced by WT FGF1. We tested if WT FGF1 and R50E generate integrin-FGF1-FGFR ternary complex. WT FGF1 induced ternary complex formation (integrin-FGF-FGFR1) and recruitment of SHP-2 to the complex in NIH 3T3 cells and human umbilical endothelial cells, but R50E was defective in these functions. It has been reported that sustained ERK1/2 activation is integrin-dependent and crucial to cell cycle entry upon FGF stimulation. We thus determined the time-course of ERK1/2 activation induced by WT FGF1 and R50E. We found that WT FGF1 induced sustained activation of ERK1/2, but R50E was defective in this function. Conclusions/Significance: Our results suggest that 1) R50E is a dominant-negative mutant, 2) Ternary complex formation is involved in FGF signaling, 3) The defect of R50E to bind to integrin may be directly related to the antagonistic action of R50E. Taken together, these results suggest that R50E has potential as a therapeutic in cancer.	[Yamaji, Satoshi; Saegusa, Jun; Ieguchi, Katsuaki; Fujita, Masaaki; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Dept Dermatol, Sch Med, Sacramento, CA 95817 USA	University of California System; University of California Davis	Yamaji, S (corresponding author), Univ Calif Davis, Dept Dermatol, Sch Med, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu		takada, yoshikazu/0000-0001-5481-9589	NIH [CA113298, CA13105, CA093373]; NATIONAL CANCER INSTITUTE [U19CA113298, P30CA093373] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants CA113298, CA13105, and CA093373 to YT (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Forsten-Williams K, 2008, ANN BIOMED ENG, V36, P2134, DOI 10.1007/s10439-008-9575-z; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KLINT P, 1999, FRONT BIOSCI, V4, P165; Kontaridis MI, 2002, MOL CELL BIOL, V22, P3875, DOI 10.1128/MCB.22.11.3875-3891.2002; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Li X, 2004, J CELL SCI, V117, P6007, DOI 10.1242/jcs.01519; Ling Y, 2003, MOL ENDOCRINOL, V17, P1824, DOI 10.1210/me.2003-0143; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Paleolog EM, 2002, ARTHRITIS RES THER, V4, pS81, DOI 10.1186/ar575; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Schwartz MA, 2001, J CELL SCI, V114, P2553; Sharrocks AD, 2006, CURR BIOL, V16, pR540, DOI 10.1016/j.cub.2006.06.038; Shi ZQ, 1998, J BIOL CHEM, V273, P4904, DOI 10.1074/jbc.273.9.4904; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Yan W, 2008, MOL BIOL CELL, V19, P2278, DOI 10.1091/mbc.E07-10-1068; Zhang BL, 2006, J BIOL CHEM, V281, P905, DOI 10.1074/jbc.M503945200	24	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10273	10.1371/journal.pone.0010273	http://dx.doi.org/10.1371/journal.pone.0010273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422052	Green Published, gold, Green Submitted			2022-12-25	WOS:000276952500028
J	Alfonso-Parra, C; Maggert, KA				Alfonso-Parra, Catalina; Maggert, Keith A.			Drosophila SAF-B Links the Nuclear Matrix, Chromosomes, and Transcriptional Activity	PLOS ONE			English	Article							HUMAN BREAST-CANCER; PROTEIN-PHOSPHORYLATION SITES; ATTACHMENT FACTOR-B; HEAT-SHOCK; GENE-EXPRESSION; LIVING CELLS; HET/SAF-B; IN-VIVO; MELANOGASTER; INTERACTS	Induction of gene expression is correlated with alterations in nuclear organization, including proximity to other active genes, to the nuclear cortex, and to cytologically distinct domains of the nucleus. Chromosomes are tethered to the insoluble nuclear scaffold/matrix through interaction with Scaffold/Matrix Attachment Region (SAR/MAR) binding proteins. Identification and characterization of proteins involved in establishing or maintaining chromosome-scaffold interactions is necessary to understand how the nucleus is organized and how dynamic changes in attachment are correlated with alterations in gene expression. We identified and characterized one such scaffold attachment factor, a Drosophila homolog of mammalian SAF-B. The large nuclei and chromosomes of Drosophila have allowed us to show that SAF-B inhabits distinct subnuclear compartments, forms weblike continua in nuclei of salivary glands, and interacts with discrete chromosomal loci in interphase nuclei. These interactions appear mediated either by DNA-protein interactions, or through RNA-protein interactions that can be altered during changes in gene expression programs. Extraction of soluble nuclear proteins and DNA leaves SAF-B intact, showing that this scaffold/matrix-attachment protein is a durable component of the nuclear matrix. Together, we have shown that SAF-B links the nuclear scaffold, chromosomes, and transcriptional activity.	[Alfonso-Parra, Catalina] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Maggert, Keith A.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Alfonso-Parra, C (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	kmaggert@tamu.edu		Alfonso-Parra, Catalina/0000-0002-5689-9356; Maggert, Keith/0000-0002-9291-9481	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076092] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM076092] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albrethsen J, 2009, J PROTEOMICS, V72, P71, DOI 10.1016/j.jprot.2008.09.005; ANGSHUMAN S, 2007, COLD SPRING HARB PRO; Arao Y, 2000, ARCH BIOCHEM BIOPHYS, V380, P228, DOI 10.1006/abbi.2000.1938; ASHBURNER M, 1979, CELL, V17, P241, DOI 10.1016/0092-8674(79)90150-8; Berger AB, 2008, NAT METHODS, V5, P1031, DOI 10.1038/nmeth.1266; Bickmore WA, 2002, EMBO J, V21, P1248, DOI 10.1093/emboj/21.6.1248; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Chan CW, 2007, BIOCHEM J, V407, P355, DOI 10.1042/BJ20070170; Chiodi I, 2000, J CELL SCI, V113, P4043; Clegg NJ, 1998, GENOME, V41, P495, DOI 10.1139/gen-41-4-495; COOK PR, 1991, CELL, V66, P627, DOI 10.1016/0092-8674(91)90109-C; Debril MB, 2005, J MOL ENDOCRINOL, V35, P503, DOI 10.1677/jme.1.01856; Dillon N, 2008, DEV CELL, V15, P182, DOI 10.1016/j.devcel.2008.07.013; Dobrzycka KM, 2006, CANCER RES, V66, P7859, DOI 10.1158/0008-5472.CAN-06-1381; Dorman ER, 2007, SEMIN CELL DEV BIOL, V18, P682, DOI 10.1016/j.semcdb.2007.08.009; Drysdale Rachel, 2008, V420, P45, DOI 10.1007/978-1-59745-583-1_3; FACKELMAYER FO, 1994, EUR J BIOCHEM, V221, P749, DOI 10.1111/j.1432-1033.1994.tb18788.x; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Gause M, 2008, BIOESSAYS, V30, P715, DOI 10.1002/bies.20787; GELBART WM, 1982, GENETICS, V102, P179; Gonzalez AN, 2008, P NATL ACAD SCI USA, V105, P18436, DOI 10.1073/pnas.0805993105; Hallson G, 2008, P NATL ACAD SCI USA, V105, P12405, DOI 10.1073/pnas.0801698105; HAMMERICHHILLE S, 2009, BREAST CANC RES TREA; HAMMERICHHILLE S, 2009, J BIOL CHEM; HESSLER AY, 1958, GENETICS, V43, P395; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; IP YT, 1994, EMBO J, V13, P5826, DOI 10.1002/j.1460-2075.1994.tb06926.x; Lee YB, 2007, EXP CELL RES, V313, P3914, DOI 10.1016/j.yexcr.2007.06.023; Lehman JA, 2008, BIOCHEMISTRY-US, V47, P4359, DOI 10.1021/bi702284c; Lin JJ, 2008, J BIOL CHEM, V283, P29681, DOI 10.1074/jbc.M802076200; Meaburn KJ, 2009, J CELL BIOL, V187, P801, DOI 10.1083/jcb.200909127; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Morris JR, 1998, P NATL ACAD SCI USA, V95, P10740, DOI 10.1073/pnas.95.18.10740; Nayler O, 1998, NUCLEIC ACIDS RES, V26, P3542, DOI 10.1093/nar/26.15.3542; Nikolakaki E, 2001, J BIOL CHEM, V276, P40175, DOI 10.1074/jbc.M104755200; Oegema K, 1997, J CELL SCI, V110, P1573; Oesterreich S, 2000, MOL ENDOCRINOL, V14, P369, DOI 10.1210/me.14.3.369; Oesterreich S, 2003, J CELL BIOCHEM, V90, P653, DOI 10.1002/jcb.10685; Oesterreich S, 1997, J CELL BIOCHEM, V67, P275, DOI 10.1002/(SICI)1097-4644(19971101)67:2<275::AID-JCB13>3.0.CO;2-E; Oesterreich S, 2001, BRIT J CANCER, V84, P493, DOI 10.1054/bjoc.2000.1606; Okubo S, 2004, J BIOL CHEM, V279, P31455, DOI 10.1074/jbc.M403561200; Pathak RU, 2007, MOL CELL BIOL, V27, P4796, DOI 10.1128/MCB.00305-07; Renz A, 1996, NUCLEIC ACIDS RES, V24, P843, DOI 10.1093/nar/24.5.843; Sandhu KS, 2009, J MOL RECOGNIT, V22, P1, DOI 10.1002/jmr.915; Sergeant KA, 2007, J CELL SCI, V120, P309, DOI 10.1242/jcs.03344; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Tai HH, 2003, BIOCHEM BIOPH RES CO, V308, P170, DOI 10.1016/S0006-291X(03)01354-8; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Townson SM, 2004, J BIOL CHEM, V279, P26074, DOI 10.1074/jbc.M313726200; Townson SM, 2003, J BIOL CHEM, V278, P20059, DOI 10.1074/jbc.M212988200; Townson SM, 2000, CLIN CANCER RES, V6, P3788; Weighardt F, 1999, J CELL SCI, V112, P1465; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025	57	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10248	10.1371/journal.pone.0010248	http://dx.doi.org/10.1371/journal.pone.0010248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422039	Green Published, gold, Green Submitted			2022-12-25	WOS:000276854300012
J	Matveeva, OV; Kang, YB; Spiridonov, AN; Saetrom, P; Nemtsov, VA; Ogurtsov, AY; Nechipurenko, YD; Shabalina, SA				Matveeva, Olga V.; Kang, Yibin; Spiridonov, Alexey N.; Saetrom, Pal; Nemtsov, Vladimir A.; Ogurtsov, Aleksey Y.; Nechipurenko, Yury D.; Shabalina, Svetlana A.			Optimization of Duplex Stability and Terminal Asymmetry for shRNA Design	PLOS ONE			English	Article							RNA SECONDARY STRUCTURE; SIRNA DESIGN; MAMMALIAN-CELLS; FUNCTIONAL SIRNAS; EFFICIENCY; INTERFERENCE; SPECIFICITY; EXPRESSION; PARAMETERS; KNOCKDOWN	Prediction of efficient oligonucleotides for RNA interference presents a serious challenge, especially for the development of genome-wide RNAi libraries which encounter difficulties and limitations due to ambiguities in the results and the requirement for significant computational resources. Here we present a fast and practical algorithm for shRNA design based on the thermodynamic parameters. In order to identify shRNA and siRNA features universally associated with high silencing efficiency, we analyzed structure-activity relationships in thousands of individual RNAi experiments from publicly available databases (ftp://ftp.ncbi.nlm.nih.gov/pub/shabalin/siRNA/si_shRNA_selector/). Using this statistical analysis, we found free energy ranges for the terminal duplex asymmetry and for fully paired duplex stability, such that shRNAs or siRNAs falling in both ranges have a high probability of being efficient. When combined, these two parameters yield a similar to 72% success rate on shRNAs from the siRecords database, with the target RNA levels reduced to below 20% of the control. Two other parameters correlate well with silencing efficiency: the stability of target RNA and the antisense strand secondary structure. Both parameters also correlate with the short RNA duplex stability; as a consequence, adding these parameters to our prediction scheme did not substantially improve classification accuracy. To test the validity of our predictions, we designed 83 shRNAs with optimal terminal asymmetry, and experimentally verified that small shifts in duplex stability strongly affected silencing efficiency. We showed that shRNAs with short fully paired stems could be successfully selected by optimizing only two parameters: terminal duplex asymmetry and duplex stability of the hypothetical cleavage product, which also relates to the specificity of mRNA target recognition. Our approach performs at the level of the best currently utilized algorithms that take into account prediction of the secondary structure of the target and antisense RNAs, but at significantly lower computational costs. Based on this study, we created the si-shRNA Selector program that predicts both highly efficient shRNAs and functional siRNAs ( ftp://ftp.ncbi.nlm.nih.gov/pub/shabalin/siRNA/si_shRNA_selector/).	[Matveeva, Olga V.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Spiridonov, Alexey N.] MIT, Dept Appl Math, Cambridge, MA 02139 USA; [Saetrom, Pal] Norwegian Univ Sci & Technol, Dept Comp & Informat Sci, N-7034 Trondheim, Norway; [Saetrom, Pal] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Nemtsov, Vladimir A.] Russian Acad Sci, MGGT, Moscow, Russia; [Nechipurenko, Yury D.] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow, Russia; [Ogurtsov, Aleksey Y.; Shabalina, Svetlana A.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	Utah System of Higher Education; University of Utah; Princeton University; Massachusetts Institute of Technology (MIT); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Russian Academy of Sciences; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Matveeva, OV (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	olga.matveeva@gmail.com; shabalin@ncbi.nlm.nih.gov	Matveeva, Olga/AAH-3851-2020; Нечипуренко, Юрий/GXF-6465-2022; Nechipurenko, Yury/AAN-9515-2020; Shabalina, Svetlana/N-8939-2013; Sætrom, Pål/AAH-1216-2019	Shabalina, Svetlana/0000-0003-2272-7473; Sætrom, Pål/0000-0001-8142-7441; Matveeva, Olga/0000-0001-8555-9847; Kang, Yibin/0000-0002-1626-6730	Department of Health and Human Services (National Institutes of Health, National Library of Medicine); Russian Foundation for Basic Research and the RAS Presidium "Molecular and cell biology''	Department of Health and Human Services (National Institutes of Health, National Library of Medicine)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Russian Foundation for Basic Research and the RAS Presidium "Molecular and cell biology''	The research was supported by the Department of Health and Human Services (National Institutes of Health, National Library of Medicine) intramural funds. YDN was supported by the Russian Foundation for Basic Research and the RAS Presidium "Molecular and cell biology''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birmingham A, 2007, NAT PROTOC, V2, P2068, DOI 10.1038/nprot.2007.278; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cullen BR, 2006, GENE THER, V13, P503, DOI 10.1038/sj.gt.3302656; Du TT, 2007, CELL RES, V17, P661, DOI 10.1038/cr.2007.67; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Futami J, 1997, DNA CELL BIOL, V16, P413, DOI 10.1089/dna.1997.16.413; Gong WM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-516; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Ichihara M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm699; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; Jia PL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-271; Jiang P, 2007, COMPUT METH PROG BIO, V87, P230, DOI 10.1016/j.cmpb.2007.06.001; Katoh T, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1120; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kondrashov AS, 2002, HUM MOL GENET, V11, P669, DOI 10.1093/hmg/11.6.669; Ladunga I, 2007, NUCLEIC ACIDS RES, V35, P433, DOI 10.1093/nar/gkl1065; Li LM, 2007, RNA, V13, P1765, DOI 10.1261/rna.599107; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, P640, DOI 10.1093/nar/gkm920; Mathews DH, 1999, RNA, V5, P1458, DOI 10.1017/S1355838299991148; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; Ogurtsov AY, 2006, BIOINFORMATICS, V22, P1317, DOI 10.1093/bioinformatics/btl083; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Saetrom P, 2004, BIOCHEM BIOPH RES CO, V321, P247, DOI 10.1016/j.bbrc.2004.06.116; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shabalina SA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-65; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Shao Y, 2007, RNA, V13, P1631, DOI 10.1261/rna.546207; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Takasaki S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S22; Taxman DJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-7; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Yiu SM, 2005, BIOINFORMATICS, V21, P144, DOI 10.1093/bioinformatics/bth498	38	25	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10180	10.1371/journal.pone.0010180	http://dx.doi.org/10.1371/journal.pone.0010180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422034	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000276854300001
J	Tsutsumi, K; Takano, T; Endo, R; Fukuda, M; Ohshima, T; Tomomura, M; Hisanaga, S				Tsutsumi, Koji; Takano, Tetsuya; Endo, Ryo; Fukuda, Mitsunori; Ohshima, Toshio; Tomomura, Mineko; Hisanaga, Shin-ichi			Phosphorylation of AATYK1 by Cdk5 Suppresses Its Tyrosine Phosphorylation	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; NEURONAL DIFFERENTIATION; SUBSTRATE-SPECIFICITY; MEMBRANE TRAFFICKING; SYNAPTIC PLASTICITY; NEURITE OUTGROWTH; BINDING-PROTEIN; MYOSIN-VI; P35; CELLS	Apoptosis-associated tyrosine kinase 1 (AATYK1), a novel serine/threonine kinase that is highly expressed in the brain, is involved in neurite extension and apoptosis of cerebellar granule neurons; however, its precise function remains unknown. In this study, we investigated the interaction of AATYK1A with Cyclin-dependent kinase 5 (Cdk5)/p35, a proline-directed protein kinase that is predominantly expressed in neurons. AATYK1A bound to the p35 activation subunit of Cdk5 in cultured cells and in mouse brains and colocalized with p35 on endosomes in COS-7 cells. AATYK1A was phosphorylated at Ser34 by Cdk5/p35 in vitro, in cultured neurons and in mouse brain. In PC12D cells, Ser34 phosphorylation increased after treatment with nerve growth factor and phosphorylated AATYK1A accumulated in growth cones of PC12D cells. Ser34 phosphorylation suppressed the tyrosine phosphorylation of AATYK1A by Src family kinases. These results suggest a possibility that AATYK1A plays a role in early to recycling endosomes and its function is regulated by phosphorylation with Cdk5 or Src-family kinases.	[Tsutsumi, Koji; Takano, Tetsuya; Endo, Ryo; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 158, Japan; [Fukuda, Mitsunori] Tohoku Univ, Dept Dev Biol & Neurosci, Sendai, Miyagi, Japan; [Ohshima, Toshio] Waseda Univ, Dept Life Sci & Med Biol Sci, Tokyo, Japan; [Tomomura, Mineko] Meikai Univ, Sch Dent, MPL, Saitama, Japan	Tokyo Metropolitan University; Tohoku University; Waseda University; Meikai University	Tsutsumi, K (corresponding author), Hamamatsu Univ, Sch Med, Dept Mol Anat,Mol Imaging Frontier Res Ctr, Higashi Ku, Shizuoka, Japan.	hisanaga-shinichi@tmu.ac.jp	Fukuda, MItsunori/I-1511-2015; Takano, Tetsuya/GMX-3535-2022	Fukuda, MItsunori/0000-0002-8620-5853; Takano, Tetsuya/0000-0002-2599-3155	Ministry of Education, Culture, Sports, and Science and Technology of Japan	Ministry of Education, Culture, Sports, and Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid from Ministry of Education, Culture, Sports, and Science and Technology of Japan (S.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada A, 2008, J NEUROCHEM, V106, P1325, DOI 10.1111/j.1471-4159.2008.05500.x; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Gaozza E, 1997, ONCOGENE, V15, P3127, DOI 10.1038/sj.onc.1201575; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hawash Ammar H., 2007, Biotechnology Journal, V2, P941, DOI 10.1002/biot.200700093; Hisanaga S, 2003, NEUROSIGNALS, V12, P221, DOI 10.1159/000074624; Honma N, 2003, BIOCHEM BIOPH RES CO, V310, P398, DOI 10.1016/j.bbrc.2003.08.143; Inoue T, 2008, GENES CELLS, V13, P483, DOI 10.1111/j.1365-2443.2008.01184.x; Jin E, 2007, NEUROCHEM INT, V51, P216, DOI 10.1016/j.neuint.2007.04.032; Kawa S, 2004, GENES CELLS, V9, P219, DOI 10.1111/j.1356-9597.2004.00714.x; Kesavapany S, 2003, J NEUROSCI, V23, P4975; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ohshima T, 2007, BRAIN RES, V1140, P84, DOI 10.1016/j.brainres.2006.01.121; Paglini G, 2001, EMBO REP, V2, P1139, DOI 10.1093/embo-reports/kve250; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Raghunath M, 2000, MOL BRAIN RES, V77, P151, DOI 10.1016/S0169-328X(00)00048-6; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; SANO M, 1988, BRAIN RES, V459, P404, DOI 10.1016/0006-8993(88)90660-9; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; Tomomura M, 2007, NEUROSCIENCE, V148, P510, DOI 10.1016/j.neuroscience.2007.05.048; Tomomura M, 2005, J BIOL CHEM, V280, P35157, DOI 10.1074/jbc.M500353200; Tomomura M, 2003, MOL BRAIN RES, V112, P103, DOI 10.1016/S0169-328X(03)00054-8; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Tsutsumi K, 2008, GENES CELLS, V13, P949, DOI 10.1111/j.1365-2443.2008.01219.x; Wang H, 2002, J BIOL CHEM, V277, P49605, DOI 10.1074/jbc.M209335200; Wang H, 2006, MOL CELL PROTEOMICS, V5, P2124, DOI 10.1074/mcp.M600188-MCP200; Yamada M, 2007, J NEUROCHEM, V102, P1477, DOI 10.1111/j.1471-4159.2007.04505.x	38	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10260	10.1371/journal.pone.0010260	http://dx.doi.org/10.1371/journal.pone.0010260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422042	gold, Green Published, Green Submitted			2022-12-25	WOS:000276854300016
J	Chen, HD; Fan, WL; Kong, SG; Lee, HC				Chen, Hong-Da; Fan, Wen-Lang; Kong, Sing-Guan; Lee, Hoong-Chien			Universal Global Imprints of Genome Growth and Evolution - Equivalent Length and Cumulative Mutation Density	PLOS ONE			English	Article							NONCODING DNA-SEQUENCES; LONG-RANGE CORRELATIONS; SEGMENTAL DUPLICATIONS; LINGUISTIC FEATURES; GENE DUPLICATION; TRANSPOSABLE ELEMENTS; PSEUDOGENES; ORGANIZATION; RECONSTRUCTION; REARRANGEMENT	Background: Segmental duplication is widely held to be an important mode of genome growth and evolution. Yet how this would affect the global structure of genomes has been little discussed. Methods/Principal Findings: Here, we show that equivalent length, or L-e, a quantity determined by the variance of fluctuating part of the distribution of the k-mer frequencies in a genome, characterizes the latter's global structure. We computed the L(e)s of 865 complete chromosomes and found that they have nearly universal but (k-dependent) values. The differences among the L-e of a chromosome and those of its coding and non-coding parts were found to be slight. Conclusions: We verified that these non-trivial results are natural consequences of a genome growth model characterized by random segmental duplication and random point mutation, but not of any model whose dominant growth mechanism is not segmental duplication. Our study also indicates that genomes have a nearly universal cumulative "point'' mutation density of about 0.73 mutations per site that is compatible with the relatively low mutation rates of ( 1 similar to 5) x 10(-3)/site/Mya previously determined by sequence comparison for the human and E. coli genomes.	[Chen, Hong-Da; Kong, Sing-Guan; Lee, Hoong-Chien] Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Chungli 32054, Taiwan; [Chen, Hong-Da; Fan, Wen-Lang; Kong, Sing-Guan; Lee, Hoong-Chien] Natl Cent Univ, Dept Phys, Chungli 32054, Taiwan; [Fan, Wen-Lang] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lee, Hoong-Chien] Cathay Gen Hosp, Cathay Med Res Inst, Taipei, Taiwan; [Lee, Hoong-Chien] Natl Ctr Theoret Sci, Shinchu, Taiwan	National Central University; National Central University; Academia Sinica - Taiwan; Cathay General Hospital	Chen, HD (corresponding author), Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Chungli 32054, Taiwan.	hclee@phy.ncu.edu.tw		Sing Guan, Kong/0000-0001-8817-781X; Chen, HongDa/0000-0002-9330-5473	National Science Council (ROC); Cathay General Hospital; National Central University	National Science Council (ROC)(Ministry of Science and Technology, Taiwan); Cathay General Hospital; National Central University	This work was funded by the National Science Council (ROC) (http://web1.nsc.gov.tw/mp.aspx?mp=7), Cathay General Hospital (http://www.cgh.org.tw/en/index.html), National Central University (http://www.ncu.edu.tw/e_web/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bapteste E, 2004, TRENDS MICROBIOL, V12, P406, DOI 10.1016/j.tim.2004.07.002; BARTEL DP, 2004, BIOGENESIS, V116, P281; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bernaola-Galvan P, 2002, GENE, V300, P105, DOI 10.1016/S0378-1119(02)01037-5; Bonhoeffer S, 1996, PHYS REV LETT, V76, P1977, DOI 10.1103/PhysRevLett.76.1977; CASTILHO BA, 1984, J BACTERIOL, V158, P488, DOI 10.1128/JB.158.2.488-495.1984; Chen HD, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.178103; Chen TY, 2005, COMPUT PHYS COMMUN, V169, P218, DOI 10.1016/j.cpc.2005.03.050; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Doolittle WF, 1997, P NATL ACAD SCI USA, V94, P12751, DOI 10.1073/pnas.94.24.12751; Drake JW, 1998, GENETICS, V148, P1667; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; FICKETT JW, 1992, GENOMICS, V13, P1056, DOI 10.1016/0888-7543(92)90019-O; FORSDYKE DR, 1995, J MOL EVOL, V41, P573; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; *GENBANK, 2009, GENB GEN DAT; Glansdorff N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-29; Grant D, 2000, P NATL ACAD SCI USA, V97, P4168, DOI 10.1073/pnas.070430597; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; HANSCHE PE, 1978, GENETICS, V88, P673; Hao BL, 2000, CHAOS SOLITON FRACT, V11, P825, DOI 10.1016/S0960-0779(98)00182-9; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; HSIEH LC, 2003, AAPPS B, V13, P22; Israeloff NE, 1996, PHYS REV LETT, V76, P1976, DOI 10.1103/PhysRevLett.76.1976; Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; KLECKNER N, 1981, ANNU REV GENET, V15, P341, DOI 10.1146/annurev.ge.15.120181.002013; Kong SG, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061911; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEVIS RW, 1993, CELL, V75, P1083, DOI 10.1016/0092-8674(93)90318-K; LEWIN B, 2000, GENES, V7, P89; Li W. H, 1997, MOL EVOLUTION; LI WH, 1981, NATURE, V292, P237, DOI 10.1038/292237a0; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; MANTEGNA RN, 1994, PHYS REV LETT, V73, P3169, DOI 10.1103/PhysRevLett.73.3169; Mantegna RN, 1996, PHYS REV LETT, V76, P1979, DOI 10.1103/PhysRevLett.76.1979; MCGRATH JM, 1993, THEOR APPL GENET, V86, P880, DOI 10.1007/BF00212616; Messer PW, 2007, J COMPUT BIOL, V14, P655, DOI 10.1089/cmb.2007.R008; Messer PW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.138103; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Nachman MW, 2000, GENETICS, V156, P297; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Ohno S., 1970, EVOLUTION GENE DUPLI; PENG CK, 1993, PHYS REV E, V47, P3730, DOI 10.1103/PhysRevE.47.3730; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Pevzner P, 2003, GENOME RES, V13, P37, DOI 10.1101/gr.757503; RUDNER R, 1968, P NATL ACAD SCI USA, V60, P921, DOI 10.1073/pnas.60.3.921; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Spring J, 2002, NAT GENET, V31, P128, DOI 10.1038/ng0602-128; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Voss RF, 1996, PHYS REV LETT, V76, P1978, DOI 10.1103/PhysRevLett.76.1978; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999; Xie HM, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P31, DOI 10.1109/CSB.2002.1039327; Yamanaka K, 1998, MOL MICROBIOL, V27, P247, DOI 10.1046/j.1365-2958.1998.00683.x; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhou FF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-546	70	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e9844	10.1371/journal.pone.0009844	http://dx.doi.org/10.1371/journal.pone.0009844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418954	Green Published, Green Submitted, gold			2022-12-25	WOS:000276706800003
J	Ravetti, MG; Rosso, OA; Berretta, R; Moscato, P				Gomez Ravetti, Martin; Rosso, Osvaldo A.; Berretta, Regina; Moscato, Pablo			Uncovering Molecular Biomarkers That Correlate Cognitive Decline with the Changes of Hippocampus' Gene Expression Profiles in Alzheimer's Disease	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; SYNAPTIC VESICLE PROTEIN; CYCLIN-DEPENDENT KINASE-5; AMYLOID PRECURSOR PROTEIN; TRANSGENIC MOUSE MODEL; PERIPHERAL BENZODIAZEPINE-RECEPTOR; IMMEDIATE-EARLY GENES; GROWTH-FACTOR-I; GLYCOGEN-SYNTHASE KINASE-3; MARIE-TOOTH-DISEASE	Background: Alzheimer's disease (AD) is characterized by a neurodegenerative progression that alters cognition. On a phenotypical level, cognition is evaluated by means of the MiniMental State Examination (MMSE) and the post-morten examination of Neurofibrillary Tangle count (NFT) helps to confirm an AD diagnostic. The MMSE evaluates different aspects of cognition including orientation, short-term memory (retention and recall), attention and language. As there is a normal cognitive decline with aging, and death is the final state on which NFT can be counted, the identification of brain gene expression biomarkers from these phenotypical measures has been elusive. Methodology/Principal Findings: We have reanalysed a microarray dataset contributed in 2004 by Blalock et al. of 31 samples corresponding to hippocampus gene expression from 22 AD subjects of varying degree of severity and 9 controls. Instead of only relying on correlations of gene expression with the associated MMSE and NFT measures, and by using modern bioinformatics methods based on information theory and combinatorial optimization, we uncovered a 1,372-probe gene expression signature that presents a high-consensus with established markers of progression in AD. The signature reveals alterations in calcium, insulin, phosphatidylinositol and wnt-signalling. Among the most correlated gene probes with AD severity we found those linked to synaptic function, neurofilament bundle assembly and neuronal plasticity. Conclusions/Significance: A transcription factors analysis of 1,372-probe signature reveals significant associations with the EGR/KROX family of proteins, MAZ, and E2F1. The gene homologous of EGR1, zif268, Egr-1 or Zenk, together with other members of the EGR family, are consolidating a key role in the neuronal plasticity in the brain. These results indicate a degree of commonality between putative genes involved in AD and prion-induced neurodegenerative processes that warrants further investigation.	[Gomez Ravetti, Martin; Rosso, Osvaldo A.; Berretta, Regina; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia; [Gomez Ravetti, Martin; Rosso, Osvaldo A.; Berretta, Regina; Moscato, Pablo] John Hunter Hosp, Informat Based Med Program, Hunter Med Res Inst, New Lambton Hts, NSW, Australia; [Gomez Ravetti, Martin; Moscato, Pablo] Ctr Excellence Bioinformat, Australian Res Council, Callaghan, NSW, Australia; [Rosso, Osvaldo A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Calculo, Buenos Aires, DF, Argentina	University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; University of Buenos Aires	Ravetti, MG (corresponding author), Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia.	pablo.moscato@newcastle.edu.au	Ravetti, Martin/K-1108-2012; Rosso, Osvaldo/O-4929-2019; MOSCATO, PABLO ALBERTO/G-7668-2013; Rosso, Osvaldo A/B-7275-2013	Ravetti, Martin/0000-0001-7781-0034; Rosso, Osvaldo/0000-0002-1288-2528; Rosso, Osvaldo A/0000-0002-1288-2528; Berretta, Regina/0000-0002-4420-3446; Moscato, Pablo/0000-0003-2570-5966	Australian Research Council (ARC) Centre for Bioinformatics, Australia; Consejo Nacional de Investigaciones Cienti-ficias y Tecnicas (CONICET), Argentina	Australian Research Council (ARC) Centre for Bioinformatics, Australia(Australian Research Council); Consejo Nacional de Investigaciones Cienti-ficias y Tecnicas (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The authors acknowledge partial support from the Australian Research Council (ARC) Centre for Bioinformatics, Australia. OAR acknowledges partial support from the Consejo Nacional de Investigaciones Cienti-ficias y Tecnicas (CONICET), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBAS T, 2009, BEHAV BRAIN RES; Abe A, 2009, J HUM GENET, V54, P94, DOI 10.1038/jhg.2008.13; Aberg K, 2006, P NATL ACAD SCI USA, V103, P7482, DOI 10.1073/pnas.0601213103; Aguado-Llera D, 2005, J NEUROCHEM, V92, P607, DOI 10.1111/j.1471-4159.2004.02889.x; Ahtiainen L, 2003, J COMP NEUROL, V455, P368, DOI 10.1002/cne.10492; Ahtiainen L, 2007, NEUROBIOL DIS, V28, P52, DOI 10.1016/j.nbd.2007.06.012; Aisa B, 2009, PSYCHONEUROENDOCRINO; Aisen PS, 2002, LANCET NEUROL, V1, P279, DOI 10.1016/S1474-4422(02)00133-3; AKIYAMA H, 1994, BRAIN RES, V639, P171, DOI 10.1016/0006-8993(94)91779-5; Alafuzoff I, 2008, BRAIN PATHOL, V18, P484, DOI 10.1111/j.1750-3639.2008.00147.x; Alder J, 2003, J NEUROSCI, V23, P10800; Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028; An L, 2009, NEUROSCI LETT, V452, P277, DOI 10.1016/j.neulet.2009.01.071; Anderton BH, 2000, MOL MED TODAY, V6, P54, DOI 10.1016/S1357-4310(99)01640-8; *AR GEN I, 2007, PATHW STUD 5 0; Aschner M, 2005, J ALZHEIMERS DIS, V8, P139; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Azim E, 2009, CEREB CORTEX, V19, pI62, DOI 10.1093/cercor/bhp030; Bachar-Dahan L, 2006, MOL BIOL CELL, V17, P2572, DOI 10.1091/mbc.E06-01-0052; Baer K, 2007, EXP NEUROL, V204, P828, DOI 10.1016/j.expneurol.2006.12.008; Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; Bailey DJ, 2005, BEHAV BRAIN RES, V162, P108, DOI 10.1016/j.bbr.2005.03.016; Bailey DJ, 2003, MOL BRAIN RES, V116, P147, DOI 10.1016/S0169-328X(03)00288-2; BAJJALIEH SM, 1993, P NATL ACAD SCI USA, V90, P2150, DOI 10.1073/pnas.90.6.2150; BAJJALIEH SM, 1994, J NEUROSCI, V14, P5223, DOI 10.1523/jneurosci.14-09-05223.1994; Bajo M, 2001, AMINO ACIDS, V21, P293, DOI 10.1007/s007260170015; Balaraman Y, 2006, CELL MOL LIFE SCI, V63, P1226, DOI 10.1007/s00018-005-5597-y; BANCHER C, 1993, NEUROSCI LETT, V162, P179, DOI 10.1016/0304-3940(93)90590-H; Banks GB, 2009, MOL CELL NEUROSCI, V40, P433, DOI 10.1016/j.mcn.2008.12.011; Bao AM, 2008, BRAIN RES REV, V57, P531, DOI 10.1016/j.brainresrev.2007.04.005; Bardoni B, 2000, CYTOGENET CELL GENET, V89, P11, DOI 10.1159/000015580; Bardoni B, 1999, HUM MOL GENET, V8, P2557, DOI 10.1093/hmg/8.13.2557; Bardoni B, 2003, EXP CELL RES, V289, P95, DOI 10.1016/S0014-4827(03)00222-2; Bataller L, 2003, ANN NEUROL, V53, P123, DOI 10.1002/ana.10434; Bauer J, 1997, Ann N Y Acad Sci, V826, P379, DOI 10.1111/j.1749-6632.1997.tb48487.x; Becker M, 2007, P NATL ACAD SCI USA, V104, P1691, DOI 10.1073/pnas.0610180104; Bellingham SA, 2009, J BIOL CHEM, V284, P1291, DOI 10.1074/jbc.M804755200; Ben-Shachar D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003676; Ben-Shachar D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000817; Bennett MR, 2008, AUST NZ J PSYCHIAT, V42, P662, DOI 10.1080/00048670802203467; Bergamaschini L, 1999, CLIN EXP IMMUNOL, V115, P526; Bernstein HG, 2009, CLIN CHEM, V55, P1041, DOI 10.1373/clinchem.2008.116970; Berretta R, 2007, J RES PRACT INF TECH, V39, P287; Berretta Regina, 2008, V453, P363, DOI 10.1007/978-1-60327-429-6_19; Beveridge NJ, 2008, HUM MOL GENET, V17, P1156, DOI 10.1093/hmg/ddn005; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bible E, 2004, NEUROBIOL DIS, V16, P346, DOI 10.1016/j.nbd.2004.02.010; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Biessels GJ, 2005, BIOCHEM SOC T, V33, P1041, DOI 10.1042/BST0331041; Biessels GJ, 2004, EUR J PHARMACOL, V490, P1, DOI 10.1016/j.ejphar.2004.02.057; BINDRA PS, 1993, GENE, V137, P299, DOI 10.1016/0378-1119(93)90024-W; Bischof HJ, 2006, REV NEUROSCIENCE, V17, P43; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blanchard J, 2008, NEUROBIOL AGING, V29, P1011, DOI 10.1016/j.neurobiolaging.2007.02.010; Blanchard J, 2009, BEHAV BRAIN RES, V201, P147, DOI 10.1016/j.bbr.2009.02.005; BLASS JP, 1994, J NEUROL SCI, V121, P132, DOI 10.1016/0022-510X(94)90341-7; BlumDegen D, 1995, J NEURAL TRANSM-SUPP, P139; Bockers TM, 2004, MOL CELL NEUROSCI, V26, P182, DOI 10.1016/j.mcn.2004.01.009; Boczan J, 2004, J BIOL CHEM, V279, P18911, DOI 10.1074/jbc.M400496200; Boeckers TM, 1999, BIOCHEM BIOPH RES CO, V264, P247, DOI 10.1006/bbrc.1999.1489; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Bogdanik L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002084; Bohm D, 2002, MOL CELL NEUROSCI, V21, P584, DOI 10.1006/mcne.2002.1199; BOISSONNEAULT V, 2009, BRAIN; Bojarski L, 2008, NEUROCHEM INT, V52, P621, DOI 10.1016/j.neuint.2007.10.002; Bonin RP, 2007, J NEUROPHYSIOL, V98, P2244, DOI 10.1152/jn.00482.2007; Bonomo SM, 2009, NEUROBIOL AGING, V30, P71, DOI 10.1016/j.neurobiolaging.2007.05.017; Boonen RACM, 2009, AGEING RES REV, V8, P71, DOI 10.1016/j.arr.2008.11.003; Bourgeron T, 2007, COLD SPRING HARB SYM, V72, P645, DOI 10.1101/sqb.2007.72.020; BOURGERON T, 2009, CURR OPIN NEUROBIOL; Bowden NA, 2006, SCHIZOPHR RES, V82, P175, DOI 10.1016/j.schres.2005.11.012; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Bozon B, 2003, PHILOS T R SOC B, V358, P805, DOI 10.1098/rstb.2002.1224; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brandstatter JH, 2004, J COMP NEUROL, V475, P551, DOI 10.1002/cne.20194; Braunewell KH, 2001, DEMENT GERIATR COGN, V12, P110, DOI 10.1159/000051244; Bresler T, 2004, J NEUROSCI, V24, P1507, DOI 10.1523/JNEUROSCI.3819-03.2004; Briand C, 2001, FEBS LETT, V505, P18, DOI 10.1016/S0014-5793(01)02764-8; Brito I, 2006, BEHAV NEUROSCI, V120, P353, DOI 10.1037/0735-7044.120.2.353; Brune S, 2003, J NEURAL TRANSM, V110, P1041, DOI 10.1007/s00702-003-0018-6; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Bulbarelli A, 2009, MOL CELL NEUROSCI, V42, P75, DOI 10.1016/j.mcn.2009.06.001; Bulchand S, 2003, DEV DYNAM, V226, P460, DOI 10.1002/dvdy.10235; Busby V, 2004, NEUROMOL MED, V5, P133, DOI 10.1385/NMM:5:2:133; Cabodi S, 2009, J CELL PHYSIOL, V218, P294, DOI 10.1002/jcp.21603; Cai C, 2008, NEUROSCIENCE, V157, P833, DOI 10.1016/j.neuroscience.2008.09.048; Cai CL, 2006, J BIOL CHEM, V281, P4267, DOI 10.1074/jbc.M505886200; Cairney CJ, 2009, BBA-MOL BASIS DIS, V1792, P353, DOI 10.1016/j.bbadis.2009.01.015; Cairns NJ, 2004, ACTA NEUROPATHOL, V108, P213, DOI 10.1007/s00401-004-0882-7; Cam JA, 2004, J BIOL CHEM, V279, P29639, DOI 10.1074/jbc.M313893200; Cam JA, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-8; Camins A, 2006, DRUG NEWS PERSPECT, V19, P453, DOI 10.1358/dnp.2006.19.8.1043961; Cao M, 2007, J NEUROSCI, V27, P12945, DOI 10.1523/JNEUROSCI.2040-07.2007; Caraiscos VB, 2004, J NEUROSCI, V24, P8454, DOI 10.1523/JNEUROSCI.2063-04.2004; Caricasole A, 2005, BIOSCIENCE REP, V25, P309, DOI 10.1007/s10540-005-2893-6; Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004; Caricasole A, 2003, TRENDS PHARMACOL SCI, V24, P233, DOI 10.1016/S0165-6147(03)00100-7; Carmon KS, 2008, BIOCHEM BIOPH RES CO, V368, P285, DOI 10.1016/j.bbrc.2008.01.088; Carrell RW, 2005, TRENDS CELL BIOL, V15, P574, DOI 10.1016/j.tcb.2005.09.005; Carro E, 2006, NEUROBIOL AGING, V27, P1618, DOI 10.1016/j.neurobiolaging.2005.09.039; Carter CJ, 2007, NEUROCHEM INT, V50, P12, DOI 10.1016/j.neuint.2006.07.007; Castri P, 2007, EUR J NEUROSCI, V26, P2469, DOI 10.1111/j.1460-9568.2007.05869.x; Cerpa W, 2008, CURR ALZHEIMER RES, V5, P233, DOI 10.2174/156720508784533321; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chang Y, 2003, J BIOL CHEM, V278, P51100, DOI 10.1074/jbc.M309561200; Chen Honghui, 2002, J Huazhong Univ Sci Technolog Med Sci, V22, P250; Chen Ming-Ling, 2008, J Biomed Sci, V15, P169, DOI 10.1007/s11373-007-9217-8; Chen S, 2008, J BIOL CHEM, V283, P10513, DOI 10.1074/jbc.M709852200; Chen W, 2004, CANCER RES, V64, P3949, DOI 10.1158/0008-5472.CAN-03-3906; Chen YM, 2009, P NATL ACAD SCI USA, V106, P3907, DOI 10.1073/pnas.0807991106; Chen YT, 2007, J BIOL CHEM, V282, P23553, DOI 10.1074/jbc.M702045200; Cheng LY, 2000, NEUROCHEM RES, V25, P107, DOI 10.1023/A:1007547701518; Cheong JK, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-8; Chiang CW, 2008, METHOD ENZYMOL, V446, P237, DOI 10.1016/S0076-6879(08)01614-5; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chohan MO, 2006, FEBS LETT, V580, P3973, DOI 10.1016/j.febslet.2006.06.021; Choi KH, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-87; Chong ZZ, 2004, HISTOL HISTOPATHOL, V19, P495, DOI 10.14670/HH-19.495; Clegg N, 2003, PROSTATE, V55, P55, DOI 10.1002/pros.10217; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; CONNOR JR, 1995, J NEUROCHEM, V65, P717; Cooper-Kuhn CM, 2002, MOL CELL NEUROSCI, V21, P312, DOI 10.1006/mcne.2002.1176; Correa SAL, 2004, NEUROPHARMACOLOGY, V47, P475, DOI 10.1016/j.neuropharm.2004.04.021; Cotta C, 2004, LECT NOTES COMPUT SC, V3005, P21; COTTA C, 2007, HDB APPROXIMATION AL; Cowburn RF, 2007, PHYSIOL BEHAV, V92, P93, DOI 10.1016/j.physbeh.2007.05.053; CREWS FT, 1992, J NEUROCHEM, V58, P1205, DOI 10.1111/j.1471-4159.1992.tb11330.x; Crowder RJ, 2000, J BIOL CHEM, V275, P34266, DOI 10.1074/jbc.M006160200; Crowther DC, 2002, HUM MUTAT, V20, P1, DOI 10.1002/humu.10100; Culbert AA, 2001, FEBS LETT, V507, P288, DOI 10.1016/S0014-5793(01)02990-8; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Dai JP, 2004, BRIT J PHARMACOL, V143, P606, DOI 10.1038/sj.bjp.0705995; Damjanac M, 2007, BRAIN RES, V1128, P40, DOI 10.1016/j.brainres.2006.05.050; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Das S, 2003, J BIOL CHEM, V278, P41221, DOI 10.1074/jbc.M304851200; Das S, 2003, MOL BRAIN RES, V116, P38, DOI 10.1016/S0169-328X(03)00212-2; Davidsson P, 1996, MOL CHEM NEUROPATHOL, V27, P195, DOI 10.1007/BF02815094; Davidsson P, 1998, Int Psychogeriatr, V10, P11, DOI 10.1017/S1041610298005110; Davis S, 2003, BEHAV BRAIN RES, V142, P17, DOI 10.1016/S0166-4328(02)00421-7; Dawson GR, 2006, J PHARMACOL EXP THER, V316, P1335, DOI 10.1124/jpet.105.092320; de Bartolomeis A, 2004, INT REV NEUROBIOL, V59, P221; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7; de Quervain DJF, 2004, HUM MOL GENET, V13, P47, DOI 10.1093/hmg/ddg361; De Strooper B, 2001, J CELL BIOL, V152, pF17, DOI 10.1083/jcb.152.4.F17; de Tullio MB, 2008, PRION, V2, P51, DOI 10.4161/pri.2.2.6710; DEGIORGIO LA, 1994, J NEUROL SCI, V124, P141, DOI 10.1016/0022-510X(94)90319-0; Deng YQ, 2008, FASEB J, V22, P138, DOI 10.1096/fj.07-8309com; Desjardins P, 1998, NEUROSCI LETT, V244, P69, DOI 10.1016/S0304-3940(98)00138-4; Desjardins S, 1997, NEUROBIOL AGING, V18, P37, DOI 10.1016/S0197-4580(96)00206-0; Deters N, 2009, BIOCHEM BIOPH RES CO, V379, P400, DOI 10.1016/j.bbrc.2008.12.140; Deutsch SI, 2006, PROG NEURO-PSYCHOPH, V30, P1369, DOI 10.1016/j.pnpbp.2006.04.007; Dhar SS, 2009, J NEUROCHEM, V108, P1595, DOI 10.1111/j.1471-4159.2009.05929.x; Dickey CA, 2004, J NEUROCHEM, V88, P434, DOI 10.1046/j.1471-4159.2003.02185.x; Dickey CA, 2003, J NEUROSCI, V23, P5219; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Dong S, 2009, P NATL ACAD SCI USA, V106, P11364, DOI 10.1073/pnas.0812998106; Dore S, 1997, P NATL ACAD SCI USA, V94, P4772, DOI 10.1073/pnas.94.9.4772; Dubois M, 2005, J NEUROSCI RES, V80, P741, DOI 10.1002/jnr.20449; Dufour A, 2000, ANN NEUROL, V47, P680; Duilio A, 1998, BIOCHEM J, V330, P513, DOI 10.1042/bj3300513; Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X; Eckert A, 1996, LIFE SCI, V59, P499, DOI 10.1016/0024-3205(96)00329-3; Eckert A, 1997, NEUROBIOL AGING, V18, P281, DOI 10.1016/S0197-4580(97)80308-9; Eda-Fujiwara H, 2003, EUR J NEUROSCI, V17, P149, DOI 10.1046/j.1460-9568.2003.02414.x; Ehlers MD, 2002, TRENDS NEUROSCI, V25, P64, DOI 10.1016/S0166-2236(02)02061-1; Ehlers MD, 1999, CURR BIOL, V9, pR848, DOI 10.1016/S0960-9822(00)80043-3; Elgh E, 2006, BIOL PSYCHIAT, V59, P155, DOI 10.1016/j.biopsych.2005.06.017; Enz R, 2003, BIOCHEM J, V372, P183, DOI 10.1042/BJ20021750; Eran A, 2009, J CLIN INVEST, V119, P679, DOI 10.1172/JCI38620; Escribano L, 2009, BIOCHEM BIOPH RES CO, V379, P406, DOI 10.1016/j.bbrc.2008.12.071; Esposito G, 2008, J CELL MOL MED, V12, P914, DOI 10.1111/j.1582-4934.2008.00159.x; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; FAIGON M, 1991, J NEUROSCI RES, V29, P490, DOI 10.1002/jnr.490290409; Falangola MF, 2007, NMR BIOMED, V20, P343, DOI 10.1002/nbm.1163; Falasca Marco, 2006, Archives of Physiology and Biochemistry, V112, P274, DOI 10.1080/13813450601094664; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Faraut B, 2003, J CELL PHYSIOL, V196, P105, DOI 10.1002/jcp.10280; Fatemi SH, 2009, CEREBELLUM, V8, P64, DOI 10.1007/s12311-008-0075-3; FAYYAD UM, 1993, P 13 INT JOINT C ART, P1022; Feng GP, 1999, J CELL BIOL, V144, P1349, DOI 10.1083/jcb.144.6.1349; Fernandez F, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-109; Fernandez M, 2007, J NEUROCHEM, V103, P190, DOI 10.1111/j.1471-4159.2007.04767.x; Ferrer I, 1998, J NEUROPATH EXP NEUR, V57, P218, DOI 10.1097/00005072-199803000-00002; Ferrero Alejandro, 2006, Vertex, V17, P165; Fiala M, 2002, EUR J CLIN INVEST, V32, P360, DOI 10.1046/j.1365-2362.2002.00994.x; Fischer AJ, 1999, NAT NEUROSCI, V2, P706, DOI 10.1038/11167; Flanagan A M, 1998, Curr Opin Hematol, V5, P181, DOI 10.1097/00062752-199805000-00006; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fortin A, 2004, J BIOL CHEM, V279, P28706, DOI 10.1074/jbc.M400376200; Fradkin LG, 2008, J NEUROSCI, V28, P5105, DOI 10.1523/JNEUROSCI.4950-07.2008; Franca-Koh J, 2002, J BIOL CHEM, V277, P43844, DOI 10.1074/jbc.M207265200; Francis SC, 2002, J BIOL CHEM, V277, P7816, DOI 10.1074/jbc.M109743200; Fraser E, 2002, J BIOL CHEM, V277, P2176, DOI 10.1074/jbc.M109462200; Freude S, 2005, DIABETES, V54, P3343, DOI 10.2337/diabetes.54.12.3343; Fritschy JM, 2003, BIOCHEM SOC T, V31, P889, DOI 10.1042/bst0310889; Frolich L, 1999, ANN NY ACAD SCI, V893, P290, DOI 10.1111/j.1749-6632.1999.tb07839.x; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Funfschilling U, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-1; Fuentealba RA, 2004, BRAIN RES REV, V47, P275, DOI 10.1016/j.brainresrev.2004.07.018; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Fukuda M, 2008, J NEUROSCI, V28, P13640, DOI 10.1523/JNEUROSCI.4023-08.2008; Funakoshi E, 2006, GENE EXPRESSION, V13, P27, DOI 10.3727/000000006783991917; Funakoshi E, 2005, GENE, V344, P259, DOI 10.1016/j.gene.2004.10.024; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Gallagher JP, 2008, EUR J PHARMACOL, V583, P215, DOI 10.1016/j.ejphar.2007.11.075; GANDY S, 1988, P NATL ACAD SCI USA, V85, P6218, DOI 10.1073/pnas.85.16.6218; Garver TD, 1996, J NEUROSCI RES, V44, P12, DOI 10.1002/(SICI)1097-4547(19960401)44:1<12::AID-JNR2>3.0.CO;2-L; Geddes JW, 1997, NEUROBIOL AGING, V18, pS99, DOI 10.1016/S0197-4580(97)00063-8; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Gerdjikov TV, 2008, NEUROBIOL LEARN MEM, V89, P87, DOI 10.1016/j.nlm.2007.06.003; Giacomello M, 2005, NEUROBIOL DIS, V18, P638, DOI 10.1016/j.nbd.2004.10.016; Gierke P, 2008, NEUROBIOL DIS, V32, P162, DOI 10.1016/j.nbd.2008.07.008; GILMORE GC, 1994, J GERONTOL, V49, pP52, DOI 10.1093/geronj/49.2.P52; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Glorioso C, 2006, MOL PSYCHIATR, V11, P633, DOI 10.1038/sj.mp.4001835; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; Go RCP, 2005, AM J MED GENET B, V139B, P28, DOI 10.1002/ajmg.b.30219; Goncalves I, 2008, BIOCHEMISTRY-US, V47, P2244, DOI 10.1021/bi7016377; Gong CX, 2003, NEUROSCI LETT, V340, P107, DOI 10.1016/S0304-3940(03)00096-X; Grabs D, 1996, EUR J NEUROSCI, V8, P162, DOI 10.1111/j.1460-9568.1996.tb01177.x; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Grilli M, 2003, FUNCT NEUROL, V18, P145; Grosse I, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041905; Grunblatt E, 2004, J NEURAL TRANSM, V111, P367, DOI 10.1007/s00702-003-0030-x; Gubern C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-57; Gulyas B, 2009, NEUROCHEM INT, V54, P28, DOI 10.1016/j.neuint.2008.10.001; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Hagen T, 2006, J BIOL CHEM, V281, P35021, DOI 10.1074/jbc.M607003200; Hahn Y, 2006, HUM GENET, V119, P169, DOI 10.1007/s00439-005-0125-6; Hamilton JA, 2002, BRAIN RES, V940, P49, DOI 10.1016/S0006-8993(02)02589-1; Hannan AJ, 2001, NAT NEUROSCI, V4, P282, DOI 10.1038/85132; Hardy RJ, 1998, J NEUROSCI RES, V54, P46, DOI 10.1002/(SICI)1097-4547(19981001)54:1<46::AID-JNR6>3.0.CO;2-H; Haroutunian V, 1999, ARCH NEUROL-CHICAGO, V56, P713, DOI 10.1001/archneur.56.6.713; Harrill JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-546; Hasegawa Y, 2000, GERONTOLOGY, V46, P185, DOI 10.1159/000022157; Hay E, 2005, J BIOL CHEM, V280, P13616, DOI 10.1074/jbc.M411999200; Hayashi T, 1998, J NEUROCHEM, V71, P356; HAYES TL, 1992, CEREB CORTEX, V2, P56, DOI 10.1093/cercor/2.1.56; Haynes LP, 2006, PROTEOMICS, V6, P1822, DOI 10.1002/pmic.200500489; Hazell AS, 2002, NEUROCHEM INT, V41, P271, DOI 10.1016/S0197-0186(02)00013-X; Heese K, 2002, MOL BRAIN RES, V104, P127, DOI 10.1016/S0169-328X(02)00326-1; Heese K, 2001, BIOCHEM BIOPH RES CO, V289, P924, DOI 10.1006/bbrc.2001.5932; Heine M, 2008, P NATL ACAD SCI USA, V105, P20947, DOI 10.1073/pnas.0804007106; Helpern JA, 2004, MAGNET RESON MED, V51, P794, DOI 10.1002/mrm.20038; Heneka MT, 2001, J NEUROPATH EXP NEUR, V60, P906, DOI 10.1093/jnen/60.9.906; Hernandez PJ, 2006, LEARN MEMORY, V13, P599, DOI 10.1101/lm.335006; Hernandez-Ortega K, 2007, J NEUROSCI RES, V85, P1744, DOI 10.1002/jnr.21301; Hino S, 2003, J BIOL CHEM, V278, P14066, DOI 10.1074/jbc.M213265200; Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003; HOLLOSI M, 1995, BIOPOLYMERS, V36, P381, DOI 10.1002/bip.360360311; HOLLOSI M, 1994, P NATL ACAD SCI USA, V91, P4902, DOI 10.1073/pnas.91.11.4902; HOLLOSI M, 1992, J MOL BIOL, V223, P673, DOI 10.1016/0022-2836(92)90983-Q; Holloway AF, 1997, FEBS LETT, V404, P41, DOI 10.1016/S0014-5793(97)00082-3; HOLLY S, 1993, BIOCHEM BIOPH RES CO, V197, P755, DOI 10.1006/bbrc.1993.2543; Hongisto V, 2003, MOL CELL BIOL, V23, P6027, DOI 10.1128/MCB.23.17.6027-6036.2003; Hongisto V, 2008, MOL CELL BIOL, V28, P1515, DOI 10.1128/MCB.02227-06; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Hou Q, 2008, P NATL ACAD SCI USA, V105, P775, DOI 10.1073/pnas.0706447105; Hourani Mou'ath, 2008, V453, P379, DOI 10.1007/978-1-60327-429-6_20; HOYER S, 1991, J NEURAL TRANSM-PARK, V3, P1, DOI 10.1007/BF02251132; HOYER S, 1994, ANN NY ACAD SCI, V719, P248, DOI 10.1111/j.1749-6632.1994.tb56833.x; HOYER S, 1987, J NEUROL, V234, P266, DOI 10.1007/BF00618265; Hoyer S, 2002, J NEURAL TRANSM, V109, P341, DOI 10.1007/s007020200028; Hoyer S, 2002, J NEURAL TRANSM, V109, P991, DOI 10.1007/s007020200082; Hoyer S, 1996, ACTA NEUROL SCAND, V93, P18; Hoyer S, 2000, ANN NY ACAD SCI, V920, P256; Hoyer S, 1998, J NEURAL TRANSM, V105, P415, DOI 10.1007/s007020050067; HOYER S, 1989, J NEURAL TRANSM, V75, P227, DOI 10.1007/BF01258634; Hoyer S, 1999, ANN NY ACAD SCI, V893, P301, DOI 10.1111/j.1749-6632.1999.tb07842.x; Hoyer S, 1994, J Neural Transm Suppl, V44, P259; Hoyer S, 1997, J NEURAL TRANSM-SUPP, P11; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Hu YY, 2002, NEUROSCI LETT, V320, P156, DOI 10.1016/S0304-3940(02)00047-2; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Huang Z, 2006, J NEUROSCI, V26, P11208, DOI 10.1523/JNEUROSCI.3526-06.2006; Hughes V, 2007, MICROBIOL-SGM, V153, P196, DOI 10.1099/mic.0.29129-0; Hunter RG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004328; Hwang JI, 2005, J BIOL CHEM, V280, P12467, DOI 10.1074/jbc.M410740200; Ihara H, 2006, BIOCHEM BIOPH RES CO, V345, P1149, DOI 10.1016/j.bbrc.2006.05.029; Illing RB, 2001, AUDIOL NEURO-OTOL, V6, P319, DOI 10.1159/000046844; Illing RB, 2002, EXP NEUROL, V175, P226, DOI 10.1006/exnr.2002.7895; Inestrosa NC, 2000, ACTA NEUROL SCAND, V102, P53, DOI 10.1034/j.1600-0404.2000.00308.x; Inestrosa NC, 2007, IUBMB LIFE, V59, P316, DOI 10.1080/15216540701242490; Inestrose Nibaldo C., 2004, Current Alzheimer Research, V1, P249, DOI 10.2174/1567205043332063; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Irie Y, 2001, BIOCHEM BIOPH RES CO, V282, P416, DOI 10.1006/bbrc.2001.4594; Ito S, 2005, FEBS LETT, V579, P1995, DOI 10.1016/j.febslet.2005.02.048; Jacobson C, 2004, P NATL ACAD SCI USA, V101, P12218, DOI 10.1073/pnas.0404240101; Jaeger S, 2008, CURR ALZHEIMER RES, V5, P15; Jafferali S, 2000, SYNAPSE, V38, P450, DOI 10.1002/1098-2396(20001215)38:4<450::AID-SYN10>3.0.CO;2-J; James AB, 2006, J NEUROSCI, V26, P1624, DOI 10.1523/JNEUROSCI.4199-05.2006; James AB, 2005, J NEUROCHEM, V95, P796, DOI 10.1111/j.1471-4159.2005.03400.x; Janz R, 1999, NEUROSCIENCE, V94, P1279, DOI 10.1016/S0306-4522(99)00370-X; Janz R, 1998, J NEUROSCI, V18, P9269; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Jaworski A, 2006, J NEUROSCI, V26, P655, DOI 10.1523/JNEUROSCI.4506-05.2006; Jenkins TA, 2006, NEUROSCIENCE, V137, P747, DOI 10.1016/j.neuroscience.2005.09.034; Ji BH, 2009, J PROTEOME RES, V8, P3633, DOI 10.1021/pr800876z; Ji B, 2008, J NEUROSCI, V28, P12255, DOI 10.1523/JNEUROSCI.2312-08.2008; Jing H, 2008, LIFE SCI, V82, P1137, DOI 10.1016/j.lfs.2008.03.022; Johansson S, 2007, BRAIN RES, V1132, P20, DOI 10.1016/j.brainres.2006.11.026; Jolivalt CG, 2008, J NEUROSCI RES, V86, P3265, DOI 10.1002/jnr.21787; Jordan-Sciutto K, 2001, MECH AGEING DEV, V123, P11, DOI 10.1016/S0047-6374(01)00334-7; Jordan-Sciutto KL, 2002, J NEUROSCI, V22, P2185, DOI 10.1523/JNEUROSCI.22-06-02185.2002; Jordan-Sciutto KL, 2002, J NEUROPATH EXP NEUR, V61, P358, DOI 10.1093/jnen/61.4.358; Jordan-Sciutto KL, 2001, EXP NEUROL, V167, P205, DOI 10.1006/exnr.2000.7594; Jordan-Sciutto KL, 2000, BIOCHEMISTRY-US, V39, P3206, DOI 10.1021/bi992211q; Jordan-Sciutto KL, 2000, AM J PATHOL, V157, P497, DOI 10.1016/S0002-9440(10)64561-0; Jordanova A, 2003, BRAIN, V126, P590, DOI 10.1093/brain/awg059; Julien JP, 1998, PROG NUCLEIC ACID RE, V61, P1, DOI 10.1016/S0079-6603(08)60823-5; Kaku M, 2003, BRAIN RES PROTOC, V12, P104, DOI 10.1016/j.brainresprot.2003.09.001; Kallur T, 2008, MOL CELL NEUROSCI, V38, P616, DOI 10.1016/j.mcn.2008.05.010; Kalviainen R, 2007, EUR J NEUROL, V14, P369, DOI 10.1111/j.1468-1331.2007.01668.x; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; KARNIGUIAN A, 1993, P NATL ACAD SCI USA, V90, P7647, DOI 10.1073/pnas.90.16.7647; Kashani AH, 2006, J NEUROSCI, V26, P8398, DOI 10.1523/JNEUROSCI.0618-06.2006; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Katoh M, 2007, STEM CELL REV, V3, P30, DOI 10.1007/s12015-007-0006-6; KAWAMATA T, 1993, AM J PATHOL, V142, P1574; Kawata T, 2005, J INT MED RES, V33, P654, DOI 10.1177/147323000503300607; Kelberman D, 2008, J CLIN ENDOCR METAB, V93, P1865, DOI 10.1210/jc.2007-2337; KERI S, 2009, SCHIZOPHR B; KERI S, 2009, NEUROCHEM INT; Kerr F, 2006, FEBS LETT, V580, P3121, DOI 10.1016/j.febslet.2006.04.064; Kesavapany S, 2003, NEUROSIGNALS, V12, P252, DOI 10.1159/000074627; Kielar C, 2007, NEUROBIOL DIS, V25, P150, DOI 10.1016/j.nbd.2006.09.001; Killick R, 2001, J BIOL CHEM, V276, P48554, DOI 10.1074/jbc.M108332200; Killick R, 2009, BIOCHEM BIOPH RES CO, V386, P257, DOI 10.1016/j.bbrc.2009.06.032; Kim AH, 2008, CELL CYCLE, V7, P3819, DOI 10.4161/cc.7.24.7215; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Kim SJ, 2008, J CLIN INVEST, V118, P3075, DOI 10.1172/JCI33482; Kinghorn KJ, 2006, J BIOL CHEM, V281, P29268, DOI 10.1074/jbc.M600690200; KIRCHER T, 2009, HUM BRAIN MAPP; Kircher T, 2009, EUR ARCH PSY CLIN N, V259, P72, DOI 10.1007/s00406-008-0837-4; Kirikoshi H, 2002, INT J ONCOL, V21, P895; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kittur S, 1994, J Geriatr Psychiatry Neurol, V7, P153; Klemmer P, 2009, J PROTEOMICS, V72, P82, DOI 10.1016/j.jprot.2008.10.005; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Kobayashi K, 1998, DEMENT GERIATR COGN, V9, P13, DOI 10.1159/000017015; Kobayashi K, 2004, J ALZHEIMERS DIS, V6, P623; Kobayashi K, 2002, NEUROPATH APPL NEURO, V28, P238, DOI 10.1046/j.1365-2990.2002.00390.x; Kondo Y, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-31; Kong Qing-li, 2002, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V24, P298; Konishi Y, 2003, J NEUROSCI, V23, P1649; Konno D, 2002, J CELL SCI, V115, P4695, DOI 10.1242/jcs.00127; Korostynski M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r128; Korzus E, 2003, ACTA BIOCHIM POL, V50, P775; Koslowski MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004496; Kreienkamp HJ, 2002, BIOCHEM SOC T, V30, P464, DOI 10.1042/bst0300464; Kreienkamp HJ, 2000, J PHYSIOLOGY-PARIS, V94, P193, DOI 10.1016/S0928-4257(00)00204-7; KSIEZAKREDING H, 1987, J NEUROCHEM, V48, P455, DOI 10.1111/j.1471-4159.1987.tb04114.x; Kumar AP, 2004, J BIOL CHEM, V279, P8300, DOI 10.1074/jbc.M311625200; Kumar RA, 2009, CURR NEUROL NEUROSCI, V9, P188, DOI 10.1007/s11910-009-0029-2; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lahiri DK, 2003, ANN NY ACAD SCI, V1010, P639, DOI 10.1196/annals.1299.117; Lam BYH, 2009, J BIOL CHEM, V284, P12562, DOI 10.1074/jbc.M901121200; Lambeng N, 2006, NEUROSCI LETT, V398, P107, DOI 10.1016/j.neulet.2005.12.059; Landfield PW, 2007, CURR ALZHEIMER RES, V4, P205, DOI 10.2174/156720507780362083; Lao GF, 2000, NEURON, V25, P191, DOI 10.1016/S0896-6273(00)80882-X; Laquintana V, 2007, BIOCONJUGATE CHEM, V18, P1397, DOI 10.1021/bc060393c; Laterza OF, 2006, CLIN CHEM, V52, P1713, DOI 10.1373/clinchem.2006.070912; Laughton JD, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-35; Lauriat TL, 2008, J NEUROSCI RES, V86, P785, DOI 10.1002/jnr.21534; Lautermilch NJ, 2005, J NEUROSCI, V25, P7062, DOI 10.1523/JNEUROSCI.0447-05.2005; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Lazzell DR, 2004, J BIOL CHEM, V279, P52124, DOI 10.1074/jbc.M407502200; Le Strat Y, 2009, CURR MOL MED, V9, P506; Le-Niculescu H, 2007, AM J MED GENET B, V144B, P129, DOI 10.1002/ajmg.b.30481; Lee EO, 2004, J NEUROIMMUNOL, V155, P21, DOI 10.1016/j.jneuroim.2004.05.012; Lee HK, 2009, MOL BIOL CELL, V20, P1533, DOI 10.1091/mbc.E08-07-0777; Lee JM, 2008, CLIN CHEM, V54, P1617, DOI 10.1373/clinchem.2008.104497; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee MS, 2003, J ALZHEIMERS DIS, V5, P127, DOI 10.3233/JAD-2003-5207; LEE MY, 2009, STEM CELLS; LEE SC, 1994, GLIA, V12, P309, DOI 10.1002/glia.440120407; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P1998, DOI 10.1073/pnas.85.6.1998; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Lepourcelet M, 2002, J BIOL CHEM, V277, P47732, DOI 10.1074/jbc.M208154200; Levers TE, 2001, J NEUROBIOL, V48, P265, DOI 10.1002/neu.1056; LEVEUGLE B, 1994, BRAIN RES, V650, P20, DOI 10.1016/0006-8993(94)90202-X; Levine S, 2009, EXP MOL PATHOL, V86, P18, DOI 10.1016/j.yexmp.2008.10.006; Lezzi M, 2005, J CELL SCI, V118, P5647, DOI 10.1242/jcs.02658; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Li CM, 2009, J BIOL CHEM, V284, P2472, DOI 10.1074/jbc.M806513200; Li DB, 2008, HIPPOCAMPUS, V18, P692, DOI 10.1002/hipo.20428; Li L, 2007, BRAIN RES REV, V56, P384, DOI 10.1016/j.brainresrev.2007.09.001; Li L, 2007, MOL CELL NEUROSCI, V35, P76, DOI 10.1016/j.mcn.2007.02.004; Li M, 2004, J NEUROCHEM, V91, P623, DOI 10.1111/j.1471-4159.2004.02765.x; Li SP, 2004, J PINEAL RES, V36, P186, DOI 10.1111/j.1600-079X.2004.00116.x; Lian QY, 2001, EXP NEUROL, V167, P158, DOI 10.1006/exnr.2000.7534; Liang ZH, 2008, J ALZHEIMERS DIS, V13, P295; Lillo C, 2006, ADV EXP MED BIOL, V572, P341; Lim ACB, 2003, J ALZHEIMERS DIS, V5, P329, DOI 10.3233/JAD-2003-5409; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Linker C, 2004, DEVELOPMENT, V131, P5671, DOI 10.1242/dev.01445; Litosch I, 2002, IUBMB LIFE, V54, P253, DOI 10.1080/15216540215673; Liu C, 2008, J NEUROSCI, V28, P5641, DOI 10.1523/JNEUROSCI.1056-08.2008; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu R, 2008, J CELL MOL MED, V12, P241, DOI 10.1111/j.1582-4934.2008.00249.x; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Liu Y, 2007, BIOCHEM BIOPH RES CO, V354, P505, DOI 10.1016/j.bbrc.2007.01.009; LLEDO PM, 1993, NATURE, V364, P540, DOI 10.1038/364540a0; LLEDO PM, 1993, CR SOC BIOL, V187, P726; Lockhart ST, 2000, J NEUROBIOL, V42, P460, DOI 10.1002/(SICI)1097-4695(200003)42:4<460::AID-NEU7>3.3.CO;2-R; Lopes JP, 2007, CELL MOL NEUROBIOL, V27, P943, DOI 10.1007/s10571-007-9224-3; Lopez-Bendito G, 2002, EUR J NEUROSCI, V15, P1766, DOI 10.1046/j.1460-9568.2002.02032.x; Lowe XR, 2007, BRAIN RES, V1174, P7, DOI 10.1016/j.brainres.2007.07.039; Lu Y, 2007, NUCLEIC ACIDS RES, V35, pW105, DOI 10.1093/nar/gkm408; Lue LF, 2001, NEUROBIOL AGING, V22, P945, DOI 10.1016/S0197-4580(01)00311-6; Lue LF, 2001, GLIA, V35, P72, DOI 10.1002/glia.1072; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Lukas J, 2009, NUCLEIC ACIDS RES, V37, P3007, DOI 10.1093/nar/gkp179; Lukiw WJ, 2007, J INORG BIOCHEM, V101, P1265, DOI 10.1016/j.jinorgbio.2007.06.004; Lus G, 2003, NEUROLOGY, V61, P988, DOI 10.1212/WNL.61.7.988; Lyly A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-22; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Macauley SL, 2009, EXP NEUROL, V217, P124, DOI 10.1016/j.expneurol.2009.01.022; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1518, DOI 10.1046/j.1432-1327.2001.02024.x; MacDonald AW, 2006, DEV PSYCHOPATHOL, V18, P853, DOI 10.1017/S0954579406060421; MacGibbon GA, 1997, EXP NEUROL, V147, P316, DOI 10.1006/exnr.1997.6600; MacManus JP, 2003, J CEREBR BLOOD F MET, V23, P1020, DOI 10.1097/01.WCB.0000084249.20114.FA; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; Madison DL, 1996, J NEUROSCI RES, V45, P258; Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200; Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046; Maiese K, 2007, CURR MED CHEM, V14, P1729; Majumdar A, 2007, MOL BIOL CELL, V18, P1490, DOI 10.1091/mbc.E06-10-0975; Malaterre J, 2008, STEM CELLS, V26, P173, DOI 10.1634/stemcells.2007-0293; Malm TM, 2008, GLIA, V56, P1767, DOI 10.1002/glia.20726; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Marchand S, 2001, EUR J NEUROSCI, V13, P221, DOI 10.1046/j.1460-9568.2001.01373.x; Marsagishvili LG, 2005, BIOFIZIKA+, V50, P803; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; Masumoto N, 1998, J EXP ZOOL, V280, P91, DOI 10.1002/(SICI)1097-010X(19980101)280:1&lt;91::AID-JEZ11&gt;3.0.CO;2-Z; Mata I, 2009, BIOL PSYCHIAT, V65, P535, DOI 10.1016/j.biopsych.2008.10.020; MATEO I, 2008, ACTA NEUROL SCAND; Matsuno A, 2003, MICROSC RES TECHNIQ, V62, P232, DOI 10.1002/jemt.10364; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Mauceri D, 2007, J NEUROCHEM, V100, P1032, DOI 10.1111/j.1471-4159.2006.04267.x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; Mead AN, 2006, BEHAV NEUROSCI, V120, P241, DOI 10.1037/0735-7044.120.2.241; Mead AN, 2003, J NEUROSCI, V23, P9500; Medvedev NI, 2008, EUR J NEUROSCI, V27, P315, DOI 10.1111/j.1460-9568.2007.06005.x; MELLO C, 1995, J NEUROSCI, V15, P6919; Mello CV, 1998, J COMP NEUROL, V393, P426, DOI 10.1002/(SICI)1096-9861(19980420)393:4<426::AID-CNE3>3.0.CO;2-2; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1995, J NEUROBIOL, V26, P145, DOI 10.1002/neu.480260112; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Mendes Alexandre, 2008, V141, P131; Mercado-Gomez O, 2008, NEUROCHEM RES, V33, P1599, DOI 10.1007/s11064-008-9714-9; Merlos-Suarez A, 2001, J BIOL CHEM, V276, P48510, DOI 10.1074/jbc.M103488200; Meske V, 2008, J BIOL CHEM, V283, P100, DOI 10.1074/jbc.M704292200; Migues PV, 2007, DEV NEUROSCI-BASEL, V29, P232, DOI 10.1159/000096408; MILLER CCJ, 1986, EMBO J, V5, P269, DOI 10.1002/j.1460-2075.1986.tb04209.x; Minatel E, 2003, MUSCLE NERVE, V28, P561, DOI 10.1002/mus.10416; Mitrasinovic OM, 2005, J NEUROSCI, V25, P4442, DOI 10.1523/JNEUROSCI.0514-05.2005; Mitrasinovic OM, 2004, J NEUROSCI RES, V77, P420, DOI 10.1002/jnr.20168; Mitrasinovic OM, 2003, NEUROBIOL AGING, V24, P807, DOI 10.1016/S0197-4580(02)00237-3; Mitrasinovic OM, 2003, NEUROSCI LETT, V344, P185, DOI 10.1016/S0304-3940(03)00474-9; Mitrasinovic OM, 2001, J BIOL CHEM, V276, P30142, DOI 10.1074/jbc.M104265200; Miyajima N, 2009, BIOCHEM BIOPH RES CO, V381, P383, DOI 10.1016/j.bbrc.2009.02.059; Monaco EA, 2004, CURR ALZHEIMER RES, V1, P33, DOI 10.2174/1567205043480519; Moncini S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-111; MONROIG O, 2009, BIOCH BIOPHYS ACTA; Moreira PI, 2007, J NEUROL SCI, V257, P206, DOI 10.1016/j.jns.2007.01.017; Morgan C, 2004, PROG NEUROBIOL, V74, P323, DOI 10.1016/j.pneurobio.2004.10.004; Morgans CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005230; Mori M, 2007, EXP ANIM TOKYO, V56, P93, DOI 10.1538/expanim.56.93; Morozova N, 2007, GENES CELLS, V12, P561, DOI 10.1111/j.1365-2443.2007.01074.x; Morris BJ, 2005, J HYPERTENS, V23, P1285, DOI 10.1097/01.hjh.0000173509.45363.dd; Moscato P, 2007, BIOSYSTEMS, V88, P56, DOI 10.1016/j.biosystems.2006.04.005; Motonaga K, 2001, BRAIN RES, V905, P250, DOI 10.1016/S0006-8993(01)02535-5; Munch G, 2003, BIOCHEM SOC T, V31, P1397; Murphy GM, 2000, AM J PATHOL, V157, P895, DOI 10.1016/S0002-9440(10)64603-2; Murray KD, 2008, J NEUROSCI, V28, P12010, DOI 10.1523/JNEUROSCI.3800-08.2008; Murray KD, 2007, P NATL ACAD SCI USA, V104, P1989, DOI 10.1073/pnas.0610742104; Nacher J, 2005, J NEUROSCI RES, V81, P753, DOI 10.1002/jnr.20596; Nakagawa K, 2006, J NEUROCHEM, V96, P924, DOI 10.1111/j.1471-4159.2005.03595.x; Nakagawa Masanori, 2004, Rinsho Shinkeigaku, V44, P991; Nakatani N, 2006, HUM MOL GENET, V15, P1949, DOI 10.1093/hmg/ddl118; Nash JE, 2005, FASEB J, V19, P583, DOI 10.1096/fj.04-1854fje; Nazwar TA, 2009, J NEUROSCI RES, V87, P1532, DOI 10.1002/jnr.21989; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Neiva TJC, 1997, BRAZ J MED BIOL RES, V30, P599, DOI 10.1590/S0100-879X1997000500005; Yan SD, 1997, P NATL ACAD SCI USA, V94, P5296, DOI 10.1073/pnas.94.10.5296; Gomez Ravetti M., 2009, FDN COMPUTATIONAL IN, V5, P149; Nelson TJ, 2005, BIOCHEM SOC T, V33, P1033, DOI 10.1042/BST0331033; Nielsen HM, 2007, NEUROLOGY, V69, P1569, DOI 10.1212/01.wnl.0000271077.82508.a0; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Nikitin V P, 2007, Neurosci Behav Physiol, V37, P607, DOI 10.1007/s11055-007-0059-7; Nikitin V P, 2007, Neurosci Behav Physiol, V37, P559, DOI 10.1007/s11055-007-0053-0; Nikolic Z, 1998, J BIOL CHEM, V273, P19708, DOI 10.1074/jbc.273.31.19708; Nishimura H, 2003, J NEUROCHEM, V85, P1216, DOI 10.1046/j.1471-4159.2003.01760.x; Nishioka H, 2005, ACTA NEUROPATHOL, V109, P598, DOI 10.1007/s00401-005-1008-6; Norris CM, 2005, J NEUROSCI, V25, P4649, DOI 10.1523/JNEUROSCI.0365-05.2005; Nowak K, 2007, BBA-GENE STRUCT EXPR, V1769, P244, DOI 10.1016/j.bbaexp.2007.04.001; Nowotny P, 2007, NEUROSCI LETT, V419, P15, DOI 10.1016/j.neulet.2007.03.071; Nussbaum J, 2008, HUM MOL GENET, V17, P1569, DOI 10.1093/hmg/ddn044; Ogasawara H, 2008, NEUROSIGNALS, V16, P300, DOI 10.1159/000123040; Okada M, 2004, HIPPOCAMPUS, V14, P337, DOI 10.1002/hipo.10185; Okamoto PM, 2001, J BIOL CHEM, V276, P48458, DOI 10.1074/jbc.M104927200; Ongwijitwat S, 2004, GENE, V337, P163, DOI 10.1016/j.gene.2004.04.024; Opii W, 2008, NEUROBIOL AGING, V29, P51, DOI 10.1016/j.neurobiolaging.2006.09.012; Orellana DI, 2007, BBA-MOL CELL RES, V1773, P254, DOI 10.1016/j.bbamcr.2006.10.010; Owen MJ, 2009, CURR OPIN GENET DEV, V19, P266, DOI 10.1016/j.gde.2009.02.008; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Pankonin MS, 2009, BRAIN RES, V1258, P1, DOI 10.1016/j.brainres.2008.12.047; Papadopoulos V, 2006, NEUROSCIENCE, V138, P749, DOI 10.1016/j.neuroscience.2005.05.063; Parent A, 1999, NEUROBIOL DIS, V6, P56, DOI 10.1006/nbdi.1998.0207; Parisiadou L, 2008, NEUROBIOL DIS, V30, P353, DOI 10.1016/j.nbd.2008.02.004; Park E, 2003, J BIOL CHEM, V278, P19220, DOI 10.1074/jbc.M301052200; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pedersen WA, 2001, NEUROBIOL DIS, V8, P492, DOI 10.1006/nbdi.2001.0395; Pedrosa E, 2009, NEUROPSYCHOBIOLOGY, V59, P205, DOI 10.1159/000223732; Peers C, 2004, BIOL CHEM, V385, P285, DOI 10.1515/BC.2004.023; Perez SE, 2009, INVEST OPHTH VIS SCI, V50, P793, DOI 10.1167/iovs.08-2384; Perlis RH, 2009, AM J PSYCHIAT, V166, P718, DOI 10.1176/appi.ajp.2009.08111633; Pfenning AR, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-20; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Poduslo SE, 2010, AM J MED GENET B, V153B, P114, DOI 10.1002/ajmg.b.30963; Poirier GL, 2008, J NEUROSCI, V28, P1034, DOI 10.1523/JNEUROSCI.4607-07.2008; Poirier R, 2008, FRONT NEUROSCI-SWITZ, V2, P47, DOI 10.3389/neuro.01.002.2008; Poirier R, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08/006.2007, 10.3389/neuro.08.006.2007]; Pollak D, 2003, J NEURAL TRANSM-SUPP, P149; Polleri A, 2002, J ENDOCRINOL INVEST, V25, P73, DOI 10.1007/BF03343964; Polter A, 2009, BIOL PSYCHIAT, V65, P150, DOI 10.1016/j.biopsych.2008.08.005; Poona HF, 2005, NEUROCHEM INT, V46, P159, DOI 10.1016/j.neuint.2004.07.008; Prata DP, 2009, PSYCHIAT GENET, V19, P113, DOI 10.1097/YPG.0b013e32832a4f69; Preece P, 2003, MOL BRAIN RES, V118, P60, DOI 10.1016/S0169-328X(03)00337-1; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; PRICE JL, 1993, NEUROBIOL AGING, V14, P661, DOI 10.1016/0197-4580(93)90062-G; Puglielli L, 2008, NEUROBIOL AGING, V29, P795, DOI 10.1016/j.neurobiolaging.2007.01.010; Putzer Brigitte M, 2006, Discov Med, V6, P123; Qiao X, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-95; Qin WP, 2008, ANN NY ACAD SCI, V1147, P335, DOI 10.1196/annals.1427.024; Qualmann B, 2004, J NEUROSCI, V24, P2481, DOI 10.1523/JNEUROSCI.5479-03.2004; Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002; Rademakers R, 2005, NEUROBIOL AGING, V26, P1145, DOI 10.1016/j.neurobiolaging.2004.10.003; Rahman A, 2006, J NEURAL TRANSM, V113, P219, DOI 10.1007/s00702-005-0313-5; Rahman A, 2005, NEUROCHEM RES, V30, P277, DOI 10.1007/s11064-005-2483-9; Ramadan H, 2007, NEUROLOGY, V68, P387, DOI 10.1212/01.wnl.0000252825.85947.2f; Ramanathan Subhadra, 2004, BMC Med Genet, V5, P10, DOI 10.1186/1471-2350-5-10; Rametti A, 2004, J BIOL CHEM, V279, P54518, DOI 10.1074/jbc.M408186200; Ranganathan S, 2003, AM J PATHOL, V162, P823, DOI 10.1016/S0002-9440(10)63879-5; Rasmuson S, 2001, BIOL PSYCHIAT, V49, P547, DOI 10.1016/S0006-3223(00)01015-5; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; RAY A, 2009, FEBS J; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reddy PH, 2005, J ALZHEIMERS DIS, V7, P103, DOI 10.3233/jad-2005-7203; REDECKER P, 1995, NEUROENDOCRINOLOGY, V62, P101, DOI 10.1159/000126994; Reimers K, 2006, INT J MOL MED, V18, P729; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; Reinhard S, 2009, NEUROCHEM RES, V34, P17, DOI 10.1007/s11064-008-9732-7; Renaudineau S, 2009, P NATL ACAD SCI USA, V106, P11771, DOI 10.1073/pnas.0900484106; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; Reynolds WF, 1999, EXP NEUROL, V155, P31, DOI 10.1006/exnr.1998.6977; Rhein Virginie, 2007, Archives of Physiology and Biochemistry, V113, P131, DOI 10.1080/13813450701572288; Ribeiro S, 1998, NEURON, V21, P359, DOI 10.1016/S0896-6273(00)80545-0; Richarz AN, 2002, ANAL BIOANAL CHEM, V372, P412, DOI 10.1007/s00216-001-1187-5; ROBBINS K, 2006, ONLINE J BIOINFORMAT, V7, P9; Roberts JC, 2009, EXP NEUROL, V216, P459, DOI 10.1016/j.expneurol.2009.01.002; RODER HM, 1991, J NEUROSCI, V11, P3325; Romcy-Pereira RN, 2009, PHYSIOL BEHAV, V98, P44, DOI 10.1016/j.physbeh.2009.04.010; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Rosso OA, 2009, J NEUROSCI METH, V181, P257, DOI 10.1016/j.jneumeth.2009.04.028; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Ruzov A, 2009, DEVELOPMENT, V136, P723, DOI 10.1242/dev.025577; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; SADAKATA T, 2009, CEREBELLUM; Sadakata T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-25; Sadakata T, 2007, J CLIN INVEST, V117, P931, DOI 10.1172/JCI29031; Sadakata T, 2007, J NEUROSCI, V27, P2472, DOI 10.1523/JNEUROSCI.2279-06.2007; Sadakata T, 2007, J HISTOCHEM CYTOCHEM, V55, P301, DOI 10.1369/jhc.6A7033.2006; Sadowski M, 2004, J NEUROPATH EXP NEUR, V63, P418, DOI 10.1093/jnen/63.5.418; Sahara N, 2004, J NEUROCHEM, V90, P829, DOI 10.1111/j.1471-4159.2004.02558.x; Saitoh T, 2001, BIOCHEM BIOPH RES CO, V281, P815, DOI 10.1006/bbrc.2001.4421; Sajan Farrah D, 2007, Am J Alzheimers Dis Other Demen, V22, P319, DOI 10.1177/1533317507302447; Sakae N, 2008, HUM MOL GENET, V17, P3191, DOI 10.1093/hmg/ddn215; Salkovic-Petrisic M, 2007, J NEURAL TRANSM-SUPP, P217; Salkovic-Petrisic M, 2006, J NEUROCHEM, V96, P1005, DOI 10.1111/j.1471-4159.2005.03637.x; Samarin J, 2009, J CELL COMMUN SIGNAL, V3, P79, DOI 10.1007/s12079-009-0055-5; Sambamurti K, 1999, J BIOL CHEM, V274, P26810, DOI 10.1074/jbc.274.38.26810; SANDEEP J, 2008, SILICO BIOL, V8, P9; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Santos ARA, 2008, J NEUROSCI RES, V86, P3684, DOI 10.1002/jnr.21796; Sasaki T, 2006, BRAIN RES, V1108, P98, DOI 10.1016/j.brainres.2006.06.009; Sato J, 2008, J NEURAL TRANSM, V115, P1355, DOI 10.1007/s00702-008-0085-9; Sato S, 2008, J NEUROSCI, V28, P14511, DOI 10.1523/JNEUROSCI.3417-08.2008; Save MP, 2004, NEUROPATH APPL NEURO, V30, P635, DOI 10.1111/j.1365-2990.2004.00578.x; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; SCHIJNDEL JE, 2009, J PSYCHIAT RES; Schinner S, 2009, HORM METAB RES, V41, P159, DOI 10.1055/s-0028-1119408; Schivell AE, 2005, MOL CELL NEUROSCI, V29, P56, DOI 10.1016/j.mcn.2004.12.011; Schivell AE, 1996, J BIOL CHEM, V271, P27770, DOI 10.1074/jbc.271.44.27770; Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; SCHMIDT ML, 1989, LAB INVEST, V60, P513; SCHMIDT ML, 1991, LAB INVEST, V64, P352; Schmitt FA, 2001, GERONTOLOGIST, V41, P716, DOI 10.1093/geront/41.6.716; Schmitt FA, 2000, NEUROLOGY, V55, P370, DOI 10.1212/WNL.55.3.370; Schnurra I, 2001, NEUROBIOL DIS, V8, P900, DOI 10.1006/nbdi.2001.0432; Schubert P, 1998, J NEURAL TRANSM-SUPP, P167; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; SCRANTON TW, 1993, J NEUROCHEM, V61, P29, DOI 10.1111/j.1471-4159.1993.tb03535.x; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; SHEN Y, 1995, BRAIN RES, V671, P282, DOI 10.1016/0006-8993(94)01264-I; SHEN ZM, 1994, BIOCHEMISTRY-US, V33, P9627, DOI 10.1021/bi00198a031; Sheng M, 2000, J CELL SCI, V113, P1851; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Shibata Noriyuki, 2008, Brain and Nerve (Tokyo), V60, P157; Shimizu T, 2004, BEHAV NEUROSCI, V118, P845, DOI 10.1037/0735-7044.118.4.845; SHIMOHAMA S, 1995, ALZ DIS ASSOC DIS, V9, P15, DOI 10.1097/00002093-199501002-00004; Shimohama S, 1997, BIOCHEM BIOPH RES CO, V236, P239, DOI 10.1006/bbrc.1997.6940; Shin OH, 2005, J BIOL CHEM, V280, P1641, DOI 10.1074/jbc.M407305200; Sidhu RS, 2001, BIOCHEM BIOPH RES CO, V289, P1039, DOI 10.1006/bbrc.2001.6113; Sim KG, 2006, CELL CYCLE, V5, P1111, DOI 10.4161/cc.5.10.2797; Small D H, 2000, IDrugs, V3, P740; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; SO HC, 2009, AM J MED GENET B; SOMERVILLE MJ, 1991, MOL BRAIN RES, V9, P1, DOI 10.1016/0169-328X(91)90123-F; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; Sons MS, 2006, BRAIN RES, V1089, P126, DOI 10.1016/j.brainres.2006.03.055; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P287, DOI 10.1093/jnen/63.4.287; Sorensen G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-114; Sotiropoulos I, 2008, NEUROSCI BIOBEHAV R, V32, P1161, DOI 10.1016/j.neubiorev.2008.05.007; Soule Jonathan, 2008, Neural Plasticity, V2008, P269097, DOI 10.1155/2008/269097; Spires TL, 2005, CEREB CORTEX, V15, P385, DOI 10.1093/cercor/bhh141; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; STETTLER O, 1995, EUR J NEUROSCI, V7, P702, DOI 10.1111/j.1460-9568.1995.tb00674.x; Steventon B, 2009, DEVELOPMENT, V136, P771, DOI 10.1242/dev.029017; Strachan GD, 2005, J CELL BIOCHEM, V96, P728, DOI 10.1002/jcb.20574; Strachan GD, 2005, EXP NEUROL, V193, P455, DOI 10.1016/j.expneurol.2004.08.038; Straessle A, 2003, EUR J NEUROSCI, V18, P2213, DOI 10.1046/j.1460-9568.2003.02964.x; Strosznajder JB, 1999, J MOL NEUROSCI, V12, P101, DOI 10.1007/BF02736924; Surena AL, 2009, BBA-MOL CELL RES, V1793, P264, DOI 10.1016/j.bbamcr.2008.09.005; Tabares-Seisdedos R, 2009, MOL PSYCHIATR, V14, P563, DOI 10.1038/mp.2009.2; Tabira Takeshi, 2003, Rinsho Shinkeigaku, V43, P775; Tajes M, 2009, MECH AGEING DEV, V130, P253, DOI 10.1016/j.mad.2008.12.006; TAKAHATA T, 2009, P NATL ACAD SCI US; Takashima Hiroshi, 2006, Rinsho Shinkeigaku, V46, P1; Takemoto-Kimura S, 2003, J BIOL CHEM, V278, P18597, DOI 10.1074/jbc.M300578200; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Tamayev R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-28; Tanahashi H, 1999, NEUROSCI LETT, V261, P143, DOI 10.1016/S0304-3940(98)00995-1; Tanahashi H, 1999, BIOCHEM BIOPH RES CO, V258, P385, DOI 10.1006/bbrc.1999.0639; Tanahashi H, 2002, ANN NEUROL, V52, P691, DOI 10.1002/ana.10368; Tang J, 2009, BIOCHEM BIOPH RES CO, V385, P341, DOI 10.1016/j.bbrc.2009.05.067; Tardy C, 2009, BBA-MOL CELL RES, V1793, P1250, DOI 10.1016/j.bbamcr.2009.03.007; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Terai K, 1997, BRAIN RES, V769, P385, DOI 10.1016/S0006-8993(97)00849-4; Terpstra NJ, 2006, J COMP NEUROL, V494, P784, DOI 10.1002/cne.20831; Terpstra NJ, 2005, J COMP NEUROL, V488, P342, DOI 10.1002/cne.20592; Terpstra NJ, 2004, J NEUROSCI, V24, P4971, DOI 10.1523/JNEUROSCI.0570-04.2004; Thomas M, 2004, CURR OPIN NEUROL, V17, P437, DOI 10.1097/01.wco.0000137534.61244.d1; Thomas U, 2002, J NEUROCHEM, V81, P407, DOI 10.1046/j.1471-4159.2002.00869.x; Tian Q, 2002, NEUROSIGNALS, V11, P262, DOI 10.1159/000067425; Tippens AL, 2007, J BIOL CHEM, V282, P8464, DOI 10.1074/jbc.M611384200; Tischmeyer W, 1999, CELL MOL LIFE SCI, V55, P564, DOI 10.1007/s000180050315; Tiveci S, 2005, COMPUT BIOL CHEM, V29, P151, DOI 10.1016/j.compbiolchem.2005.03.002; Tobaben S, 2000, J BIOL CHEM, V275, P36204, DOI 10.1074/jbc.M006448200; Todd KJ, 2007, EUR J NEUROSCI, V25, P1287, DOI 10.1111/j.1460-9568.2007.05385.x; Toledo EM, 2008, PROG NEUROBIOL, V86, P281, DOI 10.1016/j.pneurobio.2008.08.001; Toscano CD, 2006, EXP NEUROL, V200, P209, DOI 10.1016/j.expneurol.2006.02.006; Tradewell ML, 2009, J NEUROPATH EXP NEUR, V68, P642, DOI 10.1097/NEN.0b013e3181a5deeb; TROJANOWSKI JQ, 1989, ANN MED, V21, P113, DOI 10.3109/07853898909149196; TROY CM, 1992, J CELL BIOL, V117, P1085, DOI 10.1083/jcb.117.5.1085; Tsim KWK, 2003, J NEUROCYTOL, V32, P603, DOI 10.1023/B:NEUR.0000020613.25367.78; Ubeda M, 2004, ENDOCRINOLOGY, V145, P3023, DOI 10.1210/en.2003-1522; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Uemura T, 2004, MOL CELL NEUROSCI, V26, P330, DOI 10.1016/j.mcn.2004.02.007; Utreras E, 2009, NEUROSCIENCE, V161, P978, DOI 10.1016/j.neuroscience.2009.04.002; Vafai SB, 2002, FEBS LETT, V518, P1, DOI 10.1016/S0014-5793(02)02702-3; Valjent E, 2006, J NEUROSCI, V26, P4956, DOI 10.1523/JNEUROSCI.4601-05.2006; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Veerhuis R, 1999, EXP NEUROL, V160, P289, DOI 10.1006/exnr.1999.7199; Veinbergs I, 1999, PROG NEURO-PSYCHOPH, V23, P519, DOI 10.1016/S0278-5846(99)00013-5; Velho TAF, 2008, J NEUROSCI, V28, P11871, DOI 10.1523/JNEUROSCI.2307-08.2008; Velho TAF, 2007, J COMP NEUROL, V500, P477, DOI 10.1002/cne.21180; Verdaguer E, 2007, BIOMED PHARMACOTHER, V61, P390, DOI 10.1016/j.biopha.2006.11.001; Verkhratsky A, 2003, J CELL MOL MED, V7, P351, DOI 10.1111/j.1582-4934.2003.tb00238.x; Vidal R, 2008, J NEUROSCI, V28, P60, DOI 10.1523/JNEUROSCI.3962-07.2008; Vignal C, 2008, CR BIOL, V331, P347, DOI 10.1016/j.crvi.2008.02.004; Vincent VAM, 2002, J NEUROCHEM, V82, P1388, DOI 10.1046/j.1471-4159.2002.01087.x; Vincent VAM, 2002, NEUROBIOL AGING, V23, P349, DOI 10.1016/S0197-4580(01)00338-4; Voineskos D, 2009, J NEURAL TRANSM, V116, P479, DOI 10.1007/s00702-008-0182-9; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; VONMOLLARD GF, 1994, J BIOL CHEM, V269, P10971; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wakabayashi K, 1999, NEUROBIOL AGING, V20, P287, DOI 10.1016/S0197-4580(99)00035-4; Walker DG, 2008, MICROVASC RES, V75, P411, DOI 10.1016/j.mvr.2007.10.004; WALLACE MA, 1994, BBA-MOL BASIS DIS, V1227, P183, DOI 10.1016/0925-4439(94)90093-0; Walton JR, 2007, J INORG BIOCHEM, V101, P1275, DOI 10.1016/j.jinorgbio.2007.06.001; Wang CY, 2007, MOL VIS, V13, P719; Wang CY, 2007, J GLAUCOMA, V16, P230, DOI 10.1097/IJG.0b013e3180300818; Wang F, 2009, J PSYCHIATR NEUROSCI, V34, P181; Wang HJ, 2009, BRAIN RES, V1249, P237, DOI 10.1016/j.brainres.2008.10.046; Wang Huiling, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P63; Wang JZ, 2001, FEBS LETT, V507, P81, DOI 10.1016/S0014-5793(01)02944-1; Wang M, 2009, EUR J MED CHEM, V44, P2748, DOI 10.1016/j.ejmech.2008.08.001; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wang Y P, 2001, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V23, P445; Wang YH, 2008, INT J CANCER, V123, P561, DOI 10.1002/ijc.23600; Wang Yipeng, 2002, Zhonghua Yi Xue Za Zhi, V82, P519; Washizuka S, 2009, NEUROSCI RES, V63, P199, DOI 10.1016/j.neures.2008.12.004; Wei Q, 2002, CELL MOL NEUROBIOL, V22, P13, DOI 10.1023/A:1015385527187; Weidenhofer J, 2008, J PSYCHIATR RES, V43, P282, DOI 10.1016/j.jpsychires.2008.04.001; Weihl CC, 1999, J NEUROSCI, V19, P5360; Weiss J, 2008, MOL CELL NEUROSCI, V37, P40, DOI 10.1016/j.mcn.2007.08.012; White LD, 2007, TOXICOL APPL PHARM, V225, P1, DOI 10.1016/j.taap.2007.08.001; Wickelgren I, 1998, SCIENCE, V280, P517, DOI 10.1126/science.280.5363.517; Widelitz R, 2005, GROWTH FACTORS, V23, P111, DOI 10.1080/08977190500125746; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Williams C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004936; WILLIAMS D, 2009, INVEST OPHTHALMOL VI; Wimmer U, 2005, NUCLEIC ACIDS RES, V33, P5715, DOI 10.1093/nar/gki881; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; Wishart TM, 2007, MOL CELL PROTEOMICS, V6, P1318, DOI 10.1074/mcp.M600457-MCP200; Wollmer MA, 2006, NEURODEGENER DIS, V3, P334, DOI 10.1159/000097302; Wong J, 2009, J BIOL CHEM, V284, P18824, DOI 10.1074/jbc.M109.013243; Wong-Riley M, 2000, GENE, V247, P63, DOI 10.1016/S0378-1119(00)00121-9; Wood JD, 2009, HUM MOL GENET, V18, P391, DOI 10.1093/hmg/ddn361; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wurtman RJ, 2006, BRAIN RES, V1088, P83, DOI 10.1016/j.brainres.2006.03.019; Xu C, 2008, BIPOLAR DISORD, V10, P105, DOI 10.1111/j.1399-5618.2008.00535.x; Xu WH, 2007, J NEURAL TRANSM, V114, P373, DOI 10.1007/s00702-006-0588-1; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yan SD, 1998, RESTOR NEUROL NEUROS, V12, P167; Yang GF, 2008, NEUROL RES, V30, P613, DOI 10.1179/174313208X284124; Yang HC, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S30; YANG X, 2009, CELL MOL NEUROBIOL; Yao J, 2008, J BIOL CHEM, V283, P20628, DOI 10.1074/jbc.M800738200; Yao PJ, 1998, NEUROSCI LETT, V252, P33, DOI 10.1016/S0304-3940(98)00547-3; Yasojima K, 1999, AM J PATHOL, V154, P927, DOI 10.1016/S0002-9440(10)65340-0; Yasojima K, 1999, BRAIN RES, V833, P297, DOI 10.1016/S0006-8993(99)01514-0; Yasuno F, 2008, BIOL PSYCHIAT, V64, P835, DOI 10.1016/j.biopsych.2008.04.021; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Youn HS, 2007, J ALZHEIMERS DIS, V11, P385; Yu WH, 2008, NEUROCHEM RES, V33, P902, DOI 10.1007/s11064-007-9533-4; Yuan ZQ, 2008, SCIENCE, V319, P1665, DOI 10.1126/science.1152337; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; Zahir FR, 2008, J MED GENET, V45, P239, DOI 10.1136/jmg.2007.054437; Zambrzycka A, 2003, POL J PHARMACOL, V55, P915; Zang ZJ, 2007, CANCER BIOL THER, V6, P712, DOI 10.4161/cbt.6.5.3964; Zarnowska ED, 2009, J NEUROPHYSIOL, V101, P1179, DOI 10.1152/jn.91203.2008; Zhang GC, 2007, MOL PHARMACOL, V71, P1148, DOI 10.1124/mol.106.028399; Zhang Jian-min, 2004, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V26, P62; Zhang J, 2009, J NEURAL TRANSM, V116, P357, DOI 10.1007/s00702-009-0185-1; Zhang ZJ, 2007, HUM MOL GENET, V16, P837, DOI 10.1093/hmg/ddm029; Zhang ZJ, 2006, HUM MOL GENET, V15, P337, DOI 10.1093/hmg/ddi451; Zhao C, 2008, NEUROSCIENCE, V153, P1202, DOI 10.1016/j.neuroscience.2007.10.067; ZHAO C, 2008, MOL CELL NEUROSCI; ZHAO C, 2008, CELL MOL NEUROBIOL; Zhao CJ, 2009, MOL CELL NEUROSCI, V40, P280, DOI 10.1016/j.mcn.2008.11.001; Zhao CJ, 2009, CELL MOL NEUROBIOL, V29, P273, DOI 10.1007/s10571-008-9320-z; Zhao LX, 2006, MOL BIOL CELL, V17, P4179, DOI 10.1091/mbc.E06-04-0355; Zhao WQ, 2009, BBA-MOL BASIS DIS, V1792, P482, DOI 10.1016/j.bbadis.2008.10.014; Zhao WQ, 2003, NEUROBIOL DIS, V14, P458, DOI 10.1016/S0969-9961(03)00124-4; Zhou D, 2008, PHYSIOL GENOMICS, V32, P370, DOI 10.1152/physiolgenomics.00147.2007; Zhou DW, 2009, J ALZHEIMERS DIS, V16, P301, DOI 10.3233/JAD-2009-0970; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1; Zhuo JM, 2008, CURR ALZHEIMER RES, V5, P385, DOI 10.2174/156720508785132280	781	99	100	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10153	10.1371/journal.pone.0010153	http://dx.doi.org/10.1371/journal.pone.0010153			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405009	Green Published, gold			2022-12-25	WOS:000276706300009
J	Handel, AE; Handunnetthi, L; Berlanga, AJ; Watson, CT; Morahan, JM; Ramagopalan, SV				Handel, Adam E.; Handunnetthi, Lahiru; Berlanga, Antonio J.; Watson, Corey T.; Morahan, Julia M.; Ramagopalan, Sreeram V.			The Effect of Single Nucleotide Polymorphisms from Genome Wide Association Studies in Multiple Sclerosis on Gene Expression	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; REPLICATION; VARIANTS; DISEASES; ISOLATE	Background: Multiple sclerosis (MS) is a complex neurological disorder. Its aetiology involves both environmental and genetic factors. Recent genome-wide association studies have identified a number of single nucleotide polymorphisms (SNPs) associated with susceptibility to (MS). We investigated whether these genetic variations were associated with alteration in gene expression. Methods/Principal Findings: We used a database of mRNA expression and genetic variation derived from immortalised peripheral lymphocytes to investigate polymorphisms associated with MS for correlation with gene expression. Several SNPs were found to be associated with changes in expression: in particular two with HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRB1, HLA-DRB4 and HLA-DRB5, one with ZFP57, one with CD58, two with IL7 and FAM164A, and one with FAM119B, TSFM and KUB3. We found minimal cross-over with a recent whole genome expression study in MS patients. Discussion: We have shown that many susceptibility loci in MS are associated with changes in gene expression using an unbiased expression database. Several of these findings suggest novel gene candidates underlying the effects of MS-associated genetic variation.	[Handel, Adam E.; Handunnetthi, Lahiru; Berlanga, Antonio J.; Morahan, Julia M.; Ramagopalan, Sreeram V.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Handel, Adam E.; Handunnetthi, Lahiru; Berlanga, Antonio J.; Morahan, Julia M.; Ramagopalan, Sreeram V.] Univ Oxford, Dept Clin Neurol, Oxford, England; [Watson, Corey T.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Ramagopalan, Sreeram V.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, London, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Simon Fraser University; University of London; Queen Mary University London	Handel, AE (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	sreeramr@well.ox.ac.uk	Handel, Adam/F-2489-2011	Watson, Corey/0000-0001-7248-8787; Morahan, Julia/0000-0001-9278-0603; Handel, Adam/0000-0001-8385-6346; Handunnetthi, Lahiru/0000-0002-8242-3722	Wellcome Trust [075491/Z/04]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust (Grant Number 075491/Z/04). SVR is a Goodger Scholar at the University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), 2009, NAT GENET, V41, P824; Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; De Jager PL, 2009, P NATL ACAD SCI US, V106, P5264; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; GANDHI KS, 2010, HUM MOL GEN IN PRESS; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; Handel AE, 2009, TRENDS MOL MED; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Kallio SP, 2009, HUM MOL GENET, V18, P1670, DOI 10.1093/hmg/ddp073; Kono T, 2008, FEBS J, V275, P1213, DOI 10.1111/j.1742-4658.2008.06281.x; LINCOLN MR, 2009, P NATL ACAD SCI US; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Maier LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000322; McCauley JL, 2010, HUM MOL GENET, V19, P953, DOI 10.1093/hmg/ddp542; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Peltonen L, 2007, NEW ENGL J MED, V357, P927, DOI 10.1056/NEJMe078147; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100	25	52	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10142	10.1371/journal.pone.0010142	http://dx.doi.org/10.1371/journal.pone.0010142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405052	Green Published, gold, Green Submitted			2022-12-25	WOS:000276706300005
J	Anand, PK; Anand, E; Bleck, CKE; Anes, E; Griffiths, G				Anand, Paras K.; Anand, Ellis; Bleck, Christopher K. E.; Anes, Elsa; Griffiths, Gareth			Exosomal Hsp70 Induces a Pro-Inflammatory Response to Foreign Particles Including Mycobacteria	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; NF-KAPPA-B; INFECTED MACROPHAGES; PHAGOLYSOSOME FUSION; IMMUNE-RESPONSE; STRESS-PROTEINS; TUBERCULOSIS; PATHWAY; CELL; PHAGOSOME	Background: Exosomes are endosome-derived vesicles that are released when multi-vesicular bodies (MVBs) fuse with the plasma membrane. Exosomes released from mycobacteria-infected cells have recently been shown to be pro-inflammatory. A prominent host molecule that is found within these exosomes is Hsp70, a member of the heat-shock family of proteins. Methodology/Principal Findings: We first characterized the exosomes purified from control and mycobacteria-infected cells. We found that relative to uninfected cells, macrophages infected with M. smegmatis and M. avium release more exosomes and the exosomes they released had more Hsp70 on their surface. Both exosomes and exogenous Hsp70 treatment of macrophages led to NF-kappa B activation and TNF alpha release in uninfected macrophages; Hsp70 levels were elevated in mycobacteria-infected cells. Macrophage treatment with Hsp70 also led to increase in the phagocytosis and maturation of latex-bead phagosomes. Finally, Hsp70 pre-incubation of M. smegmatis- and M. avium-infected cells led to increased phago-lysosome fusion, as well as more killing of mycobacteria within macrophages. Conclusions/Significance: Our results fit into an emerging concept whereby exosomes-containing Hsp70 are effective inducers of inflammation, also in response to mycobacterial infection.	[Anand, Paras K.; Anand, Ellis; Bleck, Christopher K. E.; Griffiths, Gareth] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany; [Anes, Elsa] Univ Lisbon, URIA, Ctr Patogenese Mol, Fac Farm, P-1699 Lisbon, Portugal; [Anes, Elsa] Inst Mol Med, Lisbon, Portugal	European Molecular Biology Laboratory (EMBL); Universidade de Lisboa; Universidade de Lisboa	Anand, PK (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Paras.Anand@stjude.org	Anes, Elsa/K-3124-2013; iMed.ULisboa, HPI/B-4239-2014; Anand, Paras/D-3219-2012	Anes, Elsa/0000-0001-5934-0198; iMed.ULisboa, HPI/0000-0001-5934-0198; Anand, Paras/0000-0003-2503-3653; Bleck, Christopher/0000-0003-1029-3444	Fundacao para a Ciencia e a tecnologia (FCT) [PIC/IC/82859/2007, PTDC/SAU-MII/098024/2008]; Alexander von Humboldt foundation, Germany; European Union [MIF1-CT-2006-039351]	Fundacao para a Ciencia e a tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Alexander von Humboldt foundation, Germany(Alexander von Humboldt Foundation); European Union(European Commission)	E. A. was supported by Fundacao para a Ciencia e a tecnologia (FCT) Grant PIC/IC/82859/2007 and PTDC/SAU-MII/098024/2008. P. K. A was supported by a post-doctoral research grant from Alexander von Humboldt foundation, Germany and Marie-Curie fellowship from European Union, FP6 programme MIF1-CT-2006-039351. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2003, J INFECT DIS, V187, pS340, DOI 10.1086/374747; Anes E, 2006, CELL MICROBIOL, V8, P939, DOI 10.1111/j.1462-5822.2005.00675.x; Anes E, 2003, NAT CELL BIOL, V5, P793, DOI 10.1038/ncb1036; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2005, EXERC IMMUNOL REV, V11, P34; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Asea Alexzander, 2008, V183, P111; Asea A, 2007, METHODS, V43, P194, DOI 10.1016/j.ymeth.2007.06.002; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; Becker T, 2002, J CELL BIOL, V158, P1277, DOI 10.1083/jcb.200208083; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bhatnagar S, 2007, J BIOL CHEM, V282, P25779, DOI 10.1074/jbc.M702277200; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Calderwood SK, 2007, ANN NY ACAD SCI, V1113, P28, DOI 10.1196/annals.1391.019; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Chase MA, 2007, J IMMUNOL, V179, P6318, DOI 10.4049/jimmunol.179.9.6318; Clemens DL, 1996, TRENDS MICROBIOL, V4, P113, DOI 10.1016/0966-842X(96)81528-9; El Mezayen R, 2007, IMMUNOL LETT, V111, P36, DOI 10.1016/j.imlet.2007.04.011; Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Floto RA, 2006, SCIENCE, V314, P454, DOI 10.1126/science.1133515; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gutierrez MG, 2008, J IMMUNOL, V181, P2651, DOI 10.4049/jimmunol.181.4.2651; Gutierrez MG, 2009, CELL MICROBIOL, V11, P406, DOI 10.1111/j.1462-5822.2008.01263.x; Hmama Z, 2004, J CELL SCI, V117, P2131, DOI 10.1242/jcs.01072; Johnson JD, 2006, J LEUKOCYTE BIOL, V79, P425, DOI 10.1189/jlb.0905523; Jordao L, 2008, CELL MICROBIOL, V10, P529, DOI 10.1111/j.1462-5822.2007.01067.x; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Multhoff G, 1998, ANN NY ACAD SCI, V851, P86, DOI 10.1111/j.1749-6632.1998.tb08980.x; Multhoff G, 2007, METHODS, V43, P229, DOI 10.1016/j.ymeth.2007.06.006; Persson YAZ, 2008, MICROBES INFECT, V10, P233, DOI 10.1016/j.micinf.2007.11.007; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Roach SK, 2002, INFECT IMMUN, V70, P3040, DOI 10.1128/IAI.70.6.3040-3052.2002; Schartz NEC, 2002, CURR OPIN MOL THER, V4, P372; Schlesinger LS, 1996, CURR TOP MICROBIOL, V215, P71; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Vabulas RM, 2002, CURR TOP MICROBIOL, V270, P169; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Vega VL, 2005, J IMMUNOL, V175, P5280, DOI 10.4049/jimmunol.175.8.5280; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Wang RB, 2006, J SURG RES, V136, P58, DOI 10.1016/j.jss.2006.06.003; Zhou CG, 2005, J HIGH ENERGY PHYS; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	49	83	89	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10136	10.1371/journal.pone.0010136	http://dx.doi.org/10.1371/journal.pone.0010136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405033	Green Published, Green Submitted, gold			2022-12-25	WOS:000276705900017
J	Bjarnsholt, T; Jensen, PO; Jakobsen, TH; Phipps, R; Nielsen, AK; Rybtke, MT; Tolker-Nielsen, T; Givskov, M; Hoiby, N; Ciofu, O				Bjarnsholt, Thomas; Jensen, Peter Ostrup; Jakobsen, Tim Holm; Phipps, Richard; Nielsen, Anne Kirstine; Rybtke, Morten Theil; Tolker-Nielsen, Tim; Givskov, Michael; Hoiby, Niels; Ciofu, Oana		Scandinavian Cystic Fibrosis Study	Quorum Sensing and Virulence of Pseudomonas aeruginosa during Lung Infection of Cystic Fibrosis Patients	PLOS ONE			English	Article								Pseudomonas aeruginosa is the predominant microorganism in chronic lung infection of cystic fibrosis patients. The chronic lung infection is preceded by intermittent colonization. When the chronic infection becomes established, it is well accepted that the isolated strains differ phenotypically from the intermittent strains. Dominating changes are the switch to mucoidity ( alginate overproduction) and loss of epigenetic regulation of virulence such as the Quorum Sensing (QS). To elucidate the dynamics of P. aeruginosa QS systems during long term infection of the CF lung, we have investigated 238 isolates obtained from 152 CF patients at different stages of infection ranging from intermittent to late chronic. Isolates were characterized with regard to QS signal molecules, alginate, rhamnolipid and elastase production and mutant frequency. The genetic basis for change in QS regulation were investigated and identified by sequence analysis of lasR, rhlR, lasI and rhlI. The first QS system to be lost was the one encoded by las system 12 years ( median value) after the onset of the lung infection with subsequent loss of the rhl encoded system after 17 years ( median value) shown as deficiencies in production of the 3-oxo-C12-HSL and C4-HSL QS signal molecules respectively. The concomitant development of QS malfunction significantly correlated with the reduced production of rhamnolipids and elastase and with the occurrence of mutations in the regulatory genes lasR and rhlR. Accumulation of mutations in both lasR and rhlR correlated with development of hypermutability. Interestingly, a higher number of mucoid isolates were found to produce C4-HSL signal molecules and rhamnolipids compared to the non-mucoid isolates. As seen from the present data, we can conclude that P. aeruginosa and particularly the mucoid strains do not lose the QS regulation or the ability to produce rhamnolipids until the late stage of the chronic infection.	[Bjarnsholt, Thomas; Jakobsen, Tim Holm; Nielsen, Anne Kirstine; Rybtke, Morten Theil; Tolker-Nielsen, Tim; Givskov, Michael; Hoiby, Niels; Ciofu, Oana] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Jensen, Peter Ostrup; Hoiby, Niels] Univ Hosp, Dept Clin Microbiol, Rigshosp, Copenhagen, Denmark; [Phipps, Richard] Tech Univ Denmark, DK-2800 Lyngby, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Technical University of Denmark	Bjarnsholt, T (corresponding author), Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	ociofu@sund.ku.dk	Rybtke, Morten/G-7182-2017; Jensen, Peter Ostrup/HGD-7725-2022; Ciofu, Oana/AAE-2413-2020; Bjarnsholt, Thomas/ABD-6178-2021	Rybtke, Morten/0000-0002-6218-6774; Bjarnsholt, Thomas/0000-0002-8003-7414; Tolker-Nielsen, Tim/0000-0002-9751-474X; Givskov, Michael/0000-0001-5004-8609; Hoiby, Niels/0000-0002-1347-725X; Jakobsen, Tim Holm/0000-0002-1671-2155; Ciofu, Oana/0000-0001-5648-4858; Jensen, Peter Ostrup/0000-0003-1648-7186	Carlsberg Foundation; Lundbeck Foundation; German Mukoviszidose e.V.; Danish Strategic Research Council	Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden); German Mukoviszidose e.V.; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF))	This study was supported by The Carlsberg Foundation and Lundbeck Foundation to TB and grants from the German Mukoviszidose e.V. and the Danish Strategic Research Council to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHEDE M, 2009, MICROBIOLOGY, P3500; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; BOE L, 1994, J BACTERIOL, V176, P2781, DOI 10.1128/JB.176.10.2781-2787.1994; Bottomley MJ, 2007, J BIOL CHEM, V282, P13592, DOI 10.1074/jbc.M700556200; CHOI SH, 1992, J BACTERIOL, V174, P4064, DOI 10.1128/jb.174.12.4064-4069.1992; CHOI SH, 1991, P NATL ACAD SCI USA, V88, P11115, DOI 10.1073/pnas.88.24.11115; Ciofu O, 2005, ANTIMICROB AGENTS CH, V49, P2276, DOI 10.1128/AAC.49.6.2276-2282.2005; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; DEKIMPE V, 2009, MICROBIOLOGY 3, P712; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Garde C, 2010, J MOL BIOL, V396, P849, DOI 10.1016/j.jmb.2010.01.002; Geisenberger O, 2000, FEMS MICROBIOL LETT, V184, P273, DOI 10.1111/j.1574-6968.2000.tb09026.x; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; HANZELKA BL, 1995, J BACTERIOL, V177, P815, DOI 10.1128/jb.177.3.815-817.1995; HENTZER M, 2002, MICROBIOLOGY 1, P87; Heurlier K, 2006, INT J MED MICROBIOL, V296, P93, DOI 10.1016/j.ijmm.2006.01.043; Hoffmann N, 2005, INFECT IMMUN, V73, P2504, DOI 10.1128/IAI.73.4.2504-2514.2005; Hoiby N, 2005, J Cyst Fibros, V4 Suppl 2, P49, DOI 10.1016/j.jcf.2005.05.018; HOIBY N, 1977, SCAND J RESPIR DIS, V58, P65; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; JENSEN PO, 2007, MICROBIOLOGY 5, P1329, DOI 10.1099/mic.0.2006/003863-0; KHARAZMI A, 1984, INFECT IMMUN, V43, P161, DOI 10.1128/IAI.43.1.161-165.1984; Kiratisin P, 2002, J BACTERIOL, V184, P4912, DOI 10.1128/JB.184.17.4912-4919.2002; Kolpen M, 2010, THORAX, V65, P57, DOI 10.1136/thx.2009.114512; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; KRONBORG G, 1992, J CLIN MICROBIOL, V30, P1848, DOI 10.1128/JCM.30.7.1848-1855.1992; Lee B, 2005, J CLIN MICROBIOL, V43, P5247, DOI 10.1128/JCM.43.10.5247-5255.2005; Lequette Y, 2006, J BACTERIOL, V188, P3365, DOI 10.1128/JB.188.9.3365-3370.2006; LUJAN AM, 2007, MICROBIOLOGY 1, P225; Mandsberg LF, 2009, ANTIMICROB AGENTS CH, V53, P2483, DOI 10.1128/AAC.00428-08; MATHEE K, 1999, MICROBIOLOGY, P1349; Moser C, 2009, APMIS, V117, P95, DOI 10.1111/j.1600-0463.2008.00018.x; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; OJENIYI B, 1991, APMIS, V99, P492, DOI 10.1111/j.1699-0463.1991.tb05181.x; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; PEDERSEN SS, 1992, THORAX, V47, P6, DOI 10.1136/thx.47.1.6; PEDERSEN SS, 1990, INFECT IMMUN, V58, P3363, DOI 10.1128/IAI.58.10.3363-3368.1990; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Romling U, 2000, J CLIN MICROBIOL, V38, P464; Rumbaugh KP, 2000, MICROBES INFECT, V2, P1721, DOI 10.1016/S1286-4579(00)01327-7; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schelstraete P, 2008, EUR RESPIR J, V31, P822, DOI 10.1183/09031936.00088907; Skindersoe ME, 2008, ANTIMICROB AGENTS CH, V52, P3648, DOI 10.1128/AAC.01230-07; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Song ZJ, 2003, J MED MICROBIOL, V52, P731, DOI 10.1099/jmm.0.05122-0; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405; Van Gennip M, 2009, APMIS, V117, P537, DOI 10.1111/j.1600-0463.2009.02466.x; Wilder CN, 2009, INFECT IMMUN, V77, P5631, DOI 10.1128/IAI.00755-09; Williams P, 2000, PHILOS T R SOC B, V355, P667, DOI 10.1098/rstb.2000.0607	51	168	180	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10115	10.1371/journal.pone.0010115	http://dx.doi.org/10.1371/journal.pone.0010115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20404933	Green Published, Green Submitted, gold			2022-12-25	WOS:000276705900002
J	Chen, J; Tang, B; Chen, HX; Yao, Q; Huang, XF; Chen, J; Zhang, DW; Zhang, WQ				Chen, Jie; Tang, Bin; Chen, Hongxin; Yao, Qiong; Huang, Xiaofeng; Chen, Jing; Zhang, Daowei; Zhang, Wenqing			Different Functions of the Insect Soluble and Membrane-Bound Trehalase Genes in Chitin Biosynthesis Revealed by RNA Interference	PLOS ONE			English	Article							MOLECULAR-CLONING; TENEBRIO-MOLITOR; MIDGUT TREHALASE; ACCESSORY-GLAND; SYNTHASE GENE; LARVAL MIDGUT; EXPRESSION; LOCALIZATION; SILKWORM; PURIFICATION	Background: Trehalase, an enzyme that hydrolyzes trehalose to yield two glucose molecules, plays a pivotal role in various physiological processes. In recent years, trehalase proteins have been purified from several insect species and are divided into soluble (Tre-1) and membrane-bound (Tre-2) trehalases. However, no functions of the two trehalases in chitin biosynthesis in insects have yet been reported. Principal Findings: The membrane-bound trehalase of Spodoptera exigua (SeTre-2) was characterized in our laboratory previously. In this study, we cloned the soluble trehalase gene (SeTre-1) and investigated the tissue distribution and developmental expression pattern of the two trehalase genes. SeTre-1 was expressed highly in cuticle and Malpighian tubules, while SeTre-2 was expressed in tracheae and fat body. In the midgut, the two trehalase genes were expressed in different locations. Additionally, the expression profiles of both trehalase mRNAs and their enzyme activities suggest that they may play different roles in chitin biosynthesis. The RNA interference (RNAi) of either SeTre-1 or SeTre-2 was gene-specific and effective, with efficiency rates up to 83% at 72 h post injection. After RNAi of SeTre-1 and SeTre-2, significant higher mortality rates were observed during the larva-pupa stage and pupa-adult stage, and the lethal phenotypes were classified and analyzed. Additionally, the change trends of concentration of trehalose and glucose appeared reciprocally in RNAi-mutants. Moreover, knockdown of SeTre-1 gene largely inhibited the expression of chitin synthase gene A (CHSA) and reduced the chitin content in the cuticle to two-thirds relative to the control insects. The chitin synthase gene B (CHSB) expression, however, was inhibited more by the injection of dsRNA for SeTre-2, and the chitin content in the midgut decreased by about 25%. Conclusions: SeTre-1 plays a major role in CHSA expression and chitin synthesis in the cuticle, and SeTre-2 has an important role in CHSB expression and chitin synthesis in the midgut.	[Chen, Jie; Tang, Bin; Chen, Hongxin; Yao, Qiong; Huang, Xiaofeng; Chen, Jing; Zhang, Daowei; Zhang, Wenqing] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Bin] Hangzhou Normal Univ, Hangzhou Key Lab Anim Adaptat & Evolut, Hangzhou, Zhejiang, Peoples R China	Sun Yat Sen University; Hangzhou Normal University	Chen, J (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	Lsszwq@mail.sysu.edu.cn	zhang, wenqing/GYA-0786-2022	Chen, Hongxin/0000-0002-2955-4619	National Natural Science Foundation of China [30871634]; Research Fund for the Doctoral Program of Higher Education of China [20070558027]; Science Foundation of the State Key Laboratory of Biocontrol [SKLBC09A01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science Foundation of the State Key Laboratory of Biocontrol	This work was supported by National Natural Science Foundation of China (30871634), Research Fund for the Doctoral Program of Higher Education of China (20070558027) and Science Foundation of the State Key Laboratory of Biocontrol (SKLBC09A01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; AZUMA M, 1985, TISSUE CELL, V17, P539, DOI 10.1016/0040-8166(85)90030-8; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Borgia PT, 1996, MOL MICROBIOL, V20, P1287, DOI 10.1111/j.1365-2958.1996.tb02647.x; Chen XF, 2007, INSECT BIOCHEM MOLEC, V37, P409, DOI 10.1016/j.ibmb.2007.01.006; CLEGG JS, 1961, SCIENCE, V134, P54, DOI 10.1126/science.134.3471.54; Cruz J, 2007, MECH DEVELOP, V124, P180, DOI 10.1016/j.mod.2006.12.003; Cui SY, 2006, PEPTIDES, V27, P1226, DOI 10.1016/j.peptides.2005.11.011; de Almeida FM, 2009, PROTEIN EXPRES PURIF, V65, P185, DOI 10.1016/j.pep.2008.11.010; FRIEDMAN S, 1978, ANNU REV ENTOMOL, V23, P389, DOI 10.1146/annurev.en.23.010178.002133; Friedman S., 1985, P43; Gu JH, 2009, J INSECT PHYSIOL, V55, P997, DOI 10.1016/j.jinsphys.2009.07.003; Hallsworth JE, 1997, J MICROBIOL METH, V29, P7, DOI 10.1016/S0167-7012(97)00976-7; Kato N, 2006, INSECT BIOCHEM MOLEC, V36, P1, DOI 10.1016/j.ibmb.2005.09.003; KLEIN U, 1991, J EXP BIOL, V161, P61; Kramer K.J., 1985, P75; Kumar NS, 2008, COMP BIOCHEM PHYS B, V149, P447, DOI 10.1016/j.cbpb.2007.11.005; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Mitsumasu K, 2005, INSECT MOL BIOL, V14, P501, DOI 10.1111/j.1365-2583.2005.00581.x; Mitsumasu K, 2008, ZOOL SCI, V25, P693, DOI 10.2108/zsj.25.693; Sanchez-Fresneda R, 2009, BIOCHEM BIOPH RES CO, V383, P98, DOI 10.1016/j.bbrc.2009.03.134; Silva MCP, 2009, INSECT MOL BIOL, V18, P769, DOI 10.1111/j.1365-2583.2009.00920.x; SU ZH, 1993, BIOCHIM BIOPHYS ACTA, V1173, P217, DOI 10.1016/0167-4781(93)90184-F; SUMIDA M, 1983, INSECT BIOCHEM, V13, P257, DOI 10.1016/0020-1790(83)90047-1; TAKIGUCHI M, 1992, BIOCHEM J, V288, P19, DOI 10.1042/bj2880019; Tang B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-51; Tatun N, 2008, INSECT BIOCHEM MOLEC, V38, P788, DOI 10.1016/j.ibmb.2008.05.003; Tatun N, 2008, J INSECT PHYSIOL, V54, P351, DOI 10.1016/j.jinsphys.2007.10.006; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; Thompson SN, 2003, ADV INSECT PHYSIOL, V31, P205, DOI 10.1016/S0065-2806(03)31004-5; Yaginuma T, 1996, J COMP PHYSIOL B, V166, P1, DOI 10.1007/BF00264633; Zhu QS, 2008, INSECT BIOCHEM MOLEC, V38, P452, DOI 10.1016/j.ibmb.2007.06.010; Zhu QS, 2008, P NATL ACAD SCI USA, V105, P6650, DOI 10.1073/pnas.0800739105; Zimoch L, 2005, INSECT BIOCHEM MOLEC, V35, P515, DOI 10.1016/j.ibmb.2005.01.008	34	92	128	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10133	10.1371/journal.pone.0010133	http://dx.doi.org/10.1371/journal.pone.0010133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405036	Green Published, gold, Green Submitted			2022-12-25	WOS:000276705900015
J	Gaston, MA; Fuji, A; Weckerly, FW; Forstner, MRJ				Gaston, Michele A.; Fuji, Akiko; Weckerly, Floyd W.; Forstner, Michael R. J.			Potential Component Allee Effects and Their Impact on Wetland Management in the Conservation of Endangered Anurans	PLOS ONE			English	Article							HOUSTON TOADS; CALL SURVEYS; BEHAVIOR; ECOLOGY; DENSITY; SEX; DYNAMICS; MODELS	Effective management of wetland quantity and quality is crucial for effective conservation of declining amphibian populations. In particular, frogs and toads that employ aggregative breeding strategies may suffer negative population impacts in response to changes in availability of aquatic breeding habitat, including overabundance of suitable habitat, if density of conspecifics attending aggregations is positively correlated with reproductive success. Here we document such a positive relationship, potentially the first example of a component Allee effect in an anuran, in the critically endangered Houston toad (Bufo houstonensis). We assessed the relationship between mean yearly chorus size and reproductive success of males at the pond level using an information theoretic model selection approach and a two-sample t-test. The chosen model contained the single variable of mean yearly chorus size to predict probability of reproduction, as selected using the Akaike Information Criterion corrected for small sample size and Akaike weight. Mean chorus sizes were significantly higher among ponds exhibiting evidence of reproduction than in those that showed no evidence of reproduction. Our results suggest that chorusing alone is a poor proxy for inference of population stability and highlight a need for reassessment of widely-used amphibian monitoring protocols. Further, amphibian conservation efforts should account for potential Allee effects in order to optimize benefits and avoid underestimating critical population thresholds, particularly in species exhibiting rapid population declines.	[Gaston, Michele A.; Fuji, Akiko; Weckerly, Floyd W.; Forstner, Michael R. J.] Texas State Univ San Marcos, Dept Biol, San Marcos, TX USA	Texas State University System; Texas State University San Marcos	Gaston, MA (corresponding author), Texas State Univ San Marcos, Dept Biol, San Marcos, TX USA.	mg45447@txstate.edu			US Fish and Wildlife Service [04ERAG0002]; Texas Parks and Wildlife Department; Boy Scouts of America; United States Geological Survey; Texas Department of Transportation; US Department of Interior [14-6XXIA006]	US Fish and Wildlife Service(US Fish & Wildlife Service); Texas Parks and Wildlife Department; Boy Scouts of America; United States Geological Survey(United States Geological Survey); Texas Department of Transportation; US Department of Interior	This research was funded by a joint grant from the US Fish and Wildlife Service, Texas Parks and Wildlife Department, and the Boy Scouts of America (traditional Section 6); a grant from the United States Geological Survey and US Fish and Wildlife Service (04ERAG0002); and a grant from the Texas Department of Transportation and US Department of Interior (14-6XXIA006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 2001, NATURE, V412, P499, DOI 10.1038/35087658; Boukal DS, 2002, J THEOR BIOL, V218, P375, DOI 10.1006/jtbi.2002.3084; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Crouch WB, 2002, J HERPETOL, V36, P185, DOI 10.1670/0022-1511(2002)036[0185:ATUOCS]2.0.CO;2; De Solla SR, 2006, BIODIVERS CONSERV, V15, P3481, DOI 10.1007/s10531-004-6905-9; Duellman W. E., 1986, BIOL AMPHIBIANS; Forstner MRJ, 2003, TEX J SCI, V55, P315; HILLIS DM, 1984, J HERPETOL, V18, P56, DOI 10.2307/1563672; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; HURVICH CM, 1995, BIOMETRICS, V51, P1077, DOI 10.2307/2533006; Jackson JT, 2006, J WILDLIFE MANAGE, V70, P1461, DOI 10.2193/0022-541X(2006)70[1461:IAOHTG]2.0.CO;2; JACOBSON NL, 1989, SOUTHWEST NAT, V34, P374, DOI 10.2307/3672166; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Kramer AM, 2009, POPUL ECOL, V51, P341, DOI 10.1007/s10144-009-0152-6; LUCAS JR, 1995, AM NAT, V146, P365, DOI 10.1086/285805; Marsh DM, 2001, CONSERV BIOL, V15, P40, DOI 10.1046/j.1523-1739.2001.00129.x; Pfennig KS, 2000, BEHAV ECOL SOCIOBIOL, V48, P69, DOI 10.1007/s002650000205; POTTER FE, 1984, HOUSTON RECOVERY PLA; PRICE A, 2003, HOUSTON TOAD BASTROP, P1; RYAN MJ, 1990, EVOLUTION, V44; Semlitsch RD, 2002, CONSERV BIOL, V16, P619, DOI 10.1046/j.1523-1739.2002.00512.x; Semlitsch RD, 2003, AMPHIBIAN CONSERVATI; Smith MA, 2005, ECOGRAPHY, V28, P110; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Stevens CE, 2004, J HERPETOL, V38, P404, DOI 10.1670/195-03A; Swannack TM, 2007, SOUTHWEST NAT, V52, P386, DOI 10.1894/0038-4909(2007)52[386:PCFTSD]2.0.CO;2; TEJEDO M, 1993, COPEIA, P75, DOI 10.2307/1446297; US Fish and Wildlife Service, END THREAT WILDL PLA; WAGNER WE, 1992, COPEIA, P647, DOI 10.2307/1446140; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; YANTIS JH, 1990, 76 TEX PARKS WILDL D; YANTIS JH, 1989, 76 TEX PARKS WILDL D; YANTIS JH, 1991, 76 TEX PARKS WILDL D; YANTIS JH, 1992, 76 TEX PARKS WILDL D	36	13	14	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10102	10.1371/journal.pone.0010102	http://dx.doi.org/10.1371/journal.pone.0010102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404930	Green Published, gold, Green Submitted			2022-12-25	WOS:000276482100018
J	Huang, N; Jacobson, MP				Huang, Niu; Jacobson, Matthew P.			Binding-Site Assessment by Virtual Fragment Screening	PLOS ONE			English	Article							PROTEIN-LIGAND BINDING; MOLECULAR DOCKING; MAXIMAL AFFINITY; LEAD DISCOVERY; DRUG DESIGN; DRUGGABILITY; PREDICTION; IDENTIFICATION; DATABASE; POCKETS	The accurate prediction of protein druggability (propensity to bind high-affinity drug-like small molecules) would greatly benefit the fields of chemical genomics and drug discovery. We have developed a novel approach to quantitatively assess protein druggability by computationally screening a fragment-like compound library. In analogy to NMR-based fragment screening, we dock similar to 11000 fragments against a given binding site and compute a computational hit rate based on the fraction of molecules that exceed an empirically chosen score cutoff. We perform a large-scale evaluation of the approach on four datasets, totaling 152 binding sites. We demonstrate that computed hit rates correlate with hit rates measured experimentally in a previously published NMR-based screening method. Secondly, we show that the in silico fragment screening method can be used to distinguish known druggable and non-druggable targets, including both enzymes and protein-protein interaction sites. Finally, we explore the sensitivity of the results to different receptor conformations, including flexible protein-protein interaction sites. Besides its original aim to assess druggability of different protein targets, this method could be used to identifying druggable conformations of flexible binding site for lead discovery, and suggesting strategies for growing or joining initial fragment hits to obtain more potent inhibitors.	[Huang, Niu] Natl Inst Biol Sci, Beijing, Peoples R China; [Huang, Niu; Jacobson, Matthew P.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	National Institute of Biological Sciences, Beijing; University of California System; University of California San Francisco	Huang, N (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.	huangniu@nibs.ac.cn	Jacobson, Matthew/Y-5161-2018; Huang, Niu/J-9656-2012	Jacobson, Matthew/0000-0001-6262-655X; Huang, Niu/0000-0002-6912-033X	NIH [GM082250, AI035707]; Chinese Ministry of Science and Technology [2008AA022313]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants GM082250 and AI035707 (to M. P. J.), and the Chinese Ministry of Science and Technology 863 Grant 2008AA022313 (to N. H.). M. P. J. is a member of the Scientific Advisory Board of Schrodinger LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Jianghong, 2004, Genome Inform, V15, P31; Blundell TL, 2006, PHILOS T R SOC B, V361, P413, DOI 10.1098/rstb.2005.1800; Brady GP, 2000, J COMPUT AID MOL DES, V14, P383, DOI 10.1023/A:1008124202956; Brown SP, 2006, CHEMMEDCHEM, V1, P70, DOI 10.1002/cmdc.200500013; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Clark M, 2006, J CHEM INF MODEL, V46, P231, DOI 10.1021/ci050268f; Domling A, 2008, CURR OPIN CHEM BIOL, V12, P281, DOI 10.1016/j.cbpa.2008.04.603; Fauman Eric B, 2003, Methods Biochem Anal, V44, P477; Fry DC, 2005, J MOL MED, V83, P955, DOI 10.1007/s00109-005-0705-x; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Glaser F, 2006, PROTEINS, V62, P479, DOI 10.1002/prot.20769; Hajduk PJ, 2005, DRUG DISCOV TODAY, V10, P1675, DOI 10.1016/S1359-6446(05)03624-X; Hajduk PJ, 2005, J MED CHEM, V48, P2518, DOI 10.1021/jm049131r; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Hartshorn MJ, 2005, J MED CHEM, V48, P403, DOI 10.1021/jm0495778; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Huang N, 2006, J CHEM INF MODEL, V46, P243, DOI 10.1021/ci0502855; Huang N, 2007, CURR OPIN DRUG DISC, V10, P325; Huang N, 2006, PHYS CHEM CHEM PHYS, V8, P5166, DOI 10.1039/b608269f; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; IHLENFELDT WD, 1994, J CHEM INF COMP SCI, V34, P109, DOI 10.1021/ci00017a013; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J PHYS CHEM B, V106, P11673, DOI 10.1021/jp021564n; Keller TH, 2006, CURR OPIN CHEM BIOL, V10, P357, DOI 10.1016/j.cbpa.2006.06.014; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Landon MR, 2007, J MED CHEM, V50, P1231, DOI 10.1021/jm061134b; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Laurie ATR, 2006, CURR PROTEIN PEPT SC, V7, P395; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Liu G, 2003, J MED CHEM, V46, P4232, DOI 10.1021/jm034122o; Lorber DM, 2005, CURR TOP MED CHEM, V5, P739, DOI 10.2174/1568026054637683; Nayal M, 2006, PROTEINS, V63, P892, DOI 10.1002/prot.20897; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rossi A, 2006, PROTEIN SCI, V15, P2366, DOI 10.1110/ps.062247506; Shakespeare W, 2000, P NATL ACAD SCI USA, V97, P9373, DOI 10.1073/pnas.97.17.9373; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Soga S, 2007, J CHEM INF MODEL, V47, P400, DOI 10.1021/ci6002202; Stuart AC, 2002, BIOINFORMATICS, V18, P200, DOI 10.1093/bioinformatics/18.1.200; Vajda S, 2006, CURR OPIN DRUG DISC, V9, P354; van Dongen MJP, 2002, J AM CHEM SOC, V124, P11874, DOI 10.1021/ja017830c; Voigt JH, 2001, J CHEM INF COMP SCI, V41, P702, DOI 10.1021/ci000150t; Wang QMJ, 2001, J BIOL CHEM, V276, P19580, DOI 10.1074/jbc.M010089200; Wei BQQ, 2002, J MOL BIOL, V322, P339, DOI 10.1016/S0022-2836(02)00777-5; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Zhu K, 2007, J CHEM THEORY COMPUT, V3, P640, DOI 10.1021/ct600129f	52	50	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10109	10.1371/journal.pone.0010109	http://dx.doi.org/10.1371/journal.pone.0010109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404926	Green Submitted, gold, Green Published			2022-12-25	WOS:000276482100021
J	Thompson, BJ				Thompson, Barry J.			Mal/SRF Is Dispensable for Cell Proliferation in Drosophila	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; SRF; GRADIENT	The Mal/SRF transcription factor is regulated by the level of G-actin in cells and has important roles in cell migration and other actin-dependent processes in Drosophila. A recent report suggests that Mal/SRF and an upstream regulator, Pico, are required for cell proliferation and tissue growth in Drosophila. I find otherwise. Mutation of Mal or SRF does not affect cell proliferation in the fly wing. Furthermore, I cannot reproduce the reported effects of Pico RNAi or Pico overexpression on body size. Nevertheless, I can confirm that overexpression of Pico or Mal causes tissue overgrowth specifically in the fly wing - where SRF is most highly expressed. My results indicate that Mal/SRF can promote tissue growth when abnormally active, but is not normally required for tissue growth during development.	London Res Inst, Canc Res UK, London, England	Cancer Research UK	Thompson, BJ (corresponding author), London Res Inst, Canc Res UK, London, England.	barry.thompson@cancer.org.uk		Thompson, Barry/0000-0002-0103-040X	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Hafen E, 2003, CURR TOP MICROBIOL, V279, P153; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Lyulcheva E, 2008, DEV CELL, V15, P680, DOI 10.1016/j.devcel.2008.09.020; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Montagne J, 1996, DEVELOPMENT, V122, P2589; Piddini E, 2009, CELL, V136, P296, DOI 10.1016/j.cell.2008.11.036; Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084	9	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10077	10.1371/journal.pone.0010077	http://dx.doi.org/10.1371/journal.pone.0010077			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404916	Green Published, Green Submitted, gold			2022-12-25	WOS:000276482100006
J	Rangwala, SM; Wang, XM; Calvo, JA; Lindsley, L; Zhang, YY; Deyneko, G; Beaulieu, V; Gao, JP; Turner, G; Markovits, J				Rangwala, Shamina M.; Wang, Xiaomei; Calvo, Jennifer A.; Lindsley, Loren; Zhang, Yunyu; Deyneko, Galina; Beaulieu, Valerie; Gao, Jiaping; Turner, Gordon; Markovits, Judit			Estrogen-related Receptor gamma Is a Key Regulator of Muscle Mitochondrial Activity and Oxidative Capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SKELETAL-MUSCLE; HYPOXIA-INDUCIBLE FACTOR-2; ERR-ALPHA; TRANSCRIPTIONAL ACTIVATION; PGC-1-ALPHA; EXERCISE; EXPRESSION; GENE; COACTIVATOR-1-ALPHA; PATHWAY	Estrogen-related receptor gamma (ERR gamma) regulates the perinatal switch to oxidative metabolism in the myocardium. We wanted to understand the significance of induction of ERR gamma expression in skeletal muscle by exercise. Muscle-specific VP16ERR gamma transgenic mice demonstrated an increase in exercise capacity, mitochondrial enzyme activity, and enlarged mitochondria despite lower muscle weights. Furthermore, peak oxidative capacity was higher in the transgenics as compared with control littermates. In contrast, mice lacking one copy of ERR gamma exhibited decreased exercise capacity and muscle mitochondrial function. Interestingly, we observed that increased ERR gamma in muscle generates a gene expression profile that closely overlays that of red oxidative fiber-type muscle. We further demonstrated that a small molecule agonist of ERR beta/gamma can increase mitochondrial function in mouse myotubes. Our data indicate that ERR gamma plays an important role in causing a shift toward slow twitch muscle type and, concomitantly, a greater capacity for endurance exercise. Thus, the activation of this nuclear receptor provides a potential node for therapeutic intervention for diseases such as obesity, which is associated with reduced oxidative metabolism and a lower type I fiber content in skeletal muscle.	[Rangwala, Shamina M.; Wang, Xiaomei; Calvo, Jennifer A.; Lindsley, Loren; Zhang, Yunyu; Deyneko, Galina; Beaulieu, Valerie; Gao, Jiaping; Turner, Gordon] Novartis Inst BioMed Res, Cardiovasc & Metab Dis Area, Cambridge, MA 02139 USA	Novartis	Rangwala, SM (corresponding author), 100 Technol Sq, Cambridge, MA 02139 USA.	shamina.rangwala@novartis.com		Turner, Gordon/0000-0001-9156-7499				*AFF, 2008, PLIER TECHN; Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Alaynick WA, 2010, MOL ENDOCRINOL, V24, P299, DOI 10.1210/me.2009-0114; Ao A, 2008, P NATL ACAD SCI USA, V105, P7821, DOI 10.1073/pnas.0711677105; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031; Coward P, 2001, P NATL ACAD SCI USA, V98, P8880, DOI 10.1073/pnas.151244398; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Goodpaster BH, 2003, DIABETES, V52, P2191, DOI 10.2337/diabetes.52.9.2191; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; KIERNAN JA, 2004, HISTOLOGICAL HISTOCH, P319; Kleiner S, 2009, J BIOL CHEM, V284, P18624, DOI 10.1074/jbc.M109.008797; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lavery GG, 2008, J BIOL CHEM, V283, P8453, DOI 10.1074/jbc.M710067200; Lundby C, 2006, EUR J APPL PHYSIOL, V96, P363, DOI 10.1007/s00421-005-0085-5; Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Naranjo-Suarez S, 2003, J BIOL CHEM, V278, P31895, DOI 10.1074/jbc.M304079200; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Soriano FX, 2006, DIABETES, V55, P1783, DOI 10.2337/db05-0509; Takayanagi S, 2006, TOXICOL LETT, V167, P95, DOI 10.1016/j.toxlet.2006.08.012; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wang L, 2006, J BIOL CHEM, V281, P37773, DOI 10.1074/jbc.M608410200; Wang SCM, 2010, MOL CELL ENDOCRINOL, V315, P146, DOI 10.1016/j.mce.2009.07.012; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Willy PJ, 2004, P NATL ACAD SCI USA, V101, P8912, DOI 10.1073/pnas.0401420101; Zuercher WJ, 2005, J MED CHEM, V48, P3107, DOI 10.1021/jm050161j	49	122	126	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22619	22629		10.1074/jbc.M110.125401	http://dx.doi.org/10.1074/jbc.M110.125401			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20418374	hybrid, Green Published			2022-12-25	WOS:000279702200072
J	Mittal, R; Peak-Chew, SY; Sade, RS; Vallis, Y; McMahon, HT				Mittal, Rohit; Peak-Chew, Sew Yeu; Sade, Robert S.; Vallis, Yvonne; McMahon, Harvey T.			The Acetyltransferase Activity of the Bacterial Toxin YopJ of Yersinia Is Activated by Eukaryotic Host Cell Inositol Hexakisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-DIFFICILE TOXIN; NF-KAPPA-B; MESSENGER-RNA EXPORT; PROTEIN-KINASE; ACTIN-BINDING; EFFECTOR; ACETYLATION; INHIBITION; MAPK; PYROPHOSPHATES	Plague, one of the most devastating diseases in human history, is caused by the bacterium Yersinia pestis. The bacteria use a syringe-like macromolecular assembly to secrete various toxins directly into the host cells they infect. One such Yersinia outer protein, YopJ, performs the task of dampening innate immune responses in the host by simultaneously inhibiting the MAPK and NF kappa B signaling pathways. YopJ catalyzes the transfer of acetyl groups to serine, threonine, and lysine residues on target proteins. Acetylation of serine and threonine residues prevents them from being phosphorylated thereby preventing the activation of signaling molecules on which they are located. In this study, we describe the requirement of a host-cell factor for full activation of the acetyltransferase activity of YopJ and identify this activating factor to be inositol hexakisphosphate (IP6). We extend the applicability of our results to show that IP6 also stimulates the acetyltransferase activity of AvrA, the YopJ homologue from Salmonella typhimurium. Furthermore, an IP6-induced conformational change in AvrA suggests that IP6 acts as an allosteric activator of enzyme activity. Our results suggest that YopJ-family enzymes are quiescent in the bacterium where they are synthesized, because bacteria lack IP6; once injected into mammalian cells by the pathogen these toxins bind host cell IP6, are activated, and deregulate the MAPK and NF kappa B signaling pathways thereby subverting innate immunity.	[Mittal, Rohit; Peak-Chew, Sew Yeu; Vallis, Yvonne; McMahon, Harvey T.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Sade, Robert S.] MRC Ctr, Ctr Prot Engn, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology; MRC Laboratory Molecular Biology; University of Cambridge	Mittal, R (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	rohit@mrc-lmb.cam.ac.uk			Medical Research Council, UK; MRC [MC_U105178795] Funding Source: UKRI; Medical Research Council [MC_U105178795] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We acknowledge K. Orth (University of Texas Southwestern Medical Center, Dallas, TX) for plasmids encoding YopJ, K.L. Guan (University of Michigan, Ann Arbor, MI) for pCMV-MEK2, and A. Saiardi (MRC-Laboratory for Molecular Cell Biology, University College London, UK) for all the yeast strains used in this study. Finally, we thank E. Boucrot (MRC-Laboratory for Molecular Biology, Cambridge, UK) for S. typhimurium genomic DNA and for his careful reading of the manuscript. This work was supported by the Medical Research Council, UK.	ALI N, 1993, J BIOL CHEM, V268, P6161; Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Bolger Timothy A, 2008, Cell, V134, P624, DOI 10.1016/j.cell.2008.06.027; Brown MT, 2002, J BIOL CHEM, V277, P46298, DOI 10.1074/jbc.M202988200; Choi CH, 2003, NATURE, V424, P965, DOI 10.1038/nature01899; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; Coaker G, 2006, MOL MICROBIOL, V61, P1485, DOI 10.1111/j.1365-2958.2006.05335.x; Du FY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000595; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Guan K L, 1993, Semin Cell Biol, V4, P389, DOI 10.1006/scel.1993.1046; Haefner S, 2005, APPL MICROBIOL BIOT, V68, P588, DOI 10.1007/s00253-005-0005-y; Hanakahi LA, 2002, EMBO J, V21, P2038, DOI 10.1093/emboj/21.8.2038; Iwersen M, 2003, BIOL CHEM, V384, P1035, DOI 10.1515/BC.2003.116; Jones RM, 2008, CELL HOST MICROBE, V3, P233, DOI 10.1016/j.chom.2008.02.016; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Losito O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005580; Lrhorfi LA, 2007, BIOL CHEM, V388, P297, DOI 10.1515/BC.2007.033; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Pruitt RN, 2009, J BIOL CHEM, V284, P21934, DOI 10.1074/jbc.M109.018929; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Saiardi A, 2000, FEBS LETT, V468, P28, DOI 10.1016/S0014-5793(00)01194-7; Santos-Rosa H, 2003, NUCLEIC ACIDS RES, V31, P4285, DOI 10.1093/nar/gkg655; Sarmah B, 2005, DEV CELL, V9, P133, DOI 10.1016/j.devcel.2005.05.002; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Trasak C, 2007, J BIOL CHEM, V282, P2268, DOI 10.1074/jbc.M610071200; Trosky JE, 2004, J BIOL CHEM, V279, P51953, DOI 10.1074/jbc.M407001200; Trosky JE, 2008, CELL MICROBIOL, V10, P557, DOI 10.1111/j.1462-5822.2007.01109.x; Trosky JE, 2007, J BIOL CHEM, V282, P34299, DOI 10.1074/jbc.M706970200; VANDERKAAY J, 1995, ANAL BIOCHEM, V225, P183, DOI 10.1006/abio.1995.1135; Yang FJ, 2009, J BACTERIOL, V191, P735, DOI 10.1128/JB.01404-08; Ye ZD, 2007, AM J PATHOL, V171, P882, DOI 10.2353/ajpath.2007.070220; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194	46	55	60	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19927	19934		10.1074/jbc.M110.126581	http://dx.doi.org/10.1074/jbc.M110.126581			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20430892	Green Published, hybrid			2022-12-25	WOS:000279012000026
J	Nistal-Villan, E; Gack, MU; Martinez-Delgado, G; Maharaj, NP; Inn, KS; Yang, HY; Wang, R; Aggarwal, AK; Jung, JU; Garcia-Sastre, A				Nistal-Villan, Estanislao; Gack, Michaela U.; Martinez-Delgado, Gustavo; Maharaj, Natalya P.; Inn, Kyung-Soo; Yang, Heyi; Wang, Rong; Aggarwal, Aneel K.; Jung, Jae U.; Garcia-Sastre, Adolfo			Negative Role of RIG-I Serine 8 Phosphorylation in the Regulation of Interferon-beta Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; E3 UBIQUITIN LIGASE; DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; INFLUENZA-A; TRANSCRIPTION FACTORS; ADAPTER PROTEIN; NS1 PROTEIN; INDUCTION; RECOGNITION	RIG-I (retinoic acid-inducible gene I) and TRIM25 (tripartite motif protein 25) have emerged as key regulatory factors to induce interferon (IFN)-mediated innate immune responses to limit viral replication. Upon recognition of viral RNA, TRIM25 E3 ligase binds the first caspase recruitment domain (CARD) of RIG-I and subsequently induces lysine 172 ubiquitination of the second CARD of RIG-I, which is essential for the interaction with downstream MAVS/IPS-1/CARDIF/VISA and, thereby, IFN-beta mRNA production. Although ubiquitination has emerged as a major factor involved in RIG-I activation, the potential contribution of other post-translational modifications, such as phosphorylation, to the regulation of RIG-I activity has not been addressed. Here, we report the identification of serine 8 phosphorylation at the first CARD of RIG-I as a negative regulatory mechanism of RIG-I-mediated IFN-beta production. Immunoblot analysis with a phosphospecific antibody showed that RIG-I serine 8 phosphorylation steady-state levels were decreased upon stimulation of cells with IFN-beta or virus infection. Substitution of serine 8 in the CARD RIG-I functional domain with phosphomimetic aspartate or glutamate results in decreased TRIM25 binding, RIG-I ubiquitination, MAVS binding, and downstream signaling. Finally, sequence comparison reveals that only primate species carry serine 8, whereas other animal species carry an asparagine, indicating that serine 8 phosphorylation may represent a primate-specific regulation of RIG-I activation. Collectively, these data suggest that the phosphorylation of RIG-I serine 8 operates as a negative switch of RIG-I activation by suppressing TRIM25 interaction, further underscoring the importance of RIG-I and TRIM25 connection in type I IFN signal transduction.	[Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Div Infect Dis, Dept Med, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Yang, Heyi; Wang, Rong] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Aggarwal, Aneel K.] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Gack, Michaela U.; Maharaj, Natalya P.; Jung, Jae U.] Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA; [Gack, Michaela U.; Maharaj, Natalya P.; Jung, Jae U.] Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Div Tumor Virol, Southborough, MA 01772 USA; [Inn, Kyung-Soo; Jung, Jae U.] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard University; University of Southern California	Garcia-Sastre, A (corresponding author), Mt Sinai Sch Med, Dept Microbiol, 1 Gustave L Levy Pl,Box 1124, New York, NY 10029 USA.	adolfo.garcia-sastre@mssm.edu	Inn, Kyung-Soo/AAJ-4118-2020; Martinez-Delgado, Gustavo/X-7033-2019; Nistal-Villán, Estanislao/AAM-8029-2020; Nistal-Villan, Estanislao/GWM-7994-2022; Wang, Rong/A-8721-2009	Martinez-Delgado, Gustavo/0000-0003-4655-3770; Nistal-Villán, Estanislao/0000-0003-2458-8833; Garcia-Sastre, Adolfo/0000-0002-6551-1827	National Institutes of Health (NIH) [RR00168, CA082057, U19AI083025, AI083355, AI041706, R01AI46954]; NIH, NIAID [HHSN266200700010C]; Fletcher Jones Foundation; Hastings Foundation; NATIONAL CANCER INSTITUTE [R01CA082057] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR000168, P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046954, R01AI083355, R01AI041706, R01AI087846, U19AI083025] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fletcher Jones Foundation; Hastings Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants RR00168 (to M. U. G.); CA082057, U19AI083025, and AI083355 (to J. U. J. and M. U. G.); AI041706 (to A. K. A.); and U19AI083025 and R01AI46954 and NIH, NIAID, Contract HHSN266200700010C (to A. G.-S.). This work was also supported by grants from the Fletcher Jones Foundation and Hastings Foundation (to J. U. J. and M. U. G.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09; Gao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005760; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Levy DE, 2002, J EXP MED, V195, pF15, DOI 10.1084/jem.20020075; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Palkowitsch L, 2008, J BIOL CHEM, V283, P76, DOI 10.1074/jbc.M708856200; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Steen Hanno, 2002, Sci STKE, V2002, ppl16, DOI 10.1126/stke.2002.154.pl16; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009	42	84	90	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20252	20261		10.1074/jbc.M109.089912	http://dx.doi.org/10.1074/jbc.M109.089912			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20406818	Green Published, hybrid			2022-12-25	WOS:000279012000060
J	van Duijn, TJ; Anthony, EC; Hensbergen, PJ; Deelder, AM; Hordijk, PL				van Duijn, Trynette J.; Anthony, Eloise C.; Hensbergen, Paul J.; Deelder, Andre M.; Hordijk, Peter L.			Rac1 Recruits the Adapter Protein CMS/CD2AP to Cell-Cell Contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PODOCYTE SLIT-DIAPHRAGM; RHO GTPASES; NEPHROTIC SYNDROME; IN-VITRO; CD2AP; MIGRATION; NEPHRIN; RAP1; CMS; IDENTIFICATION	Rac1 is a member of the Rho family of small GTPases, which regulate cell adhesion and migration through their control of the actin cytoskeleton. Rho-GTPases are structurally very similar, with the exception of a hypervariable domain in the C terminus. Using peptide-based pulldown assays in combination with mass spectrometry, we previously showed that the hypervariable domain in Rac1 mediates specific protein-protein interactions. Most recently, we found that the Rac1 C terminus associates to the ubiquitously expressed adapter protein CMS/CD2AP. CD2AP is critical for the formation and maintenance of a specialized cell-cell contact between kidney podocyte foot processes, the slit diaphragm. Here, CD2AP links the cell adhesion protein nephrin to the actin cytoskeleton. In addition, CMS/CD2AP binds actin-regulating proteins, such as CAPZ and cortactin, and has been implicated in the internalization of growth factor receptors. We found that CD2AP specifically interacts with the C-terminal domain of Rac1 but not with that of other Rho family members. Efficient interaction between Rac1 and CD2AP requires both the proline-rich domain and the polybasic region in the Rac1 C terminus, and at least two of the three N-terminal SH3 domains of CD2AP. CD2AP co-localizes with Rac1 to membrane ruffles, and small interfering RNA-based experiments showed that CD2AP links Rac1 to CAPZ and cortactin. Finally, expression of constitutive active Rac1 recruits CD2AP to cell-cell contacts in epithelial cells, where we found CD2AP to participate in the control of the epithelial barrier function. These data identify CD2AP as a novel Rac1-associated adapter protein that participates in the regulation of epithelial cell-cell contact.	Univ Amsterdam, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands; [Hensbergen, Paul J.; Deelder, Andre M.] Leiden Univ, Med Ctr, Biomol Mass Spectrometry Unit, Dept Parasitol, NL-2333 ZA Leiden, Netherlands	University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hordijk, PL (corresponding author), Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	p.hordijk@sanquin.nl		Hensbergen, Paul/0000-0002-3193-5445; Hordijk, Peter/0000-0002-3348-078X				Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Attias O, 2010, NEPHRON EXP NEPHROL, V114, pE93, DOI 10.1159/000262317; Becker PM, 2001, AM J PHYSIOL-LUNG C, V281, pL1500, DOI 10.1152/ajplung.2001.281.6.L1500; Bruck S, 2006, J BIOL CHEM, V281, P19196, DOI 10.1074/jbc.M600166200; Chung CY, 2000, P NATL ACAD SCI USA, V97, P5225, DOI 10.1073/pnas.97.10.5225; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Gigante M, 2009, NEPHROL DIAL TRANSPL, V24, P1858, DOI 10.1093/ndt/gfn712; Haeusler LC, 2003, FEBS LETT, V555, P556, DOI 10.1016/S0014-5793(03)01351-6; Hajdo-Milasinovic A, 2007, J CELL SCI, V120, P555, DOI 10.1242/jcs.03364; Ho A, 2001, CANCER RES, V61, P474; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Hutchings NJ, 2003, J BIOL CHEM, V278, P22396, DOI 10.1074/jbc.M302540200; Johnson RI, 2008, J CELL BIOL, V180, P1191, DOI 10.1083/jcb.200706108; Kanters E, 2008, J BIOL CHEM, V283, P31830, DOI 10.1074/jbc.M804888200; Kawachi H, 2006, NEPHROLOGY, V11, P274, DOI 10.1111/j.1440-1797.2006.00583.x; Khoshnoodi J, 2001, EXP NEPHROL, V9, P355; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; Kirsch KH, 1999, P NATL ACAD SCI USA, V96, P6211, DOI 10.1073/pnas.96.11.6211; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Kowanetz K, 2003, J BIOL CHEM, V278, P39735, DOI 10.1074/jbc.M304541200; Lehtonen S, 2002, AM J PHYSIOL-RENAL, V283, pF734, DOI 10.1152/ajprenal.00312.2001; Li C, 2000, AM J PHYSIOL-RENAL, V279, pF785, DOI 10.1152/ajprenal.2000.279.4.F785; Lorenowicz MJ, 2008, EUR J CELL BIOL, V87, P779, DOI 10.1016/j.ejcb.2008.05.004; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Moncalian G, 2006, J BIOL CHEM, V281, P38845, DOI 10.1074/jbc.M606411200; Mustonen H, 2005, BIOCHEM BIOPH RES CO, V332, P426, DOI 10.1016/j.bbrc.2005.04.140; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; Pop M, 2004, J BIOL CHEM, V279, P35840, DOI 10.1074/jbc.M404346200; Popoff MR, 2009, BBA-BIOMEMBRANES, V1788, P797, DOI 10.1016/j.bbamem.2009.01.011; Price LS, 2004, J BIOL CHEM, V279, P35127, DOI 10.1074/jbc.M404917200; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; ten Klooster JP, 2007, BIOL CELL, V99, P1, DOI 10.1042/BC20060071; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; Voermans C, 2001, BLOOD, V97, P799, DOI 10.1182/blood.V97.3.799; Welsch T, 2001, AM J PHYSIOL-RENAL, V281, pF769, DOI 10.1152/ajprenal.2001.281.4.F769; Wolf G, 2003, LANCET, V362, P1746, DOI 10.1016/S0140-6736(03)14856-8; Yamazaki D, 2007, J CELL SCI, V120, P86, DOI 10.1242/jcs.03311; Yuan HP, 2002, AM J PHYSIOL-RENAL, V282, pF585, DOI 10.1152/ajprenal.00290.2001	50	39	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20137	20146		10.1074/jbc.M109.099481	http://dx.doi.org/10.1074/jbc.M109.099481			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20404345	Green Published, hybrid			2022-12-25	WOS:000279012000048
J	Wice, BM; Wang, SY; Crimmins, DL; Diggs-Andrews, KA; Althage, MC; Ford, EL; Tran, H; Ohlendorf, M; Griest, TA; Wang, QL; Fisher, SJ; Ladenson, JH; Polonsky, KS				Wice, Burton M.; Wang, Songyan; Crimmins, Dan L.; Diggs-Andrews, Kelly A.; Althage, Matthew C.; Ford, Eric L.; Tran, Hung; Ohlendorf, Matthew; Griest, Terry A.; Wang, Qiuling; Fisher, Simon J.; Ladenson, Jack H.; Polonsky, Kenneth S.			Xenin-25 Potentiates Glucose-dependent Insulinotropic Polypeptide Action via a Novel Cholinergic Relay Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; GASTRIC-INHIBITORY POLYPEPTIDE; MUSCARINIC ACETYLCHOLINE-RECEPTOR; ACTIVATED PROTEIN-KINASE; TYPE-2 DIABETES-MELLITUS; RAT PANCREATIC-ISLETS; BETA-CELL LINE; ENTEROINSULAR AXIS; INCRETIN HORMONES; IN-VITRO	The intestinal peptides GLP-1 and GIP potentiate glucose-mediated insulin release. Agents that increase GLP-1 action are effective therapies in type 2 diabetes mellitus (T2DM). However, GIP action is blunted in T2DM, and GIP-based therapies have not been developed. Thus, it is important to increase our understanding of the mechanisms of GIP action. We developed mice lacking GIP-producing K cells. Like humans with T2DM, "GIP/DT" animals exhibited a normal insulin secretory response to exogenous GLP-1 but a blunted response to GIP. Pharmacologic doses of xenin-25, another peptide produced by K cells, restored the GIP-mediated insulin secretory response and reduced hyperglycemia in GIP/DT mice. Xenin-25 alone had no effect. Studies with islets, insulin-producing cell lines, and perfused pancreata indicated xenin-25 does not enhance GIP-mediated insulin release by acting directly on the beta-cell. The in vivo effects of xenin-25 to potentiate insulin release were inhibited by atropine sulfate and atropine methyl bromide but not by hexamethonium. Consistent with this, carbachol potentiated GIP-mediated insulin release from in situ perfused pancreata of GIP/DT mice. In vivo, xenin-25 did not activate c-fos expression in the hind brain or paraventricular nucleus of the hypothalamus indicating that central nervous system activation is not required. These data suggest that xenin-25 potentiates GIP-mediated insulin release by activating non-ganglionic cholinergic neurons that innervate the islets, presumably part of an enteric-neuronal-pancreatic pathway. Xenin-25, or molecules that increase acetylcholine receptor signaling in beta-cells, may represent a novel approach to overcome GIP resistance and therefore treat humans with T2DM.	[Wice, Burton M.; Wang, Songyan; Diggs-Andrews, Kelly A.; Althage, Matthew C.; Ford, Eric L.; Tran, Hung; Wang, Qiuling; Fisher, Simon J.; Polonsky, Kenneth S.] Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Crimmins, Dan L.; Ohlendorf, Matthew; Griest, Terry A.; Ladenson, Jack H.] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Lab & Genom Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Wice, BM (corresponding author), Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	bwice@dom.wustl.edu			National Institutes of Health [DK31842, RC1DK086163]; American Diabetes Association; Washington University Clinical Nutrition Research Center [P30 DK056341]; Washington University Digestive Diseases Research Core Center Morphology and Transgenic Mouse Cores [5P30 DK052574]; Washington University Diabetes Research and Training Center Radioimmunoassay, Transgenic and Mouse Phenotyping Cores [P60 DK020579]; Washington University Clinical and Translational Science Award [UL1 RR024992]; Blum Kovler Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, P60DK020579, R01DK088126, R37DK031842, R01DK031842, RC1DK086163, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Washington University Clinical Nutrition Research Center; Washington University Digestive Diseases Research Core Center Morphology and Transgenic Mouse Cores; Washington University Diabetes Research and Training Center Radioimmunoassay, Transgenic and Mouse Phenotyping Cores; Washington University Clinical and Translational Science Award; Blum Kovler Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK31842 (to K.S.P.) and RC1DK086163 (to B.M.W. and K.S.P.). This work was also supported by funds from a Career Development Award from the American Diabetes Association (to B.M.W.), by a pilot and feasibility grant from the Washington University Clinical Nutrition Research Center (Grant P30 DK056341 to B.M.W.), by the Washington University Digestive Diseases Research Core Center Morphology and Transgenic Mouse Cores (Grant 5P30 DK052574), by the Washington University Diabetes Research and Training Center Radioimmunoassay, Transgenic and Mouse Phenotyping Cores (Grant P60 DK020579), by a Washington University Clinical and Translational Science Award (UL1 RR024992), and by the Blum Kovler Foundation. Washington University is pursuing a patent related to the use of xenin-25 to treat T2DM. In the future, this could lead to personal financial benefit to B.M.W., K.S.P., and the University.	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Ahren B, 2001, DIABETES, V50, P1030, DOI 10.2337/diabetes.50.5.1030; Ahren B, 2004, INT TXB DIABETES MEL, P153; Alexiou C, 1998, BRAIN RES, V800, P294, DOI 10.1016/S0006-8993(98)00535-6; Althage MC, 2008, J BIOL CHEM, V283, P18365, DOI 10.1074/jbc.M710466200; Anlauf M, 2000, J HISTOCHEM CYTOCHEM, V48, P1617, DOI 10.1177/002215540004801205; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Barrie AP, 1997, J BIOL CHEM, V272, P19666, DOI 10.1074/jbc.272.32.19666; BIESOLD D, 1989, NEUROSCI LETT, V98, P39, DOI 10.1016/0304-3940(89)90370-4; Brand SJ, 1995, TXB GASTROENTEROLOGY, P25; BREZENOFF HE, 1988, LIFE SCI, V42, P905, DOI 10.1016/0024-3205(88)90389-X; BROWN JH, 2006, GOODMAN GILMANS PHAR, P1; Campbell RK, 2007, ANN PHARMACOTHER, V41, P51, DOI 10.1345/aph.1H459; Christophe J, 1998, ANN NY ACAD SCI, V865, P323, DOI 10.1111/j.1749-6632.1998.tb11192.x; Cline MA, 2007, BEHAV BRAIN RES, V179, P28, DOI 10.1016/j.bbr.2007.01.008; Cohen A, 2007, CURR MED RES OPIN, V23, P905, DOI 10.1185/030079907X182068; Cooke JH, 2009, OBESITY, V17, P1135, DOI 10.1038/oby.2008.652; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Ehses JA, 2002, J BIOL CHEM, V277, P37088, DOI 10.1074/jbc.M205055200; ELAHI D, 1994, REGUL PEPTIDES, V51, P63, DOI 10.1016/0167-0115(94)90136-8; FEHMANN HC, 1995, ENDOCR REV, V16, P390, DOI 10.1210/er.16.3.390; Feurle GE, 1998, PEPTIDES, V19, P609, DOI 10.1016/S0196-9781(97)00378-1; Feurle GE, 2003, REGUL PEPTIDES, V111, P153, DOI 10.1016/S0167-0115(02)00281-1; Feurle GE, 1996, J PHARMACOL EXP THER, V278, P654; Feurle GE, 1997, J PEPT RES, V49, P324; Feurle GE, 2001, NEUROGASTROENT MOTIL, V13, P237, DOI 10.1046/j.1365-2982.2001.00263.x; Filipsson K, 2000, AM J PHYSIOL-REG I, V279, pR424, DOI 10.1152/ajpregu.2000.279.2.R424; Freeman R, 2005, LANCET, V365, P1259, DOI 10.1016/S0140-6736(05)74815-7; FRODIN M, 1995, J BIOL CHEM, V270, P7882, DOI 10.1074/jbc.270.14.7882; Gautam D, 2007, DIABETES OBES METAB, V9, P158, DOI 10.1111/j.1463-1326.2007.00781.x; Gautam D, 2006, CELL METAB, V4, P363, DOI 10.1016/j.cmet.2006.09.008; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; HAMSCHER G, 1995, PEPTIDES, V16, P791, DOI 10.1016/0196-9781(95)00053-M; Hojberg PV, 2009, DIABETOLOGIA, V52, P199, DOI 10.1007/s00125-008-1195-5; Idol RA, 2007, BLOOD CELL MOL DIS, V39, P35, DOI 10.1016/j.bcmd.2007.02.001; Iismaa TP, 2000, DIABETES, V49, P392, DOI 10.2337/diabetes.49.3.392; Ilcol YO, 2008, NEUROSCI LETT, V431, P71, DOI 10.1016/j.neulet.2007.11.024; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; JOHNSTON CF, 1988, HISTOCHEMISTRY, V90, P161, DOI 10.1007/BF00500981; Kamiyama Y, 2007, NEUROGASTROENT MOTIL, V19, P233, DOI 10.1111/j.1365-2982.2006.00881.x; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Kirchgessner A L, 1991, Z Gastroenterol Verh, V26, P230; KIRCHGESSNER AL, 1992, DEV DYNAM, V194, P142, DOI 10.1002/aja.1001940207; KIRCHGESSNER AL, 1990, J NEUROSCI, V10, P1626; Laterza OF, 2006, CLIN CHEM, V52, P1713, DOI 10.1373/clinchem.2006.070912; Leckstrom A, 2009, DIABETES, V58, P87, DOI 10.2337/db08-0260; Leiter EH, 2004, DIABETES, V53, pS4, DOI 10.2337/diabetes.53.2007.S4; Li L, 2005, AM J PHYSIOL-ENDOC M, V288, pE208, DOI 10.1152/ajpendo.00346.2004; MALICK JB, 1975, J PHARM SCI, V64, P1066, DOI 10.1002/jps.2600640650; McKennon SA, 2007, DIABETES EDUCATOR, V33, P55, DOI 10.1177/0145721706297451; Meier JJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE621, DOI 10.1152/ajpendo.00499.2003; Miki T, 2005, DIABETES, V54, P1056, DOI 10.2337/diabetes.54.4.1056; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Montrose-Rafizadeh C, 1999, ENDOCRINOLOGY, V140, P1132, DOI 10.1210/en.140.3.1132; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Nustede R, 1999, REGUL PEPTIDES, V81, P61, DOI 10.1016/S0167-0115(99)00019-1; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; Pamir N, 2003, AM J PHYSIOL-ENDOC M, V284, pE931, DOI 10.1152/ajpendo.00270.2002; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; Reifsnyder PC, 2002, DIABETES, V51, P825, DOI 10.2337/diabetes.51.3.825; Renuka TR, 2006, NEUROCHEM RES, V31, P313, DOI 10.1007/s11064-005-9022-6; Silvestre JS, 2005, METHOD FIND EXP CLIN, V27, P289, DOI 10.1358/mf.2005.27.5.908643; Silvestre RA, 2003, REGUL PEPTIDES, V115, P25, DOI 10.1016/S0167-0115(03)00147-2; Sreenan S, 1996, AM J PHYSIOL-ENDOC M, V271, pE742, DOI 10.1152/ajpendo.1996.271.4.E742; TERHORST GJ, 1986, BRAIN RES BULL, V16, P231; Tornoe K, 1997, AM J PHYSIOL-GASTR L, V273, pG436, DOI 10.1152/ajpgi.1997.273.2.G436; Vilsboll T, 2002, DIABETOLOGIA, V45, P1111, DOI 10.1007/s00125-002-0878-6; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; WALSH JH, 1994, PHYSL GASTROINTESTIN, V1, P1; Wice BM, 2001, DIABETOLOGIA, V44, P453, DOI 10.1007/s001250051643; Winawer MR, 2007, MAMM GENOME, V18, P23, DOI 10.1007/s00335-006-0087-6; Winzell MS, 2007, PEPTIDES, V28, P1805, DOI 10.1016/j.peptides.2007.04.024; Woods SC, 2008, J CLIN ENDOCR METAB, V93, pS37, DOI 10.1210/jc.2008-1630; Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x; Yuan J, 2008, J CELL BIOCHEM, V103, P648, DOI 10.1002/jcb.21439; Zawalich WS, 2004, BIOCHEM BIOPH RES CO, V315, P872, DOI 10.1016/j.bbrc.2004.01.139	80	57	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19842	19853		10.1074/jbc.M110.129304	http://dx.doi.org/10.1074/jbc.M110.129304			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20421298	Green Published, hybrid			2022-12-25	WOS:000279012000017
J	Atkinson, A; Khalimonchuk, O; Smith, P; Sabic, H; Eide, D; Winge, DR				Atkinson, Aaron; Khalimonchuk, Oleh; Smith, Pamela; Sabic, Hana; Eide, David; Winge, Dennis R.			Mzm1 Influences a Labile Pool of Mitochondrial Zinc Important for Respiratory Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME BC(1) COMPLEX; SACCHAROMYCES-CEREVISIAE; SYNAPTIC VESICLES; C-OXIDASE; YEAST; TRANSPORTERS; TRAFFICKING; SYNTHASE; BINDING; STORAGE	Zinc is essential for function of mitochondria as a cofactor for several matrix zinc metalloproteins. We demonstrate that a labile cationic zinc component of low molecular mass exists in the yeast mitochondrial matrix. This zinc pool is homeostatically regulated in response to the cellular zinc status. This pool of zinc is functionally important because matrix targeting of a cytosolic zinc-binding protein reduces the level of labile zinc and interferes with mitochondrial respiratory function. We identified a series of proteins that modulate the matrix zinc pool, one of which is a novel conserved mitochondrial protein designated Mzm1. Mutant mzm1 Delta cells have reduced total and labile mitochondrial zinc, and these cells are hypersensitive to perturbations of the labile pool. In addition, mzm1 Delta cells have a destabilized cytochrome c reductase (Complex III) without any effects on Complexes IV or V. Thus, we have established that a link exists between Complex III integrity and the labile mitochondrial zinc pool.	[Atkinson, Aaron; Khalimonchuk, Oleh; Smith, Pamela; Sabic, Hana; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; [Atkinson, Aaron; Khalimonchuk, Oleh; Smith, Pamela; Sabic, Hana; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA; [Eide, David] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Wisconsin System; University of Wisconsin Madison	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA.	dennis.winge@hsc.utah.edu	Khalimonchuk, Oleh/AAM-1194-2021	Khalimonchuk, Oleh/0000-0002-3972-8678	Center for Excellence in Molecular Hematology (CEMH); FPLC [DK P30 072437]; National Institutes of Health [GM083292, GM56285, T32 DK007115]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072437, T32DK007115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056285, R01GM083292] Funding Source: NIH RePORTER	Center for Excellence in Molecular Hematology (CEMH); FPLC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Amanda Bird for her gift of the Adh1 expression construct and Dr. Jared Rutter for participation in the CEMH yeast consortium efforts. We acknowledge the support of the Center for Excellence in Molecular Hematology (CEMH) core facility for FPLC chromatography and pilot project funding (DK P30 072437).; This work was supported, in whole or in part, by National Institutes of Health Grants GM083292 (to D. R. W.) and GM56285 (to D. E.).; Supported by National Institutes of Health Training Grant T32 DK007115.	Atkinson A, 2009, CHEM REV, V109, P4708, DOI 10.1021/cr900006y; Berry EA, 2000, BBA-BIOENERGETICS, V1459, P440, DOI 10.1016/S0005-2728(00)00182-1; BRAUN HP, 1992, EMBO J, V11, P3219, DOI 10.1002/j.1460-2075.1992.tb05399.x; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Coyne HJ, 2007, J BIOL CHEM, V282, P8926, DOI 10.1074/jbc.M610303200; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Dinur-Mills M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002161; Domaille DW, 2008, NAT CHEM BIOL, V4, P168, DOI 10.1038/nchembio.69; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Haase H, 2002, BIOCHEM BIOPH RES CO, V296, P923, DOI 10.1016/S0006-291X(02)02017-X; Hess DC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000407; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Jackson KA, 2007, J BIOL CHEM, V282, P10423, DOI 10.1074/jbc.M610535200; Leskovac V, 2002, FEMS YEAST RES, V2, P481, DOI 10.1111/j.1567-1364.2002.tb00116.x; Linkous DH, 2008, J HISTOCHEM CYTOCHEM, V56, P3, DOI 10.1369/jhc.6A7035.2007; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Mesecke N, 2008, EMBO REP, V9, P1107, DOI 10.1038/embor.2008.173; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Sekiya-Kawasaki M, 2002, GENETICS, V162, P663; Sensi SL, 2003, CELL CALCIUM, V34, P281, DOI 10.1016/S0143-4160(03)00122-2; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; SHANNON KW, 1988, J BIOL CHEM, V263, P7717; Simm C, 2007, EUKARYOT CELL, V6, P1166, DOI 10.1128/EC.00077-07; Thompson RB, 2002, J NEUROSCI METH, V118, P63, DOI 10.1016/S0165-0270(02)00144-9; Wang QY, 2010, J BIOL CHEM, V285, P10408, DOI 10.1074/jbc.M109.085787; WHITE C, 1987, J GEN MICROBIOL, V133, P727; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	32	48	49	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19450	19459		10.1074/jbc.M110.109793	http://dx.doi.org/10.1074/jbc.M110.109793			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404342	hybrid, Green Published			2022-12-25	WOS:000278727800055
J	Georgopoulou, E; Mermelekas, G; Karena, E; Frillingos, S				Georgopoulou, Ekaterini; Mermelekas, George; Karena, Ekaterini; Frillingos, Stathis			Purine Substrate Recognition by the Nucleobase-Ascorbate Transporter Signature Motif in the YgfO Xanthine Permease ASN-325 BINDS AND ALA-323 SENSES SUBSTRATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; ESCHERICHIA-COLI; MEMBRANE-PROTEINS; LACTOSE PERMEASE; FUNCTIONAL-CHARACTERIZATION; NAT/NCS2 FAMILY; BACTERIAL; HELIX; SPECIFICITY; SELECTIVITY	The nucleobase-ascorbate transporter (NAT) signature motif is a conserved 11-amino acid sequence of the ubiquitous NAT/NCS2 family, essential for function and selectivity of both a bacterial (YgfO) and a fungal (UapA) purine-transporting homolog. We examined the role of NAT motif in more detail, using Cys-scanning and site-directed alkylation analysis of the YgfO xanthine permease of Escherichia coli. Analysis of single-Cys mutants in the sequence 315-339 for sensitivity to inactivation by 2-sulfonatoethyl methanethiosulfonate (MTSES-) and N-ethylmaleimide (NEM) showed a similar pattern: highly sensitive mutants clustering at the motif sequence (323-329) and a short alpha-helical face downstream (332, 333, 336). In the presence of substrate, N325C is protected from alkylation with either MTSES-or NEM, whereas sensitivity of A323C to inactivation by NEM is enhanced, shifting IC50 from 34 to 14 mu M. Alkylation or sensitivity of the other mutants is unaffected by substrate; the lack of an effect on Q324C is attributed to gross inability of this mutant for high affinity binding. Site-directed mutants G333R and S336N at the alpha-helical face downstream the motif display specific changes in ligand recognition relative to wild type; G333R allows binding of 7-methyl and 8-methylxanthine, whereas S336N disrupts affinity for 6-thioxanthine. Finally, all assayable motif-mutants are highly accessible to MTSES-from the periplasmic side. The data suggest that the NAT motif region lines the solvent- and substrate-accessible inner cavity, Asn-325 is at the binding site, Ala-323 responds to binding with a specific conformational shift, and Gly-333 and Ser-336 form part of the purine permeation pathway.	[Georgopoulou, Ekaterini; Mermelekas, George; Karena, Ekaterini; Frillingos, Stathis] Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece	University of Ioannina	Frillingos, S (corresponding author), Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece.	efriligo@cc.uoi.gr	Frillingos, Stathis/AAQ-3148-2021		European Union [03ED204]	European Union(European Commission)	This work was supported by the 03ED204 research project, implemented within the framework of the "Reinforcement Programme of Human Research Manpower" (PENED) and co-financed by National and Community Funds (25% from the Greek Ministry of Development, General Secretariat for Research and Technology, and 75% from the European Union European Social Fund).	Diallinas G, 1998, EMBO J, V17, P3827, DOI 10.1093/emboj/17.14.3827; Frillingos S, 1997, BIOCHEMISTRY-US, V36, P6408, DOI 10.1021/bi970233b; Frillingos S, 1997, PROTEIN SCI, V6, P438; FRILLINGOS S, 1994, BIOCHEMISTRY-US, V33, P8074, DOI 10.1021/bi00192a012; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Goudela S, 2005, MOL MEMBR BIOL, V22, P263, DOI 10.1080/09687860500093016; Goudela S, 2008, FUNGAL GENET BIOL, V45, P459, DOI 10.1016/j.fgb.2007.08.001; Gournas C, 2008, MOL BIOSYST, V4, P404, DOI 10.1039/b719777b; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Karatza P, 2005, MOL MEMBR BIOL, V22, P251, DOI 10.1080/09687860500092927; Karatza P, 2006, J BIOL CHEM, V281, P39881, DOI 10.1074/jbc.M605748200; Karena E, 2009, J BIOL CHEM, V284, P24257, DOI 10.1074/jbc.M109.030734; KONINGS WN, 1971, J BIOL CHEM, V246, P5857; Koukaki M, 2005, J MOL BIOL, V350, P499, DOI 10.1016/j.jmb.2005.04.076; Nie Y, 2009, BIOCHEMISTRY-US, V48, P738, DOI 10.1021/bi801976r; Papageorgiou L, 2008, J MOL BIOL, V382, P1121, DOI 10.1016/j.jmb.2008.08.005; Papakostas K, 2008, J BIOL CHEM, V283, P13666, DOI 10.1074/jbc.M800261200; Stroud Robert M., 2009, Journal of Structural and Functional Genomics, V10, P193, DOI 10.1007/s10969-008-9058-3; Tamura N, 2001, J BIOL CHEM, V276, P20330, DOI 10.1074/jbc.M007993200; Tavoulari S, 2008, J MOL BIOL, V376, P681, DOI 10.1016/j.jmb.2007.12.015; TEATHER RM, 1980, EUR J BIOCHEM, V108, P223, DOI 10.1111/j.1432-1033.1980.tb04715.x; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Velho AM, 2009, EXP CELL RES, V315, P2312, DOI 10.1016/j.yexcr.2009.04.007; Vlanti A, 2006, J MOL BIOL, V357, P808, DOI 10.1016/j.jmb.2005.12.070; Yamamoto S, 2010, J BIOL CHEM, V285, P6522, DOI 10.1074/jbc.M109.032961	28	19	19	3	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19422	19433		10.1074/jbc.M110.120543	http://dx.doi.org/10.1074/jbc.M110.120543			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20406814	Green Published, hybrid			2022-12-25	WOS:000278727800053
J	Gunasekaran, K; Pentony, M; Shen, M; Garrett, L; Forte, C; Woodward, A; Bin Ng, S; Born, T; Retter, M; Manchulenko, K; Sweet, H; Foltz, IN; Wittekind, M; Yan, W				Gunasekaran, Kannan; Pentony, Martin; Shen, Min; Garrett, Logan; Forte, Carla; Woodward, Anne; Bin Ng, Soo; Born, Teresa; Retter, Marc; Manchulenko, Kathy; Sweet, Heather; Foltz, Ian N.; Wittekind, Michael; Yan, Wei			Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects APPLICATIONS TO BISPECIFIC MOLECULES AND MONOVALENT IgG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; COILED-COIL; CONSTANT DOMAINS; IN-VIVO; DESIGN; FRAGMENT; IDENTIFICATION; THERAPEUTICS; ASSOCIATION; INTERFACE	Naturally occurring IgG antibodies are bivalent and monospecific. Bispecific antibodies having binding specificities for two different antigens can be produced using recombinant technologies and are projected to have broad clinical applications. However, co-expression of multiple light and heavy chains often leads to contaminants and pose purification challenges. In this work, we have modified the CH3 domain interface of the antibody Fc region with selected mutations so that the engineered Fc proteins preferentially form heterodimers. These novel mutations create altered charge polarity across the Fc dimer interface such that coexpression of electrostatically matched Fc chains support favorable attractive interactions thereby promoting desired Fc heterodimer formation, whereas unfavorable repulsive charge interactions suppress unwanted Fc homodimer formation. This new Fc heterodimer format was used to produce bispecific single chain antibody fusions and monovalent IgGs with minimal homodimer contaminants. The strategy proposed here demonstrates the feasibility of robust production of novel Fc-based heterodimeric molecules and hence broadens the scope of bispecific molecules for therapeutic applications.	[Gunasekaran, Kannan; Pentony, Martin; Shen, Min; Garrett, Logan; Forte, Carla; Woodward, Anne; Wittekind, Michael; Yan, Wei] Amgen Inc, Dept Prot Sci, Seattle, WA 98119 USA; [Bin Ng, Soo; Born, Teresa] Amgen Inc, Dept Inflammat, Seattle, WA 98119 USA; [Retter, Marc] Amgen Inc, Dept Pharmacokinet & Drug Metab, Seattle, WA 98119 USA; [Manchulenko, Kathy; Sweet, Heather; Foltz, Ian N.] Amgen British Columbia, Burnaby, BC V5A 1V7, Canada	Amgen; Amgen; Amgen	Gunasekaran, K (corresponding author), Amgen Inc, Dept Prot Sci, Seattle, WA 98119 USA.	kannan@amgen.com; mwitteki@amgen.com; ywei@amgen.com		Sweet, Heather/0000-0001-7478-0474				Arndt KM, 2002, STRUCTURE, V10, P1235, DOI 10.1016/S0969-2126(02)00838-9; Arndt KM, 2000, J MOL BIOL, V295, P627, DOI 10.1006/jmbi.1999.3352; Arndt KM, 2001, J MOL BIOL, V312, P221, DOI 10.1006/jmbi.2001.4915; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; BERNSTEIN FC, 1977, J MOL BIOL, V112, P542; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Carter P, 2001, J IMMUNOL METHODS, V248, P7, DOI 10.1016/S0022-1759(00)00339-2; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Dumont JA, 2006, BIODRUGS, V20, P151, DOI 10.2165/00063030-200620030-00002; ELLERSON JR, 1976, J IMMUNOL, V116, P510; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Fredericks ZL, 2004, PROTEIN ENG DES SEL, V17, P95, DOI 10.1093/protein/gzh012; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; KUNG PC, 1979, SCIENCE, V206, P347, DOI 10.1126/science.314668; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Marvin JS, 2003, BIOCHEMISTRY-US, V42, P7077, DOI 10.1021/bi026947q; MATTHEWS BW, 1995, ADV PROTEIN CHEM, V46, P249, DOI 10.1016/S0065-3233(08)60337-X; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; MILLER S, 1990, J MOL BIOL, V216, P965, DOI 10.1016/S0022-2836(99)80014-X; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Pokala N, 2005, J MOL BIOL, V347, P203, DOI 10.1016/j.jmb.2004.12.019; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Worn A, 1999, BIOCHEMISTRY-US, V38, P8739, DOI 10.1021/bi9902079; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430	33	187	393	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19637	19646		10.1074/jbc.M110.117382	http://dx.doi.org/10.1074/jbc.M110.117382			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20400508	hybrid, Green Published			2022-12-25	WOS:000278727800073
J	Miedlich, SU; Zalutskaya, A; Zhu, ED; Demay, MB				Miedlich, Susanne U.; Zalutskaya, Alena; Zhu, Eric D.; Demay, Marie B.			Phosphate-induced Apoptosis of Hypertrophic Chondrocytes Is Associated with a Decrease in Mitochondrial Membrane Potential and Is Dependent upon Erk1/2 Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PEPTIDE; SIGNALING PATHWAY; RICKETS; MATURATION; MICE; MINERALIZATION; EXPRESSION	Growth plate abnormalities, associated with impaired hypertrophic chondrocyte apoptosis, are observed in humans and animals with abnormalities of vitamin D action and renal phosphate reabsorption. Low circulating phosphate levels impair hypertrophic chondrocyte apoptosis, whereas treatment of these cells with phosphate activates the mitochondrial apoptotic pathway. Because phosphate-mediated apoptosis of chondrocytes is differentiation-dependent, studies were performed to identify factors that contribute to hypertrophic chondrocyte apoptosis. An increase in the percentage of cells with low mitochondrial membrane potential, evaluated by JC-1 fluorescence, was observed during hypertrophic differentiation of primary murine chondrocytes in culture. This percentage was further increased by treatment of hypertrophic, but not proliferative, chondrocytes with phosphate. Phosphate-mediated apoptosis was observed as early as 30 min post-treatment and was dependent upon Erk1/2 phosphorylation. Inhibition of Erk1/2 phosphorylation in vivo confirmed an important role for this signaling pathway in regulating hypertrophic chondrocyte apoptosis in growing mice. Murine embryonic metatarsals cultured under phosphate-restricted conditions demonstrated a 2.5-fold increase in parathyroid hormone-related protein mRNA expression accompanied by a marked attenuation in phospho-Erk immunoreactivity in hypertrophic chondrocytes. Thus, these investigations point to an important role for phosphate in regulating mitochondrial membrane potential in hypertrophic chondrocytes and growth plate maturation by the parathyroid hormone-related protein signaling pathway.	[Miedlich, Susanne U.; Zalutskaya, Alena; Zhu, Eric D.; Demay, Marie B.] Harvard Univ, Endocrine Unit, Sch Med, Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Demay, MB (corresponding author), Harvard Univ, Endocrine Unit, Sch Med, Massachusetts Gen Hosp, 50 Blossom St,Thier 11, Boston, MA 02114 USA.	demay@helix.mgh.harvard.edu			National Institutes of Health [R01 DK46974, P50 AR054086, T32 DK007028]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046974, T32DK007028] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK46974, P50 AR054086, and T32 DK007028.	Amizuka N, 1996, ENDOCRINOLOGY, V137, P5055, DOI 10.1210/en.137.11.5055; Amling M, 1997, J CELL BIOL, V136, P205, DOI 10.1083/jcb.136.1.205; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Chang WH, 2002, ENDOCRINOLOGY, V143, P1467, DOI 10.1210/en.143.4.1467; Donohue MM, 2002, ENDOCRINOLOGY, V143, P3691, DOI 10.1210/en.2002-220454; Julien M, 2007, ENDOCRINOLOGY, V148, P530, DOI 10.1210/en.2006-0763; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Li YP, 2004, AM J PHYSIOL-REG I, V287, pR328, DOI 10.1152/ajpregu.00042.2004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magne D, 2003, J BONE MINER RES, V18, P1430, DOI 10.1359/jbmr.2003.18.8.1430; Mansfield K, 2001, BONE, V28, P1, DOI 10.1016/S8756-3282(00)00409-9; Okoumassoun LE, 2007, J CELL PHYSIOL, V212, P591, DOI 10.1002/jcp.21055; Oshima Y, 2008, J BIOL CHEM, V283, P26499, DOI 10.1074/jbc.M800933200; PETTIFOR MP, 1997, VITAMIN D DEFICIENCY; Provot S, 2008, MOL CELL BIOL, V28, P344, DOI 10.1128/MCB.00617-07; Pucci R, 2007, J CELL PHYSIOL, V210, P609, DOI 10.1002/jcp.20857; Sabbagh Y, 2005, P NATL ACAD SCI USA, V102, P9637, DOI 10.1073/pnas.0502249102; Shimada T, 2002, ENDOCRINOLOGY, V143, P3179, DOI 10.1210/en.143.8.3179; Teixeira CC, 2003, J BONE MINER RES, V18, P662, DOI 10.1359/jbmr.2003.18.4.662; Teixeira CC, 2001, AM J PHYSIOL-CELL PH, V281, pC833, DOI 10.1152/ajpcell.2001.281.3.C833; Ueda K, 2007, BONE, V41, P13, DOI 10.1016/j.bone.2007.02.028; Zalutskaya AA, 2009, J CELL BIOCHEM, V108, P668, DOI 10.1002/jcb.22302	22	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18270	18275		10.1074/jbc.M109.098616	http://dx.doi.org/10.1074/jbc.M109.098616			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20404333	Green Published, hybrid			2022-12-25	WOS:000278453900019
J	Abu-Ali, GS; Ouellette, LM; Henderson, ST; Lacher, DW; Riordan, JT; Whittam, TS; Manning, SD				Abu-Ali, Galeb S.; Ouellette, Lindsey M.; Henderson, Scott T.; Lacher, David W.; Riordan, James T.; Whittam, Thomas S.; Manning, Shannon D.			Increased Adherence and Expression of Virulence Genes in a Lineage of Escherichia coli O157:H7 Commonly Associated with Human Infections	PLOS ONE			English	Article							ENTEROCYTE EFFACEMENT GENES; SHIGA-TOXIN; GENOME SEQUENCE; O157-H7; STRAINS; LOCUS; DISEASE; SECRETION; VARIANTS; LER	Background: Enterohemorrhagic Escherichia coli (EHEC) O157:H7, a food and waterborne pathogen, can be classified into nine phylogenetically distinct lineages, as determined by single nucleotide polymorphism genotyping. One lineage (clade 8) was found to be associated with hemolytic uremic syndrome (HUS), which can lead to kidney failure and death in some cases, particularly young children. Another lineage (clade 2) differs considerably in gene content and is phylogenetically distinct from clade 8, but caused significantly fewer cases of HUS in a prior study. Little is known, however, about how these two lineages vary with regard to phenotypic traits important for disease pathogenesis and in the expression of shared virulence genes. Methodology/Principal Findings: Here, we quantified the level of adherence to and invasion of MAC-T bovine epithelial cells, and examined the transcriptomes of 24 EHEC O157:H7 strains with varying Shiga toxin profiles from two common lineages. Adherence to epithelial cells was >2-fold higher for EHEC O157:H7 strains belonging to clade 8 versus clade 2, while no difference in invasiveness was observed between the two lineages. Whole-genome 70-mer oligo microarrays, which probe for 6088 genes from O157:H7 Sakai, O157:H7 EDL 933, pO157, and K12 MG1655, detected significant differential expression between clades in 604 genes following co-incubation with epithelial cells for 30 min; 186 of the 604 genes had a >1.5 fold change difference. Relative to clade 2, clade 8 strains showed upregulation of major virulence genes, including 29 of the 41 locus of enterocyte effacement (LEE) pathogenicity island genes, which are critical for adherence, as well as Shiga toxin genes and pO157 plasmid-encoded virulence genes. Differences in expression of 16 genes that encode colonization factors, toxins, and regulators were confirmed by qRT-PCR, which revealed a greater magnitude of change than microarrays. Conclusions/Significance: These findings demonstrate that the EHEC O157:H7 lineage associated with HUS expresses higher levels of virulence genes and has an enhanced ability to attach to epithelial cells relative to another common lineage.	[Abu-Ali, Galeb S.; Ouellette, Lindsey M.; Henderson, Scott T.; Riordan, James T.; Whittam, Thomas S.; Manning, Shannon D.] Michigan State Univ, Natl Food Safety & Toxicol Ctr, Microbial Evolut Lab, E Lansing, MI 48824 USA; [Lacher, David W.] US FDA, Div Mol Biol, Ctr Food Safety & Appl Nutr, Laurel, MD USA; [Manning, Shannon D.] Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA	Michigan State University; US Food & Drug Administration (FDA); Michigan State University	Abu-Ali, GS (corresponding author), Michigan State Univ, Natl Food Safety & Toxicol Ctr, Microbial Evolut Lab, E Lansing, MI 48824 USA.	Shannon.Manning@ht.msu.edu	Abu-Ali, Galeb/AAE-9742-2020; Manning, Shannon/GXA-0622-2022	Abu-Ali, Galeb/0000-0002-2599-2937; Manning, Shannon/0000-0001-9581-0660	NIAID; NIH [N01-AI-30058]; DHHS	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DHHS	This project was funded by the NIAID, NIH, DHHS, under NIH research contract N01-AI-30058 (TSW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ali GS, 2010, MICROBIOL-SGM, V156, P408, DOI 10.1099/mic.0.033126-0; Aldick T, 2007, MICROBES INFECT, V9, P282, DOI 10.1016/j.micinf.2006.12.001; Barba J, 2005, J BACTERIOL, V187, P7918, DOI 10.1128/JB.187.23.7918-7930.2005; Bergholz TM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-97; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Cummings L, 2002, FEMS MICROBIOL LETT, V216, P133, DOI 10.1016/S0378-1097(02)00955-2; Dahan S, 2004, INFECT IMMUN, V72, P5452, DOI 10.1128/IAI.72.9.5452-5459.2004; de Sablet T, 2008, MICROBIOL-SGM, V154, P176, DOI 10.1099/mic.0.2007/009704-0; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Dibb-Fuller MP, 2001, J MED MICROBIOL, V50, P759, DOI 10.1099/0022-1317-50-9-759; Dowd SE, 2008, J FOOD PROTECT, V71, P1673, DOI 10.4315/0362-028X-71.8.1673; Eaton KA, 2008, INFECT IMMUN, V76, P3054, DOI 10.1128/IAI.01626-07; Frenzen PD, 2005, J FOOD PROTECT, V68, P2623, DOI 10.4315/0362-028X-68.12.2623; Friedberg D, 1999, MOL MICROBIOL, V34, P941, DOI 10.1046/j.1365-2958.1999.01655.x; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Grys TE, 2005, INFECT IMMUN, V73, P1295, DOI 10.1128/IAI.73.3.1295-1303.2005; Haack KR, 2003, INFECT IMMUN, V71, P384, DOI 10.1128/IAI.71.1.384-392.2003; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Herold S, 2004, INT J MED MICROBIOL, V294, P115, DOI 10.1016/j.ijmm.2004.06.023; Iyoda S, 2005, J BACTERIOL, V187, P4086, DOI 10.1128/JB.187.12.4086-4094.2005; Jandu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004889; Jelacic JK, 2003, J INFECT DIS, V188, P719, DOI 10.1086/376999; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kerr MK, 2003, J COMPUT BIOL, V10, P891, DOI 10.1089/106652703322756131; Kim Y, 2009, INT J FOOD MICROBIOL, V131, P224, DOI 10.1016/j.ijfoodmicro.2009.03.002; Klapproth JA, 2000, INFECT IMMUN, V68, P2148, DOI 10.1128/IAI.68.4.2148-2155.2000; Klapproth JMA, 2005, INFECT IMMUN, V73, P1441, DOI 10.1128/IAI.73.3.1441-1451.2005; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; Koitabashi T, 2006, MICROBIOL IMMUNOL, V50, P135, DOI 10.1111/j.1348-0421.2006.tb03779.x; KULASEKARA BR, 2009, INFECT IMMUN; Laaberki MH, 2006, INT J MED MICROBIOL, V296, P197, DOI 10.1016/j.ijmm.2006.02.017; Laing CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-287; Leopold SR, 2009, P NATL ACAD SCI USA, V106, P8713, DOI 10.1073/pnas.0812949106; Los JM, 2009, MICROB PATHOGENESIS, V47, P289, DOI 10.1016/j.micpath.2009.09.006; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; OSTROFF SM, 1989, J INFECT DIS, V160, P994, DOI 10.1093/infdis/160.6.994; OSTROFF SM, 1989, JAMA-J AM MED ASSOC, V262, P355, DOI 10.1001/jama.262.3.355; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Persson S, 2007, J CLIN MICROBIOL, V45, P2020, DOI 10.1128/JCM.02591-06; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Robinson CM, 2006, P NATL ACAD SCI USA, V103, P9667, DOI 10.1073/pnas.0602359103; Russell RM, 2007, J BACTERIOL, V189, P5387, DOI 10.1128/JB.00553-07; Saitoh T, 2008, J BACTERIOL, V190, P4822, DOI 10.1128/JB.00231-08; SCHMIDT H, 1995, INFECT IMMUN, V63, P1055, DOI 10.1128/IAI.63.3.1055-1061.1995; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serra-Moreno R, 2008, J BACTERIOL, V190, P4722, DOI 10.1128/JB.00069-08; Shin S, 2001, MOL MICROBIOL, V41, P1133, DOI 10.1046/j.1365-2958.2001.02570.x; Spears KJ, 2006, FEMS MICROBIOL LETT, V255, P187, DOI 10.1111/j.1574-6968.2006.00119.x; Stevens MP, 2004, INFECT IMMUN, V72, P5402, DOI 10.1128/IAI.72.9.5402-5411.2004; STEVENS MP, 2005, ECOSAL ESCHERICHIA C; Strauch E, 2008, INFECT IMMUN, V76, P5466, DOI 10.1128/IAI.00875-08; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tatsuno I, 2001, INFECT IMMUN, V69, P6660, DOI 10.1128/IAI.69.11.6660-6669.2001; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Tomoyasu T, 2005, FEMS MICROBIOL LETT, V253, P59, DOI 10.1016/j.femsle.2005.09.020; Vanaja SK, 2010, APPL ENVIRON MICROB, V76, P60, DOI 10.1128/AEM.01666-09; Wagner PL, 2001, J BACTERIOL, V183, P2081, DOI 10.1128/JB.183.6.2081-2085.2001; R MAANOVA	62	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10167	10.1371/journal.pone.0010167	http://dx.doi.org/10.1371/journal.pone.0010167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422047	Green Published, Green Submitted, gold			2022-12-25	WOS:000276952500002
J	Ciribilli, Y; Andreotti, V; Menendez, D; Langen, JS; Schoenfelder, G; Resnick, MA; Inga, A				Ciribilli, Yari; Andreotti, Virginia; Menendez, Daniel; Langen, Jan-Stephan; Schoenfelder, Gilbert; Resnick, Michael A.; Inga, Alberto			The Coordinated P53 and Estrogen Receptor Cis-Regulation at an FLT1 Promoter SNP Is Specific to Genotoxic Stress and Estrogenic Compound	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-SUPPRESSOR P53; FACTOR-BINDING-SITES; RESPONSE ELEMENTS; TRANSCRIPTION-FACTOR; BREAST-CANCER; DNA-DAMAGE; GENE-EXPRESSION; VEGF; CELLS	Background: Recently, we established that a C>T single nucleotide polymorphism (SNP) in the promoter of the VEGF receptor FLT1 gene generates a 1/2 site p53 response element (RE-T) that results in p53 responsiveness of the promoter. The transcriptional control required an estrogen receptor (ER) 1/2 site response element (ERE1) 225 nt upstream to the RE-T. Methodology/Principal Findings: Here we report the identification of a second ER K site (ERE2) located 145 bp downstream of the RE-T and establish that both EREs can impact p53-mediated transactivation of FLT1-T in a manner that is cell type and ER level dependent. Gene reporter assays and ChIP experiments conducted in the breast cancer-derived MCF7 cells revealed that the ERE2 site was sufficient for p53-mediated ER alpha recruitment and transactivation of the FLT1-T promoter/reporter construct. Surprisingly, unlike the case for other p53 target promoters, p53-mediated transactivation of FLT1-T constructs or expression of the endogenous FLT1 gene, as well as binding of p53 and ER at the promoter constructs, was inducible by doxorubicin but not by 5-fluorouracil. Furthermore, ER activity at FLT1-T was differentially affected by ER ligands, compared to a control TFF1/pS2 ER target promoter. The p53-related transcription factors (TFs) p73 and p63 had no effect on FLT1 transactivation. Conclusions/Significance: We establish a new dimension to the p53 master regulatory network where p53-mediated transcription from a 1/2 site RE can be determined by ER binding at one or more cis-acting EREs in manner that is dependent on level of ER protein, the type of ER ligand and the specific p53-inducing agent.	[Ciribilli, Yari; Andreotti, Virginia; Inga, Alberto] Natl Inst Canc Res, IST, Unit Mol Mutagenesis & DNA Repair, Genoa, Italy; [Menendez, Daniel; Resnick, Michael A.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; [Langen, Jan-Stephan; Schoenfelder, Gilbert] Charite, Inst Clin Pharmacol & Toxicol, D-13353 Berlin, Germany; [Schoenfelder, Gilbert] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany; [Inga, Alberto] Univ Trent, CIBIO, Ctr Integrat Biol, Trento, Italy	University of Genoa; IRCCS AOU San Martino IST; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; University of Trento	Ciribilli, Y (corresponding author), Natl Inst Canc Res, IST, Unit Mol Mutagenesis & DNA Repair, Genoa, Italy.	inga@science.unitn.it	Andreotti, Virginia/AAB-5169-2022; Ciribilli, Yari/K-2751-2018; Andreotti, Virginia/K-4506-2016; resnick, Michael/F-1668-2019; Inga, Alberto/AAC-3815-2022	Andreotti, Virginia/0000-0002-2569-0832; Ciribilli, Yari/0000-0001-9231-379X; Andreotti, Virginia/0000-0002-2569-0832; resnick, Michael/0000-0002-8473-7506; Inga, Alberto/0000-0002-8767-1637; Schonfelder, Gilbert/0000-0001-6134-1990	Italian Association for Cancer Research, AIRC; NIEHS [1 Z01 ES065079]; Charite-Universitaetsmedizin Berlin; PhD School of Genetics Oncology and Developmental Biology, University of Genoa, Italy; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065079, ZIAES065079] Funding Source: NIH RePORTER	Italian Association for Cancer Research, AIRC(Fondazione AIRC per la ricerca sul cancro); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Charite-Universitaetsmedizin Berlin; PhD School of Genetics Oncology and Developmental Biology, University of Genoa, Italy; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partially supported by the Italian Association for Cancer Research, AIRC (to AI), intramural research funds from NIEHS project 1 Z01 ES065079 (to DM and MAR) and by the Charite-Universitaetsmedizin Berlin (to GS). YC was supported by a fellowship from the PhD School of Genetics Oncology and Developmental Biology, University of Genoa, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2004, INT J CANCER, V111, P165, DOI 10.1002/ijc.20214; Andre T, 2000, INT J CANCER, V86, P174, DOI 10.1002/(SICI)1097-0215(20000415)86:2<174::AID-IJC5>3.3.CO;2-5; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chappell JC, 2009, DEV CELL, V17, P377, DOI 10.1016/j.devcel.2009.07.011; Das B, 2005, CANCER RES, V65, P7267, DOI 10.1158/0008-5472.CAN-04-4575; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Driscoll MD, 1998, J BIOL CHEM, V273, P29321, DOI 10.1074/jbc.273.45.29321; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Espinosa JM, 2008, ONCOGENE, V27, P4013, DOI 10.1038/onc.2008.37; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Fan F, 2005, ONCOGENE, V24, P2647, DOI 10.1038/sj.onc.1208246; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; GEWIRTH DT, 1995, NAT STRUCT BIOL, V2, P386, DOI 10.1038/nsb0595-386; Ghanem MA, 2003, J CLIN PATHOL, V56, P107, DOI 10.1136/jcp.56.2.107; Hall JM, 2002, J BIOL CHEM, V277, P44455, DOI 10.1074/jbc.M200849200; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Heidenreich R, 2004, INT J CANCER, V111, P348, DOI 10.1002/ijc.20260; Hyder SM, 2000, CANCER RES, V60, P3183; Ilhan N, 2004, CLIN BIOCHEM, V37, P840, DOI 10.1016/j.clinbiochem.2004.03.012; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; Ishizaki H, 2006, CLIN CANCER RES, V12, P5841, DOI 10.1158/1078-0432.CCR-06-0750; Jegga AG, 2008, P NATL ACAD SCI USA, V105, P944, DOI 10.1073/pnas.0704694105; Jordan JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000104; Ju J, 2007, CLIN CANCER RES, V13, P4245, DOI 10.1158/1078-0432.CCR-06-2890; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; Kaeser MD, 2004, ONCOGENE, V23, P4007, DOI 10.1038/sj.onc.1207536; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; KLEINHITPASS L, 1988, NUCLEIC ACIDS RES, V16, P647, DOI 10.1093/nar/16.2.647; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; KUNZ C, 1995, NUCLEIC ACIDS RES, V23, P3710, DOI 10.1093/nar/23.18.3710; LaVallee TM, 2002, CANCER RES, V62, P3691; Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186; Levrero M, 2000, J CELL SCI, V113, P1661; Luttun A, 2002, ANN NY ACAD SCI, V979, P80, DOI 10.1111/j.1749-6632.2002.tb04870.x; McLure KG, 1998, EMBO J, V17, P3342, DOI 10.1093/emboj/17.12.3342; Menendez D, 2006, MOL CELL BIOL, V26, P2297, DOI 10.1128/MCB.26.6.2297-2308.2006; Menendez D, 2006, P NATL ACAD SCI USA, V103, P1406, DOI 10.1073/pnas.0508103103; Menendez D, 2007, MOL CELL BIOL, V27, P2590, DOI 10.1128/MCB.01742-06; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Newman SP, 2004, INT J CANCER, V109, P533, DOI 10.1002/ijc.20045; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; Pal S, 2001, CANCER RES, V61, P6952; Perez CA, 2007, ONCOGENE, V26, P7363, DOI 10.1038/sj.onc.1210561; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Roger L, 2006, BIOL CELL, V98, P141, DOI 10.1042/BC20050058; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Sutherland TE, 2005, CLIN CANCER RES, V11, P1722, DOI 10.1158/1078-0432.CCR-04-1789; Teodoro JG, 2006, SCIENCE, V313, P968, DOI 10.1126/science.1126391; TOKINO T, 1994, HUM MOL GENET, V3, P1537, DOI 10.1093/hmg/3.9.1537; Veprintsev DB, 2008, NUCLEIC ACIDS RES, V36, P1589, DOI 10.1093/nar/gkm1040; Wang SZE, 2007, J BIOL CHEM, V282, P5661, DOI 10.1074/jbc.M608499200; WANG Y, 1995, MOL CELL BIOL, V15, P2157; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015	68	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10236	10.1371/journal.pone.0010236	http://dx.doi.org/10.1371/journal.pone.0010236			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422012	Green Published, gold, Green Submitted			2022-12-25	WOS:000276952500012
J	Kansra, S; Chen, SL; Bangaru, MLY; Sneade, L; Dunckley, JA; Ben-Jonathan, N				Kansra, Sanjay; Chen, Shenglin; Bangaru, Madhavi Latha Yadav; Sneade, Leighton; Dunckley, Joseph A.; Ben-Jonathan, Nira			Selective Estrogen Receptor Down-Regulator and Selective Estrogen Receptor Modulators Differentially Regulate Lactotroph Proliferation	PLOS ONE			English	Article							PITUITARY-TUMOR CELLS; PURE ANTIESTROGEN; HORMONE-RECEPTOR; ER BETA; ALPHA; ACTIVATION; BINDING; PROTEIN; DEATH; TRANSCRIPTION	Background: We recently reported that estrogen receptor alpha (ER alpha), even in absence of estrogen (E2), plays a critical role in lactotroph homeostasis. The anti-estrogen ICI 182780 ( ICI), but not tamoxifen or raloxifene, rapidly promoted the degradation of ER alpha, and inhibited cell proliferation. However, all three ER antagonists suppressed PRL release, suggesting that receptor occupation is sufficient to inhibit prl gene expression whereas receptor degradation is required to suppress lactotroph proliferation. In this study our objective was to determine whether ER alpha degradation versus occupation, differentially modulates the biological outcome of anti-estrogens. Principal Findings: Using the rat lactotroph cell line, GH3 cells, we report that ICI induced proteosome mediated degradation of ER alpha. In contrast, an ER alpha specific antagonist, MPP, that does not promote degradation of ER alpha, did not inhibit cell proliferation. Further, ICI, but not MPP, abolished anchorage independent growth of GH3 cells. Yet, both ICI and MPP were equally effective in suppressing prl expression and release, as well as ERE-mediated transcriptional activity. Conclusion: Taken together, our results demonstrate that in lactotrophs, ER alpha degradation results in decreased cell proliferation, whereas ER alpha occupation by an antagonist that does not promote degradation of ER alpha is sufficient to inhibit prl expression.	[Kansra, Sanjay; Sneade, Leighton; Dunckley, Joseph A.; Ben-Jonathan, Nira] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45221 USA; [Kansra, Sanjay; Chen, Shenglin; Bangaru, Madhavi Latha Yadav] Med Coll Wisconsin, Dept Endocrinol Metab & Clin Nutr, Milwaukee, WI 53226 USA; [Kansra, Sanjay] Med Coll Wisconsin, Dept Pharmacol, Milwaukee, WI 53226 USA	University of Cincinnati; Medical College of Wisconsin; Medical College of Wisconsin	Kansra, S (corresponding author), Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45221 USA.	skansra@mcw.edu	Chen, Shenglin/B-4049-2010		NCI NIH HHS [R01 CA096613, CA096613] Funding Source: Medline; NIEHS NIH HHS [ES012212, P30-ES06096, R01 ES012212, P30 ES006096] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA096613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012212, P30ES006096] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; Blanquart C, 2002, J BIOL CHEM, V277, P37254, DOI 10.1074/jbc.M110598200; Caporali S, 2003, MOL BIOL CELL, V14, P5051, DOI 10.1091/mbc.E03-05-0303; Dace A, 2000, P NATL ACAD SCI USA, V97, P8985, DOI 10.1073/pnas.160257997; DAUVOIS S, 1993, J CELL SCI, V106, P1377; DAUVOIS S, 1992, P NATL ACAD SCI USA, V89, P4037, DOI 10.1073/pnas.89.9.4037; FAWELL SE, 1990, P NATL ACAD SCI USA, V87, P6883, DOI 10.1073/pnas.87.17.6883; Harrington WR, 2003, MOL CELL ENDOCRINOL, V206, P13, DOI 10.1016/S0303-7207(03)00255-7; Imhof MO, 1996, MOL CELL BIOL, V16, P2594; JENSEN EV, 1969, STEROIDS, V13, P417, DOI 10.1016/0039-128X(69)90053-1; Ji Y, 2007, MOL CANCER RES, V5, P1041, DOI 10.1158/1541-7786.MCR-06-0379; Kansra S, 2005, MOL CELL ENDOCRINOL, V239, P27, DOI 10.1016/j.mce.2005.04.008; Laios I, 2003, J STEROID BIOCHEM, V87, P207, DOI 10.1016/j.jsbmb.2003.09.011; LEE JW, 1995, NATURE, V374, P91, DOI 10.1038/374091a0; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Newton CJ, 1995, J STEROID BIOCHEM, V55, P327, DOI 10.1016/0960-0760(95)00191-3; NIRMALA PB, 1995, BIOCHEM BIOPH RES CO, V213, P24, DOI 10.1006/bbrc.1995.2093; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Poukka H, 1999, J BIOL CHEM, V274, P19441, DOI 10.1074/jbc.274.27.19441; STEINMETZ R, 1994, ENDOCRINOLOGY, V135, P2737, DOI 10.1210/en.135.6.2737; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Sun J, 2002, ENDOCRINOLOGY, V143, P941, DOI 10.1210/en.143.3.941; WAKELING AE, 1991, CANCER RES, V51, P3867; Wong JK, 2003, J NEUROSCI, V23, P4984; Yu R, 2002, J ENDOCRINOL, V174, P379, DOI 10.1677/joe.0.1740379	26	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10060	10.1371/journal.pone.0010060	http://dx.doi.org/10.1371/journal.pone.0010060			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419096	Green Published, Green Submitted, gold			2022-12-25	WOS:000276853800002
J	Mazumdar, K; Alvarez, X; Borda, JT; Dufour, J; Martin, E; Bethune, MT; Khosla, C; Sestak, K				Mazumdar, Kaushiki; Alvarez, Xavier; Borda, Juan T.; Dufour, Jason; Martin, Edith; Bethune, Michael T.; Khosla, Chaitan; Sestak, Karol			Visualization of Transepithelial Passage of the Immunogenic 33-Residue Peptide from alpha-2 Gliadin in Gluten-Sensitive Macaques	PLOS ONE			English	Article							INTESTINAL BARRIER FUNCTION; CELIAC-DISEASE; TISSUE TRANSGLUTAMINASE; T-CELLS; INTERFERON-GAMMA; DERMATITIS-HERPETIFORMIS; STRUCTURAL BASIS; TIGHT JUNCTIONS; MUCOSA; SPRUE	Background: Based on clinical, histopathological and serological similarities to human celiac disease ( CD), we recently established the rhesus macaque model of gluten sensitivity. In this study, we further characterized this condition based on presence of anti-tissue transglutaminase 2 (TG2) antibodies, increased intestinal permeability and transepithelial transport of a proteolytically resistant, immunotoxic, 33-residue peptide from alpha(2)-gliadin in the distal duodenum of gluten-sensitive macaques. Methodology/Principal Findings: Six rhesus macaques were selected for study from a pool of 500, including two healthy controls and four gluten-sensitive animals with elevated anti-gliadin or anti-TG2 antibodies as well as history of noninfectious chronic diarrhea. Pediatric endoscope-guided pinch biopsies were collected from each animal's distal duodenum following administration of a gluten-containing diet (GD) and again after remission by gluten-free diet (GFD). Control biopsies always showed normal villous architecture, whereas gluten-sensitive animals on GD exhibited histopathology ranging from mild lymphocytic infiltration to villous atrophy, typical of human CD. Immunofluorescent microscopic analysis of biopsies revealed IgG+ and IgA+ plasma-like cells producing antibodies that colocalized with TG2 in gluten-sensitive macaques only. Following instillation in vivo, the Cy-3-labeled 33-residue gluten peptide colocalized with the brush border protein villin in all animals. In a substantially enteropathic macaque with "leaky'' duodenum, the peptide penetrated beneath the epithelium into the lamina propria. Conclusions/Significance: The rhesus macaque model of gluten sensitivity not only resembles the histopathology of CD but it also may provide a model for studying intestinal permeability in states of epithelial integrity and disrepair.	[Mazumdar, Kaushiki; Sestak, Karol] Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA; [Alvarez, Xavier; Borda, Juan T.] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA; [Dufour, Jason] Tulane Natl Primate Res Ctr, Div Vet Med, Covington, LA USA; [Martin, Edith; Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Bethune, Michael T.; Khosla, Chaitan] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Sestak, Karol] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	Tulane University; Tulane University; Tulane University; Stanford University; Stanford University; Stanford University; Tulane University	Mazumdar, K (corresponding author), Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA.	ksestak@tulane.edu	Mazumdar, Kaushiki/AAW-6879-2020	Mazumdar, Kaushiki/0000-0002-1036-1980; Khosla, Chaitan/0000-0001-6529-495X	National Institutes of Health [RO1DK076653, P51RR000164, RO1DK063158]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063158, R01DK076653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health grants RO1DK076653 and P51RR000164 to KS, and RO1DK063158 grant to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaedini A, 2005, ANN INTERN MED, V142, P289, DOI 10.7326/0003-4819-142-4-200502150-00011; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Arentz-Hansen H, 2002, GASTROENTEROLOGY, V123, P803, DOI 10.1053/gast.2002.35381; Bethune MT, 2009, CHEM BIOL, V16, P868, DOI 10.1016/j.chembiol.2009.07.009; Bethune MT, 2009, J PHARMACOL EXP THER, V329, P657, DOI 10.1124/jpet.108.148007; Bethune MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001614; Bethune MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001857; Cellier C, 1998, GASTROENTEROLOGY, V114, P471, DOI 10.1016/S0016-5085(98)70530-X; Clemente MG, 2003, GUT, V52, P218, DOI 10.1136/gut.52.2.218; Di Sabatino A, 2009, LANCET, V373, P1480, DOI 10.1016/S0140-6736(09)60254-3; DICKE W K, 1953, Acta Paediatr, V42, P34, DOI 10.1111/j.1651-2227.1953.tb05563.x; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; FRIIS S, 1992, GUT, V33, P1487, DOI 10.1136/gut.33.11.1487; Gass J, 2006, J PHARMACOL EXP THER, V318, P1178, DOI 10.1124/jpet.106.104315; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Jabri B, 2005, IMMUNOL REV, V206, P219, DOI 10.1111/j.0105-2896.2005.00294.x; JAVID J, 1971, AM J HUM GENET, V23, P496; Kaukinen K, 2005, SCAND J GASTROENTERO, V40, P564, DOI 10.1080/00365520510023422; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Korponay-Szabo IR, 2004, GUT, V53, P641, DOI 10.1136/gut.2003.024836; Korponay-Szabo IR, 2000, J PEDIATR GASTR NUTR, V31, P520, DOI 10.1097/00005176-200011000-00013; Lock RJ, 1999, J CLIN PATHOL, V52, P274, DOI 10.1136/jcp.52.4.274; Marzari R, 2001, J IMMUNOL, V166, P4170, DOI 10.4049/jimmunol.166.6.4170; MAWHINNEY H, 1975, CLIN EXP IMMUNOL, V21, P394; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Montalto M, 2002, DIGESTION, V65, P227, DOI 10.1159/000063817; NILSEN EM, 1995, GUT, V37, P766, DOI 10.1136/gut.37.6.766; Papp M, 2008, CLIN CHEM, V54, P697, DOI 10.1373/clinchem.2007.098780; Pizzuti D, 2004, DIGEST LIVER DIS, V36, P337, DOI 10.1016/j.dld.2004.01.013; Qiao SW, 2004, J IMMUNOL, V173, P1757, DOI 10.4049/jimmunol.173.3.1757; Quarsten H, 1999, EUR J IMMUNOL, V29, P2506, DOI 10.1002/(SICI)1521-4141(199908)29:08<2506::AID-IMMU2506>3.0.CO;2-9; Ramesh G, 2005, CLIN DIAGN LAB IMMUN, V12, P192, DOI 10.1128/CDLI.12.1.192-197.2005; Ryan BM, 2000, GASTROENTEROLOGY, V119, P243, DOI 10.1053/gast.2000.8530; Sardy M, 2002, J EXP MED, V195, P747, DOI 10.1084/jem.20011299; Schumann M, 2008, GUT, V57, P747, DOI 10.1136/gut.2007.136366; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; SHINER M, 1972, LANCET, V1, P1202; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Spurkland A, 1997, TISSUE ANTIGENS, V49, P29, DOI 10.1111/j.1399-0039.1997.tb02706.x; Tripathi A, 2009, P NATL ACAD SCI USA, V106, P16799, DOI 10.1073/pnas.0906773106; Troncone R, 1998, DIGEST DIS SCI, V43, P156, DOI 10.1023/A:1018896625699; Tursi A, 2001, HEPATO-GASTROENTEROL, V48, P462; Visser J, 2009, ANN NY ACAD SCI, V1165, P195, DOI 10.1111/j.1749-6632.2009.04037.x; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909	45	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10228	10.1371/journal.pone.0010228	http://dx.doi.org/10.1371/journal.pone.0010228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419103	Green Published, gold, Green Submitted			2022-12-25	WOS:000276853800018
J	Rajala, K; Lindroos, B; Hussein, SM; Lappalainen, RS; Pekkanen-Mattila, M; Inzunza, J; Rozell, B; Miettinen, S; Narkilahti, S; Kerkela, E; Aalto-Setala, K; Otonkoski, T; Suuronen, R; Hovatta, O; Skottman, H				Rajala, Kristiina; Lindroos, Bettina; Hussein, Samer M.; Lappalainen, Riikka S.; Pekkanen-Mattila, Mari; Inzunza, Jose; Rozell, Bjorn; Miettinen, Susanna; Narkilahti, Susanna; Kerkela, Erja; Aalto-Setala, Katriina; Otonkoski, Timo; Suuronen, Riitta; Hovatta, Outi; Skottman, Heli			A Defined and Xeno-Free Culture Method Enabling the Establishment of Clinical-Grade Human Embryonic, Induced Pluripotent and Adipose Stem Cells	PLOS ONE			English	Article							PROLONGED UNDIFFERENTIATED GROWTH; SERUM REPLACEMENT MEDIUM; HUMAN FIBROBLASTS; HUMAN FEEDERS; DERIVATION; LINES; DIFFERENTIATION; EXPANSION; MEDIA; TISSUE	Background: The growth of stem cells in in vitro conditions requires optimal balance between signals mediating cell survival, proliferation, and self-renewal. For clinical application of stem cells, the use of completely defined conditions and elimination of all animal-derived materials from the establishment, culture, and differentiation processes is desirable. Methodology/Principal Findings: Here, we report the development of a fully defined xeno-free medium (RegES), capable of supporting the expansion of human embryonic stem cells (hESC), induced pluripotent stem cells (iPSC) and adipose stem cells (ASC). We describe the use of the xeno-free medium in the derivation and long-term (>80 passages) culture of three pluripotent karyotypically normal hESC lines: Regea 06/015, Regea 07/046, and Regea 08/013. Cardiomyocytes and neural cells differentiated from these cells exhibit features characteristic to these cell types. The same formulation of the xeno-free medium is capable of supporting the undifferentiated growth of iPSCs on human feeder cells. The characteristics of the pluripotent hESC and iPSC lines are comparable to lines derived and cultured in standard undefined culture conditions. In the culture of ASCs, the xeno-free medium provided significantly higher proliferation rates than ASCs cultured in medium containing allogeneic human serum (HS), while maintaining the differentiation potential and characteristic surface marker expression profile of ASCs, although significant differences in the surface marker expression of ASCs cultured in HS and RegES media were revealed. Conclusion/Significance: Our results demonstrate that human ESCs, iPSCs and ASCs can be maintained in the same defined xeno-free medium formulation for a prolonged period of time while maintaining their characteristics, demonstrating the applicability of the simplified xeno-free medium formulation for the production of clinical-grade stem cells. The basic xeno-free formulation described herein has the potential to be further optimized for specific applications relating to establishment, expansion and differentiation of various stem cell types.	[Rajala, Kristiina; Lindroos, Bettina; Lappalainen, Riikka S.; Pekkanen-Mattila, Mari; Miettinen, Susanna; Narkilahti, Susanna; Kerkela, Erja; Aalto-Setala, Katriina; Suuronen, Riitta; Skottman, Heli] Univ Tampere, Tampere Univ Hosp, Regea Inst Regenerat Med, FIN-33101 Tampere, Finland; [Hussein, Samer M.; Otonkoski, Timo] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Hussein, Samer M.; Otonkoski, Timo] Univ Helsinki, Biomedicum, Stem Cell Ctr, Helsinki, Finland; [Inzunza, Jose] Karolinska Inst, Dept Biosci & Nutr, Div Med Nutr, Stockholm, Sweden; [Rozell, Bjorn] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Suuronen, Riitta] Tampere Univ Technol, Dept Biomed Engn, FIN-33101 Tampere, Finland; [Suuronen, Riitta] Tampere Univ Hosp, Dept Eye Ear & Oral Dis, Tampere, Finland; [Hovatta, Outi] Karolinska Inst, Karolinska Univ Hosp, Dept Clin Sci Intervent & Technol, Stockholm, Sweden	Tampere University; Tampere University Hospital; University of Helsinki; University of Helsinki; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Tampere University; Tampere University; Tampere University Hospital; Karolinska Institutet; Karolinska University Hospital	Rajala, K (corresponding author), Univ Tampere, Tampere Univ Hosp, Regea Inst Regenerat Med, FIN-33101 Tampere, Finland.	kristiina.m.rajala@regea.fi	Otonkoski, Timo/F-1189-2011; Kerkelä, Erja/P-9459-2016; Seppänen-Kaijasinkko, Riitta/AAE-1476-2021; Mannerström, Bettina IC/F-4002-2016; Mannerström, Bettina/AAL-4214-2020	Kerkelä, Erja/0000-0002-2923-5300; Mannerström, Bettina IC/0000-0001-9316-5581; Skottman, Heli/0000-0002-4127-8792; Pekkanen-Mattila, Mari/0000-0002-8621-4303; Inzunza, Jose/0000-0003-0876-6767; Miettinen, Susanna/0000-0002-0647-9556	Academy of Finland [212776]; Finnish Funding Agency for Technology and Innovation [1128/31/05, 3524/31/07]; Pirkanmaa Hospital District [9H197]; ESTOOLS; European Union;  [K2007-54X-15080-04-3]	Academy of Finland(Academy of Finland); Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Pirkanmaa Hospital District; ESTOOLS(European Commission); European Union(European Commission); 	This research was supported by the Academy of Finland (grant number 212776) http://www.aka.fi; TEKES the Finnish Funding Agency for Technology and Innovation (grant number 1128/31/05 and 3524/31/07) http://www.tekes.fi; the Competitive Research Funding of the Pirkanmaa Hospital District (grant number 9H197) http://www.pshp.fi; and the (grant number K2007-54X-15080-04-3) http://www.vr.se. The generation of iPS cell lines was supported by funding for the ESTOOLS consortium under the Sixth Research Framework Program of the European Union. The funders had no role in study design, data collection and analysis, decision to pu Swedish Research Councilblish, or preparation of the manuscript.	AKOPIAN V, 2010, IN VITRO CELL DEV BI; Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131; Cobo F, 2005, APPL MICROBIOL BIOT, V68, P456, DOI 10.1007/s00253-005-0062-2; Crook JM, 2007, CELL STEM CELL, V1, P490, DOI 10.1016/j.stem.2007.10.004; DENKER AE, 1995, DIFFERENTIATION, V59, P25, DOI 10.1046/j.1432-0436.1995.5910025.x; Ellerstrom C, 2007, STEM CELLS, V25, P1690, DOI 10.1634/stemcells.2006-0607; Ellerstrom C, 2006, STEM CELLS, V24, P2170, DOI 10.1634/stemcells.2006-0130; Fletcher JM, 2006, CLONING STEM CELLS, V8, P319, DOI 10.1089/clo.2006.8.319; Genbacev O, 2005, FERTIL STERIL, V83, P1517, DOI 10.1016/j.fertnstert.2005.01.086; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Haimi S, 2009, J BIOMED MATER RES A, V91A, P540, DOI 10.1002/jbm.a.32233; Haimi S, 2009, TISSUE ENG PT A, V15, P1473, DOI 10.1089/ten.tea.2008.0241; HAKALA H, 2009, TISSUE ENG, V15, P1; Hicks AU, 2009, EUR J NEUROSCI, V29, P562, DOI 10.1111/j.1460-9568.2008.06599.x; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Imreh MP, 2006, J CELL BIOCHEM, V99, P508, DOI 10.1002/jcb.20897; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Inzunza J, 2004, MOL HUM REPROD, V10, P461, DOI 10.1093/molehr/gah051; Kocaoemer A, 2007, STEM CELLS, V25, P1270, DOI 10.1634/stemcells.2006-0627; Koivisto H, 2004, REPROD BIOMED ONLINE, V9, P330, DOI 10.1016/S1472-6483(10)62150-5; Lee JB, 2005, BIOL REPROD, V72, P42, DOI 10.1095/biolreprod.104.033480; Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Lindroos B, 2009, CYTOTHERAPY, V11, P958, DOI 10.3109/14653240903233081; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001; Mikkola M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-40; Mirabet V, 2008, CELL TISSUE BANK, V9, P1, DOI 10.1007/s10561-007-9048-x; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Niemela SM, 2007, J CRANIOFAC SURG, V18, P325, DOI 10.1097/scs.0b013e3180333b6a; Pekkanen-Mattila M, 2009, ANN MED, V41, P360, DOI 10.1080/07853890802609542; Rajala K, 2007, HUM REPROD, V22, P1231, DOI 10.1093/humrep/del523; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Richards M, 2003, STEM CELLS, V21, P546, DOI 10.1634/stemcells.21-5-546; Skottman H, 2006, REPRODUCTION, V132, P691, DOI 10.1530/rep.1.01079; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	43	119	124	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10246	10.1371/journal.pone.0010246	http://dx.doi.org/10.1371/journal.pone.0010246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419109	Green Submitted, gold, Green Published			2022-12-25	WOS:000276853800021
J	Bangaru, MLY; Woodliff, J; Raff, H; Kansra, S				Bangaru, Madhavi Latha Yadav; Woodliff, Jeffrey; Raff, Hershel; Kansra, Sanjay			Growth Suppression of Mouse Pituitary Corticotroph Tumor AtT20 Cells by Curcumin: A Model for Treating Cushing's Disease	PLOS ONE			English	Article							FACTOR-KAPPA-B; PROSTATE-CANCER CELLS; BCL-XL; TRANSCRIPTION FACTOR; APOPTOSIS; ACTIVATION; EXPRESSION; PROLIFERATION; INHIBITION; ADENOMAS	Background: Pituitary corticotroph tumors secrete excess adrenocorticotrophic hormone (ACTH) resulting in Cushing's disease (CD). Standard treatment includes surgery and, if not successful, radiotherapy, both of which have undesirable side effects and frequent recurrence of the tumor. Pharmacotherapy using PPAR gamma agonists, dopamine receptor agonists, retinoic acid or somatostatin analogs is still experimental. Curcumin, a commonly used food additive in South Asian cooking, has potent growth inhibitory effects on cell proliferation. Our laboratory recently demonstrated that curcumin inhibited growth and induced apoptosis in prolactin-and growth hormone-producing tumor cells [1]. Subsequently, Schaaf et. al. confirmed our findings and also showed the in vivo effectiveness of curcumin to suppress pituitary tumorigenesis. However the molecular mechanism that mediate this effect of curcumin are still unknown. Principal Findings: Using the mouse corticotroph tumor cells, AtT20 cells, we report that curcumin had a robust, irreversible inhibitory effect on cell proliferation and clonogenic property. The curcumin-induced growth inhibition was accompanied by decreased NFkB activity. Further, curcumin down-regulated the pro-survival protein Bcl-xL, depolarized the mitochondrial membrane, increased PARP cleavage, which led to apoptotic cell death. Finally, curcumin had a concentration-dependent suppressive effect on ACTH secretion from AtT20 cells. Conclusion: The ability of curcumin to inhibit NFkB and induce apoptosis in pituitary corticotroph tumor cells leads us to propose developing it as a novel therapeutic agent for the treatment of CD.	[Bangaru, Madhavi Latha Yadav; Raff, Hershel; Kansra, Sanjay] Aurora St Lukes Med Ctr, Dept Endocrinol Metab & Clin Nutr, Milwaukee, WI USA; [Woodliff, Jeffrey] Aurora St Lukes Med Ctr, Dept Pediat, Milwaukee, WI USA; [Raff, Hershel] Aurora St Lukes Med Ctr, Endocrine Res Lab, Milwaukee, WI USA; [Kansra, Sanjay] Med Coll Wisconsin, Dept Pharmacol, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Bangaru, MLY (corresponding author), Aurora St Lukes Med Ctr, Dept Endocrinol Metab & Clin Nutr, Milwaukee, WI USA.	skansra@mcw.edu			Medical College of Wisconsin	Medical College of Wisconsin(General Electric)	Start up funds from the Medical College of Wisconsin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anto RJ, 2002, CARCINOGENESIS, V23, P143, DOI 10.1093/carcin/23.1.143; Bargou RC, 1997, J CLIN INVEST, V100, P2961, DOI 10.1172/JCI119849; Boscaro M, 2009, J CLIN ENDOCR METAB, V94, P115, DOI 10.1210/jc.2008-1008; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Collett GP, 2004, CARCINOGENESIS, V25, P2183, DOI 10.1093/carcin/bgh233; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Deeb D, 2007, J PHARMACOL EXP THER, V321, P616, DOI 10.1124/jpet.106.117721; Ezzat S, 2006, MOL ENDOCRINOL, V20, P2976, DOI 10.1210/me.2006-0265; Grad JM, 2000, CURR OPIN ONCOL, V12, P543, DOI 10.1097/00001622-200011000-00006; Heaney AP, 2002, NAT MED, V8, P1281, DOI 10.1038/nm784; Jee SH, 1998, J INVEST DERMATOL, V111, P656, DOI 10.1046/j.1523-1747.1998.00352.x; Jiang MC, 1996, ONCOGENE, V13, P609; Kamat AM, 2007, MOL CANCER THER, V6, P1022, DOI 10.1158/1535-7163.MCT-06-0545; Kansra S, 2005, MOL CELL ENDOCRINOL, V239, P27, DOI 10.1016/j.mce.2005.04.008; Katznelson L, 2001, CLIN ENDOCRINOL, V54, P183, DOI 10.1046/j.1365-2265.2001.01214.x; Kirito K, 2002, J BIOL CHEM, V277, P8329, DOI 10.1074/jbc.M109824200; KLEIN SB, 1992, J CELL PHYSIOL, V151, P326, DOI 10.1002/jcp.1041510214; LUD CJ, 2000, SYNAPSE, V35, P228; Miller M, 2008, ENDOCRINOLOGY, V149, P4158, DOI 10.1210/en.2007-1760; Miyoshi T, 2004, J ENDOCRINOL INVEST, V27, P1055, DOI 10.1007/BF03345309; Ohori H, 2006, MOL CANCER THER, V5, P2563, DOI 10.1158/1535-7163.MCT-06-0174; Ozer E, 2003, TUMORI, V89, P54, DOI 10.1177/030089160308900112; Paez-Pereda M, 2001, J CLIN INVEST, V108, P1123, DOI 10.1172/JCI11098; ROSS EJ, 1982, LANCET, V2, P646; Schaaf C, 2009, ENDOCR-RELAT CANCER, V16, P1339, DOI 10.1677/ERC-09-0129; Shah BH, 1999, BIOCHEM PHARMACOL, V58, P1167, DOI 10.1016/S0006-2952(99)00206-3; Shishodia S, 2005, ANN NY ACAD SCI, V1056, P206, DOI 10.1196/annals.1352.010; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Suh JH, 2002, PROSTATE, V52, P183, DOI 10.1002/pros.10082; Syng-ai C, 2004, MOL CANCER THER, V3, P1101; Wang WX, 1999, CLIN CANCER RES, V5, P119; ZALDIVAR V, NEUROENDOCRINOLOGY, V90, P292	34	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e9893	10.1371/journal.pone.0009893	http://dx.doi.org/10.1371/journal.pone.0009893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405005	Green Submitted, Green Published, gold			2022-12-25	WOS:000276706300001
J	Pang, YP; Davis, J; Wang, SH; Park, JG; Nambiar, MP; Schmidt, JJ; Millard, CB				Pang, Yuan-Ping; Davis, Jon; Wang, Shaohua; Park, Jewn Giew; Nambiar, Madhusoodana P.; Schmidt, James J.; Millard, Charles B.			Small Molecules Showing Significant Protection of Mice against Botulinum Neurotoxin Serotype A	PLOS ONE			English	Article							AB-INITIO CALCULATIONS; DYNAMICS SIMULATION; ZINC ENDOPEPTIDASE; TOXIN; INHIBITORS; IDENTIFICATION; AMBER; RECOGNITION; PERFORMANCE; MANAGEMENT	Botulinum neurotoxin serotype A (BoNTA) causes a life-threatening neuroparalytic disease known as botulism that could afflict large, unprotected populations if the toxin were employed in an act of bioterrorism. Current post-exposure therapy is limited to symptomatic treatment or passive immunization that is effective for treating infant botulism at a cost of US $45,300 per treatment regimen. Antibodies can neutralize the extracellular but not the intracellular BoNTA. Moreover, antibody production, storage, and administration in a mass casualty scenario pose logistical challenges. Alternatively, small-molecule inhibitors of BoNTA endopeptidase (BoNTAe) are sought to antagonize the extracellular or intracellular toxin. While several such molecules reportedly demonstrated efficacy in protecting cells against BoNTA, there is scant information to show that small molecules can significantly protect mammals against BoNTA. Herein we report the development of effective small-molecules BoNTAe inhibitors with promising in vivo pharmacokinetics. One such molecule has an in vivo half-life of 6.5 hours and is devoid of obvious sign of toxicity. Pre-treatment with this molecule at 2 mg/kg protected 100% and 70% of treated mice against BoNTA at 5 times of its median-lethal dose during the periods of 2 and 4 half-lives of the inhibitor, respectively. In contrast, 40% and 0% of untreated mice survived during the respective periods. Similar levels of protection were also observed with two other small molecules. These results demonstrate that small molecules can significantly protect mice against BoNTA and support the pursuit of small-molecule antagonists as a cost-effective alternative or as an adjunct to passive immunity for treating botulism.	[Pang, Yuan-Ping; Wang, Shaohua; Park, Jewn Giew] Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN 55905 USA; [Davis, Jon; Nambiar, Madhusoodana P.; Millard, Charles B.] Walter Reed Army Inst Res, Div Biochem, Silver Spring, MD USA; [Schmidt, James J.] USA, Med Res Inst Infect Dis, Integrated Toxicol Div, Ft Detrick, MD 21702 USA	Mayo Clinic; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Pang, YP (corresponding author), Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN 55905 USA.	pang@mayo.edu; charles.b.millard@us.army.mil		Pang, Yuan-Ping/0000-0003-0838-2560	United States Army Medical Research and Materiel Command [W81XWH-04-2-0001, W81XWH-08-1-0154]; United States Army Research Office [W911NF-09-1-0095]; United States Defense Threat Reduction Agency [3.10023_07_RD_B, 3.10014_08_WR_B]; University of Minnesota Supercomputing Institute	United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); United States Army Research Office; United States Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); University of Minnesota Supercomputing Institute	This work was supported by the United States Army Medical Research and Materiel Command (W81XWH-04-2-0001 and W81XWH-08-1-0154), the United States Army Research Office (W911NF-09-1-0095), the United States Defense Threat Reduction Agency (3.10023_07_RD_B and 3.10014_08_WR_B), and the University of Minnesota Supercomputing Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions and assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the United States Army, Navy or the Department of Defense.	Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Arnon SS, 2007, PEDIATRICS, V119, P785, DOI 10.1542/peds.2006-0646; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boldt GE, 2006, CHEM COMMUN, P3063, DOI 10.1039/b603099h; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Burnett JC, 2007, J BIOL CHEM, V282, P5004, DOI 10.1074/jbc.M608166200; Cai SW, 2010, TOXICON, V55, P818, DOI 10.1016/j.toxicon.2009.11.017; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Crowner BE, 2007, CLIN NEUROPHARMACOL, V30, P310, DOI 10.1097/WNF.0B013E31804B1A0D; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; El Yazal J, 2000, J PHYS CHEM B, V104, P6662, DOI 10.1021/jp994283x; El Yazal J, 1999, J PHYS CHEM B, V103, P8773, DOI 10.1021/jp991787m; Eubanks LM, 2007, P NATL ACAD SCI USA, V104, P2602, DOI 10.1073/pnas.0611213104; Foran PG, 2003, J BIOL CHEM, V278, P1363, DOI 10.1074/jbc.M209821200; Franz DR, 1997, JAMA-J AM MED ASSOC, V278, P399, DOI 10.1001/jama.278.5.399; Frisch M J, 1999, GAUSSIAN 98 REVISION; HATHEWAY CH, 1984, J INFECT DIS, V150, P407, DOI 10.1093/infdis/150.3.407; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Johnson SL, 2008, CHEM BIOL DRUG DES, V71, P131, DOI 10.1111/j.1747-0285.2007.00617.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kessler KR, 1997, NEUROTOXICOLOGY, V18, P761; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P2316, DOI 10.1001/jama.2009.780; Larsen JC, 2009, DRUG DEVELOP RES, V70, P266, DOI 10.1002/ddr.20304; Liang BA, 2006, AM J LAW MED, V32, P279, DOI 10.1177/009885880603200207; Moe ST, 2009, BIOORGAN MED CHEM, V17, P3072, DOI 10.1016/j.bmc.2009.03.013; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Pang YP, 2000, PROTEIN SCI, V9, P1857; Pang YP, 1999, J MOL MODEL, V5, P196, DOI 10.1007/s008940050119; Pang YP, 2001, PROTEINS, V45, P183, DOI 10.1002/prot.1138; Pang YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007730; Park JG, 2006, BIOORGAN MED CHEM, V14, P395, DOI 10.1016/j.bmc.2005.08.018; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Roxas-Duncan V, 2009, ANTIMICROB AGENTS CH, V53, P3478, DOI 10.1128/AAC.00141-09; SARVAS H, 1993, J CLIN IMMUNOL, V13, P145, DOI 10.1007/BF00919271; Schmidt JJ, 1998, FEBS LETT, V435, P61, DOI 10.1016/S0014-5793(98)01041-2; Schmidt JJ, 1997, J PROTEIN CHEM, V16, P19, DOI 10.1023/A:1026386710428; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; Silvaggi NR, 2008, BIOCHEMISTRY-US, V47, P5736, DOI 10.1021/bi8001067; SIMPSON LL, 1981, PHARMACOL REV, V33, P155; SPRINGEN K, 2002, NEWSWEEK, P50; Tang J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000761; Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102; Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063	45	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10129	10.1371/journal.pone.0010129	http://dx.doi.org/10.1371/journal.pone.0010129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405003	Green Published, Green Submitted, gold			2022-12-25	WOS:000276706300002
J	Azakir, BA; Di Fulvio, S; Therrien, C; Sinnreich, M				Azakir, Bilal A.; Di Fulvio, Sabrina; Therrien, Christian; Sinnreich, Michael			Dysferlin Interacts with Tubulin and Microtubules in Mouse Skeletal Muscle	PLOS ONE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; SYNAPTIC VESICLES; PLASMA-MEMBRANE; SYNAPTOTAGMIN-I; DISTINCT POOLS; PHAGE DISPLAY; PROTEIN; REPAIR; TRAFFICKING; CELLS	Dysferlin is a type II transmembrane protein implicated in surface membrane repair in muscle. Mutations in dysferlin lead to limb girdle muscular dystrophy 2B, Miyoshi Myopathy and distal anterior compartment myopathy. Dysferlin's mode of action is not well understood and only a few protein binding partners have thus far been identified. Using affinity purification followed by liquid chromatography/mass spectrometry, we identified alpha-tubulin as a novel binding partner for dysferlin. The association between dysferlin and alpha-tubulin, as well as between dysferlin and microtubules, was confirmed in vitro by glutathione S-transferase pulldown and microtubule binding assays. These interactions were confirmed in vivo by co-immunoprecipitation. Confocal microscopy revealed that dysferlin and alpha-tubulin co-localized in the perinuclear region and in vesicular structures in myoblasts, and along thin longitudinal structures reminiscent of microtubules in myotubes. We mapped dysferlin's alpha-tubulin-binding region to its C2A and C2B domains. Modulation of calcium levels did not affect dysferlin binding to alpha-tubulin, suggesting that this interaction is calcium-independent. Our studies identified a new binding partner for dysferlin and suggest a role for microtubules in dysferlin trafficking to the sarcolemma.	[Azakir, Bilal A.; Di Fulvio, Sabrina; Therrien, Christian; Sinnreich, Michael] McGill Univ, Neuromuscular Res Grp, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada; [Sinnreich, Michael] Univ Basel Hosp, Neuromuscular Ctr, Dept Neurol, CH-4031 Basel, Switzerland; [Sinnreich, Michael] Univ Basel Hosp, Neuromuscular Ctr, Dept Biomed, CH-4031 Basel, Switzerland	McGill University; University of Basel; University of Basel	Azakir, BA (corresponding author), McGill Univ, Neuromuscular Res Grp, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada.	michael.sinnreich@unibas.ch	Azakir, Bilal/AAP-9345-2020	Azakir, Bilal/0000-0003-3084-0265; Sinnreich, Michael/0000-0002-9835-1276	Canadian Institute for Health Research - ALS Society Canada - Muscular Dystrophy Association Canada (CIHR-ALS-MDAC); Fond pour la recherche en sante Quebec (FRSQ); Association Francaise contre les Myopathies, Myosuisse	Canadian Institute for Health Research - ALS Society Canada - Muscular Dystrophy Association Canada (CIHR-ALS-MDAC)(Canadian Institutes of Health Research (CIHR)); Fond pour la recherche en sante Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Association Francaise contre les Myopathies, Myosuisse(Association Francaise contre les Myopathies)	This work was supported by the Canadian Institute for Health Research - ALS Society Canada - Muscular Dystrophy Association Canada (CIHR-ALS-MDAC) Partnership Program, Fond pour la recherche en sante Quebec (FRSQ), Association Francaise contre les Myopathies, Myosuisse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampong Beryl N, 2005, Acta Myol, V24, P134; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Beurg M, 2008, J NEUROSCI, V28, P1798, DOI 10.1523/JNEUROSCI.4653-07.2008; Borgonovo B, 2002, NAT CELL BIOL, V4, P955, DOI 10.1038/ncb888; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Cloutier P, 2009, METHODS, V48, P381, DOI 10.1016/j.ymeth.2009.05.005; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Erickson HP, 1998, TRENDS CELL BIOL, V8, P133, DOI 10.1016/S0962-8924(98)01237-9; Farnaes L, 2003, J BIOL CHEM, V278, P33120, DOI 10.1074/jbc.M210852200; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Haberman Y, 2003, J CELL SCI, V116, P4307, DOI 10.1242/jcs.00719; Hayes MJ, 2004, J BIOL CHEM, V279, P14157, DOI 10.1074/jbc.M313025200; Hernandez-Deviez DJ, 2008, J BIOL CHEM, V283, P6476, DOI 10.1074/jbc.M708776200; Hernandez-Deviez DJ, 2006, HUM MOL GENET, V15, P129, DOI 10.1093/hmg/ddi434; Hino M, 2009, CELL STRUCT FUNCT, V34, P11, DOI 10.1247/csf.08033; Ho M, 2004, HUM MOL GENET, V13, P1999, DOI 10.1093/hmg/ddh212; Honda A, 2002, J BIOL CHEM, V277, P20234, DOI 10.1074/jbc.M112080200; HUANG Y, 2008, HUM MOL GENET; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Huang YC, 2005, EUR J HUM GENET, V13, P721, DOI 10.1038/sj.ejhg.5201414; Huber K, 2008, MOL CANCER THER, V7, P143, DOI 10.1158/1535-7163.MCT-07-0486; Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Matsuda C, 2005, J NEUROPATH EXP NEUR, V64, P334, DOI 10.1093/jnen/64.4.334; Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Mellgren RL, 2009, BBA-MOL CELL RES, V1793, P1886, DOI 10.1016/j.bbamcr.2009.09.013; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; PRYDZ K, 1995, BIOCHEM SOC T, V23, P535, DOI 10.1042/bst0230535; Ramsay TG, 2003, J ANIM SCI, V81, P3046; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Schiavo G, 1998, BIOCHEM BIOPH RES CO, V248, P1, DOI 10.1006/bbrc.1998.8527; Subramanian VS, 2008, AM J PHYSIOL-CELL PH, V294, pC233, DOI 10.1152/ajpcell.00468.2007; Subramanian VS, 2007, AM J PHYSIOL-CELL PH, V293, pC1717, DOI 10.1152/ajpcell.00309.2007; TASSIN AM, 1985, J CELL BIOL, V100, P35, DOI 10.1083/jcb.100.1.35; Therrien C, 2006, J NEUROL SCI, V250, P71, DOI 10.1016/j.jns.2006.07.004; Therrien C, 2009, BIOCHEMISTRY-US, V48, P2377, DOI 10.1021/bi802242r; Togo T, 2006, J CELL SCI, V119, P2780, DOI 10.1242/jcs.03006; Vandre DD, 2007, BIOL REPROD, V77, P533, DOI 10.1095/biolreprod.107.062190	47	40	43	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10122	10.1371/journal.pone.0010122	http://dx.doi.org/10.1371/journal.pone.0010122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405035	Green Submitted, gold, Green Published			2022-12-25	WOS:000276705900007
J	Han, J; Goldstein, LA; Hou, W; Gastman, BR; Rabinowich, H				Han, Jie; Goldstein, Leslie A.; Hou, Wen; Gastman, Brian R.; Rabinowich, Hannah			Regulation of Mitochondrial Apoptotic Events by p53-mediated Disruption of Complexes between Antiapoptotic Bcl-2 Members and Bim	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION-INDEPENDENT DEATH; BH3-ONLY PROTEINS PUMA; TUMOR-SUPPRESSOR P53; DNA-BINDING DOMAIN; HUMAN CANCER-CELLS; IN-VIVO; GRANZYME-B; MEMBRANE PERMEABILIZATION; BH3 DOMAINS; BAX	Multiple mechanisms have been proposed for the mitochondrial function of p53 that are either dependent on or independent of its transcriptional activity. However, none of these mechanisms involves Bim functioning downstream of p53 mitochondrial translocation. Utilizing a p53 nuclear localization signal mutant, whose nuclear import is completely abrogated, we demonstrate that its apoptotic activity at the outer mitochondrial membrane, which involves conformational changes in Bax and Bak, is mediated by Bim. We further demonstrate an inverse correlation between the binding levels of p53 and Bim to Mcl-1. Thus, enhanced binding of p53 to Mcl-1 involves the disruption of existing complexes between Mcl-1 and Bim. We propose that mitochondrial p53 functions as a Bim derepressor by releasing Bim from sequestrating complexes with Mcl-1, Bcl-2, and Bcl-XL, and allowing its engagement in Bak/Bax activation.	[Rabinowich, Hannah] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Han, Jie; Goldstein, Leslie A.; Hou, Wen; Rabinowich, Hannah] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [Gastman, Brian R.] Univ Maryland, Sch Med, Dept Otolaryngol, Baltimore, MD 21201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore	Rabinowich, H (corresponding author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Res Pavil Rm G17C,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	rabinow@pitt.edu			National Institutes of Health [RO1 CA109285, RO1 CA111786]; NATIONAL CANCER INSTITUTE [T32CA060397, R01CA111786, R01CA109285, R01CA132796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA109285 and RO1 CA111786 (to H. R.).	Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2003, J CLIN IMMUNOL, V23, P355, DOI 10.1023/A:1025365432325; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Erster S, 2005, BIOCHEM BIOPH RES CO, V331, P843, DOI 10.1016/j.bbrc.2005.03.187; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Griffiths GJ, 2001, ONCOGENE, V20, P7668, DOI 10.1038/sj.onc.1204995; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; HALL PA, 1993, ONCOGENE, V8, P203; Han J, 2006, J BIOL CHEM, V281, P10153, DOI 10.1074/jbc.M510349200; Han J, 2005, J BIOL CHEM, V280, P16383, DOI 10.1074/jbc.M411377200; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Han J, 2007, J BIOL CHEM, V282, P16223, DOI 10.1074/jbc.M611186200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Keefe K, 2003, MOL CELL BIOL, V23, P6396, DOI 10.1128/MCB.23.18.6396-6405.2003; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Petros AM, 2004, FEBS LETT, V559, P171, DOI 10.1016/s0014-5793(04)00059-6; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Talos F, 2005, CANCER RES, V65, P9971, DOI 10.1158/0008-5472.CAN-05-1084; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Vaseva AV, 2009, CELL CYCLE, V8, P1711, DOI 10.4161/cc.8.11.8596; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang GQ, 2001, J EXP MED, V194, P1325, DOI 10.1084/jem.194.9.1325; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhu YN, 2006, J EXP MED, V203, P1147, DOI 10.1084/jem.20051736; Zhu YN, 2004, P NATL ACAD SCI USA, V101, P7681, DOI 10.1073/pnas.0402293101	52	46	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22473	22483		10.1074/jbc.M109.081042	http://dx.doi.org/10.1074/jbc.M109.081042			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20404322	hybrid, Green Published			2022-12-25	WOS:000279702200059
J	Dong, CM; Yang, LL; Zhang, XP; Gu, H; Lam, ML; Claycomb, WC; Xia, HH; Wu, GY				Dong, Chunmin; Yang, Lingling; Zhang, Xiaoping; Gu, Hua; Lam, May L.; Claycomb, William C.; Xia, Houhui; Wu, Guangyu			Rab8 Interacts with Distinct Motifs in alpha(2B)- and beta(2)-Adrenergic Receptors and Differentially Modulates Their Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CELL-SURFACE EXPRESSION; DI-LEUCINE MOTIF; PLASMA-MEMBRANE; ANGIOTENSIN-II; ENDOPLASMIC-RETICULUM; ALPHA(2)-ADRENERGIC RECEPTORS; CARDIAC MYOCYTES; ANTEROGRADE TRAFFICKING; SEROTONIN RECEPTORS	The molecular mechanism underlying the post-Golgi transport of G protein-coupled receptors (GPCRs) remains poorly understood. Here we determine the role of Rab8 GTPase, which modulates vesicular protein transport between the trans-Golgi network (TGN) and the plasma membrane, in the cell surface targeting of alpha(2B)- and beta(2)-adrenergic receptors (AR). Transient expression of GDP- and GTP-bound Rab8 mutants and short hairpin RNA-mediated knockdown of Rab8 more potently inhibited the cell surface expression of alpha(2B)-AR than beta(2)-AR. The GDP-bound Rab8(T22N) mutant attenuated ERK1/2 activation by alpha(2B)-AR, but not beta(2)-AR, and arrested alpha(2B)-AR in the TGN compartment. Co-immunoprecipitation revealed that both alpha(2B)-AR and beta(2)-AR physically interacted with Rab8 and glutathione S-transferase fusion protein pulldown assays demonstrated that Rab8 interacted with the C termini of both receptors. Interestingly, mutation of the highly conserved membrane-proximal C terminus dileucine motif selectively blocked beta(2)-AR interaction with Rab8, whereas mutation of residues Val(431)-Phe(432)-Asn(433)-Gln(434), Pro(447)-Trp(448), Gln(450)-Thr(451), and Trp(453) in the C terminus impaired alpha(2B)-AR interaction with Rab8. Furthermore, transport inhibition by Rab8(T22N) of a chimeric beta(2)-AR carrying the alpha(2B)-AR C terminus was similar to alpha(2B)-AR. These data provide strong evidence indicating that Rab8 GTPase interacts with distinct motifs in the C termini of alpha(2B)-AR and beta(2)-AR and differentially modulates their traffic from the TGN to the cell surface.	[Wu, Guangyu] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Gu, Hua; Xia, Houhui] Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA; [Lam, May L.; Claycomb, William C.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Wu, GY (corresponding author), 1901 Perdido St, New Orleans, LA 70112 USA.	gwu@lsuhsc.edu			National Institutes of Health [R01GM076167, R01NS060879]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060879] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM076167 ( to G. W.) and R01NS060879 ( to H. X.).	Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Au JSY, 2007, J CELL BIOL, V177, P103, DOI 10.1083/jcb.200608126; Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Dong CM, 2006, J BIOL CHEM, V281, P38543, DOI 10.1074/jbc.M605734200; Duvernay MT, 2009, TRAFFIC, V10, P552, DOI 10.1111/j.1600-0854.2009.00890.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Fan GH, 2003, BLOOD, V101, P2115, DOI 10.1182/blood-2002-07-1965; Farr GA, 2009, J CELL BIOL, V186, P269, DOI 10.1083/jcb.200901021; Filipeanu CM, 2006, MOL PHARMACOL, V69, P1571, DOI 10.1124/mol.105.019984; Filipeanu CM, 2006, J BIOL CHEM, V281, P11097, DOI 10.1074/jbc.M511460200; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; Gimelbrant AA, 2001, J BIOL CHEM, V276, P7285, DOI 10.1074/jbc.M005433200; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Heilker R, 1996, EMBO J, V15, P2893, DOI 10.1002/j.1460-2075.1996.tb00650.x; Hu XD, 2007, J NEUROSCI, V27, P4674, DOI 10.1523/JNEUROSCI.5365-06.2007; HUBER LA, 1993, J CELL BIOL, V123, P47, DOI 10.1083/jcb.123.1.47; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Linder MD, 2007, MOL BIOL CELL, V18, P47, DOI 10.1091/mbc.E06-07-0575; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Martinez O, 1998, BBA-MOL CELL RES, V1404, P101, DOI 10.1016/S0167-4889(98)00050-0; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Murph MM, 2003, J CELL SCI, V116, P1969, DOI 10.1242/jcs.00397; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Robert J, 2005, J BIOL CHEM, V280, P2300, DOI 10.1074/jbc.M410655200; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; SCHEININ M, 1994, MOL BRAIN RES, V21, P133, DOI 10.1016/0169-328X(94)90386-7; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; Seachrist JL, 2002, J BIOL CHEM, V277, P679, DOI 10.1074/jbc.M109022200; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; VAN ISC, 2002, DEV CELL, V2, P219; Venkatesan S, 2002, J BIOL CHEM, V277, P2287, DOI 10.1074/jbc.M108321200; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Wu GY, 1998, J BIOL CHEM, V273, P7197, DOI 10.1074/jbc.273.13.7197; Xia HH, 2002, J BIOL CHEM, V277, P47765, DOI 10.1074/jbc.M207122200; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; Zhang XP, 2009, J PHARMACOL EXP THER, V330, P109, DOI 10.1124/jpet.109.153460; Zhou FG, 2006, CELL SIGNAL, V18, P318, DOI 10.1016/j.cellsig.2005.05.014; Zhu L, 2006, J BIOL CHEM, V281, P22289, DOI 10.1074/jbc.M602664200	55	45	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20369	20380		10.1074/jbc.M109.081521	http://dx.doi.org/10.1074/jbc.M109.081521			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20424170	Green Published, hybrid			2022-12-25	WOS:000279012000070
J	Kenchappa, RS; Tep, C; Korade, Z; Urra, S; Bronfman, FC; Yoon, SO; Carter, BD				Kenchappa, Rajappa S.; Tep, Chhavy; Korade, Zeljka; Urra, Soledad; Bronfman, Francisca C.; Yoon, Sung Ok; Carter, Bruce D.			p75 Neurotrophin Receptor-mediated Apoptosis in Sympathetic Neurons Involves a Biphasic Activation of JNK and Up-regulation of Tumor Necrosis Factor-alpha-converting Enzyme/ADAM17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE; C-JUN; IN-VIVO; INTRAMEMBRANE PROTEOLYSIS; NUCLEAR TRANSLOCATION; INTRACELLULAR DOMAIN; HIPPOCAMPAL-NEURONS; INTERACTING FACTOR	During the development of the sympathetic nervous system, the p75 neurotrophin receptor (p75NTR) has a dual function: promoting survival together with TrkA in response to NGF, but inducing cell death upon binding pro or mature brain-derived neurotrophic factor (BDNF). Apoptotic signaling through p75NTR requires activation of the stress kinase, JNK. However, the receptor also undergoes regulated proteolysis, first by a metalloprotease, and then by gamma-secretase, in response to pro-apoptotic ligands and this is necessary for receptor mediated neuronal death (Kenchappa, R. S., Zampieri, N., Chao, M. V., Barker, P. A., Teng, H. K., Hempstead, B. L., and Carter, B. D. (2006) Neuron 50, 219-232). Hence, the relationship between JNK activation and receptor proteolysis remains to be defined. Here, we report that JNK3 activation is necessary for p75NTR cleavage; however, following release of the intracellular domain, there is a secondary activation of JNK3 that is cleavage dependent. Receptor proteolysis and apoptosis were prevented in sympathetic neurons from jnk3(-/-) mice, while activation of JNK by ectopic expression of MEKK1 induced p75NTR cleavage and cell death. Proteolysis of the receptor was not detected until 6 h after BDNF treatment, suggesting that JNK3 promotes cleavage through a transcriptional mechanism. In support of this hypothesis, BDNF up-regulated tumor necrosis factor-alpha-converting enzyme (TACE)/ADAM17 mRNA and protein in wildtype, but not jnk3(-/-) sympathetic neurons. Down-regulation of TACE by RNA interference blocked BDNF-induced p75NTR cleavage and apoptosis, indicating that this metalloprotease is responsible for the initial processing of the receptor. Together, these results demonstrate that p75NTR-mediated activation of JNK3 is required for up-regulation of TACE, which promotes receptor proteolysis, leading to prolonged activation of JNK3 and subsequent apoptosis in sympathetic neurons.	[Kenchappa, Rajappa S.; Korade, Zeljka; Carter, Bruce D.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Kenchappa, Rajappa S.; Korade, Zeljka; Carter, Bruce D.] Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37232 USA; [Tep, Chhavy; Yoon, Sung Ok] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [Tep, Chhavy; Yoon, Sung Ok] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Urra, Soledad; Bronfman, Francisca C.] Pontificia Univ Catolica Chile, Fac Biol Sci, Ctr Aging & Regenerat,Neurobiol Unit, Nucleus Millenium Regenerat Biol,Dept Physiol, Santiago 8320000, Chile	Vanderbilt University; Vanderbilt University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Pontificia Universidad Catolica de Chile	Kenchappa, RS (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 625 Light Hall, Nashville, TN 37232 USA.	rajappa.kenchappa@vanderbilt.edu	Korade, Zeljka/AIE-2127-2022	Urra, Soledad/0000-0003-4432-6582; Korade, Zeljka/0000-0002-8690-4507	National Institutes of Health [NS038220, NS039472]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1085273]; Conicyt [PFB12/2007]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038220, R01NS039472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS038220 (to B. D. C. and R. S. K.) and NS039472 (to S. O. Y.). This work was also supported by the Fondo Nacional de Desarrollo Cientifico y Tecnologico (1085273) and Conicyt PFB12/2007 (to F. C. B.).	Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; BARNJI SX, 1998, J CELL BIOL, V140, P911; Becker EBE, 2004, J NEUROSCI, V24, P8762, DOI 10.1523/JNEUROSCI.2953-04.2004; Bertrand MJM, 2008, CELL DEATH DIFFER, V15, P1921, DOI 10.1038/cdd.2008.127; Bhakar AL, 2003, J NEUROSCI, V23, P11373; Bzowska M, 2004, EUR J BIOCHEM, V271, P2808, DOI 10.1111/j.1432-1033.2004.04215.x; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Deppmann CD, 2008, SCIENCE, V320, P369, DOI 10.1126/science.1152677; DISTEFANO PS, 1993, J NEUROSCI, V13, P2405, DOI 10.1523/JNEUROSCI.13-06-02405.1993; DISTEFANO PS, 1990, BRAIN RES, V534, P340, DOI 10.1016/0006-8993(90)90154-4; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Epa WR, 2004, J NEUROCHEM, V89, P344, DOI 10.1111/j.1471-4159.2004.02344.x; Friedman WJ, 2000, J NEUROSCI, V20, P6340, DOI 10.1523/JNEUROSCI.20-17-06340.2000; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Garton KJ, 2003, J BIOL CHEM, V278, P37459, DOI 10.1074/jbc.M305877200; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Gentry JJ, 2004, J BIOL CHEM, V279, P16646, DOI 10.1074/jbc.M309209200; Glebova NO, 2005, ANNU REV NEUROSCI, V28, P191, DOI 10.1146/annurev.neuro.28.061604.135659; Habecker BA, 2008, AUTON NEUROSCI-BASIC, V140, P40, DOI 10.1016/j.autneu.2008.03.002; Ham J, 2000, BIOCHEM PHARMACOL, V60, P1015, DOI 10.1016/S0006-2952(00)00372-5; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; Heidinger M, 2006, BIOL CHEM, V387, P69, DOI 10.1515/BC.2006.010; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Jahed A, 2005, AUTON NEUROSCI-BASIC, V118, P32, DOI 10.1016/j.autneu.2004.12.004; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Jin HO, 2006, J CELL PHYSIOL, V206, P477, DOI 10.1002/jcp.20488; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; Kohn J, 1999, J NEUROSCI, V19, P5393; KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513; Kurrasch DM, 2004, METHOD ENZYMOL, V389, P3; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; LEVIMONTALCINI R, 1960, ANN NY ACAD SCI, V85, P324; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Linggi MS, 2005, J BIOL CHEM, V280, P13801, DOI 10.1074/jbc.M410435200; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Palmada M, 2002, J CELL BIOL, V158, P453, DOI 10.1083/jcb.200112129; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Salehi AH, 2002, J BIOL CHEM, V277, P48043, DOI 10.1074/jbc.M205324200; SHELTON DL, 1984, P NATL ACAD SCI-BIOL, V81, P7951, DOI 10.1073/pnas.81.24.7951; Shen CY, 2008, J BIOL CHEM, V283, P17721, DOI 10.1074/jbc.M800013200; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Sodhi CP, 2008, BRAIN RES, V1198, P204, DOI 10.1016/j.brainres.2008.01.031; Srinivasan B, 2007, MOL CELL NEUROSCI, V36, P449, DOI 10.1016/j.mcn.2007.08.005; Urra S, 2007, J BIOL CHEM, V282, P7606, DOI 10.1074/jbc.M610458200; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Volosin M, 2008, J NEUROSCI, V28, P9870, DOI 10.1523/JNEUROSCI.2841-08.2008; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Worley JR, 2003, J BIOL CHEM, V278, P51340, DOI 10.1074/jbc.M310865200; Yeiser EC, 2004, J NEUROSCI, V24, P10521, DOI 10.1523/JNEUROSCI.1390-04.2004; Yoon SO, 1998, J NEUROSCI, V18, P3273; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200	60	97	103	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20358	20368		10.1074/jbc.M109.082834	http://dx.doi.org/10.1074/jbc.M109.082834			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20421303	hybrid, Green Published			2022-12-25	WOS:000279012000069
J	Vasudevan, SR; Lewis, AM; Chan, JW; Machin, CL; Sinha, D; Galione, A; Churchill, GC				Vasudevan, Sridhar R.; Lewis, Alexander M.; Chan, Jennifer W.; Machin, Claire L.; Sinha, Debroshi; Galione, Antony; Churchill, Grant C.			The Calcium-mobilizing Messenger Nicotinic Acid Adenine Dinucleotide Phosphate Participates in Sperm Activation by Mediating the Acrosome Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYL CYCLASE; SEA-URCHIN EGGS; LYSOSOME-RELATED ORGANELLES; PHOSPHOLIPASE-C-DELTA; INDUCED CA2+ RELEASE; STARFISH OOCYTES; INOSITOL TRISPHOSPHATE; MOLECULAR CHARACTERIZATION; BETA-CELLS; PH CHANGES	Before a sperm can fertilize an egg it must undergo a final activation step induced by the egg termed the acrosome reaction. During the acrosome reaction a lysosome-related organelle, the acrosome, fuses with the plasma membrane to release hydrolytic enzymes and expose an egg-binding protein. Because NAADP (nicotinic acid adenine dinucleotide phosphate) releases Ca2+ from acidic lysosome-related organelles in other cell types, we investigated a possible role for NAADP in mediating the acrosome reaction. We report that NAADP binds with high affinity to permeabilized sea urchin sperm. Moreover, we used Mn2+ quenching of luminal fura-2 and Ca-45(2+) to directly demonstrate NAADP regulation of a cation channel on the acrosome. Additionally, we show that NAADP synthesis occurs through base exchange and is driven by an increase in Ca2+. We propose a new model for acrosome reaction signaling in which Ca2+ influx initiated by egg jelly stimulates NAADP synthesis and that this NAADP acts on its receptor/channel on the acrosome to release Ca2+ to drive acrosomal exocytosis.	[Vasudevan, Sridhar R.; Lewis, Alexander M.; Chan, Jennifer W.; Machin, Claire L.; Sinha, Debroshi; Galione, Antony; Churchill, Grant C.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford	Churchill, GC (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	grant.churchill@pharm.ox.ac.uk	Vasudevan, Sridhar/B-1841-2015; Galione, Antony/E-5884-2011	Vasudevan, Sridhar/0000-0003-0516-2984; Galione, Antony/0000-0002-4132-7646	Wellcome Trust [075203/Z/04/Z]; Biotechnology and Biological Sciences Research Council [BB/G008523/1] Funding Source: researchfish; BBSRC [BB/G008523/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Wellcome Trust Grant 075203/Z/04/Z.	Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Allen V, 1997, BIOCHEM J, V327, P545, DOI 10.1042/bj3270545; Bacher I, 2004, BIOCHEM J, V381, P147, DOI 10.1042/BJ20031977; Beltran C, 2007, SIGNAL TRANSDUCTION, V7, P103; Billington RA, 2000, BIOCHEM BIOPH RES CO, V276, P112, DOI 10.1006/bbrc.2000.3444; Billington RA, 2002, J PHYSIOL-LONDON, V544, P107, DOI 10.1113/jphysiol.2002.030098; Brailoiu GC, 2009, BIOCHEM J, V419, P91, DOI 10.1042/BJ20081138; Churaman D, 2008, CELL SIGNAL, V20, P2347, DOI 10.1016/j.cellsig.2008.09.005; Churamani D, 2004, BIOCHEM J, V380, P449, DOI 10.1042/BJ20031754; CHURAMANI D, 2006, THESIS U COLL LONDON; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Churchill GC, 2000, J BIOL CHEM, V275, P38687, DOI 10.1074/jbc.M005827200; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Churchill GC, 2001, J BIOL CHEM, V276, P11223, DOI 10.1074/jbc.M009335200; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Coward K, 2004, BIOCHEM BIOPH RES CO, V313, P894, DOI 10.1016/j.bbrc.2003.12.029; Darszon A, 1999, PHYSIOL REV, V79, P481, DOI 10.1152/physrev.1999.79.2.481; Darszon A, 2006, CELL CALCIUM, V40, P241, DOI 10.1016/j.ceca.2006.04.028; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; Davis LC, 2008, CURR BIOL, V18, P1612, DOI 10.1016/j.cub.2008.09.024; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Docampo R, 1999, PARASITOL TODAY, V15, P443, DOI 10.1016/S0169-4758(99)01531-8; DOMINO SE, 1988, J BIOL CHEM, V263, P690; Galione A, 2005, MOL INTERV, V5, P73, DOI 10.1124/mi.5.2.4; Genazzani AA, 1997, BRIT J PHARMACOL, V121, P1489, DOI 10.1038/sj.bjp.0701295; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; Gonzalez-Martinez MT, 2001, DEV BIOL, V236, P220, DOI 10.1006/dbio.2001.0323; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gunaratne HJ, 2006, BIOCHEM BIOPH RES CO, V339, P443, DOI 10.1016/j.bbrc.2005.11.033; HAJNOCZKY G, 1994, NATURE, V370, P474, DOI 10.1038/370474a0; HALLAM TJ, 1985, FEBS LETT, V186, P175, DOI 10.1016/0014-5793(85)80703-1; Herrick SB, 2005, J CELL PHYSIOL, V202, P663, DOI 10.1002/jcp.20172; Hirohashi N, 2003, BIOCHEM BIOPH RES CO, V304, P285, DOI 10.1016/S0006-291X(03)00587-4; HORSTMAN DA, 1988, J BIOL CHEM, V263, P15297; JADOT M, 1984, BIOCHEM J, V219, P965, DOI 10.1042/bj2190965; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2000, J CELL SCI, V113, P4413; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; LEE HC, 2000, SCI STKE, pPE1; Lewis AM, 2007, ANAL BIOCHEM, V371, P26, DOI 10.1016/j.ab.2007.08.030; Love ML, 2004, STRUCTURE, V12, P477, DOI 10.1016/j.str.2004.02.006; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Moccia F, 2006, BIOCHEM BIOPH RES CO, V348, P329, DOI 10.1016/j.bbrc.2006.05.157; Moccia F, 2004, CELL CALCIUM, V36, P515, DOI 10.1016/j.ceca.2004.05.004; Moccia F, 2006, DEV BIOL, V294, P24, DOI 10.1016/j.ydbio.2006.02.011; MORGAN AJ, 2006, METHODS CALCIUM SIGN, P265; Morgan AJ, 2007, J BIOL CHEM, V282, P37730, DOI 10.1074/jbc.M704630200; Morgan AJ, 2007, BIOCHEM J, V402, P301, DOI 10.1042/BJ20060759; Munshi C, 1999, J BIOL CHEM, V274, P30770, DOI 10.1074/jbc.274.43.30770; Patel S, 2000, BIOCHEM J, V352, P725, DOI 10.1042/0264-6021:3520725; Santella L, 2000, J BIOL CHEM, V275, P8301, DOI 10.1074/jbc.275.12.8301; Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s; SCHACKMANN RW, 1978, DEV BIOL, V65, P483, DOI 10.1016/0012-1606(78)90043-X; Sethi JK, 1996, BIOCHEM J, V319, P613, DOI 10.1042/bj3190613; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Vacquier VD, 1997, DEV BIOL, V192, P125, DOI 10.1006/dbio.1997.8729; VACQUIER VD, 1977, P NATL ACAD SCI USA, V74, P2456, DOI 10.1073/pnas.74.6.2456; Vasudevan SR, 2008, BIOCHEM J, V411, P63, DOI 10.1042/BJ20071616; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Zapata O, 1997, ZYGOTE, V5, P355, DOI 10.1017/S0967199400003932	66	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18262	18269		10.1074/jbc.M109.087858	http://dx.doi.org/10.1074/jbc.M109.087858			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400502	Green Published, hybrid			2022-12-25	WOS:000278453900018
J	Daniel, JL; Dangelmaier, CA; Mada, S; Buitrago, L; Jin, JG; Langdon, WY; Tsygankov, AY; Kunapuli, SP; Sanjay, A				Daniel, James L.; Dangelmaier, Carol A.; Mada, Sripal; Buitrago, Lorena; Jin, Jianguo; Langdon, Wallace Y.; Tsygankov, Alexander Y.; Kunapuli, Satya P.; Sanjay, Archana			Cbl-b Is a Novel Physiologic Regulator of Glycoprotein VI-dependent Platelet Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CELL ANTIGEN RECEPTOR; MEDIATED NEGATIVE REGULATION; HOMOLOGY 3 DOMAIN; FORMATION IN-VIVO; C-CBL; TYROSINE KINASE; T-CELLS; PHOSPHOLIPASE C-GAMMA-2; PHOSPHORYLATION SITES	Cbl-b, a member of the Cbl family of E3 ubiquitin ligases, plays an important role in the activation of lymphocytes. However, its function in platelets remains unknown. We show that Cbl-b is expressed in human platelets along with c-Cbl, but in contrast to c-Cbl, it is not tyrosine-phosphorylated upon glycoprotein VI (GPVI) stimulation. Cbl-b, unlike c-Cbl, is not required for Syk ubiquitylation downstream of GPVI activation. Phospholipase C gamma 2 (PLC gamma 2) and Bruton's tyrosine kinase (BTK) are constituently associated with Cbl-b. Cbl-b-deficient (Cbl-b(-/-)) platelets display an inhibition in the concentration-response curve for GPVI-specific agonist-induced aggregation, secretion, and Ca2+ mobilization. A parallel inhibition is found for activation of PLC gamma 2 and BTK. However, Syk activation is not affected by the absence of Cbl-b, indicating that Cbl-b acts downstream of Syk but upstream of BTK and PLC gamma 2. When Cbl-b(-/-) mice were tested in the ferric chloride thrombosis model, occlusion time was increased and clot stability was reduced compared with wild type controls. These data indicate that Cbl-b plays a positive modulatory role in GPVI-dependent platelet signaling, which translates to an important regulatory role in hemostasis and thrombosis in vivo.	[Daniel, James L.] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Sanjay, Archana] Temple Univ, Dept Anat, Philadelphia, PA 19140 USA; [Tsygankov, Alexander Y.; Kunapuli, Satya P.] Temple Univ, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Buitrago, Lorena] Temple Univ, Dept Physiol, Philadelphia, PA 19140 USA; [Daniel, James L.; Dangelmaier, Carol A.; Mada, Sripal; Jin, Jianguo; Tsygankov, Alexander Y.; Kunapuli, Satya P.; Sanjay, Archana] Temple Univ, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Langdon, Wallace Y.] Univ Western Australia, Sch Surg & Pathol, Crawley, WA 6009, Australia	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Western Australia	Daniel, JL (corresponding author), Temple Univ, Sch Med, Dept Pharmacol, 3420 N Broad St, Philadelphia, PA 19140 USA.	james.daniel@temple.edu	Tsygankov, Alexander Y/K-6205-2017		American Heart Association; National Institutes of Health [HL60683, HL80444, HL81322, DE004724, CA 78499]; NATIONAL CANCER INSTITUTE [R01CA078499] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081322, R01HL080444, R01HL060683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE004724, R37DE004724] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by a grant from the Southeastern Pennsylvania Affiliate of the American Heart Association and National Institutes of Health Grants HL60683, HL80444, HL81322, DE004724, and CA 78499.	Andoniou CE, 1996, ONCOGENE, V12, P1981; Auger JM, 2003, J THROMB HAEMOST, V1, P2419, DOI 10.1046/j.1538-7836.2003.00464.x; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; BLAKE TJ, 1991, ONCOGENE, V6, P653; Braiman A, 2006, EMBO J, V25, P774, DOI 10.1038/sj.emboj.7600978; Bunnell SC, 1996, J BIOL CHEM, V271, P25646, DOI 10.1074/jbc.271.41.25646; Bustelo XR, 1997, ONCOGENE, V15, P2511, DOI 10.1038/sj.onc.1201430; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Dangelmaier CA, 2005, BLOOD, V105, P3918, DOI 10.1182/blood-2004-09-3689; Dogne JM, 2005, THROMB RES, V116, P431, DOI 10.1016/j.thromres.2005.02.006; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; Elly C, 1999, ONCOGENE, V18, P1147, DOI 10.1038/sj.onc.1202411; Falati S, 2006, BLOOD, V107, P535, DOI 10.1182/blood-2005-04-1512; Feshchenko EA, 1998, J BIOL CHEM, V273, P8323, DOI 10.1074/jbc.273.14.8323; Graham LJ, 1998, BIOCHEM BIOPH RES CO, V249, P537, DOI 10.1006/bbrc.1998.9177; Grossmann AH, 2004, FEBS LETT, V577, P555, DOI 10.1016/j.febslet.2004.10.054; Hechler B, 2010, J THROMB HAEMOST, V8, P173, DOI 10.1111/j.1538-7836.2009.03666.x; Horne WC, 2005, IMMUNOL REV, V208, P106, DOI 10.1111/j.0105-2896.2005.00335.x; Judd BA, 2002, J EXP MED, V195, P705, DOI 10.1084/jem.20011583; Kahner BN, 2007, BLOOD, V110, P2449, DOI 10.1182/blood-2006-11-056069; Kauffenstein G, 2001, FEBS LETT, V505, P281, DOI 10.1016/S0014-5793(01)02824-1; KEANE MM, 1995, ONCOGENE, V10, P2367; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Lian LR, 2005, BLOOD, V106, P110, DOI 10.1182/blood-2004-05-2005; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Martin V, 2010, BLOOD, V115, P2008, DOI 10.1182/blood-2009-04-217224; Miyake S, 1999, J BIOL CHEM, V274, P16619, DOI 10.1074/jbc.274.23.16619; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Nagy B, 2009, BLOOD, V113, P2557, DOI 10.1182/blood-2008-07-169268; Nakajima A, 2009, J BONE MINER RES, V24, P1162, DOI [10.1359/JBMR.090205, 10.1359/jbmr.090205]; Oda A, 1996, BLOOD, V88, P1330, DOI 10.1182/blood.V88.4.1330.bloodjournal8841330; Oksvold MP, 2008, MOL IMMUNOL, V45, P925, DOI 10.1016/j.molimm.2007.08.002; Ozdener F, 2002, MOL PHARMACOL, V62, P672, DOI 10.1124/mol.62.3.672; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; Patel HV, 1997, PROTEINS, V29, P545, DOI 10.1002/(SICI)1097-0134(199712)29:4<545::AID-PROT13>3.0.CO;2-M; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; Quinter PG, 2007, J THROMB HAEMOST, V5, P362, DOI 10.1111/j.1538-7836.2007.02309.x; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; Rellahan BL, 2003, EXP CELL RES, V289, P184, DOI 10.1016/S0014-4827(03)00260-X; Robertson JO, 2009, THROMB RES, V123, P644, DOI 10.1016/j.thromres.2008.07.003; Rumbaut RE, 2005, MICROCIRCULATION, V12, P259, DOI 10.1080/10739680590925664; Stalker TJ, 2009, J THROMB HAEMOST, V7, P1886, DOI 10.1111/j.1538-7836.2009.03606.x; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Tezuka T, 1996, J EXP MED, V183, P675, DOI 10.1084/jem.183.2.675; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Thien CBF, 1999, J IMMUNOL, V162, P7133; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tsygankov AY, 2001, ONCOGENE, V20, P6382, DOI 10.1038/sj.onc.1204781; Wang XK, 2005, THROMB RES, V115, P95, DOI 10.1016/j.thromres.2004.07.009; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5; Yasuda T, 2002, J EXP MED, V196, P51, DOI 10.1084/jem.20020068; Zhang ZH, 1999, CURR BIOL, V9, P203, DOI 10.1016/S0960-9822(99)80090-6	56	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17282	17291		10.1074/jbc.M109.080200	http://dx.doi.org/10.1074/jbc.M109.080200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20400514	Green Published, hybrid			2022-12-25	WOS:000278133400005
J	Jo, H; Loison, F; Hattori, H; Silberstein, LE; Yu, HT; Luo, HR				Jo, Hakryul; Loison, Fabien; Hattori, Hidenori; Silberstein, Leslie E.; Yu, Hongtao; Luo, Hongbo R.			Natural Product Celastrol Destabilizes Tubulin Heterodimer and Facilitates Mitotic Cell Death Triggered by Microtubule-Targeting Anti-Cancer Drugs	PLOS ONE			English	Article							INDUCED APOPTOSIS; PROTEIN; BINDING; ARREST; PARTHENOLIDE; TRITERPENE; INHIBITOR; DISCOVERY; CLEAVAGE; PATHWAY	Background: Microtubule drugs are effective anti-cancer agents, primarily due to their ability to induce mitotic arrest and subsequent cell death. However, some cancer cells are intrinsically resistant or acquire a resistance. Lack of apoptosis following mitotic arrest is thought to contribute to drug resistance that limits the efficacy of the microtubule-targeting anticancer drugs. Genetic or pharmacological agents that selectively facilitate the apoptosis of mitotic arrested cells present opportunities to strengthen the therapeutic efficacy. Methodology and Principal Findings: We report a natural product Celastrol targets tubulin and facilitates mitotic cell death caused by microtubule drugs. First, in a small molecule screening effort, we identify Celastrol as an inhibitor of neutrophil chemotaxis. Subsequent time-lapse imaging analyses reveal that inhibition of microtubule-mediated cellular processes, including cell migration and mitotic chromosome alignment, is the earliest events affected by Celastrol. Disorganization, not depolymerization, of mitotic spindles appears responsible for mitotic defects. Celastrol directly affects the biochemical properties of tubulin heterodimer in vitro and reduces its protein level in vivo. At the cellular level, Celastrol induces a synergistic apoptosis when combined with conventional microtubule-targeting drugs and manifests an efficacy toward Taxol-resistant cancer cells. Finally, by time-lapse imaging and tracking of microtubule drug-treated cells, we show that Celastrol preferentially induces apoptosis of mitotic arrested cells in a caspase-dependent manner. This selective effect is not due to inhibition of general cell survival pathways or mitotic kinases that have been shown to enhance microtubule drug-induced cell death. Conclusions and Significance: We provide evidence for new cellular pathways that, when perturbed, selectively induce the apoptosis of mitotic arrested cancer cells, identifying a potential new strategy to enhance the therapeutic efficacy of conventional microtubule-targeting anti-cancer drugs.	[Jo, Hakryul; Loison, Fabien; Hattori, Hidenori; Silberstein, Leslie E.; Luo, Hongbo R.] Harvard Univ, Sch Med, Dept Pathol, Dana Farber Harvard Canc Ctr, Boston, MA 02115 USA; [Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Pharmacol, Dallas, TX 75390 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Jo, H (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Dana Farber Harvard Canc Ctr, Boston, MA 02115 USA.	Hongbo.Luo@childrens.harvard.edu	loison, fabien/G-3385-2014	loison, fabien/0000-0002-6678-1730; Yu, Hongtao/0000-0002-8861-049X	National Institutes of Health (NIH) [HL066987, HL085100, AI076471, HL092020, GM076084]; American Cancer Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085100, T32HL066987, R01HL092020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076084] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	H. Jo is supported by National Institutes of Health (NIH) Training Grant HL066987. H. Luo is supported by NIH grants HL085100, AI076471, HL092020, and GM076084 and a Research Scholar Grant from American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee M, 2005, J MED CHEM, V48, P547, DOI 10.1021/jm0494974; BARTON JS, 1982, BIOCHIM BIOPHYS ACTA, V705, P8, DOI 10.1016/0167-4838(82)90328-4; Burris HA, 2008, SEMIN ONCOL, V35, pS15, DOI 10.1053/j.seminoncol.2008.02.002; CARLIER MF, 1984, BIOCHEMISTRY-US, V23, P1582, DOI 10.1021/bi00302a037; CORREIA JJ, 1994, ARCH BIOCHEM BIOPHYS, V309, P94, DOI 10.1006/abbi.1994.1090; CORREIA JJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P105, DOI 10.1006/abbi.1993.1015; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; de Carcer G, 2001, EMBO J, V20, P2878, DOI 10.1093/emboj/20.11.2878; Fonrose X, 2007, CANCER RES, V67, P3371, DOI 10.1158/0008-5472.CAN-06-3732; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Gaertig J, 2008, CURR TOP DEV BIOL, V85, P83, DOI 10.1016/S0070-2153(08)00804-1; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hassane DC, 2008, BLOOD, V111, P5654, DOI 10.1182/blood-2007-11-126003; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hunt JT, 2009, MOL CANCER THER, V8, P275, DOI 10.1158/1535-7163.MCT-08-0999; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Jin HZ, 2002, J NAT PROD, V65, P89, DOI 10.1021/np010428r; Jo H, 2008, MOL CELL BIOL, V28, P4285, DOI 10.1128/MCB.01240-07; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; Lin YF, 2009, CANCER RES, V69, P6879, DOI 10.1158/0008-5472.CAN-08-4700; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; MARTIN SR, 1982, BIOCHEM J, V203, P643, DOI 10.1042/bj2030643; MI L, 2009, J BIOL CHEM; Mi LX, 2008, J BIOL CHEM, V283, P22136, DOI 10.1074/jbc.M802330200; Milross CG, 1996, JNCI-J NATL CANCER I, V88, P1308, DOI 10.1093/jnci/88.18.1308; Miyata N, 2008, INT IMMUNOPHARMACOL, V8, P874, DOI 10.1016/j.intimp.2008.02.002; Mooberry Susan L, 2007, Methods Mol Med, V137, P289, DOI 10.1007/978-1-59745-442-1_20; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nagle A, 2006, CURR DRUG TARGETS, V7, P305, DOI 10.2174/138945006776054933; O'Connor DS, 2002, CANCER CELL, V2, P43, DOI 10.1016/S1535-6108(02)00084-3; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Prosser SL, 2009, MOL CELL BIOL, V29, P1760, DOI 10.1128/MCB.01124-08; Ross-Macdonald P, 2008, MOL CANCER THER, V7, P3490, DOI 10.1158/1535-7163.MCT-08-0826; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Steinmetz MO, 2008, TRENDS BIOCHEM SCI, V33, P535, DOI 10.1016/j.tibs.2008.08.006; Symmans WF, 2000, CLIN CANCER RES, V6, P4610; Toyoshima F, 2007, DEV CELL, V13, P796, DOI 10.1016/j.devcel.2007.10.014; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhu D, 2006, P NATL ACAD SCI USA, V103, P14836, DOI 10.1073/pnas.0605722103	44	36	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10318	10.1371/journal.pone.0010318	http://dx.doi.org/10.1371/journal.pone.0010318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428237	Green Published, gold, Green Submitted			2022-12-25	WOS:000277079300010
J	Khachane, AN; Harrison, PM				Khachane, Amit N.; Harrison, Paul M.			Mining Mammalian Transcript Data for Functional Long Non-Coding RNAs	PLOS ONE			English	Article							FATE DETERMINATION FACTOR; ACTIVATED-RECEPTOR-DELTA; E-2 SIGNALING PATHWAYS; BREAST-CANCER; TUMOR-SUPPRESSOR; MESSENGER-RNA; IN-VIVO; GENE; GROWTH; EXPRESSION	Background: The role of long non-coding RNAs (lncRNAs) in controlling gene expression has garnered increased interest in recent years. Sequencing projects, such as Fantom3 for mouse and H-InvDB for human, have generated abundant data on transcribed components of mammalian cells, the majority of which appear not to be protein-coding. However, much of the non-protein-coding transcriptome could merely be a consequence of 'transcription noise'. It is therefore essential to use bioinformatic approaches to identify the likely functional candidates in a high throughput manner. Principal Findings: We derived a scheme for classifying and annotating likely functional lncRNAs in mammals. Using the available experimental full-length cDNA data sets for human and mouse, we identified 78 lncRNAs that are either syntenically conserved between human and mouse, or that originate from the same protein-coding genes. Of these, 11 have significant sequence homology. We found that these lncRNAs exhibit: (i) patterns of codon substitution typical of non-coding transcripts; (ii) preservation of sequences in distant mammals such as dog and cow, (iii) significant sequence conservation relative to their corresponding flanking regions (in 50% cases, flanking regions do not have homology at all; and in the remaining, the degree of conservation is significantly less); (iv) existence mostly as single-exon forms (8/11); and, (v) presence of conserved and stable secondary structure motifs within them. We further identified orthologous protein-coding genes that are contributing to the pool of lncRNAs; of which, genes implicated in carcinogenesis are significantly over-represented. Conclusion: Our comparative mammalian genomics approach coupled with evolutionary analysis identified a small population of conserved long non-protein-coding RNAs (lncRNAs) that are potentially functional across Mammalia. Additionally, our analysis indicates that amongst the orthologous protein-coding genes that produce lncRNAs, those implicated in cancer pathogenesis are significantly over-represented, suggesting that these lncRNAs could play an important role in cancer pathomechanisms.	[Khachane, Amit N.; Harrison, Paul M.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Khachane, AN (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	amit.khachane@mail.mcgill.ca			National Science and Engineering Research Council of Canada (NSERC); Les Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Les Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT)	A.N.K. and P.M.H. would like to thank the funding support from the National Science and Engineering Research Council of Canada (NSERC), and from Les Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2009, NATURE, V457, P1028; Bajdik CD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-78; Batey RT, 2006, CURR OPIN STRUC BIOL, V16, P299, DOI 10.1016/j.sbi.2006.05.001; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blank C, 2001, CYTOGENET CELL GENET, V95, P17, DOI 10.1159/000057011; Brosius J, 2005, TRENDS GENET, V21, P287, DOI 10.1016/j.tig.2005.02.014; Buim ME, 2005, ONCOLOGY-BASEL, V69, P445, DOI 10.1159/000090984; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Faridi J, 2003, CLIN CANCER RES, V9, P2933; Finlin BS, 2001, J BIOL CHEM, V276, P42259, DOI 10.1074/jbc.M105888200; Gabory A, 2006, CYTOGENET GENOME RES, V113, P188, DOI 10.1159/000090831; Gruber AR, 2007, NUCLEIC ACIDS RES, V35, pW335, DOI 10.1093/nar/gkm222; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hooi CSF, 2006, ONCOGENE, V25, P3924, DOI 10.1038/sj.onc.1209418; Ishiguro H, 2002, ONCOGENE, V21, P6387, DOI 10.1038/sj.onc.1205751; Jaskula-Sztul Renata, 2001, Journal of Applied Genetics, V42, P223; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; Khachane AN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-435; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Li YM, 1998, J BIOL CHEM, V273, P28247, DOI 10.1074/jbc.273.43.28247; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Maeda N, 2006, PLOS GENET, V2, P498, DOI 10.1371/journal.pgen.0020062; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Morton LM, 2006, PHARMACOGENET GENOM, V16, P537, DOI 10.1097/01.fpc.0000215071.59836.29; Moslehi R, 2006, PHARMACOGENOMICS, V7, P819, DOI 10.2217/14622416.7.6.819; Nam DK, 2002, P NATL ACAD SCI USA, V99, P6152, DOI 10.1073/pnas.092140899; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nordstrom KJV, 2009, GENOMICS, V94, P169, DOI 10.1016/j.ygeno.2009.05.012; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rusiniak ME, 2000, CANCER RES, V60, P1824; Schoenmakers EFPM, 1999, CANCER RES, V59, P19; Sharma A, 2009, CLIN CANCER RES, V15, P1674, DOI 10.1158/1078-0432.CCR-08-2214; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tran MA, 2008, CANCER RES, V68, P7638, DOI 10.1158/0008-5472.CAN-07-6614; Vazquez-Martinez R, 2008, J CLIN ENDOCR METAB, V93, P2269, DOI 10.1210/jc.2007-1893; Wu KM, 2006, MOL CELL BIOL, V26, P7116, DOI 10.1128/MCB.00268-06; Wu KM, 2009, CANCER RES, V69, P3347, DOI 10.1158/0008-5472.CAN-08-3821; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xu LH, 2006, J BIOL CHEM, V281, P33982, DOI 10.1074/jbc.M600135200; Xu LH, 2006, CANCER RES, V66, P11859, DOI 10.1158/0008-5472.CAN-06-1445; Yamasaki C, 2008, NUCLEIC ACIDS RES, V36, pD793, DOI 10.1093/nar/gkm999; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yoshimizu T, 2008, P NATL ACAD SCI USA, V105, P12417, DOI 10.1073/pnas.0801540105; Zenklusen JC, 2001, NAT GENET, V27, P392, DOI 10.1038/86891	54	120	128	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10316	10.1371/journal.pone.0010316	http://dx.doi.org/10.1371/journal.pone.0010316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428234	Green Published, gold, Green Submitted			2022-12-25	WOS:000277079300009
J	Sijwali, PS; Rosenthal, PJ				Sijwali, Puran Singh; Rosenthal, Philip J.			Functional Evaluation of Plasmodium Export Signals in Plasmodium berghei Suggests Multiple Modes of Protein Export	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; HIGH-EFFICIENCY TRANSFECTION; MALARIA PARASITE PROTEINS; VARIANT ANTIGENS; HOST ERYTHROCYTE; MAURERS CLEFTS; GENE FAMILY; VIRULENCE; SURFACE; SELECTION	The erythrocytic stage development of malaria parasites occurs within the parasitophorous vacuole inside the infected-erythrocytes, and requires transport of several parasite-encoded proteins across the parasitophorous vacuole to several locations, including the cytosol and membrane of the infected cell. These proteins are called exported proteins; and a large number of such proteins have been predicted for Plasmodium falciparum based on the presence of an N-terminal motif known as the Plasmodium export element (PEXEL) or vacuolar transport signal (VTS), which has been shown to mediate export. The majority of exported proteins contain one or more transmembrane domains at the C-terminus and one of three types of N-terminuswdomain architectures. ( 1) The majority, including the knob-associated histidine rich protein ( KAHRP), contain a signal/hydrophobic sequence preceding the PEXEL/VTS motif. ( 2) Other exported proteins, including the P. berghei variant antigen family bir and the P. falciparum skeleton binding protein-1, do not appear to contain a PEXEL/VTS motif. ( 3) The P. falciparum erythrocyte membrane protein-1 (PfEMP1) family lacks a signal/hydrophobic sequence before the motif. These different domain architectures suggest the presence of multiple export pathways in malaria parasites. To determine if export pathways are conserved in plasmodia and to develop an experimental system for studying these processes, we investigated export of GFP fused with N- and C-terminus putative export domains in the rodent malaria parasite P. berghei. Export was dependent on specific N- and C-terminal domains. Constructs with a KAHRP-like or bir N- terminus, but not the PfEMP1 N- terminus, exported GFP into the erythrocyte. The C-terminus of a P. falciparum variant antigen rifin prevented GFP export by the KAHRP-like N- terminus. In contrast, GFP chimeras containing KAHRP-like N- termini and the PfEMP1 C-terminus were exported to the surface of erythrocytes. Taken together, these results suggest that proteins with KAHRP-like architecture follow a common export pathway, but that PfEMP1s utilize an alternative pathway. Functional validation of common putative export domains of malaria parasites in P. berghei provides an alternative and simpler system to investigate export mechanisms.	[Sijwali, Puran Singh] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Rosenthal, Philip J.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Sijwali, PS (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	psijwali@ccmb.res.in; prosenthal@medsfgh.ucsf.edu			Medicines for Malaria Venture; National Institutes of Health [AI35800, RR01081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035800, R56AI035800, R29AI035800] Funding Source: NIH RePORTER	Medicines for Malaria Venture; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Medicines for Malaria Venture and the National Institutes of Health (AI35800 and RR01081). PJR is a Distinguished Clinical Scientist of the Doris Duke Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Fernandez V, 1999, J EXP MED, V190, P1393, DOI 10.1084/jem.190.10.1393; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Haase S, 2009, MOL MICROBIOL, V71, P1003, DOI 10.1111/j.1365-2958.2008.06582.x; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Janssen CS, 2002, P ROY SOC B-BIOL SCI, V269, P431, DOI 10.1098/rspb.2001.1903; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Joannin N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-19; Jongco AM, 2006, MOL BIOCHEM PARASIT, V146, P242, DOI 10.1016/j.molbiopara.2006.01.001; Knuepfer E, 2005, BLOOD, V105, P4078, DOI 10.1182/blood-2004-12-4666; MacKenzie JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002405; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Niang M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000307; Pasternak ND, 2009, INT J BIOCHEM CELL B, V41, P1463, DOI 10.1016/j.biocel.2008.12.012; Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Saridaki T, 2009, TRAFFIC, V10, P137, DOI 10.1111/j.1600-0854.2008.00860.x; Sato S, 2003, MOL BIOCHEM PARASIT, V130, P155, DOI 10.1016/S0166-6851(03)00166-X; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Spielmann T, 2010, TRENDS PARASITOL, V26, P6, DOI 10.1016/j.pt.2009.10.001; Templeton TJ, 2005, TRENDS PARASITOL, V21, P399, DOI 10.1016/j.pt.2005.07.006; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392	36	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10227	10.1371/journal.pone.0010227	http://dx.doi.org/10.1371/journal.pone.0010227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419102	gold, Green Submitted, Green Published			2022-12-25	WOS:000276853800017
J	Wu, G; Zhu, LS; Dent, JE; Nardini, C				Wu, Gang; Zhu, Lisha; Dent, Jennifer E.; Nardini, Christine			A Comprehensive Molecular Interaction Map for Rheumatoid Arthritis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BLOOD MONONUCLEAR-CELLS; NECROSIS-FACTOR-ALPHA; DNA STRAND BREAKS; FACTOR-KAPPA-B; HISTONE DEACETYLASE INHIBITOR; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CARTILAGE-PANNUS JUNCTION; ANTI-TNF TREATMENT; GENE-EXPRESSION	Background: Computational biology contributes to a variety of areas related to life sciences and, due to the growing impact of translational medicine - the scientific approach to medicine in tight relation with basic science -, it is becoming an important player in clinical-related areas. In this study, we use computation methods in order to improve our understanding of the complex interactions that occur between molecules related to Rheumatoid Arthritis (RA). Methodology: Due to the complexity of the disease and the numerous molecular players involved, we devised a method to construct a systemic network of interactions of the processes ongoing in patients affected by RA. The network is based on high-throughput data, refined semi-automatically with carefully curated literature-based information. This global network has then been topologically analysed, as a whole and tissue-specifically, in order to translate the experimental molecular connections into topological motifs meaningful in the identification of tissue-specific markers and targets in the diagnosis, and possibly in the therapy, of RA. Significance: We find that some nodes in the network that prove to be topologically important, in particular AKT2, IL6, MAPK1 and TP53, are also known to be associated with drugs used for the treatment of RA. Importantly, based on topological consideration, we are also able to suggest CRKL as a novel potentially relevant molecule for the diagnosis or treatment of RA. This type of finding proves the potential of in silico analyses able to produce highly refined hypotheses, based on vast experimental data, to be tested further and more efficiently. As research on RA is ongoing, the present map is in fieri, despite being -at the moment-a reflection of the state of the art. For this reason we make the network freely available in the standardised and easily exportable. xml CellDesigner format at 'www.picb.ac.cn/ClinicalGenomicNTW/temp. html' and 'www.celldesigner.org'.	[Wu, Gang; Zhu, Lisha; Dent, Jennifer E.; Nardini, Christine] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Grp Clin Genom Networks, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Wu, G (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Grp Clin Genom Networks, Shanghai, Peoples R China.	christine@picb.ac.cn	Nardini, Christine/AGD-4177-2022; Dent, Jennifer/C-7573-2011; Nardini, Christine/G-6802-2017	Nardini, Christine/0000-0001-7601-321X	European Union, China; European commission	European Union, China; European commission(European CommissionEuropean Commission Joint Research Centre)	JED is fully funded by The European Union Science and Technology Fellowship Programme, China. The contracting authority for the Programme is the European commission, reference: EuropeAidl128952/L/ACT/CN, budget line: BGUE-B2009-19.100104-CI-AIDCO, http://www.euchinastf.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamanos Y, 2006, SEMIN ARTHRITIS RHEU, V36, P182, DOI 10.1016/j.semarthrit.2006.08.006; ALBERGHINA L, 2009, J BIOTECHNOLOGY; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alsaleh G, 2009, J IMMUNOL, V182, P5088, DOI 10.4049/jimmunol.0801613; AMANO Y, 1993, MOL PHARMACOL, V43, P176; Andreas K, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2358; Arranz A, 2008, MOL IMMUNOL, V45, P3065, DOI 10.1016/j.molimm.2008.03.011; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Auer J, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2294; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barrenas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008090; Benito MJ, 2004, ARTHRITIS RHEUM-US, V50, P1781, DOI 10.1002/art.20260; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Black AJ, 1998, ANN INTERN MED, V129, P716, DOI 10.7326/0003-4819-129-9-199811010-00007; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Brentano F, 2005, CELL IMMUNOL, V233, P90, DOI 10.1016/j.cellimm.2005.04.018; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Calzone L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.7; Carl HD, 2008, Z RHEUMATOL, V67, P485, DOI 10.1007/s00393-008-0314-5; Coenen MJH, 2007, PHARMACOGENOMICS, V8, P761, DOI 10.2217/14622416.8.7.761; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Devauchelle V, 2004, GENES IMMUN, V5, P597, DOI 10.1038/sj.gene.6364132; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Edwards CJ, 2007, MOL MED, V13, P40, DOI 10.2119/2006-000056.Edwards; Eschrich S, 2009, INT J RADIAT ONCOL, V75, P497, DOI 10.1016/j.ijrobp.2009.05.056; EYRE S, 2009, ANN RHEUM DIS; Fassbender HG, 1998, ARCH ORTHOP TRAUM SU, V117, P2, DOI 10.1007/BF00703430; FASSBENDER HG, 1984, ARTHRITIS RHEUM, V27, P956, DOI 10.1002/art.1780270819; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Galligan CL, 2007, GENES IMMUN, V8, P480, DOI 10.1038/sj.gene.6364400; Giladi H, 2008, JCR-J CLIN RHEUMATOL, V14, P97, DOI 10.1097/RHU.0b013e31816d5ea5; Glaysher S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-300; Hammaker D, 2003, ANN RHEUM DIS, V62, P86; Han ZN, 1998, AUTOIMMUNITY, V28, P197, DOI 10.3109/08916939808995367; Handel ML, 1995, ARTHRITIS RHEUM, V38, P1762, DOI 10.1002/art.1780381209; Hodgkinson CP, 2008, PHARMACOGENET GENOM, V18, P803, DOI 10.1097/FPC.0b013e3283050aff; Holt RA, 2008, GENOME RES, V18, P839, DOI 10.1101/gr.073262.107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JY, 2004, J BIOL CHEM, V279, P21637, DOI 10.1074/jbc.M400956200; Huang QC, 2008, RHEUMATOL INT, V28, P697, DOI 10.1007/s00296-008-0534-7; JACOB F, 1960, CR HEBD ACAD SCI, V250, P1727; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Ji L, 2008, J THORAC ONCOL, V3, P327, DOI 10.1097/JTO.0b013e31816bce65; Joosten LAB, 2003, J IMMUNOL, V171, P6145, DOI 10.4049/jimmunol.171.11.6145; Julia A, 2009, PHARMACOGENOMICS, V10, P1697, DOI 10.2217/PGS.09.99; Junta CM, 2009, IMMUNOLOGY, V127, P365, DOI 10.1111/j.1365-2567.2008.03005.x; Kalatzis FG, 2009, IEEE ENG MED BIO, P827, DOI 10.1109/IEMBS.2009.5333743; Kawasaki H, 2003, ONCOGENE, V22, P6839, DOI 10.1038/sj.onc.1206903; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; KLIPP E, 2007, NAT BIOTECHNOL, P390; Koczan D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2419; Kooloos WM, 2007, DRUG DISCOV TODAY, V12, P125, DOI 10.1016/j.drudis.2006.11.013; Kraan TCV, 2008, ANN RHEUM DIS, V67, P563, DOI 10.1136/ard.2007.081950; Kraan TCTMV, 2003, ARTHRITIS RHEUM-US, V48, P2132, DOI 10.1002/art.11096; Kuo CC, 2007, MOL MED, V13, P561, DOI 10.2119/2007-00021.Kuo; Lacroix BD, 2009, CLIN PHARMACOL THER, V86, P387, DOI 10.1038/clpt.2009.136; LEA P, 2009, CLIN REV ALLERGY IMM; Lequerre T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1990; Lequerre T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2744; Levin J, 2006, BEST PRACT RES CL RH, V20, P809, DOI 10.1016/j.berh.2006.05.001; LI JC, 1984, P NATL ACAD SCI-BIOL, V81, P5694, DOI 10.1073/pnas.81.18.5694; Liacini A, 2003, EXP CELL RES, V288, P208, DOI 10.1016/S0014-4827(03)00180-0; LINDBERG J, 2006, ARTHRITIS RES THER, V8; LORICO A, 1988, CANCER RES, V48, P2036; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Ludikhuize J, 2007, ARTHRITIS RHEUM-US, V56, P2180, DOI 10.1002/art.22653; MEHINDATE K, 1994, INFECT IMMUN, V62, P4716, DOI 10.1128/IAI.62.11.4716-4721.1994; Meltzer EB, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-8; Morel J, 2004, JOINT BONE SPINE, V71, P503, DOI 10.1016/j.jbspin.2004.03.004; Murakami M, 2004, BIOCHEM BIOPH RES CO, V319, P114, DOI 10.1016/j.bbrc.2004.04.153; Nakamura C, 2008, RHEUMATOLOGY, V47, P418, DOI 10.1093/rheumatology/ken003; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Nishida K, 2004, ARTHRITIS RHEUM-US, V50, P3365, DOI 10.1002/art.20709; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Oki K, 2009, INFLAMM RES, V58, P571, DOI 10.1007/s00011-009-0021-y; Olsen NJ, 2004, ANN RHEUM DIS, V63, P1387, DOI 10.1136/ard.2003.017194; Pander J, 2007, DRUG DISCOV TODAY, V12, P1054, DOI 10.1016/j.drudis.2007.10.016; Parker A, 2007, J RHEUMATOL, V34, P1817; Pohlers D, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2217; Poppe D, 2006, J IMMUNOL, V176, P640, DOI 10.4049/jimmunol.176.1.640; Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sacre SM, 2007, AM J PATHOL, V170, P518, DOI 10.2353/ajpath.2007.060657; Schett G, 2000, ARTHRITIS RHEUM, V43, P2501, DOI 10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K; Schneider M, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-54; Seibl R, 2003, AM J PATHOL, V162, P1221, DOI 10.1016/S0002-9440(10)63918-1; Sekiguchi N, 2008, RHEUMATOLOGY, V47, P780, DOI 10.1093/rheumatology/ken083; Sengupta U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008100; Sha N, 2003, COMP FUNCT GENOM, V4, P171, DOI 10.1002/cfg.264; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHIOZAWA S, 1983, ARTHRITIS RHEUM-US, V26, P472, DOI 10.1002/art.1780260404; Shiozawa S, 2009, CELL CYCLE, V8, P1539, DOI 10.4161/cc.8.10.8411; Silva GL, 2007, ANN NY ACAD SCI, V1110, P33, DOI 10.1196/annals.1423.005; Singh K, 2008, J IMMUNOL, V180, P1971, DOI 10.4049/jimmunol.180.3.1971; SMITHGALL TE, 1995, J PHARMACOL TOX MET, V34, P125, DOI 10.1016/1056-8719(95)00082-7; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Suzuki M, 2000, FEBS LETT, V465, P23, DOI 10.1016/S0014-5793(99)01717-2; Sweeney SE, 2004, CURR OPIN RHEUMATOL, V16, P231, DOI 10.1097/00002281-200405000-00011; Teixeira VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006803; Timmer TCG, 2007, ARTHRITIS RHEUM-US, V56, P2492, DOI 10.1002/art.22748; TOBLER A, 1992, BLOOD, V79, P45; Tolusso B, 2006, PHARMACOGENOMICS, V7, P683, DOI 10.2217/14622416.7.5.683; Toonen EJM, 2008, ANN RHEUM DIS, V67, P1663, DOI 10.1136/ard.2007.076588; Vallabhajosyula RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005344; van Baarsen LGM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2557; van der Heijden IM, 2000, ARTHRITIS RHEUM-US, V43, P593, DOI 10.1002/1529-0131(200003)43:3<593::AID-ANR16>3.0.CO;2-1; van der Linden MPM, 2009, ARTHRITIS RHEUM, V60, P2242, DOI 10.1002/art.24721; VISMARA P, 1997, UNION MINIMUM CYCLE; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wu CC, 2009, HUM GENET, V126, P303, DOI 10.1007/s00439-009-0672-3; Wuchty S, 2005, PROTEOMICS, V5, P444, DOI 10.1002/pmic.200400962; Zer C, 2007, PHYSIOL GENOMICS, V31, P343, DOI 10.1152/physiolgenomics.00080.2007; Zhu MZ, 2009, SCI CHINA SER C, V52, P398, DOI 10.1007/s11427-009-0055-y; Zinovyev A, 2008, BIOINFORMATICS, V24, P876, DOI 10.1093/bioinformatics/btm553; Ziober AF, 2006, CLIN CANCER RES, V12, P5960, DOI 10.1158/1078-0432.CCR-06-0535	123	44	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10137	10.1371/journal.pone.0010137	http://dx.doi.org/10.1371/journal.pone.0010137			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419126	gold, Green Published, Green Submitted			2022-12-25	WOS:000276743500008
J	Srinivasan, S; Liu, CZ; Mitchell, CM; Fiedler, TL; Thomas, KK; Agnew, KJ; Marrazzo, JM; Fredricks, DN				Srinivasan, Sujatha; Liu, Congzhou; Mitchell, Caroline M.; Fiedler, Tina L.; Thomas, Katherine K.; Agnew, Kathy J.; Marrazzo, Jeanne M.; Fredricks, David N.			Temporal Variability of Human Vaginal Bacteria and Relationship with Bacterial Vaginosis	PLOS ONE			English	Article							GARDNERELLA-VAGINALIS; METRONIDAZOLE THERAPY; QUANTITATIVE PCR; ACQUISITION; IRON; ASSOCIATIONS; VAGINOLYSIN; PREVALENCE; CYTOLYSIN; FLORA	Background: Little is known about short-term bacterial fluctuations in the human vagina. This study used PCR to assess variability in concentrations of key vaginal bacteria in healthy women and the immediate response to antibiotic in women with bacterial vaginosis (BV). Methodology/Principal Findings: Twenty-two women assessed for BV using Amsel's criteria were evaluated daily for 7 14 days, then at 2, 3 and 4 weeks, using a panel of 11 bacterium-specific quantitative PCR assays. Participants with BV treated with 5 days of intravaginal metronidazole. Participants without BV had vaginal biotas dominated by whose levels fluctuated with menses. With onset of menstruation, quantities of Lactobacillus jensenii and crispatus decreased and were found to be inversely related to Gardnerella vaginalis concentrations (p<0.001). Women BV had a variety of fastidious bacteria whose concentrations dropped below detection thresholds 1-5 days after metronidazole. Recurrent BV was characterized by initial profound decreases of BV-associated bacteria after followed by subsequent increases at relapse. Conclusions/Significance: The microbiota of the human vagina can be highly dynamic. Healthy women are colonized Lactobacillus species, but levels can change dramatically over a month. Marked increases in G. vaginalis were during menses. Participants with BV have diverse communities of fastidious bacteria that are depleted by metronidazole therapy. Women with recurrent BV initially respond to antibiotic treatment with steep declines in concentrations, but these bacteria later reemerge, suggesting that antibiotic resistance in these bacteria is not an factor mediating BV recurrence.	[Srinivasan, Sujatha; Liu, Congzhou; Fiedler, Tina L.; Fredricks, David N.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98104 USA; [Mitchell, Caroline M.; Agnew, Kathy J.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Thomas, Katherine K.] Univ Washington, Ctr AIDS & STDs, Seattle, WA 98195 USA; [Marrazzo, Jeanne M.; Fredricks, David N.] Univ Washington, Dept Med, Seattle, WA USA; [Fredricks, David N.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Srinivasan, S (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, 1124 Columbia St, Seattle, WA 98104 USA.	ssriniva@fhcrc.org; dfredric@fhcrc.org		Thomas, Katherine K/0000-0002-7024-468X; Marrazzo, Jeanne/0000-0002-9277-7364; Mitchell, Caroline M/0000-0001-9924-2349	National Institute of Allergy and Infectious Diseases (NIAID) [R01 AI061628]; National Institutes of Health (NIH); National Institute of Child Health and Human Development (NICHD) [HD-01-264]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061628] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded with a grant (R01 AI061628) to Dr. Fredricks from the National Institute of Allergy and Infectious Diseases (NIAID) (www3.niaid.nih.gov), division of National Institutes of Health (NIH). Dr. Mitchell received salary support from a Women's Reproductive Health grant (HD-01-264) from the National Institute of Child Health and Human Development (NICHD) (www.nichd.nih.gov), division of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; De Backer E, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-115; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Haggerty CL, 2004, CLIN INFECT DIS, V39, P990, DOI 10.1086/423963; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hillier SL MJ., 2008, SEX TRANSM DIS, P737; Jarosik GP, 1998, INFECT IMMUN, V66, P5041, DOI 10.1128/IAI.66.10.5041-5047.1998; Kalra Apoorv, 2007, Curr Infect Dis Rep, V9, P485, DOI 10.1007/s11908-007-0074-4; Khot PD, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-73; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137, DOI 10.1128/CMR.6.2.137-149.1993; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Mitchell CM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-89; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Randis TM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005207; SAUTTER RL, 1980, J CLIN MICROBIOL, V11, P479, DOI 10.1128/JCM.11.5.479-484.1980; Schwebke JR, 1997, SEX TRANSM DIS, V24, P236, DOI 10.1097/00007435-199704000-00009; Srinivasan S., 2008, INTERDISCIP PERSPECT, V2008; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002; Zozaya-Hinchliffe M, 2008, APPL ENVIRON MICROB, V74, P1656, DOI 10.1128/AEM.02127-07	25	276	295	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10197	10.1371/journal.pone.0010197	http://dx.doi.org/10.1371/journal.pone.0010197			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419168	Green Published, Green Submitted, gold			2022-12-25	WOS:000276707100013
J	Aziz, RK; Kansal, R; Aronow, BJ; Taylor, WL; Rowe, SL; Kubal, M; Chhatwal, GS; Walker, MJ; Kotb, M				Aziz, Ramy K.; Kansal, Rita; Aronow, Bruce J.; Taylor, William L.; Rowe, Sarah L.; Kubal, Michael; Chhatwal, Gursharan S.; Walker, Mark J.; Kotb, Malak			Microevolution of Group A Streptococci In Vivo: Capturing Regulatory Networks Engaged in Sociomicrobiology, Niche Adaptation, and Hypervirulence	PLOS ONE			English	Article							HYALURONIC-ACID CAPSULE; CYSTEINE PROTEASE; RESPONSE REGULATOR; 2-COMPONENT SYSTEM; VIRULENCE FACTOR; GENOME SEQUENCE; SPEB EXPRESSION; MOLECULAR-BASIS; STREPTOLYSIN-S; M1T1 CLONE	The onset of infection and the switch from primary to secondary niches are dramatic environmental changes that not only alter bacterial transcriptional programs, but also perturb their sociomicrobiology, often driving minor subpopulations with mutant phenotypes to prevail in specific niches. Having previously reported that M1T1 Streptococcus pyogenes become hypervirulent in mice due to selection of mutants in the covRS regulatory genes, we set out to dissect the impact of these mutations in vitro and in vivo from the impact of other adaptive events. Using a murine subcutaneous chamber model to sample the bacteria prior to selection or expansion of mutants, we compared gene expression dynamics of wild type (WT) and previously isolated animal-passaged (AP) covS mutant bacteria both in vitro and in vivo, and we found extensive transcriptional alterations of pathoadaptive and metabolic gene sets associated with invasion, immune evasion, tissue-dissemination, and metabolic reprogramming. In contrast to the virulence-associated differences between WT and AP bacteria, Phenotype Microarray analysis showed minor in vitro phenotypic differences between the two isogenic variants. Additionally, our results reflect that WT bacteria's rapid host-adaptive transcriptional reprogramming was not sufficient for their survival, and they were outnumbered by hypervirulent covS mutants with SpeB(-)/Sda(high) phenotype, which survived up to 14 days in mice chambers. Our findings demonstrate the engagement of unique regulatory modules in niche adaptation, implicate a critical role for bacterial genetic heterogeneity that surpasses transcriptional in vivo adaptation, and portray the dynamics underlying the selection of hypervirulent covS mutants over their parental WT cells.	[Aziz, Ramy K.; Kansal, Rita; Rowe, Sarah L.; Kotb, Malak] Vet Affairs Med Ctr, Res Serv, Memphis, TN USA; [Aziz, Ramy K.; Kansal, Rita; Rowe, Sarah L.; Kotb, Malak] Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45267 USA; [Aziz, Ramy K.] Cairo Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt; [Aziz, Ramy K.; Kubal, Michael] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Aronow, Bruce J.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Taylor, William L.; Rowe, Sarah L.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Chhatwal, Gursharan S.] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Kotb, Malak] Univ Cincinnati, Coll Med, Cincinnati, OH USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; Egyptian Knowledge Bank (EKB); Cairo University; University of Chicago; Cincinnati Children's Hospital Medical Center; University of Tennessee System; University of Tennessee Health Science Center; Helmholtz Association; Helmholtz-Center for Infection Research; University of Wollongong; University System of Ohio; University of Cincinnati	Aziz, RK (corresponding author), Vet Affairs Med Ctr, Res Serv, Memphis, TN USA.	ramy.aziz@salmonella.org; kotbmk@uc.edu	Aronow, Bruce J/F-8438-2012; Walker, Mark J./F-6940-2011; Aziz, Ramy/B-2918-2009	Aziz, Ramy/0000-0002-4448-7100; Walker, Mark/0000-0001-7423-2769	National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) [AI40198-06]; NIH [P30DK078392]; United States Army Medical Research Acquisition Activity [W81XWH-05-1-0227]; Research and Development Office, Medical Research Service, Department of Veterans Affairs; National Health and Medical Research Council of Australia [459103]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Medical Research Acquisition Activity; Research and Development Office, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants AI40198-06 from National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) to M. K. and NIH P30DK078392 to B. A.; by the United States Army Medical Research Acquisition Activity (W81XWH-05-1-0227 to M. K); by the Research and Development Office, Medical Research Service, Department of Veterans Affairs (Merit Award to M. K.); and by the National Health and Medical Research Council of Australia project grant 459103 (M. W. and M. K.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2007, GENES IMMUN, V8, P404, DOI 10.1038/sj.gene.6364402; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; Aziz RK, 2005, J BACTERIOL, V187, P3311, DOI 10.1128/JB.187.10.3311-3318.2005; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; AZIZ RK, 2009, MOL DISSECTION CLONA; AZIZ RK, 2006, INT C SERIES, V1289, P175; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Bernish B, 1999, J BIOL CHEM, V274, P4786, DOI 10.1074/jbc.274.8.4786; Bessen DE, 2010, J INFECT DIS, V201, P800, DOI 10.1086/651020; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; Chaussee MS, 1999, INFECT IMMUN, V67, P1715; Chaussee MS, 2003, J BACTERIOL, V185, P6016, DOI 10.1128/JB.185.20.6016-6024.2003; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Claverys JP, 2007, NAT REV MICROBIOL, V5, P219, DOI 10.1038/nrmicro1613; Cleary PP, 1998, MOL MICROBIOL, V28, P157, DOI 10.1046/j.1365-2958.1998.00786.x; Cleary PP, 1998, INFECT IMMUN, V66, P5592, DOI 10.1128/IAI.66.11.5592-5597.1998; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Dalton TL, 2006, MICROB PATHOGENESIS, V40, P221, DOI 10.1016/j.micpath.2006.01.005; Egesten A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004769; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Gryllos I, 2003, P NATL ACAD SCI USA, V100, P4227, DOI 10.1073/pnas.0636231100; Gryllos I, 2008, P NATL ACAD SCI USA, V105, P16755, DOI 10.1073/pnas.0803815105; Gusa AA, 2006, J BACTERIOL, V188, P4620, DOI 10.1128/JB.00198-06; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; HOLLANDS A, 2010, J INFECT DI IN PRESS; Hollands A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004102; Hytonen J, 2001, MOL MICROBIOL, V39, P512, DOI 10.1046/j.1365-2958.2001.02269.x; Kacharmina JE, 1999, METHOD ENZYMOL, V303, P3; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; Kazmi SU, 2001, INFECT IMMUN, V69, P4988, DOI 10.1128/IAI.69.8.4988-4995.2001; Kietzman CC, 2010, INFECT IMMUN, V78, P241, DOI 10.1128/IAI.00746-09; Kinkel TL, 2008, INFECT IMMUN, V76, P3451, DOI 10.1128/IAI.00343-08; Kotb M, 2002, NAT MED, V8, P1398, DOI 10.1038/nm800; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Leday TV, 2008, INFECT IMMUN, V76, P4659, DOI 10.1128/IAI.00597-08; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Lin WJ, 2009, MOL MICROBIOL, V71, P1477, DOI 10.1111/j.1365-2958.2009.06616.x; McIver KS, 2009, CONTRIB MICROBIOL, V16, P103, DOI 10.1159/000219375; McNeil LK, 2007, NUCLEIC ACIDS RES, V35, pD347, DOI 10.1093/nar/gkl947; Neely MN, 2003, J BACTERIOL, V185, P5166, DOI 10.1128/JB.185.17.5166-5174.2003; Nooh MM, 2006, J BIOL CHEM, V281, P35281, DOI 10.1074/jbc.M605544200; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Overbeek R, 1999, In Silico Biol, V1, P93; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Podbielski A, 1999, MED MICROBIOL IMMUN, V188, P99, DOI 10.1007/s004300050111; Quackenbush J, 2003, SCIENCE, V302, P240, DOI 10.1126/science.1090887; Raeder R, 1998, RES MICROBIOL, V149, P539, DOI 10.1016/S0923-2508(99)80001-1; Rasmussen M, 2002, MOL MICROBIOL, V43, P537, DOI 10.1046/j.1365-2958.2002.02766.x; Rasmussen M, 1999, J BIOL CHEM, V274, P15336, DOI 10.1074/jbc.274.22.15336; Rezcallah MS, 2004, MICROBIOL-SGM, V150, P365, DOI 10.1099/mic.0.26826-0; Ribardo DA, 2004, INFECT IMMUN, V72, P3668, DOI 10.1128/IAI.72.6.3668-3673.2004; Rosch JW, 2007, MOL MICROBIOL, V64, P257, DOI 10.1111/j.1365-2958.2007.05667.x; Ryan PA, 2007, PLOS COMPUT BIOL, V3, P1177, DOI 10.1371/journal.pcbi.0030132; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sendi P, 2009, TRENDS MICROBIOL, V17, P54, DOI 10.1016/j.tim.2008.11.004; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Shelburne SA, 2007, INFECT IMMUN, V75, P2981, DOI 10.1128/IAI.00081-07; Shelburne SA, 2007, J BACTERIOL, V189, P2610, DOI 10.1128/JB.01539-06; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; Sugareva V, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-34; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Taylor TB, 2004, CYTOM PART A, V59A, P254, DOI 10.1002/cyto.a.20051; TREVINO J, 2009, INFECT IMMUN; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102; von Kockritz-Blickwede M, 2009, J MOL MED, V87, P775, DOI 10.1007/s00109-009-0481-0; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612	79	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e9798	10.1371/journal.pone.0009798	http://dx.doi.org/10.1371/journal.pone.0009798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418946	Green Submitted, Green Published, gold			2022-12-25	WOS:000276706800002
J	Kozlov, G; Gehring, K				Kozlov, Guennadi; Gehring, Kalle			Molecular Basis of eRF3 Recognition by the MLLE Domain of Poly(A)-Binding Protein	PLOS ONE			English	Article							C-TERMINAL DOMAIN; POLYADENYLATE-BINDING PROTEIN; EUKARYOTIC RELEASE FACTOR-3; MESSENGER-RNA DEADENYLATION; TRANSLATION TERMINATION; PABC DOMAIN; POLY(A) NUCLEASE; STRUCTURAL BASIS; GTP-BINDING; COMPLEX	PABPC1 (cytosolic poly(A)-binding protein 1) is an RNA-binding protein that binds to the poly(A) tail of mRNAs to promote translation and mRNA turnover. In addition to RNA-binding domains, PABPC1 contains a unique protein-protein interaction domain, MLLE (also known as PABC) that binds regulatory proteins and translation factors that contain a conserved 12 amino acid peptide motif termed PAM2. Eukaryotic Release Factor 3 (eRF3/GSPT1) contains two overlapping PAM2 sequences, which are required for its activity. Here, we determined the crystal structures of the MLLE domain from PABPC1 in complex with the two PAM2 regions of eRF3. The structures reveal a mechanism of cooperativity between the two PAM2 sites that increases the binding affinity but prevents the binding of more than one molecule of eRF3 to PABPC1. Relative to previous structures, the high-resolution crystal structures force a re-evaluation of the PAM2 motif and improve our understanding of the molecular basis of MLLE peptide recognition.	[Kozlov, Guennadi; Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Kozlov, Guennadi; Gehring, Kalle] Grp Rech Axe Struct Prote, Montreal, PQ, Canada	McGill University	Kozlov, G (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	Canadian Institutes of Health Research [MOP-14219]; National Science Foundation; National Institutes of Health	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the Canadian Institutes of Health Research grant MOP-14219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge data acquisition at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation and the National Institutes of Health. The coordinates and structure factors have been deposited in the RCSB Protein Data Bank under codes 3KUI and 3KUJ.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; Cosson B, 2002, MOL CELL BIOL, V22, P3301, DOI 10.1128/MCB.22.10.3301-3315.2002; Deo RC, 2001, P NATL ACAD SCI USA, V98, P4414, DOI 10.1073/pnas.071552198; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Hauryliuk V, 2006, BIOCHIMIE, V88, P747, DOI 10.1016/j.biochi.2006.06.001; Hegde R, 2003, J BIOL CHEM, V278, P38699, DOI 10.1074/jbc.M303179200; Horiuchi M, 2009, J BIOL CHEM, V284, P13244, DOI 10.1074/jbc.M809250200; Hoshino S, 1998, J BIOL CHEM, V273, P22254, DOI 10.1074/jbc.273.35.22254; Hoshino S, 1999, J BIOL CHEM, V274, P16677, DOI 10.1074/jbc.274.24.16677; Katzenellenbogen RA, 2007, J VIROL, V81, P3786, DOI 10.1128/JVI.02007-06; Kononenko AV, 2008, PROTEINS, V70, P388, DOI 10.1002/prot.21544; Kononenko AV, 2010, NUCLEIC ACIDS RES, V38, P548, DOI 10.1093/nar/gkp908; Kozlov G, 2001, P NATL ACAD SCI USA, V98, P4409, DOI 10.1073/pnas.071024998; Kozlov G, 2004, EMBO J, V23, P272, DOI 10.1038/sj.emboj.7600048; KOZLOV G, 2010, J BIOL CHEM, V285; Kozlov G, 2010, J MOL BIOL, V397, P397, DOI 10.1016/j.jmb.2010.01.032; Kozlov Guennadi, 2002, Journal of Biological Chemistry, V277, P22822, DOI 10.1074/jbc.M201230200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim NS, 2006, J BIOL CHEM, V281, P14376, DOI 10.1074/jbc.M600307200; Mangus DA, 2004, MOL CELL BIOL, V24, P5521, DOI 10.1128/MCB.24.12.5521-5533.2004; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mitkevich VA, 2006, NUCLEIC ACIDS RES, V34, P3947, DOI 10.1093/nar/gkl549; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel GP, 2006, FEBS J, V273, P5678, DOI 10.1111/j.1742-4658.2006.05556.x; Pisareva VP, 2006, J BIOL CHEM, V281, P40224, DOI 10.1074/jbc.M607461200; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Siddiqui N, 2003, PROTEIN SCI, V12, P1925, DOI 10.1110/ps.0390103; Siddiqui N, 2007, BIOCHEMISTRY-US, V46, P4221, DOI 10.1021/bi061986d; Siddiqui N, 2007, J BIOL CHEM, V282, P25067, DOI 10.1074/jbc.M701256200; Simon E, 2007, NUCLEIC ACIDS RES, V35, P6017, DOI 10.1093/nar/gkm452; Singh G, 2008, PLOS BIOL, V6, P860, DOI 10.1371/journal.pbio.0060111; Uchida N, 2002, J BIOL CHEM, V277, P50286, DOI 10.1074/jbc.M203029200; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	39	37	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10169	10.1371/journal.pone.0010169	http://dx.doi.org/10.1371/journal.pone.0010169			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418951	Green Submitted, gold, Green Published			2022-12-25	WOS:000276706800012
J	Bellan, SE				Bellan, Steve E.			The Importance of Age Dependent Mortality and the Extrinsic Incubation Period in Models of Mosquito-Borne Disease Transmission and Control	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; MALARIA-CONTROL; VECTOR CONTROL; ADULT SIZE; CULICIDAE; TEMPERATURE; DYNAMICS; VIRUS; SIMULATION; SURVIVAL	Nearly all mathematical models of vector-borne diseases have assumed that vectors die at constant rates. However, recent empirical research suggests that mosquito mortality rates are frequently age dependent. This work develops a simple mathematical model to assess how relaxing the classical assumption of constant mortality affects the predicted effectiveness of anti-vectorial interventions. The effectiveness of mosquito control when mosquitoes die at age dependent rates was also compared across different extrinsic incubation periods. Compared to a more realistic age dependent model, constant mortality models overestimated the sensitivity of disease transmission to interventions that reduce mosquito survival. Interventions that reduce mosquito survival were also found to be slightly less effective when implemented in systems with shorter EIPs. Future transmission models that examine anti-vectorial interventions should incorporate realistic age dependent mortality rates.	Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bellan, SE (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	sbellan@berkeley.edu	Bellan, Steve/D-6368-2013	Bellan, Steve/0000-0002-4110-272X	James S. McDonnell 21st Century Science Initiative Award; National Institute of Health [GM083863]; Center for Discrete Mathematics & Theoretical Computer Science; United States National Science Foundation; South African Centre for Epidemiological Modelling and Analysis; African Institute for Mathematical Sciences; Tanada Entomology Fellowship; Rocca Center for African Studies Dissertation Fellowship; Chang-Lin Tien Environmental Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER	James S. McDonnell 21st Century Science Initiative Award; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Discrete Mathematics & Theoretical Computer Science; United States National Science Foundation(National Science Foundation (NSF)); South African Centre for Epidemiological Modelling and Analysis; African Institute for Mathematical Sciences; Tanada Entomology Fellowship; Rocca Center for African Studies Dissertation Fellowship; Chang-Lin Tien Environmental Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a James S. McDonnell 21st Century Science Initiative Award to Wayne M. Getz and National Institute of Health Ecology of Infectious Disease Grant GM083863, and arose from work begun at the 2007 Advanced Study Institute on Mathematical Modeling of Infectious Diseases of Africa that was jointly funded by the Center for Discrete Mathematics & Theoretical Computer Science, the United States National Science Foundation, the South African Centre for Epidemiological Modelling and Analysis, and the African Institute for Mathematical Sciences. During this research S. Bellan was also funded by a Tanada Entomology Fellowship, a Rocca Center for African Studies Dissertation Fellowship and a Chang-Lin Tien Environmental Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd MF, 1932, AM J HYG, V16, P851, DOI 10.1093/oxfordjournals.aje.a117892; Chan AST, 1998, ANN TROP MED PARASIT, V92, P317, DOI 10.1080/00034989859898; CLEMENTS AN, 1981, J APPL ECOL, V18, P373, DOI 10.2307/2402401; Conteh L, 2004, TROP MED INT HEALTH, V9, P125, DOI 10.1046/j.1365-3156.2003.01150.x; Dawes EJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-228; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; GRATZ NG, 1994, AM J TROP MED HYG, V50, P11, DOI 10.4269/ajtmh.1994.50.6_Suppl.TM05006S0011; GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571, DOI 10.4269/ajtmh.1989.40.571; Gunasekaran K, 2005, TROP MED INT HEALTH, V10, P160, DOI 10.1111/j.1365-3156.2004.01369.x; Guyatt HL, 2002, TROP MED INT HEALTH, V7, P298, DOI 10.1046/j.1365-3156.2002.00874.x; Hancock PA, 2009, P ROY SOC B-BIOL SCI, V276, P71, DOI 10.1098/rspb.2008.0689; Hancock PA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-98; Harrington LC, 2008, J MED ENTOMOL, V45, P307, DOI 10.1603/0022-2585(2008)45[307:ASOTDV]2.0.CO;2; Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007; Killeen Gerry F, 2002, Malar J, V1, P8, DOI 10.1186/1475-2875-1-8; Killeen GF, 2002, LANCET INFECT DIS, V2, P618, DOI 10.1016/S1473-3099(02)00397-3; Lenhart A, 2008, TROP MED INT HEALTH, V13, P56, DOI 10.1111/j.1365-3156.2007.01966.x; Lloyd AL, 2007, J R SOC INTERFACE, V4, P851, DOI 10.1098/rsif.2007.1064; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Mani TR, 2005, TROP MED INT HEALTH, V10, P1298, DOI 10.1111/j.1365-3156.2005.01522.x; MILLER BR, 1989, T ROY SOC TROP MED H, V83, P252, DOI 10.1016/0035-9203(89)90667-6; MOON TE, 1976, BIOMETRICS, V32, P355, DOI 10.2307/2529503; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Nam VS, 2005, AM J TROP MED HYG, V72, P67, DOI 10.4269/ajtmh.2005.72.67; Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825; Roberts MG, 2007, J R SOC INTERFACE, V4, P949, DOI 10.1098/rsif.2007.1031; Rozilawati H, 2005, Trop Biomed, V22, P143; Schneider JR, 2004, J MED ENTOMOL, V41, P634, DOI 10.1603/0022-2585-41.4.634; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; SCOTT TW, 2003, AEDES AEGYPTI DENSIT, P187; Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111; Styer LM, 2007, VECTOR-BORNE ZOONOT, V7, P86, DOI 10.1089/vbz.2007.0216; TESH RB, 1975, AM J TROP MED HYG, V24, P876, DOI 10.4269/ajtmh.1975.24.876; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Watson RT, 2005, J ENVIRON MONITOR, V7, P834, DOI 10.1039/b504683a; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x	45	61	61	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10165	10.1371/journal.pone.0010165	http://dx.doi.org/10.1371/journal.pone.0010165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405010	Green Published, gold, Green Submitted			2022-12-25	WOS:000276706300019
J	Luo, XL; Ding, QR; Wang, M; Li, ZG; Mao, KR; Sun, B; Pan, Y; Wang, ZZ; Zang, YQ; Chen, Y				Luo, Xiaolin; Ding, Qiurong; Wang, Min; Li, Zhigang; Mao, Kairui; Sun, Bing; Pan, Yi; Wang, Zhenzhen; Zang, Ying Qin; Chen, Yan			In Vivo Disruption of TGF-(beta) Signaling by Smad7 in Airway Epithelium Alleviates Allergic Asthma but Aggravates Lung Carcinogenesis in Mouse	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TGF-BETA; T-CELLS; INFLAMMATION; CANCER; MACROPHAGE; EXPRESSION; RECEPTOR; HYPERRESPONSIVENESS; INTERLEUKIN-10	Background: TGF-beta has been postulated to play an important role in the maintenance of epithelial homeostasis and the development of epithelium-derived cancers. However, most of previous studies are mainly focused on the function of TGF-beta in immune cells to the development of allergic asthma and how TGF-beta signaling in airway epithelium itself in allergic inflammation is largely unknown. Furthermore, the in vivo TGF-beta function specifically in the airway epithelium during lung cancer development has been largely elusive. Methodology/Principal Findings: To evaluate the in vivo contribution of TGF-beta signaling in lung epithelium to the development of allergic disease and lung cancer, we generated a transgenic mouse model with Smad7, an intracellular inhibitor of TGF-beta signaling, constitutively expressed in mouse airway Clara cells using a mouse CC10 promoter. The mice were subjected to the development of OVA-induced allergic asthma and urethane-induced lung cancer. The Smad7 transgenic animals significantly protected from OVA-induced asthma, with reduced airway inflammation, airway mucus production, extracellular matrix deposition, and production of OVA-specific IgE. Further analysis of cytokine profiles in lung homogenates revealed that the Th2 cytokines including IL-4, IL-5 and IL-13, as well as other cytokines including IL-17, IL-1, IL-6, IP10, G-CSF, and GM-CSF were significantly reduced in the transgenic mice upon OVA induction. In contrast, the Smad7 transgenic animals had an increased incidence of lung carcinogenesis when subjected to urethane treatment. Conclusion/Significance: These studies, therefore, demonstrate for the first time the in vivo function of TGF-beta signaling specifically in airway epithelium during the development of allergic asthma and lung cancer.	[Luo, Xiaolin; Ding, Qiurong; Wang, Min; Li, Zhigang; Pan, Yi; Wang, Zhenzhen; Zang, Ying Qin; Chen, Yan] Chinese Acad Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Mao, Kairui; Sun, Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Luo, XL (corresponding author), Chinese Acad Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	yqin@sibs.ac.cn; ychen3@sibs.ac.cn	Luo, Xiaolin/D-7159-2014	Luo, Xiaolin/0000-0003-3215-8112	National Natural Science Foundation of China [30830037, 30971660]; Science & Technology Commission of Shanghai Municipality [75407001]; Ministry of Science and Technology of China [2007CB947100, 2006CB503900, 2010CB529500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by research grants from National Natural Science Foundation of China (30830037), Science & Technology Commission of Shanghai Municipality (75407001), and the Ministry of Science and Technology of China (2007CB947100 and 2006CB503900) to YC. The work was also supported by Ministry of Science and Technology of China (2010CB529500) to YP and ZW, and National Natural Science Foundation of China (30971660) to YP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; BALIS JU, 1985, LAB INVEST, V52, P657; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Barczyk A, 2003, RESP MED, V97, P726, DOI 10.1053/rmed.2003.1507; Barnes PJ, 2001, RESPIR RES, V2, P64, DOI 10.1186/rr39; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Boulet LP, 1997, CHEST, V112, P45, DOI 10.1378/chest.112.1.45; BURGESS AW, 1980, BLOOD, V56, P947; Chung KF, 1999, THORAX, V54, P825, DOI 10.1136/thx.54.9.825; Ding QR, 2007, J LEUKOCYTE BIOL, V81, P1568, DOI 10.1189/jlb.1106672; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Haneda K, 1997, J IMMUNOL, V159, P4484; Haneda K, 1999, AM J RESP CELL MOL, V21, P268, DOI 10.1165/ajrcmb.21.2.3576; Hansen G, 2000, J CLIN INVEST, V105, P61, DOI 10.1172/JCI7589; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; He J, 2009, BBA-MOL BASIS DIS, V1792, P56, DOI 10.1016/j.bbadis.2008.10.010; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Jeon HS, 2008, CANCER RES, V68, P9686, DOI 10.1158/0008-5472.CAN-08-1083; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Koulis A, 2000, CLIN EXP ALLERGY, V30, P747; Kuang CZ, 2006, P NATL ACAD SCI USA, V103, P1858, DOI 10.1073/pnas.0508977103; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kundu JK, 2008, MUTAT RES-REV MUTAT, V659, P15, DOI 10.1016/j.mrrev.2008.03.002; Lai ST, 2008, PEDIATR INT, V50, P99, DOI 10.1111/j.1442-200X.2007.02533.x; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; Mcmillan SJ, 2004, CLIN EXP ALLERGY, V34, P497, DOI 10.1111/j.1365-2222.2004.01895.x; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakao A, 2001, TRENDS IMMUNOL, V22, P115, DOI 10.1016/S1471-4906(00)01827-5; Nakao A, 2002, J ALLERGY CLIN IMMUN, V110, P873, DOI 10.1067/mai.2002.129236; Nakao A, 2000, J EXP MED, V192, P151, DOI 10.1084/jem.192.2.151; OZEKI Y, 1994, JPN J CANCER RES, V85, P840, DOI 10.1111/j.1349-7006.1994.tb02956.x; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Pilette C, 2004, EUR RESPIR J, V23, P876, DOI 10.1183/09031936.04.00102504; Ray A, 1999, J CLIN INVEST, V104, P985, DOI 10.1172/JCI8204; Redington AE, 1997, AM J RESP CRIT CARE, V156, P642, DOI 10.1164/ajrccm.156.2.9605065; REITAMO S, 1994, J CLIN INVEST, V94, P2489, DOI 10.1172/JCI117618; REYNOLDS SD, 2009, INT J BIOCH CELL BIO; Schleimer RP, 2007, J ALLERGY CLIN IMMUN, V120, P1279, DOI 10.1016/j.jaci.2007.08.046; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Selzman CH, 1998, J MOL CELL CARDIOL, V30, P889, DOI 10.1006/jmcc.1998.0642; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; TOMONAGA M, 1986, BLOOD, V67, P31; Undevia NS, 2004, AM J PHYSIOL-LUNG C, V287, pL515, DOI 10.1152/ajplung.00044.2004; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yamashita N, 2002, CELL IMMUNOL, V219, P92, DOI 10.1016/S0008-8749(02)00565-8; Yamauchi K, 2006, TOHOKU J EXP MED, V209, P75, DOI 10.1620/tjem.209.75	52	22	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10149	10.1371/journal.pone.0010149	http://dx.doi.org/10.1371/journal.pone.0010149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405019	Green Submitted, gold, Green Published			2022-12-25	WOS:000276706300006
J	Baptista, MS; Melo, CV; Armelao, M; Herrmann, D; Pimentel, DO; Leal, G; Caldeira, MV; Bahr, BA; Bengtson, M; Almeida, RD; Duarte, CB				Baptista, Marcio S.; Melo, Carlos V.; Armelao, Mario; Herrmann, Dennis; Pimentel, Diogo O.; Leal, Graciano; Caldeira, Margarida V.; Bahr, Ben A.; Bengtson, Mario; Almeida, Ramiro D.; Duarte, Carlos B.			Role of the Proteasome in Excitotoxicity-Induced Cleavage of Glutamic Acid Decarboxylase in Cultured Hippocampal Neurons	PLOS ONE			English	Article							EXCITATORY AMINO-ACIDS; REDUCES INFARCTION; GABAERGIC NEURONS; GABA TRANSPORTER; MESSENGER-RNAS; BRAIN-INJURY; RAT MODEL; H-3 GABA; 2 FORMS; UBIQUITIN	Glutamic acid decarboxylase is responsible for synthesizing GABA, the major inhibitory neurotransmitter, and exists in two isoforms-GAD65 and GAD67. The enzyme is cleaved under excitotoxic conditions, but the mechanisms involved and the functional consequences are not fully elucidated. We found that excitotoxic stimulation of cultured hippocampal neurons with glutamate leads to a time-dependent cleavage of GAD65 and GAD67 in the N-terminal region of the proteins, and decrease the corresponding mRNAs. The cleavage of GAD67 was sensitive to the proteasome inhibitors MG132, YU102 and lactacystin, and was also abrogated by the E1 ubiquitin ligase inhibitor UBEI-41. In contrast, MG132 and UBEI-41 were the only inhibitors tested that showed an effect on GAD65 cleavage. Excitotoxic stimulation with glutamate also increased the amount of GAD captured in experiments where ubiquitinated proteins and their binding partners were isolated. However, no evidences were found for direct GADs ubiquitination in cultured hippocampal neurons, and recombinant GAD65 was not cleaved by purified 20S or 26S proteasome preparations. Since calpains, a group of calcium activated proteases, play a key role in GAD65/67 cleavage under excitotoxic conditions the results suggest that GADs are cleaved after ubiquitination and degradation of an unknown binding partner by the proteasome. The characteristic punctate distribution of GAD65 along neurites of differentiated cultured hippocampal neurons was significantly reduced after excitotoxic injury, and the total GAD activity measured in extracts from the cerebellum or cerebral cortex at 24h postmortem ( when there is a partial cleavage of GADs) was also decreased. The results show a role of the UPS in the cleavage of GAD65/67 and point out the deregulation of GADs under excitotoxic conditions, which is likely to affect GABAergic neurotransmission. This is the first time that the UPS has been implicated in the events triggered during excitotoxicity and the first molecular target of the UPS affected in this cell death process.	[Baptista, Marcio S.; Melo, Carlos V.; Armelao, Mario; Herrmann, Dennis; Pimentel, Diogo O.; Leal, Graciano; Caldeira, Margarida V.; Almeida, Ramiro D.; Duarte, Carlos B.] Univ Coimbra, Ctr Neurosci & Cell Biol, Dept Life Sci, Coimbra, Portugal; [Bahr, Ben A.] Univ N Carolina, Biotechnol Res & Training Ctr, Pembroke, NC USA; [Bengtson, Mario] Genom Inst Novartis Res Fdn GNF, Dept Canc & Cell Biol, San Diego, CA USA	Universidade de Coimbra; University of North Carolina; Novartis	Baptista, MS (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Dept Life Sci, Coimbra, Portugal.	cvmelo@stanford.edu	Almeida, Ramiro D./J-2656-2013; Duarte, Carlos B/K-6358-2013	Almeida, Ramiro D./0000-0001-5830-2595; Duarte, Carlos B/0000-0002-1474-0208; Vieira Melo, Carlos/0000-0001-5392-1258; Caldeira, Margarida/0000-0001-5107-1499; Leal, Graciano/0000-0001-6333-6095	Fundacao para a Ciencia e a Tecnologia (FCT); FEDER (Fundo Europeu de Desenvolvimento Regional) [PTDC/SAU-FCF/72283/2006]; Calouste Gulbenkian Foundation [71949]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER (Fundo Europeu de Desenvolvimento Regional)(European Commission); Calouste Gulbenkian Foundation	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) and FEDER (Fundo Europeu de Desenvolvimento Regional) (PTDC/SAU-FCF/72283/2006; to CBD) and by the Calouste Gulbenkian Foundation (Proc. 71949; to CVM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Asai A, 2002, J CEREBR BLOOD F MET, V22, P705, DOI 10.1097/00004647-200206000-00009; Bahr BA, 2000, J NEUROSCI RES, V59, P827, DOI 10.1002/(SICI)1097-4547(20000315)59:6<827::AID-JNR15>3.0.CO;2-Q; Baliova M, 2009, NEUROCHEM INT, V55, P288, DOI 10.1016/j.neuint.2009.03.012; Bartoli M, 2005, INT J BIOCHEM CELL B, V37, P2115, DOI 10.1016/j.biocel.2004.12.012; Battaglioli G, 2005, NEUROCHEM RES, V30, P989, DOI 10.1007/s11064-005-6772-0; Baugh JM, 2004, MOL CELL, V16, P575, DOI 10.1016/j.molcel.2004.10.017; Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; Butts BD, 2005, MOL CELL NEUROSCI, V30, P279, DOI 10.1016/j.mcn.2005.07.011; Caba E, 2002, J NEUROSCI RES, V67, P787, DOI 10.1002/jnr.10163; CARVALHO AP, 1995, ANN NY ACAD SCI, V757, P439, DOI 10.1111/j.1749-6632.1995.tb17504.x; Chen F, 1997, ARCH BIOCHEM BIOPHYS, V342, P383, DOI 10.1006/abbi.1997.0132; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; de Almeida OMMS, 2002, BRAIN RES, V925, P89, DOI 10.1016/S0006-8993(01)03265-6; DEMELLO FG, 1991, CELL MOL NEUROBIOL, V11, P485, DOI 10.1007/BF00734811; Di Napoli Mario, 2005, Curr Opin Investig Drugs, V6, P686; DUARTE CB, 1993, BRAIN RES, V611, P130, DOI 10.1016/0006-8993(93)91784-P; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Frick KM, 2002, NEUROBIOL AGING, V23, P145, DOI 10.1016/S0197-4580(01)00237-8; Gardoni F, 2006, EUR J PHARMACOL, V545, P2, DOI 10.1016/j.ejphar.2006.06.022; Ge PF, 2007, STROKE, V38, P3230, DOI 10.1161/STROKEAHA.107.487108; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hsu CC, 1999, J BIOL CHEM, V274, P24366, DOI 10.1074/jbc.274.34.24366; Hsu CC, 2000, J BIOL CHEM, V275, P20822, DOI 10.1074/jbc.M001403200; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Kanaani J, 2002, J CELL BIOL, V158, P1229, DOI 10.1083/jcb.200205053; Kanaani J, 2008, J CELL SCI, V121, P437, DOI 10.1242/jcs.011916; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; KUBISTA K, 2007, GIT LAB J, V9, P2; Lernmark A, 1996, J INTERN MED, V240, P259, DOI 10.1046/j.1365-2796.1996.27859000.x; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu CL, 2004, J CEREBR BLOOD F MET, V24, P1219, DOI 10.1097/01.WCB.0000136706.77918.21; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; Martin SB, 2003, NEUROCHEM INT, V42, P549, DOI 10.1016/S0197-0186(02)00189-4; Monnerie H, 2008, EXP NEUROL, V213, P145, DOI 10.1016/j.expneurol.2008.05.013; Monnerie H, 2007, EXP NEUROL, V205, P367, DOI 10.1016/j.expneurol.2007.02.007; Munirathinam S, 2002, TOXICOL APPL PHARM, V185, P111, DOI 10.1006/taap.2002.9534; Myung J, 2001, MOL CELL, V7, P411, DOI 10.1016/S1097-2765(01)00188-5; Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs; NATHAN B, 1995, J NEUROSCI RES, V40, P134, DOI 10.1002/jnr.490400115; Noga M, 1996, MOL BRAIN RES, V36, P261, DOI 10.1016/0169-328X(95)00260-Y; Phillips JB, 2000, STROKE, V31, P1686, DOI 10.1161/01.STR.31.7.1686; QIN ZH, 1994, MOL BRAIN RES, V21, P293, DOI 10.1016/0169-328X(94)90260-7; Ray SK, 2006, CURR MED CHEM, V13, P3425, DOI 10.2174/092986706779010342; REETZ A, 1991, EMBO J, V10, P1275, DOI 10.1002/j.1460-2075.1991.tb08069.x; Rideout HJ, 2002, MOL CELL NEUROSCI, V21, P223, DOI 10.1006/mcne.2002.1173; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SALIN P, 1993, EXP NEUROL, V119, P291, DOI 10.1006/exnr.1993.1033; Santos ARA, 2008, J NEUROSCI RES, V86, P3684, DOI 10.1002/jnr.21796; Saransaari P, 2008, NEUROCHEM RES, V33, P962, DOI 10.1007/s11064-007-9499-2; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Schwartz-Bloom RD, 2001, J NEUROCHEM, V77, P353, DOI 10.1046/j.1471-4159.2001.00274.x; Sha D, 2008, BRAIN RES, V1207, P9, DOI 10.1016/j.brainres.2008.02.033; Shah IM, 2002, BRIT J CLIN PHARMACO, V54, P269, DOI 10.1046/j.1365-2125.2002.01638.x; Sheikh SN, 1999, NEUROCHEM INT, V35, P73, DOI 10.1016/S0197-0186(99)00063-7; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; SOLIMENA M, 1994, J CELL BIOL, V126, P331, DOI 10.1083/jcb.126.2.331; Sorokin AV, 2005, EMBO J, V24, P3602, DOI 10.1038/sj.emboj.7600830; Swanwick CC, 2004, J COMP NEUROL, V478, P405, DOI 10.1002/cne.20295; Vanderklish PW, 2000, INT J EXP PATHOL, V81, P323, DOI 10.1046/j.1365-2613.2000.00169.x; Vannucci SJ, 1998, J CEREBR BLOOD F MET, V18, P376, DOI 10.1097/00004647-199804000-00005; Vemuganti R, 2005, NEUROCHEM INT, V47, P136, DOI 10.1016/j.neuint.2005.04.015; Wei JN, 2008, NEUROCHEM RES, V33, P1459, DOI 10.1007/s11064-008-9600-5; Wei JN, 2006, J NEUROCHEM, V98, P1688, DOI 10.1111/j.1471-4159.2006.04074.x; Wei JN, 2003, J BIOMED SCI, V10, P617, DOI 10.1159/000073527; Williams AJ, 2003, J CEREBR BLOOD F MET, V23, P75, DOI 10.1097/01.WCB.0000039285.37737.C2; Wu H, 2007, BRAIN RES, V1154, P80, DOI 10.1016/j.brainres.2007.04.008; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Zhang L, 2001, STROKE, V32, P2926, DOI 10.1161/hs1201.100207	77	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10139	10.1371/journal.pone.0010139	http://dx.doi.org/10.1371/journal.pone.0010139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405034	Green Submitted, Green Published, gold			2022-12-25	WOS:000276705900018
J	Bazaa, A; Pasquier, E; Defilles, C; Limam, I; Kessentini-Zouari, R; Kallech-Ziri, O; El Battari, A; Braguer, D; El Ayeb, M; Marrakchi, N; Luis, J				Bazaa, Amine; Pasquier, Eddy; Defilles, Celine; Limam, Ines; Kessentini-Zouari, Raoudha; Kallech-Ziri, Olfa; El Battari, Assou; Braguer, Diane; El Ayeb, Mohamed; Marrakchi, Naziha; Luis, Jose			MVL-PLA2, a Snake Venom Phospholipase A2, Inhibits Angiogenesis through an Increase in Microtubule Dynamics and Disorganization of Focal Adhesions	PLOS ONE			English	Article							MACROVIPERA-LEBETINA VENOM; C-TYPE LECTIN; TUMOR ANGIOGENESIS; CELL-MIGRATION; ENDOTHELIAL-CELLS; IN-VITRO; INTEGRIN; ACTIN; LEBECTIN; DISINTEGRINS	Integrins are essential protagonists of the complex multi-step process of angiogenesis that has now become a major target for the development of anticancer therapies. We recently reported and characterized that MVL-PLA2, a novel phospholipase A2 from Macrovipera lebetina venom, exhibited anti-integrin activity. In this study, we show that MVL-PLA2 also displays potent anti-angiogenic properties. This phospholipase A2 inhibited adhesion and migration of human microvascular-endothelial cells (HMEC-1) in a dose-dependent manner without being cytotoxic. Using Matrigel (TM) and chick chorioallantoic membrane assays, we demonstrated that MVL-PLA2, as well as its catalytically inactivated form, significantly inhibited angiogenesis both in vitro and in vivo. We have also found that the actin cytoskeleton and the distribution of alpha v beta 3 integrin, a critical regulator of angiogenesis and a major component of focal adhesions, were disturbed after MVL-PLA2 treatment. In order to further investigate the mechanism of action of this protein on endothelial cells, we analyzed the dynamic instability behavior of microtubules in living endothelial cells. Interestingly, we showed that MVL-PLA2 significantly increased microtubule dynamicity in HMEC-1 cells by 40%. We propose that the enhancement of microtubule dynamics may explain the alterations in the formation of focal adhesions, leading to inhibition of cell adhesion and migration.	[Bazaa, Amine; Limam, Ines; Kessentini-Zouari, Raoudha; Kallech-Ziri, Olfa; El Ayeb, Mohamed; Marrakchi, Naziha] Inst Pasteur Tunis, Lab Venins & Toxines, Tunis, Tunisia; [Pasquier, Eddy; Defilles, Celine; El Battari, Assou; Braguer, Diane; Luis, Jose] Aix Marseille Univ, INSERM, UMR 911, CRO2, Marseille, France; [Marrakchi, Naziha] Fac Med Tunis, Tunis, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT)	Bazaa, A (corresponding author), Inst Pasteur Tunis, Lab Venins & Toxines, Tunis, Tunisia.	jose.luis@univmed.fr	Limam, Ines/AHE-2257-2022; LUIS, José/M-3071-2013; Pasquier, Eddy/A-8112-2018	Limam, Ines/0000-0002-7334-7692; Pasquier, Eddy/0000-0003-2824-5002	Institut National de la Sante et de la Recherche Medicale (INSERM); Comite Mixte de Cooperation Universitaire France-Tunisie (CMCU); Conseil Regional; Canceropole of Provence-Alpes-Cote d'Azur;  [MRST/IPT/LVT-LR005 SP 05]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Comite Mixte de Cooperation Universitaire France-Tunisie (CMCU); Conseil Regional; Canceropole of Provence-Alpes-Cote d'Azur; 	This work was supported by grant MRST/IPT/LVT-LR005 SP 05, the Institut National de la Sante et de la Recherche Medicale (INSERM), the Comite Mixte de Cooperation Universitaire France-Tunisie (CMCU), the Conseil Regional and the Canceropole of Provence-Alpes-Cote d'Azur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalu A, 2005, EXPERT OPIN INV DRUG, V14, P1475, DOI 10.1517/13543784.14.12.1475; Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; Andrews RK, 2000, TOXICON, V38, P775, DOI 10.1016/S0041-0101(99)00187-7; Bazaa A, 2009, MATRIX BIOL, V28, P188, DOI 10.1016/j.matbio.2009.03.007; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Calvete JJ, 2007, CURR PHARM DESIGN, V13, P2853, DOI 10.2174/138161207782023766; Castel S, 2000, EUR J CELL BIOL, V79, P502, DOI 10.1078/0171-9335-00067; Delamarre E, 2009, AM J PATHOL, V175, P844, DOI 10.2353/ajpath.2009.080920; DRAKE CJ, 1995, J CELL SCI, V108, P2655; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Garmy-Susini Barbara, 2008, Lymphatic Research and Biology, V6, P155, DOI 10.1089/lrb.2008.1011; Hodivala-Dilke K, 2008, CURR OPIN CELL BIOL, V20, P514, DOI 10.1016/j.ceb.2008.06.007; Honore S, 2005, CELL MOL LIFE SCI, V62, P3039, DOI 10.1007/s00018-005-5330-x; Honore S, 2008, MOL CANCER THER, V7, P2080, DOI 10.1158/1535-7163.MCT-08-0156; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim SY, 2007, ARCH BIOCHEM BIOPHYS, V459, P40, DOI 10.1016/j.abb.2006.11.001; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; McLane MA, 2008, FRONT BIOSCI-LANDMRK, V13, P6617, DOI 10.2741/3177; Moissoglu K, 2006, BIOL CELL, V98, P547, DOI 10.1042/BC20060025; Olfa KZ, 2005, LAB INVEST, V85, P1507, DOI 10.1038/labinvest.3700350; Pasquier E, 2005, CANCER RES, V65, P2433, DOI 10.1158/0008-5472.CAN-04-2624; Pasquier E, 2004, MOL CANCER THER, V3, P1301; Pasquier E, 2007, CURR CANCER DRUG TAR, V7, P566, DOI 10.2174/156800907781662266; Pasquier E, 2006, DRUG RESIST UPDATE, V9, P74, DOI 10.1016/j.drup.2006.04.003; Pilorget A, 2007, J CELL PHYSIOL, V211, P307, DOI 10.1002/jcp.20935; PLETJUSHKINA OJ, 1994, EXP CELL RES, V212, P201, DOI 10.1006/excr.1994.1135; Pourroy B, 2006, CANCER RES, V66, P3256, DOI 10.1158/0008-5472.CAN-05-3885; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Sarray S, 2004, LAB INVEST, V84, P573, DOI 10.1038/labinvest.3700088; Sarray S, 2007, MATRIX BIOL, V26, P306, DOI 10.1016/j.matbio.2007.01.001; Serini G, 2006, EXP CELL RES, V312, P651, DOI 10.1016/j.yexcr.2005.10.020; Sheu JR, 1997, BBA-GEN SUBJECTS, V1336, P445, DOI 10.1016/S0304-4165(97)00057-3; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Stupack DG, 2004, CURR TOP DEV BIOL, V64, P207, DOI 10.1016/S0070-2153(04)64009-9; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107; Zouari-Kessentini R, 2009, TOXICON, V53, P444, DOI 10.1016/j.toxicon.2009.01.003	45	43	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10124	10.1371/journal.pone.0010124	http://dx.doi.org/10.1371/journal.pone.0010124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405031	Green Published, gold, Green Submitted			2022-12-25	WOS:000276705900008
J	Noguchi, K; Riggins, DP; Eldahan, KC; Kitko, RD; Slonczewski, JL				Noguchi, Ken; Riggins, Daniel P.; Eldahan, Khalid C.; Kitko, Ryan D.; Slonczewski, Joan L.			Hydrogenase-3 Contributes to Anaerobic Acid Resistance of Escherichia coli	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; GASTROINTESTINAL-TRACT; MOLECULAR-HYDROGEN; SHIGELLA-FLEXNERI; ENERGY-SOURCE; PH; FORMATE; ENZYME; EXPRESSION; GROWTH	Background: Hydrogen production by fermenting bacteria such as Escherichia coli offers a potential source of hydrogen biofuel. Because H-2 production involves consumption of 2H(+), hydrogenase expression is likely to involve pH response and regulation. Hydrogenase consumption of protons in E. coli has been implicated in acid resistance, the ability to survive exposure to acid levels (pH 2-2.5) that are three pH units lower than the pH limit of growth ( pH 5-6). Enhanced survival in acid enables a larger infective inoculum to pass through the stomach and colonize the intestine. Most acid resistance mechanisms have been defined using aerobic cultures, but the use of anaerobic cultures will reveal novel acid resistance mechanisms. Methods and Principal Findings: We analyzed the pH regulation of bacterial hydrogenases in live cultures of E. coli K-12 W3110. During anaerobic growth in the range of pH 5 to 6.5, E. coli expresses three hydrogenase isoenzymes that reversibly oxidize H-2 to 2H(+). Anoxic conditions were used to determine which of the hydrogenase complexes contribute to acid resistance, measured as the survival of cultures grown at pH 5.5 without aeration and exposed for 2 hours at pH 2 or at pH 2.5. Survival of all strains in extreme acid was significantly lower in low oxygen than for aerated cultures. Deletion of hyc (Hyd-3) decreased anoxic acid survival 3-fold at pH 2.5, and 20-fold at pH 2, but had no effect on acid survival with aeration. Deletion of hyb (Hyd-2) did not significantly affect acid survival. The pH-dependence of H-2 production and consumption was tested using a H-2-specific Clark-type electrode. Hyd-3-dependent H-2 production was increased 70-fold from pH 6.5 to 5.5, whereas Hyd-2-dependent H-2 consumption was maximal at alkaline pH. H-2 production, was unaffected by a shift in external or internal pH. H-2 production was associated with hycE expression levels as a function of external pH. Conclusions: Anaerobic growing cultures of E. coli generate H-2 via Hyd-3 at low external pH, and consume H-2 via Hyd-2 at high external pH. Hyd-3 proton conversion to H-2 is required for acid resistance in anaerobic cultures of E. coli.	[Noguchi, Ken; Riggins, Daniel P.; Eldahan, Khalid C.; Kitko, Ryan D.; Slonczewski, Joan L.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA	Kenyon College	Noguchi, K (corresponding author), Kenyon Coll, Dept Biol, Gambier, OH 43022 USA.	slonczewski@kenyon.edu	Riggins, Daniel P/C-6560-2011	Riggins, Daniel P/0000-0002-6240-6212	National Science Foundation [MCB-0644167]	National Science Foundation(National Science Foundation (NSF))	This work was supported by grant MCB-0644167 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 1997, MICROBIOL-SGM, V143, P3633, DOI 10.1099/00221287-143-11-3633; AUGER EA, 1989, MOL MICROBIOL, V3, P609, DOI 10.1111/j.1365-2958.1989.tb00208.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bagramyan K, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1159, DOI 10.1023/B:BIRY.0000009129.18714.a4; BALLANTINE SP, 1986, EUR J BIOCHEM, V156, P277, DOI 10.1111/j.1432-1033.1986.tb09578.x; BENJAMIN MM, 1995, APPL ENVIRON MICROB, V61, P1669, DOI 10.1128/AEM.61.4.1669-1672.1995; Bergholz TM, 2007, J APPL MICROBIOL, V102, P352, DOI 10.1111/j.1365-2672.2006.03099.x; Bhagwat AA, 2003, J MICROBIOL METH, V55, P399, DOI 10.1016/S0167-7012(03)00175-1; Blankenhorn D, 1999, J BACTERIOL, V181, P2209, DOI 10.1128/JB.181.7.2209-2216.1999; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; GOODSON M, 1989, LETT APPL MICROBIOL, V8, P77, DOI 10.1111/j.1472-765X.1989.tb00227.x; GORDEN J, 1993, INFECT IMMUN, V61, P364, DOI 10.1128/IAI.61.1.364-367.1993; Hansel A, 1998, APPL MICROBIOL BIOT, V50, P153, DOI 10.1007/s002530051270; Hayes ET, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-89; He GL, 1999, P NATL ACAD SCI USA, V96, P4586, DOI 10.1073/pnas.96.8.4586; Kieboom J, 2006, J BACTERIOL, V188, P5650, DOI 10.1128/JB.00323-06; KNAPPE J, 1969, EUR J BIOCHEM, V11, P316, DOI 10.1111/j.1432-1033.1969.tb00775.x; Laurinavichene TV, 2001, FEMS MICROBIOL LETT, V202, P121, DOI 10.1111/j.1574-6968.2001.tb10790.x; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; LUTZ S, 1991, MOL MICROBIOL, V5, P123, DOI 10.1111/j.1365-2958.1991.tb01833.x; Maeda T, 2007, APPL MICROBIOL BIOT, V76, P1035, DOI 10.1007/s00253-007-1086-6; Maier RJ, 2004, INFECT IMMUN, V72, P6294, DOI 10.1128/IAI.72.11.6294-6299.2004; Mates AK, 2007, J BACTERIOL, V189, P2759, DOI 10.1128/JB.01490-06; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Mnatsakanyan N, 2004, CELL BIOCHEM BIOPHYS, V41, P357, DOI 10.1385/CBB:41:3:357; MOORE WEC, 1969, J INFECT DIS, V119, P641, DOI 10.1093/infdis/119.6.641; Moss AR, 2000, ANN ZOOTECH, V49, P231, DOI 10.1051/animres:2000119; Olson JW, 2002, SCIENCE, V298, P1788, DOI 10.1126/science.1077123; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; PECK HD, 1957, J BACTERIOL, V73, P706, DOI 10.1128/JB.73.6.706-721.1957; Price SB, 2004, APPL ENVIRON MICROB, V70, P4792, DOI 10.1128/AEM.70.8.4792-4799.2004; Redwood MD, 2008, FEMS MICROBIOL LETT, V278, P48, DOI 10.1111/j.1574-6968.2007.00966.x; ROSSMANN R, 1991, MOL MICROBIOL, V5, P2807, DOI 10.1111/j.1365-2958.1991.tb01989.x; SANKAR P, 1988, J BACTERIOL, V170, P5440, DOI 10.1128/jb.170.12.5440-5445.1988; SAWERS G, 1994, ANTON LEEUW INT J G, V66, P57, DOI 10.1007/BF00871633; SAWERS RG, 1986, EUR J BIOCHEM, V156, P265, DOI 10.1111/j.1432-1033.1986.tb09577.x; SAWERS RG, 1985, J BACTERIOL, V164, P1324, DOI 10.1128/JB.164.3.1324-1331.1985; Self WT, 2004, J BACTERIOL, V186, P580, DOI 10.1128/JB.186.2.580-587.2004; SMALL P, 1994, J BACTERIOL, V176, P1729, DOI 10.1128/jb.176.6.1729-1737.1994; SMITH MW, 1983, J BACTERIOL, V154, P336, DOI 10.1128/JB.154.1.336-343.1983; Valdez-Vazquez I, 2009, RENEW SUST ENERG REV, V13, P1000, DOI 10.1016/j.rser.2008.03.003; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Yohannes E, 2004, J BACTERIOL, V186, P192, DOI 10.1128/JB.186.1.192-199.2004; Yoshida A, 2005, APPL ENVIRON MICROB, V71, P6762, DOI 10.1128/AEM.71.11.6762-6768.2005; Zilberstein B, 2007, CLINICS, V62, P47, DOI 10.1590/S1807-59322007000100008	46	79	80	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10132	10.1371/journal.pone.0010132	http://dx.doi.org/10.1371/journal.pone.0010132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405029	Green Published, gold			2022-12-25	WOS:000276705900014
J	Zhu, J; He, FH; Wang, DP; Liu, K; Huang, DW; Xiao, JF; Wu, JY; Hu, SN; Yu, J				Zhu, Jiang; He, Fuhong; Wang, Dapeng; Liu, Kan; Huang, Dawei; Xiao, Jingfa; Wu, Jiayan; Hu, Songnian; Yu, Jun			A Novel Role for Minimal Introns: Routing mRNAs to the Cytosol	PLOS ONE			English	Article							GENE-EXPRESSION; CHROMOSOME TERRITORIES; SPLICEOSOMAL INTRONS; NUCLEAR ARCHITECTURE; MAMMALIAN-CELLS; HUMAN GENOME; ORGANIZATION; EXPORT; EVOLUTION; COMPLEX	Background: Introns and their splicing are tightly coupled with the subsequent mRNA maturation steps, especially nucleocytoplasmic export. A remarkable fraction of vertebrate introns have a minimal size of about 100 bp, while majority of introns expand to several kilobases even megabases in length. Principal Findings: We carried out analyses on the evolution and function of minimal introns (50-150 bp) in human and mouse genomes. We found that minimal introns are conserved in terms of both length and sequence. They are preferentially located toward 39 end of mRNA and non-randomly distributed among chromosomes. Both the evolutionary conservation and non-random distribution are indicative of biological relevance. We showed that genes with minimal introns have higher abundance, larger size, and tend to be universally expressed as compared to genes with only large introns and intron-less genes. Genes with minimal introns replicate earlier and preferentially reside in the vicinities of open chromatin, suggesting their unique nuclear position and potential relevance to the regulation of gene expression and transcript export. Conclusions: Based on these observations, we proposed a nuclear-export routing model, where minimal introns play a regulatory role in selectively exporting the highly abundant and large housekeeping genes that reside at the surface of chromatin territories, and thus preventing entanglement with other genes located at the interior locations.	[Zhu, Jiang; He, Fuhong; Wang, Dapeng; Liu, Kan; Huang, Dawei; Xiao, Jingfa; Wu, Jiayan; Hu, Songnian; Yu, Jun] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Zhu, Jiang; He, Fuhong; Wang, Dapeng; Liu, Kan; Huang, Dawei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhu, J (corresponding author), Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China.	junyu@big.ac.cn	郑, 征/C-8514-2011; Zhu, Jiang/E-3049-2013; He, Fuhong/T-4887-2019; He, Fuhong/HHZ-2474-2022; Wang, Dapeng/HGD-4818-2022; Hu, Songnian/C-6509-2013	He, Fuhong/0000-0002-3176-8309; Hu, Songnian/0000-0003-3966-3111; Liu, Kan/0000-0001-5625-8180; wu, jia yan/0000-0001-6048-405X	Ministry of Science and Technology of the People's Republic of China [2006CB910404]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by the National Basic Research Program ( 973 Program) from the Ministry of Science and Technology of the People's Republic of China (2006CB910404 to J.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Branco MR, 2007, TRENDS CELL BIOL, V17, P127, DOI 10.1016/j.tcb.2006.12.006; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Daneholt B, 1997, CELL, V88, P585, DOI 10.1016/S0092-8674(00)81900-5; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Hieronymus H, 2004, GENE DEV, V18, P2845, DOI 10.1101/gad.1256904; Hong X, 2006, MOL BIOL EVOL, V23, P2392, DOI 10.1093/molbev/msl111; Irimia M, 2008, NUCLEIC ACIDS RES, V36, P1703, DOI 10.1093/nar/gkn012; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Misteli T, 2005, BIOESSAYS, V27, P477, DOI 10.1002/bies.20226; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Niu DK, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-46; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Reed R, 2005, CURR OPIN CELL BIOL, V17, P269, DOI 10.1016/j.ceb.2005.04.011; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; Sironi M, 2005, TRENDS GENET, V21, P484, DOI 10.1016/j.tig.2005.06.009; Tanabe H, 2002, P NATL ACAD SCI USA, V99, P4424, DOI 10.1073/pnas.072618599; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu J, 2002, GENOME RES, V12, P1185, DOI 10.1101/gr.224602; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	39	18	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10144	10.1371/journal.pone.0010144	http://dx.doi.org/10.1371/journal.pone.0010144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20419085	Green Submitted, gold, Green Published			2022-12-25	WOS:000276705900021
J	Shang, LS; Ananthakrishnan, R; Li, Q; Quadri, N; Abdillahi, M; Zhu, ZB; Qu, W; Rosario, R; Toure, F; Yan, SF; Schmidt, AM; Ramasamy, R				Shang, Linshan; Ananthakrishnan, Radha; Li, Qing; Quadri, Nosirudeen; Abdillahi, Mariane; Zhu, Zhengbin; Qu, Wu; Rosario, Rosa; Toure, Fatouma; Yan, Shi Fang; Schmidt, Ann Marie; Ramasamy, Ravichandran			RAGE Modulates Hypoxia/Reoxygenation Injury in Adult Murine Cardiomyocytes via JNK and GSK-3 beta Signaling Pathways	PLOS ONE			English	Article							N-TERMINAL KINASE; GLYCOGEN-SYNTHASE KINASE-3-BETA; PROMOTES SURVIVAL; CARDIAC MYOCYTES; CELL-DEATH; IN-VITRO; ACTIVATION; APOPTOSIS; ISCHEMIA; STRESS	Background: Advanced glycation end-products (AGEs) have been implicated in diverse pathological settings including diabetes, inflammation and acute ischemia/reperfusion injury in the heart. AGEs interact with the receptor for AGEs (RAGE) and transduce signals through activation of MAPKs and proapoptotic pathways. In the current study, adult cardiomyocytes were studied in an in vitro ischemia/reperfusion (I/R) injury model to delineate the molecular mechanisms underlying RAGE-mediated injury due to hypoxia/reoxygenation (H/R). Methodology/Principal Findings: Cardiomyocytes isolated from adult wild-type (WT), homozygous RAGE-null (RKO), and WT mice treated with soluble RAGE (sRAGE) were subjected to hypoxia for 30 minutes alone or followed by reoxygenation for 1 hour. In specific experiments, RAGE ligand carboxymethyllysine (CML)-AGE (termed "CML" in this manuscript) was evaluated in vitro. LDH, a marker of cellular injury, was assayed in the supernatant in the presence or absence of signaling inhibitor-treated cardiomyocytes. Cardiomyocyte levels of heterogeneous AGEs were measured using ELISA. A pronounced increase in RAGE expression along with AGEs was observed in H/R vs. normoxia in WT cardiomyocytes. WT cardiomyocytes after H/R displayed increased LDH release compared to RKO or sRAGE-treated cardiomyocytes. Our results revealed significant increases in phospho-JNK in WT cardiomyocytes after H/R. In contrast, neither RKO nor sRAGE-treated cardiomyocytes exhibited increased phosphorylation of JNK after H/R stress. The impact of RAGE deletion on GSK-3 beta phosphorylation in the cardiomyocytes subjected to H/R revealed significantly higher levels of phospho-GSK-3 beta/total GSK-3 beta in RKO, as well as in sRAGE-treated cardiomyocytes versus WT cardiomyocytes after H/R. Further investigation established a key role for Akt, which functions upstream of GSK-3 beta, in modulating H/R injury in adult cardiomyocytes. Conclusions/Significance: These data illustrate key roles for RAGE-ligand interaction in the pathogenesis of cardiomyocyte injury induced by hypoxia/reoxygenation and indicate that the effects of RAGE are mediated by JNK activation and dephosphorylation of GSK-3 beta. The outcome in this study lends further support to the potential use of RAGE blockade as an adjunctive therapy for protection of the ischemic heart.	[Shang, Linshan; Ananthakrishnan, Radha; Li, Qing; Quadri, Nosirudeen; Abdillahi, Mariane; Zhu, Zhengbin; Qu, Wu; Rosario, Rosa; Toure, Fatouma; Yan, Shi Fang; Schmidt, Ann Marie; Ramasamy, Ravichandran] Columbia Univ, Coll Phys & Surg, Dept Surg, Div Surg Sci, New York, NY 10027 USA	Columbia University	Shang, LS (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Surg, Div Surg Sci, New York, NY 10027 USA.	rr260@columbia.edu		Ramasamy, Ravichandran/0000-0002-3666-3346	National Heart, Lung, and Blood Institute [HL-61783, HL-60901, AG026467]; Juvenile Diabetes Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060901, R01HL061783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG026467] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Heart, Lung, and Blood Institute Grants HL-61783, HL-60901, AG026467 and the Juvenile Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin A, 2008, AM J PHYSIOL-HEART C, V294, pH1823, DOI 10.1152/ajpheart.01210.2007; Andreka P, 2001, CIRC RES, V88, P305, DOI 10.1161/01.RES.88.3.305; Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Bucciarelli LG, 2006, CIRCULATION, V113, P1226, DOI 10.1161/CIRCULATIONAHA.105.575993; Bucciarelli LG, 2008, DIABETES, V57, P1941, DOI 10.2337/db07-0326; Cataldegirmen G, 2005, J EXP MED, V201, P473, DOI 10.1084/jem.20040934; Cicconi S, 2003, J CELL PHYSIOL, V195, P27, DOI 10.1002/jcp.10219; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dougherty CJ, 2004, FASEB J, V18, P1060, DOI 10.1096/fj.04-1505com; Dougherty CJ, 2002, BIOCHEM J, V362, P561, DOI 10.1042/0264-6021:3620561; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gould TD, 2005, NEUROPSYCHOPHARMACOL, V30, P1223, DOI 10.1038/sj.npp.1300731; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; He HP, 1999, CELL DEATH DIFFER, V6, P987, DOI 10.1038/sj.cdd.4400572; Hreniuk D, 2001, MOL PHARMACOL, V59, P867, DOI 10.1124/mol.59.4.867; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Kajstura J, 1996, LAB INVEST, V74, P86; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Kumar Y, 2003, PROTEOMICS, V3, P513, DOI 10.1002/pmic.200390065; MacLellan WR, 1997, CIRC RES, V81, P137, DOI 10.1161/01.RES.81.2.137; Markou T, 2008, CELL SIGNAL, V20, P206, DOI 10.1016/j.cellsig.2007.10.004; Minamino T, 1999, P NATL ACAD SCI USA, V96, P15127, DOI 10.1073/pnas.96.26.15127; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Rong LL, 2004, FASEB J, V18, P1818, DOI 10.1096/fj.04-1900com; Sakaguchi T, 2003, J CLIN INVEST, V111, P959, DOI 10.1172/JCI200317115; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Tong HY, 2002, CIRC RES, V90, P377, DOI 10.1161/01.RES.0000012567.95445.55; WOODGETT JR, 2001, SCI STKE, pRE12; Yun H, 2009, CARCINOGENESIS, V30, P529, DOI 10.1093/carcin/bgn259	35	68	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10092	10.1371/journal.pone.0010092	http://dx.doi.org/10.1371/journal.pone.0010092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404919	gold, Green Published, Green Submitted			2022-12-25	WOS:000276482100012
J	Komurov, K; Padron, D; Cheng, TL; Roth, M; Rosenblatt, KP; White, MA				Komurov, Kakajan; Padron, David; Cheng, Tzuling; Roth, Michael; Rosenblatt, Kevin P.; White, Michael A.			Comprehensive Mapping of the Human Kinome to Epidermal Growth Factor Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST; SOMATIC MUTATIONS; DOWN-REGULATION; CANCER; KINASE; PATHWAYS; ELEMENTS; DATABASE; NETWORK; TARGET	Disregulation of epidermal growth factor receptor (EGFR) signaling directly promotes bypass of proliferation and survival restraints in a high frequency of epithelia-derived cancer. As such, much effort is currently focused on decoding the molecular architecture supporting EGFR activation and function. Here, we have leveraged high throughput reverse phase protein lysate arrays, with a sensitive fluorescent nanocrystal-based phosphoprotein detection assay, together with large scale siRNA-mediated loss of function to execute a quantitative interrogation of all elements of the human kinome supporting EGF-dependent signaling. This screening platform has captured multiple novel contributions of diverse protein kinases to modulation of EGFR signal generation, signal amplitude, and signal duration. As examples, the prometastatic SNF1/AMPK-related kinase hormonally upregulated Neu kinase was found to support EGFR activation in response to ligand binding, whereas the enigmatic kinase MGC16169 selectively supports coupling of active EGFR to ERK1/2 regulation. Of note, the receptor tyrosine kinase MERTK and the pyrimidine kinase UCK1 were both found to be required for surface accumulation of EGFR and subsequent pathway activation in multiple cancer cell backgrounds and may represent new targets for therapeutic intervention.	Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Padron, David; Roth, Michael] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Rosenblatt, Kevin P.] Brown Fdn Inst Mol Med, Ctr Clin & Translat Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	White, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75220 USA.	michael.white@utsouthwestern.edu		Roth, Michael/0000-0002-9056-332X	Welch Foundation [I-1414]; National Cancer Institute [CA71443]; NATIONAL CANCER INSTITUTE [R01CA071443] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Welch Foundation (I-1414) and the National Cancer Institute (CA71443).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bi J, 2009, INT J CANCER, V124, P1587, DOI 10.1002/ijc.24164; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Dhanasekaran DN, 2007, ONCOGENE, V26, P3097, DOI 10.1038/sj.onc.1210395; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ganesan AK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000298; Geho D, 2005, BIOCONJUGATE CHEM, V16, P559, DOI 10.1021/bc0497113; Geho David H, 2007, Methods Mol Biol, V374, P229; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Guan M, 2009, INT J CANCER, V124, P88, DOI 10.1002/ijc.23890; Herbst RS, 2004, NAT REV CANCER, V4, P956, DOI 10.1038/nrc1506; Hiraga T, 2009, J BONE MINER METAB, V27, P149, DOI 10.1007/s00774-009-0039-9; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Lovasz L, 1993, BOLYAI MATH STUD, V1, P9; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Raman M, 2003, CURR BIOL, V13, pR886, DOI 10.1016/j.cub.2003.10.053; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tagliabue E, 2010, EXPERT OPIN BIOL TH, V10, P711, DOI 10.1517/14712591003689972; Tuveson DA, 2003, CANCER CELL, V4, P95, DOI 10.1016/S1535-6108(03)00189-2; Wang JD, 2005, ONCOGENE, V24, P5637, DOI 10.1038/sj.onc.1208720; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; WU XP, 1995, J CLIN INVEST, V95, P1897, DOI 10.1172/JCI117871	39	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21134	21142		10.1074/jbc.M110.137828	http://dx.doi.org/10.1074/jbc.M110.137828			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20421302	hybrid, Green Published			2022-12-25	WOS:000279228600076
J	Mann, FM; Prisic, S; Davenport, EK; Determan, MK; Coates, RM; Peters, RJ				Mann, Francis M.; Prisic, Sladjana; Davenport, Emily K.; Determan, Mara K.; Coates, Robert M.; Peters, Reuben J.			A Single Residue Switch for Mg2+-dependent Inhibition Characterizes Plant Class II Diterpene Cyclases from Primary and Secondary Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPALYL DIPHOSPHATE SYNTHASES; SQUALENE-HOPENE CYCLASE; ENT-COPALYL; ABIETADIENE SYNTHASE; GIBBERELLIN BIOSYNTHESIS; ENZYME MECHANISMS; ENCODES; RICE; INTERMEDIATE; CYCLIZATION	Class II diterpene cyclases mediate the acid-initiated cycloisomerization reaction that serves as the committed step in biosynthesis of the large class of labdane-related diterpenoid natural products, which includes the important gibberellin plant hormones. Intriguingly, these enzymes are differentially susceptible to inhibition by their Mg2+ cofactor, with those involved in gibberellin biosynthesis being more sensitive to such inhibition than those devoted to secondary metabolism, which presumably limits flux toward the potent gibberellin phytohormones. Such inhibition has been suggested to arise from intrasteric Mg2+ binding to the DXDD motif that cooperatively acts as the catalytic acid, whose affinity must then be modulated in some fashion. While further investigating class II diterpene cyclase catalysis, we discovered a conserved basic residue that seems to act as a counter ion to the DXDD motif, enhancing the ability of aspartic acid to carry out the requisite energetically difficult protonation of a carbon-carbon double bond and also affecting inhibitory Mg2+ binding. Notably, this residue is conserved as a histidine in enzymes involved in gibberellin biosynthesis and as an arginine in those dedicated to secondary metabolism. Interchanging the identity of these residues is sufficient to switch the sensitivity of the parent enzyme to inhibition by Mg2+. These striking findings indicate that this is a single residue switch for Mg2+ inhibition, which not only supports the importance of this biochemical regulatory mechanism in limiting gibberellin biosynthesis, but the importance of its release, presumably to enable higher flux, into secondary metabolism.	[Mann, Francis M.; Prisic, Sladjana; Davenport, Emily K.; Determan, Mara K.; Peters, Reuben J.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Coates, Robert M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	Iowa State University; University of Illinois System; University of Illinois Urbana-Champaign	Peters, RJ (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, 4216 Mol Biol Bldg, Ames, IA 50011 USA.	rjpeters@iastate.edu	Peters, Reuben J./D-1196-2010	Peters, Reuben J./0000-0003-4691-8477; Prisic, Sladjana/0000-0003-3137-4358	National Science Foundation [MCB0919735]; National Institutes of Health [GM076324]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076324] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0919735] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the National Science Foundation (MCB0919735) and National Institutes of Health (GM076324) (to R.J.P.).	AitAli T, 1997, PLANT J, V11, P443, DOI 10.1046/j.1365-313X.1997.11030443.x; Alabadi D, 2004, PLANT PHYSIOL, V134, P1050, DOI 10.1104/pp.103.035451; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Buckingham J, 2002, DICT NATURAL PRODUCT; CAO R, 2010, PROTEINS IN PRESS; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Garcia-Martinez JL, 2001, J PLANT GROWTH REGUL, V20, P354, DOI 10.1007/s003440010033; Harris LJ, 2005, PLANT MOL BIOL, V59, P881, DOI 10.1007/s11103-005-1674-8; Ishijima S, 2003, ARCH BIOCHEM BIOPHYS, V412, P126, DOI 10.1016/S0003-9861(03)00038-9; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; Lloyd JC, 2004, J EXP BOT, V55, P1221, DOI 10.1093/jxb/erh143; MCGARVEY DJ, 1995, PLANT CELL, V7, P1015, DOI 10.1105/tpc.7.7.1015; Merkofer T, 1999, TETRAHEDRON LETT, V40, P2121, DOI 10.1016/S0040-4039(99)00145-8; Otomo K, 2004, PLANT J, V39, P886, DOI 10.1111/j.1365-313X.2004.02175.x; Peters RJ, 2006, PHYTOCHEMISTRY, V67, P2307, DOI 10.1016/j.phytochem.2006.08.009; Peters RJ, 2003, BIOCHEMISTRY-US, V42, P2700, DOI 10.1021/bi020492n; Peters RJ, 2002, BIOCHEMISTRY-US, V41, P1836, DOI 10.1021/bi011879d; Peters RJ, 2001, J AM CHEM SOC, V123, P8974, DOI 10.1021/ja010670k; Prisic S, 2004, PLANT PHYSIOL, V136, P4228, DOI 10.1104/pp.104.050567; Prisic S, 2007, CHEMBIOCHEM, V8, P869, DOI 10.1002/cbic.200700045; Prisic S, 2007, PLANT PHYSIOL, V144, P445, DOI 10.1104/pp.106.095208; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Sato T, 1999, BIOSCI BIOTECH BIOCH, V63, P2189, DOI 10.1271/bbb.63.2189; Schepmann HG, 2001, ARCH BIOCHEM BIOPHYS, V392, P263, DOI 10.1006/abbi.2001.2438; Silverstone AL, 1997, PLANT J, V12, P9, DOI 10.1046/j.1365-313X.1997.12010009.x; SUN TP, 1994, PLANT CELL, V6, P1509, DOI 10.1105/tpc.6.10.1509; Vogel BS, 1996, J BIOL CHEM, V271, P23262, DOI 10.1074/jbc.271.38.23262; Wendt KU, 2005, ANGEW CHEM INT EDIT, V44, P3966, DOI 10.1002/anie.200500804; Wendt KU, 1998, STRUCTURE, V6, P127, DOI 10.1016/S0969-2126(98)00015-X; Wendt KU, 2000, ANGEW CHEM INT EDIT, V39, P2812, DOI 10.1002/1521-3773(20000818)39:16<2812::AID-ANIE2812>3.0.CO;2-#	32	26	29	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20558	20563		10.1074/jbc.M110.123307	http://dx.doi.org/10.1074/jbc.M110.123307			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430888	Green Published, hybrid			2022-12-25	WOS:000279228600018
J	Luo, JL; Li, WM; Zhao, YM; Fu, HJ; Ma, DL; Tang, J; Li, CY; Peoples, RW; Li, FS; Wang, QW; Huang, PB; Xia, J; Pang, YP; Han, YF				Luo, Jialie; Li, Wenming; Zhao, Yuming; Fu, Hongjun; Ma, Dik-Lung; Tang, Jing; Li, Chaoying; Peoples, Robert W.; Li, Fushun; Wang, Qinwen; Huang, Pingbo; Xia, Jun; Pang, Yuanping; Han, Yifan			Pathologically Activated Neuroprotection via Uncompetitive Blockade of N-Methyl-D-aspartate Receptors with Fast Off-rate by Novel Multifunctional Dimer Bis(propyl)-cognitin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN-CHANNEL BLOCKER; SYNAPTIC-TRANSMISSION; IN-VITRO; MEMANTINE; GLUTAMATE; ANTAGONISTS; KINETICS; MODEL; NEURODEGENERATION; EXCITOTOXICITY	Uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonists with fast off-rate (UFO) may represent promising drug candidates for various neurodegenerative disorders. In this study, we report that bis(propyl)-cognitin, a novel dimeric acetylcholinesterase inhibitor and gamma-aminobutyric acid subtype A receptor antagonist, is such an antagonist of NMDA receptors. In cultured rat hippocampal neurons, we demonstrated that bis(propyl)-cognitin voltage-dependently, selectively, and moderately inhibited NMDA-activated currents. The inhibitory effects of bis(propyl)-cognitin increased with the rise in NMDA and glycine concentrations. Kinetics analysis showed that the inhibition was of fast onset and offset with an off-rate time constant of 1.9 s. Molecular docking simulations showed moderate hydrophobic interaction between bis(propyl)-cognitin and the MK-801 binding region in the ion channel pore of the NMDA receptor. Bis(propyl)-cognitin was further found to compete with [H-3]MK-801 with aK(i) value of 0.27 mu M, and the mutation of NR1(N616R) significantly reduced its inhibitory potency. Under glutamate-mediated pathological conditions, bis(propyl)-cognitin, in contrast to bis(heptyl)-cognitin, prevented excitotoxicity with increasing effectiveness against escalating levels of glutamate and much more effectively protected against middle cerebral artery occlusion-induced brain damage than did memantine. More interestingly, under NMD Areceptor-mediated physiological conditions, bis(propyl)-cognitin enhanced longterm potentiation in hippocampal slices, whereas MK-801 reduced and memantine did not alter this process. These results suggest that bis(propyl)-cognitin is a UFO antagonist of NMDA receptors with moderate affinity, which may provide a pathologically activated therapy for various neurodegenerative disorders associated with NMD Areceptor dysregulation.	[Luo, Jialie; Li, Wenming; Fu, Hongjun; Han, Yifan] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Inst Modern Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Luo, Jialie; Zhao, Yuming; Xia, Jun; Han, Yifan] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Huang, Pingbo] Hong Kong Univ Sci & Technol, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Ma, Dik-Lung] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Tang, Jing; Pang, Yuanping] Mayo Fdn Med Educ & Res, Rochester, MN 55905 USA; [Li, Chaoying] Jianghan Univ, Wuhan Inst Neurosci & Drug Res, Wuhan 430056, Peoples R China; [Peoples, Robert W.] Marquette Univ, Dept Biomed Sci, Milwaukee, WI 53201 USA; [Li, Fushun; Wang, Qinwen] Ningbo Univ, Dept Physiol, Sch Med, Ningbo 315211, Zhejiang, Peoples R China	Hong Kong Polytechnic University; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; University of Hong Kong; Mayo Clinic; Jianghan University; Marquette University; Ningbo University	Han, YF (corresponding author), Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Inst Modern Chinese Med, Hong Kong, Hong Kong, Peoples R China.	bcyfhan@polyu.edu.hk	Huang, Pingbo/I-1127-2019; Fu, Hongjun/ABB-3558-2021; FU, HONGJUN/H-4498-2011; Xia, Jun/C-7234-2009	Huang, Pingbo/0000-0002-4560-8760; FU, HONGJUN/0000-0001-5346-7075; Pang, Yuan-Ping/0000-0003-0838-2560; Ma, Dik-Lung/0000-0002-9515-340X; Han, Yifan/0000-0002-5833-069X; Xia, Jun/0000-0001-9308-2188	Research Grants Council of Hong Kong [PolyU6608/07M, 5609/09M, N_PolyU618/07, AoE/B15/01-II]; Hong Kong Polytechnic University [G-YX96, G-U439]; National Nature Science Foundation of China [30770684]; National Nature Science Foundation of Zhejiang [Y207193]; Ministry of Science and Technology of China [2008CB517411]; Shenzhen Shuangbai Scheme	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Hong Kong Polytechnic University(Hong Kong Polytechnic University); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science Foundation of Zhejiang; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shenzhen Shuangbai Scheme	This work was supported by grants from the Research Grants Council of Hong Kong (PolyU6608/07M, 5609/09M; N_PolyU618/07; AoE/B15/01-II), Hong Kong Polytechnic University (G-YX96, G-U439), the National Nature Science Foundation of China (30770684), Zhejiang (Y207193), the Ministry of Science and Technology of China (2008CB517411), and the Shenzhen Shuangbai Scheme 2008.	Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Carlier PR, 1999, BIOORGAN MED CHEM, V7, P351, DOI 10.1016/S0968-0896(98)00213-2; Cavalli A, 2008, J MED CHEM, V51, P347, DOI 10.1021/jm7009364; CHEN HSV, 1992, J NEUROSCI, V12, P4427; Chen HSV, 1997, J PHYSIOL-LONDON, V499, P27, DOI 10.1113/jphysiol.1997.sp021909; Cheng XP, 2006, NEUROSCI RES, V55, P142, DOI 10.1016/j.neures.2006.02.011; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Frankiewicz T, 1996, BRIT J PHARMACOL, V117, P689, DOI 10.1111/j.1476-5381.1996.tb15245.x; Gilling KE, 2007, NEUROPHARMACOLOGY, V53, P415, DOI 10.1016/j.neuropharm.2007.05.022; Giorgetti M, 2000, EUR J NEUROSCI, V12, P1941, DOI 10.1046/j.1460-9568.2000.00079.x; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Hare W, 2001, SURV OPHTHALMOL, V45, pS284, DOI 10.1016/S0039-6257(01)00200-4; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Kashiwagi K, 2002, MOL PHARMACOL, V61, P533, DOI 10.1124/mol.61.3.533; Klimaviciusa L, 2008, NEUROTOXICOLOGY, V29, P101, DOI 10.1016/j.neuro.2007.09.006; Krasel C, 2004, BIOCHEM SOC T, V32, P1029, DOI 10.1042/BST0321029; Li CY, 2007, NEUROPHARMACOLOGY, V52, P436, DOI 10.1016/j.neuropharm.2006.07.039; Li WM, 2007, CURR ALZHEIMER RES, V4, P386, DOI 10.2174/156720507781788918; Li WM, 2005, J BIOL CHEM, V280, P18179, DOI 10.1074/jbc.M411085200; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Lipton SA, 2004, J ALZHEIMERS DIS, V6, pS61; Lipton SA, 2007, NAT REV NEUROSCI, V8, P803, DOI 10.1038/nrn2229; Lipton Stuart A, 2004, NeuroRx, V1, P101, DOI 10.1602/neurorx.1.1.101; Lipton Stuart A., 2005, Current Alzheimer Research, V2, P155, DOI 10.2174/1567205053585846; Matsuyama S, 2008, NEUROREPORT, V19, P1809, DOI 10.1097/WNR.0b013e328319ab94; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; PARSONS CG, 1995, NEUROPHARMACOLOGY, V34, P1239, DOI 10.1016/0028-3908(95)00092-K; Parsons CG, 2007, NEUROPHARMACOLOGY, V53, P699, DOI 10.1016/j.neuropharm.2007.07.013; Petrovic M, 2005, Prague Med Rep, V106, P113; Planells-Cases R, 2002, J PHARMACOL EXP THER, V302, P163, DOI 10.1124/jpet.302.1.163; Rogawski MA, 2000, AMINO ACIDS, V19, P133, DOI 10.1007/s007260070042; Stieg PE, 1999, EUR J PHARMACOL, V375, P115, DOI 10.1016/S0014-2999(99)00214-9; Tai KK, 2001, P NATL ACAD SCI USA, V98, P3519, DOI 10.1073/pnas.061449498; Takadera T, 1999, J NEUROCHEM, V73, P548, DOI 10.1046/j.1471-4159.1999.0730548.x; Villmann C, 2007, NEUROSCIENTIST, V13, P594, DOI 10.1177/1073858406296259; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; Youdim MBH, 2005, TRENDS PHARMACOL SCI, V26, P27, DOI 10.1016/j.tips.2004.11.007; Zhang Y, 2006, J PHARMACOL EXP THER, V317, P973, DOI 10.1124/jpet.105.098517; Zhao XL, 2006, NEUROPHARMACOLOGY, V51, P1181, DOI 10.1016/j.neuropharm.2006.08.007	44	32	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19947	19958		10.1074/jbc.M110.111286	http://dx.doi.org/10.1074/jbc.M110.111286			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20404346	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000279012000028
J	Albert, M; Jehle, AK; Mueller, K; Eisele, C; Lipschis, M; Felix, G				Albert, Markus; Jehle, Anna K.; Mueller, Katharina; Eisele, Claudia; Lipschis, Martin; Felix, Georg			Arabidopsis thaliana Pattern Recognition Receptors for Bacterial Elongation Factor Tu and Flagellin Can Be Combined to Form Functional Chimeric Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; EXTRACELLULAR DOMAIN; MOLECULAR-PATTERNS; ELICITOR FLAGELLIN; TOMATO CELLS; KINASE; PERCEPTION; DISTINCT; FLS2; SPECIFICITY	The receptor kinase EFR of Arabidopsis thaliana detects the microbe-associated molecular pattern elf18, a peptide that represents the N terminus of bacterial elongation factor Tu. Here, we tested subdomains of EFR for their importance in receptor function. Transient expression of tagged versions of EFR and EFR lacking its cytoplasmic domain in leaves of Nicotiana benthamiana resulted in functional binding sites for elf18. No binding of ligand was found with the ectodomain lacking the transmembrane domain or with EFR lacking the first 5 of its 21 leucine-rich repeats (LRRs). EFR is structurally related to the receptor kinase flagellin-sensing 2 (FLS2) that detects bacterial flagellin. Chimeric receptors with subdomains of FLS2 substituting for corresponding parts of EFR were tested for functionality in ligand binding and receptor activation assays. Substituting the transmembrane domain and the cytoplasmic domain resulted in a fully functional receptor for elf18. Replacing also the outer juxtamembrane domain with that of FLS2 led to a receptor with full affinity for elf18 but with a lower efficiency in response activation. Extending the substitution to encompass also the last two of the LRRs abolished binding and receptor activation. Substitution of the N terminus by the first six LRRs from FLS2 reduced binding affinity and strongly affected receptor activation. In summary, chimeric receptors allow mapping of subdomains relevant for ligand binding and receptor activation. The results also show that modular assembly of chimeras from different receptors can be used to form functional receptors.	[Albert, Markus; Jehle, Anna K.; Mueller, Katharina; Eisele, Claudia; Lipschis, Martin; Felix, Georg] Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Felix, G (corresponding author), Univ Tubingen, Zentrum Mol Biol Pflanzen, Morgenstelle 5, D-72076 Tubingen, Germany.	georg.felix@uni-tuebingen.de		Albert, Markus/0000-0003-4729-2453; Witte, Anna Kristina/0000-0001-6471-0763	Deutsche Forschungsgemeinschaft [SFB 446, SFB 766]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft as part of initiatives SFB 446, SFB 766, and ERA-PG RLKRLP.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; BAUREITHEL K, 1994, J BIOL CHEM, V269, P17931; Belkhadir Y, 2006, SCIENCE, V314, P1410, DOI 10.1126/science.1134040; Boggs NA, 2009, GENETICS, V182, P1313, DOI 10.1534/genetics.109.102442; Boggs NA, 2009, CURR BIOL, V19, P786, DOI 10.1016/j.cub.2009.03.037; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Butenko MA, 2009, TRENDS PLANT SCI, V14, P255, DOI 10.1016/j.tplants.2009.02.002; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; De Smet I, 2009, NAT CELL BIOL, V11, P1166, DOI 10.1038/ncb1009-1166; Dunning FM, 2007, PLANT CELL, V19, P3297, DOI 10.1105/tpc.106.048801; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Huffaker A, 2006, P NATL ACAD SCI USA, V103, P10098, DOI 10.1073/pnas.0603727103; Ishii A, 2007, J IMMUNOL, V178, P397, DOI 10.4049/jimmunol.178.1.397; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Meindl T, 2000, PLANT CELL, V12, P1783, DOI 10.1105/tpc.12.9.1783; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Morillo SA, 2006, CURR OPIN PLANT BIOL, V9, P460, DOI 10.1016/j.pbi.2006.07.009; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Tor M, 2009, J EXP BOT, V60, P3645, DOI 10.1093/jxb/erp233; Van der Hoorn RAL, 2001, P NATL ACAD SCI USA, V98, P10493, DOI 10.1073/pnas.181241798; Van der Hoorn RAL, 2001, PLANT CELL, V13, P273, DOI 10.1105/tpc.13.2.273; Wulff BBH, 2009, MOL PLANT MICROBE IN, V22, P1191, DOI 10.1094/MPMI-22-10-1191; Wulff BBH, 2001, PLANT CELL, V13, P255, DOI 10.1105/tpc.13.2.255; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	41	62	70	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19035	19042		10.1074/jbc.M110.124800	http://dx.doi.org/10.1074/jbc.M110.124800			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410299	Green Published, hybrid			2022-12-25	WOS:000278727800012
J	Matsumoto, Y; Matsumoto, K; Irie, F; Fukushi, J; Stallcup, WB; Yamaguchi, Y				Matsumoto, Yoshihiro; Matsumoto, Kazu; Irie, Fumitoshi; Fukushi, Jun-ichi; Stallcup, William B.; Yamaguchi, Yu			Conditional Ablation of the Heparan Sulfate-synthesizing Enzyme Ext1 Leads to Dysregulation of Bone Morphogenic Protein Signaling and Severe Skeletal Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNOVIAL JOINT FORMATION; LIMB BUD; GENE-EXPRESSION; SONIC HEDGEHOG; CELL-SURFACE; CHICK LIMB; DIFFERENTIATION; CHONDROCYTES; GROWTH; RANGE	Increasing evidence indicates that heparan sulfate (HS) is an integral component of many morphogen signaling pathways. However, its mechanisms of action appear to be diverse, depending on the type of morphogen and the developmental contexts. To define the function of HS in skeletal development, we conditionally ablated Ext1, which encodes an essential glycosyltransferase for HS synthesis, in limb bud mesenchyme using the Prx1-Cre transgene. These conditional Ext1 mutant mice display severe limb skeletal defects, including shortened and malformed limb bones, oligodactyly, and fusion of joints. In developing limb buds of mutant mice, chondrogenic differentiation of mesenchymal condensations is delayed and impaired, whereas the area of differentiation is diffusely expanded. Correspondingly, the distribution of both bone morphogenic protein (BMP) signaling domains and BMP2 immunoreactivity in the mutant limb mesenchyme is broadened and diffuse. In micromass cultures, chondrogenic differentiation of mutant chondrocytes is delayed, and the responsiveness to exogenous BMPs is attenuated. Moreover, the segregation of the pSmad1/5/8-expressing chondrocytes and fibronectin-expressing perichondrium-like cells surrounding chondrocyte nodules is disrupted in mutant micromass cultures. Together, our results show that HS is essential for patterning of limb skeletal elements and that BMP signaling is one of the major targets for the regulatory role of HS in this developmental context.	[Matsumoto, Yoshihiro; Matsumoto, Kazu; Irie, Fumitoshi; Yamaguchi, Yu] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA; [Fukushi, Jun-ichi; Stallcup, William B.] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Yamaguchi, Y (corresponding author), Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yyamaguchi@burnham.org			National Institutes of Health [R01 AR055670, R01 CA95238, P01 HD25938]; MHE Coalition; MHE Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA095287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055670] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MHE Coalition; MHE Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR055670 (to Y.Y.), R01 CA95238 (to W.B.S.), and P01 HD25938 (to Y.Y.and W.B.S.).This work was also supported by the MHE Coalition and the MHE Research Foundation.	Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; BURKE AC, 1995, DEVELOPMENT, V121, P333; Colnot C, 2005, J CELL BIOCHEM, V95, P688, DOI 10.1002/jcb.20449; Deirmengian GK, 2008, J BONE JOINT SURG AM, V90A, P366, DOI 10.2106/JBJS.G.00774; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Duncan G, 2001, J CLIN INVEST, V108, P511, DOI 10.1172/JCI200113737; Duprez D, 1996, MECH DEVELOP, V57, P145, DOI 10.1016/0925-4773(96)00540-0; Fisher MC, 2006, MATRIX BIOL, V25, P27, DOI 10.1016/j.matbio.2005.07.008; Fukushi J, 2003, DEV DYNAM, V228, P143, DOI 10.1002/dvdy.10359; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; Guy RK, 2000, P NATL ACAD SCI USA, V97, P7307, DOI 10.1073/pnas.97.13.7307; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Irie A, 2003, BIOCHEM BIOPH RES CO, V308, P858, DOI 10.1016/S0006-291X(03)01500-6; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; LEFEBVRE V, 1995, J CELL BIOL, V128, P239, DOI 10.1083/jcb.128.1.239; Li CL, 2005, DEVELOPMENT, V132, P4755, DOI 10.1242/dev.02065; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Macias D, 1997, DEVELOPMENT, V124, P1109; Matsumoto Y, 2007, J NEUROSCI, V27, P4342, DOI 10.1523/JNEUROSCI.0700-07.2007; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Pizette S, 2000, DEV BIOL, V219, P237, DOI 10.1006/dbio.2000.9610; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; vanderHoeven F, 1996, MECH DEVELOP, V54, P9, DOI 10.1016/0925-4773(95)00455-6; Verheyden JM, 2005, DEVELOPMENT, V132, P4235, DOI 10.1242/dev.02001; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zak BM, 2002, BBA-GEN SUBJECTS, V1573, P346, DOI 10.1016/S0304-4165(02)00402-6; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053	46	51	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19227	19234		10.1074/jbc.M110.105338	http://dx.doi.org/10.1074/jbc.M110.105338			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404326	Green Published, hybrid			2022-12-25	WOS:000278727800032
J	Foti, R; Zucchelli, S; Biagioli, M; Roncaglia, P; Vilotti, S; Calligaris, R; Krmac, H; Girardini, JE; Del Sal, G; Gustincich, S				Foti, Rossana; Zucchelli, Silvia; Biagioli, Marta; Roncaglia, Paola; Vilotti, Sandra; Calligaris, Raffaella; Krmac, Helena; Girardini, Javier Enrique; Del Sal, Giannino; Gustincich, Stefano			Parkinson Disease-associated DJ-1 Is Required for the Expression of the Glial Cell Line-derived Neurotrophic Factor Receptor RET in Human Neuroblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINERGIC-NEURONS; OXIDATIVE STRESS; GENE-EXPRESSION; MOTOR DEFICITS; IN-VITRO; HYPOXIA; PROTEIN; INACTIVATION; APOPTOSIS; MUTANTS	Mutations in PARK7/DJ-1 are associated with autosomal recessive, early onset Parkinson disease (PD). DJ-1 is an atypical peroxiredoxin-like peroxidase that may act as a redox-dependent chaperone and a regulator of transcription. Here we show that DJ-1 plays an essential role in the expression of rearranged during transfection (RET), a receptor for the glial cell line-derived neurotrophic factor, a neuroprotective molecule for dopaminergic neurons, the main target of degeneration in PD. The inducible loss of DJ-1 triggers the establishment of hypoxia and the production of reactive oxygen species that stabilize the hypoxia-inducible factor-1 alpha (HIF-1a). HIF-1a expression is required for RET down-regulation. This study establishes for the first time a molecular link between the lack of functional DJ-1 and the glial cell line-derived neurotrophic factor signaling pathway that may explain the adult-onset loss of dopaminergic neurons. Furthermore, it suggests that hypoxia may play an important role in PD.	[Foti, Rossana; Zucchelli, Silvia; Biagioli, Marta; Roncaglia, Paola; Vilotti, Sandra; Calligaris, Raffaella; Krmac, Helena; Gustincich, Stefano] SISSA, Sector Neurobiol, Int Sch Adv Studies, I-34149 Trieste, Italy; [Zucchelli, Silvia; Gustincich, Stefano] Italian Inst Technol, SISSA Unit, Basovizza, Italy; [Zucchelli, Silvia; Biagioli, Marta; Calligaris, Raffaella; Krmac, Helena; Gustincich, Stefano] Giovanni Armenise Harvard Fdn Lab, Basovizza, Italy; [Girardini, Javier Enrique; Del Sal, Giannino] Lab Nazl CIB, I-34149 Trieste, Italy; [Del Sal, Giannino] Univ Trieste, Dipartimento Sci Vita, I-34127 Trieste, Italy	International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT; University of Trieste	Gustincich, S (corresponding author), SISSA, Sector Neurobiol, Int Sch Adv Studies, AREA Sci Pk,SS 14,Km 163-5 Basovizza, I-34149 Trieste, Italy.	gustinci@sissa.it		Foti, Rossana/0000-0003-1095-9453; DEL SAL, GIANNINO/0000-0003-2185-6003; Roncaglia, Paola/0000-0002-2825-0621; Biagioli, Marta/0000-0001-8295-8025; Gustincich, Stefano/0000-0002-2749-2514; Zucchelli, Silvia/0000-0003-4556-2990	Telethon [GGP06268]; Giovanni Armenise-Harvard Foundation; Italian Institute of Technology	Telethon(Fondazione Telethon); Giovanni Armenise-Harvard Foundation; Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT)	This work was supported by Telethon Grant GGP06268, The Giovanni Armenise-Harvard Foundation, and the Italian Institute of Technology.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Aleyasin H, 2007, P NATL ACAD SCI USA, V104, P18748, DOI 10.1073/pnas.0709379104; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; BURKE RE, 1992, NEUROSCIENCE, V50, P559, DOI 10.1016/0306-4522(92)90447-A; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Decker Michael J, 2002, Sleep Breath, V6, P205, DOI 10.1007/s11325-002-0205-y; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Gonzalez-Polo RA, 2009, J NEUROCHEM, V109, P889, DOI 10.1111/j.1471-4159.2009.06020.x; Guo SH, 2009, J NEUROCHEM, V108, P1309, DOI 10.1111/j.1471-4159.2009.05877.x; Gutsaeva DR, 2006, NEUROSCIENCE, V137, P493, DOI 10.1016/j.neuroscience.2005.07.061; Herrera FE, 2007, J BIOL CHEM, V282, P24905, DOI 10.1074/jbc.M701013200; Hirata Y, 2007, J NEUROCHEM, V102, P1606, DOI 10.1111/j.1471-4159.2007.04695.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Lavara-Culebras E, 2007, GENE, V400, P158, DOI 10.1016/j.gene.2007.06.013; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Nosrat CA, 1997, EXP BRAIN RES, V115, P410, DOI 10.1007/PL00005711; OO TF, 1995, NEUROSCIENCE, V69, P893, DOI 10.1016/0306-4522(95)00282-N; Piruat JI, 2005, J BIOL CHEM, V280, P42676, DOI 10.1074/jbc.M507044200; Pisani A, 2006, NEUROBIOL DIS, V23, P54, DOI 10.1016/j.nbd.2006.02.001; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saito Y, 2009, NEUROSCI LETT, V465, P1, DOI 10.1016/j.neulet.2009.08.074; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Ved R, 2005, J BIOL CHEM, V280, P42655, DOI 10.1074/jbc.M505910200; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zucchelli S, 2009, CELL DEATH DIFFER, V16, P428, DOI 10.1038/cdd.2008.169	49	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18565	18574		10.1074/jbc.M109.088294	http://dx.doi.org/10.1074/jbc.M109.088294			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20395301	Green Published, hybrid			2022-12-25	WOS:000278453900050
J	Kim, DJ; Tremblay, ML; DiGiovanni, J				Kim, Dae Joon; Tremblay, Michel L.; DiGiovanni, John			Protein Tyrosine Phosphatases, TC-PTP, SHP1, and SHP2, Cooperate in Rapid Dephosphorylation of Stat3 in Keratinocytes Following UVB Irradiation	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SIGNAL TRANSDUCER; SKIN CARCINOGENESIS; TRANSCRIPTION 3; EPITHELIAL CARCINOGENESIS; NEGATIVE REGULATOR; PROMOTION STAGES; ACTIVATION; SUBSTRATE; PROLIFERATION	Stat3 is initially dephosphorylated in murine keratinocytes in response to UVB irradiation. Treatment with Na(3)VO(4) desensitized keratinocytes to UVB-induced apoptosis with the recovery of phosphorylated Stat3 protein levels, implying that a protein tyrosine phosphatase (PTP) is involved in this mechanism. In the current work, we report that three PTPs including TC45 (the nuclear form of TC-PTP), SHP1, and SHP2 are involved in this rapid dephosphorylation of Stat3 in keratinocytes induced by UVB irradiation. Dephosphorylation of Stat3 was increased rapidly after UVB irradiation of cultured keratinocytes. Knockdown of TC-PTP, SHP1, or SHP2 using RNAi showed that these PTPs are likely responsible for most of the rapid Stat3 dephosphorylation observed following UVB irradiation. The level of phosphorylated Stat3 was significantly higher in keratinocytes transfected with TC-PTP, SHP1, or SHP2 siRNA in the presence or absence of UVB compared with keratinocytes transfected with control siRNA. TC45 was mainly localized in the cytoplasm of keratinocytes and translocated from cytoplasm to nucleus upon UVB irradiation. Stat3 dephosphorylation was associated with nuclear translocation of TC45. Further studies revealed that knockdown of all three phosphatases, using RNAi, prevented the rapid dephosphorylation of Stat3 following UVB irradiation. In mouse epidermis, the level of phosphorylated Stat3 was initially decreased, followed by a significant increase at later time points after UVB exposure. The levels of Stat3 target genes, such as cyclin D1 and c-Myc, followed the changes in activated Stat3 in response to UVB irradiation. Collectively, these results suggest that three phosphatases, TC45, SHP1, and SHP2, are primarily responsible for UVB-mediated Stat3 dephosphorylation and may serve as part of an initial protective mechanism against UV skin carcinogenesis.	[Kim, Dae Joon; DiGiovanni, John] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX USA; [Tremblay, Michel L.] McGill Univ, Dept Biochem, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ, Canada	University of Texas System; UTMD Anderson Cancer Center; McGill University	Kim, DJ (corresponding author), Univ Texas Austin, Dell Pediat Res Inst, Div Pharmacol & Toxicol, Austin, TX 78712 USA.	daejkim@mail.utexas.edu; jdigiovanni@mail.utexas.edu		KIM, DAE/0000-0002-7977-9955	NCI [CA105345, CA76520]; University of Texas M. D. Anderson Cancer Center [CA16672]; National Institute of Environmental Health Sciences [ES07784]; Odyssey Program; H-E-B Award for Scientific Achievement at The University of Texas; NATIONAL CANCER INSTITUTE [R01CA076520, U01CA105345, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Texas M. D. Anderson Cancer Center; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Odyssey Program; H-E-B Award for Scientific Achievement at The University of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NCI grants, CA105345, CA76520, University of Texas M. D. Anderson Cancer Center support Grant CA16672, and National Institute of Environmental Health Sciences Center Grant ES07784. Funding as an Odyssey Fellow was supported by the Odyssey Program and The H-E-B Award for Scientific Achievement at The University of Texas M. D. Anderson Cancer Center (to D.J. Kim). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Aoki N, 2002, MOL ENDOCRINOL, V16, P58, DOI 10.1210/me.16.1.58; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chan KS, 2008, ONCOGENE, V27, P1087, DOI 10.1038/sj.onc.1210726; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DLUGOSZ AA, 1995, METHOD ENZYMOL, V254, P3; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Ibarra-Sanchez MD, 2001, ONCOGENE, V20, P4728, DOI 10.1038/sj.onc.1204648; Kataoka K, 2008, CARCINOGENESIS, V29, P1108, DOI 10.1093/carcin/bgn061; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Kim DJ, 2009, ONCOGENE, V28, P950, DOI 10.1038/onc.2008.453; Kim DJ, 2007, MOL CARCINOGEN, V46, P725, DOI 10.1002/mc.20342; Kim DJ, 2009, CANCER RES, V69, P7587, DOI 10.1158/0008-5472.CAN-09-1180; KLANN RC, 1989, CANCER RES, V49, P699; Kunnumakkara AB, 2009, MOL CANCER RES, V7, P118, DOI 10.1158/1541-7786.MCR-08-0154; Lam MHC, 2001, J BIOL CHEM, V276, P37700, DOI 10.1074/jbc.M105128200; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; LORENZEN JA, 1995, J CELL BIOL, V131, P631, DOI 10.1083/jcb.131.3.631; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; MOSINGER B, 1992, P NATL ACAD SCI USA, V89, P499, DOI 10.1073/pnas.89.2.499; Pandey MK, 2009, MOL PHARMACOL, V75, P525, DOI 10.1124/mol.108.052548; Peus D, 2000, PHOTOCHEM PHOTOBIOL, V72, P135, DOI 10.1562/0031-8655(2000)072<0135:UIEGFR>2.0.CO;2; Sano S, 2005, CANCER RES, V65, P5720, DOI 10.1158/0008-5472.CAN-04-4359; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; SANO S, 2007, J DERMATOL SCI; Sekine Y, 2006, ONCOGENE, V25, P5801, DOI 10.1038/sj.onc.1209578; Shields BJ, 2008, CANCER CELL, V14, P166, DOI 10.1016/j.ccr.2008.06.003; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; TILLMANN U, 1994, MOL CELL BIOL, V14, P3030, DOI 10.1128/MCB.14.5.3030; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Wang S, 2006, J BIOL CHEM, V281, P9439, DOI 10.1074/jbc.M504977200; Xie LP, 2002, BIOCHEMISTRY-US, V41, P4032, DOI 10.1021/bi015904r; Xu YR, 2006, AM J PATHOL, V169, P823, DOI 10.2353/ajpath.2006.050449; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683; Zhang J, 2008, CANCER RES, V68, P1046, DOI 10.1158/0008-5472.CAN-07-1927; Zhang XD, 2007, P NATL ACAD SCI USA, V104, P4060, DOI 10.1073/pnas.0611665104	53	62	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10290	10.1371/journal.pone.0010290	http://dx.doi.org/10.1371/journal.pone.0010290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421975	Green Published, Green Submitted, gold			2022-12-25	WOS:000276952600009
J	McGregor, TL; Misri, A; Bartlett, J; Orabona, G; Friedman, RD; Sexton, D; Maheshwari, S; Morgan, TM				McGregor, Tracy L.; Misri, Amit; Bartlett, Jackie; Orabona, Guilherme; Friedman, Richard D.; Sexton, David; Maheshwari, Sunita; Morgan, Thomas M.			Consanguinity Mapping of Congenital Heart Disease in a South Indian Population	PLOS ONE			English	Article							VAN-CREVELD-SYNDROME; PARENTAL CONSANGUINITY; GENE; AUTISM; LINKAGE; DISEQUILIBRIUM; CITRULLINE; CHILDREN; SURGERY; TRAITS	Background: Parental consanguinity is a risk factor for congenital heart disease (CHD) worldwide, suggesting that a recessive inheritance model may contribute substantially to CHD. In Bangalore, India, uncle-niece and first cousin marriages are common, presenting the opportunity for an international study involving consanguinity mapping of structural CHD. We sought to explore the recessive model of CHD by conducting a genome-wide linkage analysis utilizing high-density oligonucleotide microarrays and enrolling 83 CHD probands born to unaffected consanguineous parents. Methodology/Principal Findings: In this linkage scan involving single nucleotide polymorphism (SNP) markers, the threshold for genome-wide statistical significance was set at the standard log-of-odds (LOD) score threshold of 3.3, corresponding to 1995:1 odds in favor of linkage. We identified a maximal single-point LOD score of 3.76 (5754:1 odds) implicating linkage of CHD with the major allele (G) of rs1055061 on chromosome 14 in the HOMEZ gene, a ubiquitously expressed transcription factor containing leucine zipper as well as zinc finger motifs. Re-sequencing of HOMEZ exons did not reveal causative mutations in Indian probands. In addition, genotyping of the linked allele (G) in 325 U. S. CHD cases revealed neither genotypic nor allele frequency differences in varied CHD cases compared to 605 non-CHD controls. Conclusions/Significance: Despite the statistical power of the consanguinity mapping approach, no single gene of major effect could be convincingly identified in a clinically heterogeneous sample of Indian CHD cases born to consanguineous parents. However, we are unable to exclude the possibility that noncoding regions of HOMEZ may harbor recessive mutations leading to CHD in the Indian population. Further research involving large multinational cohorts of patients with specific subtypes of CHD is needed to attempt replication of the observed linkage peak on chromosome 14. In addition, we anticipate that a targeted re-sequencing approach may complement linkage analysis in future studies of recessive mutation detection in CHD.	[McGregor, Tracy L.; Orabona, Guilherme; Friedman, Richard D.; Morgan, Thomas M.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [McGregor, Tracy L.; Orabona, Guilherme; Friedman, Richard D.; Morgan, Thomas M.] Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN USA; [Misri, Amit; Maheshwari, Sunita] Narayana Hrudayalaya Inst Cardiac Sci, Bangalore, Karnataka, India; [Bartlett, Jackie; Sexton, David; Morgan, Thomas M.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	McGregor, TL (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA.	thomas.morgan@vanderbilt.edu	Morgan, Tom/C-3478-2012		Children's Discovery Institute	Children's Discovery Institute	This work was funded by the Children's Discovery Institute (http://www.childrensdiscovery.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; [Anonymous], DAT SINGL NUCL POL D; Barr FE, 2007, J THORAC CARDIOV SUR, V134, P319, DOI 10.1016/j.jtcvs.2007.02.043; Barrett S, 1999, AM J MED GENET, V88, P609; Bayarsaihan D, 2003, P NATL ACAD SCI USA, V100, P10358, DOI 10.1073/pnas.1834010100; Becker S, 1999, Community Genet, V2, P69, DOI 10.1159/000016189; Becker SM, 2001, AM J MED GENET, V99, P8, DOI 10.1002/1096-8628(20010215)99:1<8::AID-AJMG1116>3.0.CO;2-U; Bittles A. H., 2002, Indian Journal of Human Genetics, V8, P45; Bradford Y, 2001, AM J MED GENET, V105, P539, DOI 10.1002/ajmg.1497; Collaborative Linkage Study of Autism, 2001, Am J Med Genet, V105, P609; Galdzicka M, 2002, MOL GENET METAB, V77, P291, DOI 10.1016/S1096-7192(02)00178-6; Genin E, 2002, GENET EPIDEMIOL, V22, P116, DOI 10.1002/gepi.0174; Gnanalingham MG, 1999, ACTA PAEDIATR, V88, P473, DOI 10.1080/08035259950169936; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hu-Lince D, 2005, AM J PHARMACOGENOMIC, V5, P233, DOI 10.2165/00129785-200505040-00004; Hutcheson HB, 2003, AM J MED GENET B, V117B, P90, DOI 10.1002/ajmg.b.10033; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LIFTON RP, 2010, N ENGL J MED    0310; LUPSKI JR, 2010, N ENGL J MED    0310; Mani A, 2002, P NATL ACAD SCI USA, V99, P15054, DOI 10.1073/pnas.192582999; *MCKUS NATH I GEN, 2009, ONL MEND INH MAN OMI; Morgan TM, 2007, JAMA-J AM MED ASSOC, V297, P1551, DOI 10.1001/jama.297.14.1551; Nabulsi MM, 2003, AM J MED GENET A, V116A, P342, DOI 10.1002/ajmg.a.10020; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pemberton TJ, 2008, ANN HUM GENET, V72, P535, DOI 10.1111/j.1469-1809.2008.00457.x; Petrini J, 2002, TERATOLOGY, V66, pS3, DOI 10.1002/tera.90002; Polymeropoulos MH, 1996, GENOMICS, V35, P1, DOI 10.1006/geno.1996.0315; Ramegowda S, 2006, ANN HUM BIOL, V33, P519, DOI 10.1080/03014460600909349; Ruiz-Perez VL, 2000, NAT GENET, V24, P283, DOI 10.1038/73508; Saxena Anita, 2005, Indian Journal of Pediatrics, V72, P595, DOI 10.1007/BF02724185; SEXTON DP, 2007, WHOLE GENOME ASS STU; Smith HAB, 2006, J THORAC CARDIOV SUR, V132, P58, DOI 10.1016/j.jtcvs.2006.02.012	35	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10286	10.1371/journal.pone.0010286	http://dx.doi.org/10.1371/journal.pone.0010286			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422016	Green Published, Green Submitted, gold			2022-12-25	WOS:000276952500031
J	Luah, YH; Chaal, BK; Ong, EZ; Bozdech, Z				Luah, Yen-Hoon; Chaal, Balbir Kaur; Ong, Eugenia Ziying; Bozdech, Zbynek			A Moonlighting Function of Plasmodium falciparum Histone 3, Mono-Methylated at Lysine 9?	PLOS ONE			English	Article							HOST CELL INTERFACE; MALARIA PARASITES; ANTIGENIC VARIATION; VIRULENCE GENES; EXPRESSION; PROTEIN; BLOOD; LOCALIZATION; ACETYLATION; GENOME	Background: In the human malaria parasites Plasmodium falciparum, histone modifications have been implicated in the transcriptional regulation. The acetylation and methylation status of the histones have been linked with transcriptional regulation of the parasite surface virulence factors as well as other genes with stage specific expression. In P. falciparum as well as other eukaryotes, different histone modifications were found to be compartmentalized to distinct regions in the nuclei. This compartmentalization is believed to be one of the main prerequisites for their function in epigenetic regulation of gene expression. Methodology/Principal Findings: Here we investigate intracellular distributions of five previously uncharacterized histone modifications including histone 4 acetylation on lysine residue 5 (H4K5Ac), H4K8Ac, H3K9Ac, H4Ac4 and H3K9Me1 during the asexual developmental stages. With the exception of H3K9Me1, the modified histones were localized to the nuclear periphery. This provides a strong indication that the P. falciparum nuclear periphery is one of the most active regions in epigenetic regulation of gene expression. Interestingly, H3K9Me1 is not associated with the nuclei but instead resides in the parasitophorous vacuole (PV), the double membrane compartments surrounding the parasite cell within the host erythrocyte. In this compartment, H3K9Me1 partially co-localizes with Etramp proteins. The localization of H3K9Me1 in the PV is conserved in the other species including P. yoelii and P. vivax. Conclusions: Similar to other eukaryotes, the periphery of the P. falciparum nuclei is likely one of the most active areas in epigenetic regulation of gene expression involving multiple histone modifications. On the other hand, H3K9Me1 evolved a new function that is linked with the PV. This functional role appears to be evolutionarily conserved in Plasmodium species.	[Luah, Yen-Hoon; Chaal, Balbir Kaur; Ong, Eugenia Ziying; Bozdech, Zbynek] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Luah, YH (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	zbozdech@ntu.edu.sg	Bozdech, Zbynek/A-2205-2011	Ong, Eugenia/0000-0003-2187-7058; Bozdech, Zbynek/0000-0002-9830-8446	Singapore Biomedical Research Council [ID BMRC 07/1/22/19/518]	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was funded by the Singapore Biomedical Research Council Grant ID BMRC 07/1/22/19/518. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2008, J CELL SCI, V121, P137, DOI 10.1242/jcs.005777; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bhowmick IP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-179; Bosch J, 2007, P NATL ACAD SCI USA, V104, P7015, DOI 10.1073/pnas.0605301104; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; Bozdech Z, 1998, MOL BIOCHEM PARASIT, V97, P81, DOI 10.1016/S0166-6851(98)00135-2; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; CHAAL BK, PLOS PATHOG, V6; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; Cui L, 2007, EUKARYOT CELL, V6, P1219, DOI 10.1128/EC.00062-07; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gabler C, 2004, ANN RHEUM DIS, V63, P1135, DOI 10.1136/ard.2003.011452; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Issar N, 2009, MICROBES INFECT, V11, P403, DOI 10.1016/j.micinf.2008.12.010; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lingelbach K, 1998, J CELL SCI, V111, P1467; Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Martini EMD, 2002, GENETICS, V160, P1375; Miao J, 2006, GENE, V369, P53, DOI 10.1016/j.gene.2005.10.022; Pal-Bhowmick I, 2007, INFECT IMMUN, V75, P5500, DOI 10.1128/IAI.00551-07; Ralph SA, 2005, CURR OPIN MICROBIOL, V8, P434, DOI 10.1016/j.mib.2005.06.007; Rose FRAJ, 1998, INFECT IMMUN, V66, P3255, DOI 10.1128/IAI.66.7.3255-3263.1998; Salcedo-Amaya AM, 2009, P NATL ACAD SCI USA, V106, P9655, DOI 10.1073/pnas.0902515106; Spielmann T, 2006, MOL MICROBIOL, V59, P779, DOI 10.1111/j.1365-2958.2005.04983.x; Spielmann T, 2003, MOL BIOL CELL, V14, P1529, DOI 10.1091/mbc.E02-04-0240; Sriprawat K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-115; Taddei A, 2007, CURR OPIN CELL BIOL, V19, P305, DOI 10.1016/j.ceb.2007.04.012; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; VOLZ J, INT J PARASITOL, V40, P109; WATSON K, 1995, BIOCHEM PHARMACOL, V50, P299, DOI 10.1016/0006-2952(95)00142-M	38	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10252	10.1371/journal.pone.0010252	http://dx.doi.org/10.1371/journal.pone.0010252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419108	Green Submitted, Green Published, gold			2022-12-25	WOS:000276853800022
J	Koene, JM; Sloot, W; Montagne-Wajer, K; Cummins, SF; Degnan, BM; Smith, JS; Nagle, GT; ter Maat, A				Koene, Joris M.; Sloot, Wiebe; Montagne-Wajer, Kora; Cummins, Scott F.; Degnan, Bernard M.; Smith, John S.; Nagle, Gregg T.; ter Maat, Andries			Male Accessory Gland Protein Reduces Egg Laying in a Simultaneous Hermaphrodite	PLOS ONE			English	Article							FRESH-WATER SNAIL; SEMINAL FLUID; LYMNAEA-STAGNALIS; SEXUAL SELECTION; POND SNAIL; SPERM; ALLOCATION; CONFLICT; ALLOHORMONES; ADAPTATION	Seminal fluid is an important part of the ejaculate of internally fertilizing animals. This fluid contains substances that nourish and activate sperm for successful fertilization. Additionally, it contains components that influence female physiology to further enhance fertilization success of the sperm donor, possibly beyond the recipient's optimum. Although evidence for such substances abounds, few studies have unraveled their identities, and focus has been exclusively on separate-sex species. We present the first detailed study into the seminal fluid composition of a hermaphrodite ( Lymnaea stagnalis). Eight novel peptides and proteins were identified from the seminal-fluid-producing prostate gland and tested for effects on oviposition, hatching and consumption. The gene for the protein found to suppress egg mass production, Ovipostatin, was sequenced, thereby providing the first fully-characterized seminal fluid substance in a simultaneous hermaphrodite. Thus, seminal fluid peptides and proteins have evolved and can play a crucial role in sexual selection even when the sexes are combined.	[Koene, Joris M.; Sloot, Wiebe; Montagne-Wajer, Kora] Vrije Univ Amsterdam, Fac Earth & Life Sci, Amsterdam, Netherlands; [Cummins, Scott F.; Degnan, Bernard M.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Smith, John S.] Univ Texas Med Branch, Biomol Resource Facil, Galveston, TX USA; [Nagle, Gregg T.] Univ Georgia, Dept Cellular Biol & Anat, Med Coll Georgia, Athens, GA 30602 USA; [ter Maat, Andries] Max Planck Inst Ornithol, Seewiesen, Germany	Vrije Universiteit Amsterdam; University of Queensland; University of Texas System; University of Texas Medical Branch Galveston; University System of Georgia; Augusta University; University of Georgia; Max Planck Society	Koene, JM (corresponding author), Vrije Univ Amsterdam, Fac Earth & Life Sci, Amsterdam, Netherlands.	joris.koene@falw.vu.nl	Koene, Joris M./B-4502-2009; Smith, John/GYJ-1302-2022; Cummins, Scott/I-6420-2016	Koene, Joris M./0000-0001-8188-3439; Cummins, Scott/0000-0002-1454-2076; Degnan, Bernard/0000-0001-7573-8518	Netherlands Organization for Scientific Research (NWO) [814.01.011]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by the Research Council for Earth and Life Sciences (ALW) with financial aid from the Netherlands Organization for Scientific Research (NWO) to ATM and JMK (grant number 814.01.011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anthes N, 2007, BIOL LETTERS, V3, P121, DOI 10.1098/rsbl.2006.0596; Arnqvist Goran, 2005, pUnpaginated; Baer B, 2009, PROTEOMICS, V9, P2085, DOI 10.1002/pmic.200800708; Bedhomme S, 2009, BIOL LETTERS, V5, P717, DOI 10.1098/rsbl.2009.0401; Birkhead T.R., 2008, SPERM BIOL EVOLUTION; Blanckenhorn WU, 2002, BEHAV ECOL, V13, P353, DOI 10.1093/beheco/13.3.353; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; CHARNOV EL, 1979, P NATL ACAD SCI USA, V76, P2480, DOI 10.1073/pnas.76.5.2480; Chase R, 2006, P ROY SOC B-BIOL SCI, V273, P1471, DOI 10.1098/rspb.2006.3474; Cinelli LP, 2009, COMP BIOCHEM PHYS B, V154, P108, DOI 10.1016/j.cbpb.2009.05.004; Darwin G., 1871, P423; DeBoer PACM, 1997, J EXP BIOL, V200, P941; DEVISSER JAGM, 1994, AM NAT, V144, P861; Engqvist L, 2006, J EVOLUTION BIOL, V19, P1448, DOI 10.1111/j.1420-9101.2006.01134.x; Findlay GD, 2009, GENOME RES, V19, P886, DOI 10.1101/gr.089391.108; Findlay GD, 2008, PLOS BIOL, V6, P1417, DOI 10.1371/journal.pbio.0060178; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Koene JM, 2005, INVERTEBR REPROD DEV, V48, P101, DOI 10.1080/07924259.2005.9652176; Koene JM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-25; Koene JM, 2005, BEHAV ECOL SOCIOBIOL, V59, P243, DOI 10.1007/s00265-005-0030-y; Koene JM, 1998, J EXP BIOL, V201, P2313; Koene JM, 2001, J COMP PHYSIOL A, V187, P323, DOI 10.1007/s003590100214; Koene JM, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-212; Koene JM, 2006, INTEGR COMP BIOL, V46, P419, DOI 10.1093/icb/icj040; Koene JM, 2006, BEHAV ECOL SOCIOBIOL, V60, P332, DOI 10.1007/s00265-006-0169-1; Koene JM, 2009, ANIM BIOL, V59, P435, DOI 10.1163/157075509X12499949744306; Koene JM, 2009, EVOL ECOL, V23, P533, DOI 10.1007/s10682-008-9253-5; LEONARD JL, 1984, AM NAT, V124, P282, DOI 10.1086/284269; Loose MJ, 2008, INVERTEBR BIOL, V127, P162, DOI 10.1111/j.1744-7410.2007.00121.x; Lung O, 2002, GENETICS, V160, P211; Mann T, 1981, MALE REPROD FUNCTION; Michiels NK, 2006, INTEGR COMP BIOL, V46, P473, DOI 10.1093/icb/icj043; Michiels NK, 1998, NATURE, V391, P647, DOI 10.1038/35527; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; PLESCH B, 1971, Netherlands Journal of Zoology, V21, P180; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rogers DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000272; VANDUIVENBODEN YA, 1985, ANIM BEHAV, V33, P1184, DOI 10.1016/S0003-3472(85)80179-2; VANDUIVENBODEN YA, 1983, INT J INVER REP DEV, V6, P249, DOI 10.1080/01651269.1983.10510049; Watts RA, 2004, MOL BIOL EVOL, V21, P1032, DOI 10.1093/molbev/msh093; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051	43	53	54	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10117	10.1371/journal.pone.0010117	http://dx.doi.org/10.1371/journal.pone.0010117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20404934	Green Published, Green Submitted, gold			2022-12-25	WOS:000276705900004
J	Hashidate, T; Murakami, N; Nakagawa, M; Ichikawa, M; Kurokawa, M; Shimizu, T; Nakamura, M				Hashidate, Tomomi; Murakami, Naoka; Nakagawa, Masahiro; Ichikawa, Motoshi; Kurokawa, Mineo; Shimizu, Takao; Nakamura, Motonao			AML1 enhances the expression of leukotriene B-4 type-1 receptor in leukocytes	FASEB JOURNAL			English	Article						G-protein-coupled receptor; BLT1	HISTONE DEACETYLASE INHIBITORS; ACUTE MYELOID-LEUKEMIA; RETINOIC ACID; CELL-DIFFERENTIATION; T-CELLS; AIRWAY HYPERRESPONSIVENESS; TRANSCRIPTION FACTORS; ADULT HEMATOPOIESIS; GENE-EXPRESSION; HL-60 CELLS	Leukotriene B-4 type-1 receptor (BLT1), which plays a role in various inflammatory diseases, is exclusively expressed in peripheral leukocytes, which suggests that its expression is stringently regulated. However, the precise mechanism of BLT1 expression is not fully understood. Here we report that acute myeloid leukemia 1 (AML1/Runx1) is involved in the enhancement of BLT1 expression in leukocytes. In retinoic acid (RA)-stimulated human promyelocytic leukemia (HL-60) cells, the transcription of the BLT1 gene was found to be significantly activated. RA did not directly modulate the BLT1 promoter, suggesting enhancers in other loci. DNase I-hypersensitivity analyses revealed an activated region, termed AE-BLex, at the intron-I: exon-II boundary. AE-BLex acts as an enhancer for the BLT1 promoter and possesses 2 AML1 recognition sites. The importance of AML1 was determined using electrophoretic mobility shift assays, reporter assays, and knockdown experiments. We demonstrated that the enhancement of BLT1 expression during the RA-induced differentiation of HL-60 cells is due to a loosening of the chromatin structure around AE-BLex, which leads to the incremental binding of AML1. The AML1/AE-BLex complex was confirmed in other BLT1-expressing leukemia cell lines and human peripheral leukocytes. Thus, AML1 enhances BLT1 expression by binding to AE-BLex, which is accessible in leukocytes.-Hashidate, T., Murakami, N., Nakagawa, M., Ichikawa, M., Kurokawa, M., Shimizu, T., Nakamura, M. AML1 enhances the expression of leukotriene B-4 type-1 receptor in leukocytes. FASEB J. 24, 3500-3510 (2010). www.fasebj.org	[Nakamura, Motonao] Univ Tokyo, Dept Biochem & Mol Biol, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; [Nakagawa, Masahiro; Ichikawa, Motoshi; Kurokawa, Mineo] Univ Tokyo, Fac Med, Dept Hematol & Oncol, Tokyo 1130033, Japan; [Shimizu, Takao; Nakamura, Motonao] Univ Tokyo, Ctr NanoBio Integrat, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Nakamura, M (corresponding author), Univ Tokyo, Dept Biochem & Mol Biol, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	moto-nakamura@umin.net	Shimizu, Takao/AAV-7052-2021	Nakagawa, Masahiro/0000-0002-6420-2555; Ichikawa, Motoshi/0000-0001-6497-0848	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Ministry of Health, Labor, and Welfare; Grants-in-Aid for Scientific Research [19679004, 22790901] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Drs. S. Ishii, Y. Kita, H. Shindou, and all laboratory members for their constructive comments. The authors are also grateful to Dr. T. Yokomizo (Department of Medical Biochemistry, Graduate School of Medical Sciences, Kyushu University) for discussions. This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M.N. and T. S.), and a Global COE program (University of Tokyo) from the Japan Society for the Promotion of Science (to T. S.). M. K. was supported in part by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science, and by Health and Labor Science Research grants from the Ministry of Health, Labor, and Welfare. T. H. was supported by research fellowships for young scientists from the Japan Society for the Promotion of Science.	BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; CASOLARO V, 1995, P NATL ACAD SCI USA, V92, P11623, DOI 10.1073/pnas.92.25.11623; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; Cockerill PN, 1996, CELL GROWTH DIFFER, V7, P917; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Ferrara FF, 2001, CANCER RES, V61, P2; FISCHKOFF SA, 1988, LEUKEMIA RES, V12, P679, DOI 10.1016/0145-2126(88)90103-8; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; GOETZL EJ, 1981, J EXP MED, V153, P482, DOI 10.1084/jem.153.2.482; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; HOYOS B, 1989, SCIENCE, V244, P457, DOI 10.1126/science.2497518; Huang G, 2008, NAT GENET, V40, P51, DOI 10.1038/ng.2007.7; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Kato K, 2000, J EXP MED, V192, P413, DOI 10.1084/jem.192.3.413; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; LUBBERT M, 1991, BLOOD, V78, P345; Maeda T, 2000, BLOOD, V96, P3847, DOI 10.1182/blood.V96.12.3847.h8003847_3847_3856; Merzvinskyte R, 2006, ANN NY ACAD SCI, V1091, P356, DOI 10.1196/annals.1378.080; MICHAELIS L, 1903, Z KREBSFORSCH, V1, P105; Miyahara N, 2005, J IMMUNOL, V174, P4979, DOI 10.4049/jimmunol.174.8.4979; Murakami N, 2009, GENES CELLS, V14, P1441, DOI 10.1111/j.1365-2443.2009.01360.x; Nagpal S, 1999, J BIOL CHEM, V274, P22563, DOI 10.1074/jbc.274.32.22563; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; Obinata H, 2003, BIOCHEM BIOPH RES CO, V309, P114, DOI 10.1016/S0006-291X(03)01554-7; Ohnishi Hiroshi, 2008, Allergol Int, V57, P291, DOI 10.2332/allergolint.08-RAI-0019; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Petrovick HS, 1998, MOL CELL BIOL, V18, P3915, DOI 10.1128/MCB.18.7.3915; Puig-Kroger A, 2003, BLOOD, V102, P3252, DOI 10.1182/blood-2003-02-0618; Savickiene J, 2006, EUR J PHARMACOL, V549, P9, DOI 10.1016/j.ejphar.2006.08.010; Savickiene J, 2009, ANN NY ACAD SCI, V1171, P321, DOI 10.1111/j.1749-6632.2009.04718.x; SHAW RJ, 1985, ALLERGY, V40, P1, DOI 10.1111/j.1398-9995.1985.tb04147.x; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Stankova J, 2002, J IMMUNOL, V168, P3570, DOI 10.4049/jimmunol.168.7.3570; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; TANAKA T, 1995, EMBO J, V14, P341, DOI 10.1002/j.1460-2075.1995.tb07008.x; Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217; Wu JB, 2009, J BIOL CHEM, V284, P16723, DOI 10.1074/jbc.M901779200; YEN A, 1985, LEUKEMIA RES, V9, P51, DOI 10.1016/0145-2126(85)90021-9; Yokomizo T, 2001, ARCH BIOCHEM BIOPHYS, V385, P231, DOI 10.1006/abbi.2000.2168; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	48	9	9	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3500	3510		10.1096/fj.10-156844	http://dx.doi.org/10.1096/fj.10-156844			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20395453				2022-12-25	WOS:000281446400037
J	Hmila, I; Saerens, D; Ben Abderrazek, R; Vincke, C; Abidi, N; Benlasfar, Z; Govaert, J; El Ayeb, M; Bouhaouala-Zahar, B; Muyldermans, S				Hmila, Issam; Saerens, Dirk; Ben Abderrazek, Rahma; Vincke, Cecile; Abidi, Naima; Benlasfar, Zakaria; Govaert, Jochen; El Ayeb, Mohamed; Bouhaouala-Zahar, Balkiss; Muyldermans, Serge			A bispecific nanobody to provide full protection against lethal scorpion envenoming	FASEB JOURNAL			English	Article							ANDROCTONUS-AUSTRALIS-HECTOR; HEAVY-CHAIN ANTIBODIES; SINGLE-DOMAIN ANTIBODIES; ANTIVENOM IMMUNOTHERAPY; MONOCLONAL-ANTIBODIES; FUNCTIONAL-EVALUATION; ANTIGEN-BINDING; ALPHA-TOXIN; VENOM; NEUROTOXIN	Envenoming following scorpion sting is a common emergency in many parts of the world. Our aim was to ameliorate the current 100-kDa horse plasma antivenom serum (PAS)-derived Fab(2)' to more quickly reach the highly diffusible scorpion toxins (7 kDa). We immunized dromedaries with toxins from Androctonus australis hector (Aah) scorpions and cloned the single-domain antibody fragments or nanobodies (15 kDa) from their B cells. Nanobodies against AahI' toxin (with AahII the most toxic compound of the venom) were retrieved from the libraries, and their AahI'-toxin neutralization was monitored in mice. Remarkably, the NbAahI'F12 fully protected mice against 100 LD50 of AahI' administered intracerebroventricularly. Moreover, where PAS failed completely to neutralize 2 LD50 of crude venom injected subcutaneously, the designed bispecific NbF12-10 against AahI'/AahII toxins succeeded in neutralizing 5 LD50. Finally, in a challenge assay in which mice were subcutaneously injected with a lethal dose of scorpion venom, the subsequent intravenous injection of 85 mu g of NbF12-10 protected all mice, even if the whole procedure was repeated 3 times. Furthermore, the NbF12-10 remained fully protective when mice with severe signs of envenoming were treated a few minutes before the untreated mice died.-Hmila, I., Saerens, D., Ben Abderrazek, R., Vincke, C., Abidi, N., Benlasfar, Z., Govaert, J., El Ayeb, M., Bouhaouala-Zahar, B., Muyldermans, S. A bispecific nanobody to provide full protection against lethal scorpion envenoming. FASEB J. 24, 3479-3489 (2010). www.fasebj.org	[Hmila, Issam; Ben Abderrazek, Rahma; Abidi, Naima; El Ayeb, Mohamed; Bouhaouala-Zahar, Balkiss] Inst Pasteur, Lab Venins & Toxines, Tunis 1002, Tunisia; [Benlasfar, Zakaria] Inst Pasteur, Serv Unites Anim, Tunis 1002, Tunisia; [Saerens, Dirk; Vincke, Cecile; Govaert, Jochen; Muyldermans, Serge] Vrije Univ Brussel VIB, Cellular & Mol Immunol Lab, B-1050 Brussels, Belgium; [Saerens, Dirk; Vincke, Cecile; Govaert, Jochen; Muyldermans, Serge] Vrije Univ Brussel VIB, Dept Cellular & Mol Interact, B-1050 Brussels, Belgium; [Bouhaouala-Zahar, Balkiss] Univ Tunis El Manar, Fac Med Tunis, Tunis, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT)	Bouhaouala-Zahar, B (corresponding author), Inst Pasteur, Lab Venins & Toxines, 13 Pl Pasteur,BP 74, Tunis 1002, Tunisia.	balkiss.bouhaouala@pasteur.rns.tn	Muyldermans, Serge/AAC-7374-2019; Saerens, Dirk/B-9162-2008; Muyldermans, Serge V/C-6418-2016; Vincke, Cecile/C-6590-2016	Muyldermans, Serge/0000-0002-3678-3575; Muyldermans, Serge V/0000-0002-3678-3575; Saerens, Dirk/0000-0001-8894-8039; BOUHAOUALA-ZAHAR, Balkiss/0000-0003-3147-245X; Vincke, Cecile/0000-0003-0681-7444	International Foundation for Science (IFS) [F/2762-2]; NATO project [sfp981865]; Pasteur Institute, Ministry of Health and Research and Development [Tox10]	International Foundation for Science (IFS)(International Foundation for Science); NATO project(NATO (North Atlantic Treaty Organisation)); Pasteur Institute, Ministry of Health and Research and Development	The authors thank Professor Hechmi Louzir, General Director of Pasteur Institute, for constant encouragements. The authors thank Ms. T. Chagour and Ms. E. Ghribi for technical assistance on toxin purifications and neutralization assays, respectively. The authors thank Dr. A. Meddeb-Garnaoui for help on lymphocyte extraction, and Dr. H. Dabbek (Centre regional de production animaliere de Kebili) for his invaluable help on dromedary immunization. The authors greatly appreciate the gift of the rabbit anti-AahI' and anti-AahII sera from Dr. C. Devaux (Institut Jean Roche, Marseille, France). This work was partially supported by grants from the International Foundation for Science (IFS; F/2762-2), NATO project sfp981865, and by the Pasteur Institute, Ministry of Health and Research and Development (Tox10).	Abroug F, 1999, LANCET, V354, P906, DOI 10.1016/S0140-6736(98)12083-4; Aubrey N, 2004, TOXICON, V43, P233, DOI 10.1016/j.toxicon.2003.11.024; Aubrey N, 2003, CELL MOL LIFE SCI, V60, P617, DOI 10.1007/s000180300053; BAHRAOUI E, 1988, J IMMUNOL, V141, P214; Ben Abderrazek R, 2009, BIOCHEM J, V424, P263, DOI 10.1042/BJ20090697; BouhaoualaZahar B, 1996, EUR J BIOCHEM, V238, P653, DOI 10.1111/j.1432-1033.1996.0653w.x; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Chippaux JP, 1998, TOXICON, V36, P1503, DOI 10.1016/S0041-0101(98)00140-8; Clot-Faybesse O, 1999, FEBS LETT, V458, P313, DOI 10.1016/S0014-5793(99)01179-5; Conrath K, 2005, J MOL BIOL, V350, P112, DOI 10.1016/j.jmb.2005.04.050; Conrath KE, 2003, DEV COMP IMMUNOL, V27, P87, DOI 10.1016/S0145-305X(02)00071-X; Conrath KE, 2001, J BIOL CHEM, V276, P7346, DOI 10.1074/jbc.M007734200; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Devaux C, 2001, EUR J BIOCHEM, V268, P694, DOI 10.1046/j.1432-1327.2001.01923.x; ELAYEB M, 1985, TOXICON, V23, P755, DOI 10.1016/0041-0101(85)90005-4; ELAYEB M, 1986, BIOCHEMISTRY-US, V25, P6671, DOI 10.1021/bi00369a052; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; GRANIER C, 1989, MOL IMMUNOL, V26, P503, DOI 10.1016/0161-5890(89)90001-1; Hmila I, 2008, MOL IMMUNOL, V45, P3847, DOI 10.1016/j.molimm.2008.04.011; Ismail M, 1998, TOXICON, V36, P1523, DOI 10.1016/S0041-0101(98)00144-5; Juste M, 2007, CELL MOL LIFE SCI, V64, P206, DOI 10.1007/s00018-006-6401-3; Krifi MN, 2005, TOXICON, V45, P187, DOI 10.1016/j.toxicon.2004.10.007; Krifi MN, 2001, TOXICON, V39, P1317, DOI 10.1016/S0041-0101(01)00083-6; Meddeb-Mouelhi F, 2003, TOXICON, V42, P785, DOI 10.1016/j.toxicon.2003.10.021; Miranda F., 1970, EUR J BIOCHEM, V16, P279; Mousli M, 1999, FEBS LETT, V442, P183, DOI 10.1016/S0014-5793(98)01647-0; Nguyen VK, 2000, EMBO J, V19, P921, DOI 10.1093/emboj/19.5.921; PACE CM, 1997, PROTEIN STRUCTURE PR, P297; Presta LG, 2006, ADV DRUG DELIVER REV, V58, P640, DOI 10.1016/j.addr.2006.01.026; Saerens D, 2004, J BIOL CHEM, V279, P51965, DOI 10.1074/jbc.M409292200; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200	32	75	85	3	40	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3479	3489		10.1096/fj.09-148213	http://dx.doi.org/10.1096/fj.09-148213			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20410443				2022-12-25	WOS:000281446400035
J	Humphrey, RK; Newcomb, CJ; Yu, SMA; Hao, E; Yu, D; Krajewski, S; Du, KY; Jhala, US				Humphrey, Rohan K.; Newcomb, Christina J.; Yu, Shu-Mei A.; Hao, Ergeng; Yu, Doris; Krajewski, Stan; Du, Keyong; Jhala, Ulupi S.			Mixed Lineage Kinase-3 Stabilizes and Functionally Cooperates with TRIBBLES-3 to Compromise Mitochondrial Integrity in Cytokine-induced Death of Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FACTOR-INDEPENDENT SURVIVAL; MEMBRANE PERMEABILIZATION; NEURONAL APOPTOSIS; SCAFFOLD PROTEINS; BCL-2 FAMILY; IN-VIVO; B-RAF; AKT; BAX	Mixed lineage kinases (MLKs) have been implicated in cytokine signaling as well as in cell death pathways. Our studies show that MLK3 is activated in leukocyte-infiltrated islets of non-obese diabetic mice and that MLK3 activation compromises mitochondrial integrity and induces apoptosis of beta cells. Using an ex vivo model of islet-splenocyte co-culture, we show that MLK3 mediates its effects via the pseudokinase TRB3, a mammalian homolog of Drosophila Tribbles. TRB3 expression strongly coincided with conformational change and mitochondrial translocation of BAX. Mechanistically, MLK3 directly interacted with and stabilized TRB3, resulting in inhibition of Akt, a strong suppressor of BAX translocation and mitochondrial membrane permeabilization. Accordingly, attenuation of MLK3 or TRB3 expression each prevented cytokine-induced BAX conformational change and attenuated the progression to apoptosis. We conclude that MLKs compromise mitochondrial integrity and suppress cellular survival mechanisms via TRB3-dependent inhibition of Akt.	[Humphrey, Rohan K.; Newcomb, Christina J.; Yu, Shu-Mei A.; Hao, Ergeng; Yu, Doris; Jhala, Ulupi S.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92037 USA; [Krajewski, Stan] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Du, Keyong] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; Tufts Medical Center	Jhala, US (corresponding author), Pediat Diabet Res Ctr UCSD, 3525 John Hopkins Ct, San Diego, CA 92121 USA.	ujhala@ucsd.edu			National Institutes of Health [R01DK080147]; University of California San Diego-UCLA Diabetes Endocrinology Research Center; Juvenile Diabetes Research Foundation; Hillblom Foundation network; Thomas R. Lee ADA career development award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego-UCLA Diabetes Endocrinology Research Center; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Hillblom Foundation network; Thomas R. Lee ADA career development award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK080147. This work was also supported by a University of California San Diego-UCLA Diabetes Endocrinology Research Center Pilot and feasibility grant, a Juvenile Diabetes Research Foundation grant, and a Hillblom Foundation network grant (to U.S.J.).; Recipient of the Thomas R. Lee ADA career development award.	Bodner A, 2002, J NEUROCHEM, V82, P1424, DOI 10.1046/j.1471-4159.2002.01088.x; Bouzakri K, 2009, J BIOL CHEM, V284, P27892, DOI 10.1074/jbc.M109.048058; Brancho D, 2005, MOL CELL BIOL, V25, P3670, DOI 10.1128/MCB.25.9.3670-3681.2005; Bresson D, 2006, J CLIN INVEST, V116, P1371, DOI 10.1172/JCI27191; Chadee DN, 2004, CELL CYCLE, V3, P1227, DOI 10.4161/cc.3.10.1187; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Chang LK, 2002, BIOCHIMIE, V84, P223, DOI 10.1016/S0300-9084(02)01372-X; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Cho SG, 2002, J BIOCHEM MOL BIOL, V35, P24, DOI 10.5483/BMBRep.2002.35.1.024; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Collier JJ, 2006, DIABETES, V55, P1398, DOI 10.2337/db05-1000; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Dansen TB, 2006, J BIOL CHEM, V281, P10890, DOI 10.1074/jbc.M513655200; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Humphrey RK, 2010, J BIOL CHEM, V285, P3406, DOI 10.1074/jbc.M109.006734; Kato S, 2007, BIOCHEM BIOPH RES CO, V353, P933, DOI 10.1016/j.bbrc.2006.12.161; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Kim S, 2007, P NATL ACAD SCI USA, V104, P1913, DOI 10.1073/pnas.0610690104; Korchnak AC, 2009, CELL SIGNAL, V21, P1620, DOI 10.1016/j.cellsig.2009.06.008; Krajewska M, 2002, NEOPLASIA, V4, P129, DOI 10.1038/sj.neo.7900222; Krajewska M, 2004, EXP NEUROL, V189, P261, DOI 10.1016/j.expneurol.2004.05.020; Krajewska M, 2002, CELL DEATH DIFFER, V9, P145, DOI 10.1038/sj/cdd/4400934; Krajewski S, 1997, J IMMUNOL, V159, P5841; Krajewski S, 1997, CLIN CANCER RES, V3, P199; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lemasters JJ, 2002, ANTIOXID REDOX SIGN, V4, P769, DOI 10.1089/152308602760598918; Mayumi-Matsuda K, 1999, BIOCHEM BIOPH RES CO, V258, P260, DOI 10.1006/bbrc.1999.0576; Miyamoto S, 2009, J BIOENERG BIOMEMBR, V41, P169, DOI 10.1007/s10863-009-9205-y; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Murakata C, 2002, BIOORG MED CHEM LETT, V12, P147, DOI 10.1016/S0960-894X(01)00690-4; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pan J, 2005, NEUROSCIENCE, V131, P147, DOI 10.1016/j.neuroscience.2004.09.031; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Qian B, 2008, J ENDOCRINOL, V199, P407, DOI 10.1677/JOE-08-0331; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Roy SK, 2005, J BIOL CHEM, V280, P24462, DOI 10.1074/jbc.M413661200; Sathyanarayana P, 2002, MOL CELL, V10, P1527, DOI 10.1016/S1097-2765(02)00734-7; Sharma S, 1997, MOL CELL BIOL, V17, P2598, DOI 10.1128/MCB.17.5.2598; Sheridan C, 2008, TRENDS CELL BIOL, V18, P353, DOI 10.1016/j.tcb.2008.06.002; Stronach B, 2002, GENE DEV, V16, P377, DOI 10.1101/gad.953002; Szabadkai G, 2009, APOPTOSIS, V14, P1405, DOI 10.1007/s10495-009-0363-5; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Venieratos PD, 2010, CELL SIGNAL, V22, P791, DOI 10.1016/j.cellsig.2010.01.003; Wang LH, 2004, ANNU REV PHARMACOL, V44, P451, DOI 10.1146/annurev.pharmtox.44.101802.121840; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xu ZH, 2005, MOL CELL BIOL, V25, P9949, DOI 10.1128/MCB.25.22.9949-9959.2005; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984; Yasuda J, 1999, MOL CELL BIOL, V19, P7245	57	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22426	22436		10.1074/jbc.M110.123786	http://dx.doi.org/10.1074/jbc.M110.123786			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20421299	hybrid, Green Published			2022-12-25	WOS:000279702200055
J	LowKam, C; Liotard, B; Sygusch, J				LowKam, Clotilde; Liotard, Brigitte; Sygusch, Jurgen			Structure of a Class I Tagatose-1,6-bisphosphate Aldolase INVESTIGATION INTO AN APPARENT LOSS OF STEREOSPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROXYACETONE PHOSPHATE; FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE; MUSCLE ALDOLASE; RABBIT MUSCLE; TAGATOSE; LIVER; STEREOSELECTIVITY; CARBOXYPEPTIDASE; CRYSTALLOGRAPHY; CRYSTALLIZATION	Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes is a class I aldolase that exhibits a remarkable lack of chiral discrimination with respect to the configuration of hydroxyl groups at both C3 and C4 positions. The enzyme catalyzes the reversible cleavage of four diastereoisomers (fructose 1,6-bisphosphate (FBP), psicose 1,6-bisphosphate, sorbose 1,6-bisphosphate, and tagatose 1,6-bisphosphate) to dihydroxyacetone phosphate (DHAP) and D-glyceraldehyde 3-phosphate with high catalytic efficiency. To investigate its enzymatic mechanism, high resolution crystal structures were determined of both native enzyme and native enzyme in complex with dihydroxyacetone-P. The electron density map revealed a (alpha/beta)(8) fold in each dimeric subunit. Flash-cooled crystals of native enzyme soaked with dihydroxyacetone phosphate trapped a covalent intermediate with carbanionic character at Lys(205), different from the enamine mesomer bound in stereospecific class I FBP aldolase. Structural analysis indicates extensive active site conservation with respect to class I FBP aldolases, including conserved conformational responses to DHAP binding and conserved stereospecific proton transfer at the DHAP C3 carbon mediated by a proximal water molecule. Exchange reactions with tritiated water and tritium-labeled DHAP at C3 hydrogen were carried out in both solution and crystalline state to assess stereochemical control at C3. The kinetic studies show labeling at both pro-R and pro-S C3 positions of DHAP yet detritiation only at the C3 pro-S-labeled position. Detritiation of the C3 pro-R label was not detected and is consistent with preferential cis-trans isomerism about the C2-C3 bond in the carbanion as the mechanism responsible for C3 epimerization in tagatose-1,6-bisphosphate aldolase.	[LowKam, Clotilde; Liotard, Brigitte; Sygusch, Jurgen] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Sygusch, J (corresponding author), CP 6128,Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada.	Jurgen.Sygusch@UMontreal.ca		Sygusch, Jurgen/0000-0002-6629-2128	Natural Science and Engineering Research Council (Canada); Canadian Institutes for Health Research; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Natural Science and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by grants from the Natural Science and Engineering Research Council (Canada) and Canadian Institutes for Health Research (to J.S.).; Work was carried out in part at beamlines X12B, X25, and X29 of the National Synchrotron Light Source (supported principally by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and the National Center for Research Resources of the National Institutes of Health). Assistance by beamline personnel, Drs. L. Flaks, D. K. Schneider, A. Soares, A. Heroux, and H. Robinson, is gratefully acknowledged. The help of Laurent Cappadoccia in data collection was particularly appreciated. Critical reading of the manuscript by Dr. Casimir Blonski was also appreciated. Tagatose 1,6-bisphosphate was a generous gift of Dr. W. Fessner.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BISSETT DL, 1980, J BIOL CHEM, V255, P8750; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHIU TH, 1969, BIOCHEMISTRY-US, V8, P98, DOI 10.1021/bi00829a015; CHIU TH, 1965, BIOCHEM BIOPH RES CO, V19, P511, DOI 10.1016/0006-291X(65)90155-5; Chudzik DM, 2000, J MOL BIOL, V300, P697, DOI 10.1006/jmbi.2000.3910; CORINA DL, 1976, BIOCHEM J, V157, P573, DOI 10.1042/bj1570573; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dalby AR, 2001, ACTA CRYSTALLOGR D, V57, P1526, DOI 10.1107/S0907444901012719; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DIAMOND R, 1992, PROTEIN SCI, V1, P1279, DOI 10.1002/pro.5560011006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espelt L, 2005, CHEM-EUR J, V11, P1392, DOI 10.1002/chem.200400648; Fessner WD, 1998, CURR OPIN CHEM BIOL, V2, P85, DOI 10.1016/S1367-5931(98)80040-9; GRAZI E, 1962, BIOCHEM BIOPH RES CO, V9, P38, DOI 10.1016/0006-291X(62)90083-9; GRAZI E, 1962, BIOCHEM BIOPH RES CO, V7, P250, DOI 10.1016/0006-291X(62)90184-5; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HARRIS CE, 1969, BIOCHEMISTRY-US, V8, P2442, DOI 10.1021/bi00834a029; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; JENCKS WP, 1987, CATALYSIS CHEM ENZYM, P120; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOBASHI K, 1966, ARCH BIOCHEM BIOPHYS, V117, P437, DOI 10.1016/0003-9861(66)90433-4; KOBES RD, 1969, J BIOL CHEM, V244, P1919; KOBES RD, 1969, BIOCHEMISTRY-US, V8, P585, DOI 10.1021/bi00830a018; Lee JH, 2006, BIOCHEM BIOPH RES CO, V347, P616, DOI 10.1016/j.bbrc.2006.06.139; Liotard B, 2004, ACTA CRYSTALLOGR D, V60, P528, DOI 10.1107/S0907444903028427; Lorentzen E, 2004, BIOCHEM SOC T, V32, P259, DOI 10.1042/BST0320259; Loughman JA, 2007, MOL MICROBIOL, V64, P269, DOI 10.1111/j.1365-2958.2007.05663.x; Loughman JA, 2006, EMBO J, V25, P5414, DOI 10.1038/sj.emboj.7601393; MELOCHE HP, 1973, J BIOL CHEM, V248, P6333; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RACKER E, 1947, J BIOL CHEM, V167, P843; Rose I.A., 1969, COMPR BIOCHEM, V17, P93; ROSE IA, 1958, J AM CHEM SOC, V80, P5835, DOI 10.1021/ja01554a063; ROSE IA, 1958, J BIOL CHEM, V231, P315; RUTTER WJ, 1961, J BIOL CHEM, V236, P3193; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SPOLTER PD, 1965, J BIOL CHEM, V240, P1327; St-Jean M, 2005, J BIOL CHEM, V280, P27262, DOI 10.1074/jbc.M502413200; St-Jean M, 2007, J BIOL CHEM, V282, P31028, DOI 10.1074/jbc.M704968200; Suri JT, 2006, J ORG CHEM, V71, P3822, DOI 10.1021/jo0602017; SYGUSCH J, 1987, P NATL ACAD SCI USA, V84, P7846, DOI 10.1073/pnas.84.22.7846; Takayama S, 1997, ANNU REV MICROBIOL, V51, P285, DOI 10.1146/annurev.micro.51.1.285; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Williams GJ, 2003, P NATL ACAD SCI USA, V100, P3143, DOI 10.1073/pnas.0635924100; WONG CH, 1994, ENZYMES SYNTHETIC OR, P195; Zgiby SM, 2000, EUR J BIOCHEM, V267, P1858, DOI 10.1046/j.1432-1327.2000.01191.x	51	19	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21143	21152		10.1074/jbc.M109.080358	http://dx.doi.org/10.1074/jbc.M109.080358			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20427286	Green Published, hybrid			2022-12-25	WOS:000279228600077
J	Roell, MK; Issafras, H; Bauer, RJ; Michelson, KS; Mendoza, N; Vanegas, SI; Gross, LM; Larsen, PD; Bedinger, DH; Bohmann, DJ; Nonet, GH; Liu, NC; Lee, SR; Handa, M; Kantak, SS; Horwitz, AH; Hunter, JJ; Owyang, AM; Mirza, AM; Corbin, JA; White, ML				Roell, Marina K.; Issafras, Hassan; Bauer, Robert J.; Michelson, Kristen S.; Mendoza, Nerissa; Vanegas, Sandra I.; Gross, Lisa M.; Larsen, Paul D.; Bedinger, Daniel H.; Bohmann, David J.; Nonet, Genevieve H.; Liu, Naichi; Lee, Steve R.; Handa, Masahisa; Kantak, Seema S.; Horwitz, Arnold H.; Hunter, John J.; Owyang, Alexander M.; Mirza, Amer M.; Corbin, John A.; White, Mark L.			Kinetic Approach to Pathway Attenuation Using XOMA 052, a Regulatory Therapeutic Antibody That Modulates Interleukin-1 beta Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR ACCESSORY PROTEIN; IL-1 RECEPTOR; II INTERLEUKIN-1; IIIL-1 RECEPTOR; DECOY RECEPTOR; GENE-TRANSFER; HOST-DEFENSE; ANTAGONIST; IL-1-BETA; RESPONSIVENESS	Many therapeutic antibodies act as antagonists to competitively block cellular signaling pathways. We describe here an approach for the therapeutic use of monoclonal antibodies based on context-dependent attenuation to reduce pathologically high activity while allowing homeostatic signaling in biologically important pathways. Such attenuation is achieved by modulating the kinetics of a ligand binding to its various receptors and regulatory proteins rather than by complete blockade of signaling pathways. The anti-interleukin-1 beta (IL-1 beta) antibody XOMA 052 is a potent inhibitor of IL-1 beta activity that reduces the affinity of IL-1 beta for its signaling receptor and co-receptor but not for its decoy and soluble inhibitory receptors. This mechanism shifts the effective dose response of the cytokine so that the potency of IL-1 beta bound by XOMA 052 is 20-100-fold lower than that of IL-1 beta in the absence of antibody in a variety of in vitro cell-based assays. We propose that by decreasing potency of IL-1 beta while allowing binding to its clearance and inhibitory receptors, XOMA 052 treatment will attenuate IL-1 beta activity in concert with endogenous regulatory mechanisms. Furthermore, the ability to bind the decoy receptor may reduce the potential for accumulation of antibody target complexes. Regulatory antibodies like XOMA 052, which selectively modulate signaling pathways, may represent a new mechanistic class of therapeutic antibodies.	[Roell, Marina K.; Issafras, Hassan; Bauer, Robert J.; Michelson, Kristen S.; Mendoza, Nerissa; Vanegas, Sandra I.; Gross, Lisa M.; Larsen, Paul D.; Bedinger, Daniel H.; Bohmann, David J.; Nonet, Genevieve H.; Liu, Naichi; Lee, Steve R.; Handa, Masahisa; Kantak, Seema S.; Horwitz, Arnold H.; Hunter, John J.; Owyang, Alexander M.; Mirza, Amer M.; Corbin, John A.; White, Mark L.] XOMA US LLC, Preclin Res Dept, Berkeley, CA 94710 USA		Roell, MK (corresponding author), 2910 7th St, Berkeley, CA 94710 USA.	roell@xoma.com		Hunter, John/0000-0001-8262-4404; Bedinger, Daniel/0000-0001-5009-9369				Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; BOSSU P, 1995, AM J PATHOL, V147, P1852; Bourke E, 2003, J IMMUNOL, V170, P5999, DOI 10.4049/jimmunol.170.12.5999; BURGER D, 1995, J CLIN INVEST, V96, P38, DOI 10.1172/JCI118045; CLIN TRIALS, 2004, Patent No. 20040063913; CURTIS BM, 1989, P NATL ACAD SCI USA, V86, P3045, DOI 10.1073/pnas.86.9.3045; Dinarello CA, 2004, CURR OPIN PHARMACOL, V4, P378, DOI 10.1016/j.coph.2004.03.010; Dinarello CA, 2005, ARTHRITIS RHEUM-US, V52, P1960, DOI 10.1002/art.21107; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Donath MY, 2008, DIABETOLOGIA, V51, pS7; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Donath MY, 2008, NAT CLIN PRACT ENDOC, V4, P240, DOI 10.1038/ncpendmet0783; Donath MY, 2009, DIABETES, V58, pA30; Ehses Jan A., 2009, Archives of Physiology and Biochemistry, V115, P240, DOI 10.1080/13813450903025879; Einstein R, 1996, CYTOKINE, V8, P206, DOI 10.1006/cyto.1996.0029; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Gosselin D, 2007, BRAIN BEHAV IMMUN, V21, P281, DOI 10.1016/j.bbi.2006.12.004; Graves DT, 2000, INFECT IMMUN, V68, P4746, DOI 10.1128/IAI.68.8.4746-4751.2000; GREEN L, 2008, Patent No. 7566772; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Hofmeister R, 1997, J BIOL CHEM, V272, P27730, DOI 10.1074/jbc.272.44.27730; Lachmann HJ, 2009, J EXP MED, V206, P1029, DOI 10.1084/jem.20082481; Lang D, 1998, J IMMUNOL, V161, P6871; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lebeis SL, 2009, INFECT IMMUN, V77, P604, DOI 10.1128/IAI.00907-08; Liu XY, 2008, IMMUNOL REV, V222, P9, DOI 10.1111/j.1600-065X.2008.00601.x; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2006, DIABETES, V55, P2713, DOI 10.2337/db05-1430; Masat L, 2009, IL-1&beta; binding antibodies and fragments thereof, Patent No. [7531166, US7531166]; OWYANG A, 2009, DIABETES, V58, P310; OWYANG AM, 2010, ENDOCRINOLO IN PRESS; Re F, 1996, J EXP MED, V183, P1841, DOI 10.1084/jem.183.4.1841; Rol GP, 1997, EUR CYTOKINE NETW, V8, P265; Schreuder H, 1997, NATURE, V386, P194, DOI 10.1038/386194a0; Smith DE, 2003, IMMUNITY, V18, P87, DOI 10.1016/S1074-7613(02)00514-9; SPINAS GA, 1988, ACTA ENDOCRINOL-COP, V119, P307, DOI 10.1530/acta.0.1190307; SPINAS GA, 1986, ACTA ENDOCRINOL-COP, V113, P551, DOI 10.1530/acta.0.1130551; Stylianou E, 1998, INT J BIOCHEM CELL B, V30, P1075, DOI 10.1016/S1357-2725(98)00081-8; Trikha M, 2002, CURR OPIN BIOTECH, V13, P609, DOI 10.1016/S0958-1669(02)00348-8; Vonk AG, 2006, J INFECT DIS, V193, P1419, DOI 10.1086/503363; Waterhouse CCM, 2001, EXP CELL RES, V269, P109, DOI 10.1006/excr.2001.5303	42	33	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20607	20614		10.1074/jbc.M110.115790	http://dx.doi.org/10.1074/jbc.M110.115790			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20410301	hybrid, Green Published			2022-12-25	WOS:000279228600024
J	Tsai, YL; Chiang, YR; Narberhaus, F; Baron, C; Lai, EM				Tsai, Yun-Long; Chiang, Yin-Ru; Narberhaus, Franz; Baron, Christian; Lai, Erh-Min			The Small Heat-shock Protein HspL Is a VirB8 Chaperone Promoting Type IV Secretion-mediated DNA Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CRYSTALLIN; AGROBACTERIUM-TUMEFACIENS; IN-VIVO; MYCOBACTERIUM-TUBERCULOSIS; MEMBRANE-PROTEIN; T-PILUS; MUTATION; SYSTEM; MECHANISM; IDENTIFICATION	Agrobacterium tumefaciens is a plant pathogen that utilizes a type IV secretion system (T4SS) to transfer DNA and effector proteins into host cells. In this study we discovered that an alpha-crystallin type small heat-shock protein (alpha-Hsp), HspL, is a molecular chaperone for VirB8, a T4SS assembly factor. HspL is a typical alpha-Hsp capable of protecting the heat-labile model substrate citrate synthase from thermal aggregation. It forms oligomers in a concentration-dependent manner in vitro. Biochemical fractionation revealed that HspL is mainly localized in the inner membrane and formed large complexes with certain VirB protein subassemblies. Protein-protein interaction studies indicated that HspL interacts with VirB8, a bitopic integral inner membrane protein that is essential for T4SS assembly. Most importantly, HspL is able to prevent the aggregation of VirB8 fused with glutathione S-transferase in vitro, suggesting that it plays a role as VirB8 chaperone. The chaperone activity of two HspL variants with amino acid substitutions (F98A and G118A) for both citrate synthase and glutathione S-transferase-VirB8 was reduced and correlated with HspL functions in T4SS-mediated DNA transfer and virulence. This study directly links in vitro and in vivo functions of an alpha-Hsp and reveals a novel alpha-Hsp function in T4SS stability and bacterial virulence.	[Tsai, Yun-Long; Chiang, Yin-Ru; Lai, Erh-Min] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan; [Narberhaus, Franz] Ruhr Univ Bochum, Lehrstuhl Biol Mikroorganismen, D-44780 Bochum, Germany; [Baron, Christian] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Academia Sinica - Taiwan; Ruhr University Bochum; Universite de Montreal	Lai, EM (corresponding author), 128,Sec 2,Acad Rd, Taipei 11529, Taiwan.	emlai@gate.sinica.edu.tw	Chiang, Yin-Ru/L-7727-2019; Lai, Erh-Min/ABG-9558-2020	Lai, Erh-Min/0000-0003-3630-8683; Chiang, Yin-Ru/0000-0001-6899-3166; Narberhaus, Franz/0000-0002-8552-5310	Taiwan National Science Council [NSC 95-2320-B-001-009, 0970029248P]; NSC; German Academic Exchange Service (DAAD) and Taiwan National Science Council [0970029248P]; Canadian Institutes of Health Research [MOP-84239]; Canada Foundation for Innovation; Fonds de la Recherche en Sante du Quebec	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); NSC(Ministry of Science and Technology, Taiwan); German Academic Exchange Service (DAAD) and Taiwan National Science Council(Deutscher Akademischer Austausch Dienst (DAAD)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by Taiwan National Science Council (NSC) Grant NSC 95-2320-B-001-009 (to E.-M.L.), an NSC postdoctoral fellowship (to Y.-L.T.), and a joint grant from the German Academic Exchange Service (DAAD) and Taiwan National Science Council PPP Grant 0970029248P (to F.N. and E.-M.L.). This work was also supported by Canadian Institutes of Health Research Grant MOP-84239, the Canada Foundation for Innovation, and the Fonds de la Recherche en Sante du Quebec.	Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Andley UP, 2008, BIOCHEMISTRY-US, V47, P9697, DOI 10.1021/bi800594t; Bailey S, 2006, P NATL ACAD SCI USA, V103, P2582, DOI 10.1073/pnas.0511216103; Balsiger S, 2004, J BACTERIOL, V186, P6824, DOI 10.1128/JB.186.20.6824-6829.2004; Baron C, 2001, J BACTERIOL, V183, P6852, DOI 10.1128/JB.183.23.6852-6861.2001; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; Basha E, 2004, J BIOL CHEM, V279, P7566, DOI 10.1074/jbc.M310684200; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; BEIJERSBERGEN A, 1992, SCIENCE, V256, P1324, DOI 10.1126/science.256.5061.1324; Biswas A, 2006, BIOCHEMISTRY-US, V45, P4569, DOI 10.1021/bi052574s; BUCHANANWOLLASTON V, 1987, NATURE, V328, P172, DOI 10.1038/328172a0; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; CHANG BY, 1994, J BACTERIOL, V176, P3102, DOI 10.1128/jb.176.11.3102-3110.1994; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; DELLAGOSTIN OA, 1995, MICROBIOL-UK, V141, P1785, DOI 10.1099/13500872-141-8-1785; DEMAAGD RA, 1986, J BACTERIOL, V167, P1083, DOI 10.1128/jb.167.3.1083-1085.1986; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Giese KC, 2004, J BIOL CHEM, V279, P32674, DOI 10.1074/jbc.M404455200; Giese KC, 2005, P NATL ACAD SCI USA, V102, P18896, DOI 10.1073/pnas.0506169103; Giese KC, 2002, J BIOL CHEM, V277, P46310, DOI 10.1074/jbc.M208926200; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Horvath I, 1998, P NATL ACAD SCI USA, V95, P3513, DOI 10.1073/pnas.95.7.3513; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; KADO CI, 1970, PHYTOPATHOLOGY, V60, P969, DOI 10.1094/Phyto-60-969; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kitagawa M, 2000, FEMS MICROBIOL LETT, V184, P165, DOI 10.1111/j.1574-6968.2000.tb09009.x; Kitagawa M, 2002, EUR J BIOCHEM, V269, P2907, DOI 10.1046/j.1432-1033.2002.02958.x; Krall L, 2002, P NATL ACAD SCI USA, V99, P11405, DOI 10.1073/pnas.172390699; Lai EM, 2000, TRENDS MICROBIOL, V8, P361, DOI 10.1016/S0966-842X(00)01802-3; Lai EM, 1998, J BACTERIOL, V180, P2711, DOI 10.1128/JB.180.10.2711-2717.1998; Lai EM, 2006, PROTEOMICS, V6, P4130, DOI 10.1002/pmic.200600254; Laskowska E, 2004, MICROBIOL-SGM, V150, P247, DOI 10.1099/mic.0.26470-0; LEE BY, 1992, INFECT IMMUN, V60, P2066, DOI 10.1128/IAI.60.5.2066-2074.1992; Lentze N, 2003, J MOL BIOL, V328, P927, DOI 10.1016/S0022-2836(03)00356-5; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; Munchbach M, 1999, J BACTERIOL, V181, P83; Munchbach M, 1999, EUR J BIOCHEM, V264, P39, DOI 10.1046/j.1432-1327.1999.00567.x; Nakamoto H, 2000, FEBS LETT, V483, P169, DOI 10.1016/S0014-5793(00)02097-4; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Paschos A, 2006, P NATL ACAD SCI USA, V103, P7252, DOI 10.1073/pnas.0600862103; Rashkova S, 1997, J BACTERIOL, V179, P583, DOI 10.1128/jb.179.3.583-591.1997; Rosen R, 2002, J BACTERIOL, V184, P1772, DOI 10.1128/JB.184.6.1772-1778.2002; Sambrook J, 2001, MOL CLONING LAB MANU; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHIRASU K, 1993, FEMS MICROBIOL LETT, V111, P287, DOI 10.1111/j.1574-6968.1993.tb06400.x; Stewart GR, 2005, MOL MICROBIOL, V55, P1127, DOI 10.1111/j.1365-2958.2004.04450.x; Stewart JN, 2006, MICROBIOL-SGM, V152, P233, DOI 10.1099/mic.0.28275-0; Tsai YL, 2009, MICROBIOL-SGM, V155, P3270, DOI 10.1099/mic.0.030676-0; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Ward DV, 2002, P NATL ACAD SCI USA, V99, P11493, DOI 10.1073/pnas.172390299; Wilkinson KA, 2005, J IMMUNOL, V174, P4237, DOI 10.4049/jimmunol.174.7.4237; Xi JH, 2008, J BIOL CHEM, V283, P5801, DOI 10.1074/jbc.M708704200; Yuan Q, 2005, J BIOL CHEM, V280, P26349, DOI 10.1074/jbc.M502347200	57	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19757	19766		10.1074/jbc.M110.110296	http://dx.doi.org/10.1074/jbc.M110.110296			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427270	Green Published, hybrid			2022-12-25	WOS:000279012000008
J	Lane, D; Goncharenko-Khaider, N; Rancourt, C; Piche, A				Lane, D.; Goncharenko-Khaider, N.; Rancourt, C.; Piche, A.			Ovarian cancer ascites protects from TRAIL-induced cell death through alpha v beta 5 integrin-mediated focal adhesion kinase and Akt activation	ONCOGENE			English	Article						integrins; death receptors; ovarian carcinoma; ascites; PI3K/Akt pathway; TRAIL	LYSOPHOSPHATIDIC ACID LPA; GROWTH-FACTOR RECEPTOR; INDUCED APOPTOSIS; COUPLED RECEPTOR; EXPRESSION; CARCINOMA; MIGRATION; PATHWAY; LIGAND; IDENTIFICATION	Interactions between ovarian cancer cells and the surrounding tumor microenvironment are not well characterized. We have earlier shown that ovarian cancer ascites induces Akt activation and protect tumor cells from TRAIL-induced apoptosis. Here, we investigated the mechanism by which ascites activates Akt. The ability of ovarian cancer ascites to activate Akt and inhibit TRAIL-induced cell death and caspase activity was decreased by heat inactivation, but was retained in ascites fractions >5 kDa. The survival promoting activity of ascites was not affected by inhibitors of growth factor receptor including epidermal growth factor receptor (EGFR), VEGFR, FGFR, Her2/neu, and IGF-R1. However, this activity was inhibited by an alpha v beta 5 integrin-blocking antibody, but not by blocking antibodies against alpha v beta 3, beta 1, or beta 3 integrins. alpha v beta 5 integrin-blocking antibodies also inhibited ascites-induced Akt phosphorylation and c-FLIPs up-regulation. Ovarian cancer ascites induced a rapid phosphorylation of focal adhesion kinase (FAK), which closely correlated with the phosphorylation of Akt overtime. FAK phosphorylation was strongly inhibited by alpha v beta 5 integrin-blocking antibodies. Depletion of FAK content by RNA interference was also associated with inhibition of ascites-mediated Akt activation and survival. These results suggest that ovarian cancer ascites induces FAK and Akt activation in an alpha v beta 5 integrin-dependent pathway, which confers protection from TRAIL-induced cell death and caspase activation. Oncogene (2010) 29, 3519-3531; doi:10.1038/onc.2010.107; published online 19 April 2010	[Lane, D.; Goncharenko-Khaider, N.; Rancourt, C.; Piche, A.] Univ Sherbrooke, Fac Med, Dept Microbiol & Infectiol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Piche, A (corresponding author), Univ Sherbrooke, Fac Med, Dept Microbiol & Infectiol, 3001,12Ieme Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Alain.Piche@USherbrooke.ca			Cancer Research Society	Cancer Research Society	Funding for this study was provided by the Cancer Research Society. We thank the Tumor Bank from the 'Reseau de Recherche en Cancer du Fond de Recherche en Sante du Quebec' for providing the ovarian cancer ascites.	Abendstein B, 2000, CYTOKINE, V12, P1115, DOI 10.1006/cyto.1999.0632; Alper O, 2001, J NATL CANCER I, V93, P1375, DOI 10.1093/jnci/93.18.1375; Carreiras F, 1999, INT J CANCER, V80, P285; Contos JJA, 2000, MOL PHARMACOL, V58, P1188, DOI 10.1124/mol.58.6.1188; Cruet-Hennequart S, 2003, ONCOGENE, V22, P1688, DOI 10.1038/sj.onc.1206347; Damiano JS, 2002, CURR CANCER DRUG TAR, V2, P37, DOI 10.2174/1568009023334033; Dan HC, 2004, ONCOGENE, V23, P706, DOI 10.1038/sj.onc.1207171; Davidson B, 2006, CLIN CANCER RES, V12, P791, DOI 10.1158/1078-0432.CCR-05-2516; Fornaro M, 2003, J BIOL CHEM, V278, P50402, DOI 10.1074/jbc.M307627200; Fraser M, 2003, CANCER RES, V63, P7081; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Gillan L, 2002, CANCER RES, V62, P5358; Goetzl EJ, 1999, CANCER RES, V59, P5370; Graves LE, 2004, CANCER RES, V64, P7045, DOI 10.1158/0008-5472.CAN-04-1800; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kandasamy K, 2002, CANCER RES, V62, P4929; Kang YC, 2004, CELL DEATH DIFFER, V11, P1287, DOI 10.1038/sj.cdd.4401489; Kobayashi-Sakamoto M, 2008, MICROVASC RES, V76, P139, DOI 10.1016/j.mvr.2008.06.004; KOHLER M, 1989, ANTICANCER RES, V9, P1537; KOHLER M, 1992, EUR J CANCER, V28A, P1432, DOI 10.1016/0959-8049(92)90538-D; Lane D, 2008, INT J GYNECOL CANCER, V18, P670, DOI 10.1111/j.1525-1438.2007.01062.x; Lane D, 2007, INT J CANCER, V121, P1227, DOI 10.1002/ijc.22840; Matei D, 2006, ONCOGENE, V25, P2060, DOI 10.1038/sj.onc.1209232; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; MILLS GB, 1988, CANCER RES, V48, P1066; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Miyamoto S, 2004, CANCER RES, V64, P5720, DOI 10.1158/0008-5472.CAN-04-0811; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Puiffe ML, 2007, NEOPLASIA, V9, P820, DOI 10.1593/neo.07472; Puls LE, 1996, GYNECOL ONCOL, V61, P109, DOI 10.1006/gyno.1996.0106; Ren J, 2006, CANCER RES, V66, P3006, DOI 10.1158/0008-5472.CAN-05-1292; Saltzman AK, 1999, GYNECOL OBSTET INVES, V47, P200, DOI 10.1159/000010095; Shen-Gunther J, 2002, GYNECOL ONCOL, V87, P77, DOI 10.1006/gyno.2002.6800; Sivaprasad U, 2007, CELL DEATH DIFFER, V14, P851, DOI 10.1038/sj.cdd.4402077; Stoica A, 2000, J CELL BIOCHEM, V76, P605, DOI 10.1002/(SICI)1097-4644(20000315)76:4<605::AID-JCB9>3.0.CO;2-T; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Uhm JH, 1999, CLIN CANCER RES, V5, P1587; Westermann AM, 1998, ANN ONCOL, V9, P437, DOI 10.1023/A:1008217129273; Yamada T, 2004, J BIOL CHEM, V279, P6595, DOI 10.1074/jbc.M308133200; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Ye XQ, 2002, BBA-MOL CELL BIOL L, V1585, P108, DOI 10.1016/S1388-1981(02)00330-X; ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161	43	66	67	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 17	2010	29	24					3519	3531		10.1038/onc.2010.107	http://dx.doi.org/10.1038/onc.2010.107			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	611QN	20400979				2022-12-25	WOS:000278835400007
J	Dunne, A; Carpenter, S; Brikos, C; Gray, P; Strelow, A; Wesche, H; Morrice, N; O'Neill, LAJ				Dunne, Aisling; Carpenter, Susan; Brikos, Constantinos; Gray, Pearl; Strelow, Astrid; Wesche, Holger; Morrice, Nick; O'Neill, Luke A. J.			IRAK1 and IRAK4 Promote Phosphorylation, Ubiquitination, and Degradation of MyD88 Adaptor-like (Mal)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; SIGNAL-TRANSDUCTION; KINASE; ACTIVATION; BETA; EXPRESSION; REGULATOR; MOLECULE; CELLS	Signal transduction by Toll-like receptor 2 (TLR2) and TLR4 requires the adaptors MyD88 and Mal (MyD88 adaptor-like) and serine/threonine kinases, interleukin-1 receptor-associated kinases IRAK1 and IRAK4. We have found that both IRAK1 and IRAK4 can directly phosphorylate Mal. In addition, co-expression of Mal with either IRAK resulted in depletion of Mal from cell lysates. This is likely to be due to Mal phosphorylation by the IRAKs because kinase-inactive forms of either IRAK had no effect. Furthermore, lipopolysaccharide stimulation resulted in ubiquitination and degradation of Mal, which was inhibited using an IRAK1/4 inhibitor or by knocking down expression of IRAK1 and IRAK4. MyD88 is not a substrate for either IRAK and did not undergo degradation. We there fore conclude that Mal is a substrate for IRAK1 and IRAK4 with phosphorylation promoting ubiquitination and degradation of Mal. This process may serve to negatively regulate signaling by TLR2 and TLR4.	[Dunne, Aisling; Carpenter, Susan; Brikos, Constantinos; Gray, Pearl; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; [Wesche, Holger] Amgen San Francisco, San Francisco, CA 94080 USA; [Strelow, Astrid] CFD Therapeut, San Francisco, CA 94080 USA; [Morrice, Nick] Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland	Trinity College Dublin; Amgen; University of Dundee	Dunne, A (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	aidunne@tcd.ie		dunne, aisling/0000-0002-2342-9518; O'Neill, Luke/0000-0002-4333-2748	Science Foundation of Ireland; Health Research Board	Science Foundation of Ireland(Science Foundation Ireland); Health Research Board	This work was supported by grants from the Science Foundation of Ireland and the Health Research Board.	Bhattacharyya S, 2007, AM J PHYSIOL-GASTR L, V293, pG429, DOI 10.1152/ajpgi.00149.2007; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Huang YS, 2004, J BIOL CHEM, V279, P51697, DOI 10.1074/jbc.M410369200; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Kubo-Murai M, 2008, J BIOCHEM, V143, P295, DOI 10.1093/jb/mvm234; Liu G, 2008, FASEB J, V22, P2285, DOI 10.1096/fj.07-101816; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Meylan E, 2008, NAT IMMUNOL, V9, P581, DOI 10.1038/ni0608-581; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Song KW, 2009, MOL IMMUNOL, V46, P1458, DOI 10.1016/j.molimm.2008.12.012; Strelow A, 2003, FEBS LETT, V547, P157, DOI 10.1016/S0014-5793(03)00697-5; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	23	39	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18276	18282		10.1074/jbc.M109.098137	http://dx.doi.org/10.1074/jbc.M109.098137			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400509	Green Published, hybrid			2022-12-25	WOS:000278453900020
J	Litonin, D; Sologub, M; Shi, YH; Savkina, M; Anikin, M; Falkenberg, M; Gustafsson, CM; Temiakov, D				Litonin, Dmitry; Sologub, Marina; Shi, Yonghong; Savkina, Maria; Anikin, Michael; Falkenberg, Maria; Gustafsson, Claes M.; Temiakov, Dmitry			Human Mitochondrial Transcription Revisited ONLY TFAM AND TFB2M ARE REQUIRED FOR TRANSCRIPTION OF THE MITOCHONDRIAL GENES IN VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MTDNA COPY NUMBER; RNA-POLYMERASE; RIBOSOMAL-RNA; FACTOR-A; MULTIPLE FUNCTIONS; INITIATION SITES; MAMMALIAN-CELLS; GENE-EXPRESSION; DISTINCT ROLES; IN-VIVO	Human mitochondrial transcription is driven by a single subunit RNA polymerase and a set of basal transcription factors. The development of a recombinant in vitro transcription system has allowed for a detailed molecular characterization of the individual components and their contribution to transcription initiation. We found that TFAM and TFB2M act synergistically and increase transcription efficiency 100-200-fold as compared with RNA polymerase alone. Both the light-strand promoter (LSP) and the HSP1 promoters displayed maximal levels of in vitro transcription when TFAM was present in an amount equimolar to the DNA template. Importantly, we did not detect any significant transcription activity in the presence of the TFB2M paralog, TFB1M, or when templates containing the putative HSP2 promoter were used. These data confirm previous observations that TFB1M does not function as a bona fide transcription factor and raise questions as to whether HSP2 serves as a functional promoter in vivo. In addition, we did not detect transcription stimulation by the ribosomal protein MRPL12. Thus, only two essential initiation factors, TFAM and TFB2M, and two promoters, LSP and HSP1, are required to drive transcription of the mitochondrial genome.	[Shi, Yonghong; Falkenberg, Maria; Gustafsson, Claes M.] Univ Gothenburg, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden; [Litonin, Dmitry; Sologub, Marina; Savkina, Maria; Anikin, Michael; Temiakov, Dmitry] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA	University of Gothenburg; Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Gustafsson, CM (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.	claes.gustafsson@medkem.gu.se; d.temiakov@umdnj.edu	Savkina, Maria/C-9075-2018; shi, yonghong/E-8254-2017	Savkina, Maria/0000-0002-8527-2157; shi, yonghong/0000-0002-5265-7982; Gustafsson, Claes/0000-0003-3531-8468	National Institutes of Health [GM38147]; University of Medicine and Dentistry of New Jersey (UMDNJ) Research Foundation; Swedish Research Council; Swedish Cancer Society; Goran Gustafsson Foundation; Foundation for Strategic Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Medicine and Dentistry of New Jersey (UMDNJ) Research Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Goran Gustafsson Foundation; Foundation for Strategic Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM38147 (to Dr. William McAllister). This work was also supported in part by a University of Medicine and Dentistry of New Jersey (UMDNJ) Research Foundation grant (to D. T.) and by grants from the Swedish Research Council, the Swedish Cancer Society, the Goran Gustafsson Foundation, and the Foundation for Strategic Research (to C. M. G. and M. F.).	ANTOSHECHKIN I, 1995, MOL CELL BIOL, V15, P7032; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; CHRISTIANSON TW, 1986, P NATL ACAD SCI USA, V83, P6277, DOI 10.1073/pnas.83.17.6277; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; DAIRAGHI DJ, 1995, BBA-MOL BASIS DIS, V1271, P127, DOI 10.1016/0925-4439(95)00019-Z; Dubrovsky EB, 2004, NUCLEIC ACIDS RES, V32, P255, DOI 10.1093/nar/gkh182; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; FISHER RP, 1987, CELL, V50, P247, DOI 10.1016/0092-8674(87)90220-0; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; HIXSON JE, 1985, P NATL ACAD SCI USA, V82, P2660, DOI 10.1073/pnas.82.9.2660; Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921; Maniura-Weber K, 2006, NUCLEIC ACIDS RES, V34, P6404, DOI 10.1093/nar/gkl727; Markov DA, 2009, YEAST, V26, P423, DOI 10.1002/yea.1672; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Marty L, 1996, J BIOL CHEM, V271, P11468, DOI 10.1074/jbc.271.19.11468; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200; McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9; MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Sato H, 2004, PROTOPLASMA, V223, P175, DOI 10.1007/s00709-004-0040-z; Savkina M, 2010, J BIOL CHEM, V285, P3957, DOI 10.1074/jbc.M109.051003; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200; Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105; Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010; YOZA BK, 1984, J BIOL CHEM, V259, P3909	33	138	146	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18129	18133		10.1074/jbc.C110.128918	http://dx.doi.org/10.1074/jbc.C110.128918			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20410300	Green Published, hybrid			2022-12-25	WOS:000278453900002
J	Poeggeler, B; Sambamurti, K; Siedlak, SL; Perry, G; Smith, MA; Pappolla, MA				Poeggeler, Burkhard; Sambamurti, Kumar; Siedlak, Sandra L.; Perry, George; Smith, Mark A.; Pappolla, Miguel A.			A Novel Endogenous Indole Protects Rodent Mitochondria and Extends Rotifer Lifespan	PLOS ONE			English	Article							COMPLEX-I; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; MELATONIN; BRAIN; GENERATION; PREVENTION; CHEMISTRY; NITRONE; SITES	Aging is a multi-factorial process, however, it is generally accepted that reactive oxygen species (ROS) are significant contributors. Mitochondria are important players in the aging process because they produce most of the cellular ROS. Despite the strength of the free-radical hypothesis, the use of free radical scavengers to delay aging has generated mixed results in vertebrate models, and clinical evidence of efficacy is lacking. This is in part due to the production of pro-oxidant metabolites by many antioxidants while scavenging ROS, which counteract their potentially beneficial effects. As such, a more effective approach is to enhance mitochondrial metabolism by reducing electron leakage with attendant reduction of ROS generation. Here, we report on the actions of a novel endogenous indole derivative, indolepropionamide (IPAM), which is similar in structure to melatonin. Our results suggest that IPAM binds to the rate-limiting component of oxidative phosphorylation in complex I of the respiratory chain and acts as a stabilizer of energy metabolism, thereby reducing ROS production. IPAM reversed the age-dependent decline of mitochondrial energetic capacity and increased rotifer lifespan, and it may, in fact, constitute a novel endogenous anti-aging substance of physiological importance.	[Poeggeler, Burkhard] Univ Lubeck, Dept Dermatol, Lubeck, Germany; [Sambamurti, Kumar; Pappolla, Miguel A.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Perry, George] Univ Texas San Antonio, Coll Sci, UTSA Neurosci Inst, San Antonio, TX USA; [Perry, George] Univ Texas San Antonio, Dept Biol, Coll Sci, San Antonio, TX USA; [Siedlak, Sandra L.; Smith, Mark A.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	University of Lubeck; Medical University of South Carolina; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); Case Western Reserve University	Poeggeler, B (corresponding author), Univ Lubeck, Dept Dermatol, Lubeck, Germany.	sambak@musc.e; pappolla@aol.com	Pappolla, Miguel/ABE-4966-2021; Perry, George/A-8611-2009; Sambamurti, Kumar/A-1620-2012; Smith, Mark A/A-9053-2009	Perry, George/0000-0002-6547-0172; Sambamurti, Kumar/0000-0001-9507-9214; 	Alzheimer's Association [IIRG-09-132087]; National Institutes of Health [AG022103, AG10483, AG023055, AG028679]; German Research Foundation DFG [662/1-1]; NATIONAL INSTITUTE ON AGING [U01AG010483, R01AG022103, R01AG028679, R01AG023055] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Work in the authors' laboratories is supported by the Alzheimer's Association (Zenith Award to MAP; IIRG-09-132087 to MAS), the National Institutes of Health (AG022103, AG10483, and AG023055 to MAP and KS; AG028679 to MAS), and the German Research Foundation DFG (Deutsche Forschungsgemeinschaft PO 662/1-1 to BP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Brenner-Lavie H, 2008, BBA-BIOENERGETICS, V1777, P173, DOI 10.1016/j.bbabio.2007.10.006; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Chyan YJ, 1999, J BIOL CHEM, V274, P21937, DOI 10.1074/jbc.274.31.21937; Dabbeni-Sala F, 2001, FASEB J, V15, P164, DOI 10.1096/fj.00-0129com; Durand G, 2007, J MED CHEM, V50, P3976, DOI 10.1021/jm0706968; Hardeland R, 2005, ENDOCRINE, V27, P119, DOI 10.1385/ENDO:27:2:119; Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hensley K, 1998, J NEUROCHEM, V71, P2549; Kudin AP, 2008, BBA-BIOENERGETICS, V1777, P689, DOI 10.1016/j.bbabio.2008.05.010; Lee SJ, 2005, BRIT J PHARMACOL, V145, P469, DOI 10.1038/sj.bjp.0706206; Lenaz G, 2006, ANTIOXID REDOX SIGN, V8, P417, DOI 10.1089/ars.2006.8.417; Leon J, 2005, J PINEAL RES, V38, P1, DOI 10.1111/j.1600-079X.2004.00181.x; Martin M, 2002, INT J BIOCHEM CELL B, V34, P348, DOI 10.1016/S1357-2725(01)00138-8; Martin M, 2000, FASEB J, V14, P1677; Poeggeler B, 2005, J NEUROCHEM, V95, P962, DOI 10.1111/j.1471-4159.2005.03425.x; Poeggeler B, 2005, ENDOCRINE, V27, P201, DOI 10.1385/ENDO:27:2:201; POEGGELER B, 1994, ANN NY ACAD SCI, V738, P419, DOI 10.1111/j.1749-6632.1994.tb21831.x; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Sohal RS, 2000, RES PRO CEL, V29, P45; Stockl P, 2006, EXP GERONTOL, V41, P674, DOI 10.1016/j.exger.2006.04.009; YUAN H, 1991, J ENDOCRINOL, V128, P475, DOI 10.1677/joe.0.1280475	25	37	37	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10206	10.1371/journal.pone.0010206	http://dx.doi.org/10.1371/journal.pone.0010206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20421998	Green Submitted, gold, Green Published			2022-12-25	WOS:000276952500007
J	Block, GJ; DiMattia, GD; Prockop, DJ				Block, Gregory J.; DiMattia, Gabriel D.; Prockop, Darwin J.			Stanniocalcin-1 Regulates Extracellular ATP-Induced Calcium Waves in Human Epithelial Cancer Cells by Stimulating ATP Release from Bystander Cells	PLOS ONE			English	Article							ADENINE-NUCLEOTIDES; RECEPTORS; GROWTH; COMMUNICATION; ACTIVATION; INHIBITOR; MIGRATION; GENE; ACTS; UTP	Background: The epithelial cell response to stress involves the transmission of signals between contiguous cells that can be visualized as a calcium wave. In some cell types, this wave is dependent on the release of extracellular trinucleotides from injured cells. In particular, extracellular ATP has been reported to be critical for the epithelial cell response to stress and has recently been shown to be upregulated in tumors in vivo. Methodology/Principal Findings: Here, we identify stanniocalcin-1 (STC1), a secreted pleiotrophic protein, as a critical mediator of calcium wave propagation in monolayers of pulmonary (A549) and prostate (PC3) epithelial cells. Addition of STC1 enhanced and blocking STC1 decreased the distance traveled by an extracellular ATP-dependent calcium wave. The same effects were observed when calcium was stimulated by the addition of exogenous ATP. We uncover a positive feedback loop in which STC1 promotes the release of ATP from cells in vitro and in vivo. Conclusions/Significance: The results indicated that STC1 plays an important role in the early response to mechanical injury by epithelial cells by modulating signaling of extracellular ATP. This is the first report to describe STC1 as a modulator or purinergic receptor signaling.	[Block, Gregory J.; Prockop, Darwin J.] Scott & White Hosp, Inst Regenerat Med, Texas A&M Hlth Sci Ctr, Temple, TX USA; [DiMattia, Gabriel D.] Univ Western Ontario, London Reg Canc Program, London, ON, Canada; [DiMattia, Gabriel D.] Univ Western Ontario, Dept Oncol, London, ON, Canada	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Western University (University of Western Ontario); Western University (University of Western Ontario)	Block, GJ (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.	Prockop@medicine.tamhsc.edu			NIH [P40 RR 17447, P01 HL 075161]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR017447] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075161] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NIH grants P40 RR 17447 and P01 HL 075161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asl MN, 2008, PHYTOTHER RES, V22, P709, DOI 10.1002/ptr.2362; BLOCK GJ, 2008, STEM CELLS; BOITANO S, 1994, J CELL SCI, V107, P3037; Chakraborty A, 2007, AM J PHYSIOL-RENAL, V292, pF895, DOI 10.1152/ajprenal.00219.2006; Chang ACM, 2005, MOL CELL BIOL, V25, P10604, DOI 10.1128/MCB.25.23.10604-10610.2005; Chang ACM, 2003, ENDOCR-RELAT CANCER, V10, P359, DOI 10.1677/erc.0.0100359; D'hondt C, 2007, INVEST OPHTH VIS SCI, V48, P120, DOI 10.1167/iovs.06-0770; Dignass AU, 1998, EUR J CLIN INVEST, V28, P554; Drury AN, 1929, J PHYSIOL-LONDON, V68, P213, DOI 10.1113/jphysiol.1929.sp002608; Ehring GR, 2000, J PHYSIOL PHARMACOL, V51, P799; Ellard JP, 2007, MOL CELL ENDOCRINOL, V264, P90, DOI 10.1016/j.mce.2006.10.008; Erb L, 2006, PFLUG ARCH EUR J PHY, V452, P552, DOI 10.1007/s00424-006-0069-2; Filvaroff EH, 2002, ENDOCRINOLOGY, V143, P3681, DOI 10.1210/en.2001-211424; Gagliardi AD, 2005, AM J PHYSIOL-ENDOC M, V288, pE92, DOI 10.1152/ajpendo.00268.2004; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; Gorman MW, 2003, LUMINESCENCE, V18, P173, DOI 10.1002/bio.721; Homolya L, 2000, J CELL BIOL, V150, P1349, DOI 10.1083/jcb.150.6.1349; Huang LP, 2009, AM J PATHOL, V174, P1368, DOI 10.2353/ajpath.2009.080476; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V250, P252, DOI 10.1006/bbrc.1998.9300; Janssens R, 2001, BRIT J PHARMACOL, V132, P536, DOI 10.1038/sj.bjp.0703833; KALCKAR HM, 1947, AM J PHYSIOL, V149, P240, DOI 10.1152/ajplegacy.1947.149.1.240; Kanellis J, 2004, AM J PHYSIOL-RENAL, V286, pF356, DOI 10.1152/ajprenal.00138.2003; Kawamura M, 2004, J NEUROSCI, V24, P10835, DOI 10.1523/JNEUROSCI.3028-04.2004; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Klepeis VE, 2004, J CELL BIOCHEM, V93, P1115, DOI 10.1002/jcb.20258; Koizumi S, 2003, P NATL ACAD SCI USA, V100, P11023, DOI 10.1073/pnas.1834448100; LAFEBER FPJG, 1989, J EXP BIOL, V143, P165; Madsen KL, 1998, AM J PHYSIOL-GASTR L, V274, pG96, DOI 10.1152/ajpgi.1998.274.1.G96; Nguyen A, 2009, ONCOGENE, V28, P1982, DOI 10.1038/onc.2009.65; Olsen HS, 1996, P NATL ACAD SCI USA, V93, P1792, DOI 10.1073/pnas.93.5.1792; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Satterwhite CM, 1999, AM J PHYSIOL-HEART C, V276, pH1091, DOI 10.1152/ajpheart.1999.276.3.H1091; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Shabir S, 2008, CELL CALCIUM, V44, P453, DOI 10.1016/j.ceca.2008.02.008; Sheikh-Hamad D, 2003, AM J PHYSIOL-HEART C, V285, pH442, DOI 10.1152/ajpheart.01071.2002; Varghese R, 2002, ENDOCRINOLOGY, V143, P868, DOI 10.1210/en.143.3.868; WAGNER GF, 1986, GEN COMP ENDOCR, V63, P481, DOI 10.1016/0016-6480(86)90149-8; Wagner GF, 1997, J BONE MINER RES, V12, P165, DOI 10.1359/jbmr.1997.12.2.165; WANG D, 1990, BIOCHEM BIOPH RES CO, V166, P251, DOI 10.1016/0006-291X(90)91938-O; Weinger Ilene, 2005, Purinergic Signal, V1, P281, DOI 10.1007/s11302-005-8132-6; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; WESTBERG JA, 2007, AM J PHYSL HEART CIR; Westberg JA, 2007, STROKE, V38, P1025, DOI 10.1161/01.STR.0000258113.67252.fa; Wu SF, 2006, J BIOL CHEM, V281, P5120, DOI 10.1074/jbc.M506667200; Yin J, 2007, J CELL SCI, V120, P815, DOI 10.1242/jcs.03389	45	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10237	10.1371/journal.pone.0010237	http://dx.doi.org/10.1371/journal.pone.0010237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422040	Green Published, Green Submitted, gold			2022-12-25	WOS:000276854300006
J	Wenger, JB; Naumova, EN				Wenger, Julia B.; Naumova, Elena N.			Seasonal Synchronization of Influenza in the United States Older Adult Population	PLOS ONE			English	Article							MORTALITY; EPIDEMICS; SPREAD; VIRUS; HOSPITALIZATIONS; SURVEILLANCE; PNEUMONIA; EVOLUTION; DYNAMICS	Background: In temperate regions, influenza epidemics occur annually with the highest activity occurring during the winter months. While seasonal dynamics of the influenza virus, such as time of onset and circulating strains, are well documented by the Centers for Disease Control and Prevention Influenza Surveillance System, an accurate prediction of timing, magnitude, and composition of circulating strains of seasonal influenza remains elusive. To facilitate public health preparedness for seasonal influenza and to obtain better insights into the spatiotemporal behavior of emerging strains, it is important to develop measurable characteristics of seasonal oscillation and to quantify the relationships between those parameters on a spatial scale. The objectives of our research were to examine the seasonality of influenza on a national and state level as well as the relationship between peak timing and intensity of influenza in the United States older adult population. Methodology/Principal Findings: A total of 248,889 hospitalization records were extracted from the Centers for Medicare and Medicaid Services for the influenza seasons 1991-2004. Harmonic regression models were used to quantify the peak timing and absolute intensity for each of the 48 contiguous states and Washington, DC. We found that individual influenza seasons showed spatial synchrony with consistent late or early timing occurring across all 48 states during each influenza season in comparison to the overall average. On a national level, seasons that had an earlier peak also had higher rates of influenza (r(s) = -0.5). We demonstrated a spatial trend in peak timing of influenza; western states such as Nevada, Utah, and California peaked earlier and New England States such as Rhode Island, Maine, and New Hampshire peaked later. Conclusions/Significance: Our findings suggest that a systematic description of influenza seasonal patterns is a valuable tool for disease surveillance and can facilitate strategies for prevention of severe disease in the vulnerable, older adult population.	[Wenger, Julia B.; Naumova, Elena N.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA	Massachusetts Department of Public Health; Tufts University	Wenger, JB (corresponding author), Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA.	elena.naumova@tufts.edu	Naumova, Elena N/C-5954-2011; Naumova, Elena/AAP-3395-2020	Naumova, Elena/0000-0002-9562-4734	National Institute of Allergy and Infectious Diseases [HHSN266200500032C]; National Institute of Environmental Health Sciences [R01ES013171]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI050032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013171] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding Sources: National Institute of Allergy and Infectious Diseases (HHSN266200500032C) and the National Institute of Environmental Health Sciences (R01ES013171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Bonabeau E, 1998, P ROY SOC B-BIOL SCI, V265, P2421, DOI 10.1098/rspb.1998.0593; Boni MF, 2006, P ROY SOC B-BIOL SCI, V273, P1307, DOI 10.1098/rspb.2006.3466; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P1197; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P1095; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P375; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Grais R F, 2004, Health Care Manag Sci, V7, P127, DOI 10.1023/B:HCMS.0000020652.38181.da; Greene SK, 2006, AM J EPIDEMIOL, V163, P316, DOI 10.1093/aje/kwj040; Lipsitch M, 2009, P NATL ACAD SCI USA, V106, P3645, DOI 10.1073/pnas.0900933106; Lofgren E, 2007, LECT NOTES COMPUT SC, V4506, P114; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Naumova EN, 2007, EPIDEMIOL INFECT, V135, P281, DOI 10.1017/S0950268806006698; Naumova EN, 2007, STAT IND TECHNOL, P437, DOI 10.1007/978-0-8176-4542-7_28; Naumova EN, 2005, ENVIRONMETRICS, V16, P749, DOI 10.1002/env.734; NAUMOVA EN, SPATIOTEMPORAL UNPUB; NAUMOVA EN, 2009, J AM GERIAT IN PRESS; Nuno M, 2007, LECT NOTES COMPUT SC, V4506, P37; Proff R, 2009, EMERG INFECT DIS, V15, P892, DOI 10.3201/eid1506.081645; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Simonsen L, 1997, EPIDEMIOLOGY, V8, P390, DOI 10.1097/00001648-199707000-00007; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; Smith DJ, 2006, SCIENCE, V312, P392, DOI 10.1126/science.1122665; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Toubiana L, 1998, EUR J EPIDEMIOL, V14, P465, DOI 10.1023/A:1007481929237; Upshur REG, 1999, AM J EPIDEMIOL, V149, P85, DOI 10.1093/oxfordjournals.aje.a009731; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2004, EMERG INFECT DIS, V10, P32, DOI 10.3201/eid1001.020705; Webby RJ, 2000, J VIROL, V74, P8243, DOI 10.1128/JVI.74.18.8243-8251.2000	38	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10187	10.1371/journal.pone.0010187	http://dx.doi.org/10.1371/journal.pone.0010187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419169	Green Published, gold, Green Submitted			2022-12-25	WOS:000276707100008
J	Winkler, CJ; Ponce, A; Courey, AJ				Winkler, Clint J.; Ponce, Alberto; Courey, Albert J.			Groucho-Mediated Repression May Result from a Histone Deacetylase-Dependent Increase in Nucleosome Density	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSION; DROSOPHILA EMBRYO; GENE-EXPRESSION; FUNCTIONAL INTERACTION; VESTIGIAL GENE; CO-REPRESSORS; BHLH PROTEINS; IN-VIVO; ACETYLATION; DOMAIN	Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor that directly interacts with the histone deacetylase Rpd3. Although previous studies suggest that this interaction is required for repression of Gro-responsive reporters in cultured cells, the in vivo significance of this interaction and the mechanism by which it leads to repression remain largely unexplored. In this study, we show that Gro is partially dependent on Rpd3 for repression, supporting the idea that Rpd3-mediated repression is one mode of Gro-mediated repression. We demonstrate that Gro colocalizes with Rpd3 to the chromatin of a target gene and that this is accompanied by the deacetylation of specific lysines within the N-terminal tails of histones H3 and H4. Gro overexpression leads to wing patterning defects and ectopic repression in the wing disc of transcription directed by the vestigial quadrant enhancer. These effects are reversed by the histone deacetylase inhibitors TSA and HC-Toxin and by the reduction of Rpd3 gene dosage. Furthermore, repression of the vestigial quadrant enhancer is accompanied by a Gro-mediated increase in nucleosome density, an effect that is reversed by histone deacetylase inhibitors. We propose a model in which Gro-mediated histone deacetylation results in increased nucleosome density leading to transcriptional repression.	[Winkler, Clint J.; Ponce, Alberto; Courey, Albert J.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Winkler, CJ (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	courey@chem.ucla.edu			National Institutes of Health (NIH) [RO1 GM44522]; United States Public Health Service (USPHS) [GM07104]; NIH/Minority Access to Research Careers [T34GM-08563-14]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008563, R01GM044522, T32GM007104] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service (USPHS)(United States Department of Health & Human ServicesUnited States Public Health Service); NIH/Minority Access to Research Careers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant RO1 GM44522. C. Winkler was supported by United States Public Health Service (USPHS) National Research Service Award GM07104 while a portion of this work was conducted. A. Ponce was supported by NIH/Minority Access to Research Careers - Undergraduate Student Training in Academic Research (MARC U*STAR) T34GM-08563-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Allen T, 2006, CANCER RES, V66, P1294, DOI 10.1158/0008-5472.CAN-05-1634; Bajoghli B, 2007, DEV BIOL, V303, P347, DOI 10.1016/j.ydbio.2006.11.020; Barolo S, 1997, EMBO J, V16, P2883, DOI 10.1093/emboj/16.10.2883; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; Buscarlet M, 2008, J BIOL CHEM, V283, P24881, DOI 10.1074/jbc.M800722200; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chen GQ, 1998, MOL CELL BIOL, V18, P7259, DOI 10.1128/MCB.18.12.7259; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Cho YS, 2005, GENOMICS, V86, P606, DOI 10.1016/j.ygeno.2005.07.007; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; Cinnamon E, 2008, DEVELOPMENT, V135, P829, DOI 10.1242/dev.015206; Courey AJ, 2001, GENE DEV, V15, P2786; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; deCelis JF, 1997, DEVELOPMENT, V124, P1919; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Flores-Saaib RD, 2000, NUCLEIC ACIDS RES, V28, P4189, DOI 10.1093/nar/28.21.4189; Fraga MF, 2008, CANCER RES, V68, P4116, DOI 10.1158/0008-5472.CAN-08-0085; Hasson P, 2006, BRIT J CANCER, V94, P771, DOI 10.1038/sj.bjc.6603019; Hasson P, 2001, EMBO J, V20, P5725, DOI 10.1093/emboj/20.20.5725; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Hong JW, 2008, P NATL ACAD SCI USA, V105, P20072, DOI 10.1073/pnas.0806476105; KEENE MA, 1981, P NATL ACAD SCI-BIOL, V78, P143, DOI 10.1073/pnas.78.1.143; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lee SB, 2003, DEVELOPMENT, V130, P4001, DOI 10.1242/dev.00595; Liu ZC, 2008, TRENDS PLANT SCI, V13, P137, DOI 10.1016/j.tplants.2007.12.005; MALLO M, 1993, MECH DEVELOP, V42, P67, DOI 10.1016/0925-4773(93)90099-J; Mannervik M, 1999, P NATL ACAD SCI USA, V96, P6797, DOI 10.1073/pnas.96.12.6797; Martinez CA, 2008, MOL CELL BIOL, V28, P2792, DOI 10.1128/MCB.01203-07; MIYASAKA H, 1993, EUR J BIOCHEM, V216, P343, DOI 10.1111/j.1432-1033.1993.tb18151.x; Moreno CS, 2005, CANCER RES, V65, P10214, DOI 10.1158/0008-5472.CAN-05-0884; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Nagel AC, 2005, MOL CELL BIOL, V25, P10433, DOI 10.1128/MCB.25.23.10433-10441.2005; Nuthall HN, 2002, J BIOL CHEM, V277, P51049, DOI 10.1074/jbc.M111660200; Orian A, 2007, P NATL ACAD SCI USA, V104, P15771, DOI 10.1073/pnas.0707418104; Palaparti A, 1997, J BIOL CHEM, V272, P26604, DOI 10.1074/jbc.272.42.26604; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Payankaulam S, 2009, P NATL ACAD SCI USA, V106, P17314, DOI 10.1073/pnas.0904507106; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; Pollard KJ, 1999, EMBO J, V18, P5622, DOI 10.1093/emboj/18.20.5622; Ruebel KH, 2006, ENDOCRINE, V29, P435, DOI 10.1385/ENDO:29:3:435; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Song HY, 2004, MOL CELL BIOL, V24, P4341, DOI 10.1128/MCB.24.10.4341-4350.2004; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Yao LC, 2008, DEVELOPMENT, V135, P2183, DOI 10.1242/dev.015826; Zhang HL, 1999, P NATL ACAD SCI USA, V96, P535, DOI 10.1073/pnas.96.2.535; Zheng CY, 2003, J BIOL CHEM, V278, P24217, DOI 10.1074/jbc.M302817200	52	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10166	10.1371/journal.pone.0010166	http://dx.doi.org/10.1371/journal.pone.0010166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405012	Green Published, Green Submitted, gold			2022-12-25	WOS:000276706300020
J	Mott, NN; Chung, WCJ; Tsai, PS; Pak, TR				Mott, Natasha N.; Chung, Wilson C. J.; Tsai, Pei-San; Pak, Toni R.			Differential Fibroblast Growth Factor 8 (FGF8)-Mediated Autoregulation of Its Cognate Receptors, Fgfr1 and Fgfr3, in Neuronal Cell Lines	PLOS ONE			English	Article							HORMONE PROMOTER ACTIVITY; DOWN-REGULATION; BREAST-CANCER; KINASE DOMAIN; PROTEIN; PROLIFERATION; EXPRESSION; PATHWAY; MODULATION; ACTIVATION	Fibroblast growth factors (FGFs) mediate a vast range of CNS developmental processes including neural induction, proliferation, migration, and cell survival. Despite the critical role of FGF signaling for normal CNS development, few reports describe the mechanisms that regulate FGF receptor gene expression in the brain. We tested whether FGF8 could autoregulate two of its cognate receptors, Fgfr1 and Fgfr3, in three murine cell lines with different lineages: fibroblast-derived cells (3T3 cells), neuronal cells derived from hippocampus (HT-22 cells), and neuroendocrine cells derived from hypothalamic gonadotropin-releasing hormone ( GnRH) neurons (GT1-7 cells). GnRH is produced by neurons in the hypothalamus and is absolutely required for reproductive competence in vertebrate animals. Several lines of evidence strongly suggest that Fgf8 is critical for normal development of the GnRH system, therefore, the GT1-7 cells provided us with an additional endpoint, Gnrh gene expression and promoter activity, to assess potential downstream consequences of FGF8-induced modulation of FGF receptor levels. Results from this study suggest that the autoregulation of its cognate receptor represents a common downstream effect of FGF8. Further, we show that Fgfr1 and Fgfr3 are differentially regulated within the same cell type, implicating these two receptors in different biological roles. Moreover, Fgfr1 and Fgfr3 are differentially regulated among different cell types, suggesting such autoregulation occurs in a cell type-specific fashion. Lastly, we demonstrate that FGF8b decreases Gnrh promoter activity and gene expression, possibly reflecting a downstream consequence of altered FGF receptor populations. Together, our data bring forth the possibility that, in addition to the FGF synexpression group, autoregulation of FGFR expression by FGF8 represents a mechanism by which FGF8 could fine-tune its regulatory actions.	[Mott, Natasha N.; Pak, Toni R.] Loyola Univ, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL 60153 USA; [Chung, Wilson C. J.; Tsai, Pei-San] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA	Loyola University Chicago; University of Colorado System; University of Colorado Boulder	Mott, NN (corresponding author), Loyola Univ, Stritch Sch Med, Dept Cell & Mol Physiol, 2160 S 1st Ave, Maywood, IL 60153 USA.	tpak@lumc.edu		Tsai, Pei-San/0000-0002-8650-647X; Chung, Wilson/0000-0003-0550-7567	NIH [RO1 AG033605, RO1 HD042634]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042634] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K99HD058044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033605] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by NIH RO1 AG033605 to TRP and NIH RO1 HD042634 to PST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarid ET, 2006, MOL ENDOCRINOL, V20, P1972, DOI 10.1210/me.2005-0481; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Arnaud-Dabernat S, 2008, J CELL PHYSIOL, V216, P261, DOI 10.1002/jcp.21401; Arnaud-Dabernat S, 2007, DIABETES, V56, P96, DOI 10.2337/db05-1073; Bridges TM, 2008, ACS CHEM BIOL, V3, P530, DOI 10.1021/cb800116f; CHANDRAN UR, 1994, ENDOCRINOLOGY, V134, P1467, DOI 10.1210/en.134.3.1467; Chung WCJ, 2008, ENDOCRINOLOGY, V149, P4997, DOI 10.1210/en.2007-1634; Estival A, 1996, J BIOL CHEM, V271, P5663, DOI 10.1074/jbc.271.10.5663; Gill JC, 2004, ENDOCRINOLOGY, V145, P3830, DOI 10.1210/en.2004-0214; Grand EK, 2004, LEUKEMIA, V18, P962, DOI 10.1038/sj.leu.2403347; GUO Q, DEV BIOL, V338, P183; Guo QX, 2007, DEVELOPMENT, V134, P2251, DOI 10.1242/dev.004929; Inglis-Broadgate SL, 2005, DEV BIOL, V279, P73, DOI 10.1016/j.ydbio.2004.11.035; Jang JH, 2005, ONCOGENE, V24, P945, DOI 10.1038/sj.onc.1208254; Jen WC, 1999, GENE DEV, V13, P1486, DOI 10.1101/gad.13.11.1486; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Kwabi-Addo B, 2004, ENDOCR-RELAT CANCER, V11, P709, DOI 10.1677/erc.1.00535; Lamar E, 2001, GENE DEV, V15, P1885, DOI 10.1101/gad.908101; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; MORIMOTO BH, 1990, NEURON, V5, P875, DOI 10.1016/0896-6273(90)90347-I; MOSCATELLI D, 1989, J CELL BIOL, V109, P2519, DOI 10.1083/jcb.109.5.2519; NEUFELD G, 1985, J BIOL CHEM, V260, P3860; Niehrs C, 2002, NATURE, V417, P35, DOI 10.1038/417035a; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Pak TR, 2006, ENDOCRINOLOGY, V147, P1924, DOI 10.1210/en.2005-1297; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Schoff CK, 2004, JCT COATINGSTECH, V1, P8; Skaper SD, 2000, J NEUROCHEM, V75, P1520, DOI 10.1046/j.1471-4159.2000.0751520.x; Thomson RE, 2007, J NEUROCHEM, V100, P1565, DOI 10.1111/j.1471-4159.2006.04285.x; Tomlinson DC, 2009, CANCER RES, V69, P4613, DOI 10.1158/0008-5472.CAN-08-2816; Tsai PS, 2005, MOL ENDOCRINOL, V19, P225, DOI 10.1210/me.2004-0330; Walker DM, 2009, ENDOCRINOLOGY, V150, P2308, DOI 10.1210/en.2008-1396; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	34	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10143	10.1371/journal.pone.0010143	http://dx.doi.org/10.1371/journal.pone.0010143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405041	Green Submitted, gold, Green Published			2022-12-25	WOS:000276705900020
J	Tunney, RJ; Fernie, G; Astle, DE				Tunney, Richard J.; Fernie, Gordon; Astle, Duncan E.			An ERP Analysis of Recognition and Categorization Decisions in a Prototype-Distortion Task	PLOS ONE			English	Article							PERCEPTUAL CATEGORIZATION; CATEGORY KNOWLEDGE; MEMORY; CLASSIFICATION; RECOLLECTION; POTENTIALS; VARIANCE; PATTERNS; IMPLICIT; EXPLICIT	Background: Theories of categorization make different predictions about the underlying processes used to represent categories. Episodic theories suggest that categories are represented in memory by storing previously encountered exemplars in memory. Prototype theories suggest that categories are represented in the form of a prototype independently of memory. A number of studies that show dissociations between categorization and recognition are often cited as evidence for the prototype account. These dissociations have compared recognition judgements made to one set of items to categorization judgements to a different set of items making a clear interpretation difficult. Instead of using different stimuli for different tests this experiment compares the processes by which participants make decisions about category membership in a prototype-distortion task and with recognition decisions about the same set of stimuli by examining the Event Related Potentials (ERPs) associated with them. Method: Sixty-three participants were asked to make categorization or recognition decisions about stimuli that either formed an artificial category or that were category non-members. We examined the ERP components associated with both kinds of decision for pre-exposed and control participants. Conclusion: In contrast to studies using different items we observed no behavioural differences between the two kinds of decision; participants were equally able to distinguish category members from non-members, regardless of whether they were performing a recognition or categorisation judgement. Interestingly, this did not interact with prior-exposure. However, the ERP data demonstrated that the early visual evoked response that discriminated category members from nonmembers was modulated by which judgement participants performed and whether they had been pre-exposed to category members. We conclude from this that any differences between categorization and recognition reflect differences in the information that participants focus on in the stimuli to make the judgements at test, rather than any differences in encoding or process.	[Tunney, Richard J.] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Fernie, Gordon] Univ Liverpool, Sch Psychol, Liverpool L69 3BX, Merseyside, England; [Astle, Duncan E.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Nottingham; University of Liverpool; University of Oxford	Tunney, RJ (corresponding author), Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England.	richard.tunney@nottingham.ac.uk		Astle, Duncan/0000-0002-7042-5392; Tunney, Richard/0000-0003-4673-757X	UK Economic and Social Research Council [RES-000-22-1830]; Economic and Social Research Council [ES/E002730/1] Funding Source: researchfish; ESRC [ES/E002730/1] Funding Source: UKRI	UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by a grant to Richard Tunney from the UK Economic and Social Research Council (RES-000-22-1830). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Curran T, 2000, MEM COGNITION, V28, P923, DOI 10.3758/BF03209340; Curran T, 2002, COGN AFFECT BEHAV NE, V2, P1, DOI 10.3758/CABN.2.1.1; Duzel E, 2001, P NATL ACAD SCI USA, V98, P8101, DOI 10.1073/pnas.131205798; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; JENNINGS JR, 1976, PSYCHOPHYSIOLOGY, V13, P277; KNOWLTON BJ, 1993, SCIENCE, V262, P1747, DOI 10.1126/science.8259522; KOLODNY JA, 1994, PSYCHOL SCI, V5, P164, DOI 10.1111/j.1467-9280.1994.tb00654.x; Little DM, 2006, BRAIN COGNITION, V60, P233, DOI 10.1016/j.bandc.2005.06.004; Little DM, 2006, BRAIN COGNITION, V60, P244, DOI 10.1016/j.bandc.2005.09.016; Luck S.J., 2005, INTRO EVENT RELATED; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; MEDIN DL, 1978, PSYCHOL REV, V85, P207, DOI 10.1037/0033-295X.85.3.207; Nosofsky RM, 1998, PSYCHOL SCI, V9, P247, DOI 10.1111/1467-9280.00051; Nosofsky RM, 2000, PSYCHON B REV, V7, P375; NOSOFSKY RM, 1992, ANNU REV PSYCHOL, V43, P25, DOI 10.1146/annurev.ps.43.020192.000325; Palmeri TJ, 1999, PSYCHOL SCI, V10, P526, DOI 10.1111/1467-9280.00200; POSNER MI, 1967, J EXP PSYCHOL, V73, P28, DOI 10.1037/h0024135; Reber PJ, 1998, P NATL ACAD SCI USA, V95, P747, DOI 10.1073/pnas.95.2.747; Reber PJ, 1998, LEARN MEMORY, V5, P420; Reber PJ, 2003, J COGNITIVE NEUROSCI, V15, P574, DOI 10.1162/089892903321662958; Reber PJ, 2002, COGNITIVE BRAIN RES, V14, P245, DOI 10.1016/S0926-6410(02)00122-2; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; SHIN HJ, 1992, J EXP PSYCHOL GEN, V121, P278, DOI 10.1037/0096-3445.121.3.278; SMITH JD, 2002, J EXPT PSYCHOL LEARN, V28, P200; Squire LR, 1995, P NATL ACAD SCI USA, V92, P12470, DOI 10.1073/pnas.92.26.12470; Tucker DM., 1994, HUM BRAIN MAPP, V1, DOI DOI 10.1002/HBM.460010206; Urbach TP, 2002, PSYCHOPHYSIOLOGY, V39, P791, DOI 10.1111/1469-8986.3960791; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190	29	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10116	10.1371/journal.pone.0010116	http://dx.doi.org/10.1371/journal.pone.0010116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	583UR	20404932	Green Published, Green Accepted, gold			2022-12-25	WOS:000276705900003
J	Shaya, D; Zhao, WJ; Garron, ML; Xiao, ZP; Cui, QZ; Zhang, ZQ; Sulea, T; Linhardt, RJ; Cygler, M				Shaya, David; Zhao, Wenjing; Garron, Marie-Line; Xiao, Zhongping; Cui, Qizhi; Zhang, Zhenqing; Sulea, Traian; Linhardt, Robert J.; Cygler, Miroslaw			Catalytic Mechanism of Heparinase II Investigated by Site-directed Mutagenesis and the Crystal Structure with Its Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN AC LYASE; FLAVOBACTERIUM-HEPARINUM; HEPARAN-SULFATE; COMPLEX; GLYCOSAMINOGLYCANS; PROTEOGLYCANS; PURIFICATION; DEGRADATION; PRODUCT; ENZYMES	Heparinase II (HepII) is an 85-kDa dimeric enzyme that depolymerizes both heparin and heparan sulfate glycosaminoglycans through a beta-elimination mechanism. Recently, we determined the crystal structure of HepII from Pedobacter heparinus (previously known as Flavobacterium heparinum) in complex with a heparin disaccharide product, and identified the location of its active site. Here we present the structure of HepII complexed with a heparan sulfate disaccharide product, proving that the same binding/active site is responsible for the degradation of both uronic acid epimers containing substrates. The key enzymatic step involves removal of a proton from the C5 carbon (a chiral center) of the uronic acid, posing a topological challenge to abstract the proton from either side of the ring in a single active site. We have identified three potential active site residues equidistant from C5 and located on both sides of the uronate product and determined their role in catalysis using a set of defined tetrasaccharide substrates. HepII H202A/Y257A mutant lost activity for both substrates and we determined its crystal structure complexed with a heparan sulfate-derived tetrasaccharide. Based on kinetic characterization of various mutants and the structure of the enzyme-substrate complex we propose residues participating in catalysis and their specific roles.	[Cui, Qizhi; Sulea, Traian; Cygler, Miroslaw] NRC, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Shaya, David; Garron, Marie-Line; Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Zhao, Wenjing; Xiao, Zhongping; Zhang, Zhenqing; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Zhao, Wenjing; Xiao, Zhongping; Zhang, Zhenqing; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol Chem, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Zhao, Wenjing; Xiao, Zhongping; Zhang, Zhenqing; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Zhao, Wenjing; Xiao, Zhongping; Zhang, Zhenqing; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol & Chem Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	National Research Council Canada; McGill University; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Cygler, M (corresponding author), NRC, Biotechnol Res Inst, 6100 Royalmt Ave, Montreal, PQ H4P 2R2, Canada.	mirek@bri.nrc.ca		Garron, Marie-Line/0000-0001-5846-1246	National Institutes of Health [HL62244, GM38060]; Canadian Institutes for Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL62244 and GM38060 (to R.J.L.) and the Canadian Institutes for Health Research (to M.C.). This is NRCC publication number 50698.	[Anonymous], 2008, AMBER 10; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chi LL, 2005, CURR ANAL CHEM, V1, P223, DOI 10.2174/157341105774573929; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Huang WJ, 2003, J MOL BIOL, V328, P623, DOI 10.1016/S0022-2836(03)00345-0; Huang WJ, 1999, J MOL BIOL, V294, P1257, DOI 10.1006/jmbi.1999.3292; Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; LINHARDT RJ, 1986, APPL BIOCHEM BIOTECH, V12, P135; LOHSE DL, 1992, J BIOL CHEM, V267, P24347; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; Menozzi FD, 2002, MOL MICROBIOL, V43, P1379, DOI 10.1046/j.1365-2958.2002.02841.x; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; MOFFAT CF, 1991, EUR J BIOCHEM, V202, P531, DOI 10.1111/j.1432-1033.1991.tb16405.x; MOFFAT CF, 1991, EUR J BIOCHEM, V197, P449, DOI 10.1111/j.1432-1033.1991.tb15931.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NADER HB, 1990, J BIOL CHEM, V265, P16807; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Petitou M, 1999, NATURE, V398, P417, DOI 10.1038/18877; Rhomberg AJ, 1998, P NATL ACAD SCI USA, V95, P12232, DOI 10.1073/pnas.95.21.12232; Shaya D, 2004, ACTA CRYSTALLOGR D, V60, P1644, DOI 10.1107/S0907444904016695; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Su HS, 2001, MICROBIOL-UK, V147, P581, DOI 10.1099/00221287-147-3-581; Su HS, 1996, APPL ENVIRON MICROB, V62, P2723, DOI 10.1128/AEM.62.8.2723-2734.1996; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wolff JJ, 2007, J AM SOC MASS SPECTR, V18, P234, DOI 10.1016/j.jasms.2006.09.020; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509; Zhang ZQ, 2008, J AM SOC MASS SPECTR, V19, P82, DOI 10.1016/j.jasms.2007.10.012	37	38	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20051	20061		10.1074/jbc.M110.101071	http://dx.doi.org/10.1074/jbc.M110.101071			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20404324	Green Published, hybrid			2022-12-25	WOS:000279012000039
J	Bang, S; Yoo, S; Yang, TJ; Cho, H; Hwang, SW				Bang, Sangsu; Yoo, Sungjae; Yang, Tae-Jin; Cho, Hawon; Hwang, Sun Wook			Farnesyl Pyrophosphate Is a Novel Pain-producing Molecule via Specific Activation of TRPV3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSORY NEURONS; 2-AMINOETHOXYDIPHENYL BORATE; ENDOGENOUS LIGANDS; ION CHANNELS; RECEPTOR; HEAT; KERATINOCYTES; SKIN; BISPHOSPHONATES; IDENTIFICATION	Temperature-sensitive transient receptor potential ion channels (thermoTRPs) expressed in epidermal keratinocytes and sensory afferents play an important role as peripheral pain detectors for our body. Many natural and synthetic compounds have been found to act on the thermoTRPs leading to altered nociception, but little is known about endogenous painful molecules activating TRPV3. Here, we show that farnesyl pyrophosphate (FPP), an intermediate metabolite in the mevalonate pathway, specifically activates TRPV3 among six thermoTRPs using Ca2+ imaging and electrophysiology with cultured keratinocytes and TRPV3-overexpressing cells. Agonistic potencies of related compounds in the FPP metabolism were ignorable. Voltage-dependence of TRPV3 was shifted by FPP, which appears to be the activation mechanism. An intraplantar injection of FPP acutely elicits nociceptive behaviors in inflamed animals, indicating that FPP is a novel endogenous pain-producing substance via TRPV3 activation. Co-culture experiments demonstrated that this FPP-evoked signal in the keratinocytes is transmitted to sensory neurons. In addition, FPP reduced TRPV3 heat threshold resulting in heightened behavioral sensitivity to noxious heat. Taken together, our data suggest that FPP is the firstly identified endogenous TRPV3 activator that causes nociception. Our results may provide useful chemical information to elucidate TRPV3 physiology and novel pain-related metabolisms.	Korea Univ, Grad Sch Med, Seoul 136705, South Korea; [Cho, Hawon] Seoul Natl Univ, Sensory Res Ctr, Coll Pharm, CRI, Seoul 151742, South Korea	Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Hwang, SW (corresponding author), Korea Univ, Ansan Hosp, 3513,Gojan 1 Dong, Ansan 425707, Gyeonggi Do, South Korea.	sunhwang@korea.ac.kr	bang, sangsu/U-4313-2017; Bang, Sangsu/AAN-7238-2020	bang, sangsu/0000-0002-9092-0075; Hwang, Sun Wook/0000-0001-8460-7480	Korea Research Foundation, the Republic of Korea [KRF-2008-331-E00457, 2009-0076543]	Korea Research Foundation, the Republic of Korea(National Research Foundation of Korea)	This work was supported by Korea Research Foundation Grants (Codes KRF-2008- 331-E00457 and 2009-0076543), the Republic of Korea.	Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Bang S, 2007, EUR J NEUROSCI, V26, P2516, DOI 10.1111/j.1460-9568.2007.05882.x; Bang SS, 2007, NEUROSCI LETT, V425, P120, DOI 10.1016/j.neulet.2007.08.035; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Henneman L, 2008, ANAL BIOCHEM, V383, P18, DOI 10.1016/j.ab.2008.08.023; Hu HZ, 2006, J CELL PHYSIOL, V208, P201, DOI 10.1002/jcp.20648; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huang SM, 2008, J NEUROSCI, V28, P13727, DOI 10.1523/JNEUROSCI.5741-07.2008; Kim KY, 2008, BIOCHEM BIOPH RES CO, V370, P295, DOI 10.1016/j.bbrc.2008.03.077; Koizumi S, 2004, BIOCHEM J, V380, P329, DOI 10.1042/BJ20031089; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Liliom K, 2006, BBA-MOL CELL BIOL L, V1761, P1506, DOI 10.1016/j.bbalip.2006.09.012; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Mandadi S, 2009, PFLUG ARCH EUR J PHY, V458, P1093, DOI 10.1007/s00424-009-0703-x; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Moussaieff A, 2008, FASEB J, V22, P3024, DOI 10.1096/fj.07-101865; Oh DY, 2008, J BIOL CHEM, V283, P21054, DOI 10.1074/jbc.M708908200; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Russell RGG, 2007, ANN NY ACAD SCI, V1117, P209, DOI 10.1196/annals.1402.089; Saisho Y, 1997, ANAL BIOCHEM, V252, P89, DOI 10.1006/abio.1997.2314; Sharma A, 2006, CURR OPIN ANESTHESIO, V19, P566, DOI 10.1097/01.aco.0000245286.30282.ab; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Stotz SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002082; Sutherland S P, 2000, Prog Brain Res, V129, P21; Vogt-Eisele AK, 2007, BRIT J PHARMACOL, V151, P530, DOI 10.1038/sj.bjp.0707245; von Moos R, 2008, SUPPORT CARE CANCER, V16, P1105, DOI 10.1007/s00520-008-0487-0; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Vyklicky L, 1999, J PHYSIOL-LONDON, V517, P181, DOI 10.1111/j.1469-7793.1999.0181z.x; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yoo S, 2009, MOL CELLS, V27, P417, DOI 10.1007/s10059-009-0059-2; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Yoshioka T, 2009, J INVEST DERMATOL, V129, P714, DOI 10.1038/jid.2008.245	37	94	96	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19362	19371		10.1074/jbc.M109.087742	http://dx.doi.org/10.1074/jbc.M109.087742			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20395302	Green Published, hybrid			2022-12-25	WOS:000278727800047
J	Thompson, CL; Hofer, MJ; Campbell, IL; Holmes, AJ				Thompson, Claire L.; Hofer, Markus J.; Campbell, Iain L.; Holmes, Andrew J.			Community Dynamics in the Mouse Gut Microbiota: A Possible Role for IRF9-Regulated Genes in Community Homeostasis	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; INFLAMMATORY-BOWEL-DISEASE; INBRED MICE; TARGETED DISRUPTION; IMMUNE-RESPONSES; INNATE IMMUNITY; REVEALS; CELLS; SUSCEPTIBILITY; ACTIVATION	Background: Gut microbial communities of mammals are thought to show stable differences between individuals. This means that the properties imparted by the gut microbiota become a unique and constant characteristic of the host. Manipulation of the microbiota has been proposed as a useful tool in health care, but a greater understanding of mechanisms which lead to community stability is required. Here we have examined the impact of host immunoregulatory phenotype on community dynamics. Methods and Findings: Denaturing gradient gel electrophoresis was used to analyse the faecal bacterial community of BALB/c and C57BL/6 mice and C57BL/6 mice deficient for either type I interferon (IFN) signalling (IRF9 KO mice) or type I and type II IFN signalling (STAT1 KO mice). Temporal variation was found in all mouse strains. A measure of the ability for a community structure characteristic of the host to be maintained over time, the individuality index, varied between mouse strains and available data from pigs and human models. IRF9 KO mice had significantly higher temporal variation, and lower individuality, than other mouse strains. Examination of the intestinal mucosa of the IRF9 KO mice revealed an increased presence of T-cells and neutrophils in the absence of inflammation. Significance: The high temporal variation observed in the gut microbiota of inbred laboratory mice has implications for their use as experimental models for the human gut microbiota. The distinct IRF9 and STAT1 phenotypes suggest a role for IRF9 in immune regulation within the gut mucosa and that further study of interferon responsive genes is necessary to understand host-gut microbe relationships.	[Thompson, Claire L.; Hofer, Markus J.; Campbell, Iain L.; Holmes, Andrew J.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Hofer, Markus J.] Univ Marburg, Dept Neuropathol, Marburg, Germany	University of Sydney; Philipps University Marburg	Thompson, CL (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia.	claire.thompson@mpi-marburg.mpg.de	Hofer, Markus J/C-3688-2013; Holmes, Andrew/AAI-2845-2020	Hofer, Markus J/0000-0001-5111-3978; 	National Health and Medical Research Council (NHMRC) [512407]; Selby Research Trust; Australian Postgraduate Award (APA); Deutsche Forschungsgemeinschaft (DFG) [HO3298/1-1]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Selby Research Trust; Australian Postgraduate Award (APA)(Australian Government); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants from the National Health and Medical Research Council (NHMRC) (512407) and the Selby Research Trust. CT was the recipient of an Australian Postgraduate Award (APA). MJH was a postdoctoral fellow from the Deutsche Forschungsgemeinschaft (DFG HO3298/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; ALPERS JH, 1972, CLIN EXP IMMUNOL, V12, P121; AUTENRIETH IB, 1994, INFECT IMMUN, V62, P2590, DOI 10.1128/IAI.62.6.2590-2599.1994; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bellier S, 2005, AM J PHYSIOL-GASTR L, V288, pG151, DOI 10.1152/ajpgi.00048.2004; BLUYSSEN HAR, 1995, P NATL ACAD SCI USA, V92, P5645, DOI 10.1073/pnas.92.12.5645; BRALEY HC, 1971, CELL IMMUNOL, V2, P73, DOI 10.1016/0008-8749(71)90026-8; Calleri DV, 2006, P ROY SOC B-BIOL SCI, V273, P2633, DOI 10.1098/rspb.2006.3622; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Cosseau C, 2008, INFECT IMMUN, V76, P4163, DOI 10.1128/IAI.00188-08; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DELPRETE GF, 1993, EUR J IMMUNOL, V23, P1445, DOI 10.1002/eji.1830230707; DeSesso JM, 2001, FOOD CHEM TOXICOL, V39, P209, DOI 10.1016/S0278-6915(00)00136-8; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; EBINO KY, 1988, LAB ANIM, V22, P1, DOI 10.1258/002367788780746548; Ferrari VC, 1999, HYDROBIOLOGIA, V401, P55, DOI 10.1023/A:1003773907789; Fushuku S, 2008, EXP ANIM TOKYO, V57, P95, DOI 10.1538/expanim.57.95; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; KETT K, 1995, GASTROENTEROLOGY, V109, P819, DOI 10.1016/0016-5085(95)90389-5; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li HK, 2007, J PROTEOME RES, V6, P1364, DOI 10.1021/pr060513q; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; McCracken VJ, 2001, J NUTR, V131, P1862, DOI 10.1093/jn/131.6.1862; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Moeseneder MM, 1999, APPL ENVIRON MICROB, V65, P3518; Munder A, 2005, MICROBES INFECT, V7, P600, DOI 10.1016/j.micinf.2004.12.021; Neaville WA, 2003, J ALLERGY CLIN IMMUN, V112, P740, DOI 10.1016/S0091-6749(03)01868-2; NIESSNER M, 1995, CLIN EXP IMMUNOL, V101, P428; Nubel U, 1996, J BACTERIOL, V178, P5636; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Reid JM, 2003, P ROY SOC B-BIOL SCI, V270, P2151, DOI 10.1098/rspb.2003.2480; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SALYERS AA, 1977, APPL ENVIRON MICROB, V34, P529, DOI 10.1128/AEM.34.5.529-533.1977; Sambrook J, 2001, MOL CLONING LAB MANU; Saric J, 2008, J PROTEOME RES, V7, P352, DOI 10.1021/pr070340k; Schindler C, 1999, CELL MOL LIFE SCI, V55, P1509, DOI 10.1007/s000180050391; Schultz M, 1999, AM J PHYSIOL-GASTR L, V276, pG1461, DOI 10.1152/ajpgi.1999.276.6.G1461; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Simpson JM, 2000, APPL ENVIRON MICROB, V66, P4705, DOI 10.1128/AEM.66.11.4705-4714.2000; Simpson JM, 1999, J MICROBIOL METH, V36, P167, DOI 10.1016/S0167-7012(99)00029-9; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sun B, 1997, J IMMUNOL, V159, P1004; Thibault DL, 2008, J CLIN INVEST, V118, P1417, DOI 10.1172/JCI30065; Thompson CL, 2008, ISME J, V2, P739, DOI 10.1038/ismej.2008.29; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; WEAVER GA, 1989, GUT, V30, P19, DOI 10.1136/gut.30.1.19; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Yeates C, 1998, Biol Proced Online, V1, P40, DOI 10.1251/bpo6; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	60	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10335	10.1371/journal.pone.0010335	http://dx.doi.org/10.1371/journal.pone.0010335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428250	Green Published, Green Submitted, gold			2022-12-25	WOS:000277079300019
J	Kolwijck, E; Wevers, RA; Engelke, UF; Woudenberg, J; Bulten, J; Blom, HJ; Massuger, LFAG				Kolwijck, Eva; Wevers, Ron A.; Engelke, Udo F.; Woudenberg, Jannes; Bulten, Johan; Blom, Henk J.; Massuger, Leon F. A. G.			Ovarian Cyst Fluid of Serous Ovarian Tumors Contains Large Quantities of the Brain Amino Acid N-acetylaspartate	PLOS ONE			English	Article							MAST-CELLS; NERVOUS-SYSTEM; BLOOD	Background: In humans, N-acetyl L-aspartate (NAA) has not been detected in other tissues than the brain. The physiological function of NAA is yet undefined. Recently, it has been suggested that NAA may function as a molecular water pump, responsible for the removal of large amounts of water from the human brain. Ovarian tumors typically present as large cystic masses with considerable fluid accumulation. Methodology and Principal Findings: Using Gas Chromatography-Mass Spectrometry, we demonstrated that NAA was present in a high micromolar concentration in oCF of epithelial ovarian tumors (EOTs) of serous histology, sometimes in the same range as found in the extracellular space of the human brain. In contrast, oCF of EOTs with a mucinous, endometrioid and clear cell histological subtype contained a low micromolar concentration of NAA. Serous EOTs have a cellular differentiation pattern which resembles the lining of the fallopian tube and differs from the other histological subtypes. The NAA concentration in two samples of fluid accumulation in the fallopian tube (hydrosalpinx) was in the same ranges as NAA found in oCF of serous EOTs. The NAA concentration in oCF of patients with serous EOTs was mostly 10 to 50 fold higher than their normal serum NAA concentration, whereas in patients with other EOT subtypes, serum and cyst fluid NAA concentration was comparable. Conclusions and Significance: The high concentration of NAA in cyst fluid of serous EOTs and low serum concentrations of NAA in these patients, suggest a local production of NAA in serous EOTs. Our findings provide the first identification of NAA concentrations high enough to suggest local production outside the human brain. Our findings contribute to the ongoing research understanding the physiological function of NAA in the human body.	[Kolwijck, Eva; Massuger, Leon F. A. G.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynecol, NL-6525 ED Nijmegen, Netherlands; [Wevers, Ron A.; Engelke, Udo F.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat & Neurol, NL-6525 ED Nijmegen, Netherlands; [Woudenberg, Jannes] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol, NL-6525 ED Nijmegen, Netherlands; [Bulten, Johan] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Blom, Henk J.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Amsterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Vrije Universiteit Amsterdam	Kolwijck, E (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynecol, NL-6525 ED Nijmegen, Netherlands.	r.wevers@labgk.umcn.nl	Engelke, U.F.H./L-4293-2015; Kolwijck, E./L-4444-2015; Wevers, Ron A./H-8116-2014; Bulten, J./L-4237-2015; Massuger, Leon F.A.G./H-8072-2014	Wevers, Ron A./0000-0003-2278-9746; Bulten, J./0000-0002-8168-6045; Blom, Henk/0000-0001-5202-9241				Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Baslow MH, 1999, NEUROCHEM INT, V34, P77, DOI 10.1016/S0197-0186(98)00073-4; Baslow MH, 2002, NEUROCHEM INT, V40, P295, DOI 10.1016/S0197-0186(01)00095-X; Baslow MH, 1997, EXP EYE RES, V64, P283, DOI 10.1006/exer.1996.0205; Bell DA, 2005, MODERN PATHOL, V18, pS19, DOI 10.1038/modpathol.3800306; Boss EA, 2000, NMR BIOMED, V13, P297, DOI 10.1002/1099-1492(200008)13:5<297::AID-NBM648>3.0.CO;2-I; Burlina AP, 2006, ADV EXP MED BIOL, V576, P283; Burlina AP, 1997, J NEUROCHEM, V69, P1314; Chan JK, 2005, GYNECOL ONCOL, V99, P20, DOI 10.1016/j.ygyno.2005.05.042; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Galinsky DST, 2008, CRIT REV ONCOL HEMAT, V68, P115, DOI 10.1016/j.critrevonc.2008.06.001; George RL, 2004, BBA-MOL BASIS DIS, V1690, P63, DOI 10.1016/j.bbadis.2004.05.009; JAKOBS C, 1991, J INHERIT METAB DIS, V14, P653, DOI 10.1007/BF01799929; KOLWIJCK E, 2009, NMR BIOMED, V10; KURMAN RJ, 2002, BLAUSTEINS PATHOLOGY, P3; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Naora Honami, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000324; Pecorelli S, 1999, INT J GYNECOL OBSTET, V65, P243, DOI 10.1016/S0020-7292(99)00070-3; Samoszuk M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-121; SCHRAGER J, 1970, GUT, V11, P450, DOI 10.1136/gut.11.5.450; SERVOV SF, 1973, INT HISTOLOGIC CLASS, V9; Soslow RA, 2008, INT J GYNECOL PATHOL, V27, P161, DOI 10.1097/PGP.0b013e31815ea812; VALENT P, 1989, BLOOD, V73, P1778	23	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10293	10.1371/journal.pone.0010293	http://dx.doi.org/10.1371/journal.pone.0010293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421982	Green Published, gold, Green Submitted			2022-12-25	WOS:000276952600011
J	Ge, BS; Yang, F; Yu, DY; Liu, S; Xu, H				Ge, Baosheng; Yang, Feng; Yu, Daoyong; Liu, Shuang; Xu, Hai			Designer Amphiphilic Short Peptides Enhance Thermal Stability of Isolated Photosystem-I	PLOS ONE			English	Article							CYANOBACTERIUM SPIRULINA-PLATENSIS; PROTEIN-COUPLED RECEPTOR; CIRCULAR-DICHROISM; HIGHER-PLANTS; MEMBRANE; COMPLEX; PURIFICATION; ANGSTROM; FORMS	Stability of membrane protein is crucial during protein purification and crystallization as well as in the fabrication of protein-based devices. Several recent studies have examined how various surfactants can stabilize membrane proteins out of their native membrane environment. However, there is still no single surfactant that can be universally employed for all membrane proteins. Because of the lack of knowledge on the interaction between surfactants and membrane proteins, the choice of a surfactant for a specific membrane protein remains purely empirical. Here we report that a group of short amphiphilic peptides improve the thermal stability of the multi-domain protein complex photosystem-I (PS-I) in aqueous solution and that the peptide surfactants have obvious advantages over other commonly used alkyl chain based surfactants. Of all the short peptides studied, Ac-I(5)K(2)-CONH(2) (I(5)K(2)) showed the best stabilizing effect by enhancing the melting temperature of PS-I from 48.0 degrees C to 53.0 degrees C at concentration of 0.65 mM and extending the half life of isolated PS-I significantly. AFM experiments showed that PS-I/I(5)K(2)/Triton X-100 formed large and stable vesicles and thus provide interfacial environment mimicking that of native membranes, which may partly explain why I(5)K(2) enhanced the thermal stability of PS-I. Hydrophobic and hydrophilic group length of I(x)K(y) had an important influence on the stabilization of PS-I. Our results showed that longer hydrophobic group was more effective in stabilizing PS-I. These simple short peptides therefore exhibit significant potential for applications in membrane protein studies.	[Ge, Baosheng; Yang, Feng; Yu, Daoyong; Liu, Shuang; Xu, Hai] China Univ Petr, Ctr Bioengn & Biotechnol, Qingdao, Peoples R China	China University of Petroleum	Ge, BS (corresponding author), China Univ Petr, Ctr Bioengn & Biotechnol, Qingdao, Peoples R China.	daoyong@upc.edu.cn; xuh@upc.edu.cn	Yu, Daoyong/E-5269-2013; Ge, Baosheng/AAT-4788-2020	Yu, Daoyong/0000-0002-3380-1897; Ge, Baosheng/0000-0001-9906-2081	Jiangsu Key Laboratory of Marine Biotechnology; Huaihai Institute of Technology [2007HS008]; Fundamental Research Funds for the Central Universitiesty [09CX05005A]; National Natural Science Foundation of China [20773164]	Jiangsu Key Laboratory of Marine Biotechnology; Huaihai Institute of Technology; Fundamental Research Funds for the Central Universitiesty; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported in part by the Open-End Funds of Jiangsu Key Laboratory of Marine Biotechnology, Huaihai Institute of Technology (2007HS008), the Fundamental Research Funds for the Central Universitiesty (09CX05005A), and the National Natural Science Foundation of China (20773164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Baumann MK, 2008, LANGMUIR, V24, P7645, DOI 10.1021/la801605b; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Bieri C, 1999, NAT BIOTECHNOL, V17, P1105, DOI 10.1038/15090; Brettel K, 1998, BBA-BIOENERGETICS, V1363, P175, DOI 10.1016/S0005-2728(98)00010-3; BRUCE BD, 1988, J BIOL CHEM, V263, P7302; Cometta A, 2000, BIOPHYS J, V79, P3235, DOI 10.1016/S0006-3495(00)76556-8; Dahlin C, 2003, PHOTOSYNTHETICA, V41, P635, DOI 10.1023/B:PHOT.0000027532.55335.a7; Das R, 2004, NANO LETT, V4, P1079, DOI 10.1021/nl049579f; Engelmann E, 2001, FEBS LETT, V499, P112, DOI 10.1016/S0014-5793(01)02533-9; Fang Ye, 2004, Methods Mol Biol, V264, P233; Fersht A, 1999, STRUCTURE MECH PROTE, P510; HOFFMAN A, 1997, PLAYBACK        1201, P1; Hong Q, 2001, BIOCHEM SOC T, V29, P578, DOI 10.1042/BST0290578; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kiley P, 2005, PLOS BIOL, V3, P1180, DOI 10.1371/journal.pbio.0030230; KOMIYAMA T, 1984, J BIOCHEM-TOKYO, V95, P1569, DOI 10.1093/oxfordjournals.jbchem.a134769; Li DH, 2004, ACTA BOT SIN, V46, P423; Matsumoto K, 2009, J PHYS CHEM B, V113, P75, DOI 10.1021/jp8021425; NAO T, 2008, THIN SOLID FILMS, V516, P2553; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; SCHAFMEISTER CE, 1993, SCIENCE, V262, P734, DOI 10.1126/science.8235592; Sener MK, 2005, BIOPHYS J, V89, P1630, DOI 10.1529/biophysj.105.066464; SHUBIN VV, 1993, FEBS LETT, V334, P79, DOI 10.1016/0014-5793(93)81685-S; Sun HX, 2008, J SEP SCI, V31, P1201, DOI 10.1002/jssc.200700508; YANG F, 2009, SEPARATION CHARACTER, P22; Yeh JI, 2005, BIOCHEMISTRY-US, V44, P16912, DOI 10.1021/bi051357o; Zhao BB, 2008, PLANT SCI, V175, P556, DOI 10.1016/j.plantsci.2008.06.003; Zhao XJ, 2006, P NATL ACAD SCI USA, V103, P17707, DOI 10.1073/pnas.0607167103; Zhao XJ, 2009, CURR OPIN COLLOID IN, V14, P340, DOI 10.1016/j.cocis.2009.07.002	30	25	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10233	10.1371/journal.pone.0010233	http://dx.doi.org/10.1371/journal.pone.0010233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422003	gold, Green Published, Green Submitted			2022-12-25	WOS:000276952500010
J	Kim, S; Rusmevichientong, A; Dong, BH; Remenyi, R; Silverman, RH; Chow, SA				Kim, Sanggu; Rusmevichientong, Alice; Dong, Beihua; Remenyi, Roland; Silverman, Robert H.; Chow, Samson A.			Fidelity of Target Site Duplication and Sequence Preference during Integration of Xenotropic Murine Leukemia Virus-Related Virus	PLOS ONE			English	Article							RETROVIRAL DNA INTEGRATION; GENOME-WIDE ANALYSIS; PROSTATE-CANCER; CONCERTED INTEGRATION; INFECTIOUS RETROVIRUS; HIV-1 INTEGRATION; CORE DOMAIN; RNASE-L; TYPE-1; SPECIFICITY	Xenotropic murine leukemia virus (MLV)-related virus (XMRV) is a new human retrovirus associated with prostate cancer and chronic fatigue syndrome. The causal relationship of XMRV infection to human disease and the mechanism of pathogenicity have not been established. During retrovirus replication, integration of the cDNA copy of the viral RNA genome into the host cell chromosome is an essential step and involves coordinated joining of the two ends of the linear viral DNA into staggered sites on target DNA. Correct integration produces proviruses that are flanked by a short direct repeat, which varies from 4 to 6 bp among the retroviruses but is invariant for each particular retrovirus. Uncoordinated joining of the two viral DNA ends into target DNA can cause insertions, deletions, or other genomic alterations at the integration site. To determine the fidelity of XMRV integration, cells infected with XMRV were clonally expanded and DNA sequences at the viral-host DNA junctions were determined and analyzed. We found that a majority of the provirus ends were correctly processed and flanked by a 4-bp direct repeat of host DNA. A weak consensus sequence was also detected at the XMRV integration sites. We conclude that integration of XMRV DNA involves a coordinated joining of two viral DNA ends that are spaced 4 bp apart on the target DNA and proceeds with high fidelity.	[Kim, Sanggu; Chow, Samson A.] Univ Calif Los Angeles, Biomed Engn Interdepartmental Program, Los Angeles, CA 90024 USA; [Rusmevichientong, Alice; Remenyi, Roland; Chow, Samson A.] Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; [Rusmevichientong, Alice; Remenyi, Roland; Chow, Samson A.] Univ Calif Los Angeles, Sch Med, AIDS Inst, Los Angeles, CA 90024 USA; [Dong, Beihua; Silverman, Robert H.] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44106 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cleveland Clinic Foundation	Kim, S (corresponding author), Univ Calif Los Angeles, Biomed Engn Interdepartmental Program, Los Angeles, CA 90024 USA.	schow@mednet.ucla.edu	/D-4928-2018	/0000-0003-1644-6464	National Institutes of Health (NIH) [CA68859]; The Margaret E. Early Medical Research Trust; U.S. Department of Defense Prostate Cancer Research Program [W81XWH-07-1-338]; NIH [CA103943]; Charlotte Geyer Foundation; Mal and Lea Bank Chair; UCLA Graduate Division; NATIONAL CANCER INSTITUTE [R01CA068859, R01CA103943] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Margaret E. Early Medical Research Trust; U.S. Department of Defense Prostate Cancer Research Program(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charlotte Geyer Foundation; Mal and Lea Bank Chair; UCLA Graduate Division; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health (NIH) Grant CA68859 and The Margaret E. Early Medical Research Trust Grant to S. A. C., and by grant number W81XWH-07-1-338 from the U.S. Department of Defense Prostate Cancer Research Program, NIH Grant CA103943, the Charlotte Geyer Foundation, and the Mal and Lea Bank Chair to R. H. S. S. K. is partly supported by a Dissertation Year Fellowship Award from the UCLA Graduate Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar A, 1996, J VIROL, V70, P3571, DOI 10.1128/JVI.70.6.3571-3580.1996; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; BOR YC, 1995, P NATL ACAD SCI USA, V92, P10334, DOI 10.1073/pnas.92.22.10334; Brown P. O., 1997, P161; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Casey G, 2002, NAT GENET, V32, P582, DOI 10.1038/ng1021; CRAIGIE R, 1992, TRENDS GENET, V8, P187, DOI 10.1016/0168-9525(92)90223-Q; Derse D, 2007, J VIROL, V81, P6731, DOI 10.1128/JVI.02752-06; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Gabriel R, 2009, NAT MED, V15, P1431, DOI 10.1038/nm.2057; Goodarzi G, 1999, J VIROL, V73, P8104, DOI 10.1128/JVI.73.10.8104-8111.1999; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Hacker CV, 2006, MOL THER, V14, P536, DOI 10.1016/j.ymthe.2006.06.006; Hindmarsh P, 1999, J VIROL, V73, P2994, DOI 10.1128/JVI.73.4.2994-3003.1999; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Holmes-Son M L, 2001, Adv Genet, V43, P33, DOI 10.1016/S0065-2660(01)43003-3; HOROWITZ JM, 1987, J VIROL, V61, P701, DOI 10.1128/JVI.61.3.701-707.1987; Kang YB, 2006, J VIROL, V80, P8820, DOI 10.1128/JVI.00719-06; KATZMAN M, 1995, J VIROL, V69, P5687, DOI 10.1128/JVI.69.9.5687-5696.1995; Kim S, 2008, J VIROL, V82, P9964, DOI 10.1128/JVI.01299-08; Kim S, 2006, J VIROL, V80, P11313, DOI 10.1128/JVI.01737-06; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Lewinski MK, 2005, J VIROL, V79, P6610, DOI 10.1128/JVI.79.11.6610-6619.2005; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Mikkers H, 2003, ADV CANCER RES, V88, P53, DOI 10.1016/S0065-230X(03)88304-5; Moalic Y, 2006, J VIROL, V80, P10980, DOI 10.1128/JVI.00904-06; Moreau K, 2004, VIROLOGY, V318, P566, DOI 10.1016/j.virol.2003.09.037; Moreau K, 2000, VIROLOGY, V278, P133, DOI 10.1006/viro.2000.0641; MUESING MA, 1985, NATURE, V313, P450, DOI 10.1038/313450a0; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; MURPHY JE, 1992, J VIROL, V66, P5092, DOI 10.1128/JVI.66.8.5092-5095.1992; Nowrouzi A, 2006, J GEN VIROL, V87, P1339, DOI 10.1099/vir.0.81554-0; Oh J, 2006, J VIROL, V80, P451, DOI 10.1128/JVI.80.1.451-459.2006; Oh J, 2006, J VIROL, V80, P10281, DOI 10.1128/JVI.00361-06; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; Rosenberg N., 1997, P475; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shibagaki Y, 1997, J BIOL CHEM, V272, P8361, DOI 10.1074/jbc.272.13.8361; SHIMOTOHNO K, 1980, P NATL ACAD SCI-BIOL, V77, P7357, DOI 10.1073/pnas.77.12.7357; SHIMOTOHNO K, 1980, NATURE, V285, P550, DOI 10.1038/285550a0; SHOEMAKER C, 1981, J VIROL, V40, P164, DOI 10.1128/JVI.40.1.164-172.1981; SHOEMAKER C, 1980, P NATL ACAD SCI-BIOL, V77, P3932, DOI 10.1073/pnas.77.7.3932; Silverman RH, 2003, BIOCHEMISTRY-US, V42, P1805, DOI 10.1021/bi027147i; Sinha S, 2002, J VIROL, V76, P3105, DOI 10.1128/JVI.76.7.3105-3113.2002; Taganov K, 2001, J VIROL, V75, P9549, DOI 10.1128/JVI.75.19.9549-9552.2001; Taganov KD, 2004, J VIROL, V78, P5848, DOI 10.1128/JVI.78.11.5848-5855.2004; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; Vatakis DN, 2009, J VIROL, V83, P6222, DOI 10.1128/JVI.00356-09; VINCENT KA, 1990, NUCLEIC ACIDS RES, V18, P6045, DOI 10.1093/nar/18.20.6045; VINK C, 1990, J VIROL, V64, P5626, DOI 10.1128/JVI.64.11.5626-5627.1990; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; WITHERSWARD ES, 1994, GENE DEV, V8, P1473, DOI 10.1101/gad.8.12.1473; Xiang Y, 2003, CANCER RES, V63, P6795; Yoder KE, 2000, J VIROL, V74, P11191, DOI 10.1128/JVI.74.23.11191-11200.2000	61	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10255	10.1371/journal.pone.0010255	http://dx.doi.org/10.1371/journal.pone.0010255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20421928	Green Published, Green Submitted, gold			2022-12-25	WOS:000276854300014
J	Hu, JW; Ljubimova, JY; Inoue, S; Konda, B; Patil, R; Ding, H; Espinoza, A; Wawrowsky, KA; Patil, C; Ljubimov, AV; Black, KL				Hu, Jinwei; Ljubimova, Julia Y.; Inoue, Satoshi; Konda, Bindu; Patil, Rameshwar; Ding, Hui; Espinoza, Andres; Wawrowsky, Kolja A.; Patil, Chirag; Ljubimov, Alexander V.; Black, Keith L.			Phosphodiesterase Type 5 Inhibitors Increase Herceptin Transport and Treatment Efficacy in Mouse Metastatic Brain Tumor Models	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; BREAST-CANCER; BLOOD-BRAIN; BARRIER PERMEABILITY; INTRACAROTID INFUSION; BRADYKININ ANALOG; NITRIC-OXIDE; LUNG-CANCER; IN-VIVO; CHEMOTHERAPY	Background: Chemotherapeutic drugs and newly developed therapeutic monoclonal antibodies are adequately delivered to most solid and systemic tumors. However, drug delivery into primary brain tumors and metastases is impeded by the blood-brain tumor barrier (BTB), significantly limiting drug use in brain cancer treatment. Methodology/Principal Findings: We examined the effect of phosphodiesterase 5 (PDE5) inhibitors in nude mice on drug delivery to intracranially implanted human lung and breast tumors as the most common primary tumors forming brain metastases, and studied underlying mechanisms of drug transport. In vitro assays demonstrated that PDE5 inhibitors enhanced the uptake of [C-14] dextran and trastuzumab (Herceptin (R), a humanized monoclonal antibody against HER2/neu) by cultured mouse brain endothelial cells (MBEC). The mechanism of drug delivery was examined using inhibitors for caveolae-mediated endocytosis, macropinocytosis and coated pit/clathrin endocytosis. Inhibitor analysis strongly implicated caveolae and macropinocytosis endocytic pathways involvement in the PDE5 inhibitor-enhanced Herceptin uptake by MBEC. Oral administration of PDE5 inhibitor, vardenafil, to mice with HER2-positive intracranial lung tumors led to an increased tumor permeability to high molecular weight [C-14] dextran (2.6-fold increase) and to Herceptin (2-fold increase). Survival time of intracranial lung cancer-bearing mice treated with Herceptin in combination with vardenafil was significantly increased as compared to the untreated, vardenafil- or Herceptin-treated mice (p<0.01). Log-rank survival analysis of mice bearing HER2-positive intracranial breast tumor also showed a significant survival increase (p<0.02) in the group treated with Herceptin plus vardenafil as compared to other groups. However, vardenafil did not exert any beneficial effect on survival of mice bearing intracranial breast tumor with low HER2 expression and co-treated with Herceptin (p>0.05). Conclusions/Significance: These findings suggest that PDE5 inhibitors may effectively modulate BTB permeability, and enhance delivery and therapeutic efficacy of monoclonal antibodies in hard-to-treat brain metastases from different primary tumors that had metastasized to the brain.	[Hu, Jinwei; Ljubimova, Julia Y.; Inoue, Satoshi; Konda, Bindu; Patil, Rameshwar; Ding, Hui; Espinoza, Andres; Patil, Chirag; Black, Keith L.] Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Dept Neurosurg, Los Angeles, CA 90048 USA; [Wawrowsky, Kolja A.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Ljubimov, Alexander V.] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Ljubimov, Alexander V.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hu, JW (corresponding author), Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Dept Neurosurg, Los Angeles, CA 90048 USA.	ljubimovaj@cshs.org	Ljubimov, Alexander/CAE-9130-2022; Ljubimov, Alexander V/E-5883-2013	Patil, Chirag/0000-0001-9068-1898; Ljubimov, Alexander/0000-0003-2398-5319; Black, Keith/0000-0002-0546-4934	NATIONAL CANCER INSTITUTE [R01CA123495] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013431] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA123495] Funding Source: Medline; NCRR NIH HHS [M01 RR000425, M01 RR00425] Funding Source: Medline; NEI NIH HHS [R01 EY13431, R01 EY013431] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arpino G, 2007, JNCI-J NATL CANCER I, V99, P694, DOI 10.1093/jnci/djk151; Asotra Kamlesh, 2003, Methods Mol Med, V89, P177; Black KL, 2008, BRAIN RES, V1230, P290, DOI 10.1016/j.brainres.2008.06.122; Black KL, 1997, J NEUROSURG, V86, P603, DOI 10.3171/jns.1997.86.4.0603; Boolell M, 1996, Int J Impot Res, V8, P47; Contessa JN, 2008, MOL PHARMACOL, V73, P271, DOI 10.1124/mol.107.042986; Cornford Eain M, 2005, NeuroRx, V2, P27, DOI 10.1007/BF03206640; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Doolittle ND, 2007, J NEURO-ONCOL, V81, P81, DOI 10.1007/s11060-006-9209-y; Fine RL, 2006, CLIN CANCER RES, V12, P5770, DOI 10.1158/1078-0432.CCR-05-2356; Fujita Manabu, 2006, Angiogenesis, V9, P183, DOI 10.1007/s10456-006-9046-9; Hashizume K, 2002, J NEUROPATH EXP NEUR, V61, P725, DOI 10.1093/jnen/61.8.725; Hau P, 2004, CANCER, V100, P1199, DOI 10.1002/cncr.20073; Hu JW, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-22; INAMURA T, 1994, J CEREBR BLOOD F MET, V14, P862, DOI 10.1038/jcbfm.1994.108; Juilfs D M, 1999, Rev Physiol Biochem Pharmacol, V135, P67, DOI 10.1007/BFb0033670; Laquintana V, 2009, EXPERT OPIN DRUG DEL, V6, P1017, DOI 10.1517/17425240903167942; Lin NU, 2004, J CLIN ONCOL, V22, P3608, DOI 10.1200/JCO.2004.01.175; Linder AE, 2005, J PHARMACOL EXP THER, V314, P9, DOI 10.1124/jpet.105.083634; Lu Jing, 2009, Cancer Res, V69, P4951, DOI 10.1158/0008-5472.CAN-09-0099; Matsukado K, 1996, NEUROSURGERY, V39, P125, DOI 10.1097/00006123-199607000-00025; Meijering BDM, 2009, CIRC RES, V104, P679, DOI 10.1161/CIRCRESAHA.108.183806; Menendez JA, 2005, ANN ONCOL, V16, P359, DOI 10.1093/annonc/mdi090; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Michel CC, 1998, J MOL CELL CARDIOL, V30, P2541, DOI 10.1006/jmcc.1998.0825; Nakano S, 1996, CANCER RES, V56, P4027; Nam HY, 2009, J CONTROL RELEASE, V135, P259, DOI 10.1016/j.jconrel.2009.01.018; Ningaraj NS, 2009, EUR J PHARMACOL, V602, P188, DOI 10.1016/j.ejphar.2008.10.056; Ningaraj NS, 2003, CANCER RES, V63, P8899; Ningaraj NS, 2003, DRUG NEWS PERSPECT, V16, P291, DOI 10.1358/dnp.2003.16.5.878815; Ningaraj NS, 2002, J PHARMACOL EXP THER, V301, P838, DOI 10.1124/jpet.301.3.838; Ono M, 2009, INT J CLIN ONCOL, V14, P48, DOI 10.1007/s10147-008-0797-8; Pestalozzi BC, 2000, J CLIN ONCOL, V18, P2350, DOI 10.1200/JCO.2000.18.11.2349; RIZZI A, 1990, TUMORI, V76, P579, DOI 10.1177/030089169007600614; Sagita M, 1998, CANCER RES, V58, P914; SCHNITZER JE, 1994, J BIOL CHEM, V269, P6072; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stark S, 2001, EUR UROL, V40, P181, DOI 10.1159/000049770; STEWART PA, 1994, MICROSC RES TECHNIQ, V27, P516, DOI 10.1002/jemt.1070270606; Sun MH, 2009, CLIN CANCER RES, V15, P4829, DOI 10.1158/1078-0432.CCR-08-2921; Tan M, 2006, CANCER RES, V66, P3764, DOI 10.1158/0008-5472.CAN-05-2747; Yau T, 2006, ACTA ONCOL, V45, P196, DOI 10.1080/02841860500486630; Yumoto R, 2006, AM J PHYSIOL-LUNG C, V290, pL946, DOI 10.1152/ajplung.00173.2005	43	35	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10108	10.1371/journal.pone.0010108	http://dx.doi.org/10.1371/journal.pone.0010108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419092	gold, Green Submitted, Green Published			2022-12-25	WOS:000276853800005
J	Nergiz-Unal, R; Cosemans, JMEM; Feijge, MAH; van der Meijden, PEJ; Storey, RF; van Giezen, JJJ; Egbrink, MGAO; Heemskerk, JWM; Kuijpers, MJE				Nergiz-Unal, Reyhan; Cosemans, Judith M. E. M.; Feijge, Marion A. H.; van der Meijden, Paola E. J.; Storey, Robert F.; van Giezen, J. J. J.; Egbrink, Mirjam G. A. Oude; Heemskerk, Johan W. M.; Kuijpers, Marijke J. E.			Stabilizing Role of Platelet P2Y(12) Receptors in Shear-Dependent Thrombus Formation on Ruptured Plaques	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; GLYCOPROTEIN-VI; PROCOAGULANT ACTIVITY; WHOLE-BLOOD; ATHEROSCLEROTIC PLAQUES; COMPLEMENTARY ROLES; FLOWING BLOOD; ACTIVATION; COLLAGEN; ADHESION	Background: In most models of experimental thrombosis, healthy blood vessels are damaged. This results in the formation of a platelet thrombus that is stabilized by ADP signaling via P2Y(12) receptors. However, such models do not predict involvement of P2Y(12) in the clinically relevant situation of thrombosis upon rupture of atherosclerotic plaques. We investigated the role of P2Y(12) in thrombus formation on (collagen-containing) atherosclerotic plaques in vitro and in vivo, by using a novel mouse model of atherothrombosis. Methodology: Plaques in the carotid arteries from Apoe(-/-) mice were acutely ruptured by ultrasound treatment, and the thrombotic process was monitored via intravital fluorescence microscopy. Thrombus formation in vitro was assessed in mouse and human blood perfused over collagen or plaque material under variable conditions of shear rate and coagulation. Effects of two reversible P2Y(12) blockers, ticagrelor (AZD6140) and cangrelor (AR-C69931MX), were investigated. Principal Findings: Acute plaque rupture by ultrasound treatment provoked rapid formation of non-occlusive thrombi, which were smaller in size and unstable in the presence of P2Y(12) blockers. In vitro, when mouse or human blood was perfused over collagen or atherosclerotic plaque material, blockage or deficiency of P2Y(12) reduced the thrombi and increased embolization events. These P2Y(12) effects were present at shear rates >500 s(-1), and they persisted in the presence of coagulation. P2Y(12)-dependent thrombus stabilization was accompanied by increased fibrin(ogen) binding. Conclusions/Significance: Platelet P2Y(12) receptors play a crucial role in the stabilization of thrombi formed on atherosclerotic plaques. This P2Y(12) function is restricted to high shear flow conditions, and is preserved in the presence of coagulation.	[Nergiz-Unal, Reyhan; Cosemans, Judith M. E. M.; Feijge, Marion A. H.; van der Meijden, Paola E. J.; Heemskerk, Johan W. M.; Kuijpers, Marijke J. E.] Maastricht Univ, Dept Biochem, CARIM, Maastricht, Netherlands; [Storey, Robert F.] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [van Giezen, J. J. J.] AstraZeneca R&D, Molndal, Sweden; [Egbrink, Mirjam G. A. Oude] Maastricht Univ, Dept Physiol, CARIM, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); University of Sheffield; AstraZeneca; Maastricht University; Maastricht University Medical Centre (MUMC)	Nergiz-Unal, R (corresponding author), Maastricht Univ, Dept Biochem, CARIM, Maastricht, Netherlands.	Marijke.Kuijpers@bioch.unimaas.nl	Heemskerk, Johan/AAM-8323-2021; Egbrink, Mirjam oude/AAZ-7305-2020; Cosemans, Judith MEM/C-8161-2016; Storey, Robert/AAA-6853-2019; Kuijpers, Marijke/AAN-9876-2021; Nergiz Unal, Reyhan/I-9967-2013	Heemskerk, Johan/0000-0002-2848-5121; Cosemans, Judith MEM/0000-0001-7429-0109; Storey, Robert/0000-0002-6677-6229; Nergiz Unal, Reyhan/0000-0002-3143-7710; van der Meijden, Paola/0000-0002-6532-2583	AstraZeneca; Hacettepe University (Ankara, Turkey); Netherlands Organization for Scientific Research [11.400.0076]; Netherlands Heart Foundation [2005B079]	AstraZeneca(AstraZeneca); Hacettepe University (Ankara, Turkey)(Hacettepe University); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Heart Foundation(Netherlands Heart Foundation)	Partial financial support for the conductance of this study was provided by AstraZeneca. Support is acknowledged from the Hacettepe University (Ankara, Turkey), the Netherlands Organization for Scientific Research (11.400.0076) and the Netherlands Heart Foundation (2005B079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2003, J CLIN INVEST, V112, P398, DOI 10.1172/JCI200317864; Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; Cosemans JMEM, 2008, J THROMB HAEMOST, V6, P1253, DOI 10.1111/j.1538-7836.2008.03041.x; Cosemans JMEM, 2005, ATHEROSCLEROSIS, V181, P19, DOI 10.1016/j.atherosclerosis.2004.12.037; Cosemans JMEM, 2006, BLOOD, V108, P3045, DOI 10.1182/blood-2006-03-006338; De Meyer GRY, 1999, ARTERIOSCL THROM VAS, V19, P2524, DOI 10.1161/01.ATV.19.10.2524; Denis CV, 2007, ARTERIOSCL THROM VAS, V27, P728, DOI 10.1161/01.ATV.0000259359.52265.62; Evans DJW, 2009, CIRCULATION, V119, P116, DOI 10.1161/CIRCULATIONAHA.107.762690; Fintel DJ, 2007, CLIN CARDIOL, V30, P604, DOI 10.1002/clc.20154; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Gachet C, 2008, THROMB HAEMOSTASIS, V99, P466, DOI 10.1160/TH07-11-0673; Goto S, 2006, J AM COLL CARDIOL, V47, P155, DOI 10.1016/j.jacc.2005.08.055; Griend JPV, 2008, PHARMACOTHERAPY, V28, P1233, DOI 10.1592/phco.28.10.1233; Guyton JR, 1996, ARTERIOSCL THROM VAS, V16, P4, DOI 10.1161/01.ATV.16.1.4; Haseruck N, 2004, BLOOD, V103, P2585, DOI 10.1182/blood-2003-04-1127; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jakubowski JA, 2007, CARDIOVASC DRUG REV, V25, P357, DOI 10.1111/j.1527-3466.2007.00027.x; Katsuda Shogo, 2003, J Atheroscler Thromb, V10, P267; Kuijpers MJE, 2009, J THROMB HAEMOST, V7, P152, DOI 10.1111/j.1538-7836.2008.03186.x; Kuijpers MJE, 2003, FASEB J, V17, P685, DOI 10.1096/fj.02-0381fje; Leon C, 2003, ARTERIOSCL THROM VAS, V23, P1941, DOI 10.1161/01.ATV.0000092127.16125.E6; Munnix ICA, 2005, ARTERIOSCL THROM VAS, V25, P2673, DOI 10.1161/01.ATV.0000193568.71980.4a; Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100; Munnix ICA, 2009, THROMB HAEMOSTASIS, V102, P1149, DOI 10.1160/TH09-05-0289; Penz S, 2005, FASEB J, V19, P898, DOI 10.1096/fj.04-2748com; Penz SM, 2007, THROMB HAEMOSTASIS, V97, P435, DOI 10.1160/TH06-07-0415; Remijn JA, 2002, ARTERIOSCL THROM VAS, V22, P686, DOI 10.1161/01.ATV.0000012805.49079.23; Resendiz JC, 2003, MOL PHARMACOL, V63, P639, DOI 10.1124/mol.63.3.639; Rother E, 2003, CIRCULATION, V108, P741, DOI 10.1161/01.CIR.0000083715.37658.C4; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Siljander P, 1999, ARTERIOSCL THROM VAS, V19, P3033, DOI 10.1161/01.ATV.19.12.3033; Siljander PRM, 2004, BLOOD, V103, P1333, DOI 10.1182/blood-2003-03-00869; Strassel C, 2009, J THROMB HAEMOST, V7, P1935, DOI 10.1111/j.1538-7836.2009.03608.x; Turner NA, 2001, BLOOD, V98, P3340, DOI 10.1182/blood.V98.12.3340; van der Meijden PEJ, 2008, FEBS J, V275, P371, DOI 10.1111/j.1742-4658.2007.06207.x; van der Meijden PEJ, 2009, BLOOD, V114, P881, DOI 10.1182/blood-2008-07-171066; van der Meijden PEJ, 2005, THROMB HAEMOSTASIS, V93, P1128, DOI 10.1160/TH04-09-0597; VANGIEZEN JJ, 2009, J THROMB HAEMOST; Vanschoonbeek K, 2004, J THROMB HAEMOST, V2, P476, DOI 10.1111/j.1538-7933.2004.00618.x; VARON D, 2002, PLATELETS, P337; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	42	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10130	10.1371/journal.pone.0010130	http://dx.doi.org/10.1371/journal.pone.0010130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405028	gold, Green Published			2022-12-25	WOS:000276705900013
J	Furukawa, Y; Kaneko, K; Yamanaka, K; Nukina, N				Furukawa, Yoshiaki; Kaneko, Kumi; Yamanaka, Koji; Nukina, Nobuyuki			Mutation-dependent Polymorphism of Cu,Zn-Superoxide Dismutase Aggregates in the Familial Form of Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CU/ZN SUPEROXIDE-DISMUTASE; MOTOR-NEURON DEGENERATION; COPPER-BINDING-SITE; TRANSGENIC MICE; PROTEIN AGGREGATION; HUMAN-DISEASE; CELL-DEATH; SOD1; ALS; SUPEROXIDE-DISMUTASE-1	More than 100 different mutations in Cu, Zn-superoxide dismutase (SOD1) are linked to a familial form of amyotrophic lateral sclerosis (fALS). Pathogenic mutations facilitate fibrillar aggregation of SOD1, upon which significant structural changes of SOD1 have been assumed; in general, however, a structure of protein aggregate remains obscure. Here, we have identified a protease-resistant core in wild-type as well as fALS-causing mutant SOD1 aggregates. Three different regions within an SOD1 sequence are found as building blocks for the formation of an aggregate core, and fALS-causing mutations modulate interactions among these three regions to form a distinct core, namely SOD1 aggregates exhibit mutation-dependent structural polymorphism, which further regulates biochemical properties of aggregates such as solubility. Based upon these results, we propose a new pathomechanism of fALS in which mutation-dependent structural polymorphism of SOD1 aggregates can affect disease phenotypes.	[Furukawa, Yoshiaki; Kaneko, Kumi; Nukina, Nobuyuki] RIKEN Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan; [Yamanaka, Koji] RIKEN Brain Sci Inst, Lab Motor Neuron Dis, Wako, Saitama 3510198, Japan	RIKEN; RIKEN	Nukina, N (corresponding author), 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	nukina@brain.riken.jp	Nukina, Nobuyuki/GPP-6265-2022; Yamanaka, Koji/H-5806-2011; Yamanaka, Koji/ABD-1034-2020; Furukawa, Yoshiaki/F-2871-2014	Yamanaka, Koji/0000-0003-4655-0035; Yamanaka, Koji/0000-0003-4655-0035; Furukawa, Yoshiaki/0000-0002-1918-372X	Scientific Research on Priority Areas [17025044]; Ministry of Education, Culture, Sports, Science and Technology of Japan [20770130, 21390274]; Health and Labour Science Research	Scientific Research on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labour Science Research	This work was supported by Grant-in-aid for Scientific Research on Priority Areas (Research on Pathomechanisms of Brain Disorders) 17025044 (to N.N.), Grants-in-aid 20770130 (to Y.F.) and 21390274 (to K.Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Health and Labour Science Research grant (to K.Y.).	Andersen PM, 1997, BRAIN, V120, P1723, DOI 10.1093/brain/120.10.1723; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Ghadge GD, 2006, NEUROBIOL DIS, V21, P194, DOI 10.1016/j.nbd.2005.07.006; Gidalevitz T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000399; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Khare SD, 2005, PROTEINS, V61, P617, DOI 10.1002/prot.20629; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Molnar KS, 2009, J BIOL CHEM, V284, P30965, DOI 10.1074/jbc.M109.023945; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Shaw BF, 2006, J BIOL CHEM, V281, P18167, DOI 10.1074/jbc.M600623200; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Teilum K, 2009, P NATL ACAD SCI USA, V106, P18273, DOI 10.1073/pnas.0907387106; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2005, HUM MOL GENET, V14, P2335, DOI 10.1093/hmg/ddi236; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506	39	78	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22221	22231		10.1074/jbc.M110.113597	http://dx.doi.org/10.1074/jbc.M110.113597			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20404329	Green Published, hybrid			2022-12-25	WOS:000279702200035
J	Berdichevsky, A; Guarente, L; Bose, A				Berdichevsky, Alina; Guarente, Leonard; Bose, Avirup			Acute Oxidative Stress Can Reverse Insulin Resistance by Inactivation of Cytoplasmic JNK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; HUMAN SKELETAL-MUSCLE; ALPHA-LIPOIC ACID; DIABETES-MELLITUS; GLUCOSE-TRANSPORT; DNA-DAMAGE; EXERCISE; OBESITY; RAT	Chronic oxidative stress results in decreased responsiveness to insulin, eventually leading to diabetes and cardiovascular disease. Activation of the JNK signaling pathway can mediate many of the effects of stress on insulin resistance through inhibitory phosphorylation of insulin receptor substrate 1. By contrast, exercise, which acutely increases oxidative stress in the muscle, improves insulin sensitivity and glucose tolerance in patients with Type 2 diabetes. To elucidate the mechanism underlying the contrasting effects of acute versus chronic oxidative stress on insulin sensitivity, we used a cellular model of insulin-resistant muscle to induce either chronic or acute oxidative stress and investigate their effects on insulin and JNK signaling. Chronic oxidative stress resulted in increased levels of phosphorylated ( activated) JNK in the cytoplasm, whereas acute oxidative stress led to redistribution of JNK-specific phosphatase MKP7 from the nucleus into the cytoplasm, reduction in cytoplasmic phospho-JNK, and a concurrent accumulation of phospho-JNK in the nucleus. Acute oxidative stress restored normal insulin sensitivity and glucose uptake in insulin-resistant muscle cells, and this effect was dependent on MKP7. We propose that the contrasting effects of acute and chronic stress on insulin sensitivity are driven by changes in subcellular distribution of MKP7 and activated JNK.	Novartis Inst Biomed Res, Cardiovasc & Metab Dis Area, Cambridge, MA 02139 USA; [Guarente, Leonard] MIT, Dept Biol, Cambridge, MA 02139 USA	Novartis; Massachusetts Institute of Technology (MIT)	Bose, A (corresponding author), 100 Technol Sq, Cambridge, MA 02139 USA.	Avirup.Bose@novartis.com			National Institutes of Health; Paul F. Glenn Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul F. Glenn Foundation	This work was supported, in whole or in part, by a National Institutes of Health grant and the Paul F. Glenn Foundation (to L. G.).	Aronson D, 1998, BIOCHEM BIOPH RES CO, V251, P106, DOI 10.1006/bbrc.1998.9435; Bjornholm M, 2005, BIOCHEM SOC T, V33, P354; Bloch-Damti A, 2006, DIABETOLOGIA, V49, P2463, DOI 10.1007/s00125-006-0349-6; Demirbag R, 2006, INT J CLIN PRACT, V60, P1187, DOI 10.1111/j.1742-1241.2006.01042.x; Evans JL, 2005, ANTIOXID REDOX SIGN, V7, P1040, DOI 10.1089/ars.2005.7.1040; Fujii N, 2006, AM J PHYSIOL-ENDOC M, V291, pE867, DOI 10.1152/ajpendo.00207.2006; Gao L, 2008, VET CLIN N AM-SMALL, V38, P137, DOI 10.1016/j.cvsm.2007.10.004; Higaki Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE889, DOI 10.1152/ajpendo.00150.2007; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2005, DIABETES, V54, pS73, DOI 10.2337/diabetes.54.suppl_2.S73; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Kayatekin BM, 2002, EUR J APPL PHYSIOL, V87, P141, DOI 10.1007/s00421-002-0607-3; Kozlovsky N, 1997, FREE RADICAL BIO MED, V23, P859, DOI 10.1016/S0891-5849(97)00069-5; Kramer HF, 2007, J APPL PHYSIOL, V103, P388, DOI 10.1152/japplphysiol.00085.2007; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404; Masuda K, 2001, J BIOL CHEM, V276, P39002, DOI 10.1074/jbc.M104600200; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Muellenbach EA, 2008, METABOLISM, V57, P1465, DOI 10.1016/j.metabol.2008.05.018; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rehman A, 1999, FEBS LETT, V448, P120, DOI 10.1016/S0014-5793(99)00339-7; Song FF, 2007, CLIN SCI, V112, P599, DOI 10.1042/CS20060323; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Villa-Caballero L, 2007, DIABETES RES CLIN PR, V75, P285, DOI 10.1016/j.diabres.2006.07.011; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Winnick JJ, 2008, J CLIN ENDOCR METAB, V93, P771, DOI 10.1210/jc.2007-1524	28	46	47	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21581	21589		10.1074/jbc.M109.093633	http://dx.doi.org/10.1074/jbc.M109.093633			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20430894	Green Published, hybrid			2022-12-25	WOS:000279516100044
J	Luong, P; Kinch, LN; Brautigam, CA; Grishin, NV; Tomchick, DR; Orth, K				Luong, Phi; Kinch, Lisa N.; Brautigam, Chad A.; Grishin, Nick V.; Tomchick, Diana R.; Orth, Kim			Kinetic and Structural Insights into the Mechanism of AMPylation by VopS Fic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIBRIO-PARAHAEMOLYTICUS; AUTOPHAGY; PROTEINS; BINDING; MODEL	The bacterial pathogen Vibrio parahemeolyticus manipulates host signaling pathways during infections by injecting type III effectors into the cytoplasm of the target cell. One of these effectors, VopS, blocks actin assembly by AMPylation of a conserved threonine residue in the switch 1 region of Rho GTPases. The modified GTPases are no longer able to interact with downstream effectors due to steric hindrance by the covalently linked AMP moiety. Herein we analyze the structure of VopS and its evolutionarily conserved catalytic residues. Steady-state analysis of VopS mutants provides kinetic understanding on the functional role of each residue for AMPylation activity by the Fic domain. Further mechanistic analysis of VopS with its two substrates, ATP and Cdc42, demonstrates that VopS utilizes a sequential mechanism to AMPylate Rho GTPases. Discovery of a ternary reaction mechanism along with structural insight provides critical groundwork for future studies for the family of AMPylators that modify hydroxyl-containing residues with AMP.	[Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Brautigam, Chad A.; Grishin, Nick V.; Tomchick, Diana R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	kim.orth@utsouthwestern.edu	Tomchick, Diana/HGV-2018-2022; Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Tomchick, Diana/0000-0002-7529-4643; Brautigam, Chad/0000-0001-6563-1338; Kinch, Lisa/0000-0003-3041-2615	National Institutes of Health [R01-AI056404]; Welch Research Foundation [I-1561, I-1505]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI056404 (NIAID, to K.O. and P.L.). This work was also funded in part by Welch Research Foundation Grant I-1561 (to K.O.).; Supported by the Welch Foundation (I-1505).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Broberg CA, 2010, CURR OPIN MICROBIOL, V13, P34, DOI 10.1016/j.mib.2009.12.004; Burdette DL, 2008, P NATL ACAD SCI USA, V105, P12497, DOI 10.1073/pnas.0802773105; Burdette DL, 2009, MOL MICROBIOL, V73, P639, DOI 10.1111/j.1365-2958.2009.06798.x; Casselli T, 2008, INFECT IMMUN, V76, P2202, DOI 10.1128/IAI.01704-07; Chen GJ, 2000, BIOCHEMISTRY-US, V39, P2079, DOI 10.1021/bi9919495; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Das D, 2009, PROTEINS, V75, P264, DOI 10.1002/prot.22338; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gill HS, 2002, BIOCHEMISTRY-US, V41, P9863, DOI 10.1021/bi020254s; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Ono T, 2006, INFECT IMMUN, V74, P1032, DOI 10.1128/IAI.74.2.1032-1042.2006; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Park KS, 2004, MICROBIOL IMMUNOL, V48, P313, DOI 10.1111/j.1348-0421.2004.tb03512.x; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Yarbrough ML, 2009, NAT CHEM BIOL, V5, P378, DOI 10.1038/nchembio0609-378; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	30	62	68	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20155	20163		10.1074/jbc.M110.114884	http://dx.doi.org/10.1074/jbc.M110.114884			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20410310	Green Published, hybrid			2022-12-25	WOS:000279012000050
J	Gruschke, S; Grone, K; Heublein, M; Holz, S; Israel, L; Imhof, A; Herrmann, JM; Ott, M				Gruschke, Steffi; Groene, Kerstin; Heublein, Manfred; Hoelz, Stefanie; Israel, Lars; Imhof, Axel; Herrmann, Johannes M.; Ott, Martin			Proteins at the Polypeptide Tunnel Exit of the Yeast Mitochondrial Ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SUBUNIT; OXA1; TRANSLATION; COMPONENT; INSERTION; EVOLUTION; MBA1; YIDC	Oxidative phosphorylation in mitochondria requires the synthesis of proteins encoded in the mitochondrial DNA. The mitochondrial translation machinery differs significantly from that of the bacterial ancestor of the organelle. This is especially evident from many mitochondria-specific ribosomal proteins. An important site of the ribosome is the polypeptide tunnel exit. Here, nascent chains are exposed to an aqueous environment for the first time. Many biogenesis factors interact with the tunnel exit of pro-and eukaryotic ribosomes to help the newly synthesized proteins to mature. To date, nothing is known about the organization of the tunnel exit of mitochondrial ribosomes. We therefore undertook a comprehensive approach to determine the composition of the yeast mitochondrial ribosomal tunnel exit. Mitochondria contain homologues of the ribosomal proteins located at this site in bacterial ribosomes. Here, we identified proteins located in their proximity by chemical cross-linking and mass spectrometry. Our analysis revealed a complex network of interacting proteins including proteins and protein domains specific to mitochondrial ribosomes. This network includes Mba1, the membrane-bound ribosome receptor of the inner membrane, as well as Mrpl3, Mrpl13, and Mrpl27, which constitute ribosomal proteins exclusively found in mitochondria. This unique architecture of the tunnel exit is presumably an adaptation of the translation system to the specific requirements of the organelle.	[Herrmann, Johannes M.; Ott, Martin] Tech Univ Kaiserslautern, Abt Zellbiol, D-67663 Kaiserslautern, Germany; [Israel, Lars; Imhof, Axel] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany	University of Kaiserslautern; University of Munich	Ott, M (corresponding author), Tech Univ Kaiserslautern, Abt Zellbiol, Erwin Schrodinger Str 13, D-67663 Kaiserslautern, Germany.	martin.ott@biologie.uni-kl.de	Imhof, Axel/AAU-5313-2021	Imhof, Axel/0000-0003-2993-8249; Ott, Martin/0000-0001-6367-3091	Stiftung Rheinland-Pfalz fur Innovation; Deutsche Forschungsgemeinschaft [FOR967]	Stiftung Rheinland-Pfalz fur Innovation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Stiftung Rheinland-Pfalz fur Innovation and by Deutsche Forschungsgemeinschaft (Research Unit FOR967).	Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BORST P, 1978, CELL, V15, P705, DOI 10.1016/0092-8674(78)90257-X; DAUM G, 1982, J BIOL CHEM, V257, P3028; Houben ENG, 2005, J CELL BIOL, V170, P27, DOI 10.1083/jcb.200503035; Jia LX, 2009, EUKARYOT CELL, V8, P1792, DOI 10.1128/EC.00219-09; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Lafontaine D, 1996, NUCLEIC ACIDS RES, V24, P3469, DOI 10.1093/nar/24.17.3469; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; Prestele M, 2009, MOL BIOL CELL, V20, P2615, DOI 10.1091/mbc.E08-12-1162; Preuss M, 2005, J BIOL CHEM, V280, P13004, DOI 10.1074/jbc.M414093200; Preuss M, 2001, J CELL BIOL, V153, P1085, DOI 10.1083/jcb.153.5.1085; Sharma MR, 2009, P NATL ACAD SCI USA, V106, P9637, DOI 10.1073/pnas.0901631106; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Smits P, 2007, NUCLEIC ACIDS RES, V35, P4686, DOI 10.1093/nar/gkm441; Spremulli LL, 2004, PROG NUCLEIC ACID RE, V77, P211, DOI 10.1016/S0079-6603(04)77006-3; Suzuki T, 2001, J BIOL CHEM, V276, P33181, DOI 10.1074/jbc.M103236200; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Williams EH, 2005, EUKARYOT CELL, V4, P337, DOI 10.1128/EC.4.2.337-345.2005	23	49	50	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19022	19028		10.1074/jbc.M110.113837	http://dx.doi.org/10.1074/jbc.M110.113837			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404317	hybrid, Green Published			2022-12-25	WOS:000278727800010
J	Plaghki, L; Decruynaere, C; Van Dooren, P; Le Bars, D				Plaghki, Leon; Decruynaere, Celine; Van Dooren, Paul; Le Bars, Daniel			The Fine Tuning of Pain Thresholds: A Sophisticated Double Alarm System	PLOS ONE			English	Article							C-FIBER NOCICEPTORS; SPATIAL SUMMATION; THERMAL THRESHOLDS; ANESTHETIZED MONKEY; TEMPERATURE-CHANGE; WARM RECEPTORS; HEAT STIMULI; LOW RATES; SKIN; RESPONSES	Two distinctive features characterize the way in which sensations including pain, are evoked by heat: (1) a thermal stimulus is always progressive; (2) a painful stimulus activates two different types of nociceptors, connected to peripheral afferent fibers with medium and slow conduction velocities, namely A delta-and C-fibers. In the light of a recent study in the rat, our objective was to develop an experimental paradigm in humans, based on the joint analysis of the stimulus and the response of the subject, to measure the thermal thresholds and latencies of pain elicited by A delta-and C-fibers. For comparison, the same approach was applied to the sensation of warmth elicited by thermoreceptors. A CO2 laser beam raised the temperature of the skin filmed by an infrared camera. The subject stopped the beam when he/she perceived pain. The thermal images were analyzed to provide four variables: true thresholds and latencies of pain triggered by heat via A delta- and C-fibers. The psychophysical threshold of pain triggered by A delta-fibers was always higher (2.5-3 degrees C) than that triggered by C-fibers. The initial skin temperature did not influence these thresholds. The mean conduction velocities of the corresponding fibers were 13 and 0.8 m/s, respectively. The triggering of pain either by C-or by A delta-fibers was piloted by several factors including the low/high rate of stimulation, the low/high base temperature of the skin, the short/long peripheral nerve path and some pharmacological manipulations (e. g. Capsaicin). Warming a large skin area increased the pain thresholds. Considering the warmth detection gave a different picture: the threshold was strongly influenced by the initial skin temperature and the subjects detected an average variation of 2.7 degrees C, whatever the initial temperature. This is the first time that thresholds and latencies for pain elicited by both A delta-and C-fibers from a given body region have been measured in the same experimental run. Such an approach illustrates the role of nociception as a "double level" and "double release" alarm system based on level detectors. By contrast, warmth detection was found to be based on difference detectors. It is hypothesized that pain results from a CNS build-up process resulting from population coding and strongly influenced by the background temperatures surrounding at large the stimulation site. We propose an alternative solution to the conventional methods that only measure a single "threshold of pain", without knowing which of the two systems is involved.	[Plaghki, Leon; Decruynaere, Celine] Catholic Univ Louvain, Unite READ, B-1200 Brussels, Belgium; [Van Dooren, Paul] Catholic Univ Louvain, CESAME, B-3000 Louvain, Belgium; [Le Bars, Daniel] CNRS, UMR 7225, INSERM UMRS 975, Team Pain, Paris, France; [Le Bars, Daniel] Univ Paris 06, Fac Med, Paris, France	Universite Catholique Louvain; Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Plaghki, L (corresponding author), Catholic Univ Louvain, Unite READ, B-1200 Brussels, Belgium.	daniel.le_bars@upmc.fr			Fondation de France, Caisse Nationale de prevoyance and Cooperation Franco-Belge en recherche medicale; INSERM - FNRS - CGRI (Institut national de la sante et de la recherche medicale - Fonds de la Recherche Scientifique - Commissariat general aux relations internationales)	Fondation de France, Caisse Nationale de prevoyance and Cooperation Franco-Belge en recherche medicale(Fondation de France); INSERM - FNRS - CGRI (Institut national de la sante et de la recherche medicale - Fonds de la Recherche Scientifique - Commissariat general aux relations internationales)	This work was supported by grants of Fondation de France, Caisse Nationale de prevoyance and Cooperation Franco-Belge en recherche medicale, Accord INSERM - FNRS - CGRI (Institut national de la sante et de la recherche medicale - Fonds de la Recherche Scientifique - Commissariat general aux relations internationales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Assoc Electrodiagnost Med, 2004, MUSCLE NERVE, V29, P734, DOI 10.1002/mus.20053; BANKS WP, 1973, PERCEPT PSYCHOPHYS, V13, P321, DOI 10.3758/BF03214147; Benoist JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003125; BROMM B, 1984, HUM NEUROBIOL, V3, P33; CAMPBELL JN, 1983, BRAIN RES, V266, P203, DOI 10.1016/0006-8993(83)90650-9; DARIANSMITH I, 1979, J NEUROPHYSIOL, V42, P1297, DOI 10.1152/jn.1979.42.5.1297; Defrin R, 2006, CLIN J PAIN, V22, P130, DOI 10.1097/01.ajp.0000154048.68273.d8; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Diller KR, 1999, ANN NY ACAD SCI, V888, P153, DOI 10.1111/j.1749-6632.1999.tb07954.x; DUCLAUX R, 1980, J NEUROPHYSIOL, V43, P1; FRUHSTORFER H, 1976, J NEUROL NEUROSUR PS, V39, P1071, DOI 10.1136/jnnp.39.11.1071; Gibbons C, 2004, NEUROL CLIN, V22, P683, DOI 10.1016/j.ncl.2004.03.002; Golub G.H., 1996, MATRIX COMPUTATIONS, V3rd; Granot M, 2003, EUR J PAIN, V7, P139, DOI 10.1016/S1090-3801(02)00087-3; Hagander L. G., 2000, Clinical Neurophysiology, V111, P17, DOI 10.1016/S1388-2457(99)00192-3; HALLIN RG, 1982, J NEUROL NEUROSUR PS, V45, P313, DOI 10.1136/jnnp.45.4.313; HANDWERKER HO, 1993, PHYSIOL REV, V73, P639, DOI 10.1152/physrev.1993.73.3.639; Hardy JD, 1937, J CLIN INVEST, V16, P533, DOI 10.1172/JCI100879; HENSEL H, 1974, ANNU REV PHYSIOL, V36, P233, DOI 10.1146/annurev.ph.36.030174.001313; Hensel H., 1973, Handbook of sensory physiology, volume II., P79; Iannetti GD, 2006, J PHYSIOL-LONDON, V577, P235, DOI 10.1113/jphysiol.2006.115675; JAMAL GA, 1985, J NEUROL NEUROSUR PS, V48, P354, DOI 10.1136/jnnp.48.4.354; KANUI TI, 1985, PAIN, V21, P231, DOI 10.1016/0304-3959(85)90087-9; KANUI TI, 1987, BRAIN RES, V402, P160, DOI 10.1016/0006-8993(87)91060-2; KAVALIERS M, 1988, BRAIN RES BULL, V21, P923, DOI 10.1016/0361-9230(88)90030-5; Kelly KG, 2005, MUSCLE NERVE, V32, P179, DOI 10.1002/mus.20355; Kenshalo D R, 1970, Contrib Sens Physiol, V4, P19; KENSHALO DR, 1975, J APPL PHYSIOL, V39, P1038, DOI 10.1152/jappl.1975.39.6.1038; KENSHALO DR, 1967, J COMP PHYSIOL PSYCH, V63, P510, DOI 10.1037/h0024610; Kirk J A, 1968, Ann Phys Med, V9, P270; Kumazawa T, 1998, NEUROSCI RES, V32, P9, DOI 10.1016/S0168-0102(98)00060-1; LAMOTTE RH, 1983, FED PROC, V42, P2548; LAMOTTE RH, 1982, J NEUROSCI, V2, P765; LAMOTTE RH, 1978, J NEUROPHYSIOL, V41, P509, DOI 10.1152/jn.1978.41.2.509; Lewis T, 1937, CLIN SCI, V3, P67; Lin YH, 2005, J PERIPHER NERV SYST, V10, P269, DOI 10.1111/j.1085-9489.2005.10305.x; Luce R, 1986, RESPONSE TIMES THEIR, DOI [10.1093/acprof:oso/9780195070019.001.0001, DOI 10.1093/ACPROF:OSO/9780195070019.001.0001]; MACKENZIE RA, 1975, J NEUROL NEUROSUR PS, V38, P865, DOI 10.1136/jnnp.38.9.865; Magda P, 2002, J PERIPHER NERV SYST, V7, P225, DOI 10.1046/j.1529-8027.2002.02029.x; MARKS LE, 1973, AM J PSYCHOL, V86, P251, DOI 10.2307/1421436; Masuda A, 2005, PSYCHOTHER PSYCHOSOM, V74, P288, DOI 10.1159/000086319; McKemy DD, 2007, PFLUG ARCH EUR J PHY, V454, P777, DOI 10.1007/s00424-006-0199-6; MEYER RA, 1976, IEEE T BIO-MED ENG, V23, P54, DOI 10.1109/TBME.1976.324616; MEYER RA, 1981, SCIENCE, V213, P1527, DOI 10.1126/science.7280675; MORITZ AR, 1947, AM J PATHOL, V23, P695; Nagasako EM, 2003, PAIN, V101, P213, DOI 10.1016/S0304-3959(02)00482-7; NATHAN PW, 1986, BRAIN, V109, P1003, DOI 10.1093/brain/109.5.1003; Nuhr M, 2004, SPINE, V29, P1499, DOI 10.1097/01.BRS.0000131439.87553.99; Palmer ST, 2000, SOMATOSENS MOT RES, V17, P325; Pastor J, 1996, J NEUROPHYSIOL, V75, P2268, DOI 10.1152/jn.1996.75.6.2268; PERTOVAARA A, 1985, EXP NEUROL, V87, P439, DOI 10.1016/0014-4886(85)90174-8; Plaghki L, 2003, NEUROPHYSIOL CLIN, V33, P269, DOI 10.1016/j.neucli.2003.10.003; Plaghki Leon, 2005, Curr Opin Investig Drugs, V6, P58; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reulen JPH, 2003, CLIN NEUROPHYSIOL, V114, P556, DOI 10.1016/S1388-2457(02)00405-4; RINGKAMP M, 2008, SENSES COMPREHENSIVE, V5, P97, DOI DOI 10.1016/B978-012370880-9.00146-8; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Schepers RJ, 2009, NEUROSCI BIOBEHAV R, V33, P205, DOI 10.1016/j.neubiorev.2008.07.009; Shy ME, 2003, NEUROLOGY, V60, P898, DOI 10.1212/01.WNL.0000058546.16985.11; STEVENS JC, 1974, PHYSIOL BEHAV, V13, P825, DOI 10.1016/0031-9384(74)90269-8; STEVENS JC, 1971, PERCEPT PSYCHOPHYS, V9, P391, DOI 10.3758/BF03210236; STOLL AM, 1959, J APPL PHYSIOL, V14, P373, DOI 10.1152/jappl.1959.14.3.373; STOLWIJK JA, 1965, J APPL PHYSIOL, V20, P1006, DOI 10.1152/jappl.1965.20.5.1006; Svensson P, 1997, SOMATOSENS MOT RES, V14, P113, DOI 10.1080/08990229771114; SWERUP C, 1987, ACTA PHYSIOL SCAND, V131, P623, DOI 10.1111/j.1748-1716.1987.tb08284.x; TILLMAN DB, 1995, J PHYSIOL-LONDON, V485, P753, DOI 10.1113/jphysiol.1995.sp020766; TILLMAN DB, 1995, J PHYSIOL-LONDON, V485, P767, DOI 10.1113/jphysiol.1995.sp020767; Tobin DM, 2004, J NEUROBIOL, V61, P161, DOI 10.1002/neu.20082; TREEDE RD, 1995, J PHYSIOL-LONDON, V483, P747, DOI 10.1113/jphysiol.1995.sp020619; VERDUGO RJ, 1993, MUSCLE NERVE, V16, P1056, DOI 10.1002/mus.880161009; Vriens J, 2004, PFLUG ARCH EUR J PHY, V449, P213, DOI 10.1007/s00424-004-1314-1; WALTERS ET, 1994, INT REV NEUROBIOL, V36, P325, DOI 10.1016/S0074-7742(08)60307-4; WALTERS ET, 2008, SENSES COMPREHENSIVE, V5, P175; YARNITSKY D, 1990, PAIN, V40, P85, DOI 10.1016/0304-3959(90)91055-N; YARNITSKY D, 1994, J NEUROL SCI, V125, P39, DOI 10.1016/0022-510X(94)90239-9; YARNITSKY D, 1991, BRAIN, V114, P1819, DOI 10.1093/brain/114.4.1819; Yarnitsky D, 2006, HAND CLINIC, V81, P397, DOI 10.1016/S0072-9752(06)80031-X; Yeomans DC, 1996, PAIN, V68, P141, DOI 10.1016/S0304-3959(96)03177-6; Yeomans DC, 1996, PAIN, V68, P133, DOI 10.1016/S0304-3959(96)03176-4; YEOMANS DC, 1994, PAIN, V59, P85, DOI 10.1016/0304-3959(94)90051-5	80	35	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10269	10.1371/journal.pone.0010269	http://dx.doi.org/10.1371/journal.pone.0010269			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428245	Green Submitted, Green Published, gold			2022-12-25	WOS:000277079300004
J	Wang, L; Clark, ME; Crossman, DK; Kojima, K; Messinger, JD; Mobley, JA; Curcio, CA				Wang, Lan; Clark, Mark E.; Crossman, David K.; Kojima, Kyoko; Messinger, Jeffrey D.; Mobley, James A.; Curcio, Christine A.			Abundant Lipid and Protein Components of Drusen	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; AGE-RELATED MACULOPATHY; HUMAN BRUCHS MEMBRANE; HIGH-DENSITY-LIPOPROTEIN; MACULAR DEGENERATION; SCAVENGER RECEPTORS; BASAL DEPOSITS; UNESTERIFIED CHOLESTEROL; PROGRESSIVE STAGES; APOLIPOPROTEIN-E	Background: Drusen are extracellular lesions characteristic of aging and age-related maculopathy, a major retinal disease of the elderly. We determined the relative proportions of lipids and proteins in drusen capped with retinal pigment epithelium (RPE) and in RPE isolated from non-macular regions of 36 human retinas with grossly normal maculas obtained <6 hr after death. Methodology/Principal Findings: Druse pellets were examined by light and electron microscopy. Component proteins were extracted using novel methods for preserved tissues, separated, subjected to tryptic digestion and LC-MS(MS)(2) analysis using an ion trap mass spectrometer, and identified with reference to databases. Lipid classes were separated using thin layer chromatography and quantified by densitometry. Major druse components were esterified cholesterol (EC), phosphatidylcholine (PC), and protein (37.5 +/- 13.7, 36.9 +/- 12.9, and 43.0 +/- 11.5 ng/druse, respectively). Lipid-containing particles (median diameter, 77 nm) occupied 37-44% of druse volume. Major proteins include vitronectin, complement component 9, apoE, and clusterin, previously seen in drusen, and ATP synthase subunit beta, scavenger receptor B2, and retinol dehydrogenase 5, previously seen in RPE. Drusen and RPE had similar protein profiles, with higher intensities and greater variability in drusen. C8, part of the complement membrane attack complex, was localized in drusen by immunofluorescence. Conclusions/Significance: At least 40% of druse content is comprised by lipids dominated by EC and PC, 2 components that are potentially accounted for by just one pathway, the secretion of lipoproteins by RPE. Manipulating genes encoding apolipoprotein pathways would be a fruitful approach to producing drusen with high EC content in laboratory animals. Therapies that directly mitigate drusen should prepare for the substantial volume of neutral lipids. The catalog of major druse proteins is nearing completion.	[Wang, Lan; Clark, Mark E.; Messinger, Jeffrey D.; Curcio, Christine A.] Univ Alabama, Dept Ophthalmol, Birmingham, AL 35294 USA; [Crossman, David K.] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; [Kojima, Kyoko] Univ Alabama, Dept Epidemiol, Birmingham, AL 35294 USA; [Mobley, James A.] Univ Alabama, Dept Surg, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, L (corresponding author), Univ Alabama, Dept Ophthalmol, Birmingham, AL 35294 USA.	curcio@uab.edu		Crossman, David/0000-0002-0981-169X; mobley, james/0000-0002-3229-7975	NIH [EY06109]; International Retinal Research Foundation; Research to Prevent Blindness, Inc.; EyeSight Foundation of Alabama; Roger Johnson Prize in Macular Degeneration Research (CAC); NIAID [T32AI007041-15]; NATIONAL EYE INSTITUTE [R01EY006109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007041] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Retinal Research Foundation; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); EyeSight Foundation of Alabama; Roger Johnson Prize in Macular Degeneration Research (CAC); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH grant EY06109, International Retinal Research Foundation, unrestricted funds to the Department of Ophthalmology from Research to Prevent Blindness, Inc., EyeSight Foundation of Alabama, and the 2002 Roger Johnson Prize in Macular Degeneration Research (CAC); NIAID, T32AI007041-15 (DKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar O, 2009, MOL CELL PROTEOMICS, V8, P2201, DOI 10.1074/mcp.M900203-MCP200; Anderson DH, 2004, EXP EYE RES, V78, P243, DOI 10.1016/j.exer.2003.10.011; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson DH, 2001, AM J OPHTHALMOL, V131, P767, DOI 10.1016/S0002-9394(00)00961-2; Binder S, 2007, PROG RETIN EYE RES, V26, P516, DOI 10.1016/j.preteyeres.2007.02.002; Booij JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-164; Bretillon L, 2008, INVEST OPHTH VIS SCI, V49, P1307, DOI 10.1167/iovs.07-0808; Bretillon L, 2008, EXP EYE RES, V87, P521, DOI 10.1016/j.exer.2008.08.010; CasaroliMarano RP, 1996, J LIPID RES, V37, P1037; Chang AA, 2003, CLIN EXP OPHTHALMOL, V31, P300, DOI 10.1046/j.1442-9071.2003.00664.x; Chung BH, 2005, BBA-MOL CELL BIOL L, V1733, P76, DOI 10.1016/j.bbalip.2004.12.002; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Curcio CA, 2005, EXP EYE RES, V81, P731, DOI 10.1016/j.exer.2005.04.012; Curcio CA, 2005, EXP EYE RES, V80, P761, DOI 10.1016/j.exer.2004.09.017; Curcio CA, 1999, ARCH OPHTHALMOL-CHIC, V117, P329, DOI 10.1001/archopht.117.3.329; Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265; Curcio CA, 2009, PROG RETIN EYE RES, V28, P393, DOI 10.1016/j.preteyeres.2009.08.001; Decanini A, 2008, DIABETOLOGIA, V51, P1051, DOI 10.1007/s00125-008-0991-2; Del Priore LV, 1998, ARCH OPHTHALMOL-CHIC, V116, P335, DOI 10.1001/archopht.116.3.335; Dentchev T, 2003, MOL VIS, V9, P184; DOWHAN W, 2002, BIOCH LIPIDS LIPOPRO, P1; Duncan KG, 2002, BIOCHEM BIOPH RES CO, V292, P1017, DOI 10.1006/bbrc.2002.6756; During A, 2008, J LIPID RES, V49, P1715, DOI 10.1194/jlr.M700580-JLR200; Eckhardt ERM, 2004, J BIOL CHEM, V279, P14372, DOI 10.1074/jbc.M313793200; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fujihara M, 2009, EXP EYE RES, V88, P1115, DOI 10.1016/j.exer.2009.01.017; GAMBLE W, 1978, J LIPID RES, V19, P1068; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gouras P, 2009, GRAEF ARCH CLIN EXP, V247, P1051, DOI 10.1007/s00417-009-1091-9; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; Gullapalli VK, 2008, EXP EYE RES, V86, P189, DOI 10.1016/j.exer.2007.10.009; GUYTON JR, 1988, J HISTOCHEM CYTOCHEM, V36, P1319, DOI 10.1177/36.10.2458408; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haimovici R, 2001, INVEST OPHTH VIS SCI, V42, P1592; HAYES KC, 1989, INVEST OPHTH VIS SCI, V30, P225; Holm C, 1999, METH MOL B, V109, P109; ISHIBASHI T, 1986, AM J OPHTHALMOL, V101, P342, DOI 10.1016/0002-9394(86)90830-5; Johnson LV, 2000, EXP EYE RES, V70, P441, DOI 10.1006/exer.1999.0798; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Kamei M, 2007, INVEST OPHTH VIS SCI, V48, P1801, DOI 10.1167/iovs.06-0699; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Kochounian H, 2009, EXP EYE RES, V88, P1129, DOI 10.1016/j.exer.2009.01.019; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Lengyel I, 2004, INVEST OPHTH VIS SCI, V45, P2886, DOI 10.1167/iovs.03-1083; Lengyel I, 2007, EXP EYE RES, V84, P772, DOI 10.1016/j.exer.2006.12.015; Li CM, 2007, EXP EYE RES, V85, P192, DOI 10.1016/j.exer.2007.04.002; Li CM, 2006, INVEST OPHTH VIS SCI, V47, P3119, DOI 10.1167/iovs.05-1446; Li CM, 2005, INVEST OPHTH VIS SCI, V46, P2576, DOI 10.1167/iovs.05-0034; Li CM, 2005, J LIPID RES, V46, P628, DOI 10.1194/jlr.M400428-JLR200; Lin MY, 2007, MOL VIS, V13, P1203; Loane E, 2008, SURV OPHTHALMOL, V53, P68, DOI 10.1016/j.survophthal.2007.10.008; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Luibl V, 2006, J CLIN INVEST, V116, P378, DOI 10.1172/JCI25843; Malek G, 2005, P NATL ACAD SCI USA, V102, P11900, DOI 10.1073/pnas.0503015102; Malek G, 2003, AM J PATHOL, V162, P413, DOI 10.1016/S0002-9440(10)63836-9; Moreira EF, 2009, INVEST OPHTH VIS SCI, V50, P523, DOI 10.1167/iovs.08-2373; Mullins RF, 1999, J HISTOCHEM CYTOCHEM, V47, P1533, DOI 10.1177/002215549904701205; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Ng KP, 2008, MOL CELL PROTEOMICS, V7, P1397, DOI 10.1074/mcp.M700525-MCP200; Nickle B, 2007, CELL MOL LIFE SCI, V64, P2917, DOI 10.1007/s00018-007-7253-1; Nordgaard CL, 2006, INVEST OPHTH VIS SCI, V47, P815, DOI 10.1167/iovs.05-0976; Nordgaard CL, 2008, INVEST OPHTH VIS SCI, V49, P2848, DOI 10.1167/iovs.07-1352; Oksjoki R, 2007, FRONT BIOSCI-LANDMRK, V12, P4696, DOI 10.2741/2419; PAULEIKHOFF D, 1990, OPHTHALMOLOGY, V97, P171; PAULEIKHOFF D, 1992, OPHTHALMOLOGY, V99, P1548; Raoul W, 2008, OPHTHAL RES, V40, P115, DOI 10.1159/000119860; Rudolf M, 2008, INVEST OPHTH VIS SCI, V49, P1200, DOI 10.1167/iovs.07-1466; Sallo FB, 2009, EXP EYE RES, V89, P178, DOI 10.1016/j.exer.2009.03.006; SARKS JP, 1988, EYE, V2, P552, DOI 10.1038/eye.1988.106; SARKS SH, 1980, AUST J OPHTHALMOL, V8, P117, DOI 10.1111/j.1442-9071.1980.tb01670.x; Schloendorn J, 2009, REJUV RES, V12, P411, DOI 10.1089/rej.2009.0917; Schmidt-Erfurth U, 2008, INVEST OPHTH VIS SCI, V49, P390, DOI 10.1167/iovs.07-0227; Schreck SF, 2000, BBA-PROTEIN STRUCT M, V1482, P199, DOI 10.1016/S0167-4838(00)00155-2; Seth A, 2008, INVEST OPHTH VIS SCI, V49, P743, DOI 10.1167/iovs.07-1072; Spaide RF, 1999, RETINA-J RET VIT DIS, V19, P141, DOI 10.1097/00006982-199902000-00010; Suzuki M, 2007, MOL VIS, V13, P772; Tezel TH, 2004, INVEST OPHTH VIS SCI, V45, P3337, DOI 10.1167/iovs.04-0193; Tserentsoodol N, 2006, MOL VIS, V12, P1319; VANDERSCHAFT TL, 1992, OPHTHALMOLOGY, V99, P278; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Wang JJ, 2007, OPHTHALMOLOGY, V114, P92, DOI 10.1016/j.ophtha.2006.07.017; Wang L, 2009, INVEST OPHTH VIS SCI, V50, P870, DOI 10.1167/iovs.08-2376; Warburton S, 2007, MOL VIS, V13, P318; Webb NR, 1998, J BIOL CHEM, V273, P15241, DOI 10.1074/jbc.273.24.15241; West KA, 2003, MOL CELL PROTEOMICS, V2, P37, DOI 10.1074/mcp.D200001-MCP200; White C Roger, 2009, Vasc Dis Prev, V6, P122; WOLTER JR, 1962, ARCH OPHTHALMOL-CHIC, V68, P219; Yamada Y, 2008, J NEUROCHEM, V105, P1187, DOI 10.1111/j.1471-4159.2008.05211.x; Yamamoto H, 1999, NAT GENET, V22, P188, DOI 10.1038/9707; Zerbib J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007341; [No title captured]; [No title captured]; [No title captured]; [No title captured]	97	226	229	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10329	10.1371/journal.pone.0010329	http://dx.doi.org/10.1371/journal.pone.0010329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428236	Green Published, Green Submitted, gold			2022-12-25	WOS:000277079300016
J	Kumada, Y; Zhang, SG				Kumada, Yoshiyuki; Zhang, Shuguang			Significant Type I and Type III Collagen Production from Human Periodontal Ligament Fibroblasts in 3D Peptide Scaffolds without Extra Growth Factors	PLOS ONE			English	Article							SELF-COMPLEMENTARY OLIGOPEPTIDE; ENAMEL MATRIX PROTEINS; FURCATION DEFECTS; NANOFIBER SCAFFOLDS; TISSUE REGENERATION; BONE REGENERATION; BEAGLE DOGS; FACTOR-BETA; CELLS; ATTACHMENT	We here report the development of two peptide scaffolds designed for periodontal ligament fibroblasts. The scaffolds consist of one of the pure self-assembling peptide scaffolds RADA16 through direct coupling to short biologically active motifs. The motifs are 2-unit RGD binding sequence PRG (PRGDSGYRGDS) and laminin cell adhesion motif PDS (PDSGR). RGD and laminin have been previously shown to promote specific biological activities including periodontal ligament fibroblasts adhesion, proliferation and protein production. Compared to the pure RADA16 peptide scaffold, we here show that these designer peptide scaffolds significantly promote human periodontal ligament fibroblasts to proliferate and migrate into the scaffolds (for similar to 300 mu m/two weeks). Moreover these peptide scaffolds significantly stimulated periodontal ligament fibroblasts to produce extracellular matrix proteins without using extra additional growth factors. Immunofluorescent images clearly demonstrated that the peptide scaffolds were almost completely covered with type I and type III collagens which were main protein components of periodontal ligament. Our results suggest that these designer self-assembling peptide nanofiber scaffolds may be useful for promoting wound healing and especially periodontal ligament tissue regeneration.	[Kumada, Yoshiyuki; Zhang, Shuguang] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; [Kumada, Yoshiyuki] Olympus Amer Inc, Center Valley, PA USA	Massachusetts Institute of Technology (MIT); Olympus Corporation	Kumada, Y (corresponding author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	shuguang@mit.edu		Zhang, Shuguang/0000-0002-3856-3752	Olympus America	Olympus America	Olympus America sent a researcher who is fully funded by Olympus America to Zhang's laboratory at MIT to carry out the research. Olympus America also provided reagents and material funding for the researcher. However the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKOVITZ BKB, 1990, EUR J ORTHODONT, V12, P51, DOI 10.1093/ejo/12.1.51; Camelo M, 1998, INT J PERIODONT REST, V18, P321; CENTRELLA M, 1987, J BIOL CHEM, V262, P2869; Chiquet M, 2003, MATRIX BIOL, V22, P73, DOI 10.1016/S0945-053X(03)00004-0; Chiquet M, 2007, APPL PHYSIOL NUTR ME, V32, P967, DOI 10.1139/H07-053; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; Galbraith CG, 1998, CURR OPIN CELL BIOL, V10, P566, DOI 10.1016/S0955-0674(98)80030-6; GANTES B, 1988, J CLIN PERIODONTOL, V15, P232, DOI 10.1111/j.1600-051X.1988.tb01576.x; Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119; Giannobile WV, 1996, BONE, V19, pS23, DOI 10.1016/S8756-3282(96)00127-5; Giannopoulou C, 1996, J DENT RES, V75, P895, DOI 10.1177/00220345960750030601; Grzesik WJ, 1998, J DENT RES, V77, P1606, DOI 10.1177/00220345980770080801; Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P669, DOI 10.1111/j.1600-051X.1997.tb00248.x; Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P658, DOI 10.1111/j.1600-051X.1997.tb00247.x; Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190; Jovanovic SA, 2007, CLIN ORAL IMPLAN RES, V18, P224, DOI 10.1111/j.1600-0501.2006.01324.x; KARIMBUX NY, 1995, J DENT RES, V74, P313, DOI 10.1177/00220345950740010501; KESKIOJA J, 1988, J BIOL CHEM, V263, P3111; Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106; LINDHE J, 1995, J CLIN PERIODONTOL, V22, P276, DOI 10.1111/j.1600-051X.1995.tb00148.x; MacKenna D, 2000, CARDIOVASC RES, V46, P257, DOI 10.1016/S0008-6363(00)00030-4; MATSUDA N, 1992, J PERIODONTOL, V63, P515, DOI 10.1902/jop.1992.63.6.515; Murakami S, 2003, J PERIODONTAL RES, V38, P97, DOI 10.1034/j.1600-0765.2003.00640.x; Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205; NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x; Okubo K, 2003, J PERIODONTAL RES, V38, P1, DOI 10.1034/j.1600-0765.2003.01607.x; Palaiologou AA, 2001, J PERIODONTOL, V72, P798, DOI 10.1902/jop.2001.72.6.798; PARK JB, 1995, J PERIODONTOL, V66, P462, DOI 10.1902/jop.1995.66.6.462; Shyy JYJ, 1997, CURR OPIN CELL BIOL, V9, P707, DOI 10.1016/S0955-0674(97)80125-1; Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785; Taba M Jr, 2005, Orthod Craniofac Res, V8, P292; Takayama S, 1997, J PERIODONTAL RES, V32, P667, DOI 10.1111/j.1600-0765.1997.tb00577.x; Takeda K, 2005, TISSUE ENG, V11, P1618, DOI 10.1089/ten.2005.11.1618; Wang XM, 2008, SOFT MATTER, V4, P2388, DOI 10.1039/b807155a; Windisch P, 2002, J PERIODONTOL, V73, P409, DOI 10.1902/jop.2002.73.4.409; WRANA JL, 1988, J CELL BIOL, V106, P915, DOI 10.1083/jcb.106.3.915; Yang YL, 2009, NANO TODAY, V4, P193, DOI 10.1016/j.nantod.2009.02.009; Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102; ZHANG S, 2005, SCAFFOLDING TISSUE E, P218; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334; ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	43	79	90	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10305	10.1371/journal.pone.0010305	http://dx.doi.org/10.1371/journal.pone.0010305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421985	Green Published, gold, Green Submitted			2022-12-25	WOS:000276952600022
J	Roperto, S; De Tullio, R; Raso, C; Stifanese, R; Russo, V; Gaspari, M; Borzacchiello, G; Averna, M; Paciello, O; Cuda, G; Roperto, F				Roperto, Sante; De Tullio, Roberta; Raso, Cinzia; Stifanese, Roberto; Russo, Valeria; Gaspari, Marco; Borzacchiello, Giuseppe; Averna, Monica; Paciello, Orlando; Cuda, Gianni; Roperto, Franco			Calpain3 Is Expressed in a Proteolitically Active Form in Papillomavirus-Associated Urothelial Tumors of the Urinary Bladder in Cattle	PLOS ONE			English	Article							MUSCLE-SPECIFIC CALPAIN; SKELETAL-MUSCLE; RETINOBLASTOMA PROTEIN; CELLULAR PROLIFERATION; CANCER-RESEARCH; ANIMAL-MODEL; BRACKEN-FERN; GROWTH; CELLS; OVEREXPRESSION	Background: Calpain 3 (Capn3), also named p94, is a skeletal muscle tissue-specific protein known to be responsible for limb-girdle muscular dystrophy type 2A (LGMD2A). Recent experimental studies have hypothesized a pro-apoptotic role of Capn3 in some melanoma cell lines. So far the link between calpain3 and tumors comes from in vitro studies. The objective of this study was to describe Capn3 activation in naturally occurring urothelial tumors of the urinary bladder in cattle. Methods and Findings: Here we describe, for the first time in veterinary and comparative oncology, the activation of Capn3 in twelve urothelial tumor cells of the urinary bladder of cattle. Capn3 protein was initially identified with nanoscale liquid chromatography coupled with tandem mass spectrometry (nano LC-MS/MS) in a co-immunoprecipitation experiment on E2F3, known to be a transcription factor playing a crucial role in bladder carcinogenesis in humans. Capn3 expression was then confirmed by reverse transcription polymerase chain reaction (RT-PCR). Finally, the Ca2+-dependent proteolytic activity of Capn3 was assayed following ion exchange chromatography. Morphologically, Capn3 expression was documented by immunohistochemical methods. In fact numerous tumor cells showed an intracytoplasmic immunoreactivity, which was more rarely evident also at nuclear level. In urothelial tumors, bovine papillomavirus type 2 (BPV-2) DNA was amplified by PCR and the expression of E5 protein, the major oncogenic protein of BVP-2, was detected by western blotting, immunohistochemistry, and immunofluorescence. E2F3 overexpression and pRb protein downregulation were shown by western blotting. Conclusion: The role of capn3 protein in urothelial cancer of the urinary bladder remains to be elucidated: further studies would be required to determine the precise function of this protease in tumor development and progression. However, we suggest that activated Capn3 may be involved in molecular pathways leading to the overexpression of E2F3, which in turn could be responsible for urothelial tumor cell proliferation also in cattle, though other mechanisms are likely to exist. If further studies corroborate the important role of Capn3 in urothelial tumors of the urinary bladder, cattle with urinary tumors may prove useful as animal model for bladder carcinogenesis.	[Roperto, Sante] Univ Naples Federico II, Div Infect Dis, Dept Pathol & Anim Hlth, Naples, Italy; [De Tullio, Roberta; Stifanese, Roberto; Averna, Monica] Univ Genoa, Dept Expt Med, DIMES, Biochem Sect, Genoa, Italy; [De Tullio, Roberta; Stifanese, Roberto; Averna, Monica] Univ Genoa, CEBR, Genoa, Italy; [Raso, Cinzia; Gaspari, Marco; Cuda, Gianni] Univ Catanzaro Magna Graecia, Dept Expt Med & Clin, Catanzaro, Italy; [Russo, Valeria; Borzacchiello, Giuseppe; Paciello, Orlando; Roperto, Franco] Univ Naples Federico II, Dept Pathol & Anim Hlth, Div Gen Pathol, Naples, Italy	University of Naples Federico II; University of Genoa; University of Genoa; Magna Graecia University of Catanzaro; University of Naples Federico II	Roperto, S (corresponding author), Univ Naples Federico II, Div Infect Dis, Dept Pathol & Anim Hlth, Naples, Italy.	sante.roperto@unina.it	Gaspari, Marco/ABE-1539-2020; Cuda, Giovanni/F-5359-2012; AVERNA, MONICA/R-5719-2019; Cuda, Giovanni/AAC-2821-2019; Gaspari, Marco/HGB-2399-2022; Gaspari, Marco/C-2756-2009	Gaspari, Marco/0000-0002-5411-8800; Cuda, Giovanni/0000-0001-6313-1866; AVERNA, MONICA/0000-0002-9463-7533; Cuda, Giovanni/0000-0001-6313-1866; Gaspari, Marco/0000-0002-5411-8800; Borzacchiello, Giuseppe/0000-0003-3943-2604; roperto, sante/0000-0001-6210-5519; DE TULLIO, ROBERTA/0000-0001-6925-3207	Ministero delle Politiche Agricole, Alimentari, Forestali; Assessorato alla Sanita della Regione Campania e della Regione Basilicata; Legge Regionale; PRIN 2007 and 2008	Ministero delle Politiche Agricole, Alimentari, Forestali; Assessorato alla Sanita della Regione Campania e della Regione Basilicata; Legge Regionale; PRIN 2007 and 2008(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by grants from the Ministero delle Politiche Agricole, Alimentari, Forestali, as well as from the Assessorato alla Sanita della Regione Campania e della Regione Basilicata, from the Legge Regionale n. 5 and PRIN 2007 and 2008. The funders had no role in study design, interpretation of data, writing of the paper, and decision to submit it for publication.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Azuma M, 2000, CURR EYE RES, V21, P710, DOI 10.1076/0271-3683(200009)21:3;1-R;FT710; Bai DS, 2009, HEPATOLOGY, V49, P460, DOI 10.1002/hep.22638; BESSER TE, 1990, AM J MED GENET, V37, P159, DOI 10.1002/ajmg.1320370137; Blazquez L, 2008, NEUROGENETICS, V9, P173, DOI 10.1007/s10048-008-0129-1; Borzacchiello G, 2006, ONCOGENE, V25, P1251, DOI 10.1038/sj.onc.1209152; Borzacchiello G, 2008, VET RES, V39, DOI 10.1051/vetres:2008022; Burger MM, 2000, INT J CANCER, V85, P303, DOI 10.1002/(SICI)1097-0215(20000201)85:3<303::AID-IJC1>3.0.CO;2-2; CAMPO MS, 1992, CANCER RES, V52, P6898; Chan E, 2009, BJU INT, V104, P1286, DOI 10.1111/j.1464-410X.2009.08577.x; Cohen N, 2006, PROTEOMICS, V6, P6075, DOI 10.1002/pmic.200600199; Darnell GA, 2007, J BIOL CHEM, V282, P37492, DOI 10.1074/jbc.M706860200; De Tullio R, 2003, BIOCHEM J, V375, P689, DOI 10.1042/BJ20030706; Demarchi F, 2007, AUTOPHAGY, V3, P235, DOI 10.4161/auto.3661; Demarchi F, 2007, CELL CYCLE, V6, P136; Demarchi F, 2006, J CELL BIOL, V175, P595, DOI 10.1083/jcb.200601024; Diaz BEG, 2006, BIOCHEMISTRY-US, V45, P3714, DOI 10.1021/bi051917j; Drogemuller C, 2008, GENOMICS, V92, P474, DOI 10.1016/j.ygeno.2008.07.014; Feber A, 2004, ONCOGENE, V23, P1627, DOI 10.1038/sj.onc.1207274; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hurst CD, 2008, ONCOGENE, V27, P2716, DOI 10.1038/sj.onc.1210934; Huynh KM, 2009, GENE, V433, P32, DOI 10.1016/j.gene.2008.11.013; Kawabata Y, 2003, FEBS LETT, V555, P623, DOI 10.1016/S0014-5793(03)01324-3; Konig N, 2003, J CHEM NEUROANAT, V25, P129, DOI 10.1016/S0891-0618(02)00102-3; Kuznetsov S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003997; Lee SJ, 2007, INT J GYNECOL CANCER, V17, P248, DOI 10.1111/j.1525-1438.2006.00756.x; Ma H, 2000, CURR EYE RES, V20, P183, DOI 10.1076/0271-3683(200003)20:3;1-9;FT183; Moretti D, 2009, CARCINOGENESIS, V30, P960, DOI 10.1093/carcin/bgp098; Murphy RM, 2009, J BIOL CHEM, V284, P7811, DOI 10.1074/jbc.M808655200; Oeggerli M, 2004, ONCOGENE, V23, P5616, DOI 10.1038/sj.onc.1207749; Olsson AY, 2007, ONCOGENE, V26, P1028, DOI 10.1038/sj.onc.1209854; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Yasuko, 2007, Biotechnology Journal, V2, P565, DOI 10.1002/biot.200700018; PAMUKCU AM, 1976, VET PATHOL, V13, P110, DOI 10.1177/030098587601300205; PONTREMOLI S, 1991, ARCH BIOCHEM BIOPHYS, V288, P646, DOI 10.1016/0003-9861(91)90247-G; Rey MA, 2002, FEBS LETT, V532, P401, DOI 10.1016/S0014-5793(02)03722-5; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Roperto S, 2010, J COMP PATHOL, V142, P95, DOI 10.1016/j.jcpa.2009.08.156; Roperto S, 2010, J COMP PATHOL, V142, P19, DOI 10.1016/j.jcpa.2009.06.001; Roperto S, 2008, J GEN VIROL, V89, P3027, DOI 10.1099/vir.0.2008/004457-0; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Stifanese R, 2008, ARCH BIOCHEM BIOPHYS, V479, P145, DOI 10.1016/j.abb.2008.09.002; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Zeng CB, 2007, CANCER RES, V67, P6708, DOI 10.1158/0008-5472.CAN-06-3803; Zhang WF, 2010, VIROLOGY, V397, P139, DOI 10.1016/j.virol.2009.10.051	50	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10299	10.1371/journal.pone.0010299	http://dx.doi.org/10.1371/journal.pone.0010299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421977	Green Published, gold, Green Submitted			2022-12-25	WOS:000276952600016
J	Teklenburg, G; Salker, M; Molokhia, M; Lavery, S; Trew, G; Aojanepong, T; Mardon, HJ; Lokugamage, AU; Rai, R; Landles, C; Roelen, BAJ; Quenby, S; Kuijk, EW; Kavelaars, A; Heijnen, CJ; Regan, L; Brosens, JJ; Macklon, NS				Teklenburg, Gijs; Salker, Madhuri; Molokhia, Mariam; Lavery, Stuart; Trew, Geoffrey; Aojanepong, Tepchongchit; Mardon, Helen J.; Lokugamage, Amali U.; Rai, Raj; Landles, Christian; Roelen, Bernard A. J.; Quenby, Siobhan; Kuijk, Ewart W.; Kavelaars, Annemieke; Heijnen, Cobi J.; Regan, Lesley; Brosens, Jan J.; Macklon, Nick S.			Natural Selection of Human Embryos: Decidualizing Endometrial Stromal Cells Serve as Sensors of Embryo Quality upon Implantation	PLOS ONE			English	Article							ONGOING PREGNANCY; MATERNAL AGE; EXPRESSION; RECEPTIVITY; INHIBITION; ACTIVATION; MORPHOLOGY; RATES	Background: Pregnancy is widely viewed as dependent upon an intimate dialogue, mediated by locally secreted factors between a developmentally competent embryo and a receptive endometrium. Reproductive success in humans is however limited, largely because of the high prevalence of chromosomally abnormal preimplantation embryos. Moreover, the transient period of endometrial receptivity in humans uniquely coincides with differentiation of endometrial stromal cells (ESCs) into highly specialized decidual cells, which in the absence of pregnancy invariably triggers menstruation. The role of cyclic decidualization of the endometrium in the implantation process and the nature of the decidual cytokines and growth factors that mediate the crosstalk with the embryo are unknown. Methodology/Principal Findings: We employed a human co-culture model, consisting of decidualizing ESCs and single hatched blastocysts, to identify the soluble factors involved in implantation. Over the 3-day co-culture period, approximately 75% of embryos arrested whereas the remainder showed normal development. The levels of 14 implantation factors secreted by the stromal cells were determined by multiplex immunoassay. Surprisingly, the presence of a developing embryo had no significant effect on decidual secretions, apart from a modest reduction in IL-5 levels. In contrast, arresting embryos triggered a strong response, characterized by selective inhibition of IL-1 beta, -6, -10, -17, -18, eotaxin, and HB-EGF secretion. Co-cultures were repeated with undifferentiated ESCs but none of the secreted cytokines were affected by the presence of a developing or arresting embryo. Conclusions: Human ESCs become biosensors of embryo quality upon differentiation into decidual cells. In view of the high incidence of gross chromosomal errors in human preimplantation embryos, cyclic decidualization followed by menstrual shedding may represent a mechanism of natural embryo selection that limits maternal investment in developmentally impaired pregnancies.	[Teklenburg, Gijs; Kuijk, Ewart W.; Macklon, Nick S.] Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands; [Salker, Madhuri; Lavery, Stuart; Trew, Geoffrey; Aojanepong, Tepchongchit; Rai, Raj; Landles, Christian; Regan, Lesley; Brosens, Jan J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Inst Reprod & Dev Biol, London, England; [Molokhia, Mariam] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Mardon, Helen J.] Univ Oxford, John Radcliffe Hosp, Womens Ctr, Nuffield Dept Obstet & Gynecol, Oxford OX3 9DU, England; [Lokugamage, Amali U.] Whittington Hosp NHS Trust, Dept Obstet & Gynecol, London, England; [Roelen, Bernard A. J.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands; [Quenby, Siobhan] Univ Liverpool, Liverpool Womens Hosp, Dept Reprod & Dev Hlth, Liverpool L69 3BX, Merseyside, England; [Teklenburg, Gijs; Kavelaars, Annemieke; Heijnen, Cobi J.] Univ Med Ctr Utrecht, Lab Psychoneuroimmunol, Utrecht, Netherlands; [Macklon, Nick S.] Univ Southampton, Princess Anne Hosp, Div Dev Origins Hlth & Dis, Southampton, Hants, England	Utrecht University; Utrecht University Medical Center; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Utrecht University; University of Liverpool; Utrecht University; Utrecht University Medical Center; University of Southampton	Teklenburg, G (corresponding author), Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands.	j.brosens@imperial.ac.uk	Kuijk, Ewart/I-2569-2019	Kuijk, Ewart/0000-0002-1385-6516; Quenby, Siobhan/0000-0003-3221-5471; Salker, Madhuri Sonal/0000-0002-7939-289X; Brosens, Jan/0000-0003-0116-9329; Landles, Christian/0000-0001-9715-6447; Lokugamage, Amali/0000-0002-7439-2700	Netherlands Organisation for Scientific Research; CONRAD/Consortium for Industrial Collaboration in Contraceptive Research (CICCR) [640510, CIG-08-122]; Wellcome Trust [084336]; Institute of Obstetrics and Gynaecology (IOG) Trust; NIHR Biomedical Research Centre	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); CONRAD/Consortium for Industrial Collaboration in Contraceptive Research (CICCR); Wellcome Trust(Wellcome TrustEuropean Commission); Institute of Obstetrics and Gynaecology (IOG) Trust; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was supported by funds from the Netherlands Organisation for Scientific Research (NWO; http://www. nwo. nl), CONRAD/Consortium for Industrial Collaboration in Contraceptive Research (CICCR) Grant (640510) (CIG-08-122; http://www.conrad.org/), the Wellcome Trust (084336; http://www.wellcome.ac.uk/), the Institute of Obstetrics and Gynaecology (IOG) Trust (www. iogt. org. uk) and the NIHR Biomedical Research Centre funding scheme (http://www.nihr.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki R, 2000, SEMIN REPROD MED, V18, P265, DOI 10.1055/s-2000-12564; Benson GV, 1996, DEVELOPMENT, V122, P2687; Boomsma CM, 2009, HUM REPROD, V24, P1427, DOI 10.1093/humrep/dep011; Brosens JJ, 2006, J MOL ENDOCRINOL, V36, P389, DOI 10.1677/jme.1.02060; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; Brosens JJ, 2002, AM J OBSTET GYNECOL, V187, P1416, DOI 10.1067/mob.2002.127305; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Cai KQ, 2008, DEV DYNAM, V237, P2820, DOI 10.1002/dvdy.21703; Catalano RD, 2005, P NATL ACAD SCI USA, V102, P8585, DOI 10.1073/pnas.0502343102; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; de Jong D, 2002, J ASSIST REPROD GEN, V19, P561, DOI 10.1023/A:1021211115337; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Donaghay M, 2007, SEMIN REPROD MED, V25, P461, DOI 10.1055/s-2007-991044; Evers JLH, 2002, LANCET, V360, P151, DOI 10.1016/S0140-6736(02)09417-5; GELLERSEN B, 2010, HUM REPROD; Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Haig D, 1996, J EVOLUTION BIOL, V9, P357, DOI 10.1046/j.1420-9101.1996.9030357.x; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Horcajadas JA, 2007, HUM REPROD UPDATE, V13, P77, DOI 10.1093/humupd/dml046; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021; Jones MC, 2006, P NATL ACAD SCI USA, V103, P16272, DOI 10.1073/pnas.0603002103; Ledbetter DH, 2009, NAT MED, V15, P490, DOI 10.1038/nm0509-490; Leese HJ, 2008, MOL HUM REPROD, V14, P667, DOI 10.1093/molehr/gan065; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lopes FL, 2004, REPRODUCTION, V128, P669, DOI 10.1530/rep.1.00444; Lynch VJ, 2008, P NATL ACAD SCI USA, V105, P14928, DOI 10.1073/pnas.0802355105; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Mansouri-Attia N, 2009, P NATL ACAD SCI USA, V106, P5687, DOI 10.1073/pnas.0812722106; Munne S, 2007, REPROD BIOMED ONLINE, V14, P628, DOI 10.1016/S1472-6483(10)61057-7; MUNNE S, 1995, FERTIL STERIL, V64, P382, DOI 10.1016/S0015-0282(16)57739-5; Nakamura H, 2006, FEBS LETT, V580, P2717, DOI 10.1016/j.febslet.2006.04.029; Promislow JHE, 2007, HUM REPROD, V22, P853, DOI 10.1093/humrep/del417; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Vitzthum VJ, 2001, CONTRACEPTION, V64, P319, DOI 10.1016/S0010-7824(01)00260-8; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; WYNN RM, 1974, AM J OBSTET GYNECOL, V118, P652, DOI 10.1016/S0002-9378(16)33740-1	39	193	199	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10258	10.1371/journal.pone.0010258	http://dx.doi.org/10.1371/journal.pone.0010258			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422011	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000276952500016
J	Zhang, YJ; Xuan, JH; de los Reyes, BG; Clarke, R; Ressom, HW				Zhang, Yuji; Xuan, Jianhua; de los Reyes, Benildo G.; Clarke, Robert; Ressom, Habtom W.			Reconstruction of Gene Regulatory Modules in Cancer Cell Cycle by Multi-Source Data Integration	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTION; TRANSCRIPTIONAL REGULATION; INTERACTION NETWORK; DNA-REPLICATION; EXPRESSION DATA; MICROARRAY DATA; IDENTIFICATION; BIOLOGY; E2F; COREGULATION	Background: Precise regulation of the cell cycle is crucial to the growth and development of all organisms. Understanding the regulatory mechanism of the cell cycle is crucial to unraveling many complicated diseases, most notably cancer. Multiple sources of biological data are available to study the dynamic interactions among many genes that are related to the cancer cell cycle. Integrating these informative and complementary data sources can help to infer a mutually consistent gene transcriptional regulatory network with strong similarity to the underlying gene regulatory relationships in cancer cells. Results and Principal Findings: We propose an integrative framework that infers gene regulatory modules from the cell cycle of cancer cells by incorporating multiple sources of biological data, including gene expression profiles, gene ontology, and molecular interaction. Among 846 human genes with putative roles in cell cycle regulation, we identified 46 transcription factors and 39 gene ontology groups. We reconstructed regulatory modules to infer the underlying regulatory relationships. Four regulatory network motifs were identified from the interaction network. The relationship between each transcription factor and predicted target gene groups was examined by training a recurrent neural network whose topology mimics the network motif(s) to which the transcription factor was assigned. Inferred network motifs related to eight well-known cell cycle genes were confirmed by gene set enrichment analysis, binding site enrichment analysis, and comparison with previously published experimental results. Conclusions: We established a robust method that can accurately infer underlying relationships between a given transcription factor and its downstream target genes by integrating different layers of biological data. Our method could also be beneficial to biologists for predicting the components of regulatory modules in which any candidate gene is involved. Such predictions can then be used to design a more streamlined experimental approach for biological validation. Understanding the dynamics of these modules will shed light on the processes that occur in cancer cells resulting from errors in cell cycle regulation.	[Zhang, Yuji; Clarke, Robert; Ressom, Habtom W.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Zhang, Yuji; Xuan, Jianhua] Virginia Polytech Inst & State Univ, Dept Elect & Comp Engn, Arlington, VA USA; [de los Reyes, Benildo G.] Univ Maine, Sch Biol & Ecol, Orono, ME USA	Georgetown University; Virginia Polytechnic Institute & State University; University of Maine System; University of Maine Orono	Zhang, YJ (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	hwr@georgetown.edu	Zhang, Yuji/J-4599-2013; zhang, yuji/B-9446-2012; Clarke, Robert/A-6485-2008	Clarke, Robert/0000-0002-9278-0854; Zhang, Yuji/0000-0002-5429-6762	National Institutes of Health [CA109872, NS29525, EB00830, CA096483]; Department of Defense [BC030280]; NATIONAL CANCER INSTITUTE [R01CA096483, R21CA109872, R33CA109872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB000830, R33EB000830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study is supported in part by grants from the National Institutes of Health (CA109872, NS29525, EB00830, and CA096483) and the Department of Defense (BC030280). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Chen HC, 2004, BIOINFORMATICS, V20, P1914, DOI 10.1093/bioinformatics/bth178; Chen L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-416; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; de Hoon MJL, 2002, BIOINFORMATICS, V18, P1477, DOI 10.1093/bioinformatics/18.11.1477; Dembele D, 2003, BIOINFORMATICS, V19, P973, DOI 10.1093/bioinformatics/btg119; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Hong R, 2003, J BIOL CHEM, V278, P44505, DOI 10.1074/jbc.M303138200; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; JAMES CB, RECOGNITION FUZZY OB, P256; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Keedwell E, 2005, IEEE ACM T COMPUT BI, V2, P231, DOI 10.1109/TCBB.2005.40; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Li CW, 2006, CANCER INFORM, V2, P223; Lin D., 1998, ICML, V98, P296; Martin PJ, 2005, NUCLEIC ACIDS RES, V33, P4311, DOI 10.1093/nar/gki745; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Persico M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S21; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Ressom H, 2003, PHYSIOL GENOMICS, V13, P107, DOI 10.1152/physiolgenomics.00097.2002; RESSOM HW, 2006, P 28 IEEE ENG MED BI, P4241; Romer KA, 2007, NUCLEIC ACIDS RES, V35, pW217, DOI 10.1093/nar/gkm376; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Shah JV, 2000, CELL, V103, P997, DOI 10.1016/S0092-8674(00)00202-6; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Takahashi Y, 2000, GENE DEV, V14, P804; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; XU R, 2005, GENE REGULATORY NETW, P286; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Yeung KY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r48; Zhang GL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S19; Zhu JW, 2001, MOL CELL BIOL, V21, P8547, DOI 10.1128/MCB.21.24.8547-8564.2001	56	3	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10268	10.1371/journal.pone.0010268	http://dx.doi.org/10.1371/journal.pone.0010268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422009	Green Published, gold, Green Submitted			2022-12-25	WOS:000276952500020
J	da Hora, RR; Delabie, JHC; dos Santos, CG; Serrao, JE				da Hora, Riviane Rodigues; Charles Delabie, Jacques Hubert; dos Santos, Carolina Goncalves; Serrao, Jose Eduardo			Glandular Epithelium as a Possible Source of a Fertility Signal in Ectatomma tuberculatum (Hymenoptera: Formicidae) Queens	PLOS ONE			English	Article							CUTICULAR HYDROCARBONS; NESTMATE RECOGNITION; REPRODUCTIVE STATUS; GERMAN-COCKROACH; WAX SECRETION; ANT; LARVAE; CUTICLE; BIOSYNTHESIS; CIRCULATION	The wax layer covering the insect's cuticle plays an important protective role, as for example, uncontrolled water loss. In social insects, wax production is well-known in some bees that use it for nest building. Curiously, mated-fertile queens of the ant Ectatomma tuberculatum produce an uncommon extra-wax coat and, consequently queens (mated-fertile females) are matte due to such extra cuticular hydrocarbon (CHC) coat that covers the cuticle and masks the brightness of the queens' cuticle while gynes (virgin-infertile queens) are shiny. In this study, histological analysis showed differences in the epidermis between fertile (i.e., queens or gynes with highly ovarian activity) and infertile females ( gynes or workers with non developed ovaries). In fertile females the epidermis is a single layer of cubic cells found in all body segments whereas in infertile females it is a thin layer of flattened cells. Ultrastructural features showed active secretory tissue from fertile females similar to the glandular epithelium of wax-producing bees ( type I gland). Different hypotheses related to the functions of the glandular epithelium exclusive to the E. tuberculatum fertile queens are discussed.	[da Hora, Riviane Rodigues; dos Santos, Carolina Goncalves; Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil; [da Hora, Riviane Rodigues; Charles Delabie, Jacques Hubert] Convenio UESC CEPEC CEPLAC, UPA Lab Mirmecol, Itabuna, Brazil	Universidade Federal de Vicosa; Universidade Estadual de Santa Cruz	da Hora, RR (corresponding author), Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil.	jeserrao@ufv.br	Serrão, Jose Eduardo/H-2935-2012; Delabie, Jacques H C/F-3405-2010	Delabie, Jacques H C/0000-0002-2695-1061	National Council of Research (CNPq); Minas Gerais State Research Agency (FAPEMIG); PRONEX FAPESB/CNPq [PNX0011/2009]	National Council of Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais State Research Agency (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); PRONEX FAPESB/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Brazilian research agencies National Council of Research (CNPq), Minas Gerais State Research Agency (FAPEMIG) and PRONEX FAPESB/CNPq PNX0011/2009. The funders had no role in study design, data collection and and analysis, decision to publish, or preparation of the manuscript.	Agarwala BK, 2001, ENTOMOL EXP APPL, V100, P101, DOI 10.1023/A:1019234526303; Azevedo DD, 2007, ANIM BIOL, V57, P329, DOI 10.1163/157075607781753074; Billen J, 2002, BELG J ZOOL, V132, P175; Billen J, 2006, ACTA ZOOL-STOCKHOLM, V87, P291, DOI 10.1111/j.1463-6395.2006.00244.x; BLOMQUIST GJ, 1980, INSECT BIOCHEM, V10, P313, DOI 10.1016/0020-1790(80)90026-8; BRADLEY GA, 1973, CAN ENTOMOL, V105, P1113, DOI 10.4039/Ent1051113-8; BREED MD, 1988, P NATL ACAD SCI USA, V85, P8766, DOI 10.1073/pnas.85.22.8766; Chapman R.F., 2012, INSECTS STRUCTURE FU; Cruz Landim C. da., 1963, Journal of the New York Entomological Society, V71, P2; CRUZLANDIM C, 1993, NATURALIA, V8, P173; Cuvillier-Hot V, 2001, J INSECT PHYSIOL, V47, P485, DOI 10.1016/S0022-1910(00)00137-2; D'Ettorre P, 2006, ANIM BEHAV, V71, P773, DOI 10.1016/j.anbehav.2005.05.014; D'Ettorre P, 2004, J EXP BIOL, V207, P1085, DOI 10.1242/jeb.00865; Dapporto L, 2008, J INSECT PHYSIOL, V54, P89, DOI 10.1016/j.jinsphys.2007.08.005; de Biseau JC, 2004, J INSECT PHYSIOL, V50, P585, DOI 10.1016/j.jinsphys.2004.04.005; DIEHL PA, 1975, J INSECT PHYSIOL, V21, P1237, DOI 10.1016/0022-1910(75)90093-1; Dietemann V, 2003, P NATL ACAD SCI USA, V100, P10341, DOI 10.1073/pnas.1834281100; Eelen D, 2004, ARTHROPOD STRUCT DEV, V33, P471, DOI 10.1016/j.asd.2004.08.001; EISNER T, 1994, J CHEM ECOL, V20, P2743, DOI 10.1007/BF02036205; Endler A, 2004, P NATL ACAD SCI USA, V101, P2945, DOI 10.1073/pnas.0308447101; Falleiros Angela M. F., 1995, Revista Brasileira de Zoologia, V12, P751, DOI 10.1590/S0101-81751995000400004; Fan YL, 2003, NATURWISSENSCHAFTEN, V90, P121, DOI 10.1007/s00114-003-0402-y; GAMBOA GJ, 1986, ANNU REV ENTOMOL, V31, P431, DOI 10.1146/annurev.en.31.010186.002243; Gibbs AG, 1998, AM ZOOL, V38, P268; Gobin B, 2003, ACTA ZOOL-STOCKHOLM, V84, P285, DOI 10.1046/j.1463-6395.2003.00149.x; GU X, 1995, J INSECT PHYSIOL, V41, P257, DOI 10.1016/0022-1910(94)00100-U; Guerino Adriane C., 2003, Neotrop. entomol., V32, P261, DOI 10.1590/S1519-566X2003000200010; Hadley N.F., 1984, BIOL INTEGUMENT INVE, P685; HADLEY NF, 1982, J EXP ZOOL, V222, P239, DOI 10.1002/jez.1402220306; HADLEY NF, 1979, SCIENCE, V203, P367, DOI 10.1126/science.203.4378.367; Hannonen M, 2002, ANIM BEHAV, V64, P477, DOI 10.1006/anbe.2002.4001; Hefetz Abraham, 2007, Myrmecological News, V10, P59; HOLLDOBLER B, 1994, INSECT SOC, V41, P63, DOI 10.1007/BF01240573; Hora RR, 2008, NATURWISSENSCHAFTEN, V95, P55, DOI 10.1007/s00114-007-0287-2; Hora RR, 2005, INSECT SOC, V52, P194, DOI 10.1007/s00040-004-0794-5; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Johnson RA, 2004, J INSECT PHYSIOL, V50, P943, DOI 10.1016/j.jinsphys.2004.07.006; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; Lucas C, 2004, J INSECT PHYSIOL, V50, P595, DOI 10.1016/j.jinsphys.2004.04.006; Manfredini F, 2008, TISSUE CELL, V40, P103, DOI 10.1016/j.tice.2007.10.003; Marques-Silva S, 2006, MICROSC RES TECHNIQ, V69, P885, DOI 10.1002/jemt.20356; MICHENER C D, 1974, P404; Monnin T, 1998, J CHEM ECOL, V24, P473, DOI 10.1023/A:1022360718870; Monnin T, 2006, ANN ZOOL FENN, V43, P515; MOTA M H V B, 1988, Revista Brasileira de Zoologia, V5, P119, DOI 10.1590/S0101-81751988000100010; NOIROT C, 1991, ANN SOC ENTOMOL FR, V27, P123; Oettler J, 2008, J INSECT PHYSIOL, V54, P672, DOI 10.1016/j.jinsphys.2008.01.004; Patel Sejal, 2001, Journal of Insect Science (Tucson), V1, P1; Pearse A.G.E., 1985, HISTOCHEMISTRY THEOR; Peeters C, 1999, P ROY SOC B-BIOL SCI, V266, P1323, DOI 10.1098/rspb.1999.0782; Pope R.D., 1985, Antenna, V9, P4; POPE RD, 1979, SYST ENTOMOL, V4, P171, DOI 10.1111/j.1365-3113.1979.tb00632.x; Raccaud-Schoeller J., 1980, INSECTES PHYSL DEV, P296; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; ROMA CR, 2010, MICRON, DOI DOI 10.1016/J.MICRON.2009.12.007; Roma GC, 2009, ANIM BIOL, V59, P241, DOI 10.1163/157075609X437745; ROMER F, 1980, HISTOCHEMISTRY, V69, P69, DOI 10.1007/BF00508368; Schal C, 1998, AM ZOOL, V38, P382; Serrao JE, 2009, MICROSC RES TECHNIQ, V72, P28, DOI 10.1002/jemt.20641; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Soroker V, 2000, J INSECT PHYSIOL, V46, P1097, DOI 10.1016/S0022-1910(99)00219-X; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; TAKABAYASHI J, 1993, J INSECT BEHAV, V6, P107, DOI 10.1007/BF01049151; Turillazzi S, 2006, CURR BIOL, V16, pR530, DOI 10.1016/j.cub.2006.06.050; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Volkl W, 1996, OECOLOGIA, V107, P498, DOI 10.1007/BF00333941; Zinck L, 2007, BEHAV ECOL, V18, P701, DOI 10.1093/beheco/arm033	69	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10219	10.1371/journal.pone.0010219	http://dx.doi.org/10.1371/journal.pone.0010219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419093	Green Published, Green Submitted, gold			2022-12-25	WOS:000276853800011
J	Rapin, N; Lund, O; Bernaschi, M; Castiglione, F				Rapin, Nicolas; Lund, Ole; Bernaschi, Massimo; Castiglione, Filippo			Computational Immunology Meets Bioinformatics: The Use of Prediction Tools for Molecular Binding in the Simulation of the Immune System	PLOS ONE			English	Article							MHC CLASS-I; HIV TYPE-1 INFECTION; DIPLOID CELL STRAINS; T-CELLS; PEPTIDE-BINDING; VIRAL DYNAMICS; QUANTITATIVE PREDICTIONS; VACCINE RESEARCH; VIRUS-INFECTION; COMPUTER-MODEL	We present a new approach to the study of the immune system that combines techniques of systems biology with information provided by data-driven prediction methods. To this end, we have extended an agent-based simulator of the immune response, C-IMMSIM, such that it represents pathogens, as well as lymphocytes receptors, by means of their amino acid sequences and makes use of bioinformatics methods for T and B cell epitope prediction. This is a key step for the simulation of the immune response, because it determines immunogenicity. The binding of the epitope, which is the immunogenic part of an invading pathogen, together with activation and cooperation from T helper cells, is required to trigger an immune response in the affected host. To determine a pathogen's epitopes, we use existing prediction methods. In addition, we propose a novel method, which uses Miyazawa and Jernigan protein-protein potential measurements, for assessing molecular binding in the context of immune complexes. We benchmark the resulting model by simulating a classical immunization experiment that reproduces the development of immune memory. We also investigate the role of major histocompatibility complex (MHC) haplotype heterozygosity and homozygosity with respect to the influenza virus and show that there is an advantage to heterozygosity. Finally, we investigate the emergence of one or more dominating clones of lymphocytes in the situation of chronic exposure to the same immunogenic molecule and show that high affinity clones proliferate more than any other. These results show that the simulator produces dynamics that are stable and consistent with basic immunological knowledge. We believe that the combination of genomic information and simulation of the dynamics of the immune system, in one single tool, can offer new perspectives for a better understanding of the immune system.	[Rapin, Nicolas] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Rapin, Nicolas] Univ Copenhagen, Bioinformat Ctr, Copenhagen, Denmark; [Lund, Ole] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Bernaschi, Massimo; Castiglione, Filippo] CNR, Inst Comp Applicat, Rome, Italy	University of Copenhagen; University of Copenhagen; Technical University of Denmark; Consiglio Nazionale delle Ricerche (CNR)	Rapin, N (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark.	f.castiglione@iac.rm.cnr.it	Lund, Ole/F-4437-2014; Castiglione, Filippo/B-1366-2010	Lund, Ole/0000-0003-1108-0491; Castiglione, Filippo/0000-0002-1442-3552; Rapin, Nicolas/0000-0001-5208-8874	European Community [FP6-2004-IST-4]	European Community(European Commission)	This work was supported by the European Community under the contract FP6-2004-IST-4, No. 028069 (ImmunoGrid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN PM, 1987, IMMUNOL TODAY, V8, P270, DOI 10.1016/0167-5699(87)90187-3; ALTSHUL SF, 1997, NUCLEIC ACIDS RES, V25, P402; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; BEREK C, 1993, IMMUNOL TODAY, V14, P400, DOI 10.1016/0167-5699(93)90143-9; Bernaschi M, 2001, COMPUT BIOL MED, V31, P303, DOI 10.1016/S0010-4825(01)00011-7; Berzofsky J A, 1985, Year Immunol, P18; Bian HJ, 2004, METHODS, V34, P468, DOI 10.1016/j.ymeth.2004.06.002; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P6971, DOI 10.1073/pnas.94.13.6971; BRUSIC V, 1994, NUCLEIC ACIDS RES, V22, P3663, DOI 10.1093/nar/22.17.3663; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Castiglione F, 2004, AIDS RES HUM RETROV, V20, P1314, DOI 10.1089/aid.2004.20.1314; Castiglione F, 2007, BIOINFORMATICS, V23, P1371, DOI 10.1093/bioinformatics/btm044; CELADA F, 1992, IMMUNOL TODAY, V13, P56, DOI 10.1016/0167-5699(92)90135-T; CELADA F, 1971, PROG ALLERGY, V15, P223; Celada F, 1996, EUR J IMMUNOL, V26, P1350, DOI 10.1002/eji.1830260626; Cheng YM, 2009, VACCINE, V27, P833, DOI 10.1016/j.vaccine.2008.11.109; DEBOER RJ, 1994, J THEOR BIOL, V169, P375, DOI 10.1006/jtbi.1994.1160; deJong MD, 1997, AIDS, V11, pF79, DOI 10.1097/00002030-199711000-00002; Effros RB, 1997, IMMUNOL TODAY, V18, P450, DOI 10.1016/S0167-5699(97)01079-7; ESSUNGER P, 1994, J THEOR BIOL, V170, P367, DOI 10.1006/jtbi.1994.1199; FARMER JD, 1986, PHYSICA D, V22, P187, DOI 10.1016/0167-2789(86)90240-X; Folcik VA, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-39; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; Herz AVM, 1996, P NATL ACAD SCI USA, V93, P7247, DOI 10.1073/pnas.93.14.7247; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; HOWARD JC, 1985, NATURE, V314, P494, DOI 10.1038/314494a0; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Kalita J K, 2006, Int J Bioinform Res Appl, V2, P63; Klenerman P, 1996, P NATL ACAD SCI USA, V93, P15323, DOI 10.1073/pnas.93.26.15323; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; LARSEN JE, 2006, IMMUNOME RES, V2; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Lin HH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S22; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; Lundegaard C, 2007, BIOINFORMATICS, V23, P3265, DOI 10.1093/bioinformatics/btm471; MANCA F, 1985, EUR J IMMUNOL, V15, P345, DOI 10.1002/eji.1830150408; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; MCLEAN AR, 1992, AIDS, V6, P71, DOI 10.1097/00002030-199201000-00009; MEIERSCHELLERSH.M, 1999, SIMMUNE TOOL SIMULAT; Mittler JE, 1996, J ACQ IMMUN DEF SYND, V12, P233, DOI 10.1097/00042560-199607000-00003; Miyazawa S, 2000, PROTEIN ENG, V13, P459, DOI 10.1093/protein/13.7.459; Miyazawa S, 1999, PROTEINS, V36, P357, DOI 10.1002/(SICI)1097-0134(19990815)36:3<357::AID-PROT10>3.3.CO;2-L; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; MORPURGO D, 1995, INT IMMUNOL, V7, P505, DOI 10.1093/intimm/7.4.505; Motta Santo, 2005, Immunome Res, V1, P5, DOI 10.1186/1745-7580-1-5; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; NOSSAL GJV, 1980, P NATL ACAD SCI-BIOL, V77, P1602, DOI 10.1073/pnas.77.3.1602; Nowak MA, 1997, J VIROL, V71, P7518, DOI 10.1128/JVI.71.10.7518-7525.1997; Nowak MA, 1997, J THEOR BIOL, V184, P205, DOI 10.1006/jtbi.1996.0307; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A; PERELSON AS, 1989, IMMUNOL REV, V110, P5, DOI 10.1111/j.1600-065X.1989.tb00025.x; PERELSON AS, 1993, MATH BIOSCI, V114, P81, DOI 10.1016/0025-5564(93)90043-A; PERELSON AS, 1979, J THEOR BIOL, V81, P645, DOI 10.1016/0022-5193(79)90275-3; Perelson AS, 1997, REV MOD PHYS, V69, P1219, DOI 10.1103/RevModPhys.69.1219; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; RAPIN N, 2008, IMMUNOGENETICS; Reche PA, 2005, BIOINFORMATICS, V21, P2140, DOI 10.1093/bioinformatics/bti269; Santoni D, 2008, BIOINFORMATICS, V24, P1374, DOI 10.1093/bioinformatics/btn135; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; SEIDEN PE, 1992, J THEOR BIOL, V158, P329, DOI 10.1016/S0022-5193(05)80737-4; SEIDMAN JG, 1978, NATURE, V276, P790, DOI 10.1038/276790a0; Sette A, 2005, IMMUNOGENETICS, V57, P53, DOI 10.1007/s00251-004-0749-z; Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093; SPRENT J, 1988, IMMUNOL REV, V101, P173, DOI 10.1111/j.1600-065X.1988.tb00737.x; Stilianakis NI, 1997, J VIROL, V71, P161, DOI 10.1128/JVI.71.1.161-168.1997; Sulzer B, 1996, MATH BIOSCI, V135, P147, DOI 10.1016/0025-5564(96)00022-3; Tang ST, 2008, ARCH VIROL, V153, P1833, DOI 10.1007/s00705-008-0194-7; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wein LM, 1997, J THEOR BIOL, V185, P15, DOI 10.1006/jtbi.1996.0253; WHITACRE CC, 1991, J IMMUNOL, V147, P2155; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51	85	280	287	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e9862	10.1371/journal.pone.0009862	http://dx.doi.org/10.1371/journal.pone.0009862			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419125	Green Submitted, Green Published, gold			2022-12-25	WOS:000276743500004
J	Feunou, PF; Bertout, J; Locht, C				Feunou, Pascal Feunou; Bertout, Julie; Locht, Camille			T- and B-Cell-Mediated Protection Induced by Novel, Live Attenuated Pertussis Vaccine in Mice. Cross Protection against Parapertussis	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; FILAMENTOUS HEMAGGLUTININ; TH17 CELLS; RESPIRATORY-INFECTION; HELPER TYPE-1; MURINE MODEL; WHOLE-CELL; IMMUNITY; TOXIN; EPIDEMIOLOGY	Background: Despite the extensive use of efficacious vaccines, pertussis still ranks among the major causes of childhood mortality worldwide. Two types of pertussis vaccines are currently available, whole-cell, and the more recent acellular vaccines. Because of reduced reactogenicity and comparable efficacy acellular vaccines progressively replace whole-cell vaccines. However, both types require repeated administrations for optimal efficacy. We have recently developed a live attenuated vaccine candidate, named BPZE1, able to protect infant mice after a single nasal administration. Methodology/Principal Findings: We determined the protective mechanism of BPZE1-mediated immunity by using passive transfer of T cells and antibodies from BPZE1-immunized mice to SCID mice. Clearance of Bordetella pertussis from the lungs was mediated by both BPZE1-induced antibodies and CD4(+), but not by CD8(+) T cells. The protective CD4(+) T cells comprised IFN-gamma-producing and IL-17-producing subsets, indicating that BPZE1 induces both Th1 and Th17 CD4(+) T cells. In addition, and in contrast to acellular pertussis vaccines, BPZE1 also cross-protected against Bordetella parapertussis infection, but in this case only the transfer of CD4(+) T cells conferred protection. Serum from BPZE1-immunized mice was not able to kill B. parapertussis and did not protect SCID mice against B. parapertussis infection. Conclusions/Significance: The novel live attenuated pertussis vaccine BPZE1 protects in a pre-clinical mouse model against B. pertussis challenge by both BPZE1-induced antibodies and CD4(+) T cell responses. It also protects against B. parapertussis infection. However, in this case protection is only T cell mediated.	[Feunou, Pascal Feunou; Locht, Camille] INSERM, U1019, F-59045 Lille, France; [Feunou, Pascal Feunou; Locht, Camille] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, F-59019 Lille, France; [Feunou, Pascal Feunou; Bertout, Julie; Locht, Camille] Univ Lille Nord France, Lille, France; [Bertout, Julie] IFR142, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Feunou, PF (corresponding author), INSERM, U1019, F-59045 Lille, France.	camille.locht@pasteur-lille.fr	Locht, Camille/L-3516-2018	Locht, Camille/0000-0001-7295-7336	Agence Nationale de Recherche (ANR), France [BP-VAC MIME 2005]; European Commission [201502]	Agence Nationale de Recherche (ANR), France(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the Agence Nationale de Recherche (ANR), France, under grant number BP-VAC MIME 2005 and by a grant from the European Commission under the grant agreement number 201502 (Child-Innovac). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; ANTOINE R, 1990, INFECT IMMUN, V58, P1518, DOI 10.1128/IAI.58.6.1518-1526.1990; Bergfors E, 1999, Int J Infect Dis, V3, P140, DOI 10.1016/S1201-9712(99)90035-8; Byrne P, 2004, EUR J IMMUNOL, V34, P2579, DOI 10.1002/eji.200425092; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P131; Chen X, 2007, J IMMUNOL, V178, P6123, DOI 10.4049/jimmunol.178.10.6123; Crowcroft NS, 2003, LANCET INFECT DIS, V3, P413, DOI 10.1016/S1473-3099(03)00669-8; David S, 2004, VACCINE, V22, P1892, DOI 10.1016/j.vaccine.2003.11.005; Decker MD, 2000, PEDIATR CLIN N AM, V47, P309, DOI 10.1016/S0031-3955(05)70209-1; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Edwards KM, 2005, PEDIATR INFECT DIS J, V24, pS104, DOI 10.1097/01.inf.0000166154.47013.47; Fedele G, 2008, J IMMUNOL, V181, P208, DOI 10.4049/jimmunol.181.1.208; Feunou PF, 2008, VACCINE, V26, P5722, DOI 10.1016/j.vaccine.2008.08.018; Goebel EM, 2008, INFECT IMMUN, V76, P1774, DOI 10.1128/IAI.01629-07; Greenberg David P, 2005, Pediatr Infect Dis J, V24, pS39, DOI 10.1097/01.inf.0000160911.65632.e1; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; He QS, 1998, JAMA-J AM MED ASSOC, V280, P635, DOI 10.1001/jama.280.7.635; HEININGER U, 1994, PEDIATR INFECT DIS J, V13, P306, DOI 10.1097/00006454-199404000-00011; Hellwig SMM, 2001, INFECT IMMUN, V69, P4846, DOI 10.1128/IAI.69.8.4846-4850.2001; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Jefferson T, 2003, VACCINE, V21, P2003, DOI 10.1016/S0264-410X(02)00770-3; Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003; Leef M, 2000, J EXP MED, V191, P1841, DOI 10.1084/jem.191.11.1841; Letowska I, 2004, EUR J CLIN MICROBIOL, V23, P499, DOI 10.1007/s10096-004-1141-5; LOCHT C, 1992, EMBO J, V11, P3175, DOI 10.1002/j.1460-2075.1992.tb05394.x; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Mahon BP, 1997, J EXP MED, V186, P1843, DOI 10.1084/jem.186.11.1843; Mascart F, 2003, J IMMUNOL, V170, P1504, DOI 10.4049/jimmunol.170.3.1504; Mastrantonio P, 1997, DEV BIOL STAND, V89, P255; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Mclntyre P, 2009, CURR OPIN INFECT DIS, V22, P215, DOI 10.1097/QCO.0b013e32832b3540; MENOZZI FD, 1994, INFECT IMMUN, V62, P769, DOI 10.1128/IAI.62.3.769-778.1994; MENOZZI FD, 1991, FEMS MICROBIOL LETT, V78, P59; Mielcarek N, 2006, PLOS PATHOG, V2, P662, DOI 10.1371/journal.ppat.0020065; Mills KHG, 1998, INFECT IMMUN, V66, P594, DOI 10.1128/IAI.66.2.594-602.1998; MILLS KHG, 1993, INFECT IMMUN, V61, P399, DOI 10.1128/IAI.61.2.399-410.1993; Mills KHG, 2001, MICROBES INFECT, V3, P655, DOI 10.1016/S1286-4579(01)01421-6; Nasso M, 2009, J IMMUNOL, V183, P1892, DOI 10.4049/jimmunol.0901071; Olin P, 1997, LANCET, V350, P1569, DOI 10.1016/S0140-6736(97)06508-2; Page G, 2004, AM J PATHOL, V164, P409, DOI 10.1016/S0002-9440(10)63131-8; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pichichero ME, 1997, PEDIATRICS, V100, P772, DOI 10.1542/peds.100.5.772; Rowan AG, 2008, J IMMUNOL, V181, P4485, DOI 10.4049/jimmunol.181.7.4485; SATO Y, 1984, LANCET, V1, P122; SEKURA RD, 1983, J BIOL CHEM, V258, P4647; Storsaeter J, 2007, BORDETELLA MOL MICRO, P245; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8; Watanabe M, 2001, INFECT IMMUN, V69, P6981, DOI 10.1128/IAI.69.11.6981-6986.2001; Watanabe Mineo, 2004, Expert Rev Anti Infect Ther, V2, P447, DOI 10.1586/14787210.2.3.447; Wolfe DN, 2007, INFECT IMMUN, V75, P4972, DOI 10.1128/IAI.00763-07; Woolard MD, 2008, INFECT IMMUN, V76, P2651, DOI 10.1128/IAI.01412-07	52	52	54	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10178	10.1371/journal.pone.0010178	http://dx.doi.org/10.1371/journal.pone.0010178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419113	gold, Green Submitted, Green Published			2022-12-25	WOS:000276707100006
J	Ruchala, P; Navab, M; Jung, CL; Hama-Levy, S; Micewicz, ED; Luong, H; Reyles, JE; Sharma, S; Waring, AJ; Fogelman, AM; Lehrer, RI				Ruchala, Piotr; Navab, Mohamad; Jung, Chun-Ling; Hama-Levy, Susan; Micewicz, Ewa D.; Luong, Hai; Reyles, Jonathan E.; Sharma, Shantanu; Waring, Alan J.; Fogelman, Alan M.; Lehrer, Robert I.			Oxpholipin 11D: An Anti-Inflammatory Peptide That Binds Cholesterol and Oxidized Phospholipids	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN-1; POLYUNSATURATED FATTY-ACIDS; MIMETIC PEPTIDES; INFLAMMATORY MEDIATORS; MEMBRANE INTERACTIONS; RHEUMATOID-ARTHRITIS; SECONDARY STRUCTURE; CIRCULAR-DICHROISM	Background: Many Gram-positive bacteria produce pore-forming exotoxins that contain a highly conserved, 12-residue (ECTGLAWEWWRT) that binds cholesterol. This domain is usually flanked N-terminally by arginine and C-terminally valine. We used this 14-residue sequence as a template to create a small library of peptides that bind cholesterol and lipids. Methodology/Results: Several of these peptides manifested anti-inflammatory properties in a predictive in vitro monocyte assay, and some also diminished the pro-inflammatory effects of low-density lipoprotein in apoE-deficient The most potent analog, Oxpholipin-11D (OxP-11D), contained D-amino acids exclusively and was identical to the 14-design template except that diphenylalanine replaced cysteine-3. In surface plasmon resonance binding studies, 11D bound oxidized (phospho) lipids and sterols in much the same manner as D-4F, a widely studied cardioprotective I-mimetic peptide with anti-inflammatory properties. In contrast to D-4F, which adopts a stable a-helical structure in the OxP-11D structure was flexible and contained multiple turn-like features. Conclusion: Given the substantial evidence that oxidized phospholipids are pro-inflammatory in vivo, OxP-11D and other may have therapeutic potential.	[Ruchala, Piotr; Navab, Mohamad; Jung, Chun-Ling; Hama-Levy, Susan; Luong, Hai; Waring, Alan J.; Fogelman, Alan M.; Lehrer, Robert I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Micewicz, Ewa D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA; [Reyles, Jonathan E.; Sharma, Shantanu] Calif State Polytech Univ Pomona, Dept Chem, Pomona, CA 91768 USA; [Reyles, Jonathan E.; Sharma, Shantanu] Calif State Polytech Univ Pomona, Ctr Macromol Modeling & Mat Design, Pomona, CA 91768 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California State University System; California State Polytechnic University Pomona; California State University System; California State Polytechnic University Pomona	Ruchala, P (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	pruchala@mednet.ucla.edu		RUCHALA, PIOTR/0000-0002-5574-2779	U.S. Public Health Service [HL-30568]; Laubisch; Castera; UCLA; Dean's Office of the David Geffen School of Medicine at UCLA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Laubisch; Castera; UCLA; Dean's Office of the David Geffen School of Medicine at UCLA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported in part by U.S. Public Health Service Grant HL-30568, the Laubisch, Castera, and M.K. Grey Funds at UCLA and funds from the Adams and Burnham endowments provided by the Dean's Office of the David Geffen School of Medicine at UCLA (PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharamaiah GM, 2006, CURR OPIN LIPIDOL, V17, P233, DOI 10.1097/01.mol.0000226114.89812.75; Back M, 2009, CARDIOVASC DRUG THER, V23, P41, DOI 10.1007/s10557-008-6140-9; BECHINGER B, 1991, CHEM PHYS LIPIDS, V58, P1, DOI 10.1016/0009-3084(91)90105-K; Bjorkhem I, 2002, J CLIN INVEST, V110, P725, DOI 10.1172/JCI200216388; Bloedon LT, 2008, J LIPID RES, V49, P1344, DOI 10.1194/jlr.P800003-JLR200; Boyce JA, 2008, CURR MOL MED, V8, P335, DOI 10.2174/156652408785160989; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Capra V, 2006, CURR MED CHEM, V13, P3213, DOI 10.2174/092986706778742963; Chiesa G, 2003, CURR OPIN LIPIDOL, V14, P159, DOI 10.1097/00041433-200304000-00007; Claria J, 2006, RECENT PAT ANTI-CANC, V1, P369, DOI 10.2174/157489206778776961; Datta G, 2004, J BIOL CHEM, V279, P26509, DOI 10.1074/jbc.M314276200; Datta G, 2001, J LIPID RES, V42, P1096; Epand RM, 2004, J BIOL CHEM, V279, P51404, DOI 10.1074/jbc.M408581200; Epand RM, 2004, BIOCHEMISTRY-US, V43, P5073, DOI 10.1021/bi049786u; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; FOGELMAN AM, 1988, J LIPID RES, V29, P1243; Gharavi NM, 2007, ARTERIOSCL THROM VAS, V27, P1346, DOI 10.1161/ATVBAHA.107.141283; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gordon LM, 1996, PROTEIN SCI, V5, P1662, DOI 10.1002/pro.5560050820; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hirata I, 2001, DIGESTION, V63, P73, DOI 10.1159/000051915; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; JOHNSON WC, 1990, PROTEIN-STRUCT FUNCT, V7, P214; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Keane D, 2008, BIOCHEM SOC T, V36, P955, DOI 10.1042/BST0360955; KLINGENBERG R, 2009, EUR HEART J; Krishnamoorthy Sriram, 2008, V49, P145, DOI 10.1007/978-1-4020-8831-5_6; Ku IA, 2009, CIRC J, V73, P977, DOI 10.1253/circj.CJ-09-0274; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Miles AJ, 2003, SPECTROSC-INT J, V17, P653, DOI 10.1155/2003/379137; Montecucco F, 2009, RHEUMATOLOGY, V48, P11, DOI 10.1093/rheumatology/ken395; Montecucco F, 2009, BEST PRACT RES CL EN, V23, P389, DOI 10.1016/j.beem.2008.12.003; Montecucco F, 2009, SEMIN IMMUNOPATHOL, V31, P127, DOI 10.1007/s00281-009-0150-y; Montecucco F, 2009, SEMIN IMMUNOPATHOL, V31, P1, DOI 10.1007/s00281-009-0146-7; Moreno JJ, 2009, BIOCHEM PHARMACOL, V77, P1, DOI 10.1016/j.bcp.2008.07.033; Moubayed SP, 2007, CURR OPIN LIPIDOL, V18, P638, DOI 10.1097/MOL.0b013e3282f0ee11; Navab M, 1997, J CLIN INVEST, V99, P2005, DOI 10.1172/JCI119369; Navab M, 2000, J LIPID RES, V41, P1495; Navab M, 2005, CIRC RES, V97, P524, DOI 10.1161/01.RES.0000181229.69508.2f; Navab M, 2005, ARTERIOSCL THROM VAS, V25, P1325, DOI 10.1161/01.ATV.0000165694.39518.95; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; NAVAB M, 1991, J CLIN INVEST, V88, P2039, DOI 10.1172/JCI115532; Navab M, 2008, CURR DRUG TARGETS, V9, P204, DOI 10.2174/138945008783755584; Navab M, 2006, NAT CLIN PRACT CARD, V3, P540, DOI 10.1038/ncpcardio0661; Navab M, 2009, J LIPID RES, V50, P1538, DOI 10.1194/jlr.M800539-JLR200; Nieto N, 2002, J NUTR, V132, P11, DOI 10.1093/jn/132.1.11; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Olkkonen VM, 2009, MOL ASPECTS MED, V30, P123, DOI 10.1016/j.mam.2009.02.004; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Patel MI, 2008, J UROLOGY, V179, P1668, DOI 10.1016/j.juro.2007.12.037; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Riccioni G, 2002, INT J IMMUNOPATH PH, V15, P171, DOI 10.1177/039463200201500303; Riccioni G, 2008, J LEUKOCYTE BIOL, V84, P1374, DOI 10.1189/jlb.0808476; Roccatano D, 2005, PROTEIN SCI, V14, P2582, DOI 10.1110/ps.051426605; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Sethi AA, 2007, CURR OPIN INVEST DR, V8, P201; SHARON P, 1984, GASTROENTEROLOGY, V86, P453; Subbanagounder G, 2002, J BIOL CHEM, V277, P7271, DOI 10.1074/jbc.M107602200; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; TAYLOR FR, 1984, J BIOL CHEM, V259, P2382; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Torocsik D, 2009, MOL ASPECTS MED, V30, P134, DOI 10.1016/j.mam.2009.02.002; ULRICH AS, 1994, BIOPHYS J, V66, P1441, DOI 10.1016/S0006-3495(94)80934-8; Umetani M, 2007, NAT MED, V13, P1185, DOI 10.1038/nm1641; Van Lenten BJ, 2008, J LIPID RES, V49, P2302, DOI 10.1194/jlr.M800075-JLR200; Vejux A, 2009, MOL ASPECTS MED, V30, P153, DOI 10.1016/j.mam.2009.02.006; VENKATACHALAPATHI YV, 1993, PROTEINS, V15, P349, DOI 10.1002/prot.340150403; Yamaguchi H, 2003, BIOSCI BIOTECH BIOCH, V67, P2269, DOI 10.1271/bbb.67.2269; Yamaguchi S, 2001, BIOPHYS J, V81, P2203, DOI 10.1016/S0006-3495(01)75868-7; Zhu XW, 2005, J LIPID RES, V46, P1303, DOI 10.1194/jlr.M400401-JLR200	75	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10181	10.1371/journal.pone.0010181	http://dx.doi.org/10.1371/journal.pone.0010181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418958	Green Published, gold, Green Submitted			2022-12-25	WOS:000276706800018
J	Strunk, T; Coombs, MRP; Currie, AJ; Richmond, P; Golenbock, DT; Stoler-Barak, L; Gallington, LC; Otto, M; Burgner, D; Levy, O				Strunk, Tobias; Coombs, Melanie R. Power; Currie, Andrew J.; Richmond, Peter; Golenbock, Douglas T.; Stoler-Barak, Liat; Gallington, Leighanne C.; Otto, Michael; Burgner, David; Levy, Ofer			TLR2 Mediates Recognition of Live Staphylococcus epidermidis and Clearance of Bacteremia	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; PHENOL-SOLUBLE MODULIN; CUTTING EDGE; CYTOKINE PRODUCTION; SIGNAL-TRANSDUCTION; IFN-GAMMA; AUREUS; ACTIVATION; CELLS; PHAGOCYTOSIS	Background: Staphylococcus epidermidis (SE) is a nosocomial pathogen that causes catheter-associated bacteremia in the immunocompromised, including those at the extremes of age, motivating study of host clearance mechanisms. SE-derived soluble components engage TLR2; but additional signaling pathways have also been implicated, and TLR2 can play complex, at times detrimental, roles in host defense against other Staphylococcal spp. The role of TLR2 in responses of primary blood leukocytes to live SE and in clearance of SE bacteremia, the most common clinical manifestation of SE infection, is unknown. Methodology/Principal Findings: We studied TLR2-mediated recognition of live clinical SE strain 1457 employing TLR2-transfected cells, neutralizing anti-TLR antibodies and TLR2-deficient mice. TLR2 mediated SE-induced cytokine production in human embryonic kidney cells, human whole blood and murine primary macrophages, in part via recognition of a soluble TLR2 agonist. After i.v. challenge with SE, early (1 h) cytokine/chemokine production and subsequent clearance of bacteremia (24-48 h) were markedly impaired in TLR2-deficient mice. Conclusions/Significance: TLR2 mediates recognition of live SE and clearance of SE bacteremia in vivo.	[Strunk, Tobias; Currie, Andrew J.; Richmond, Peter; Burgner, David] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Coombs, Melanie R. Power; Stoler-Barak, Liat; Gallington, Leighanne C.; Levy, Ofer] Childrens Hosp Boston, Div Infect Dis, Boston, MA USA; [Coombs, Melanie R. Power; Levy, Ofer] Harvard Univ, Sch Med, Boston, MA USA; [Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Otto, Michael] NIAID, NIH, Bethesda, MD 20892 USA; [Burgner, David] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	University of Western Australia; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Strunk, T (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia.	ofer.levy@childrens.harvard.edu	Coombs, Melanie/GQH-9000-2022; Currie, Andrew/C-2778-2015; Richmond, Peter C/G-3379-2012; Gallington, Leighanne C/G-9341-2011; Strunk, Tobias/AIE-3407-2022	Richmond, Peter C/0000-0001-7562-7228; Gallington, Leighanne C/0000-0002-0383-7522; Strunk, Tobias/0000-0001-7079-2339; Coombs, Melanie/0000-0002-2036-8414; Currie, Andrew/0000-0002-5193-3404; Otto, Michael/0000-0002-2222-4115; Burgner, David/0000-0002-8304-4302; Levy, Ofer/0000-0002-5859-1945	National Institute of Allergy and Infectious Diseases, National Institutes of Health [RO1 AI067353-01A1]; Princess Margaret Hospital; Women's and Infants' Research Foundation Western Australia; Clive and Vera Ramaciotti Medical Research Foundation; U. Western Australia; Rebecca Cooper Medical Research Foundation; Channel7 Telethon; European Society for Paediatric Infectious Diseases; National Health and Medical Research Council, Australia; Intramural Research Program of the National Institute of Allergy and Infectious Diseases; U.S. National Institutes of Health; Deutsche Forschungsgemeinschaft [STR1022/1-1]; University of Western Australia; Harvard Club of Australia; Canadian Institutes of Health Research; Children's Health Research Foundation of Western Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001080, R01AI067353, R01AI052455] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Princess Margaret Hospital; Women's and Infants' Research Foundation Western Australia; Clive and Vera Ramaciotti Medical Research Foundation; U. Western Australia; Rebecca Cooper Medical Research Foundation; Channel7 Telethon; European Society for Paediatric Infectious Diseases; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Intramural Research Program of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Western Australia; Harvard Club of Australia; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Children's Health Research Foundation of Western Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support: National Institute of Allergy and Infectious Diseases, National Institutes of Health RO1 AI067353-01A1 (O. L.); Princess Margaret Hospital, Women's and Infants' Research Foundation Western Australia, Clive and Vera Ramaciotti Medical Research Foundation, U. Western Australia, Rebecca Cooper Medical Research Foundation, Channel7 Telethon, European Society for Paediatric Infectious Diseases and the National Health and Medical Research Council, Australia (T. S., A. C., P. R., and D. B.); Intramural Research Program of the National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health (M. O.). T. S. was supported by a Research Fellowship of the Deutsche Forschungsgemeinschaft (STR1022/1-1) and an International Postgraduate Research Scholarship of the University of Western Australia. Support was also provided by fellowships from the Harvard Club of Australia (O. L.), Canadian Institutes of Health Research (M. C.) and the Children's Health Research Foundation of Western Australia (A. J. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Albanyan EA, 2000, INFECT IMMUN, V68, P5794, DOI 10.1128/IAI.68.10.5794-5802.2000; Cole LE, 2008, J IMMUNOL, V180, P6885, DOI 10.4049/jimmunol.180.10.6885; Cuzzola M, 2000, J IMMUNOL, V164, P5871, DOI 10.4049/jimmunol.164.11.5871; Equils O, 2003, J IMMUNOL, V170, P5159, DOI 10.4049/jimmunol.170.10.5159; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Gekara NO, 2009, J INFECT DIS, V199, P124, DOI 10.1086/595562; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Hartel C, 2008, ARCH DIS CHILD-FETAL, V93, pF140, DOI 10.1136/adc.2007.124685; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Henneke P, 2008, J IMMUNOL, V180, P6149, DOI 10.4049/jimmunol.180.9.6149; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Kapetanovic R, 2007, INFECT IMMUN, V75, P830, DOI 10.1128/IAI.01199-06; Karchmer AW, 2008, CLIN INFECT DIS, V46, pS342, DOI 10.1086/533589; Knuefermann P, 2004, CIRCULATION, V110, P3693, DOI 10.1161/01.CIR.0000143081.13042.04; Kristian SA, 2008, J INFECT DIS, V197, P1028, DOI 10.1086/528992; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Levy O, 2003, INFECT IMMUN, V71, P6344, DOI 10.1128/IAI.71.11.6344-6353.2003; MACK D, 1992, INFECT IMMUN, V60, P2048, DOI 10.1128/IAI.60.5.2048-2057.1992; McCurdy JD, 2003, J IMMUNOL, V170, P1625, DOI 10.4049/jimmunol.170.4.1625; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; Megyeri K, 2002, CYTOKINE, V19, P206, DOI 10.1006/cyto.2002.0876; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Natsuka M, 2008, INNATE IMMUN-LONDON, V14, P298, DOI 10.1177/1753425908096518; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2004, J INFECT DIS, V190, P748, DOI 10.1086/422157; Puel A, 2008, J IMMUNOL, V180, P647, DOI 10.4049/jimmunol.180.1.647; Raby AC, 2009, J IMMUNOL, V183, P506, DOI 10.4049/jimmunol.0802909; ROBINSON WA, 1977, NEW ENGL J MED, V297, P1129, DOI 10.1056/NEJM197711242972101; Rowe J, 2004, J ALLERGY CLIN IMMUN, V113, P710, DOI 10.1016/j.jaci.2003.12.585; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Schaffer AC, 2009, INFECT DIS CLIN N AM, V23, P153, DOI 10.1016/j.idc.2008.10.005; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Skerrett SJ, 2004, J IMMUNOL, V172, P3377, DOI 10.4049/jimmunol.172.6.3377; STEVENS NT, 2008, CELL MICROBIOL; Strunk T, 2007, CURR OPIN INFECT DIS, V20, P370, DOI 10.1097/QCO.0b013e3281a7ec98; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Stuyt RJL, 2003, CYTOKINE, V21, P65, DOI 10.1016/S1043-4666(02)00501-X; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Venkatesh Mohan P, 2006, Semin Pediatr Infect Dis, V17, P120, DOI 10.1053/j.spid.2006.06.005; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Watanabe I, 2007, J IMMUNOL, V178, P4917, DOI 10.4049/jimmunol.178.8.4917; Wetzler LM, 2003, VACCINE, V21, pS55, DOI 10.1016/S0264-410X(03)00201-9	46	59	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10111	10.1371/journal.pone.0010111	http://dx.doi.org/10.1371/journal.pone.0010111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404927	Green Submitted, Green Published, gold			2022-12-25	WOS:000276482100022
J	Vinci, CR; Clarke, SG				Vinci, Chris R.; Clarke, Steven G.			Homocysteine Methyltransferases Mht1 and Sam4 Prevent the Accumulation of Age-damaged (R,S)-AdoMet in the Yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYL-L-METHIONINE; S-ADENOSYLMETHIONINE; 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE; OXIDATIVE STRESS; ACTIVE-TRANSPORT; SULFONIUM CENTER; DNA-REPAIR; SPECIFICITY; CONFIGURATION; RECOGNITION	The biological methyl donor S-adenosyl-L-methionine (AdoMet) is spontaneously degraded by inversion of its sulfonium center to form the R,S diastereomer. Unlike its precursor, (S,S)AdoMet, (R,S)-AdoMet has no known cellular function and may have some toxicity. Although the rate of (R,S)-AdoMet formation under physiological conditions is significant, it has not been detected at substantial levels in vivo in a wide range of organisms. These observations imply that there are mechanisms that either dispose of (R,S)-AdoMet or convert it back to (S,S)-AdoMet. Previously, we identified two homocysteine methyl-transferases (Mht1 and Sam4) in yeast capable of recognizing and metabolizing (R,S)-AdoMet. We found similar activities in worms, plants, and flies. However, it was not established whether these activities could prevent R,S accumulation. In this work, we show that both the Mht1 and Sam4 enzymes are capable of preventing R,S accumulation in Saccharomyces cerevisiae grown to stationary phase; deletion of both genes results in significant (R,S)-AdoMet accumulation. To our knowledge, this is the first time that such an accumulation of (R,S)-AdoMet has been reported in any organism. We show that yeast cells can take up (R,S)-AdoMet from the medium using the same transporter (Sam3) used to import (S,S)-AdoMet. Our results suggest that yeast cells have evolved efficient mechanisms not only for dealing with the spontaneous intracellular generation of the (R,S)AdoMet degradation product but for utilizing environmental sources as a nutrient.	[Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu			National Institutes of Health [GM026020, AG032303]; Ellison Medical Foundation; UCLA Older Americans Independence Center, NIA, National Institutes of Health [P30-AG028748]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026020, R01GM026020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); UCLA Older Americans Independence Center, NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM026020 and AG032303. This work was also supported by the Ellison Medical Foundation.; Supported by the UCLA Older Americans Independence Center, NIA, National Institutes of Health Grant P30-AG028748. To whom correspondence should be addressed: UCLA Dept. of Chemistry and Biochemistry and the Molecular Biology Institute, 607 Charles E. Young Drive East, Los Angeles, CA 90095-1569. Tel.: 310-825-8754; Fax: 310-825-1968; E-mail: clarke@mbi.ucla.edu.	Argueso JL, 2009, GENOME RES, V19, P2258, DOI 10.1101/gr.091777.109; Barnett JA, 2008, YEAST, V25, P689, DOI 10.1002/yea.1630; Baynes JW, 2000, BIOGERONTOLOGY, V1, P235, DOI 10.1023/A:1010034213093; BEAUDOUIN C, 1993, J NEUROCHEM, V61, P928, DOI 10.1111/j.1471-4159.1993.tb03604.x; BORCHARDT RT, 1976, J MED CHEM, V19, P1099, DOI 10.1021/jm00231a004; Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029; Cai H, 2001, BIOCHEMISTRY-US, V40, P2210, DOI 10.1021/bi0022902; CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251; Chan SY, 2003, J BIOL CHEM, V278, P43051, DOI 10.1074/jbc.M308696200; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; CORNFORTH JW, 1977, J AM CHEM SOC, V99, P7292, DOI 10.1021/ja00464a032; CREASON GL, 1985, PHYTOCHEMISTRY, V24, P1151, DOI 10.1016/S0031-9422(00)81092-4; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; DELAHABA G, 1959, J AM CHEM SOC, V81, P3975, DOI 10.1021/ja01524a039; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; Hanna GM, 2004, PHARMAZIE, V59, P251; Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95; Hipkiss AR, 2001, BIOGERONTOLOGY, V2, P173, DOI 10.1023/A:1011599321168; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Katju V, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r75; Kim I, 2007, J MICROBIOL BIOTECHN, V17, P207; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lopez-Villar E, 2006, PROTEOMICS, V6, pS107, DOI 10.1002/pmic.200500479; Lu SC, 2000, INT J BIOCHEM CELL B, V32, P391, DOI 10.1016/S1357-2725(99)00139-9; McCarthy DL, 2001, BIOCHEMISTRY-US, V40, P12276, DOI 10.1021/bi011050z; NAKAMURA KD, 1974, J BACTERIOL, V120, P482, DOI 10.1128/JB.120.1.482-487.1974; Petrossian T, 2009, EPIGENOMICS-UK, V1, P163, DOI 10.2217/EPI.09.3; PETROTTASIMPSON TF, 1975, J BACTERIOL, V123, P516, DOI 10.1128/JB.123.2.516-522.1975; Rouillon A, 1999, J BIOL CHEM, V274, P28096, DOI 10.1074/jbc.274.40.28096; Rzem R, 2007, J INHERIT METAB DIS, V30, P681, DOI 10.1007/s10545-007-0487-0; SATOH S, 1989, ARCH BIOCHEM BIOPHYS, V271, P107, DOI 10.1016/0003-9861(89)90260-9; SPENCE KD, 1971, J BACTERIOL, V106, P325, DOI 10.1128/JB.106.2.325-330.1971; UGARTE N, 2010, ANTIOXID RE IN PRESS; Veiga-Da-Cunha M, 2006, BIOCHEM J, V399, P257, DOI 10.1042/BJ20060684; Vinci CR, 2007, J BIOL CHEM, V282, P8604, DOI 10.1074/jbc.M610029200; Vinci CR, 2010, REJUV RES, V13, P362, DOI 10.1089/rej.2009.0956; Wiederhold E, 2009, MOL CELL PROTEOMICS, V8, P380, DOI 10.1074/mcp.M800372-MCP200; Woo DK, 2009, BBA-GENE REGUL MECH, V1789, P135, DOI 10.1016/j.bbagrm.2008.09.008; WU SE, 1983, BIOCHEMISTRY-US, V22, P2828, DOI 10.1021/bi00281a009; Yasokawa D, 2010, APPL BIOCHEM BIOTECH, V160, P1685, DOI 10.1007/s12010-009-8684-y; Yiu G, 2008, J GERONTOL A-BIOL, V63, P21, DOI 10.1093/gerona/63.1.21	44	20	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20526	20531		10.1074/jbc.M110.113076	http://dx.doi.org/10.1074/jbc.M110.113076			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20421295	Green Published, hybrid			2022-12-25	WOS:000279228600014
J	Kim, TH; Franco, HL; Jung, SY; Qin, J; Broaddus, RR; Lydon, JP; Jeong, JW				Kim, T. H.; Franco, H. L.; Jung, S. Y.; Qin, J.; Broaddus, R. R.; Lydon, J. P.; Jeong, J-W			The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression	ONCOGENE			English	Article						Mig-6; Pten; uterus; endometrial cancer	APOPTOSIS-INHIBITORY PROTEIN; ESTROGEN-RECEPTOR-ALPHA; TUMOR-SUPPRESSOR GENE; PROGESTERONE-RECEPTOR; AKT-PHOSPHORYLATION; SIGNAL-TRANSDUCTION; EXPRESSION; CARCINOMA; ACTIVATION; STRESS	Ablation of Mig-6 in the murine uterus leads to the development of endometrial hyperplasia and estrogen-induced endometrial cancer. An additional endometrial cancer mouse model is generated by the ablation of phosphatase and tensin homolog deleted from chromosome 10 (Pten) (either as heterozygotes or by conditional uterine ablation). To determine the interplay between Mig-6 and the PTEN/phosphoinositide 3-kinase signaling pathway during endometrial tumorigenesis, we generated mice with Mig-6 and Pten conditionally ablated in progesterone receptor-positive cells (PR(cre/+)Mig-6(f/f)Pten(f/f); Mig-6(d/d)Pten(d/d)). The ablation of both Mig-6 and Pten dramatically accelerated the development of endometrial cancer compared with the single ablation of either gene. The epithelium of Mig-6(d/d)Pten(d/d) mice showed a significant decrease in the number of apoptotic cells compared with Pten(d/d) mice. The expression of the estrogen-induced apoptotic inhibitors Birc1 was significantly increased in Mig-6(d/d)Pten(d/d) mice. We identified extracellular signal-regulated kinase 2 (ERK2) as an MIG-6 interacting protein by coimmunoprecipitation and demonstrated that the level of ERK2 phosphorylation was increased upon Mig-6 ablation either singly or in combination with Pten ablation. These results suggest that Mig-6 exerts a tumor-suppressor function in endometrial cancer by promoting epithelial cell apoptosis through the downregulation of the estrogen-induced apoptosis inhibitors Birc1 and the inhibition of ERK2 phosphorylation. Oncogene (2010) 29, 3770-3780; doi: 10.1038/onc.2010.126; published online 26 April 2010	[Kim, T. H.; Franco, H. L.; Jung, S. Y.; Qin, J.; Lydon, J. P.; Jeong, J-W] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Jung, S. Y.; Qin, J.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Broaddus, R. R.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Jeong, JW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza,M725, Houston, TX 77030 USA.	jjeong@bcm.edu		Jung, Sung Yun/0000-0003-1521-7977	Reproductive Biology Training [T32HD007165]; Baylor Research Advocates for Student Scientists; NIH [R01CA77530, P50CA098258, R01HD057873]; Dan Duncan Cancer Center in Baylor College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007165, R01HD057873] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P50CA098258, R01CA077530, P30CA016672] Funding Source: NIH RePORTER	Reproductive Biology Training; Baylor Research Advocates for Student Scientists; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dan Duncan Cancer Center in Baylor College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Francesco J DeMayo for fruitful discussion; Jinghua Li for technical assistance; Cory A Rubel, MS and Michael J Large for manuscript preparation. We also thank Dr Hong Wu for the floxed Pten mice. This work was supported by the Reproductive Biology Training Grant T32HD007165 and a scholarship from Baylor Research Advocates for Student Scientists (to HLF), NIH R01CA77530 (to JPL), NIH P50CA098258 (to RRB) and NIH R01HD057873 (to J-WJ). We thank the support of the pathway discovery core of the Dan Duncan Cancer Center in Baylor College of Medicine for proteomic work.	Acconcia F, 2006, CANCER LETT, V238, P1, DOI 10.1016/j.canlet.2005.06.018; Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; Anastasi S, 2005, ONCOGENE, V24, P4540, DOI 10.1038/sj.onc.1208658; Bhat-Nakshatri P, 2008, MOL CELL BIOL, V28, P7487, DOI 10.1128/MCB.00799-08; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Boland R, 2008, STEROIDS, V73, P859, DOI 10.1016/j.steroids.2007.12.027; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chambliss KL, 2002, MOL ENDOCRINOL, V16, P938, DOI 10.1210/me.16.5.938; Cheskis BJ, 2008, STEROIDS, V73, P901, DOI 10.1016/j.steroids.2007.12.028; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; Davoodi J, 2004, J BIOL CHEM, V279, P40622, DOI 10.1074/jbc.M405963200; DELIGDISCH L, 1987, CANCER DETECT PREV, V10, P237; Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905; Ejskjaer K, 2007, GYNECOL ONCOL, V104, P158, DOI 10.1016/j.ygyno.2006.07.015; ELDREDGE ER, 1994, MOL CELL BIOL, V14, P7527, DOI 10.1128/MCB.14.11.7527; Endrizzi MG, 2000, GENOME RES, V10, P1095, DOI 10.1101/gr.10.8.1095; Erhardt P, 1999, MOL CELL BIOL, V19, P5308; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Franco HL, 2008, SEMIN CELL DEV BIOL, V19, P178, DOI 10.1016/j.semcdb.2007.12.001; Freeman D, 2006, CANCER RES, V66, P6492, DOI 10.1158/0008-5472.CAN-05-4143; Fukuda M, 1997, J BIOL CHEM, V272, P32642, DOI 10.1074/jbc.272.51.32642; Gesty-Palmer D, 2005, J BIOL CHEM, V280, P32157, DOI 10.1074/jbc.M507460200; Ito K, 2007, ENDOCR J, V54, P667, DOI 10.1507/endocrj.KR-114; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jeong JW, 2009, P NATL ACAD SCI USA, V106, P8677, DOI 10.1073/pnas.0903632106; Jiang BH, 2008, BBA-PROTEINS PROTEOM, V1784, P150, DOI 10.1016/j.bbapap.2007.09.008; Jin N, 2007, GENESIS, V45, P716, DOI 10.1002/dvg.20348; Jung SY, 2008, ANAL CHEM, V80, P1721, DOI 10.1021/ac7021025; Jung SY, 2005, MOL ENDOCRINOL, V19, P2451, DOI 10.1210/me.2004-0476; Kakinuma N, 2008, J CELL BIOL, V181, P537, DOI 10.1083/jcb.200707022; Kanamori Y, 2001, CLIN CANCER RES, V7, P892; KHALIFA MA, 1994, GYNECOL ONCOL, V53, P84, DOI 10.1006/gyno.1994.1092; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Levine RL, 1998, CANCER RES, V58, P3254; Lian ZL, 2006, J CELL PHYSIOL, V208, P255, DOI 10.1002/jcp.20681; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Maier JKX, 2002, J NEUROSCI, V22, P2035, DOI 10.1523/JNEUROSCI.22-06-02035.2002; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; Malathi K, 2005, P NATL ACAD SCI USA, V102, P14533, DOI 10.1073/pnas.0507551102; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Saarikoski ST, 2002, FEBS LETT, V530, P186, DOI 10.1016/S0014-5793(02)03475-0; Sivridis E, 2004, INT J SURG PATHOL, V12, P99, DOI 10.1177/106689690401200202; Slaets H, 2008, PROTEOMICS, V8, P1237, DOI 10.1002/pmic.200700641; SMITH WL, 2000, ANNU REV BIOCHEM, V145, P182; Song RXD, 2003, APOPTOSIS, V8, P55, DOI 10.1023/A:1021649019025; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Spyridopoulos I, 1997, CIRCULATION, V95, P1505; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sun HB, 2001, AM J CLIN PATHOL, V115, P32; Tashker JS, 2002, MOL BIOL CELL, V13, P393, DOI 10.1091/mbc.01-06-0291; Thomas RS, 2008, J MOL ENDOCRINOL, V40, P173, DOI 10.1677/JME-07-0165; Vilgelm A, 2006, CANCER RES, V66, P3375, DOI 10.1158/0008-5472.CAN-05-4019; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yin Y, 2008, MOL ENDOCRINOL, V22, P113, DOI 10.1210/me.2007-0295; Zhang YW, 2007, ONCOGENE, V26, P269, DOI 10.1038/sj.onc.1209790; Zhang YW, 2007, CELL CYCLE, V6, P507, DOI 10.4161/cc.6.5.3928	61	45	46	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 1	2010	29	26					3770	3780		10.1038/onc.2010.126	http://dx.doi.org/10.1038/onc.2010.126			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	618VW	20418913	Bronze, Green Accepted			2022-12-25	WOS:000279385200005
J	Brannmark, C; Palmer, R; Glad, ST; Cedersund, G; Stralfors, P				Brannmark, Cecilia; Palmer, Robert; Glad, S. Torkel; Cedersund, Gunnar; Stralfors, Peter			Mass and Information Feedbacks through Receptor Endocytosis Govern Insulin Signaling as Revealed Using a Parameter-free Modeling Framework	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; HUMAN ADIPOCYTES; CAVEOLAE; LOCALIZATION; PATHWAYS; DYNAMICS; BINDING; LEVEL; IRS1; RAT	Insulin and other hormones control target cells through a network of signal-mediating molecules. Such networks are extremely complex due to multiple feedback loops in combination with redundancy, shared signal mediators, and cross-talk between signal pathways. We present a novel framework that integrates experimental work and mathematical modeling to quantitatively characterize the role and relation between coexisting submechanisms in complex signaling networks. The approach is independent of knowing or uniquely estimating model parameters because it only relies on (i) rejections and (ii) core predictions (uniquely identified properties in unidentifiable models). The power of our approach is demonstrated through numerous iterations between experiments, model-based data analyses, and theoretical predictions to characterize the relative role of co-existing feedbacks governing insulin signaling. We examined phosphorylation of the insulin receptor and insulin receptor substrate-1 and endocytosis of the receptor in response to various different experimental perturbations in primary human adipocytes. The analysis revealed that receptor endocytosis is necessary for two identified feedback mechanisms involving mass and information transfer, respectively. Experimental findings indicate that interfering with the feedback may substantially increase overall signaling strength, suggesting novel therapeutic targets for insulin resistance and type 2 diabetes. Because the central observations are present in other signaling networks, our results may indicate a general mechanism in hormonal control.	[Brannmark, Cecilia; Palmer, Robert; Cedersund, Gunnar; Stralfors, Peter] Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, Lab Diabet & Integrated Syst Biol, SE-58185 Linkoping, Sweden; [Glad, S. Torkel] Linkoping Univ, Dept Elect Engn, SE-58185 Linkoping, Sweden; [Cedersund, Gunnar] Univ Freiburg, Sch Life Sci, Freiburg Inst Adv Studies, D-79104 Freiburg, Germany	Linkoping University; Linkoping University; University of Freiburg	Cedersund, G (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, Lab Diabet & Integrated Syst Biol, SE-58185 Linkoping, Sweden.	gunnar.cedersund@liu.se; peter.stralfors@liu.se	Brännmark, Cecilia/K-2132-2012	Stralfors, Peter/0000-0002-1196-1806	European Commission Network of Excellence Biosim; Ostergotland County Council; Novo Nordisk Foundation; Lions; Swedish Diabetes Association; Swedish Research Council	European Commission Network of Excellence Biosim(European CommissionEuropean Commission Joint Research Centre); Ostergotland County Council; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lions; Swedish Diabetes Association; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the European Commission Network of Excellence Biosim, Ostergotland County Council, Novo Nordisk Foundation, Lions, Swedish Diabetes Association, and Swedish Research Council.	Borisov N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.19; Cedersund G, 2009, FEBS J, V276, P903, DOI 10.1111/j.1742-4658.2008.06845.x; Cedersund G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000096; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Conzelmann H, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-78; Danielsson A, 2005, FEBS J, V272, P141, DOI 10.1111/j.1432-1033.2004.04396.x; Fagerholm S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005985; Foti M, 2007, P NATL ACAD SCI USA, V104, P1242, DOI 10.1073/pnas.0610523104; Gustavsson J, 1999, FASEB J, V13, P1961, DOI 10.1096/fasebj.13.14.1961; Hori SS, 2006, ANN BIOMED ENG, V34, P879, DOI 10.1007/s10439-005-9065-5; Karlsson M, 2004, EUR J BIOCHEM, V271, P2471, DOI 10.1111/j.1432-1033.2004.04177.x; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; KUBLAOUI B, 1995, J BIOL CHEM, V270, P59, DOI 10.1074/jbc.270.1.59; KUISMANEN E, 1989, METHOD CELL BIOL, V32, P257; MARTIN TJ, 1986, J RECEPTOR RES, V6, P323, DOI 10.3109/10799898609074818; Nahmad M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000202; Ortegren U, 2006, FEBS J, V273, P3381, DOI 10.1111/j.1742-4658.2006.05345.x; PETTERSSON T, 2008, THESIS LINKOPING U L; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; Stenkula KG, 2007, BIOCHEM BIOPH RES CO, V363, P840, DOI 10.1016/j.bbrc.2007.09.065; STRALFORS P, 1989, EUR J BIOCHEM, V182, P379, DOI 10.1111/j.1432-1033.1989.tb14842.x; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thorn H, 2003, MOL BIOL CELL, V14, P3967, DOI 10.1091/mbc.E03-01-0050; Wanant S, 2000, J THEOR BIOL, V205, P355, DOI 10.1006/jtbi.2000.2069	24	52	53	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20171	20179		10.1074/jbc.M110.106849	http://dx.doi.org/10.1074/jbc.M110.106849			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20421297	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000279012000052
J	Liu, RQ; Zhou, QH; Ji, SR; Zhou, Q; Feng, D; Wu, Y; Sui, SF				Liu, Rui-Qin; Zhou, Qing-Hua; Ji, Shang-Rong; Zhou, Qiang; Feng, Du; Wu, Yi; Sui, Sen-Fang			Membrane Localization of beta-Amyloid 1-42 in Lysosomes A POSSIBLE MECHANISM FOR LYSOSOME LABILIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRANEURONAL A-BETA-42 ACCUMULATION; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; PLASMA-MEMBRANE; TRANSGENIC MICE; APOLIPOPROTEIN E4; BILAYER-MEMBRANES; FIBRIL FORMATION; DOWN-SYNDROME; LIPID RAFTS	beta-Amyloid peptide (A beta 42) is the core protein of amyloid plaque in Alzheimer disease. The intracellular accumulation of A beta 42 in the endosomal/lysosomal system has been under investigation for many years, but the direct link between A beta 42 accumulation and dysfunction of the endosomal/lysosomal system is still largely unknown. Here, we found that both in vitro and in vivo, a major portion of A beta 42 was tightly inserted into and a small portion peripherally associated with the lysosomal membrane, whereas its soluble portion was minimal. We also found that the A beta 42 molecules inserted into the membrane tended to form multiple oligomeric aggregates, whereas A beta 40 peptides formed only dimers. Neutralizing lysosomal pH in differentiated PC12 cells decreased the lysosomal membrane insertion of A beta 42 and moderated A beta 42-induced lysosomal labilization and cytotoxicity. Our findings, thus, suggest that the membrane-inserted portion of A beta 42 accumulated in lysosomes may destabilize the lysosomal membrane and induce neurotoxicity.	[Liu, Rui-Qin; Zhou, Qing-Hua; Ji, Shang-Rong; Zhou, Qiang; Feng, Du; Wu, Yi; Sui, Sen-Fang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University	Sui, SF (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China.	suisf@mail.tsinghua.edu.cn	Zhou, Qinghua/I-2484-2014	Zhou, Qinghua/0000-0003-0468-9266; Wu, Yi/0000-0003-0365-5590; Ji, Shang-Rong/0000-0001-8595-3756	National Natural Science Foundation of China [30830028, 30970591]; National Basic Research program of China [2010CB912400, 2010CD833706]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grant 30830028/30970591 and National Basic Research program of China Grant 2010CB912400/2010CD833706.	Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; AMES B, 1996, METHOD ENZYMOL, V8, P115; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; BONIFACINO JS, 2001, CURR PROTOC CELL BIO; Burdick D, 1997, BRAIN RES, V746, P275, DOI 10.1016/S0006-8993(96)01262-0; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; DEMEL RA, 1973, BIOCHIM BIOPHYS ACTA, V311, P507, DOI 10.1016/0005-2736(73)90126-0; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; GREEN SA, 1987, J CELL BIOL, V105, P1227, DOI 10.1083/jcb.105.3.1227; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Ji SR, 2002, J BIOL CHEM, V277, P6273, DOI 10.1074/jbc.M104146200; Ji ZS, 2006, J BIOL CHEM, V281, P2683, DOI 10.1074/jbc.M506646200; Ji ZS, 2002, J BIOL CHEM, V277, P21821, DOI 10.1074/jbc.M112109200; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kim SI, 2006, J CELL BIOCHEM, V99, P878, DOI 10.1002/jcb.20978; KNAUER MF, 1992, P NATL ACAD SCI USA, V89, P7437, DOI 10.1073/pnas.89.16.7437; KNOPS J, 1995, J BIOL CHEM, V270, P2419, DOI 10.1074/jbc.270.6.2419; Koistinaho M, 2001, P NATL ACAD SCI USA, V98, P14675, DOI 10.1073/pnas.261562998; Koo EH, 1996, J CELL SCI, V109, P991; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kremer JJ, 2000, BIOCHEMISTRY-US, V39, P10309, DOI 10.1021/bi0001980; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Langui D, 2004, AM J PATHOL, V165, P1465, DOI 10.1016/S0002-9440(10)63405-0; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Marmagne A, 2004, MOL CELL PROTEOMICS, V3, P675, DOI 10.1074/mcp.M400001-MCP200; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Morelli L, 1999, NEUROSCI LETT, V262, P5, DOI 10.1016/S0304-3940(99)00023-3; Mori C, 2002, AMYLOID, V9, P88, DOI 10.3109/13506120208995241; Morishima-Kawashima M, 1998, BIOCHEMISTRY-US, V37, P15247, DOI 10.1021/bi981843u; NAKAMURA Y, 1989, NEUROSCI LETT, V97, P215, DOI 10.1016/0304-3940(89)90166-3; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Smaby JM, 1996, BIOCHEMISTRY-US, V35, P5696, DOI 10.1021/bi953057k; Sun ZX, 2005, NEUROSCI LETT, V391, P71, DOI 10.1016/j.neulet.2005.08.034; SWANSON J, 1987, J CELL BIOL, V104, P1217, DOI 10.1083/jcb.104.5.1217; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Wang SX, 1998, BIOCHEM J, V335, P225, DOI 10.1042/bj3350225; YAMADA H, 1984, J BIOCHEM, V95, P1155, DOI 10.1093/oxfordjournals.jbchem.a134704; Yamazaki T, 2001, J BIOL CHEM, V276, P4454, DOI 10.1074/jbc.M009598200; Yamazaki T, 1996, J CELL SCI, V109, P999; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; YANG AJ, 1995, J BIOL CHEM, V270, P14786, DOI 10.1074/jbc.270.24.14786; Zhang W, 2003, ELECTROPHORESIS, V24, P2855, DOI 10.1002/elps.200305569; Zhao HF, 2005, FEBS LETT, V579, P1551, DOI 10.1016/j.febslet.2005.01.061	68	42	44	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19986	19996		10.1074/jbc.M109.036798	http://dx.doi.org/10.1074/jbc.M109.036798			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20430896	Green Published, hybrid			2022-12-25	WOS:000279012000032
J	Sen, P; Sahoo, S; Pendurthi, UR; Rao, LVM				Sen, Prosenjit; Sahoo, Sanghamitra; Pendurthi, Usha R.; Rao, L. Vijaya Mohan			Zinc Modulates the Interaction of Protein C and Activated Protein C with Endothelial Cell Protein C Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CARBOXYGLUTAMIC ACID; THROMBIN-THROMBOMODULIN COMPLEX; WASHED HUMAN-PLATELETS; DIVALENT METAL-IONS; TISSUE FACTOR; FACTOR-VIIA; FACTOR-XII; FACTOR-IX; BINDING; PLASMA	Zinc is an essential trace element for human nutrition and is critical to the structure, stability, and function of many proteins. Zinc ions were shown to enhance activation of the intrinsic pathway of coagulation but down-regulate the extrinsic pathway of coagulation. The protein C pathway plays a key role in blood coagulation and inflammation. At present there is no information on whether zinc modulates the protein C pathway. In the present study we found that Zn2+ enhanced the binding of protein C/activated protein C (APC) to endothelial cell protein C receptor (EPCR) on endothelial cells. Binding kinetics revealed that Zn2+ increased the binding affinities of protein C/APC to EPCR. Equilibrium dialysis with Zn-65(2+) revealed that Zn2+ bound to the Gla domain as well as sites outside of the Gla domain of protein C/APC. Intrinsic fluorescence measurements suggested that Zn2+ binding induces conformational changes in protein C/APC. Zn2+ binding to APC inhibited the amidolytic activity of APC, but the inhibition was reversed by Ca2+. Zn2+ increased the rate of APC generation on endothelial cells in the presence of physiological concentrations of Ca2+ but did not further enhance increased APC generation obtained in the presence of physiological concentrations of Mg2+ with Ca2+. Zn2+ had no effect on the anticoagulant activity of APC. Zn2+ enhanced APC-mediated activation of protease activated receptor 1 and p44/42 MAPK. Overall, our data show that Zn2+ binds to proteinC/APC, which results in conformational changes in protein C/APC that favor their binding to EPCR.	[Sen, Prosenjit; Sahoo, Sanghamitra; Pendurthi, Usha R.; Rao, L. Vijaya Mohan] Univ Texas Hlth Ctr Tyler, Ctr Biomed Res, Tyler, TX 75708 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Rao, LVM (corresponding author), Univ Texas Hlth Ctr Tyler, Ctr Biomed Res, 11937 US Highway 271, Tyler, TX 75708 USA.	Vijaya.Rao@uthct.edu			National Institutes of Health [HL58869, HL65500]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058869, R01HL065500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58869 ( to L. V. M. R.) and HL65500 ( to U. R. P.).	Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Bajaj SP, 2006, J BIOL CHEM, V281, P24873, DOI 10.1074/jbc.M509971200; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; BERNARDO MM, 1993, J BIOL CHEM, V268, P12468; Brewer G J, 1983, Prog Clin Biol Res, V129, P35; BUTENAS S, 1994, BIOCHEMISTRY-US, V33, P3449, DOI 10.1021/bi00177a039; BYRNE R, 1980, J BIOL CHEM, V255, P1430; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; CHURCH WR, 1989, J BIOL CHEM, V264, P17882; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; CSERMELY P, 1989, BIOCHEM BIOPH RES CO, V165, P838, DOI 10.1016/S0006-291X(89)80042-7; Esmon CT, 2004, CRIT CARE MED, V32, pS298, DOI 10.1097/01.CCM.0000126128.64614.81; Esmon CT, 2003, J THROMB HAEMOST, V1, P1343, DOI 10.1046/j.1538-7836.2003.00261.x; ESMON NL, 1983, J BIOL CHEM, V258, P5548; Falchuk K H, 1993, Prog Clin Biol Res, V380, P91; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Fukudome K, 1996, J BIOL CHEM, V271, P17491, DOI 10.1074/jbc.271.29.17491; Ghosh S, 2007, J BIOL CHEM, V282, P11849, DOI 10.1074/jbc.M609283200; GORDON PR, 1982, AM J CLIN NUTR, V35, P113, DOI 10.1093/ajcn/35.1.113; GORODETSKY R, 1993, AM J HEMATOL, V42, P278, DOI 10.1002/ajh.2830420307; GREENGARD JS, 1984, BIOCHEMISTRY-US, V23, P6863, DOI 10.1021/bi00321a090; GREENGARD JS, 1986, BIOCHEMISTRY-US, V25, P3884, DOI 10.1021/bi00361a022; He XH, 1999, J BIOL CHEM, V274, P4970, DOI 10.1074/jbc.274.8.4970; Heeb MJ, 2009, FASEB J, V23, P2244, DOI 10.1096/fj.08-123174; JOHNSON AE, 1983, J BIOL CHEM, V258, P5554; Liaw PCY, 2000, J BIOL CHEM, V275, P5447, DOI 10.1074/jbc.275.8.5447; Ludeman MJ, 2005, J BIOL CHEM, V280, P13122, DOI 10.1074/jbc.M410381200; PEDERSEN AH, 1991, THROMB HAEMOSTASIS, V65, P528; Petersen LC, 2000, PROTEIN SCI, V9, P859, DOI 10.1110/ps.9.5.859; Regan LM, 1997, J BIOL CHEM, V272, P26279, DOI 10.1074/jbc.272.42.26279; REZAIE AR, 1992, J BIOL CHEM, V267, P26104; REZAIE AR, 1995, BIOCHEMISTRY-US, V34, P12221, DOI 10.1021/bi00038a016; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; SCHOUSBOE I, 1993, BLOOD COAGUL FIBRIN, V4, P671, DOI 10.1097/00001721-199304050-00002; Sekiya F, 1996, J BIOL CHEM, V271, P8541, DOI 10.1074/jbc.271.15.8541; SHIMADA T, 1987, J BIOCHEM-TOKYO, V102, P913, DOI 10.1093/oxfordjournals.jbchem.a122132; SHORE JD, 1987, BIOCHEMISTRY-US, V26, P2250, DOI 10.1021/bi00382a027; Shu NJ, 2008, BIOINFORMATICS, V24, P775, DOI 10.1093/bioinformatics/btm618; Tubek S, 2008, BIOL TRACE ELEM RES, V121, P1, DOI 10.1007/s12011-007-8038-y; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Yang LK, 2004, J BIOL CHEM, V279, P38519, DOI 10.1074/jbc.M407304200	42	11	11	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20410	20420		10.1074/jbc.M110.111575	http://dx.doi.org/10.1074/jbc.M110.111575			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20413590	hybrid, Green Published			2022-12-25	WOS:000279012000074
J	Suvasini, R; Somasundaram, K				Suvasini, R.; Somasundaram, K.			Essential role of PI3-kinase pathway in p53-mediated transcription: Implications in cancer chemotherapy	ONCOGENE			English	Article						p53; PI3-kinase; chemosensitivity; chemotherapy	PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY; DNA-DAMAGE; BREAST-CANCER; TUMOR-CELLS; P53; AKT; INHIBITION; PHOSPHORYLATION; ACTIVATION; APOPTOSIS	The PI3-kinase pathway is the target of inactivation in achieving better cancer chemotherapy. Here, we report that p53-mediated transcription is inhibited by pharmacological inhibitors and a dominant-negative mutant of PI3-kinase, and this inhibition was relieved by a constitutively active mutant of PI3-kinase. Akt/PKB and mTOR, the downstream effectors of PI3-kinase, were also found to be essential. LY294002 (PI3-kinase inhibitor) pre-treatment altered the post-translational modifications and the sub-cellular localization of p53. Although LY294002 increased the chemosensitivity of cells to low concentrations of adriamycin (adriamycin-low), it protected the cells from cytotoxicity induced by high concentrations of adriamycin (adriamycin-high) in a p53-dependent manner. Further, we found that LY294002 completely abolished the activation of p53 target genes (particularly pro-apoptotic) under adriamycin-high conditions, whereas it only marginally repressed the p53 target genes under adriamycin-low conditions; in fact, it further activated the transcription of NOXA, HRK, APAF1 and CASP5 genes. Thus, the differential effect of PI3-kinase on p53 functions seems to be responsible for the differential regulation of DNA damage-induced cytotoxicity and cell death by PI3-kinase. Our finding becomes relevant in the light of ongoing combination chemotherapy trials with the PI3-kinase pathway inhibitors and underscores the importance of p53 status in the careful formulation of combination chemotherapies. Oncogene (2010) 29, 3605-3618; doi: 10.1038/onc.2010.123; published online 26 April 2010	[Suvasini, R.; Somasundaram, K.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Somasundaram, K (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, CV Raman Ave, Bangalore 560012, Karnataka, India.	skumar@mcbl.iisc.ernet.in			ICMR; DBT; DST; UGC	ICMR(Indian Council of Medical Research (ICMR)); DBT(Department of Biotechnology (DBT) India); DST(Department of Science & Technology (India)); UGC(University Grants Commission, India)	KS is a Wellcome Trust International Senior Research Fellow. Infrastructural support by funding from ICMR, DBT, DST and UGC to MCB is acknowledged. RS gratefully acknowledges SRF from CSIR.	Bar J, 2005, CELL DEATH DIFFER, V12, P1578, DOI 10.1038/sj.cdd.4401677; Das S, 2003, J BIOL CHEM, V278, P18313, DOI 10.1074/jbc.M211704200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fujiwara Y, 2006, BIOCHEM BIOPH RES CO, V340, P560, DOI 10.1016/j.bbrc.2005.12.039; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Guillard S, 2009, CELL CYCLE, V8, P443, DOI 10.4161/cc.8.3.7643; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; KEMLER I, 1989, EMBO J, V8, P2001, DOI 10.1002/j.1460-2075.1989.tb03607.x; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li XQ, 2005, BREAST CANCER RES, V7, pR589, DOI 10.1186/bcr1259; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Meek DW, 1997, PATHOL BIOL, V45, P804; Min YH, 2003, LEUKEMIA, V17, P995, DOI 10.1038/sj.leu.2402874; Mungamuri SK, 2006, CANCER RES, V66, P4715, DOI 10.1158/0008-5472.CAN-05-3830; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Price BD, 1996, CANCER RES, V56, P246; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Reddy SP, 2008, CLIN CANCER RES, V14, P2978, DOI 10.1158/1078-0432.CCR-07-4821; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; Sakai A, 1998, BLOOD, V92, P3410, DOI 10.1182/blood.V92.9.3410.421a06_3410_3415; Somasundaram K, 2000, FRONT BIOSCI, V5, pD424, DOI 10.2741/Somasund; Somasundaram K, 1997, ONCOGENE, V14, P1047, DOI 10.1038/sj.onc.1201002; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vousden KH, 2006, J CELL SCI, V119, P5015, DOI 10.1242/jcs.03293; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	37	11	11	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 24	2010	29	25					3605	3618		10.1038/onc.2010.123	http://dx.doi.org/10.1038/onc.2010.123			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	615CG	20418912				2022-12-25	WOS:000279108600002
J	Takaku, T; Ogura, K; Kumeta, H; Yoshida, N; Inagaki, F				Takaku, Tomoyuki; Ogura, Kenji; Kumeta, Hiroyuki; Yoshida, Naoki; Inagaki, Fuyuhiko			Solution Structure of a Novel Cdc42 Binding Module of Bem1 and Its Interaction with Ste20 and Cdc42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; P21-ACTIVATED KINASE STE20; SACCHAROMYCES-CEREVISIAE; PC MOTIF; NMR STRUCTURE; PROTEIN BEM1; SH3 DOMAINS; PB1 DOMAIN; CDC24; POLARITY	Bem1 is a scaffold protein essential for the establishment of cell polarity in Saccharomyces cerevisiae. This work reports the solution structure of a Cdc42 binding module of Bem1 comprising the second SH3 domain (SH3b) and its C-terminal flanking region termed Cdc42 interacting (CI). First, the structure of Bem1 SH3b-CI was determined by NMR spectroscopy, which shows that Bem1 SH3b-CI is a structurally and functionally related domain that binds Cdc42. Next, the solution structure of Bem1 SH3b-CI in complex with the proline-rich region of p21-activated kinase Ste20 (Ste20 PRR) was determined. Finally, the interaction surface of Bem1 SH3b-CI with Cdc42 was identified based on chemical shift perturbation studies which reveals that Bem1 SH3b-CI interacts simultaneously with both Ste20 PRR and Cdc42 using the opposite surfaces. Thus, Bem1 can tether Cdc42 and Ste20 in close proximity so that Cdc42 can efficiently interact with Ste20 Cdc42 and Rac interactive binding (CRIB). Based on the present results together with the previous biochemical studies (Lamson, R. E., Winters, M. J., and Pryciak, P. M. (2002) Mol. Cell. Biol. 22, 2939-2951 and Winters, M. J., and Pryciak, P. M. (2005) Mol. Cell. Biol. 25, 2177-2190), a model was suggested that the autoinhibition of Ste20 kinase activity by CRIB is released through the Cdc42-CRIB interaction, which is mediated by Bem1, and Ste20 is subsequently activated, an initial step for the establishment of the cell polarity.	[Ogura, Kenji; Kumeta, Hiroyuki; Inagaki, Fuyuhiko] Hokkaido Univ, Struct Biol Lab, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; Hokkaido Univ, Grad Sch Life Sci, Struct Biol Lab, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hokkaido University; Hokkaido University	Inagaki, F (corresponding author), Hokkaido Univ, Struct Biol Lab, Grad Sch Pharmaceut Sci, Kita Ku, N-12,W-6, Sapporo, Hokkaido 0600812, Japan.	finagaki@pharm.hokudai.ac.jp		Kumeta, Hiroyuki/0000-0003-3713-2122	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for Scientific Research (Kiban S) and the National Projects on Targeted Proteins Research Program (TPRP) from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Benton BK, 1997, MOL CELL BIOL, V17, P5067, DOI 10.1128/MCB.17.9.5067; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chant T, 1999, ANNU REV CELL DEV BI, V15, P365, DOI 10.1146/annurev.cellbio.15.1.365; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Endo M, 2003, J BIOL CHEM, V278, P843, DOI 10.1074/jbc.M209714200; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Ito T, 2001, EMBO J, V20, P3938, DOI 10.1093/emboj/20.15.3938; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kneller D., 1997, SPARKY 3 105; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lamson RE, 2002, MOL CELL BIOL, V22, P2939, DOI 10.1128/MCB.22.9.2939-2951.2002; Mayer BJ, 2001, J CELL SCI, V114, P1253; Ogura K, 2009, J BIOCHEM, V146, P317, DOI 10.1093/jb/mvp075; Terasawa H, 2001, EMBO J, V20, P3947, DOI 10.1093/emboj/20.15.3947; Wheatley E, 2005, BIOCHEM J, V388, P177, DOI 10.1042/BJ20041838; Winters MJ, 2005, MOL CELL BIOL, V25, P2177, DOI 10.1128/MCB.25.6.2177-2190.2005; Yamaguchi Y, 2007, J BIOL CHEM, V282, P29, DOI 10.1074/jbc.M609308200; Yoshinaga S, 2003, EMBO J, V22, P4888, DOI 10.1093/emboj/cdg475; ZHENG Y, 1994, J BIOL CHEM, V269, P2369	23	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19346	19353		10.1074/jbc.M110.116749	http://dx.doi.org/10.1074/jbc.M110.116749			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410294	Green Published, hybrid			2022-12-25	WOS:000278727800045
J	Avila, ME; Sepulveda, FJ; Burgos, CF; Moraga-Cid, G; Parodi, J; Moon, RT; Aguayo, LG; Opazo, C; De Ferrari, GV				Avila, Miguel E.; Sepulveda, Fernando J.; Burgos, Carlos F.; Moraga-Cid, Gustavo; Parodi, Jorge; Moon, Randall T.; Aguayo, Luis G.; Opazo, Carlos; De Ferrari, Giancarlo V.			Canonical Wnt3a Modulates Intracellular Calcium and Enhances Excitatory Neurotransmission in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE CYCLE; BETA-CATENIN; SPINAL NEURONS; KINASE-C; RELEASE; PROTEIN; DIFFERENTIATION; PATHWAY; PHOSPHORYLATION; COLOCALIZATION	A role for Wnt signal transduction in the development and maintenance of brain structures is widely acknowledged. Recent studies have suggested that Wnt signaling may be essential for synaptic plasticity and neurotransmission. However, the direct effect of a Wnt protein on synaptic transmission had not been demonstrated. Here we show that nanomolar concentrations of purified Wnt3a protein rapidly increase the frequency of miniature excitatory synaptic currents in embryonic rat hippocampal neurons through a mechanism involving a fast influx of calcium from the extracellular space, induction of post-translational modifications on the machinery involved in vesicle exocytosis in the presynaptic terminal leading to spontaneous Ca2+ transients. Our results identify the Wnt3a protein and a member of its complex receptor at the membrane, the low density lipoprotein receptor-related protein 6 (LRP6) coreceptor, as key molecules in neurotransmission modulation and suggest crosstalk between canonical and Wnt/Ca2+ signaling in central neurons.	[De Ferrari, Giancarlo V.] Univ Andres Bello, Ctr Biomed Res, Fac Biol Sci, Santiago, Chile; [De Ferrari, Giancarlo V.] Univ Andres Bello, Fac Med, Santiago, Chile; [Avila, Miguel E.; Burgos, Carlos F.; De Ferrari, Giancarlo V.] Univ Concepcion, Fac Biol Sci, Dept Biochem & Mol Biol, Concepcion, Chile; [Sepulveda, Fernando J.; Moraga-Cid, Gustavo; Parodi, Jorge; Aguayo, Luis G.; Opazo, Carlos] Univ Concepcion, Fac Biol Sci, Dept Physiol, Concepcion, Chile; [Moon, Randall T.] Univ Washington, Howard Hughes Med Inst, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Moon, Randall T.] Univ Washington, Inst Stem Cell & Regenerat Med, Sch Med, Seattle, WA 98195 USA	Universidad Andres Bello; Universidad Andres Bello; Universidad de Concepcion; Universidad de Concepcion; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	De Ferrari, GV (corresponding author), Univ Andres Bello, Ctr Biomed Res, Fac Biol Sci, POB 8370134, Santiago, Chile.	gdeferrari@unab.cl	Moon, Randall/M-5605-2019; Moraga-Cid, Gustavo/AAC-3314-2021; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Burgos, Carlos Felipe/0000-0001-6738-8589; Opazo, Carlos/0000-0003-3473-7548; De Ferrari, Giancarlo/0000-0003-0932-125X; Parodi, Jorge/0000-0002-9117-5433	Chilean government [ACT-04]; Howard Hughes Medical Institute	Chilean government; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by associative Comision Nacional de Investigacion Cientifica y Tecnologica Grant Programa Bicentenario en Ciencia y Tecnologia ACT-04 from the Chilean government (to G.V.D., C.O., and L.G.A.).; Supported as an Investigator of the Howard Hughes Medical Institute.	AGUAYO LG, 1994, J PHARMACOL EXP THER, V270, P61; Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Beaumont V, 2007, MOL CELL NEUROSCI, V35, P513, DOI 10.1016/j.mcn.2007.03.004; Becherer U, 2003, NAT NEUROSCI, V6, P846, DOI 10.1038/nn1087; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Carrasco MA, 2007, NEUROSCIENCE, V145, P484, DOI 10.1016/j.neuroscience.2006.12.019; Carrasco MA, 2007, J NEUROCHEM, V100, P1143, DOI 10.1111/j.1471-4159.2006.04306.x; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104; Farias GG, 2007, J NEUROSCI, V27, P5313, DOI 10.1523/JNEUROSCI.3934-06.2007; Grove EA, 1998, DEVELOPMENT, V125, P2315; GU XN, 1994, J NEUROSCI, V14, P6325; Halabisky B, 2000, J NEUROSCI, V20, P5124; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Kishida S, 2004, MOL CELL BIOL, V24, P4487, DOI 10.1128/MCB.24.10.4487-4501.2004; Kishida S, 2007, GENES CELLS, V12, P49, DOI 10.1111/j.1365-2443.2006.01030.x; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Lee SMK, 2000, DEVELOPMENT, V127, P457; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pozzi D, 2008, P NATL ACAD SCI USA, V105, P323, DOI 10.1073/pnas.0706211105; Roelink H, 2000, CURR BIOL, V10, pR279, DOI 10.1016/S0960-9822(00)00407-3; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003; Spinsanti P, 2008, J NEUROCHEM, V104, P1588, DOI 10.1111/j.1471-4159.2007.05111.x; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tai YL, 2008, J CELL SCI, V121, P2301, DOI 10.1242/jcs.026906; Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002; Wang JM, 2003, NAT NEUROSCI, V6, P1017, DOI 10.1038/nn1128; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zhou CJ, 2004, J NEUROSCI, V24, P121, DOI 10.1523/JNEUROSCI.4071-03.2004	43	54	61	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18939	18947		10.1074/jbc.M110.103028	http://dx.doi.org/10.1074/jbc.M110.103028			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20404321	hybrid, Green Published			2022-12-25	WOS:000278453900084
J	Deguchi, A; Miyoshi, H; Kojima, Y; Okawa, K; Aoki, M; Taketo, MM				Deguchi, Atsuko; Miyoshi, Hiroyuki; Kojima, Yasushi; Okawa, Katsuya; Aoki, Masahiro; Taketo, Makoto M.			LKB1 Suppresses p21-activated Kinase-1 (PAK1) by Phosphorylation of Thr(109) in the p21-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; PEUTZ-JEGHERS-SYNDROME; CANCER-CELLS; HEPATOCELLULAR-CARCINOMA; KNOCKOUT MICE; ACTIVATION; GENE; METASTASIS; EXPRESSION; POLYPOSIS	The serine/threonine protein kinase LKB1 is a tumor suppressor gene mutated in Peutz-Jeghers syndrome patients. The mutations are found also in several types of sporadic cancer. Although LKB1 is implicated in suppression of cell growth and metastasis, the detailed mechanisms have not yet been elucidated. In this study, we investigated the effect of LKB1 on cell motility, whose acquisition occurs in early metastasis. The knockdown of LKB1 enhanced cell migration and PAK1 activity in human colon cancer HCT116 cells, whereas forced expression of LKB1 in Lkb1-null mouse embryonic fibroblasts suppressed PAK1 activity and PAK1-mediated cell migration simultaneously. Notably, LKB1 directly phosphorylated PAK1 at Thr(109) inthep21-binding domain in vitro. The phosphomimetic T109E mutant showed significantly lower protein kinase activity than wild-type PAK1, suggesting that the phosphorylation at Thr(109) by LKB1 was responsible for suppression of PAK1. Consistently, the nonphosphorylatable T109A mutant was resistant to suppression by LKB1. Furthermore, we found that PAK1 was activated in the hepatocellular carcinomas and the precancerous liver lesions of Lkb1(+/-) mice. Taken together, these results suggest that PAK1 is a direct down-stream target of LKB1 and plays an essential role in LKB1-induced suppression of cell migration.	[Taketo, Makoto M.] Kyoto Univ, Dept Pharmacol, Grad Sch Med, Sakyo Ku, Kyoto 6058501, Japan; [Okawa, Katsuya] Kyowa Hakko Kirin Co Ltd, Drug Discovery Res Labs, Shizuoka 4118731, Japan	Kyoto University; Kyowa Kirin Ltd	Taketo, MM (corresponding author), Kyoto Univ, Dept Pharmacol, Grad Sch Med, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6058501, Japan.	taketo@mfour.med.kyoto-u.ac.jp	Aoki, Masahiro/A-5149-2016	Aoki, Masahiro/0000-0003-4316-9490; Miyoshi, Hiroyuki/0000-0001-7400-0714	Ministry of Education, Culture, Sports, Science and Technology of Japan; Littlefield-American Association for Cancer Research	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Littlefield-American Association for Cancer Research	This work was supported by a grant-in-aid for scientific research (to M. M. T.), a grant-in-aid for young scientist (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Littlefield-American Association for Cancer Research grants in metastatic colon cancer research (to M. M. T.).	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Balasenthil S, 2004, J BIOL CHEM, V279, P1422, DOI 10.1074/jbc.M309937200; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; BUTT E, 1994, J BIOL CHEM, V269, P14509; Carter JH, 2004, CLIN CANCER RES, V10, P3448, DOI 10.1158/1078-0432.CCR-03-0210; Ching YP, 2007, CANCER RES, V67, P3601, DOI 10.1158/0008-5472.CAN-06-3994; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Deguchi A, 2002, MOL CANCER THER, V1, P803; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Holm C, 2006, JNCI-J NATL CANCER I, V98, P671, DOI 10.1093/jnci/djj185; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Katajisto P, 2007, BBA-REV CANCER, V1775, P63, DOI 10.1016/j.bbcan.2006.08.003; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kojima Y, 2007, J BIOL CHEM, V282, P23532, DOI 10.1074/jbc.M700590200; Kumar R, 2002, J CELL PHYSIOL, V193, P133, DOI 10.1002/jcp.10167; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; Launonen V, 2005, HUM MUTAT, V26, P291, DOI 10.1002/humu.20222; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Miyoshi H, 2002, CANCER RES, V62, P2261; Miyoshi H, 2009, CANCER SCI, V100, P2046, DOI 10.1111/j.1349-7006.2009.01284.x; Nakau M, 2002, CANCER RES, V62, P4549; PARTIN AW, 1988, CANCER RES, V48, P6050; Rossi DJ, 2002, P NATL ACAD SCI USA, V99, P12327, DOI 10.1073/pnas.192301399; Sandig V, 2000, P NATL ACAD SCI USA, V97, P1002, DOI 10.1073/pnas.97.3.1002; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Tsakiridis T, 1996, J BIOL CHEM, V271, P19664, DOI 10.1074/jbc.271.33.19664; Wang RA, 2006, ONCOGENE, V25, P2931, DOI 10.1038/sj.onc.1209309; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103; Zhang SM, 2008, CANCER RES, V68, P740, DOI 10.1158/0008-5472.CAN-07-2989; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104	44	27	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18283	18290		10.1074/jbc.M109.079137	http://dx.doi.org/10.1074/jbc.M109.079137			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400510	Green Published			2022-12-25	WOS:000278453900021
J	Hayashi, T; Funato, Y; Terabayashi, T; Morinaka, A; Sakamoto, R; Ichise, H; Fukuda, H; Yoshida, N; Miki, H				Hayashi, Tatsuya; Funato, Yosuke; Terabayashi, Takeshi; Morinaka, Akifumi; Sakamoto, Reiko; Ichise, Hirotake; Fukuda, Hiroyuki; Yoshida, Nobuaki; Miki, Hiroaki			Nucleoredoxin Negatively Regulates Toll-like Receptor 4 Signaling via Recruitment of Flightless-I to Myeloid Differentiation Primary Response Gene (88)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; GELSOLIN-LIKE; X-CHROMOSOME; PROTEIN; THIOREDOXIN; DOMAINS; DEGENERATION; SYNTENIN; ENCODES; PATHWAY	We previously characterized nucleoredoxin (NRX) as a negative regulator of the Wnt signaling pathway through Dishevelled (Dvl). We perform a comprehensive search for other NRX-interacting proteins and identify Flightless-I (Fli-I) as a novel NRX-binding partner. Fli-I binds to NRX and other related proteins, such as Rod-derived cone viability factor (RdCVF), whereas Dvl binds only to NRX. Endogenous NRX and Fli-I in vivo interactions are confirmed. Both NRX and RdCVF link Fli-I with myeloid differentiation primary response gene (88) (MyD88), an important adaptor protein for innate immune response. NRX and RdCVF also potentiate the negative effect of Fli-I upon lipopolysaccharide-induced activation of NF-kappa B through the Toll-like receptor 4/MyD88 pathway. Embryonic fibroblasts derived from NRX gene-targeted mice show aberrant NF-kappa B activation upon lipopolysaccharide stimulation. These results suggest that the NRX subfamily of proteins forms a link between MyD88 and Fli-I to mediate negative regulation of the Toll-like receptor 4/MyD88 pathway.	[Hayashi, Tatsuya; Funato, Yosuke; Terabayashi, Takeshi; Morinaka, Akifumi; Miki, Hiroaki] Osaka Univ, Lab Intracellular Signaling, Inst Prot Res, Suita, Osaka 5650871, Japan; [Sakamoto, Reiko; Ichise, Hirotake; Yoshida, Nobuaki] Univ Tokyo, Lab Dev Genet, Ctr Expt Med & Syst Biol, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Fukuda, Hiroyuki] THERAVALUES Corp, Chiyoda Ku, Tokyo 1020094, Japan	Osaka University; University of Tokyo	Miki, H (corresponding author), Osaka Univ, Lab Intracellular Signaling, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hmiki@protein.osaka-u.ac.jp	Ichise, Hirotake/V-3536-2019	Ichise, Hirotake/0000-0002-3424-6637; Terabayashi, Takeshi/0000-0001-7102-784X	Ministry of Education, Culture, Sports, Science and Technology-Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology-Japan and the Japan Society for the Promotion of Science.	Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; CAMPBELL HD, 1993, P NATL ACAD SCI USA, V90, P11386, DOI 10.1073/pnas.90.23.11386; Campbell HD, 2002, MOL CELL BIOL, V22, P3518, DOI 10.1128/MCB.22.10.3518-3526.2002; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dalpke A, 2008, IMMUNOBIOLOGY, V213, P225, DOI 10.1016/j.imbio.2007.10.008; Davy DA, 2001, J CELL SCI, V114, P549; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Funato Y, 2008, GENES CELLS, V13, P965, DOI 10.1111/j.1365-2443.2008.01220.x; Funato Y, 2007, ANTIOXID REDOX SIGN, V9, P1035, DOI 10.1089/ars.2007.1550; Goshima M, 1999, BIOCHEM BIOPH RES CO, V257, P111, DOI 10.1006/bbrc.1999.0420; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Jeong KW, 2009, J BIOL CHEM, V284, P29298, DOI 10.1074/jbc.M109.037010; Kang BS, 2003, STRUCTURE, V11, P459, DOI 10.1016/S0969-2126(03)00052-2; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kurooka H, 1997, GENOMICS, V39, P331, DOI 10.1006/geno.1996.4493; Kuwajima T, 2004, J BIOL CHEM, V279, P40484, DOI 10.1074/jbc.M404143200; Lee YH, 2004, MOL CELL BIOL, V24, P2103, DOI 10.1128/MCB.24.5.2103-2117.2004; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Li JY, 2008, J CELL BIOL, V181, P321, DOI 10.1083/jcb.200711082; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; MIKLOS GLG, 1990, J NEUROGENET, V6, P133, DOI 10.3109/01677069009107106; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; PERRIMON N, 1989, GENETICS, V121, P313; Shechter R, 2008, J CELL BIOL, V183, P393, DOI 10.1083/jcb.200804010; Terabayashi T, 2007, J NEUROSCI, V27, P13098, DOI 10.1523/JNEUROSCI.3986-07.2007; Wang TY, 2005, J PROTEOME RES, V4, P941, DOI 10.1021/pr050031z; Wang TY, 2006, J IMMUNOL, V176, P1355, DOI 10.4049/jimmunol.176.3.1355; Zareparsi S, 2005, HUM MOL GENET, V14, P1449, DOI 10.1093/hmg/ddi154	30	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18586	18593		10.1074/jbc.M110.106468	http://dx.doi.org/10.1074/jbc.M110.106468			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400501	hybrid, Green Published			2022-12-25	WOS:000278453900052
J	Converse, PJ; Eisenach, KD; Theus, SA; Nuermberger, EL; Tyagi, S; Ly, LH; Geiman, DE; Guo, HD; Nolan, ST; Akar, NC; Klinkenberg, LG; Gupta, R; Lun, S; Karakousis, PC; Lamichhane, G; McMurray, DN; Grosset, JH; Bishai, WR				Converse, Paul J.; Eisenach, Kathleen D.; Theus, Sue A.; Nuermberger, Eric L.; Tyagi, Sandeep; Ly, Lan H.; Geiman, Deborah E.; Guo, Haidan; Nolan, Scott T.; Akar, Nicole C.; Klinkenberg, Lee G.; Gupta, Radhika; Lun, Shichun; Karakousis, Petros C.; Lamichhane, Gyanu; McMurray, David N.; Grosset, Jacques H.; Bishai, William R.			The Impact of Mouse Passaging of Mycobacterium tuberculosis Strains prior to Virulence Testing in the Mouse and Guinea Pig Aerosol Models	PLOS ONE			English	Article							SIGMA-FACTOR; RESISTANCE; EXPRESSION; RELEVANCE; LIPIDS; MICE	Background: It has been hypothesized that the virulence of lab-passaged Mycobacterium tuberculosis and recombinant M. tuberculosis mutants might be reduced due to multiple in vitro passages, and that virulence might be augmented by passage of these strains through mice before quantitative virulence testing in the mouse or guinea pig aerosol models. Methodology/Principal Findings: By testing three M. tuberculosis H37Rv samples, one deletion mutant, and one recent clinical isolate for survival by the quantitative organ CFU counting method in mouse or guinea pig aerosol or intravenous infection models, we could discern no increase in bacterial fitness as a result of passaging of M. tuberculosis strains in mice prior to quantitative virulence testing in two animal models. Surface lipid expression as assessed by neutral red staining and thin-layer chromatography for PDIM analysis also failed to identify virulence correlates. Conclusions/Significance: These results indicate that animal passaging of M. tuberculosis strains prior to quantitative virulence testing in mouse or guinea pig models does not enhance or restore potency to strains that may have lost virulence due to in vitro passaging. It is critical to verify virulence of parental strains before genetic manipulations are undertaken and comparisons are made.	[Converse, Paul J.; Nuermberger, Eric L.; Tyagi, Sandeep; Geiman, Deborah E.; Guo, Haidan; Nolan, Scott T.; Akar, Nicole C.; Klinkenberg, Lee G.; Gupta, Radhika; Lun, Shichun; Karakousis, Petros C.; Lamichhane, Gyanu; Grosset, Jacques H.; Bishai, William R.] Johns Hopkins Univ, Dept Med, Ctr TB Res, Baltimore, MD 21218 USA; [Eisenach, Kathleen D.; Theus, Sue A.] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Ly, Lan H.; McMurray, David N.] Texas A&M Univ, Dept Microbial & Mol Pathogenesis, College Stn, TX USA	Johns Hopkins University; University of Arkansas System; University of Arkansas Medical Sciences; Texas A&M University System; Texas A&M University College Station	Converse, PJ (corresponding author), Johns Hopkins Univ, Dept Med, Ctr TB Res, Baltimore, MD 21218 USA.	pconvers@jhsph.edu	Karakousis, Petros Constantine/AAR-7899-2020	Gupta, Radhika/0000-0002-0445-0194; Lamichhane, Gyanu/0000-0002-2214-0114	National Institutes of Health [N01-AI30036]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The support of National Institutes of Health contract N01-AI30036 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2009, J INFECT DIS, V200, P1136, DOI 10.1086/605605; Andreu N, 2008, TUBERCULOSIS, V88, P553, DOI 10.1016/j.tube.2008.03.005; [Anonymous], 1882, BERLINER KLIN WOCHEN, V19, P221; BLOCH H, 1950, J EXP MED, V92, P507, DOI 10.1084/jem.92.6.507; Brock TD., 1988, R KOCH LIFE MED BACT; Calmette A, 1920, INFECT BACILLAIRE TU; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Cardona PJ, 2006, MICROBES INFECT, V8, P183, DOI 10.1016/j.micinf.2005.06.011; Collins FM, 1998, TUBERCLE LUNG DIS, V78, P99, DOI 10.1016/S0962-8479(98)80002-6; Converse PJ, 2009, INFECT IMMUN, V77, P1230, DOI 10.1128/IAI.01117-08; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; CUMMINGS DONALD E., 1932, AMER REV TUBERC, V26, P369; Daniel Thomas M., 2000, PIONEERS MED THEIR I; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; DUBOS RJ, 1948, AM REV TUBERC PULM, V58, P698; FALK IS, 1928, NEWER KNOWLEDGE BACT; GOREN MB, 1974, INFECT IMMUN, V9, P142, DOI 10.1128/IAI.9.1.142-149.1974; GROSSET J, 1988, MYCOBACTERIA, V2; HADLEY P, 1928, NEWER KNOWLEDGE BACT; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Koch R, 1901, Br Med J, V2, P189; Kramnik I, 2000, P NATL ACAD SCI USA, V97, P8560, DOI 10.1073/pnas.150227197; KRAMNIK I, 2007, COMMUNICATION; KUBICA G P, 1972, International Journal of Systematic Bacteriology, V22, P99; Linton Derek S., 2005, E VONBEHRING INFECT; MITCHISON DA, 1954, BRIT MED J, V1, P128, DOI 10.1136/bmj.1.4854.128; Palanisamy GS, 2008, TUBERCULOSIS, V88, P295, DOI 10.1016/j.tube.2007.12.003; Parrish NM, 1999, J ANTIMICROB CHEMOTH, V43, P219, DOI 10.1093/jac/43.2.219; PIERCE CH, 1953, J EXP MED, V97, P189, DOI 10.1084/jem.97.2.189; Rich A., 1951, PATHOGENESIS TUBERCU, V2nd; Scanga CA, 2000, J EXP MED, V192, P347, DOI 10.1084/jem.192.3.347; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; SMITH H, 1988, J COMP PATHOL, V98, P253, DOI 10.1016/0021-9975(88)90036-9; STEENKEN W, 1950, AM REV TUBERC PULM, V62, P22; STEENKEN W, 1946, AM REV TUBERC PULM, V54, P62; Sun RG, 2004, MOL MICROBIOL, V52, P25, DOI 10.1111/j.1365-2958.2003.03958.x; VONBEHRING E, 1967, NOBEL LECT PHYSL MED; VONBEHRING E, 1903, COMBATTING TUBERCULO; WIEGESHAUS EH, 1970, AM REV RESPIR DIS, V102, P422; WILLIS HENRY STUART, 1933, AMER REV TUBERC, V28, P884	42	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10289	10.1371/journal.pone.0010289	http://dx.doi.org/10.1371/journal.pone.0010289			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422019	Green Published, gold, Green Submitted			2022-12-25	WOS:000276952500034
J	Bish, LT; Morine, KJ; Sleeper, MM; Sweeney, HL				Bish, Lawrence T.; Morine, Kevin J.; Sleeper, Meg M.; Sweeney, H. Lee			Myostatin Is Upregulated Following Stress in an Erk-Dependent Manner and Negatively Regulates Cardiomyocyte Growth in Culture and in a Mouse Model	PLOS ONE			English	Article							CARDIAC GENE-TRANSFER; SKELETAL-MUSCLE MASS; MUSCULAR-DYSTROPHY; TRANSFER SUPERIOR; EXPRESSION; MICE; HYPERTROPHY; VECTORS; MODULATION; TRANSDUCTION	Myostatin is well established as a negative regulator of skeletal muscle growth, but its role in the heart is controversial. Our goal in this study was to characterize myostatin regulation following cardiomyocyte stress and to examine the role of myostatin in the regulation of cardiomyocyte size. Neonatal cardiomyocytes were cultured and stressed with phenylephrine. Adenovirus was used to overexpress myostatin or dominant negative myostatin in culture. Adeno-associated virus was used to overexpress myostatin or dominant negative myostatin in mice. Myostatin is upregulated following cardiomyocyte stress in an Erk-dependent manner that is associated with increased nuclear translocation and DNA binding activity of MEF-2. Myostatin overexpression leads to decreased and myostatin inhibition to increased cardiac growth both in vitro and in vivo due to modulation of Akt and NFAT3 pathways. Myostatin is a negative regulator of cardiac growth, and further studies are warranted to investigate the role of myostatin in the healthy and failing heart.	[Bish, Lawrence T.; Morine, Kevin J.; Sweeney, H. Lee] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Sleeper, Meg M.] Univ Penn, Vet Hosp, Dept Clin Studies, Cardiol Sect, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Bish, LT (corresponding author), Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.	bish@mail.med.upenn.edu	Sweeney, H Lee/F-1862-2010		National Institutes of Health [P01-HL059407, U54-AR052646, T32-HL-007748]; Parent Project Muscular Dystrophy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059407, T32HL007748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parent Project Muscular Dystrophy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health (P01-HL059407 to H. L. S., U54-AR052646 to H. L. S., T32-HL-007748 to L. T. B.); and by the Parent Project Muscular Dystrophy (to H. L. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SB, 2008, J BIOL CHEM, V283, P7027, DOI 10.1074/jbc.M706678200; Artaza JN, 2007, J ENDOCRINOL, V194, P63, DOI 10.1677/JOE-07-0072; Bish LT, 2008, HUM GENE THER, V19, P1359, DOI 10.1089/hum.2008.123; BISH LT, 2010, VIRUS METHODS PROTOC; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2005, FASEB J, V19, P543, DOI 10.1096/fj.04-2796com; Bogdanovich S, 2008, MUSCLE NERVE, V37, P308, DOI 10.1002/mus.20920; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Bunger L, 2004, GENET RES, V84, P161, DOI 10.1017/S0016672304007165; Cohn RD, 2007, NEUROMUSCULAR DISORD, V17, P290, DOI 10.1016/j.nmd.2007.01.011; Costelli P, 2008, EUR J CLIN INVEST, V38, P531, DOI 10.1111/j.1365-2362.2008.01970.x; Dunn SE, 2001, J BIOL CHEM, V276, P45243, DOI 10.1074/jbc.M105445200; Gao G, 2003, GENE THER, V10, P1926, DOI 10.1038/sj.gt.3302088; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gaussin V, 2005, CARDIOVASC RES, V68, P347, DOI 10.1016/j.cardiores.2005.09.007; George I, 2010, EUR J HEART FAIL, V12, P444, DOI 10.1093/eurjhf/hfq039; Granger A, 2008, FASEB J, V22, P3549, DOI 10.1096/fj.08-108548; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Ji M, 2008, CELL SIGNAL, V20, P1452, DOI 10.1016/j.cellsig.2008.03.013; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Kinouchi N, 2008, GENE THER, V15, P1126, DOI 10.1038/gt.2008.24; Lee SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001628; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Lee SJ, 2007, TRENDS GENET, V23, P475, DOI 10.1016/j.tig.2007.08.008; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Magee TR, 2006, J GENE MED, V8, P1171, DOI 10.1002/jgm.946; Matsakas A, 2006, EXP PHYSIOL, V91, P983, DOI 10.1113/expphysiol.2006.033571; Mckoy G, 2007, CARDIOVASC RES, V74, P304, DOI 10.1016/j.cardiores.2007.02.023; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Michel RN, 2004, P NUTR SOC, V63, P341, DOI 10.1079/PNS2004362; Michel RN, 2007, APPL PHYSIOL NUTR ME, V32, P921, DOI 10.1139/H07-093; Morine KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009176; Morissette MR, 2006, CIRC RES, V99, P15, DOI 10.1161/01.RES.0000231290.45676.d4; Nishi M, 2002, BIOCHEM BIOPH RES CO, V293, P247, DOI 10.1016/S0006-291X(02)00209-7; Pacak CA, 2006, CIRC RES, V99, pE3, DOI 10.1161/01.RES.0000237661.18885.f6; Qiao CP, 2008, HUM GENE THER, V19, P241, DOI 10.1089/hum.2007.159; Reisz-Porszasz S, 2003, AM J PHYSIOL-ENDOC M, V285, pE876, DOI 10.1152/ajpendo.00107.2003; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Sharma M, 1999, J CELL PHYSIOL, V180, P1; Shyu KG, 2006, EUR J CLIN INVEST, V36, P713, DOI 10.1111/j.1365-2362.2006.01718.x; Shyu KG, 2005, CARDIOVASC RES, V68, P405, DOI 10.1016/j.cardiores.2005.06.028; Silcocks PB, 1997, HEART, V78, P237, DOI 10.1136/hrt.78.3.237; Spiller MP, 2002, MOL CELL BIOL, V22, P7066, DOI 10.1128/MCB.22.20.7066-7082.2002; Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338; Wagner KR, 2002, ANN NEUROL, V52, P832, DOI 10.1002/ana.10385; Wang RW, 2008, J ENDOCRINOL, V197, P85, DOI 10.1677/JOE-07-0596; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097; Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200; Zhang JCL, 1999, J MOL CELL CARDIOL, V31, P721, DOI 10.1006/jmcc.1998.0905; Zhao M, 1999, MOL CELL BIOL, V19, P21; Zhu XL, 2000, FEBS LETT, V474, P71, DOI 10.1016/S0014-5793(00)01570-2; Zhu XY, 2004, CYTOKINE, V26, P262, DOI 10.1016/j.cyto.2004.03.007; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	59	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10230	10.1371/journal.pone.0010230	http://dx.doi.org/10.1371/journal.pone.0010230			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419100	Green Published, gold			2022-12-25	WOS:000276853800020
J	Hawtin, RE; Stockett, DE; Byl, JAW; McDowell, RS; Tan, N; Arkin, MR; Conroy, A; Yang, WJ; Osheroff, N; Fox, JA				Hawtin, Rachael E.; Stockett, David E.; Byl, Jo Ann W.; McDowell, Robert S.; Tan, Nguyen; Arkin, Michelle R.; Conroy, Andrew; Yang, Wenjin; Osheroff, Neil; Fox, Judith A.			Voreloxin Is an Anticancer Quinolone Derivative that Intercalates DNA and Poisons Topoisomerase II	PLOS ONE			English	Article							7-SUBSTITUTED 1,4-DIHYDRO-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACIDS; ANTHRACYCLINE ANTITUMOR DRUGS; CANCER-CHEMOTHERAPY; IN-VITRO; CELLS; DOXORUBICIN; AGENTS; CLEAVAGE; CARDIOTOXICITY; DAUNORUBICIN	Background: Topoisomerase II is critical for DNA replication, transcription and chromosome segregation and is a well validated target of anti-neoplastic drugs including the anthracyclines and epipodophyllotoxins. However, these drugs are limited by common tumor resistance mechanisms and side-effect profiles. Novel topoisomerase II-targeting agents may benefit patients who prove resistant to currently available topoisomerase II-targeting drugs or encounter unacceptable toxicities. Voreloxin is an anticancer quinolone derivative, a chemical scaffold not used previously for cancer treatment. Voreloxin is completing Phase 2 clinical trials in acute myeloid leukemia and platinum-resistant ovarian cancer. This study defined voreloxin's anticancer mechanism of action as a critical component of rational clinical development informed by translational research. Methods/Principal Findings: Biochemical and cell-based studies established that voreloxin intercalates DNA and poisons topoisomerase II, causing DNA double-strand breaks, G2 arrest, and apoptosis. Voreloxin is differentiated both structurally and mechanistically from other topoisomerase II poisons currently in use as chemotherapeutics. In cell-based studies, voreloxin poisoned topoisomerase II and caused dose-dependent, site-selective DNA fragmentation analogous to that of quinolone antibacterials in prokaryotes; in contrast etoposide, the nonintercalating epipodophyllotoxin topoisomerase II poison, caused extensive DNA fragmentation. Etoposide's activity was highly dependent on topoisomerase II while voreloxin and the intercalating anthracycline topoisomerase II poison, doxorubicin, had comparable dependence on this enzyme for inducing G2 arrest. Mechanistic interrogation with voreloxin analogs revealed that intercalation is required for voreloxin's activity; a nonintercalating analog did not inhibit proliferation or induce G2 arrest, while an analog with enhanced intercalation was 9.5-fold more potent. Conclusions/Significance: As a first-in-class anticancer quinolone derivative, voreloxin is a toposiomerase II-targeting agent with a unique mechanistic signature. A detailed understanding of voreloxin's molecular mechanism, in combination with its evolving clinical profile, may advance our understanding of structure-activity relationships to develop safer and more effective topoisomerase II-targeted therapies for the treatment of cancer.	[Hawtin, Rachael E.; Stockett, David E.; Conroy, Andrew; Fox, Judith A.] Sunesis Pharmaceut Inc, San Francisco, CA USA; [Byl, Jo Ann W.; Osheroff, Neil] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Byl, Jo Ann W.; Osheroff, Neil] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [McDowell, Robert S.] 3V Biosci, Palo Alto, CA USA; [Tan, Nguyen] Genentech Inc, San Francisco, CA 94080 USA; [Arkin, Michelle R.] Univ Calif San Francisco, Small Mol Discovery Ctr, San Francisco, CA 94143 USA; [Yang, Wenjin] Eiger Biopharmaceut Inc, Palo Alto, CA USA	Vanderbilt University; Vanderbilt University; Roche Holding; Genentech; University of California System; University of California San Francisco	Hawtin, RE (corresponding author), Sunesis Pharmaceut Inc, San Francisco, CA USA.	rhawtin@sunesis.com	arkin, michelle/AAN-4298-2021; Arkin, Michelle/AAO-2009-2021	arkin, michelle/0000-0002-9366-6770; 	Sunesis Pharmaceuticals; NIH [GM33944]; Vanderbilt University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033944] Funding Source: NIH RePORTER	Sunesis Pharmaceuticals; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The experiments were conducted at Vanderbilt University and Sunesis Pharmaceuticals. The funders for the study are Sunesis Pharmaceuticals and the NIH (Grant number GM33944). The research objectives and plan were formulated collaboratively between the Osheroff laboratory (Vanderbilt University) and the Sunesis scientific research employees who are listed as co-authors. Data were generated, collected from experiments and analyzed by researchers at each site. For data generated at Vanderbilt University, Sunesis provided financial support and the decision to publish was mutual. Sunesis lead authors drafted the manuscript in collaboration with co-authors from the Osheroff laboratory.	Anderson VE, 2001, CURR PHARM DESIGN, V7, P337, DOI 10.2174/1381612013398013; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; BODLEY A, 1989, CANCER RES, V49, P5969; BUZDAR AU, 1985, CANCER, V55, P2761, DOI 10.1002/1097-0142(19850615)55:12<2761::AID-CNCR2820551206>3.0.CO;2-P; CAPRANICO G, 1990, NUCLEIC ACIDS RES, V18, P6611, DOI 10.1093/nar/18.22.6611; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Doroshow JH, 2001, BLOOD, V97, P2839, DOI 10.1182/blood.V97.9.2839; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Fortune JM, 2000, PROG NUCLEIC ACID RE, V64, P221, DOI 10.1016/S0079-6603(00)64006-0; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Guo A, 2002, DRUG METAB DISPOS, V30, P457, DOI 10.1124/dmd.30.4.457; Hanada M, 2007, CANCER SCI, V98, P447, DOI 10.1111/j.1349-7006.2007.00404.x; HECK MMS, 1988, P NATL ACAD SCI USA, V85, P1086, DOI 10.1073/pnas.85.4.1086; HIRTE H, 2009, AM SOC CLIN ONC ASCO; Hoch U, 2009, CANCER CHEMOTH PHARM, V64, P53, DOI 10.1007/s00280-008-0850-3; Hooper DC, 2001, CLIN INFECT DIS, V32, pS9, DOI 10.1086/319370; Igawa S, 2008, ANTICANCER RES, V28, P3855; Jannazzo A, 2008, ANN PHARMACOTHER, V42, P99, DOI 10.1345/aph.1K359; Kato S, 2000, CHEM RES TOXICOL, V13, P509, DOI 10.1021/tx000008m; Kolitz JE, 2004, J CLIN ONCOL, V22, P4290, DOI 10.1200/JCO.2004.11.106; LANCET J, 2009, P AM SOC CLIN ONC AS; LANCET JE, 2009, ASH ANN M, V114, P635; McClendon AK, 2007, MUTAT RES-FUND MOL M, V623, P83, DOI 10.1016/j.mrfmmm.2007.06.009; McClendon AK, 2006, BIOCHEMISTRY-US, V45, P3040, DOI 10.1021/bi051987q; Mechetner E, 1998, CLIN CANCER RES, V4, P389; MILLER KG, 1981, J BIOL CHEM, V256, P9334; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mitscher LA, 2005, CHEM REV, V105, P559, DOI 10.1021/cr030101q; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Noble CG, 2003, ANTIMICROB AGENTS CH, V47, P854, DOI 10.1128/AAC.47.3.854-862.2003; O'Reilly EK, 2002, BIOCHEMISTRY-US, V41, P7989, DOI 10.1021/bi025897m; Osheroff N., 2001, METHODS MOL BIOL, V95; POMMIER Y, 1993, CANCER CHEMOTH PHARM, V32, P103, DOI 10.1007/BF00685611; Ravandi F, 2009, ASH ANN M, V114, P1037; Richter SN, 2007, NUCLEIC ACIDS RES, V35, P6075, DOI 10.1093/nar/gkm653; Scatena C, 2010, CANC CHEMOTHERA 0107; Schoeffler AJ, 2005, BIOCHEM SOC T, V33, P1465, DOI 10.1042/BST0331465; SHAW JL, 1975, ANAL BIOCHEM, V65, P125, DOI 10.1016/0003-2697(75)90498-4; Skeel RT, 2003, HDB CANC CHEMOTHERAP, V98-9, P425; Spencer DMS, 2008, MUTAT RES-FUND MOL M, V638, P110, DOI 10.1016/j.mrfmmm.2007.09.005; SUBRAMANIAN D, 1995, CANCER RES, V55, P2097; Swift LP, 2006, CANCER RES, V66, P4863, DOI 10.1158/0008-5472.CAN-05-3410; Taatjes DJ, 2001, CURR MED CHEM, V8, P15, DOI 10.2174/0929867013374029; Tomita K, 2002, J MED CHEM, V45, P5564, DOI 10.1021/jm010057b; Tsuzuki Y, 2004, J MED CHEM, V47, P2097, DOI 10.1021/jm0304966; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; WORLAND ST, 1989, J BIOL CHEM, V264, P4412; Yu TW, 1997, MUTAT RES-FUND MOL M, V379, P201, DOI 10.1016/S0027-5107(97)00141-3; Zeman SM, 1998, P NATL ACAD SCI USA, V95, P11561, DOI 10.1073/pnas.95.20.11561	53	103	109	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10186	10.1371/journal.pone.0010186	http://dx.doi.org/10.1371/journal.pone.0010186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419121	gold, Green Published, Green Submitted			2022-12-25	WOS:000276707100007
J	Dhanoa, PK; Richardson, LGL; Smith, MD; Gidda, SK; Henderson, MPA; Andrews, DW; Mullen, RT				Dhanoa, Preetinder K.; Richardson, Lynn G. L.; Smith, Matthew D.; Gidda, Satinder K.; Henderson, Matthew P. A.; Andrews, David W.; Mullen, Robert T.			Distinct Pathways Mediate the Sorting of Tail-Anchored Proteins to the Plastid Outer Envelope	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; IMPORT APPARATUS; PLANT BIOLOGY; CYTOCHROME B5; GTP-BINDING; ASCORBATE PEROXIDASE; TRANSMEMBRANE DOMAIN; CHLOROPLAST IMPORT; CYTOSOLIC PROTEINS	Background: Tail-anchored (TA) proteins are a distinct class of membrane proteins that are sorted post-translationally to various organelles and function in a number of important cellular processes, including redox reactions, vesicular trafficking and protein translocation. While the molecular targeting signals and pathways responsible for sorting TA proteins to their correct intracellular destinations in yeasts and mammals have begun to be characterized, relatively little is known about TA protein biogenesis in plant cells, especially for those sorted to the plastid outer envelope. Methodology/Principal Findings: Here we investigated the biogenesis of three plastid TA proteins, including the 33-kDa and 34-kDa GTPases of the translocon at the outer envelope of chloroplasts (Toc33 and Toc34) and a novel 9-kDa protein of unknown function that we define here as an outer envelope TA protein (OEP9). Using a combination of in vivo and in vitro assays we show that OEP9 utilizes a different sorting pathway than that used by Toc33 and Toc34. For instance, while all three TA proteins interact with the cytosolic OEP chaperone/receptor, AKR2A, the plastid targeting information within OEP9 is distinct from that within Toc33 and Toc34. Toc33 and Toc34 also appear to differ from OEP9 in that their insertion is dependent on themselves and the unique lipid composition of the plastid outer envelope. By contrast, the insertion of OEP9 into the plastid outer envelope occurs in a proteinaceous-dependent, but Toc33/34-independent manner and membrane lipids appear to serve primarily to facilitate normal thermodynamic integration of this TA protein. Conclusions/Significance: Collectively, the results provide evidence in support of at least two sorting pathways for plastid TA outer envelope proteins and shed light on not only the complex diversity of pathways involved in the targeting and insertion of proteins into plastids, but also the molecular mechanisms that underlie the delivery of TA proteins to their proper intracellular locations in general.	[Dhanoa, Preetinder K.; Richardson, Lynn G. L.; Gidda, Satinder K.; Mullen, Robert T.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Smith, Matthew D.] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON N2L 3C5, Canada; [Henderson, Matthew P. A.; Andrews, David W.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	University of Guelph; Wilfrid Laurier University; McMaster University	Dhanoa, PK (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rtmullen@uoguelph.ca	Smith, Matthew/M-4726-2014	Smith, Matthew/0000-0002-2855-5126; Andrews, David/0000-0002-9266-7157	Canadian Institutes of Heath Research [FRN 10490]; Natural Sciences and Engineering Research Council (NSERC) [312143-05, 217291]; Ontario Graduate Scholarship Program; Ontario Early Researcher Award	Canadian Institutes of Heath Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship Program(Ontario Graduate Scholarship); Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario)	This work was supported by grants from the Canadian Institutes of Heath Research (www.cihr-irsc.gc.ca/) (FRN 10490) to D. W. A. and the Natural Sciences and Engineering Research Council (NSERC) (www.nserc-crsng.gc.ca/) (312143-05) to M. D. S. and (217291) to R. T. M. M. P. A. H. and L. R. were supported by an NSERC Graduate Scholarship and P. K. D. was supported by a post-graduate award from the Ontario Graduate Scholarship Program (http://osap.gov.on.ca/). D. W. A. holds a Canada Research Chair in Membrane Biogenesis, R. T. M. holds a University of Guelph Research Chair, and M. D. S. is a recipient of an Ontario Early Researcher Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Bae W, 2008, NAT CELL BIOL, V10, P220, DOI 10.1038/ncb1683; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Baginsky S, 2004, J PROTEOME RES, V3, P1128, DOI 10.1021/pr0499186; Block MA, 2007, PHOTOSYNTH RES, V92, P225, DOI 10.1007/s11120-007-9195-8; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Bruce BD, 1998, PLANT MOL BIOL, V38, P223, DOI 10.1023/A:1006094308805; Chen DD, 1997, J BIOL CHEM, V272, P6614, DOI 10.1074/jbc.272.10.6614; Chen YM, 2006, J BIOL CHEM, V281, P5726, DOI 10.1074/jbc.M510945200; CHUA NH, 1978, P NATL ACAD SCI USA, V75, P6110, DOI 10.1073/pnas.75.12.6110; Colombo SF, 2009, J CELL SCI, V122, P2383, DOI 10.1242/jcs.049460; Constan D, 2004, PLANT J, V38, P93, DOI 10.1111/j.1365-313X.2004.02024.x; Delille HK, 2008, J BIOL CHEM, V283, P31107, DOI 10.1074/jbc.M803332200; Dhugga KS, 1997, P NATL ACAD SCI USA, V94, P7679, DOI 10.1073/pnas.94.14.7679; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fritze CE, 2000, METHOD ENZYMOL, V327, P3, DOI 10.1016/S0076-6879(00)27263-7; Gutensohn M, 2000, PLANT J, V23, P771, DOI 10.1046/j.1365-313x.2000.00849.x; Halbach A, 2006, J CELL SCI, V119, P2508, DOI 10.1242/jcs.02979; Hawes C., 2003, CURR PROTOC CELL BIO, V19, P1, DOI [DOI 10.1002/0471143030.CB0107S19, 10.1002/0471143030.cb0107s19]; Heins L, 2002, EMBO J, V21, P2616, DOI 10.1093/emboj/21.11.2616; Henderson MPA, 2007, METHODS, V41, P427, DOI 10.1016/j.ymeth.2006.07.004; Henderson MPA, 2007, BIOCHEM J, V401, P701, DOI 10.1042/BJ20060990; Hofmann NR, 2005, TRENDS PLANT SCI, V10, P450, DOI 10.1016/j.tplants.2005.07.009; Hwang YT, 2004, PLANT CELL, V16, P3002, DOI 10.1105/tpc.104.026039; Inoue K, 2007, J INTEGR PLANT BIOL, V49, P1100, DOI 10.1111/j.1672-9072.2007.00543.x; JANIAK F, 1994, J BIOL CHEM, V269, P9842; Jarvis P, 1998, SCIENCE, V282, P100, DOI 10.1126/science.282.5386.100; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kemper C, 2008, J CELL SCI, V121, P1990, DOI 10.1242/jcs.024034; Kessler F, 2009, CURR OPIN CELL BIOL, V21, P494, DOI 10.1016/j.ceb.2009.03.004; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; KRIECHBAUMER V, 2009, TRAFFIC IN PRESS; Kubis S, 2003, PLANT CELL, V15, P1859, DOI 10.1105/tpc.012955; KUNCE CM, 1988, BIOCHEM J, V251, P147, DOI 10.1042/bj2510147; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; LEE J, 2009, J BIOL CHEM IN PRESS; Lee MS, 1997, PLANT CELL, V9, P185, DOI 10.1105/tpc.9.2.185; Lee YJ, 2004, MOL CELLS, V17, P281; Lee YJ, 2001, PLANT CELL, V13, P2175, DOI 10.1105/tpc.13.10.2175; Leister D, 2008, CELL RES, V18, P1081, DOI 10.1038/cr.2008.297; Li HM, 1997, J BIOL CHEM, V272, P10968; Lingard MJ, 2008, PLANT CELL, V20, P1567, DOI 10.1105/tpc.107.057679; Lipka V, 2007, ANNU REV CELL DEV BI, V23, P147, DOI 10.1146/annurev.cellbio.23.090506.123529; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; LUETHY MH, 1995, J PLANT PHYSL, V145, P442; Maggio C, 2007, J EXP BOT, V58, P1365, DOI 10.1093/jxb/erl303; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; May T, 1998, J CELL BIOL, V141, P895, DOI 10.1083/jcb.141.4.895; McCartney AW, 2004, PLANT J, V37, P156, DOI 10.1111/j.1365-313X.2004.01949.x; Meyers BC, 2004, PLANT PHYSIOL, V135, P801, DOI 10.1104/pp.104.039495; Mullen RT, 2000, J BIOL CHEM, V275, P16337, DOI 10.1074/jbc.M001266200; Nito K, 2001, PLANT CELL PHYSIOL, V42, P20, DOI 10.1093/pcp/pce003; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Qbadou S, 2003, J CELL SCI, V116, P837, DOI 10.1242/jcs.00291; Rabu C, 2008, J BIOL CHEM, V283, P27504, DOI 10.1074/jbc.M804591200; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schleiff E, 2001, MOL BIOL CELL, V12, P4090, DOI 10.1091/mbc.12.12.4090; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; SEEDORF M, 1995, PLANT J, V7, P401, DOI 10.1046/j.1365-313X.1995.7030401.x; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Simpson JP, 2008, J EXP BOT, V59, P2545, DOI 10.1093/jxb/ern123; Smith Matthew D, 2003, Curr Protoc Cell Biol, VChapter 11, DOI 10.1002/0471143030.cb1116s17; Stojanovski D, 2007, J CELL BIOL, V179, P881, DOI 10.1083/jcb.200706043; SULOWAY CJ, 2009, P NATL ACAD IN PRESS; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Tsai LY, 1999, J BIOL CHEM, V274, P18735, DOI 10.1074/jbc.274.26.18735; Tu SL, 2000, PLANT CELL, V12, P1951, DOI 10.1105/tpc.12.10.1951; Tu SL, 2004, PLANT CELL, V16, P2078, DOI 10.1105/tpc.104.023952; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1633, DOI 10.1111/j.1365-3040.2009.02040.x; Wang F, 2008, J CELL BIOL, V183, P87, DOI 10.1083/jcb.200803034; Yeh YH, 2007, J BIOL CHEM, V282, P13845, DOI 10.1074/jbc.M608385200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	81	54	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10098	10.1371/journal.pone.0010098	http://dx.doi.org/10.1371/journal.pone.0010098			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418952	gold, Green Published, Green Submitted			2022-12-25	WOS:000276706800008
J	Dong, QC; Meng, P; Wang, T; Qin, WW; Qin, WJ; Wang, FL; Yuan, JL; Chen, ZN; Yang, AG; Wang, H				Dong, Qingchuan; Meng, Ping; Wang, Tao; Qin, Weiwei; Qin, Weijun; Wang, Fuli; Yuan, Jianlin; Chen, Zhinan; Yang, Angang; Wang, He			MicroRNA Let-7a Inhibits Proliferation of Human Prostate Cancer Cells In Vitro and In Vivo by Targeting E2F2 and CCND2	PLOS ONE			English	Article							TRANSCRIPTIONAL NETWORK; COLON-CANCER; EXPRESSION; DIFFERENTIATION; SUPPRESSOR; REPRESSES; PROGNOSIS; FAMILY; GROWTH	Background: Previous work has shown reduced expression levels of let-7 in lung tumors. But little is known about the expression or mechanisms of let-7a in prostate cancer. In this study, we used in vitro and in vivo approaches to investigate whether E2F2 and CCND2 are direct targets of let-7a, and if let-7a acts as a tumor suppressor in prostate cancer by down-regulating E2F2 and CCND2. Methodology/Principal: Findings Real-time RT-PCR demonstrated that decreased levels of let-7a are present in resected prostate cancer samples and prostate cancer cell lines. Cellular proliferation was inhibited in PC3 cells and LNCaP cells after transfection with let-7a. Cell cycle analysis showed that let-7a induced cell cycle arrest at the G1/S phase. A dual-luciferase reporter assay demonstrated that the 3'UTR of E2F2 and CCND2 were directly bound to let-7a and western blotting analysis further indicated that let-7a down-regulated the expression of E2F2 and CCND2. Our xenograft models of prostate cancer confirmed the capability of let-7a to inhibit prostate tumor development in vivo. Conclusions/Significance: These findings help to unravel the anti-proliferative mechanisms of let-7a in prostate cancer. Let-7a may also be novel therapeutic candidate for prostate cancer given its ability to induce cell-cycle arrest and inhibit cell growth, especially in hormone-refractory prostate cancer.	[Dong, Qingchuan; Meng, Ping; Qin, Weijun; Wang, Fuli; Yuan, Jianlin; Wang, He] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Peoples R China; [Wang, Tao; Qin, Weiwei; Yang, Angang] Fourth Mil Med Univ, Dept Biochem, Xian 710032, Peoples R China; [Chen, Zhinan] Fourth Mil Med Univ, State Key Lab Canc Biol, Cell Engn Res Ctr, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Dong, QC (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Peoples R China.	dongqc168@yahoo.com.cn	Jackson, Benjamin L/C-4297-2012; Wang, Tao/ABB-7764-2021; Wang, Tao/AEN-3843-2022		National Basic Research Program of China [2009CB521705]; Nature Science Foundation of China [30672097]	National Basic Research Program of China(National Basic Research Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of China, 2009CB521705; and the Nature Science Foundation of China, 30672097. The funders had no role in study design, data collection and analysis, decision to publish.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000912; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dhillon VS, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-33; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Inamura K, 2007, LUNG CANCER, V58, P392, DOI 10.1016/j.lungcan.2007.07.013; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lee YS, 2006, CURR OPIN INVEST DR, V7, P560; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Mermelshtein A, 2005, BRIT J CANCER, V93, P338, DOI 10.1038/sj.bjc.6602709; Okamoto OK, 2007, BBA-GENE STRUCT EXPR, V1769, P437, DOI 10.1016/j.bbaexp.2007.05.002; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Takano Y, 2000, AM J PATHOL, V156, P585, DOI 10.1016/S0002-9440(10)64763-3; Vidal A, 2000, GENE, V247, P1, DOI 10.1016/S0378-1119(00)00092-5; Wu W, 2007, INT J CANCER, V120, P953, DOI 10.1002/ijc.22454; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	25	193	204	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10147	10.1371/journal.pone.0010147	http://dx.doi.org/10.1371/journal.pone.0010147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418948	Green Published, gold, Green Submitted			2022-12-25	WOS:000276706800010
J	Inghammar, M; Ekbom, A; Engstrom, G; Ljungberg, B; Romanus, V; Lofdahl, CG; Egesten, A				Inghammar, Malin; Ekbom, Anders; Engstrom, Gunnar; Ljungberg, Bengt; Romanus, Victoria; Lofdahl, Claes-Goran; Egesten, Arne			COPD and the Risk of Tuberculosis - A Population-Based Cohort Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-DISEASE; RESPIRATORY SYMPTOMS; SOUTHERN SWEDEN; NORTHERN SWEDEN; PREVALENCE; SMOKING; TOBACCO; METAANALYSIS; ASSOCIATION	Background: Both chronic obstructive pulmonary disease (COPD) and tuberculosis (TB) primarily affect the lungs and are major causes of morbidity and mortality worldwide. COPD and TB have common risk factors such as smoking, low socioeconomic status and dysregulation of host defence functions. COPD is a prevalent co-morbid condition, especially in elderly with TB but in contrast to other diseases known to increase the risk of TB, relatively little is known about the specific relationship and impact from COPD on TB-incidence and mortality. Methods and Findings: All individuals $40 years of age, discharged with a diagnosis of COPD from Swedish hospitals 1987-2003 were identified in the Swedish Inpatient Register (n = 115,867). Records were linked to the Swedish Tuberculosis Register 1989-2007 and the relative risk of active TB in patients with COPD compared to control subjects randomly selected from the general population (matched for sex, year of birth and county of residence) was estimated using Cox regression. The analyses were stratified by year of birth, sex and county of residence and adjusted for immigration status, socioeconomic status (SES) and inpatient co-morbidities previously known to increase the risk of TB. COPD patients had a three-fold increased hazard ratio (HR) of developing active TB (HR 3.0 (95% confidence interval 2.4 to 4.0)) that was mainly dependent on an increased risk of pulmonary TB. In addition, logistic regression estimates showed that COPD patients who developed active TB had a two-fold increased risk of death from all causes within first year after the TB diagnosis compared to the general population control subjects with TB (OR 2.2, 95% confidence interval 1.2 to 4.1). Conclusions: This population-based study comprised of a large number of COPD patients shows that these patients have an increased risk of developing active TB compared to the general population. The results raise concerns that the increasing global burden of COPD will increase the incidence of active TB. The underlying contributory factors need to be disentangled in further studies.	[Inghammar, Malin; Ljungberg, Bengt] Lund Univ, Univ Lund Hosp, Dept Clin Sci Lund, Sect Infect Med, Lund, Sweden; [Inghammar, Malin; Lofdahl, Claes-Goran; Egesten, Arne] Lund Univ, Univ Lund Hosp, Dept Clin Sci Lund, Sect Resp Med, Lund, Sweden; [Ekbom, Anders] Karolinska Hosp & Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Ekbom, Anders] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Engstrom, Gunnar] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Malmo, Malmo, Sweden; [Romanus, Victoria] Swedish Inst Infect Dis Control, Stockholm, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Karolinska Institutet; Karolinska University Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Lund University; Skane University Hospital; Swedish Institute for Infectious Disease Control	Inghammar, M (corresponding author), Lund Univ, Univ Lund Hosp, Dept Clin Sci Lund, Sect Infect Med, Lund, Sweden.	malin.inghammar@med.lu.se		Engstrom, Gunnar/0000-0002-8618-9152; Inghammar, Malin/0000-0003-2995-1312	Swedish Heart and Lung Foundation [20080246]; GlaxoSmithKline; Swedish Research Council [K2008-57X-20674]; Avtal om Lakares Forskning (ALF); University Hospital in Lund; Foundation of Th C Bergh; Foundation of Crafood; Foundation of Hedberg; Foundation of Bengt Ihre; Foundation of Greta Johan Kock; Foundation of Alfred Osterlund; Foundation of Marianne & Marcus Wallenberg	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); GlaxoSmithKline(GlaxoSmithKline); Swedish Research Council(Swedish Research CouncilEuropean Commission); Avtal om Lakares Forskning (ALF); University Hospital in Lund; Foundation of Th C Bergh; Foundation of Crafood; Foundation of Hedberg; Foundation of Bengt Ihre; Foundation of Greta Johan Kock; Foundation of Alfred Osterlund; Foundation of Marianne & Marcus Wallenberg	This study was supported by grants from the Swedish Heart and Lung Foundation (project 20080246), an unrestricted grant from GlaxoSmithKline, the Swedish Research Council (project K2008-57X-20674), the Swedish Government Funds for Clinical Research, i.e. Avtal om Lakares Forskning (ALF), the University Hospital in Lund, and the Foundations of Th C Bergh, Crafoord, Hedberg, Bengt Ihre, Greta & Johan Kock, Alfred Osterlund, and Marianne & Marcus Wallenberg. M. I. is the recipient of a fellowship from ALF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktogu S, 1996, EUR RESPIR J, V9, P2031, DOI 10.1183/09031936.96.09102031; [Anonymous], 2000, AM J RESP CRIT CARE, V161, pS221; Bahceciler NN, 2000, PEDIATR INFECT DIS J, V19, P215, DOI 10.1097/00006454-200003000-00008; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Benfield T, 2008, CHEST, V134, P46, DOI 10.1378/chest.07-2933; Calverley PMA, 2003, LANCET, V362, P1053, DOI 10.1016/S0140-6736(03)14416-9; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; *CTR EP, 2009, CAUS DEATH 2007; *CTR EP SWED NAT B, 2009, COD QUAL HOSP DISCH; *CTR EP SWED NAT B, 2008, QUAL CONT SWED HOSP; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Fielder JF, 2002, INT J TUBERC LUNG D, V6, P1114; Hasselgren M, 2001, SCAND J PRIM HEALTH, V19, P54, DOI 10.1080/028134301300034701; Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lin HH, 2009, AM J RESP CRIT CARE, V180, P475, DOI 10.1164/rccm.200904-0549OC; Lindberg A, 2006, RESP MED, V100, P264, DOI 10.1016/j.rmed.2005.04.029; Lindberg A, 2005, RESPIRATION, V72, P471, DOI 10.1159/000087670; Liu SF, 2005, INT J TUBERC LUNG D, V9, P111; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Lundback B, 2003, RESP MED, V97, P115, DOI 10.1053/rmed.2003.1446; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Montnemery P, 2006, INT J TUBERC LUNG D, V10, P490; Montnemery P, 1998, RESP MED, V92, P1337, DOI 10.1016/S0954-6111(98)90139-1; Ormerod LP, 2002, INT J TUBERC LUNG D, V6, P662; ROMANUS V, 2003, SMITTSKYDDSBOKEN STU, P377; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; SCHATZ M, 1976, ANN INTERN MED, V84, P261, DOI 10.7326/0003-4819-84-3-261; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; Silverman Edwin K, 2006, Proc Am Thorac Soc, V3, P405, DOI 10.1513/pats.200603-092AW; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; *STAT SWED, 1982, SOC CLASS; Stenfors N, 2006, CHEST, V130, P666, DOI 10.1378/chest.130.3.666; *SWED I INF DIS, 2008, EP ANN REP; Wang JY, 2005, INT J TUBERC LUNG D, V9, P777; 2007, CONSUPTION ALCOHOL T	41	86	91	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10138	10.1371/journal.pone.0010138	http://dx.doi.org/10.1371/journal.pone.0010138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405056	Green Published, gold, Green Submitted			2022-12-25	WOS:000276706300003
J	Ross, B; Schneider, B; Snyder, JS; Alain, C				Ross, Bernhard; Schneider, Bruce; Snyder, Joel S.; Alain, Claude			Biological Markers of Auditory Gap Detection in Young, Middle-Aged, and Older Adults	PLOS ONE			English	Article							DETECTION THRESHOLDS; GAMMA-ACTIVITY; SELECTIVE ATTENTION; EVOKED-POTENTIALS; LATENCY RESPONSE; CEREBRAL-CORTEX; WITHIN-CHANNEL; BRAIN ACTIVITY; FREQUENCY; NOISE	The capability of processing rapid fluctuations in the temporal envelope of sound declines with age and this contributes to older adults' difficulties in understanding speech. Although, changes in central auditory processing during aging have been proposed as cause for communication deficits, an open question remains which stage of processing is mostly affected by age related changes. We investigated auditory temporal resolution in young, middle-aged, and older listeners with neuromagnetic evoked responses to gap stimuli with different leading marker and gap durations. Signal components specific for processing the physical details of sound stimuli as well as the auditory objects as a whole were derived from the evoked activity and served as biological markers for temporal processing at different cortical levels. Early oscillatory 40-Hz responses were elicited by the onsets of leading and lagging markers and indicated central registration of the gap with similar amplitude in all three age groups. High-gamma responses were predominantly related to the duration of no-gap stimuli or to the duration of gaps when present, and decreased in amplitude and phase locking with increasing age. Correspondingly, low-frequency activity around 200 ms and later was reduced in middle aged and older participants. High-gamma band, and long-latency low-frequency responses were interpreted as reflecting higher order processes related to the grouping of sound items into auditory objects and updating of memory for these objects. The observed effects indicate that age-related changes in auditory acuity have more to do with higher-order brain functions than previously thought.	[Ross, Bernhard; Alain, Claude] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; [Ross, Bernhard] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Schneider, Bruce; Alain, Claude] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Snyder, Joel S.] Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Ross, B (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada.	bross@rotman-baycrest.on.ca	Snyder, Joel S/B-4675-2008; /AIE-5811-2022	Snyder, Joel S/0000-0002-5565-3063; Ross, Bernhard/0000-0001-7290-631X	Canadian Institutes of Health Research [81135, 74482]; Canada Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by funds from the Canadian Institutes of Health Research (Grant No. 81135 to BR and Grant No. 74482 to CA) and the Canada Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL SM, 1990, SCAND AUDIOL, V19, P43, DOI 10.3109/01050399009070751; Alain C, 2002, J ACOUST SOC AM, V111, P990, DOI 10.1121/1.1434942; Alain C, 2007, J NEUROSCI, V27, P1308, DOI 10.1523/JNEUROSCI.5433-06.2007; Barsz K, 2002, NEUROBIOL AGING, V23, P565, DOI 10.1016/S0197-4580(02)00008-8; BASAR E, 1987, INT J NEUROSCI, V33, P103; BERTRAND O, 1994, IEEE T BIO-MED ENG, V41, P77, DOI 10.1109/10.277274; Buus S., 1985, TIME RESOLUTION AUDI, P159; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; CHAMBERS RD, 1991, HEARING RES, V51, P1, DOI 10.1016/0378-5955(91)90002-Q; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Draganova R, 2002, EAR HEARING, V23, P254, DOI 10.1097/00003446-200206000-00009; Eddins AC, 1999, J SPEECH LANG HEAR R, V42, P516, DOI 10.1044/jslhr.4203.516; Edwards E, 2005, J NEUROPHYSIOL, V94, P4269, DOI 10.1152/jn.00324.2005; Eggermont JJ, 2000, J NEUROPHYSIOL, V84, P1453, DOI 10.1152/jn.2000.84.3.1453; Gage N, 2006, BRAIN RES, V1069, P166, DOI 10.1016/j.brainres.2005.11.023; GORDONSALANT S, 1993, J SPEECH HEAR RES, V36, P1276, DOI 10.1044/jshr.3606.1276; GREEN DM, 1989, J ACOUST SOC AM, V86, P961, DOI 10.1121/1.398731; Guo YQ, 2002, HEARING RES, V171, P158, DOI 10.1016/S0378-5955(02)00496-3; Heinrich A, 2004, NEUROREPORT, V15, P2051, DOI 10.1097/00001756-200409150-00011; JOLIOT M, 1994, P NATL ACAD SCI USA, V91, P11748, DOI 10.1073/pnas.91.24.11748; Jones EG, 2009, ANN NY ACAD SCI, V1157, P10, DOI 10.1111/j.1749-6632.2009.04534.x; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; Kobayashi T, 1999, IEEE T BIO-MED ENG, V46, P951, DOI 10.1109/10.775405; Lagerlund TD, 1997, J CLIN NEUROPHYSIOL, V14, P73, DOI 10.1097/00004691-199701000-00007; Leonard CM, 1998, CEREB CORTEX, V8, P397, DOI 10.1093/cercor/8.5.397; Lister JJ, 2007, EAR HEARING, V28, P862, DOI 10.1097/AUD.0b013e3181576cba; Llinas R, 2001, ANN NY ACAD SCI, V929, P166; Llinas R, 2003, INT CONGR SER, V1250, P409, DOI 10.1016/S0531-5131(03)01067-7; MCCROSKEY RL, 1980, J LEARN DISABIL, V13, P69, DOI 10.1177/002221948001300205; Metherate R, 1999, EXP BRAIN RES, V126, P160, DOI 10.1007/s002210050726; NAATANEN R, 1982, PSYCHOL BULL, V92, P605; NAATANEN R, 2007, CLIN NEUROPHYSIOL; Pantev C, 1998, AUDIOL NEURO-OTOL, V3, P183, DOI 10.1159/000013789; PANTEV C, 1991, P NATL ACAD SCI USA, V88, P8996, DOI 10.1073/pnas.88.20.8996; Phillips D P, 1999, J Am Acad Audiol, V10, P343; PLOMP R, 1964, J ACOUST SOC AM, V36, P277, DOI 10.1121/1.1918946; Pratt H, 2005, CLIN NEUROPHYSIOL, V116, P2648, DOI 10.1016/j.clinph.2005.08.001; Pratt H, 2007, CLIN NEUROPHYSIOL, V118, P1078, DOI 10.1016/j.clinph.2007.01.005; Ray S, 2008, CLIN NEUROPHYSIOL, V119, P116, DOI 10.1016/j.clinph.2007.09.136; RIBARY U, 1991, P NATL ACAD SCI USA, V88, P11037, DOI 10.1073/pnas.88.24.11037; ROBIN DA, 1989, PSYCHOL AGING, V4, P144; ROBIN DA, 1987, J ACOUST SOC AM, V82, P1207, DOI 10.1121/1.395257; Ross B, 2000, J ACOUST SOC AM, V108, P679, DOI 10.1121/1.429600; Ross B, 2007, J NEUROSCI, V27, P11172, DOI 10.1523/JNEUROSCI.1813-07.2007; Ross B, 2009, NEUROIMAGE, V47, P678, DOI 10.1016/j.neuroimage.2009.04.051; Rupp A, 2000, NEUROREPORT, V11, P3731, DOI 10.1097/00001756-200011270-00028; Rupp A, 2004, J NEUROPHYSIOL, V92, P2239, DOI 10.1152/jn.00163.2004; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; SCHNEIDER BA, 1994, J ACOUST SOC AM, V95, P980, DOI 10.1121/1.408403; Schneider BA, 1999, J ACOUST SOC AM, V106, P371, DOI 10.1121/1.427062; SHAILER MJ, 1983, J ACOUST SOC AM, V74, P467, DOI 10.1121/1.389812; Snell KB, 1999, J ACOUST SOC AM, V106, P3571, DOI 10.1121/1.428210; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; WOODS DL, 1986, ELECTROEN CLIN NEURO, V65, P297, DOI 10.1016/0168-5597(86)90008-0	55	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10101	10.1371/journal.pone.0010101	http://dx.doi.org/10.1371/journal.pone.0010101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404929	gold, Green Published, Green Submitted			2022-12-25	WOS:000276482100017
J	Urs, S; Venkatesh, D; Tang, YF; Henderson, T; Yang, XH; Friesel, RE; Rosen, CJ; Liaw, L				Urs, Sumithra; Venkatesh, Deepak; Tang, Yuefeng; Henderson, Terry; Yang, Xuehui; Friesel, Robert E.; Rosen, Clifford J.; Liaw, Lucy			Sprouty1 is a critical regulatory switch of mesenchymal stem cell lineage allocation	FASEB JOURNAL			English	Article						adipocyte; osteoblast; growth factor signaling; body fat; bone mass	PPAR-GAMMA; INSULIN-RESISTANCE; DIFFERENTIATION; TAZ; BONE; FAT; ACTIVATION; MUSCLE; PREADIPOCYTES; LIPODYSTROPHY	Development of bone and adipose tissue are linked processes arising from a common progenitor cell, but having an inverse relationship in disease conditions such as osteoporosis. Cellular differentiation of both tissues relies on growth factor cues, and we focus this study on Sprouty1 (Spry1), an inhibitor of growth factor signaling. We tested whether Spry1 can modify the development of fat cells through its activity in regulating growth factors known to be important for adipogenesis. We utilized conditional expression and genetic-null mouse models of Spry1 in adipocytes using the fatty acid binding promoter (aP2). Conditional deletion of Spry1 results in 10% increased body fat and decreased bone mass. This phenotype was rescued on Spry1 expression, which results in decreased body fat and increased bone mass. Ex vivo bone marrow experiments indicate Spry1 in bone marrow and adipose progenitor cells favors differentiation of osteoblasts at the expense of adipocytes by suppressing CEBP-beta and PPAR gamma while up regulating TAZ. Age and gender-matched littermates expressing only Cre recombinase were used as controls. Spry1 is a critical regulator of adipocyte differentiation and mesenchymal stem cell (MSC) lineage allocation, potentially acting through regulation of CEBP-beta and TAZ.-Urs, S., Venkatesh, D., Tang, Y., Henderson, T., Yang, X., Friesel, R. E., Rosen, C. J., Liaw, L. Sprouty1 is a critical regulatory switch of mesenchymal stem cell lineage allocation. FASEB J. 24, 3264-3273 (2010). www.fasebj.org	[Urs, Sumithra; Venkatesh, Deepak; Tang, Yuefeng; Henderson, Terry; Yang, Xuehui; Friesel, Robert E.; Rosen, Clifford J.; Liaw, Lucy] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA	Maine Medical Center	Liaw, L (corresponding author), Maine Med Ctr, Res Inst, Ctr Mol Med, 81 Res Dr, Scarborough, ME 04074 USA.	liawl@mmc.org	Pillay, Nischalan/F-9536-2012; Tang, Yuefeng/J-9770-2012		U.S. National Institutes of Health (NIH) [R01HL070865, AR54604, DK73871, P20RR1555]; NIH [P20RR1555]; National Center for Research Resources;  [P20RR181789]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001555] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073871] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors gratefully acknowledge the support of their histopathology core (K. Carrier and V. Lindner), mouse transgenic core (A. Harrington), animal facility personnel, and clinical and translational research laboratory services (P. Le and C.J.R.). This work was supported by U.S. National Institutes of Health (NIH) grants R01HL070865 (to L. L.), AR54604 (to C.J.R.), DK73871 (to R. E. F.) and P20RR1555 (PI: R. E. F.). The Histopathology Core Facility was supported by P20RR181789 (PI: D. Wojchowski), and the Mouse Transgenic Facility was supported by NIH grant P20RR1555 (PI: R. E. F.), both from the National Center for Research Resources.	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Duque G, 2008, CURR OPIN RHEUMATOL, V20, P429, DOI 10.1097/BOR.0b013e3283025e9c; Eda H, 2008, BIOCHEM BIOPH RES CO, V366, P471, DOI 10.1016/j.bbrc.2007.11.140; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Havrda MC, 2006, THROMB HAEMOSTASIS, V96, P361, DOI 10.1160/TH06-04-0224; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hibuse T, 2005, P NATL ACAD SCI USA, V102, P10993, DOI 10.1073/pnas.0503291102; Hong D, 2009, J STEROID BIOCHEM, V116, P86, DOI 10.1016/j.jsbmb.2009.05.007; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hughess FJ, 1998, METHODS BONE BIOL, P1; Kakudo N, 2007, BIOCHEM BIOPH RES CO, V359, P239, DOI 10.1016/j.bbrc.2007.05.070; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Koutnikova H, 2003, P NATL ACAD SCI USA, V100, P14457, DOI 10.1073/pnas.2336090100; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Lin YF, 2008, CELL PROLIFERAT, V41, P803, DOI 10.1111/j.1365-2184.2008.00542.x; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Newell FS, 2006, FASEB J, V20, P2615, DOI 10.1096/fj.05-5710fje; Novakofski J, 2004, J ANIM SCI, V82, P905; Rodriguez JP, 2008, CURR STEM CELL RES T, V3, P208, DOI 10.2174/157488808785740325; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Rosen CJ, 2009, AM J MED, V122, P409, DOI 10.1016/j.amjmed.2008.11.027; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Urs S, 2006, TRANSGENIC RES, V15, P647, DOI 10.1007/s11248-006-9000-z; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Widberg CH, 2009, AM J PHYSIOL-ENDOC M, V296, pE121, DOI 10.1152/ajpendo.90602.2008; Yang XH, 2008, DEV BIOL, V321, P64, DOI 10.1016/j.ydbio.2008.05.555	34	40	42	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3264	3273		10.1096/fj.10-155127	http://dx.doi.org/10.1096/fj.10-155127			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20410440	Green Published			2022-12-25	WOS:000281446400015
J	Daniels, IS; Zhang, JF; O'Brien, WG; Tao, ZY; Miki, T; Zhao, ZY; Blackburn, MR; Lee, CC				Daniels, Isadora Susan; Zhang, Jianfa; O'Brien, William G., III; Tao, Zhenyin; Miki, Tomoko; Zhao, Zhaoyang; Blackburn, Michael R.; Lee, Cheng Chi			A Role of Erythrocytes in Adenosine Monophosphate Initiation of Hypometabolism in Mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE; HYPOTHERMIA; HYPOXIA; KINASE; MODEL; TIME	Biochemical and mechanistic aspects into how various hypometabolic states are initiated in mammals are poorly understood. Here, we show how a state of hypometabolism is initiated by 5'-AMP uptake by erythrocytes. Wild type, ecto-5'-nucleotidase-deficient, and adenosine receptor-deficient mice undergo 5'-AMP-induced hypometabolism in a similar fashion. Injection of 5'-AMP leads to two distinct declining phases of oxygen consumption (VO2). The phase I response displays a rapid and steep decline in VO2 that is independent of body temperature (T-b) and ambient temperature (T-a). It is followed by a phase II decline that is linked to T-b and moderated by T-a. Altering the dosages of 5'-AMP from 0.25- to 2-fold does not change the phase I response. For mice, a T-a of 15 degrees C is effective for induction of DH with the appropriate dose of 5'-AMP. Erythrocyte uptake of 5'-AMP leads to utilization of ATP to synthesize ADP. This is accompanied by increased glucose but decreased lactate levels, suggesting that glycolysis has slowed. Reduction in glycolysis is known to stimulate erythrocytes to increase intracellular levels of 2,3-bisphosphoglycerate, a potent allosteric inhibitor of hemoglobin's affinity for oxygen. Our studies showed that both 2,3-bisphosphoglycerate and deoxyhemoglobin levels rose following 5'-AMP administration and is in parallel with the phase I decline in VO2. In summary, our investigations reveal that 5'-AMP mediated hypometabolism is probably triggered by reduced oxygen transport by erythrocytes initiated by uptake of 5'-AMP.	[Blackburn, Michael R.; Lee, Cheng Chi] Univ Texas Hlth Sci Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Zhang, Jianfa] Nanjing Univ Sci & Technol, Ctr Mol Metab, Nanjing 210094, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; Nanjing University of Science & Technology	Lee, CC (corresponding author), MSB 6-200,6431 Fannin St, Houston, TX 77030 USA.	cheng.c.lee@uth.tmc.edu		Daniels, Isadora/0000-0002-1351-2908; Blackburn, Michael/0000-0002-1394-9966	National Institutes of Health (NIH/NDPA) [5DP1 OD000895]; NASA; Ministry of Education of P. R. China; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000895] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NDPA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA(National Aeronautics & Space Administration (NASA)); Ministry of Education of P. R. China(Ministry of Education, China); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by a National Institutes of Health Director Pioneer award (to C. C. L.) (NIH/NDPA: 5DP1 OD000895).; Supported in part by a NASA/Texas Space Grant Consortium Fellowship.; Supported in part by Ministry of Education of P. R. China.	CHANCE B, 1988, P NATL ACAD SCI USA, V85, P4971, DOI 10.1073/pnas.85.14.4971; Csoka B, 2007, BLOOD, V110, P2685, DOI 10.1182/blood-2007-01-065870; DARK J, 1994, AM J PHYSIOL, V267, P496; EVANS CL, 1967, Q J EXP PHYSIOL CMS, V52, P231, DOI 10.1113/expphysiol.1967.sp001909; HAWKINS CF, 1987, BIOCHEMISTRY-US, V26, P1982, DOI 10.1021/bi00381a030; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; IKEDA S, 1965, TOHOKU J EXP MED, V87, P185, DOI 10.1620/tjem.87.185; KNUDSEN TB, 1992, TERATOLOGY, V45, P91, DOI 10.1002/tera.1420450109; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Lehninger A L, 1982, PRINCIPLES BIOCH; Mulquiney PJ, 1999, BIOCHEM J, V342, P597, DOI 10.1042/0264-6021:3420597; Noji T, 2004, EUR J PHARMACOL, V495, P1, DOI 10.1016/j.ejphar.2004.05.003; Overton JM, 2004, PHYSIOL BEHAV, V81, P749, DOI 10.1016/j.physbeh.2004.04.025; Pritlove DC, 2006, PLACENTA, V27, P924, DOI 10.1016/j.placenta.2005.08.010; Rhee P, 2000, J TRAUMA, V48, P439, DOI 10.1097/00005373-200003000-00011; Salvatore CA, 2000, J BIOL CHEM, V275, P4429, DOI 10.1074/jbc.275.6.4429; SHEPHERD AP, 1975, J APPL PHYSIOL, V39, P152, DOI 10.1152/jappl.1975.39.1.152; Simpkins CE, 2007, AM J TRANSPLANT, V7, P99, DOI 10.1111/j.1600-6143.2006.01597.x; Sun DQ, 2001, P NATL ACAD SCI USA, V98, P9983, DOI 10.1073/pnas.171317998; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; TSUBOI KK, 1975, J BIOL CHEM, V250, P132; WOOD SC, 1991, ANNU REV PHYSIOL, V53, P71, DOI 10.1146/annurev.physiol.53.1.71; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368	23	38	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20716	20723		10.1074/jbc.M109.090845	http://dx.doi.org/10.1074/jbc.M109.090845			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430891	hybrid, Green Published			2022-12-25	WOS:000279228600035
J	Ullrich, S; Munch, A; Neumann, S; Kremmer, E; Tatzelt, J; Lichtenthaler, SF				Ullrich, Sylvia; Muench, Anna; Neumann, Stephanie; Kremmer, Elisabeth; Tatzelt, Joerg; Lichtenthaler, Stefan F.			The Novel Membrane Protein TMEM59 Modulates Complex Glycosylation, Cell Surface Expression, and Secretion of the Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCOSYLATION; TRANS-GOLGI NETWORK; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; ALPHA-SECRETASE; BETA-SECRETASE; INTRAMEMBRANE PROTEOLYSIS; MEDIATED ENDOCYTOSIS; CONVERTING-ENZYME; CLEAVING ENZYME	Ectodomain shedding of the amyloid precursor protein (APP) by the two proteases alpha- and beta-secretase is a key regulatory event in the generation of the Alzheimer disease amyloid beta peptide (A beta). At present, little is known about the cellular mechanisms that control APP shedding and A beta generation. Here, we identified a novel protein, transmembrane protein 59 (TMEM59), as a new modulator of APP shedding. TMEM59 was found to be a ubiquitously expressed, Golgi-localized protein. TMEM59 transfection inhibited complex N- and O-glycosylation of APP in cultured cells. Additionally, TMEM59 induced APP retention in the Golgi and inhibited A beta generation as well as APP cleavage by alpha- and beta-secretase cleavage, which occur at the plasma membrane and in the endosomes, respectively. Moreover, TMEM59 inhibited the complex N-glycosylation of the prion protein, suggesting a more general modulation of Golgi glycosylation reactions. Importantly, TMEM59 did not affect the secretion of soluble proteins or the alpha-secretase like shedding of tumor necrosis factor alpha, demonstrating that TMEM59 did not disturb the general Golgi function. The phenotype of TMEM59 transfection on APP glycosylation and shedding was similar to the one observed in cells lacking conserved oligomeric Golgi (COG) proteins COG1 and COG2. Both proteins are required for normal localization and activity of Golgi glycosylation enzymes. In summary, this study shows that TMEM59 expression modulates complex N-and O-glycosylation and suggests that TMEM59 affects APP shedding by reducing access of APP to the cellular compartments, where it is normally cleaved by alpha- and beta-secretase.	[Ullrich, Sylvia; Muench, Anna; Neumann, Stephanie; Tatzelt, Joerg; Lichtenthaler, Stefan F.] Univ Munich, German Ctr Neurodegenerat Dis Munich DZNE, D-80336 Munich, Germany; [Ullrich, Sylvia; Muench, Anna; Neumann, Stephanie; Tatzelt, Joerg; Lichtenthaler, Stefan F.] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Mol Immunol, D-81377 Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lichtenthaler, SF (corresponding author), Univ Munich, German Ctr Neurodegenerat Dis Munich DZNE, D-80336 Munich, Germany.	Stefan.Lichtenthaler@med.uni-muenchen.de	Lichtenthaler, Stefan F/B-6587-2016	Lichtenthaler, Stefan F/0000-0003-2211-2575; Tatzelt, Jorg/0000-0001-5017-5528	Deutsche Forschungsgemeinschaft [SFB596, B12, B4, Z2]; Bundesministerium fur Bildung und Forschung; European Commission (NeuroNE); Friedrich-Baur-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Commission (NeuroNE)(European CommissionEuropean Commission Joint Research Centre); Friedrich-Baur-Stiftung	This work was supported by grants from Deutsche Forschungsgemeinschaft SFB596 Projects B12 (to S. F. L.), B4 (to J. T.), and Z2 (to E. K.), the competence network degenerative dementias (Bundesministerium fur Bildung und Forschung) (to S. F. L.), the European Commission (NeuroNE), and the Friedrich-Baur-Stiftung (to S. F. L.).	Allinson TMJ, 2004, EUR J BIOCHEM, V271, P2539, DOI 10.1111/j.1432-1033.2004.04184.x; Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Andrau D, 2003, J BIOL CHEM, V278, P25859, DOI 10.1074/jbc.M302622200; Breen KC, 1998, MOL NEUROBIOL, V16, P163, DOI 10.1007/BF02740643; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Chatterton JE, 1999, P NATL ACAD SCI USA, V96, P915, DOI 10.1073/pnas.96.3.915; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; Cisse MA, 2006, BIOCHEM BIOPH RES CO, V347, P254, DOI 10.1016/j.bbrc.2006.06.065; Cole SL, 2008, CURR ALZHEIMER RES, V5, P100, DOI 10.2174/156720508783954758; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Elson GCA, 1999, BIOCHEM BIOPH RES CO, V264, P55, DOI 10.1006/bbrc.1999.1481; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Fellgiebel A, 2009, J GERIATR PSYCH NEUR, V22, P3, DOI 10.1177/0891988708327810; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Gleeson PA, 1996, J CELL SCI, V109, P2811; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lefranc-Jullien S, 2005, BRIT J PHARMACOL, V145, P228, DOI 10.1038/sj.bjp.0706183; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lichtenthaler SF, 1997, BIOCHEMISTRY-US, V36, P15396, DOI 10.1021/bi971071m; Lichtenthaler SF, 2006, NEURODEGENER DIS, V3, P262, DOI 10.1159/000095265; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; LINSTEDT AD, 1995, P NATL ACAD SCI USA, V92, P5102, DOI 10.1073/pnas.92.11.5102; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; MAGUIRE TM, 1995, DEMENTIA, V6, P185, DOI 10.1159/000106944; McFarlane I, 1999, NEUROSCIENCE, V90, P15, DOI 10.1016/S0306-4522(98)00361-3; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Nakagawa K, 2006, J NEUROCHEM, V96, P924, DOI 10.1111/j.1471-4159.2005.03595.x; Neumann S, 2006, J BIOL CHEM, V281, P7583, DOI 10.1074/jbc.M508340200; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Oka T, 2005, J BIOCHEM, V137, P109, DOI 10.1093/jb/mvi024; Okita C, 2004, BIOTECHNIQUES, V36, P418, DOI 10.2144/04363ST01; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; PAHLSSON P, 1992, BIOCHEM BIOPH RES CO, V189, P1667, DOI 10.1016/0006-291X(92)90269-Q; Pahlsson P, 1996, ARCH BIOCHEM BIOPHYS, V331, P177, DOI 10.1006/abbi.1996.0296; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Sannerud R, 2009, SEMIN CELL DEV BIOL, V20, P183, DOI 10.1016/j.semcdb.2008.11.004; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schobel S, 2006, INT J DEV NEUROSCI, V24, P141, DOI 10.1016/j.ijdevneu.2005.11.003; Schobel S, 2008, J BIOL CHEM, V283, P14257, DOI 10.1074/jbc.M801531200; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Slack BE, 2001, BIOCHEM J, V357, P787, DOI 10.1042/0264-6021:3570787; Smith RD, 2008, CARBOHYD RES, V343, P2024, DOI 10.1016/j.carres.2008.01.034; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Sugiura H, 2004, J BIOL CHEM, V279, P23343, DOI 10.1074/jbc.M312607200; Ungar D, 2006, TRENDS CELL BIOL, V16, P113, DOI 10.1016/j.tcb.2005.12.004; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Waldron E, 2008, NEUROBIOL DIS, V31, P188, DOI 10.1016/j.nbd.2008.04.006; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Westmeyer GG, 2004, J BIOL CHEM, V279, P53205, DOI 10.1074/jbc.M410378200; Whitmarsh AJ, 2006, BIOCHEM SOC T, V34, P828, DOI 10.1042/BST0340828; Winklhofer KF, 2003, TRAFFIC, V4, P313, DOI 10.1034/j.1600-0854.2003.00088.x; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006; Yazaki M, 1996, NEUROSCI LETT, V221, P57, DOI 10.1016/S0304-3940(96)13285-7; Zeevaert R, 2008, MOL GENET METAB, V93, P15, DOI 10.1016/j.ymgme.2007.08.118	72	53	63	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20664	20674		10.1074/jbc.M109.055608	http://dx.doi.org/10.1074/jbc.M109.055608			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20427278	hybrid, Green Published			2022-12-25	WOS:000279228600030
J	Gomez-Mejiba, SE; Zhai, Z; Gimenez, MS; Ashby, MT; Chilakapati, J; Kitchin, K; Mason, RP; Ramirez, DC				Gomez-Mejiba, Sandra E.; Zhai, Zili; Gimenez, Maria S.; Ashby, Michael T.; Chilakapati, Jaya; Kitchin, Kirk; Mason, Ronald P.; Ramirez, Dario C.			Myeloperoxidase-induced Genomic DNA-centered Radicals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSOLUTE RATE CONSTANTS; HYPOCHLOROUS ACID; HUMAN-NEUTROPHILS; REACTIVE OXYGEN; RESPIRATORY BURST; RESVERATROL; DAMAGE; CARCINOGENESIS; INFLAMMATION; PROTEIN	Myeloperoxidase (MPO) released by activated neutrophils can initiate and promote carcinogenesis. MPO produces hypochlorous acid (HOCl) that oxidizes the genomic DNA in inflammatory cells as well as in surrounding epithelial cells. DNA-centered radicals are early intermediates formed during DNA oxidation. Once formed, DNA-centered radicals decay by mechanisms that are not completely understood, producing a number of oxidation products that are studied as markers of DNA oxidation. In this study we employed the 5,5-dimethyl-1-pyrroline N-oxide-based immuno-spin trapping technique to investigate the MPO-triggered formation of DNA-centered radicals in inflammatory and epithelial cells and to test whether resveratrol blocks HOCl-induced DNA-centered radical formation in these cells. We found that HOCl added exogenously or generated intracellularly by MPO that has been taken up by the cell or by MPO newly synthesized produces DNA-centered radicals inside cells. We also found that resveratrol passed across cell membranes and scavenged HOCl before it reacted with the genomic DNA, thus blocking DNA-centered radical formation. Taken together our results indicate that the formation of DNA-centered radicals by intracellular MPO may be a useful point of therapeutic intervention in inflammation-induced carcinogenesis.	[Gomez-Mejiba, Sandra E.; Zhai, Zili; Ramirez, Dario C.] Oklahoma Med Res Fdn, Expt Therapeut Res Program, Oklahoma City, OK 73104 USA; [Gimenez, Maria S.] Univ Nacl San Luis, Inst Multidisciplinario Invest Biol, Consejo Nacl Invest Cient & Tecn, RA-5700 San Luis, Argentina; [Ashby, Michael T.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Mason, Ronald P.] NIEHS, Pharmacol Lab, NIH, Res Triangle Pk, NC 27709 USA	Oklahoma Medical Research Foundation; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Luis; University of Oklahoma System; University of Oklahoma - Norman; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Gomez-Mejiba, SE (corresponding author), Oklahoma Med Res Fdn, Expt Therapeut Res Program, Oklahoma City, OK 73104 USA.	sandra-gomez-mejiba@omrf.org; dario-ramirez@omrf.org	Mason, Ronald P/G-5967-2019; RAMIREZ, DARIO C/K-3312-2013	Mason, Ronald P/0000-0002-1859-9109; RAMIREZ, DARIO C/0000-0001-6725-3326; GOMEZ MEJIBA, SANDRA/0000-0002-8515-0483; Gimenez, Maria Sofia/0000-0003-1312-0661; Zhai, Zili/0000-0001-5164-3696	National Institutes of Health [5R00ES015415-03]; Presbyterian Health Foundation; Oklahoma Medical Research Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES015415, ZIAES050139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Presbyterian Health Foundation; Oklahoma Medical Research Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R00ES015415-03 (NIEHS). This work was also supported by a start-up grant from the Presbyterian Health Foundation and Oklahoma Medical Research Foundation (to D.C.R.).	Athar M, 2007, TOXICOL APPL PHARM, V224, P274, DOI 10.1016/j.taap.2006.12.025; BABIOR BM, 1988, HEMATOL ONCOL CLIN N, V2, P201, DOI 10.1016/S0889-8588(18)30615-4; BERNOFSKY C, 1990, FREE RADICAL BIO MED, V8, P231, DOI 10.1016/0891-5849(90)90068-T; BILZER M, 1991, EUR J CLIN INVEST, V21, P316, DOI 10.1111/j.1365-2362.1991.tb01376.x; Birrell MA, 2005, FASEB J, V19, P840, DOI 10.1096/fj.04-2691fje; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; CERUTTI PA, 1991, CANCER CELL-MON REV, V3, P1; Cheson Bruce D, 2009, Clin Adv Hematol Oncol, V7, P142; Dunforb HB, 1999, HEME PEROXIDASES, P349; FOLKES LK, 1995, ARCH BIOCHEM BIOPHYS, V323, P120, DOI 10.1006/abbi.1995.0017; Gomez-Mejiba SE, 2009, FREE RADICAL BIO MED, V46, P853, DOI 10.1016/j.freeradbiomed.2008.12.020; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Gungor N, 2010, MUTAGENESIS, V25, P149, DOI 10.1093/mutage/gep053; Hawkins CL, 2002, CHEM RES TOXICOL, V15, P83, DOI 10.1021/tx015548d; HENSLEY KL, 1999, Patent No. 1999059561; JANZEN EG, 1984, METHOD ENZYMOL, V105, P188; KLEBANOFF SJ, 1970, SCIENCE, V169, P1095, DOI 10.1126/science.169.3950.1095; Knaapen AM, 2006, MUTAGENESIS, V21, P225, DOI 10.1093/mutage/gel032; Knaapen AM, 1999, FREE RADICAL BIO MED, V27, P234, DOI 10.1016/S0891-5849(98)00285-8; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Leonard SS, 2003, BIOCHEM BIOPH RES CO, V309, P1017, DOI 10.1016/j.bbrc.2003.08.105; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Mason RP, 2004, FREE RADICAL BIO MED, V36, P1214, DOI 10.1016/j.freeradbiomed.2004.02.077; MURAO S, 1988, P NATL ACAD SCI USA, V85, P1232, DOI 10.1073/pnas.85.4.1232; Nagy P, 2007, CHEM RES TOXICOL, V20, P79, DOI 10.1021/tx060184g; Nauseef William M., 2007, V412, P15, DOI 10.1007/978-1-59745-467-4_2; NAUSEEF WM, 1983, BLOOD, V61, P483; Ohshima H, 2003, ARCH BIOCHEM BIOPHYS, V417, P3, DOI 10.1016/S0003-9861(03)00283-2; Park DW, 2009, EXP MOL MED, V41, P171, DOI 10.3858/emm.2009.41.3.020; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Pattison DI, 2002, J CHEM SOC PERK T 2, P1461, DOI 10.1039/b202526d; Prutz WA, 1996, ARCH BIOCHEM BIOPHYS, V332, P110, DOI 10.1006/abbi.1996.0322; Pullar JM, 2000, IUBMB LIFE, V50, P259, DOI 10.1080/15216540051080958; Ramirez DC, 2007, NAT PROTOC, V2, P512, DOI 10.1038/nprot.2007.5; Ramirez DC, 2006, NAT METHODS, V3, P123, DOI 10.1038/NMETH852; Sengottuvelan M, 2009, CHEM-BIOL INTERACT, V181, P193, DOI 10.1016/j.cbi.2009.06.004; Shen ZZ, 2000, BIOCHEMISTRY-US, V39, P5474, DOI 10.1021/bi992809y; Szewczuk LM, 2004, J BIOL CHEM, V279, P22727, DOI 10.1074/jbc.M314302200; WASHKO P, 1989, J BIOL CHEM, V264, P18996; WEITZMAN SA, 1981, SCIENCE, V212, P546, DOI 10.1126/science.6259738; WEITZMAN SA, 1985, SCIENCE, V227, P1231, DOI 10.1126/science.3975611; WEITZMAN SA, 1990, BLOOD, V76, P655; Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85	46	67	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20062	20071		10.1074/jbc.M109.086579	http://dx.doi.org/10.1074/jbc.M109.086579			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20406811	Green Published, hybrid			2022-12-25	WOS:000279012000040
J	Miki, H; Zhou, Z; Li, M; Hwang, TC; Bompadre, SG				Miki, Haruna; Zhou, Zhen; Li, Min; Hwang, Tzyh-Chang; Bompadre, Silvia G.			Potentiation of Disease-associated Cystic Fibrosis Transmembrane Conductance Regulator Mutants by Hydrolyzable ATP Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; CFTR CHLORIDE CHANNEL; DELTA-F508 MUTATION; AIRWAY EPITHELIA; PLASMA-MEMBRANE; CASSETTE DIMER; WILD-TYPE; PROTEIN; PHOSPHORYLATION; HYDROLYSIS	The cystic fibrosis transmembrane conductance regulator (CFTR) is a chloride channel belonging to the ATP-binding cassette transporter superfamily. CFTR is gated by ATP binding and hydrolysis at its two nucleotide-binding domains (NBDs), which dimerize in the presence of ATP to form two ATP-binding pockets (ABP1 and ABP2). Mutations reducing the activity of CFTR result in the genetic disease cystic fibrosis. Two of the most common mutations causing a severe phenotype are G551D and Delta F508. Previously we found that the ATP analog N-6-(2-phenylethyl)-ATP (P-ATP) potentiates the activity of G551D by similar to 7-fold. Here we show that 2'-deoxy-ATP (dATP), but not 3'-deoxy-ATP, increases the activity of G551D-CFTR by similar to 8-fold. We custom synthesized N-6-(2-phenylethyl)-2'-deoxy-ATP (P-dATP), an analog combining the chemical modifications in dATP and P-ATP. This new analog enhances G551D current by 36.2 +/- 5.4-fold suggesting an independent but energetically additive action of these two different chemical modifications. We show that P-dATP binds to ABP1 to potentiate the activity of G551D, and mutations in both sides of ABP1 (W401G and S1347G) decrease its potentiation effect, suggesting that the action of P-dATP takes place at the interface of both NBDs. Interestingly, P-dATP completely rectified the gating abnormality of Delta F508-CFTR by increasing its activity by 19.5 +/- 3.8-fold through binding to both ABPs. This result highlights the severity of the gating defect associated with Delta F508, the most prevalent disease-associated mutation. The new analog P-dATP can be not only an invaluable tool to study CFTR gating, but it can also serve as a proof-of-principle that, by combining elements that potentiate the channel activity independently, the increase in chloride transport necessary to reach a therapeutic target is attainable.	[Miki, Haruna; Zhou, Zhen; Li, Min; Hwang, Tzyh-Chang; Bompadre, Silvia G.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Hwang, Tzyh-Chang] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA; [Miki, Haruna] Osaka Univ Pharmaceut Sci, Osaka 5691094, Japan	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Osaka University of Pharmaceutical Sciences	Bompadre, SG (corresponding author), Univ Missouri, Dalton Cardiovasc Res Ctr, 134 Res Pk Dr, Columbia, MO 65211 USA.	bompadres@missouri.edu			National Institutes of Health [R01DK55835, R01HL53455, K01DK075408]; Cystic Fibrosis Foundation [BOMPAD06G0]; National Center for Research Resources, NIH [C06 RR-016489-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055835, K01DK075408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK55835, R01HL53455 (to T.-C.H.), and K01DK075408 (to S.G.B.). This work was also supported by the Cystic Fibrosis Foundation (Research Grant BOMPAD06G0 to S.G.B.). This investigation was conducted in a facility constructed with support from the Research Facilities Improvement Program (Grant C06 RR-016489-01) from the National Center for Research Resources, NIH.	Aleksandrov AA, 2002, FEBS LETT, V518, P183, DOI 10.1016/S0014-5793(02)02698-4; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Amaral MD, 2007, TRENDS PHARMACOL SCI, V28, P334, DOI 10.1016/j.tips.2007.05.004; Bompadre SG, 2005, J GEN PHYSIOL, V125, P377, DOI 10.1085/jgp.200409228; Bompadre SG, 2008, J BIOL CHEM, V283, P5364, DOI 10.1074/jbc.M709417200; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; CHANG XB, 1993, J BIOL CHEM, V268, P11304; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; CHENG SH, 1990, CELL, V65; Csanady L, 2000, BIOPHYS J, V78, P785, DOI 10.1016/S0006-3495(00)76636-7; Csanady L, 2006, J GEN PHYSIOL, V128, P523, DOI 10.1085/jgp.200609558; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DENNING GM, 1992, J CELL BIOL, V118, P551, DOI 10.1083/jcb.118.3.551; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; GRAY MA, 1988, J MEMBRANE BIOL, V105, P131, DOI 10.1007/BF02009166; Haws CM, 1996, AM J PHYSIOL-CELL PH, V270, pC1544, DOI 10.1152/ajpcell.1996.270.5.C1544; Huang SY, 2009, J MOL GRAPH MODEL, V27, P822, DOI 10.1016/j.jmgm.2008.12.005; Hwang TC, 1997, AM J PHYSIOL-CELL PH, V273, pC988, DOI 10.1152/ajpcell.1997.273.3.C988; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; LI CH, 1993, NAT GENET, V3, P311, DOI 10.1038/ng0493-311; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powe AC, 2002, J PHYSIOL-LONDON, V539, P333, DOI 10.1113/jphysiol.2001.013162; QUINTON PM, 1986, AM J PHYSIOL, V251, pC649, DOI 10.1152/ajpcell.1986.251.4.C649; Ramjeesingh M, 2008, BIOCHEM J, V412, P315, DOI 10.1042/BJ20071719; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schultz BD, 1999, J MEMBRANE BIOL, V170, P51, DOI 10.1007/s002329900537; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tsai MF, 2010, J GEN PHYSIOL, V135, P399, DOI 10.1085/jgp.201010399; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WELSH MJ, 1986, NATURE, V322, P467, DOI 10.1038/322467a0; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhou Z, 2005, J PHYSIOL-LONDON, V569, P447, DOI 10.1113/jphysiol.2005.095083; Zhou Z, 2001, J PHYSIOL-LONDON, V532, P435, DOI 10.1111/j.1469-7793.2001.0435f.x; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622	48	47	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19967	19975		10.1074/jbc.M109.092684	http://dx.doi.org/10.1074/jbc.M109.092684			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20406820	Green Published, hybrid			2022-12-25	WOS:000279012000030
J	Ozawa, S; Onishi, T; Takahashi, Y				Ozawa, Shin-ichiro; Onishi, Takahito; Takahashi, Yuichiro			Identification and Characterization of an Assembly Intermediate Subcomplex of Photosystem I in the Green Alga Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; THYLAKOID MEMBRANE; ANGSTROM RESOLUTION; STATE TRANSITIONS; PROCESSING SITE; SUBUNIT-G; WILD-TYPE; PSI; CHLOROPLAST; PROTEIN	Photosystem I (PSI) is a multiprotein complex consisting of the PSI core and peripheral light-harvesting complex I (LHCI) that together form the PSI-LHCI supercomplex in algae and higher plants. The supercomplex is synthesized in steps during which 12-15 core and 4-9 LHCI subunits are assembled. Here we report the isolation of a PSI subcomplex that separated on a sucrose density gradient from the thylakoid membranes isolated from logarithmic growth phase cells of the green alga Chlamydomonas reinhardtii. Pulse-chase labeling of total cellular proteins revealed that the subcomplex was synthesized de novo within 1 min and was converted to the mature PSI-LHCI during the 2-h chase period, indicating that the subcomplex was an assembly intermediate. The subcomplex was functional; it photo-oxidized P700 and demonstrated electron transfer activity. The subcomplex lacked PsaK and PsaG, however, and it bound PsaF and PsaJ weakly and was not associated with LHCI. It seemed likely that LHCI had been integrated into the subcomplex unstably and was dissociated during solubilization and/or fractionation. We, thus, infer that PsaK and PsaG stabilize the association between PSI core and LHCI complexes and that PsaK and PsaG bind to the PSI core complex after the integration of LHCI in one of the last steps of PSI complex assembly.	[Ozawa, Shin-ichiro; Onishi, Takahito; Takahashi, Yuichiro] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan	Okayama University	Takahashi, Y (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, 3-1-1 Kita Ku, Okayama 7008530, Japan.	taka@cc.okayama-u.ac.jp	Ozawa, Shin-Ichiro/O-7408-2015; Takahashi, Yuichiro/B-2062-2011	Ozawa, Shin-Ichiro/0000-0001-7698-5350; Takahashi, Yuichiro/0000-0001-6410-0447	Japan Society for the Promotion of Science [18GSO318]; Japan Society for the Promotion of Science Research Fellowships [17003605]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science Research Fellowships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Japan Society for the Promotion of Science Grant-in-aid for General Research for Creative Scientific Research 18GSO318 (to Y.T.) and Japan Society for the Promotion of Science Research Fellowships for Young Scientists Grant 17003605 (to S.O.).	Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Boudreau E, 1997, EMBO J, V16, P6095, DOI 10.1093/emboj/16.20.6095; CHUA NH, 1975, P NATL ACAD SCI USA, V72, P2175, DOI 10.1073/pnas.72.6.2175; During U, 2007, J BIOL CHEM, V282, P10915, DOI 10.1074/jbc.M609206200; FARAH J, 1995, EMBO J, V14, P4976, DOI 10.1002/j.1460-2075.1995.tb00180.x; Fischer N, 1999, BIOCHEMISTRY-US, V38, P5546, DOI 10.1021/bi982821a; Germano M, 2002, FEBS LETT, V525, P121, DOI 10.1016/S0014-5793(02)03100-9; GIRARDBASCOU J, 1987, CURR GENET, V12, P489, DOI 10.1007/BF00419557; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Haldrup A, 2000, J BIOL CHEM, V275, P31211, DOI 10.1074/jbc.M002933200; Hansson A, 2007, FEBS J, V274, P1734, DOI 10.1111/j.1742-4658.2007.05722.x; Hippler M, 2002, PROTIST, V153, P197, DOI 10.1078/1434-4610-00098; Hippler M, 1996, EMBO J, V15, P6374, DOI 10.1002/j.1460-2075.1996.tb01028.x; Jensen PE, 2000, J BIOL CHEM, V275, P24701, DOI 10.1074/jbc.M000550200; Jensen PE, 2004, J BIOL CHEM, V279, P24212, DOI 10.1074/jbc.M403147200; Jensen PE, 2002, J BIOL CHEM, V277, P2798, DOI 10.1074/jbc.M110448200; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kargul J, 2003, J BIOL CHEM, V278, P16135, DOI 10.1074/jbc.M300262200; MANNAN RM, 1994, ARCH BIOCHEM BIOPHYS, V315, P68, DOI 10.1006/abbi.1994.1472; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Naver H, 2001, PLANT CELL, V13, P2731, DOI 10.1105/tpc.010253; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; NIELSEN VS, 1994, J BIOL CHEM, V269, P3762; Ohnishi N, 2001, J BIOL CHEM, V276, P33798, DOI 10.1074/jbc.M104454200; Onishi T, 2009, PLANT CELL PHYSIOL, V50, P1750, DOI 10.1093/pcp/pcp117; Ozawa S, 2009, PLANT CELL, V21, P2424, DOI 10.1105/tpc.108.063313; Rosgaard L, 2005, FEBS J, V272, P4002, DOI 10.1111/j.1742-4658.2005.04824.x; Schoettler Mark Aurel, 2008, V69, P89, DOI 10.1007/978-3-540-72954-9_4; Stauber EJ, 2003, EUKARYOT CELL, V2, P978, DOI 10.1128/EC.2.5.978-994.2003; Stockel J, 2006, PLANT PHYSIOL, V141, P870, DOI 10.1104/pp.106.078147; Sugimoto I, 2003, J BIOL CHEM, V278, P45004, DOI 10.1074/jbc.M307537200; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; TAKAHASHI Y, 1982, ARCH BIOCHEM BIOPHYS, V219, P209, DOI 10.1016/0003-9861(82)90151-5; TAKAHASHI Y, 1991, EMBO J, V10, P2033, DOI 10.1002/j.1460-2075.1991.tb07733.x; Takahashi Y, 2004, BIOCHEMISTRY-US, V43, P7816, DOI 10.1021/bi035988z; Takahashi Y, 1996, PLANT CELL PHYSIOL, V37, P161, DOI 10.1093/oxfordjournals.pcp.a028927; Tokutsu R, 2004, PLANT CELL PHYSIOL, V45, P138, DOI 10.1093/pcp/pch013; Varotto C, 2002, PLANT PHYSIOL, V129, P616, DOI 10.1104/pp.002089; Wilde A, 2001, BIOCHEM J, V357, P211, DOI 10.1042/0264-6021:3570211; WILDE A, 1995, PLANT CELL, V7, P649, DOI 10.1105/tpc.7.5.649; Wollman FA, 1999, BBA-BIOENERGETICS, V1411, P21, DOI 10.1016/S0005-2728(99)00043-2; Wostrikoff K, 2004, EMBO J, V23, P2696, DOI 10.1038/sj.emboj.7600266; YU JP, 1995, PLANT MOL BIOL, V29, P331, DOI 10.1007/BF00043656	45	50	53	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20072	20079		10.1074/jbc.M109.098954	http://dx.doi.org/10.1074/jbc.M109.098954			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20413595	Green Published, hybrid			2022-12-25	WOS:000279012000041
J	Willoughby, D; Masada, N; Wachten, S; Pagano, M; Halls, ML; Everett, KL; Ciruela, A; Cooper, DMF				Willoughby, Debbie; Masada, Nanako; Wachten, Sebastian; Pagano, Mario; Halls, Michelle L.; Everett, Katy L.; Ciruela, Antonio; Cooper, Dermot M. F.			AKAP79/150 Interacts with AC8 and Regulates Ca2+-dependent cAMP Synthesis in Pancreatic and Neuronal Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CAPACITATIVE CA2+ ENTRY; NMDA RECEPTOR ACTIVATION; TYPE-8 ADENYLYL-CYCLASE; ENERGY-TRANSFER FRET; ANCHORING PROTEIN; BINDING-PROTEIN; MOUSE-BRAIN; CYCLIC-AMP; CELLS	Protein kinase A anchoring proteins (AKAPs) provide the backbone for targeted multimolecular signaling complexes that serve to localize the activities of cAMP. Evidence is accumulating of direct associations between AKAPs and specific adenylyl cyclase (AC) isoforms to facilitate the actions of protein kinase A on cAMP production. It happens that some of the AC isoforms (AC1 and AC5/6) that bind specific AKAPs are regulated by submicromolar shifts in intracellular Ca2+. However, whether AKAPs play a role in the control of AC activity by Ca2+ is unknown. Using a combination of co-immunoprecipitation and high resolution live cell imaging techniques, we reveal an association of the Ca2+-stimulable AC8 with AKAP79/150 that limits the sensitivity of AC8 to intracellular Ca2+ events. This functional interaction between AKAP79/150 and AC8 was observed in HEK293 cells overexpressing the two signaling molecules. Similar findings were made in pancreatic insulin-secreting cells and cultured hippocampal neurons that endogenously express AKAP79/150 and AC8, which suggests important physiological implications for this protein-protein interaction with respect to Ca2+-stimulated cAMP production.	[Willoughby, Debbie; Masada, Nanako; Wachten, Sebastian; Pagano, Mario; Halls, Michelle L.; Everett, Katy L.; Ciruela, Antonio; Cooper, Dermot M. F.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Cooper, DMF (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	dmfc2@cam.ac.uk		Halls, Michelle/0000-0001-8555-8959	Wellcome Trust [RG31760]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grant RG31760.; A Royal Society Wolfson Research Fellow.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Belfield JL, 2006, J BIOL CHEM, V281, P27724, DOI 10.1074/jbc.M601485200; BREGMAN DB, 1989, J BIOL CHEM, V264, P4648; CARR DW, 1992, J BIOL CHEM, V267, P16816; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Conti AC, 2007, NEUROSCIENCE, V146, P713, DOI 10.1016/j.neuroscience.2007.01.045; Crossthwaite AJ, 2006, MOL PHARMACOL, V69, P608, DOI 10.1124/mol.105.018275; Di Biase V, 2008, J NEUROSCI, V28, P13845, DOI 10.1523/JNEUROSCI.3213-08.2008; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Fagan KA, 1998, J BIOL CHEM, V273, P9297, DOI 10.1074/jbc.273.15.9297; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Ferguson GD, 2004, PHYSIOLOGY, V19, P271, DOI 10.1152/physiol.00010.2004; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Genin A, 2003, EUR J NEUROSCI, V17, P331, DOI 10.1046/j.1460-9568.2003.02462.x; Gomez LL, 2002, J NEUROSCI, V22, P7027; Gu C, 2002, EUR J BIOCHEM, V269, P413, DOI 10.1046/j.0014-2956.2001.02708.x; Gu C, 1999, J BIOL CHEM, V274, P8012, DOI 10.1074/jbc.274.12.8012; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Martin ACL, 2009, MOL PHARMACOL, V75, P830, DOI 10.1124/mol.108.051748; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Nakahashi Y, 1997, J BIOL CHEM, V272, P18093, DOI 10.1074/jbc.272.29.18093; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Ostroveanu A, 2007, BRAIN RES, V1145, P97, DOI 10.1016/j.brainres.2007.01.117; Pagano M, 2009, AM J PHYSIOL-CELL PH, V296, pC607, DOI 10.1152/ajpcell.00488.2008; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Piggott LA, 2008, P NATL ACAD SCI USA, V105, P13835, DOI 10.1073/pnas.0712100105; Simpson RE, 2006, J BIOL CHEM, V281, P17379, DOI 10.1074/jbc.M510992200; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Tu HP, 2004, J BIOL CHEM, V279, P19375, DOI 10.1074/jbc.M313476200; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Wang HB, 2003, J NEUROSCI, V23, P9710; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Willoughby D, 2006, J CELL SCI, V119, P828, DOI 10.1242/jcs.02812; Willoughby D, 2002, J PHYSIOL-LONDON, V544, P487, DOI 10.1113/jphysiol.2002.027508; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Willoughby D, 2010, J CELL SCI, V123, P107, DOI 10.1242/jcs.062067; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Zhang M, 2008, J NEUROSCI, V28, P4736, DOI 10.1523/JNEUROSCI.1177-08.2008	49	64	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20328	20342		10.1074/jbc.M110.120725	http://dx.doi.org/10.1074/jbc.M110.120725			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20410303	Green Published, hybrid			2022-12-25	WOS:000279012000067
J	Chernov, AV; Baranovskaya, S; Golubkov, VS; Wakeman, DR; Snyder, EY; Williams, R; Strongin, AY				Chernov, Andrei V.; Baranovskaya, Svetlana; Golubkov, Vladislav S.; Wakeman, Dustin R.; Snyder, Evan Y.; Williams, Roy; Strongin, Alex Y.			Microarray-based Transcriptional and Epigenetic Profiling of Matrix Metalloproteinases, Collagens, and Related Genes in Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3; LYSINE-9 METHYLATION; TISSUE INHIBITOR; CELL-MIGRATION; GROWTH-FACTOR; GLIOMA; EXPRESSION; SUPPRESSION; RECOGNITION; ACTIVATION	Epigenetic parameters (DNA methylation, histone modifications, and miRNAs) play a significant role in cancer. To identify the common epigenetic signatures of both the individual matrix metalloproteinases (MMPs) and the additional genes, the function of which is also linked to proteolysis, migration, and tumorigenesis, we performed epigenetic profiling of 486 selected genes in unrelated non-migratory MCF-7 breast carcinoma and highly migratory U251 glioma cells. Genome-wide transcriptional profiling, quantitative reverse transcription-PCR, and microRNA analyses were used to support the results of our epigenetic studies. Transcriptional silencing in both glioma and breast carcinoma cells predominantly involved the repressive histone H3 Lys-27 trimethylation (H3K27me3) mark. In turn, epigenetic stimulation was primarily performed through a gain in the histone H3 Lys-4 dimethylation (H3K4me2) and H3 hyperacetylation and by a global reduction of H3K27me3. Inactive pro-invasive genes in MCF-7 cells but not in U251 cells frequently exhibited a stem cell-like bivalent mark (enrichment in both H3K27me3 and H3K4me2), a characteristic of developmental genes. In contrast with other MMPs, MMP-8 was epigenetically silenced in both cell types, thus providing evidence for the strict epigenetic control of this anti-tumorigenic proteinase in cancer. Epigenetic stimulation of multiple collagen genes observed in cultured glioma cells was then directly confirmed using orthotopic xenografts and tumor specimens. We suggest that the epigenetic mechanisms allow gliomas to deposit an invasion-promoting collagen-enriched matrix and then to use this matrix to accomplish their rapid migration through the brain tissue.	[Chernov, Andrei V.; Golubkov, Vladislav S.; Wakeman, Dustin R.; Snyder, Evan Y.; Williams, Roy; Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Baranovskaya, Svetlana] Agilent Technol, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Agilent Technologies	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, N Torrey Pines Rd, La Jolla, CA 92037 USA.	strongin@burnham.org	Chernov, Andrei/I-1623-2019; Strongin, Alex/R-6609-2019; Golubkov, Vladislav/L-6828-2017	Chernov, Andrei/0000-0002-3294-5418; Strongin, Alex/0000-0003-3765-3016; Williams, Roy/0000-0002-5442-9166	NATIONAL CANCER INSTITUTE [R01CA077470, R01CA083017] Funding Source: NIH RePORTER; NCI NIH HHS [CA77470, R01 CA077470, R01 CA083017, CA83017] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Chen Y, 2008, CANCER LETT, V272, P197, DOI 10.1016/j.canlet.2008.06.034; Chernov AV, 2009, J BIOL CHEM, V284, P12727, DOI 10.1074/jbc.M900273200; Chicoine E, 2002, BIOCHEM BIOPH RES CO, V297, P765, DOI 10.1016/S0006-291X(02)02283-0; Clark IM, 2007, FRONT BIOSCI, V12, P528, DOI 10.2741/2079; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Deryugina EI, 2002, CANCER RES, V62, P580; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gutierrez-Fernandez A, 2008, CANCER RES, V68, P2755, DOI 10.1158/0008-5472.CAN-07-5154; Hau P, 2009, EXPERT REV ANTICANC, V9, P1663, DOI [10.1586/era.09.138, 10.1586/ERA.09.138]; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kassiri Z, 2009, J BIOL CHEM, V284, P29893, DOI 10.1074/jbc.M109.028449; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LEVY A, 1992, GENOMICS, V13, P881, DOI 10.1016/0888-7543(92)90175-R; Lingel A, 2005, CURR OPIN STRUC BIOL, V15, P107, DOI 10.1016/j.sbi.2005.01.010; Messaritou G, 2009, J CELL SCI, V122, P4042, DOI 10.1242/jcs.044305; Nacu N, 2008, J IMMUNOL, V180, P5036, DOI 10.4049/jimmunol.180.7.5036; Nagase H, 1997, BIOL CHEM, V378, P151; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Novakova J, 2009, BIOCHEM BIOPH RES CO, V386, P1, DOI 10.1016/j.bbrc.2009.06.034; Okano K, 2006, J BIOL CHEM, V281, P26196, DOI 10.1074/jbc.M606710200; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Poncelet AC, 2001, J BIOL CHEM, V276, P6983, DOI 10.1074/jbc.M006442200; Pulukuri SM, 2007, ONCOGENE, V26, P5229, DOI 10.1038/sj.onc.1210329; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Roach HI, 2005, ARTHRITIS RHEUM-US, V52, P3110, DOI 10.1002/art.21300; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Rozen S, 2000, Methods Mol Biol, V132, P365; Shelton L, 2009, INVEST OPHTH VIS SCI, V50, P3542, DOI 10.1167/iovs.09-3460; Shi L, 2010, BRAIN RES, V1312, P120, DOI 10.1016/j.brainres.2009.11.056; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Sun T, 2006, CLIN CANCER RES, V12, P7009, DOI 10.1158/1078-0432.CCR-06-0464; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Turner BM, 2005, NAT STRUCT MOL BIOL, V12, P110, DOI 10.1038/nsmb0205-110; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Watson JA, 2009, HUM MOL GENET, V18, P3594, DOI 10.1093/hmg/ddp307; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; Zhang CZ, 2009, INT J ONCOL, V34, P1653, DOI 10.3892/ijo_00000296; Zhang JX, 2010, INT J ONCOL, V36, P913, DOI 10.3892/ijo_00000570; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126	61	41	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19647	19659		10.1074/jbc.M109.088153	http://dx.doi.org/10.1074/jbc.M109.088153			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404328	hybrid, Green Published			2022-12-25	WOS:000278727800074
J	Dick, O; Bading, H				Dick, Oliver; Bading, Hilmar			Synaptic Activity and Nuclear Calcium Signaling Protect Hippocampal Neurons from Death Signal-associated Nuclear Translocation of FoxO3a Induced by Extrasynaptic N-Methyl-D-aspartate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; ACTIVITY-DEPENDENT NEUROPROTECTION; DUAL-SPECIFICITY PHOSPHATASES; GENE-EXPRESSION; KINASE-IV; OXIDATIVE STRESS; RESPONSE ELEMENT; CELL-SURVIVAL; ACTIVATION; PATHWAY	Synaptic activity and the generation of nuclear calcium signals promote neuronal survival through a transcription-dependent process that is not fully understood. Here we show that one mechanism of activity-induced acquired neuroprotection involves the Forkhead transcription factor, FoxO3a, which is known to induce genomic death responses upon translocation from the cytosol to the nucleus. Depletion of endogenous FoxO3a using RNA interference renders hippocampal neurons more resistant to excitotoxic cell death. Using a FoxO3a-green fluorescent protein (GFP) fusion protein to monitor in real time the localization of FoxO3a in hippocampal neurons, we found that several cell death inducing stimuli, including the stimulation of extrasynaptic N-methyl-D-aspartate receptors, growth factor withdrawal, and oxygen-glucose deprivation, caused a swift translocation of FoxO3a-GFP from the cytosol to the cell nucleus. This translocation was inhibited in hippocampal neurons that had undergone prolonged periods of synaptic activity before exposure to cell death-inducing conditions. The activity-dependent protection from death signal-induced FoxO3a-GFP nuclear translocation required synaptic N-methyl-D-aspartate receptor activation and was dependent on nuclear calcium signaling and calcium/calmodulin-dependent protein kinase IV. The modulation of nucleo-cytoplasmic shuttling of FoxO3a may represent one mechanism through which nuclear calcium-induced genomic responses affect cell death processes.	[Dick, Oliver; Bading, Hilmar] Univ Heidelberg, Dept Neurobiol, Interdisciplinary Ctr Neurosci IZN, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Bading, H (corresponding author), Univ Heidelberg, Dept Neurobiol, Interdisciplinary Ctr Neurosci, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.	hilmar.bading@uni-hd.de			Alexander von Humboldt Foundation; European Union; Sonderforschungsbereich (SFB) 488; European Research Council	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Union(European Commission); Sonderforschungsbereich (SFB) 488(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Alexander von Humboldt Foundation (Wolfgang-Paul Prize (to H. B.), European Union Project GRIPANNT, the European Union Network of Excellence NeuroNE, the Sonderforschungsbereich (SFB) 488, and an European Research Council Advanced Grant (to H. B.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Al-Mubarak B, 2009, CHANNELS, V3, P233; Anderson KA, 1997, MOL ENDOCRINOL, V11, P725, DOI 10.1210/me.11.6.725; Arden KC, 2004, MOL CELL, V14, P416, DOI 10.1016/S1097-2765(04)00213-8; Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; BADING H, 1995, NEUROSCIENCE, V64, P653, DOI 10.1016/0306-4522(94)00462-E; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Barthelemy C, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-48; Bengtson CP, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-11; Bertoli C, 2009, ONCOGENE, V28, P721, DOI 10.1038/onc.2008.425; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chong ZZ, 2007, BRIT J PHARMACOL, V150, P839, DOI 10.1038/sj.bjp.0707161; Chow FA, 2005, J BIOL CHEM, V280, P20530, DOI 10.1074/jbc.M500067200; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Davila D, 2008, MOL BIOL CELL, V19, P2014, DOI 10.1091/mbc.E07-08-0811; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Durham SK, 1999, ENDOCRINOLOGY, V140, P3140, DOI 10.1210/en.140.7.3140; Eder A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-57; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Hu YY, 2005, MOL BIOL CELL, V16, P3705, DOI 10.1091/mbc.E05-04-0301; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Lau D, 2009, J NEUROSCI, V29, P4420, DOI 10.1523/JNEUROSCI.0802-09.2009; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Mattila J, 2008, P NATL ACAD SCI USA, V105, P14873, DOI 10.1073/pnas.0803022105; Means AR, 1997, RECENT PROG HORM RES, V52, P389; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Morris BJ, 2005, J HYPERTENS, V23, P1285, DOI 10.1097/01.hjh.0000173509.45363.dd; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Rebhun JF, 2000, J BIOL CHEM, V275, P13406, DOI 10.1074/jbc.C000085200; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; Won CK, 2006, NEUROSCI LETT, V398, P39, DOI 10.1016/j.neulet.2005.12.060; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604	60	65	67	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19354	19361		10.1074/jbc.M110.127654	http://dx.doi.org/10.1074/jbc.M110.127654			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404335	Green Published, hybrid			2022-12-25	WOS:000278727800046
J	Hirota, S; Tanaka, N; Micetic, I; Di Muro, P; Nagao, S; Kitagishi, H; Kano, K; Magliozzo, RS; Peisach, J; Beltramini, M; Bubacco, L				Hirota, Shun; Tanaka, Naoki; Micetic, Ivan; Di Muro, Paolo; Nagao, Satoshi; Kitagishi, Hiroaki; Kano, Koji; Magliozzo, Richard S.; Peisach, Jack; Beltramini, Mariano; Bubacco, Luigi			Structural Basis of the Lactate-dependent Allosteric Regulation of Oxygen Binding in Arthropod Hemocyanin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALLINECTES-SAPIDUS HEMOCYANIN; CARCINUS-MAENAS HEMOCYANIN; CRYSTAL-STRUCTURE; RESOLUTION; MECHANISM; SCATTERING; TRANSPORT; PROTONS; O-2	Hemocyanin (Hc) is an oxygen carrier protein in which oxygen binding is regulated by allosteric effectors such as H+ and L-lactate. Isothermal titration calorimetric measurements showed that L-lactate binds to dodecameric and heterohexameric Hc and to the CaeSS3 homohexamer but not to the CaeSS2 monomer. The binding of lactate caused no change in the optical absorption and x-ray absorption spectra of either oxy- or deoxy-Hc, suggesting that no structural rearrangement of the active site occurred. At pH 6.5, the oxygen binding rate constant kappa(obs) obtained by flash photolysis showed a significant increase upon addition of L-lactate, whereas L-lactate addition had little effect at pH 8.3. Lactate binding caused a concentration-dependent shift in the interhexameric distances at pH 6.5 based on small angle x-ray scattering measurements. These results show that L-lactate affects oxygen affinity at pH 6.5 by modulating the global structure of Hc without affecting its binuclear copper center (the active site). In contrast to this, the active site structure of deoxy-Hc is affected by changes in pH (Hirota, S., Kawahara, T., Beltramini, M., Di Muro, P., Magliozzo, R. S., Peisach, J., Powers, L. S., Tanaka, N., Nagao, S., and Bubacco, L. (2008) J. Biol. Chem. 283, 31941-31948). Upon addiction of lactate, the kinetic behavior of oxygen rebinding for Hc was heterogeneous under low oxygen concentrations at pH 6.5 due to changes in the T and R state populations, and the equilibrium was found to shift from the T toward the R state with addition of lactate.	Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan; [Micetic, Ivan; Di Muro, Paolo; Beltramini, Mariano; Bubacco, Luigi] Univ Padua, Dept Biol, I-35121 Padua, Italy; [Kitagishi, Hiroaki; Kano, Koji] Doshisha Univ, Fac Engn, Dept Mol Sci & Technol, Kyoto 6100321, Japan; [Magliozzo, Richard S.] CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA; [Peisach, Jack] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	Nara Institute of Science & Technology; University of Padua; Doshisha University; City University of New York (CUNY) System; Brooklyn College (CUNY); Yeshiva University; Albert Einstein College of Medicine		hirota@ms.naist.jp; luigi.bubacco@unipd.it	Mičetić, Ivan/A-7146-2015; Bubacco, Luigi/B-5602-2012; Di Muro, Paolo/F-5811-2013; Hirota, Shun/AAD-2651-2021	Mičetić, Ivan/0000-0003-1691-8425; Bubacco, Luigi/0000-0001-7927-9208; Hirota, Shun/0000-0003-3227-8376; Kitagishi, Hiroaki/0000-0003-4682-7217; Nagao, Satoshi/0000-0003-1674-7697	National Institutes of Health [GM40168]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science; Fondo per gli Investimenti della Ricerca di Base; Ministero universita e ricerca; University of Padova [CPDA051777]; Executive Program of Cooperation in the Fields of Science and Technology between the Government of Italy and the Government of Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040168, R37GM040168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Ministero universita e ricerca(Ministry of Education, Universities and Research (MIUR)); University of Padova; Executive Program of Cooperation in the Fields of Science and Technology between the Government of Italy and the Government of Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM40168 (to J.P.). This work was also supported by Grants-in-aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology, Japan and Japan Society for the Promotion of Science (to S.H.), Fondo per gli Investimenti della Ricerca di Base, Ministero universita e ricerca, and "Progetto di Ateneo" CPDA051777 from the University of Padova (to L.B.and M.B.) and by the Executive Program of Cooperation in the Fields of Science and Technology between the Government of Italy and the Government of Japan(to L.B.andS.H.).	Beltramini M, 2005, FEBS J, V272, P2060, DOI 10.1111/j.1742-4658.2005.04634.x; Bruneaux M, 2009, PROTEINS, V77, P589, DOI 10.1002/prot.22471; BUBACCO L, 1992, BIOCHEMISTRY-US, V31, P9294, DOI 10.1021/bi00153a024; Cong Y, 2009, STRUCTURE, V17, P749, DOI 10.1016/j.str.2009.03.005; Dainese E, 1998, EUR J BIOCHEM, V256, P350, DOI 10.1046/j.1432-1327.1998.2560350.x; DECKER H, 1990, J MOL BIOL, V211, P281, DOI 10.1016/0022-2836(90)90027-J; Dimitrov D, 2009, COMP GEOM-THEOR APPL, V42, P772, DOI 10.1016/j.comgeo.2008.02.007; Dissanayake A, 2008, MAR ENVIRON RES, V66, P445, DOI 10.1016/j.marenvres.2008.07.006; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Hartmann H, 2002, BBA-PROTEINS PROTEOM, V1601, P132, DOI 10.1016/S1570-9639(02)00459-4; Hartmann H, 2001, J BIOL CHEM, V276, P19954, DOI 10.1074/jbc.M010435200; HAZES B, 1993, PROTEIN SCI, V2, P597; Hirota S, 2005, J AM CHEM SOC, V127, P17966, DOI 10.1021/ja0541128; Hirota S, 2008, J BIOL CHEM, V283, P31941, DOI 10.1074/jbc.M803433200; JOHNSON BA, 1988, BIOCHEMISTRY-US, V27, P1995, DOI 10.1021/bi00406a028; JOHNSON BA, 1984, BIOCHEMISTRY-US, V23, P872, DOI 10.1021/bi00300a013; JOHNSON BA, 1987, BIOCHIM BIOPHYS ACTA, V916, P376, DOI 10.1016/0167-4838(87)90183-X; LALLIER F, 1989, RESP PHYSIOL, V77, P323, DOI 10.1016/0034-5687(89)90120-5; MAGNUS KA, 1994, PROTEINS, V19, P302, DOI 10.1002/prot.340190405; MANGUM CP, 1972, COMP BIOCHEM PHYSIOL, V42, P693, DOI 10.1016/0300-9629(72)90447-1; Markl J., 1992, Advances in Comparative and Environmental Physiology, V13, P325; Markl J, 2009, J MOL BIOL, V392, P362, DOI 10.1016/j.jmb.2009.06.082; Martin AG, 2007, J MOL BIOL, V366, P1332, DOI 10.1016/j.jmb.2006.11.075; Menze MA, 2000, BIOCHEMISTRY-US, V39, P10806, DOI 10.1021/bi000008l; Metz M, 2001, J AM CHEM SOC, V123, P4938, DOI 10.1021/ja004166b; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Truchot J.P., 1992, Advances in Comparative and Environmental Physiology, V13, P377; VOLBEDA A, 1989, J MOL BIOL, V209, P249, DOI 10.1016/0022-2836(89)90276-3; Weber RE, 2008, J EXP BIOL, V211, P1057, DOI 10.1242/jeb.013433	30	7	7	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19338	19345		10.1074/jbc.M109.076067	http://dx.doi.org/10.1074/jbc.M109.076067			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20406810	hybrid, Green Published			2022-12-25	WOS:000278727800044
J	Julian, E; Dave, RK; Robson, JP; Hallahan, AR; Wainwright, BJ				Julian, E.; Dave, R. K.; Robson, J. P.; Hallahan, A. R.; Wainwright, B. J.			Canonical Notch signaling is not required for the growth of Hedgehog pathway-induced medulloblastoma	ONCOGENE			English	Article						medulloblastoma; Notch; Hedgehog; therapy; RBP-J	GRANULE NEURON PRECURSORS; POSTNATAL MOUSE-BRAIN; BASAL-CELL CARCINOMA; SONIC-HEDGEHOG; STEM-CELLS; HUMAN HOMOLOG; MUTANT MICE; GLIAL DIFFERENTIATION; GENETIC ALTERATIONS; FATE DETERMINATION	Current treatment for medulloblastoma is successful in more than half of all cases but results in substantial disability in survivors. Accordingly, there is considerable interest in drugs that may target specific signaling pathways activated in the tumors, with inhibitors of both the Hedgehog and Notch pathways currently proposed as possible therapeutics. Here, we tested the hypothesis that Notch pathway inhibition in vivo may block the formation of Hedgehog-dependent medulloblastoma. We took the general approach of using a cre recombinase under the control of the GFAP promoter to generate medulloblastoma in mice carrying a conditional Ptc1 allele and introduced a conditional RBP-J allele to ablate canonical Notch signaling. Loss of RBP-J from the developing cerebellum led to a modest loss of stem cells and an overall developmental delay. These phenotypes could be partially compensated by activation of the Hedgehog pathway. Hedgehog-dependent medulloblastoma were not blocked by loss of RBP-J, indicating that canonical Notch signaling is not required for tumor initiation and growth in this model. Oncogene (2010) 29, 3465-3476; doi:10.1038/onc.2010.101; published online 26 April 2010	[Julian, E.; Dave, R. K.; Robson, J. P.; Wainwright, B. J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Hallahan, A. R.] Univ Queensland, Dept Paediat & Child Hlth, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Wainwright, BJ (corresponding author), Univ Queensland, Inst Mol Biosci, Bldg 80,St Lucia Campus, Brisbane, Qld 4072, Australia.	b.wainwright@imb.uq.edu.au	Hallahan, Andrew R/F-1757-2010	Wainwright, Brandon/0000-0003-0406-2092	National Health and Medical Research Council of Australia; John Trivett Foundation; ARC Special Research Centre for Functional and Applied Genomics; Australian Cancer Research Fund	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); John Trivett Foundation; ARC Special Research Centre for Functional and Applied Genomics(Australian Research Council); Australian Cancer Research Fund	E Julian is an ANZ Trustees Research Scholar. This work was supported by funds from the National Health and Medical Research Council of Australia, The John Trivett Foundation, the ARC Special Research Centre for Functional and Applied Genomics and the Australian Cancer Research Fund. We thank Professor Tasuku Honjo for RBP-J mice and Professor Ryoichiro Kageyama and Dr Zeng-jie Yang for helpful discussions.	Adolphe C, 2006, CANCER RES, V66, P2081, DOI 10.1158/0008-5472.CAN-05-2146; Adolphe C, 2004, DEVELOPMENT, V131, P5009, DOI 10.1242/dev.01367; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Binning MJ, 2008, CANCER RES, V68, P7838, DOI 10.1158/0008-5472.CAN-08-1899; Briggs KJ, 2008, GENE DEV, V22, P770, DOI 10.1101/gad.1640908; Corbin JG, 2008, J NEUROCHEM, V106, P2272, DOI 10.1111/j.1471-4159.2008.05522.x; Dakubo GD, 2006, J NEURO-ONCOL, V79, P221, DOI 10.1007/s11060-006-9132-2; Di Marcotullio L, 2004, P NATL ACAD SCI USA, V101, P10833, DOI 10.1073/pnas.0400690101; Dong J, 2000, Hum Mutat, V16, P89, DOI 10.1002/1098-1004(200007)16:1<89::AID-HUMU18>3.3.CO;2-Z; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Frappart PO, 2007, EMBO J, V26, P2732, DOI 10.1038/sj.emboj.7601703; Fujikura J, 2006, CELL METAB, V3, P59, DOI 10.1016/j.cmet.2005.12.005; Galli R, 2002, DEVELOPMENT, V129, P1633; Gao F, 2009, MOL CELL NEUROSCI, V40, P442, DOI 10.1016/j.mcn.2008.12.008; Garzia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004998; Gazit R, 2004, DEVELOPMENT, V131, P903, DOI 10.1242/dev.00982; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; Imayoshi I, 2008, DEVELOPMENT, V135, P2531, DOI 10.1242/dev.021535; Ingram WJ, 2008, ONCOGENE, V27, P1489, DOI 10.1038/sj.onc.1210767; Irvin DK, 2004, J NEUROSCI RES, V75, P330, DOI 10.1002/jnr.10843; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Klein AL, 2004, DEV BIOL, V266, P161, DOI 10.1016/j.ydbio.2003.10.017; Komine O, 2007, DEV BIOL, V311, P238, DOI 10.1016/j.ydbio.2007.08.042; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Lelievre V, 2008, DEV BIOL, V313, P359, DOI 10.1016/j.ydbio.2007.10.031; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lutolf S, 2002, DEVELOPMENT, V129, P373; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; Marino S, 2000, GENE DEV, V14, P994; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Packer Roger J., 1994, Current Opinion in Oncology, V6, P240, DOI 10.1097/00001622-199405000-00004; Pazzaglia S, 2006, ONCOGENE, V25, P5575, DOI 10.1038/sj.onc.1209544; Pietsch T, 1997, CANCER RES, V57, P2085; Purow B, 2009, CURR PHARM BIOTECHNO, V10, P154, DOI 10.2174/138920109787315060; Rao G, 2004, ONCOGENE, V23, P6156, DOI 10.1038/sj.onc.1207818; Romer J, 2005, CANCER RES, V65, P4975, DOI 10.1158/0008-5472.CAN-05-0481; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Saran A, 2009, CURR MOL MED, V9, P1046, DOI 10.2174/156652409789839080; Sasai K, 2006, CANCER RES, V66, P4215, DOI 10.1158/0008-5472.CAN-05-4505; Sasai K, 2007, CANCER RES, V67, P3871, DOI 10.1158/0008-5472.CAN-07-0493; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; Sottile V, 2006, BRAIN RES, V1099, P8, DOI 10.1016/j.brainres.2006.04.127; Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Talora C, 2008, BBA-MOL BASIS DIS, V1782, P489, DOI 10.1016/j.bbadis.2008.06.008; Tanaka M, 1999, J NEUROBIOL, V41, P524, DOI 10.1002/(SICI)1097-4695(199912)41:4<524::AID-NEU8>3.3.CO;2-9; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Tanori M, 2008, CARCINOGENESIS, V29, P1911, DOI 10.1093/carcin/bgn174; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Thomas WD, 2009, ONCOGENE, V28, P1605, DOI 10.1038/onc.2009.3; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Vorechovsky I, 1997, ONCOGENE, V15, P361, DOI 10.1038/sj.onc.1201340; Wall DS, 2009, CELL CYCLE, V8, P1301, DOI 10.4161/cc.8.9.8284; Wall DS, 2009, J CELL BIOL, V184, P101, DOI 10.1083/jcb.200805155; Wang JP, 2003, J CLIN INVEST, V112, P535, DOI 10.1172/JCI200318637; Weller M, 2006, DEV NEUROSCI-BASEL, V28, P70, DOI 10.1159/000090754; Wetmore C, 2001, CANCER RES, V61, P513; Wicking C, 1999, ONCOGENE, V18, P7844, DOI 10.1038/sj.onc.1203282; Yamamoto N, 2003, CURR BIOL, V13, P333, DOI 10.1016/S0960-9822(03)00081-2; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yokota N, 2004, ONCOGENE, V23, P3444, DOI 10.1038/sj.onc.1207475; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008; Zindy F, 2007, CANCER RES, V67, P2676, DOI 10.1158/0008-5472.CAN-06-3418	71	18	19	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 17	2010	29	24					3465	3476		10.1038/onc.2010.101	http://dx.doi.org/10.1038/onc.2010.101			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	611QN	20418906				2022-12-25	WOS:000278835400002
J	Vichalkovski, A; Gresko, E; Hess, D; Restuccia, DF; Hemmings, BA				Vichalkovski, A.; Gresko, E.; Hess, D.; Restuccia, D. F.; Hemmings, B. A.			PKB/AKT phosphorylation of the transcription factor Twist-1 at Ser42 inhibits p53 activity in response to DNA damage	ONCOGENE			English	Article						PKB/Akt; Twist-1 transcription factor; DNA damage; cancer	PROTEIN-KINASE B/AKT; SAETHRE-CHOTZEN-SYNDROME; BREAST-CANCER CELLS; TUMOR SUPPRESSION; UP-REGULATION; EXPRESSION; METASTASIS; SURVIVAL; RESISTANCE; INVASION	Protein kinase B (PKB/Akt) is ubiquitously expressed in cells. Phosphorylation of its multiple targets in response to various stimuli, including growth factors or cytokines, promotes cell survival and inhibits apoptosis. PKB is upregulated in many different cancers and a significant amount of the enzyme is present in its activated form. Here we show that PKB phosphorylates one of the anti-apoptotic proteins-transcription factor Twist-1 at Ser42. Cells expressing Twist-1 displayed inefficient p53 upregulation in response to DNA damage induced by gamma-irradiation or the genotoxic drug adriamycin. This influenced the activation of p53 target genes such as p21(Waf1) and Bax and led to aberrant cell-cycle regulation and the inhibition of apoptosis. The impaired induction of these p53 effector molecules is likely to be mediated by PKB-dependent phosphorylation of Twist-1 because, unlike the wild-type mutant, the Twist-1 S42A mutant did not confer cell resistance to DNA damage. Moreover, phosphorylation of Twist-1 at Ser42 was shown in vivo in various human cancer tissues, suggesting that this post-translational modi. cation ensures functional activation of Twist-1 after promotion of survival during carcinogenesis. Oncogene (2010) 29, 3554-3565; doi:10.1038/onc.2010.115; published online 19 April 2010	[Vichalkovski, A.; Gresko, E.; Hess, D.; Restuccia, D. F.; Hemmings, B. A.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Hemmings, BA (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	brian.hemmings@fmi.ch	Restuccia, David/D-7114-2012	Restuccia, David/0000-0001-7131-8065	Novartis Research Foundation; Swiss Cancer League Grant [OCS 01667-02-2005]	Novartis Research Foundation; Swiss Cancer League Grant	We thank S Bichet and A Bogucki for their help with immunohistochemistry and P King for critical comments on the article. This work was supported by the Novartis Research Foundation and the Swiss Cancer League Grant OCS 01667-02-2005 (to EG).	Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Cai JL, 2005, BIOESSAYS, V27, P1102, DOI 10.1002/bies.20313; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elias MC, 2005, NEOPLASIA, V7, P824, DOI 10.1593/neo.04352; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Firulli AB, 2008, CURR MED CHEM, V15, P2641, DOI 10.2174/092986708785908987; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Funato N, 2005, HUM MUTAT, V25, P550, DOI 10.1002/humu.20176; GHOUZZI V, 2001, FEBS LETT, V492, P112; Gitelman I, 1997, DEV BIOL, V189, P205, DOI 10.1006/dbio.1997.8614; Gripp KW, 2000, HUM MUTAT, V15, P150, DOI 10.1002/(SICI)1098-1004(200002)15:2<150::AID-HUMU3>3.0.CO;2-D; Guenou H, 2006, AM J PATHOL, V169, P1303, DOI 10.2353/ajpath.2006.060102; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Hayashi M, 2007, J CELL SCI, V120, P1350, DOI 10.1242/jcs.000067; Hess D, 2008, J BIOL CHEM, V283, P7354, DOI 10.1074/jbc.M710251200; Hosono S, 2007, BRIT J CANCER, V96, P314, DOI 10.1038/sj.bjc.6603533; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kwok WK, 2007, CARCINOGENESIS, V28, P2467, DOI 10.1093/carcin/bgm185; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Kyo S, 2006, HUM PATHOL, V37, P431, DOI 10.1016/j.humpath.2005.12.021; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pham CG, 2007, MOL CELL BIOL, V27, P3920, DOI 10.1128/MCB.01219-06; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Restuccia DF, 2009, SCIENCE, V325, P1083, DOI 10.1126/science.1179972; Shibata K, 2008, ANN ONCOL, V19, P81, DOI 10.1093/annonc/mdm344; Shiota M, 2008, CANCER RES, V68, P98, DOI 10.1158/0008-5472.CAN-07-2981; Singh S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-47; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; Stasinopoulos IA, 2005, J BIOL CHEM, V280, P2294, DOI 10.1074/jbc.M411018200; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yang J, 2006, CANCER RES, V66, P4549, DOI 10.1158/0008-5472.CAN-05-3850; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561; Zhang XM, 2007, INT J CANCER, V120, P1891, DOI 10.1002/ijc.22489; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	54	98	104	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 17	2010	29	24					3554	3565		10.1038/onc.2010.115	http://dx.doi.org/10.1038/onc.2010.115			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	611QN	20400976				2022-12-25	WOS:000278835400010
J	Karna, P; Zughaier, S; Pannu, V; Simmons, R; Narayan, S; Aneja, R				Karna, Prasanthi; Zughaier, Susu; Pannu, Vaishali; Simmons, Robert; Narayan, Satya; Aneja, Ritu			Induction of Reactive Oxygen Species-mediated Autophagy by a Novel Microtubule-modulating Agent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALIGNANT GLIOMA-CELLS; MITOCHONDRIAL PERMEABILITY TRANSITION; CYTOCHROME-C; CANCER-CELLS; BREAST-CANCER; MOLECULAR-MECHANISMS; MULTIDRUG-RESISTANT; TUMOR PROGRESSION; UNDERGO APOPTOSIS; ACIDIC VESICLES	Autophagy is being increasingly implicated in both cell survival and death. However, the intricate relationships between drug-induced autophagy and apoptosis remain elusive. Here we demonstrate that a tubulin-binding noscapine analog, (R)-9-bromo-5-((S)-4,5-dimethoxy-1,3-dihydroisobenzofuran-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]-di-oxolo[4,5-g]isoquinoline (Red-Br-nos), exerts a novel autophagic response followed by apoptotic cell death in human prostate cancer PC-3 cells. Red-Br-nos-induced autophagy was an early event detectable within 12 h that displayed a wide array of characteristic features including double membranous vacuoles with entrapped organelles, acidic vesicular organelles, and increased expression of LC3-II and beclin-1. Red-Br-nos-triggered release of reactive oxygen species (ROS) and attenuation of ROS by ti-ron, a ROS scavenger, reduced the sub-G(1) population suggesting ROS-dependent apoptosis. Abrogation of ROS also reduced autophagy indicating that ROS triggers autophagy. Pharmacological and genetic approaches to inhibit autophagy uncovered the protective role of Red-Br-nos-induced autophagy in PC-3 cells. Direct effects of the drug on mitochondria viz. disruption of normal cristae architecture and dissipation of mitochondrial transmembrane potential revealed a functional link between ROS generation, autophagy, and apoptosis induction. This is the first report to demonstrate the protective role of ROS-mediated autophagy and induction of caspase-independent ROS-dependent apoptosis in PC-3 cells by Red-Br-nos, a member of the noscapinoid family of microtubule-modulating anticancer agents.	[Karna, Prasanthi; Pannu, Vaishali; Simmons, Robert; Aneja, Ritu] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Zughaier, Susu] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30033 USA; [Narayan, Satya] Univ Florida, Shands Canc Ctr, Dept Anat & Cell Biol, Gainesville, FL 32610 USA	University System of Georgia; Georgia State University; Emory University; State University System of Florida; University of Florida	Aneja, R (corresponding author), Georgia State Univ, Dept Biol, POB 4010, Atlanta, GA 30303 USA.	raneja@gsu.edu	Zughaier, Susu/N-3185-2019; Zughaier, Susu/GLQ-9288-2022	Zughaier, Susu/0000-0001-7487-8770; 	National Institutes of Health, NCI [1K99CA131489]; Department of Defense [PC073104]; Georgia Research Alliance; NATIONAL CANCER INSTITUTE [R00CA131489, K99CA131489] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Georgia Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1K99CA131489 from the NCI and Department of Defense Grant PC073104 (to R. A.) and a grant from the Georgia Research Alliance.	Aneja R, 2006, CANCER RES, V66, P3782, DOI 10.1158/0008-5472.CAN-05-2962; Aneja R, 2006, BLOOD, V107, P2486, DOI 10.1182/blood-2005-08-3516; Aneja R, 2008, CANCER RES, V68, P1495, DOI 10.1158/0008-5472.CAN-07-1874; Aneja R, 2006, MOL CANCER THER, V5, P2366, DOI 10.1158/1535-7163.MCT-06-0205; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; Chen YQ, 2008, AUTOPHAGY, V4, P246, DOI 10.4161/auto.5432; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Heidemann S, 2006, BLOOD, V107, P2216, DOI 10.1182/blood-2005-12-5142; Hoyer-Hansen M, 2005, CELL DEATH DIFFER, V12, P1297, DOI 10.1038/sj.cdd.4401651; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanzawa T, 2003, CANCER RES, V63, P2103; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kim RH, 2009, CANCER RES, V69, P700, DOI 10.1158/0008-5472.CAN-08-3157; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kondo Y, 2006, AUTOPHAGY, V2, P85, DOI 10.4161/auto.2.2.2463; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lee SB, 2007, DNA CELL BIOL, V26, P713, DOI 10.1089/dna.2007.0577; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2009, CELL DEATH DIFFER, V16, P1, DOI 10.1038/cdd.2008.139; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Matsui Y, 2008, AUTOPHAGY, V4, P409, DOI 10.4161/auto.5638; Millot C, 1997, J HISTOCHEM CYTOCHEM, V45, P1255, DOI 10.1177/002215549704500909; Mizumachi T, 2008, ONCOGENE, V27, P831, DOI 10.1038/sj.onc.1210681; Nur-E-Kamal A, 2004, J BIOL CHEM, V279, P24911, DOI 10.1074/jbc.C400051200; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Paglin S, 2001, CANCER RES, V61, P439; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Peng XH, 2007, MOL PHARMACOL, V71, P101, DOI 10.1124/mol.106.027367; Perchellet EM, 2004, ANTI-CANCER DRUG, V15, P929, DOI 10.1097/00001813-200411000-00002; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Rosenbluth JM, 2009, AUTOPHAGY, V5, P114, DOI 10.4161/auto.5.1.7294; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schneiders UM, 2009, MOL CANCER THER, V8, P2914, DOI 10.1158/1535-7163.MCT-08-1179; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; VandenHoek TL, 1997, J MOL CELL CARDIOL, V29, P2571, DOI 10.1006/jmcc.1997.0497; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zhou J, 2002, J BIOL CHEM, V277, P17200, DOI 10.1074/jbc.M110369200; Zhou J, 2005, CANCER CHEMOTH PHARM, V55, P461, DOI 10.1007/s00280-004-0903-1; Zhou J, 2004, BIOCHEM PHARMACOL, V68, P2435, DOI 10.1016/j.bcp.2004.08.032; Zhou J, 2003, MOL PHARMACOL, V63, P799, DOI 10.1124/mol.63.4.799	60	72	73	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18737	18748		10.1074/jbc.M109.091694	http://dx.doi.org/10.1074/jbc.M109.091694			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20404319	Green Published, hybrid			2022-12-25	WOS:000278453900065
J	Casarotto, S; Lauro, LJR; Bellina, V; Casali, AG; Rosanova, M; Pigorini, A; Defendi, S; Mariotti, M; Massimini, M				Casarotto, Silvia; Lauro, Leonor J. Romero; Bellina, Valentina; Casali, Adenauer G.; Rosanova, Mario; Pigorini, Andrea; Defendi, Stefano; Mariotti, Maurizio; Massimini, Marcello			EEG Responses to TMS Are Sensitive to Changes in the Perturbation Parameters and Repeatable over Time	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; CORTICAL EXCITABILITY; EVOKED-POTENTIALS; COIL ORIENTATION; BRAIN RESPONSES; CONNECTIVITY; HUMANS; SLEEP; DEPRESSION	Background: High-density electroencephalography (hd-EEG) combined with transcranial magnetic stimulation (TMS) provides a direct and non-invasive measure of cortical excitability and connectivity in humans and may be employed to track over time pathological alterations, plastic changes and therapy-induced modifications in cortical circuits. However, the diagnostic/monitoring applications of this technique would be limited to the extent that TMS-evoked potentials are either stereotypical (non-sensitive) or random (non-repeatable) responses. Here, we used controlled changes in the stimulation parameters (site, intensity, and angle of stimulation) and repeated longitudinal measurements (same day and one week apart) to evaluate the sensitivity and repeatability of TMS/hd-EEG potentials. Methodology/Principal Findings: In 10 volunteers, we performed 92 single-subject comparisons to evaluate the similarities/differences between pairs of TMS-evoked potentials recorded in the same/different stimulation conditions. For each pairwise comparison, we used non-parametric statistics to calculate a Divergence Index (DI), i.e., the percentage of samples that differed significantly, considering all scalp locations and the entire post-stimulus period. A receiver operating characteristic analysis showed that it was possible to find an optimal DI threshold of 1.67%, yielding 96.7% overall accuracy of TMS/hd-EEG in detecting whether a change in the perturbation parameters occurred or not. Conclusions/Significance: These results demonstrate that the EEG responses to TMS essentially reflect deterministic properties of the stimulated neuronal circuits as opposed to stereotypical responses or uncontrolled variability. To the extent that TMS-evoked potentials are sensitive to changes and repeatable over time, they may be employed to detect longitudinal changes in the state of cortical circuits.	[Casarotto, Silvia; Lauro, Leonor J. Romero; Bellina, Valentina; Casali, Adenauer G.; Rosanova, Mario; Pigorini, Andrea; Defendi, Stefano; Mariotti, Maurizio; Massimini, Marcello] Univ Milan, Dept Clin Sci L Sacco, Milan, Italy	University of Milan	Casarotto, S (corresponding author), Univ Milan, Dept Clin Sci L Sacco, Milan, Italy.	marcello.massimini@unimi.it	Pigorini, Andrea/ABC-8351-2021; Rosanova, Mario/S-8440-2017; Lauro, Leonor Josefina Romero/AAB-2491-2019; Casali, Adenauer G/G-9911-2012; Casarotto, Silvia/Q-9402-2019; Casarotto, Silvia/F-1251-2015; Massimini, Marcello/T-8115-2017	Pigorini, Andrea/0000-0002-1856-3413; Rosanova, Mario/0000-0001-7486-7617; Lauro, Leonor Josefina Romero/0000-0002-6478-2502; Casali, Adenauer G/0000-0001-7024-9029; Casarotto, Silvia/0000-0002-7548-7664; Casarotto, Silvia/0000-0002-7548-7664; MARIOTTI, MAURIZIO/0000-0001-8415-4880; Massimini, Marcello/0000-0003-2271-957X	European Grant Strep [LSHM-CT-2005-51818, ICT-2007-224328]; PRIN 2006; Italian Ministry of Research and University	European Grant Strep; PRIN 2006(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Research and University(Ministry of Education, Universities and Research (MIUR))	This work was supported by European Grant Strep LSHM-CT-2005-51818, by PRIN 2006 (Progetti di Ricerca di Interesse Nazionale - National Interest Research Projects) supported by the Italian Ministry of Research and University, and by European Grant Strep ICT-2007-224328 "Predict AD" (to M. Massimini). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CJ, 2001, SCAND J PSYCHOL, V42, P297, DOI 10.1111/1467-9450.00239; Balslev D, 2007, J NEUROSCI METH, V162, P309, DOI 10.1016/j.jneumeth.2007.01.021; Bender S, 2005, ANN NEUROL, V58, P58, DOI 10.1002/ana.20521; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P58, DOI 10.1016/0013-4694(94)90113-9; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; Boly M, 2009, PROG BRAIN RES, V177, P383, DOI 10.1016/S0079-6123(09)17727-0; Bonato C, 2006, CLIN NEUROPHYSIOL, V117, P1699, DOI 10.1016/j.clinph.2006.05.006; Butefisch CM, 2003, BRAIN, V126, P470, DOI 10.1093/brain/awg044; Casali AG, 2010, NEUROIMAGE, V49, P1459, DOI 10.1016/j.neuroimage.2009.09.026; Chen R, 1997, ANN NEUROL, V41, P247, DOI 10.1002/ana.410410216; Chistyakov AV, 2005, CLIN NEUROPHYSIOL, V116, P386, DOI 10.1016/j.clinph.2004.09.008; Clarkson AN, 2009, BIOCHEM SOC T, V37, P1412, DOI 10.1042/BST0371412; Dubach P, 2004, CLIN NEUROPHYSIOL, V115, P862, DOI 10.1016/j.clinph.2003.11.033; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Friston KJ, 2006, HUM BRAIN MAPP, V27, P722, DOI 10.1002/hbm.20214; Friston KJ, 2009, SCIENCE, V326, P399, DOI 10.1126/science.1174521; Friston KJ, 2002, NEUROIMAGE, V16, P465, DOI 10.1006/nimg.2002.1090; Hill AC, 2000, NEUROREPORT, V11, P3257, DOI 10.1097/00001756-200009280-00041; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; Ilmoniemi RJ, 2010, BRAIN TOPOGR, V22, P233, DOI 10.1007/s10548-009-0123-4; Ilmoniemi RJ, 1999, CRIT REV BIOMED ENG, V27, P241; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; Kahkonen S, 2005, PSYCHOPHARMACOLOGY, V181, P16, DOI 10.1007/s00213-005-2197-3; Kahkonen S, 2005, NEUROIMAGE, V24, P955, DOI 10.1016/j.neuroimage.2004.09.048; Kahkonen S, 2004, CLIN NEUROPHYSIOL, V115, P583, DOI 10.1016/j.clinph.2003.10.032; Kahkonen S, 2003, NEUROPSYCHOPHARMACOL, V28, P747, DOI 10.1038/sj.npp.1300099; Kahkonen S, 2001, NEUROIMAGE, V14, P322, DOI 10.1006/nimg.2001.0849; Kahkonen S, 2005, ALCOHOL, V37, P129, DOI 10.1016/j.alcohol.2006.03.003; Komssi S, 2004, HUM BRAIN MAPP, V21, P154, DOI 10.1002/hbm.10159; Komssi S, 2002, CLIN NEUROPHYSIOL, V113, P175, DOI 10.1016/S1388-2457(01)00721-0; Lioumis P, 2009, HUM BRAIN MAPP, V30, P1387, DOI 10.1002/hbm.20608; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Massimini M, 2007, P NATL ACAD SCI USA, V104, P8496, DOI 10.1073/pnas.0702495104; Massimini M, 2009, PROG BRAIN RES, V177, P201, DOI 10.1016/S0079-6123(09)17714-2; Mattout J, 2006, NEUROIMAGE, V30, P753, DOI 10.1016/j.neuroimage.2005.10.037; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Paus T, 1997, J NEUROSCI, V17, P3178; Paus T, 2005, PHILOS T R SOC B, V360, P1109, DOI 10.1098/rstb.2005.1652; Paus T, 1998, HUM BRAIN MAPP, V6, P399, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<399::AID-HBM13>3.0.CO;2-H; Phillips C, 2005, NEUROIMAGE, V24, P997, DOI 10.1016/j.neuroimage.2004.10.030; Rosanova M, 2009, J NEUROSCI, V29, P7679, DOI 10.1523/JNEUROSCI.0445-09.2009; Thut G, 2005, J NEUROSCI METH, V141, P207, DOI 10.1016/j.jneumeth.2004.06.016; Thut G, 2010, BRAIN TOPOGR, V22, P219, DOI 10.1007/s10548-009-0115-4; Tikhonov A., 1977, SOLUTIONS ILL POSED; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; van de Velde M, 1998, ELECTROEN CLIN NEURO, V107, P149, DOI 10.1016/S0013-4694(98)00052-2; Van der Werf YD, 2006, EXP BRAIN RES, V175, P231, DOI 10.1007/s00221-006-0551-2; Virtanen J, 1999, MED BIOL ENG COMPUT, V37, P322, DOI 10.1007/BF02513307; YOUNDEN WJ, 1950, CANCER, V3, P32	52	136	139	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10281	10.1371/journal.pone.0010281	http://dx.doi.org/10.1371/journal.pone.0010281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421968	Green Published, gold			2022-12-25	WOS:000276952600005
J	Raman, D; Sai, JQ; Neel, NF; Chew, CS; Richmond, A				Raman, Dayanidhi; Sai, Jiqing; Neel, Nicole F.; Chew, Catherine S.; Richmond, Ann			LIM and SH3 Protein-1 Modulates CXCR2-Mediated Cell Migration	PLOS ONE			English	Article							INFLUENCES ZYXIN LOCALIZATION; II INTERLEUKIN-8 RECEPTOR; CAMP SIGNALING PATHWAY; BREAST-CANCER; TUMOR-GROWTH; LLKIL MOTIF; IN-VITRO; LASP-1; CXCR2; CHEMOTAXIS	Background: The chemokine receptor CXCR2 plays a pivotal role in migration of neutrophils, macrophages and endothelial cells, modulating several biological responses such as angiogenesis, wound healing and acute inflammation. CXCR2 is also involved in pathogenesis of chronic inflammation, sepsis and atherosclerosis. The ability of CXCR2 to associate with a variety of proteins dynamically is responsible for its effects on directed cell migration or chemotaxis. The dynamic network of such CXCR2 binding proteins is termed as "CXCR2 chemosynapse''. Proteomic analysis of proteins that co-immunoprecipitated with CXCR2 in neutrophil-like dHL-60 cells revealed a novel protein, LIM and SH3 protein 1 (LASP-1), binds CXCR2 under both basal and ligand activated conditions. LASP-1 is an actin binding cytoskeletal protein, involved in the cell migration. Methodology/Principal Findings: We demonstrate that CXCR2 and LASP-1 co-immunoprecipitate and co-localize at the leading edge of migrating cells. The LIM domain of LASP-1 directly binds to the carboxy-terminal domain (CTD) of CXCR2. Moreover, LASP-1 also directly binds the CTD of CXCR1, CXCR3 and CXCR4. Using a site-directed and deletion mutagenesis approach, Iso323-Leu324 of the conserved LKIL motif on CXCR2-CTD was identified as the binding site for LASP-1. Interruption of the interaction between CXCR2-CTD and LIM domain of LASP-1 by dominant negative and knock down approaches inhibited CXCR2-mediated chemotaxis. Analysis for the mechanism for inhibition of CXCR2-mediated chemotaxis indicated that LASP-1/CXCR2 interaction is essential for cell motility and focal adhesion turnover involving activation of Src, paxillin, PAK1, p130CAS and ERK1/2. Conclusions/Significance: We demonstrate here for the first time that LASP-1 is a key component of the "CXCR2 chemosynapse'' and LASP-1 interaction with CXCR2 is critical for CXCR2-mediated chemotaxis. Furthermore, LASP-1 also directly binds the CTD of CXCR1, CXCR3 and CXCR4, suggesting that LASP-1 is a general mediator of CXC chemokine mediated chemotaxis. Thus, LASP-1 may serve as a new link coordinating the flow of information between chemokine receptors and nascent focal adhesions, especially at the leading edge. Thus the association between the chemokine receptors and LASP-1 suggests to the presence of a CXC chemokine receptor-LASP-1 pro-migratory module in cells governing the cell migration.	[Raman, Dayanidhi; Sai, Jiqing; Neel, Nicole F.; Richmond, Ann] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Richmond, Ann] Dept Vet Affairs, Nashville, TN USA; [Chew, Catherine S.] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA	Vanderbilt University; University System of Georgia; Augusta University	Raman, D (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA.	ann.richmond@vanderbilt.edu	Richmond, Ann/A-3048-2014	RICHMOND, ANN/0000-0002-9580-900X	National Institutes of Health (NIH) [CA-34590, DK-20593, DK-58404, HD-15052, DK-59637, EY-08126]; Specialized Neuroscience Research Program [U54NS041071-6, CA-64845]; Department of Veterans Affairs and Ingram; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA119925, T32CA009592, R23CA034590, P30CA068485, R01CA034590] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, U2CDK059637, P60DK020593, U24DK059637, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041071] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Specialized Neuroscience Research Program; Department of Veterans Affairs and Ingram; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in whole or in part by National Institutes of Health (NIH) Grants - CA-34590 (A. R.), Specialized Neuroscience Research Program grant U54NS041071-6 under Project 2 (A. R.), and CA-64845 (A. R.) in support of the Vanderbilt-Ingram Cancer Center. This work was also supported by a Senior Research Career Scientist Award from the Department of Veterans Affairs and Ingram Professorship (A. R.). The authors acknowledge the VUMC cell imaging shared resource used in confocal studies (supported by NIH grants DK-20593, DK-58404, HD-15052, DK-59637 and EY-08126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; Baugher PJ, 2008, J BIOL CHEM, V283, P30868, DOI 10.1074/jbc.M804054200; Butt E, 2003, J BIOL CHEM, V278, P15601, DOI 10.1074/jbc.M209009200; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Chew CS, 2000, J CELL SCI, V113, P2035; Chew CS, 2002, J CELL SCI, V115, P4787, DOI 10.1242/jcs.00174; Chew CS, 1998, AM J PHYSIOL-CELL PH, V275, pC56, DOI 10.1152/ajpcell.1998.275.1.C56; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; Efimov A, 2008, J CELL SCI, V121, P196, DOI 10.1242/jcs.012666; Fan GH, 2002, J BIOL CHEM, V277, P6590, DOI 10.1074/jbc.M110588200; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Fan GH, 2001, J BIOL CHEM, V276, P16960, DOI 10.1074/jbc.M009292200; Fulton AM, 2009, CURR ONCOL REP, V11, P125, DOI 10.1007/s11912-009-0019-1; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Grunewald TGP, 2006, EXP CELL RES, V312, P974, DOI 10.1016/j.yexcr.2005.12.016; Grunewald TGP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-31; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Horton LW, 2007, CANCER RES, V67, P9791, DOI 10.1158/0008-5472.CAN-07-0246; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Li B, 2004, J BIOL CHEM, V279, P20401, DOI 10.1074/jbc.M310304200; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Ma XR, 2009, MOL CANCER THER, V8, P490, DOI 10.1158/1535-7163.MCT-08-0485; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Matsuo Y, 2009, INT J CANCER, V125, P1027, DOI 10.1002/ijc.24383; MUELLER SG, 1994, J BIOL CHEM, V269, P1973; NEEL NF, 2008, THESIS VANDERBILT U; Neel NF, 2009, J CELL SCI, V122, P1882, DOI 10.1242/jcs.039057; Parekh A, 2009, CELL ADHES MIGR, V3, P288, DOI 10.4161/cam.3.3.8888; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Petit V, 2000, J CELL BIOL, V148, P957, DOI 10.1083/jcb.148.5.957; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Raman D, 2009, METHOD ENZYMOL, V460, P315, DOI 10.1016/S0076-6879(09)05215-X; Sai JQ, 2008, J BIOL CHEM, V283, P26538, DOI 10.1074/jbc.M805611200; Sai JQ, 2006, J BIOL CHEM, V281, P35931, DOI 10.1074/jbc.M605883200; Sai JQ, 2004, J CELL SCI, V117, P5489, DOI 10.1242/jcs.01398; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; SCHRAW W, 1995, BIOCHEMISTRY-US, V34, P13760, DOI 10.1021/bi00042a006; Siesser PMF, 2008, CELL MOTIL CYTOSKEL, V65, P25, DOI 10.1002/cm.20241; Spence HJ, 2006, MOL CELL BIOL, V26, P1480, DOI 10.1128/MCB.26.4.1480-1495.2006; Stephens L, 2002, CURR OPIN CELL BIOL, V14, P203, DOI 10.1016/S0955-0674(02)00311-3; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Strieter RM, 2005, CYTOKINE GROWTH F R, V16, P593, DOI 10.1016/j.cytogfr.2005.04.007; TOMASETTO C, 1995, FEBS LETT, V373, P245, DOI 10.1016/0014-5793(95)01040-L; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Wang DZ, 2002, BIOCHEMISTRY-US, V41, P7100, DOI 10.1021/bi025902m; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Wendt MK, 2009, J BIOL CHEM, V284, P34145, DOI 10.1074/jbc.M109.023614; Yanagawa J, 2009, CLIN CANCER RES, V15, P6820, DOI 10.1158/1078-0432.CCR-09-1558; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Zhang H, 2009, PHYSIOL GENOMICS, V38, P372, DOI 10.1152/physiolgenomics.00048.2009	60	52	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10050	10.1371/journal.pone.0010050	http://dx.doi.org/10.1371/journal.pone.0010050			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419088	Green Published, gold, Green Submitted			2022-12-25	WOS:000276853800001
J	Doering, P; Stoltenberg, M; Penkowa, M; Rungby, J; Larsen, A; Danscher, G				Doering, Peter; Stoltenberg, Meredin; Penkowa, Milena; Rungby, Jorgen; Larsen, Agnete; Danscher, Gorm			Chemical Blocking of Zinc Ions in CNS Increases Neuronal Damage Following Traumatic Brain Injury (TBI) in Mice	PLOS ONE			English	Article							ENRICHED ZEN TERMINALS; HIPPOCAMPAL-NEURONS; CONTAINING PATHWAYS; MOUSE-BRAIN; CELL-DEATH; IN-VIVO; LOCALIZATION; BOUTONS; TRANSLOCATION; ACCUMULATION	Background: Traumatic brain injury (TBI) is one of the leading causes of disability and death among young people. Although much is already known about secondary brain damage the full range of brain tissue responses to TBI remains to be elucidated. A population of neurons located in cerebral areas associated with higher cognitive functions harbours a vesicular zinc pool co-localized with glutamate. This zinc enriched pool of synaptic vesicles has been hypothesized to take part in the injurious signalling cascade that follows pathological conditions such as seizures, ischemia and traumatic brain injury. Pathological release of excess zinc ions from pre-synaptic vesicles has been suggested to mediate cell damage/death to postsynaptic neurons. Methodology/Principal Findings: In order to substantiate the influence of vesicular zinc ions on TBI, we designed a study in which damage and zinc movements were analysed in several different ways. Twenty-four hours after TBI ZnT3-KO mice (mice without vesicular zinc) were compared to littermate Wild Type (WT) mice (mice with vesicular zinc) with regard to histopathology. Furthermore, in order to evaluate a possible neuro-protective dimension of chemical blocking of vesicular zinc, we treated lesioned mice with either DEDTC or selenite. Our study revealed that chemical blocking of vesicular zinc ions, either by chelation with DEDTC or accumulation in zinc-selenium nanocrystals, worsened the effects on the aftermath of TBI in the WT mice by increasing the number of necrotic and apoptotic cells within the first 24 hours after TBI, when compared to those of chemically untreated WT mice. Conclusion/Significance: ZnT3-KO mice revealed more damage after TBI compared to WT controls. Following treatment with DEDTC or selenium an increase in the number of both dead and apoptotic cells were seen in the controls within the first 24 hours after TBI while the degree of damage in the ZnT3-KO mice remained largely unchanged. Further analyses revealed that the damage development in the two mouse strains was almost identical after either zinc chelation or zinc complexion therapy.	[Doering, Peter; Stoltenberg, Meredin; Larsen, Agnete; Danscher, Gorm] Univ Aarhus, Inst Anat, Aarhus, Denmark; [Penkowa, Milena] Univ Copenhagen, Panum Inst, Fac Hlth Sci, Sect Neuroprotect,Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Rungby, Jorgen] Univ Aarhus, Dept Pharmacol, Aarhus, Denmark	Aarhus University; University of Copenhagen; Aarhus University	Doering, P (corresponding author), Univ Aarhus, Inst Anat, Aarhus, Denmark.	pdj@neuro.au.dk	Doering, Peter/GYQ-8720-2022; Rungby, Jørgen/AAQ-4332-2021	Doering, Peter/0000-0002-5561-9076; Larsen, Agnete/0000-0001-8765-8443	Augustinus Foundation; Aase and Ejnar Danielsen Foundation; Aarhus University Research Foundation; Beckett Foundation; Danish Medical Association; Lundbeck Foundation; Direktor Jacob Madsen og Hustrus Fond	Augustinus Foundation; Aase and Ejnar Danielsen Foundation; Aarhus University Research Foundation; Beckett Foundation; Danish Medical Association; Lundbeck Foundation(Lundbeckfonden); Direktor Jacob Madsen og Hustrus Fond	This study was supported by The Augustinus Foundation, The Aase and Ejnar Danielsen Foundation, The Aarhus University Research Foundation, The Beckett Foundation, The Danish Medical Association Research Fund, The Lundbeck Foundation and Direktor Jacob Madsen og Hustrus Fond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Bitanihirwe BKY, 2009, SYNAPSE, V63, P1029, DOI 10.1002/syn.20683; Brown CE, 2004, J COMP NEUROL, V479, P156, DOI 10.1002/cne.20308; Carrasco J, 2000, EUR J NEUROSCI, V12, P2311, DOI 10.1046/j.1460-9568.2000.00128.x; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Cole TB, 2000, EPILEPSY RES, V39, P153, DOI 10.1016/S0920-1211(99)00121-7; Cote A, 2005, J PHYSIOL-LONDON, V566, P821, DOI 10.1113/jphysiol.2005.089458; DANSCHER G, 1982, HISTOCHEMISTRY, V76, P281, DOI 10.1007/BF00543951; Danscher G, 2005, J HISTOCHEM CYTOCHEM, V53, P141, DOI 10.1369/jhc.4R6460.2005; Danscher G, 2001, NEUROSCIENCE, V105, P941, DOI 10.1016/S0306-4522(01)00243-3; DANSCHER G, 1975, BRAIN RES, V85, P522, DOI 10.1016/0006-8993(75)90825-2; DANSCHER G, 1973, EXP BRAIN RES, V16, P521, DOI 10.1007/BF00234478; DANSCHER G, 1976, THESIS AARHUS U; DANSCHER G, 1984, NEUROBIOLOGY ZINC B, P177; Danscher G, 2006, PROG HISTOCHEM CYTO, V41, P57, DOI 10.1016/j.proghi.2006.06.001; Dineley KE, 2003, J NEUROCHEM, V85, P563, DOI 10.1046/j.1471-4159.2003.01678.x; Doering P, 2007, NEUROSCIENCE, V150, P93, DOI 10.1016/j.neuroscience.2007.09.066; Dominguez MI, 2006, EPILEPSIA, V47, P887, DOI 10.1111/j.1528-1167.2006.00501.x; Frederickson CJ, 2005, J ALZHEIMERS DIS, V8, P155; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; Frederickson CJ, 2004, J NEUROSCI METH, V139, P79, DOI 10.1016/j.jneumeth.2004.04.033; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; Hellmich HL, 2008, NEUROSCI LETT, V440, P155, DOI 10.1016/j.neulet.2008.05.068; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Ismail T, 2008, NEUROSCIENCE, V157, P697, DOI 10.1016/j.neuroscience.2008.09.011; Kitamura Y, 2006, J PHARMACOL SCI, V100, P142, DOI 10.1254/jphs.FP0050805; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Larsen A, 2008, HISTOCHEM CELL BIOL, V130, P681, DOI 10.1007/s00418-008-0448-1; Lee JM, 2002, NEUROSCIENCE, V115, P871, DOI 10.1016/S0306-4522(02)00513-4; Lee JY, 2003, EXP NEUROL, V184, P337, DOI 10.1016/S0014-4886(03)00382-0; Lee JY, 2000, J NEUROSCI, V20; Linkous DH, 2008, J HISTOCHEM CYTOCHEM, V56, P3, DOI 10.1369/jhc.6A7035.2007; Maret W, 2009, BIOMETALS, V22, P149, DOI 10.1007/s10534-008-9186-z; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; PEREZCLAUSELL J, 1985, BRAIN RES, V337, P91, DOI 10.1016/0006-8993(85)91612-9; PerezClausell J, 1996, J CHEM NEUROANAT, V11, P99, DOI 10.1016/0891-0618(96)00131-7; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; SLOMIANKA L, 1990, NEUROSCIENCE, V38, P843, DOI 10.1016/0306-4522(90)90076-G; SLOMIANKA L, 1992, NEUROSCIENCE, V48, P325, DOI 10.1016/0306-4522(92)90494-M; Sorensen JC, 1998, BRAIN RES, V812, P265, DOI 10.1016/S0006-8993(98)00943-3; Stoltenberg M, 2007, NEUROSCIENCE, V150, P357, DOI 10.1016/j.neuroscience.2007.09.025; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2001, BRAIN RES, V895, P25, DOI 10.1016/S0006-8993(01)01996-5; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Takeda A, 2000, BRAIN RES REV, V34, P137, DOI 10.1016/S0165-0173(00)00044-8; Takeda A, 2001, BIOMETALS, V14, P343, DOI 10.1023/A:1012982123386; Valente T, 2002, MOL CELL NEUROSCI, V21, P189, DOI 10.1006/mcne.2002.1159; Wang ZY, 2002, NEUROSCI LETT, V321, P37, DOI 10.1016/S0304-3940(01)02560-5; Wang ZY, 2001, BRAIN RES, V921, P165, DOI 10.1016/S0006-8993(01)03114-6; Wei G, 2004, NEUROSCIENCE, V125, P867, DOI 10.1016/j.neuroscience.2004.03.011; Weiss JH, 2000, TRENDS NEUROSCI, V23, P365, DOI 10.1016/S0166-2236(00)01610-6; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Yeiser EC, 2002, NUTR NEUROSCI, V5, P345, DOI 10.1080/1028415021000033811; Yeiser EC, 1999, NEUROSCI LETT, V277, P75, DOI 10.1016/S0304-3940(99)00825-3	55	34	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10131	10.1371/journal.pone.0010131	http://dx.doi.org/10.1371/journal.pone.0010131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20396380	Green Published, gold, Green Submitted			2022-12-25	WOS:000276482100027
J	Igosheva, N; Abramov, AY; Poston, L; Eckert, JJ; Fleming, TP; Duchen, MR; McConnell, J				Igosheva, Natalia; Abramov, Andrey Y.; Poston, Lucilla; Eckert, Judith J.; Fleming, Tom P.; Duchen, Michael R.; McConnell, Josie			Maternal Diet-Induced Obesity Alters Mitochondrial Activity and Redox Status in Mouse Oocytes and Zygotes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HIGH-FAT DIET; OXIDATIVE STRESS; PREIMPLANTATION DEVELOPMENT; LEPTIN; DNA; TRANSITION; LIVER; HYPERLEPTINEMIA; REPRODUCTION	The negative impact of obesity on reproductive success is well documented but the stages at which development of the conceptus is compromised and the mechanisms responsible for the developmental failure still remain unclear. Recent findings suggest that mitochondria may be a contributing factor. However to date no studies have directly addressed the consequences of maternal obesity on mitochondria in early embryogenesis. Using an established murine model of maternal diet induced obesity and a live cell dynamic fluorescence imaging techniques coupled with molecular biology we have investigated the underlying mechanisms of obesity-induced reduced fertility. Our study is the first to show that maternal obesity prior to conception is associated with altered mitochondria in mouse oocytes and zygotes. Specifically, maternal diet-induced obesity in mice led to an increase in mitochondrial potential, mitochondrial DNA content and biogenesis. Generation of reactive oxygen species (ROS) was raised while glutathione was depleted and the redox state became more oxidised, suggestive of oxidative stress. These altered mitochondrial properties were associated with significant developmental impairment as shown by the increased number of obese mothers who failed to support blastocyst formation compared to lean dams. We propose that compromised oocyte and early embryo mitochondrial metabolism, resulting from excessive nutrient exposure prior to and during conception, may underlie poor reproductive outcomes frequently reported in obese women.	[Igosheva, Natalia; Poston, Lucilla; McConnell, Josie] Kings Coll London, Div Reprod & Endocrinol, London WC2R 2LS, England; [Abramov, Andrey Y.] UCL, Dept Mol Neurosci, Inst Neurol, London, England; [Eckert, Judith J.] Univ Southampton, Sch Med, Southampton, Hants, England; [Fleming, Tom P.] Univ Southampton, Sch Biol Sci, Southampton, Hants, England; [Duchen, Michael R.] UCL, Dept Cell & Dev Biol, London, England	University of London; King's College London; University of London; University College London; University of Southampton; University of Southampton; University of London; University College London	Igosheva, N (corresponding author), Kings Coll London, Div Reprod & Endocrinol, London WC2R 2LS, England.	ni4@sanger.ac.uk	Abramov, Andrey Y/H-9053-2012; Abramov, Andrey/AAC-6712-2019; duchen, michael/A-2116-2009	Abramov, Andrey Y/0000-0002-7646-7235; Abramov, Andrey/0000-0002-7646-7235; duchen, michael/0000-0003-2548-4294; Poston, Lucilla/0000-0003-1100-2821	Biotechnology and Biological Sciences Research Council [BB/C518273/1, F007450]; Tommys Charity, UK; BBSRC [BB/F007450/1] Funding Source: UKRI; MRC [G0100558, G0601943] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [G18784, BB/F007450/1] Funding Source: researchfish; Medical Research Council [G0601943, G0100558] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tommys Charity, UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Biotechnology and Biological Sciences Research Council (grants BB/C518273/1; F007450) and by Tommys Charity, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Acton BM, 2004, MOL HUM REPROD, V10, P23, DOI 10.1093/molehr/gah004; Baker P., 2007, OBESITY REPROD HLTH; Barrientos A, 1997, BIOCHEM MOL MED, V62, P165, DOI 10.1006/bmme.1997.2647; Brannian JD, 2005, REPROD NUTR DEV, V45, P143, DOI 10.1051/rnd:2005011; Brannian JD, 2001, HUM REPROD, V16, P1819, DOI 10.1093/humrep/16.9.1819; Chinopoulos C, 1999, J NEUROCHEM, V73, P220, DOI 10.1046/j.1471-4159.1999.0730220.x; Cummins JM, 2004, EUR J OBSTET GYN R B, V115, pS23, DOI 10.1016/j.ejogrb.2004.01.011; Davidson Sean M, 2007, Methods Mol Biol, V372, P421, DOI 10.1007/978-1-59745-365-3_30; Di Paola M, 2006, BBA-BIOENERGETICS, V1757, P1330, DOI 10.1016/j.bbabio.2006.03.024; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Dumollard R, 2009, SEMIN CELL DEV BIOL, V20, P346, DOI 10.1016/j.semcdb.2008.12.013; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Fedorcsak P, 2003, BIOL REPROD, V69, P1531, DOI 10.1095/biolreprod.103.019034; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; Fleming TP, 2004, BIOL REPROD, V71, P1046, DOI 10.1095/biolreprod.104.030957; GARDINER CS, 1995, ARCH BIOCHEM BIOPHYS, V318, P30, DOI 10.1006/abbi.1995.1200; HANDYSIDE AH, 1984, J EXP ZOOL, V231, P429, DOI 10.1002/jez.1402310317; Harris SE, 2005, THERIOGENOLOGY, V64, P992, DOI 10.1016/j.theriogenology.2005.01.004; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; Iossa S, 2002, INT J OBESITY, V26, P65, DOI 10.1038/sj.ijo.0801844; Jansen RPS, 2004, MITOCHONDRION, V4, P577, DOI 10.1016/j.mito.2004.07.038; Keelan J, 2001, J NEUROSCI RES, V66, P873, DOI 10.1002/jnr.10085; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; Leese HJ, 2008, MOL HUM REPROD, V14, P667, DOI 10.1093/molehr/gan065; Maheshwari A, 2007, HUM REPROD UPDATE, V13, P433, DOI 10.1093/humupd/dmm017; Malik NM, 2001, ENDOCRINOLOGY, V142, P5198, DOI 10.1210/en.142.12.5198; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; McConnell JML, 2004, REPROD BIOMED ONLINE, V9, P418, DOI 10.1016/S1472-6483(10)61277-1; Metwally M, 2007, OBES REV, V8, P515, DOI 10.1111/j.1467-789X.2007.00406.x; Minamikawa T, 1999, EXP CELL RES, V246, P26, DOI 10.1006/excr.1998.4290; Minge CE, 2008, ENDOCRINOLOGY, V149, P2646, DOI 10.1210/en.2007-1570; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mitchell M, 2009, BIOL REPROD, V80, P622, DOI 10.1095/biolreprod.108.072595; Mollica MP, 1998, MOL CELL BIOCHEM, V178, P213, DOI 10.1023/A:1006899632413; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; MUGGLETONHARRIS AL, 1988, HUM REPROD, V3, P1020, DOI 10.1093/oxfordjournals.humrep.a136815; Ramsay JE, 2006, BMJ-BRIT MED J, V333, P1159, DOI 10.1136/bmj.39049.439444.DE1; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Robker Rebecca L, 2008, Pathophysiology, V15, P115, DOI 10.1016/j.pathophys.2008.04.004; Robker RL, 2009, J CLIN ENDOCR METAB, V94, P1533, DOI 10.1210/jc.2008-2648; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schieke SM, 2008, J BIOL CHEM, V283, P28506, DOI 10.1074/jbc.M802763200; Shitara H, 2000, GENETICS, V156, P1277; Souza-Pinto NC, 1999, NUCLEIC ACIDS RES, V27, P1935, DOI 10.1093/nar/27.8.1935; Suliman HB, 2003, J BIOL CHEM, V278, P41510, DOI 10.1074/jbc.M304719200; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Thouas GA, 2006, BIOL REPROD, V74, P969, DOI 10.1095/biolreprod.105.048611; Van Blerkom J, 2008, REPROD BIOMED ONLINE, V16, P553, DOI 10.1016/S1472-6483(10)60463-4; Wakefield SL, 2008, AM J PHYSIOL-ENDOC M, V294, pE425, DOI 10.1152/ajpendo.00409.2007; Wilding M, 2002, Reprod Biomed Online, V5, P39	54	328	344	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10074	10.1371/journal.pone.0010074	http://dx.doi.org/10.1371/journal.pone.0010074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404917	Green Published, gold, Green Submitted			2022-12-25	WOS:000276482100005
J	Svensson, AKE; Bilsel, O; Kayatekin, C; Adefusika, JA; Zitzewitz, JA; Matthews, CR				Svensson, Anna-Karin E.; Bilsel, Osman; Kayatekin, Can; Adefusika, Jessica A.; Zitzewitz, Jill A.; Matthews, C. Robert			Metal-Free ALS Variants of Dimeric Human Cu,Zn-Superoxide Dismutase Have Enhanced Populations of Monomeric Species	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN SUPEROXIDE-DISMUTASE; FREE-ENERGY SURFACE; DISULFIDE REDUCTION; FREE CYSTEINES; FAMILIAL ALS; MUTANT; SOD1; COPPER; AGGREGATION	Amino acid replacements at dozens of positions in the dimeric protein human, Cu, Zn superoxide dismutase (SOD1) can cause amyotrophic lateral sclerosis (ALS). Although it has long been hypothesized that these mutations might enhance the populations of marginally-stable aggregation-prone species responsible for cellular toxicity, there has been little quantitative evidence to support this notion. Perturbations of the folding free energy landscapes of metal-free versions of five ALS-inducing variants, A4V, L38V, G93A, L106V and S134N SOD1, were determined with a global analysis of kinetic and thermodynamic folding data for dimeric and stable monomeric versions of these variants. Utilizing this global analysis approach, the perturbations on the global stability in response to mutation can be partitioned between the monomer folding and association steps, and the effects of mutation on the populations of the folded and unfolded monomeric states can be determined. The 2- to 10-fold increase in the population of the folded monomeric state for A4V, L38V and L106V and the 80- to 480-fold increase in the population of the unfolded monomeric states for all but S134N would dramatically increase their propensity for aggregation through high-order nucleation reactions. The wild-type-like populations of these states for the metal-binding region S134N variant suggest that even wild-type SOD1 may also be prone to aggregation in the absence of metals.	[Svensson, Anna-Karin E.; Bilsel, Osman; Kayatekin, Can; Adefusika, Jessica A.; Zitzewitz, Jill A.; Matthews, C. Robert] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester	Svensson, AKE (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.	jill.zitzewitz@umassmed.edu; c.robert.matthews@umassmed.edu	Kayatekin, Can/B-6618-2009	Bilsel, Osman/0000-0003-0414-3060; Kayatekin, Can/0000-0002-4367-9645	National Institutes of Health [GM 54836, 5R25HL92610-2]; National Institutute of Child Health and Human Development Intellectual and Developmental Disabilities Research Center [HD04147]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004147] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL092610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutute of Child Health and Human Development Intellectual and Developmental Disabilities Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (http://www.nih.gov/) grant GM 54836 to C. R. M. Support for mass spectrometry analysis was provided by National Institutute of Child Health and Human Development Intellectual and Developmental Disabilities Research Center Core Grant HD04147 (http://www.iddrc.org/). Summer undergraduate research support for J.A.A. was provided by NIH grant 5R25HL92610-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Banci L, 1998, BIOCHEMISTRY-US, V37, P11780, DOI 10.1021/bi9803473; Banci L, 2002, PROTEIN SCI, V11, P2479, DOI 10.1110/ps.0210802; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Crow JP, 1997, J NEUROCHEM, V69, P1936; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; GETZOFF ED, 1989, PROTEINS, V5, P322, DOI 10.1002/prot.340050408; Goto JJ, 1998, J BIOL CHEM, V273, P30104, DOI 10.1074/jbc.273.46.30104; HALLEWELL RA, 1991, BIOCHEM BIOPH RES CO, V181, P474, DOI 10.1016/S0006-291X(05)81443-3; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; KAYATEKIN C, 2010, J MOL BIOL IN PRESS; Kayatekin C, 2008, J MOL BIOL, V384, P540, DOI 10.1016/j.jmb.2008.09.045; LEPOCK JR, 1990, J BIOL CHEM, V265, P21612; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; MATTHEWS CR, 1987, METHOD ENZYMOL, V154, P498; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mulligan VK, 2008, J MOL BIOL, V383, P424, DOI 10.1016/j.jmb.2008.08.024; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Noel AF, 2009, J MOL BIOL, V387, P1002, DOI 10.1016/j.jmb.2008.12.061; Nordlund A, 2009, P NATL ACAD SCI USA, V106, P9667, DOI 10.1073/pnas.0812046106; Perry JJP, 2010, BBA-PROTEINS PROTEOM, V1804, P245, DOI 10.1016/j.bbapap.2009.11.004; PRUDENCIO M, 2009, HUM MOL GENET; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Rumfeldt JAO, 2006, J MOL BIOL, V355, P106, DOI 10.1016/j.jmb.2005.10.042; Rumfeldt JAO, 2009, J MOL BIOL, V385, P278, DOI 10.1016/j.jmb.2008.10.003; Shipp EL, 2003, BIOCHEMISTRY-US, V42, P1890, DOI 10.1021/bi026704y; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Strange RW, 2006, J MOL BIOL, V356, P1152, DOI 10.1016/j.jmb.2005.11.081; Svensson AKE, 2006, J MOL BIOL, V364, P1084, DOI 10.1016/j.jmb.2006.09.005; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; Teilum K, 2009, P NATL ACAD SCI USA, V106, P18273, DOI 10.1073/pnas.0907387106; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Vassall KA, 2006, BIOCHEMISTRY-US, V45, P7366, DOI 10.1021/bi0600953; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Zitzewitz JA, 2000, J MOL BIOL, V296, P1105, DOI 10.1006/jmbi.2000.3507	53	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10064	10.1371/journal.pone.0010064	http://dx.doi.org/10.1371/journal.pone.0010064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404910	Green Published, Green Submitted, gold			2022-12-25	WOS:000276482100003
J	Chakroun, N; Prigent, S; Dreiss, CA; Noinville, S; Chapuis, C; Fraternali, F; Rezaei, H				Chakroun, Nesrine; Prigent, Stephanie; Dreiss, Cecile A.; Noinville, Sylvie; Chapuis, Celine; Fraternali, Franca; Rezaei, Human			The oligomerization properties of prion protein are restricted to the H2H3 domain	FASEB JOURNAL			English	Article						polymerization pathway; beta-hairpin; intermediate; strain	MOLECULAR-DYNAMICS SIMULATIONS; PARTICLE MESH EWALD; CONFORMATIONAL TRANSITION; SCRAPIE; CONVERSION; DISEASE; PROPAGATION; PARALLEL; MUTATION; SYSTEMS	The propensity of the prion protein (PrP) to adopt different structures is a clue to its pathological behavior. The determination of the region involved in the PrPC to PrPSc conversion is fundamental for the understanding of the mechanisms underlying this process at the molecular level. In this paper, the polymerization of the helical H2H3 domain of ovine PrP (OvPrP) was compared to the full-length construct (using chromatography and light scattering). We show that the oligomerization patterns are identical, although the H2H3 domain has a higher polymerization rate. Furthermore, the depolymerization kinetics of purified H2H3 oligomers compared to those purified from the full-length PrP reveal that regions outside H2H3 do not significantly contribute to the oligomerization process. By combining rational mutagenesis and molecular dynamics to investigate the early stages of H2H3 oligomerization, we observe a conformationally stable beta-sheet structure that we propose as a possible nucleus for oligomerization; we also show that single point mutations in H2 and H3 present structural polymorphisms and oligomerization properties that could constitute the basis of species or strain variability.-Chakroun, N., Prigent, S., Dreiss, C. A., Noinville, S., Chapuis, C., Fraternali, F., Rezaei, H. The oligomerization properties of prion protein are restricted to the H2H3 domain. FASEB J. 24, 3222-3231 (2010). www.fasebj.org	[Chakroun, Nesrine; Prigent, Stephanie; Noinville, Sylvie; Chapuis, Celine; Rezaei, Human] INRA, Equipe Biol Physicochim Prions, F-78352 Jouy En Josas, France; [Chakroun, Nesrine; Fraternali, Franca] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Chakroun, Nesrine; Dreiss, Cecile A.] Kings Coll London, Div Pharmaceut Sci, London SE1 1UL, England	INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of London; King's College London; University of London; King's College London	Rezaei, H (corresponding author), INRA, Equipe Biol Physicochim Prions, F-78352 Jouy En Josas, France.	franca.fraternali@kcl.ac.uk; rezaei@jouy.inra.fr	Fraternali, Franca/C-8912-2009; Noinville, Sylvie/S-8318-2019; Noinville, Sylvie/B-1086-2009; Fraternali, Franca/D-4410-2011	Fraternali, Franca/0000-0002-3143-6574; Noinville, Sylvie/0000-0002-8320-9488; 	French National Institute of Agronomic Research (INRA); Alliance Biosecure; Royal Society	French National Institute of Agronomic Research (INRA); Alliance Biosecure; Royal Society(Royal Society of London)	Financial support for this work was provided by the French National Institute of Agronomic Research (INRA) including INRA-Package, Alliance Biosecure, and the Royal Society (travel expenses). The authors acknowledge EPSRC/Diamond Light Source for the provision of a CASE studentship (N.C.). The authors thank Annalisa Pastore and Jens Kleinjung for their advice and suggestions. The authors also thank G. van der Rest for access to MS facilities and interest in this work. H. R., F. F., and C. A. D. designed the research plan with the contribution of S. P. and N.C.; H. R., S. P., C. C., and S.N. performed the kinetic experiments, oligomer purification, mutant design, and in vitro data analysis; F. F., N.C., and C. A. D. performed the MD analysis; H. R., S. P., and D. S. designed and constructed the MWSLS device. All authors contributed to writing the paper.	Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Blinov N, 2009, BIOCHEMISTRY-US, V48, P1488, DOI 10.1021/bi802043h; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Chebaro Y, 2009, J PHYS CHEM B, V113, P6942, DOI 10.1021/jp900334s; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Simone A, 2005, P NATL ACAD SCI USA, V102, P7535, DOI 10.1073/pnas.0501748102; De Simone A, 2007, BIOPHYS J, V93, P1284, DOI 10.1529/biophysj.107.108613; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Ferreiro E, 2008, J NEUROCHEM, V104, P766, DOI 10.1111/j.1471-4159.2007.05048.x; Fioriti L, 2005, MOL CELL NEUROSCI, V28, P165, DOI 10.1016/j.mcn.2004.09.006; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Gu W, 2003, BIOPHYS CHEM, V104, P79, DOI 10.1016/S0301-4622(02)00340-X; Haire LF, 2004, J MOL BIOL, V336, P1175, DOI 10.1016/j.jmb.2003.12.059; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Langella E, 2004, BIOPHYS J, V87, P3623, DOI [10.1529/biophysj.104.043448, 10.1529/biophysj.104.043449]; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Lu BY, 2002, BIOCHEM J, V364, P81, DOI 10.1042/bj3640081; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rezaei H, 2005, J MOL BIOL, V347, P665, DOI 10.1016/j.jmb.2005.01.043; Rezaei H, 2000, EUR J BIOCHEM, V267, P2833, DOI 10.1046/j.1432-1033.2000.01347.x; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Sokolowski F, 2003, J BIOL CHEM, V278, P40481, DOI 10.1074/jbc.M304391200; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; VANGUNSTEREN WF, 1984, J MOL BIOL, V176, P559, DOI 10.1016/0022-2836(84)90177-3; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499	39	69	69	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3222	3231		10.1096/fj.09-153924	http://dx.doi.org/10.1096/fj.09-153924			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20410442				2022-12-25	WOS:000281446400011
J	Choocheep, K; Hatano, S; Takagi, H; Watanabe, H; Kimata, K; Kongtawelert, P; Watanabe, H				Choocheep, Kanyamas; Hatano, Sonoko; Takagi, Hidekazu; Watanabe, Hiroki; Kimata, Koji; Kongtawelert, Prachya; Watanabe, Hideto			Versican Facilitates Chondrocyte Differentiation and Regulates Joint Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; GROWTH-FACTOR-BETA; SYNOVIAL JOINT; PG-M; TGF-BETA; MESENCHYMAL CONDENSATION; MOUSE LIMB; EXPRESSION; CHONDROGENESIS; HYALURONAN	Versican/PG-M is a large chondroitin sulfate proteoglycan in the extracellular matrix, which is transiently expressed in mesenchymal condensation areas during tissue morphogenesis. Here, we generated versican conditional knock-out mice Prx1-Cre/Vcan(flox/flox), in which Vcan is pruned out by site-specific Cre recombinase driven by the Prx1 promoter. Although Prx1-Cre/Vcan(flox/flox) mice are viable and fertile, they develop distorted digits. Histological analysis of newborn mice reveals hypertrophic chondrocytic nodules in cartilage, tilting of the joint, and a slight delay of chondrocyte differentiation in digits. By immunostaining, whereas the joint interzone of Prx1-Cre/Vcan(+/+) shows an accumulation of TGF-beta, concomitant with versican, that of Prx1-Cre/Vcan(flox/flox) without versican expression exhibits a decreased incorporation of TGF-beta. In a micro-mass culture system of mesenchymal cells from limb bud, whereas TGF-beta and versican are co-localized in the perinodular regions of developing cartilage in Prx1-Cre/Vcan(+/+), TGF-beta is widely distributed in Prx1-Cre/Vcan(flox/flox). These results suggest that versican facilitates chondrogenesis and joint morphogenesis, by localizing TGF-beta in the extracellular matrix and regulating its signaling.	[Choocheep, Kanyamas; Hatano, Sonoko; Takagi, Hidekazu; Watanabe, Hiroki; Kimata, Koji; Watanabe, Hideto] Aichi Med Univ, Inst Mol Sci Med, Karimata 21, Aichi 4801195, Japan; [Choocheep, Kanyamas; Kongtawelert, Prachya] Chiang Mai Univ, Fac Med, Dept Biochem, Thailand Excellence Ctr Tissue Engn, Chiang Mai 50200, Thailand	Aichi Medical University; Chiang Mai University	Watanabe, H (corresponding author), Aichi Med Univ, Inst Mol Sci Med, Karimata 21, Aichi 4801195, Japan.	wannabee@aichi-med-u.ac.jp		kongtawelert, prachya/0000-0002-5963-2796; Watanabe, Hideto/0000-0001-5291-0696	KAKENHI; Royal Golden Jubilee Ph.D. Program [PHD/0183/2547]; Aikeikai scholarship	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Aikeikai scholarship	This work was supported by Grants-in-aid for Scientific Research (B) (KAKENHI) (to Hideto Watanabe) and grants-in-aid for priority areas (to Hideto Watanabe).r Recipient of Royal Golden Jubilee Ph.D. Program Grants PHD/0183/2547 and an Aikeikai scholarship.	Archer Charles W., 2003, Birth Defects Research, V69, P144, DOI 10.1002/bdrc.10015; Aspberg A, 1997, P NATL ACAD SCI USA, V94, P10116, DOI 10.1073/pnas.94.19.10116; BLESSING M, 1993, GENE DEV, V7, P204, DOI 10.1101/gad.7.2.204; BodeLesniewska B, 1996, J HISTOCHEM CYTOCHEM, V44, P303, DOI 10.1177/44.4.8601689; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; CRAIG FM, 1990, J ANAT, V171, P17; Daniels K, 1996, METHOD CELL BIOL, V51, P237, DOI 10.1016/S0091-679X(08)60631-7; Day JM, 2004, J BIOL CHEM, V279, P12511, DOI 10.1074/jbc.M400242200; DOURSZIMMERMANN MT, 1994, J BIOL CHEM, V269, P32992; EDWARDS JCW, 1994, J ANAT, V185, P355; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; HALL BK, 1992, ANAT EMBRYOL, V186, P107; Hamrick MW, 2001, EVOL DEV, V3, P355, DOI 10.1046/j.1525-142X.2001.01032.x; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; HOLDER N, 1977, J EMBRYOL EXP MORPH, V39, P115; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; ITO K, 1995, J BIOL CHEM, V270, P958, DOI 10.1074/jbc.270.2.958; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kamiya N, 2006, J BIOL CHEM, V281, P2390, DOI 10.1074/jbc.M509341200; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; KIMATA K, 1986, J BIOL CHEM, V261, P3517; Kishimoto J, 1999, P NATL ACAD SCI USA, V96, P7336, DOI 10.1073/pnas.96.13.7336; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; LEONARD CM, 1991, DEV BIOL, V145, P99, DOI 10.1016/0012-1606(91)90216-P; LEUSSINK B, 1995, MECH DEVELOP, V52, P51, DOI 10.1016/0925-4773(95)00389-I; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Matsumoto K, 2003, J BIOL CHEM, V278, P41205, DOI 10.1074/jbc.M305060200; Matsumoto K, 2006, J BIOL CHEM, V281, P18257, DOI 10.1074/jbc.M510330200; Matsumoto K, 2009, DEVELOPMENT, V136, P2825, DOI 10.1242/dev.038505; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Pacifici Maurizio, 2005, Birth Defects Research, V75, P237, DOI 10.1002/bdrc.20050; PITSILLIDES AA, 1995, J HISTOCHEM CYTOCHEM, V43, P263, DOI 10.1177/43.3.7868856; Pitsillides AA, 2003, CELL BIOCHEM FUNCT, V21, P235, DOI 10.1002/cbf.1079; Shepard JB, 2007, INT J BIOL SCI, V3, P380; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; Snow HE, 2005, ANAT REC PART A, V282A, P95, DOI 10.1002/ar.a.20151; Spagnoli A, 2007, J CELL BIOL, V177, P1105, DOI 10.1083/jcb.200611031; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Todorovic V, 2007, DEVELOPMENT, V134, P3723, DOI 10.1242/dev.008599; UJITA M, 1994, J BIOL CHEM, V269, P27603; Williams DR, 2005, BIOCHEM BIOPH RES CO, V334, P960, DOI 10.1016/j.bbrc.2005.06.189; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; YAMAGATA M, 1993, J CELL SCI, V106, P55; ZAKO M, 1995, J BIOL CHEM, V270, P3914, DOI 10.1074/jbc.270.8.3914	46	73	75	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21114	21125		10.1074/jbc.M109.096479	http://dx.doi.org/10.1074/jbc.M109.096479			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20404343	Green Published, hybrid			2022-12-25	WOS:000279228600074
J	Lieutaud, A; van Lis, R; Duval, S; Capowiez, L; Muller, D; Lebrun, R; Lignon, S; Fardeau, ML; Lett, MC; Nitschke, W; Schoepp-Cothenet, B				Lieutaud, Aurelie; van Lis, Robert; Duval, Simon; Capowiez, Line; Muller, Daniel; Lebrun, Regine; Lignon, Sabrina; Fardeau, Marie-Laure; Lett, Marie-Claire; Nitschke, Wolfgang; Schoepp-Cothenet, Barbara			Arsenite Oxidase from Ralstonia sp 22 CHARACTERIZATION OF THE ENZYME AND ITS INTERACTION WITH SOLUBLE CYTOCHROMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCALIGENES-FAECALIS; SIGNAL PEPTIDES; RIESKE-PROTEIN; SP NOV.; OXIDATION; ARSENATE; GENES; REDUCTION; SULFUR; PURIFICATION	We characterized the aro arsenite oxidation system in the novel strain Ralstonia sp. 22, a beta-proteobacterium isolated from soil samples of the Salsigne mine in southern France. The inducible aro system consists of a heterodimeric membrane-associated enzyme reacting with a dedicated soluble cytochrome c(554). Our biochemical results suggest that the weak association of the enzyme to the membrane probably arises from a still unknown interaction partner. Analysis of the phylogeny of the aro gene cluster revealed that it results from a lateral gene transfer from a species closely related to Achromobacter sp. SY8. This constitutes the first clear cut case of such a transfer in the Aro phylogeny. The biochemical study of the enzyme demonstrates that it can accommodate in vitro various cytochromes, two of which, c(552) and c(554), are from the parent species. Cytochrome c(552) belongs to the sox and not the aro system. Kinetic studies furthermore established that sulfite and sulfide, substrates of the sox system, are both inhibitors of Aro activity. These results reinforce the idea that sulfur and arsenic metabolism are linked.	[Nitschke, Wolfgang; Schoepp-Cothenet, Barbara] CNRS, Lab Bioenerget & Ingn Prot, UPR 9036, IFR88, F-13402 Marseille 20, France; [Muller, Daniel; Lett, Marie-Claire] Univ Strasbourg, CNRS, UMR7156, F-67083 Strasbourg, France; [Lebrun, Regine; Lignon, Sabrina] CNRS, Marseille Prote IBiSA, Plate Forme Prote IMM, F-13402 Marseille 20, France; [Fardeau, Marie-Laure] Univ Aix Marseille 1, LMBEC, IRD ESIL, F-13288 Marseille 9, France; [Fardeau, Marie-Laure] Univ Mediterranee, LMBEC, IRD ESIL, F-13288 Marseille 9, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Schoepp-Cothenet, B (corresponding author), CNRS, Lab Bioenerget & Ingn Prot, UPR 9036, IFR88, F-13402 Marseille 20, France.	schoepp@ifr88.cnrs-mrs.fr	Duval, Simon/ABS-5379-2022; Schoepp-Cothenet, Barbara/AAH-8911-2021; Nitschke, Wolfgang/C-4812-2012; Muller, Daniel/C-6827-2008	Duval, Simon/0000-0003-2946-6771; Schoepp-Cothenet, Barbara/0000-0002-6820-4478; Muller, Daniel/0000-0002-6619-4691; Nitschke, Wolfgang/0000-0003-2084-3032	ADEME/BRGM; Ministere Francais de la Recherche	ADEME/BRGM; Ministere Francais de la Recherche(Ministry of Research, France)	Supported by a Ph.D. grant from ADEME/BRGM.; Supported by a Ministere Francais de la Recherche Ph.D. grant.	ANDERSON GL, 1992, J BIOL CHEM, V267, P23674; Baymann F, 2001, BIOCHEMISTRY-US, V40, P13681, DOI 10.1021/bi011201y; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Branco R, 2009, APPL ENVIRON MICROB, V75, P5141, DOI 10.1128/AEM.02798-08; Cai L, 2009, APPL MICROBIOL BIOT, V83, P715, DOI 10.1007/s00253-009-1929-4; Cai L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-4; Chang JS, 2010, ENVIRON GEOCHEM HLTH, V32, P95, DOI 10.1007/s10653-009-9268-z; Donahoe-Christiansen J, 2004, APPL ENVIRON MICROB, V70, P1865, DOI 10.1128/AEM.70.3.1865-1868.2004; Dowdle PR, 1996, APPL ENVIRON MICROB, V62, P1664, DOI 10.1128/AEM.62.5.1664-1669.1996; Duquesne K, 2008, ENVIRON MICROBIOL, V10, P228, DOI 10.1111/j.1462-2920.2007.01447.x; DUTTON PL, 1971, BIOCHIM BIOPHYS ACTA, V226, P63, DOI 10.1016/0005-2728(71)90178-2; DUVAL S, 2008, THESIS U PROVENCE MA; Duval S, 2010, J BIOL CHEM, V285, P20442, DOI 10.1074/jbc.M110.113811; Duval S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-206; Ellis PJ, 2001, STRUCTURE, V9, P125, DOI 10.1016/S0969-2126(01)00566-4; ENOCH HG, 1975, J BIOL CHEM, V250, P6693; Fisher JC, 2008, ENVIRON SCI TECHNOL, V42, P81, DOI 10.1021/es0713936; FORGET P, 1971, EUR J BIOCHEM, V18, P422; Friedrich CG, 2000, J BACTERIOL, V182, P4677, DOI 10.1128/JB.182.17.4677-4687.2000; GARDLIK S, 1991, J BIOL CHEM, V266, P16627; Green H. H., 1918, S AFR J SCI, V14, P465; Hamamura N, 2009, ENVIRON MICROBIOL, V11, P421, DOI 10.1111/j.1462-2920.2008.01781.x; Handley KM, 2009, INT J SYST EVOL MICR, V59, P886, DOI 10.1099/ijs.0.003145-0; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; Hoeft SE, 2007, INT J SYST EVOL MICR, V57, P504, DOI 10.1099/ijs.0.64576-0; Inskeep WP, 2002, BOOK SOIL P, P183; Judd R. C., 2002, PROTEIN PROTOCOLS HD, P73; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Kallas T, 1994, MOL BIOL CYANOBACTER, V1, P259, DOI DOI 10.1007/978-94-011-0227-8_9; Kashyap DR, 2006, J BACTERIOL, V188, P1081, DOI 10.1128/JB.188.3.1081-1088.2006; Kelly DP, 1997, ANTON LEEUW INT J G, V71, P95, DOI 10.1023/A:1000135707181; Kulp TR, 2008, SCIENCE, V321, P967, DOI 10.1126/science.1160799; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langner HW, 2001, ENVIRON SCI TECHNOL, V35, P3302, DOI 10.1021/es0105562; Lebrun E, 2003, MOL BIOL EVOL, V20, P686, DOI 10.1093/molbev/msg071; Lebrun E, 2006, MOL BIOL EVOL, V23, P1180, DOI 10.1093/molbev/msk010; LIM CK, 1993, J BACTERIOL, V175, P4492, DOI 10.1128/JB.175.14.4492-4498.1993; Malasarn D, 2008, J BACTERIOL, V190, P135, DOI 10.1128/JB.01110-07; Muller D, 2003, J BACTERIOL, V185, P135, DOI 10.1128/JB.185.1.135-141.2003; MULLER D, 2004, THESIS U STRASBOURG; Murphy JN, 2007, J BACTERIOL, V189, P2283, DOI 10.1128/JB.01698-06; NASSER D, 1967, J BACTERIOL, V94, P1706, DOI 10.1128/JB.94.5.1706-1714.1967; Newman DK, 1997, ARCH MICROBIOL, V168, P380, DOI 10.1007/s002030050512; NRIAGU JO, 1994, ARSENIC ENV; Oremland RS, 2005, TRENDS MICROBIOL, V13, P45, DOI 10.1016/j.tim.2004.12.002; PHILLIPS SE, 1976, APPL ENVIRON MICROB, V32, P392, DOI 10.1128/AEM.32.3.392-399.1976; Prasad KS, 2009, BIOMETALS, V22, P711, DOI 10.1007/s10534-009-9215-6; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Rochette EA, 2000, ENVIRON SCI TECHNOL, V34, P4714, DOI 10.1021/es000963y; Rother D, 2001, J BACTERIOL, V183, P4499, DOI 10.1128/JB.183.15.4499-4508.2001; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santini JM, 2004, J BACTERIOL, V186, P1614, DOI 10.1128/JB.186.6.1614-1619.2004; Santini JM, 2000, APPL ENVIRON MICROB, V66, P92, DOI 10.1128/AEM.66.1.92-97.2000; Santini JM, 2007, BBA-BIOENERGETICS, V1767, P189, DOI 10.1016/j.bbabio.2007.01.009; Silver S, 2005, APPL ENVIRON MICROB, V71, P599, DOI 10.1128/AEM.71.2.599-608.2005; Simeonova DD, 2004, FEMS MICROBIOL LETT, V237, P249, DOI 10.1111/j.1574-6968.2004.tb09703.x; Slyemi D, 2007, ADV MATER RES-SWITZ, V20-21, P427, DOI 10.4028/www.scientific.net/AMR.20-21.427; Stauder S, 2005, ENVIRON SCI TECHNOL, V39, P5933, DOI 10.1021/es048034k; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053; Sun WJ, 2009, FEMS MICROBIOL ECOL, V68, P72, DOI 10.1111/j.1574-6941.2009.00653.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valenzuela C, 2009, B ENVIRON CONTAM TOX, V82, P593, DOI 10.1007/s00128-009-9659-y; vanden Hoven RN, 2004, BBA-BIOENERGETICS, V1656, P148, DOI 10.1016/j.bbabio.2004.03.001; Weeger W, 1999, BIOMETALS, V12, P141, DOI 10.1023/A:1009255012328	66	42	44	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20433	20441		10.1074/jbc.M110.113761	http://dx.doi.org/10.1074/jbc.M110.113761			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20421652	Green Published, hybrid			2022-12-25	WOS:000279228600003
J	Mauk, MR; Mauk, AG				Mauk, Marcia R.; Mauk, A. Grant			Metal Ions and Electrolytes Regulate the Dissociation of Heme from Human Hemopexin at Physiological pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED UPTAKE; PEPTIDE-BOND HYDROLYSIS; POLYMORPHONUCLEAR LEUKOCYTES; CRYSTAL-STRUCTURE; ACUTE HEMOLYSIS; HIGH-AFFINITY; BINDING-SITE; SERUM; LIVER; COMPLEX	The stability of the hemopexin-heme (Hx-heme) complex to dissociation of the heme prosthetic group has been examined in bicarbonate buffers in the presence and absence of various divalent metal ions. In NH4HCO3 buffer (pH 7.4, 20 mM, 25 degrees C) containing Zn2+ (100 mu M), 14% of the heme dissociates from this complex (4.5 mu M) within 10 min, and 50% dissociates within 2 h. In the absence of metal ions, the rate of dissociation of this complex is far lower, is decreased further in KHCO3 solution, and is minimal in NaHCO3. In NH4HCO3 buffer, dissociation of the Hx-heme complex is accelerated by addition of divalent metals with decreasing efficiency in the order Zn2+ > Cu2+ >> Ni2+ > Co2+ >> Mn2+. Addition of Ca2+ prior to addition of Zn2+ stabilizes the Hx-heme complex to dissociation of the heme group, and addition of Ca2+ after Zn2+-induced dissociation of the Hx-heme complex results in re-formation of the Hx-heme complex. These effects are greatly accelerated at 37 degrees C and diminished in other buffers. Overall, the solution conditions that promote formation of the Hx-heme complex are similar to those found in blood plasma, and conditions that promote release of heme are similar to those that the Hx-heme complex should encounter in endosomes following endocytosis of the complex formed with its hepatic receptor.	Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Ctr Blood Res, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Mauk, AG (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	mauk@interchange.ubc.ca			CBS-CIHR; Canada Research Chair	CBS-CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by a CBS-CIHR Partnership grant and by a Canada Research Chair (to A.G.M.).	Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Blindauer CA, 2009, J BIOL CHEM, V284, P23116, DOI 10.1074/jbc.M109.003459; BOWERS GN, 1986, CLIN CHEM, V32, P1437; CAROLI S, 1994, CRIT REV ANAL CHEM, V24, P363, DOI 10.1080/10408349408048824; CARTWRIGHT GE, 1960, AM J MED, V28, P555, DOI 10.1016/0002-9343(60)90150-9; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Clague MJ, 1998, BIOCHEM J, V336, P271, DOI 10.1042/bj3360271; DAVIES DM, 1979, BIOCHEM BIOPH RES CO, V91, P1504, DOI 10.1016/0006-291X(79)91235-X; DEEB RS, 1994, BBA-GEN SUBJECTS, V1200, P161, DOI 10.1016/0304-4165(94)90131-7; Delanghe JR, 2001, CLIN CHIM ACTA, V312, P13, DOI 10.1016/S0009-8981(01)00586-1; FABER HR, 1995, STRUCTURE, V3, P551, DOI 10.1016/S0969-2126(01)00189-7; Flaherty MM, 2008, BIOMETALS, V21, P239, DOI 10.1007/s10534-007-9112-9; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; GOLDENTHAL KL, 1988, J HISTOCHEM CYTOCHEM, V36, P391, DOI 10.1177/36.4.2450119; Holt S, 1999, LANCET, V353, P1241, DOI 10.1016/S0140-6736(98)05768-7; HRKAL Z, 1974, EUR J BIOCHEM, V43, P73, DOI 10.1111/j.1432-1033.1974.tb03386.x; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; KAMBOH MI, 1987, AM J HUM GENET, V41, P645; Krezel A, 2006, ACTA BIOCHIM POL, V53, P721, DOI 10.18388/abp.2006_3299; Krezel A, 2010, J AM CHEM SOC, V132, P3355, DOI 10.1021/ja907567r; Kuzelova K, 1997, BBA-GEN SUBJECTS, V1336, P497, DOI 10.1016/S0304-4165(97)00062-7; LINDER RE, 1978, ANAL BIOCHEM, V90, P474, DOI 10.1016/0003-2697(78)90140-9; Mauk MR, 2007, BIOCHEMISTRY-US, V46, P15033, DOI 10.1021/bi701821a; Mauk MR, 2007, NAT PROD REP, V24, P523, DOI 10.1039/b604184c; Mauk MR, 2009, J AM CHEM SOC, V131, P16976, DOI 10.1021/ja907484j; MAUK MR, 1994, BIOCHEMISTRY-US, V33, P12609, DOI 10.1021/bi00208a011; Mauk MR, 2005, BIOCHEMISTRY-US, V44, P1864, DOI 10.1021/bi0481747; McLEAN FRANKLIN C, 1934, JOUR BIOL CHEM, V107, P337; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Miller YI, 1999, BBA-MOL BASIS DIS, V1454, P153, DOI 10.1016/S0925-4439(99)00027-7; MORGAN WT, 1976, BIOCHIM BIOPHYS ACTA, V434, P311, DOI 10.1016/0005-2795(76)90223-3; MORROW JS, 1974, J BIOL CHEM, V249, P7484; MULLEREBERHARD U, 1988, METHOD ENZYMOL, V163, P536; O'Neil M.J., 2006, MERCK INDEX; OKAZAKI H, 1989, CELL STRUCT FUNCT, V14, P129, DOI 10.1247/csf.14.129; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Paoli M, 1999, NAT STRUCT BIOL, V6, P926; POTTER D, 1993, ARCH BIOCHEM BIOPHYS, V300, P98, DOI 10.1006/abbi.1993.1014; Rosell FI, 2007, BIOCHEMISTRY-US, V46, P9301, DOI 10.1021/bi7008079; Rosell FI, 2005, BIOCHEMISTRY-US, V44, P1872, DOI 10.1021/bi0480077; Rozga M, 2007, J BIOL INORG CHEM, V12, P913, DOI 10.1007/s00775-007-0244-8; SEERY VL, 1972, ARCH BIOCHEM BIOPHYS, V150, P269, DOI 10.1016/0003-9861(72)90035-5; Shipulina NV, 2001, J PROTEIN CHEM, V20, P145, DOI 10.1023/A:1011033625009; SMITH A, 1979, BIOCHEM J, V182, P47, DOI 10.1042/bj1820047; SMITH A, 1990, EUR J CELL BIOL, V53, P234; SMITH A, 1978, BIOCHEM BIOPH RES CO, V84, P151, DOI 10.1016/0006-291X(78)90276-0; Smith A, 2009, BIOMETALS, V22, P421, DOI 10.1007/s10534-008-9178-z; Sonawane ND, 2003, J CELL BIOL, V160, P1129, DOI 10.1083/jcb.200211098; Sonawane ND, 2002, J BIOL CHEM, V277, P5506, DOI 10.1074/jbc.M110818200; Suzuki K, 2003, CELL STRUCT FUNCT, V28, P243, DOI 10.1247/csf.28.243; TAKAHASHI N, 1985, J CHROMATOGR, V326, P373, DOI 10.1016/S0021-9673(01)87463-X; Tolosano E, 1999, BLOOD, V94, P3906, DOI 10.1182/blood.V94.11.3906; Tolosano E, 1996, BIOCHEM BIOPH RES CO, V218, P694, DOI 10.1006/bbrc.1996.0124; Tolosano E, 2002, BLOOD, V100, P4201, DOI 10.1182/blood-2002-04-1270; Tolosano E, 2002, DNA CELL BIOL, V21, P297, DOI 10.1089/104454902753759717; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; VALLEE BL, 1948, J BIOL CHEM, V176, P445; VANDYKE RW, 1995, AM J PHYSIOL-CELL PH, V269, pC943, DOI 10.1152/ajpcell.1995.269.4.C943; WITTMANN B, 1981, J BIOL CHEM, V256, P8332; Wu A.H.B., 2006, TIETZ CLIN GUIDE LAB; Zak O, 2003, BIOCHEMISTRY-US, V42, P12330, DOI 10.1021/bi034991f	62	3	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20499	20506		10.1074/jbc.M110.123406	http://dx.doi.org/10.1074/jbc.M110.123406			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430887	hybrid, Green Published			2022-12-25	WOS:000279228600010
J	Mistretta, N; Seguin, D; Thiebaud, J; Vialle, S; Blanc, F; Brossaud, M; Talaga, P; Norheim, G; Moreau, M; Rokbi, B				Mistretta, Noelle; Seguin, Delphine; Thiebaud, Jerome; Vialle, Sandrine; Blanc, Frederic; Brossaud, Marina; Talaga, Philippe; Norheim, Gunnstein; Moreau, Monique; Rokbi, Bachra			Genetic and Structural Characterization of L11 Lipooligosaccharide from Neisseria meningitidis Serogroup A Strains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE CORE OLIGOSACCHARIDES; INNER-CORE; MOLECULAR EPIDEMIOLOGY; PHASE VARIATION; SUBGROUP-III; IDENTIFICATION; BIOSYNTHESIS; PHOSPHOETHANOLAMINE; LOS; LOCALIZATION	The lipooligosaccharide (LOS) of immunotype L11 is unique within serogroup A meningococci. In order to resolve its molecular structure, we conducted LOS genotyping by PCR analysis of genes responsible for alpha-chain sugar addition (lgtA, -B, -C, -E, -H, and -F) and inner core substituents (lgtG, lpt-3, and lpt-6). For this study, we selected seven strains belonging to subgroup III, a major clonal complex responsible for meningococcal meningitis epidemics in Africa. In addition, we sequenced the homopolymeric tract regions of three phase-variable genes (lgtA, lgtG, and lot-3) to predict gene functionality. The fine structure of the L11 LOS of each strain was determined using composition and glycosyl linkage analyses, NMR, and mass spectrometry. The masses of the dephosphorylated oligosaccharides were consistent with an oligosaccharide composed of two hexoses, one N-acetyl-hexosamine, two heptoses, and one KDO, as proposed previously. The molar composition of LOS showed two glucose residues to be present, in agreement with lgtH sequence prediction. Despite phosphoethanolaminetransferase genes lpt-3 and lpt-6 being present in all seven Neisseria meningitidis strains, phosphoethanolamine (PEtn) was found at both O-3 and O-6 of HepII among the three ST-5 strains, whereas among the four ST-7 strains, only one PEtn was found and located at O-3 of the HepII. The L11 LOS was found to be O-acetylated, as was indicated by the presence of the lot-3 gene being in-frame in all of the seven N. meningitidis strains. To our knowledge, these studies represent the first full genetic and structural characterization of the L11 LOS of N. meningitidis. These investigations also suggest the presence of further regulatory mechanisms affecting LOS structure microheterogeneity in N. meningitidis related to PEtn decoration of the inner core.	[Mistretta, Noelle; Seguin, Delphine; Thiebaud, Jerome; Vialle, Sandrine; Blanc, Frederic; Brossaud, Marina; Talaga, Philippe; Moreau, Monique; Rokbi, Bachra] Sanofi Pasteur, F-69280 Marcy Letoile, France; [Norheim, Gunnstein] Univ Oxford, Dept Paediat, Oxford OX14, England	University of Oxford	Rokbi, B (corresponding author), Sanofi Pasteur, 1541 Ave Marcel Merieux, F-69280 Marcy Letoile, France.	bachra.rokbi@sanofipasteur.com						ACHTMAN M, 1992, J INFECT DIS, V165, P53, DOI 10.1093/infdis/165.1.53; Banerjee A, 1998, P NATL ACAD SCI USA, V95, P10872, DOI 10.1073/pnas.95.18.10872; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; Berrington AW, 2002, FEMS IMMUNOL MED MIC, V34, P267, DOI 10.1016/S0928-8244(02)00369-3; Braun JM, 2004, VACCINE, V22, P898, DOI 10.1016/j.vaccine.2003.11.036; Caugant DA, 1998, APMIS, V106, P505, DOI 10.1111/j.1699-0463.1998.tb01379.x; Caugant DA, 2007, VACCINE, V25, pA8, DOI 10.1016/j.vaccine.2007.04.033; Choudhury B, 2008, CARBOHYD RES, V343, P2971, DOI 10.1016/j.carres.2008.08.026; Cox AD, 2002, CARBOHYD RES, V337, P1435, DOI 10.1016/S0008-6215(02)00161-1; Cox AD, 2002, EUR J BIOCHEM, V269, P4169, DOI 10.1046/j.1432-1033.2002.03131.x; DIFABIO JL, 1990, CAN J CHEM, V68, P1029, DOI 10.1139/v90-160; GAMIAN A, 1992, J BIOL CHEM, V267, P922; GIBSON BW, 1993, J BACTERIOL, V175, P2702, DOI 10.1128/JB.175.9.2702-2712.1993; GOTSCHLICH EC, 1994, J EXP MED, V180, P2181, DOI 10.1084/jem.180.6.2181; Griffiss JM, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P179; Jennings MP, 1999, MICROBIOL-UK, V145, P3013, DOI 10.1099/00221287-145-11-3013; Kahler CM, 2006, J BIOL CHEM, V281, P19939, DOI 10.1074/jbc.M601308200; Kahler CM, 1998, CRIT REV MICROBIOL, V24, P281, DOI 10.1080/10408419891294216; Kahler CM, 2005, GLYCOBIOLOGY, V15, P409, DOI 10.1093/glycob/cwi018; KIM JJ, 1994, INFECT IMMUN, V62, P1566, DOI 10.1128/IAI.62.5.1566-1575.1994; KIM JJ, 1988, INFECT IMMUN, V56, P2631, DOI 10.1128/IAI.56.10.2631-2638.1988; Kim JS, 2006, CARBOHYD RES, V341, P1061, DOI 10.1016/j.carres.2006.03.008; Kogan G, 1997, CARBOHYD RES, V298, P191, DOI 10.1016/S0008-6215(96)00305-9; Lapeyssonnie L., 1963, B WHO              S, V28, P3; Mackinnon FG, 2002, MOL MICROBIOL, V43, P931, DOI 10.1046/j.1365-2958.2002.02754.x; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; MANDRELL RE, 1977, INFECT IMMUN, V16, P471, DOI 10.1128/IAI.16.2.471-475.1977; MICHON F, 1990, J BIOL CHEM, V265, P7243; Nicolas P, 2005, J CLIN MICROBIOL, V43, P5129, DOI 10.1128/JCM.43.10.5129-5135.2005; Norheim G, 2006, J CLIN MICROBIOL, V44, P861, DOI 10.1128/JCM.44.3.861-871.2006; Norheim G, 2008, CLIN VACCINE IMMUNOL, V15, P863, DOI 10.1128/CVI.00252-07; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; PAVLIAK V, 1993, J BIOL CHEM, V268, P14146; Rahman MM, 1998, CARBOHYD RES, V307, P311; Talaga P, 2002, VACCINE, V20, P2474, DOI 10.1016/S0264-410X(02)00183-4; Tsai CM, 2009, J BIOL CHEM, V284, P4616, DOI 10.1074/jbc.M808209200; Tsai CM, 2002, INFECT IMMUN, V70, P407, DOI 10.1128/IAI.70.1.407-411.2002; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vialle S, 2005, CARBOHYD RES, V340, P91, DOI 10.1016/j.carres.2004.10.021; Wakarchuk WW, 1998, EUR J BIOCHEM, V254, P626, DOI 10.1046/j.1432-1327.1998.2540626.x; Wenzel CQ, 2010, J BACTERIOL, V192, P208, DOI 10.1128/JB.00558-09; WESTPHAL O, 1965, METHODS CARBOHYDR RE, V5, P91; Wright JC, 2004, J BACTERIOL, V186, P6970, DOI 10.1128/JB.186.20.6970-6982.2004; Wright JC, 2006, HDB MENINGOCOCCAL DI, P163, DOI DOI 10.1002/3527608508.CH9; Zhu PX, 2006, MICROBIOL-SGM, V152, P123, DOI 10.1099/mic.0.28327-0; Zhu PX, 2002, MICROBIOL-SGM, V148, P1833, DOI 10.1099/00221287-148-6-1833; Zhu PX, 2001, FEMS MICROBIOL LETT, V203, P173, DOI 10.1111/j.1574-6968.2001.tb10837.x; Zhu PX, 2001, P NATL ACAD SCI USA, V98, P5234, DOI 10.1073/pnas.061386098; ZOLLINGER WD, 1980, INFECT IMMUN, V28, P451; ZOLLINGER WD, 1977, INFECT IMMUN, V18, P424, DOI 10.1128/IAI.18.2.424-433.1977	50	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19874	19883		10.1074/jbc.M110.100636	http://dx.doi.org/10.1074/jbc.M110.100636			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20421293	Green Published, hybrid			2022-12-25	WOS:000279012000020
J	Nurisso, A; Blanchard, B; Audfray, A; Rydner, L; Oscarson, S; Varrot, A; Imberty, A				Nurisso, Alessandra; Blanchard, Bertrand; Audfray, Aymeric; Rydner, Lina; Oscarson, Stefan; Varrot, Annabelle; Imberty, Anne			Role of Water Molecules in Structure and Energetics of Pseudomonas aeruginosa Lectin I Interacting with Disaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORCE-FIELD; PA-I; CARBOHYDRATE-BINDING; AUTOMATED DOCKING; FREE-ENERGIES; D-GALACTOSE; DYNAMICS; DERIVATIVES; MECHANICS; GLYCOSPHINGOLIPIDS	Calcium-dependent lectin I from Pseudomonas aeruginosa (PA-IL) binds specifically to oligosaccharides presenting an alpha-galactose residue at their nonreducing end, such as the disaccharides alpha Gal1-2 beta GalOMe, alpha Gal1-3 beta GalOMe, and alpha Gal1-4 beta GalOMe. This provides a unique model for studying the effect of the glycosidic linkage of the ligands on structure and thermodynamics of the complexes by means of experimental and theoretical tools. The structural features of PA-IL in complex with the three disaccharides were established by docking and molecular dynamics simulations and compared with those observed in available crystal structures, including PA-IL center dot alpha Gal1-2 beta GalOMe complex, which was solved at 2.4 angstrom resolution and reported herein. The role of a structural bridge water molecule in the binding site of PA-IL was also elucidated through molecular dynamics simulations and free energy calculations. This water molecule establishes three very stable hydrogen bonds with O6 of nonreducing galactose, oxygen from Pro-51 main chain, and nitrogen from Gln-53 main chain of the lectin binding site. Binding free energies for PA-IL in complex with the three disaccharides were investigated, and the results were compared with the experimental data determined by titration microcalorimetry. When the bridge water molecule was included in the free energy calculations, the simulations predicted the correct binding affinity trends with the 1-2-linked disaccharide presenting three times stronger affinity ligand than the other two. These results highlight the role of the water molecule in the binding site of PA-IL and indicate that it should be taken into account when designing glycoderivatives active against P. aeruginosa adhesion.	[Nurisso, Alessandra; Blanchard, Bertrand; Audfray, Aymeric; Varrot, Annabelle; Imberty, Anne] Univ Grenoble 1, CNRS, CERMAV, F-38041 Grenoble 09, France; [Nurisso, Alessandra; Blanchard, Bertrand; Audfray, Aymeric; Varrot, Annabelle; Imberty, Anne] Inst Chim Mol Grenoble, CNRS, CERMAV, F-38041 Grenoble 09, France; [Rydner, Lina; Oscarson, Stefan] Univ Coll Dublin, Sch Chem & Chem Biol, Ctr Synth & Chem Biol, Dublin 4, Ireland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University College Dublin	Imberty, A (corresponding author), Univ Grenoble 1, CNRS, CERMAV, BP53, F-38041 Grenoble 09, France.	Imberty@cermav.cnrs.fr	; Imberty, Anne/P-6451-2018	Varrot, Annabelle/0000-0001-6667-8162; Imberty, Anne/0000-0001-6825-9527; Oscarson, Stefan/0000-0002-8273-4918	CNRS; European Economic Community [MEST-CT-2004-503322, MRTN-CT-2006-035546]; French Ministry of Research; Science Foundation Ireland; Association Vaincre la Mucoviscidose; GDR Pseudomonas	CNRS(Centre National de la Recherche Scientifique (CNRS)); European Economic Community; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Association Vaincre la Mucoviscidose; GDR Pseudomonas	This work was supported by CNRS. This work was also supported by European Economic Community Programs MEST-CT-2004-503322 (CermavTrain) and MRTN-CT-2006-035546 (NODPERCEPTION) (to A. N.) and funds from the French Ministry of Research (to B. B.), the Science Foundation Ireland (to L. R.), the Association Vaincre la Mucoviscidose, and the GDR Pseudomonas.	ALLINGER NL, 1989, J AM CHEM SOC, V111, P8551, DOI 10.1021/ja00205a001; Andersson C, 1999, J MOL GRAPH MODEL, V17, P101, DOI 10.1016/S1093-3263(99)00022-4; ANDREINI M, 2010, CARBOHYDR R IN PRESS; AVILA JL, 1992, AM J TROP MED HYG, V47, P413, DOI 10.4269/ajtmh.1992.47.413; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blanchard B, 2008, J MOL BIOL, V383, P837, DOI 10.1016/j.jmb.2008.08.028; Bradbrook GM, 1998, J CHEM SOC FARADAY T, V94, P1603, DOI 10.1039/a800429c; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cecioni S, 2009, CHEM-EUR J, V15, P13232, DOI 10.1002/chem.200901799; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Cioci G, 2003, FEBS LETT, V555, P297, DOI 10.1016/S0014-5793(03)01249-3; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Corzana F, 2002, GLYCOBIOLOGY, V12, P241, DOI 10.1093/glycob/12.4.241; Dam TK, 2002, CHEM REV, V102, P387, DOI 10.1021/cr000401x; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DOGGETT RG, 1972, INFECT IMMUN, V6, P628, DOI 10.1128/IAI.6.4.628-635.1972; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fogolari F, 2003, BIOPHYS J, V85, P159, DOI 10.1016/S0006-3495(03)74462-2; GARBER N, 1992, BIOCHIM BIOPHYS ACTA, V1116, P331, DOI 10.1016/0304-4165(92)90048-Y; GAREGG PJ, 1982, CARBOHYD RES, V110, P261, DOI 10.1016/0008-6215(82)84007-X; GAREGG PJ, 1985, CARBOHYD RES, V137, P270, DOI 10.1016/0008-6215(85)85169-7; GILBOAGARBER N, 1982, METHOD ENZYMOL, V83, P378; GILBOAGARBER N, 1994, GLYCOCONJUGATE J, V11, P414, DOI 10.1007/BF00731276; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; Goldstein I J, 1978, Adv Carbohydr Chem Biochem, V35, P127; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imberty A, 2004, MICROBES INFECT, V6, P221, DOI 10.1016/j.micinf.2003.10.016; IMBERTY A, 1999, PERSPECTIVES STRUCTU; Kadirvelraj R, 2008, J AM CHEM SOC, V130, P16933, DOI 10.1021/ja8039663; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; LANNE B, 1994, GLYCOCONJUGATE J, V11, P292, DOI 10.1007/BF00731201; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; Lepsik M, 2004, PROTEINS, V57, P279, DOI 10.1002/prot.20192; LESLIE AG, 1992, JNT CCP4 ESF EACMB N, V26; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; MARCHESSAULT RH, 1979, BIOPOLYMERS, V18, P2369, DOI 10.1002/bip.1979.360180925; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mishra NK, 2008, PROTEINS, V72, P382, DOI 10.1002/prot.21935; Mitchell E, 2002, NAT STRUCT BIOL, V9, P918, DOI 10.1038/nsb865; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NISHIDA Y, 1984, TETRAHEDRON LETT, V25, P1575, DOI 10.1016/S0040-4039(01)90014-0; Nurisso A, 2008, MOL SIMULAT, V34, P469, DOI 10.1080/08927020701697709; Perez S, 1998, CARBOHYD RES, V314, P141, DOI 10.1016/S0008-6215(98)00305-X; PREUSSER A, 1989, ACM T MATH SOFTWARE, V15, P79, DOI 10.1145/62038.69651; Rockey WM, 2000, PROTEINS, V40, P299, DOI 10.1002/(SICI)1097-0134(20000801)40:2<299::AID-PROT100>3.0.CO;2-G; RYCKAERT JP, 1977, J COMP CHEM, V23; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Tielker D, 2005, MICROBIOL-SGM, V151, P1313, DOI 10.1099/mic.0.27701-0; Treesuwan W, 2009, J MOL GRAPH MODEL, V27, P921, DOI 10.1016/j.jmgm.2009.02.007; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Wen X, 2005, BIOCHEMISTRY-US, V44, P6729, DOI 10.1021/bi0500426; Wong S, 2009, J CHEM THEORY COMPUT, V5, P422, DOI 10.1021/ct8003707	56	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20316	20327		10.1074/jbc.M110.108340	http://dx.doi.org/10.1074/jbc.M110.108340			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20410292	hybrid, Green Published			2022-12-25	WOS:000279012000066
J	Xia, M; Chen, YH; Wang, LC; Zandi, E; Yang, HP; Bemanian, S; Martinez-Chantar, ML; Mato, JM; Lu, SC				Xia, Meng; Chen, Yongheng; Wang, Ling-Chi; Zandi, Ebrahim; Yang, Heping; Bemanian, Sean; Luz Martinez-Chantar, M.; Mato, Jose M.; Lu, Shelly C.			Novel Function and Intracellular Localization of Methionine Adenosyltransferase 2 beta Splicing Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE; EXPRESSION; PROTEIN; CELLS	Human methionine adenosyltransferase 2 beta ( MAT2 beta) encodes for two major splicing variants, V1 and V2, which are differentially expressed in normal tissues. Both variants are induced in human liver cancer and positively regulate growth. The aim of this work was to identify interacting proteins of V1 and V2. His-tagged V1 and V2 were overexpressed in Rosetta pLysS cells, purified, and used in a pulldown assay to identify interacting proteins from human colon cancer cell line RKO cell lysates. The eluted lysates were subjected to Western blot and in solution proteomic analyses. HuR, an mRNA-binding protein known to stabilize the mRNA of several cyclins, was identified to interact with V1 and V2. Immunoprecipitation and Western blotting confirmed their interaction in both liver and colon cancer cells. These variant proteins are located in both nucleus and cytoplasm in liver and colon cancer cells and, when overexpressed, increased the cytoplasmic HuR content. This led to increased expression of cyclin D1 and cyclin A, known targets of HuR. When endogenous expression of V1 or V2 is reduced by small interference RNA, cytoplasmic HuR content fell and the expression of these HuR target genes also decreased. Knockdown of cyclin D1 or cyclin A blunted, whereas knockdown of HuR largely prevented, the ability of V1 or V2 overexpression to induce growth. In conclusion, MAT2 beta variants reside mostly in the nucleus and regulate HuR subcellular content to affect cell proliferation.	[Lu, Shelly C.] Univ So Calif, Div Gastrointestinal & Liver Dis, Dept Med, Keck Sch Med,Res Ctr Liver Dis,USC UCLA Res Ctr A, Los Angeles, CA 90033 USA; [Chen, Yongheng] Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA; [Wang, Ling-Chi; Zandi, Ebrahim] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Luz Martinez-Chantar, M.; Mato, Jose M.] Ctr Cooperat Res Biosci, Derio 48160, Bizkaia, Spain	University of Southern California; University of Southern California; University of Southern California; CIC bioGUNE	Lu, SC (corresponding author), Univ So Calif, Div Gastrointestinal & Liver Dis, Dept Med, Keck Sch Med,Res Ctr Liver Dis,USC UCLA Res Ctr A, HMR Bldg 415,2011 Zonal Ave, Los Angeles, CA 90033 USA.	shellylu@usc.edu	Lu, Shelly/AAH-5937-2021; MATO, JOSE/A-5187-2011; Chantar, Maria Luz Martinez/F-5190-2011	Lu, Shelly/0000-0003-2128-5407; MATO, JOSE/0000-0003-1264-3153; Chantar, Maria Luz Martinez/0000-0002-6446-9911	National Institutes of Health [DK51719, AT004896, GM065325]; Plan Nacional of I+D SAF [2008-04800, HEPADIP-EULSHM-CT-205]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051719, P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plan Nacional of I+D SAF; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK51719 (to S.C.L.), AT004896 (to S.C.L. and J.M.M.), and GM065325 (to E.Z.). This work was also supported by Plan Nacional of I+D SAF 2008-04800 and HEPADIP-EULSHM-CT-205 (to J.M.M.). HepG2, HuH-7, and RKO cells were provided by the Cell Culture Core, confocal microscope was provided by the Cell and Tissue Imaging Core, and in solution proteomics was provided by USC and Mass Spectrometry-based Proteomics Core of the USC Research Center for Liver Diseases (Grant DK48522).	Chen H, 2007, GASTROENTEROLOGY, V133, P207, DOI 10.1053/j.gastro.2007.03.114; Chen J, 2006, BIOINFORMATICS, V22, P1998, DOI 10.1093/bioinformatics/btl335; Fukaya Y, 2008, J BIOL CHEM, V283, P18573, DOI 10.1074/jbc.M803115200; Lu SC, 2008, J GASTROEN HEPATOL, V23, pS73, DOI 10.1111/j.1440-1746.2007.05289.x; Martinez-Chantar ML, 2006, GASTROENTEROLOGY, V131, P223, DOI 10.1053/j.gastro.2006.04.019; Martinez-Chantar ML, 2003, GASTROENTEROLOGY, V124, P940, DOI 10.1053/gast.2003.50151; Ramani K, 2008, HEPATOLOGY, V47, P521, DOI 10.1002/hep.22064; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang W, 2002, MOL CELL BIOL, V22, P3425, DOI 10.1128/MCB.22.10.3425-3436.2002; Yang HP, 2008, GASTROENTEROLOGY, V134, P281, DOI 10.1053/j.gastro.2007.10.027	10	27	29	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20015	20021		10.1074/jbc.M109.094821	http://dx.doi.org/10.1074/jbc.M109.094821			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20421296	Green Published, hybrid			2022-12-25	WOS:000279012000035
J	Fujita, Y; Kojima, K; Ohhashi, R; Hamada, N; Nozawa, Y; Kitamoto, A; Sato, A; Kondo, S; Kojima, T; Deguchi, T; Ito, M				Fujita, Yasunori; Kojima, Keitaro; Ohhashi, Riyako; Hamada, Nanako; Nozawa, Yoshinori; Kitamoto, Aya; Sato, Akira; Kondo, Shinji; Kojima, Toshio; Deguchi, Takashi; Ito, Masafumi			MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-ACTIVATED PROTEIN-KINASE-1; PROTEIN KINASE-1 MSK1; MICRORNA EXPRESSION; HISTONE H3; INDUCED PHOSPHORYLATION; C-FOS; POSTTRANSCRIPTIONAL REGULATION; LYSOPHOSPHATIDIC ACID; TUMOR-SUPPRESSOR; GENE-EXPRESSION	MicroRNAs are involved in cancer pathogenesis and act as tumor suppressors or oncogenes. It has been recently reported that miR-148a expression is down-regulated in several types of cancer. The functional roles and target genes of miR-148a in prostate cancer, however, remain unknown. In this report, we showed that miR-148a expression levels were lower in PC3 and DU145 hormone-refractory prostate cancer cells in comparison to PrEC normal human prostate epithelial cells and LNCaP hormone-sensitive prostate cancer cells. Transfection with miR-148a precursor inhibited cell growth, and cell migration and invasion, and increased the sensitivity to anti-cancer drug paclitaxel in PC3 cells. Computer-aided algorithms predicted mitogen-and stress-activated protein kinase, MSK1, as a potential target of miR-148a. Indeed, miR-148a overexpression decreased expression of MSK1. Using luciferase reporter assays, we identified MSK1 as a direct target of miR-148a. Suppression of MSK1 expression by siRNA, however, showed little or no effects on malignant phenotypes of PC3 cells. In PC3PR cells, a paclitaxel-resistant cell line established from PC3 cells, miR-148a inhibited cell growth, and cell migration and invasion, and also attenuated the resistance to paclitaxel. MiR-148a reduced MSK1 expression by directly targeting its 3'-UTR in PC3PR cells. Furthermore, MSK1 knockdown reduced paclitaxel-resistance of PC3PR cells, indicating that miR-148a attenuates paclitaxel-resistance of hormone-refractory, drug-resistant PC3PR cells in part by regulating MSK1 expression. Our findings suggest that miR-148a plays multiple roles as a tumor suppressor and can be a promising therapeutic target for hormone-refractory prostate cancer especially for drug-resistant prostate cancer.	[Fujita, Yasunori; Kojima, Keitaro; Ohhashi, Riyako; Hamada, Nanako; Nozawa, Yoshinori; Ito, Masafumi] Gifu Int Inst Biotechnol, Dept Longev & Aging Res, Gifu 5040838, Japan; [Kojima, Keitaro; Deguchi, Takashi] Gifu Univ, Grad Sch Med, Dept Urol, Gifu 5011193, Japan; [Nozawa, Yoshinori] Tokai Gakuin Univ, Dept Food & Hlth, Gifu 5048511, Japan; [Kitamoto, Aya; Sato, Akira; Kondo, Shinji; Kojima, Toshio] RIKEN Yokohama, Adv Sci Inst, Computat Syst Biol Res Grp, Konagawa 230045, Japan	Gifu University; RIKEN	Ito, M (corresponding author), 1-1 Naka Fudogaoka, Gifu 5040838, Japan.	mito@giib.or.jp		Kitamoto, Aya/0000-0002-0223-3874	Gifu prefecture, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [22700669] Funding Source: KAKEN	Gifu prefecture, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant for Biological Research from Gifu prefecture, Japan and grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Clark DE, 2005, CANCER RES, V65, P3108; Davie James R, 2003, Sci STKE, V2003, pPE33; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Duncan EA, 2006, J BIOL CHEM, V281, P12521, DOI 10.1074/jbc.M513333200; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Esteller M, 2006, BRIT J CANCER, V94, P179, DOI 10.1038/sj.bjc.6602918; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Funding AT, 2006, J INVEST DERMATOL, V126, P1784, DOI 10.1038/sj.jid.5700252; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gupta P, 2002, J BIOL CHEM, V277, P50550, DOI 10.1074/jbc.M209799200; Janknecht R, 2003, ONCOGENE, V22, P746, DOI 10.1038/sj.onc.1206185; Katada T, 2009, INT J ONCOL, V34, P537, DOI 10.3892/ijo_00000179; Kim HG, 2008, CANCER RES, V68, P2538, DOI 10.1158/0008-5472.CAN-07-6597; Lee CW, 2008, J CELL BIOCHEM, V104, P785, DOI 10.1002/jcb.21663; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Markou T, 2009, MOL CELL BIOCHEM, V322, P103, DOI 10.1007/s11010-008-9945-8; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mott JL, 2009, HEPATOLOGY, V50, P630, DOI 10.1002/hep.23010; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pathak SK, 2006, J IMMUNOL, V177, P7950, DOI 10.4049/jimmunol.177.11.7950; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Schiller M, 2006, ONCOGENE, V25, P4449, DOI 10.1038/sj.onc.1209479; Schuck S, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-6; Seux M, 2009, PANCREATOLOGY, V9, P66, DOI 10.1159/000178876; Shi XB, 2008, J CELL MOL MED, V12, P1456, DOI 10.1111/j.1582-4934.2008.00420.x; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Stallings RL, 2009, CURR PHARM DESIGN, V15, P456, DOI 10.2174/138161209787315837; Strelkov IS, 2002, CANCER RES, V62, P75; Takagi S, 2008, J BIOL CHEM, V283, P9674, DOI 10.1074/jbc.M709382200; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang QZ, 2009, CURR CANCER DRUG TAR, V9, P572, DOI 10.2174/156800909788486731; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Yaqinuddin A, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-13; Zhang H, 2009, SCI CHINA SER C, V52, P224, DOI 10.1007/s11427-009-0036-1; Zhong SP, 2001, J BIOL CHEM, V276, P33213, DOI 10.1074/jbc.M103973200	39	163	183	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19076	19084		10.1074/jbc.M109.079525	http://dx.doi.org/10.1074/jbc.M109.079525			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20406806	hybrid, Green Published			2022-12-25	WOS:000278727800017
J	Nawaratne, V; Leach, K; Felder, CC; Sexton, PM; Christopoulos, A				Nawaratne, Vindhya; Leach, Katie; Felder, Christian C.; Sexton, Patrick M.; Christopoulos, Arthur			Structural Determinants of Allosteric Agonism and Modulation at the M-4 Muscarinic Acetylcholine Receptor IDENTIFICATION OF LIGAND-SPECIFIC AND GLOBAL ACTIVATION MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; SITE-DIRECTED MUTAGENESIS; GALLAMINE; BINDING; MODELS; SWITCH; DRUG; SCHIZOPHRENIA; SELECTIVITY; MUTATIONS	The recently identified small molecule, 3-amino-5-chloro-6-methoxy-4-methylthieno[2,3-b]pyridine-2-carboxylic acid cyclopropylamide (LY2033298), is the first selective allosteric modulator of the muscarinic acetylcholine receptors (mAChRs) that mediates both receptor activation and positive modulation of the endogenous agonist, acetylcholine (ACh), via the same allosteric site on the M-4 mAChR. We thus utilized this novel chemical tool, as well as ACh, the bitopic (orthosteric/allosteric) agonist, McN-A-343, and the clinically efficacious M-1/M-4 mAChR-preferring agonist, xanomeline, in conjunction with site-directed mutagenesis of four different regions of the M-4 mAChR (extracellular loops 1, 2, and 3, and transmembrane domain 7), to identify regions that govern ligand-specific modes of binding, signaling, and allosteric modulation. In the first extracellular loop (E1), we identified Ile(93) and Lys(95) as key residues that specifically govern the signaling efficacy of LY2033298 and its binding cooperativity with ACh, whereas Phe(186) in the E2 loop was identified as a key contributor to the binding affinity of the modulator for the allosteric site, and Asp(432) in the E3 loop appears to be involved in the functional (activation) cooperativity between the modulator and the endogenous agonist. In contrast, the highly conserved transmembrane domain 7 residues, Tyr(439) and Tyr(443), were identified as contributing to a key activation switch utilized by all classes of agonists. These results provide new insights into the existence of multiple activation switches in G protein-coupled receptors (GPCRs), some of which can be selectively exploited by allosteric agonists, whereas others represent global activation mechanisms for all classes of ligand.	[Nawaratne, Vindhya; Leach, Katie; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Nawaratne, Vindhya; Leach, Katie; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Felder, Christian C.] Eli Lilly & Co, Indianapolis, IN 46285 USA	Monash University; Monash University; Eli Lilly	Sexton, PM (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia.	patrick.sexton@med.monash.edu.au; arthur.christopoulos@med.monash.edu.au	Sexton, Patrick M/B-1319-2008; Christopoulos, Arthur/B-6207-2013	Sexton, Patrick M/0000-0001-8902-2473; Christopoulos, Arthur/0000-0003-4442-3294; Leach, Katherine/0000-0002-9280-1803; Felder, Christian/0000-0003-1134-8881	National Health and Medical Research Council (NHMRC) of Australia [519461]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Program Grant 519461 of the National Health and Medical Research Council (NHMRC) of Australia.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Chan WY, 2008, P NATL ACAD SCI USA, V105, P10978, DOI 10.1073/pnas.0800567105; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; CHRISTOPOULOS A, 2004, FITTING MODELS BIOL; Gnagey AL, 1999, MOL PHARMACOL, V56, P1245, DOI 10.1124/mol.56.6.1245; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Harmar AJ, 2009, NUCLEIC ACIDS RES, V37, pD680, DOI 10.1093/nar/gkn728; Huang XP, 2005, MOL PHARMACOL, V68, P769, DOI 10.1124/mol.105.014043; Hulme EC, 2003, BIOCHEM SOC T, V31, P29, DOI 10.1042/bst0310029; Jones CK, 2008, J NEUROSCI, V28, P10422, DOI 10.1523/JNEUROSCI.1850-08.2008; Krejci A, 2001, MOL PHARMACOL, V60, P761; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; LAZARENO S, 1995, MOL PHARMACOL, V48, P362; Leach K, 2010, NEUROPSYCHOPHARMACOL, V35, P855, DOI 10.1038/npp.2009.194; Lu ZL, 2001, J BIOL CHEM, V276, P34098, DOI 10.1074/jbc.M104217200; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; Nawaratne V, 2008, MOL PHARMACOL, V74, P1119, DOI 10.1124/mol.108.049353; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shekhar A, 2008, AM J PSYCHIAT, V165, P1033, DOI 10.1176/appi.ajp.2008.06091591; Spalding TA, 2002, MOL PHARMACOL, V61, P1297, DOI 10.1124/mol.61.6.1297; Sur C, 2003, P NATL ACAD SCI USA, V100, P13674, DOI 10.1073/pnas.1835612100; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; WESS J, 1991, EMBO J, V10, P3729, DOI 10.1002/j.1460-2075.1991.tb04941.x; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006	31	57	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19012	19021		10.1074/jbc.M110.125096	http://dx.doi.org/10.1074/jbc.M110.125096			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20406819	hybrid, Green Published			2022-12-25	WOS:000278727800009
J	Caballero, F; Fernandez, A; Matias, N; Martinez, L; Fucho, R; Elena, M; Caballeria, J; Morales, A; Fernandez-Checa, JC; Garcia-Ruiz, C				Caballero, Francisco; Fernandez, Anna; Matias, Nuria; Martinez, Laura; Fucho, Raquel; Elena, Montserrat; Caballeria, Joan; Morales, Albert; Fernandez-Checa, Jose C.; Garcia-Ruiz, Carmen			Specific Contribution of Methionine and Choline in Nutritional Nonalcoholic Steatohepatitis IMPACT ON MITOCHONDRIAL S-ADENOSYL-L-METHIONINE AND GLUTATHIONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; INSULIN-RESISTANCE; FREE-CHOLESTEROL; RAT HEPATOCYTES; DEFICIENT DIET; LIVER; MODEL; MICE; DISEASE; PHOSPHATIDYLCHOLINE	The pathogenesis and treatment of nonalcoholic steatohepatitis (NASH) are not well established. Feeding a diet deficient in both methionine and choline (MCD) is one of the most common models of NASH, which is characterized by steatosis, mitochondrial dysfunction, hepatocellular injury, oxidative stress, inflammation, and fibrosis. However, the individual contribution of the lack of methionine and choline in liver steatosis, advanced pathology and impact on mitochondrial S-adenosyl-L-methionine (SAM) and glutathione (GSH), known regulators of disease progression, has not been specifically addressed. Here, we examined the regulation of mitochondrial SAM and GSH and signs of disease in mice fed a MCD, methionine-deficient (MD), or choline-deficient (CD) diet. The MD diet reproduced most of the deleterious effects of MCD feeding, including weight loss, hepatocellular injury, oxidative stress, inflammation, and fibrosis, whereas CD feeding was mainly responsible for steatosis, characterized by triglycerides and free fatty acids accumulation. These findings were preceded by MCD- or MD-mediated SAM and GSH depletion in mitochondria due to decreased mitochondrial membrane fluidity associated with a lower phosphatidylcholine/phosphatidylethanolamine ratio. MCD and MD but not CD feeding resulted in increased ceramide levels by acid sphingomyelinase. Moreover, GSH ethyl ester or SAM therapy restored mitochondrial GSH and ameliorated hepatocellular injury in mice fed a MCD or MD diet. Thus, the depletion of SAM and GSH in mitochondria is an early event in the MCD model of NASH, which is determined by the lack of methionine. Moreover, therapy using permeable GSH prodrugs may be of relevance in NASH.	[Caballero, Francisco; Fernandez, Anna; Matias, Nuria; Martinez, Laura; Fucho, Raquel; Morales, Albert; Fernandez-Checa, Jose C.; Garcia-Ruiz, Carmen] IIBB CSIC, Dept Cell Death & Proliferat, Barcelona 08036, Spain; [Elena, Montserrat] Hosp Clin Barcelona, Ctr Diagnost Biomed, Barcelona 08936, Spain; [Fernandez-Checa, Jose C.] Univ So Calif, Keck Sch Med, Res Ctr Alcohol Liver & Pancreat Dis, Los Angeles, CA 90089 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Southern California	Fernandez-Checa, JC (corresponding author), IIBB CSIC, Dept Cell Death & Proliferat, C Rosello 161, Barcelona 08036, Spain.	checa229@yahoo.com; cgrbam@iibb.csic.es	Martinez-Gili, Laura/GPT-3558-2022; Fernández-Checa, José Carlos/L-8342-2014; Fernandez, Anna/M-4711-2015; Morales, Albert/E-2988-2013; Fucho, Raquel/A-6684-2016; Garcia-Ruiz, Carmen/L-8211-2014	Martinez-Gili, Laura/0000-0001-5271-9672; Fernández-Checa, José Carlos/0000-0003-3422-2990; Fernandez, Anna/0000-0002-0252-7442; Morales, Albert/0000-0001-8702-2269; Fucho, Raquel/0000-0002-1774-9099; Garcia-Ruiz, Carmen/0000-0002-2652-6102	Research Center for Liver and Pancreatic Diseases [P50-AA-11999]; Plan Nacional de I+D Grants [SAF2006-06780, SAF2008-02199, SAF2008-04974, SAF2009-11417]; Instituto de Salud Carlos III [PI070193, PI09/00056]; Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas from the Intituto Carlos III, the Mutua Madrilena; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999] Funding Source: NIH RePORTER	Research Center for Liver and Pancreatic Diseases; Plan Nacional de I+D Grants; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas from the Intituto Carlos III, the Mutua Madrilena; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institute on Alcohol Abuse and Alcoholism Center Grant P50-AA-11999 from the Research Center for Liver and Pancreatic Diseases. This work was also supported by Plan Nacional de I+D Grants SAF2006-06780, SAF2008-02199, SAF2008-04974, and SAF2009-11417, Instituto de Salud Carlos III Grants PI070193 and PI09/00056, by Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas from the Intituto Carlos III, the Mutua Madrilena.	Ahsan MK, 2009, ANTIOXID REDOX SIGN, V11, P2573, DOI 10.1089/ars.2009.2385; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Baumgardner JN, 2008, J NUTR, V138, P1872, DOI 10.1093/jn/138.10.1872; Behari J, 2010, AM J PATHOL, V176, P744, DOI 10.2353/ajpath.2010.090667; Brunt EM, 2004, SEMIN LIVER DIS, V24, P3; Caballero F, 2009, J HEPATOL, V50, P789, DOI 10.1016/j.jhep.2008.12.016; Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007; Colell A, 2003, J BIOL CHEM, V278, P33928, DOI 10.1074/jbc.M210943200; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Fernandez A, 2009, ALCOHOL CLIN EXP RES, V33, P1169, DOI 10.1111/j.1530-0277.2009.00940.x; Fernandez A, 2009, J NEUROSCI, V29, P6394, DOI 10.1523/JNEUROSCI.4909-08.2009; Garcia-Ruiz C, 2000, HEPATOLOGY, V32, P56, DOI 10.1053/jhep.2000.8267; GARCIARUIZ C, 1995, HEPATOLOGY, V21, P207, DOI 10.1002/hep.1840210133; Henkel AS, 2009, J BIOL CHEM, V284, P31807, DOI 10.1074/jbc.M109.017970; Ji C, 2004, WORLD J GASTROENTERO, V10, P1699; KENNEDY EP, 1956, J BIOL CHEM, V222, P185; Kulinski A, 2004, J BIOL CHEM, V279, P23916, DOI 10.1074/jbc.M312676200; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Llacuna L, 2006, HEPATOLOGY, V44, P561, DOI 10.1002/hep.21285; Malaguarnera M, 2009, J MOL MED, V87, P679, DOI 10.1007/s00109-009-0464-1; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; Mari M, 2010, ANTIOXID REDOX SIGN, V12, P1295, DOI 10.1089/ars.2009.2634; Mas E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007929; Mato JM, 2007, HEPATOLOGY, V45, P1306, DOI 10.1002/hep.21650; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; Oz HS, 2008, DIGEST DIS SCI, V53, P767, DOI 10.1007/s10620-007-9900-7; Oz HS, 2006, J BIOCHEM MOL TOXIC, V20, P39, DOI 10.1002/jbt.20109; Pogribny IP, 2009, J HEPATOL, V51, P176, DOI 10.1016/j.jhep.2009.03.021; Ramos B, 2003, MOL PHARMACOL, V64, P502, DOI 10.1124/mol.64.2.502; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Serviddio G, 2008, GUT, V57, P957, DOI 10.1136/gut.2007.147496; TANG B, 2010, NUTRITION IN PRESS; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; Tomita K, 2008, HEPATOLOGY, V48, P458, DOI 10.1002/hep.22365; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Varela-Rey M, 2009, INT J BIOCHEM CELL B, V41, P969, DOI 10.1016/j.biocel.2008.10.027; Vetelainen R, 2007, J GASTROEN HEPATOL, V22, P1526, DOI 10.1111/j.1440-1746.2006.04701.x; Witek RP, 2009, HEPATOLOGY, V50, P1421, DOI 10.1002/hep.23167; Yen CLE, 2002, J NUTR, V132, P1840, DOI 10.1093/jn/132.7.1840	42	158	167	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18528	18536		10.1074/jbc.M109.099333	http://dx.doi.org/10.1074/jbc.M109.099333			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20395294	Green Published, hybrid			2022-12-25	WOS:000278453900046
J	Inoue, N; Kasahara, T; Ikawa, M; Okabe, M				Inoue, Naokazu; Kasahara, Tatsuya; Ikawa, Masahito; Okabe, Masaru			Identification and Disruption of Sperm-Specific Angiotensin Converting Enzyme-3 (ACE3) in Mouse	PLOS ONE			English	Article							EGG PLASMA-MEMBRANE; CD9-DEFICIENT MICE; MALE-FERTILITY; PROTEIN IZUMO; FUSION; FERTILIZATION; MECHANISMS; HOMOLOG; BINDING; TESTIS	Background: IZUMO1 is the only sperm protein which is proven to be essential for sperm-egg fusion. However, the IZUMO1 is a structurally simple protein with single Ig domain and seems not to include either a "fusogenic peptide" or a fusion machinery domain. This led us to assume the existence of an ZUMO1-interacting protein(s) which makes a functional fusion machine interacting with IZUMO1. Methodology/Principal Findings: We produced a transgenic mouse line which expresses His-tagged IZUMO1 in the Izumo1(-/-) genetic background. After solubilization of sperm membranes, we purified His-tagged IZUMO1 using anti-His affinity chromatography and found a protein that interacts with IZUMO1. After being separated on SDS-PAGE gel, the IZUMO1-interacting protein was subjected to LC-MS/MS analysis and from the partial fragments, we identified the protein as ACE3. We raised the antibody against ACE3 and found that ACE3 is localized on the acrosomal cap area as in the case of IZUMO1. However, ACE3 disappeared from sperm after acrosome reaction while IZUMO1 remained on sperm. In order to investigate the role of ACE3 in vivo, we generated Ace3-deficient mice by homologous recombination and examined the fertilizing ability of the males. Unexpectedly, the male mice showed no defect in fertilizing ability in in vivo or in an in vitro fertilization system. Conclusions/Significance: We identified an IZUMO1-interacting protein in sperm, which we identified as testis specific ACE homologue ACE3. We produced an Ace3 disrupted mouse line, and found the localization of IZUMO1 spread in a little wider area on sperm, but the elimination of ACE3 did not result in a loss of sperm fertilizing ability, differing from the case of ACE disruption.	[Inoue, Naokazu; Kasahara, Tatsuya; Ikawa, Masahito; Okabe, Masaru] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan	Osaka University	Inoue, N (corresponding author), Osaka Univ, Microbial Dis Res Inst, Osaka, Japan.	Okabe@gen-info.osaka-u.ac.jp	ikawa, masahito/A-5315-2009; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Inoue, Naokazu/0000-0002-6187-8293; Okabe, Masaru/0000-0002-0803-9044	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Nakajima Foundation; Uehara Memorial Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science; Senri Life Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakajima Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Senri Life Science Foundation	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, The Nakajima Foundation, The Uehara Memorial Foundation, NOVARTIS Foundation (Japan) for the Promotion of Science, and The Senri Life Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Deguchi E, 2007, BIOL REPROD, V77, P794, DOI 10.1095/biolreprod.107.060004; Douglas GC, 2004, ENDOCRINOLOGY, V145, P4703, DOI 10.1210/en.2004-0443; Ellerman DA, 2009, MOL REPROD DEV, V76, P1188, DOI 10.1002/mrd.21092; Fuchs S, 2005, NAT MED, V11, P1140, DOI 10.1038/nm1105-1140; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Ikawa M, 2010, J CLIN INVEST, V120, P984, DOI 10.1172/JCI41585; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Inoue Naokazu, 2007, Soc Reprod Fertil Suppl, V65, P363; Inoue N, 2008, BIOCHEM BIOPH RES CO, V377, P910, DOI 10.1016/j.bbrc.2008.10.073; Kaji K, 2000, NAT GENET, V24, P279, DOI 10.1038/73502; Kessler SP, 2000, J BIOL CHEM, V275, P26259, DOI 10.1074/jbc.M004006200; Kim KS, 2001, BIOL REPROD, V64, P36, DOI 10.1095/biolreprod64.1.36; Kondoh G, 2005, NAT MED, V11, P160, DOI 10.1038/nm1179; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Ramalho-Santos J, 2001, EXP CELL RES, V267, P45, DOI 10.1006/excr.2000.5119; Rella M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-194; Sun XO, 2008, BIOL CHEM, V389, P1477, DOI 10.1515/BC.2008.168; Yamagata K, 2002, DEV BIOL, V250, P348, DOI 10.1006/dbio.2002.0803; Yamashita M, 2008, GENES CELLS, V13, P1001, DOI 10.1111/j.1365-2443.2008.01222.x	23	38	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10301	10.1371/journal.pone.0010301	http://dx.doi.org/10.1371/journal.pone.0010301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421979	Green Submitted, Green Published, gold			2022-12-25	WOS:000276952600018
J	Cooper, PR; Mesaros, AC; Zhang, J; Christmas, P; Stark, CM; Douaidy, K; Mittelman, MA; Soberman, RJ; Blair, IA; Panettieri, RA				Cooper, Philip R.; Mesaros, A. Clementina; Zhang, Jie; Christmas, Peter; Stark, Christopher M.; Douaidy, Karim; Mittelman, Michael A.; Soberman, Roy J.; Blair, Ian A.; Panettieri, Reynold A., Jr.			20-HETE Mediates Ozone-Induced, Neutrophil-Independent Airway Hyper-Responsiveness in Mice	PLOS ONE			English	Article							ALLERGEN-SENSITIZED MICE; 20-HYDROXYEICOSATETRAENOIC ACID; CYTOCHROME-P450 4A; MESSENGER-RNA; GUINEA-PIGS; INFLAMMATION; EXPOSURE; LUNG; RAT; INHIBITION	Background: Ozone, a pollutant known to induce airway hyper-responsiveness (AHR), increases morbidity and mortality in patients with obstructive airway diseases and asthma. We postulate oxidized lipids mediate in vivo ozone-induced AHR in murine airways. Methodology/Principal Findings: Male BALB/c mice were exposed to ozone (3 or 6 ppm) or filtered air (controls) for 2 h. Precision cut lung slices (PCLS; 250 mu m thickness) containing an intrapulmonary airway (similar to 0.01 mm(2) lumen area) were prepared immediately after exposure or 16 h later. After 24 h, airways were contracted to carbachol (CCh). Log EC(50) and E(max) values were then calculated by measuring the airway lumen area with respect to baseline. In parallel studies, dexamethasone (2.5 mg/kg), or 1-aminobenzotriazol (ABT) (50 mg/kg) were given intraperitoneal injection to naive mice 18 h prior to ozone exposure. Indomethacin (10 mg/kg) was administered 2 h prior. Cell counts, cytokine levels and liquid chromatography-mass spectrometry (LC-MS) for lipid analysis were assessed in bronchoalveolar lavage (BAL) fluid from ozone exposed and control mice. Ozone acutely induced AHR to CCh. Dexamethasone or indomethacin had little effect on the ozone-induced AHR; while, ABT, a cytochrome P450 inhibitor, markedly attenuated airway sensitivity. BAL fluid from ozone exposed animals, which did not contain an increase in neutrophils or interleukin (IL)-6 levels, increased airway sensitivity following in vitro incubation with a naive PCLS. In parallel, significant increases in oxidized lipids were also identified using LC-MS with increases of 20-HETE that were decreased following ABT treatment. Conclusions/Significance: These data show that ozone acutely induces AHR to CCh independent of inflammation and is insensitive to steroid treatment or cyclooxygenase (COX) inhibition. BAL fluid from ozone exposed mice mimicked the effects of in vivo ozone exposure that were associated with marked increases in oxidized lipids. 20-HETE plays a pivotal role in mediating acute ozone-induced AHR.	[Cooper, Philip R.; Zhang, Jie; Mittelman, Michael A.; Panettieri, Reynold A., Jr.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Cooper, Philip R.; Zhang, Jie; Mittelman, Michael A.; Panettieri, Reynold A., Jr.] Univ Penn, Sch Med, Airways Biol Initiat, Philadelphia, PA 19104 USA; [Mesaros, A. Clementina; Blair, Ian A.; Panettieri, Reynold A., Jr.] Univ Penn, Ctr Canc Pharmacol, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Christmas, Peter] Radford Univ, Dept Biol, Radford, VA 24142 USA; [Christmas, Peter; Stark, Christopher M.; Douaidy, Karim; Soberman, Roy J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp E, Charlestown, MA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Radford University; Harvard University	Cooper, PR (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.	RAP@mail.med.upenn.edu; RAP@mail.med.upenn.edu	Blair, Ian A/B-3320-2010; panettieri, reynold/AAG-9485-2019	Stark, Christopher/0000-0003-1146-7063	NIH [RO1 AI-068871, RO1 RO1DK74821, P30ES013508, R01CA091016]; NATIONAL CANCER INSTITUTE [R01CA091016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	NIH RO1 AI-068871, RO1 RO1DK74821, P30ES013508 and R01CA091016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro MF, 2007, EXP LUNG RES, V33, P115, DOI 10.1080/01902140701364367; Arjomandi M, 2005, AM J RESP CRIT CARE, V172, P427, DOI 10.1164/rccm.200502-272OC; Balmes JR, 1996, AM J RESP CRIT CARE, V153, P904, DOI 10.1164/ajrccm.153.3.8630571; Bascom R, 1996, AM J RESP CRIT CARE, V153, P3, DOI 10.1164/ajrccm.153.1.8542133; Blomberg A, 1999, EUR RESPIR J, V13, P1418, DOI 10.1034/j.1399-3003.1999.13f31.x; Chen C, 2007, ENVIRON HEALTH PERSP, V115, P1732, DOI 10.1289/ehp.10294; Christmas P, 2006, J BIOL CHEM, V281, P7189, DOI 10.1074/jbc.M513101200; Cloutier M, 2003, AM J PHYSIOL-LUNG C, V285, pL560, DOI 10.1152/ajplung.00381.2002; Depuydt P, 1999, EUR RESPIR J, V14, P125, DOI 10.1034/j.1399-3003.1999.14a21.x; EVANS TW, 1988, AM REV RESPIR DIS, V138, P140, DOI 10.1164/ajrccm/138.1.140; Galan I, 2003, EUR RESPIR J, V22, P802, DOI 10.1183/09031936.03.00013003; Hazucha MJ, 1996, EUR J APPL PHYSIOL O, V73, P17, DOI 10.1007/BF00262805; Held HD, 1999, BRIT J PHARMACOL, V126, P1191, DOI 10.1038/sj.bjp.0702394; Henjakovic M, 2008, TOXICOL SCI, V106, P444, DOI 10.1093/toxsci/kfn178; Imig JD, 1996, AM J PHYSIOL-REG I, V270, pR217, DOI 10.1152/ajpregu.1996.270.1.R217; Ito K, 2008, AM J RESP CELL MOL, V39, P543, DOI 10.1165/rcmb.2008-0028OC; Jang AS, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-24; Jorres RA, 2000, AM J RESP CRIT CARE, V161, P1855; Kafoury RM, 1998, TOXICOL APPL PHARM, V150, P338, DOI 10.1006/taap.1998.8418; Kierstein S, 2008, ALLERGY, V63, P438, DOI 10.1111/j.1398-9995.2007.01587.x; Kroetz DL, 2005, ANNU REV PHARMACOL, V45, P413, DOI 10.1146/annurev.pharmtox.45.120403.100045; Le Bouquin R, 2004, FUND CLIN PHARMACOL, V18, P181, DOI 10.1111/j.1472-8206.2004.00228.x; LEE HK, 1985, AM REV RESPIR DIS, V132, P1005; Lee SH, 2007, METHOD ENZYMOL, V433, P159, DOI 10.1016/S0076-6879(07)33009-7; Marwick JA, 2007, EXPERT OPIN THER TAR, V11, P745, DOI 10.1517/14728222.11.6.745; Medina-Ramon M, 2006, AM J EPIDEMIOL, V163, P579, DOI 10.1093/aje/kwj078; MESAROS C, 2009, J CHROMATOGR B; Miyata N, 2001, BRIT J PHARMACOL, V133, P325, DOI 10.1038/sj.bjp.0704101; Morin C, 2007, AM J PHYSIOL-LUNG C, V293, pL1037, DOI 10.1152/ajplung.00145.2007; Muller DN, 2007, BIOCHEM J, V403, P109, DOI 10.1042/BJ20061328; Nakano H, 2000, EUR J PHARMACOL, V403, P267, DOI 10.1016/S0014-2999(00)00524-0; PINO MV, 1992, TOXICOL APPL PHARM, V114, P268, DOI 10.1016/0041-008X(92)90077-6; PRAKASH C, 1992, BIOCHEM BIOPH RES CO, V185, P728, DOI 10.1016/0006-291X(92)91686-K; Ratto J, 2006, ENVIRON HEALTH PERSP, V114, P209, DOI 10.1289/ehp.8341; SCHELEGLE ES, 1991, AM REV RESPIR DIS, V143, P1353, DOI 10.1164/ajrccm/143.6.1353; SCHLESINGER RB, 1990, J TOXICOL ENV HEALTH, V31, P275, DOI 10.1080/15287399009531456; SELTZER J, 1986, J APPL PHYSIOL, V60, P1321, DOI 10.1152/jappl.1986.60.4.1321; Stokstad E, 2008, SCIENCE, V319, P1602, DOI 10.1126/science.319.5870.1602a; Su P, 1998, AM J PHYSIOL-REG I, V275, pR426, DOI 10.1152/ajpregu.1998.275.2.R426; Williams AS, 2007, J APPL PHYSIOL, V103, P1189, DOI 10.1152/japplphysiol.00172.2007; Williams AS, 2007, J PHARMACOL EXP THER, V322, P351, DOI 10.1124/jpet.107.121624; Wu S, 1997, J BIOL CHEM, V272, P12551, DOI 10.1074/jbc.272.19.12551; Zhu DL, 2002, J APPL PHYSIOL, V93, P330, DOI 10.1152/japplphysiol.01159.2001; Zhu DL, 1998, AM J RESP CELL MOL, V19, P121, DOI 10.1165/ajrcmb.19.1.3145	44	35	36	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10235	10.1371/journal.pone.0010235	http://dx.doi.org/10.1371/journal.pone.0010235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422032	Green Published, gold, Green Submitted			2022-12-25	WOS:000276854300005
J	Kuznetsov, IR; Herant, M; Dembo, M				Kuznetsov, Igor R.; Herant, Marc; Dembo, Micah			Analysis of Actin FLAP Dynamics in the Leading Lamella	PLOS ONE			English	Article							NEUTROPHIL PHAGOCYTOSIS; CRAWLING CELLS; MECHANICS; FIBROBLASTS; MORPHOLOGY; MOTION; LOCOMOTION; CYTOPLASM; TRANSPORT; SURFACE	Background: The transport of labeled G-actin from the mid-lamella region to the leading edge in a highly motile malignant rat fibroblast line has been studied using fluorescence localization after photobleaching or FLAP, and the transit times recorded in these experiments were so fast that simple diffusion was deemed an insufficient explanation (see Zicha et al., Science, v. 300, pp. 142-145 [ 1]). Methodology/Principal Findings: We re-examine the Zicha FLAP experiments using a two-phase reactive interpenetrating flow formalism to model the cytoplasm and the transport dynamics of bleached and unbleached actin. By allowing an improved treatment of effects related to the retrograde flow of the cytoskeleton and of the geometry and finite thickness of the lamella, this new analysis reveals a mechanism that can realistically explain the timing and the amplitude of all the FLAP signals observed in [ 1] without invoking special transport modalities. Conclusions/Significance: We conclude that simple diffusion is sufficent to explain the observed transport rates, and that variations in the transport of labeled actin through the lamella are minor and not likely to be the cause of the observed physiological variations among different segments of the leading edge. We find that such variations in labeling can easily arise from differences and changes in the microscopic actin dynamics inside the edge compartment, and that the key dynamical parameter in this regard is the so-called "dilatation rate'' ( the velocity of cytoskeletal retrograde flow divided by a characteristic dimension of the edge compartment where rapid polymerization occurs). If our dilatation hypothesis is correct, the transient kinetics of bleached actin relocalization constitute a novel and very sensitive method for probing the cytoskeletal dynamics in leading edge micro-environments which are otherwise very difficult to directly interrogate.	[Kuznetsov, Igor R.; Herant, Marc; Dembo, Micah] Boston Univ, Boston, MA 02215 USA	Boston University	Kuznetsov, IR (corresponding author), Boston Univ, Boston, MA 02215 USA.	kouznets@bu.edu	Dembo, Micah/C-2755-2013		Whitaker biomedical engineering research [RG-02-0714]; National Institutes of Health (NIH) [RO1 GM72002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072002] Funding Source: NIH RePORTER	Whitaker biomedical engineering research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Whitaker biomedical engineering research grant RG-02-0714 to MH and National Institutes of Health (NIH) grant RO1 GM72002 to MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROM.M, 1971, EXP CELL RES, V67, P359, DOI 10.1016/0014-4827(71)90420-4; Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Alt W, 1999, MATH BIOSCI, V156, P207, DOI 10.1016/S0025-5564(98)10067-6; Atilgan E, 2005, BIOPHYS J, V89, P3589, DOI 10.1529/biophysj.105.065383; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; DEMBO M, 1989, BIOPHYS J, V55, P1053, DOI 10.1016/S0006-3495(89)82904-2; DEMBO M, 1981, J CELL BIOL, V91, P528, DOI 10.1083/jcb.91.2.528; DEMBO M, 1986, BIOPHYS J, V50, P109, DOI 10.1016/S0006-3495(86)83444-0; Drury JL, 2001, BIOPHYS J, V81, P3166, DOI 10.1016/S0006-3495(01)75953-X; DUNN G, 2004, CURRENT PROTOCOLS CE, V21, P1; Dunn GA, 2002, J MICROSC-OXFORD, V205, P109, DOI 10.1046/j.0022-2720.2001.001007.x; Fischer H.B., 1979, MIXING INLAND COASTA, P80, DOI [10.1016/B978-0-08-051177-1.50008-8, DOI 10.1016/B978-0-08-051177-1.50008-8, 10.1016/13978-0-08-051177-1.50008-8]; FISHER GW, 1988, CELL MOTIL CYTOSKEL, V11, P235, DOI 10.1002/cm.970110403; He XY, 1997, EXP CELL RES, V233, P252, DOI 10.1006/excr.1997.3585; HEACOCK CS, 1984, EXP CELL RES, V153, P402, DOI 10.1016/0014-4827(84)90609-8; Herant M, 2005, J CELL SCI, V118, P1789, DOI 10.1242/jcs.02275; Herant M, 2003, BIOPHYS J, V84, P3389, DOI 10.1016/S0006-3495(03)70062-9; Herant M, 2006, J CELL SCI, V119, P1903, DOI 10.1242/jcs.02876; KAMIYA N, 1981, ANNU REV PLANT PHYS, V32, P205, DOI 10.1146/annurev.pp.32.060181.001225; Keller H, 2002, CELL MOTIL CYTOSKEL, V53, P189, DOI 10.1002/cm.10063; Olbris DJ, 1999, BIOPHYS J, V77, P3407, DOI 10.1016/S0006-3495(99)77172-9; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Revell CM, 2006, MATRIX BIOL, V25, P523, DOI 10.1016/j.matbio.2006.07.007; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; THERIOT JA, 1992, J CELL BIOL, V119, P367, DOI 10.1083/jcb.119.2.367; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	27	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10082	10.1371/journal.pone.0010082	http://dx.doi.org/10.1371/journal.pone.0010082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419164	Green Submitted, Green Published, gold			2022-12-25	WOS:000276707100003
J	Liu, SP; Lee, SD; Lee, HT; Liu, DD; Wang, HJ; Liu, RS; Lin, SZ; Shyu, WC				Liu, Shih-Ping; Lee, Shin-Da; Lee, Hsu-Tung; Liu, Demeral David; Wang, Hsiao-Jung; Liu, Ren-Shyan; Lin, Shinn-Zong; Shyu, Woei-Cherng			Granulocyte Colony-Stimulating Factor Activating HIF-1 alpha Acts Synergistically with Erythropoietin to Promote Tissue Plasticity	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; SMOOTH-MUSCLE-CELLS; FACTOR-I; BONE-MARROW; STEM-CELLS; G-CSF; MYELODYSPLASTIC SYNDROMES; FUNCTIONAL RECOVERY; PROGENITOR CELLS	Stroke and peripheral limb ischemia are serious clinical problems with poor prognosis and limited treatment. The cytokines erythropoietin (EPO) and granulocyte-colony stimulating factor (G-CSF) have been used to induce endogenous cell repair and angiogenesis. Here, we demonstrated that the combination therapy of EPO and G-CSF exerted synergistic effects on cell survival and functional recovery from cerebral and peripheral limbs ischemia. We observed that even under normoxic conditions, G-CSF activates hypoxia-inducible factor-1 alpha (HIF-1 alpha), which then binds to the EPO promoter and enhances EPO expression. Serum EPO level was significantly increased by G-CSF injection, with the exception of Tg-HIF-1 alpha(+f/+f) mice. The neuroplastic mechanisms exerted by EPO combined with G-CSF included enhanced expression of the antiapoptotic protein of Bcl-2, augmented neurotrophic factors synthesis, and promoted neovascularization. Further, the combination therapy significantly increased homing and differentiation of bone marrow stem cells (BMSCs) and intrinsic neural progenitor cells (INPCs) into the ischemic area. In summary, EPO in combination with G-CSF synergistically enhanced angiogenesis and tissue plasticity in ischemic animal models, leading to greater functional recovery than either agent alone.	[Liu, Shih-Ping; Wang, Hsiao-Jung; Lin, Shinn-Zong; Shyu, Woei-Cherng] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Liu, Shih-Ping] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Lee, Shin-Da] China Med Univ, Grad Inst Rehabil Sci, Dept Phys Therapy, Taichung, Taiwan; [Lee, Shin-Da] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Lee, Hsu-Tung] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Liu, Demeral David] China Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Liu, Ren-Shyan] Natl Yang Ming Univ, Dept Nucl Med, Taipei Vet Gen Hosp, Taipei 112, Taiwan; [Lin, Shinn-Zong; Shyu, Woei-Cherng] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; China Medical University Taiwan	Liu, SP (corresponding author), China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan.	shyu9423@yahoo.com.tw	Lee, Shin-Da/Q-2798-2015; Lin, Shinn-Zong/AAX-2379-2020	Lee, Shin-Da/0000-0002-8393-8349; Liu, Shih-Ping/0000-0002-5803-4460	Chen-Han Foundation for Education; China Medical University [CMU98-N1-07]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH99-TD-B-111-004]; Topnotch Stroke Center (CMUH); National Science Council [NSC97-2628-B-039-001-MY3]	Chen-Han Foundation for Education; China Medical University(China Medical University); Taiwan Department of Health Clinical Trial and Research Center of Excellence; Topnotch Stroke Center (CMUH); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported in part by research grants from the Chen-Han Foundation for Education, the China Medical University (CMU98-N1-07), Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH99-TD-B-111-004), Topnotch Stroke Center (CMUH) and the National Science Council (NSC97-2628-B-039-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balleari E, 2006, ANN HEMATOL, V85, P174, DOI 10.1007/s00277-005-0044-6; Bath PMW, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005207.pub3; Casadevall N, 2004, BLOOD, V104, P321, DOI 10.1182/blood-2003-07-2252; Dai Y, 2007, J MOL CELL CARDIOL, V42, P1036, DOI 10.1016/j.yjmcc.2007.04.001; DEHAAN G, 1994, BLOOD, V84, P4157, DOI 10.1182/blood.V84.12.4157.bloodjournal84124157; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Doronzo G, 2006, DIABETOLOGIA, V49, P1049, DOI 10.1007/s00125-006-0156-0; FRAMPTON JE, 1994, DRUGS, V48, P731, DOI 10.2165/00003495-199448050-00007; Franklin TB, 2006, PSYCHONEUROENDOCRINO, V31, P38, DOI 10.1016/j.psyneuen.2005.05.008; Fujii K, 2004, BRIT J HAEMATOL, V124, P190, DOI 10.1046/j.1365-2141.2003.04745.x; Gorlach A, 2001, CIRC RES, V89, P47, DOI 10.1161/hh1301.092678; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Hess DC, 2002, STROKE, V33, P1362, DOI 10.1161/01.STR.0000014925.09415.C3; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Huang LE, 2002, J BIOL CHEM, V277, P41750, DOI 10.1074/jbc.M207280200; Ieda Y, 2007, J MOL CELL CARDIOL, V42, P540, DOI 10.1016/j.yjmcc.2006.11.015; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Jung KH, 2006, BRAIN RES, V1073, P190, DOI 10.1016/j.brainres.2005.12.037; Kawada H, 2006, CIRCULATION, V113, P701, DOI 10.1161/CIRCULATIONAHA.105.563668; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kirito K, 2005, BLOOD, V105, P4258, DOI 10.1182/blood-2004-07-2712; Lee ST, 2005, BRAIN RES, V1058, P120, DOI 10.1016/j.brainres.2005.07.076; Li Y, 2007, J CEREBR BLOOD F MET, V27, P1043, DOI 10.1038/sj.jcbfm.9600417; Ohki Y, 2005, FASEB J, V19, P2005, DOI 10.1096/fj.04-3496fje; Park HK, 2005, BRAIN RES, V1041, P125, DOI 10.1016/j.brainres.2004.11.067; Park L, 2005, J NEUROSCI, V25, P1769, DOI 10.1523/JNEUROSCI.5207-04.2005; Pi XC, 2005, CIRC RES, V96, P1145, DOI 10.1161/01.RES.0000168802.43528.e1; Pierelli L, 1999, J CLIN ONCOL, V17, P1288, DOI 10.1200/JCO.1999.17.4.1288; Richard DE, 2000, J BIOL CHEM, V275, P26765; Roeder I, 1998, BLOOD, V91, P3222, DOI 10.1182/blood.V91.9.3222.3222_3222_3229; Ryan HE, 2000, CANCER RES, V60, P4010; Sawamoto K, 2001, J NEUROSCI, V21, P3895, DOI 10.1523/JNEUROSCI.21-11-03895.2001; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Sehara Y, 2007, NEUROSCI LETT, V418, P248, DOI 10.1016/j.neulet.2007.03.047; Shams Imad, 2005, FASEB J, V19, P307; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; SHWEIKI D, 1992, NATURE, V359, P845; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Shyu WC, 2008, J CLIN INVEST, V118, P133, DOI 10.1172/JCI32723; Signore AP, 2006, J NEUROCHEM, V96, P428, DOI 10.1111/j.1471-4159.2005.03587.x; Spandou E, 2005, BRAIN RES, V1045, P22, DOI 10.1016/j.brainres.2005.03.013; Tan YH, 2007, CARDIOVASC RES, V73, P823, DOI 10.1016/j.cardiores.2006.12.015; ULICH TR, 1991, BLOOD, V78, P1954; Varney ML, 2005, J INTERF CYTOK RES, V25, P674, DOI 10.1089/jir.2005.25.674; Veschini L, 2007, BLOOD, V109, P2565, DOI 10.1182/blood-2006-06-032664; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2004, NEUROREPORT, V15, P1225, DOI 10.1097/01.wnr.0000127636.15181.c1; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Wei L, 2006, J PHARMACOL EXP THER, V317, P109, DOI 10.1124/jpet.105.094391; Wenger RH, 2000, J EXP BIOL, V203, P1253; Zhao LR, 2007, STROKE, V38, P2584, DOI 10.1161/STROKEAHA.106.476457	52	26	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10093	10.1371/journal.pone.0010093	http://dx.doi.org/10.1371/journal.pone.0010093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404921	Green Submitted, Green Published, gold			2022-12-25	WOS:000276482100013
J	Gautier, T; Paul, C; Deckert, V; Desrumaux, C; Klein, A; Labbe, J; Le Guern, N; Athias, A; Monier, S; Hammann, A; Bettaieb, A; Jeannin, JF; Lagrost, L				Gautier, Thomas; Paul, Catherine; Deckert, Valerie; Desrumaux, Catherine; Klein, Alexis; Labbe, Jerome; Le Guern, Naig; Athias, Anne; Monier, Serge; Hammann, Arlette; Bettaieb, Ali; Jeannin, Jean-Francois; Lagrost, Laurent			Innate immune response triggered by triacyl lipid A is dependent on phospholipid transfer protein (PLTP) gene expression	FASEB JOURNAL			English	Article						lipopolysaccharide; inflammation; lipoprotein; lipid transfer protein; cancer	LIPOPOLYSACCHARIDE-BINDING PROTEIN; CELL-BOUND LPS; HIGH-DENSITY; BACTERIAL LIPOPOLYSACCHARIDE; MACROPHAGE ACTIVATION; AGGREGATION BEHAVIOR; PLASMA-LIPOPROTEINS; BIOLOGICAL-ACTIVITY; COLON-CANCER; ENDOTOXIN	Hexaacyl lipopolysaccharide (LPS) aggregates in aqueous media, but its partially deacylated lipid A moiety forms monomers with weaker toxicity. Because plasma phospholipid transfer protein (PLTP) transfers hexaacyl LPS, its impact on metabolism and biological activity of triacyl lipid A in mice was addressed. Triacyl lipid A bound readily to plasma high-density lipoproteins (HDLs) when active PLTP was expressed [HDL-associated lipid A after 4.5 h: 59.1 +/- 16.0% of total in wild-type (WT) vs. 32.5 +/- 10.3% in PLTP-deficient mice, P<0.05]. In the opposite to hexaacyl LPS, plasma residence time of lipid A was extended by PLTP, and proinflammatory cytokines were produced in higher amounts in WT than PLTP-/- mice (remaining lipid A after 8 h: 53 +/- 12 vs. 35 +/- 7%, and IL6 concentration after 4.5 h: 45.5 +/- 5.9 vs. 14.6 +/- 7.8 ng/ml, respectively; P<0.05 in all cases). After 1 wk, onset of B16-induced melanoma was observed in only 30% of lipid A-treated WT mice, whereas >80% of the untreated WT, untreated PLTP-deficient, or lipid A-treated PLTP-deficient animals bore tumors (P<0.05 in all cases). It is concluded that PLTP is essential in mediating the association of triacyl lipid A with lipoproteins, leading to extension of its residence time and to magnification of its proinflammatory and anticancer properties.-Gautier, T., Paul, C., Deckert, V., Desrumaux, C., Klein, A., Labbe, J., Le Guern, N., Athias, A., Monier, S., Hammann, A., Bettaieb, A., Jeannin, J.-F., Lagrost, L. Innate immune response triggered by triacyl lipid A is dependent on phospholipid transfer protein (PLTP) gene expression. FASEB J. 24, 3544-3554 (2010). www.fasebj.org	[Lagrost, Laurent] Univ Bourgogne, Fac Med, Ctr Rech, INSERM,UMR866, F-21079 Dijon, France; [Paul, Catherine; Labbe, Jerome; Bettaieb, Ali; Jeannin, Jean-Francois] EPHE, Lab Immunol & Immunotherapie Canc, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Bourgogne	Lagrost, L (corresponding author), Univ Bourgogne, Fac Med, Ctr Rech, INSERM,UMR866, 7 Blvd Jeanne dArc,BP87900, F-21079 Dijon, France.	laurent.lagrost@u-bourgogne.fr	Paul, Catherine/F-8376-2019; Desrumaux, Catherine/O-1925-2018; Gautier, Thomas/Q-5371-2018	Gautier, Thomas/0000-0003-1119-7382; DECKERT, Valerie/0000-0001-5728-1710; Paul, Catherine/0000-0002-7657-5535; Bettaieb, Ali/0000-0002-6018-9592	Universite de Bourgogne; Conseil Regional de Bourgogne; INSERM (Institut National de la Sante et de la Recherche Medicale); ANR (Agence Nationale de la Recherche); Fondation pour la Recherche Medicale (FRM)	Universite de Bourgogne; Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	The authors thank Philip Bastable for manuscript editing. This work was supported by grants from the Universite de Bourgogne, the Conseil Regional de Bourgogne, INSERM (Institut National de la Sante et de la Recherche Medicale), the ANR (Agence Nationale de la Recherche), and the Fondation pour la Recherche Medicale (FRM).	Bergstrand A, 2006, COLLOID SURFACE B, V53, P9, DOI 10.1016/j.colsurfb.2006.06.007; Brandenburg K, 2002, EUR J BIOCHEM, V269, P5972, DOI 10.1046/j.1432-1033.2002.03333.x; BRANDENBURG K, 1993, EUR J BIOCHEM, V218, P555, DOI 10.1111/j.1432-1033.1993.tb18409.x; Brandenburg K, 2000, EUR J BIOCHEM, V267, P3370, DOI 10.1046/j.1432-1327.2000.01370.x; BUCHWALD H, 1992, LANCET, V339, P1154, DOI 10.1016/0140-6736(92)90744-N; Buchau AS, 2010, J IMMUNOL, V184, P369, DOI 10.4049/jimmunol.0902110; Cai L, 2008, J CLIN INVEST, V118, P364, DOI 10.1172/JCI31539; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Cockerill GW, 2001, CIRCULATION, V103, P108; D'Agostini C, 2005, INT IMMUNOPHARMACOL, V5, P1205, DOI 10.1016/j.intimp.2005.02.013; Garay RP, 2007, EUR J PHARMACOL, V563, P1, DOI 10.1016/j.ejphar.2007.02.018; Gautier T, 2008, J BIOL CHEM, V283, P18702, DOI 10.1074/jbc.M802802200; Guyard-Dangremont V, 1998, COMP BIOCHEM PHYS B, V120, P517, DOI 10.1016/S0305-0491(98)10038-X; Hailman E, 1996, J BIOL CHEM, V271, P12172, DOI 10.1074/jbc.271.21.12172; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; JEANNIN JF, 1991, GASTROENTEROLOGY, V101, P726, DOI 10.1016/0016-5085(91)90532-P; Jiang XC, 1999, J CLIN INVEST, V103, P907, DOI 10.1172/JCI5578; Kitchens RL, 1999, J BIOL CHEM, V274, P34116, DOI 10.1074/jbc.274.48.34116; Kitchens RL, 2001, J CLIN INVEST, V108, P485, DOI 10.1172/JCI200113139; Klimp AH, 2002, CRIT REV ONCOL HEMAT, V44, P143, DOI 10.1016/S1040-8428(01)00203-7; Koch PJ, 1999, J COLLOID INTERF SCI, V213, P557, DOI 10.1006/jcis.1999.6137; Lakomy D, 2009, ARTERIOSCL THROM VAS, V29, P1923, DOI 10.1161/ATVBAHA.109.193201; Levels JHM, 2005, INFECT IMMUN, V73, P2321, DOI 10.1128/IAI.73.4.2321-2326.2005; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Mueller M, 2004, J BIOL CHEM, V279, P26307, DOI 10.1074/jbc.M401231200; NISHIJIMA M, 1985, P NATL ACAD SCI USA, V82, P282, DOI 10.1073/pnas.82.2.282; OLSSON NO, 1982, ANN INST PASTEUR IMM, VD133, P245; Onier N, 1999, CLIN EXP METASTAS, V17, P299, DOI 10.1023/A:1006663017149; Salmon AHJ, 2009, CURR OPIN NEPHROL HY, V18, P197, DOI 10.1097/MNH.0b013e328329f837; Sasaki H, 2008, BIOPHYS J, V95, P986, DOI 10.1529/biophysj.108.129197; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; SHNYRA A, 1993, INFECT IMMUN, V61, P5351, DOI 10.1128/IAI.61.12.5351-5360.1993; Sprong T, 2004, J LIPID RES, V45, P742, DOI 10.1194/jlr.M300453-JLR200; Szponar B, 2003, CLIN CHEM, V49, P1149, DOI 10.1373/49.7.1149; Thompson PA, 2003, J BIOL CHEM, V278, P28367, DOI 10.1074/jbc.M302921200; Tzotzas T, 2009, OBES REV, V10, P403, DOI 10.1111/j.1467-789X.2009.00586.x; ULEVITCH RJ, 1981, J CLIN INVEST, V67, P827, DOI 10.1172/JCI110100; Van Lenten BJ, 2001, CIRCULATION, V103, P2283; VANLENTEN BJ, 1986, P NATL ACAD SCI USA, V83, P2704; Vesy CJ, 2000, INFECT IMMUN, V68, P2410, DOI 10.1128/IAI.68.5.2410-2417.2000; Vikstedt R, 2007, ARTERIOSCL THROM VAS, V27, P578, DOI 10.1161/01.ATV.0000254815.49414.be; Vreugdenhil ACE, 2001, J CLIN INVEST, V107, P225, DOI 10.1172/JCI10832; Wendel M, 2007, INTENS CARE MED, V33, P25, DOI 10.1007/s00134-006-0433-x	43	9	9	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3544	3554		10.1096/fj.09-152876	http://dx.doi.org/10.1096/fj.09-152876			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20418497				2022-12-25	WOS:000281446400041
J	Shibata, M; Hakuno, F; Yamanaka, D; Okajima, H; Fukushima, T; Hasegawa, T; Ogata, T; Toyoshima, Y; Chida, K; Kimura, K; Sakoda, H; Takenaka, A; Asano, T; Takahashi, SI				Shibata, Michihiro; Hakuno, Fumihiko; Yamanaka, Daisuke; Okajima, Hiroshi; Fukushima, Toshiaki; Hasegawa, Takashi; Ogata, Tomomi; Toyoshima, Yuka; Chida, Kazuhiro; Kimura, Kumi; Sakoda, Hideyuki; Takenaka, Asako; Asano, Tomoichiro; Takahashi, Shin-Ichiro			Paraquat-induced Oxidative Stress Represses Phosphatidylinositol 3-Kinase Activities Leading to Impaired Glucose Uptake in 3T3-L1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; PROTEIN-KINASE; GLUT4 TRANSLOCATION; SIGNALING PATHWAYS; REGULATORY SUBUNIT; TRANSPORT ACTIVITY; TYROSINE KINASE; CELLS; RESISTANCE; GROWTH	Accumulated evidence indicates that oxidative stress causes and/or promotes insulin resistance; however, the mechanism by which this occurs is not fully understood. This study was undertaken to elucidate the molecular mechanism by which oxidative stress induced by paraquat impairs insulin-dependent glucose uptake in 3T3-L1 adipocytes. We confirmed that paraquat-induced oxidative stress decreased glucose transporter 4 (GLUT4) translocation to the cell surface, resulting in repression of insulin-dependent 2-deoxyglucose uptake. Under these conditions, oxidative stress did not affect insulin-dependent tyrosine phosphorylation of insulin receptor, insulin receptor substrate (IRS)-1 and -2, or binding of the phosphatidylinositol 3'-OH kinase (PI 3-kinase) p85 regulatory subunit or p110 alpha catalytic subunit to each IRS. In contrast, we found that oxidative stress induced by paraquat inhibited activities of PI 3-kinase bound to IRSs and also inhibited phosphorylation of Akt, the downstream serine/threonine kinase that has been shown to play an essential role in insulin-dependent translocation of GLUT4 to the plasma membrane. Overexpression of active form Akt (myr-Akt) restored inhibition of insulin-dependent glucose uptake by paraquat, indicating that paraquat-induced oxidative stress inhibits insulin signals upstream of Akt. Paraquat treatment with and without insulin treatment decreased the activity of class Ia PI 3-kinases p110 alpha and p110 beta that are mainly expressed in 3T3-L1 adipocytes. However, paraquat treatment did not repress the activity of the PI 3-kinase p110 alpha mutated at Cys(90) in the p85 binding region. These results indicate that the PI 3-kinase p110 is a possible primary target of paraquat-induced oxidative stress to reduce the PI 3-kinase activity and impaired glucose uptake in 3T3-L1 adipocytes.	[Shibata, Michihiro; Hakuno, Fumihiko; Yamanaka, Daisuke; Okajima, Hiroshi; Fukushima, Toshiaki; Hasegawa, Takashi; Ogata, Tomomi; Toyoshima, Yuka; Chida, Kazuhiro; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Sci, Lab Cell Regulat,Bunkyo Ku, Tokyo 1138657, Japan; [Shibata, Michihiro; Hakuno, Fumihiko; Yamanaka, Daisuke; Okajima, Hiroshi; Fukushima, Toshiaki; Hasegawa, Takashi; Ogata, Tomomi; Toyoshima, Yuka; Chida, Kazuhiro; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Kimura, Kumi; Takenaka, Asako] Meiji Univ, Fac Agr, Dept Agr Chem, Kawasaki Ku, Kanagawa 2148571, Japan; [Sakoda, Hideyuki] Asahi Life Fdn, Inst Adult Dis, Dept Internal Med, Chiyoda Ku, Tokyo 1000005, Japan; [Asano, Tomoichiro] Hiroshima Univ, Grad Sch Biomed Sci, Div Mol Med Sci, Hiroshima 7348553, Japan	University of Tokyo; University of Tokyo; Meiji University; Asahi Life Foundation; Hiroshima University	Takahashi, SI (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Sci, Lab Cell Regulat,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	atkshin@mail.ecc.u-tokyo.ac.jp		Takahashi, Shin-Ichiro/0000-0002-2323-2010; Hakuno, Fumihiko/0000-0002-4447-6225	Ministry of Education, Science, Culture and Sports, Japan [16208028]; Grants-in-Aid for Scientific Research [22780249] Funding Source: KAKEN	Ministry of Education, Science, Culture and Sports, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research 16208028 from the Ministry of Education, Science, Culture and Sports, Japan (to S.-I.T.).	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Anderson KE, 2003, INT J BIOCHEM CELL B, V35, P1028, DOI 10.1016/S1357-2725(02)00270-4; Asano T, 2000, J BIOL CHEM, V275, P17671, DOI 10.1074/jbc.M910391199; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; Chen SR, 2000, FREE RADICAL BIO MED, V28, P1266, DOI 10.1016/S0891-5849(00)00265-3; Cho Y, 2006, ENDOCRINOLOGY, V147, P5374, DOI 10.1210/en.2006-0518; Chu F, 2005, CANCER RES, V65, P10478, DOI 10.1158/0008-5472.CAN-05-1989; CLARKE JF, 1994, BIOCHEM J, V300, P631, DOI 10.1042/bj3000631; Dragin N, 2006, FEBS LETT, V580, P3845, DOI 10.1016/j.febslet.2006.06.006; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Ferroni P, 2006, NUTR METAB CARDIOVAS, V16, P222, DOI 10.1016/j.numecd.2005.11.012; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Hakuno F, 2007, J BIOL CHEM, V282, P37747, DOI 10.1074/jbc.M702472200; HALEY TJ, 1979, CLIN TOXICOL, V14, P1; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; Holzenberger M, 2004, HORM RES, V62, P89, DOI 10.1159/000080765; Humphries KM, 2005, J BIOL CHEM, V280, P2750, DOI 10.1074/jbc.M410242200; Inukai K, 1996, J BIOL CHEM, V271, P5317, DOI 10.1074/jbc.271.10.5317; Jacob S, 1996, EXP CLIN ENDOCR DIAB, V104, P284, DOI 10.1055/s-0029-1211455; Kabuta T, 2002, J BIOL CHEM, V277, P6846, DOI 10.1074/jbc.M107058200; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; KANAI F, 1993, BIOCHEM BIOPH RES CO, V195, P762, DOI 10.1006/bbrc.1993.2111; Katagiri H, 1996, J BIOL CHEM, V271, P16987, DOI 10.1074/jbc.271.29.16987; Kimura K, 2007, BIOSCI BIOTECH BIOCH, V71, P16, DOI 10.1271/bbb.60016; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Le Roith D, 2001, DIABETES CARE, V24, P588, DOI 10.2337/diacare.24.3.588; Lee JW, 2004, BIOCHEM J, V382, P631, DOI 10.1042/BJ20040624; Lu L, 2006, J CELL PHYSIOL, V206, P119, DOI 10.1002/jcp.20439; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Mitra P, 2004, J BIOL CHEM, V279, P37431, DOI 10.1074/jbc.C400180200; Nedachi T, 2000, ENDOCRINOLOGY, V141, P2429, DOI 10.1210/en.141.7.2429; Ogihara T, 1997, J BIOL CHEM, V272, P12868, DOI 10.1074/jbc.272.19.12868; OKADA T, 1994, J BIOL CHEM, V269, P3568; PAOLISSO G, 1995, J AM COLL NUTR, V14, P387; PAOLISSO G, 1993, AM J CLIN NUTR, V57, P650, DOI 10.1093/ajcn/57.5.650; Park HS, 2004, J BIOL CHEM, V279, P7584, DOI 10.1074/jbc.M304183200; Peng J, 2005, J BIOL CHEM, V280, P29194, DOI 10.1074/jbc.M500984200; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Rao AW, 1998, J BIOL CHEM, V273, P25450, DOI 10.1074/jbc.273.39.25450; Rosen P, 2001, DIABETES-METAB RES, V17, P189, DOI 10.1002/dmrr.196; Shigematsu S, 2002, MOL ENDOCRINOL, V16, P1060, DOI 10.1210/me.16.5.1060; Shimada H, 1998, ARCH BIOCHEM BIOPHYS, V351, P75, DOI 10.1006/abbi.1997.0557; Shin BC, 1998, BIOCHEM BIOPH RES CO, V246, P313, DOI 10.1006/bbrc.1998.8606; Tirosh A, 1999, J BIOL CHEM, V274, P10595, DOI 10.1074/jbc.274.15.10595; Wang QH, 1998, BIOCHEM J, V331, P917, DOI 10.1042/bj3310917; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Wu ZH, 2006, J CELL PHYSIOL, V209, P996, DOI 10.1002/jcp.20819	52	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20915	20925		10.1074/jbc.M110.126482	http://dx.doi.org/10.1074/jbc.M110.126482			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430890	Green Published, hybrid			2022-12-25	WOS:000279228600056
J	Tang, TTT; Badger, JD; Roche, PA; Roche, KW				Tang, Tina Tze-Tsang; Badger, John D., II; Roche, Paul A.; Roche, Katherine W.			Novel Approach to Probe Subunit-specific Contributions to N-Methyl-D-aspartate (NMDA) Receptor Trafficking Reveals a Dominant Role for NR2B in Receptor Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC PLASTICITY; C-TERMINUS; ENDOCYTOSIS; EXPRESSION; MOLECULES; SYNAPSES; BINDING	N-Methyl-D-aspartate (NMDA) receptors are expressed at excitatory synapses throughout the brain and are essential for neuronal development and synaptic plasticity. Functional NMDA receptors are tetramers, typically composed of NR1 and NR2 subunits (NR2A-D). NR2A and NR2B are expressed in the forebrain and are thought to assemble as diheteromers (NR1/NR2A, NR1/NR2B) and triheteromers (NR1/NR2A/NR2B). NR2A and NR2B contain cytosolic domains that regulate distinct postendocytic sorting events, with NR2A sorting predominantly into the degradation pathway, and NR2B preferentially trafficking through the recycling pathway. However, the interplay between these two subunits remains an open question. We have now developed a novel approach based on the dimeric feature of the alpha- and beta-chains of the human major histocompatibility complex class II molecule. We created chimeras of alpha- and beta-chains with the NR2A and NR2B C termini and evaluated endocytosis of dimers. Like chimeric proteins containing only a single NR2A or NR2B C-terminal domain, major histocompatibility complex class II-NR2A homodimers sort predominantly to late endosomes, whereas NR2B homodimers traffic to recycling endosomes. Interestingly, NR2A/NR2B heterodimers traffic preferentially through the recycling pathway, and NR2B is dominant in regulating dimer trafficking in both heterologous cells and neurons. In addition, the recycling of NR2B-containing NMDARs in wild-type neurons is not significantly different from NR2A(-/-) neurons. These data support a dominant role for NR2B in regulating the trafficking of triheteromeric NMDARs in vivo. Furthermore, our molecular approach allows for the direct and selective evaluation of dimeric assemblies and can be used to define dominant trafficking domains in other multisubunit protein complexes.	[Roche, Katherine W.] NINDS, Receptor Biol Sect, NIH, Bethesda, MD 20892 USA; [Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Tang, Tina Tze-Tsang] Univ Bristol, Sch Med Sci, Dept Anat, Med Res Council,Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Bristol	Roche, KW (corresponding author), NINDS, Receptor Biol Sect, NIH, Bldg 35,Rm 2C903, Bethesda, MD 20892 USA.	rochek@ninds.nih.gov	Roche, Katherine/W-9893-2019; tang, tina/GRX-7859-2022	Roche, Paul/0000-0002-8949-9172; Roche, Katherine/0000-0001-7282-6539	NINDS, National Institutes of Health; NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002994] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Intramural Research Program of NINDS and NCI, National Institutes of Health.	Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; LAMPSON LA, 1980, J IMMUNOL, V125, P293; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; PINET V, 1995, NATURE, V375, P603, DOI 10.1038/375603a0; RADKA SF, 1984, HUM IMMUNOL, V10, P177, DOI 10.1016/0198-8859(84)90038-7; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Scott DB, 2004, J NEUROSCI, V24, P7096, DOI 10.1523/JNEUROSCI.0780-04.2004; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803	20	24	25	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20975	20981		10.1074/jbc.M110.102210	http://dx.doi.org/10.1074/jbc.M110.102210			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20427279	Green Published, hybrid			2022-12-25	WOS:000279228600061
J	Charriere, GM; Ip, WKE; Dejardin, S; Boyer, L; Sokolovska, A; Cappillino, MP; Cherayil, BJ; Podolsky, DK; Kobayashi, KS; Silverman, N; Lacy-Hulbert, A; Stuart, LM				Charriere, Guillaume M.; Ip, W. K. Eddie; Dejardin, Stephanie; Boyer, Laurent; Sokolovska, Anna; Cappillino, Michael P.; Cherayil, Bobby J.; Podolsky, Daniel K.; Kobayashi, Koichi S.; Silverman, Neal; Lacy-Hulbert, Adam; Stuart, Lynda M.			Identification of Drosophila Yin and PEPT2 as Evolutionarily Conserved Phagosome-associated Muramyl Dipeptide Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-SYSTEM; TOLL-LIKE RECEPTORS; NF-KAPPA-B; CROHNS-DISEASE; NOD2; RECOGNITION; ACTIVATION; CELLS; INTERNALIZATION; SUSCEPTIBILITY	NOD2 (nucleotide-binding oligomerization domain containing 2) is an important cytosolic pattern recognition receptor that activates NF-kappa B and other immune effector pathways such as autophagy and antigen presentation. Despite its intracellular localization, NOD2 participates in sensing of extracellular microbes such as Staphylococcus aureus. NOD2 ligands similar to the minimal synthetic ligand muramyl dipeptide (MDP) are generated by internalization and processing of bacteria in hydrolytic phagolysosomes. However, how these derived ligands exit this organelle and access the cytosol to activate NOD2 is poorly understood. Here, we address how phagosome-derived NOD2 ligands access the cytosol in human phagocytes. Drawing on data from Drosophila phagosomes, we identify an evolutionarily conserved role of SLC15A transporters, Drosophila Yin and PEPT2, as MDP transporters in fly and human phagocytes, respectively. We show that PEPT2 is highly expressed by human myeloid cells. Ectopic expression of both Yin and PEPT2 increases the sensitivity of NOD2-dependent NF-kappa B activation. Additionally, we show that PEPT2 associates with phagosome membranes. Together, these data identify Drosophila Yin and PEPT2 as evolutionarily conserved phagosome-associated transporters that are likely to be of particular importance in delivery of bacteria-derived ligands generated in phagosomes to cytosolic sensors recruited to the vicinity of these organelles.	[Cherayil, Bobby J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mucosal Immunol Lab, Boston, MA 02144 USA; [Podolsky, Daniel K.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Kobayashi, Koichi S.] Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Silverman, Neal] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA 01605 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester	Stuart, LM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Jackson 14,55 Fruit St, Boston, MA 02114 USA.	lstuart@partners.org	Ip, W. K. Eddie/C-3042-2012; BOYER, Laurent/AAH-4543-2021; Charriere, Guillaume M/O-8317-2014; Charriere, Guillaume/Z-1574-2019; Boyer, laurent/F-8921-2015	Ip, W. K. Eddie/0000-0003-1953-972X; BOYER, Laurent/0000-0002-1375-1706; Charriere, Guillaume M/0000-0002-4796-1488; Charriere, Guillaume/0000-0002-4796-1488; Boyer, laurent/0000-0002-1375-1706; Silverman, Neal/0000-0002-4259-456X; dejardin, stephanie/0000-0001-5328-1414; Kobayashi, Koichi/0000-0003-2930-0114; Lacy-Hulbert, Adam/0000-0003-2162-0156	NIAID NIH HHS [R01 AI074958, R01 AI079198, R01 AI079198-02] Funding Source: Medline; NIDDK NIH HHS [P30 DK040561-15, R01 DK074738, P30 DK043351, P30 DK040561, R01 DK074738-05] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079198, R01AI074958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, P30DK043351, R01DK074738] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Ismair MG, 2006, CAN J PHYSIOL PHARM, V84, P1313, DOI 10.1139/Y06-076; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kapetanovic R, 2007, INFECT IMMUN, V75, P830, DOI 10.1128/IAI.01199-06; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lecine P, 2007, J BIOL CHEM, V282, P15197, DOI 10.1074/jbc.M606242200; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Marina-Garcia N, 2008, J IMMUNOL, V180, P4050, DOI 10.4049/jimmunol.180.6.4050; Marina-Garcia N, 2009, J IMMUNOL, V182, P4321, DOI 10.4049/jimmunol.0802197; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; SHIMADA T, CELL HOST MICROBE, V7, P38; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Swaan PW, 2008, AM J RESP CELL MOL, V39, P536, DOI 10.1165/rcmb.2008-0059OC; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Viala M, 2004, CR BIOL, V327, P551, DOI 10.1016/j.crvi.2004.02.010; Warren HS, 2009, J LEUKOCYTE BIOL, V86, P199, DOI 10.1189/jlb.0309210	36	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20147	20154		10.1074/jbc.M110.115584	http://dx.doi.org/10.1074/jbc.M110.115584			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20406817	Green Published, hybrid			2022-12-25	WOS:000279012000049
J	Biswas-Fiss, EE; Kurpad, DS; Joshi, K; Biswas, SB				Biswas-Fiss, Esther E.; Kurpad, Deepa S.; Joshi, Kinjalben; Biswas, Subhasis B.			Interaction of Extracellular Domain 2 of the Human Retina-specific ATP-binding Cassette Transporter (ABCA4) with All-trans-retinal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; EYE PIGMENT PRECURSORS; MUTATIONAL ANALYSIS; SECONDARY STRUCTURE; SEQUENCE VARIATIONS; FUNCTIONAL-ANALYSIS; STARGARDT-DISEASE; ESTROGEN-RECEPTOR; GENE-THERAPY; RIM PROTEIN	The retina-specific ATP-binding cassette (ABC) transporter, ABCA4, is essential for transport of all-trans-retinal from the rod outer segment discs in the retina and is associated with a broad range of inherited retinal diseases, including Stargardt disease, autosomal recessive cone rod dystrophy, and fundus flavimaculatus. A unique feature of the ABCA subfamily of ABC transporters is the presence of highly conserved, long extracellular loops or domains (ECDs) with unknown function. The high degree of sequence conservation and mapped disease-associated mutations in these domains suggests an important physiological significance. Conformational analysis using CD spectroscopy of purified, recombinant ECD2 protein demonstrated that it has an ordered and stable structure composed of 27 +/- 3% alpha-helix, 20 +/- 3% beta-pleated sheet, and 53 +/- 3% coil. Significant conformational changes were observed in disease-associated mutant proteins. Using intrinsic tryptophan fluorescence emission spectrum of ECD2 polypeptide and fluorescence anisotropy, we have demonstrated that this domain specifically interacts with all-trans-retinal. Furthermore, the retinal interaction appeared preferential for the all-trans-isomer and was directly measurable through fluorescence anisotropy analysis. Our results demonstrate that the three macular degeneration-associated mutations lead to significant changes in the secondary structure of the ECD2 domain of ABCA4, as well as in its interaction with all-trans-retinal.	[Biswas-Fiss, Esther E.; Kurpad, Deepa S.; Joshi, Kinjalben] Thomas Jefferson Univ, Dept Biosci Technol, Program Biotechnol, Jefferson Sch Hlth Profess, Philadelphia, PA 19107 USA; [Biswas-Fiss, Esther E.; Kurpad, Deepa S.; Biswas, Subhasis B.] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Mol Biol, Stratford, NJ 08084 USA	Jefferson University; Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Biswas-Fiss, EE (corresponding author), Thomas Jefferson Univ, Dept Biosci Technol, Program Biotechnol, Jefferson Sch Hlth Profess, Edison Bldg,Ste 1924,130 S 9th St, Philadelphia, PA 19107 USA.	esther.biswas@jefferson.edu			NEI [EY 013113]; NATIONAL EYE INSTITUTE [R15EY013113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI064974, R42AI064974] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant EY 013113 from NEI and an administrative supplement, Quantitative Physical Measurements at the Nanoscale (to E. E. B.- F.) and AI064974 (to S. B. B.).	Ahn J, 2000, METHOD ENZYMOL, V315, P864; Ahn J, 2000, J BIOL CHEM, V275, P20399, DOI 10.1074/jbc.M000555200; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Arnell H, 1998, ACTA OPHTHALMOL SCAN, V76, P649, DOI 10.1034/j.1600-0420.1998.760602.x; Balan A, 2008, GENET MOL RES, V7, P117, DOI 10.4238/vol7-1gmr392; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; Bennett J, 2009, NEW ENGL J MED, V361, P2483, DOI 10.1056/NEJMcibr0908643; BERKOWER C, 1991, EMBO J, V10, P3777, DOI 10.1002/j.1460-2075.1991.tb04947.x; Biswas EE, 2001, BIOCHEMISTRY-US, V40, P8181, DOI 10.1021/bi0106686; Biswas-Fiss EE, 2006, BIOCHEMISTRY-US, V45, P3813, DOI 10.1021/bi052059u; Biswas-Fiss EE, 2003, BIOCHEMISTRY-US, V42, P10683, DOI 10.1021/bi034481l; Booth CL, 2000, BIOCHEMISTRY-US, V39, P5518, DOI 10.1021/bi992931x; Boyer M, 2000, NUCLEIC ACIDS RES, V28, P2494, DOI 10.1093/nar/28.13.2494; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briggs CE, 2001, INVEST OPHTH VIS SCI, V42, P2229; Brunkhorst C, 2005, RES MICROBIOL, V156, P322, DOI 10.1016/j.resmic.2004.10.016; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; CHEN WY, 1993, MOL CELL ENDOCRINOL, V91, P35, DOI 10.1016/0303-7207(93)90252-F; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Duffieux F, 2000, EUR J BIOCHEM, V267, P5306, DOI 10.1046/j.1432-1327.2000.01614.x; EWART GD, 1994, J BIOL CHEM, V269, P10370; Ewart GD, 1998, METHOD ENZYMOL, V292, P213; Fishman GA, 2003, ARCH OPHTHALMOL-CHIC, V121, P851, DOI 10.1001/archopht.121.6.851; Fishman GA, 1999, ARCH OPHTHALMOL-CHIC, V117, P504, DOI 10.1001/archopht.117.4.504; GRYCZYNSKI I, 1988, BIOPHYS CHEM, V32, P173, DOI 10.1016/0301-4622(88)87005-4; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2001, SCIENCE, V293, P1782, DOI 10.1126/science.1065588; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Jaakson K, 2003, HUM MUTAT, V22, P395, DOI 10.1002/humu.10263; KENNEDY MW, 1995, BIOCHEMISTRY-US, V34, P6700, DOI 10.1021/bi00020a015; Klevering BJ, 2005, GRAEF ARCH CLIN EXP, V243, P90, DOI 10.1007/s00417-004-1079-4; Klevering BJ, 2002, INVEST OPHTH VIS SCI, V43, P1980; KOTIK M, 1993, EUR J BIOCHEM, V211, P267, DOI 10.1111/j.1432-1033.1993.tb19895.x; Kreimer DI, 2000, EUR J BIOCHEM, V267, P4242; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakowicz JR, 2006, PRINCIPALS FLUORESCE, P533; LAKOWICZ JR, 1999, PRINCIPLES FLUORESCE, P449; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Liao JH, 2009, MOL VIS, V15, P1429; Ling V, 1997, CANCER CHEMOTH PHARM, V40, pS3, DOI 10.1007/s002800051053; Lugo MR, 2009, ARCH BIOCHEM BIOPHYS, V492, P17, DOI 10.1016/j.abb.2009.10.002; Mace PD, 2007, PROTEIN EXPRES PURIF, V52, P40, DOI 10.1016/j.pep.2006.07.025; Massiah MA, 1999, BIOCHEMISTRY-US, V38, P7453, DOI 10.1021/bi9903603; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Molday RS, 2009, BBA-MOL CELL BIOL L, V1791, P573, DOI 10.1016/j.bbalip.2009.02.004; Nahoum V, 2007, P NATL ACAD SCI USA, V104, P17323, DOI 10.1073/pnas.0705356104; Ozers MS, 1997, J BIOL CHEM, V272, P30405, DOI 10.1074/jbc.272.48.30405; PAPERMASTER DS, 1978, J CELL BIOL, V78, P415, DOI 10.1083/jcb.78.2.415; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Pogenberg V, 2005, J BIOL CHEM, V280, P1625, DOI 10.1074/jbc.M409302200; Radu RA, 2004, P NATL ACAD SCI USA, V101, P5928, DOI 10.1073/pnas.0308302101; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; Samanta U, 2001, PROTEIN ENG, V14, P7, DOI 10.1093/protein/14.1.7; SAMBROOK J, 1989, MOL CLONING LAB MANU, P391; September AV, 2004, INVEST OPHTH VIS SCI, V45, P1705, DOI 10.1167/iovs.03-1167; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Shroyer NF, 2001, HUM MOL GENET, V10, P2671, DOI 10.1093/hmg/10.23.2671; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Suarez T, 2002, J BIOL CHEM, V277, P21759, DOI 10.1074/jbc.M202053200; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Webster AR, 2001, INVEST OPHTH VIS SCI, V42, P1179; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Winterfeld S, 2009, BIOCHEMISTRY-US, V48, P6684, DOI 10.1021/bi9003809; Yatsenko AN, 2005, J MOL EVOL, V60, P72, DOI 10.1007/s00239-004-0118-4; Zhang GP, 2008, J IMMUNOL METHODS, V334, P21, DOI 10.1016/j.jim.2008.01.020; Zhang K, 1999, GENOMICS, V60, P234, DOI 10.1006/geno.1999.5896	73	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19372	19383		10.1074/jbc.M110.112896	http://dx.doi.org/10.1074/jbc.M110.112896			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404325	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000278727800048
J	Wu, JJ; Weis, MA; Kim, LS; Eyre, DR				Wu, Jiann-Jiu; Weis, Mary Ann; Kim, Lammy S.; Eyre, David R.			Type III Collagen, a Fibril Network Modifier in Articular Cartilage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING SITES; OSTEOARTHRITIC CARTILAGE; EXTRACELLULAR-MATRIX; DERMAL COLLAGEN; IX COLLAGEN; BONE; XI; VERTEBRATE; MOLECULES; CLEAVAGE	The collagen framework of hyaline cartilages, including articular cartilage, consists largely of type II collagen that matures from a cross-linked heteropolymeric fibril template of types II, IX, and XI collagens. In the articular cartilages of adult joints, type III collagen makes an appearance in varying amounts superimposed on the original collagen fibril network. In a study to understand better the structural role of type III collagen in cartilage, we find that type III collagen molecules with unprocessed N-propeptides are present in the extracellular matrix of adult human and bovine articular cartilages as covalently crosslinked polymers extensively cross-linked to type II collagen. Cross-link analyses revealed that telopeptides from both N and C termini of type III collagen were linked in the tissue to helical cross-linking sites in type II collagen. Reciprocally, telopeptides from type II collagen were recovered cross-linked to helical sites in type III collagen. Cross-linked peptides were also identified in which a trifunctional pyridinoline linked both an alpha 1(II) and an alpha 1(III) telopeptide to the alpha 1(III) helix. This can only have arisen from a cross-link between three different collagen molecules, types II and III in register staggered by 4D from another type III molecule. Type III collagen is known to be prominent at sites of healing and repair in skin and other tissues. The present findings emphasize the role of type III collagen, which is synthesized in mature articular cartilage, as a covalent modifier that may add cohesion to a weakened, existing collagen type II fibril network as part of a chondrocyte healing response to matrix damage.	[Wu, Jiann-Jiu; Weis, Mary Ann; Kim, Lammy S.; Eyre, David R.] Univ Washington, Dept Orthoped & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Wu, JJ (corresponding author), 1959 NE Pacific St,HSB BB1052, Seattle, WA 98195 USA.	wujj@u.washington.edu			National Institutes of Health [AR 37318, AR 36794]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR037318, R01AR037318, R37AR036794, R01AR036794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants AR 37318 and AR 36794.	Ahsan T, 2005, OSTEOARTHR CARTILAGE, V13, P709, DOI 10.1016/j.joca.2005.03.005; Aigner T, 2002, CELL MOL LIFE SCI, V59, P5, DOI 10.1007/s00018-002-8400-3; AIGNER T, 1993, J CLIN INVEST, V91, P829, DOI 10.1172/JCI116303; Atley LM, 2000, BONE, V26, P241, DOI 10.1016/S8756-3282(99)00270-7; ATLEY LM, 1998, T ORTHOP RES SOC, V23, P850; BAILEY AJ, 1976, BIOCHEM J, V153, P211, DOI 10.1042/bj1530211; Bailey WJ, 1997, MOL BIOL EVOL, V14, P843, DOI 10.1093/oxfordjournals.molbev.a025825; BECKER J, 1991, J HISTOCHEM CYTOCHEM, V39, P103, DOI 10.1177/39.1.1983870; BONASSAR LJ, 1995, ARTHRITIS RHEUM, V38, P173, DOI 10.1002/art.1780380205; Boot-Handford RP, 2003, J BIOL CHEM, V278, P31067, DOI 10.1074/jbc.M212889200; CHUNG E, 1974, SCIENCE, V183, P1200, DOI 10.1126/science.183.4130.1200; EPSTEIN EH, 1974, J BIOL CHEM, V249, P3225; Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; Eyre DR, 2006, EUR CELLS MATER, V12, P57, DOI 10.22203/eCM.v012a07; Eyre DR, 2010, J BIOL CHEM, V285, P16675, DOI 10.1074/jbc.M110.111534; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; Eyre DR, 2004, J BIOL CHEM, V279, P2568, DOI 10.1074/jbc.M311653200; EYRE DR, 1987, FEBS LETT, V220, P337, DOI 10.1016/0014-5793(87)80842-6; EYRE DR, 1980, SCIENCE, V207, P1315, DOI 10.1126/science.7355290; EYRE DR, 1976, BIOCHEM J, V157, P267, DOI 10.1042/bj1570267; EYRE DR, 1975, CONNECT TISSUE RES, V4, P11, DOI 10.3109/03008207509152192; EYRE DR, 1983, FEBS LETT, V158, P265, DOI 10.1016/0014-5793(83)80592-4; EYRE DR, 1980, BIOCHEM BIOPH RES CO, V92, P403, DOI 10.1016/0006-291X(80)90347-2; Fernandes RJ, 2003, EUR J BIOCHEM, V270, P3243, DOI 10.1046/j.1432-1033.2003.03711.x; FLEISCHMAJER R, 1983, P NATL ACAD SCI-BIOL, V80, P3354, DOI 10.1073/pnas.80.11.3354; FLEISCHMAJER R, 1990, J STRUCT BIOL, V105, P162, DOI 10.1016/1047-8477(90)90110-X; FLEISCHMAJER R, 1990, ANN NY ACAD SCI, V580, P161, DOI 10.1111/j.1749-6632.1990.tb17927.x; HANSON DA, 1992, J BONE MINER RES, V7, P1251; HENKEL W, 1982, EUR J BIOCHEM, V122, P205, DOI 10.1111/j.1432-1033.1982.tb05868.x; Henkel W, 1996, BIOCHEM J, V318, P497, DOI 10.1042/bj3180497; Huxley-Jones J, 2007, MATRIX BIOL, V26, P2, DOI 10.1016/j.matbio.2006.09.008; KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P59, DOI 10.1177/39.1.1983874; KEENE DR, 1987, J CELL BIOL, V105, P2393, DOI 10.1083/jcb.105.5.2393; Kinter M, 2000, PROTEIN SEQUENCING I, V1st, P152; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHTO M, 1985, RES EXP MED, V185, P95, DOI 10.1007/BF01854894; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; MILLER EJ, 1969, P NATL ACAD SCI USA, V64, P1264, DOI 10.1073/pnas.64.4.1264; MILLER EJ, 1976, ARCH BIOCHEM BIOPHYS, V173, P631, DOI 10.1016/0003-9861(76)90300-3; MULLERGLAUSER W, 1986, J CELL BIOL, V102, P1931, DOI 10.1083/jcb.102.5.1931; NICHOLSON R, 1989, BIOCHEMISTRY-US, V28, P5195, DOI 10.1021/bi00438a042; Ricard-Blum S, 2005, TOP CURR CHEM, V247, P35, DOI 10.1007/b103819; SHAPIRO F, 1979, ARCH BIOCHEM BIOPHYS, V198, P205, DOI 10.1016/0003-9861(79)90411-9; Sicot FX, 1997, EUR J BIOCHEM, V246, P50, DOI 10.1111/j.1432-1033.1997.00050.x; SWANN DA, 1972, INVEST OPHTH VISUAL, V11, P735; TRELSTAD RL, 1974, BIOCHEM BIOPH RES CO, V57, P717, DOI 10.1016/0006-291X(74)90605-6; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; WOTTON SF, 1994, HISTOCHEM J, V26, P412, DOI 10.1007/BF00160053; Wu JJ, 2009, J BIOL CHEM, V284, P5539, DOI 10.1074/jbc.M806369200; WU JJ, 1995, J BIOL CHEM, V270, P18865, DOI 10.1074/jbc.270.32.18865; WU JJ, 1984, BIOCHEMISTRY-US, V23, P1850, DOI 10.1021/bi00303a041; WU JJ, 1992, J BIOL CHEM, V267, P23007; WU JJ, 1991, J BIOL CHEM, V266, P5625; Young RD, 2000, J HISTOCHEM CYTOCHEM, V48, P423, DOI 10.1177/002215540004800312	57	58	59	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18537	18544		10.1074/jbc.M110.112904	http://dx.doi.org/10.1074/jbc.M110.112904			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20404341	Green Published, hybrid			2022-12-25	WOS:000278453900047
J	Larriba, MJ; Casado-Vela, J; Pendas-Franco, N; Pena, R; de Herreros, AG; Berciano, MT; Lafarga, M; Casal, JI; Munoz, A				Jesus Larriba, Maria; Casado-Vela, Juan; Pendas-Franco, Natalia; Pena, Raul; Garcia de Herreros, Antonio; Teresa Berciano, Maria; Lafarga, Miguel; Ignacio Casal, J.; Munoz, Alberto			Novel Snail1 Target Proteins in Human Colon Cancer Identified by Proteomic Analysis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR SNAIL; ERBB-3 BINDING-PROTEIN; VITAMIN-D-RECEPTOR; CELL-CYCLE REGULATION; E-CADHERIN; GENE-EXPRESSION; BREAST-CANCER; BETA-CATENIN; MEDIATED TRANSCRIPTION	Background: The transcription factor Snail1 induces epithelial-to-mesenchymal transition (EMT), a process responsible for the acquisition of invasiveness during tumorigenesis. Several transcriptomic studies have reported Snail1-regulated genes in different cell types, many of them involved in cell adhesion. However, only a few studies have used proteomics as a tool for the characterization of proteins mediating EMT. Methodology/Principal Findings: We identified by proteomic analysis using 2D-DIGE electrophoresis combined with MALDI-TOF-TOF and ESI-linear ion trap mass spectrometry a number of proteins with variable functions whose expression is modulated by Snail1 in SW480-ADH human colon cancer cells. Validation was performed by Western blot and immunofluorescence analyses. Snail1 repressed several members of the 14-3-3 family of phosphoserine/phosphothreonine binding proteins and also the expression of the Proliferation-associated protein 2G4 (PA2G4) that was mainly localized at the nuclear Cajal bodies. In contrast, the expression of two proteins involved in RNA processing, the Cleavage and polyadenylation specificity factor subunit 6 (CPSF6) and the Splicing factor proline/glutamine-rich (SFPQ), was higher in Snail1-expressing cells than in controls. The regulation of 14-3-3 epsilon, 14-3-3 tau, 14-3-3 zeta and PA2G4 by Snail1 was reproduced in HT29 colon cancer cells. In addition, we found an inverse correlation between 14-3-3 sigma and Snail1 expression in human colorectal tumors. Conclusions/Significance: We have identified a set of novel Snail1 target proteins in colon cancer that expand the cellular processes affected by Snail1 and thus its relevance for cell function and phenotype.	[Jesus Larriba, Maria; Pendas-Franco, Natalia; Munoz, Alberto] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Casado-Vela, Juan] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Pena, Raul; Garcia de Herreros, Antonio] Hosp Mar, IMIM, Barcelona, Spain; [Teresa Berciano, Maria; Lafarga, Miguel] Univ Cantabria, Dept Anat & Biol Celular, Inst Formac & Invest Marques Valdecilla, E-39005 Santander, Spain; [Ignacio Casal, J.] CSIC, Ctr Invest Biol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Larriba, MJ (corresponding author), Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain.	mjlarriba@iib.uam.es	Casado-Vela, Juan/C-5086-2013; Casal, Ignacio/M-2312-2014; Lafarga, Miguel/K-3733-2014; Munoz, Alberto/O-6393-2014; LARRIBA, MARIA JESUS/O-4652-2014; de Herreros, A Garcia/H-3104-2014	Casado-Vela, Juan/0000-0001-5924-6601; Casal, Ignacio/0000-0003-1085-2840; Munoz, Alberto/0000-0003-3890-4251; LARRIBA, MARIA JESUS/0000-0001-9035-7414; de Herreros, A Garcia/0000-0001-5270-0808; Berciano, Maria T./0000-0002-8225-6995; Pena Arranz, Raul/0000-0002-1650-9720; Lafarga, Miguel/0000-0003-3402-1152	Ministerio de Ciencia e Innovacion of Spain [SAF2007-60341, BIO2006-07689, RD06/0020/0009, RD06/0020/0040]; Comunidad de Madrid [S-GEN-0266/2006]; European Union [MRTN-CT-2005-019496]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid); European Union(European Commission)	This work was supported by the Ministerio de Ciencia e Innovacion of Spain (SAF2007-60341, BIO2006-07689, ISCIII-RETIC RD06/0020/0009 and RD06/0020/0040), Comunidad de Madrid (S-GEN-0266/2006) and the European Union (MRTN-CT-2005-019496, NucSys). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Akahira J, 2004, CLIN CANCER RES, V10, P2687, DOI 10.1158/1078-0432.CCR-03-0510; Alfonso P, 2005, PROTEOMICS, V5, P2602, DOI 10.1002/pmic.200401196; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Casado-Vela J, 2007, PROTEOMICS, V7, P2522, DOI 10.1002/pmic.200700026; De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Franci C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005595; Gonzalez-Santiago L, 2007, J PROTEOME RES, V6, P1286, DOI 10.1021/pr060430+; Guweidhi A, 2004, CARCINOGENESIS, V25, P1575, DOI 10.1093/carcin/bgh159; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Hidalgo-Curtis C, 2008, GENE CHROMOSOME CANC, V47, P379, DOI 10.1002/gcc.20541; Higashikawa K, 2008, CANCER LETT, V264, P256, DOI 10.1016/j.canlet.2008.01.045; Holm R, 2009, ONCOL REP, V22, P11, DOI 10.3892/or_00000399; Honore B, 2000, BBA-GENE STRUCT EXPR, V1492, P108, DOI 10.1016/S0167-4781(00)00092-0; Larriba MJ, 2009, CARCINOGENESIS, V30, P1459, DOI 10.1093/carcin/bgp140; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Joyce T, 2009, CLIN EXP METASTAS, V26, P569, DOI 10.1007/s10585-009-9256-9; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keshamouni VG, 2009, J PROTEOME RES, V8, P35, DOI 10.1021/pr8006478; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Kowalinski E, 2007, FEBS LETT, V581, P4450, DOI 10.1016/j.febslet.2007.08.024; Lafarga M, 2009, CHROMOSOMA, V118, P437, DOI 10.1007/s00412-009-0212-x; Larriba MJ, 2007, ENDOCR-RELAT CANCER, V14, P141, DOI 10.1677/ERC-06-0028; Lessor TJ, 2000, J CELL PHYSIOL, V183, P321, DOI 10.1002/(SICI)1097-4652(200006)183:3<321::AID-JCP4>3.0.CO;2-O; Li FQ, 2008, J CELL BIOL, V181, P1141, DOI 10.1083/jcb.200709091; Liu SH, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-162; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Madoz-Gurpide J, 2006, MOL CELL PROTEOMICS, V5, P1471, DOI 10.1074/mcp.M600048-MCP200; Mathias RA, 2009, BBA-PROTEINS PROTEOM, V1794, P1325, DOI 10.1016/j.bbapap.2009.05.001; Monie TP, 2007, EMBO J, V26, P3936, DOI 10.1038/sj.emboj.7601817; Moreira JMA, 2004, MOL CELL PROTEOMICS, V3, P410, DOI 10.1074/mcp.M300134-MCP200; Moreira JMA, 2008, MOL CELL PROTEOMICS, V7, P1225, DOI 10.1074/mcp.M700439-MCP200; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Morris GE, 2008, BBA-MOL CELL RES, V1783, P2108, DOI 10.1016/j.bbamcr.2008.07.016; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Palmer HG, 2004, NAT MED, V10, P917, DOI 10.1038/nm1095; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pena C, 2005, HUM MOL GENET, V14, P3361, DOI 10.1093/hmg/ddi366; REIMER G, 1987, ARTHRITIS RHEUM, V30, P793, DOI 10.1002/art.1780300709; Sarrio D, 2004, ONCOGENE, V23, P3272, DOI 10.1038/sj.onc.1207439; Schultz J, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-53; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Solanas G, 2008, J CELL SCI, V121, P2224, DOI 10.1242/jcs.021667; Squatrito M, 2004, ONCOGENE, V23, P4454, DOI 10.1038/sj.onc.1207579; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Taki M, 2006, INT J ONCOL, V28, P487; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Willipinski-Stapelfeldt B, 2005, CLIN CANCER RES, V11, P8006, DOI 10.1158/1078-0432.CCR-05-0632; Xia XM, 2001, J CELL PHYSIOL, V187, P209, DOI 10.1002/jcp.1075; Yoo JY, 2000, BRIT J CANCER, V82, P683; Yu YC, 2007, INT J CANCER, V120, P1909, DOI 10.1002/ijc.22541; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zhang Y, 2008, CANCER LETT, V265, P298, DOI 10.1016/j.canlet.2008.02.024; Zhang YX, 2005, NUCLEIC ACIDS RES, V33, P6024, DOI 10.1093/nar/gki903; Zhang YX, 2003, NUCLEIC ACIDS RES, V31, P2168, DOI 10.1093/nar/gkg318; Zhang YX, 2002, ONCOGENE, V21, P5609, DOI 10.1038/sj.onc.1205638	64	29	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10221	10.1371/journal.pone.0010221	http://dx.doi.org/10.1371/journal.pone.0010221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20421926	Green Published, Green Submitted, gold			2022-12-25	WOS:000276854300004
J	Daemen, A; Signoretto, M; Gevaert, O; Suykens, JAK; De Moor, B				Daemen, Anneleen; Signoretto, Marco; Gevaert, Olivier; Suykens, Johan A. K.; De Moor, Bart			Improved Microarray-Based Decision Support with Graph Encoded Interactome Data	PLOS ONE			English	Article							BREAST-CANCER; GENE-EXPRESSION; HISTOLOGIC GRADE; CLASSIFICATION; PREDICTION; TARGETS; CHEMOTHERAPY; CLASSIFIERS; METASTASIS; COLLECTION	In the past, microarray studies have been criticized due to noise and the limited overlap between gene signatures. Prior biological knowledge should therefore be incorporated as side information in models based on gene expression data to improve the accuracy of diagnosis and prognosis in cancer. As prior knowledge, we investigated interaction and pathway information from the human interactome on different aspects of biological systems. By exploiting the properties of kernel methods, relations between genes with similar functions but active in alternative pathways could be incorporated in a support vector machine classifier based on spectral graph theory. Using 10 microarray data sets, we first reduced the number of data sources relevant for multiple cancer types and outcomes. Three sources on metabolic pathway information (KEGG), protein-protein interactions (OPHID) and miRNA-gene targeting (microRNA.org) outperformed the other sources with regard to the considered class of models. Both fixed and adaptive approaches were subsequently considered to combine the three corresponding classifiers. Averaging the predictions of these classifiers performed best and was significantly better than the model based on microarray data only. These results were confirmed on 6 validation microarray sets, with a significantly improved performance in 4 of them. Integrating interactome data thus improves classification of cancer outcome for the investigated microarray technologies and cancer types. Moreover, this strategy can be incorporated in any kernel method or non-linear version of a non-kernel method.	[Daemen, Anneleen; Signoretto, Marco; Gevaert, Olivier; Suykens, Johan A. K.; De Moor, Bart] Katholieke Univ Leuven, Dept Elect Engn, ESAT SCD, Leuven, Belgium	KU Leuven	Daemen, A (corresponding author), Katholieke Univ Leuven, Dept Elect Engn, ESAT SCD, Leuven, Belgium.	anneleen.daemen@esat.kuleuven.be	Suykens, Johan A.K./C-9781-2014; Gevaert, Olivier/H-3413-2019	Suykens, Johan A.K./0000-0002-8846-6352; Gevaert, Olivier/0000-0002-9965-5466	Scientific Research - Flanders (FWO-Vlaanderen); Research Council KUL [CoE EF/05/007]; SymBioSys; PTROMEA [0241.04, 0499.04, 0318.05, 0302.07]	Scientific Research - Flanders (FWO-Vlaanderen)(FWO); Research Council KUL(KU Leuven); SymBioSys; PTROMEA	AD is research assistant of the Fund for Scientific Research - Flanders (FWO-Vlaanderen). OG is supported by the Research Foundation - Flanders (FWO). JS is a professor and BDM a full professor at the Katholieke Universiteit Leuven, Belgium. This work is partially supported by: 1. Research Council KUL: GOA AMBioRICS, CoE EF/05/007 SymBioSys, PTROMEA, several PhD/postdoc & fellow grants. 2. Flemish Government: a. FWO: PhD/postdoc grants, projects G.0241.04 (Functional Genomics), G.0499.04 (Statistics), G.0318.05 (subfunctionalization), G.0302.07 (SVM/Kernel), research communities (ICCoS, ANMMM, MLDM); b. IWT: PhD Grants, GBOU-McKnow-E (Knowledge management algorithms), GBOU-ANA (biosensors), TAD-BioScope-IT, Silicos; SBO-BioFrame, SBO-MoKa, TBM-Endometriosis. 3. Belgian Federal Science Policy Office: IUAP P6/25 (BioMaGNet, Bioinformatics and Modeling: from Genomes to Networks, 2007 - 2011). 4. EU-RTD: ERNSI: European Research Network on System Identification; FP6-NoE Biopattern; FP6-IP e-Tumours, FP6-MC-EST Bioptrain, FP6-STREP Strokemap. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Berchuck A, 2005, CLIN CANCER RES, V11, P3686, DOI 10.1158/1078-0432.CCR-04-2398; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bjorkholm P, 2009, BIOINFORMATICS, V25, P3020, DOI 10.1093/bioinformatics/btp522; Brabanter J.D., 2002, LEAST SQUARES SUPPOR, DOI DOI 10.1142/9789812776655; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Brown KV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r95; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Cawley GC, 2006, IEEE IJCNN, P1661; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Daemen A, 2009, GENOME MED, V1, DOI 10.1186/gm39; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Demsar J, 2006, J MACH LEARN RES, V7, P1; Desmedt C, 2006, CELL CYCLE, V5, P2198, DOI 10.4161/cc.5.19.3254; Duin RPW, 2002, INT C PATT RECOG, P765, DOI 10.1109/ICPR.2002.1048415; Duin RPW, 2000, LECT NOTES COMPUT SC, V1857, P16; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fouss F, 2007, IEEE T KNOWL DATA EN, V19, P355, DOI 10.1109/TKDE.2007.46; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Futschik Matthias E, 2003, Appl Bioinformatics, V2, pS53; Galperin MY, 2009, NUCLEIC ACIDS RES, V37, pD1, DOI 10.1093/nar/gkn942; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hanisch D., 2002, BIOINFORMATICS, V18, pS145, DOI [10.1093/bioinformatics/18.suppl_1.S145, DOI 10.1093/BI0INF0RMATICS/18.SUPPL_]; HANSEN PC, 1992, INVERSE PROBL, V8, P849, DOI 10.1088/0266-5611/8/6/005; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kittler J, 1998, PATTERN ANAL APPL, V1, P18, DOI 10.1007/BF01238023; Kondor R. I., 2002, PROC 19 INT C MACH L, P315; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Lewis DP, 2006, BIOINFORMATICS, V22, P2753, DOI 10.1093/bioinformatics/btl475; Li CY, 2008, BIOINFORMATICS, V24, P1175, DOI 10.1093/bioinformatics/btn081; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Oakman C, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2238; Pittman J, 2004, P NATL ACAD SCI USA, V101, P8431, DOI 10.1073/pnas.0401736101; Pochet N, 2004, BIOINFORMATICS, V20, P3185, DOI 10.1093/bioinformatics/bth383; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Prieto C, 2006, NUCLEIC ACIDS RES, V34, pW298, DOI 10.1093/nar/gkl128; Raghavachari B, 2008, NUCLEIC ACIDS RES, V36, pD656, DOI 10.1093/nar/gkm761; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Raudys S, 1998, PATTERN RECOGN LETT, V19, P385, DOI 10.1016/S0167-8655(98)00016-6; Rish I., 2001, P IJCAI 01 WORKSH EM, P41; Romero P, 2005, GENOME BIOL, V6; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schu┬lkopf B., 2004, KERNEL METHODS COMPU; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Sima C, 2008, PATTERN RECOGN LETT, V29, P1667, DOI 10.1016/j.patrec.2008.04.010; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Vapnik V., 1998, STAT LEARNING THEORY; Vert JP, 2003, BIOINFORMATICS, V19, pII238, DOI 10.1093/bioinformatics/btg1084; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yu JX, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-182	77	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10225	10.1371/journal.pone.0010225	http://dx.doi.org/10.1371/journal.pone.0010225			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419106	Green Submitted, Green Published, gold			2022-12-25	WOS:000276853800015
J	Volpe, S; Thelen, S; Pertel, T; Lohse, MJ; Thelen, M				Volpe, Silvia; Thelen, Sylvia; Pertel, Thomas; Lohse, Martin J.; Thelen, Marcus			Polarization of Migrating Monocytic Cells Is Independent of PI 3-Kinase Activity	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; NEUTROPHIL CHEMOTAXIS; CHEMOKINE RECEPTORS; LEADING-EDGE; LIVING CELLS; ALPHA(2)-ADRENERGIC RECEPTORS; PHOSPHATIDYLINOSITOL 3-KINASE; INTRACELLULAR TRAFFICKING; CHEMOATTRACTANT PROTEIN-1; FLUORESCENT PROTEIN	Background: Migration of mammalian cells is a complex cell type and environment specific process. Migrating hematopoietic cells assume a rapid amoeboid like movement when exposed to gradients of chemoattractants. The underlying signaling mechanisms remain controversial with respect to localization and distribution of chemotactic receptors within the plasma membrane and the role of PI 3-kinase activity in cell polarization. Methodology/Principal Findings: We present a novel model for the investigation of human leukocyte migration. Monocytic THP-1 cells transfected with the alpha(2A)-adrenoceptor (alpha(2A)AR) display comparable signal transduction responses, such as calcium mobilization, MAP-kinase activation and chemotaxis, to the noradrenaline homlogue UK 14'304 as when stimulated with CCL2, which binds to the endogenous chemokine receptor CCR2. Time-lapse video microcopy reveals that chemotactic receptors remain evenly distributed over the plasma membrane and that their internalization is not required for migration. Measurements of intramolecular fluorescence resonance energy transfer ( FRET) of alpha(2A)AR-YFP/CFP suggest a uniform activation of the receptors over the entire plasma membrane. Nevertheless, PI 3-kinse activation is confined to the leading edge. When reverting the gradient of chemoattractant by moving the dispensing micropipette, polarized monocytes - in contrast to neutrophils - rapidly flip their polarization axis by developing a new leading edge at the previous posterior side. Flipping of the polarization axis is accompanied by re-localization of PI-3-kinase activity to the new leading edge. However, reversal of the polarization axis occurs in the absence of PI 3-kinase activation. Conclusions/Significance: Accumulation and internalization of chemotactic receptors at the leading edge is dispensable for cell migration. Furthermore, uniformly distributed receptors allow the cells to rapidly reorient and adapt to changes in the attractant cue. Polarized monocytes, which display typical amoeboid like motility, can rapidly develop a new leading edge facing the highest chemoattractant concentration at any site of the plasma membrane, including the uropod. The process appears to be independent of PI 3-kinase activity.	[Volpe, Silvia; Thelen, Sylvia; Thelen, Marcus] Biomed Res Inst, Bellinzona, Switzerland; [Pertel, Thomas] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland; [Lohse, Martin J.] Univ Wurzburg, Rudolf Virchow Ctr, Wurzburg, Germany; [Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany	Universita della Svizzera Italiana; University of Geneva; University of Wurzburg; University of Wurzburg	Volpe, S (corresponding author), Biomed Res Inst, Bellinzona, Switzerland.	marcus.thelen@irb.unisi.ch	Lohse, Martin J/A-7160-2012	Lohse, Martin J/0000-0002-0599-3510; Pertel, Thomas/0000-0002-2286-6011	European Community; 6th Framework Program, Network of Excellence Grant (MAIN) [LSHG-CT-2003-502935]; Swiss National Science Foundation [316000-117395]; Helmut Horten Foundation	European Community(European Commission); 6th Framework Program, Network of Excellence Grant (MAIN); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Helmut Horten Foundation	The study was co-financed by the European Community through a Marie Curie Action (INTEGRAMM) and the 6th Framework Program, Network of Excellence Grant (MAIN) LSHG-CT-2003-502935 and supported by the Swiss National Science Foundation program R'Equip 316000-117395. The Institute for Research in Biomedicine is supported by the Helmut Horten Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Bourne HR, 2002, NATURE, V419, P21, DOI 10.1038/419021a; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Chen SH, 2008, MOL BIOL CELL, V19, P3909, DOI 10.1091/mbc.E08-04-0433; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; Dalous J, 2008, BIOPHYS J, V94, P1063, DOI 10.1529/biophysj.107.114702; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Dormann D, 2006, EMBO J, V25, P3480, DOI 10.1038/sj.emboj.7601227; DOWNING JR, 1991, MOL CELL BIOL, V11, P2489, DOI 10.1128/MCB.11.5.2489; Fan GH, 2002, J BIOL CHEM, V277, P6590, DOI 10.1074/jbc.M110588200; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; GERISCH G, 1995, CURR BIOL, V5, P1280, DOI 10.1016/S0960-9822(95)00254-5; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Herzmark P, 2007, P NATL ACAD SCI USA, V104, P13349, DOI 10.1073/pnas.0705889104; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Janetopoulos C, 2008, FEBS LETT, V582, P2075, DOI 10.1016/j.febslet.2008.04.035; Knaus AE, 2007, NEUROCHEM INT, V51, P277, DOI 10.1016/j.neuint.2007.06.036; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Lohse MJ, 2007, CURR OPIN PHARMACOL, V7, P547, DOI 10.1016/j.coph.2007.08.007; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Neagu MR, 2009, J CLIN INVEST, V119, P3035, DOI 10.1172/JCI39354; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; Neel NF, 2009, J CELL SCI, V122, P1882, DOI 10.1242/jcs.039057; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Nieto M, 1997, J EXP MED, V186, P153, DOI 10.1084/jem.186.1.153; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Ogilvie P, 2004, J IMMUNOL, V172, P6715, DOI 10.4049/jimmunol.172.11.6715; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Pierce KL, 2000, P NATL ACAD SCI USA, V97, P1489, DOI 10.1073/pnas.97.4.1489; Richardson RM, 1998, J BIOL CHEM, V273, P23830, DOI 10.1074/jbc.273.37.23830; ROMMELSPACHER H, 1987, J NEURAL TRANSM, V69, P85, DOI 10.1007/BF01244099; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sanchez-Madrid F, 2009, NAT REV MOL CELL BIO, V10, P353, DOI 10.1038/nrm2680; Schramm NL, 1999, J BIOL CHEM, V274, P24935, DOI 10.1074/jbc.274.35.24935; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; Thelen M, 1995, BIOCHEM BIOPH RES CO, V217, P1255, DOI 10.1006/bbrc.1995.2903; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Turner SJ, 1998, J BIOL CHEM, V273, P25987, DOI 10.1074/jbc.273.40.25987; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; VONTSCHARNER V, 1986, NATURE, V324, P369, DOI 10.1038/324369a0; Wang JX, 2002, INT J MOL SCI, V3, P4, DOI 10.3390/i3010004; Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; YOSHIMURA T, 1990, J IMMUNOL, V145, P292; ZHANG YJ, 1994, J BIOL CHEM, V269, P15918; ZIGMOND SH, 1981, J CELL BIOL, V89, P585, DOI 10.1083/jcb.89.3.585	71	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10159	10.1371/journal.pone.0010159	http://dx.doi.org/10.1371/journal.pone.0010159			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419163	Green Published, Green Submitted, gold			2022-12-25	WOS:000276707100005
J	Maffettone, C; Chen, GH; Drozdov, I; Ouzounis, C; Pantopoulos, K				Maffettone, Carmen; Chen, Guohua; Drozdov, Ignat; Ouzounis, Christos; Pantopoulos, Kostas			Tumorigenic Properties of Iron Regulatory Protein 2 (IRP2) Mediated by Its Specific 73-Amino Acids Insert	PLOS ONE			English	Article							RESPONSIVE ELEMENT; DEPENDENT DEGRADATION; TARGETED DELETION; HOMEOSTASIS; FERRITIN; OXYGEN; MICE; MYC; METABOLISM; EXPRESSION	Iron regulatory proteins, IRP1 and IRP2, bind to mRNAs harboring iron responsive elements and control their expression. IRPs may also perform additional functions. Thus, IRP1 exhibited apparent tumor suppressor properties in a tumor xenograft model. Here we examined the effects of IRP2 in a similar setting. Human H1299 lung cancer cells or clones engineered for tetracycline-inducible expression of wild type IRP2, or the deletion mutant IRP2D73 (lacking a specific insert of 73 amino acids), were injected subcutaneously into nude mice. The induction of IRP2 profoundly stimulated the growth of tumor xenografts, and this response was blunted by addition of tetracycline in the drinking water of the animals, to turnoff the IRP2 transgene. Interestingly, IRP2D73 failed to promote tumor growth above control levels. As expected, xenografts expressing the IRP2 transgene exhibited high levels of transferrin receptor 1 (TfR1); however, the expression of other known IRP targets was not affected. Moreover, these xenografts manifested increased c-MYC levels and ERK1/2 phosphorylation. A microarray analysis identified distinct gene expression patterns between control and tumors containing IRP2 or IRP1 transgenes. By contrast, gene expression profiles of control and IRP2D73-related tumors were more similar, consistently with their growth phenotype. Collectively, these data demonstrate an apparent pro-oncogenic activity of IRP2 that depends on its specific 73 amino acids insert, and provide further evidence for a link between IRPs and cancer biology.	[Maffettone, Carmen; Chen, Guohua; Pantopoulos, Kostas] McGill Univ, Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Gen Hosp, Montreal, PQ, Canada; [Maffettone, Carmen; Chen, Guohua; Pantopoulos, Kostas] McGill Univ, Dept Med, Montreal, PQ, Canada; [Drozdov, Ignat] Kings Coll London, Div Cardiovasc, Ctr Excellence, BHF, London WC2R 2LS, England; [Drozdov, Ignat; Ouzounis, Christos] Kings Coll London, Sch Phys Sci & Engn, Ctr Bioinformat, London WC2R 2LS, England	Lady Davis Institute; McGill University; McGill University; University of London; King's College London; University of London; King's College London	Maffettone, C (corresponding author), McGill Univ, Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Gen Hosp, Montreal, PQ, Canada.	kostas.pantopoulos@mcgill.ca	Ouzounis, Christos A/G-2302-2010; Pantopoulos, Kostas/A-9668-2008	Ouzounis, Christos A/0000-0002-0086-8657; Pantopoulos, Kostas/0000-0002-2305-0057; Drozdov, Ignat/0000-0001-6727-4688	Cancer Research Society Inc; Government of CanadaBritish Heart Foundation (BHF) Centre of Excellence, Cardiovascular Division, King's College London; Fonds de la Recherche en Sante du Quebec	Cancer Research Society Inc; Government of CanadaBritish Heart Foundation (BHF) Centre of Excellence, Cardiovascular Division, King's College London(British Heart Foundation); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Cancer Research Society Inc (http://src-crs.ca/main.php?lang=2). CM was a recipient of a Post-Doctoral Research Fellowship (PDFR) from the Government of Canada (http://www.scholarships.gc.ca/PDRFNonCdn-BRPDEtr-Eng.aspx). ID holds a pre-doctoral fellowship from the British Heart Foundation (BHF) Centre of Excellence, Cardiovascular Division, King's College London. KP holds a Chercheur National senior career award from the Fonds de la Recherche en Sante du Quebec (http://www.frsq.gouv.qc.ca/en/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen GH, 2007, CARCINOGENESIS, V28, P785, DOI 10.1093/carcin/bgl210; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; Dycke C, 2007, BIOCHEM J, V408, P429, DOI 10.1042/BJ20070983; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Freeman TC, 2007, PLOS COMPUT BIOL, V3, P2032, DOI 10.1371/journal.pcbi.0030206; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Galy B, 2008, CELL METAB, V7, P79, DOI 10.1016/j.cmet.2007.10.006; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; Junttila MR, 2008, CELL CYCLE, V7, P592, DOI 10.4161/cc.7.5.5492; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Mueller S, 2002, METHOD ENZYMOL, V348, P324, DOI 10.1016/S0076-6879(02)48651-X; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Sanchez M, 2006, J BIOL CHEM, V281, P22865, DOI 10.1074/jbc.M603876200; Schumann K, 2010, J TRACE ELEM MED BIO, V24, P58, DOI 10.1016/j.jtemb.2009.10.002; Smith SR, 2006, BLOOD CELL MOL DIS, V36, P283, DOI 10.1016/j.bcmd.2005.12.006; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Wang J, 2002, MOL CELL BIOL, V22, P4638, DOI 10.1128/MCB.22.13.4638-4651.2002; Wang J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-15; Wang J, 2007, MOL CELL BIOL, V27, P2423, DOI 10.1128/MCB.01111-06; Wang W, 2007, J BIOL CHEM, V282, P24650, DOI 10.1074/jbc.M703167200; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006; Zimmer M, 2008, MOL CELL, V32, P838, DOI 10.1016/j.molcel.2008.12.004	34	51	54	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10163	10.1371/journal.pone.0010163	http://dx.doi.org/10.1371/journal.pone.0010163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405006	gold, Green Submitted, Green Published			2022-12-25	WOS:000276706300017
J	Nakatani, SM; Santos, CA; Riediger, IN; Krieger, MA; Duarte, CAB; Lacerda, MA; Biondo, AW; Carilho, FJ; Ono-Nita, SK				Nakatani, Sueli M.; Santos, Carlos A.; Riediger, Irina N.; Krieger, Marco A.; Duarte, Cesar A. B.; Lacerda, Marco A.; Biondo, Alexander W.; Carilho, Flair J.; Ono-Nita, Suzane K.			Development of Hepatitis C Virus Genotyping by Real-Time PCR Based on the NS5B Region	PLOS ONE			English	Article							MELTING CURVE ANALYSIS; ASSAY; INFECTION	Background: Hepatitis C virus (HCV) genotyping is the most significant predictor of the response to antiviral therapy. The aim of this study was to develop and evaluate a novel real-time PCR method for HCV genotyping based on the NS5B region. Methodology/Principal Findings: Two triplex reaction sets were designed, one to detect genotypes 1a, 1b and 3a; and another to detect genotypes 2a, 2b, and 2c. This approach had an overall sensitivity of 97.0%, detecting 295 of the 304 tested samples. All samples genotyped by real-time PCR had the same type that was assigned using LiPA version 1 (Line in Probe Assay). Although LiPA v. 1 was not able to subtype 68 of the 295 samples (23.0%) and rendered different subtype results from those assigned by real-time PCR for 12/295 samples (4.0%), NS5B sequencing and real-time PCR results agreed in all 146 tested cases. Analytical sensitivity of the real-time PCR assay was determined by end-point dilution of the 5000 IU/ml member of the OptiQuant HCV RNA panel. The lower limit of detection was estimated to be 125 IU/ml for genotype 3a, 250 IU/ml for genotypes 1b and 2b, and 500 IU/ml for genotype 1a. Conclusions/Significance: The total time required for performing this assay was two hours, compared to four hours required for LiPA v. 1 after PCR-amplification. Furthermore, the estimated reaction cost was nine times lower than that of available commercial methods in Brazil. Thus, we have developed an efficient, feasible, and affordable method for HCV genotype identification.	[Nakatani, Sueli M.; Riediger, Irina N.] LACEN PR, Lab Cent Estado, Sao Jose Dos Pinhais, Parana, Brazil; [Santos, Carlos A.] Ctr Genomas, Sao Paulo, Brazil; [Krieger, Marco A.; Duarte, Cesar A. B.] ICC FioCruz, Fundacao Oswaldo Cruz, Inst Carlos Chagas, Curitiba, Parana, Brazil; [Lacerda, Marco A.] Indiana Univ, Div Gastroenterol & Hepatol, Indianapolis, IN 46204 USA; [Biondo, Alexander W.] Univ Fed Parana, Dept Vet Med, BR-80060000 Curitiba, Parana, Brazil; [Biondo, Alexander W.] Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA; [Nakatani, Sueli M.; Carilho, Flair J.; Ono-Nita, Suzane K.] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil; [Riediger, Irina N.] Univ Fed Parana, Dept Biol Celular, BR-80060000 Curitiba, Parana, Brazil	Fundacao Oswaldo Cruz; Indiana University System; Indiana University-Purdue University Indianapolis; Universidade Federal do Parana; University of Illinois System; University of Illinois Urbana-Champaign; Universidade de Sao Paulo; Universidade Federal do Parana	Nakatani, SM (corresponding author), LACEN PR, Lab Cent Estado, Sao Jose Dos Pinhais, Parana, Brazil.	skon@usp.br	BIONDO, ALEXANDER WELKER/AAU-8955-2021; Ono, Suzane K/I-3107-2012; BIONDO, ALEXANDER WELKER W/E-8823-2018; Krieger, Marco/AAE-8611-2020; Publica, Inct Saude/J-9544-2013; P, CM/B-1358-2013	BIONDO, ALEXANDER WELKER/0000-0002-4182-5821; BIONDO, ALEXANDER WELKER W/0000-0002-4182-5821; Krieger, Marco Aurelio/0000-0003-0030-3952	Secretaria de Estado da Saude do Parana; Araucaria Foundation; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Alves de Queiroz Family Fund for Research	Secretaria de Estado da Saude do Parana; Araucaria Foundation(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Alves de Queiroz Family Fund for Research	These investigations were partially supported by grants from Secretaria de Estado da Saude do Parana, Araucaria Foundation, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Alves de Queiroz Family Fund for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bullock GC, 2002, CLIN CHEM, V48, P2147; Campiotto S, 2005, BRAZ J MED BIOL RES, V38, P41, DOI 10.1590/S0100-879X2005000100007; Cantaloube JF, 2006, J CLIN MICROBIOL, V44, P2051, DOI 10.1128/JCM.02463-05; Cook L, 2006, J CLIN MICROBIOL, V44, P4149, DOI 10.1128/JCM.01230-06; Corbet S, 2003, J CLIN MICROBIOL, V41, P1091, DOI 10.1128/JCM.41.3.1091-1100.2003; DAVIDSON F, 1995, J GEN VIROL, V76, P1197, DOI 10.1099/0022-1317-76-5-1197; Fujigaki H, 2004, ANN CLIN BIOCHEM, V41, P130, DOI 10.1258/000456304322880014; Holland PV, 1996, J CLIN MICROBIOL, V34, P2372, DOI 10.1128/JCM.34.10.2372-2378.1996; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; KUSSER W, PROTOCOL REAL TIME R; Levi JE, 2002, J CLIN MICROBIOL, V40, P2645, DOI 10.1128/JCM.40.7.2645-2647.2002; Lindh M, 2005, J CLIN VIROL, V34, P108, DOI 10.1016/j.jcv.2005.02.002; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Peters IR, 2004, J IMMUNOL METHODS, V286, P203, DOI 10.1016/j.jim.2004.01.003; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Rolfe KJ, 2005, J CLIN VIROL, V34, P115, DOI 10.1016/j.jcv.2005.02.011; Schroter M, 2002, J CLIN MICROBIOL, V40, P2046, DOI 10.1128/JCM.40.6.2046-2050.2002; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; SIMMONDS P, 1994, HEPATOLOGY, V19, P1321, DOI 10.1016/0270-9139(94)90887-7; Stahlberg A, 2004, CLIN CHEM, V50, P1678, DOI 10.1373/clinchem.2004.035469; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON WD, 1988, J CLIN EPIDEMIOL, V41, P969, DOI 10.1016/0895-4356(88)90033-9; Weck K, 2005, EXPERT REV MOL DIAGN, V5, P507, DOI 10.1586/14737159.5.4.507	24	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10150	10.1371/journal.pone.0010150	http://dx.doi.org/10.1371/journal.pone.0010150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405017	Green Published, Green Submitted, gold			2022-12-25	WOS:000276706300007
J	Novitsky, V; Wang, R; Bussmann, H; Lockman, S; Baum, M; Shapiro, R; Thior, I; Wester, C; Wester, CW; Ogwu, A; Asmelash, A; Musonda, R; Campa, A; Moyo, S; van Widenfelt, E; Mine, M; Moffat, C; Mmalane, M; Makhema, J; Marlink, R; Gilbert, P; Seage, GR; DeGruttola, V; Essex, M				Novitsky, Vladimir; Wang, Rui; Bussmann, Hermann; Lockman, Shahin; Baum, Marianna; Shapiro, Roger; Thior, Ibou; Wester, Carolyn; Wester, C. William; Ogwu, Anthony; Asmelash, Aida; Musonda, Rosemary; Campa, Adriana; Moyo, Sikhulile; van Widenfelt, Erik; Mine, Madisa; Moffat, Claire; Mmalane, Mompati; Makhema, Joseph; Marlink, Richard; Gilbert, Peter; Seage, George R., III; DeGruttola, Victor; Essex, M.			HIV-1 Subtype C-Infected Individuals Maintaining High Viral Load as Potential Targets for the "Test-and-Treat'' Approach to Reduce HIV Transmission	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CLINICAL-TRIAL; ANTIRETROVIRAL THERAPY; HETEROSEXUAL TRANSMISSION; TYPE-1 INFECTION; NATURAL-HISTORY; SOUTHERN AFRICA; RISK-FACTORS; RNA LEVELS; BOTSWANA	The first aim of the study is to assess the distribution of HIV-1 RNA levels in subtype C infection. Among 4,348 drug-naive HIV-positive individuals participating in clinical studies in Botswana, the median baseline plasma HIV-1 RNA levels differed between the general population cohorts (4.1-4.2 log(10)) and cART-initiating cohorts (5.1-5.3 log(10)) by about one log(10). The proportion of individuals with high (>= 50,000 (4.7 log(10)) copies/ml) HIV-1 RNA levels ranged from 24%-28% in the general HIV-positive population cohorts to 65%-83% in cART-initiating cohorts. The second aim is to estimate the proportion of individuals who maintain high HIV-1 RNA levels for an extended time and the duration of this period. For this analysis, we estimate the proportion of individuals who could be identified by repeated 6- vs. 12-month-interval HIV testing, as well as the potential reduction of HIV transmission time that can be achieved by testing and ARV treating. Longitudinal analysis of 42 seroconverters revealed that 33% (95% CI: 20%-50%) of individuals maintain high HIV-1 RNA levels for at least 180 days post seroconversion (p/s) and the median duration of high viral load period was 350 ( 269; 428) days p/s. We found that it would be possible to identify all HIV-infected individuals with viral load >= 50,000 ( 4.7 log(10)) copies/ml using repeated six-month-interval HIV testing. Assuming individuals with high viral load initiate cART after being identified, the period of high transmissibility due to high viral load can potentially be reduced by 77% ( 95% CI: 71%-82%). Therefore, if HIV-infected individuals maintaining high levels of plasma HIV-1 RNA for extended period of time contribute disproportionally to HIV transmission, a modified "test-and-treat'' strategy targeting such individuals by repeated HIV testing (followed by initiation of cART) might be a useful public health strategy for mitigating the HIV epidemic in some communities.	[Novitsky, Vladimir; Bussmann, Hermann; Lockman, Shahin; Shapiro, Roger; Thior, Ibou; Wester, Carolyn; Wester, C. William; Ogwu, Anthony; Asmelash, Aida; Musonda, Rosemary; Moffat, Claire; Makhema, Joseph; Marlink, Richard; Essex, M.] Harvard Univ, Sch Publ Hlth, AIDS Initiat, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Novitsky, Vladimir; Bussmann, Hermann; Lockman, Shahin; Shapiro, Roger; Thior, Ibou; Wester, Carolyn; Wester, C. William; Ogwu, Anthony; Asmelash, Aida; Musonda, Rosemary; Moyo, Sikhulile; van Widenfelt, Erik; Mine, Madisa; Moffat, Claire; Mmalane, Mompati; Makhema, Joseph; Marlink, Richard; Essex, M.] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Wang, Rui; DeGruttola, Victor] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Baum, Marianna; Campa, Adriana] Florida Int Univ, Dept Nutr & Dietet, Robert R Stempel Sch Publ Hlth, Miami, FL 33199 USA; [Gilbert, Peter] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Gilbert, Peter] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Seage, George R., III] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wester, C. William] Vanderbilt Univ, Sch Med, Div Infect Dis, VIGH, Nashville, TN 37212 USA	Harvard University; Harvard T.H. Chan School of Public Health; Botswana-Harvard AIDS Institute Partnership; Harvard University; Harvard T.H. Chan School of Public Health; State University System of Florida; Florida International University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Harvard University; Harvard T.H. Chan School of Public Health; Vanderbilt University	Novitsky, V (corresponding author), Harvard Univ, Sch Publ Hlth, AIDS Initiat, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	messex@hsph.harvard.edu	Wang, Rui/X-1699-2019; Moyo, Sikhulile/E-1464-2015	Wang, Rui/0000-0001-5007-193X; Moyo, Sikhulile/0000-0003-3821-4592	NIH [R01 HD37793, R01 HD44391, R01 AI057027, R01 AI052032, R01 DA016551, R37 AI24643, U01 AI066454]; Bristol-Myers Squibb Foundation; African Comprehensive HIV/AIDS Partnerships (ACHAP); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044391, R01HD037793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051164, K23AI073141, R01AI052032, R01AI057027, U01AI066454, R37AI024643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016551] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol-Myers Squibb Foundation(Bristol-Myers Squibb); African Comprehensive HIV/AIDS Partnerships (ACHAP); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The studies presented were supported and funded by NIH grants R01 HD37793 (Mashi), R01 HD44391 (Mashi+), R01 AI057027 (Tshedimoso), R01 AI052032 (Botsogo), R01 DA016551 (Dikotlana), R37 AI24643, and U01 AI066454 (Mma Bana), by a grant from the Bristol-Myers Squibb Foundation (Tshepo), and by a grant from the African Comprehensive HIV/AIDS Partnerships (ACHAP) (Bomolemo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blattner WA, 2004, J INFECT DIS, V189, P1793, DOI 10.1086/386306; Bussmann H, 2009, JAIDS-J ACQ IMM DEF, V51, P37, DOI 10.1097/QAI.0b013e31819ff102; DAAR ES, 1991, NEW ENGL J MED, V324, P961, DOI 10.1056/NEJM199104043241405; deWolf F, 1997, AIDS, V11, P1799, DOI 10.1097/00002030-199715000-00003; Dyer JR, 1998, J INFECT DIS, V177, P1742, DOI 10.1086/517436; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray CM, 2005, AIDS RES HUM RETROV, V21, P285, DOI 10.1089/aid.2005.21.285; Hisada M, 2000, J INFECT DIS, V181, P1475, DOI 10.1086/315396; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; John GC, 2001, J INFECT DIS, V183, P206, DOI 10.1086/317918; Kaufmann GR, 1998, J INFECT DIS, V178, P1812, DOI 10.1086/314480; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kumwenda JJ, 2008, CLIN INFECT DIS, V46, P1913, DOI 10.1086/588478; Little SJ, 1999, J EXP MED, V190, P841, DOI 10.1084/jem.190.6.841; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; *LOS AL HIV, LOS AL HIV DAT COMP; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mmiro FA, 2009, JAIDS-J ACQ IMM DEF, V52, P32, DOI 10.1097/QAI.0b013e3181afd352; Modjarrad K, 2008, AIDS, V22, P2179, DOI 10.1097/QAD.0b013e328312c756; Novitsky V, 2008, AIDS CARE, V20, P806, DOI 10.1080/09540120701694055; Novitsky V, 2002, J VIROL, V76, P5435, DOI 10.1128/JVI.76.11.5435-5451.2002; Novitsky V, 2007, AIDS RES HUM RETROV, V23, P868, DOI 10.1089/aid.2006.0298; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V50, P65, DOI 10.1097/QAI.0b013e3181900141; Novitsky V, 2009, VIROLOGY, V383, P47, DOI 10.1016/j.virol.2008.09.017; Novitsky V, 2007, CLIN INFECT DIS, V45, pE68, DOI 10.1086/520683; Novitsky V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007727; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V52, P265, DOI 10.1097/QAI.0b013e3181ab6ef0; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rezza G, 2000, J ACQ IMMUN DEF SYND, V25, P56, DOI 10.1097/00126334-200009010-00008; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Schacker TW, 1998, ANN INTERN MED, V128, P613, DOI 10.7326/0003-4819-128-8-199804150-00001; Shapiro RL, 2005, J INFECT DIS, V192, P720, DOI 10.1086/432483; Shapiro RL, 2007, J INFECT DIS, V196, P562, DOI 10.1086/519847; Shapiro RL, 2006, AIDS, V20, P1281, DOI 10.1097/01.aids.0000232236.26630.35; Shapiro RL, 2009, J INFECT DIS, V199, P414, DOI 10.1086/596034; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Tovanabutra S, 2002, J ACQ IMMUN DEF SYND, V29, P275, DOI 10.1097/00126334-200203010-00008; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Walensky Rochelle P, 2009, Top HIV Med, V17, P130; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wester CW, 2007, JAIDS-J ACQ IMM DEF, V46, P318, DOI 10.1097/QAI.0b013e3181568e3f	49	44	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10148	10.1371/journal.pone.0010148	http://dx.doi.org/10.1371/journal.pone.0010148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405044	Green Published, Green Submitted, gold			2022-12-25	WOS:000276705900023
J	Salomaa, V; Havulinna, A; Saarela, O; Zeller, T; Jousilahti, P; Jula, A; Munzel, T; Aromaa, A; Evans, A; Kuulasmaa, K; Blankenberg, S				Salomaa, Veikko; Havulinna, Aki; Saarela, Olli; Zeller, Tanja; Jousilahti, Pekka; Jula, Antti; Muenzel, Thomas; Aromaa, Arpo; Evans, Alun; Kuulasmaa, Kari; Blankenberg, Stefan			Thirty-One Novel Biomarkers as Predictors for Clinically Incident Diabetes	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; MIDDLE-AGED MEN; ATHEROSCLEROSIS RISK; ELEVATED LEVELS; LIFE-STYLE; TYPE-2; ANTAGONIST; MELLITUS; ADIPONECTIN	Background: The prevalence of diabetes is increasing in all industrialized countries and its prevention has become a public health priority. However, the predictors of diabetes risk are insufficiently understood. We evaluated, whether 31 novel biomarkers could help to predict the risk of incident diabetes. Methods and Findings: The biomarkers were evaluated primarily in the FINRISK97 cohort (n = 7,827; 417 cases of clinically incident diabetes during the follow-up). The findings were replicated in the Health 2000 cohort (n = 4,977; 179 cases of clinically incident diabetes during the follow-up). We used Cox proportional hazards models to calculate the relative risk of diabetes, after adjusting for the classic risk factors, separately for each biomarker. Next, we assessed the discriminatory ability of single biomarkers using receiver operating characteristic curves and C-statistics, integrated discrimination improvement (IDI) and net reclassification improvement (NRI). Finally, we derived a biomarker score in the FINRISK97 cohort and validated it in the Health 2000 cohort. A score consisting of adiponectin, apolipoprotein B, C-reactive protein and ferritin almost doubled the relative risk of diabetes in the validation cohort (HR per one standard deviation increase 1.88, p = 2.8 e-5). It also improved discrimination of the model (IDI = 0.0149, p < 0.0001) and reclassification of diabetes risk (NRI = 11.8%, p = 0.006). Gender-specific analyses suggested that the best score differed between men and women. Among men, the best results were obtained with the score of four biomarkers: adiponectin, apolipoprotein B, ferritin and interleukin-1 receptor antagonist, which gave an NRI of 25.4% (p < 0.0001). Among women, the best score included adiponectin, apolipoprotein B, C-reactive protein and insulin. It gave an NRI of 13.6% (p = 0.041). Conclusions: We identified novel biomarkers that were associated with the risk of clinically incident diabetes over and above the classic risk factors. This gives new insights into the pathogenesis of diabetes and may help with targeting prevention and treatment.	[Salomaa, Veikko; Havulinna, Aki; Saarela, Olli; Jousilahti, Pekka; Jula, Antti; Aromaa, Arpo; Kuulasmaa, Kari] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Evans, Alun] Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth, Belfast, Antrim, North Ireland; [Zeller, Tanja; Muenzel, Thomas; Blankenberg, Stefan] Johannes Gutenberg Univ Mainz, Dept Med 2, Mainz, Germany	Finland National Institute for Health & Welfare; Queens University Belfast; Johannes Gutenberg University of Mainz	Salomaa, V (corresponding author), Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland.	veikko.salomaa@thl.fi; blankenberg@2-med.klinik.uni-mainz.de	Munzel, Thomas/A-2912-2014; Havulinna, Aki/AAM-4769-2021	Munzel, Thomas/0000-0001-5503-4150; Kuulasmaa, Kari/0000-0003-2165-1411; Zeller, Tanja/0000-0003-3379-2641; Blankenberg, Stefan/0000-0001-6488-2362	Medical Research Council London [Medical Research Council London (G0601463]; Finnish Foundation for Cardiovascular Research; Finnish Academy [129494]; MRC [G0601463] Funding Source: UKRI; Medical Research Council [G0601463] Funding Source: researchfish	Medical Research Council London(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Finnish Foundation for Cardiovascular Research; Finnish Academy(Academy of Finland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The biomarker determinations in FINRISK97 were funded in part by the Medical Research Council London (G0601463, ID no: 80983: Biomarkers in the MORGAM populations). Abbott Diagnostics, BRAHMS AG, Diadexus and Roche Diagnostics provided test reagents (for details see Supplementary Table S1). VS was supported by the Finnish Foundation for Cardiovascular Research and by the Finnish Academy, grant no 129494. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolini L, 2004, COMMUN STAT-THEOR M, V33, P2117, DOI 10.1081/STA-200026579; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Caramori ML, 2003, CURR OPIN NEPHROL HY, V12, P273, DOI 10.1097/00041552-200305000-00008; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Duncan BB, 2004, DIABETES, V53, P2473, DOI 10.2337/diabetes.53.9.2473; Forouhi NG, 2007, DIABETOLOGIA, V50, P949, DOI 10.1007/s00125-007-0604-5; Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Herder C, 2009, DIABETES CARE, V32, P421, DOI 10.2337/dc08-1161; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Jehn ML, 2007, AM J EPIDEMIOL, V165, P1047, DOI 10.1093/aje/kwk093; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Kattainen A, 2006, EUR HEART J, V27, P296, DOI 10.1093/eurheartj/ehi630; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kolberg JA, 2009, DIABETES CARE, V32, P1207, DOI 10.2337/dc08-1935; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Rossing Peter, 2006, Curr Diab Rep, V6, P479, DOI 10.1007/s11892-006-0083-y; Sattar N, 2008, DIABETOLOGIA, V51, P926, DOI 10.1007/s00125-008-0954-7; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369; STEYERBERG EW, ANN INTERN MED, V152, P196; Steyerberg EW, 2010, ANN INTERN MED, V152, P195, DOI 10.7326/0003-4819-152-3-201002020-00019; Thorand B, 2005, DIABETES, V54, P2932, DOI 10.2337/diabetes.54.10.2932; Thorand B, 2003, ARCH INTERN MED, V163, P93, DOI 10.1001/archinte.163.1.93; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vartiainen E, 2009, INT J EPIDEMIOL; Wannamethee SG, 2007, DIABETES CARE, V30, P1200, DOI 10.2337/dc06-2416; Wannamethee SG, 2008, NUTR METAB CARDIOVAS, V18, P581, DOI 10.1016/j.numecd.2008.07.002; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068	35	134	143	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10100	10.1371/journal.pone.0010100	http://dx.doi.org/10.1371/journal.pone.0010100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20396381	Green Published, Green Submitted, gold			2022-12-25	WOS:000276482100016
J	Vembar, SS; Jonikas, MC; Hendershot, LM; Weissman, JS; Brodsky, JL				Vembar, Shruthi S.; Jonikas, Martin C.; Hendershot, Linda M.; Weissman, Jonathan S.; Brodsky, Jeffrey L.			J Domain Co-chaperone Specificity Defines the Role of BiP during Protein Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ENDOPLASMIC-RETICULUM; MULTISPANNING MEMBRANE-PROTEIN; HSP70 MOLECULAR CHAPERONE; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-BINDING; DNAJ HOMOLOG; POLYPEPTIDE TRANSLOCATION; DISTINCT FUNCTIONS; UNFOLDED PROTEINS; COCHAPERONE DNAJ	Hsp70 chaperones can potentially interact with one of several J domain-containing Hsp40 co-chaperones to regulate distinct cellular processes. However, features within Hsp70s that determine Hsp40 specificity are undefined. To investigate this question, we introduced mutations into the ER-lumenal Hsp70, BiP/Kar2p, and found that an R217A substitution in the J domain-interacting surface of BiP compromised the physical and functional interaction with Sec63p, an Hsp40 required for ER translocation. In contrast, interaction with Jem1p, an Hsp40 required for ER-associated degradation, was unaffected. Moreover, yeast expressing R217A BiP exhibited defects in translocation but not in ER-associated degradation. Finally, the genetic interactions of the R217A BiP mutant were found to correlate with those of known translocation mutants. Together, our results indicate that residues within the Hsp70 J domain-interacting surface help confer Hsp40 specificity, in turn influencing distinct chaperone-mediated cellular activities.	[Vembar, Shruthi S.; Hendershot, Linda M.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Jonikas, Martin C.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Jonikas, Martin C.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Jonikas, Martin C.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Jonikas, Martin C.; Weissman, Jonathan S.] Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA; [Hendershot, Linda M.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Hendershot, Linda M.] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN 38163 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, 4249 5th Ave,A320 Langley Hall, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu	Vembar, Shruthi Sridhar/AAE-2479-2019; Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274; Weissman, Jonathan/0000-0003-2445-670X	National Institutes of Health [GM75061, GM54068]; Cancer Center [CA21765]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; University of Pittsburgh; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054068, R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); University of Pittsburgh(University of Pittsburgh); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM75061 (to J. L. B.) and GM54068 (to L. M. H.). This work was also supported by the Cancer Center CORE Grant CA21765 and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital (to L. M. H.).; Recipient of a Mellon Graduate Fellowship from the University of Pittsburgh.	Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; ANG D, 1991, J BIOL CHEM, V266, P24233; Awad W, 2008, P NATL ACAD SCI USA, V105, P1164, DOI 10.1073/pnas.0702132105; BOHNI PC, 1988, J CELL BIOL, V106, P1035, DOI 10.1083/jcb.106.4.1035; BRODSKY JL, 1993, J CELL BIOL, V120, P95, DOI 10.1083/jcb.120.1.95; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Brodsky JL, 1996, TRENDS BIOCHEM SCI, V21, P122, DOI 10.1016/0968-0004(96)20010-6; BUCHBERGER A, 1994, EMBO J, V13, P1687, DOI 10.1002/j.1460-2075.1994.tb06433.x; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; CYR DM, 1992, J BIOL CHEM, V267, P20927; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; FELDHEIM D, 1992, MOL CELL BIOL, V12, P3288, DOI 10.1128/MCB.12.7.3288; FELDHEIM D, 1993, MOL BIOL CELL, V4, P931, DOI 10.1091/mbc.4.9.931; Fernandez-Saiz V, 2006, J BIOL CHEM, V281, P7479, DOI 10.1074/jbc.M512744200; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; HANSEN W, 1986, CELL, V45, P397, DOI 10.1016/0092-8674(86)90325-9; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Jin Y, 2008, EMBO J, V27, P2873, DOI 10.1038/emboj.2008.207; Johnson AE, 1997, TRENDS CELL BIOL, V7, P90, DOI 10.1016/S0962-8924(97)01029-5; Johnson AE, 2009, J CELL BIOL, V185, P765, DOI 10.1083/jcb.200902014; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kabani M, 2003, MOL BIOL CELL, V14, P3437, DOI 10.1091/mbc.E02-12-0847; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Kimata Y, 2003, MOL BIOL CELL, V14, P2559, DOI 10.1091/mbc.E02-11-0708; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McClellan AJ, 1998, MOL BIOL CELL, V9, P3533, DOI 10.1091/mbc.9.12.3533; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Moro F, 2004, J BIOL CHEM, V279, P19600, DOI 10.1074/jbc.M400921200; Morrow MW, 2001, TRAFFIC, V2, P705, DOI 10.1034/j.1600-0854.2001.21005.x; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Nishikawa S, 1998, BIOCHEM BIOPH RES CO, V244, P785, DOI 10.1006/bbrc.1998.8342; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Nishikawa S, 1997, J BIOL CHEM, V272, P12889, DOI 10.1074/jbc.272.20.12889; Pierpaoli EV, 1998, BIOCHEMISTRY-US, V37, P16741, DOI 10.1021/bi981762y; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; ROSE M, 1983, METHOD ENZYMOL, V101, P167; SADLER I, 1989, J CELL BIOL, V109, P2665, DOI 10.1083/jcb.109.6.2665; Saibil H, 2000, CURR OPIN STRUC BIOL, V10, P251, DOI 10.1016/S0959-440X(00)00074-9; SCHLENSTEDT G, 1995, J CELL BIOL, V129, P979, DOI 10.1083/jcb.129.4.979; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Silberstein S, 1998, J CELL BIOL, V143, P921, DOI 10.1083/jcb.143.4.921; SIMONS JF, 1995, J CELL BIOL, V130, P41, DOI 10.1083/jcb.130.1.41; Suh WC, 1999, J BIOL CHEM, V274, P30534, DOI 10.1074/jbc.274.43.30534; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Tam A, 2001, J BIOL CHEM, V276, P46798, DOI 10.1074/jbc.M106150200; TEHEESEN S, 1994, EUR J BIOCHEM, V222, P631; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Van Driessche B, 2005, YEAST, V22, P1061, DOI 10.1002/yea.1293; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	69	33	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22484	22494		10.1074/jbc.M110.102186	http://dx.doi.org/10.1074/jbc.M110.102186			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20430885	hybrid, Green Published			2022-12-25	WOS:000279702200060
J	Duval, S; Santini, JM; Nitschke, W; Hille, R; Schoepp-Cothenet, B				Duval, Simon; Santini, Joanne M.; Nitschke, Wolfgang; Hille, Russ; Schoepp-Cothenet, Barbara			The Small Subunit AroB of Arsenite Oxidase LESSONS ON THE [2Fe-2S] RIESKE PROTEIN SUPERFAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME BC(1) COMPLEX; IRON-SULFUR PROTEIN; ELECTRON-PARAMAGNETIC-RESONANCE; MULTIPLE SEQUENCE ALIGNMENTS; FORMING HYDROGEN-BONDS; CHLOROFLEXUS-AURANTIACUS; REDUCTION POTENTIALS; ALCALIGENES-FAECALIS; RESPIRATORY-CHAIN; OXIDATION-STATE	Here, we describe the characterization of the [2Fe-2S] clusters of arsenite oxidases from Rhizobium sp. NT-26 and Ralstonia sp. 22. Both reduced Rieske proteins feature EPR signals similar to their homologs from Rieske-cyt b complexes, with g values at 2.027, 1.88, and 1.77. Redox titrations in a range of pH values showed that both [2Fe-2S] centers have constant E-m values up to pH 8 at similar to+210 mV. Above this pH value, the E-m values of both centers are pH-dependent, similar to what is observed for the Rieske-cyt b complexes. The redox properties of these two proteins, together with the low E-m value (+160 mV) of the Alcaligenes faecalis arsenite oxidase Rieske (confirmed herein), are in line with the structural determinants observed in the primary sequences, which have previously been deduced from the study of Rieske-cyt b complexes. Since the published E-m value of the Chloroflexus aurantiacus Rieske (+100 mV) is in conflict with this sequence analysis, we re-analyzed membrane samples of this organism and obtain a new value (+200 mV). Arsenite oxidase activity was affected by quinols and quinol analogs, which is similar to what is found with the Rieske-cyt b complexes. Together, these results show that the Rieske protein of arsenite oxidase shares numerous properties with its counterpart in the Rieske-cyt b complex. However, two cysteine residues, strictly conserved in the Rieske-cyt b-Rieske and considered to be crucial for its function, are not conserved in the arsenite oxidase counterpart. We discuss the role of these residues.	[Duval, Simon; Nitschke, Wolfgang; Schoepp-Cothenet, Barbara] CNRS, Inst Biol Struct & Microbiol, Lab Bioenerget & Ingn Prot, UPR 9036, F-13402 Marseille 20, France; [Santini, Joanne M.] UCL, Inst Struct & Mol Biol, London WC1E 6BT, England; [Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of London; Birkbeck University London; University College London; University of California System; University of California Riverside	Schoepp-Cothenet, B (corresponding author), CNRS, Inst Biol Struct & Microbiol, Lab Bioenerget & Ingn Prot, UPR 9036, F-13402 Marseille 20, France.	schoepp@ifr88.cnrs-mrs.fr	Schoepp-Cothenet, Barbara/AAH-8911-2021; Duval, Simon/ABS-5379-2022; Nitschke, Wolfgang/C-4812-2012	Schoepp-Cothenet, Barbara/0000-0002-6820-4478; Duval, Simon/0000-0003-2946-6771; Nitschke, Wolfgang/0000-0003-2084-3032				ANDERSON GL, 1992, J BIOL CHEM, V267, P23674; Baymann F, 2003, PHILOS T ROY SOC B, V358, P267, DOI 10.1098/rstb.2002.1184; BERTRAND P, 1987, BIOCHIM BIOPHYS ACTA, V916, P24, DOI 10.1016/0167-4838(87)90206-8; Brugna M, 1999, J BIOL CHEM, V274, P16766, DOI 10.1074/jbc.274.24.16766; Carrell CJ, 1997, STRUCTURE, V5, P1613, DOI 10.1016/S0969-2126(97)00309-2; Colbert CL, 2000, STRUCTURE, V8, P1267, DOI 10.1016/S0969-2126(00)00536-0; DAVIDSON E, 1992, BIOCHEMISTRY-US, V31, P3342, DOI 10.1021/bi00128a006; Denke E, 1998, J BIOL CHEM, V273, P9085, DOI 10.1074/jbc.273.15.9085; Ding H, 1995, BIOCHEMISTRY-US, V34, P15979, DOI 10.1021/bi00049a012; DUTTON PL, 1971, BIOCHIM BIOPHYS ACTA, V226, P63, DOI 10.1016/0005-2728(71)90178-2; DUVAL S, 2008, THESIS U PROVENCE MA; Duval S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-206; Ellis PJ, 2001, STRUCTURE, V9, P125, DOI 10.1016/S0969-2126(01)00566-4; Green H. H., 1918, S AFR J SCI, V14, P465; Henninger T, 1999, J BIOENERG BIOMEMBR, V31, P119, DOI 10.1023/A:1005447710894; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; Hoeft SE, 2007, INT J SYST EVOL MICR, V57, P504, DOI 10.1099/ijs.0.64576-0; Hoke KR, 2004, BIOCHEMISTRY-US, V43, P1667, DOI 10.1021/bi0357154; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; IWASAKI T, 1995, J BACTERIOL, V177, P2576, DOI 10.1128/jb.177.9.2576-2582.1995; Iwasaki T, 1996, J BIOL CHEM, V271, P27659, DOI 10.1074/jbc.271.44.27659; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Iwata S, 1996, STRUCTURE, V4, P567, DOI 10.1016/S0969-2126(96)00062-7; Kallas T, 1994, MOL BIOL CYANOBACTER, V1, P259, DOI DOI 10.1007/978-94-011-0227-8_9; Kashyap DR, 2006, J BACTERIOL, V188, P1081, DOI 10.1128/JB.188.3.1081-1088.2006; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; Kolling DJ, 2007, STRUCTURE, V15, P29, DOI 10.1016/j.str.2006.11.012; Kulp TR, 2008, SCIENCE, V321, P967, DOI 10.1126/science.1160799; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Lebrun E, 2006, MOL BIOL EVOL, V23, P1180, DOI 10.1093/molbev/msk010; Leggate EJ, 2005, BIOCHEMISTRY-US, V44, P7048, DOI 10.1021/bi050189x; Liebl U, 1997, BIOCHEMISTRY-US, V36, P11675, DOI 10.1021/bi970776l; LIEUTAUD A, 2007, THESIS U PROVENCE MA; Lieutaud A, 2010, J BIOL CHEM, V285, P20433, DOI 10.1074/jbc.M110.113761; Link TA, 1999, ADV INORG CHEM, V47, P83, DOI 10.1016/S0898-8838(08)60077-X; MASON JR, 1992, ANNU REV MICROBIOL, V46, P277, DOI 10.1146/annurev.mi.46.100192.001425; Merbitz-Zahradnik T, 2003, BIOCHEMISTRY-US, V42, P13637, DOI 10.1021/bi035344r; Muller D, 2003, J BACTERIOL, V185, P135, DOI 10.1128/JB.185.1.135-141.2003; Nitscke W, 1995, PHOTOSYNTHESIS LIGHT, V1, P945; Palsdottir H, 2003, J BIOL CHEM, V278, P31303, DOI 10.1074/jbc.M302195200; PIERSON BK, 1974, ARCH MICROBIOL, V100, P5, DOI 10.1007/BF00446302; RIEDEL A, 1991, J BIOL CHEM, V266, P17838; RIESKE JS, 1964, J BIOL CHEM, V239, P3017; Santini JM, 2004, J BACTERIOL, V186, P1614, DOI 10.1128/JB.186.6.1614-1619.2004; Schmidt CL, 2001, J BIOENERG BIOMEMBR, V33, P9, DOI 10.1023/A:1005616505962; Schoepp B, 1999, FEBS LETT, V450, P245, DOI 10.1016/S0014-5793(99)00511-6; Schoepp B, 1999, ADV INORG CHEM, V47, P335, DOI 10.1016/S0898-8838(08)60082-3; Schoepp-Cothenet B, 2009, P NATL ACAD SCI USA, V106, P8549, DOI 10.1073/pnas.0813173106; Schroter T, 1998, EUR J BIOCHEM, V255, P100, DOI 10.1046/j.1432-1327.1998.2550100.x; Schutz M, 2003, BIOCHEMISTRY-US, V42, P10800, DOI 10.1021/bi034452a; Schutz M, 2000, J MOL BIOL, V300, P663, DOI 10.1006/jmbi.2000.3915; Silver S, 2005, APPL ENVIRON MICROB, V71, P599, DOI 10.1128/AEM.71.2.599-608.2005; SLATER EC, 1980, NATURE, V288, P717, DOI 10.1038/288717a0; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; THIERBACH G, 1984, BIOCHIM BIOPHYS ACTA, V765, P227, DOI 10.1016/0005-2728(84)90017-3; Ugulava NB, 1998, FEBS LETT, V440, P409, DOI 10.1016/S0014-5793(98)01493-8; vanden Hoven RN, 2004, BBA-BIOENERGETICS, V1656, P148, DOI 10.1016/j.bbabio.2004.03.001; VONJAGOW G, 1985, FEBS LETT, V185, P311, DOI 10.1016/0014-5793(85)80929-7; ZANNONI D, 1985, FEBS LETT, V193, P93, DOI 10.1016/0014-5793(85)80086-7; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zu YB, 2003, BIOCHEMISTRY-US, V42, P12400, DOI 10.1021/bi0350957	61	27	30	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20442	20451		10.1074/jbc.M110.113811	http://dx.doi.org/10.1074/jbc.M110.113811			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20421651	Green Published, hybrid			2022-12-25	WOS:000279228600004
J	Vest, RS; O'Leary, H; Coultrap, SJ; Kindy, MS; Bayer, KU				Vest, Rebekah S.; O'Leary, Heather; Coultrap, Steven J.; Kindy, Mark S.; Bayer, K. Ulrich			Effective Post-insult Neuroprotection by a Novel Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-ASPARTATE RECEPTOR; INDUCED CELL-DEATH; TISSUE-PLASMINOGEN ACTIVATOR; ISCHEMIC BRAIN-DAMAGE; NMDA RECEPTOR; GLUTAMATE NEUROTOXICITY; HIPPOCAMPAL-NEURONS; CEREBRAL-ISCHEMIA; SELF-ASSOCIATION; GLUCOSE DEPRIVATION	Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) is a major mediator of physiological glutamate signaling involved in higher brain functions. Here, we show CaMKII involvement in pathological glutamate signaling relevant in stroke. The novel inhibitor tatCN21 was neuroprotective even when added hours after glutamate insults. By contrast, the "traditional" inhibitor KN93 attenuated excitotoxicity only when present during the insult. Both inhibitors efficiently blocked Ca2+/CaM-stimulated CaMKII activity, CaMKII interaction with NR2B and aggregation of CaMKII holoenzymes. However, only tatCN21 but not KN93 blocked the Ca2+-independent "autonomous" activity generated by Thr-286 autophosphorylation, the hallmark feature of CaMKII regulation. Mutational analysis further validated autonomous CaMKII activity as the drug target crucial for post-insult neuroprotection. Overexpression of CaMKII wild type but not the autonomy-deficient T286A mutant significantly increased glutamate-induced neuronal death. Maybe most importantly, tatCN21 also significantly reduced infarct size in a mouse stroke model (middle cerebral arterial occlusion) when injected (1 mg/kg intravenously) 1 h after onset of arterial occlusion. Together, these data demonstrate that inhibition of autonomous CaMKII activity provides a promising therapeutic avenue for post-insult neuro-protection after stroke.	Univ Colorado, Denver Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Kindy, Mark S.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Kindy, Mark S.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29425 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center		ulli.bayer@ucdenver.edu			National Institutes of Health [P30NS048154, F31NS061584, T32GM007635]; Veterans Affairs Merit Review; State of Colorado TTO BDEGP; University of Colorado, Denver [P20RR017677-08, R01NS052644]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052644, P30NS048154, F31NS061584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); State of Colorado TTO BDEGP; University of Colorado, Denver; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30NS048154 (University of Colorado, Denver, center grant), P20RR017677-08, and R01NS052644 (to K. U. B.). This work was also supported by Veterans Affairs Merit Review (to M. S. K.) and State of Colorado TTO BDEGP. The University of Colorado is currently seeking patent protection for tatCN21 and its uses.; Supported by National Institutes of Health Training Grant F31NS061584.; Supported by National Institutes of Health Training Grant T32GM007635.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Aarts MM, 2004, CURR MOL MED, V4, P137, DOI 10.2174/1566524043479202; Alev C, 2008, P NATL ACAD SCI USA, V105, P20964, DOI 10.1073/pnas.0805408105; Antonelli T, 2008, CEREB CORTEX, V18, P1748, DOI 10.1093/cercor/bhm217; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Bargiotas P, 2009, CURR MOL MED, V9, P186, DOI 10.2174/156652409787581646; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Bayer KU, 2002, EMBO J, V21, P3590, DOI 10.1093/emboj/cdf360; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Buddle M, 2003, BRAIN RES, V978, P38, DOI 10.1016/S0006-8993(03)02758-6; BUTLER LS, 1995, P NATL ACAD SCI USA, V92, P6852, DOI 10.1073/pnas.92.15.6852; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chen HX, 2001, J NEUROPHYSIOL, V85, P1368, DOI 10.1152/jn.2001.85.4.1368; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOI DW, 1987, J NEUROSCI, V7, P357; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; Contreras JE, 2004, BRAIN RES REV, V47, P290, DOI 10.1016/j.brainresrev.2004.08.002; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Fan W, 2006, BRAIN RES, V1067, P48, DOI 10.1016/j.brainres.2005.10.030; FELIPO V, 1993, J NEUROCHEM, V60, P1626, DOI 10.1111/j.1471-4159.1993.tb13384.x; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; FRANDSEN A, 1989, J NEUROCHEM, V53, P297, DOI 10.1111/j.1471-4159.1989.tb07327.x; Gardoni F, 1998, J NEUROCHEM, V71, P1733; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Govindaswami M, 2008, ACAD EMERG MED, V15, P250, DOI 10.1111/j.1553-2712.2008.00048.x; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; HAJIMOHAMMADREZA I, 1995, J NEUROSCI, V15, P4093; Hara MR, 2007, ANNU REV PHARMACOL, V47, P117, DOI 10.1146/annurev.pharmtox.47.120505.105311; Huang C, 2009, BRAIN RES, V1257, P75, DOI 10.1016/j.brainres.2008.11.088; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Hudmon A, 1996, J BIOL CHEM, V271, P8800, DOI 10.1074/jbc.271.15.8800; Hudmon A, 2001, J NEUROCHEM, V76, P1364, DOI 10.1046/j.1471-4159.2001.00119.x; HVALBY O, 1994, P NATL ACAD SCI USA, V91, P4761, DOI 10.1073/pnas.91.11.4761; Illario M, 2003, J BIOL CHEM, V278, P45101, DOI 10.1074/jbc.M305355200; Kaur J, 2004, J CEREBR BLOOD F MET, V24, P945, DOI 10.1097/01.WCB.0000137868.50767.E8; Laabich A, 2000, MOL BRAIN RES, V85, P32, DOI 10.1016/S0169-328X(00)00226-6; Ledoux J, 1999, J PHARMACOL EXP THER, V290, P1165; LI GD, 1992, MOL PHARMACOL, V42, P489; Li GL, 2000, APMIS, V108, P98; Linseman DA, 2003, J BIOL CHEM, V278, P41472, DOI 10.1074/jbc.M307245200; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; MICHAELS RL, 1990, J NEUROSCI, V10, P283; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Oguro K, 2001, J NEUROSCI, V21, P7534, DOI 10.1523/JNEUROSCI.21-19-07534.2001; Rameau GA, 2004, J BIOL CHEM, V279, P14307, DOI 10.1074/jbc.M311103200; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SMITH MK, 1990, J BIOL CHEM, V265, P1837; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Sun HS, 2008, STROKE, V39, P2544, DOI 10.1161/STROKEAHA.107.506048; Takano H, 2003, BRAIN RES, V962, P41, DOI 10.1016/S0006-8993(02)03932-X; Tao-Cheng JH, 2001, NEUROSCIENCE, V106, P69, DOI 10.1016/S0306-4522(01)00262-7; Tremper-Wells B, 2002, J NEUROCHEM, V81, P314, DOI 10.1046/j.1471-4159.2002.00829.x; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2009, FEBS LETT, V583, P3577, DOI 10.1016/j.febslet.2009.10.028; Villmann C, 2007, NEUROSCIENTIST, V13, P594, DOI 10.1177/1073858406296259; Wang XY, 2004, STROKE, V35, P2726, DOI 10.1161/01.STR.0000143219.16695.af; Waxham MN, 1996, J CEREBR BLOOD F MET, V16, P1, DOI 10.1097/00004647-199601000-00001; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Yu CZ, 2009, NEUROCHEM RES, V34, P2008, DOI 10.1007/s11064-009-9990-z; Yu J, 2008, BRAIN RES, V1238, P143, DOI 10.1016/j.brainres.2008.08.053; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200	72	82	91	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20675	20682		10.1074/jbc.M109.088617	http://dx.doi.org/10.1074/jbc.M109.088617			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20424167	Green Published, hybrid			2022-12-25	WOS:000279228600031
J	Hegazy, SA; Wang, P; Anand, M; Ingham, RJ; Gelebart, P; Lai, R				Hegazy, Samar A.; Wang, Peng; Anand, Mona; Ingham, Robert J.; Gelebart, Pascal; Lai, Raymond			The Tyrosine 343 Residue of Nucleophosmin (NPM)-Anaplastic Lymphoma Kinase (ALK) Is Important for Its Interaction with SHP1, a Cytoplasmic Tyrosine Phosphatase with Tumor Suppressor Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-CELL LYMPHOMA; NON-HODGKINS-LYMPHOMA; GROWTH-FACTOR RECEPTOR; ANAPLASTIC LYMPHOMA; NPM-ALK; DOWN-REGULATION; NEGATIVE REGULATION; CATALYTIC-ACTIVITY; JAK/STAT PATHWAY; FUSION PROTEIN	The cytoplasmic tyrosine phosphatase SHP1 has been shown to inhibit the oncogenic fusion protein nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK), and loss of SHP1 contributes to NPM-ALK-mediated tumorigenesis. In this study, we aimed to further understand how SHP1 interacts and regulates NPM-ALK. We employed an in vitro model in which GP293 cells were transfected with various combinations of NPM-ALK (or mutants) and SHP1 (or mutants) expression vectors. We found that SHP1 co-immunoprecipitated with NPM-ALK, but not the enzymatically inactive NPM-ALK(K210R) mutant, or the mutant in which all three functionally important tyrosine residues (namely, Tyr(338), Tyr(342), and Tyr(343)) in the kinase activation loop (KAL) of ALK were mutated. Interestingly, whereas mutation of Tyr(338) or Tyr(342) did not result in any substantial change in the NPM-ALK/SHP1 binding (assessed by co-immunoprecipitation), mutation of Tyr(343) abrogated this interaction. Furthermore, the NPM-ALK/SHP1 binding was readily detectable when each of the remaining 8 tyrosine residues known to be phosphorylated were mutated. Although the expression of SHP1 effectively reduced the level of tyrosine phosphorylation of NPM-ALK, it did not affect that of the NPM-ALK(Y343F) mutant. In soft agar clonogenic assay, SHP1 expression significantly reduced the tumorigenicity of NPM-ALK but not that of NPM-ALK(Y343F). In conclusion, we identified Tyr(343) of NPM-ALK as the crucial site for mediating the NPM-ALK/SHP1 interaction. Our results also support the notion that the tumor suppressor effects of SHP1 on NPM-ALK are dependent on its ability to bind to this oncogenic protein.	[Lai, Raymond] Univ Alberta, Dept Lab Med & Pathol, Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Ingham, Robert J.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 1Z2, Canada	University of Alberta; University of Alberta	Lai, R (corresponding author), Univ Alberta, Dept Lab Med & Pathol, Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada.	rlai@ualberta.ca	Gelebart, Pascal/AAI-1439-2020	Gelebart, Pascal/0000-0003-2434-8987	Canadian Institutes of Health Research; Alberta Cancer Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Research Institute	This work was supported by grants from the Canadian Institutes of Health Research and the Alberta Cancer Research Institute (to R.L.).	Adachi T, 1998, J IMMUNOL, V160, P4662; Ambrogio C, 2005, BLOOD, V106, P3907, DOI 10.1182/blood-2005-03-1204; Amin HM, 2007, J PATHOL, V212, P402, DOI 10.1002/path.2178; Amin HM, 2007, BLOOD, V110, P2259, DOI 10.1182/blood-2007-04-060715; Amin HM, 2003, ONCOGENE, V22, P5399, DOI 10.1038/sj.onc.1206849; Bai RY, 1998, MOL CELL BIOL, V18, P6951, DOI 10.1128/MCB.18.12.6951; Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; Bard JD, 2009, AM J PATHOL, V175, P825, DOI 10.2353/ajpath.2009.080982; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Bonvini P, 2002, CANCER RES, V62, P1559; Chim CS, 2004, LEUKEMIA, V18, P356, DOI 10.1038/sj.leu.2403216; Cussac D, 2004, BLOOD, V103, P1464; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; DAVID M, 1995, MOL CELL BIOL, V15, P7050; Delsol G, 2008, ANN PATHOL, V28, pS20, DOI 10.1016/j.annpat.2008.09.002; Hampel K, 2006, CHEMMEDCHEM, V1, P869, DOI 10.1002/cmdc.200600037; Han Y, 2006, LEUKEMIA, V20, P1602, DOI 10.1038/sj.leu.2404323; Han YJ, 2006, BLOOD, V108, P2796, DOI 10.1182/blood-2006-04-017434; Hennige AM, 2001, ENDOCRINOLOGY, V142, P4441, DOI 10.1210/en.142.10.4441; Honorat JF, 2006, BLOOD, V107, P4130, DOI 10.1182/blood-2005-06-2421; Khoury JD, 2004, BLOOD, V104, P1580, DOI 10.1182/blood-2004-03-1151; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Kosugi A, 2001, IMMUNITY, V14, P669, DOI 10.1016/S1074-7613(01)00146-7; Koyama M, 2003, LAB INVEST, V83, P1849, DOI 10.1097/01.LAB.0000106503.65258.2B; KOZLOWSKI M, 1993, J EXP MED, V178, P2157, DOI 10.1084/jem.178.6.2157; LEBEAU MM, 1989, LEUKEMIA, V3, P866; Lim YM, 2000, P NATL ACAD SCI USA, V97, P12233, DOI 10.1073/pnas.210253497; Lorenz U, 1996, J EXP MED, V184, P1111, DOI 10.1084/jem.184.3.1111; Mathew P, 1997, BLOOD, V89, P1678, DOI 10.1182/blood.V89.5.1678.1678_1678_1685; Migone TS, 1998, P NATL ACAD SCI USA, V95, P3845, DOI 10.1073/pnas.95.7.3845; MORGAN R, 1986, NEW ENGL J MED, V314, P1322; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Oka T, 2002, CANCER RES, V62, P6390; Otipoby KL, 2001, J BIOL CHEM, V276, P44315, DOI 10.1074/jbc.M105446200; PLUTZKY J, 1992, P NATL ACAD SCI USA, V89, P1123, DOI 10.1073/pnas.89.3.1123; Qiu L, 2006, BLOOD, V108, P2407, DOI 10.1182/blood-2006-04-020305; RIMOKH R, 1989, BRIT J HAEMATOL, V71, P31, DOI 10.1111/j.1365-2141.1989.tb06270.x; Roccato E, 2005, J BIOL CHEM, V280, P3382, DOI 10.1074/jbc.M407522200; SHIOTA M, 1994, ONCOGENE, V9, P1567; Tartari CJ, 2008, J BIOL CHEM, V283, P3743, DOI 10.1074/jbc.M706067200; Tenev T, 1997, J BIOL CHEM, V272, P5966, DOI 10.1074/jbc.272.9.5966; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; UCHIDA T, 1994, J BIOL CHEM, V269, P12220; Voena C, 2007, CANCER RES, V67, P4278, DOI 10.1158/0008-5472.CAN-06-4350; Wang P, 2010, J BIOL CHEM, V285, P95, DOI 10.1074/jbc.M109.059758; Witkiewicz A, 2007, HUM PATHOL, V38, P462, DOI 10.1016/j.humpath.2006.09.012; Wu CY, 2003, GENE, V306, P1, DOI 10.1016/S0378-1119(03)00400-1; Wu YJ, 1998, CURR BIOL, V8, P1009, DOI 10.1016/S0960-9822(07)00421-6; Yang J, 2003, J BIOL CHEM, V278, P6516, DOI 10.1074/jbc.M210430200; YI TL, 1995, BLOOD, V85, P87, DOI 10.1182/blood.V85.1.87.bloodjournal85187; YI TL, 1993, MOL CELL BIOL, V13, P7577, DOI 10.1128/MCB.13.12.7577; Yu ZB, 1998, J BIOL CHEM, V273, P3687, DOI 10.1074/jbc.273.6.3687; Zamo A, 2002, ONCOGENE, V21, P1038, DOI 10.1038/sj.onc.1205152; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223; Zhang Q, 2000, AM J PATHOL, V157, P1137, DOI 10.1016/S0002-9440(10)64629-9	55	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19813	19820		10.1074/jbc.M110.121988	http://dx.doi.org/10.1074/jbc.M110.121988			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20424160	Green Published, hybrid			2022-12-25	WOS:000279012000014
J	Shao, CL; Lawrence, MC; Cobb, MH				Shao, Chunli; Lawrence, Michael C.; Cobb, Melanie H.			Regulation of CCAAT/Enhancer-binding Protein Homologous Protein (CHOP) Expression by Interleukin-1 beta in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ENDOPLASMIC-RETICULUM STRESS; INSULIN GENE-EXPRESSION; OXIDATIVE STRESS; INDUCED APOPTOSIS; TERMINAL KINASE; NOD MICE; TRANSCRIPTION; DEATH; PATHWAY	Apoptosis contributes to immune-mediated pancreatic beta cell destruction in type I diabetes. Exposure of beta cells to interleukin-1 beta (IL-1 beta) causes endoplasmic reticulum stress and activates proapoptotic networks. Here, we show that nuclear factor kappa B (NF-kappa B) and mitogen-activated protein kinase (MAPK) signaling pathways regulate the expression of CCAAT/enhancer-binding protein homologous protein (CHOP), which mediates endoplasmic reticulum stress-induced apoptosis. Both CHOP mRNA and protein increase in beta cells treated with IL-1 beta. In addition, prolonged exposure to high glucose further increases IL-1 beta-triggered CHOP expression. IL-1 beta also causes increased expression of C/EBP-beta and a reduction of MafA, NFATc2, and Pdx-1 expression in beta cells. Inhibition of the NF-kappa B and MAPK signaling pathways differentially attenuates CHOP expression. Knocking down CHOP by RNA interference protects beta cells from IL-1 beta-induced apoptosis. These studies provide direct mechanistic links between cytokine-induced signaling pathways and CHOP-mediated apoptosis of beta cells.	[Shao, Chunli; Lawrence, Michael C.; Cobb, Melanie H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	melanie.cobb@utsouthwestern.edu		Cobb, Melanie/0000-0003-0833-5473	National Institutes of Health [DK55310]; Robert A. Welch Foundation [I1243]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK55310. This work was also supported by Robert A. Welch Foundation Grant I1243.	Ammendrup A, 2000, DIABETES, V49, P1468, DOI 10.2337/diabetes.49.9.1468; Augstein P, 2004, J AUTOIMMUN, V23, P301, DOI 10.1016/j.jaut.2004.09.006; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Chin-Chance CVT, 2006, J INVEST MED, V54, P132, DOI 10.2310/6650.2006.05035; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Eizirik DL, 2008, BIOCHEM SOC T, V36, P321, DOI 10.1042/BST0360321; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Ferdaoussi M, 2008, DIABETES, V57, P1205, DOI 10.2337/db07-1214; GERMAN M, 1995, DIABETES, V44, P1002, DOI 10.2337/diab.44.8.1002; Giannoukakis N, 2000, J BIOL CHEM, V275, P36509, DOI 10.1074/jbc.M005943200; Glauser DA, 2007, FASEB J, V21, P3240, DOI 10.1096/fj.06-7798com; Gurzov EN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003030; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; Kaneto H, 2007, CURR MOL MED, V7, P674, DOI 10.2174/156652407782564408; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Khoo S, 1997, P NATL ACAD SCI USA, V94, P5599, DOI 10.1073/pnas.94.11.5599; Kim S, 2007, P NATL ACAD SCI USA, V104, P1913, DOI 10.1073/pnas.0610690104; Lamhamedi-Cherradi SE, 2003, J IMMUNOL, V171, P4886, DOI 10.4049/jimmunol.171.9.4886; Larsen L, 2005, DIABETOLOGIA, V48, P2582, DOI 10.1007/s00125-005-0039-9; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lawrence MC, 2008, P NATL ACAD SCI USA, V105, P13315, DOI 10.1073/pnas.0806465105; Lawrence MC, 2007, P NATL ACAD SCI USA, V104, P11518, DOI 10.1073/pnas.0704618104; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee MS, 2004, MOL GENET METAB, V83, P82, DOI 10.1016/j.ymgme.2004.08.002; Lu M, 1997, J BIOL CHEM, V272, P28349, DOI 10.1074/jbc.272.45.28349; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2006, DIABETES, V55, P2713, DOI 10.2337/db05-1430; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Naamane N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-55; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Pavlovic D, 2000, EUR CYTOKINE NETW, V11, P267; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Shao CL, 2009, J BIOL CHEM, V284, P3117, DOI 10.1074/jbc.M806286200; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001	48	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19710	19719		10.1074/jbc.M109.087486	http://dx.doi.org/10.1074/jbc.M109.087486			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20424162	Green Published, hybrid			2022-12-25	WOS:000279012000003
J	Gabbay, KH; Bohren, KM; Morello, R; Bertin, T; Liu, J; Vogel, P				Gabbay, Kenneth H.; Bohren, Kurt M.; Morello, Roy; Bertin, Terry; Liu, Jeff; Vogel, Peter			Ascorbate Synthesis Pathway DUAL ROLE OF ASCORBATE IN BONE HOMEOSTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINERAL DENSITY; VITAMIN-C; GULONOLACTONE-OXIDASE; ALDOSE REDUCTASE; SORBITOL PATHWAY; GENE-EXPRESSION; ACID; DEFICIENCY; MICE; DIFFERENTIATION	Using mouse gene knock-out models, we identify aldehyde reductase (EC 1.1.1.2, Akr1a4 (GR)) and aldose reductase (EC 1.1.1.21, Akr1b3 (AR)) as the enzymes responsible for conversion of D-glucuronate to L-gulonate, a key step in the ascorbate (ASC) synthesis pathway in mice. The gene knock-out (KO) mice show that the two enzymes, GR and AR, provide similar to 85 and similar to 15% of L-gulonate, respectively. GRKO/ARKO double knockout mice are unable to synthesize ASC (>95% ASC deficit) and develop scurvy. The GRKO mice (similar to 85% ASC deficit) develop and grow normally when fed regular mouse chow (ASC content = 0) but suffer severe osteopenia and spontaneous fractures with stresses that increase ASC requirements, such as pregnancy or castration. Castration greatly increases osteoclast numbers and activity in GRKO mice and promotes increased bone loss as compared with wild-type controls and additionally induces proliferation of immature dysplastic osteoblasts likely because of an ASC-sensitive block(s) in early differentiation. ASC and the antioxidants pycnogenol and resveratrol block osteoclast proliferation and bone loss, but only ASC feeding restores osteoblast differentiation and prevents their dysplastic proliferation. This is the first in vivo demonstration of two independent roles for ASC as an antioxidant suppressing osteoclast activity and number as well as a cofactor promoting osteoblast differentiation. Although humans have lost the ability to synthesize ASC, our mouse models suggest the mechanisms by which suboptimal ASC availability facilitates the development of osteoporosis, which has important implications for human osteoporosis.	[Gabbay, Kenneth H.; Bohren, Kurt M.] Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Morello, Roy; Bertin, Terry] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Liu, Jeff; Vogel, Peter] Lexicon Pharmaceut Inc, The Woodlands, TX 77381 USA	Baylor College of Medicine; Baylor College of Medicine; Lexicon Pharmaceuticals	Gabbay, KH (corresponding author), Harry B & Aileen B Gordon Diabet Res Ctr, 1102 Bates,Suite 550,MC3-2353, Houston, TX 77030 USA.	kgabbay@bcm.tmc.edu	Vogel, Peter/N-2490-2018	Vogel, Peter/0000-0002-7535-0545; Bohren, Kurt/0000-0002-3183-4118	Harry B & Aileen B Gordon Foundation; Jacob & Louise Gabbay Foundation; Agar Corporation; USDA [ARS 6250-51000-051]	Harry B & Aileen B Gordon Foundation; Jacob & Louise Gabbay Foundation; Agar Corporation; USDA(United States Department of Agriculture (USDA))	This work was supported by grants (to K. H. G.) from the Harry B & Aileen B Gordon Foundation, the Jacob & Louise Gabbay Foundation, the Agar Corporation, and USDA ARS 6250-51000-051.	Basu S, 2001, BIOCHEM BIOPH RES CO, V288, P275, DOI 10.1006/bbrc.2001.5747; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beamer WG, 2000, BONE, V27, P619, DOI 10.1016/S8756-3282(00)00369-0; BOHREN KM, 1989, J BIOL CHEM, V264, P9547; BOHREN KM, 1991, J BIOL CHEM, V266, P24031; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; FRANCESCHI RT, 1992, NUTR REV, V50, P65; GABBAY KH, 1966, SCIENCE, V151, P209, DOI 10.1126/science.151.3707.209; GABBAY KH, 1973, NEW ENGL J MED, V288, P831, DOI 10.1056/NEJM197304192881609; HEINEGAR.D, 1973, CLIN CHIM ACTA, V43, P305, DOI 10.1016/0009-8981(73)90466-X; Ho HTB, 2000, MOL CELL BIOL, V20, P5840, DOI 10.1128/MCB.20.16.5840-5846.2000; KAWAI T, 1992, J BIOL CHEM, V267, P21973; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Lean J, 2004, BIOCHEM BIOPH RES CO, V321, P845, DOI 10.1016/j.bbrc.2004.07.035; Lean JM, 2005, ENDOCRINOLOGY, V146, P728, DOI 10.1210/en.2004-1021; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; MacKinnon R, 2004, BIOSCIENCE REP, V24, P75, DOI 10.1007/s10540-004-7190-2; Mohan S, 2005, J BONE MINER RES, V20, P1597, DOI 10.1359/JBMR.050406; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Morton DJ, 2001, J BONE MINER RES, V16, P135, DOI 10.1359/jbmr.2001.16.1.135; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Oates PJ, 2008, CURR DRUG TARGETS, V9, P14, DOI 10.2174/138945008783431781; Omaye S T, 1979, Methods Enzymol, V62, P3, DOI 10.1016/0076-6879(79)62181-X; Packer L, 1999, FREE RADICAL BIO MED, V27, P704, DOI 10.1016/S0891-5849(99)00090-8; Pan YP, 2008, J BIOL CHEM, V283, P8634, DOI 10.1074/jbc.M709304200; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parsons KK, 2006, AM J PHYSIOL-ENDOC M, V290, pE1131, DOI 10.1152/ajpendo.00339.2005; Rohdewald P, 2002, INT J CLIN PHARM TH, V40, P158; Sahni S, 2009, OSTEOPOROSIS INT, V20, P1853, DOI 10.1007/s00198-009-0897-y; Sahni S, 2008, J NUTR, V138, P1931, DOI 10.1093/jn/138.10.1931; SATO P, 1978, ARCH BIOCHEM BIOPHYS, V187, P158, DOI 10.1016/0003-9861(78)90018-8; Schnitzler CM, 2005, CALCIFIED TISSUE INT, V76, P79, DOI 10.1007/s00223-004-0053-9; SILVER J, 1989, J VIROL, V63, P1924, DOI 10.1128/JVI.63.5.1924-1928.1989; Simon JA, 2001, AM J EPIDEMIOL, V154, P427, DOI 10.1093/aje/154.5.427; SULLIVAN TA, 1994, J BIOL CHEM, V269, P22500; van den Hoogen BM, 1998, ANAL BIOCHEM, V257, P107, DOI 10.1006/abio.1997.2538; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Wolf RL, 2005, AM J CLIN NUTR, V82, P581, DOI 10.1093/ajcn/82.3.581; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Xing WR, 2007, J BIOL CHEM, V282, P22052, DOI 10.1074/jbc.M702614200; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100	43	79	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19510	19520		10.1074/jbc.M110.110247	http://dx.doi.org/10.1074/jbc.M110.110247			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410296	hybrid, Green Published			2022-12-25	WOS:000278727800061
J	Sage, JM; Gildemeister, OS; Knight, KL				Sage, Jay M.; Gildemeister, Otto S.; Knight, Kendall L.			Discovery of a Novel Function for Human Rad51 MAINTENANCE OF THE MITOCHONDRIAL GENOME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STALLED REPLICATION FORKS; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; REPAIR; PROTEIN; LOCALIZATION; BREAKS; BRCA2; XRCC3; CELLS	Homologous recombination (HR) plays a critical role in facilitating replication fork progression when the polymerase complex encounters a blocking DNA lesion, and it also serves as the primary mechanism for error-free repair of DNA double strand breaks. Rad51 is the central catalyst of HR in all eukaryotes, and to this point studies of human Rad51 have focused exclusively on events occurring within the nucleus. However, substantial amounts of HR proteins exist in the cytoplasm, yet the function of these protein pools has not been addressed. Here, we provide the first demonstration that Rad51 and the related HR proteins Rad51C and Xrcc3 exist in human mitochondria. We show stress-induced increases in both the mitochondrial levels of each protein and, importantly, the physical interaction between Rad51 and mitochondrial DNA (mtDNA). Depletion of Rad51, Rad51C, or Xrcc3 results in a dramatic decrease in mtDNA copy number as well as the complete suppression of a characteristic oxidative stress-induced copy number increase. Our results identify human mtDNA as a novel Rad51 substrate and reveal an important role for HR proteins in the maintenance of the human mitochondrial genome.	[Sage, Jay M.; Gildemeister, Otto S.; Knight, Kendall L.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Knight, KL (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Aaron Lazare Med Res Bldg,364 Plantat St, Worcester, MA 01605 USA.	kendall.knight@umassmed.edu			National Institutes of Health [GM65851, GM44772]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065851, R01GM044772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM65851 and GM44772 (to K. L. K.).	Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; Bennett BT, 2005, J CELL BIOCHEM, V96, P1095, DOI 10.1002/jcb.20640; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; Flores-Rozas H, 2000, TRENDS BIOCHEM SCI, V25, P196, DOI 10.1016/S0968-0004(00)01568-1; Forget AL, 2004, J CELL BIOCHEM, V93, P429, DOI 10.1002/jcb.20232; Frossi B, 2002, J CELL PHYSIOL, V193, P180, DOI 10.1002/jcp.10159; Gildemeister OS, 2009, J BIOL CHEM, V284, P31945, DOI 10.1074/jbc.M109.024646; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Henry-Mowatt J, 2003, MOL CELL, V11, P1109, DOI 10.1016/S1097-2765(03)00132-1; Henson SE, 2006, MUTAT RES-FUND MOL M, V601, P113, DOI 10.1016/j.mrfmmm.2006.06.016; Hori A, 2009, NUCLEIC ACIDS RES, V37, P749, DOI 10.1093/nar/gkn993; Ikeda S, 1998, J BIOL CHEM, V273, P21585, DOI 10.1074/jbc.273.34.21585; Kajander OA, 2001, EMBO REP, V2, P1007, DOI 10.1093/embo-reports/kve233; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Kraakman-van der Zwet M, 2002, MOL CELL BIOL, V22, P669, DOI 10.1128/MCB.22.2.669-679.2002; Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342; Kreuzer KN, 2005, ANNU REV MICROBIOL, V59, P43, DOI 10.1146/annurev.micro.59.030804.121255; Lakshmipathy U, 1999, NUCLEIC ACIDS RES, V27, P1198, DOI 10.1093/nar/27.4.1198; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Liu N, 2005, J CELL BIOCHEM, V95, P942, DOI 10.1002/jcb.20457; Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8; Mladenov E, 2006, GENES CELLS, V11, P513, DOI 10.1111/j.1365-2443.2006.00958.x; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Salazar JJ, 1997, MUTAT RES-DNA REPAIR, V385, P139, DOI 10.1016/S0921-8777(97)00047-5; Shedge V, 2007, PLANT CELL, V19, P1251, DOI 10.1105/tpc.106.048355; Stuart JA, 2006, BBA-BIOENERGETICS, V1757, P79, DOI 10.1016/j.bbabio.2006.01.003; Tarsounas M, 2003, ONCOGENE, V22, P1115, DOI 10.1038/sj.onc.1206263; Tembe V, 2007, CELL SIGNAL, V19, P1113, DOI 10.1016/j.cellsig.2007.03.001; Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536; Trzeciak AR, 2004, CARCINOGENESIS, V25, P1359, DOI 10.1093/carcin/bgh144; Yoshida Y, 2002, BIOCHEM BIOPH RES CO, V295, P945, DOI 10.1016/S0006-291X(02)00757-X; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024	37	75	80	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					18984	18990		10.1074/jbc.M109.099846	http://dx.doi.org/10.1074/jbc.M109.099846			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20413593	hybrid, Green Published			2022-12-25	WOS:000278727800006
J	Yang, ZG; Kahn, BB; Shi, H; Xue, BZ				Yang, Zhenggang; Kahn, Barbara B.; Shi, Hang; Xue, Bing-zhong			Macrophage alpha 1 AMP-activated Protein Kinase (alpha 1AMPK) Antagonizes Fatty Acid-induced Inflammation through SIRT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; PERIPHERAL-TISSUES; ADIPOSE-TISSUE; ENERGY-BALANCE; PPAR-GAMMA; IKK-BETA; IN-VIVO; OBESITY; SENSITIVITY; DIET	In this study, we aim to determine cellular mechanisms linking nutrient metabolism to the regulation of inflammation and insulin resistance. The nutrient sensors AMP-activated protein kinase (AMPK) and SIRT1 show striking similarities in nutrient sensing and regulation of metabolic pathways. We find that the expression, activity, and signaling of the major isoform alpha 1AMPK in adipose tissue and macrophages are substantially down-regulated by inflammatory stimuli and in nutrient-rich conditions, such as exposure to lipopolysaccharide (LPS), free fatty acids (FFAs), and diet-induced obesity. Activating AMPK signaling in macrophages by 5-aminoimidazole-4-carboxamide-1-beta 4-ribofuranoside or constitutively active alpha 1AMPK (CA alpha 1) significantly inhibits; although inhibiting alpha 1AMPK by short hairpin RNA knock-down or dominant-negative alpha 1AMPK (DN-alpha 1) increases LPS- and FFA-induced tumor necrosis factor alpha expression. Chromatin immunoprecipitation and luciferase reporter assays show that activation of AMPK by CA-alpha 1 in macrophages significantly inhibits LPS- or FFA-induced NF-kappa B signaling. More importantly, in a macrophage-adipocyte co-culture system, we find that inactivation of macrophage AMPK signaling inhibits adipocyte insulin signaling and glucose uptake. Activation of AMPK by CA-alpha 1 increases the SIRT1 activator NAD(+) content and SIRT1 expression in macrophages. Furthermore, alpha 1AMPK activation mimics the effect of SIRT1 on deacetylating NF-kappa B, and the full capacity of AMPK to deacetylate NF-kappa B and inhibit its signaling requires SIRT1. In conclusion, AMPK negatively regulates lipid-induced inflammation, which acts through SIRT1, thereby contributing to the protection against obesity, inflammation, and insulin resistance. Our study defines a novel role for AMPK in bridging the signaling between nutrient metabolism and inflammation.	[Yang, Zhenggang; Shi, Hang; Xue, Bing-zhong] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA; [Kahn, Barbara B.] Harvard Univ, Sch Med, Dept Med, Div Endocrinol Diabet & Metab,Beth Israel Deacone, Boston, MA 02115 USA	Wake Forest University; Wake Forest Baptist Medical Center; Harvard University; Harvard Medical School	Shi, H (corresponding author), Med Ctr Blvd, Winston Salem, NC 27157 USA.	hshi@wfubmc.edu; bxue@wfubmc.edu			National Institutes of Health [R01DK084172, P01DK56116]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056116, R37DK043051, R01DK084172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK084172 (to H. S.) and P01DK56116 (to B. B. K.).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Fisher JS, 2002, AM J PHYSIOL-ENDOC M, V282, pE18, DOI 10.1152/ajpendo.2002.282.1.E18; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Pilon G, 2004, J BIOL CHEM, V279, P20767, DOI 10.1074/jbc.M401390200; Pold R, 2005, DIABETES, V54, P928, DOI 10.2337/diabetes.54.4.928; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Saha AK, 2004, BIOCHEM BIOPH RES CO, V314, P580, DOI 10.1016/j.bbrc.2003.12.120; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shi H, 2004, J BIOL CHEM, V279, P34733, DOI 10.1074/jbc.M403886200; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Xue B, 2009, MOL CELL BIOL, V29, P4563, DOI 10.1128/MCB.01914-08; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	41	313	330	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19051	19059		10.1074/jbc.M110.123620	http://dx.doi.org/10.1074/jbc.M110.123620			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20421294	Green Published, hybrid			2022-12-25	WOS:000278727800014
J	Fernando, GJP; Chen, XF; Prow, TW; Crichton, ML; Fairmaid, EJ; Roberts, MS; Frazer, IH; Brown, LE; Kendall, MAF				Fernando, Germain J. P.; Chen, Xianfeng; Prow, Tarl W.; Crichton, Michael L.; Fairmaid, Emily J.; Roberts, Michael S.; Frazer, Ian H.; Brown, Lorena E.; Kendall, Mark A. F.			Potent Immunity to Low Doses of Influenza Vaccine by Probabilistic Guided Micro-Targeted Skin Delivery in a Mouse Model	PLOS ONE			English	Article							EPIDERMAL LANGERHANS CELLS; COATED MICRONEEDLE ARRAYS; PANDEMIC INFLUENZA; DENDRITIC CELLS; GENE DELIVERY; IMMUNIZATION; PATCH; CHALLENGE; INJECTION; PATHOGENS	Background: Over 14 million people die each year from infectious diseases despite extensive vaccine use [1]. The needle and syringe-first invented in 1853-is still the primary delivery device, injecting liquid vaccine into muscle. Vaccines could be far more effective if they were precisely delivered into the narrow layer just beneath the skin surface that contains a much higher density of potent antigen-presenting cells (APCs) essential to generate a protective immune response. We hypothesized that successful vaccination could be achieved this way with far lower antigen doses than required by the needle and syringe. Methodology/Principal Findings: To meet this objective, using a probability-based theoretical analysis for targeting skin APCs, we designed the Nanopatch (TM), which contains an array of densely packed projections (21025/cm(2)) invisible to the human eye (110 mu m in length, tapering to tips with a sharpness of <1000 nm), that are dry-coated with vaccine and applied to the skin for two minutes. Here we show that the Nanopatches deliver a seasonal influenza vaccine (Fluvax (R) 2008) to directly contact thousands of APCs, in excellent agreement with theoretical prediction. By physically targeting vaccine directly to these cells we induced protective levels of functional antibody responses in mice and also protection against an influenza virus challenge that are comparable to the vaccine delivered intramuscularly with the needle and syringe-but with less than 1/100(th) of the delivered antigen. Conclusions/Significance: Our results represent a marked improvement-an order of magnitude greater than reported by others-for injected doses administered by other delivery methods, without reliance on an added adjuvant, and with only a single vaccination. This study provides a proven mathematical/engineering delivery device template for extension into human studies-and we speculate that successful translation of these findings into humans could uniquely assist with problems of vaccine shortages and distribution-together with alleviating fear of the needle and the need for trained practitioners to administer vaccine, e.g., during an influenza pandemic.	[Fernando, Germain J. P.; Chen, Xianfeng; Prow, Tarl W.; Crichton, Michael L.; Kendall, Mark A. F.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Delivery Drugs & Genes Grp D2G2, Brisbane, Qld, Australia; [Roberts, Michael S.] Univ Queensland, Sch Med, Therapeut Res Unit, Brisbane, Qld, Australia; [Frazer, Ian H.; Kendall, Mark A. F.] Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia; [Fairmaid, Emily J.; Brown, Lorena E.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	University of Queensland; University of Queensland; University of Queensland; University of Melbourne	Fernando, GJP (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Delivery Drugs & Genes Grp D2G2, Brisbane, Qld, Australia.	m.kendall@uq.edu.au	Kendall, Mark/M-4122-2017; Roberts, Michael S/C-5247-2014; Crichton, Michael/B-5970-2014; Roberts, Michael/F-4289-2010; Fernando, Germain JP/C-3733-2009; Prow, Tarl/AAB-8359-2019; Chen, Xianfeng/O-3359-2019; Roberts, Michael/F-7502-2010; Chen, Xianfeng/D-1709-2010; Prow, Tarl W/A-4764-2010; Frazer, Ian/A-1137-2007	Roberts, Michael S/0000-0003-3894-5301; Crichton, Michael/0000-0002-3683-802X; Roberts, Michael/0000-0002-5837-246X; Fernando, Germain JP/0000-0003-3260-0548; Prow, Tarl/0000-0003-2892-6238; Chen, Xianfeng/0000-0002-3189-2756; Chen, Xianfeng/0000-0002-3189-2756; Prow, Tarl W/0000-0003-2892-6238; Frazer, Ian/0000-0002-8002-4680; Brown, Lorena/0000-0001-9342-909X	National Health and Medical Research Council (Australia) [569726, 456150]; Australian Research Council [DP077464]; Queensland Smart State Scheme	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Queensland Smart State Scheme	National Health and Medical Research Council (Australia) Grants ID# 569726 (MAFK, GJPF, LEB), ID# 456150 (MAFK), Australian Research Council Grant ID# DP077464 (MAFK, MSR) and the Queensland Smart State Scheme funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XF, 2009, J CONTROL RELEASE, V139, P212, DOI 10.1016/j.jconrel.2009.06.029; Coulter A, 1998, VACCINE, V16, P1243, DOI 10.1016/S0264-410X(98)80125-4; Crichton ML, 2010, BIOMATERIALS, V31, P4562, DOI 10.1016/j.biomaterials.2010.02.022; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; Doukas AG, 1996, ULTRASOUND MED BIOL, V22, P151, DOI 10.1016/0301-5629(95)02026-8; FALSTIEJENSEN N, 1988, SCAND J CLIN LAB INV, V48, P519, DOI 10.3109/00365518809085767; FERNANDO GJP, 1995, VACCINE, V13, P1460, DOI 10.1016/0264-410X(95)00029-Z; Fernando GJP, 1998, J IMMUNOL, V161, P2421; Food and Drug Administration, 2007, GUID IND CLIN DAT NE; FRIEDMANN PS, 1981, BRIT J DERMATOL, V105, P219, DOI 10.1111/j.1365-2133.1981.tb01209.x; Frolov VG, 2008, INFLUENZA OTHER RESP, V2, P53, DOI 10.1111/j.1750-2659.2008.00040.x; FURTH PA, 1995, HYBRIDOMA, V14, P149, DOI 10.1089/hyb.1995.14.149; Glenn Gregory M, 2003, Expert Rev Vaccines, V2, P253, DOI 10.1586/14760584.2.2.253; Han SW, 2005, BIOCHEM BIOPH RES CO, V332, P633, DOI 10.1016/j.bbrc.2005.04.059; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Kendall M, 2004, J BIOMECH, V37, P1733, DOI 10.1016/j.jbiomech.2004.01.032; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; KOLS A, HPV VACCINES PROMISE; Koutsonanos DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004773; KOYAMA Y, 1987, J INVEST DERMATOL, V88, P541, DOI 10.1111/1523-1747.ep12470104; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Laurent PE, 2007, VACCINE, V25, P8833, DOI 10.1016/j.vaccine.2007.10.020; Lopez-Bravo M, 2008, IMMUNITY, V29, P343, DOI 10.1016/j.immuni.2008.08.008; Matriano JA, 2002, PHARMACEUT RES, V19, P63, DOI 10.1023/A:1013607400040; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; Mulholland WJ, 2006, J INVEST DERMATOL, V126, P1541, DOI 10.1038/sj.jid.5700290; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ng LG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000222; Noah DL, 2009, CLIN VACCINE IMMUNOL, V16, P558, DOI 10.1128/CVI.00368-08; Palache B, 2008, VACCINE, V26, P6232, DOI 10.1016/j.vaccine.2008.07.022; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Poland GA, 2006, NEW ENGL J MED, V354, P1411, DOI 10.1056/NEJMe068047; Reed ML, 2004, P IEEE, V92, P56, DOI 10.1109/JPROC.2003.820542; Seielstad M, 2000, NAT GENET, V26, P131, DOI 10.1038/79829; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; Tacket CO, 1999, VACCINE, V17, P2826, DOI 10.1016/S0264-410X(99)00094-8; Van Damme P, 2009, VACCINE, V27, P454, DOI 10.1016/j.vaccine.2008.10.077; Widera G, 2006, VACCINE, V24, P1653, DOI 10.1016/j.vaccine.2005.09.049; YU RC, 1994, BRIT J DERMATOL, V131, P843, DOI 10.1111/j.1365-2133.1994.tb08587.x; Zhu QY, 2009, P NATL ACAD SCI USA, V106, P7968, DOI 10.1073/pnas.0812652106	42	127	134	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10266	10.1371/journal.pone.0010266	http://dx.doi.org/10.1371/journal.pone.0010266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422002	Green Accepted, Green Published, gold			2022-12-25	WOS:000276952500018
J	Ballentine, B; Greenberg, R				Ballentine, Barbara; Greenberg, Russell			Common Garden Experiment Reveals Genetic Control of Phenotypic Divergence between Swamp Sparrow Subspecies That Lack Divergence in Neutral Genotypes	PLOS ONE			English	Article							EVOLUTIONARY PROCESSES; BIOLOGICAL DIVERSITY; CONSERVATION; POPULATIONS; DIFFERENTIATION; DIMORPHISM; ADAPTATION; MARKERS; ECOLOGY; PATTERN	Background: Adaptive divergence between populations in the face of strong selection on key traits can lead to morphological divergence between populations without concomitant divergence in neutral DNA. Thus, the practice of identifying genetically distinct populations based on divergence in neutral DNA may lead to a taxonomy that ignores evolutionarily important, rapidly evolving, locally-adapted populations. Providing evidence for a genetic basis of morphological divergence between rapidly evolving populations that lack divergence in selectively neutral DNA will not only inform conservation efforts but also provide insight into the mechanisms of the early processes of speciation. The coastal plain swamp sparrow, a recent colonist of tidal marsh habitat, differs from conspecific populations in a variety of phenotypic traits yet remains undifferentiated in neutral DNA. Methods and Principal Findings: Here we use an experimental approach to demonstrate that phenotypic divergence between ecologically separated populations of swamp sparrows is the result of local adaptation despite the lack of divergence in neutral DNA. We find that morphological ( bill size and plumage coloration) and life history ( reproductive effort) differences observed between wild populations were maintained in laboratory raised individuals suggesting genetic divergence of fitness related traits. Conclusions and Significance: Our results support the hypothesis that phenotypic divergence in swamps sparrows is the result of genetic differentiation, and demonstrate that adaptive traits have evolved more rapidly than neutral DNA in these ecologically divergent populations that may be in the early stages of speciation. Thus, identifying evolutionarily important populations based on divergence in selectively neutral DNA could miss an important level of biodiversity and mislead conservation efforts.	[Ballentine, Barbara] Univ W Georgia, Smithsonian Migratory Bird Ctr, Natl Zool Pk, Carrollton, GA USA; [Greenberg, Russell] Smithsonian Inst, Natl Zool Pk, Smithsonian Migratory Bird Ctr, Washington, DC 20008 USA	Smithsonian Institution; University System of Georgia; University of West Georgia; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Ballentine, B (corresponding author), Univ W Georgia, Smithsonian Migratory Bird Ctr, Natl Zool Pk, Carrollton, GA USA.	bballent@westga.edu			Smithsonian Institution Endowment; Smithsonian Institution; National Zoo; Maryland Ornithological Society	Smithsonian Institution Endowment; Smithsonian Institution(Smithsonian Institution); National Zoo(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute); Maryland Ornithological Society	Funding for this project was provided to Russell Greenberg through a Smithsonian Institution Endowment Grant. Funding for this project to Barbara Ballentine was provided by the Smithsonian Institution, Friends of the National Zoo and The Maryland Ornithological Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P., 1990, SALTMARSH ECOLOGY; Avise JC, 2000, PHYLOGEOGRAPHY; BALABAN E, 1988, BEHAVIOUR, V105, P250, DOI 10.1163/156853988X00043; Buerkle CA, 1999, EVOLUTION, V53, P1915, DOI 10.1111/j.1558-5646.1999.tb04572.x; Bulgin NL, 2003, MOL ECOL, V12, P831, DOI 10.1046/j.1365-294X.2003.01774.x; BURTT JEH, 2004, GLOGERS RULE FEATHER, P681; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Endler J.A., 1986, Monographs in Population Biology, pviii; Fallon SM, 2007, CONSERV BIOL, V21, P1186, DOI 10.1111/j.1523-1739.2007.00775.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Grant PR, 2006, BIOL J LINN SOC, V88, P17, DOI 10.1111/j.1095-8312.2006.00595.x; Grapputo A, 1998, MOL ECOL, V7, P1173, DOI 10.1046/j.1365-294x.1998.00441.x; GREENBERG R, 1990, CONDOR, V92, P393, DOI 10.2307/1368236; Greenberg R, 1998, AUK, V115, P706, DOI 10.2307/4089418; GREENBERG R, 1988, J FIELD ORNITHOL, V59, P149; Greenberg Russell, 2006, Studies in Avian Biology, P96; Grenier JL, 2005, EVOLUTION, V59, P1588; Griffiths R, 1996, P ROY SOC B-BIOL SCI, V263, P1251, DOI 10.1098/rspb.1996.0184; JAMES FC, 1983, SCIENCE, V221, P184, DOI 10.1126/science.221.4606.184; Leck M. A., 1989, ECOLOGY SOIL SEED BA, P283; Mace GM, 2008, MOL ECOL, V17, P9, DOI 10.1111/j.1365-294X.2007.03455.x; Malamud-Roam Karl P., 2006, Studies in Avian Biology, P11; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Mundy N.I., 2006, BIRD COLORATION; Neigel J. E., 1986, PHYLOGENETIC RELATIO; Olsen B, 2008, OECOLOGIA, V158, P421, DOI 10.1007/s00442-008-1148-1; Orr MR, 1998, TRENDS ECOL EVOL, V13, P502, DOI 10.1016/S0169-5347(98)01511-0; Patten MA, 2002, AUK, V119, P26, DOI 10.1642/0004-8038(2002)119[0026:DVMDOS]2.0.CO;2; PATTEN MA, 2010, ORNITHOLOGI IN PRESS; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; StatSoft Inc, 2003, STATISTICA DAT AN SO; Winker Kevin, 2007, Ornithological Monographs, V63, P30, DOI 10.1642/0078-6594(2007)63[30:VBTASD]2.0.CO;2; Zink RM, 2007, ANIM CONSERV, V10, P369, DOI 10.1111/j.1469-1795.2007.00125.x; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617	35	35	41	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10229	10.1371/journal.pone.0010229	http://dx.doi.org/10.1371/journal.pone.0010229			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419104	Green Submitted, gold, Green Published			2022-12-25	WOS:000276853800019
J	McCabe, CJ; Goldie, SJ; Fisman, DN				McCabe, Caitlin J.; Goldie, Sue J.; Fisman, David N.			The Cost-Effectiveness of Directly Observed Highly-Active Antiretroviral Therapy in the Third Trimester in HIV-Infected Pregnant Women	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PERSISTENT MITOCHONDRIAL DYSFUNCTION; ELECTIVE CESAREAN DELIVERY; MONTE-CARLO-SIMULATION; PERINATAL TRANSMISSION; VERTICAL TRANSMISSION; GESTATIONAL-AGE; PRETERM INFANTS; VIRAL LOAD; ADHERENCE	Background: In HIV-infected pregnant women, viral suppression prevents mother-to-child HIV transmission. Directly observed highly-active antiretroviral therapy (HAART) enhances virological suppression, and could prevent transmission. Our objective was to project the effectiveness and cost-effectiveness of directly observed administration of antiretroviral drugs in pregnancy. Methods and Findings: A mathematical model was created to simulate cohorts of one million asymptomatic HIV-infected pregnant women on HAART, with women randomly assigned self-administered or directly observed antiretroviral therapy (DOT), or no HAART, in a series of Monte Carlo simulations. Our primary outcome was the quality-adjusted life expectancy in years (QALY) of infants born to HIV-infected women, with the rates of Caesarean section and HIV-transmission after DOT use as intermediate outcomes. Both self-administered HAART and DOT were associated with decreased costs and increased life-expectancy relative to no HAART. The use of DOT was associated with a relative risk of HIV transmission of 0.39 relative to conventional HAART; was highly cost-effective in the cohort as a whole (cost-utility ratio $14,233 per QALY); and was cost-saving in women whose viral loads on self-administered HAART would have exceeded 1000 copies/ml. Results were stable in wide-ranging sensitivity analyses, with directly observed therapy cost-saving or highly cost-effective in almost all cases. Conclusions: Based on the best available data, programs that optimize adherence to HAART through direct observation in pregnancy have the potential to diminish mother-to-child HIV transmission in a highly cost-effective manner. Targeted use of DOT in pregnant women with high viral loads, who could otherwise receive self-administered HAART would be a cost-saving intervention. These projections should be tested with randomized clinical trials.	[McCabe, Caitlin J.; Fisman, David N.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Goldie, Sue J.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Fisman, David N.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Fisman, David N.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Harvard T.H. Chan School of Public Health; University of Toronto; University of Toronto	McCabe, CJ (corresponding author), Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	david.fisman@gmail.com			Ontario Ministry of Research and Innovation	Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	Dr. Fisman is supported by an Early Researcher Award of the Ontario Ministry of Research and Innovation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaasa AM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-241; Ades AE, 2000, PHARMACOECONOMICS, V18, P9, DOI 10.2165/00019053-200018010-00002; Andiman W, 1999, NEW ENGL J MED, V340, P977, DOI 10.1056/NEJM199904013401301; [Anonymous], 2009, CHOOS INT AR COST EF; Barret B, 2003, AIDS, V17, P1769, DOI 10.1097/00002030-200308150-00006; Blanche S, 1999, LANCET, V354, P1084, DOI 10.1016/S0140-6736(99)07219-0; Bulterys M, 2000, J ACQ IMMUN DEF SYND, V25, P261, DOI 10.1097/00126334-200011010-00009; *BUR LAB STAT, 2009, PRIC LIV COND; Burdge DR, 2003, CAN MED ASSOC J, V168, P1683; Burman WJ, 1997, CHEST, V112, P63, DOI 10.1378/chest.112.1.63; CASCADE Collaboration, 2000, LANCET, V355, P1158, DOI 10.1016/S0140-6736(00)02069-9; *CDCP, 2009, VITALSTATS; *CDCP, 2009, HIV AIDS SURV REP 20; Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P285; Chen KT, 2001, OBSTET GYNECOL, V97, P161, DOI 10.1016/S0029-7844(00)01107-8; Chesney MA, 1999, AIDS, V13, pS271; Clumeck N, 2003, AIDS, V17, pS3, DOI 10.1097/01.aids.0000060397.18106.12; COHEN H, 2003, 2003 DRUG TOPICS RED; Dabis F, 2004, JAIDS-J ACQ IMM DEF, V35, P167, DOI 10.1097/00126334-200402010-00011; De Jose MI, 2001, ARCH INTERN MED, V161, P2738, DOI 10.1001/archinte.161.22.2738; de Kleine MJK, 2003, ARCH DIS CHILD, V88, P870, DOI 10.1136/adc.88.10.870; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; DeHovitz JA, 2000, J INFECT DIS, V182, P1527, DOI 10.1086/315875; Dybul Mark, 2002, MMWR Recomm Rep, V51, P1; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Giaquinto C, 2005, CLIN INFECT DIS, V40, P458, DOI 10.1086/427287; Gilbert WM, 2003, OBSTET GYNECOL, V102, P488, DOI 10.1016/S0029-7844(03)00617-3; Granados JMS, 2003, PEDIATR INFECT DIS J, V22, P863, DOI 10.1097/01.inf.0000091282.70253.5f; Halpern EF, 2000, MED DECIS MAKING, V20, P314, DOI 10.1177/0272989X0002000308; Halpern MT, 2000, AIDS, V14, P691, DOI 10.1097/00002030-200004140-00008; Havens PL, 1997, PEDIATR INFECT DIS J, V16, P607, DOI 10.1097/00006454-199706000-00012; Holmgren PA, 2001, ACTA OBSTET GYN SCAN, V80, P525, DOI 10.1034/j.1600-0412.2001.080006525.x; Immergluck LC, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e54; Ioannidis JPA, 1999, NEW ENGL J MED, V341, P1698; Ioannidis JPA, 2001, J INFECT DIS, V183, P539, DOI 10.1086/318530; John-Stewart G, 2004, JAIDS-J ACQ IMM DEF, V35, P196, DOI 10.1097/00126334-200402010-00015; Khanlou H, 2003, JAIDS-J ACQ IMM DEF, V33, P651, DOI 10.1097/00126334-200308150-00017; Kirkland LR, 2002, CLIN INFECT DIS, V34, P511, DOI 10.1086/338400; Laine C, 2000, OBSTET GYNECOL, V95, P167, DOI 10.1016/S0029-7844(99)00523-2; Lanzafame M, 2000, J ACQ IMMUN DEF SYND, V25, P200, DOI 10.1097/00126334-200010010-00018; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; Lipshultz SE, 2002, LANCET, V360, P368, DOI 10.1016/S0140-6736(02)09607-1; Lucas GM, 2002, AIDS PATIENT CARE ST, V16, P527, DOI 10.1089/108729102761041083; Macalino GE, 2007, AIDS, V21, P1473, DOI 10.1097/QAD.0b013e32811ebf68; Maru DSR, 2009, JAIDS-J ACQ IMM DEF, V50, P176, DOI 10.1097/QAI.0b013e3181938e7e; Mellins CA, 2008, AIDS CARE, V20, P958, DOI 10.1080/09540120701767208; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mitty JA, 2002, CLIN INFECT DIS, V34, P984, DOI 10.1086/339447; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Mrus JM, 2000, AIDS, V14, P2543, DOI 10.1097/00002030-200011100-00017; Mrus JM, 2002, MED DECIS MAKING, V22, pS38, DOI 10.1177/027298902237710; NEWELL ML, 1994, LANCET, V343, P1464; Paltiel AD, 1998, MED DECIS MAKING, V18, pS93, DOI 10.1177/0272989X9801800211; Parazzini F, 1999, LANCET, V353, P1035, DOI 10.1016/S0140-6736(98)08084-2; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; *PER HIV GUID WORK, 2009, REC US ANT DRUGS PRE, P1; Pinkerton SD, 2000, PREV MED, V30, P64, DOI 10.1006/pmed.1999.0601; SANDE M, 2003, ANTIRETROVIRAL THERA, P18; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Selik RM, 2003, PEDIATR INFECT DIS J, V22, P635, DOI 10.1097/00006454-200307000-00013; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Snyder DC, 1999, AM J RESP CRIT CARE, V160, P582, DOI 10.1164/ajrccm.160.2.9901049; Stone VE, 2001, J ACQ IMMUN DEF SYND, V28, P124, DOI 10.1097/00042560-200110010-00003; Tarnow-Mordi W, 2000, ARCH DIS CHILD-FETAL, V82, pF118; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; Torrance GW, 1996, MED CARE, V34, P702, DOI 10.1097/00005650-199607000-00004; Tuomala RE, 2002, NEW ENGL J MED, V346, P1863, DOI 10.1056/NEJMoa991159; Turner BJ, 2000, MED CARE, V38, P911, DOI 10.1097/00005650-200009000-00005; Turner BJ, 2000, AM J PUBLIC HEALTH, V90, P85, DOI 10.2105/AJPH.90.1.85; Vollmer B, 2003, PEDIATRICS, V112, P1108, DOI 10.1542/peds.112.5.1108; WAITZMAN NJ, 1994, INQUIRY-J HEALTH CAR, V31, P188; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; White BL, 2006, AIDS PATIENT CARE ST, V20, P408, DOI 10.1089/apc.2006.20.408; Wohl AR, 2006, CLIN INFECT DIS, V42, P1619, DOI 10.1086/503906; World Bank, 2009, DAT STAT COUNTR GROU; Zaric GS, 2000, J ACQ IMMUN DEF SYND, V25, P403, DOI 10.1097/00126334-200012150-00004; Zupancic JAF, 2003, PEDIATRICS, V111, P146, DOI 10.1542/peds.111.1.146	80	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10154	10.1371/journal.pone.0010154	http://dx.doi.org/10.1371/journal.pone.0010154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	583UV	20405011	Green Submitted, Green Published, gold			2022-12-25	WOS:000276706300010
J	Crum-Cianflone, N; Roediger, MP; Eberly, L; Headd, M; Marconi, V; Ganesan, A; Weintrob, A; Barthel, RV; Fraser, S; Agan, BK				Crum-Cianflone, Nancy; Roediger, Mollie Poehlman; Eberly, Lynn; Headd, Maryam; Marconi, Vincent; Ganesan, Anuradha; Weintrob, Amy; Barthel, R. Vincent; Fraser, Susan; Agan, Brian K.		Infect Dis Clinical Res Program HI	Increasing Rates of Obesity among HIV-Infected Persons during the HIV Epidemic	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; WEIGHT-LOSS; BODY-COMPOSITION; RISK; ERA; OVERWEIGHT; PREDICTORS; HIV/AIDS; SURVIVAL	Background: The prevalence and factors associated with overweight/obesity among human immunodeficiency virus (HIV)-infected persons are unknown. Methods: We evaluated prospective data from a U. S. Military HIV Natural History Study (1985-2004) consisting of early diagnosed patients. Statistics included multivariate linear regression and longitudinal linear mixed effects models. Results: Of 1682 patients, 2% were underweight, 37% were overweight, and 9% were obese at HIV diagnosis. Multivariate predictors of a higher body mass index (BMI) at diagnosis included more recent year of HIV diagnosis, older age, African American race, and earlier HIV stage (all p < 0.05). The majority of patients (62%) gained weight during HIV infection. Multivariate factors associated with a greater increase in BMI during HIV infection included more recent year of diagnosis, lower BMI at diagnosis, higher CD4 count, lower HIV RNA level, lack of AIDS diagnosis, and longer HIV duration (all p < 0.05). Nucleoside agents were associated with less weight gain; other drug classes had no significant impact on weight change in the HAART era. Conclusions: HIV-infected patients are increasingly overweight/obese at diagnosis and during HIV infection. Weight gain appears to reflect improved health status and mirror trends in the general population. Weight management programs may be important components of HIV care.	[Crum-Cianflone, Nancy; Roediger, Mollie Poehlman; Eberly, Lynn; Marconi, Vincent; Ganesan, Anuradha; Weintrob, Amy; Barthel, R. Vincent; Fraser, Susan; Agan, Brian K.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Crum-Cianflone, Nancy] USN, Infect Dis Clin, San Diego Med Ctr, San Diego, CA 92152 USA; [Crum-Cianflone, Nancy; Headd, Maryam] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Roediger, Mollie Poehlman; Eberly, Lynn] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Marconi, Vincent] San Antonio Mil Med Ctr, Infect Dis Clin, San Antonio, TX USA; [Ganesan, Anuradha] Natl Naval Med Ctr, Infect Dis Clin, Bethesda, MD USA; [Weintrob, Amy] Walter Reed Army Med Ctr, Infect Dis Clin, Washington, DC 20307 USA; [Barthel, R. Vincent] USN, Med Ctr Portsmouth, Infect Dis Clin, Portsmouth, VA USA; [Fraser, Susan] Tripler Med Ctr, Infect Dis Clin, Honolulu, HI USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Navy; California State University System; San Diego State University; University of Minnesota System; University of Minnesota Twin Cities; San Antonio Military Medical Center; Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; United States Department of Defense; United States Navy	Crum-Cianflone, N (corresponding author), Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA.	nancy.crum@med.navy.mil	Marconi, Vincent/AFK-5812-2022; Marconi, Vincent/GRJ-4553-2022; Marconi, Vincent/N-3210-2014	Marconi, Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689; Agan, Brian/0000-0002-5114-1669; Eberly, Lynn/0000-0003-4763-330X	Infectious Disease Clinical Research Program (IDCRP); Department of Defense (DoD); National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [Y1-AI-5072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005072] Funding Source: NIH RePORTER	Infectious Disease Clinical Research Program (IDCRP); Department of Defense (DoD)(United States Department of Defense); National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences. This project has been funded in whole, or in part, with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement Y1-AI-5072. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorosa V, 2005, JAIDS-J ACQ IMM DEF, V39, P557; [Anonymous], 1995, PHYS STAT US INT ANT; Blanck H. M., 2006, Morbidity and Mortality Weekly Report, V55, P985; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bray RM, 2005, DEP DEFENSE SURVEY H; Campa A, 2005, CLIN INFECT DIS, V41, P1179, DOI 10.1086/444499; Crum-Cianflone N, 2008, AIDS PATIENT CARE ST, V22, P925, DOI 10.1089/apc.2008.0082; Dube MP, 2000, CLIN INFECT DIS, V31, P1467, DOI 10.1086/317491; Duran ACFL, 2008, J HUM NUTR DIET, V21, P346, DOI 10.1111/j.1365-277X.2008.00886.x; Ferrando SJ, 2005, AIDS PATIENT CARE ST, V19, P216, DOI 10.1089/apc.2005.19.216; Finkelstein EA, 2003, HEALTH AFFAIR, V22, pW219; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Forrester JE, 2001, PUBLIC HEALTH NUTR, V4, P743, DOI 10.1079/PHN200099; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Hendricks KM, 2006, J AM COLL NUTR, V25, P321, DOI 10.1080/07315724.2006.10719542; Hodgson LM, 2001, AIDS, V15, P2341, DOI 10.1097/00002030-200111230-00024; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Jaime PC, 2006, REV SAUDE PUBL, V40, P634, DOI 10.1590/S0034-89102006000500012; Mallon PWG, 2003, AIDS, V17, P971, DOI 10.1097/00002030-200305020-00005; McDermott AY, 2005, CLIN INFECT DIS, V41, P1662, DOI 10.1086/498022; Mocroft A, 1999, J ACQ IMMUN DEF SYND, V21, P401; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PALENICEK JP, 1995, J ACQ IMMUN DEF SYND, V10, P366; Parikh NI, 2007, AM J MED, V120, P242, DOI 10.1016/j.amjmed.2006.06.004; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Prentice A M, 2001, Obes Rev, V2, P141, DOI 10.1046/j.1467-789x.2001.00031.x; REDFIELD RR, 1986, NEW ENGL J MED, V314, P131, DOI 10.1056/NEJM198601093140232; Shevitz AH, 2001, CLIN INFECT DIS, V32, P1769, DOI 10.1086/320761; Shikuma CM, 2004, CLIN INFECT DIS, V39, P1223, DOI 10.1086/424665; Shor-Posner G, 2000, J ACQ IMMUN DEF SYND, V23, P81; Smit E, 2002, AM J EPIDEMIOL, V156, P211, DOI 10.1093/aje/kwf039; Tang AM, 2002, JAIDS-J ACQ IMM DEF, V31, P230, DOI 10.1097/00126334-200210010-00014; Tang AM, 2005, JAIDS-J ACQ IMM DEF, V40, P70, DOI 10.1097/01.qai.0000159627.54149.2e; Wanke CA, 2000, CLIN INFECT DIS, V31, P803, DOI 10.1086/314027; Wheeler DA, 1998, J ACQ IMMUN DEF SYND, V18, P80, DOI 10.1097/00042560-199805010-00012; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867	40	160	163	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10106	10.1371/journal.pone.0010106	http://dx.doi.org/10.1371/journal.pone.0010106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20419086	Green Published, gold, Green Submitted			2022-12-25	WOS:000276482100019
J	Oh, CD; Maity, SN; Lu, JF; Zhang, JX; Liang, SD; Coustry, F; de Crombrugghe, B; Yasuda, H				Oh, Chun-do; Maity, Sankar N.; Lu, Jing-Fang; Zhang, Jiexin; Liang, Shoudan; Coustry, Francoise; de Crombrugghe, Benoit; Yasuda, Hideyo			Identification of SOX9 Interaction Sites in the Genome of Chondrocytes	PLOS ONE			English	Article							PRO-ALPHA-1(II) COLLAGEN GENE; SEX DETERMINATION; TRANSGENIC MICE; BONE-FORMATION; ENDOCHONDRAL OSSIFICATION; CAMPOMELIC DYSPLASIA; SKELETAL DEVELOPMENT; PARATHYROID-HORMONE; SONIC-HEDGEHOG; RETINOIC ACID	Background: Our previous work has provided strong evidence that the transcription factor SOX9 is completely needed for chondrogenic differentiation and cartilage formation acting as a "master switch" in this differentiation. Heterozygous mutations in SOX9 cause campomelic dysplasia, a severe skeletal dysmorphology syndrome in humans characterized by a generalized hypoplasia of endochondral bones. To obtain insights into the logic used by SOX9 to control a network of target genes in chondrocytes, we performed a ChIP-on-chip experiment using SOX9 antibodies. Methodology/Principal Findings: The ChIP DNA was hybridized to a microarray, which covered 80 genes, many of which are involved in chondrocyte differentiation. Hybridization peaks were detected in a series of cartilage extracellular matrix (ECM) genes including Col2a1, Col11a2, Aggrecan and Cdrap as well as in genes for specific transcription factors and signaling molecules. Our results also showed SOX9 interaction sites in genes that code for proteins that enhance the transcriptional activity of SOX9. Interestingly, a strong SOX9 signal was also observed in genes such as Col1a1 and Osx, whose expression is strongly down regulated in chondrocytes but is high in osteoblasts. In the Col2a1 gene, in addition to an interaction site on a previously identified enhancer in intron 1, another strong interaction site was seen in intron 6. This site is free of nucleosomes specifically in chondrocytes suggesting an important role of this site on Col2a1 transcription regulation by SOX9. Conclusions/Significance: Our results provide a broad understanding of the strategies used by a "master" transcription factor of differentiation in control of the genetic program of chondrocytes.	[Oh, Chun-do; Maity, Sankar N.; Lu, Jing-Fang; Coustry, Francoise; de Crombrugghe, Benoit; Yasuda, Hideyo] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Zhang, Jiexin; Liang, Shoudan] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Oh, CD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	bdecromb@mdanderson.org; hyasuda@mdanderson.org		Maity, Sankar/0000-0002-2387-6545; Oh, Chundo/0000-0002-5419-8011	NIH [RO1 AR053568]; Arthritis Foundation; NATIONAL CANCER INSTITUTE [K25CA123344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053568] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grant, RO1 AR053568, (to B. de Crombrugghe) and postdoctoral fellowships from the Arthritis Foundation (to C. Oh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Annunen S, 1999, SCIENCE, V285, P409, DOI 10.1126/science.285.5426.409; BAICI A, 1988, ANN RHEUM DIS, V47, P684, DOI 10.1136/ard.47.8.684; Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; Camper L, 2001, CELL TISSUE RES, V306, P107, DOI 10.1007/s004410100385; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; CHOW G, 1995, J BIOL CHEM, V270, P27734, DOI 10.1074/jbc.270.46.27734; Davidson RK, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2013; Drake CJ, 1999, J HISTOCHEM CYTOCHEM, V47, P1351, DOI 10.1177/002215549904701101; Flannery CR, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1925; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hattori T, 2008, NUCLEIC ACIDS RES, V36, P3011, DOI 10.1093/nar/gkn150; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Huang WD, 2001, P NATL ACAD SCI USA, V98, P160, DOI 10.1073/pnas.011393998; Hwang SG, 2005, J BIOL CHEM, V280, P12758, DOI 10.1074/jbc.M413367200; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; JARVELAINEN HT, 1991, J BIOL CHEM, V266, P23274; Johnson HJ, 1997, J BIOL CHEM, V272, P18709, DOI 10.1074/jbc.272.30.18709; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; KINGSLEY DM, 1992, CELL, V71, P399, DOI 10.1016/0092-8674(92)90510-J; Kirsch T, 2002, J BIOL CHEM, V277, P42171, DOI 10.1074/jbc.M207209200; Kist R, 2002, GENESIS, V32, P121, DOI 10.1002/gene.10050; Kitagaki J, 2003, OSTEOARTHR CARTILAGE, V11, P36, DOI 10.1053/joca.2002.0863; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Laforest L, 1998, DEVELOPMENT, V125, P4175; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; LEE K, 1993, BONE, V14, P341, DOI 10.1016/8756-3282(93)90162-4; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Legeai-Mallet L, 2004, BONE, V34, P26, DOI 10.1016/j.bone.2003.09.002; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Martel-Pelletier J, 1999, FRONT BIOSCI, V4, pD694; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; MUKHOPADHYAY K, 1995, J BIOL CHEM, V270, P27711, DOI 10.1074/jbc.270.46.27711; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Murakami S, 2000, J BIOL CHEM, V275, P3687, DOI 10.1074/jbc.275.5.3687; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nakayama N, 2001, DEV BIOL, V232, P372, DOI 10.1006/dbio.2001.0200; Naski MC, 1998, DEVELOPMENT, V125, P4977; OLLIVIERRE F, 1986, BIOCHEM BIOPH RES CO, V141, P904, DOI 10.1016/S0006-291X(86)80128-0; Pathi S, 1999, DEV BIOL, V209, P239, DOI 10.1006/dbio.1998.9181; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Savage SA, 2007, CANCER EPIDEM BIOMAR, V16, P1667, DOI 10.1158/1055-9965.EPI-07-0214; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shen ZX, 1998, BIOCHEM J, V330, P549, DOI 10.1042/bj3300549; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Sundararaj KP, 2004, J BIOL CHEM, V279, P6152, DOI 10.1074/jbc.M310549200; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; ten Berge D, 1998, DEVELOPMENT, V125, P3831; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wang K, 2004, J BIOL CHEM, V279, P53848, DOI 10.1074/jbc.M403114200; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Woods A, 2007, J CELL PHYSIOL, V213, P1, DOI 10.1002/jcp.21110; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Xie WF, 1999, J BONE MINER RES, V14, P757, DOI 10.1359/jbmr.1999.14.5.757; Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041; Zhang R, 2006, P NATL ACAD SCI USA, V103, P365, DOI 10.1073/pnas.0507979103; Zhen XC, 2001, J BIOL CHEM, V276, P4879, DOI 10.1074/jbc.M004990200; ZHOU G, 1995, J CELL SCI, V108, P3677	74	70	72	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10113	10.1371/journal.pone.0010113	http://dx.doi.org/10.1371/journal.pone.0010113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404928	Green Submitted, gold, Green Published			2022-12-25	WOS:000276482100023
J	Bryan, BA; Dennstedt, E; Mitchell, DC; Walshe, TE; Noma, K; Loureiro, R; Saint-Geniez, M; Campaigniac, JP; Liao, JK; D'Amore, PA				Bryan, Brad A.; Dennstedt, Emily; Mitchell, Dianne C.; Walshe, Tony E.; Noma, Kensuke; Loureiro, Robyn; Saint-Geniez, Magali; Campaigniac, Jean-Paul; Liao, James K.; D'Amore, Patricia A.			RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis	FASEB JOURNAL			English	Article						endothelial cells; Y-27632; Rho kinase; GTPase; vascular endothelial growth factor	ENDOTHELIAL GROWTH-FACTOR; VENTRAL BODY-WALL; CELL-MIGRATION; ROCK-I; RHO-KINASE; GTPASE RHO; PROTEIN; ACTIVATION; EXPRESSION; PHOSPHORYLATION	The small GTPase RhoA and its downstream effectors, ROCK1 and ROCK2, regulate a number of cellular processes, including cell motility, proliferation, survival, and permeability. Pharmacological inhibitors of the Rho pathway reportedly block angiogenesis; however, the molecular details of this inhibition are largely unknown. We demonstrate that vascular endothelial growth factor-A (VEGF) rapidly induces RhoA activation in endothelial cells (ECs). Moreover, the pharmacological inhibition of ROCK1/2 using 10 mu M Y-27632 (the IC50 for this compound in ECs) strongly disrupts vasculogenesis in pluripotent embryonic stem cell cultures, VEGF-mediated regenerative angiogenesis in ex vivo retinal explants, and VEGF-mediated in vitro EC tube formation. Furthermore, using small interfering RNA knockdown and mouse heterozygote knockouts of ROCK1 and ROCK2, we provide data indicating that VEGF-driven angiogenesis is largely mediated through ROCK2. These data demonstrate that Rho/ROCK signaling is an important mediator in a number of angiogenic processes, including EC migration, survival, and cell permeability, and suggest that Rho/ROCK inhibition may prove useful for the treatment of angiogenesis-related disorders.-Bryan, B. A., Dennstedt, E., Mitchell, D. C., Walshe, T. E., Noma, K., Loureiro, R., Saint-Geniez, M., Campaigniac, J.-P., Liao, J. K., D'Amore, P. A. RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis. FASEB J. 24, 3186 -3195 (2010). www.fasebj.org	[Bryan, Brad A.; Mitchell, Dianne C.; Walshe, Tony E.; Loureiro, Robyn; Saint-Geniez, Magali; D'Amore, Patricia A.] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA; [Bryan, Brad A.; Mitchell, Dianne C.; Walshe, Tony E.; Loureiro, Robyn; Saint-Geniez, Magali; D'Amore, Patricia A.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA; [Bryan, Brad A.; Mitchell, Dianne C.; Walshe, Tony E.; Loureiro, Robyn; Saint-Geniez, Magali; D'Amore, Patricia A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02114 USA; [Bryan, Brad A.; Dennstedt, Emily; Campaigniac, Jean-Paul] Worcester State Coll, Dept Biol, Worcester, MA USA; [Noma, Kensuke; Liao, James K.] Brigham & Womens Hosp, Vasc Med Res Unit, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts System of Public Higher Education; Worcester State University; Harvard University; Brigham & Women's Hospital	D'Amore, PA (corresponding author), Harvard Univ, Sch Med, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	damore@schepens.harvard.edu	SAINT-GENIEZ, MAGALI/P-3509-2019; D'Amore, Patricia A/G-5660-2017; Walshe, Tony/AAJ-8833-2020	SAINT-GENIEZ, MAGALI/0000-0001-9897-138X; D'Amore, Patricia A/0000-0001-9652-8974; 	U.S. National Institutes of Health [EY-05318, EY-015435, CA-45548, HL-052233, HL-098931]; NATIONAL CANCER INSTITUTE [P01CA045548] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005318, R01EY015435] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL098931, R01HL080187, R01HL052233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070001] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by U.S. National Institutes of Health grants EY-05318, EY-015435, and CA-45548 to P. A. D; HL-052233 to J.K.L.; and HL-098931 to B. A. B. P. A. D is a Research to Prevent Blindness Senior Scientific Investigator. The authors thank Dr. M. Liu (Texas A&M University Health Science Center, Houston, TX, USA) for the use of the Rhotekin-GST expression plasmid.	Abecassis I, 2003, EXP CELL RES, V291, P363, DOI 10.1016/j.yexcr.2003.08.006; Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Bobak D, 1997, ONCOGENE, V15, P2179, DOI 10.1038/sj.onc.1201396; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Bryan BA, 2005, CELL MOL LIFE SCI, V62, P1547, DOI 10.1007/s00018-005-5029-z; Bryan BA, 2008, MOL BIOL CELL, V19, P994, DOI 10.1091/mbc.E07-09-0856; CLAUSS M, 1990, J EXP MED, V172, P1535, DOI 10.1084/jem.172.6.1535; Cleaver O, 1998, DEVELOPMENT, V125, P3905; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Darland D. C., 2001, Angiogenesis, V4, P11, DOI 10.1023/A:1016611824696; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2000, RECENT PROG HORM RES, V55, P15; Fiorentini C, 1997, J BIOL CHEM, V272, P19532, DOI 10.1074/jbc.272.31.19532; Ghosh K, 2008, P NATL ACAD SCI USA, V105, P11305, DOI 10.1073/pnas.0800835105; GIRY M, 1995, INFECT IMMUN, V63, P4063, DOI 10.1128/IAI.63.10.4063-4071.1995; Hasmim M, 2007, J THROMB HAEMOST, V5, P166, DOI 10.1111/j.1538-7836.2006.02259.x; Hata Y, 2008, JPN J OPHTHALMOL, V52, P16, DOI 10.1007/s10384-007-0487-5; Henning SW, 1997, EMBO J, V16, P2397, DOI 10.1093/emboj/16.9.2397; Hoang MV, 2004, P NATL ACAD SCI USA, V101, P1874, DOI 10.1073/pnas.0308525100; Holinstat M, 2003, J BIOL CHEM, V278, P28793, DOI 10.1074/jbc.M303900200; Im E, 2005, MOL BIOL CELL, V16, P3488, DOI 10.1091/mbc.E04-11-1029; Im E, 2007, J BIOL CHEM, V282, P29122, DOI 10.1074/jbc.M702637200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JIMENEZ B, 1995, ONCOGENE, V10, P811; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kaneko T, 2000, BIOCHEM BIOPH RES CO, V273, P110, DOI 10.1006/bbrc.2000.2901; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Kroll J, 2009, AM J PHYSIOL-HEART C, V296, pH893, DOI 10.1152/ajpheart.01038.2008; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lum H, 1996, CAN J PHYSIOL PHARM, V74, P787, DOI 10.1139/cjpp-74-7-787; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; McLaughlin AP, 2001, AM J PHYSIOL-CELL PH, V281, pC1448, DOI 10.1152/ajpcell.2001.281.5.C1448; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Ng YS, 2004, LAB INVEST, V84, P1209, DOI 10.1038/labinvest.3700150; Noma K, 2008, J CLIN INVEST, V118, P1632, DOI 10.1172/JCI29226; Park HJ, 2002, CIRC RES, V91, P143, DOI 10.1161/01.RES.0000028149.15986.4C; Petrache I, 2003, BIOCHEM BIOPH RES CO, V306, P244, DOI 10.1016/S0006-291X(03)00945-8; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ramsauer M, 2007, J CELL SCI, V120, P1810, DOI 10.1242/jcs.003533; RATAJSKA A, 1995, DEV DYNAM, V203, P399, DOI 10.1002/aja.1002030403; Rikitake Y, 2005, CIRCULATION, V112, P2959, DOI 10.1161/CIRCULATIONAHA.105.584623; Rikitake Y, 2005, STROKE, V36, P2251, DOI 10.1161/01.STR.0000181077.84981.11; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; Thumkeo D, 2003, MOL CELL BIOL, V23, P5043, DOI 10.1128/MCB.23.14.5043-5055.2003; Titus B, 2005, CRIT REV EUKAR GENE, V15, P103, DOI 10.1615/CritRevEukaryotGeneExpr.v15.i2.20; Vincent L, 2001, FEBS LETT, V495, P159, DOI 10.1016/S0014-5793(01)02337-7; Wang H, 1998, CIRC RES, V83, P832, DOI 10.1161/01.RES.83.8.832; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Wei L, 2001, DEVELOPMENT, V128, P2953; Yin LM, 2007, MOL CANCER THER, V6, P1517, DOI 10.1158/1535-7163.MCT-06-0689; Yoshida A, 1996, GROWTH FACTORS, V13, P57, DOI 10.3109/08977199609034566; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zeng HY, 2002, J BIOL CHEM, V277, P46791, DOI 10.1074/jbc.M206133200; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje; Zhang YM, 2006, FASEB J, V20, P916, DOI 10.1096/fj.05-5129com; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638	64	186	196	2	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3186	3195		10.1096/fj.09-145102	http://dx.doi.org/10.1096/fj.09-145102			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20400538	Green Published			2022-12-25	WOS:000281446400008
J	Cardenas, C; Juretic, N; Bevilacqua, JA; Garcia, IE; Figueroa, R; Hartley, R; Taratuto, AL; Gejman, R; Riveros, N; Molgo, J; Jaimovich, E				Cardenas, Cesar; Juretic, Nevenka; Bevilacqua, Jorge A.; Garcia, Isaac E.; Figueroa, Reinaldo; Hartley, Ricardo; Taratuto, Ana L.; Gejman, Roger; Riveros, Nora; Molgo, Jordi; Jaimovich, Enrique			Abnormal distribution of inositol 1,4,5-trisphosphate receptors in human muscle can be related to altered calcium signals and gene expression in Duchenne dystrophy-derived cells	FASEB JOURNAL			English	Article						skeletal muscle; excitation-transcription coupling; dystrophin; muscle plasticity; myofiber types	ELEMENT-BINDING PROTEIN; SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; CA2+ TRANSIENTS; UP-REGULATION; MEMBRANE DEPOLARIZATION; CARDIAC MYOCYTES; SATELLITE CELLS; IP3 RECEPTORS; MDX MUSCLE	Inositol 1,4,5-trisphosphate (IP3) receptors (IP(3)Rs) drive calcium signals involved in skeletal muscle excitation-transcription coupling and plasticity; IP3R subtype distribution and downstream events evoked by their activation have not been studied in human muscle nor has their possible alteration in Duchenne muscular dystrophy (DMD). We studied the expression and localization of IP3R subtypes in normal and DMD human muscle and in normal (RCMH) and dystrophic (RCDMD) human muscle cell lines. In normal muscle, both type 1 IP(3)Rs (IP(3)R1) and type 2 IP(3)Rs (IP(3)R2) show a higher expression in type II fibers, whereas type 3 IP(3)Rs (IP(3)R3) show uniform distribution. In DMD biopsies, all fibers display a homogeneous IP(3)R2 label, whereas 24 +/- 7% of type II fibers have lost the IP(3)R1 label. RCDMD cells show 5-fold overexpression of IP(3)R2 and down-regulation of IP(3)R3 compared with RCMH cells. A tetanic stimulus induces IP3-dependent slow Ca2+ transients significantly larger and faster in RCDMD cells than in RCMH cells as well as significant ERK1/2 phosphorylation in normal but not in dystrophic cells. Excitation-driven gene expression was different among cell lines; 44 common genes were repressed in RCMH cells and expressed in RCDMD cells or vice versa. IP3-dependent Ca2+ release may play a significant role in DMD pathophysiology.-Cardenas, C., Juretic, N., Bevilacqua, J. A., Garcia, I. E., Figueroa, R., Hartley, R., Taratuto, A. L., Gejman, R., Riveros, N., Molgo, J., Jaimovich, E. Abnormal distribution of inositol 1,4,5-trisphosphate receptors in human muscle can be related to altered calcium signals and gene expression in Duchenne dystrophy-derived cells. FASEB J. 24, 3210-3221 (2010). www.fasebj.org	[Cardenas, Cesar; Juretic, Nevenka; Bevilacqua, Jorge A.; Garcia, Isaac E.; Figueroa, Reinaldo; Hartley, Ricardo; Riveros, Nora; Jaimovich, Enrique] Univ Chile, Inst Ciencias Biomed, Ctr Estudios Mol Celula, Fac Med, Santiago 1027 7, Chile; [Bevilacqua, Jorge A.] Univ Chile, Inst Ciencias Biomed, Programa Anat & Biol Desarrollo, Fac Med, Santiago 7, Chile; [Cardenas, Cesar; Molgo, Jordi] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Bevilacqua, Jorge A.] Univ Chile, Hosp Clin, Dept Neurol & Neurocirugia, Independencia, Chile; [Taratuto, Ana L.] FLENI, Inst Invest Neurol, Dept Neuropatol, Buenos Aires, DF, Argentina; [Gejman, Roger] Pontificia Univ Catolica Chile, Fac Med, Dept Anat Patol, Santiago, Chile; CNRS, Inst Neurobiol Alfred Fessard, FRC2118, Lab Neurobiol Cellulaire & Mol,UPR9040, Gif Sur Yvette, France	Universidad de Chile; Universidad de Chile; University of Pennsylvania; Universidad de Chile; Pontificia Universidad Catolica de Chile; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Jaimovich, E (corresponding author), Univ Chile, Inst Ciencias Biomed, Ctr Estudios Mol Celula, Fac Med, Santiago 1027 7, Chile.	ejaimovi@med.uchile.cl	Figueroa Contreras, Reinaldo/GXF-6114-2022; Jaimovich, Enrique/AAY-7632-2020; Bevilacqua, Jorge A./I-3113-2013; Juretic, Nevenka/N-6973-2018	Figueroa Contreras, Reinaldo/0000-0002-7718-0201; Bevilacqua, Jorge A./0000-0002-0525-9308; Juretic, Nevenka/0000-0003-1098-435X; Hartley, Ricardo/0000-0001-5058-9309	Fondo de Investigacion Avanzada en Areas Prioritarias (FONDAP) [15010006]; Fondo Nacional de Investigacion Cientifica y Tecnologica [1080120]; ECOS Sud-CONICYT exchange program [C03S02]; Proyecto OAIC [OAIC 106-05]; Hospital Clinico Universidad de Chile; Association Francaise Contre les Myopathies; FONDAP; AFM at Laboratoire de Neurobiologie Cellulaire et Moleculaire (France); Programa Bicentenario de Ciencia y Tecnologia [PSD24]	Fondo de Investigacion Avanzada en Areas Prioritarias (FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Fondo Nacional de Investigacion Cientifica y Tecnologica(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ECOS Sud-CONICYT exchange program; Proyecto OAIC; Hospital Clinico Universidad de Chile; Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); FONDAP; AFM at Laboratoire de Neurobiologie Cellulaire et Moleculaire (France); Programa Bicentenario de Ciencia y Tecnologia	The authors are grateful to Monica Silva for culture preparations and to Dr. Ulises Urzua for microarray laboratory facilities. The authors thank Dr. Marcos Ganga (Department of Traumatology, Hospital Clinico Universidad de Chile, Independencia, Chile) and Drs. Christian Bermudez and Ernesto Larrain (Department of Cardiology, Hospital Clinico Universidad de Chile) for their collaboration in obtaining normal tissue samples. This work was supported by Fondo de Investigacion Avanzada en Areas Prioritarias (FONDAP; grant 15010006) and Fondo Nacional de Investigacion Cientifica y Tecnologica (grant 1080120 to E.J.), ECOS Sud-CONICYT exchange program (C03S02), Proyecto OAIC (OAIC 106-05), Hospital Clinico Universidad de Chile (J.A.B. and C. C.), and the Association Francaise Contre les Myopathies (AFM) (J.M.). C. C. was supported by a postdoctoral fellowship from FONDAP and by a short-term fellowship from AFM at Laboratoire de Neurobiologie Cellulaire et Moleculaire (France). N.J. was supported by a postdoctoral fellowship from project PSD24, Programa Bicentenario de Ciencia y Tecnologia.	Alderton JM, 2000, TRENDS CARDIOVAS MED, V10, P268, DOI 10.1016/S1050-1738(00)00075-X; Araya R, 2003, J GEN PHYSIOL, V121, P3, DOI 10.1085/jgp.20028671; Balghi H, 2006, J GEN PHYSIOL, V127, P171, DOI 10.1085/jgp.200509456; Balghi H, 2006, J GEN PHYSIOL, V128, P219, DOI 10.1085/jgp.200609559; Basset O, 2004, J BIOL CHEM, V279, P47092, DOI 10.1074/jbc.M405054200; Batchelor CL, 2006, TRENDS CELL BIOL, V16, P198, DOI 10.1016/j.tcb.2006.02.001; Buvinic S, 2009, J BIOL CHEM, V284, P34490, DOI 10.1074/jbc.M109.057315; Canto C, 2006, J BIOL CHEM, V281, P21690, DOI 10.1074/jbc.M600475200; Cardenas C, 2005, J CELL SCI, V118, P3131, DOI 10.1242/jcs.02446; Cardenas C, 2004, J BIOL CHEM, V279, P39122, DOI 10.1074/jbc.M401044200; Carrasco MA, 2003, AM J PHYSIOL-CELL PH, V284, pC1438, DOI 10.1152/ajpcell.00117.2002; CAVIEDES R, 1992, BIOCHIM BIOPHYS ACTA, V1134, P247, DOI 10.1016/0167-4889(92)90183-C; CAVIEDES R, 1994, MUSCLE NERVE, V17, P1021, DOI 10.1002/mus.880170909; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; Culligan K, 2002, J APPL PHYSIOL, V92, P435, DOI 10.1152/japplphysiol.00903.2001; Deval E, 2002, NEUROMUSCULAR DISORD, V12, P665, DOI 10.1016/S0960-8966(02)00022-6; Dominov JA, 1996, DEV GENET, V19, P108, DOI 10.1002/(SICI)1520-6408(1996)19:2<108::AID-DVG2>3.0.CO;2-D; Dubowitz V., 1985, MUSCLE BIOPSY PRACTI; Eltit JM, 2006, J BIOL CHEM, V281, P12143, DOI 10.1074/jbc.M511218200; Eltit JM, 2004, BIOPHYS J, V86, P3042, DOI 10.1016/S0006-3495(04)74353-2; Froemming GR, 2000, BBA-BIOMEMBRANES, V1466, P151, DOI 10.1016/S0005-2736(00)00195-4; Gailly P, 2002, BBA-PROTEINS PROTEOM, V1600, P38, DOI 10.1016/S1570-9639(02)00442-9; Gillis JM, 1999, J MUSCLE RES CELL M, V20, P605, DOI 10.1023/A:1005545325254; Haslett JN, 2003, NEUROGENETICS, V4, P163, DOI 10.1007/s10048-003-0148-x; Haslett JN, 2002, P NATL ACAD SCI USA, V99, P15000, DOI 10.1073/pnas.192571199; Herrero J, 2004, NUCLEIC ACIDS RES, V32, pW485, DOI 10.1093/nar/gkh421; Hirata M, 2007, ACTA NEUROPATHOL, V113, P451, DOI 10.1007/s00401-007-0198-5; Ibarra C, 2004, J BIOL CHEM, V279, P7554, DOI 10.1074/jbc.M311604200; IMBERT N, 1995, CELL CALCIUM, V18, P177, DOI 10.1016/0143-4160(95)90062-4; JAIMOVICH E, 1994, CELL CALCIUM, V15, P356, DOI 10.1016/0143-4160(94)90011-6; Jaimovich E, 2000, AM J PHYSIOL-CELL PH, V278, pC998, DOI 10.1152/ajpcell.2000.278.5.C998; Jordan T, 2005, J CELL SCI, V118, P2295, DOI 10.1242/jcs.02341; Jorquera G, 2009, AM J PHYSIOL-CELL PH, V297, pC581, DOI 10.1152/ajpcell.00167.2009; Juretic N, 2006, AM J PHYSIOL-CELL PH, V290, pC1428, DOI 10.1152/ajpcell.00449.2005; Juretic N, 2007, J CELL PHYSIOL, V210, P819, DOI 10.1002/jcp.20902; Kasri NN, 2006, CELL CALCIUM, V40, P41, DOI 10.1016/j.ceca.2006.03.005; Kolodziejczyk SM, 2001, CURR BIOL, V11, P1278, DOI 10.1016/S0960-9822(01)00397-9; Krag TOB, 2004, P NATL ACAD SCI USA, V101, P13856, DOI 10.1073/pnas.0405972101; Kumar A, 2004, FASEB J, V18, P102, DOI 10.1096/fj.03-0453com; Laflamme K, 2002, J CELL BIOCHEM, V85, P219, DOI 10.1002/jcb.10124; Langenbach KJ, 2002, MUSCLE NERVE, V26, P644, DOI 10.1002/mus.10258; Lebrasseur NK, 2003, AM J PHYSIOL-CELL PH, V284, pC1149, DOI 10.1152/ajpcell.00487.2002; Liberona JL, 1998, MUSCLE NERVE, V21, P902, DOI 10.1002/(SICI)1097-4598(199807)21:7<902::AID-MUS8>3.0.CO;2-A; MOSCHELLA MC, 1993, J CELL BIOL, V120, P1137, DOI 10.1083/jcb.120.5.1137; MOSCHELLA MC, 1995, J MUSCLE RES CELL M, V16, P390, DOI 10.1007/BF00114504; Nakamura A, 2005, BBA-MOL BASIS DIS, V1740, P326, DOI 10.1016/j.bbadis.2004.12.003; NEWTON CL, 1994, J BIOL CHEM, V269, P28613; Noguchi S, 2003, HUM MOL GENET, V12, P595, DOI 10.1093/hmg/ddg065; O'Brien SP, 2000, P NATL ACAD SCI USA, V97, P12074, DOI 10.1073/pnas.97.22.12074; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Powell JA, 2003, J NEUROSCI, V23, P8185; Powell JA, 2001, J CELL SCI, V114, P3673; Ramos-Franco J, 1998, BIOPHYS J, V75, P2783, DOI 10.1016/S0006-3495(98)77721-5; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; Salanova M, 2008, HISTOCHEM CELL BIOL, V130, P105, DOI 10.1007/s00418-008-0399-6; Tasker PN, 1999, CIRC RES, V84, P536, DOI 10.1161/01.RES.84.5.536; Turk R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-98; TURNER PR, 1993, J MEMBRANE BIOL, V133, P243; Vaquerizas JM, 2004, BIOINFORMATICS, V20, P3656, DOI 10.1093/bioinformatics/bth401	59	18	18	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3210	3221		10.1096/fj.09-152017	http://dx.doi.org/10.1096/fj.09-152017			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20395455				2022-12-25	WOS:000281446400010
J	Gibbs, PEM; Miralem, T; Maines, MD				Gibbs, Peter E. M.; Miralem, Tihomir; Maines, Mahin D.			Characterization of the human biliverdin reductase gene structure and regulatory elements: promoter activity is enhanced by hypoxia and suppressed by TNF-alpha-activated NF-kappa B	FASEB JOURNAL			English	Article						oxidative stress; antioxidants; bile pigments; cytokines; heme oxygenase; HIF-1	HEME OXYGENASE-1 GENE; TRANSCRIPTION FACTORS; RAT-LIVER; SIGNAL-TRANSDUCTION; MEDIATED INDUCTION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; OXIDATIVE STRESS; CARBON-MONOXIDE; BINDING-SITES	hBVR is a Ser/Thr/Tyr kinase/scaffold protein/transcription factor/intracellular transporter of regulators. hBVR is an upstream activator of the insulin/IGF-1/MAPK/PI3K signaling pathway, and of NF-kappa B. As a reductase, it converts biliverdin to the antioxidant, bilirubin. hBVR gene has 8 exons; exon 1 is not translated. We report the characterization of hBVR promoter and its negative and positive regulation, respectively, by TNF-alpha and hypoxia. The 5' end of exon 1 was defined by primer extension analyses; deletion of an inhibitor sequence 350-425 bp upstream of this exon enhanced the promoter activity. One of two NF-kappa B binding sites in the 836-bp promoter was functional; the P65 subunit of NF-kappa B and TNF-alpha acted as inhibitors. On the basis of EMSA and ChIP assays, TNF-alpha treatment increases binding of NF-kappa B to its regulatory element. Overexpression of I kappa B increased hBVR mRNA. Biliverdin, but not bilirubin, was as effective as TNF-alpha in inhibiting hBVR promoter activity. Only one of 4 hypoxia responsive elements (HREs) bound to HIF-1 alpha and ARNT expressed in HEK293A cells. An abasic site was introduced at the 3' G of the HRE. This element bound HIF-1 in the gel shift and in in-cell luciferase assays. hBVR was detected in the nucleus at 1, 2, and 4 h after hypoxia (1% O-2), at which times its kinase and reductase activities were increased. Because hypoxia positively influences hBVR promoter and phosphorylation and TNF-alpha activated NF-kappa B inhibits the promoter, while biliverdin inhibits both NF-kappa B activity and hBVR promoter, we propose a regulatory mechanism for NF-kappa B by hypoxia and TNF-alpha centered on hBVR/biliverdin.-Gibbs, P. E. M., Miralem, T., Maines, M. D. Characterization of the human biliverdin reductase gene structure and regulatory elements: promoter activity is enhanced by hypoxia and suppressed by TNF-alpha-activated NF-kappa B. FASEB J. 24, 3239-3254 (2010). www.fasebj.org	[Gibbs, Peter E. M.; Miralem, Tihomir; Maines, Mahin D.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Maines, MD (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave, Rochester, NY 14642 USA.	mahin_maines@urmc.rochester.edu	Miralem, Tihomir/F-7576-2013	Miralem, Tihomir/0000-0001-7705-0442	NIEHS NIH HHS [R01 ES004066-26, R01 ES004066, R01 ES012187, R01 ES012187-08] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012187, R01ES004066] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Ahmad Z, 2002, J BIOL CHEM, V277, P9226, DOI 10.1074/jbc.M108239200; ALAM J, 1995, J BIOL CHEM, V270, P11977, DOI 10.1074/jbc.270.20.11977; ALAM J, 1992, J BIOL CHEM, V267, P21894; AUST SD, 1982, FREE RADICALS BIOL, V5, P1; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; EWING JF, 1995, BRAIN RES, V672, P29, DOI 10.1016/0006-8993(94)01290-X; EWING JF, 1993, J NEUROCHEM, V61, P1015, DOI 10.1111/j.1471-4159.1993.tb03615.x; Florczyk UM, 2008, PHARMACOL REP, V60, P38; Gibbs PEM, 2007, INT J CANCER, V121, P2567, DOI 10.1002/ijc.22978; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gong PF, 2002, ARCH BIOCHEM BIOPHYS, V405, P265, DOI 10.1016/S0003-9861(02)00404-6; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; HUANG TJ, 1989, ARCH BIOCHEM BIOPHYS, V270, P513, DOI 10.1016/0003-9861(89)90533-X; Immenschuh S, 2006, HISTOL HISTOPATHOL, V21, P679, DOI 10.14670/HH-21.679; Jozkowicz A, 2004, BIOCHEM BIOPH RES CO, V314, P31, DOI 10.1016/j.bbrc.2003.12.059; Kapitulnik J, 2004, MOL PHARMACOL, V66, P773, DOI 10.1124/mol.104.002832; Kapitulnik J, 2009, TRENDS PHARMACOL SCI, V30, P129, DOI 10.1016/j.tips.2008.12.003; KARIN M, 1992, TRENDS BIOCHEM SCI, V17, P418, DOI 10.1016/0968-0004(92)90012-X; Kikuchi A, 2001, NAT STRUCT BIOL, V8, P221, DOI 10.1038/84955; Kravets A, 2004, J BIOL CHEM, V279, P19916, DOI 10.1074/jbc.M314251200; KUTTY RK, 1981, J BIOL CHEM, V256, P3956; Lee PJ, 2003, FREE RADICAL BIO MED, V35, P341, DOI 10.1016/S0891-5849(03)00279-X; Lee PJ, 2000, AM J PHYSIOL-LUNG C, V279, pL175, DOI 10.1152/ajplung.2000.279.1.L175; Lehmann E, 2010, HEPATOLOGY, V51, P398, DOI 10.1002/hep.23339; Lerner-Marmarosh N, 2005, P NATL ACAD SCI USA, V102, P7109, DOI 10.1073/pnas.0502173102; Lerner-Marmarosh N, 2008, P NATL ACAD SCI USA, V105, P6870, DOI 10.1073/pnas.0800750105; Lerner-Marmarosh N, 2007, FASEB J, V21, P3949, DOI 10.1096/fj.07-8544com; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Maghzal GJ, 2009, J BIOL CHEM, V284, P29251, DOI 10.1074/jbc.M109.037119; Maines MD, 2007, J BIOL CHEM, V282, P8110, DOI 10.1074/jbc.M513427200; Maines MD, 2005, PHYSIOLOGY, V20, P382, DOI 10.1152/physiol.00029.2005; Maines MD, 1996, EUR J BIOCHEM, V235, P372, DOI 10.1111/j.1432-1033.1996.00372.x; Maines MD, 1999, J UROLOGY, V162, P1467, DOI 10.1016/S0022-5347(05)68342-5; Maines MD, 2001, J PHARMACOL EXP THER, V296, P1091; MAINES MD, 1986, J BIOL CHEM, V261, P411; Mancuso C, 2006, ANTIOXID REDOX SIGN, V8, P487, DOI 10.1089/ars.2006.8.487; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MCCOUBREY WK, 1995, GENE, V160, P235, DOI 10.1016/0378-1119(95)00112-J; McDonagh AF, 2001, NAT STRUCT BIOL, V8, P198, DOI 10.1038/84915; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; Michel G, 2002, BBA-GENE STRUCT EXPR, V1578, P73, DOI 10.1016/S0167-4781(02)00484-0; Miralem T, 2005, J BIOL CHEM, V280, P17084, DOI 10.1074/jbc.M413121200; Miralem T, 2010, J BIOL CHEM, V285, P12551, DOI 10.1074/jbc.M109.032771; Nakao A, 2005, AM J TRANSPLANT, V5, P282, DOI 10.1111/j.1600-6143.2004.00695.x; Nakao A, 2004, GASTROENTEROLOGY, V127, P595, DOI 10.1053/j.gastro.2004.05.059; Ovcharenko I, 2004, GENOME RES, V14, P472, DOI 10.1101/gr.2129504; Ozgenc AI, 2005, J BACTERIOL, V187, P1974, DOI 10.1128/JB.187.6.1974-1984.2005; Alok SP, 2007, J MOL CELL CARDIOL, V43, P580, DOI 10.1016/j.yjmcc.2007.08.003; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pastukh V, 2007, FREE RADICAL BIO MED, V43, P1616, DOI 10.1016/j.freeradbiomed.2007.08.027; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Ryter SW, 2007, AM J RESP CELL MOL, V36, P175, DOI 10.1165/rcmb.2006-0333TR; Ryter SW, 2005, ANTIOXID REDOX SIGN, V7, P80, DOI 10.1089/ars.2005.7.80; Salim M, 2001, J BIOL CHEM, V276, P10929, DOI 10.1074/jbc.M010753200; Sedlak TW, 2009, P NATL ACAD SCI USA, V106, P5171, DOI 10.1073/pnas.0813132106; Sinal CJ, 1997, MOL PHARMACOL, V52, P590, DOI 10.1124/mol.52.4.590; TAKEDA K, 1994, J BIOL CHEM, V269, P22858; Thomas JW, 2003, MAMM GENOME, V14, P673, DOI 10.1007/s00335-003-2300-1; Tongers J, 2004, CARDIOVASC RES, V63, P545, DOI 10.1016/j.cardiores.2004.04.015; Tudor C, 2008, BIOCHEM J, V413, P405, DOI 10.1042/BJ20080018; Wegiel B, 2009, J BIOL CHEM, V284, P21369, DOI 10.1074/jbc.M109.027433; Whitby FG, 2002, J MOL BIOL, V319, P1199, DOI 10.1016/S0022-2836(02)00383-2; Wright MM, 2009, BIOCHEM J, V422, P353, DOI 10.1042/BJ20090339; Zeng R, 2008, J AM SOC NEPHROL, V19, P380, DOI 10.1681/ASN.2006111194; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448; Ziel KA, 2005, FASEB J, V19, P387, DOI 10.1096/fj.04-2805com	74	20	21	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3239	3254		10.1096/fj.09-144592	http://dx.doi.org/10.1096/fj.09-144592			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20410444	Green Published			2022-12-25	WOS:000281446400013
J	Colnaghi, R; Wheatley, SP				Colnaghi, Rita; Wheatley, Sally P.			Liaisons between Survivin and Plk1 during Cell Division and Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASE-1; AURORA-B; MITOTIC ROLES; IN-VIVO; PHOSPHORYLATION; APOPTOSIS; REVEALS; PROTEIN; MITOSIS; CYTOKINESIS	Survivin and Plk1 kinase are important mediators of cell survival that are required for chromosome alignment, cytokinesis, and protection from apoptosis. Interference with either survivin or Plk1 activity manifests many similar outcomes: prometaphase delay/arrest, multinucleation, and increased apoptosis. Moreover, the expression of both survivin and Plk1 is deregulated in cancer. Given these similarities, we speculated that these two proteins may cooperate during mitosis and/or in cell death pathways. Here we report that survivin and Plk1 interact during mitosis and that Plk1 phosphorylates survivin at serine 20. Importantly, we find that overexpression of a non-phosphorylatable version, S20A, is unable to correct chromosomes connected to the spindle in a syntelic manner during prometaphase and allows cells harboring these maloriented chromosomes to enter anaphase, evading the spindle tension checkpoint. By contrast, the constitutive phosphomimic, S20D, completes congression and division ahead of schedule and, unlike S20A, is able to support proliferation in the absence of the endogenous protein. Despite the importance of this residue in mitosis, its mutation does not appear to affect the anti-apoptotic activity of survivin in response to TRAIL. Together, these data suggest that phosphorylation of survivin at Ser(20) by Plk1 kinase is essential for accurate chromosome alignment and cell proliferation but is dispensable for its anti-apoptotic activity in cancer cells.	[Wheatley, Sally P.] Univ Nottingham, Sch Med, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England; [Colnaghi, Rita] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Nottingham; University of Sussex	Wheatley, SP (corresponding author), Univ Nottingham, Sch Med, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England.	sally.wheatley@nottingham.ac.uk			Cancer Research-UK	Cancer Research-UK(Cancer Research UK)	The majority of this work was supported by Cancer Research-UK via a senior fellowship (to S. P. W.).	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Arnaud L, 1998, CHROMOSOMA, V107, P424, DOI 10.1007/s004120050326; Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200; Barrett RMA, 2009, CELL CYCLE, V8, P278, DOI 10.4161/cc.8.2.7587; Beardmore VA, 2004, J CELL SCI, V117, P4033, DOI 10.1242/jcs.01242; Bourhis E, 2007, J BIOL CHEM, V282, P35018, DOI 10.1074/jbc.M706233200; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; Colnaghi R, 2006, J BIOL CHEM, V281, P33450, DOI 10.1074/jbc.C600164200; Delacour-Larose M, 2007, CELL CYCLE, V6, P1878, DOI 10.4161/cc.6.15.4482; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Feng YB, 2009, INT J CANCER, V124, P578, DOI 10.1002/ijc.23990; Goto H, 2006, NAT CELL BIOL, V8, P180, DOI 10.1038/ncb1350; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Jones MK, 2008, J CELL PHYSIOL, V215, P750, DOI 10.1002/jcp.21358; Knauer SK, 2007, CELL CYCLE, V6, P518, DOI 10.4161/cc.6.5.3902; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Liu XQ, 2007, BIOCHEM BIOPH RES CO, V353, P960, DOI 10.1016/j.bbrc.2006.12.142; Liu XQ, 2004, J CELL SCI, V117, P3233, DOI 10.1242/jcs.01173; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Matsumura S, 2007, J BIOL CHEM, V282, P15217, DOI 10.1074/jbc.M611053200; McKay TR, 2003, ONCOGENE, V22, P3539, DOI 10.1038/sj.onc.1206417; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Noton EA, 2006, J BIOL CHEM, V281, P1286, DOI 10.1074/jbc.M508773200; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Qian YW, 2001, MOL BIOL CELL, V12, P1791, DOI 10.1091/mbc.12.6.1791; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Scutt PJ, 2009, J BIOL CHEM, V284, P15880, DOI 10.1074/jbc.M109.005694; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; SUNKEL CE, 1988, J CELL SCI, V89, P25; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Wheatley SP, 2007, CELL CYCLE, V6, P1220, DOI 10.4161/cc.6.10.4179; Wheatley SP, 2005, INT REV CYTOL, V247, P35, DOI 10.1016/S0074-7696(05)47002-3; Wheatley SP, 2004, J BIOL CHEM, V279, P5655, DOI 10.1074/jbc.M311299200; Yue ZJ, 2008, J CELL BIOL, V183, P279, DOI 10.1083/jcb.200806118	45	31	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22592	22604		10.1074/jbc.M109.065003	http://dx.doi.org/10.1074/jbc.M109.065003			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20427271	Green Published, hybrid			2022-12-25	WOS:000279702200070
J	Vivar, OI; Zhao, XY; Saunier, EF; Griffin, C; Mayba, OS; Tagliaferri, M; Cohen, I; Speed, TP; Leitman, DC				Vivar, Omar I.; Zhao, Xiaoyue; Saunier, Elise F.; Griffin, Chandi; Mayba, Oleg S.; Tagliaferri, Mary; Cohen, Isaac; Speed, Terence P.; Leitman, Dale C.			Estrogen Receptor beta Binds to and Regulates Three Distinct Classes of Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ALPHA; CHIP-SEQ; CANCER CELLS; PROLIFERATION; TRANSCRIPTION; EXPRESSION; TAMOXIFEN; SYSTEM; RECRUITMENT; DISRUPTION	Estrogen receptor beta (ER beta) has potent antiproliferative and anti-inflammatory properties, suggesting that ER beta-selective agonists might be a new class of therapeutic and chemopreventative agents. To understand how ER beta regulates genes, we identified genes regulated by the unliganded and liganded forms of ER alpha and ER beta in U2OS cells. Microarray data demonstrated that virtually no gene regulation occurred with unliganded ER alpha, whereas many genes were regulated by estradiol (E-2). These results demonstrated that ER alpha requires a ligand to regulate a single class of genes. In contrast, ER beta regulated three classes of genes. Class I genes were regulated primarily by unliganded ER beta. Class II genes were regulated only with E-2, whereas class III genes were regulated by both unliganded ER beta and E-2. There were 453 class I genes, 258 class II genes, and 83 class III genes. To explore the mechanism whereby ER beta regulates different classes of genes, chromatin immunoprecipitation-sequencing was performed to identify ER beta binding sites and adjacent transcription factor motifs in regulated genes. AP1 binding sites were more enriched in class I genes, whereas ERE, NF kappa B1, and SP1 sites were more enriched in class II genes. ER beta bound to all three classes of genes, demonstrating that ER beta binding is not responsible for differential regulation of genes by unliganded and liganded ER beta. The coactivator NCOA2 was differentially recruited to several target genes. Our findings indicate that the unliganded and liganded forms of ER beta regulate three classes of genes by interacting with different transcription factors and coactivators.	[Vivar, Omar I.; Leitman, Dale C.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Zhao, Xiaoyue; Saunier, Elise F.; Griffin, Chandi; Tagliaferri, Mary; Cohen, Isaac] Bionovo Inc, Emeryville, CA 94608 USA; [Mayba, Oleg S.; Speed, Terence P.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Speed, Terence P.] Walter & Eliza Hall Inst Med Res, Div Bioinformat, Parkville, Vic 3052, Australia	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Walter & Eliza Hall Institute	Leitman, DC (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, 44 Morgan Hall, Berkeley, CA 94720 USA.	dale@leitmanlab.com	Speed, Terence P/B-8085-2009	Speed, Terence P/0000-0002-5403-7998	American Cancer Society; Bionovo, Inc.	American Cancer Society(American Cancer Society); Bionovo, Inc.	This work was supported by a grant from the American Cancer Society (to D. C. L.).; Recipient of a gift of financial support for research from Bionovo, Inc. To whom correspondence should be addressed: University of California, Dept. of Nutritional Science and Toxicology, 44 Morgan Hall, Berkeley, CA 94720. Tel.: 510-642-0862; E-mail: dale@leitmanlab.com.	Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; Cvoro A, 2008, J IMMUNOL, V180, P630, DOI 10.4049/jimmunol.180.1.630; Cvoro A, 2007, ENDOCRINOLOGY, V148, P538, DOI 10.1210/en.2006-0803; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Hartman J, 2006, CANCER RES, V66, P11207, DOI 10.1158/0008-5472.CAN-06-0017; Hartman J, 2009, CANCER RES, V69, P6100, DOI 10.1158/0008-5472.CAN-09-0506; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hewitt SC, 2005, ANNU REV PHYSIOL, V67, P285, DOI 10.1146/annurev.physiol.67.040403.115914; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Katzenellenbogen BS, 2000, RECENT PROG HORM RES, V55, P163; KIAN TM, 2004, MOL BIOL CELL, V15, P1262; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Levy N, 2008, MOL ENDOCRINOL, V22, P287, DOI 10.1210/me.2007-0340; Levy N, 2010, MOL CELL ENDOCRINOL, V315, P201, DOI 10.1016/j.mce.2009.08.030; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Lupien M, 2009, ENDOCR-RELAT CANCER, V16, P381, DOI 10.1677/ERC-09-0038; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Monroe DG, 2003, J CELL BIOCHEM, V90, P315, DOI 10.1002/jcb.10633; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Saville B, 2000, J BIOL CHEM, V275, P5379, DOI 10.1074/jbc.275.8.5379; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shim GJ, 2003, P NATL ACAD SCI USA, V100, P6694, DOI 10.1073/pnas.0731830100; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Vivar OI, 2010, ENDOCRINOLOGY, V151, P1662, DOI 10.1210/en.2009-1028; Vivar OI, 2009, BIOCHEM PHARMACOL, V78, P469, DOI 10.1016/j.bcp.2009.05.008; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Westin S, 2000, ADV PHARMACOL, V47, P89; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	47	86	88	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22059	22066		10.1074/jbc.M110.114116	http://dx.doi.org/10.1074/jbc.M110.114116			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20404318	Green Published, hybrid			2022-12-25	WOS:000279702200018
J	Bartoi, T; Rigbolt, KTG; Du, D; Kohr, G; Blagoev, B; Kornau, HC				Bartoi, Tudor; Rigbolt, Kristoffer T. G.; Du, Dan; Koehr, Georg; Blagoev, Blagoy; Kornau, Hans-Christian			GABA(B) Receptor Constituents Revealed by Tandem Affinity Purification from Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR-LOCALIZATION; STRUCTURAL-ANALYSIS; STRESS INDUCTION; MESSENGER-RNA; T1 DOMAIN; PROTEINS; CLONING; GENE; EXPRESSION; RAT	GABA(B) receptors function as heterodimeric G-protein-coupled receptors for the neurotransmitter gamma-aminobutyric acid (GABA). Receptor subtypes, based on isoforms of the ligand-binding subunit GABA(B1), are thought to involve a differential set of associated proteins. Here, we describe two mouse lines that allow a straightforward biochemical isolation of GABA(B) receptors. The transgenic mice express GABA(B1) isoforms that contain sequences for a two-step affinity purification, in addition to their endogenous subunit repertoire. Comparative analyses of purified samples from the transgenic mice and wild-type control animals revealed two novel components of the GABA(B1) complex. One of the identified proteins, potassium channel tetramerization domain-containing protein 12, associates with heterodimeric GABA(B) receptors via the GABA(B2) subunit. In transfected hippocampal neurons, potassium channel tetramerization domain-containing protein 12 augmented axonal surface targeting of GABA(B2). The mice equipped with tags on GABA(B1) facilitate validation and identification of native binding partners of GABA(B) receptors, providing insight into the molecular mechanisms of synaptic modulation.	Univ Hamburg, Ctr Mol Neurobiol ZMNH, D-20251 Hamburg, Germany; [Rigbolt, Kristoffer T. G.; Blagoev, Blagoy] Univ So Denmark, Dept Biochem & Mol Biol, CEBI, DK-5230 Odense M, Denmark; [Du, Dan; Koehr, Georg] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany	University of Hamburg; University of Southern Denmark; Max Planck Society		hckornau@zmnh.uni-hamburg.de		Blagoev, Blagoy/0000-0002-3596-0066	Deutsche Forschungsgemeinschaft [SFB444]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Deutsche Forschungsgemeinschaft (SFB444).	Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bettler B, 2006, PHARMACOL THERAPEUT, V110, P533, DOI 10.1016/j.pharmthera.2006.03.006; Billinton A, 1999, BRIT J PHARMACOL, V126, P1387, DOI 10.1038/sj.bjp.0702460; Bischoff S, 1999, J COMP NEUROL, V412, P1; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Blein S, 2004, J BIOL CHEM, V279, P48292, DOI 10.1074/jbc.M406540200; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Chang WH, 2007, J BIOL CHEM, V282, P25030, DOI 10.1074/jbc.M700924200; Daulat AM, 2007, MOL CELL PROTEOMICS, V6, P835, DOI 10.1074/mcp.M600298-MCP200; DEAN D, 1981, GENE, V15, P99, DOI 10.1016/0378-1119(81)90108-6; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GAY P, 1983, J BACTERIOL, V153, P1424, DOI 10.1128/JB.153.3.1424-1431.1983; Goloubinoff P, 2007, TRENDS BIOCHEM SCI, V32, P372, DOI 10.1016/j.tibs.2007.06.008; Gregan J, 2007, NAT PROTOC, V2, P1145, DOI 10.1038/nprot.2007.172; Grunewald S, 2002, MOL PHARMACOL, V61, P1070, DOI 10.1124/mol.61.5.1070; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Guetg N, 2009, J NEUROSCI, V29, P1414, DOI 10.1523/JNEUROSCI.3697-08.2009; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; HARTMANN D, 1995, DEV NEUROSCI-BASEL, V17, P246, DOI 10.1159/000111293; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Kornau HC, 2006, CELL TISSUE RES, V326, P517, DOI 10.1007/s00441-006-0264-7; Kulik A, 2006, J NEUROSCI, V26, P4289, DOI 10.1523/JNEUROSCI.4178-05.2006; Kulik A, 2003, J NEUROSCI, V23, P11026; Lamp K, 2001, CYTOGENET CELL GENET, V92, P116, DOI 10.1159/000056880; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Nagy A., 2003, MANIPULATING MOUSE E; Narayanan K, 1999, GENE THER, V6, P442, DOI 10.1038/sj.gt.3300901; Nefedov M, 2000, Nucleic Acids Res, V28, pE79, DOI 10.1093/nar/28.17.e79; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Peters HC, 1998, NEUROGENETICS, V2, P47, DOI 10.1007/s100480050051; Prokhorova TA, 2009, MOL CELL PROTEOMICS, V8, P959, DOI 10.1074/mcp.M800287-MCP200; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Resendes BL, 2004, JARO-J ASSOC RES OTO, V5, P185, DOI 10.1007/s10162-003-4042-x; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rivera JF, 2005, EUR J NEUROSCI, V22, P1853, DOI 10.1111/j.1460-9568.2005.04384.x; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stables J, 1997, ANAL BIOCHEM, V252, P115, DOI 10.1006/abio.1997.2308; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Suehara Y, 2008, CLIN CANCER RES, V14, P1707, DOI 10.1158/1078-0432.CCR-07-1478; Tabata T, 2004, P NATL ACAD SCI USA, V101, P16952, DOI 10.1073/pnas.0405387101; Takada T, 2003, GENOME RES, V13, P589, DOI 10.1101/gr.975303; Tiao JY, 2008, J BIOL CHEM, V283, P31005, DOI 10.1074/jbc.M804464200; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Xu MX, 2007, J NEUROSCI, V27, P14158, DOI 10.1523/JNEUROSCI.3675-07.2007; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	56	40	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20625	20633		10.1074/jbc.M109.049700	http://dx.doi.org/10.1074/jbc.M109.049700			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20406808	Green Published, hybrid			2022-12-25	WOS:000279228600026
J	Watanabe, N; Takagi, S; Tominaga, A; Tomita, T; Iwatsubo, T				Watanabe, Naoto; Takagi, Shizuka; Tominaga, Aya; Tomita, Taisuke; Iwatsubo, Takeshi			Functional Analysis of the Transmembrane Domains of Presenilin 1 PARTICIPATION OF TRANSMEMBRANE DOMAINS 2 AND 6 IN THE FORMATION OF INITIAL SUBSTRATE-BINDING SITE OF gamma-SECRETASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; CATALYTIC PORE; ACTIVE-SITE; C-TERMINUS; CELL-SURFACE; COMPLEX; NICASTRIN; STABILIZATION; TRAFFICKING; INHIBITOR	gamma-Secretase is a multimeric membrane protein complex composed of presenilin ( PS), nicastrin, Aph-1, and Pen-2, which mediates intramembrane proteolysis of a range of type I transmembrane proteins. We previously analyzed the functional roles of the N-terminal transmembrane domains (TMDs) 1-6 of PS1 in the assembly and proteolytic activity of the gamma-secretase using a series of TMD-swap PS1 mutants. Here we applied the TMD-swap method to all the TMDs of PS1 for the structure-function analysis of the proteolytic mechanism of gamma-secretase. We found that TMD2- or -6-swapped mutant PS1 failed to bind the helical peptide-based, substrate-mimic gamma-secretase inhibitor. Cross-linking experiments revealed that both TMD2 and TMD6 of PS1 locate in proximity to the TMD9, the latter being implicated in the initial substrate binding. Taken together, our data suggest that TMD2 and the luminal side of TMD6 are involved in the formation of the initial substrate-binding site of the gamma-secretase complex.	[Tomita, Taisuke] Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol, Grad Sch Med, Tokyo 1130033, Japan; [Tomita, Taisuke; Iwatsubo, Takeshi] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Tomita, T (corresponding author), Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	taisuke@mol.f.u-tokyo.ac.jp	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Science and Technology Corporation (JST); Core Research for Evolutional Science and Technology of JST, Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology of JST, Japan(Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by grants-in-aid for young scientists (S) from the Japan Society for the Promotion of Science (JSPS), Scientific Research on Priority Areas "Research on Pathomechanisms of Brain Disorders" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), by the Targeted Proteins Research Program of the Japan Science and Technology Corporation (JST), and by the Core Research for Evolutional Science and Technology of JST, Japan.	Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Bergman A, 2004, J BIOL CHEM, V279, P45564, DOI 10.1074/jbc.M407717200; Brunkan AL, 2005, J NEUROCHEM, V94, P1315, DOI 10.1111/j.1471-4159.2005.03278.x; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fuwa H, 2007, ACS CHEM BIOL, V2, P408, DOI 10.1021/cb700073y; Hayashi I, 2009, J BIOL CHEM, V284, P27838, DOI 10.1074/jbc.M109.055061; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Imamura Y, 2009, J AM CHEM SOC, V131, P7353, DOI 10.1021/ja9001458; Isoo N, 2007, J BIOL CHEM, V282, P12388, DOI 10.1074/jbc.M611549200; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Laudon H, 2004, J NEUROCHEM, V89, P44, DOI 10.1046/j.1471-4159.2003.02298.x; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Leem JY, 2002, NEUROBIOL DIS, V11, P64, DOI 10.1006/nbdi.2002.0546; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Ratovitski T, 1997, J BIOL CHEM, V272, P24536, DOI 10.1074/jbc.272.39.24536; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Saura CA, 2000, J BIOL CHEM, V275, P17136, DOI 10.1074/jbc.M909624199; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; Shirotani K, 2003, J BIOL CHEM, V278, P16474, DOI 10.1074/jbc.C300095200; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 2001, J BIOL CHEM, V276, P33273, DOI 10.1074/jbc.M011152200; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011; Zhao B, 2008, J BIOL CHEM, V283, P2927, DOI 10.1074/jbc.M708870200	39	51	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19738	19746		10.1074/jbc.M110.101287	http://dx.doi.org/10.1074/jbc.M110.101287			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20418378	Green Published, hybrid			2022-12-25	WOS:000279012000006
J	Zraika, S; Aston-Mourney, K; Marek, P; Hull, RL; Green, PS; Udayasankar, J; Subramanian, SL; Raleigh, DP; Kahn, SE				Zraika, Sakeneh; Aston-Mourney, Kathryn; Marek, Peter; Hull, Rebecca L.; Green, Pattie S.; Udayasankar, Jayalakshmi; Subramanian, Shoba L.; Raleigh, Daniel P.; Kahn, Steven E.			Neprilysin Impedes Islet Amyloid Formation by Inhibition of Fibril Formation Rather Than Peptide Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-DEGRADING ENZYME; NEUTRAL ENDOPEPTIDASE; DIABETES-MELLITUS; POLYPEPTIDE IAPP; IN-VITRO; TRANSGENIC MICE; MOUSE ISLETS; A-BETA; CELL; SECRETION	Deposition of islet amyloid polypeptide (IAPP) as islet amyloid in type 2 diabetes contributes to loss of beta-cell function and mass, yet the mechanism for its occurrence is unclear. Neprilysin is a metallopeptidase known to degrade amyloid in Alzheimer disease. We previously demonstrated neprilysin to be present in pancreatic islets and now sought to determine whether it plays a role in degrading islet amyloid. We used an in vitro model where cultured human IAPP (hIAPP) transgenic mouse islets develop amyloid and thereby have increased beta-cell apoptosis. Islet neprilysin activity was inhibited or up-regulated using a specific inhibitor or adenovirus encoding neprilysin, respectively. Following neprilysin inhibition, islet amyloid deposition and beta-cell apoptosis increased by 54 and 75%, respectively, whereas when neprilysin was up-regulated islet amyloid deposition and beta-cell apoptosis both decreased by 79%. To determine if neprilysin modulated amyloid deposition by cleaving hIAPP, analysis of hIAPP incubated with neprilysin was performed by mass spectrometry, which failed to demonstrate neprilysin-induced cleavage. Rather, neprilysin may act by reducing hIAPP fibrillogenesis, which we showed to be the case by fluorescence-based thioflavin T binding studies and electron microscopy. In summary, neprilysin decreases islet amyloid deposition by inhibiting hIAPP fibril formation, rather than degrading hIAPP. These findings suggest that targeting the role of neprilysin in IAPP fibril assembly, in addition to IAPP cleavage by other peptidases, may provide a novel approach to reduce and/or prevent islet amyloid deposition in type 2 diabetes.	[Zraika, Sakeneh; Aston-Mourney, Kathryn; Hull, Rebecca L.; Green, Pattie S.; Udayasankar, Jayalakshmi; Subramanian, Shoba L.; Kahn, Steven E.] Vet Affairs Puget Sound Hlth Care Syst, Dept Med, Seattle, WA 98108 USA; [Zraika, Sakeneh; Aston-Mourney, Kathryn; Hull, Rebecca L.; Green, Pattie S.; Udayasankar, Jayalakshmi; Subramanian, Shoba L.; Kahn, Steven E.] Univ Washington, Seattle, WA 98108 USA; [Marek, Peter; Raleigh, Daniel P.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zraika, S (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Dept Med, 1660 S Columbian Way 151, Seattle, WA 98108 USA.	zraikas@u.washington.edu	Hull-Meichle, Rebecca L./CAG-5879-2022; Aston-Mourney, Kathryn/AGY-5164-2022	Aston-Mourney, Kathryn/0000-0003-1412-6715; Hull, Rebecca/0000-0001-9690-4087; Kahn, Steven/0000-0001-7307-9002; raleigh, daniel/0000-0003-3248-7493	National Institutes of Health [DK-080945, DK-074404, GM-078114]; Dept. of Veterans Affairs, Virginia; NIH [DK-017047]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK080945, K01DK074404, R00DK080945, P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Veterans Affairs, Virginia(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-080945 (to S. Z.), DK-074404 (to R. L. H.), and GM-078114 (to D. P. R.). This work was also supported by the Dept. of Veterans Affairs, Virginia Affairs Puget Sound Health Care System, Seattle, WA. Mass spectrometry work was performed at the University of Washington's Diabetes Endocrinology Research Center Mass Spectrometry Core, which is supported by NIH Grant DK-017047.	Andrikopoulos S, 2000, DIABETES, V49, P2056, DOI 10.2337/diabetes.49.12.2056; Aston-Mourney K, 2008, DIABETES, V57, pA457; Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; BETSHOLTZ C, 1989, FEBS LETT, V251, P261, DOI 10.1016/0014-5793(89)81467-X; BETSHOLTZ C, 1989, EXP CELL RES, V183, P484, DOI 10.1016/0014-4827(89)90407-2; CLARK A, 1990, DIABETOLOGIA, V33, P285, DOI 10.1007/BF00403322; DALESSIO DA, 1994, DIABETES, V43, P1457, DOI 10.2337/diabetes.43.12.1457; Eckman EA, 2006, J BIOL CHEM, V281, P30471, DOI 10.1074/jbc.M605827200; ENOKI S, 1992, DIABETES RES CLIN PR, V15, P97, DOI 10.1016/0168-8227(92)90074-2; Fukami S, 2002, NEUROSCI RES, V43, P39, DOI 10.1016/S0168-0102(02)00015-9; Ganju RK, 1996, BLOOD, V88, P4159; Gotz J, 2009, CELL MOL LIFE SCI, V66, P1321, DOI 10.1007/s00018-009-9070-1; Hersh LB, 2008, CURR ALZHEIMER RES, V5, P225, DOI 10.2174/156720508783954703; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Iwase A, 2004, J BIOL CHEM, V279, P11898, DOI 10.1074/jbc.M212737200; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; KAHN SE, 1991, HORM METAB RES, V23, P577, DOI 10.1055/s-2007-1003759; KAUTZKYWILLER A, 1994, DIABETOLOGIA, V37, P188, DOI 10.1007/s001250050092; Lau T, 2004, DIABETOLOGIA, V47, P240, DOI 10.1007/s00125-003-1295-1; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Maloyan A, 2007, P NATL ACAD SCI USA, V104, P5995, DOI 10.1073/pnas.0609202104; Marr RA, 2003, J NEUROSCI, V23, P1992; Meng FL, 2008, BIOCHEMISTRY-US, V47, P6016, DOI 10.1021/bi702518m; Raharjo SB, 2001, J BIOL CHEM, V276, P25612, DOI 10.1074/jbc.M101703200; ROQUES BP, 1995, METHOD ENZYMOL, V248, P263; Rose C, 2002, BIOCHEM J, V363, P697, DOI 10.1042/0264-6021:3630697; Scaglia L, 1997, ENDOCRINOLOGY, V138, P1736, DOI 10.1210/en.138.4.1736; Shen RQ, 2002, ANTICANCER RES, V22, P2533; Sumitomo M, 2004, CANCER CELL, V5, P67, DOI 10.1016/S1535-6108(03)00331-3; Trebbien R, 2004, AM J PHYSIOL-ENDOC M, V287, pE431, DOI 10.1152/ajpendo.00353.2003; Verchere CB, 1996, P NATL ACAD SCI USA, V93, P3492, DOI 10.1073/pnas.93.8.3492; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Yan LM, 2006, P NATL ACAD SCI USA, V103, P2046, DOI 10.1073/pnas.0507471103; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zraika S, 2002, ARCH BIOCHEM BIOPHYS, V405, P275, DOI 10.1016/S0003-9861(02)00397-1; Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x; Zraika S, 2007, BIOCHEM BIOPH RES CO, V354, P234, DOI 10.1016/j.bbrc.2006.12.187; Zraika S, 2007, DIABETES, V56, P304, DOI 10.2337/db06-0430	44	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18177	18183		10.1074/jbc.M109.082032	http://dx.doi.org/10.1074/jbc.M109.082032			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400513	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000278453900008
J	Dietrich, N; Lienenklaus, S; Weiss, S; Gekara, NO				Dietrich, Nicole; Lienenklaus, Stefan; Weiss, Siegfried; Gekara, Nelson O.			Murine Toll-Like Receptor 2 Activation Induces Type I Interferon Responses from Endolysosomal Compartments	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; IFN-BETA; GENE INDUCTION; TARGETED DISRUPTION; VIRAL-INFECTION; INNATE IMMUNITY; TLR2; RECOGNITION; EXPRESSION; MACROPHAGES	Background: Toll-like receptors (TLRs) are among the first-line sentinels for immune detection and responsiveness to pathogens. The TLR2 subfamily of TLRs (TLR1, TLR2, TLR6) form heterodimers with each other and are thus able to recognize a broad range of components from several microbes such as yeast, Gram-positive bacteria and protozoa. Until now, TLR2 activation by bacterial ligands has long been associated with pro-inflammatory cytokines but not type I interferon responses. Methodology/Principal Findings: Using a variety of transgenic mice, here we provide in vivo and in vitro data showing that TLR2 activation does in fact induce interferon-beta and that this occurs via MyD88-IRF1 and -IRF7 pathways. Interestingly, by microscopy we demonstrate that although a cell surface receptor, TLR2 dependent induction of type I interferons occurs in endolysosomal compartments where it is translocated to upon ligand engagement. Furthermore, we could show that blocking receptor internalization or endolysosomal acidification inhibits the ability of TLR2 to trigger the induction type I interferon but not pro-inflammatory responses. Conclusion/Significance: The results indicate that TLR2 activation induces pro-inflammatory and type I interferon responses from distinct subcellular sites: the plasma membrane and endolysosomal compartments respectively. Apart from identifying and characterizing a novel pathway for induction of type I interferons, the present study offers new insights into how TLR signaling discriminates and regulates the nature of responses to be elicited against extracellular and endocytosed microbes. These findings may also have clinical implication. Excessive production of pro-inflammatory cytokines and type I IFNs following activation of TLRs is a central pathologic event in several hyper-inflammatory conditions. The discovery that the induction of pro-inflammatory and type I IFN responses can be uncoupled through pharmacological manipulation of endolysosomal acidification suggests new avenues for potential therapeutic intervention against inflammations and sepsis.	[Dietrich, Nicole; Lienenklaus, Stefan; Weiss, Siegfried; Gekara, Nelson O.] Helmholtz Ctr Infect Res, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Dietrich, N (corresponding author), Helmholtz Ctr Infect Res, Braunschweig, Germany.	nelson.gekara@gmail.com	Gekara, Nelson/P-9208-2019; Gekara, Nelson/AAG-7944-2020; Lienenklaus, Stefan/HIK-0899-2022	Lienenklaus, Stefan/0000-0003-4790-3445; Gekara, Nelson O./0000-0002-1269-8288	German Research Council (DFG) [SFB 566]; Kultusministerium of Niedersachsen via the Lichtenberg PhD program; centre for infection biology (ZIB) [VH-KO-106]; Helmholtz International Research School for Infection Biology (HIRSIB); German Federal Ministry of Education and Research (BMBF)	German Research Council (DFG)(German Research Foundation (DFG)); Kultusministerium of Niedersachsen via the Lichtenberg PhD program; centre for infection biology (ZIB); Helmholtz International Research School for Infection Biology (HIRSIB); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was supported in part by the German Research Council (DFG) via SFB 566, the Kultusministerium of Niedersachsen via the Lichtenberg PhD program, the centre for infection biology (ZIB) via contract number VH-KO-106, the Helmholtz International Research School for Infection Biology (HIRSIB) and the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Cole BC, 2005, INFECT IMMUN, V73, P6039, DOI 10.1128/IAI.73.9.6039-6047.2005; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Erlandsson L, 1998, CURR BIOL, V8, P223, DOI 10.1016/S0960-9822(98)70086-7; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gekara NO, 2007, CELL MICROBIOL, V9, P2008, DOI 10.1111/j.1462-5822.2007.00932.x; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hickman-Davis J, 1999, P NATL ACAD SCI USA, V96, P4953, DOI 10.1073/pnas.96.9.4953; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Mun HS, 2003, INT IMMUNOL, V15, P1081, DOI 10.1093/intimm/dxg108; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; Noppert SJ, 2007, IMMUNOL CELL BIOL, V85, P446, DOI 10.1038/sj.icb.7100099; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Triantafilou M, 2004, J BIOL CHEM, V279, P40882, DOI 10.1074/jbc.M400466200; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Verthelyi D, 2001, J IMMUNOL, V166, P2372, DOI 10.4049/jimmunol.166.4.2372; Vilcek J, 2006, IMMUNITY, V25, P343, DOI 10.1016/j.immuni.2006.08.008; Zhu JG, 2007, BLOOD, V109, P619, DOI 10.1182/blood-2006-06-027136	47	117	119	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10250	10.1371/journal.pone.0010250	http://dx.doi.org/10.1371/journal.pone.0010250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422028	Green Published, Green Submitted, gold			2022-12-25	WOS:000276854300013
J	Mohapatra, SK; Guri, AJ; Climent, M; Vives, C; Carbo, A; Horne, WT; Hontecillas, R; Bassaganya-Riera, J				Mohapatra, Saroj K.; Guri, Amir J.; Climent, Montse; Vives, Cristina; Carbo, Adria; Horne, William T.; Hontecillas, Raquel; Bassaganya-Riera, Josep			Immunoregulatory Actions of Epithelial Cell PPAR gamma at the Colonic Mucosa of Mice with Experimental Inflammatory Bowel Disease	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; COLITIS; ROSIGLITAZONE; PROTECTION; MODELS	Background: Peroxisome proliferator-activated receptors are nuclear receptors highly expressed in intestinal epithelial cells (IEC) and immune cells within the gut mucosa and are implicated in modulating inflammation and immune responses. The objective of this study was to investigate the effect of targeted deletion of PPAR gamma in IEC on progression of experimental inflammatory bowel disease (IBD). Methodology/Principal Findings: In the first phase, PPAR gamma flfl; Villin Cre- (VC-) and PPAR gamma flfl; Villin Cre+ (VC+) mice in a mixed FVB/C57BL/6 background were challenged with 2.5% dextran sodium sulfate (DSS) in drinking water for 0, 2, or 7 days. VC+ mice express a transgenic recombinase under the control of the Villin-Cre promoter that causes an IEC-specific deletion of PPAR gamma. In the second phase, we generated VC- and VC+ mice in a C57BL/6 background that were challenged with 2.5% DSS. Mice were scored on disease severity both clinically and histopathologically. Flow cytometry was used to phenotypically characterize lymphocyte and macrophage populations in blood, spleen and mesenteric lymph nodes. Global gene expression analysis was profiled using Affymetrix microarrays. The IEC-specific deficiency of PPAR gamma in mice with a mixed background worsened colonic inflammatory lesions, but had no effect on disease activity (DAI) or weight loss. In contrast, the IEC-specific PPAR gamma null mice in C57BL/6 background exhibited more severe inflammatory lesions, DAI and weight loss in comparison to their littermates expressing PPAR gamma in IEC. Global gene expression profiling revealed significantly down-regulated expression of lysosomal pathway genes and flow cytometry results demonstrated suppressed production of IL-10 by CD4+ T cells in mesenteric lymph nodes (MLN) of IEC-specific PPAR gamma null mice. Conclusions/Significance: Our results demonstrate that adequate expression of PPAR gamma in IEC is required for the regulation of mucosal immune responses and prevention of experimental IBD, possibly by modulation of lysosomal and antigen presentation pathways.	[Mohapatra, Saroj K.; Guri, Amir J.; Climent, Montse; Vives, Cristina; Carbo, Adria; Horne, William T.; Hontecillas, Raquel; Bassaganya-Riera, Josep] Virginia Polytech Inst & State Univ, Nutr Immunol & Mol Nutr Lab, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Mohapatra, SK (corresponding author), Virginia Polytech Inst & State Univ, Nutr Immunol & Mol Nutr Lab, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	rmagarzo@vt.edu; jbassaga@vt.edu	Climent, Montserrat/K-6490-2019; Vives, Cristina/Y-2136-2019	Climent, Montserrat/0000-0002-9029-7914; Vives, Cristina/0000-0001-7190-4320; Mohapatra, Saroj Kant/0000-0003-4723-5109	Virginia Bioinformatics Institute exploratory	Virginia Bioinformatics Institute exploratory	This research was funded by a Virginia Bioinformatics Institute exploratory grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2006, GUT, V55, P1104, DOI 10.1136/gut.2005.081745; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bassaganya-Riera J, 2006, CLIN NUTR, V25, P454, DOI 10.1016/j.clnu.2005.12.008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen L, 2006, MOL CELL ENDOCRINOL, V251, P17, DOI 10.1016/j.mce.2006.02.006; Clark RB, 2002, J LEUKOCYTE BIOL, V71, P388; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; GURI AJ, 2010, CLIN NUTR IN PRESS; GURI AJ, 2010, BMC GASTROE IN PRESS; Hershberg RM, 2000, IMMUNOL TODAY, V21, P123, DOI 10.1016/S0167-5699(99)01575-3; Hontecillas R, 2002, J NUTR, V132, P2019, DOI 10.1093/jn/132.7.2019; Hontecillas R, 2007, J IMMUNOL, V178, P2940, DOI 10.4049/jimmunol.178.5.2940; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jiang M, 2010, CELL DEATH DIFFER, V17, P469, DOI 10.1038/cdd.2009.148; Jiang M, 2010, AUTOPHAGY, V6, P175, DOI 10.4161/auto.6.1.10700; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Lewis JD, 2001, AM J GASTROENTEROL, V96, P3323; Lonnstedt I, 2002, STAT SINICA, V12, P31; Martin H, 2009, MUTAT RES-FUND MOL M, V669, P1, DOI 10.1016/j.mrfmmm.2009.06.009; Matsutani T, 2005, CYTOKINE, V30, P168, DOI 10.1016/j.cyto.2004.12.019; OMORAIN C, 1984, GUT, V25, P455, DOI 10.1136/gut.25.5.455; R Development Core Team, 2009, R FDN STAT COMP; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamamoto-Furusho JK, 2007, WORLD J GASTROENTERO, V13, P5594, DOI 10.3748/wjg.v13.i42.5594; Zhang WW, 2003, J BIOL CHEM, V278, P35508, DOI 10.1074/jbc.M305030200	30	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10215	10.1371/journal.pone.0010215	http://dx.doi.org/10.1371/journal.pone.0010215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422041	Green Published, gold, Green Submitted			2022-12-25	WOS:000276854300003
J	Morgan, JL; Darling, AE; Eisen, JA				Morgan, Jenna L.; Darling, Aaron E.; Eisen, Jonathan A.			Metagenomic Sequencing of an In Vitro-Simulated Microbial Community	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; PHYLOGENETIC CLASSIFICATION; DNA; GENOME; EXTRACTION; SOILS; DIVERSITY; LIBRARIES; INFERENCE; ALIGNMENT	Background: Microbial life dominates the earth, but many species are difficult or even impossible to study under laboratory conditions. Sequencing DNA directly from the environment, a technique commonly referred to as metagenomics, is an important tool for cataloging microbial life. This culture-independent approach involves collecting samples that include microbes in them, extracting DNA from the samples, and sequencing the DNA. A sample may contain many different microorganisms, macroorganisms, and even free-floating environmental DNA. A fundamental challenge in metagenomics has been estimating the abundance of organisms in a sample based on the frequency with which the organism's DNA was observed in reads generated via DNA sequencing. Methodology/Principal Findings: We created mixtures of ten microbial species for which genome sequences are known. Each mixture contained an equal number of cells of each species. We then extracted DNA from the mixtures, sequenced the DNA, and measured the frequency with which genomic regions from each organism was observed in the sequenced DNA. We found that the observed frequency of reads mapping to each organism did not reflect the equal numbers of cells that were known to be included in each mixture. The relative organism abundances varied significantly depending on the DNA extraction and sequencing protocol utilized. Conclusions/Significance: We describe a new data resource for measuring the accuracy of metagenomic binning methods, created by in vitro-simulation of a metagenomic community. Our in vitro simulation can be used to complement previous in silico benchmark studies. In constructing a synthetic community and sequencing its metagenome, we encountered several sources of observation bias that likely affect most metagenomic experiments to date and present challenges for comparative metagenomic studies. DNA preparation methods have a particularly profound effect in our study, implying that samples prepared with different protocols are not suitable for comparative metagenomics.	[Morgan, Jenna L.; Darling, Aaron E.; Eisen, Jonathan A.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Morgan, Jenna L.; Darling, Aaron E.; Eisen, Jonathan A.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Morgan, Jenna L.; Eisen, Jonathan A.] Joint Genome Inst, US DOE, Walnut Creek, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Morgan, JL (corresponding author), Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	jaeisen@ucdavis.edu	Darling, Aaron/G-8119-2017; Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Lang, Jenna/0000-0002-4871-4497; Darling, Aaron/0000-0003-2397-7925	Lawrence Berkeley National Laboratory; Office of Science of the U.S. Department of Energy [DE-AC02-5CH11231]; NSF [DBI-0630765]	Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF))	This project was funded primarily by Laboratory Directed Research and Development Program funds from the Lawrence Berkeley National Laboratory. The work was conducted in part at the U.S. Department of Energy Joint Genome Institute which is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-5CH11231. A. Darling was supported by NSF fellowship DBI-0630765. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barabote RD, 2009, GENOME RES, V19, P1033, DOI 10.1101/gr.084848.108; Bertrand H, 2005, J MICROBIOL METH, V62, P1, DOI 10.1016/j.mimet.2005.01.003; Blow N, 2008, NATURE, V453, P687, DOI 10.1038/453687a; Breuert S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000092; Carrigg C, 2007, APPL MICROBIOL BIOT, V77, P955, DOI 10.1007/s00253-007-1219-y; Chan CKK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-215; Chan CKK, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/513701; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; Darling A, 2003, 4 INT C LIN CLUST CL; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Donachie WD, 2001, MOL MICROBIOL, V40, P779, DOI 10.1046/j.1365-2958.2001.02439.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Frostegard A, 1999, APPL ENVIRON MICROB, V65, P5409; Goffeau A, 1996, YEAST, V12, P1603; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jakobsen JS, 2004, J BACTERIOL, V186, P4361, DOI 10.1128/JB.186.13.4361-4368.2004; Johnson PLF, 2006, GENOME RES, V16, P1320, DOI 10.1101/gr.5431206; Krsek M, 1999, J MICROBIOL METH, V39, P1, DOI 10.1016/S0167-7012(99)00093-7; Kugelberg E, 2006, P NATL ACAD SCI USA, V103, P17319, DOI 10.1073/pnas.0608309103; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; LANGILLE M, 2010, PLOS ONE IN PRESS; Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; McHardy AC, 2007, CURR OPIN MICROBIOL, V10, P499, DOI 10.1016/j.mib.2007.08.004; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; McMurray AA, 1998, GENOME RES, V8, P562, DOI 10.1101/gr.8.5.562; McOrist AL, 2002, J MICROBIOL METH, V50, P131, DOI 10.1016/S0167-7012(02)00018-0; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Palenik B, 2009, ENVIRON MICROBIOL, V11, P349, DOI 10.1111/j.1462-2920.2008.01772.x; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5467; Singh Jagtar, 2009, Biotechnology Journal, V4, P480, DOI 10.1002/biot.200800201; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; Temperton B, 2009, ISME J, V3, P792, DOI 10.1038/ismej.2009.32; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Van Burik JAH, 1998, MED MYCOL, V36, P299, DOI 10.1080/02681219880000471; Venkateswaran K, 1998, INT J SYST BACTERIOL, V48, P965, DOI 10.1099/00207713-48-3-965; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857	47	152	157	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10209	10.1371/journal.pone.0010209	http://dx.doi.org/10.1371/journal.pone.0010209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419134	Green Submitted, gold, Green Published			2022-12-25	WOS:000276743500016
J	Suarez-Alvarez, B; Rodriguez, RM; Calvanese, V; Blanco-Gelaz, MA; Suhr, ST; Ortega, F; Otero, J; Cibelli, JB; Moore, H; Fraga, MF; Lopez-Larrea, C				Suarez-Alvarez, Beatriz; Rodriguez, Ramon M.; Calvanese, Vincenzo; Blanco-Gelaz, Miguel A.; Suhr, Steve T.; Ortega, Francisco; Otero, Jesus; Cibelli, Jose B.; Moore, Harry; Fraga, Mario F.; Lopez-Larrea, Carlos			Epigenetic Mechanisms Regulate MHC and Antigen Processing Molecules in Human Embryonic and Induced Pluripotent Stem Cells	PLOS ONE			English	Article							CHAIN-RELATED MOLECULES; I-RELATED CHAIN; DIFFERENTIATED DERIVATIVES; DOWN-REGULATION; NKG2D RECEPTOR; APM COMPONENTS; HLA-F; EXPRESSION; LIGANDS; IMMUNOGENICITY	Background: Human embryonic stem cells (hESCs) are an attractive resource for new therapeutic approaches that involve tissue regeneration. hESCs have exhibited low immunogenicity due to low levels of Mayor Histocompatibility Complex (MHC) class-I and absence of MHC class-II expression. Nevertheless, the mechanisms regulating MHC expression in hESCs had not been explored. Methodology/Principal Findings: We analyzed the expression levels of classical and non-classical MHC class-I, MHC class-II molecules, antigen-processing machinery (APM) components and NKG2D ligands (NKG2D-L) in hESCs, induced pluripotent stem cells (iPSCs) and NTera2 (NT2) teratocarcinoma cell line. Epigenetic mechanisms involved in the regulation of these genes were investigated by bisulfite sequencing and chromatin immunoprecipitation (ChIP) assays. We showed that low levels of MHC class-I molecules were associated with absent or reduced expression of the transporter associated with antigen processing 1 (TAP-1) and tapasin (TPN) components in hESCs and iPSCs, which are involved in the transport and load of peptides. Furthermore, lack of beta 2-microglobulin (beta 2m) light chain in these cells limited the expression of MHC class I trimeric molecule on the cell surface. NKG2D ligands (MICA, MICB) were observed in all pluripotent stem cells lines. Epigenetic analysis showed that H3K9me3 repressed the TPN gene in undifferentiated cells whilst HLA-B and beta 2m acquired the H3K4me3 modification during the differentiation to embryoid bodies (EBs). Absence of HLA-DR and HLA-G expression was regulated by DNA methylation. Conclusions/Significance: Our data provide fundamental evidence for the epigenetic control of MHC in hESCs and iPSCs. Reduced MHC class I and class II expression in hESCs and iPSCs can limit their recognition by the immune response against these cells. The knowledge of these mechanisms will further allow the development of strategies to induce tolerance and improve stem cell allograft acceptance.	[Suarez-Alvarez, Beatriz; Blanco-Gelaz, Miguel A.; Lopez-Larrea, Carlos] Hosp Univ Cent Asturias, Histocompatibil & Transplantat Unit, Oviedo, Spain; [Rodriguez, Ramon M.; Suhr, Steve T.; Cibelli, Jose B.] Michigan State Univ, Dept Anim Sci & Physiol, E Lansing, MI 48824 USA; [Ortega, Francisco] Hosp Univ Cent Asturias, Dept Nephrol, Oviedo, Spain; [Rodriguez, Ramon M.; Otero, Jesus] Hosp Univ Cent Asturias, Unidad Coordinac Trasplantes & Terapia Celular, Oviedo, Spain; [Calvanese, Vincenzo; Fraga, Mario F.] Hosp Univ Cent Asturias, IUOPA, Canc Epigenet Lab, Oviedo, Spain; [Calvanese, Vincenzo; Fraga, Mario F.] CSIC, CNB, Natl Biotechnol Ctr, Dept Immunol & Oncol, Madrid, Spain; [Cibelli, Jose B.] Programa Andaluz Terapia Celular & Med Regenerat, Andalucia, Spain; [Moore, Harry] Univ Sheffield, Western Bank, Ctr Stem Cell Biol, Sheffield, S Yorkshire, England; [Ortega, Francisco; Lopez-Larrea, Carlos] Fdn Renal Inigo Alvarez Toledo, Madrid, Spain	Central University Hospital Asturias; Michigan State University; Central University Hospital Asturias; Central University Hospital Asturias; Central University Hospital Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Sheffield	Suarez-Alvarez, B (corresponding author), Hosp Univ Cent Asturias, Histocompatibil & Transplantat Unit, Oviedo, Spain.	inmuno@hca.es	Calvanese, Vincenzo/E-1145-2016; Fraga, Mario F/H-7824-2017; Calvanese, Vincenzo/AAO-4311-2020; Otero, Jesus/J-1858-2017; Rodriguez, Ramon Maria/AAF-9376-2019	Calvanese, Vincenzo/0000-0002-7937-1511; Fraga, Mario F/0000-0001-8450-2603; Calvanese, Vincenzo/0000-0002-7937-1511; Otero, Jesus/0000-0003-4097-3846; Rodriguez, Ramon Maria/0000-0002-6770-5123; Lopez-Larrea, Carlos/0000-0001-9988-1730; Cibelli, Jose/0000-0002-2176-3854	Red de Investigacion Renal (REDinREN); Institute Carlos III [PI051707, PI080566]; Fundacion Mutua Madrilena [2007-2009]; MRC [G0801059] Funding Source: UKRI; Medical Research Council [G0801059] Funding Source: researchfish	Red de Investigacion Renal (REDinREN); Institute Carlos III(Instituto de Salud Carlos III); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Red de Investigacion Renal (REDinREN) grant, FIS PI051707 and PI080566 from Institute Carlos III grants, and Fundacion Mutua Madrilena 2007-2009 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguera-Gonzalez S, 2009, J IMMUNOL, V182, P4800, DOI 10.4049/jimmunol.0800713; Apps R, 2008, HUM REPROD, V23, P2535, DOI 10.1093/humrep/den223; Bonde S, 2006, STEM CELLS, V24, P2192, DOI 10.1634/stemcells.2006-0022; Bubenik J, 2004, INT J ONCOL, V25, P487; Cabrera CM, 2007, CELL BIOL INT, V31, P1072, DOI 10.1016/j.cellbi.2007.03.015; Calvanese V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003294; Chou SD, 2005, INT IMMUNOL, V17, P1483, DOI 10.1093/intimm/dxh326; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Di Tomaso T, 2010, CLIN CANCER RES, V16, P800, DOI 10.1158/1078-0432.CCR-09-2730; Draper JS, 2004, STEM CELLS DEV, V13, P325, DOI 10.1089/1547328041797525; Dressel R, 2010, FASEB J, V24, P2164, DOI 10.1096/fj.09-134957; Dressel R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002622; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Frenzel LP, 2009, STEM CELLS, V27, P307, DOI 10.1634/stemcells.2008-0528; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Gonzalez S, 2008, TRENDS IMMUNOL, V29, P397, DOI 10.1016/j.it.2008.04.007; Grinnemo KH, 2008, CELL TISSUE RES, V331, P67, DOI 10.1007/s00441-007-0486-3; Hedlund M, 2009, J IMMUNOL, V183, P340, DOI 10.4049/jimmunol.0803477; HUNT JS, 2009, CURR OPIN PHARM 0629; Ishitani A, 2006, J REPROD IMMUNOL, V69, P101, DOI 10.1016/j.jri.2005.10.004; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Koch CA, 2008, STEM CELLS, V26, P89, DOI 10.1634/stemcells.2007-0151; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Lopez-Larrea C, 2008, TRENDS MOL MED, V14, P179, DOI 10.1016/j.molmed.2008.02.004; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Megiorni F, 2005, NEUROSCI LETT, V373, P105, DOI 10.1016/j.neulet.2004.09.070; Menendez L, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-43; Mincheva-Nilsson L, 2006, J IMMUNOL, V176, P3585, DOI 10.4049/jimmunol.176.6.3585; Morandi F, 2008, STEM CELLS, V26, P1275, DOI 10.1634/stemcells.2007-0878; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Robertson NJ, 2007, P NATL ACAD SCI USA, V104, P20920, DOI 10.1073/pnas.0710265105; Seliger B, 2008, CANCER IMMUNOL IMMUN, V57, P1719, DOI 10.1007/s00262-008-0515-4; Seliger B, 2008, J IMMUNOTOXICOL, V5, P361, DOI 10.1080/15476910802482870; Selmani Z, 2009, TRANSPLANTATION, V87, pS62, DOI 10.1097/TP.0b013e3181a2a4b3; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Suarez-Alvarez B, 2009, AM J TRANSPLANT, V9, P251, DOI 10.1111/j.1600-6143.2008.02526.x; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Swijnenburg RJ, 2005, CIRCULATION, V112, pI166, DOI 10.1161/CIRCULATIONAHA.104.525824; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; van den Elsen PJ, 2001, J REPROD IMMUNOL, V52, P129, DOI 10.1016/S0165-0378(01)00115-2; Wright KL, 2006, TRENDS IMMUNOL, V27, P405, DOI 10.1016/j.it.2006.07.007; Wu DC, 2008, STEM CELLS, V26, P1939, DOI 10.1634/stemcells.2008-0078; Yachimovich-Cohen N, 2010, J IMMUNOL, V184, P1300, DOI 10.4049/jimmunol.0804261; Yadav D, 2009, J IMMUNOL, V182, P39, DOI 10.4049/jimmunol.182.1.39; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Zika E, 2005, CURR OPIN IMMUNOL, V17, P58, DOI 10.1016/j.coi.2004.11.008	51	83	101	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10192	10.1371/journal.pone.0010192	http://dx.doi.org/10.1371/journal.pone.0010192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419139	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000276743500012
J	Fu, J; Jin, F; Zhang, JR; Fong, K; Bassi, DE; De Cicco, RL; Ramaraju, D; Braunewell, KH; Conti, C; Benavides, F; Klein-Szanto, AJP				Fu, Jian; Jin, Fang; Zhang, Jirong; Fong, Kathryn; Bassi, Daniel E.; De Cicco, Ricardo Lopez; Ramaraju, Divya; Braunewell, Karl-Heinz; Conti, Claudio; Benavides, Fernando; Klein-Szanto, Andres J. P.			VILIP-1 Expression In Vivo Results in Decreased Mouse Skin Keratinocyte Proliferation and Tumor Development	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; VISININ-LIKE PROTEIN-1; TISSUE INHIBITOR; HACAT KERATINOCYTES; DIFFERENTIATION; FAMILY; METALLOPROTEINASE-1; CARCINOGENESIS; PROGRESSION; SUPPRESSES	VILIP-1, a member of the neuronal Ca(2+) sensor protein family, is able to act as a tumor suppressor in carcinoma cells by inhibiting cell proliferation and migration. In order to study the role of VILIP-1 in skin carcinogenesis we generated transgenic mice overexpressing VILIP-1 in epidermis under the control of the bovine keratin K5 promoter (K5-VILIP-1). We studied the susceptibility of FVB wild type and VILIP-1 transgenic mice to chemically mediated carcinogenesis. After 30 weeks of treatment with a two-stage carcinogenesis protocol, all animals showed numerous skin tumors. Nevertheless, K5-VILIP-1 mice showed decreased squamous cell carcinoma (SCC) multiplicity of similar to 49% (p<0.02) with respect to the corresponding SCC multiplicity observed in wild type (WT) mice. In addition, the relative percentage of low-grade cutaneous SCCs grade I (defined by the differentiation pattern according to the Broders grading scale) increased approximately 50% in the K5-VILIP1 mice when compared with SCCs in WT mice. Similar tendency was observed using a complete carcinogenesis protocol for skin carcinogenesis using benzo(a) pyrene (B(a)P). Further studies of tumors and primary epidermal keratinocyte cultures showed that matrix metalloproteinase 9 (MMP-9) levels and cell proliferation decreased in K5-VILIP-1 mice when compared with their wild counterparts. In addition tissue inhibitor of metalloproteinase 1 (TIMP-1) expression was higher in K5-VILIP-1 keratinocytes. These results show that VILIP-1 overexpression decreases the susceptibility to skin carcinogenesis in experimental mouse cancer models, thus supporting its role as a tumor suppressor gene.	[Fu, Jian; Jin, Fang; Zhang, Jirong; Fong, Kathryn; Bassi, Daniel E.; De Cicco, Ricardo Lopez; Ramaraju, Divya; Klein-Szanto, Andres J. P.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Fu, Jian; Bassi, Daniel E.; De Cicco, Ricardo Lopez; Klein-Szanto, Andres J. P.] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Braunewell, Karl-Heinz] So Res Inst, Birmingham, AL 35255 USA; [Conti, Claudio; Benavides, Fernando] MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX USA	Fox Chase Cancer Center; Fox Chase Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Fu, J (corresponding author), Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA.	aj_klein-szanto@fccc.edu		Benavides, Fernando/0000-0003-1275-4320	National Institutes of Health [CA107257, CA06927]; Commonwealth of Pennsylvania; Deutsche Krebshilfe; NATIONAL CANCER INSTITUTE [R01CA107257, P30CA006927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; Deutsche Krebshilfe(Deutsche Krebshilfe); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health CA107257, CA06927 and by an appropriation from the Commonwealth of Pennsylvania. K.-H. B. was supported by a grant from Deutsche Krebshilfe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassi DE, 2005, CANCER RES, V65, P7310, DOI 10.1158/0008-5472.CAN-05-1213; Boekhoff I, 1997, EUR J CELL BIOL, V72, P151; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Braunewell KH, 2001, J NEUROCHEM, V78, P1277, DOI 10.1046/j.1471-4159.2001.00506.x; Braunewell KH, 1997, NEUROSCI LETT, V234, P139, DOI 10.1016/S0304-3940(97)00696-4; Braunewell KH, 2005, TRENDS PHARMACOL SCI, V26, P345, DOI 10.1016/j.tips.2005.04.008; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Charpentier E, 2000, J CELL BIOL, V149, P503, DOI 10.1083/jcb.149.2.503; CHIBA M, 1991, INVAS METAST, V11, P288; Fu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001698; Gierke P, 2004, BIOCHEM BIOPH RES CO, V323, P38, DOI 10.1016/j.bbrc.2004.08.055; Glick AB, 2005, SEMIN CANCER BIOL, V15, P75, DOI 10.1016/j.semcancer.2004.08.008; Gronning LM, 2000, BIOL REPROD, V62, P1040, DOI 10.1095/biolreprod62.4.1040; Guerrico AMG, 2005, ONCOGENE, V24, P2307, DOI 10.1038/sj.onc.1208476; Junghanel A, 1998, Mund Kiefer Gesichtschir, V2, P250, DOI 10.1007/s100060050069; KLEINSZANTO AJP, 1980, CARCINOGENESIS, V1, P1007, DOI 10.1093/carcin/1.12.1007; Kralisch S, 2006, J ENDOCRINOL, V189, P665, DOI 10.1677/joe.1.06645; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Mahloogi H, 2003, CANCER RES, V63, P4997; Malumbres M, 1997, BIOTECHNIQUES, V22, P1114, DOI 10.2144/97226st03; Mammone T, 1998, SKIN PHARMACOL APPL, V11, P152, DOI 10.1159/000029821; Mitsunaga S, 1997, J CELL BIOCHEM, P81; Papp H, 2003, EXP DERMATOL, V12, P811, DOI 10.1111/j.0906-6705.2003.00097.x; PATSKAN GJ, 1987, CANCER LETT, V34, P121, DOI 10.1016/0304-3835(87)90002-4; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; Ree AH, 1996, CLIN EXP METASTAS, V14, P381, DOI 10.1007/BF00123397; RUGGERI B, 1993, P NATL ACAD SCI USA, V90, P1013, DOI 10.1073/pnas.90.3.1013; RUGGERI B, 1992, AM J PATHOL, V140, P1179; Slaga T J, 1980, Curr Probl Dermatol, V10, P193; Slaga T J, 1995, Prog Clin Biol Res, V391, P1; TANAKA K, 1995, CANCER RES, V55, P2927; Tumuluri V, 2002, J ORAL PATHOL MED, V31, P598, DOI 10.1034/j.1600-0714.2002.00042.x; Wickborn C, 2006, MOL CARCINOGEN, V45, P572, DOI 10.1002/mc.20201	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10196	10.1371/journal.pone.0010196	http://dx.doi.org/10.1371/journal.pone.0010196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419170	gold, Green Submitted, Green Published			2022-12-25	WOS:000276707100012
J	Wines-Samuelson, M; Schulte, EC; Smith, MJ; Aoki, C; Liu, XR; Kelleher, RJ; Shen, J				Wines-Samuelson, Mary; Schulte, Eva C.; Smith, Miriam J.; Aoki, Chiye; Liu, Xinran; Kelleher, Raymond J., III; Shen, Jie			Characterization of Age-Dependent and Progressive Cortical Neuronal Degeneration in Presenilin Conditional Mutant Mice	PLOS ONE			English	Article							INDUCED APOPTOTIC NEURODEGENERATION; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; ACTIVATION; MEMORY; RESPONSES; KNOCKOUT; CELLS	Presenilins are the major causative genes of familial Alzheimer's disease ( AD). Our previous study has demonstrated essential roles of presenilins in memory and neuronal survival. Here, we explore further how loss of presenilins results in age-related, progressive neurodegeneration in the adult cerebral cortex, where the pathogenesis of AD occurs. To circumvent the requirement of presenilins for embryonic development, we used presenilin conditional double knockout (Psen cDKO) mice, in which presenilin inactivation is restricted temporally and spatially to excitatory neurons of the postnatal forebrain beginning at 4 weeks of age. Increases in the number of degenerating (Fluoro-Jade B+, 7.6-fold) and apoptotic (TUNEL+, 7.4-fold) neurons, which represent similar to 0.1% of all cortical neurons, were first detected at 2 months of age when there is still no significant loss of cortical neurons and volume in Psen cDKO mice. By 4 months of age, significant loss of cortical neurons (similar to 9%) and gliosis was found in Psen cDKO mice. The apoptotic cell death is associated with caspase activation, as shown by increased numbers of cells immunoreactive for active caspases 9 and 3 in the Psen cDKO cortex. The vulnerability of cortical neurons to loss of presenilins is region-specific with cortical neurons in the lateral cortex most susceptible. Compared to the neocortex, the increase in apoptotic cell death and the extent of neurodegeneration are less dramatic in the Psen cDKO hippocampus, possibly in part due to increased neurogenesis in the aging dentate gyrus. Neurodegeneration is also accompanied with mitochondrial defects, as indicated by reduced mitochondrial density and altered mitochondrial size distribution in aging Psen cortical neurons. Together, our findings show that loss of presenilins in cortical neurons causes apoptotic cell death occurring in a very small percentage of neurons, which accumulates over time and leads to substantial loss of cortical neurons in the aging brain. The low occurrence and significant delay of apoptosis among cortical neurons lacking presenilins suggest that loss of presenilins may induce apoptotic neuronal death through disruption of cellular homeostasis rather than direct activation of apoptosis pathways.	[Wines-Samuelson, Mary; Schulte, Eva C.; Smith, Miriam J.; Shen, Jie] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis,Dept Neurol, Boston, MA 02115 USA; [Aoki, Chiye] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Liu, Xinran] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Kelleher, Raymond J., III] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; New York University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; Massachusetts General Hospital	Wines-Samuelson, M (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis,Dept Neurol, Boston, MA 02115 USA.	jshen@rics.bwh.harvard.edu	Shen, Jie/GXH-9449-2022; Schulte, Eva C./AAT-2410-2021; Smith, Miriam/J-4001-2015; Aoki, Chiye/T-9405-2019	Smith, Miriam/0000-0002-3184-0817; Aoki, Chiye/0000-0003-4010-9425; Schulte, Eva Christina/0000-0003-3105-5672	National Institutes of Health [5R01NS41783]; Alzheimer's Association (IIRG); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041783, R01NS075346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association (IIRG)(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (5R01NS41783) and the Alzheimer's Association (IIRG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Auer RN, 2002, GREENFIELDS NEUROPAT, P233; Beglopoulos V, 2004, J BIOL CHEM, V279, P46907, DOI 10.1074/jbc.M409544200; Cole-Edwards KK, 2006, J NEUROSCI, V26, P8295, DOI 10.1523/JNEUROSCI.1986-05.2006; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Feng RB, 2004, P NATL ACAD SCI USA, V101, P8162, DOI 10.1073/pnas.0402733101; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; GRAEBER MB, 2002, GREENFIELDS NEUROPAT, P123; Guo Q, 1998, NAT MED, V4, P957, DOI 10.1038/nm0898-957; Handler M, 2000, DEVELOPMENT, V127, P2593; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Ikonomidou C, 2001, BIOCHEM PHARMACOL, V62, P401, DOI 10.1016/S0006-2952(01)00696-7; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kim WY, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-2; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; Olney JW, 2000, APOPTOSIS, V5, P515, DOI 10.1023/A:1009685428847; Olney JW, 2001, MENT RETARD DEV D R, V7, P267, DOI 10.1002/mrdd.1037; Perry G, 1998, NAT MED, V4, P897, DOI 10.1038/nm0898-897; Perry G, 1998, SCIENCE, V282, P1268; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; Summers B, 1995, VET NEUROPATHOLOGY; Tabuchi K, 2009, J NEUROSCI, V29, P7290, DOI 10.1523/JNEUROSCI.1320-09.2009; Wines-Samuelson M, 2005, NEUROSCIENTIST, V11, P441, DOI 10.1177/1073858405278922; Wines-Samuelson M, 2005, DEV BIOL, V277, P332, DOI 10.1016/j.ydbio.2004.09.024; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Xu G, 2007, NEUROLOGY, V69, P1650, DOI 10.1212/01.wnl.0000296941.06685.22; Yu HK, 2000, GENESIS, V26, P5, DOI 10.1002/(SICI)1526-968X(200001)26:1<5::AID-GENE3>3.0.CO;2-8; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177	37	63	65	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10195	10.1371/journal.pone.0010195	http://dx.doi.org/10.1371/journal.pone.0010195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419112	Green Published, gold, Green Submitted			2022-12-25	WOS:000276707100011
J	Baltgalvis, KA; Greising, SM; Warren, GL; Lowe, DA				Baltgalvis, Kristen A.; Greising, Sarah M.; Warren, Gordon L.; Lowe, Dawn A.			Estrogen Regulates Estrogen Receptors and Antioxidant Gene Expression in Mouse Skeletal Muscle	PLOS ONE			English	Article							MESSENGER-RNA; CONTRACTILE FUNCTION; FEMALE MICE; ER-ALPHA; ESTRADIOL; BETA; OVARIECTOMY; CELLS; RAT; TISSUE	Background: Estrogens are associated with the loss of skeletal muscle strength in women with age. Ovarian hormone removal by ovariectomy in mice leads to a loss of muscle strength, which is reversed with 17 beta-estradiol replacement. Aging is also associated with an increase in antioxidant stress, and estrogens can improve antioxidant status via their interaction with estrogen receptors (ER) to regulate antioxidant gene expression. The purpose of this study was to determine if ER and antioxidant gene expression in skeletal muscle are responsive to changes in circulating estradiol, and if ERs regulate antioxidant gene expression in this tissue. Methodology/Principal Findings: Adult C57BL/6 mice underwent ovariectomies or sham surgeries to remove circulating estrogens. These mice were implanted with placebo or 17 beta-estradiol pellets acutely or chronically. A separate experiment examined mice that received weekly injections of Faslodex to chronically block ERs. Skeletal muscles were analyzed for expression of ER genes and proteins and antioxidant genes. ER alpha was the most abundant, followed by Gper and ER beta in both soleus and EDL muscles. The loss of estrogens through ovariectomy induced ER alpha gene and protein expression in the soleus, EDL, and TA muscles at both the acute and chronic time points. Gpx3 mRNA was also induced both acutely and chronically in all 3 muscles in mice receiving 17 beta-estradiol. When ERs were blocked using Faslodex, Gpx3 mRNA was downregulated in the soleus muscle, but not the EDL and TA muscles. Conclusions/Significance: These data suggest that Gpx3 and ER alpha gene expression are sensitive to circulating estrogens in skeletal muscle. ERs may regulate Gpx3 gene expression in the soleus muscle, but skeletal muscle regulation of Gpx3 via ERs is dependent upon muscle type. Further work is needed to determine the indirect effects of estrogen and ER alpha on Gpx3 expression in skeletal muscle, and their importance in the aging process.	[Baltgalvis, Kristen A.] Univ Minnesota, Sch Med, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Greising, Sarah M.; Lowe, Dawn A.] Univ Minnesota, Sch Med, Dept Phys Med & Rehabil, Minneapolis, MN 55455 USA; [Warren, Gordon L.] Georgia State Univ, Div Phys Therapy, Atlanta, GA 30303 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University System of Georgia; Georgia State University	Baltgalvis, KA (corresponding author), Univ Minnesota, Sch Med, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	baltg001@umn.edu	Warren, Gordon/A-9794-2008	Warren, Gordon/0000-0002-7073-8524; Lowe, Dawn/0000-0002-5784-9289	NIH [R01AG031743]; NATIONAL INSTITUTE ON AGING [R01AG031743, K02AG036827] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by a grant awarded to Dawn A. Lowe from the NIH (R01AG031743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boland R, 2008, STEROIDS, V73, P859, DOI 10.1016/j.steroids.2007.12.027; Brigelius-Flohe R, 2006, BIOL CHEM, V387, P1329, DOI 10.1515/BC.2006.166; Brown M, 2009, AM J PHYSIOL-ENDOC M, V296, pE854, DOI 10.1152/ajpendo.90696.2008; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Couse JF, 1997, ENDOCRINOLOGY, V138, P4613, DOI 10.1210/en.138.11.4613; Deroo BJ, 2004, ENDOCRINOLOGY, V145, P5485, DOI 10.1210/en.2004-0471; Dieli-Conwright CM, 2009, ACTA PHYSIOL, V197, P187, DOI 10.1111/j.1748-1716.2009.01997.x; Enns DL, 2008, ACTA PHYSIOL, V194, P81, DOI 10.1111/j.1748-1716.2008.01861.x; Galluzzo P, 2009, AM J PHYSIOL-CELL PH, V297, pC1249, DOI 10.1152/ajpcell.00188.2009; Gorzek JF, 2007, MED SCI SPORT EXER, V39, P248, DOI 10.1249/01.mss.0000241649.15006.b8; Greising SM, 2009, J GERONTOL A-BIOL, V64, P1071, DOI 10.1093/gerona/glp082; Gustafsson J A, 1984, Prog Clin Biol Res, V142, P261; Hansen PA, 1996, J APPL PHYSIOL, V80, P1605, DOI 10.1152/jappl.1996.80.5.1605; Hertrampf T, 2008, BRIT J PHARMACOL, V153, P1432, DOI 10.1038/sj.bjp.0707664; Isensee J, 2009, ENDOCRINOLOGY, V150, P1722, DOI 10.1210/en.2008-1488; Kamanga-Sollo E, 2008, DOMEST ANIM ENDOCRIN, V35, P254, DOI 10.1016/j.domaniend.2008.06.001; Lee YS, 2008, MOL ENDOCRINOL, V22, P2176, DOI 10.1210/me.2008-0023; Lemoine S, 2003, MED SCI SPORT EXER, V35, P439, DOI 10.1249/01.MSS.0000053654.14410.78; Lemoine S, 2002, ACTA PHYSIOL SCAND, V175, P211, DOI 10.1046/j.1365-201X.2002.00992.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundholm L, 2008, J ENDOCRINOL, V196, P547, DOI 10.1677/JOE-07-0277; McClung JM, 2006, J APPL PHYSIOL, V100, P2012, DOI 10.1152/japplphysiol.01583.2005; Milanesi L, 2008, J CELL BIOCHEM, V104, P1254, DOI 10.1002/jcb.21706; Milanesi L, 2009, STEROIDS, V74, P489, DOI 10.1016/j.steroids.2009.01.005; Mohamed MK, 2000, EUR J ENDOCRINOL, V142, P307, DOI 10.1530/eje.0.1420307; Moran AL, 2006, J APPL PHYSIOL, V100, P548, DOI 10.1152/japplphysiol.01029.2005; Moran AL, 2007, J APPL PHYSIOL, V102, P1387, DOI 10.1152/japplphysiol.01305.2006; Munoz-Castaneda JR, 2005, EUR J PHARMACOL, V523, P86, DOI 10.1016/j.ejphar.2005.08.056; Ogawa S, 2003, ENDOCRINOLOGY, V144, P230, DOI 10.1210/en.2002-220519; Owman C, 1996, BIOCHEM BIOPH RES CO, V228, P285, DOI 10.1006/bbrc.1996.1654; Papaconstantinou AD, 2000, TOXICOL SCI, V56, P332, DOI 10.1093/toxsci/56.2.332; Pedraza-Alva G, 2009, BIOCHEM BIOPH RES CO, V389, P360, DOI 10.1016/j.bbrc.2009.08.153; Pellegrino MA, 2003, J PHYSIOL-LONDON, V546, P677, DOI 10.1113/jphysiol.2002.027375; Prochniewicz E, 2008, AM J PHYSIOL-CELL PH, V294, pC613, DOI 10.1152/ajpcell.00232.2007; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; ROGERS NH, BIOCH BIOPHYS RES CO, V392, P1; Rogers NH, 2009, BIOCHEM BIOPH RES CO, V382, P646, DOI 10.1016/j.bbrc.2009.02.154; Ronkainen PHA, 2009, J APPL PHYSIOL, V107, P25, DOI 10.1152/japplphysiol.91518.2008; Rush JWE, 2003, CLIN BIOCHEM, V36, P345, DOI 10.1016/S0009-9120(03)00039-0; SAARTOK T, 1984, INT J SPORTS MED, V5, P130, DOI 10.1055/s-2008-1025894; Sen CK, 1999, MOL CELL BIOCHEM, V196, P31, DOI 10.1023/A:1006910011048; Sitnick M, 2006, J APPL PHYSIOL, V100, P286, DOI 10.1152/japplphysiol.00869.2005; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; THOMAS A, ACTA PHYSL OXF, V198, P81; Thompson LV, 2009, EXP GERONTOL, V44, P106, DOI 10.1016/j.exger.2008.05.003; Vasconsuelo A, 2008, J ENDOCRINOL, V196, P385, DOI 10.1677/JOE-07-0250; VINA J, 2005, SCI AGING KNOWLEDGE; WADE GN, 1993, AM J PHYSIOL, V265, pR1392, DOI 10.1152/ajpregu.1993.265.6.R1392; Warren GL, 1996, J APPL PHYSIOL, V80, P1660, DOI 10.1152/jappl.1996.80.5.1660; Wiik A, 2003, ACTA PHYSIOL SCAND, V179, P381, DOI 10.1046/j.0001-6772.2003.01186.x; Wiik A, 2005, HISTOCHEM CELL BIOL, V124, P161, DOI 10.1007/s00418-005-0030-z; Wiik A, 2009, HISTOCHEM CELL BIOL, V131, P181, DOI 10.1007/s00418-008-0512-x	52	108	112	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10164	10.1371/journal.pone.0010164	http://dx.doi.org/10.1371/journal.pone.0010164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405008	Green Submitted, Green Published, gold			2022-12-25	WOS:000276706300018
J	Jimenez-Guri, E; Udina, F; Colas, JF; Sharpe, J; Padron-Barthe, L; Torres, M; Pujades, C				Jimenez-Guri, Eva; Udina, Frederic; Colas, Jean-Francois; Sharpe, James; Padron-Barthe, Laura; Torres, Miguel; Pujades, Cristina			Clonal Analysis in Mice Underlines the Importance of Rhombomeric Boundaries in Cell Movement Restriction during Hindbrain Segmentation	PLOS ONE			English	Article							CHICK-EMBRYO HINDBRAIN; LINEAGE RESTRICTIONS; ZEBRAFISH; SPECIFICATION; DROSOPHILA	Background: Boundaries that prevent cell movement allow groups of cells to maintain their identity and follow independent developmental trajectories without the need for ongoing instructive signals from surrounding tissues. This is the case of vertebrate rhombomeric boundaries. Analysis in the developing chick hindbrain provided the first evidence that rhombomeres are units of cell lineage. The appearance of morphologically visible rhombomeres requires the segment restricted expression of a series of transcription factors, which position the boundaries and prefigure where morphological boundaries will be established. When the boundaries are established, when the cells are committed to a particular rhombomere and how they are organized within the hindbrain are important questions to our understanding of developmental regionalization. Methodology/Principal Findings: Sophisticated experimental tools with high-resolution analysis have allowed us to explore cell lineage restriction within the hindbrain in mouse embryos. This novel strategy is based on knock-in alleles of ubiquitous expression and allows unrestricted clonal analysis of cell lineage from the two-cell stage to the adult mouse. Combining this analysis with statistical and mathematical tools we show that there is lineage compartmentalization along the anteroposterior axis from very early stages of mouse embryonic development. Conclusions: Our results show that the compartment border coincides with the morphological boundary in the mouse hindbrain. The restriction of the cells to cross rhombomeric boundaries seen in chick is also observed in mouse. We show that the rhombomeric boundaries themselves are involved in cell movement restriction, although an underlying pre-pattern during early embryonic development might influence the way that cell populations organize.	[Jimenez-Guri, Eva; Pujades, Cristina] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain; [Jimenez-Guri, Eva; Pujades, Cristina] PRBB, Barcelona, Spain; [Udina, Frederic] Univ Pompeu Fabra, Dept Econ & Business, Barcelona, Spain; [Sharpe, James] CRG, EMBL, Syst Biol Res Unit, ICREA, Barcelona, Spain; [Padron-Barthe, Laura; Torres, Miguel] CNIC, Madrid, Spain	Pompeu Fabra University; Pompeu Fabra University; Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); ICREA; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Jimenez-Guri, E (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain.	cristina.pujades@upf.edu	Sharpe, James/L-1150-2014; Padron-Barthe, Laura/G-8897-2015; Sharpe, James/AAB-7948-2019; Torres, Miguel/A-7388-2013; Udina, Frederic/D-6772-2013; Torres, Miguel/CAG-0003-2022; Pujades, Cristina/F-7908-2014; udina, frederic/O-7572-2019	Sharpe, James/0000-0002-1434-9743; Padron-Barthe, Laura/0000-0002-7726-7761; Torres, Miguel/0000-0003-0906-4767; Udina, Frederic/0000-0002-7155-4153; Torres, Miguel/0000-0003-0906-4767; Pujades, Cristina/0000-0001-6423-7451; jimenez-guri, eva/0000-0002-9592-1077	MICINN, Spain [MTM2009-09063, BFU2007-62744/BMC, BFU2009-07010]; MADRICEL [S-SAL-0190-2006]; ICREA Funding Source: Custom; Medical Research Council [MC_U127574434] Funding Source: researchfish; MRC [MC_U127574434] Funding Source: UKRI	MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MADRICEL; ICREA(ICREA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	EJG was a recipient of a postdoctoral fellowship Beatriu de Pinos (Generalitat de Catalunya, Spain). The work was funded by MTM2009-09063 to FU, BFU2007-62744/BMC (MICINN, Spain) to JS, MADRICEL S-SAL-0190-2006 (Madrid Regional Government) to MT and BFU2009-07010 (MICINN, Spain) to CP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoyel M, 2005, DEVELOPMENT, V132, P775, DOI 10.1242/dev.01616; Aragon F, 2005, DEV DYNAM, V234, P567, DOI 10.1002/dvdy.20528; Arques CG, 2007, DEVELOPMENT, V134, P3713, DOI 10.1242/dev.02873; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; GUTHRIE S, 1991, J NEUROBIOL, V22, P742, DOI 10.1002/neu.480220709; Hastie T, 2011, GAM GEN ADDITIVE MOD; HASTIE TJ, 1990, GEN ADDITIVE; Kemp HA, 2009, DEV BIOL, V327, P313, DOI 10.1016/j.ydbio.2008.12.010; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; LAWRENCE PA, 1973, NATURE-NEW BIOL, V242, P31, DOI 10.1038/newbio242031a0; LUMSDEN A, 1991, PHILOS T R SOC B, V331, P281, DOI 10.1098/rstb.1991.0017; Moens CB, 2002, DEV DYNAM, V224, P1, DOI 10.1002/dvdy.10086; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; R Development Core Team, 2009, R FDN STAT COMP; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Trainor PA, 2001, CURR OPIN CELL BIOL, V13, P698, DOI 10.1016/S0955-0674(00)00273-8; WILKINSON DG, 1995, PERSPECT DEV NEUROBI, V3, P29; Wizenmann A, 1997, MOL CELL NEUROSCI, V9, P448, DOI 10.1006/mcne.1997.0642; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452	22	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10112	10.1371/journal.pone.0010112	http://dx.doi.org/10.1371/journal.pone.0010112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20404937	gold, Green Published, Green Submitted			2022-12-25	WOS:000276705900001
J	Yamamoto, Y; Moore, R; Flavell, RA; Lu, BF; Negishi, M				Yamamoto, Yukio; Moore, Rick; Flavell, Richard A.; Lu, Binfeng; Negishi, Masahiko			Nuclear Receptor CAR Represses TNF alpha-Induced Cell Death by Interacting with the Anti-Apoptotic GADD45B	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; CROSS-TALK; LIVER; GENE; ACTIVATION; MICE; METABOLISM; MKK7/JNKK2; INDUCTION	Background: Phenobarbital (PB) is the most well-known among numerous non-genotoxic carcinogens that cause the development of hepatocellular carcinoma (HCC). PB activates nuclear xenobiotic receptor Constitutive Active/Androstane Receptor ( CAR; NR1I3) and this activation is shown to determine PB promotion of HCC in mice. The molecular mechanism of CAR-mediated tumor promotion, however, remains elusive at the present time. Here we have identified Growth Arrest and DNA Damage-inducible 45 beta (GADD45B) as a novel CAR target, through which CAR represses cell death. Methodology/Principal Findings: PB activation of nuclear xenobiotic receptor CAR is found to induce the Gadd45b gene in mouse liver throughout the development of HCC as well as in liver tumors. Given the known function of GADD45B as a factor that represses Mitogen-activated protein Kinase Kinase 7 - c-Jun N-terminal Kinase (MKK7-JNK) pathway-mediated apoptosis, we have now demonstrated that CAR interacts with GADD45B to repress Tumor Necrosis Factor alpha (TNF alpha)-induced JNK1 phosphorylation as well as cell death. Primary hepatocytes, prepared from Car(+/+), Car(-/-), Gadd45b(+/+) and Gadd45b(-/-) mice, were treated with TNF alpha and Actinomycin D to induce phosphorylation of JNK1 and cell death. Co-treatment with the CAR activating ligand TCPOBOP (1,4 bis[2-(3,5-dichloropyridyloxy)]benzene) has resulted in repression of both phosphorylation and cell death in the primary hepatocytes from Car(+/+) but not Car(-/-) mice. Repression by TCPOBOP was not observed in those prepared from Gadd45b(-/-) mice. In vitro protein-protein interaction and phosphorylation assays have revealed that CAR interacts with MKK7 and represses the MKK7-mediated phosphorylation of JNK1. Conclusions/Significance: CAR can form a protein complex with GADD45B, through which CAR represses MKK7-mediated phosphorylation of JNK1. In addition to activating the Gadd45b gene, CAR may repress death of mouse primary hepatocytes by forming a GADD45B complex and repressing MKK7-mediated phosphorylation of JNK1. The present finding that CAR can repress cell death via its interaction with GADD45B provides an insight for further investigations into the CAR-regulated molecular mechanism by which PB promotes development of HCC.	[Yamamoto, Yukio; Moore, Rick; Negishi, Masahiko] Natl Inst Environm Hlth Sci, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC USA; [Flavell, Richard A.] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT USA; [Lu, Binfeng] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yamamoto, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Tokyo, Japan.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928; Yamamoto, Yukio/0000-0002-8530-0701	National Institutes of Health (NIH); National Institute of Environmental Health [Z01ES71005-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040, Z01ES071005] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health: Z01ES71005-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOLLAHI A, 1991, ONCOGENE, V6, P165; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Columbano A, 2005, HEPATOLOGY, V42, P1118, DOI 10.1002/hep.20883; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kobayashi K, 2003, MOL PHARMACOL, V64, P1069, DOI 10.1124/mol.64.5.1069; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004; Kodama S, 2007, BIOCHEM J, V407, P373, DOI 10.1042/BJ20070481; Ledda-Columbano GM, 2004, HEPATOLOGY, V40, P981, DOI 10.1002/hep.20403; LEIST M, 1994, J IMMUNOL, V153, P1778; Lu BF, 2004, NAT IMMUNOL, V5, P38, DOI 10.1038/ni1020; Nakamura K, 2007, J BIOL CHEM, V282, P9768, DOI 10.1074/jbc.M610072200; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Papa S, 2008, J CLIN INVEST, V118, P1911, DOI 10.1172/JCI33913; Papa S, 2007, J BIOL CHEM, V282, P19029, DOI 10.1074/jbc.M703112200; PEARCE D, 1993, SCIENCE, V259, P1161, DOI 10.1126/science.8382376; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; PITOT HC, 1978, NATURE, V271, P456, DOI 10.1038/271456a0; Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200; Rosenfeld JM, 2003, MOL ENDOCRINOL, V17, P1268, DOI 10.1210/me.2002-0421; SELVAKUMARAN M, 1994, BLOOD, V84, P1036; Shiraki T, 2003, J BIOL CHEM, V278, P11344, DOI 10.1074/jbc.M212859200; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; ZHAN QM, 1994, MOL CELL BIOL, V14, P2361, DOI 10.1128/MCB.14.4.2361	30	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10121	10.1371/journal.pone.0010121	http://dx.doi.org/10.1371/journal.pone.0010121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20404936	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000276705900006
J	Yi, H; Xue, L; Guo, MX; Ma, JA; Zeng, Y; Wang, W; Cai, JY; Hu, HM; Shu, HB; Shi, YB; Li, WX				Yi, Hong; Xue, Lu; Guo, Ming-Xiong; Ma, Jian; Zeng, Yan; Wang, Wei; Cai, Jin-Yang; Hu, Hai-Ming; Shu, Hong-Bing; Shi, Yun-Bo; Li, Wen-Xin			Gene expression atlas for human embryogenesis	FASEB JOURNAL			English	Article						human embryonic development; gene regulation database; organogenesis; microarrays; maternal genes	HUMAN OOCYTES; TRANSCRIPTOME; FEATURES; ZNF268	Human embryogenesis is believed to involve an integrated set of complex yet coordinated development of different organs and tissues mediated by the changes in the spatiotemporal expression of many genes. Here, we report a genome-wide expression analysis during wk 4-9 of human embryogenesis, a critical period when most organs develop. About half of all human genes are expressed, and 18.6% of the expressed genes were significantly regulated during this important period. We further identified >5000 regulated genes, most of which previously were not known to be associated with animal development. Our study fills an important gap in mammalian developmental studies by identifying functional pathways involved in this critical but previously not studied period. Our study also revealed that the genes involved here are distinct from those during early embryogenesis, which include three groups of maternal genes. Furthermore, we discovered that genes in a given developmental process are regulated coordinately. This led us to develop an easily searchable database of this entire collection of gene expression profiles, allowing for the identification new genes important for a particular developmental process/pathway and deducing the potential function of a novel gene. The validity of the predictions from the database was demonstrated with two examples through spatiotemporal analyses of the two novel genes. Such a database should serve as a highly valuable resource for the molecular analysis of human development and pathogenesis.-Yi, H., Xue, L., Guo, M.-X. Ma, J., Zeng, Y., Wang, W., Cai, J.-Y. Hu, H.-M., Shu, H.-B. Shi, Y.-B., Li, W.-X. Gene expression atlas for human embryogenesis. FASEB J. 24, 3341-3350 (2010). www.fasebj.org	[Li, Wen-Xin] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China; [Shi, Yun-Bo] NICHHD, Sect Mol Morphogenesis, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	Wuhan University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Li, WX (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China.	shi@helix.nih.gov; liwxlab@whu.edu.cn	Cai, Jinyang/HCH-0290-2022	Shi, Yun-Bo/0000-0002-6330-0639; Cai, Jinyang/0000-0002-7385-8281; Wang, Wei/0000-0001-7429-1013	National High Technology Research and Development Program of China (863 Program) [2006AA02A306]; National Natural Science Foundation of China [30871245]; Program of Introducing Talents of Discipline to Universities [B06018]; National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001901] Funding Source: NIH RePORTER	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National High Technology Research and Development Program of China (863 Program) grant 2006AA02A306, National Natural Science Foundation of China grant 30871245, Program of Introducing Talents of Discipline to Universities grant B06018. Y.-B. S. was supported by the National Institute of Child Health and Human Development Intramural Research Program, National Institutes of Health.	Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065; Bermudez M, 2004, REPROD BIOMED ONLINE, V8, P325, DOI 10.1016/S1472-6483(10)60913-3; Cai JL, 2005, HUM MOL GENET, V14, P903, DOI 10.1093/hmg/ddi083; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; DARBY IA, 2000, SITU HYBRIDIZATION P; Dobson AT, 2004, HUM MOL GENET, V13, P1461, DOI 10.1093/hmg/ddh157; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gaskell TL, 2004, BIOL REPROD, V71, P2012, DOI 10.1095/biolreprod.104.028381; Gou DM, 2001, GENE, V278, P141, DOI 10.1016/S0378-1119(01)00701-6; Gou DM, 2001, BBA-GENE STRUCT EXPR, V1518, P306, DOI 10.1016/S0167-4781(01)00194-4; Gu LH, 2007, CURR OPIN CELL BIOL, V19, P13, DOI 10.1016/j.ceb.2006.12.007; Guo MX, 2006, J BIOL CHEM, V281, P24623, DOI 10.1074/jbc.M602753200; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Hill MA, 2007, CLIN OBSTET GYNECOL, V50, P2, DOI 10.1097/GRF.0b013e31802f119d; Horsford DJ, 2005, DEVELOPMENT, V132, P177, DOI 10.1242/dev.01571; Kennedy BN, 2004, DEV BIOL, V270, P336, DOI 10.1016/j.ydbio.2004.02.026; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; Lee MLT, 2000, P NATL ACAD SCI USA, V97, P9834, DOI 10.1073/pnas.97.18.9834; Li SSL, 2006, BIOCHEM BIOPH RES CO, V340, P48, DOI 10.1016/j.bbrc.2005.11.149; Lindsay S, 2005, TRENDS GENET, V21, P586, DOI 10.1016/j.tig.2005.08.011; LIU B, 1996, HUMAN EMBRYOLOGY; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; Piper K, 2004, J ENDOCRINOL, V181, P11, DOI 10.1677/joe.0.1810011; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Sarma S, 2005, BRAIN RES BULL, V66, P449, DOI 10.1016/j.brainresbull.2005.05.022; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Wang YP, 2002, NAT NEUROSCI, V5, P831, DOI 10.1038/nn911; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	33	32	32	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3341	3350		10.1096/fj.10-158782	http://dx.doi.org/10.1096/fj.10-158782			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20430792	Green Published			2022-12-25	WOS:000281446400022
J	Dias, MVB; Huang, FL; Chirgadze, DY; Tosin, M; Spiteller, D; Dry, EFV; Leadlay, PF; Spencer, JB; Blundell, TL				Dias, Marcio V. B.; Huang, Fanglu; Chirgadze, Dimitri Y.; Tosin, Manuela; Spiteller, Dieter; Dry, Emily F. V.; Leadlay, Peter F.; Spencer, Jonathan B.; Blundell, Tom L.			Structural Basis for the Activity and Substrate Specificity of Fluoroacetyl-CoA Thioesterase FlK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; 4-HYDROXYBENZOYL-COA THIOESTERASE; FLUOROMETABOLITE BIOSYNTHESIS; FOLD; MECHANISM; ENZYME; ACID; IDENTIFICATION; FLUORINASE; INHIBITOR	The thioesterase FlK from the fluoroacetate-producing Streptomyces cattleya catalyzes the hydrolysis of fluoroacetyl-coenzyme A. This provides an effective self-defense mechanism, preventing any fluoroacetyl-coenzyme A formed from being further metabolized to 4-hydroxy-trans-aconitate, a lethal inhibitor of the tricarboxylic acid cycle. Remarkably, FlK does not accept acetyl-coenzyme A as a substrate. Crystal structure analysis shows that FlK forms a dimer, in which each subunit adopts a hot dog fold as observed for type II thioesterases. Unlike other type II thioesterases, which invariably utilize either an aspartate or a glutamate as catalytic base, we show by site-directed mutagenesis and crystallography that FlK employs a catalytic triad composed of Thr(42), His(76), and a water molecule, analogous to the Ser/Cys-His-acid triad of type I thioesterases. Structural comparison of FlK complexed with various substrate analogues suggests that the interaction between the fluorine of the substrate and the side chain of Arg(120) located opposite to the catalytic triad is essential for correct coordination of the substrate at the active site and therefore accounts for the substrate specificity.	[Huang, Fanglu; Tosin, Manuela; Dry, Emily F. V.; Spencer, Jonathan B.] Univ Cambridge, Univ Chem Lab, Cambridge CB2 1EW, England; [Dias, Marcio V. B.; Chirgadze, Dimitri Y.; Spiteller, Dieter; Leadlay, Peter F.; Blundell, Tom L.] Univ Cambridge, Dept Biochem, Cambridge CB2 1EW, England	University of Cambridge; University of Cambridge	Huang, FL (corresponding author), Univ Cambridge, Univ Chem Lab, Lensfield Rd, Cambridge CB2 1EW, England.	fh223@cam.ac.uk	Dias, Marcio/K-4610-2017	Leadlay, Peter/0000-0002-3247-509X; Tosin, Manuela/0000-0003-4340-9431; Dias, Marcio/0000-0002-5312-0191; Chirgadze, Dimitri/0000-0001-9942-0993	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Biotechnology and Biological Sciences Research Council [BBSB13357]; Wellcome Trust [079281/Z/06/Z]; Herchel Smith Fund	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Herchel Smith Fund	Recipient of a postdoctoral fellowship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.; Supported by Biotechnology and Biological Sciences Research Council Grant BBSB13357.; Supported by Wellcome Trust Programme Grant 079281/Z/06/Z.; Recipient of the Herchel Smith Fund Fellowship.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALLAIRE M, 1994, NATURE, V369, P72, DOI 10.1038/369072a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benning MM, 1998, J BIOL CHEM, V273, P33572, DOI 10.1074/jbc.273.50.33572; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng H, 2004, NAT PROD REP, V21, P773, DOI 10.1039/b415087m; Dillon SC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-109; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Dong CJ, 2004, NATURE, V427, P561, DOI 10.1038/nature02280; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Hisano T, 2003, J BIOL CHEM, V278, P617, DOI 10.1074/jbc.M205484200; Huang FL, 2006, CHEM BIOL, V13, P475, DOI 10.1016/j.chembiol.2006.02.014; KUHL PW, 1994, BIOCHEM J, V298, P171, DOI 10.1042/bj2980171; Kunishima N, 2005, J MOL BIOL, V352, P212, DOI 10.1016/j.jmb.2005.07.008; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lauble H, 1996, P NATL ACAD SCI USA, V93, P13699, DOI 10.1073/pnas.93.24.13699; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li J, 2000, NAT STRUCT BIOL, V7, P555; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; O'Hagan D, 2002, NATURE, V416, P279, DOI 10.1038/416279a; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PETERS R, 1953, PROC R SOC SER B-BIO, V140, P497, DOI 10.1098/rspb.1953.0004; Pidugu LS, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-37; Pleiss J, 1998, CHEM PHYS LIPIDS, V93, P67, DOI 10.1016/S0009-3084(98)00030-9; SANADA M, 1986, J ANTIBIOT, V39, P259, DOI 10.7164/antibiotics.39.259; Schaffrath C, 2003, FEBS LETT, V547, P111, DOI 10.1016/S0014-5793(03)00688-4; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Song F, 2006, J BIOL CHEM, V281, P11028, DOI 10.1074/jbc.M513896200; Thoden JB, 2003, J BIOL CHEM, V278, P43709, DOI 10.1074/jbc.M308198200; Wang F, 2007, CHEM BIOL, V14, P543, DOI 10.1016/j.chembiol.2007.04.005; Willis MA, 2008, BIOCHEMISTRY-US, V47, P2797, DOI 10.1021/bi702336d; Yokoyama T, 2009, BBA-PROTEINS PROTEOM, V1794, P1073, DOI 10.1016/j.bbapap.2009.03.002; Zhu XF, 2007, J AM CHEM SOC, V129, P14597, DOI 10.1021/ja0731569	39	21	22	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22495	22504		10.1074/jbc.M110.107177	http://dx.doi.org/10.1074/jbc.M110.107177			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20430898	Green Published, hybrid			2022-12-25	WOS:000279702200061
J	Doi, R; Oishi, K; Ishida, N				Doi, Ryosuke; Oishi, Katsutaka; Ishida, Norio			CLOCK Regulates Circadian Rhythms of Hepatic Glycogen Synthesis through Transcriptional Activation of Gys2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; MOLECULAR ANALYSIS; TARGET GENE; PPAR-ALPHA; MOUSE; LIVER; METABOLISM; SYNTHASE; MICE; INSULIN	Hepatic glycogen content is important for glucose homeostasis and exhibits robust circadian rhythms that peak at the end of the active phase in mammals. The activities of the rate-limiting enzymes for glycogenesis and glycogenolysis also show circadian rhythms, and the balance between them forms the circadian rhythm of the hepatic glycogen content. However, no direct evidence has yet implicated the circadian clock in the regulation of glycogen metabolism at the molecular level. We show here that a Clock gene mutation damps the circadian rhythm of the hepatic glycogen content, as well as the circadian mRNA and protein expression of Gys2 (glycogen synthase 2), which is the rate-limiting enzyme of glycogenesis in the liver. Transient reporter assays revealed that CLOCK drives the transcriptional activation of Gys2 via two tandemly located E-boxes. Chromatin immunoprecipitation assays of liver tissues revealed that CLOCK binds to these E-box elements in vivo, and real time reporter assays showed that these elements are sufficient for circadian Gys2 expression in vitro. Thus, CLOCK regulates the circadian rhythms of hepatic glycogen synthesis through transcriptional activation of Gys2.	[Oishi, Katsutaka] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Biol Clock Res Grp, Tsukuba, Ibaraki 3058566, Japan; [Doi, Ryosuke; Ishida, Norio] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Ishida Grp Clock Gene, Tsukuba, Ibaraki 3058566, Japan; [Doi, Ryosuke; Ishida, Norio] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 058572, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Oishi, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Biol Clock Res Grp, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	k-ooishi@aist.go.jp; n.ishida@aist.go.jp	; Oishi, Katsutaka/L-6906-2018	DOI, RYOSUKE/0000-0002-1725-2082; Oishi, Katsutaka/0000-0002-4870-0837	Ministry of Education, Culture, Sports, Science and Technology of Japan [18770057]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Young Scientists (B) 18770057 (to K.O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Allaman-Pillet N, 2004, MOL CELL ENDOCRINOL, V226, P59, DOI 10.1016/j.mce.2004.06.001; Ando H, 2009, CLIN EXP HYPERTENS, V31, P201, DOI 10.1080/10641960902822450; Bandsma RHJ, 2004, J BIOL CHEM, V279, P8930, DOI 10.1074/jbc.M310067200; Bertolucci C, 2008, MOL CELL BIOL, V28, P3070, DOI 10.1128/MCB.01931-07; Bollen M, 1998, BIOCHEM J, V336, P19, DOI 10.1042/bj3360019; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; BRYSON JM, 1993, BIOCHEM J, V295, P731, DOI 10.1042/bj2950731; Burcelin R, 2000, J BIOL CHEM, V275, P10930, DOI 10.1074/jbc.275.15.10930; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Ferrer JC, 2003, FEBS LETT, V546, P127, DOI 10.1016/S0014-5793(03)00565-9; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; ISHIKAWA K, 1976, LIFE SCI, V19, P1873, DOI 10.1016/0024-3205(76)90119-3; Kadotani A, 2007, ARCH BIOCHEM BIOPHYS, V466, P283, DOI 10.1016/j.abb.2007.08.006; KASLOW HR, 1985, J BIOL CHEM, V260, P9953; Kennaway DJ, 2007, AM J PHYSIOL-REG I, V293, pR1528, DOI 10.1152/ajpregu.00018.2007; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kobayashi Y, 2000, GENES CELLS, V5, P725, DOI 10.1046/j.1365-2443.2000.00364.x; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Kudo Takashi, 2009, J Circadian Rhythms, V7, P4, DOI 10.1186/1740-3391-7-4; Kumaki Y, 2008, P NATL ACAD SCI USA, V105, P14946, DOI 10.1073/pnas.0802636105; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Mandard S, 2007, CELL MOL LIFE SCI, V64, P1145, DOI 10.1007/s00018-007-7006-1; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; OBRIEN RM, 1990, DIABETES CARE, V13, P327, DOI 10.2337/diacare.13.3.327; Ohno T, 2007, NUCLEIC ACIDS RES, V35, P648, DOI 10.1093/nar/gkl868; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Oishi K, 2002, BIOCHEM BIOPH RES CO, V298, P198, DOI 10.1016/S0006-291X(02)02427-0; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pando MP, 2001, NATURE, V410, P311, DOI 10.1038/35066655; Radziuk J, 2001, DIABETES-METAB RES, V17, P250, DOI 10.1002/dmrr.217; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sakamoto K, 1998, J BIOL CHEM, V273, P27039, DOI 10.1074/jbc.273.42.27039; Tsuchiya Y, 2003, GENES CELLS, V8, P713, DOI 10.1046/j.1365-2443.2003.00669.x; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102	45	91	100	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22114	22121		10.1074/jbc.M110.110361	http://dx.doi.org/10.1074/jbc.M110.110361			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20430893	hybrid, Green Published			2022-12-25	WOS:000279702200024
J	Ekanayake, DK; Andi, B; Bobyk, KD; West, AH; Cook, PF				Ekanayake, Devi K.; Andi, Babak; Bobyk, Kostyantyn D.; West, Ann H.; Cook, Paul F.			Glutamates 78 and 122 in the Active Site of Saccharopine Dehydrogenase Contribute to Reactant Binding and Modulate the Basicity of the Acid-Base Catalysts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMINOADIPATE PATHWAY; LYSINE BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; ENZYME; FUNGI; AUXOTROPHS; MECHANISM	Saccharopine dehydrogenase catalyzes the NAD-dependent oxidative deamination of saccharopine to give L-lysine and alpha-ketoglutarate. There are a number of conserved hydrophilic, ionizable residues in the active site, all of which must be important to the overall reaction. In an attempt to determine the contribution to binding and rate enhancement of each of the residues in the active site, mutations at each residue are being made, and double mutants are being made to estimate the interrelationship between residues. Here, we report the effects of mutations of active site glutamate residues, Glu(78) and Glu(122), on reactant binding and catalysis. Site-directed mutagenesis was used to generate E78Q, E122Q, E78Q/E122Q, E78A, E122A, and E78A/E122A mutant enzymes. Mutation of these residues increases the positive charge of the active site and is expected to affect the pK(a) values of the catalytic groups. Each mutant enzyme was completely characterized with respect to its kinetic and chemical mechanism. The kinetic mechanism remains the same as that of wild type enzymes for all of the mutant enzymes, with the exception of E78A, which exhibits binding of alpha-ketoglutarate to E and E.NADH. Large changes in V/K-Lys, but not V, suggest that Glu(78) and Glu(122) contribute binding energy for lysine. Shifts of more than a pH unit to higher and lower pH of the pK(a) values observed in the V/K-Lys pH-rate profile of the mutant enzymes suggests that the presence of Glu(78) and Glu(122) modulates the basicity of the catalytic groups.	[Ekanayake, Devi K.; Andi, Babak; Bobyk, Kostyantyn D.; West, Ann H.; Cook, Paul F.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Cook, PF (corresponding author), Univ Oklahoma, Dept Chem & Biochem, 620 Parrington Oval, Norman, OK 73019 USA.	pcook@ou.edu		Andi, Babak/0000-0002-7666-639X	National Institutes of Health [GM071417]; Grayce B. Kerr Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grayce B. Kerr Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071417 (to P. F. C. and A. H. W.). This work was also supported by the Grayce B. Kerr Endowment to the University of Oklahoma (for P. F. C.).	Andi B, 2007, BIOCHEMISTRY-US, V46, P12512, DOI 10.1021/bi701428m; BHATTACHARJEE JK, 1985, CRC CR REV MICROBIOL, V12, P131, DOI 10.3109/10408418509104427; BISHOP CM, 1995, NEURAL NETWORKS PATT, P290; BRADFORD MM, 1976, FED PROC, V35, P274; Burk DL, 2007, J MOL BIOL, V373, P745, DOI 10.1016/j.jmb.2007.08.044; Chen YI, 2003, BIOCHEM J, V374, P633, DOI 10.1042/BJ20030268; Cleland W W, 1979, Methods Enzymol, V63, P103; Cook P. F., 2007, ENZYME KINETICS MECH; DeLano WL, 2004, PYMOL MOL GRAPHICS S; GARRAD RC, 1992, J BACTERIOL, V174, P7379, DOI 10.1128/jb.174.22.7379-7384.1992; Johansson E, 2000, STRUCTURE, V8, P1037, DOI 10.1016/S0969-2126(00)00512-8; KLINMAN JP, 1985, J AM CHEM SOC, V107, P1058, DOI 10.1021/ja00290a052; OGAWA H, 1978, J BIOL CHEM, V253, P3666; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; VIOLA RE, 1979, ANAL BIOCHEM, V96, P334, DOI 10.1016/0003-2697(79)90590-6; Xu HY, 2007, BIOCHEMISTRY-US, V46, P871, DOI 10.1021/bi061980o; Xu HY, 2006, BIOCHEMISTRY-US, V45, P12156, DOI 10.1021/bi0610808; Xu HY, 2006, CELL BIOCHEM BIOPHYS, V46, P43, DOI 10.1385/CBB:46:1:43; YE ZH, 1988, J BACTERIOL, V170, P5968, DOI 10.1128/jb.170.12.5968-5970.1988; Zabriskie TM, 2000, NAT PROD REP, V17, P85, DOI 10.1039/a801345d	20	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20756	20768		10.1074/jbc.M110.119826	http://dx.doi.org/10.1074/jbc.M110.119826			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20427272	Green Published, hybrid			2022-12-25	WOS:000279228600040
J	Bergstrom, R; Savary, K; Moren, A; Guibert, S; Heldin, CH; Ohlsson, R; Moustakas, A				Bergstrom, Rosita; Savary, Katia; Moren, Anita; Guibert, Sylvain; Heldin, Carl-Henrik; Ohlsson, Rolf; Moustakas, Aristidis			Transforming Growth Factor beta Promotes Complexes between Smad Proteins and the CCCTC-binding Factor on the H19 Imprinting Control Region Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; MH1 DOMAIN; CTCF; METHYLATION; GENOME; GENE; DNA; TRANSCRIPTION; REPLICATION; ASSOCIATION	Whether signal transduction pathways regulate epigenetic states in response to environmental cues remains poorly understood. We demonstrate here that Smad3, signaling downstream of transforming growth factor beta, interacts with the zinc finger domain of CCCTC-binding factor (CTCF), a nuclear protein known to act as "the master weaver of the genome." This interaction occurs via the Mad homology 1 domain of Smad3. Although Smad2 and Smad4 fail to interact, an alternatively spliced form of Smad2 lacking exon 3 interacts with CTCF. CTCF does not perturb well established transforming growth factor beta gene responses. However, Smads and CTCF co-localize to the H19 imprinting control region (ICR), which emerges as an insulator in cis and regulator of transcription and replication in trans via direct CTCF binding to the ICR. Smad recruitment to the ICR requires intact CTCF binding to this locus. Smad2/3 binding to the ICR requires Smad4, which potentially provides stability to the complex. Because the CTCF-Smad complex is not essential for the chromatin insulator function of the H19 ICR, we propose that it can play a role in chromatin cross-talk organized by the H19 ICR.	[Bergstrom, Rosita; Savary, Katia; Moren, Anita; Heldin, Carl-Henrik; Moustakas, Aristidis] Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, SE-75124 Uppsala, Sweden; [Bergstrom, Rosita; Guibert, Sylvain; Ohlsson, Rolf] Uppsala Univ, Dept Genet & Dev, Evolut Biol Ctr, SE-75236 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University; Uppsala University	Ohlsson, R (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Nobels Vag 16,Box 280, SE-17177 Stockholm, Sweden.	rolf.ohlsson@ki.se; aris.moustakas@licr.uu.se			Ludwig Institute for Cancer Research; Swedish Cancer Society [4855-B03-01XAC]; Natural Sciences Foundation of Sweden [K2004-32XD-14936-01A]; Swedish Science Research Council; Swedish Pediatric Cancer Foundation; Lundberg Foundation; HEROIC European Union	Ludwig Institute for Cancer Research; Swedish Cancer Society(Swedish Cancer Society); Natural Sciences Foundation of Sweden; Swedish Science Research Council; Swedish Pediatric Cancer Foundation; Lundberg Foundation(European Commission); HEROIC European Union	This work was supported by grants from the Ludwig Institute for Cancer Research, Swedish Cancer Society Project 4855-B03-01XAC, and Natural Sciences Foundation of Sweden Project K2004-32XD-14936-01A (to A. M.) and grants from the Swedish Science Research Council, the Swedish Cancer Society, the Swedish Pediatric Cancer Foundation, the Lundberg Foundation, and the HEROIC European Union integrated project (to R.O.).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bergstrom R, 2007, CELL CYCLE, V6, P450, DOI 10.4161/cc.6.4.3854; Burton T, 2002, BIOCHEM BIOPH RES CO, V295, P713, DOI 10.1016/S0006-291X(02)00725-8; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dean W, 1998, DEVELOPMENT, V125, P2273; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dennler S, 1999, ONCOGENE, V18, P1643, DOI 10.1038/sj.onc.1202729; Gondor A, 2009, NATURE, V461, P212, DOI 10.1038/nature08453; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kanduri C, 2002, J BIOL CHEM, V277, P18106, DOI 10.1074/jbc.M200031200; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Kurisaki K, 2003, MOL CELL BIOL, V23, P4494, DOI 10.1128/MCB.23.13.4494-4510.2003; Lutz M, 2000, NUCLEIC ACIDS RES, V28, P1707, DOI 10.1093/nar/28.8.1707; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Moren A, 2003, J BIOL CHEM, V278, P33571, DOI 10.1074/jbc.M300159200; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Ohlsson R, 2001, TRENDS GENET, V17, P136, DOI 10.1016/S0168-9525(00)02211-3; Ohlsson R, 2010, BIOESSAYS, V32, P37, DOI 10.1002/bies.200900118; Pant V, 2004, MOL CELL BIOL, V24, P3497, DOI 10.1128/MCB.24.8.3497-3504.2004; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Smith ST, 2009, DEV BIOL, V328, P518, DOI 10.1016/j.ydbio.2008.12.039; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Xu GX, 2002, BIOCHEM BIOPH RES CO, V294, P1079, DOI 10.1016/S0006-291X(02)00605-8; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	38	26	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19727	19737		10.1074/jbc.M109.088385	http://dx.doi.org/10.1074/jbc.M109.088385			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427289	hybrid, Green Published			2022-12-25	WOS:000279012000005
J	Daher, W; Pierrot, C; Kalamou, H; Pinder, JC; Margos, G; Dive, D; Franke-Fayard, B; Janse, CJ; Khalife, J				Daher, Wassim; Pierrot, Christine; Kalamou, Hadidjatou; Pinder, Jennifer C.; Margos, Gabriele; Dive, Daniel; Franke-Fayard, Blandine; Janse, Chris J.; Khalife, Jamal			Plasmodium falciparum Dynein Light Chain 1 Interacts with Actin/Myosin during Blood Stage Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH REPEAT PROTEIN; OUTER ARM DYNEIN; MALARIA PARASITES; MOLECULAR MOTOR; TOXOPLASMA-GONDII; CELL INVASION; LIFE-CYCLE; XIV MYOSIN; ACTIN; IDENTIFICATION	Dynein light chain 1 (LC1), a member of the leucine-rich repeat protein family, has been shown to be engaged in controlling flagellar motility in Chlamydomonas reinhardtii and Trypanosoma brucei via its interaction with the dynein gamma heavy chain. In Plasmodium falciparum, we have identified the LC1 ortholog, designated Pfdlc1. Negative attempts to disrupt the dlc1 gene by reverse genetic approaches in both P. falciparum and P. berghei suggest either its essentiality for parasite survival or the inaccessibility of its locus. Expression studies revealed high levels of DLC1 protein in late trophozoites and schizonts, pointing to an unexpected role of this protein in blood-stage parasites as they do not have flagella. Interactions studies and co-immunoprecipitation experiments revealed that PfDLC1 was able to bind to P. falciparum myosin A and actin 1. The PfDLC1 interacting domains present in P. falciparum myosin A and actin 1 were mapped to sequences containing SDIE and/or EEMKT motifs present in the upper 50-kDa segment of the myosin A head domain and in the subdomain IV of actin 1, respectively. Detection of PfDLC1 by fluorescence tagging and immunofluorescence staining using specific antibodies showed a cytoplasmic location similar to actin and immunofluorescence studies showed a co-localization of PfDLC1 and myosin A. Taken together, these findings suggest that PfDLC1 might play an important role in P. falciparum erythrocytic stages by its interaction with myosin A and actin 1, known to be essential for parasite development.	[Khalife, Jamal] Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun Lille, INSERM,U1019,CNRS,UMR 8204, F-59019 Lille, France; [Khalife, Jamal] Univ Lille Nord France, Inst Pasteur Lille, CNRS, INSERM,U547,UMR 8204, F-59019 Lille, France; [Pinder, Jennifer C.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Margos, Gabriele] Kings Coll London, Sch Med, Dept Immunobiol, Guys Hosp, London SE1 9RT, England; [Margos, Gabriele] Kings Coll London, Sch Med, Dept Immunobiol, Univ London Kings Coll Hosp, London SE1 9RT, England; [Margos, Gabriele] Kings Coll London, Sch Med, Dept Immunobiol, St Thomas Hosp, London SE1 9RT, England; [Franke-Fayard, Blandine; Janse, Chris J.] Leiden Univ, Med Ctr, Ctr Infect Dis, Dept Parasitol,Leiden Malaria Res Grp, NL-2300 RC Leiden, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Khalife, J (corresponding author), Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun Lille, INSERM,U1019,CNRS,UMR 8204, 1 Rue Prof Calmette, F-59019 Lille, France.	jamal.khalife@pasteur-lille.fr	DAHER, Wassim/AAB-6720-2019; Khalife, Jamal/AAZ-2833-2020; DAHER, Wassim/M-7166-2017	DAHER, Wassim/0000-0001-9026-5333; DAHER, Wassim/0000-0001-9026-5333; Khalife, Jamal/0000-0002-4359-8976; MARGOS, Gabriele/0000-0001-5304-9615; Pierrot, Christine/0000-0002-6835-6789; Janse, Chris J/0000-0002-6410-6205; , Blandine/0000-0001-6041-4182	INSERM; Institut Pasteur de Lille; Universite Lille Nord de France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Pasteur de Lille; Universite Lille Nord de France	This work was supported by INSERM, Institut Pasteur de Lille, and Universite Lille Nord de France.	Augustijn KD, 2007, INFECT IMMUN, V75, P1116, DOI 10.1128/IAI.00902-06; Baron DM, 2007, J CELL SCI, V120, P1513, DOI 10.1242/jcs.004846; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Baum J, 2008, CELL HOST MICROBE, V3, P188, DOI 10.1016/j.chom.2008.02.006; Benashski SE, 1999, BIOCHEMISTRY-US, V38, P7253, DOI 10.1021/bi990466y; Chaparro-Olaya J, 2005, CELL MOTIL CYTOSKEL, V60, P200, DOI 10.1002/cm.20055; Daher W, 2006, MOL MICROBIOL, V60, P578, DOI 10.1111/j.1365-2958.2006.05119.x; Daher W, 2007, MOL BIOCHEM PARASIT, V155, P161, DOI 10.1016/j.molbiopara.2007.07.001; Daher W, 2009, CURR OPIN MICROBIOL, V12, P408, DOI 10.1016/j.mib.2009.06.008; de Koning-Ward TF, 2009, TRENDS PARASITOL, V25, P4, DOI 10.1016/j.pt.2008.09.009; de Koning-Ward TF, 2000, ANNU REV MICROBIOL, V54, P157, DOI 10.1146/annurev.micro.54.1.157; Downing KH, 2007, CURR OPIN STRUC BIOL, V17, P253, DOI 10.1016/j.sbi.2007.03.013; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fowler RE, 2001, MOL BIOCHEM PARASIT, V117, P187, DOI 10.1016/S0166-6851(01)00351-6; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Gilk SD, 2009, EUKARYOT CELL, V8, P190, DOI 10.1128/EC.00201-08; GINSBURG H, 1987, ANN PARASIT HUM COMP, V62, P418, DOI 10.1051/parasite/1987625418; Githui EK, 2009, INFECT GENET EVOL, V9, P337, DOI 10.1016/j.meegid.2008.03.002; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; HOLZBAUR ELF, 1994, ANNU REV CELL BIOL, V10, P339, DOI 10.1146/annurev.cb.10.110194.002011; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Johnson TM, 2007, MOL BIOL CELL, V18, P3039, DOI 10.1091/mbc.E07-01-0040; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KAGAMI O, 1992, J CELL SCI, V103, P653; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; KING SM, 1995, J CELL SCI, V108, P3757; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; LEDIZET M, 1995, MOL BIOL CELL, V6, P697, DOI 10.1091/mbc.6.6.697; Menard R, 1997, METHODS, V13, P148, DOI 10.1006/meth.1997.0507; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; MOHANTY JG, 1989, COMP IMMUNOL MICROB, V12, P153, DOI 10.1016/0147-9571(89)90064-7; Patel-King RS, 2009, J CELL BIOL, V186, P283, DOI 10.1083/jcb.200905083; Pierrot C, 2006, INFECT IMMUN, V74, P3347, DOI 10.1128/IAI.01724-05; Pinder JC, 1998, J CELL SCI, V111, P1831; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Saeki K, 2000, BIOCHEM BIOPH RES CO, V275, P428, DOI 10.1006/bbrc.2000.3321; Santos JM, 2009, INT J PARASITOL, V39, P153, DOI 10.1016/j.ijpara.2008.10.007; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Smythe WA, 2008, CELL MICROBIOL, V10, P452, DOI 10.1111/j.1462-5822.2007.01058.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; UMLAS J, 1971, AM J TROP MED HYG, V20, P527, DOI 10.4269/ajtmh.1971.20.527; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VERNES A, 1984, AM J TROP MED HYG, V33, P197, DOI 10.4269/ajtmh.1984.33.197; Waters AP, 1997, METHODS, V13, P134, DOI 10.1006/meth.1997.0506; Wu HW, 2000, NAT STRUCT BIOL, V7, P575	49	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20180	20191		10.1074/jbc.M110.102806	http://dx.doi.org/10.1074/jbc.M110.102806			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20421304	Green Published, hybrid			2022-12-25	WOS:000279012000053
J	Erlich, P; Dumestre-Perard, C; Ling, WL; Lemaire-Vieille, C; Schoehn, G; Arlaud, GJ; Thielens, NM; Gagnon, J; Cesbron, JY				Erlich, Paul; Dumestre-Perard, Chantal; Ling, Wai Li; Lemaire-Vieille, Catherine; Schoehn, Guy; Arlaud, Gerard J.; Thielens, Nicole M.; Gagnon, Jean; Cesbron, Jean-Yves			Complement Protein C1q Forms a Complex with Cytotoxic Prion Protein Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRILS; SOLUBLE OLIGOMERS; TERMINAL DOMAIN; BETA; ACTIVATION; COMPONENT; BINDING; CONVERSION; PATHWAY; CASCADE	A growing number of studies have investigated the interaction between C1q and PrP, but the oligomeric form of PrP involved in this interaction remains to be determined. Aggregation of recombinant full-length murine PrP in the presence of 100 mM NaCl allowed us to isolate three different types of oligomers by size-exclusion chromatography. In contrast to PrP monomers and fibrils, these oligomers activate the classical complement pathway, the smallest species containing 8-15 PrP protomers being the most efficient. We used Thioflavine T fluorescence to monitor PrP aggregation and showed that, when added to the reaction, C1q has a cooperative effect on PrP aggregation and leads to the formation of C1q-PrP complexes. In these complexes, C1q interacts through its globular domains preferentially with the smallest oligomers, as shown by electron microscopy, and retains the ability to activate the classical complement pathway. Using two cell lines, we also provide evidence that C1q inhibits the cytotoxicity induced by the smallest PrP oligomers. The cooperative interaction between C1q and PrP could represent an early step in the disease, where it prevents elimination of the prion seed, leading to further aggregation.	[Cesbron, Jean-Yves] Univ Grenoble 1, Lab Adaptat & Pathogenie Microorganisme, UMR 5163, F-38042 Grenoble 9, France; [Erlich, Paul; Dumestre-Perard, Chantal; Lemaire-Vieille, Catherine; Gagnon, Jean; Cesbron, Jean-Yves] CNRS, UMR 5163, F-38042 Grenoble 9, France; [Dumestre-Perard, Chantal; Cesbron, Jean-Yves] CHU Grenoble, Dept Biol, Immunol Lab, F-38043 Grenoble 9, France; [Ling, Wai Li; Schoehn, Guy; Arlaud, Gerard J.; Thielens, Nicole M.] Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble 9, France; [Ling, Wai Li; Schoehn, Guy; Arlaud, Gerard J.; Thielens, Nicole M.] CNRS, UMR 5075, F-38042 Grenoble 9, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Cesbron, JY (corresponding author), Univ Grenoble 1, Lab Adaptat & Pathogenie Microorganisme, UMR 5163, F-38042 Grenoble 9, France.	jean-yves.cesbron@ujf-grenoble.fr	Thielens, Nicole M/F-2512-2013; Gagnon, Jean/C-3136-2008; Ling, Wai Li W/F-9823-2012; Lemaire-Vieille, Catherine/C-1495-2009	Thielens, Nicole M/0000-0002-7354-0302; Gagnon, Jean/0000-0002-0177-824X; Ling, Wai Li W/0000-0002-4264-5750; Schoehn, Guy/0000-0002-1459-3201				ARLAUD GJ, 1979, MOL IMMUNOL, V16, P445, DOI 10.1016/0161-5890(79)90069-5; Bailly Y, 2004, J COMP NEUROL, V473, P244, DOI 10.1002/cne.20117; Baskakov IV, 2009, FEBS LETT, V583, P2618, DOI 10.1016/j.febslet.2009.05.044; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2005, BIOCHEMISTRY-US, V44, P2339, DOI 10.1021/bi048322t; Biro A, 2007, MOL IMMUNOL, V44, P1169, DOI 10.1016/j.molimm.2006.06.013; Blanquet-Grossard F, 2005, BIOCHEMISTRY-US, V44, P4349, DOI 10.1021/bi047370a; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Carrell RW, 2008, FEBS LETT, V582, P2537, DOI 10.1016/j.febslet.2008.06.021; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Dumestre-Perard C, 2007, CELL MICROBIOL, V9, P2870, DOI 10.1111/j.1462-5822.2007.01002.x; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Erlich P, 2008, BIOCHEM BIOPH RES CO, V365, P478, DOI 10.1016/j.bbrc.2007.10.202; Flores-Langarica A, 2009, J IMMUNOL, V182, P1305, DOI 10.4049/jimmunol.182.3.1305; Fourgeaud L, 2007, CELL, V131, P1034, DOI 10.1016/j.cell.2007.11.031; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Gehlenborg N, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap011; Graham JF, 2010, J BIOL CHEM, V285, P9868, DOI 10.1074/jbc.M109.093484; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Jain S, 2008, J MOL BIOL, V382, P1228, DOI 10.1016/j.jmb.2008.07.052; Kazlauskaite J, 2005, BIOCHEM BIOPH RES CO, V328, P292, DOI 10.1016/j.bbrc.2004.12.172; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Perry VH, 2008, NAT REV NEUROSCI, V9, P807, DOI 10.1038/nrn2394; Pisalyaput K, 2008, J NEUROCHEM, V104, P696, DOI 10.1111/j.1471-4159.2007.05012.x; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; REID KBM, 1976, BIOCHEM J, V155, P19, DOI 10.1042/bj1550019; Rezaei H, 2005, J MOL BIOL, V347, P665, DOI 10.1016/j.jmb.2005.01.043; Rezaei H, 2008, CURR ALZHEIMER RES, V5, P572, DOI 10.2174/156720508786898497; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Shin TM, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-16; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sim RB, 2007, IMMUNOBIOLOGY, V212, P355, DOI 10.1016/j.imbio.2007.04.001; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Sjoberg AP, 2008, MOL IMMUNOL, V45, P3213, DOI 10.1016/j.molimm.2008.02.023; Sorgjerd K, 2008, BIOCHEM BIOPH RES CO, V377, P1072, DOI 10.1016/j.bbrc.2008.10.121; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tacnet-Delorme P, 2001, J IMMUNOL, V167, P6374, DOI 10.4049/jimmunol.167.11.6374; Valazquez P, 1997, NAT MED, V3, P77, DOI 10.1038/nm0197-77; Vendrely C, 2005, BBA-GEN SUBJECTS, V1724, P355, DOI 10.1016/j.bbagen.2005.05.017	44	22	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19267	19276		10.1074/jbc.M109.071860	http://dx.doi.org/10.1074/jbc.M109.071860			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410306	Green Published, hybrid			2022-12-25	WOS:000278727800036
J	Ji, P; Smith, SM; Wang, Y; Jiang, R; Song, SW; Li, B; Sawaya, R; Bruner, JM; Kuang, J; Yu, H; Fuller, GN; Zhang, W				Ji, P.; Smith, S. M.; Wang, Y.; Jiang, R.; Song, S. W.; Li, B.; Sawaya, R.; Bruner, J. M.; Kuang, J.; Yu, H.; Fuller, G. N.; Zhang, W.			Inhibition of gliomagenesis and attenuation of mitotic transition by MIIP	ONCOGENE			English	Article						MIIP; mitotic transition; gliomagenesis; APC/C(Cdc20); centrosome; mitotic catastrophe	ANAPHASE-PROMOTING COMPLEX; PRIMARY BRAIN-TUMORS; CELL-MIGRATION; SPINDLE CHECKPOINT; CYCLIN-B; CDC20; GLIOMA; DESTRUCTION; DEGRADATION; INVASION	The migration and invasion inhibitor protein (MIIP, also known as IIp45) was discovered as a negative regulator of cell migration and invasion in glioma. Our previous studies have shown that the MIIP protein was reduced or undetectable in some tissue samples obtained from patients with glioblastoma. The significance of MIIP in gliomagenesis is unknown. In this study, we report that MIIP has an important role in the inhibition of gliomagenesis and attenuation of mitotic transition. Increased MIIP expression levels inhibited colony formation and cell growth of glioma cell lines in vitro, whereas decreased expression by specific small interfering RNA for MIIP resulted in increased cell growth. Expression of MIIP in a glial-specific mouse model blocked glioma development and progression, thus showing that MIIP is an inhibitor of gliomagenesis. Furthermore, we show that MIIP attenuates mitotic transition and results in increased mitotic catastrophe. The biochemical mechanism of MIIP in this process is associated with its regulation of anaphase-promoting complex (APC/C) activity. MIIP interacts directly with Cdc20, and the interaction of MIIP with Cdc20 inhibits APC/C-mediated degradation of cyclin B1. Thus, MIIP attenuates mitotic transition and increases mitotic catastrophe, thereby inhibiting glioma development and progression. Oncogene (2010) 29, 3501-3508; doi:10.1038/onc.2010.114; published online 26 April 2010	[Ji, P.; Smith, S. M.; Wang, Y.; Jiang, R.; Song, S. W.; Bruner, J. M.; Fuller, G. N.; Zhang, W.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Smith, S. M.] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Wang, Y.] Tianjin Med Univ, Gen Hosp, Dept Gynecol, Tianjin, Peoples R China; [Wang, Y.] Tianjin Med Univ, Gen Hosp, Dept Obstet, Tianjin, Peoples R China; [Jiang, R.] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Song, S. W.] Capital Med Univ, Beijing Shijitan Hosp, Canc Res Lab, Beijing, Peoples R China; [Li, B.; Yu, H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Sawaya, R.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Kuang, J.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Capital Medical University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Zhang, W (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, 1515 Holcombe Blvd,Unit 85, Houston, TX 77030 USA.	wzhang@mdanderson.org		Wang, Yingmei/0000-0001-6457-3420; Fuller, Gregory/0000-0001-9447-2647; Yu, Hongtao/0000-0002-8861-049X	Texas Higher Education Coordinating Board; Anthony Bullock Brain Tumor Research Fund; NIH [RO1 CA98503]; National Foundation for Cancer Research; Goldhirsh Foundation; James S McDonnell Foundation; Oreffice Foundation; American Legion Fellowship; NATIONAL CANCER INSTITUTE [R01CA098503] Funding Source: NIH RePORTER	Texas Higher Education Coordinating Board; Anthony Bullock Brain Tumor Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; Goldhirsh Foundation; James S McDonnell Foundation; Oreffice Foundation; American Legion Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Kanchana Natarajan-Mendes for her contribution to the cell-cycle assays in this study, and Hong Zheng for her technical assistance. We thank Drs Ying Wu, Limei Hu and Paul Chiao for critically reviewing the manuscript and providing valuable comments. We gratefully thank Dr Kate J Newberry at the Department of Scientific Publications of MD Anderson Cancer Center for editing this paper. This study was partially supported by an ARP Grant from the Texas Higher Education Coordinating Board, the Anthony Bullock Brain Tumor Research Fund and NIH grant RO1 CA98503 (to WZ and GNF). We also thank the National Foundation for Cancer Research, the Goldhirsh Foundation, the James S McDonnell Foundation and the Oreffice Foundation for their support. Sarah M Smith (formerly Sarah M Dunlap) was supported by an NIH Pharmacoinformatics Training Fellowship and an American Legion Fellowship.	Behin A, 2003, LANCET, V361, P323, DOI 10.1016/S0140-6736(03)12328-8; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Dunlap SM, 2007, P NATL ACAD SCI USA, V104, P11736, DOI 10.1073/pnas.0703145104; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Fraschini R, 1999, J CELL BIOL, V145, P979, DOI 10.1083/jcb.145.5.979; Fujita T, 2008, JNCI-J NATL CANCER I, V100, P940, DOI 10.1093/jnci/djn176; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Hoffman S, 2006, NEURO-ONCOLOGY, V8, P27, DOI 10.1215/S1522851705000323; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Homer HA, 2005, REPRODUCTION, V130, P829, DOI 10.1530/rep.1.00856; Janoueix-Lerosey I, 2004, ONCOGENE, V23, P5912, DOI 10.1038/sj.onc.1207784; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Munirajan AK, 2008, J BIOL CHEM, V283, P24426, DOI 10.1074/jbc.M802316200; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Ragnarsson G, 1999, BRIT J CANCER, V79, P1468, DOI 10.1038/sj.bjc.6690234; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Smith JS, 1999, ONCOGENE, V18, P4144, DOI 10.1038/sj.onc.1202759; Song FF, 2010, CANCER RES, V70, P1024, DOI 10.1158/0008-5472.CAN-09-3742; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Song SW, 2005, CANCER RES, V65, P3562, DOI 10.1158/0008-5472.CAN-04-3392; Song SW, 2003, P NATL ACAD SCI USA, V100, P13970, DOI 10.1073/pnas.2332186100; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Wu Y, 2010, J BIOL CHEM, V285, P3554, DOI 10.1074/jbc.M109.063354; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009	30	30	35	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 17	2010	29	24					3501	3508		10.1038/onc.2010.114	http://dx.doi.org/10.1038/onc.2010.114			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	611QN	20418911				2022-12-25	WOS:000278835400005
J	Gregoretti, F; Belcastro, V; di Bernardo, D; Oliva, G				Gregoretti, Francesco; Belcastro, Vincenzo; di Bernardo, Diego; Oliva, Gennaro			A Parallel Implementation of the Network Identification by Multiple Regression (NIR) Algorithm to Reverse-Engineer Regulatory Gene Networks	PLOS ONE			English	Article								The reverse engineering of gene regulatory networks using gene expression profile data has become crucial to gain novel biological knowledge. Large amounts of data that need to be analyzed are currently being produced due to advances in microarray technologies. Using current reverse engineering algorithms to analyze large data sets can be very computational-intensive. These emerging computational requirements can be met using parallel computing techniques. It has been shown that the Network Identification by multiple Regression (NIR) algorithm performs better than the other ready-to-use reverse engineering software. However it cannot be used with large networks with thousands of nodes - as is the case in biological networks - due to the high time and space complexity. In this work we overcome this limitation by designing and developing a parallel version of the NIR algorithm. The new implementation of the algorithm reaches a very good accuracy even for large gene networks, improving our understanding of the gene regulatory networks that is crucial for a wide range of biomedical applications.	[Gregoretti, Francesco; Oliva, Gennaro] Inst High Performance Comp & Networking, Naples, Italy; [Belcastro, Vincenzo; di Bernardo, Diego] Telethon Inst Genet & Med, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Calcolo e Reti ad Alte Prestazioni (ICAR-CNR); Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Gregoretti, F (corresponding author), Inst High Performance Comp & Networking, Naples, Italy.	francesco.gregoretti@na.icar.cnr.it; gennaro.oliva@na.icar.cnr.it	di Bernardo, Diego/I-9440-2012; di Bernardo, Diego/AAF-5881-2021; Gregoretti, Francesco/B-7600-2015	di Bernardo, Diego/0000-0002-1911-7407; di Bernardo, Diego/0000-0002-1911-7407; Gregoretti, Francesco/0000-0003-3822-1215; Oliva, Gennaro/0000-0001-5676-2133; Belcastro, Vincenzo/0000-0003-3749-0018	Telethon [TGM06E01] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDERSON E, 1992, LAPACKS USERS GUIDE; [Anonymous], 1995, TUTORIAL LEARNING BA; BANSAL M, 2007, MOL SYST BIOL, V3; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Butte A J, 2000, Pac Symp Biocomput, P418; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Margolin LG, 2006, J TURBUL, V7, P1, DOI 10.1080/14685240500331595; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448	10	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10179	10.1371/journal.pone.0010179	http://dx.doi.org/10.1371/journal.pone.0010179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422008	gold, Green Published, Green Submitted			2022-12-25	WOS:000276952500005
J	Rafalska-Metcalf, IU; Powers, SL; Joo, LM; LeRoy, G; Janicki, SM				Rafalska-Metcalf, Ilona U.; Powers, Sara Lawrence; Joo, Lucy M.; LeRoy, Gary; Janicki, Susan M.			Single Cell Analysis of Transcriptional Activation Dynamics	PLOS ONE			English	Article							RNA-POLYMERASE-II; BROMODOMAIN PROTEIN BRD4; LIVING CELLS; GENE-EXPRESSION; IN-VIVO; P-TEFB; HISTONE ACETYLATION; ORDERED RECRUITMENT; MITOTIC CHROMOSOMES; CHROMATIN-STRUCTURE	Background: Gene activation is thought to occur through a series of temporally defined regulatory steps. However, this process has not been completely evaluated in single living mammalian cells. Methodology/Principal Findings: To investigate the timing and coordination of gene activation events, we tracked the recruitment of GCN5 (histone acetyltransferase), RNA polymerase II, Brd2 and Brd4 (acetyl-lysine binding proteins), in relation to a VP16-transcriptional activator, to a transcription site that can be visualized in single living cells. All accumulated rapidly with the VP16 activator as did the transcribed RNA. RNA was also detected at significantly more transcription sites in cells expressing the VP16-activator compared to a p53-activator. After a-amanitin pre-treatment, the VP16-activator, GCN5, and Brd2 are still recruited to the transcription site but the chromatin does not decondense. Conclusions/Significance: This study demonstrates that a strong activator can rapidly overcome the condensed chromatin structure of an inactive transcription site and supercede the expected requirement for regulatory events to proceed in a temporally defined order. Additionally, activator strength determines the number of cells in which transcription is induced as well as the extent of chromatin decondensation. As chromatin decondensation is significantly reduced after alpha-amanitin pre-treatment, despite the recruitment of transcriptional activation factors, this provides further evidence that transcription drives large-scale chromatin decondensation.	[Rafalska-Metcalf, Ilona U.; Powers, Sara Lawrence; Joo, Lucy M.; Janicki, Susan M.] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA; [LeRoy, Gary] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	The Wistar Institute; Princeton University	Rafalska-Metcalf, IU (corresponding author), Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA.	sjanicki@wistar.org			Emerald Foundation; Mallinckrodt Foundation; Beckman Young Investigators Program; V Foundation; Wistar Institute Cancer Center [P30CA10815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER	Emerald Foundation; Mallinckrodt Foundation; Beckman Young Investigators Program; V Foundation; Wistar Institute Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following foundations: The Emerald Foundation, The Mallinckrodt Foundation, the Beckman Young Investigators Program, the V Foundation, and the Wistar Institute Cancer Center Support Grant (P30CA10815) for use of the Genomics/Sequencing Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; BRESNICK EH, 1992, NUCLEIC ACIDS RES, V20, P273, DOI 10.1093/nar/20.2.273; CHUA P, 1995, MOL CELL BIOL, V15, P3685; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Denis GV, 2000, CELL GROWTH DIFFER, V11, P417; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dey A, 2009, MOL BIOL CELL; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; Hall DB, 2002, J BIOL CHEM, V277, P46043, DOI 10.1074/jbc.M208911200; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Hu Y, 2009, J CELL BIOL, V185, P87, DOI 10.1083/jcb.200809196; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Koutroubas G, 2008, MOL CELL BIOL, V28, P926, DOI 10.1128/MCB.01344-07; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurosu T, 2004, CURR BIOL, V14, P1112, DOI 10.1016/j.cub.2004.06.020; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; MARCUS GA, 1994, EMBO J, V13, P4807, DOI 10.1002/j.1460-2075.1994.tb06806.x; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Muller WG, 2007, J CELL BIOL, V177, P957, DOI 10.1083/jcb.200703157; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; Nishiyama A, 2006, MOL BIOL CELL, V17, P814, DOI 10.1091/mbc.E05-08-0729; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Rafalska-Metcalf IU, 2007, J CELL SCI, V120, P2301, DOI 10.1242/jcs.008664; Rickards B, 2007, MOL CELL BIOL, V27, P937, DOI 10.1128/MCB.01584-06; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sinha A, 2005, BIOCHEM J, V387, P257, DOI 10.1042/BJ20041793; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Toyama R, 2008, DEV DYNAM, V237, P1636, DOI 10.1002/dvdy.21576; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Wu SY, 2003, MOL CELL BIOL, V23, P6229, DOI 10.1128/MCB.23.17.6229-6242.2003; YAN J, J VIROL, V84, P76; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yao J, 2008, METHODS, V45, P233, DOI 10.1016/j.ymeth.2008.06.004; Yao J, 2007, MOL CELL, V28, P978, DOI 10.1016/j.molcel.2007.10.017; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; You JX, 2006, J VIROL, V80, P8909, DOI 10.1128/JVI.00502-06	62	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10272	10.1371/journal.pone.0010272	http://dx.doi.org/10.1371/journal.pone.0010272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422051	Green Published, gold			2022-12-25	WOS:000276952500027
J	Salker, M; Teklenburg, G; Molokhia, M; Lavery, S; Trew, G; Aojanepong, T; Mardon, HJ; Lokugamage, AU; Rai, R; Landles, C; Roelen, BAJ; Quenby, S; Kuijk, EW; Kavelaars, A; Heijnen, CJ; Regan, L; Macklon, NS; Brosens, JJ				Salker, Madhuri; Teklenburg, Gijs; Molokhia, Mariam; Lavery, Stuart; Trew, Geoffrey; Aojanepong, Tepchongchit; Mardon, Helen J.; Lokugamage, Amali U.; Rai, Raj; Landles, Christian; Roelen, Bernard A. J.; Quenby, Siobhan; Kuijk, Ewart W.; Kavelaars, Annemieke; Heijnen, Cobi J.; Regan, Lesley; Macklon, Nick S.; Brosens, Jan J.			Natural Selection of Human Embryos: Impaired Decidualization of Endometrium Disables Embryo-Maternal Interactions and Causes Recurrent Pregnancy Loss	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; RECEPTORS; CELLS; IMPLANTATION; MISCARRIAGE; EXPRESSION; EPITHELIUM; PROLACTIN; TIME	Background: Recurrent pregnancy loss (RPL), defined as 3 or more consecutive miscarriages, is widely attributed either to repeated chromosomal instability in the conceptus or to uterine factors that are poorly defined. We tested the hypothesis that abnormal cyclic differentiation of endometrial stromal cells (ESCs) into specialized decidual cells predisposes to RPL, based on the observation that this process may not only be indispensable for placenta formation in pregnancy but also for embryo recognition and selection at time of implantation. Methodology/Principal Findings: Analysis of mid-secretory endometrial biopsies demonstrated that RPL is associated with decreased expression of the decidual marker prolactin (PRL) but increased levels of prokineticin-1 (PROK1), a cytokine that promotes implantation. These in vivo findings were entirely recapitulated when ESCs were purified from patients with and without a history of RPL and decidualized in culture. In addition to attenuated PRL production and prolonged and enhanced PROK1 expression, RPL was further associated with a complete dysregulation of both markers upon treatment of ESC cultures with human chorionic gonadotropin, a glycoprotein hormone abundantly expressed by the implanting embryo. We postulated that impaired embryo recognition and selection would clinically be associated with increased fecundity, defined by short time-to-pregnancy (TTP) intervals. Woman-based analysis of the mean and mode TTP in a cohort of 560 RPL patients showed that 40% can be considered "superfertile'', defined by a mean TTP of 3 months or less. Conclusions: Impaired cyclic decidualization of the endometrium facilitates implantation yet predisposes to subsequent pregnancy failure by disabling natural embryo selection and by disrupting the maternal responses to embryonic signals. These findings suggest a novel pathological pathway that unifies maternal and embryonic causes of RPL.	[Salker, Madhuri; Lavery, Stuart; Trew, Geoffrey; Aojanepong, Tepchongchit; Rai, Raj; Landles, Christian; Regan, Lesley; Brosens, Jan J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Inst Reprod & Dev Biol, London, England; [Teklenburg, Gijs; Kuijk, Ewart W.; Macklon, Nick S.] Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands; [Molokhia, Mariam] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Mardon, Helen J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynecol, Womens Ctr, Oxford OX3 9DU, England; [Lokugamage, Amali U.] Whittington Hosp NHS Trust, Dept Obstet & Gynecol, London, England; [Roelen, Bernard A. J.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands; [Quenby, Siobhan] Univ Liverpool, Dept Reprod & Dev Hlth, Liverpool Womens Hosp, Liverpool L69 3BX, Merseyside, England; [Kavelaars, Annemieke; Heijnen, Cobi J.] Univ Med Ctr Utrecht, Lab Psychoneuroimmunol, Utrecht, Netherlands; [Macklon, Nick S.] Univ Southampton, Div Dev Origins Hlth & Dis, Princess Anne Hosp, Southampton, Hants, England	Imperial College London; Utrecht University; Utrecht University Medical Center; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Utrecht University; University of Liverpool; Utrecht University; Utrecht University Medical Center; University of Southampton	Salker, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Inst Reprod & Dev Biol, London, England.	j.brosens@imperial.ac.uk	Kuijk, Ewart/I-2569-2019	Kuijk, Ewart/0000-0002-1385-6516; Landles, Christian/0000-0001-9715-6447; Salker, Madhuri Sonal/0000-0002-7939-289X; Quenby, Siobhan/0000-0003-3221-5471; Brosens, Jan/0000-0003-0116-9329; Lokugamage, Amali/0000-0002-7439-2700	Netherlands Organisation for Scientific Research (NWO); CONRAD/Consortium for Industrial Collaboration in Contraceptive Research (CICCR) [640510, CIG-08-122]; Wellcome Trust [084336]; Institute of Obstetrics and Gynaecology (IOG) Trust; NIHR Biomedical Research Centre	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); CONRAD/Consortium for Industrial Collaboration in Contraceptive Research (CICCR); Wellcome Trust(Wellcome TrustEuropean Commission); Institute of Obstetrics and Gynaecology (IOG) Trust; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was supported by funds from the Netherlands Organisation for Scientific Research (NWO; http://www.nwo.nl), CONRAD/Consortium for Industrial Collaboration in Contraceptive Research (CICCR) Grant (640510) (CIG-08-122; http://www.conrad.org/), the Wellcome Trust (084336; http://www.wellcome.ac.uk/), the Institute of Obstetrics and Gynaecology (IOG) Trust (www.iogt.org.uk) and the NIHR Biomedical Research Centre funding scheme (http://www. nihr.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin JD, 1996, AM J REPROD IMMUNOL, V35, P261; Backdahl L, 2009, INT J BIOCHEM CELL B, V41, P176, DOI 10.1016/j.biocel.2008.08.023; Berndt S, 2006, FASEB J, V20, P2630, DOI 10.1096/fj.06-5885fje; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; Brosens JJ, 2010, MOL HUM REPROD, V16, P273, DOI 10.1093/molehr/gap108; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Christiansen OB, 2008, GYNECOL OBSTET INVES, V66, P257, DOI 10.1159/000149575; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Evans J, 2009, FASEB J, V23, P2165, DOI 10.1096/fj.08-124495; Evers JLH, 2002, LANCET, V360, P151, DOI 10.1016/S0140-6736(02)09417-5; Fluhr H, 2006, FERTIL STERIL, V86, P236, DOI 10.1016/j.fertnstert.2005.12.031; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Hiby SE, 2008, HUM REPROD, V23, P972, DOI 10.1093/humrep/den011; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Jasinska A, 2006, ENDOCRINOLOGY, V147, P4112, DOI 10.1210/en.2005-1577; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Jauniaux E, 2006, HUM REPROD, V21, P2216, DOI 10.1093/humrep/del150; Joffe M, 2005, AM J EPIDEMIOL, V162, P115, DOI 10.1093/aje/kwi172; Jones MC, 2006, P NATL ACAD SCI USA, V103, P16272, DOI 10.1073/pnas.0603002103; Kajihara T, 2006, MOL ENDOCRINOL, V20, P2444, DOI 10.1210/me.2006-0118; Kane N, 2009, ENDOCRINOLOGY, V150, P2882, DOI 10.1210/en.2008-1309; KORN EL, 1990, AM STAT, V44, P270, DOI 10.2307/2684345; Lynch VJ, 2008, P NATL ACAD SCI USA, V105, P14928, DOI 10.1073/pnas.0802355105; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Quenby S, 2002, HUM REPROD, V17, P1959, DOI 10.1093/humrep/17.8.1959; Quinn CE, 2009, HUM REPROD UPDATE, V15, P229, DOI 10.1093/humupd/dmn052; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Simon L, 2009, ENDOCRINOLOGY, V150, P3871, DOI 10.1210/en.2008-1691; TIETZE C, 1950, FERTIL STERIL, V1, P338; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304	31	245	265	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10287	10.1371/journal.pone.0010287	http://dx.doi.org/10.1371/journal.pone.0010287			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422017	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000276952500032
J	Williams, CT; Azad, AF				Williams, Calvin T.; Azad, Abdu F.			Transcriptional Analysis of the Pre-Erythrocytic Stages of the Rodent Malaria Parasite, Plasmodium yoelii	PLOS ONE			English	Article							INDUCED FALCIPARUM MALARIA; GENE-EXPRESSION; MICROARRAY PLATFORMS; CLUSTER-ANALYSIS; LIVER STAGES; SPOROZOITES; VACCINE; PROTEIN; IMMUNIZATION; RADIATION	The molecular biology of the clinically silent pre-erythrocytic stages of mammalian Plasmodium spp, composed of both the sporozoite and liver stages, has remained largely uncharacterized. Improved understanding of the biological processes required for progression through the pre-erythrocytic stages could lead to the identification of novel drug and vaccine targets. To gain insights into the molecular events that occur during the pre-erythrocytic stages of Plasmodium, comparative transcriptional analysis was performed on radiation attenuated sporozoites (RAS), wild type sporozoites (wtSPZ) and liver stage parasites collected either 24 hours (24hrLS) or 48 hours (48hrLS) after mice were infected with Plasmodium yoelii. Our results revealed 1100 Plasmodium genes that were differentially expressed in one or more constituents of the pre-erythrocytic stages relative to the mixed blood stages. Overall, the transcriptional profile of P. yoelii gradually became more similar to the mixed blood stages as pre-erythrocytic stage development progressed into the mature liver stage schizont. The transcriptional profiles of RAS and wtSPZ were found to be nearly identical. Likewise, the transcriptional profile of 24hrLS was very similar to that of the 48hrLS parasites. The largest differences in gene expression were observed when comparing wtSPZ or RAS to either of the liver stage samples. Further characterization of the differentially expressed genes identified in this study could help elucidate the biological mechanisms employed by Plasmodium during the pre-erythrocytic stages.	[Williams, Calvin T.; Azad, Abdu F.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Williams, CT (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	aazad@umaryland.edu			NIH [A107828-26]; NIAID [AI07540]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007540] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant A107828-26 to A. A and NIAID T32 Training Grant: AI07540. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly ASI, 2008, MOL MICROBIOL, V69, P152, DOI 10.1111/j.1365-2958.2008.06271.x; Bodescot M, 2004, PARASITOL RES, V92, P449, DOI 10.1007/s00436-003-1061-9; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; CLYDE DF, 1973, AM J MED SCI, V266, P398, DOI 10.1097/00000441-197312000-00001; CLYDE DF, 1975, AM J TROP MED HYG, V24, P397, DOI 10.4269/ajtmh.1975.24.397; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Doolan DL, 1996, J BIOL CHEM, V271, P17861, DOI 10.1074/jbc.271.30.17861; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fiscella M, 2003, NAT BIOTECHNOL, V21, P302, DOI 10.1038/nbt797; GREENWOOD BM, 1990, B WORLD HEALTH ORGAN, V68, P184; Hardiman G, 2004, PHARMACOGENOMICS, V5, P487, DOI 10.1517/14622416.5.5.487; Hoffman BU, 2008, EXP PARASITOL, V118, P247, DOI 10.1016/j.exppara.2007.08.014; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOFFMAN SL, 1989, SCIENCE, V244, P1078, DOI 10.1126/science.2524877; HOFFMAN SL, 1987, SCIENCE, V237, P639, DOI 10.1126/science.3299709; Janssen CS, 2002, P ROY SOC B-BIOL SCI, V269, P431, DOI 10.1098/rspb.2001.1903; Jarvinen AK, 2004, GENOMICS, V83, P1164, DOI 10.1016/j.ygeno.2004.01.004; Kuo WP, 2002, BIOINFORMATICS, V18, P405, DOI 10.1093/bioinformatics/18.3.405; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Pei Y, 2010, MOL MICROBIOL, V75, P957, DOI 10.1111/j.1365-2958.2009.07034.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; RICHARDS W. H. G., 1966, NATURE, V212, P1492, DOI 10.1038/2121492a0; Roxas BAP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-187; Sacci JB, 2005, MOL BIOCHEM PARASIT, V142, P177, DOI 10.1016/j.molbiopara.2005.03.018; Sharma SK, 2003, J BIOL CHEM, V278, P45661, DOI 10.1074/jbc.M304283200; Siau A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000121; Silvie O, 2002, PARASITE IMMUNOL, V24, P221, DOI 10.1046/j.1365-3024.2002.00450.x; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wen XL, 1998, P NATL ACAD SCI USA, V95, P334, DOI 10.1073/pnas.95.1.334; Yu Min, 2008, Cell Host Microbe, V4, P567, DOI 10.1016/j.chom.2008.11.001; Zhang M, 2008, BIOINFORMATICS, V24, P2057, DOI 10.1093/bioinformatics/btn365; Zhou YY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001570	43	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10267	10.1371/journal.pone.0010267	http://dx.doi.org/10.1371/journal.pone.0010267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422005	Green Published, Green Submitted, gold			2022-12-25	WOS:000276952500019
J	Neueder, A; Jakob, S; Poll, G; Linnemann, J; Deutzmann, R; Tschochner, H; Milkereit, P				Neueder, Andreas; Jakob, Steffen; Poell, Gisela; Linnemann, Jan; Deutzmann, Rainer; Tschochner, Herbert; Milkereit, Philipp			A Local Role for the Small Ribosomal Subunit Primary Binder rpS5 in Final 18S rRNA Processing in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; RIBONUCLEOPROTEIN PARTICLE; CYTOPLASMIC MATURATION; THERMUS-THERMOPHILUS; 40S RIBOSOME; 80S RIBOSOME; PROTEINS; DOMAIN; BIOGENESIS	In vivo depletion of the yeast small ribosomal subunit (SSU) protein S5 (rpS5) leads to nuclear degradation of nascent SSUs and to a perturbed global assembly state of the SSU head domain. Here, we report that rpS5 plays an additional local role at the head/platform interface in efficient SSU maturation. We find that yeast small ribosomal subunits which incorporated an rpS5 variant lacking the seven C-terminal amino acids have a largely assembled head domain and are exported to the cytoplasm. On the other hand, 39 processing of 18S rRNA precursors is inhibited in these ribosomal particles, although they associate with the putative endonuclease Nob1p and other late acting 40S biogenesis factors. We suggest that the SSU head component rpS5 and platform components as rpS14 are crucial constituents of a highly defined spatial arrangement in the head - platform interface of nascent SSUs, which is required for efficient processing of the therein predicted SSU rRNA 39 end. Positioning of rpS5 in nascent SSUs, including its relative orientation towards platform components in the head-platform cleft, will depend on the general assembly and folding state of the head domain. Therefore, the suggested model can explain 18S precursor rRNA 39 processing phenotypes observed in many eukaryotic SSU head assembly mutants.	[Neueder, Andreas; Jakob, Steffen; Poell, Gisela; Linnemann, Jan; Deutzmann, Rainer; Tschochner, Herbert; Milkereit, Philipp] Univ Regensburg, Inst Biochem Genetik & Mikrobiol, Regensburg, Germany	University of Regensburg	Neueder, A (corresponding author), Univ Regensburg, Inst Biochem Genetik & Mikrobiol, Regensburg, Germany.	herbert.tschochner@vkl.uni-regensburg.de; philipp.milkereit@vkl.uni-regensburg.de	Neueder, Andreas/K-4319-2015	Neueder, Andreas/0000-0002-2389-5236	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was in part financed by the Deutsche Forschungsgemeinschaft (DFG) (http://www.dfg.de/) research unit FOR 1068. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalarov SC, 1998, P NATL ACAD SCI USA, V95, P999, DOI 10.1073/pnas.95.3.999; Agalarov SC, 1999, EUR J BIOCHEM, V266, P533, DOI 10.1046/j.1432-1327.1999.00890.x; Bohnsack MT, 2009, MOL CELL, V36, P583, DOI 10.1016/j.molcel.2009.09.039; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Burke D., 2000, METHODS YEAST GENETI; Chandramouli P, 2008, STRUCTURE, V16, P535, DOI 10.1016/j.str.2008.01.007; Cole SE, 2009, MOL CELL, V34, P440, DOI 10.1016/j.molcel.2009.04.017; Devaraj A, 2009, RNA, V15, P255, DOI 10.1261/rna.1320109; Fang F, 2004, MOL CELL BIOL, V24, P10766, DOI 10.1128/MCB.24.24.10766-10776.2004; Fatica A, 2003, MOL CELL BIOL, V23, P1798, DOI 10.1128/MCB.23.5.1798-1807.2003; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Ford CL, 1999, CANCER RES, V59, P704; Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073; Granneman S, 2005, MOL CELL BIOL, V25, P10352, DOI 10.1128/MCB.25.23.10352-10364.2005; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Jakovljevic J, 2004, MOL CELL, V14, P331, DOI 10.1016/S1097-2765(04)00215-1; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; Lacombe T, 2009, MOL MICROBIOL, V72, P69, DOI 10.1111/j.1365-2958.2009.06622.x; LAFONTAINE D, 1994, J MOL BIOL, V241, P492, DOI 10.1006/jmbi.1994.1525; Lamanna AC, 2009, P NATL ACAD SCI USA, V106, P14259, DOI 10.1073/pnas.0905403106; Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252; Liang XH, 2007, MOL CELL, V28, P965, DOI 10.1016/j.molcel.2007.10.012; Liang XH, 2009, RNA, V15, P1716, DOI 10.1261/rna.1724409; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lumsden T, 2010, NUCLEIC ACIDS RES, V38, P1261, DOI 10.1093/nar/gkp1113; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; PERTSCHY B, 2009, J BIOL CHEM; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Robert F, 2003, J BIOL CHEM, V278, P44913, DOI 10.1074/jbc.M306534200; Robert F, 2001, NUCLEIC ACIDS RES, V29, P677, DOI 10.1093/nar/29.3.677; SAMAHA RR, 1994, P NATL ACAD SCI USA, V91, P7884, DOI 10.1073/pnas.91.17.7884; Sambrook J., 2002, MOL CLONING LAB MANU; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; SOUDET J, EMBO J; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Sykes MT, 2009, ANNU REV BIOPHYS, V38, P197, DOI 10.1146/annurev.biophys.050708.133615; Tabb-Massey A, 2003, NUCLEIC ACIDS RES, V31, P6798, DOI 10.1093/nar/gkg899; Tone Y, 2002, GENE DEV, V16, P3142, DOI 10.1101/gad.1025602; TRAPMAN J, 1976, BIOCHIM BIOPHYS ACTA, V442, P265, DOI 10.1016/0005-2787(76)90301-4; UDEM SA, 1973, J BIOL CHEM, V248, P1412; Vanrobays E, 2004, RNA, V10, P645, DOI 10.1261/rna.5162204; Vanrobays E, 2003, MOL CELL BIOL, V23, P2083, DOI 10.1128/MCB.23.6.2083-2095.2003; WEITZMANN CJ, 1993, FASEB J, V7, P177, DOI 10.1096/fasebj.7.1.7916699; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P534, DOI 10.1038/nsmb.1408; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519	52	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10194	10.1371/journal.pone.0010194	http://dx.doi.org/10.1371/journal.pone.0010194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419091	Green Submitted, gold, Green Published			2022-12-25	WOS:000276853800007
J	Macey, PM; Woo, MA; Kumar, R; Cross, RL; Harper, RM				Macey, Paul M.; Woo, Mary A.; Kumar, Rajesh; Cross, Rebecca L.; Harper, Ronald M.			Relationship between Obstructive Sleep Apnea Severity and Sleep, Depression and Anxiety Symptoms in Newly-Diagnosed Patients	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; QUALITY-OF-LIFE; INTERMITTENT HYPOXIA; PSYCHOMETRIC EVALUATION; NEURAL ALTERATIONS; INVENTORY-II; RISK-FACTOR; INDEX; HYPERTENSION; RELIABILITY	Obstructive sleep apnea (OSA) occurs in at least 10% of the population, and leads to higher morbidity and mortality; however, relationships between OSA severity and sleep or psychological symptoms are unclear. Existing studies include samples with wide-ranging comorbidities, so we assessed relationships between severity of OSA and common sleep and psychological disturbances in recently diagnosed OSA patients with minimal co-morbidities. We studied 49 newly diagnosed, untreated OSA patients without major co-morbidities such as mental illness, cardiovascular disease, or stroke; subjects were not using psychoactive medications or tobacco (mean +/- std age: 46.8 +/- 9.1 years; apnea/hyponea index [AHI]: 32.1 +/- 20.5 events/hour; female/male: 12/37; weight <125 kg). We evaluated relationships between the AHI and daytime sleepiness (Epworth Sleepiness Scale; ESS), sleep quality (Pittsburg Sleep Quality Index; PSQI), depressive symptoms (Beck Depression Inventory-II; BDI), and anxiety symptoms (Beck Anxiety Inventory; BAI), as well as sex and body mass index (BMI). AHI was similar in females and males. Mean levels of all symptoms were above normal thresholds, but AHI was not correlated with age, ESS, PSQI, BDI, or BAI; only BMI was correlated with OSA severity. No differences in mean AHI appeared when subjects were grouped by normal versus elevated values of ESS, PSQI, BDI, or BAI. Consistent with other studies, a strong link between OSA severity and psychological symptoms did not appear in these newly diagnosed patients, suggesting that mechanisms additional to the number and frequency of hypoxic events and arousals occurring with apneas contribute to adverse health effects in OSA. OSA patients presenting with mild or moderate severity, and no major comorbidities will not necessarily have low levels of sleep or psychological disturbances.	[Macey, Paul M.; Woo, Mary A.; Cross, Rebecca L.] Univ Calif Los Angeles, Sch Nursing, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Macey, Paul M.; Harper, Ronald M.] Univ Calif Los Angeles, Brain Res Inst, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Kumar, Rajesh; Harper, Ronald M.] Univ Calif Los Angeles, Dept Neurobiol, David Geffen Sch Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Macey, PM (corresponding author), Univ Calif Los Angeles, Sch Nursing, David Geffen Sch Med, Los Angeles, CA 90024 USA.	pmacey@ucla.edu	Macey, Paul M./B-5037-2008	Macey, Paul M./0000-0003-4093-7458	National Institutes of Health [HL60296, NR009116, NR011230]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R21NR011230, R01NR009116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Funded by the National Institutes of Health HL60296, NR009116, and NR011230. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashiba T, 2002, CHEST, V122, P861, DOI 10.1378/chest.122.3.861; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; American Psychiatric Association Task Force on DSM-IV, 1994, DIAGN STAT MAN MENT; Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; ASANO K, 2009, RESPIRATION; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Baguet JP, 2005, CHEST, V128, P3407, DOI 10.1378/chest.128.5.3407; Baldwin CM, 2001, SLEEP, V24, P96, DOI 10.1093/sleep/24.1.96; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bixler EO, 2005, J CLIN ENDOCR METAB, V90, P4510, DOI 10.1210/jc.2005-0035; Borak J, 1996, J SLEEP RES, V5, P123, DOI 10.1046/j.1365-2869.1996.d01-60.x; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Cross RL, 2008, SLEEP, V31, P1103; Dominici M, 2009, ARQ NEURO-PSIQUIAT, V67, P35, DOI 10.1590/S0004-282X2009000100009; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Gottlieb DJ, 1999, AM J RESP CRIT CARE, V159, P502, DOI 10.1164/ajrccm.159.2.9804051; Gozal E, 2005, AM J PHYSIOL-CELL PH, V288, pC535, DOI 10.1152/ajpcell.00270.2004; Harper RM, 2009, SLEEP, V32, pA341; Hossain JL, 2005, J SLEEP RES, V14, P245, DOI 10.1111/j.1365-2869.2005.00466.x; Iber C., 2007, AASM MANUAL SCORING; Johansson P, 2009, SLEEP MED, V10, P1005, DOI 10.1016/j.sleep.2009.01.011; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Kezirian EJ, 2009, SLEEP, V32, P253, DOI 10.1093/sleep/32.2.253; Kumar R, 2009, DEPRESS ANXIETY, V26, P480, DOI 10.1002/da.20531; Lamm J, 2008, J AM ACAD NURSE PRAC, V20, P225, DOI 10.1111/j.1745-7599.2008.00308.x; Lavie P, 2000, BRIT MED J, V320, P479, DOI 10.1136/bmj.320.7233.479; Lopez-Jimenez F, 2006, SLEEP, V29, P743, DOI 10.1093/sleep/29.6.743; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; MACEY PM, 2008, 7 ANN RES EV BAS PRA; Marshall NS, 2008, SLEEP, V31, P1079; McCall WV, 2006, J CLIN SLEEP MED, V2, P424; Mediano O, 2007, EUR RESPIR J, V30, P110, DOI 10.1183/09031936.00009506; MILLMAN RP, 1989, J CLIN PSYCHIAT, V50, P348; Morrell MJ, 2003, SLEEP MED, V4, P451, DOI 10.1016/S1389-9457(03)00159-X; Naismith S, 2004, J CLIN EXP NEUROPSYC, V26, P43, DOI 10.1076/jcen.26.1.43.23929; Pae EK, 2005, NEUROSCI LETT, V375, P123, DOI 10.1016/j.neulet.2004.10.091; REYNOLDS CF, 1984, J CLIN PSYCHIAT, V45, P287; Richardson HL, 2008, J SLEEP RES, V17, P450, DOI [10.1111/j.1365-2869.2008.00663.x, 10.1111/j.1365-2869.2008.00667.x, 10.1111/j.1365-2869.2008.00682.x, 10.1111/j.1365-2869.2008.00672.x, 10.1111/j.1365-2869.2008.00683.x]; Ronksley PE, 2009, THORAX, V64, P834, DOI 10.1136/thx.2009.115105; Roure N, 2008, SLEEP MED, V9, P727, DOI 10.1016/j.sleep.2008.02.006; Saunamaeki T, 2007, ACTA NEUROL SCAND, V116, P277, DOI 10.1111/j.1600-0404.2007.00901.x; Sauter C, 2000, J SLEEP RES, V9, P293; Seneviratne U, 2004, SLEEP MED, V5, P339, DOI 10.1016/j.sleep.2004.01.021; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Thong JF, 2008, J OTOLARYNGOL-HEAD N, V37, P894, DOI 10.2310/7070.2008.OA0200; VALLADARES EM, 2007, SOC NEUR ABS; Vandeputte M, 2003, SLEEP MED, V4, P343, DOI 10.1016/S1389-9457(03)00059-5; Veasey SC, 2004, SLEEP, V27, P194, DOI 10.1093/sleep/27.2.194; Veasey SC, 2006, SLEEP MED, V7, P5, DOI 10.1016/j.sleep.2005.08.012; Xu W, 2004, NEUROSCIENCE, V126, P313, DOI 10.1016/j.neuroscience.2004.03.055; Yaouhi K, 2009, J SLEEP RES, V18, P36, DOI 10.1111/j.1365-2869.2008.00705.x; Young T, 2008, SLEEP, V31, P1071; YUE HJ, 2009, SLEEP BREATH	58	115	120	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10211	10.1371/journal.pone.0010211	http://dx.doi.org/10.1371/journal.pone.0010211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	584HZ	20419135	Green Published, gold, Green Submitted			2022-12-25	WOS:000276743500017
J	Zhan, SH; Lukens, L				Zhan, Shuhua; Lukens, Lewis			Identification of Novel miRNAs and miRNA Dependent Developmental Shifts of Gene Expression in Arabidopsis thaliana	PLOS ONE			English	Article							MICRORNA METABOLISM; PHASE-CHANGE; RNA; BIOGENESIS; TARGETS; PROTEIN; EVOLUTION; CLEAVAGE; EXPORT; DICER	microRNAs (miRNAs) are small, endogenous RNAs of 20,25 nucleotides, processed from stem-loop regions of longer RNA precursors. Plant miRNAs act as negative regulators of target mRNAs predominately by slicing target transcripts, and a number of miRNAs play important roles in development. We analyzed a number of published datasets from Arabidopsis thaliana to characterize novel miRNAs, novel miRNA targets, and miRNA-regulated developmental changes in gene expression. These data include microarray profiling data and small RNA (sRNA) deep sequencing data derived from miRNA biogenesis/transport mutants, microarray profiling data of mRNAs in a developmental series, and computational predictions of conserved genomic stem-loop structures. Our conservative analyses identified five novel mature miRNAs and seven miRNA targets, including one novel target gene. Two complementary miRNAs that target distinct mRNAs were encoded by one gene. We found that genes targeted by known miRNAs, and genes up-regulated or down-regulated in miRNA mutant inflorescences, are highly expressed in the wild type inflorescence. In addition, transcripts upregulated within the mutant inflorescences were abundant in wild type leaves and shoot meristems and low in pollen and seed. Downregulated transcripts were abundant in wild type pollen and seed and low in shoot meristems, roots and leaves. Thus, disrupting miRNA function causes the inflorescence transcriptome to resemble the leaf and meristem and to differ from pollen and seed. Applications of our computational approach to other species and the use of more liberal criteria than reported here will further expand the number of identified miRNAs and miRNA targets. Our findings suggest that miRNAs have a global role in promoting vegetative to reproductive transitions in A. thaliana.	[Zhan, Shuhua; Lukens, Lewis] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada	University of Guelph	Zhan, SH (corresponding author), Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada.	llukens@uoguelph.ca		Lukens, Lewis/0000-0003-3963-2008	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Natural Sciences and Engineering Research Council of Canada, www.nserc-crsng.gc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alves L, 2009, NUCLEIC ACIDS RES, V37, P4010, DOI 10.1093/nar/gkp272; Backman TWH, 2008, NUCLEIC ACIDS RES, V36, pD982, DOI 10.1093/nar/gkm997; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bollman KM, 2003, DEVELOPMENT, V130, P1493, DOI 10.1242/dev.00362; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chen XM, 2008, CURR TOP MICROBIOL, V320, P117; Chia T, 2004, PLANT J, V37, P853, DOI 10.1111/j.1365-313X.2003.02012.x; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Nagasaki H, 2007, P NATL ACAD SCI USA, V104, P14867, DOI 10.1073/pnas.0704339104; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pouch-Pelissier MN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000096; Ray A, 1996, DEVELOPMENT, V122, P2631; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Willmann MR, 2007, CURR OPIN PLANT BIOL, V10, P503, DOI 10.1016/j.pbi.2007.07.004; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Yu B, 2008, P NATL ACAD SCI USA, V105, P10073, DOI 10.1073/pnas.0804218105; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716	52	17	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10157	10.1371/journal.pone.0010157	http://dx.doi.org/10.1371/journal.pone.0010157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405016	Green Published, gold, Green Submitted			2022-12-25	WOS:000276706300013
J	Zanetti, M; Teardo, E; La Rocca, N; Zulkifli, L; Checchetto, V; Shijuku, T; Sato, Y; Giacometti, GM; Uozumi, N; Bergantino, E; Szabo, I				Zanetti, Manuela; Teardo, Enrico; La Rocca, Nicoletta; Zulkifli, Lalu; Checchetto, Vanessa; Shijuku, Toshiaki; Sato, Yuki; Giacometti, Giorgio Mario; Uozumi, Noboyuki; Bergantino, Elisabetta; Szabo, Ildiko			A Novel Potassium Channel in Photosynthetic Cyanobacteria	PLOS ONE			English	Article							SYNECHOCYSTIS SP PCC-6803; GATED K+ CHANNEL; THYLAKOID MEMBRANES; ESCHERICHIA-COLI; ION-CHANNEL; FUNCTIONAL-CHARACTERIZATION; STREPTOMYCES-LIVIDANS; PATCH-CLAMP; ARABIDOPSIS; SYSTEM	Elucidation of the structure-function relationship of a small number of prokaryotic ion channels characterized so far greatly contributed to our knowledge on basic mechanisms of ion conduction. We identified a new potassium channel (SynK) in the genome of the cyanobacterium Synechocystis sp. PCC6803, a photosynthetic model organism. SynK, when expressed in a K+-uptake-system deficient E. coli strain, was able to recover growth of these organisms. The protein functions as a potassium selective ion channel when expressed in Chinese Hamster Ovary cells. The location of SynK in cyanobacteria in both thylakoid and plasmamembranes was revealed by immunogold electron microscopy and Western blotting of isolated membrane fractions. SynK seems to be conserved during evolution, giving rise to a TPK (two-pore K+ channel) family member which is shown here to be located in the thylakoid membrane of Arabidopsis. Our work characterizes a novel cyanobacterial potassium channel and indicates the molecular nature of the first higher plant thylakoid cation channel, opening the way to functional studies.	[Zanetti, Manuela; Teardo, Enrico; La Rocca, Nicoletta; Checchetto, Vanessa; Giacometti, Giorgio Mario; Bergantino, Elisabetta; Szabo, Ildiko] Univ Padua, Dept Biol, Padua, Italy; [Zulkifli, Lalu; Shijuku, Toshiaki; Sato, Yuki; Uozumi, Noboyuki] Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi 980, Japan	University of Padua; Tohoku University	Zanetti, M (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	elisabetta.bergantino@unipd.it; ildi@civ.bio.unipd.it	Szabo, Ildiko/AAW-5972-2021; Padova, Ildiko/K-5344-2016; Zanetti, Manuela/C-3535-2015; La Rocca, Nicoletta/AAA-2241-2021; Uozumi, Nobuyuki/AAG-3252-2019; Zulkifli, Lalu/AAD-8401-2021	Szabo, Ildiko/0000-0002-3637-3947; Zanetti, Manuela/0000-0002-9176-6313; La Rocca, Nicoletta/0000-0003-4866-5952; Zulkifli, Lalu/0000-0001-9213-1670; Uozumi, Nobuyuki/0000-0003-4268-1126; checchetto, vanessa/0000-0001-8911-6146	Italian Ministry for University and Research (MIUR); University of Padova; MEXT [17078005, 19380058, 20-08103]; JSPS	Italian Ministry for University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Padova; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The European Molecular Biology Organization (Young Investigator Program grant to I. S.), the Italian Ministry for University and Research (MIUR) (to I. S.) and the University of Padova (to E. B. and I. S.) are acknowledged for financial support. This work was also supported by grant FISR from MIUR to G. M. G. This work was also supported by grants-in-aid for scientific research (17078005, 19380058 and 20-08103 to N.U.) from MEXT and JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge C, 2008, MOL MICROBIOL, V70, P140, DOI 10.1111/j.1365-2958.2008.06401.x; Bergantino E, 2003, P NATL ACAD SCI USA, V100, P15265, DOI 10.1073/pnas.2533072100; Berry S, 2003, FEBS LETT, V548, P53, DOI 10.1016/S0014-5793(03)00729-4; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bolter B, 1998, P NATL ACAD SCI USA, V95, P15831, DOI 10.1073/pnas.95.26.15831; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Cortes DM, 1997, BIOCHEMISTRY-US, V36, P10343, DOI 10.1021/bi971018y; Derst C, 1998, J EXP BIOL, V201, P2791; Downey P, 2000, J BIOL CHEM, V275, P39420, DOI 10.1074/jbc.M002962200; ENZ C, 1993, BIOCHIM BIOPHYS ACTA, V1143, P67, DOI 10.1016/0005-2728(93)90217-4; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; FANG ZW, 1995, PLANT PHYSIOL, V108, P1725, DOI 10.1104/pp.108.4.1725; Gazzarrini S, 2003, FEBS LETT, V552, P12, DOI 10.1016/S0014-5793(03)00777-4; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Herrero A., 2008, CYANOBACTERIA MOL BI; HILLE B, 2003, ION CHANNELS EXCITAB, pCH5; Hinnah SC, 1998, EUR J BIOCHEM, V253, P606, DOI 10.1046/j.1432-1327.1998.2530606.x; Ishikawa F, 2005, FEBS LETT, V579, P5814, DOI 10.1016/j.febslet.2005.09.076; Ishikawa M, 2009, PLANT CELL PHYSIOL, V50, P773, DOI 10.1093/pcp/pcp027; Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Kaneko T, 1996, DNA Res, V3, P109; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Kuo MMC, 2007, J BIOL CHEM, V282, P24294, DOI 10.1074/jbc.M703618200; Kuo MMC, 2005, FEMS MICROBIOL REV, V29, P961, DOI 10.1016/j.femsre.2005.03.003; Ma S, 2004, PLANT J, V40, P845, DOI 10.1111/j.1365-313X.2004.02265.x; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; Matsuda N, 2006, BIOSCI BIOTECH BIOCH, V70, P273, DOI 10.1271/bbb.70.273; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; Pottosin II, 1996, J MEMBRANE BIOL, V152, P223, DOI 10.1007/s002329900100; Pulina MV, 2006, J BIOL CHEM, V281, P19645, DOI 10.1074/jbc.M602033200; Rascio N, 1999, PLANT CELL ENVIRON, V22, P205, DOI 10.1046/j.1365-3040.1999.00394.x; REMIS D, 1986, BIOCHIM BIOPHYS ACTA, V852, P68, DOI 10.1016/0005-2728(86)90057-5; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Santos JS, 2006, J GEN PHYSIOL, V128, P283, DOI 10.1085/jgp.200609572; Sato Naoki, 2006, V23, P75; SCHONKNECHT G, 1988, NATURE, V336, P589, DOI 10.1038/336589a0; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Stingl K, 2007, EMBO J, V26, P232, DOI 10.1038/sj.emboj.7601471; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; Szabo I, 2008, P NATL ACAD SCI USA, V105, P14861, DOI [10.1073/pnas.0804236105, 10.1073/pnas.0804236T05]; Teardo E, 2007, BBA-BIOENERGETICS, V1767, P703, DOI 10.1016/j.bbabio.2006.12.002; TESTER M, 1989, PLANT PHYSIOL, V91, P249, DOI 10.1104/pp.91.1.249; Tholema N, 1999, FEBS LETT, V450, P217, DOI 10.1016/S0014-5793(99)00504-9; Tsunekawa K, 2009, J BIOL CHEM, V284, P16513, DOI 10.1074/jbc.M109.001875; Uozumi N, 2001, AM J PHYSIOL-CELL PH, V281, pC733, DOI 10.1152/ajpcell.2001.281.3.C733; Voelker C, 2006, PLANT J, V48, P296, DOI 10.1111/j.1365-313X.2006.02868.x; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898	50	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10118	10.1371/journal.pone.0010118	http://dx.doi.org/10.1371/journal.pone.0010118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20404935	gold, Green Published			2022-12-25	WOS:000276705900005
J	Gluck, JM; Hoffmann, S; Koenig, BW; Willbold, D				Glueck, Julian M.; Hoffmann, Silke; Koenig, Bernd W.; Willbold, Dieter			Single Vector System for Efficient N-myristoylation of Recombinant Proteins in E. coli	PLOS ONE			English	Article							VIRUS TYPE-1 NEF; CD4 CYTOPLASMIC DOMAIN; LENGTH HIV-1 NEF; ESCHERICHIA-COLI; CATALYTIC SUBUNIT; MEMBRANE-BINDING; BACTERIAL EXPRESSION; NMR-SPECTROSCOPY; CALCIUM; KINASE	Background: N-myristoylation is a crucial covalent modification of numerous eukaryotic and viral proteins that is catalyzed by N-myristoyltransferase (NMT). Prokaryotes are lacking endogeneous NMT activity. Recombinant production of N-myristoylated proteins in E. coli cells can be achieved by coexpression of heterologous NMT with the target protein. In the past, dual plasmid systems were used for this purpose. Methodology/Principal Findings: Here we describe a single vector system for efficient coexpression of substrate and enzyme suitable for production of co- or posttranslationally modified proteins. The approach was validated using the HIV-1 Nef protein as an example. A simple and efficient protocol for production of highly pure and completely N-myristoylated Nef is presented. The yield is about 20 mg myristoylated Nef per liter growth medium. Conclusions/Significance: The single vector strategy allows diverse modifications of target proteins recombinantly coexpressed in E. coli with heterologous enzymes. The method is generally applicable and provides large amounts of quantitatively processed target protein that are sufficient for comprehensive biophysical and structural studies.	[Glueck, Julian M.; Hoffmann, Silke; Koenig, Bernd W.; Willbold, Dieter] Res Ctr Julich, Inst Struct Biol & Biophys, Julich, Germany; [Glueck, Julian M.; Koenig, Bernd W.; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, D-4000 Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf	Gluck, JM (corresponding author), Res Ctr Julich, Inst Struct Biol & Biophys, Julich, Germany.	d.willbold@fz-juelich.de	Willbold, Dieter/A-6280-2013; Hoffmann, Silke/H-5059-2013; Gluck, Julian/G-5668-2013; Koenig, Bernd W/B-4315-2008	Willbold, Dieter/0000-0002-0065-7366; Hoffmann, Silke/0000-0003-1414-8957; Gluck, Julian/0000-0002-2833-3988; Koenig, Bernd W/0000-0002-5300-6276	Helmholtz Society	Helmholtz Society(Helmholtz Association)	This work was supported by a grant of the Helmholtz Society (www.helmholtz.de, "Virtual Institute for Structural Biology") to D. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn T, 2004, ARCH PHARM RES, V27, P319, DOI 10.1007/BF02980067; AMES JB, 1994, BIOCHEMISTRY-US, V33, P10743, DOI 10.1021/bi00201a023; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Arien KK, 2008, CURR HIV RES, V6, P200, DOI 10.2174/157016208784325001; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; BENSON RE, 1993, J EXP MED, V177, P1561, DOI 10.1084/jem.177.6.1561; Bentham M, 2006, J GEN VIROL, V87, P563, DOI 10.1099/vir.0.81200-0; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Breuer S, 2006, BIOCHEMISTRY-US, V45, P2339, DOI 10.1021/bi052052c; Briese L, 2005, J BIOMED SCI, V12, P451, DOI 10.1007/s11373-005-6797-z; BURNETTE B, 1992, PROTEIN EXPRES PURIF, V3, P395, DOI 10.1016/S1046-5928(05)80041-5; CARR SA, 1982, P NATL ACAD SCI-BIOL, V79, P6128, DOI 10.1073/pnas.79.20.6128; DURONIO RJ, 1992, P NATL ACAD SCI USA, V89, P4129, DOI 10.1073/pnas.89.9.4129; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; Fackler OT, 2006, CURR OPIN MICROBIOL, V9, P409, DOI 10.1016/j.mib.2006.06.010; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Giese SI, 2006, VIROLOGY, V355, P175, DOI 10.1016/j.virol.2006.07.003; Gillam EMJ, 1997, ARCH BIOCHEM BIOPHYS, V346, P81, DOI 10.1006/abbi.1997.0286; Glover CJ, 1997, J BIOL CHEM, V272, P28680, DOI 10.1074/jbc.272.45.28680; Gluck JM, 2009, J AM CHEM SOC, V131, P12060, DOI 10.1021/ja904897p; Harrer E, 2005, ANTIVIR THER, V10, P285; Hermida-Matsumoto L, 1999, J VIROL, V73, P1902, DOI 10.1128/JVI.73.3.1902-1908.1999; Hoffmann S, 2007, BIOL CHEM, V388, P181, DOI 10.1515/BC.2007.020; Kim KJ, 2004, PROTEIN SCI, V13, P1698, DOI 10.1110/ps.04644504; Kirchhoff F, 2009, NAT REV MICROBIOL, V7, P467, DOI 10.1038/nrmicro2111; LADANT D, 1995, J BIOL CHEM, V270, P3179; Lim S, 2009, BIOCHEMISTRY-US, V48, P850, DOI 10.1021/bi801897p; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Ma HH, 2003, PROTEIN EXPRES PURIF, V27, P49, DOI 10.1016/S1046-5928(02)00541-7; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Preusser A, 2002, BIOCHEM BIOPH RES CO, V292, P734, DOI 10.1006/bbrc.2002.6700; Preusser A, 2001, J VIROL, V75, P3960, DOI 10.1128/JVI.75.8.3960-3964.2001; RAY S, 1992, P NATL ACAD SCI USA, V89, P5705, DOI 10.1073/pnas.89.13.5705; Renkema GH, 2000, FRONT BIOSCI-LANDMRK, V5, pD268, DOI 10.2741/Renkema; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; SHUMAN S, 1990, J BIOL CHEM, V265, P11960; Stangler T, 2007, BIOL CHEM, V388, P611, DOI 10.1515/BC.2007.075; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; WEAVER TA, 1990, J VIROL, V64, P3995, DOI 10.1128/JVI.64.8.3995-4001.1990; Willbold D, 2005, PROTEIN REV, V1, P269; Witte V, 2004, MOL CELL, V13, P179, DOI 10.1016/S1097-2765(04)00004-8; Wittlich M, 2007, BBA-BIOMEMBRANES, V1768, P2949, DOI 10.1016/j.bbamem.2007.10.023; YONEMOTO W, 1993, J BIOL CHEM, V268, P2348; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003	52	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10081	10.1371/journal.pone.0010081	http://dx.doi.org/10.1371/journal.pone.0010081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404920	gold, Green Published			2022-12-25	WOS:000276482100008
J	Carius, Y; Christian, H; Faust, A; Zander, U; Klink, BU; Kornberger, P; Kohring, GW; Giffhorn, F; Scheidig, AJ				Carius, Yvonne; Christian, Henning; Faust, Annette; Zander, Ulrich; Klink, Bjoern U.; Kornberger, Petra; Kohring, Gert-Wieland; Giffhorn, Friedrich; Scheidig, Axel J.			Structural Insight into Substrate Differentiation of the Sugar-metabolizing Enzyme Galactitol Dehydrogenase from Rhodobacter sphaeroides D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; BIOCATALYTIC KETONE REDUCTION; CRYSTAL-STRUCTURE; DIFFRACTION DATA; 1,5-ANHYDRO-D-FRUCTOSE REDUCTASE; BIOCHEMICAL-CHARACTERIZATION; SINORHIZOBIUM-MORELENSE; SORBITOL DEHYDROGENASE; ANGSTROM RESOLUTION; PYRANOSE 2-OXIDASE	Galactitol 2-dehydrogenase (GatDH) belongs to the protein superfamily of short-chain dehydrogenases. As an enzyme capable of the stereo- and regioselective modification of carbohydrates, it exhibits a high potential for application in biotechnology as a biocatalyst. We have determined the crystal structure of the binary form of GatDH in complex with its cofactor NAD(H) and of the ternary form in complex with NAD(H) and three different substrates. The active form of GatDH constitutes a homo-tetramer with two magnesium-ion binding sites each formed by two opposing C termini. The catalytic tetrad is formed by Asn(116), Ser(144), Tyr(159), and Lys(163). GatDH structurally aligns well with related members of the short-chain dehydrogenase family. The substrate binding pocket can be divided into two parts of different size and polarity. In the smaller part, the side chains of amino acids Ser(144), Ser(146), and Asn(151) are important determinants for the binding specificity and the orientation of (pro-) chiral compounds. The larger part of the pocket is elongated and flanked by polar and non-polar residues, enabling a rather broad substrate spectrum. The presented structures provide valuable information for a rational design of this enzyme to improve its stability against pH, temperature, or solvent concentration and to optimize product yield in bioreactors.	[Kornberger, Petra; Kohring, Gert-Wieland; Giffhorn, Friedrich] Univ Saarland, Inst Appl Microbiol, D-66123 Saarbrucken, Germany; [Carius, Yvonne; Christian, Henning; Faust, Annette; Zander, Ulrich; Scheidig, Axel J.] Univ Kiel, Dept Biol Struct, Inst Zool, D-24118 Kiel, Germany; [Klink, Bjoern U.] Helmholtz Ctr Infect Res, Div Struct Biol, D-38124 Braunschweig, Germany; [Christian, Henning] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Struct Biol, D-37077 Gottingen, Germany; [Carius, Yvonne; Zander, Ulrich; Klink, Bjoern U.; Scheidig, Axel J.] Univ Saarland, Dept Biophys, D-66421 Homburg, Germany	Saarland University; University of Kiel; Helmholtz Association; Helmholtz-Center for Infection Research; University of Gottingen; Saarland University	Kohring, GW (corresponding author), Univ Saarland, Inst Appl Microbiol, D-66123 Saarbrucken, Germany.	gkohring@mx.uni-saarland.de; axel.scheidig@strubio.uni-kiel.de	Scheidig, Axel/C-9141-2011	Carius, Yvonne/0000-0003-3902-3122	European Union [NMP3-SL-2008-213487]	European Union(European Commission)	This work was supported by the Seventh Framework Programme of the European Union for the Small Scale Collaborative Project Electrochemical Reactors Using Dehydrogenases for Enantiopure Synthon Preparations (ERUDESP) under Contract NMP3-SL-2008-213487.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bannwarth M, 2006, BIOCHEMISTRY-US, V45, P6587, DOI 10.1021/bi052465d; Bastian S, 2005, APPL MICROBIOL BIOT, V67, P654, DOI 10.1007/s00253-004-1813-1; Benach J, 2002, BIOCHEMISTRY-US, V41, P14659, DOI 10.1021/bi0203684; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bottoms CA, 2002, PROTEIN SCI, V11, P2125, DOI 10.1110/ps.0213502; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Dambe TR, 2006, BIOCHEMISTRY-US, V45, P10030, DOI 10.1021/bi052589q; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Duax WL, 2003, PROTEINS, V53, P931, DOI 10.1002/prot.10512; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; FREIMUND S, 2000, CARBOHYDR LETT, V3, P1585; FURNEAUX RH, 1993, TETRAHEDRON LETT, V34, P3609, DOI 10.1016/S0040-4039(00)73649-5; Gajdizik J, 2007, J SOLID STATE ELECTR, V11, P144, DOI 10.1007/s10008-006-0213-0; GHOSH D, 1991, P NATL ACAD SCI USA, V88, P10064, DOI 10.1073/pnas.88.22.10064; Goldberg K, 2007, APPL MICROBIOL BIOT, V76, P237, DOI 10.1007/s00253-007-1002-0; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hummel W, 1997, Adv Biochem Eng Biotechnol, V58, P145; Huwig A, 1997, CARBOHYD RES, V305, P337, DOI 10.1016/S0008-6215(97)00265-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Jornvall H, 2008, CELL MOL LIFE SCI, V65, P3875, DOI 10.1007/s00018-008-8586-0; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Kallberg Y, 2002, PROTEIN SCI, V11, P636, DOI 10.1110/ps.26902; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; KLASEN R, 1995, J BACTERIOL, V177, P2637, DOI 10.1128/jb.177.10.2637-2643.1995; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kohring G. W., 2003, Communications in Agricultural and Applied Biological Sciences, V68, P309; Kornberger P, 2009, LANGMUIR, V25, P12380, DOI 10.1021/la9010168; Krishnakumar AM, 2006, BIOCHEMISTRY-US, V45, P8831, DOI 10.1021/bi0603569; Kuhn A, 2006, APPL ENVIRON MICROB, V72, P1248, DOI 10.1128/AEM.72.2.1248-1257.2006; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE LG, 1985, J AM CHEM SOC, V107, P6999, DOI 10.1021/ja00310a043; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Liao DI, 2001, BIOCHEMISTRY-US, V40, P8696, DOI 10.1021/bi0107243; MCREE DE, 1993, PRACTICAL PROTEIN CR, P223; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niefind K, 2003, J MOL BIOL, V327, P317, DOI 10.1016/S0022-2836(03)00081-0; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Panke S, 2004, CURR OPIN BIOTECH, V15, P272, DOI 10.1016/j.copbio.2004.06.011; Persson B, 2008, CELL MOL LIFE SCI, V65, P3879, DOI 10.1007/s00018-008-8587-z; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Philippsen A, 2005, ACTA CRYSTALLOGR D, V61, P374, DOI 10.1107/S0907444904034390; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; ROSSMANN MG, 1973, J MOL BIOL, V76, P533, DOI 10.1016/0022-2836(73)90491-9; Rotinen M, 2009, J ENDOCRINOL, V200, P85, DOI 10.1677/JOE-08-0134; SCHNEIDER KH, 1995, MICROBIOL-SGM, V141, P1865, DOI 10.1099/13500872-141-8-1865; SCHNEIDER KH, 1989, EUR J BIOCHEM, V184, P15, DOI 10.1111/j.1432-1033.1989.tb14984.x; SCHUTTE H, 1976, EUR J BIOCHEM, V62, P151, DOI 10.1111/j.1432-1033.1976.tb10108.x; Stein MA, 1997, J BACTERIOL, V179, P6335, DOI 10.1128/jb.179.20.6335-6340.1997; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tickle IJ, 2000, ACTA CRYSTALLOGR D, V56, P442, DOI 10.1107/S0907444999016868; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Zaccai NR, 2008, PROTEINS, V70, P562, DOI 10.1002/prot.21624; Zhang QM, 2009, PROTEIN SCI, V18, P294, DOI 10.1002/pro.32	65	14	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20006	20014		10.1074/jbc.M110.113738	http://dx.doi.org/10.1074/jbc.M110.113738			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20410293	Green Published, hybrid			2022-12-25	WOS:000279012000034
J	Yang, SNY; Takeda, AAS; Fontes, MRM; Harris, JM; Jans, DA; Kobe, B				Yang, Sundy N. Y.; Takeda, Agnes A. S.; Fontes, Marcos R. M.; Harris, Jonathan M.; Jans, David A.; Kobe, Bostjan			Probing the Specificity of Binding to the Major Nuclear Localization Sequence-binding Site of Importin-alpha Using Oriented Peptide Library Screening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SV40 T-ANTIGEN; STRUCTURAL BASIS; KARYOPHERIN ALPHA; PROTEIN IMPORT; CRYSTALLOGRAPHIC ANALYSIS; DIFFERENTIAL EXPRESSION; IN-VIVO; SIGNAL; RECOGNITION; TRANSPORT	Importin-alpha is the nuclear import receptor that recognizes the classic monopartite and bipartite nuclear localization sequences (cNLSs), which contain one or two clusters of basic amino acids, respectively. Different importin-alpha paralogs in a single organism are specific for distinct repertoires of cargos. Structural studies revealed that monopartite cNLSs and the C-terminal basic clusters of the bipartite cNLSs bind to the same site on importin-alpha, termed the major cNLS-binding site. We used an oriented peptide library approach with five degenerate positions to probe the specificity of the major cNLS-binding site in importin-alpha. We identified the sequences KKKRR, KKKRK, and KKRKK as the optimal sequences for binding to this site for mouse importin-alpha 2, human importin-alpha 1, and human importin-alpha 5, respectively. The crystal structure of mouse importin-alpha 2 with its optimal peptide confirmed the expected binding mode resembling the binding of simian virus 40 large tumor-antigen cNLS. Binding assays confirmed that the peptides containing these sequences bound to the corresponding proteins with low nanomolar affinities. Nuclear import assays showed that the sequences acted as functional cNLSs, with specificity for particular importin-alpha s. This is the first time that structural information has been linked to an oriented peptide library screening approach for importin-alpha; the results will contribute to understanding of the sequence determinants of cNLSs, and may help identify as yet unidentified cNLSs in novel proteins.	[Yang, Sundy N. Y.; Takeda, Agnes A. S.; Fontes, Marcos R. M.; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Yang, Sundy N. Y.; Takeda, Agnes A. S.; Fontes, Marcos R. M.; Kobe, Bostjan] Univ Queensland, Ctr Infect Dis Res, Brisbane, Qld 4072, Australia; [Yang, Sundy N. Y.; Jans, David A.] Monash Univ, Nucl Signalling Lab, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia; [Takeda, Agnes A. S.; Fontes, Marcos R. M.] Univ Estadual Paulista, Dept Fis & Biofis, Inst Biociencias, BR-18618000 Sao Paulo, Brazil; [Harris, Jonathan M.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Fac Sci, Brisbane, Qld 4059, Australia; [Harris, Jonathan M.] Queensland Univ Technol, Sch Life Sci, Fac Sci, Brisbane, Qld 4059, Australia	University of Queensland; University of Queensland; Monash University; Universidade de Sao Paulo; Universidade Estadual Paulista; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Kobe, B (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	b.kobe@uq.edu.au	Takeda, Agnes/A-1352-2014; Takeda, Agnes/AAH-3413-2020; Fontes, Marcos Roberto/B-1941-2009; Kobe, Bostjan/D-1292-2009	Takeda, Agnes/0000-0001-5000-6652; Takeda, Agnes/0000-0001-5000-6652; Fontes, Marcos Roberto/0000-0002-4634-6221; Kobe, Bostjan/0000-0001-9413-9166; Harris, Jonathan/0000-0003-4209-2380; yang, sundy/0000-0003-2418-1611; Jans, David/0000-0001-5115-4745	Australian Research Council (ARC); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil	Australian Research Council (ARC)(Australian Research Council); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported in part by grants from the Australian Research Council (ARC, to B.K.) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil, to M.R.M.F.).	Aitchison JD, 2007, NATURE, V450, P621, DOI 10.1038/450621a; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Efthymiadis A, 1997, J BIOL CHEM, V272, P22134, DOI 10.1074/jbc.272.35.22134; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Fontes MRM, 2003, BIOCHEM J, V375, P339, DOI 10.1042/BJ20030510; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Guillemain G, 2002, BIOCHEM J, V364, P201, DOI 10.1042/bj3640201; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Hu W, 2005, J CELL BIOCHEM, V95, P782, DOI 10.1002/jcb.20439; Hu W, 1999, J BIOL CHEM, V274, P15820, DOI 10.1074/jbc.274.22.15820; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; Jiang CJ, 2001, J BIOL CHEM, V276, P9322, DOI 10.1074/jbc.M006430200; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; Kohler M, 2002, CELL PHYSIOL BIOCHEM, V12, P335; Kohler M, 2001, VIROLOGY, V289, P186, DOI 10.1006/viro.2001.1151; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Malik HS, 1997, P NATL ACAD SCI USA, V94, P13738, DOI 10.1073/pnas.94.25.13738; Mason DA, 2009, J MOL EVOL, V68, P351, DOI 10.1007/s00239-009-9215-8; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Miyamoto Y, 1997, J BIOL CHEM, V272, P26375, DOI 10.1074/jbc.272.42.26375; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nadler SG, 1997, J BIOL CHEM, V272, P4310, DOI 10.1074/jbc.272.7.4310; OBryan JP, 1996, J BIOL CHEM, V271, P11787, DOI 10.1074/jbc.271.20.11787; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; SIMONS K, 1987, EMBO J, V6, P2241, DOI 10.1002/j.1460-2075.1987.tb02496.x; Stryhn A, 1996, EUR J IMMUNOL, V26, P1911, DOI 10.1002/eji.1830260836; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Tsuji L, 1997, FEBS LETT, V416, P30, DOI 10.1016/S0014-5793(97)01092-2; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zhou SY, 2001, METHOD ENZYMOL, V332, P183	61	51	51	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19935	19946		10.1074/jbc.M109.079574	http://dx.doi.org/10.1074/jbc.M109.079574			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20406804	Green Published, hybrid			2022-12-25	WOS:000279012000027
J	Snodgrass, RG; Collier, AC; Coon, AE; Pritsos, CA				Snodgrass, Ryan G.; Collier, Abby C.; Coon, Amy E.; Pritsos, Chris A.			Mitomycin C Inhibits Ribosomal RNA A NOVEL CYTOTOXIC MECHANISM FOR BIOREDUCTIVE DRUGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XANTHINE OXIDOREDUCTASE; REDUCTIVE ACTIVATION; ESCHERICHIA-COLI; DT-DIAPHORASE; DNA; CELLS; TARGET; ADDUCT; BIOACTIVATION; PORFIROMYCIN	Mitomycin C (MMC) is a commonly used and extensively studied chemotherapeutic agent requiring biological reduction for activity. Damage to nuclear DNA is thought to be its primary mechanism of cell death. Due to a lack of evidence for significant MMC activation in the nucleus and for in vivo studies demonstrating the formation of MMC-DNA adducts, we chose to investigate alternative nucleic acid targets. Real-time reverse transcription-PCR was used to determine changes in mitochondrial gene expression induced by MMC treatment. Although no consistent effects on mitochondrial mRNA expression were observed, complementary results from reverse transcription PCR experiments and gel-shift and binding assays demonstrated that MMC rapidly decreased the transcript levels of 18S ribosomal RNA in a concentration-dependent manner. Under hypoxic conditions, transcript levels of 18S rRNA decreased by 1.5-fold compared with untreated controls within 30 min. Recovery to base line required several hours, indicating that de novo synthesis of 18S was necessary. Addition of MMC to an in vitro translation reaction significantly decreased protein production in the cell-free system. Functional assays performed using a luciferase reporter construct in vivo determined that protein translation was inhibited, further confirming this mechanism of toxicity. The interaction of MMC with ribosomal RNA and subsequent inhibition of protein translation is consistent with mechanisms proposed for other natural compounds.	[Collier, Abby C.; Pritsos, Chris A.] Univ Nevada, Grad Program Environm Sci & Hlth, Reno, NV 89557 USA; [Snodgrass, Ryan G.; Collier, Abby C.; Coon, Amy E.; Pritsos, Chris A.] Univ Nevada, Dept Nutr, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Pritsos, CA (corresponding author), 1664 N Virginia MS 142, Reno, NV 89557 USA.	pritsos@cabnr.unr.edu	Snodgrass, Ryan G./AAH-5110-2021; Snodgrass, Ryan G/U-1031-2018	Snodgrass, Ryan G./0000-0001-9896-5297; Snodgrass, Ryan G/0000-0001-9896-5297; Collier, Abby/0000-0002-5382-2644	Nevada Agricultural Experiment Station	Nevada Agricultural Experiment Station	This work was supported in part by the Nevada Agricultural Experiment Station.	Bianchi NO, 2001, MUTAT RES-REV MUTAT, V488, P9, DOI 10.1016/S1383-5742(00)00063-6; BIZANEK R, 1993, CANCER RES, V53, P5127; Briggs LA, 1999, BIOCHEM PHARMACOL, V58, P1609, DOI 10.1016/S0006-2952(99)00254-3; CANTATORE P, 1987, FEBS LETT, V213, P144, DOI 10.1016/0014-5793(87)81480-1; COOPER HL, 1973, J CELL BIOL, V59, P250, DOI 10.1083/jcb.59.1.250; Cullinane C, 1998, CANCER RES, V58, P1400; Danson S, 2004, CANCER TREAT REV, V30, P437, DOI 10.1016/j.ctrv.2004.01.002; Doudna JA, 2002, CELL, V109, P153, DOI 10.1016/S0092-8674(02)00725-0; Ecker DJ, 1999, DRUG DISCOV TODAY, V4, P420, DOI 10.1016/S1359-6446(99)01389-6; EMERSON CP, 1971, NATURE-NEW BIOL, V232, P101, DOI 10.1038/newbio232101a0; FEIGON J, 1982, NUCLEIC ACIDS RES, V10, P749, DOI 10.1093/nar/10.2.749; Fitzsimmons SA, 1996, J NATL CANCER I, V88, P259, DOI 10.1093/jnci/88.5.259; GATTI C, 1975, BIOCHIM BIOPHYS ACTA, V407, P308, DOI 10.1016/0005-2787(75)90098-2; GUSTAFSON DL, 1992, JNCI-J NATL CANCER I, V84, P1180, DOI 10.1093/jnci/84.15.1180; HODNICK WF, 1993, CANCER RES, V53, P4907; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; Iyer V.N., 1964, MICROBIAL GENETICS B, V21, P16; IYER VN, 1963, P NATL ACAD SCI USA, V50, P355, DOI 10.1073/pnas.50.2.355; IYER VN, 1964, SCIENCE, V145, P55, DOI 10.1126/science.145.3627.55; KATO N, 1970, J BIOCHEM, V67, P175, DOI 10.1093/oxfordjournals.jbchem.a129241; KEOHANE A, 1990, BRIT J CANCER, V61, P722, DOI 10.1038/bjc.1990.162; Linder N, 2006, J CLIN PATHOL, V59, P965, DOI 10.1136/jcp.2005.032524; Linder N, 2005, CLIN CANCER RES, V11, P4372, DOI 10.1158/1078-0432.CCR-04-2280; MARSHALL RS, 1991, BIOCHEM PHARMACOL, V41, P1351, DOI 10.1016/0006-2952(91)90108-H; MATSUMOTO I, 1963, EXP CELL RES, V32, P192, DOI 10.1016/0014-4827(63)90089-2; MAUCK JC, 1973, P NATL ACAD SCI USA, V70, P2819, DOI 10.1073/pnas.70.10.2819; McKeown SR, 2007, CLIN ONCOL-UK, V19, P427, DOI 10.1016/j.clon.2007.03.006; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; PAN SS, 1984, J BIOL CHEM, V259, P959; Park SJ, 2003, MUTAT RES-GEN TOX EN, V536, P131, DOI 10.1016/S1383-5718(03)00041-X; Perry R P, 1973, Basic Life Sci, V1, P149; Perry R P, 1973, Biochem Soc Symp, V37, P105; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pritsos CA, 1997, ONCOL RES, V9, P333; RAUTH AM, 1983, CANCER RES, V43, P4154; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; SCHMID M, 1994, HUM GENET, V93, P375; Seow HA, 2005, MOL PHARMACOL, V67, P417, DOI 10.1124/mol.104.004929; Seow HA, 2004, J BIOL CHEM, V279, P31606, DOI 10.1074/jbc.M404910200; SIEGEL D, 1992, BIOCHEMISTRY-US, V31, P7879, DOI 10.1021/bi00149a019; SIEGEL D, 1990, CANCER RES, V50, P7483; Spanswick VJ, 1996, BIOCHEM PHARMACOL, V51, P1623, DOI 10.1016/0006-2952(96)00104-9; SUZUKI H, 1967, J BACTERIOL, V94, P666, DOI 10.1128/JB.94.3.666-676.1967; TEICHER BA, 1981, CANCER RES, V41, P73; TENG SP, 1989, BIOCHEMISTRY-US, V28, P3901, DOI 10.1021/bi00435a041; TOMASZ M, 1991, CANCER COMMUN, V3, P213, DOI 10.3727/095535491820873227; TOMASZ M, 1987, SCIENCE, V235, P1204, DOI 10.1126/science.3103215; VERWEIJ J, 1990, Anti-Cancer Drugs, V1, P5, DOI 10.1097/00001813-199010000-00002; WEISSBAC.A, 1965, BIOCHEMISTRY-US, V4, P196, DOI 10.1021/bi00878a003	50	45	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19068	19075		10.1074/jbc.M109.040477	http://dx.doi.org/10.1074/jbc.M109.040477			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20418373	Green Published, hybrid			2022-12-25	WOS:000278727800016
J	Iwamoto, T; Nakamura, T; Doyle, A; Ishikawa, M; de Vega, S; Fukumoto, S; Yamada, Y				Iwamoto, Tsutomu; Nakamura, Takashi; Doyle, Andrew; Ishikawa, Masaki; de Vega, Susana; Fukumoto, Satoshi; Yamada, Yoshihiko			Pannexin 3 Regulates Intracellular ATP/cAMP Levels and Promotes Chondrocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PEPTIDE; GAP-JUNCTION PROTEINS; BONE MORPHOGENETIC PROTEIN-2; PARATHYROID-HORMONE; PTH/PTHRP RECEPTOR; GROWTH-PLATE; ATDC5 CELLS; CYCLIN D1; EXPRESSION; FAMILY	Pannexin 3 (Panx3) is a new member of the gap junction pannexin family, but its expression profiles and physiological function are not yet clear. We demonstrate in this study that Panx3 is expressed in cartilage and regulates chondrocyte proliferation and differentiation. Panx3 mRNA was expressed in the prehypertrophic zone in the developing growth plate and was induced during the differentiation of chondrogenic ATDC5 and N1511 cells. Panx3-transfected ATDC5 and N1511 cells promoted chondrogenic differentiation, but the suppression of endogenous Panx3 inhibited differentiation of ATDC5 cells and primary chondrocytes. Panx3-transfected ATDC5 cells reduced parathyroid hormone-induced cell proliferation and promoted the release of ATP into the extracellular space, possibly by action of Panx3 as a hemichannel. Panx3 expression in ATDC5 cells reduced intracellular cAMP levels and the activation of cAMP-response element-binding, a protein kinase A downstream effector. These Panx3 activities were blocked by anti-Panx3 antibody. Our results suggest that Panx3 functions to switch the chondrocyte cell fate from proliferation to differentiation by regulating the intracellular ATP/cAMP levels.	[Iwamoto, Tsutomu; Nakamura, Takashi; Doyle, Andrew; Ishikawa, Masaki; de Vega, Susana; Yamada, Yoshihiko] NIDCR, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA; [Iwamoto, Tsutomu; Nakamura, Takashi; Fukumoto, Satoshi] Tohoku Univ, Grad Sch Dent, Dept Pediat Dent, Sendai, Miyagi 9808576, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Tohoku University	Yamada, Y (corresponding author), NIDCR, Lab Cell & Dev Biol, NIH, Bldg 30,Rm 407,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	yoshi.yamada@nih.gov	Iwamoto, Tsutomu/AAA-6597-2019; Iwamoto, Tsutomu/AAI-8952-2021; Nakamura, Takashi/P-7796-2016; Nakamura, Takashi/A-8931-2012; de Vega, Susana/AAH-4775-2020	Iwamoto, Tsutomu/0000-0001-8472-605X; Nakamura, Takashi/0000-0001-9904-1037; Nakamura, Takashi/0000-0001-9904-1037; Fukumoto, Satoshi/0000-0002-5046-6891	National Institutes of Health, NIDCR; Japan Society for the Promotion of Science [20791583]; Ministry of Education, Science, and Culture of Japan [20679006]; Grants-in-Aid for Scientific Research [22659373] Funding Source: KAKEN; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000524, ZIADE000483, ZIADE000720] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by a National Institutes of Health grant from Intramural Research Program of NIDCR (to Y. Y.). This work was also supported by Grant-in-aid for Research Fellows 20791583 from the Japan Society for the Promotion of Science (to T. I.) and Grant-in-aid from the Ministry of Education, Science, and Culture of Japan 20679006 (to S. F.).	ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Beier F, 2002, MOL ENDOCRINOL, V16, P2163, DOI 10.1210/me.2001-0103; Beier F, 2001, MOL BIOL CELL, V12, P3852, DOI 10.1091/mbc.12.12.3852; BRINGHURST FR, 1993, ENDOCRINOLOGY, V132, P2090, DOI 10.1210/en.132.5.2090; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Cooper DMF, 2003, BIOCHEM J, V375, P517, DOI 10.1042/BJ20031061; Ionescu AM, 2001, J BIOL CHEM, V276, P11639, DOI 10.1074/jbc.M006564200; Kamiya N, 2002, J BONE MINER RES, V17, P1832, DOI 10.1359/jbmr.2002.17.10.1832; Kaplan AD, 1996, ENDOCRINOLOGY, V137, P4757, DOI 10.1210/en.137.11.4757; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Kjaer AW, 2004, AM J MED GENET A, V127A, P152, DOI 10.1002/ajmg.a.20614; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Miao DS, 2002, J CLIN INVEST, V109, P1173, DOI 10.1172/JCI200214817; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2008, CELL COMMUN ADHES, V15, P133, DOI 10.1080/15419060802014115; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Richardson RR, 2004, J MED GENET, V41, P60, DOI 10.1136/jmg.2003.012005; Schipani E, 1997, P NATL ACAD SCI USA, V94, P13689, DOI 10.1073/pnas.94.25.13689; Schwindinger WF, 1998, ENDOCRINE, V8, P201, DOI 10.1385/ENDO:8:2:201; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; Singh ATK, 2005, ENDOCRINOLOGY, V146, P2171, DOI 10.1210/en.2004-1283; Tonon R, 2000, J BONE MINER RES, V15, P1669, DOI 10.1359/jbmr.2000.15.9.1669; Vanden Abeele F, 2006, J CELL BIOL, V174, P535, DOI 10.1083/jcb.200601115; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Wang XH, 2009, J COMP NEUROL, V512, P336, DOI 10.1002/cne.21898; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Weir EC, 1996, P NATL ACAD SCI USA, V93, P10240, DOI 10.1073/pnas.93.19.10240; Williams JA, 2009, DEV BIOL, V328, P315, DOI 10.1016/j.ydbio.2009.01.031; Yamasaki H, 1996, CARCINOGENESIS, V17, P1199, DOI 10.1093/carcin/17.6.1199; Zhang W, 2002, J CELL PHYSIOL, V193, P233, DOI 10.1002/jcp.10168	40	107	110	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18948	18958		10.1074/jbc.M110.127027	http://dx.doi.org/10.1074/jbc.M110.127027			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20404334	Green Published, hybrid			2022-12-25	WOS:000278453900085
J	Lachmann, PJ				Lachmann, Peter J.			Religion-An evolutionary adaptation	FASEB JOURNAL			English	Article									Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	University of Cambridge	Lachmann, PJ (corresponding author), Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England.	pjl1000@cam.ac.uk	Lachmann, P J/I-7968-2019	Lachmann, P J/0000-0003-2849-3524				Conze E., 1951, BUDDHISM ITS ESSENCE; Dawkins R, 1976, SELFISH GENE; DIAMOND J, 2005, COLLAPSE, pCH8; FITZGERALD E, 1868, RUBAIYAT OMAR KHAYYA, P108; GRAHAMSMITH F, 1994, POPULATION COMPLEX R; Lachmann PJ, 2009, AM J PSYCHOL, V122, P272; Lachmann P. J., 1983, CAMBRIDGE REV, V104, P22; LACHMANN PJ, 2010, EUR REV IN PRESS; Lumsden C. J., 1981, GENES MIND CULTURE; Oldstone-Moore J, 2002, CONFUCIANISM; POPPER KR, 1959, ECONOMETRICA; SMITH JM, 1964, NATURE, V201, P1145, DOI 10.1038/2011145a0; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; Wilson David Sloan., 2002, DARWINS CATHEDRAL	14	4	4	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2010	24	5					1301	1307		10.1096/fj.10-0502ufm	http://dx.doi.org/10.1096/fj.10-0502ufm			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20430796				2022-12-25	WOS:000277158900002
J	Obeso, D; Dawson, DS				Obeso, David; Dawson, Dean S.			Temporal Characterization of Homology-Independent Centromere Coupling in Meiotic Prophase	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX PROTEIN; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SYNAPSIS; BUDDING YEAST; MEIOSIS; PROMOTES; RECOMBINATION; BEHAVIOR; MUTANTS	Background: Over the past thirty years several reports of the pairing or association of non-homologous centromeres during meiotic prophase have appeared in the literature. Recently, the homology-independent pairwise association of centromeres, termed centromere coupling, was also reported in budding yeast. It seems paradoxical that centromeres would pair with non-homologous partners during a process intended to align homologous chromosomes, yet the conservation of this phenomenon across a wide range of species suggests it may play an important role in meiosis. Principal Findings: To better define the role of this phenomenon in budding yeast, experiments were preformed to place centromere coupling within the context of landmark meiotic events. Soon after the initiation of the meiotic program, centromeres were found to re-organize from a single cluster into non-homologous couples. Centromere coupling is detected as soon as chromosome replication is finished and persists while the recombination protein Dmc1 is loaded onto the chromosomes, suggesting that centromere coupling persists through the time of double strand break formation. In the absence of the synaptonemal complex component, Zip1, centromere coupling was undetectable, at all times examined, confirming the essential role of this protein on this process. Finally, the timely release of centromere coupling depends on the recombination-initiating enzyme, Spo11, suggesting a connection between events in homologous pairing/recombination and the regulation of centromere coupling. Conclusions: Based on our results we propose a role for centromere coupling in blocking interactions between homologous centromeres as recombination initiation is taking place.	[Obeso, David; Dawson, Dean S.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Obeso, David; Dawson, Dean S.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Obeso, D (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	dawsond@omrf.org			Barrett Scholarship; National Institutes of Health (NIH) [GM75363]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075363] Funding Source: NIH RePORTER	Barrett Scholarship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Barrett Scholarship to DO and National Institutes of Health (NIH) grant GM75363 to DD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDHAN A, 2010, MOL BIOL CE IN PRESS; Bhuiyan H, 2004, GENETICS, V168, P775, DOI 10.1534/genetics.104.029660; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Borner GV, 2008, P NATL ACAD SCI USA, V105, P3327, DOI 10.1073/pnas.0711864105; Burke D., 2000, METHODS YEAST GENETI; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; CHURCH K, 1976, CHROMOSOMA, V56, P249, DOI 10.1007/BF00293189; CLARKE L, 1983, NATURE, V305, P23, DOI 10.1038/305023a0; Corredor E, 2007, GENETICS, V177, P699, DOI 10.1534/genetics.107.078121; DRESSER ME, 1988, J CELL BIOL, V106, P567, DOI 10.1083/jcb.106.3.567; Gladstone MN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000771; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Haase Steven B, 2004, Curr Protoc Cytom, VChapter 7, DOI 10.1002/0471142956.cy0723s26; Hayashi A, 1998, GENES CELLS, V3, P587, DOI 10.1046/j.1365-2443.1998.00215.x; Henderson KA, 2004, P NATL ACAD SCI USA, V101, P4519, DOI 10.1073/pnas.0400843101; Jin QW, 1998, J CELL BIOL, V141, P21, DOI 10.1083/jcb.141.1.21; Koehler KE, 1996, HUM MOL GENET, V5, P1495, DOI 10.1093/hmg/5.Supplement_1.1495; LAMBIE EJ, 1986, GENETICS, V114, P769; LOIDL J, 1994, J CELL BIOL, V125, P1191, DOI 10.1083/jcb.125.6.1191; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; NAG DK, 1995, GENETICS, V141, P75; Newnham L, 2010, P NATL ACAD SCI USA, V107, P781, DOI 10.1073/pnas.0913435107; Rockmill B, 2006, GENETICS, V174, P1745, DOI 10.1534/genetics.106.058933; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Stewart MN, 2008, TRENDS GENET, V24, P564, DOI 10.1016/j.tig.2008.08.006; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Tsubouchi T, 2005, SCIENCE, V308, P870, DOI 10.1126/science.1108283; Tsubouchi T, 2008, GENE DEV, V22, P3217, DOI 10.1101/gad.1709408; Tung KS, 1998, GENETICS, V149, P817; WEINER BM, 1994, CELL, V77, P977, DOI 10.1016/0092-8674(94)90438-3	31	32	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10336	10.1371/journal.pone.0010336	http://dx.doi.org/10.1371/journal.pone.0010336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428251	gold, Green Published, Green Submitted			2022-12-25	WOS:000277079300020
J	Etchegaray, JP; Yu, EA; Indic, P; Dallmann, R; Weaver, DR				Etchegaray, Jean-Pierre; Yu, Elizabeth A.; Indic, Premananda; Dallmann, Robert; Weaver, David R.			Casein Kinase 1 Delta (CK1 delta) Regulates Period Length of the Mouse Suprachiasmatic Circadian Clock In Vitro	PLOS ONE			English	Article							GENE-EXPRESSION; CKI-EPSILON; WAVELET ANALYSIS; RHYTHMS; MAMMALS; PHOSPHORYLATION; DEGRADATION; PROTEINS; REVEALS; ROLES	Background: Casein kinase 1 delta (CK1 delta) plays a more prominent role in the regulation of circadian cycle length than its homologue casein kinase 1 epsilon (CK1 epsilon) in peripheral tissues such as liver and embryonic fibroblasts. Mice lacking CK1 delta die shortly after birth, so it has not been possible to assess the impact of loss of CK1 delta on behavioral rhythms controlled by the master circadian oscillator in the suprachiasmatic nuclei (SCN). Methodology/Principal Findings: In the present study, mPER2::LUCIFERASE bioluminescence rhythms were monitored from SCN explants collected from neonatal mice. The data demonstrate that SCN explants from neonatal CK1 delta-deficient mice oscillate, but with a longer circadian period than littermate controls. The cycle length of rhythms recorded from neonatal SCN explants of CK1 epsilon-deficient mice did not differ from control explants. Conclusions/Significance: The results indicate that CK1 delta plays a more prominent role than CK1 epsilon in the maintenance of 24-hour rhythms in the master circadian oscillator.	[Etchegaray, Jean-Pierre; Yu, Elizabeth A.; Dallmann, Robert; Weaver, David R.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Indic, Premananda] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Etchegaray, JP (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	David.weaver@umassmed.edu	Dallmann, Bob/AAA-4929-2022	Dallmann, Robert/0000-0002-7490-0218; Weaver, David/0000-0001-7941-6719	National Institutes of Neurological Diseases and Stroke, National Institutes of Health [R01 NS056125]; Deutsche Forschungsgemeinschaft (DFG) [DA525/2-1]; Diabetes Endocrinology Research Center [DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056125] Funding Source: NIH RePORTER	National Institutes of Neurological Diseases and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Diabetes Endocrinology Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Award R01 NS056125 from the National Institutes of Neurological Diseases and Stroke (to DRW). RD was supported in part by grant DA525/2-1 from the Deutsche Forschungsgemeinschaft (DFG). Core resources supported by the Diabetes Endocrinology Research Center grant DK32520 were also used. DRW is a member of the University of Massachusetts Medical School Diabetes and Endocrinology Research Center (DK 32520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; Badura L, 2007, J PHARMACOL EXP THER, V322, P730, DOI 10.1124/jpet.107.122846; Carmona RA, 1999, IEEE T SIGNAL PROCES, V47, P480, DOI 10.1109/78.740131; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Etchegaray JP, 2009, MOL CELL BIOL, V29, P3853, DOI 10.1128/MCB.00338-09; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Isojima Y, 2009, P NATL ACAD SCI USA, V106, P15744, DOI 10.1073/pnas.0908733106; Izumo M, 2003, P NATL ACAD SCI USA, V100, P16089, DOI 10.1073/pnas.2536313100; Lee H, 2009, P NATL ACAD SCI USA, V106, P21359, DOI 10.1073/pnas.0906651106; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Price TS, 2008, BIOINFORMATICS, V24, P2794, DOI 10.1093/bioinformatics/btn521; Priestley M. B., 1981, SPECTRAL ANAL TIME S, V1; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Sprouse J, 2009, PSYCHOPHARMACOLOGY, V204, P735, DOI 10.1007/s00213-009-1503-x; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tsuchiya Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000305; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Walton KM, 2009, J PHARMACOL EXP THER, V330, P430, DOI 10.1124/jpet.109.151415; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7	25	33	35	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10303	10.1371/journal.pone.0010303	http://dx.doi.org/10.1371/journal.pone.0010303			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421981	Green Published, gold, Green Submitted			2022-12-25	WOS:000276952600020
J	Gao, MC; Bellugi, U; Dai, L; Mills, DL; Sobel, EM; Lange, K; Korenberg, JR				Gao, Michael C.; Bellugi, Ursula; Dai, Li; Mills, Debra L.; Sobel, Eric M.; Lange, Kenneth; Korenberg, Julie R.			Intelligence in Williams Syndrome Is Related to STX1A, Which Encodes a Component of the Presynaptic SNARE Complex	PLOS ONE			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; GENE-EXPRESSION; MOLECULAR-GENETICS; SYNTAXIN; IMMUNE; BRAIN; 1A; COGNITION; DOPAMINE; GTF2IRD1	Although genetics is the most significant known determinant of human intelligence, specific gene contributions remain largely unknown. To accelerate understanding in this area, we have taken a new approach by studying the relationship between quantitative gene expression and intelligence in a cohort of 65 patients with Williams Syndrome (WS), a neurodevelopmental disorder caused by a 1.5 Mb deletion on chromosome 7q11.23. We find that variation in the transcript levels of the brain gene STX1A correlates significantly with intelligence in WS patients measured by principal component analysis (PCA) of standardized WAIS-R subtests, r = 0.40 (Pearson correlation, Bonferroni corrected p-value = 0.007), accounting for 15.6% of the cognitive variation. These results suggest that syntaxin 1A, a neuronal regulator of presynaptic vesicle release, may play a role in WS and be a component of the cellular pathway determining human intelligence.	[Gao, Michael C.; Korenberg, Julie R.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Gao, Michael C.; Sobel, Eric M.; Lange, Kenneth; Korenberg, Julie R.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Gao, Michael C.; Korenberg, Julie R.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Bellugi, Ursula] Salk Inst Biol Studies, Cognit Neurosci Lab, La Jolla, CA USA; [Dai, Li; Korenberg, Julie R.] Univ Utah, Dept Pediat, Inst Brain, Ctr Integrated Neurosci & Human Behav, Salt Lake City, UT USA; [Mills, Debra L.] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Lange, Kenneth] Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA; [Lange, Kenneth] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Salk Institute; Utah System of Higher Education; University of Utah; Bangor University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gao, MC (corresponding author), Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA.	julie.korenberg@hsc.utah.edu		Sobel, Eric/0000-0002-1718-0031	National Institute of Child Health and Human Development [P01 HD33113]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD033113] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from the National Institute of Child Health and Human Development Grant: P01 HD33113 (U.B., J.R.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, WAIS R MANUAL; Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; Bellugi U, 1999, TRENDS NEUROSCI, V22, P197, DOI 10.1016/S0166-2236(99)01397-1; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Botta A, 1999, J MED GENET, V36, P478; Bowden NA, 2006, SCHIZOPHR RES, V82, P175, DOI 10.1016/j.schres.2005.11.012; Burdick KE, 2006, HUM MOL GENET, V15, P1563, DOI 10.1093/hmg/ddi481; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Collette JC, 2009, J HUM GENET, V54, P193, DOI 10.1038/jhg.2009.5; Dai L, 2009, AM J MED GENET A, V149A, P302, DOI 10.1002/ajmg.a.32652; Dick DM, 2007, BEHAV GENET, V37, P265, DOI 10.1007/s10519-006-9131-2; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Enns RA, 1998, J CLIN PSYCHOL, V54, P447, DOI 10.1002/(SICI)1097-4679(199806)54:4<447::AID-JCLP7>3.0.CO;2-K; FARAJ BA, 1991, PHARMACOLOGY, V42, P135, DOI 10.1159/000138790; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbp.2004.01.009; GUADAGNOLI E, 1988, PSYCHOL BULL, V103, P265, DOI 10.1037/0033-2909.103.2.265; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; Howlin P, 1998, J CHILD PSYCHOL PSYC, V39, P183, DOI 10.1017/S0021963097001789; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Joy S, 2003, ASSESSMENT, V10, P56, DOI 10.1177/0095399702250335; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Korenberg JR, 2000, J COGNITIVE NEUROSCI, V12, P89, DOI 10.1162/089892900562002; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; Lam PPL, 2005, DIABETES, V54, P2744, DOI 10.2337/diabetes.54.9.2744; Maes OC, 2007, NEUROBIOL AGING, V28, P1795, DOI 10.1016/j.neurobiolaging.2006.08.004; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Minger SL, 2001, J NEUROPATH EXP NEUR, V60, P929, DOI 10.1093/jnen/60.10.929; Nakamura K, 2008, INT J NEUROPSYCHOPH, V11, P1073, DOI 10.1017/S1461145708009036; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Plomin R, 1999, NATURE, V402, pC25, DOI 10.1038/35011520; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; Quick MW, 1997, J NEUROSCI, V17, P2967; RuizMontasell B, 1996, EUR J NEUROSCI, V8, P2544, DOI 10.1111/j.1460-9568.1996.tb01548.x; Ryten Mina, 2009, Briefings in Functional Genomics & Proteomics, V8, P194, DOI 10.1093/bfgp/elp028; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Tassabehji M, 1999, AM J HUM GENET, V64, P118, DOI 10.1086/302214; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Wang Y, 2008, J IMMUNOL, V181, P8226, DOI 10.4049/jimmunol.181.12.8226; Yamaguchi Y, 2004, AM J PHYSIOL-ENDOC M, V287, pE970, DOI 10.1152/ajpendo.00027.2003	43	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10292	10.1371/journal.pone.0010292	http://dx.doi.org/10.1371/journal.pone.0010292			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422020	Green Published, gold			2022-12-25	WOS:000276952500035
J	Halsey, LG; White, CR				Halsey, Lewis G.; White, Craig R.			Measuring Energetics and Behaviour Using Accelerometry in Cane Toads Bufo marinus	PLOS ONE			English	Article							ESTIMATING ENERGY-EXPENDITURE; DOUBLY LABELED WATER; HEART-RATE; METABOLIC-RATE; LOCOMOTORY ENERGETICS; BODY-TEMPERATURE; THERMAL-DEPENDENCE; OXYGEN-CONSUMPTION; DYNAMIC ACTION; MEAL SIZE	Cane toads Bufo marinus were introduced to Australia as a control agent but now have a rapidly progressing invasion front and damage new habitats they enter. Predictive models that can give expansion rates as functions of energy supply and feeding ground distribution could help to maximise control efficiency but to date no study has measured rates of field energy expenditure in an amphibian. In the present study we used the accelerometry technique to generate behavioural time budgets and, through the derivation of ODBA (overall dynamic body acceleration), to obtain estimates of energetics in free ranging cane toads. This represents the first time that accelerometers have been used to not only quantify the behaviour of animals but also assign to those behaviours rates of energy expenditure. Firstly, laboratory calibrations between ODBA and metabolic rate were obtained and used to generate a common prediction equation for the subject toads (R-2 = 0.74). Furthermore, acceleration data recorded during different behaviours was studied to ascertain threshold values for objectively defining behaviour categories. Importantly, while subsequent accelerometer field deployments were relatively short they agreed with previous studies on the proportion of time that cane toads locomote yet suggest that the metabolic rate of cane toads in the wild may sometimes be considerably higher than might be assumed based on data for other species.	[Halsey, Lewis G.] Roehampton Univ, Sch Life Sci, London, England; [White, Craig R.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	Roehampton University; University of Queensland	Halsey, LG (corresponding author), Roehampton Univ, Sch Life Sci, London, England.	l.halsey@roehampton.ac.uk	Halsey, Lewis/B-8498-2011; White, Craig R/F-9062-2010	Halsey, Lewis/0000-0002-0786-7585; White, Craig R/0000-0002-0200-2187	University of Queensland; Royal Society; Australian Research Council [DP0987626]	University of Queensland(University of Queensland); Royal Society(Royal Society of London); Australian Research Council(Australian Research Council)	LGH was supported by a University of Queensland Travel Award for International Collaborative Research and a Royal Society International Travel Grant. CRW is an Australian Research Council QEII Fellow (project number DP0987626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2003, ECOL LETT, V6, P343, DOI 10.1046/j.1461-0248.2003.00435.x; Anderson KJ, 2005, ECOL LETT, V8, P310, DOI 10.1111/j.1461-0248.2005.00723.x; Barton DP, 1997, AUST J ECOL, V22, P316, DOI 10.1111/j.1442-9993.1997.tb00677.x; Beebee TJC, 2002, CONSERV BIOL, V16, P1454, DOI 10.1046/j.1523-1739.2002.02102.x; BENNETT AF, 1984, J COMP PHYSIOL B, V155, P21, DOI 10.1007/BF00688787; Boland CRJ, 2004, BIOL CONSERV, V120, P53, DOI 10.1016/j.biocon.2004.01.025; BOYD IL, 1995, FUNCT ECOL, V9, P151, DOI 10.2307/2390559; Bryce JM, 2001, P ROY SOC B-BIOL SCI, V268, P1731, DOI 10.1098/rspb.2001.1700; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Clark TD, 2005, PHYSIOL BIOCHEM ZOOL, V78, P347, DOI 10.1086/430034; EVANS DL, 1988, J COMP PHYSIOL B, V157, P791, DOI 10.1007/BF00691010; FEDAK MA, 1981, J APPL PHYSIOL, V51, P772, DOI 10.1152/jappl.1981.51.3.772; Green JA, 2009, J EXP BIOL, V212, P471, DOI 10.1242/jeb.026377; HALSEY L, COMP BIOC A IN PRESS; Halsey LG, 2009, PHYSIOL BIOCHEM ZOOL, V82, P396, DOI 10.1086/589815; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Halsey LG, 2008, ZOOLOGY, V111, P231, DOI 10.1016/j.zool.2007.07.011; Halsey LG, 2009, J FIELD ORNITHOL, V80, P171, DOI 10.1111/j.1557-9263.2009.00219.x; HALSEY LG, PHYSL BIOCH IN PRESS; HERREID CF, 1981, J EXP BIOL, V94, P189; HUTCHISON VH, 1971, Z VERGL PHYSIOL, V75, P367, DOI 10.1007/BF00630557; JOHNALDER HB, 1983, J COMP PHYSIOL, V151, P119, DOI 10.1007/BF00689909; JOHNALDER HB, 1981, AM J PHYSIOL, V241, pR342, DOI 10.1152/ajpregu.1981.241.5.R342; JOHNSON C R, 1972, Journal of Herpetology, V6, P35, DOI 10.2307/1563091; KARASOV WH, 1992, AM ZOOL, V32, P238, DOI 10.1093/icb/32.2.238; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Kram R, 1996, J EXP BIOL, V199, P609; Lampo M, 1998, ECOL APPL, V8, P388, DOI 10.2307/2641079; LIGHTON JRB, 1993, J EXP BIOL, V181, P49; LIGHTON JRB, 1989, NATURE, V342, P174, DOI 10.1038/342174a0; MOBERLY WR, 1968, COMP BIOCHEM PHYSIOL, V27, P21, DOI 10.1016/0010-406X(68)90750-0; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; Natori Y, 2007, ECOL APPL, V17, P1441, DOI 10.1890/06-1785.1; Phillips BL, 2008, WILDLIFE RES, V35, P222, DOI 10.1071/WR07101; Phillips BL, 2007, AUSTRAL ECOL, V32, P169, DOI 10.1111/j.1442-9993.2007.01664.x; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; Schmidt-Nielsen, 1984, SCALING WHY IS ANIMA; Secor SM, 2002, PHYSIOL BIOCHEM ZOOL, V75, P557, DOI 10.1086/344493; Secor SM, 2007, J COMP PHYSIOL B, V177, P165, DOI 10.1007/s00360-006-0119-2; Secor SM, 2009, J COMP PHYSIOL B, V179, P1, DOI 10.1007/s00360-008-0283-7; SHEPARD E, 2008, IDENTIFICATION ANIMA; SHEPARD E, 2009, P ROYAL SOC LONDON B; Simberloff D, 2003, CONSERV BIOL, V17, P83, DOI 10.1046/j.1523-1739.2003.02028.x; TAYLOR CR, 1982, J EXP BIOL, V97, P1; Todd M. Jason, 2003, Journal of the North Carolina Academy of Science, V119, P103; Tsuda Y, 2006, ECOL FRESHW FISH, V15, P264, DOI 10.1111/j.1600-0633.2006.00147.x; Urban MC, 2007, P ROY SOC B-BIOL SCI, V274, P1413, DOI 10.1098/rspb.2007.0114; WALTON M, 1988, J EXP BIOL, V136, P273; Walton P, 1998, ANIM BEHAV, V56, P165, DOI 10.1006/anbe.1998.0759; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; White CR, 2001, AUST J ZOOL, V49, P663, DOI 10.1071/ZO00076; White CR, 2006, PHYSIOL BIOCHEM ZOOL, V79, P977, DOI 10.1086/505994; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2	55	53	53	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10170	10.1371/journal.pone.0010170	http://dx.doi.org/10.1371/journal.pone.0010170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422048	Green Published, gold, Green Submitted			2022-12-25	WOS:000276952500003
J	Popelut, A; Valet, F; Fromentin, O; Thomas, A; Bouchard, P				Popelut, Antoine; Valet, Fabien; Fromentin, Olivier; Thomas, Aurelie; Bouchard, Philippe			Relationship between Sponsorship and Failure Rate of Dental Implants: A Systematic Approach	PLOS ONE			English	Article							FIXED PARTIAL DENTURES; LEAST 5 YEARS; COMPLICATION RATES; OBSERVATION PERIOD; COST-EFFECTIVENESS; TOOTH LOSS; SURVIVAL; OUTCOMES; REPLACEMENT; FPDS	Background: The number of dental implant treatments increases annually. Dental implants are manufactured by competing companies. Systematic reviews and meta-analysis have shown a clear association between pharmaceutical industry funding of clinical trials and pro-industry results. So far, the impact of industry sponsorship on the outcomes and conclusions of dental implant clinical trials has never been explored. The aim of the present study was to examine financial sponsorship of dental implant trials, and to evaluate whether research funding sources may affect the annual failure rate. Methods and Findings: A systematic approach was used to identify systematic reviews published between January 1993 and December 2008 that specifically deal with the length of survival of dental implants. Primary articles were extracted from these reviews. The failure rate of the dental implants included in the trials was calculated. Data on publication year, Impact Factor, prosthetic design, periodontal status reporting, number of dental implants included in the trials, methodological quality of the studies, presence of a statistical advisor, and financial sponsorship were extracted by two independent reviewers (kappa = 0.90; CI95% [0.77-1.00]). Univariate quasi-Poisson regression models and multivariate analysis were used to identify variables that were significantly associated with failure rates. Five systematic reviews were identified from which 41 analyzable trials were extracted. The mean annual failure rate estimate was 1.09%.(CI95% [0.84-1.42]). The funding source was not reported in 63% of the trials (26/41). Sixty-six percent of the trials were considered as having a risk of bias (27/41). Given study age, both industry associated (OR = 0.21; CI95% [0.12-0.38]) and unknown funding source trials (OR = 0.33; (CI95% [0.21-0.51]) had a lower annual failure rates compared with non-industry associated trials. A conflict of interest statement was disclosed in 2 trials. Conclusions: When controlling for other factors, the probability of annual failure for industry associated trials is significantly lower compared with non-industry associated trials. This bias may have significant implications on tooth extraction decision making, research on tooth preservation, and governmental health care policies.	[Popelut, Antoine; Bouchard, Philippe] Paris 7 Denis Diderot Univ, Dept Periodontol, Serv Odontol, AP HP,UFR Odontol,Hotel Dieu Hosp, Paris, France; [Valet, Fabien] Inst Curie, Dept Biostat, Paris, France; [Fromentin, Olivier] Paris 7 Denis Diderot Univ, Dept Prosthet Dent, Serv Odontol, AP HP,UFR Odontol,Hotel Dieu Hosp, Paris, France; [Thomas, Aurelie] Paris 7 Denis Diderot Univ, Lib Odontol, UFR Odontol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Popelut, A (corresponding author), Paris 7 Denis Diderot Univ, Dept Periodontol, Serv Odontol, AP HP,UFR Odontol,Hotel Dieu Hosp, Paris, France.	phbouch@noos.fr		Bouchard, Philippe/0000-0003-2500-3219	University Paris Diderot, U.F.R. of Odontologie (Paris, France)	University Paris Diderot, U.F.R. of Odontologie (Paris, France)	This study was supported by a grant from the University Paris Diderot, U.F.R. of Odontologie (Paris, France). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRESTI A, 2002, CATEGORICAL DATA ANA, P385; Bell CM, 2006, BMJ-BRIT MED J, V332, P699, DOI 10.1136/bmj.38737.607558.80; Berglundh T, 2002, J CLIN PERIODONTOL, V29, P197, DOI 10.1034/j.1600-051X.29.s3.12.x; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Bouchard P, 2009, CLIN ORAL IMPLAN RES, V20, P583, DOI 10.1111/j.1600-0501.2008.01702.x; Bragger U, 2005, CLIN ORAL IMPLAN RES, V16, P335, DOI 10.1111/j.1600-0501.2005.01112.x; Branemark PI., 1977, SCAND J PLAST RECO S, V16, P1; BRESLOW NE, 1996, STAT APPL, V8, P23; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Doucet M, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2007.022467; Esposito M, 1999, INT J ORAL MAX IMPL, V14, P473; Esposito M, 2009, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003878.PUB4; ESPOSITO M, 2007, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003815.PUB3; ESPOSITO MA, 2006, COCHRANE DB SYST REV, V4; Goodacre CJ, 2003, J PROSTHET DENT, V90, P121, DOI 10.1016/S0022-3913(03)00212-9; HUNTER JM, 1995, SOC SCI MED, V40, P1331, DOI 10.1016/0277-9536(94)00255-R; Jones JA, 2003, INT DENT J, V53, P327, DOI 10.1111/j.1875-595X.2003.tb00906.x; Jung RE, 2008, CLIN ORAL IMPLAN RES, V19, P119, DOI 10.1111/j.1600-0501.2007.01453.x; Karoussis IK, 2007, CLIN ORAL IMPLAN RES, V18, P669, DOI 10.1111/j.1600-0501.2007.01406.x; KIRKWOOD BR, 2004, ESSENTIAL MED STAT, P272; LANDIS JR, 1977, BIOMETRICS, V33, P174; Lang NP, 2004, CLIN ORAL IMPLAN RES, V15, P643, DOI 10.1111/j.1600-0501.2004.01118.x; Lesser LI, 2007, PLOS MED, V4, P41, DOI 10.1371/journal.pmed.0040005; Lindh T, 1998, CLIN ORAL IMPLAN RES, V9, P80, DOI 10.1034/j.1600-0501.1998.090203.x; *MILL RES GROUP, 2009, EUR MARK DENT IMPL 2; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Neely AL, 2005, J CLIN PERIODONTOL, V32, P984, DOI 10.1111/j.1600-051X.2005.00797.x; Ong CTT, 2008, J CLIN PERIODONTOL, V35, P438, DOI 10.1111/j.1600-051X.2008.01207.x; Pjetursson BE, 2004, CLIN ORAL IMPLAN RES, V15, P625, DOI 10.1111/j.1600-0501.2004.01117.x; Salinas TJ, 2007, INT J ORAL MAX IMPL, V22, P71; Tonetti MS, 2008, J CLIN PERIODONTOL, V35, P168, DOI 10.1111/j.1600-051X.2008.01268.x; Torabinejad M, 2007, J PROSTHET DENT, V98, P285, DOI 10.1016/S0022-3913(07)60102-4; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; VENABLES WN, 2002, MODERN APPL STAT S, P172; *WINTERGREEN, 2009, WORLDWIDE NAN DENT I; World Health Organization, 2009, HLTH STAT HLTH INF S; Zuur Alain F., 2009, P1; 2007, PLOS MED, V4, P399	38	57	56	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10274	10.1371/journal.pone.0010274	http://dx.doi.org/10.1371/journal.pone.0010274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422000	Green Published, gold, Green Submitted			2022-12-25	WOS:000276952500029
J	Tillmann, B; Jolicoeur, P; Ishihara, M; Gosselin, N; Bertrand, O; Rossetti, Y; Peretz, I				Tillmann, Barbara; Jolicoeur, Pierre; Ishihara, Masami; Gosselin, Nathalie; Bertrand, Olivier; Rossetti, Yves; Peretz, Isabelle			The Amusic Brain: Lost in Music, but Not in Space	PLOS ONE			English	Article							LINE BISECTION; CONGENITAL AMUSIA; TONE-DEAFNESS; INDIVIDUAL VARIATION; SPATIAL NEGLECT; PERCEPTION; DEFICITS; PITCH; REPRESENTATION; DISCRIMINATION	Congenital amusia is a neurogenetic disorder of music processing that is currently ascribed to a deficit in pitch processing. A recent study challenges this view and claims the disorder might arise as a consequence of a general spatial-processing deficit. Here, we assessed spatial processing abilities in two independent samples of individuals with congenital amusia by using line bisection tasks (Experiment 1) and a mental rotation task (Experiment 2). Both amusics and controls showed the classical spatial effects on bisection performance and on mental rotation performance, and amusics and controls did not differ from each other. These results indicate that the neurocognitive impairment of congenital amusia does not affect the processing of space.	[Tillmann, Barbara; Bertrand, Olivier; Rossetti, Yves] Univ Lyon 1, F-69365 Lyon, France; [Tillmann, Barbara] CNRS, UMR 5020, Lyon, France; [Jolicoeur, Pierre; Gosselin, Nathalie; Peretz, Isabelle] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Jolicoeur, Pierre; Gosselin, Nathalie; Peretz, Isabelle] Univ Montreal, BRAMS Lab, Montreal, PQ H3C 3J7, Canada; [Ishihara, Masami] Max Planck Inst CBS, Leipzig, Germany; [Bertrand, Olivier] INSERM, U821, F-69008 Lyon, France; [Rossetti, Yves] Hosp Civils Lyon, INSERM, U864, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Universite de Montreal; Universite de Montreal; Max Planck Society; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Tillmann, B (corresponding author), Univ Lyon 1, F-69365 Lyon, France.	barbara.tillmann@olfac.univ-lyon1.fr	Rossetti, Yves/H-3693-2017; Bertrand, Olivier/B-6165-2008	Rossetti, Yves/0000-0001-8867-4496; Bertrand, Olivier/0000-0003-0733-7979	Cluster 11 of the Region Rhone-Alpes; Fonds de Recherche en Sante du Quebec; Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation; Canadian Institutes of Health Research; Deutsche Forschungsgemeinschaft	Cluster 11 of the Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by grants from the Cluster 11 of the Region Rhone-Alpes to BT and OB, by an infrastructure grant from the Fonds de Recherche en Sante du Quebec to IP and PJ, research grants from the Natural Sciences and Engineering Research Council of Canada to PJ and to IP, grants from the Canadian Foundation for Innovation to IP and PJ, a grant from the Canadian Institutes of Health Research to IP, and a grant from the Deutsche Forschungsgemeinschaft to MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayotte J, 2002, BRAIN, V125, P238, DOI 10.1093/brain/awf028; Beecham R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005543; Brochard R, 2004, BRAIN COGNITION, V54, P103, DOI 10.1016/S0278-2626(03)00264-1; Brozzoli C, 2008, P NATL ACAD SCI USA, V105, P5644, DOI 10.1073/pnas.0708414105; Calabria M, 2005, NEUROPSYCHOLOGIA, V43, P779, DOI 10.1016/j.neuropsychologia.2004.06.027; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Douglas KM, 2007, NAT NEUROSCI, V10, P915, DOI 10.1038/nn1925; Fischer MH, 2001, NEUROLOGY, V57, P822, DOI 10.1212/WNL.57.5.822; Foxton JM, 2006, BRAIN COGNITION, V62, P24, DOI 10.1016/j.bandc.2006.03.005; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; Golay L, 2005, NEUROPSYCHOLOGIA, V43, P1258, DOI 10.1016/j.neuropsychologia.2004.12.006; HALLIGAN PW, 1990, NEUROPSYCHOLOGIA, V28, P1043, DOI 10.1016/0028-3932(90)90139-F; HARVEY M, 1994, CORTEX, V30, P343, DOI 10.1016/S0010-9452(13)80204-3; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Hyde KL, 2007, J NEUROSCI, V27, P13028, DOI 10.1523/JNEUROSCI.3039-07.2007; Hyde KL, 2006, BRAIN, V129, P2562, DOI 10.1093/brain/awl204; ISHIAI S, 1989, BRAIN, V112, P1485, DOI 10.1093/brain/112.6.1485; ISHIHARA M, LOWER HIGHE IN PRESS; Ishihara M, 2006, NEUROPSYCHOLOGIA, V44, P1009, DOI 10.1016/j.neuropsychologia.2005.11.008; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; KALMUS H, 1980, ANN HUM GENET, V43, P369, DOI 10.1111/j.1469-1809.1980.tb01571.x; Keller P. E., 2006, ADV COGN PSYCHOL, V2, P269, DOI [10.2478/v10053-008-0061-9, DOI 10.2478/V10053-008-0061-9]; Leonards U, 2007, PERCEPTION, V36, P171; Lidji P, 2007, J EXP PSYCHOL HUMAN, V33, P1189, DOI 10.1037/0096-1523.33.5.1189; Loui P, 2008, CURR BIOL, V18, pR331, DOI 10.1016/j.cub.2008.02.045; MANNING L, 1990, NEUROPSYCHOLOGIA, V28, P647, DOI 10.1016/0028-3932(90)90119-9; McIntosh RD, 2005, COGNITIVE BRAIN RES, V25, P833, DOI 10.1016/j.cogbrainres.2005.09.008; Michel F, 2004, BEHAV NEUROL, V15, P3, DOI 10.1155/2004/836830; MILNER AD, 1992, NEUROPSYCHOLOGIA, V30, P515, DOI 10.1016/0028-3932(92)90055-Q; MUDD SA, 1963, J EXP PSYCHOL, V66, P347, DOI 10.1037/h0040045; OLSHO LW, 1982, DEV PSYCHOL, V18, P721; Oriet C, 2005, MEM COGNITION, V33, P913, DOI 10.3758/BF03193085; Patel AD, 2008, MUSIC PERCEPT, V25, P357, DOI 10.1525/MP.2008.25.4.357; Patston LLM, 2006, PSYCHOL SCI, V17, P1029, DOI 10.1111/j.1467-9280.2006.01823.x; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2003, TRENDS COGN SCI, V7, P362, DOI 10.1016/S1364-6613(03)00150-5; Peretz I, 2001, ANN NY ACAD SCI, V930, P153, DOI 10.1111/j.1749-6632.2001.tb05731.x; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Peretz I, 2008, CURR DIR PSYCHOL SCI, V17, P329, DOI 10.1111/j.1467-8721.2008.00600.x; Peretz I, 2007, AM J HUM GENET, V81, P582, DOI 10.1086/521337; Rusconi E, 2006, COGNITION, V99, P113, DOI 10.1016/j.cognition.2005.01.004; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Sluming V, 2007, J NEUROSCI, V27, P3799, DOI 10.1523/JNEUROSCI.0147-07.2007; Stewart L, 2007, CURR BIOL, V17, pR892, DOI 10.1016/j.cub.2007.08.012; Tillmann B, 2000, PSYCHOL REV, V107, P885, DOI 10.1037/0033-295X.107.4.885	45	32	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10173	10.1371/journal.pone.0010173	http://dx.doi.org/10.1371/journal.pone.0010173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586YS	20422050	Green Published, gold, Green Submitted			2022-12-25	WOS:000276952500004
J	Lin, BY; Madan, A; Yoon, JG; Fang, XF; Yan, XW; Kim, TK; Hwang, D; Hood, L; Foltz, G				Lin, Biaoyang; Madan, Anup; Yoon, Jae-Geun; Fang, Xuefeng; Yan, Xiaowei; Kim, Taek-Kyun; Hwang, Daehee; Hood, Leroy; Foltz, Gregory			Massively Parallel Signature Sequencing and Bioinformatics Analysis Identifies Up-Regulation of TGFBI and SOX4 in Human Glioblastoma	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GENE-EXPRESSION; MICROARRAY ANALYSIS; CELL; CANCER; PROGRESSION; TUMORIGENICITY; PROLIFERATION; TRANSCRIPTION; NEUROGRANIN	Background: A comprehensive network-based understanding of molecular pathways abnormally altered in glioblastoma multiforme (GBM) is essential for developing effective therapeutic approaches for this deadly disease. Methodology/Principal Findings: Applying a next generation sequencing technology, massively parallel signature sequencing (MPSS), we identified a total of 4535 genes that are differentially expressed between normal brain and GBM tissue. The expression changes of three up-regulated genes, CHI3L1, CHI3L2, and FOXM1, and two down-regulated genes, neurogranin and L1CAM, were confirmed by quantitative PCR. Pathway analysis revealed that TGF- beta pathway related genes were significantly up-regulated in GBM tumor samples. An integrative pathway analysis of the TGF beta signaling network identified two alternative TGF-beta signaling pathways mediated by SOX4 ( sex determining region Y-box 4) and TGFBI ( Transforming growth factor beta induced). Quantitative RT-PCR and immunohistochemistry staining demonstrated that SOX4 and TGFBI expression is elevated in GBM tissues compared with normal brain tissues at both the RNA and protein levels. In vitro functional studies confirmed that TGFBI and SOX4 expression is increased by TGF- beta stimulation and decreased by a specific inhibitor of TGF- beta receptor 1 kinase. Conclusions/Significance: Our MPSS database for GBM and normal brain tissues provides a useful resource for the scientific community. The identification of non-SMAD mediated TGF-beta signaling pathways acting through SOX4 and TGFBI ( GENE ID: 7045) in GBM indicates that these alternative pathways should be considered, in addition to the canonical SMAD mediated pathway, in the development of new therapeutic strategies targeting TGF-beta signaling in GBM. Finally, the construction of an extended TGF- beta signaling network with overlaid gene expression changes between GBM and normal brain extends our understanding of the biology of GBM.	[Lin, Biaoyang; Yoon, Jae-Geun; Foltz, Gregory] Swedish Med Ctr, Swedish Neurosci Inst, Seattle, WA USA; [Lin, Biaoyang] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Lin, Biaoyang; Fang, Xuefeng] Zhejiang Univ, Zhejiang Calif Int NanoSyst Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Yan, Xiaowei; Hood, Leroy; Foltz, Gregory] Inst Syst Biol, Seattle, WA USA; [Madan, Anup] Seattle Mol Diagnost Res Inst, Bellevue, WA USA; [Kim, Taek-Kyun; Hwang, Daehee] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang, Kyungbuk, South Korea; [Kim, Taek-Kyun; Hwang, Daehee] Pohang Univ Sci & Technol, I Bio Program, Pohang, South Korea	Swedish Medical Center; University of Washington; University of Washington Seattle; Zhejiang University; Institute for Systems Biology (ISB); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Lin, BY (corresponding author), Swedish Med Ctr, Swedish Neurosci Inst, Seattle, WA USA.	Biaoyang.Lin@swedish.org; Greg.Foltz@swedish.org	Lin, Biaoyang/AAA-1258-2020; Kim, Taekkyun/A-9810-2017	Lin, Biaoyang/0000-0002-2189-0407; Kim, Taekkyun/0000-0002-3703-6790	Swedish Medical Foundation	Swedish Medical Foundation	We thank the Swedish Medical Foundation for providing financial support for the studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Cheung M, 2000, MOL BRAIN RES, V79, P180, DOI 10.1016/S0169-328X(00)00109-1; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; FOLTZ G, 2009, ONCOGENE; Foltz G, 2006, CANCER RES, V66, P6665, DOI 10.1158/0008-5472.CAN-05-4453; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Golembieski WA, 1999, INT J DEV NEUROSCI, V17, P463, DOI 10.1016/S0736-5748(99)00009-X; Grigoriadis A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1604; Gui JG, 2007, INT J BIOL SCI, V3, P212; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hu B, 1996, J BIOL CHEM, V271, P19415, DOI 10.1074/jbc.271.32.19415; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Izumoto S, 1996, CANCER RES, V56, P1440; Jayapandian M, 2007, NUCLEIC ACIDS RES, V35, pD566, DOI 10.1093/nar/gkl859; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kawataki T, 2000, NEUROPATHOLOGY, V20, P161, DOI 10.1046/j.1440-1789.2000.00327.x; Kjellman C, 2000, INT J CANCER, V89, P251, DOI 10.1002/1097-0215(20000520)89:3<251::AID-IJC7>3.0.CO;2-5; Lesne S, 2002, J CEREBR BLOOD F MET, V22, P1114, DOI 10.1097/00004647-200209000-00009; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Lin BY, 2005, CANCER RES, V65, P3081, DOI 10.1158/0008-5472.CAN-04-3218; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Man MZ, 2000, BIOINFORMATICS, V16, P953, DOI 10.1093/bioinformatics/16.11.953; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mischel PS, 2003, ONCOGENE, V22, P2361, DOI 10.1038/sj.onc.1206344; Munaut C, 2003, INT J CANCER, V106, P848, DOI 10.1002/ijc.11313; Oudes AJ, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-86; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piek E, 1999, INT J CANCER, V80, P756, DOI 10.1002/(SICI)1097-0215(19990301)80:5<756::AID-IJC21>3.0.CO;2-N; Platten M, 2001, MICROSC RES TECHNIQ, V52, P401, DOI 10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C; Pramoonjago P, 2006, ONCOGENE, V25, P5626, DOI 10.1038/sj.onc.1209566; Ranganathan P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-98; Rehli M, 1997, GENOMICS, V43, P221, DOI 10.1006/geno.1997.4778; REPRESA A, 1990, J NEUROSCI, V10, P3782, DOI 10.1523/JNEUROSCI.10-12-03782.1990; Rich JN, 2005, CANCER RES, V65, P4051, DOI 10.1158/0008-5472.CAN-04-3936; Ruebel KH, 2008, ENDOCRINE, V33, P62, DOI 10.1007/s12020-008-9060-3; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Scharer CD, 2009, CANCER RES, V69, P709, DOI 10.1158/0008-5472.CAN-08-3415; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang B, 2007, CANCER RES, V67, P8643, DOI 10.1158/0008-5472.CAN-07-0982; Tanwar MK, 2002, CANCER RES, V62, P4364; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Wang Y, 2005, J NANOSCI NANOTECHNO, V5, P1249, DOI 10.1166/jnn.2005.218; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; WOLFF JM, 1988, J BIOL CHEM, V263, P11943	56	69	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10210	10.1371/journal.pone.0010210	http://dx.doi.org/10.1371/journal.pone.0010210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419098	Green Submitted, Green Published, gold			2022-12-25	WOS:000276853800008
J	Neri, M; Maderna, C; Ferrari, D; Cavazzin, C; Vescovi, AL; Gritti, A				Neri, Margherita; Maderna, Claudio; Ferrari, Daniela; Cavazzin, Chiara; Vescovi, Angelo L.; Gritti, Angela			Robust Generation of Oligodendrocyte Progenitors from Human Neural Stem Cells and Engraftment in Experimental Demyelination Models in Mice	PLOS ONE			English	Article							SUBCORTICAL WHITE-MATTER; CENTRAL-NERVOUS-SYSTEM; RAT CEREBRAL-CORTEX; EMBRYONIC HUMAN CNS; ADULT HUMAN BRAIN; GROWTH-FACTORS; SPINAL-CORD; IN-VITRO; NEUROTROPHIC FACTOR; PRECURSOR CELLS	Background: Cell-based therapy holds great promises for demyelinating diseases. Human-derived fetal and adult oligodendrocyte progenitors (OPC) gave encouraging results in experimental models of dysmyelination but their limited proliferation in vitro and their potential immunogenicity might restrict their use in clinical applications. Virtually unlimited numbers of oligodendroglial cells could be generated from long-term self-renewing human (h)-derived neural stem cells (hNSC). However, robust oligodendrocyte production from hNSC has not been reported so far, indicating the need for improved understanding of the molecular and environmental signals controlling hNSC progression through the oligodendroglial lineage. The aim of this work was to obtain enriched and renewable cultures of hNSC-derived oligodendroglial cells by means of epigenetic manipulation. Methodology/Principal Findings: We report here the generation of large numbers of hNSC-derived oligodendroglial cells by concurrent/sequential in vitro exposure to combinations of growth factors (FGF2, PDGF-AA), neurotrophins (NT3) and hormones (T3). In particular, the combination FGF2+NT3+PDGF-AA resulted in the maintenance and enrichment of an oligodendroglial cell population displaying immature phenotype (i.e., proliferation capacity and expression of PDGFR alpha, Olig1 and Sox10), limited self-renewal and increased migratory activity in vitro. These cells generate large numbers of oligodendroglial progeny at the early stages of maturation, both in vitro and after transplantation in models of CNS demyelination. Conclusions/Significance: We describe a reliable method to generate large numbers of oligodendrocytes from a renewable source of somatic, non-immortalized NSC from the human foetal brain. We also provide insights on the mechanisms underlying the pro-oligodendrogenic effect of the treatments in vitro and discuss potential issues responsible for the limited myelinating capacity shown by hNSC-derived oligodendrocytes in vivo.	[Neri, Margherita; Maderna, Claudio; Cavazzin, Chiara; Gritti, Angela] San Raffaele Telethon Inst Gene Therapy HSR TIGET, San Raffaele Sci Inst, Milan, Italy; [Neri, Margherita] Univ Vita Salute San Raffaele, Milan, Italy; [Ferrari, Daniela; Vescovi, Angelo L.] Univ Milano Bicocca, Biosci & Biotechnol Dept, Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Milano-Bicocca	Neri, M (corresponding author), San Raffaele Telethon Inst Gene Therapy HSR TIGET, San Raffaele Sci Inst, Milan, Italy.	vescovi@tin.it; gritti.angela@hsr.it	Vescovi, Angelo Luigi/A-4919-2015; Ferrari, Daniela/AHE-7647-2022; Gritti, Angela/K-2729-2016	Vescovi, Angelo Luigi/0000-0002-1742-4112; Ferrari, Daniela/0000-0001-7251-9854; Gritti, Angela/0000-0002-9845-0370; maderna, claudio/0000-0002-1404-5408	Italian Ministry of Health [RF03.168]; Italian Multiple Sclerosis Foundation [2002/R/33]; Fondazione Telethon Funding Source: Custom	Italian Ministry of Health(Ministry of Health, Italy); Italian Multiple Sclerosis Foundation; Fondazione Telethon(Fondazione Telethon)	This work was supported by the Italian Ministry of Health (RF03.168; www.ministerosalute.it) and the Italian Multiple Sclerosis Foundation (FISM; grant 2002/R/33; www.aism.it) to AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOISI F, 1992, J NEUROSCI RES, V32, P494, DOI 10.1002/jnr.490320405; ARMSTRONG RC, 1992, J NEUROSCI, V12, P1538; Baron W, 2003, CURR BIOL, V13, P151, DOI 10.1016/S0960-9822(02)01437-9; Barres BA, 1996, MOL CELL NEUROSCI, V8, P146, DOI 10.1006/mcne.1996.0053; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0; Behrstock S, 2006, GENE THER, V13, P379, DOI 10.1038/sj.gt.3302679; Billon N, 2002, EMBO J, V21, P6452, DOI 10.1093/emboj/cdf662; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Buchet D, 2009, NEUROSCI LETT, V456, P112, DOI 10.1016/j.neulet.2008.09.086; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; CAVAZZIN C, 2005, GLIA; Chandran S, 2004, GLIA, V47, P314, DOI 10.1002/glia.20011; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; De Filippis L, 2007, STEM CELLS, V25, P2312, DOI 10.1634/stemcells.2007-0040; De Filippis L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003310; Decker L, 2000, MOL CELL NEUROSCI, V16, P422, DOI 10.1006/mcne.2000.0885; Decker L, 2004, J NEUROSCI, V24, P3816, DOI 10.1523/JNEUROSCI.5725-03.2004; Dietrich J, 2002, GLIA, V40, P65, DOI 10.1002/glia.10116; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Ebert AD, 2005, REJUV RES, V8, P131, DOI 10.1089/rej.2005.8.131; FERNANDEZ M, 2009, INT J DEV NEUROSCI; Finzsch M, 2008, DEVELOPMENT, V135, P637, DOI 10.1242/dev.010454; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Gallo V, 2008, CURR OPIN NEUROL, V21, P278, DOI 10.1097/WCO.0b013e3282fd1875; Goldman SA, 2007, CLIN PHARMACOL THER, V82, P453, DOI 10.1038/sj.clpt.6100337; Grever WE, 1999, J NEUROSCI RES, V57, P304, DOI 10.1002/(SICI)1097-4547(19990801)57:3<304::AID-JNR2>3.0.CO;2-6; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Gritti A, 2009, J COMP NEUROL, V517, P333, DOI 10.1002/cne.22153; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kitada M, 2006, GLIA, V54, P35, DOI 10.1002/glia.20354; Kumar S, 2007, NEUROCHEM RES, V32, P783, DOI 10.1007/s11064-006-9208-6; Lee HJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000156; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; MACIACZYK J, 2009, STEM CELLS DEV; MAIRE CL, 2009, J NEUROSCI RES; McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176; Murray K, 1997, J NEUROSCI RES, V50, P146; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Park SK, 2001, DEV NEUROSCI-BASEL, V23, P327, DOI 10.1159/000048716; Pluchino S, 2009, ANN NEUROL, V66, P343, DOI 10.1002/ana.21745; RAO RC, 2008, STEM CELLS; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Rodriguez-Pena A, 1999, J NEUROBIOL, V40, P497, DOI 10.1002/(SICI)1097-4695(19990915)40:4<497::AID-NEU7>3.0.CO;2-#; Rosser AE, 2007, CURR OPIN NEUROL, V20, P688, DOI 10.1097/WCO.0b013e3282f132fc; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; Svendsen CN, 1999, BRAIN PATHOL, V9, P499, DOI 10.1111/j.1750-3639.1999.tb00538.x; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; Tamura Y, 2007, NEUROSCIENCE, V148, P535, DOI 10.1016/j.neuroscience.2007.06.026; Targett MP, 1996, NEUROPATH APPL NEURO, V22, P199; Terada N, 2005, GLIA, V50, P212, DOI 10.1002/glia.20175; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Vescovi AL, 1999, J NEUROTRAUM, V16, P689, DOI 10.1089/neu.1999.16.689; Wilson HC, 2003, GLIA, V44, P153, DOI 10.1002/glia.10280; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Windrem MS, 2002, J NEUROSCI RES, V69, P966, DOI 10.1002/jnr.10397; Wright LS, 2006, EXP CELL RES, V312, P2107, DOI 10.1016/j.yexcr.2006.03.012; Wu CS, 2009, J NEUROSCI, V29, P7649, DOI 10.1523/JNEUROSCI.1027-09.2009; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Zhang SC, 2000, J NEUROSCI RES, V59, P421, DOI 10.1002/(SICI)1097-4547(20000201)59:3<421::AID-JNR17>3.3.CO;2-3	73	31	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10145	10.1371/journal.pone.0010145	http://dx.doi.org/10.1371/journal.pone.0010145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405042	gold, Green Submitted, Green Published			2022-12-25	WOS:000276705900022
J	Zhao, FQ; Bai, J; Wu, JY; Liu, J; Zhou, MM; Xia, SL; Wang, SJ; Yao, XD; Yi, HG; Lin, ML; Gao, SJ; Zhou, TL; Xu, ZY; Niu, YX; Bao, QY				Zhao, Fangqing; Bai, Jie; Wu, Jinyu; Liu, Jing; Zhou, Mingming; Xia, Shilin; Wang, Shanjin; Yao, Xiaoding; Yi, Huiguang; Lin, Meili; Gao, Shengjie; Zhou, Tieli; Xu, Zuyuan; Niu, Yuxin; Bao, Qiyu			Sequencing and Genetic Variation of Multidrug Resistance Plasmids in Klebsiella pneumoniae	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; BETA-LACTAMASES	Background: The development of multidrug resistance is a major problem in the treatment of pathogenic microorganisms by distinct antimicrobial agents. Characterizing the genetic variation among plasmids from different bacterial species or strains is a key step towards understanding the mechanism of virulence and their evolution. Results: We applied a deep sequencing approach to 206 clinical strains of Klebsiella pneumoniae collected from 2002 to 2008 to understand the genetic variation of multidrug resistance plasmids, and to reveal the dynamic change of drug resistance over time. First, we sequenced three plasmids ( 70 Kb, 94 Kb, and 147 Kb) from a clonal strain of K. pneumoniae using Sanger sequencing. Using the Illumina sequencing technology, we obtained more than 17 million of short reads from two pooled plasmid samples. We mapped these short reads to the three reference plasmid sequences, and identified a large number of single nucleotide polymorphisms ( SNPs) in these pooled plasmids. Many of these SNPs are present in drug-resistance genes. We also found that a significant fraction of short reads could not be mapped to the reference sequences, indicating a high degree of genetic variation among the collection of K. pneumoniae isolates. Moreover, we identified that plasmid conjugative transfer genes and antibiotic resistance genes are more likely to suffer from positive selection, as indicated by the elevated rates of nonsynonymous substitution. Conclusion: These data represent the first large-scale study of genetic variation in multidrug resistance plasmids and provide insight into the mechanisms of plasmid diversification and the genetic basis of antibiotic resistance.	[Zhao, Fangqing; Bai, Jie; Wu, Jinyu; Liu, Jing; Zhou, Mingming; Xia, Shilin; Wang, Shanjin; Yao, Xiaoding; Yi, Huiguang; Lin, Meili; Gao, Shengjie; Zhou, Tieli; Xu, Zuyuan; Niu, Yuxin; Bao, Qiyu] Wenzhou Med Coll, Inst Biomed Informat, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China; [Zhao, Fangqing] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Bai, Jie] Fudan Univ, Dept Microbiol & Microbial Engn, Sch Life Sci, Shanghai 200433, Peoples R China	Wenzhou Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Fudan University	Zhao, FQ (corresponding author), Wenzhou Med Coll, Inst Biomed Informat, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China.	niuyuxin@gmail.com; baoqy@genomics.org.cn	Bao, Qiyu/AAH-6113-2020; Zhao, Fangqing/P-6309-2019; Gao, Shengjie/S-4016-2017	Bao, Qiyu/0000-0001-6523-8763; Yi, Huiguang/0000-0002-9676-7438; Zhao, Fangqing/0000-0002-6216-1235; Xia, Shilin/0000-0003-1187-3192; Gao, Shengjie/0000-0002-5221-8381	Science and Technology Foundation of Zhejiang Province [2008C23074]; Natural Science Foundation of Zhejiang Province [Y2090694]; Zhejiang Provincial Medical Foundation [2009QN021]; Foundation of Zhejiang Provincial Top Key Discipline of Laboratory Medicine, China	Science and Technology Foundation of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Medical Foundation; Foundation of Zhejiang Provincial Top Key Discipline of Laboratory Medicine, China	This work was supported by the Science and Technology Foundation of Zhejiang Province (2008C23074), Natural Science Foundation of Zhejiang Province (Y2090694), Zhejiang Provincial Medical Foundation (No. 2009QN021) and Foundation of Zhejiang Provincial Top Key Discipline of Laboratory Medicine, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BERES SB, P NATL ACAD SCI US; Bistue AJCS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001800; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Chen YT, 2007, ANTIMICROB AGENTS CH, V51, P3004, DOI 10.1128/AAC.00167-07; Chen YT, 2006, ANTIMICROB AGENTS CH, V50, P3861, DOI 10.1128/AAC.00456-06; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Deguchi T, 1997, ANTIMICROB AGENTS CH, V41, P699, DOI 10.1128/AAC.41.3.699; Fouts DE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000141; Fu YM, 2008, ANTIMICROB AGENTS CH, V52, P2980, DOI 10.1128/AAC.00151-08; Golebiewski M, 2007, ANTIMICROB AGENTS CH, V51, P3789, DOI 10.1128/AAC.00457-07; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; HEASLET H, 2009, PROTEINS; KNOTHE H, 1983, INFECTION, V11, P315, DOI 10.1007/BF01641355; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; McKeegan KS, 2002, TRENDS MICROBIOL, V10, pS8, DOI 10.1016/S0966-842X(02)02429-0; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Ogawa W, 2005, BIOL PHARM BULL, V28, P1505, DOI 10.1248/bpb.28.1505; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Sarno R, 2002, ANTIMICROB AGENTS CH, V46, P3422, DOI 10.1128/AAC.46.11.3422-3427.2002; Schneiders T, 2003, ANTIMICROB AGENTS CH, V47, P2831, DOI 10.1128/AAC.47.9.2831-2837.2003; Shen P, 2008, J ANTIMICROB CHEMOTH, V62, P1252, DOI 10.1093/jac/dkn397; SOUGAKOFF W, 1988, REV INFECT DIS, V10, P879	26	32	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10141	10.1371/journal.pone.0010141	http://dx.doi.org/10.1371/journal.pone.0010141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405037	Green Submitted, gold, Green Published			2022-12-25	WOS:000276705900019
J	Milkau, M; Kohler, R; de Wit, C				Milkau, Malte; Kohler, Ralf; de Wit, Cor			Crucial importance of the endothelial K+ channel SK3 and connexin40 in arteriolar dilations during skeletal muscle contraction	FASEB JOURNAL			English	Article						Ca2+-activated K+ channels; gap junctions; endothelium-derived hyperpolarizing factor; exercise hyperemia	MICROCIRCULATION IN-VIVO; NITRIC-OXIDE SYNTHASE; EXERCISING HUMAN LEG; BLOOD-FLOW; HYPERPOLARIZING FACTOR; POTASSIUM CHANNELS; GAP-JUNCTIONS; FEED ARTERIES; FUNCTIONAL HYPEREMIA; CONDUCTED RESPONSES	Skeletal muscle activity requires substantial increases in blood flow, and the underlying vasodilation involves endothelial activity, but the contribution of the endothelium-dependent hyperpolarizing factor (EDHF) is only poorly defined. In EDHF signaling, endothelial hyperpolarization mediated by the Ca2+-activated K+ channels SK3 and IK1 is a key step and also initiates gap junction-dependent conducted dilations. We assessed the role of SK3, IK1, and connexin40 (Cx40) in muscular contraction-induced dilations in the microcirculation in vivo. Hitherto, arterioles were observed in the electrically stimulated cremaster skeletal muscle of anesthetized mice lacking SK3, IK1, or Cx40 using intravital microscopy. Genetic deficiency of SK3, but not of IK1, strongly attenuated dilations to muscular contraction. Similarly, pharmacologic blockade of SK3 by the specific blocker UCL1684 impaired such dilations in wild-type and IK1-deficient mice. In contrast, IK1 was required for acetylcholine-induced dilations. Genetic deficiency of Cx40 also attenuated dilations induced by muscular contraction but not by acetylcholine. These data support the concept that endothelial hyperpolarization through activation of SK3 contributes to exercise hyperemia and the hyperpolarization ascends the vascular tree through gap junctions formed by Cx40 to orchestrate dilation. The differential impact of SK3- and IK1-deficiency on dilations to distinct stimuli suggests stimulus-dependent activation of these endothelial channels.-Milkau, M., Kohler, R., de Wit, C. Crucial importance of the endothelial K+ channel SK3 and connexin40 in arteriolar dilations during skeletal muscle contraction. FASEB J. 24, 3572-3579 (2010). www.fasebj.org	[Milkau, Malte; de Wit, Cor] Univ Lubeck, Inst Physiol, D-23538 Lubeck, Germany; [Kohler, Ralf] Univ So Denmark, Inst Mol Med, Odense, Denmark	University of Lubeck; University of Southern Denmark	de Wit, C (corresponding author), Univ Lubeck, Inst Physiol, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	dewit@uni-luebeck.de	babakinejad, babak/G-2674-2012; de Wit, Cor/A-5560-2009	de Wit, Cor/0000-0003-4621-0399; Kohler, Ralf/0000-0001-9563-2913	Deutsche Forschungsgemeinschaft [WI 2071/2-1, KO1899/10-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Rita Meuer for excellent technical assistance. This work was supported by grants of the Deutsche Forschungsgemeinschaft (WI 2071/2-1 and KO1899/10-1).	Boushel R, 2002, J PHYSIOL-LONDON, V543, P691, DOI 10.1113/jphysiol.2002.021477; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; Clifford PS, 2007, J PHYSIOL-LONDON, V583, P825, DOI 10.1113/jphysiol.2007.135673; Clifford PS, 2006, J PHYSIOL-LONDON, V572, P561, DOI 10.1113/jphysiol.2005.099507; Clifford PS, 2004, J APPL PHYSIOL, V97, P393, DOI 10.1152/japplphysiol.00179.2004; de Wit C, 2004, NEWS PHYSIOL SCI, V19, P148, DOI 10.1152/nips.01520.2004; de Wit C, 2000, CIRC RES, V86, P649, DOI 10.1161/01.RES.86.6.649; de Wit C, 2007, CURR PHARM BIOTECHNO, V8, P11; de Wit C, 2010, CARDIOVASC RES, V85, P604, DOI 10.1093/cvr/cvp340; de Wit C, 2008, CELL COMMUN ADHES, V15, P231, DOI 10.1080/15419060802440260; Dora KA, 2008, CIRC RES, V102, P1247, DOI 10.1161/CIRCRESAHA.108.172379; Dua AK, 2009, AM J PHYSIOL-HEART C, V297, pH433, DOI 10.1152/ajpheart.00216.2009; Duza T, 2004, J PHYSIOL-LONDON, V555, P459, DOI 10.1113/jphysiol.2003.051029; Feletou M, 2009, CLIN SCI, V117, P139, DOI 10.1042/CS20090096; Frandsen U, 2001, J PHYSIOL-LONDON, V531, P257, DOI 10.1111/j.1469-7793.2001.0257j.x; GILLIGAN DM, 1994, CIRCULATION, V90, P2853, DOI 10.1161/01.CIR.90.6.2853; Grgic I, 2009, BRIT J PHARMACOL, V157, P509, DOI 10.1111/j.1476-5381.2009.00132.x; Griffith TM, 2004, BRIT J PHARMACOL, V141, P881, DOI 10.1038/sj.bjp.0705698; Hamann JJ, 2004, J PHYSIOL-LONDON, V557, P1013, DOI 10.1113/jphysiol.2004.062836; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; HESTER RL, 1993, AM J PHYSIOL, V265, pH146; Hillig T, 2003, J PHYSIOL-LONDON, V546, P307, DOI 10.1113/jphysiol.2002.030833; Inoue R, 2006, CIRC RES, V99, P119, DOI 10.1161/01.RES.0000233356.10630.8a; Joyner MJ, 2007, J PHYSIOL-LONDON, V583, P855, DOI 10.1113/jphysiol.2007.135889; Kirby BS, 2007, J PHYSIOL-LONDON, V583, P861, DOI 10.1113/jphysiol.2007.131250; Kirchhoff S, 1998, CURR BIOL, V8, P299, DOI 10.1016/S0960-9822(98)70114-9; Kohler R, 2007, KIDNEY INT, V72, P145, DOI 10.1038/sj.ki.5002303; Koller A, 2002, AM J PHYSIOL-HEART C, V283, pH2250, DOI 10.1152/ajpheart.00545.2002; LAMONTAGNE D, 1992, CIRC RES, V70, P123, DOI 10.1161/01.RES.70.1.123; Lau KS, 2000, PHYSIOL GENOMICS, V2, P21, DOI 10.1152/physiolgenomics.2000.2.1.21; Ledoux J, 2008, P NATL ACAD SCI USA, V105, P9627, DOI 10.1073/pnas.0801963105; Marvar PJ, 2007, MICROCIRCULATION, V14, P779, DOI 10.1080/10739680701444057; Mather S, 2005, CIRC RES, V97, P399, DOI 10.1161/01.RES.0000178008.46759.d0; Maxwell AJ, 1998, CIRCULATION, V98, P369, DOI 10.1161/01.CIR.98.4.369; McKay MK, 1998, HYPERTENSION, V31, P213, DOI 10.1161/01.HYP.31.1.213; Merkus D, 2006, AM J PHYSIOL-HEART C, V291, pH2090, DOI 10.1152/ajpheart.00315.2006; Mortensen SP, 2007, J PHYSIOL-LONDON, V581, P853, DOI 10.1113/jphysiol.2006.127423; Mortensen SP, 2009, HYPERTENSION, V53, P993, DOI 10.1161/HYPERTENSIONAHA.109.130880; Murrant CL, 2000, ACTA PHYSIOL SCAND, V168, P531, DOI 10.1046/j.1365-201x.2000.00706.x; Murrant CL, 2000, AM J PHYSIOL-HEART C, V279, pH2285, DOI 10.1152/ajpheart.2000.279.5.H2285; Murrant CL, 2002, AM J PHYSIOL-REG I, V282, pR969, DOI 10.1152/ajpregu.00405.2001; Musch TI, 2001, EXP PHYSIOL, V86, P749, DOI 10.1111/j.1469-445X.2001.tb00040.x; Radegran G, 1999, AM J PHYSIOL-HEART C, V276, pH1951, DOI 10.1152/ajpheart.1999.276.6.H1951; Ray CJ, 2009, J PHYSIOL-LONDON, V587, P1579, DOI 10.1113/jphysiol.2008.163691; Rosa JC, 1998, J MED CHEM, V41, P2, DOI 10.1021/jm970571a; Rowell LB, 2004, J APPL PHYSIOL, V97, P384, DOI 10.1152/japplphysiol.01220.2003; SAGACH VF, 1992, J CARDIOVASC PHARM, V20, pS170, DOI 10.1097/00005344-199204002-00048; Saltin B, 1998, ACTA PHYSIOL SCAND, V162, P421, DOI 10.1046/j.1365-201X.1998.0293e.x; Sandow SL, 2006, J ANAT, V209, P689, DOI 10.1111/j.1469-7580.2006.00647.x; Sandow SL, 2003, CARDIOVASC RES, V60, P643, DOI 10.1016/j.cardiores.2003.09.017; Sankaranarayanan A, 2009, MOL PHARMACOL, V75, P281, DOI 10.1124/mol.108.051425; Saunders NR, 2005, AM J PHYSIOL-HEART C, V288, pH214, DOI 10.1152/ajpheart.00762.2004; Schrage WG, 2006, J APPL PHYSIOL, V100, P1506, DOI 10.1152/japplphysiol.01639.2005; Segal SS, 2005, MICROCIRCULATION, V12, P33, DOI 10.1080/10739680590895028; Segal SS, 2001, J PHYSIOL-LONDON, V536, P937, DOI 10.1111/j.1469-7793.2001.00937.x; Segal SS, 2000, ACTA PHYSIOL SCAND, V168, P511, DOI 10.1046/j.1365-201x.2000.00703.x; Si H, 2006, CIRC RES, V99, P537, DOI 10.1161/01.RES.0000238377.08219.0c; Siegl D, 2005, CIRC RES, V97, P781, DOI 10.1161/01.RES.0000186193.22438.6c; Welsh DG, 1997, AM J PHYSIOL-HEART C, V273, pH156, DOI 10.1152/ajpheart.1997.273.1.H156; Welsh DG, 1998, AM J PHYSIOL-HEART C, V274, pH178, DOI 10.1152/ajpheart.1998.274.1.H178; Wolfle SE, 2007, CIRC RES, V101, P1292, DOI 10.1161/CIRCRESAHA.107.163279; Wolfle SE, 2009, CARDIOVASC RES, V82, P476, DOI 10.1093/cvr/cvp060; Wolfle SE, 2005, J VASC RES, V42, P475, DOI 10.1159/000088101	64	56	60	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2010	24	9					3572	3579		10.1096/fj.10-158956	http://dx.doi.org/10.1096/fj.10-158956			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20427707				2022-12-25	WOS:000281446400044
J	Billet, A; Melin, P; Jollivet, M; Mornon, JP; Callebaut, I; Becq, F				Billet, Arnaud; Melin, Patricia; Jollivet, Mathilde; Mornon, Jean-Paul; Callebaut, Isabelle; Becq, Frederic			C Terminus of Nucleotide Binding Domain 1 Contains Critical Features for Cystic Fibrosis Transmembrane Conductance Regulator Trafficking and Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNEL; CYTOPLASMIC DOMAIN; ATPASE ACTIVITY; CFTR CHANNEL; WILD-TYPE; GENISTEIN; CELLS; G551D; DEGRADATION; DERIVATIVES	The cystic fibrosis transmembrane conductance regulator (CFTR) is a Cl- channel physiologically important in fluid-transporting epithelia and pathologically relevant in several human diseases. Here, we show that mutations in the C terminus of the first nucleotide binding domain comprising the latest beta strands (beta(c)5 and beta(c)6) influence the trafficking, channel activity, and pharmacology of CFTR. We mutated CFTR amino acids located in the beta(c)5-beta(c)6 hairpin, within the beta(c)5 strand (H620Q), within the beta-turn linking the two beta strands (E621G, G622D), as well as within (S623A, S624A) and at the extremity (G628R) of the beta(c)6 strand. Functional analysis reveals that the current density was largely reduced for G622D and G628R channels compared with wt CFTR, similar for E621G and S624A, but increased for H620Q and S623A. For G622D and G628R, the abnormal activity is likely due to a defective maturation process, as assessed by the augmented activity and mature C-band observed in the presence of the trafficking corrector miglustat. In addition, in presence of the CFTR activator benzo[c] quinolizinium, the CFTR current density compared with that of wt CFTR was abolished for G622D and G628R channels, but similar for H620Q, S623A, and S624A or slightly increased for E621G. Finally, G622D and G628R were activated by the CFTR agonists genistein, RP-107, and isobutylmethylxanthine. Our results identify the C terminus of the CFTR first nucleotide binding domain as an important molecular site for the trafficking of CFTR protein, for the control of CFTR channel gating, and for the pharmacological effect of a dual activity agent.	[Billet, Arnaud; Melin, Patricia; Jollivet, Mathilde; Becq, Frederic] Univ Poitiers, CNRS, Inst Physiol & Biol Cellulaires, F-86022 Poitiers, France; [Mornon, Jean-Paul; Callebaut, Isabelle] Univ Paris 06 & 07, Inst Mineral & Phys Milieux Condenses, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Becq, F (corresponding author), Univ Poitiers, CNRS, Inst Physiol & Biol Cellulaires, 40 Ave Recteur Pineau, F-86022 Poitiers, France.	frederic.becq@univ-poitiers.fr	Billet, Arnaud/AAZ-3834-2020; Becq, Frederic/P-9233-2016; billet, arnaud/P-9503-2016	Becq, Frederic/0000-0003-3915-0973; Billet, Arnaud/0000-0002-9738-7330	Vaincre La Mucoviscidose; MucoVie; ABCF2; Ministere de l'Enseignement Superieur et de la Recherche	Vaincre La Mucoviscidose; MucoVie; ABCF2; Ministere de l'Enseignement Superieur et de la Recherche	This work was supported by grants from Vaincre La Mucoviscidose, MucoVie, and ABCF2.; Supported by a studentship from the Ministere de l'Enseignement Superieur et de la Recherche.	Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Babenko AP, 2000, J BIOL CHEM, V275, P717, DOI 10.1074/jbc.275.2.717; Becq F, 1999, J BIOL CHEM, V274, P27415, DOI 10.1074/jbc.274.39.27415; Becq F, 2010, DRUGS, V70, P241, DOI 10.2165/11316160-000000000-00000; Callebaut I, 2004, CELL MOL LIFE SCI, V61, P230, DOI 10.1007/s00018-003-3386-z; Chan KM, 2000, J GEN PHYSIOL, V116, P163, DOI 10.1085/jgp.116.2.163; Chappe V, 1998, BRIT J PHARMACOL, V123, P683, DOI 10.1038/sj.bjp.0701648; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Derand R, 2002, J BIOL CHEM, V277, P35999, DOI 10.1074/jbc.M206121200; Derand R, 2001, AM J PHYSIOL-CELL PH, V281, pC1657, DOI 10.1152/ajpcell.2001.281.5.C1657; Dormer RL, 2001, J CELL SCI, V114, P4073; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Gadsby D. C., 1999, PHYSIOL REV, V79, pS77; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; ILLEK B, 1995, AM J PHYSIOL-CELL PH, V268, pC886, DOI 10.1152/ajpcell.1995.268.4.C886; Kidd JF, 2004, J BIOL CHEM, V279, P41664, DOI 10.1074/jbc.M407666200; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Marivingt-Mounir C, 2004, J MED CHEM, V47, P962, DOI 10.1021/jm0308848; Melin P, 2004, BIOCHEM PHARMACOL, V67, P2187, DOI 10.1016/j.bcp.2004.02.022; Melin P, 2007, BBA-BIOMEMBRANES, V1768, P2438, DOI 10.1016/j.bbamem.2007.05.013; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Noel S, 2006, J PHARMACOL EXP THER, V319, P349, DOI 10.1124/jpet.106.104521; Norez C, 2006, FEBS LETT, V580, P2081, DOI 10.1016/j.febslet.2006.03.010; Norez C, 2009, AM J RESP CELL MOL, V41, P217, DOI 10.1165/rcmb.2008-0285OC; RIORDAN JR, 1989, SCIENCE, V245, P1066; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Stratford FLL, 2003, BIOCHEM BIOPH RES CO, V300, P524, DOI 10.1016/S0006-291X(02)02883-8; Vankeerberghen A, 1998, HUM MOL GENET, V7, P1761, DOI 10.1093/hmg/7.11.1761; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6	34	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22132	22140		10.1074/jbc.M110.120683	http://dx.doi.org/10.1074/jbc.M110.120683			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20435887	Green Published, hybrid			2022-12-25	WOS:000279702200026
J	Kaieda, S; Shin, K; Nigrovic, PA; Seki, K; Lee, RT; Stevens, RL; Lee, DM				Kaieda, Shinjiro; Shin, Kichul; Nigrovic, Peter A.; Seki, Kenjiro; Lee, Richard T.; Stevens, Richard L.; Lee, David M.			Synovial Fibroblasts Promote the Expression and Granule Accumulation of Tryptase via Interleukin-33 and Its Receptor ST-2 (IL1RL1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE MAST-CELL; GROWTH-FACTOR; COMPLEMENTARY-DNA; SURFACE MOLECULE; HUMAN BASOPHILS; IL-33; CYTOKINE; TISSUE; MICE; GENE	A characteristic feature of tissue resident human mast cells (MCs) is their hTryptase-beta-rich cytoplasmic granules. Mouse MC protease-6 (mMCP-6) is the ortholog of hTryptase-beta, and we have shown that this tetramer-forming tryptase has beneficial roles in innate immunity but adverse roles in inflammatory disorders like experimental arthritis. Because the key tissue factors that control tryptase expression in MCs have not been identified, we investigated the mechanisms by which fibroblasts mediate the expression and granule accumulation of mMCP-6. Immature mouse bone marrow-derived MCs (mBMMCs) co-cultured with fibroblast-like synoviocytes (FLS) or mouse 3T3 fibroblasts markedly increased their levels of mMCP-6. This effect was caused by an undefined soluble factor whose levels could be increased by exposing FLS to tumor necrosis factor-alpha or interleukin (IL)-1 beta. Gene expression profiling of mBMMCs and FLS for receptor ligand pairs of potential relevance raised the possibility that IL-33 was a sought after fibroblast-derived factor that promotes tryptase expression and granule maturation via its receptor IL1RL1/ST2. MCs lacking IL1RL1 exhibited defective fibroblast-driven tryptase accumulation, whereas recombinant IL-33 induced mMCP-6 mRNA and protein accumulation in wild-type mBMMCs. In agreement with these data, synovial MCs from IL1RL1-null mice exhibited a marked reduction in mMCP-6 expression. IL-33 is the first factor shown to modulate tryptase expression in MCs at the mRNA and protein levels. We therefore have identified a novel pathway by which mesenchymal cells exposed to inflammatory cytokines modulate the phenotype of local MCs to shape their immune responses.	[Kaieda, Shinjiro; Shin, Kichul; Nigrovic, Peter A.; Stevens, Richard L.; Lee, David M.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Nigrovic, Peter A.] Childrens Hosp, Dept Med, Div Immunol, Boston, MA 02115 USA; [Seki, Kenjiro; Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Kaieda, Shinjiro; Shin, Kichul; Nigrovic, Peter A.; Seki, Kenjiro; Lee, Richard T.; Stevens, Richard L.; Lee, David M.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Lee, DM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Smith Bldg,Rm 552B,1 Jimmy Fund Way, Boston, MA 02115 USA.	dlee@rics.bwh.harvard.edu	Seki, Kenjiro/AAI-3220-2020	Lee, Richard/0000-0003-4687-1381	National Institutes of Health [AI059746, AI065858, HL036610]; Cogan Family Foundation; Harvard Club of Australia Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059746, P01AI065858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cogan Family Foundation; Harvard Club of Australia Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI059746, AI065858, and HL036610. This work was also supported by research grants from The Cogan Family Foundation and the Harvard Club of Australia Foundation.	Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; ANDERSON DM, 1990, CELL, V63, P235, DOI 10.1016/0092-8674(90)90304-W; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; CRISP AJ, 1984, ARTHRITIS RHEUM, V27, P845, DOI 10.1002/art.1780270802; DAYTON ET, 1988, P NATL ACAD SCI USA, V85, P569, DOI 10.1073/pnas.85.2.569; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Funaba M, 2005, CELL SIGNAL, V17, P121, DOI 10.1016/j.cellsig.2004.06.005; GHILDYAL N, 1994, J IMMUNOL, V153, P2624; GHILDYAL N, 1993, J IMMUNOL, V151, P3206; Ghildyal N, 1996, J EXP MED, V184, P1061, DOI 10.1084/jem.184.3.1061; GRUBER B, 1986, ARTHRITIS RHEUM, V29, P944, DOI 10.1002/art.1780290802; GURISH MF, 1995, IMMUNITY, V3, P175, DOI 10.1016/1074-7613(95)90087-X; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; GURISH MF, 2001, J EXP MED, V194, P1; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Huang CF, 2001, J BIOL CHEM, V276, P26276, DOI 10.1074/jbc.M102356200; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Hunt JE, 1996, J BIOL CHEM, V271, P2851, DOI 10.1074/jbc.271.5.2851; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; KANAKURA Y, 1988, BLOOD, V72, P877; Kearley J, 2009, AM J RESP CRIT CARE, V179, P772, DOI 10.1164/rccm.200805-666OC; KITAMURA Y, 1979, BLOOD, V53, P492; Kroeger KM, 2009, J LEUKOCYTE BIOL, V86, P769, DOI 10.1189/jlb.0708452; LEALBERUMEN I, 1994, J IMMUNOL, V152, P5468; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; LEE DM, 2005, KELLEYS TXB RHEUMATO, P175; LEVISCHAFFER F, 1987, J IMMUNOL, V139, P3431; LEVISCHAFFER F, 1987, J IMMUNOL, V139, P494; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; LEVISCHAFFER F, 1985, J IMMUNOL, V135, P3454; Liu XJ, 2009, BIOCHEM BIOPH RES CO, V386, P181, DOI 10.1016/j.bbrc.2009.06.008; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; MCNEIL HP, 1992, J IMMUNOL, V149, P2466; MCNEIL HP, 1992, P NATL ACAD SCI USA, V89, P11174, DOI 10.1073/pnas.89.23.11174; MILLER JS, 1990, J CLIN INVEST, V86, P864, DOI 10.1172/JCI114786; Moritz DR, 1998, J IMMUNOL, V161, P4866; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Nigrovic PA, 2005, ARTHRITIS RES THER, V7, P1, DOI 10.1186/ar1446; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; OTSU K, 1987, J EXP MED, V165, P615, DOI 10.1084/jem.165.3.615; Palmer G, 2009, ARTHRITIS RHEUM-US, V60, P738, DOI 10.1002/art.24305; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; RAZIN E, 1984, J IMMUNOL, V132, P1479; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; Rittner HL, 2006, J LEUKOCYTE BIOL, V79, P1022, DOI 10.1189/jlb.0805452; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; Seki K, 2009, CIRC-HEART FAIL, V2, P684, DOI 10.1161/CIRCHEARTFAILURE.109.873240; SERAFIN WE, 1987, J IMMUNOL, V139, P3771; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Shin K, 2006, ARTHRITIS RHEUM-US, V54, P2863, DOI 10.1002/art.22058; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; STEVENS RL, 1992, ARTHRITIS RHEUM, V35, P325, DOI 10.1002/art.1780350312; STEVENS RL, 1982, J BIOL CHEM, V257, P253; Suzukawa Maho, 2008, Lab Invest, V88, P1245, DOI 10.1038/labinvest.2008.82; Tajima S, 2007, EXP LUNG RES, V33, P81, DOI 10.1080/01902140701198583; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; TOMINAGA S, 1992, BIOCHIM BIOPHYS ACTA, V1171, P215, DOI 10.1016/0167-4781(92)90125-J; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Ugajin T, 2009, INTERNAL MED, V48, P693, DOI 10.2169/internalmedicine.48.1736; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; Wong GW, 2004, J BIOL CHEM, V279, P2438, DOI 10.1074/jbc.M308209200; Wong UW, 1999, J BIOL CHEM, V274, P30784, DOI 10.1074/jbc.274.43.30784; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105	75	52	53	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21478	21486		10.1074/jbc.M110.114991	http://dx.doi.org/10.1074/jbc.M110.114991			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20427273	hybrid, Green Published			2022-12-25	WOS:000279516100034
J	Serchov, T; Dubois-Pot-Schneider, H; Charlot, C; Rosl, F; Wasylyk, B				Serchov, Tsvetan; Dubois-Pot-Schneider, Helene; Charlot, Celine; Roesl, Frank; Wasylyk, Bohdan			Involvement of Net and Hif1 alpha in Distinct yet Intricately Linked Hypoxia-induced Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX FACTOR NET; TRANSCRIPTION FACTOR; HIF-ALPHA; PROLYL HYDROXYLASES; OXYGEN SENSOR; CELLS; RAS; HIF-1-ALPHA; INHIBITION; CANCER	The present study compares negative Ets transcription factor (Net) and hypoxia-inducible factor 1 alpha (HIF1 alpha) regulation by hypoxia. Their protein stabilities are differently regulated by hypoxia, defining three periods in the kinetics: normoxia (high Net levels and low HIF1 alpha levels), early hypoxia (high levels of Net and HIF1 alpha), and late hypoxia (degradation of Net and HIF1 alpha). Modulators of prolyl hydroxylase domain protein (PHD) activity induce a mobility shift of Net, similar to HIF1 alpha, suggesting that post-translational modifications of both factors depend on PHD activity. The three PHD shave different roles in the regulation of Net protein levels; PHD1 and PHD3 are involved in the stabilization of Net, whereas PHD2 controls its degradation in late hypoxia. Net physically interacts with PHD2 in hypoxia, whereas PHD1 and PHD3 bind to Net in normoxia and hypoxia. Under the same conditions, PHD2 and PHD3 regulate both HIF1 alpha stabilization in early hypoxia and its degradation at late hypoxia, whereas PHD1 is involved in HIF1 alpha degradation in late hypoxia. We describe interconnections between the regulation of both Net and HIF1 alpha at the protein level. Evidence is provided for a direct physical interaction between Net and HIF1 alpha and indirect transcriptional regulation loops that involve the PHDs. Taken together our results indicate that Net and HIF1 alpha are components of distinct signaling pathways that are intricately linked.	[Serchov, Tsvetan; Dubois-Pot-Schneider, Helene; Charlot, Celine; Wasylyk, Bohdan] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM,UMR 7104,U964, F-67404 Illkirch Graffenstaden, Graffenstaden, France; [Roesl, Frank] Deutsch Krebsforschungszentrum, Abt Virale Transformationsmechanismen, D-69120 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; German Cancer Research Center (DKFZ)	Wasylyk, B (corresponding author), Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM,UMR 7104,U964, 1 Rue Laurent Fries,BP 10142, F-67404 Illkirch Graffenstaden, Graffenstaden, France.	boh@igbmc.u-strasbg.fr	Wasylyk, Bohdan/ABG-6778-2020	Wasylyk, Bohdan/0000-0002-1718-1237; Serchov, Tsvetan/0000-0002-2234-2875	Association pour la Recherche Contre le Cancer; Ligue Regionale (Bas-Rhin) Contre le Cancer; Ligue Regionale (Haut-Rhin) Contre le Cancer, Conference de Coordination Interregionale du Grand Est (CCIR-GE) de la Ligue Contre le Cancer; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; European Union [504587]; l'Institut National du Cancer (INCa); Regional Council of Alsace; Ministere de l'Education Nationale, de la Recherche et de la Technologie; Wasylyk laboratory	Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Regionale (Bas-Rhin) Contre le Cancer; Ligue Regionale (Haut-Rhin) Contre le Cancer, Conference de Coordination Interregionale du Grand Est (CCIR-GE) de la Ligue Contre le Cancer; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Union(European Commission); l'Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Regional Council of Alsace(Region Grand-Est); Ministere de l'Education Nationale, de la Recherche et de la Technologie; Wasylyk laboratory	This work was supported by grants from the Association pour la Recherche Contre le Cancer, the Ligue Regionale (Bas-Rhin) Contre le Cancer and the Ligue Regionale (Haut-Rhin) Contre le Cancer, Conference de Coordination Interregionale du Grand Est (CCIR-GE) de la Ligue Contre le Cancer, the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale, the European Union (FP6 Prima Project 504587), and l'Institut National du Cancer (INCa) (AxeIV and DKFZ-Canceropole du Grande Est (CGE) projects).; Recipient of a fellowship from the Regional Council of Alsace.; Recipient of a fellowship from the Ministere de l'Education Nationale, de la Recherche et de la Technologie.; Recipient of a fellowship from l'Institut National du Cancer.; We thank Prof. Eric Stanbridge for providing the 444 cells, Dr. Alain Jung for critical reading of the manuscript, the Wasylyk laboratory members for support and encouragement, and the IGBMC core facilities.	Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Ayadi A, 2001, MECH DEVELOP, V102, P205, DOI 10.1016/S0925-4773(01)00289-1; Berra E, 2006, EMBO REP, V7, P41, DOI 10.1038/sj.embor.7400598; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Buchwalter G, 2005, MOL CELL BIOL, V25, P10853, DOI 10.1128/MCB.25.24.10853-10862.2005; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Cioffi CL, 2003, BIOCHEM BIOPH RES CO, V303, P947, DOI 10.1016/S0006-291X(03)00453-4; Criqui-Filipe P, 1999, EMBO J, V18, P3392, DOI 10.1093/emboj/18.12.3392; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Ducret C, 2000, ONCOGENE, V19, P5063, DOI 10.1038/sj.onc.1203892; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; GIOVANE A, 1994, GENE DEV, V8, P1502, DOI 10.1101/gad.8.13.1502; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Gross C, 2008, ONCOGENE, V27, P1333, DOI 10.1038/sj.onc.1210736; Gross C, 2007, MOL CELL BIOL, V27, P4133, DOI 10.1128/MCB.01867-06; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Maira SM, 1996, EMBO J, V15, P5849, DOI 10.1002/j.1460-2075.1996.tb00972.x; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; STANBRIDGE EJ, 1976, LANCET, V2, P525; STANBRIDGE EJ, 1976, NATURE, V260, P17, DOI 10.1038/260017a0; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; van Riggelen J, 2005, J BIOL CHEM, V280, P3286, DOI 10.1074/jbc.M409915200; Wasylyk C, 2008, CANCER RES, V68, P1275, DOI 10.1158/0008-5472.CAN-07-2674; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Zheng H, 2003, GENE DEV, V17, P2283, DOI 10.1101/gad.272503; Ziello Jennifer E, 2007, Yale J Biol Med, V80, P51	35	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21223	21232		10.1074/jbc.M110.121723	http://dx.doi.org/10.1074/jbc.M110.121723			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20427288	Green Published, hybrid			2022-12-25	WOS:000279516100007
J	Liu, PS; Jong, TH; Maa, MC; Leu, TH				Liu, P-S; Jong, T-H; Maa, M-C; Leu, T-H			The interplay between Eps8 and IRSp53 contributes to Src-mediated transformation	ONCOGENE			English	Article						IRSp53; Eps8; v-Src; Stat3; oncogenic proteins; cancer cells	TYROSINE KINASE SUBSTRATE; MISSING-IN-METASTASIS; INSULIN-RECEPTOR; STRUCTURAL BASIS; HOMOLOGY DOMAIN; SH3 DOMAIN; V-SRC; EXPRESSION; PHOSPHORYLATION; ACTIVATION	As an oncoprotein, Eps8 participates in v-Src-induced cellular transformation. To delineate the underlying mechanism, we conducted a yeast two-hybrid screening and identified IRSp53S, a protein critical in cell mobilization, as one of the Eps8-binding partners from a human brain cDNA library. The association was mediated by the multiple proline-rich regions of Eps8 and the C-terminal SH3-WWB containing domains of IRSp53S. In this study, we observed that Eps8 modulated the expression of IRSp53 in v-Src-transformed cells (IV5), raising the question of whether Eps8/IRSp53 interaction was crucial in carcinogenesis. To address this issue, we generated IV5-expressing irsp53 siRNA cells. Attenuation of IRSp53 reduced cell proliferation of IV5 in culture dish and tumor formation in mice, which could be partly rescued by ectopically expressed human IRSp53S. In addition, IRSp53 knockdown impaired activity of phosphatidylinositol 3-kinase (as reflected by Pi-Ser473 AKT) and Stat3 (as reflected by Pi-Tyr705 Stat3), and reduced cyclin D1 expression that culminated to impede G(1)-phase cell-cycle progression. Ectopically expressed human IRSp53S, but not its Eps8-binding defective mutants (that is, Delta 363 and PPPDA), rescued these defects and partly restored cell proliferation. Remarkably, through activation of Src, EGF increased the formation of Eps8/IRSp53 complex and Stat3 activation in HeLa cells. With these results, we show for the first time that IRSp53, through its interaction with Eps8, not only affects cell migration but also dictates cellular growth in cancer cells. Oncogene (2010) 29, 3977-3989; doi:10.1038/onc.2010.144; published online 26 April 2010	[Jong, T-H; Leu, T-H] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Liu, P-S; Leu, T-H] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Maa, M-C] China Med Univ, Inst Med Sci, Taichung, Taiwan; [Maa, M-C] China Med Univ, Inst Mol Syst Biomed, Taichung, Taiwan; [Leu, T-H] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; China Medical University Taiwan; China Medical University Taiwan; National Cheng Kung University	Leu, TH (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, 1 Univ Rd, Tainan 70101, Taiwan.	mcmaa@mail.cmu.edu.tw; tzengleu@mail.ncku.edu.tw			National Science Council [NSC98-2311-B-039-002-MY3, NSC97-2320-B-006-024-MY3, NSC 94-3112-B-001-003, NSC 94-3112-B-001-018-Y]; NHRI [NHRI-EX-98-9828BI]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH99-TD-B-111-004]; China Medical University [CMU98-C-05]	National Science Council(Ministry of Science and Technology, Taiwan); NHRI(National Health Research Institutes - Taiwan); Taiwan Department of Health Clinical Trial and Research Center of Excellence; China Medical University(China Medical University)	This work was supported by National Science Council grants to M-CM (NSC98-2311-B-039-002-MY3) and T-HL (NSC97-2320-B-006-024-MY3). Additional support came from NHRI (NHRI-EX-98-9828BI to T-H Leu), Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH99-TD-B-111-004 to M-C Maa) and China Medical University (CMU98-C-05 to M-C Maa). The DNA constructs of pLKO.1-mirsp53-b and pLKO.1-mirsp53-c were provided by the National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, supported by the National Research Program for Genomic Medicine Grants of NSC (NSC 94-3112-B-001-003 and NSC 94-3112-B-001-018-Y).	Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999; Aitio O, 2008, J MOL BIOL, V382, P167, DOI 10.1016/j.jmb.2008.07.008; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Chen YJ, 2008, MOL CANCER THER, V7, P1376, DOI 10.1158/1535-7163.MCT-07-2388; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Funato Y, 2004, CANCER RES, V64, P5237, DOI 10.1158/0008-5472.CAN-04-0327; Gallo R, 1997, ONCOGENE, V15, P1929, DOI 10.1038/sj.onc.1201344; HARLOW E, 1988, ANTIBODIES LAB MANUA, P522; Lee SH, 2007, STRUCTURE, V15, P145, DOI 10.1016/j.str.2006.12.005; Leu TH, 2004, J BIOL CHEM, V279, P9875, DOI 10.1074/jbc.M309884200; Maa MC, 1998, BIOCHEM BIOPH RES CO, V251, P344, DOI 10.1006/bbrc.1998.9464; Maa MC, 1999, BBA-MOL CELL RES, V1450, P341, DOI 10.1016/S0167-4889(99)00069-5; Maa MC, 2001, ONCOGENE, V20, P106, DOI 10.1038/sj.onc.1204069; Maa MC, 2007, J BIOL CHEM, V282, P19399, DOI 10.1074/jbc.M610280200; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Miyahara A, 2003, J HUM GENET, V48, P410, DOI 10.1007/s10038-003-0047-x; Mongiovi AM, 1999, EMBO J, V18, P5300, DOI 10.1093/emboj/18.19.5300; Oda K, 1999, CYTOGENET CELL GENET, V84, P75, DOI 10.1159/000015219; Okamura-Oho Y, 1999, HUM MOL GENET, V8, P947, DOI 10.1093/hmg/8.6.947; Okamura-Oho Y, 2001, BIOCHEM BIOPH RES CO, V289, P957, DOI 10.1006/bbrc.2001.6102; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Suetsugu S, 2006, J BIOL CHEM, V281, P35347, DOI 10.1074/jbc.M606814200; Xu M, 2009, ENDOCRINOLOGY, V150, P2064, DOI 10.1210/en.2008-1265; Yap LF, 2009, ONCOGENE, V28, P2524, DOI 10.1038/onc.2009.105; Yeh TC, 1996, J BIOL CHEM, V271, P2921, DOI 10.1074/jbc.271.6.2921	30	24	25	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 8	2010	29	27					3977	3989		10.1038/onc.2010.144	http://dx.doi.org/10.1038/onc.2010.144			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	621SL	20418908				2022-12-25	WOS:000279603200010
J	Jiang, YQ; Bernard, D; Yu, YK; Xie, YH; Zhang, T; Li, YY; Burnett, JP; Fu, XQ; Wang, SM; Sun, DX				Jiang, Yiqun; Bernard, Denzil; Yu, Yanke; Xie, Yehua; Zhang, Tao; Li, Yanyan; Burnett, Joseph P.; Fu, Xueqi; Wang, Shaomeng; Sun, Duxin			Split Renilla Luciferase Protein Fragment-assisted Complementation (SRL-PFAC) to Characterize Hsp90-Cdc37 Complex and Identify Critical Residues in Protein/Protein Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 INHIBITORS; LIVING SUBJECTS; KINASE CHAPERONE; ATPASE CYCLE; CANCER-CELLS; BINDING SITE; CO-CHAPERONE; CDC37; IDENTIFICATION; EXPRESSION	Hsp90 requires cochaperone Cdc37 to load its clients to the Hsp90 superchaperone complex. The purpose of this study was to utilize split Renilla luciferase protein fragment-assisted complementation (SRL-PFAC) bioluminescence to study the full-length human Hsp90-Cdc37 complex and to identity critical residues and their contributions for Hsp90/Cdc37 interaction in living cells. SRL-PFAC showed that full-length human Hsp90/Cdc37 interaction restored dramatically high luciferase activity through Hsp90-Cdc37-assisted complementation of the N and C termini of luciferase (compared with the set of controls). Immunoprecipitation confirmed that the expressed fusion proteins (NRL-Hsp90 and Cdc37-CRL) preserved their ability to interact with each other and also with native Hsp90 or Cdc37. Molecular dynamic simulation revealed several critical residues in the two interaction patches (hydrophobic and polar) at the interface of Hsp90/Cdc37. Mutagenesis confirmed the critical residues for Hsp90-Cdc37 complex formation. SRL-PFAC bioluminescence evaluated the contributions of these critical residues in Hsp90/Cdc37 interaction. The results showed that mutations in Hsp90 (Q133A, F134A, and A121N) and mutations in Cdc37 (M164A, R167A, L205A, and Q208A) reduced the Hsp90/Cdc37 interaction by 70-95% as measured by the resorted luciferase activity through Hsp90-Cdc37-assisted complementation. In comparison, mutations in Hsp90 (E47A and S113A) and a mutation in Cdc37 (A204E) decreased the Hsp90/Cdc37 interaction by 50%. In contrast, mutations of Hsp90 (R46A, S50A, C481A, and C598A) and mutations in Cdc37 (C54S, C57S, and C64S) did not change Hsp90/Cdc37 interactions. The data suggest that single amino acid mutation in the interface of Hsp90/Cdc37 is sufficient to disrupt its interaction, although Hsp90/Cdc37 interactions are through large regions of hydrophobic and polar interactions. These findings provides a rationale to develop inhibitors for disruption of the Hsp90/Cdc37 interaction.	[Jiang, Yiqun; Yu, Yanke; Xie, Yehua; Zhang, Tao; Li, Yanyan; Burnett, Joseph P.; Sun, Duxin] Univ Michigan, Dept Pharmaceut Sci, Coll Pharm, Ann Arbor, MI 48109 USA; [Bernard, Denzil; Wang, Shaomeng] Univ Michigan, Ctr Comprehens Canc, Dept Internal Med, Dept Pharmacol & Med Chem, Ann Arbor, MI 48109 USA; [Jiang, Yiqun; Fu, Xueqi] Jilin Univ, Coll Life Sci, Edmond H Fischer Signal Transduct Lab, Changchun 130023, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Jilin University	Fu, XQ (corresponding author), Univ Michigan, Dept Pharmaceut Sci, Coll Pharm, Ann Arbor, MI 48109 USA.	fxq@jlu.edu.cn; shaomeng@umich.edu; duxins@umich.edu	Sun, Duxin/AAA-1774-2022; Zhang, Tao/A-7339-2012; Yu, Yanke/E-4919-2012	Bernard, Denzil/0000-0001-7529-3336; Wang, Shaomeng/0000-0002-8782-6950; Burnett, Joseph/0000-0002-4844-6613	National Institutes of Health [RO1 CA120023, R21 CA143474]; University of Michigan Cancer Center; Chinese Scholarship Council; NATIONAL CANCER INSTITUTE [R21CA143474, R01CA120023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Cancer Center(University of Michigan System); Chinese Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by the National Institutes of Health (RO1 CA120023 and R21 CA143474); University of Michigan Cancer Center Research Grant (Munn); and University of Michigan Cancer Center Core Grant (to D. S.). This study was also partially supported by Chinese Scholarship Council (to Y. J.) (2009).	Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; Chan CT, 2008, CANCER RES, V68, P216, DOI 10.1158/0008-5472.CAN-07-2268; FERRARINI M, 1992, INT J CANCER, V51, P613, DOI 10.1002/ijc.2910510418; FINKELSTEIN DB, 1983, J BIOL CHEM, V258, P1908; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; He HZ, 2006, J MED CHEM, V49, P381, DOI 10.1021/jm0508078; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; Kaihara A, 2003, ANAL CHEM, V75, P4176, DOI 10.1021/ac0300800; Kaihara A, 2008, CHEM-ASIAN J, V3, P38, DOI 10.1002/asia.200700186; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; LAI BT, 1984, MOL CELL BIOL, V4, P2802, DOI 10.1128/MCB.4.12.2802; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Massoud TF, 2004, FASEB J, V18, P1105, DOI 10.1096/fj.03-1128fje; MATTHEWS JC, 1977, BIOCHEMISTRY-US, V16, P85, DOI 10.1021/bi00620a014; Neckers L, 2003, CURR MED CHEM, V10, P733, DOI 10.2174/0929867033457818; Pascale RM, 2005, HEPATOLOGY, V42, P1310, DOI 10.1002/hep.20962; Paulmurugan R, 2004, CANCER RES, V64, P2113, DOI 10.1158/0008-5472.CAN-03-2972; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; REED SI, 1980, GENETICS, V95, P561; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; Shao JY, 2003, BIOCHEMISTRY-US, V42, P12577, DOI 10.1021/bi035138j; Shao JY, 2003, J BIOL CHEM, V278, P38117, DOI 10.1074/jbc.C300330200; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Smith JR, 2009, ONCOGENE, V28, P157, DOI 10.1038/onc.2008.380; Solit DB, 2008, DRUG DISCOV TODAY, V13, P38, DOI 10.1016/j.drudis.2007.10.007; Soti C, 2003, EUR J BIOCHEM, V270, P2421, DOI 10.1046/j.1432-1033.2003.03610.x; Sreeramulu S, 2009, J BIOL CHEM, V284, P3885, DOI 10.1074/jbc.M806715200; Sreeramulu S, 2009, ANGEW CHEM INT EDIT, V48, P5853, DOI 10.1002/anie.200900929; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stepanova L, 2000, ONCOGENE, V19, P2186, DOI 10.1038/sj.onc.1203561; Stepanova L, 2000, MOL CELL BIOL, V20, P4462, DOI 10.1128/MCB.20.12.4462-4473.2000; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007	44	33	33	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21023	21036		10.1074/jbc.M110.103390	http://dx.doi.org/10.1074/jbc.M110.103390			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20413594	Green Published, hybrid			2022-12-25	WOS:000279228600066
J	Kaizuka, T; Hara, T; Oshiro, N; Kikkawa, U; Yonezawa, K; Takehana, K; Iemura, S; Natsume, T; Mizushima, N				Kaizuka, Takeshi; Hara, Taichi; Oshiro, Noriko; Kikkawa, Ushio; Yonezawa, Kazuyoshi; Takehana, Kenji; Iemura, Shun-ichiro; Natsume, Tohru; Mizushima, Noboru			Tti1 and Tel2 Are Critical Factors in Mammalian Target of Rapamycin Complex Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; KINASE-ACTIVITY; MTOR; CHECKPOINT; RAPTOR; AUTOPHAGY; PROTEIN; RICTOR; PATHWAY; DEFINES	Mammalian target of rapamycin (mTOR) is a member of the phosphatidylinositol 3-kinase-related kinase (PIKK) family and is a major regulator of translation, cell growth, and autophagy. mTOR exists in two distinct complexes, mTORC1 and mTORC2, that differ in their subunit composition. In this study, we identified KIAA0406 as a novel mTOR-interacting protein. Because it has sequence homology with Schizosaccharomyces pombe Tti1, we named it mammalian Tti1. Tti1 constitutively interacts with mTOR in both mTORC1 and mTORC2. Knockdown of Tti1 suppresses phosphorylation of both mTORC1 substrates (S6K1 and 4F-BP1) and an mTORC2 substrate (Akt) and also induces autophagy. S. pombe Tti1 binds to Tel2, a protein whose mammalian homolog was recently reported to regulate the stability of PIKKs. We confirmed that Tti1 binds to Tel2 also in mammalian cells, and Tti1 interacts with and stabilizes all six members of the PIKK family of proteins (mTOR, ATM, ATR, DNA-PKcs, SMG-1, and TRRAP). Furthermore, using immuno-precipitation and size-exclusion chromatography analyses, we found that knockdown of either Tti1 or Tel2 causes disassembly of mTORC1 and mTORC2. These results indicate that Tti1 and Tel2 are important not only for mTOR stability but also for assembly of the mTOR complexes to maintain their activities.	[Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, Tokyo 1138519, Japan; [Oshiro, Noriko; Kikkawa, Ushio; Yonezawa, Kazuyoshi] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan; [Takehana, Kenji] Ajinomoto Co Inc, Exploratory Res, Pharmacol Res Lab, Kawasaki, Kanagawa 2108681, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biol Syst Control Team, Biomed Informat Res Ctr, Tokyo 1350064, Japan	Tokyo Medical & Dental University (TMDU); Kobe University; Ajinomoto Co Inc; National Institute of Advanced Industrial Science & Technology (AIST)	Mizushima, N (corresponding author), Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	nmizu.phy2@tmd.ac.jp	Mizushima, Noboru/C-3635-2009; Natsume, Tohru/M-7627-2018	Mizushima, Noboru/0000-0002-6258-6444; Natsume, Tohru/0000-0002-1510-2582; Kaizuka, Takeshi/0000-0002-5253-1896	Ministry of Education, Culture, Sports, Science and Technology, Japan; Toray Science Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toray Science Foundation(Toray Industries, Inc.); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, the Toray Science Foundation, and the Takeda Science Foundation (to N.M.).	Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Danielsen JMR, 2009, J BIOL CHEM, V284, P4140, DOI 10.1074/jbc.M808174200; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; HARTMAN PS, 1982, GENETICS, V102, P159; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Izumi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000468; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanoh J, 2007, GENES CELLS, V12, P1301, DOI 10.1111/j.1365-2443.2007.01142.x; Kanu N, 2007, EMBO J, V26, P2933, DOI 10.1038/sj.emboj.7601733; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; Murr R, 2007, ONCOGENE, V26, P5358, DOI 10.1038/sj.onc.1210605; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nishiuma T, 1998, BIOCHEM BIOPH RES CO, V252, P440, DOI 10.1006/bbrc.1998.9671; Runge KW, 1996, MOL CELL BIOL, V16, P3094; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shikata M, 2007, J BIOL CHEM, V282, P5346, DOI 10.1074/jbc.M607432200; Takahara T, 2006, J BIOL CHEM, V281, P28605, DOI 10.1074/jbc.M606087200; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	41	178	196	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20109	20116		10.1074/jbc.M110.121699	http://dx.doi.org/10.1074/jbc.M110.121699			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427287	Green Published, hybrid			2022-12-25	WOS:000279012000045
J	Kobayashi, Y; Zhuang, JL; Peltz, S; Dougherty, J				Kobayashi, Yoshifumi; Zhuang, Jianling; Peltz, Stuart; Dougherty, Joseph			Identification of a Cellular Factor That Modulates HIV-1 Programmed Ribosomal Frameshifting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MURINE LEUKEMIA-VIRUS; STRANDED-RNA VIRUS; POL FUSION PROTEIN; STIMULATORY SIGNAL; IN-VIVO; TYPE-1; YEAST; TRANSLATION; EFFICIENCY	Programmed -1 ribosomal frameshifting (PRF) is a distinctive mode of gene expression utilized by some viruses, including human immunodeficiency virus type 1 (HIV-1), to produce multiple proteins from a single mRNA. -1 PRF induces a subset of elongating ribosomes to shift their translational reading frame by 1 base in the 5' direction. The appropriate ratio of Gag to Gag-Pol synthesis is tightly regulated by the PRF signal which promotes ribosomes to shift frame, and even small changes in PRF efficiency, either up or down, have significant inhibitory effects upon virus production, making PRF essential for HIV-1 replication. Although little has been reported about the cellular factors that modulate HIV-1 PRF, the cis-acting elements regulating PRF have been extensively investigated, and the PRF signal of HIV-1 was shown to include a slippery site and frameshift stimulatory signal. Recently, a genome-wide screen performed to identify cellular factors that affect HIV-1 replication demonstrated that down-regulation of eukaryotic release factor 1 (eRF1) inhibited HIV-1 replication. Because of the eRF1 role in translation, we hypothesized that eRF1 is important for HIV-1 PRF. Using a dual luciferase reporter system harboring a HIV-1 PRF signal, results showed that depletion or inhibition of eRF1 enhanced PRF in yeast, rabbit reticulocyte lysates, and mammalian cells. Consistent with the eRF1 role in modulating HIV PRF, depleting eRF1 increased the Gag-Pol to Gag ratio in cells infected with replication-competent virus. The increase in PRF was independent of a proximal termination codon and did not result from increased ribosomal pausing at the slippery site. This is the first time that a cellular factor has been identified which can promote HIV-1 PRF and highlights HIV-1 PRF as essential for replication and an important but under exploited antiviral drug target.	[Kobayashi, Yoshifumi; Zhuang, Jianling; Dougherty, Joseph] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA; [Peltz, Stuart] PTC Therapeut Inc, Plainfield, NJ 07080 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Dougherty, J (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, 675 Hoes La, Piscataway, NJ 08854 USA.	doughejp@umdnj.edu			National Institutes of Health [P01AI057596]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant P01AI057596.	Baril M, 2003, RNA, V9, P1246, DOI 10.1261/rna.5113603; Baril M, 2003, J MOL BIOL, V331, P571, DOI 10.1016/S0022-2836(03)00784-8; Bidou L, 1997, RNA, V3, P1153; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; BRIERLEY I, 1992, J MOL BIOL, V227, P463, DOI 10.1016/0022-2836(92)90901-U; BRIERLEY I, 1995, J GEN VIROL, V76, P1885, DOI 10.1099/0022-1317-76-8-1885; Dinman J. D., 2007, TRANSLATIONAL CONTRO, P625; DINMAN JD, 1992, J VIROL, V66, P3669, DOI 10.1128/JVI.66.6.3669-3676.1992; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; Dulude D, 2002, NUCLEIC ACIDS RES, V30, P5094, DOI 10.1093/nar/gkf657; FELSENSTEIN KM, 1988, J VIROL, V62, P2179, DOI 10.1128/JVI.62.6.2179-2182.1988; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Freed Eric O., 2001, Somatic Cell and Molecular Genetics, V26, P13, DOI 10.1023/A:1021070512287; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Gaudin C, 2005, J MOL BIOL, V349, P1024, DOI 10.1016/j.jmb.2005.04.045; Gould PS, 2005, BIOTECHNIQUES, V38, P397, DOI 10.2144/05383ST02; Grentzmann G, 1998, RNA, V4, P479; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; Hayes S, 1999, ACTA BIOCHIM POL, V46, P879, DOI 10.18388/abp.1999_4109; HORSFIELD JA, 1995, NUCLEIC ACIDS RES, V23, P1487, DOI 10.1093/nar/23.9.1487; Hung M, 1998, J VIROL, V72, P4819, DOI 10.1128/JVI.72.6.4819-4824.1998; Inge-Vechtomov S, 2003, BIOL CELL, V95, P195, DOI 10.1016/S0248-4900(03)00035-2; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; JACKS T, 1990, CURR TOP MICROBIOL, V157, P93; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; KARACOSTAS V, 1993, VIROLOGY, V193, P661, DOI 10.1006/viro.1993.1174; KOLLMUS H, 1994, J VIROL, V68, P6087, DOI 10.1128/JVI.68.9.6087-6091.1994; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; MORIKAWA S, 1992, VIROLOGY, V186, P389, DOI 10.1016/0042-6822(92)90004-9; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Orlova M, 2003, CELL, V115, P319, DOI 10.1016/S0092-8674(03)00805-5; Park HJ, 2009, FEBS LETT, V583, P665, DOI 10.1016/j.febslet.2009.01.015; PARK JS, 1991, J VIROL, V65, P5111, DOI 10.1128/JVI.65.9.5111-5117.1991; Paulus C, 2004, VIROLOGY, V330, P271, DOI 10.1016/j.virol.2004.09.013; Sachs MS, 2002, METHODS, V26, P105, DOI 10.1016/S1046-2023(02)00013-0; Shehu-Xhilaga M, 2001, J VIROL, V75, P1834, DOI 10.1128/JVI.75.4.1834-1841.2001; Shigemoto K, 2001, NUCLEIC ACIDS RES, V29, P4079, DOI 10.1093/nar/29.19.4079; SOMOGYI P, 1993, MOL CELL BIOL, V13, P6931, DOI 10.1128/MCB.13.11.6931; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; Stansfield I, 1997, EUR J BIOCHEM, V245, P557, DOI 10.1111/j.1432-1033.1997.00557.x; Staple DW, 2005, J MOL BIOL, V349, P1011, DOI 10.1016/j.jmb.2005.03.038; Staple DW, 2003, NUCLEIC ACIDS RES, V31, P4326, DOI 10.1093/nar/gkg654; Tan M, 2001, J EUKARYOT MICROBIOL, V48, P575, DOI 10.1111/j.1550-7408.2001.tb00193.x; Telenti A, 2002, J VIROL, V76, P7868, DOI 10.1128/JVI.76.15.7868-7873.2002; TU CL, 1992, P NATL ACAD SCI USA, V89, P8636, DOI 10.1073/pnas.89.18.8636; Vimaladithan A, 1998, METH MOL B, V77, P399; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; WILSON W, 1988, CELL, V55, P1159, DOI 10.1016/0092-8674(88)90260-7	49	26	30	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19776	19784		10.1074/jbc.M109.085621	http://dx.doi.org/10.1074/jbc.M109.085621			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20418372	Green Published, hybrid			2022-12-25	WOS:000279012000010
J	Marino, F; Pelc, LA; Vogt, A; Gandhi, PS; Di Cera, E				Marino, Francesca; Pelc, Leslie A.; Vogt, Austin; Gandhi, Prafull S.; Di Cera, Enrico			Engineering Thrombin for Selective Specificity toward Protein C and PAR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOVALENT CATION SPECIFICITY; XIII ACTIVATION PEPTIDE; ANTICOAGULANT ACTIVITY; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; POTENT ANTICOAGULANT; MUTANT W215A/E217A; BLOOD-COAGULATION; STRUCTURAL BASIS; ALPHA-THROMBIN	Thrombin elicits functional responses critical to blood homeostasis by interacting with diverse physiological substrates. Ala-scanning mutagenesis of 97 residues covering 53% of the solvent accessible surface area of the enzyme identifies Trp(215) as the single most important determinant of thrombin specificity. Saturation mutagenesis of Trp(215) produces constructs featuring k(cat)/K-m values for the hydrolysis of fibrinogen, protease-activated receptor PAR1, and protein C that span five orders of magnitude. Importantly, the effect of Trp(215) replacement is context dependent. Mutant W215E is 10-fold more specific for protein C than fibrinogen and PAR1, which represents a striking shift in specificity relative to wild-type that is 100-fold more specific for fibrinogen and PAR1 than protein C. However, when the W215E mutation is combined with deletion of nine residues in the autolysis loop, which by itself shifts the specificity of the enzyme from fibrinogen and PAR1 to protein C, the resulting construct features significant activity only toward PAR1. These findings demonstrate that thrombin can be re-engineered for selective specificity toward protein C and PAR1. Mutations of Trp(215) provide important reagents for dissecting the multiple functional roles of thrombin in the blood and for clinical applications.	[Marino, Francesca; Pelc, Leslie A.; Vogt, Austin; Gandhi, Prafull S.; Di Cera, Enrico] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu	Vogt, Austin/E-9731-2012		National Institutes of Health Research [HL49413, HL58141, HL73813, HL95315]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073813, R29HL049413, R01HL058141, R01HL049413, R44HL095315] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Research Grants HL49413, HL58141, HL73813, and HL95315 (to E. D. C.).	Arosio D, 2000, BIOCHEMISTRY-US, V39, P8095, DOI 10.1021/bi0006215; Ayala YM, 2001, PROTEINS, V45, P107, DOI 10.1002/prot.1130; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; Bah A, 2009, J BIOL CHEM, V284, P20034, DOI 10.1074/jbc.M109.012344; Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; Berny MA, 2008, ARTERIOSCL THROM VAS, V28, P329, DOI 10.1161/ATVBAHA.107.156273; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bode W, 2006, BLOOD CELL MOL DIS, V36, P122, DOI 10.1016/j.bcmd.2005.12.027; BODE W, 1992, PROTEIN SCI, V1, P426; Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S; Busch M, 2004, EUR J MED RES, V9, P199; Bush-Pelc LA, 2007, J BIOL CHEM, V282, P27165, DOI 10.1074/jbc.M703202200; Cantwell AM, 2000, J BIOL CHEM, V275, P39827, DOI 10.1074/jbc.C000751200; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dang QD, 1997, J BIOL CHEM, V272, P19649, DOI 10.1074/jbc.272.32.19649; Dang QD, 1997, NAT BIOTECHNOL, V15, P146, DOI 10.1038/nbt0297-146; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Di Cera E, 2008, NAT CHEM BIOL, V4, P270, DOI 10.1038/nchembio0508-270; Feistritzer C, 2006, J BIOL CHEM, V281, P20077, DOI 10.1074/jbc.M600506200; FENTON JW, 1986, ANN NY ACAD SCI, V485, P5, DOI 10.1111/j.1749-6632.1986.tb34563.x; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; Gandhi PS, 2009, J BIOL CHEM, V284, P24098, DOI 10.1074/jbc.M109.025403; Gerszten RE, 2008, NATURE, V451, P949, DOI 10.1038/nature06802; GIBBS CS, 1995, NATURE, V378, P413, DOI 10.1038/378413a0; Griffin JH, 2002, SEMIN HEMATOL, V39, P197, DOI 10.1053/shem.2002.34093; GRIFFIN JH, 1995, NATURE, V378, P337, DOI 10.1038/378337a0; Grinnell BW, 1997, NAT BIOTECHNOL, V15, P124, DOI 10.1038/nbt0297-124; Gruber A, 2006, J THROMB HAEMOST, V4, P392, DOI 10.1111/j.1538-7836.2006.01760.x; Gruber A, 2002, J BIOL CHEM, V277, P27581, DOI 10.1074/jbc.C200237200; Gruber A, 2007, BLOOD, V109, P3733, DOI 10.1182/blood-2006-07-035147; Guinto ER, 1999, P NATL ACAD SCI USA, V96, P1852, DOI 10.1073/pnas.96.5.1852; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Isetti G, 2007, BIOCHEMISTRY-US, V46, P2444, DOI 10.1021/bi0622120; Krem MM, 2002, J BIOL CHEM, V277, P40260, DOI 10.1074/jbc.M206173200; LEBONNIEC BF, 1991, P NATL ACAD SCI USA, V88, P7371, DOI 10.1073/pnas.88.16.7371; Mosnier LO, 2007, J BIOL CHEM, V282, P33022, DOI 10.1074/jbc.M705824200; Mosnier LO, 2009, BLOOD, V113, P5970, DOI 10.1182/blood-2008-10-183327; Niu WL, 2009, J BIOL CHEM, V284, P36175, DOI 10.1074/jbc.M109.069500; Padma Vasantha, 2005, Expert Rev Neurother, V5, P223, DOI 10.1586/14737175.5.2.223; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Papaconstantinou ME, 2008, CELL MOL LIFE SCI, V65, P1943, DOI 10.1007/s00018-008-8179-y; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Pineda AO, 2006, J BIOL CHEM, V281, P32922, DOI 10.1074/jbc.M605530200; Pineda AO, 2004, J BIOL CHEM, V279, P39824, DOI 10.1074/jbc.M407272200; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Prasad S, 2003, P NATL ACAD SCI USA, V100, P13785, DOI 10.1073/pnas.2333109100; Prasad S, 2004, J BIOL CHEM, V279, P10103, DOI 10.1074/jbc.M312614200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Sadasivan C, 2000, J BIOL CHEM, V275, P36942, DOI 10.1074/jbc.M006076200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; STUBBS MT, 1992, EUR J BIOCHEM, V206, P187, DOI 10.1111/j.1432-1033.1992.tb16916.x; TSIANG M, 1995, J BIOL CHEM, V270, P16854, DOI 10.1074/jbc.270.28.16854; Tsiang M, 1996, BIOCHEMISTRY-US, V35, P16449, DOI 10.1021/bi9616108; Varadarajan N, 2008, NAT CHEM BIOL, V4, P290, DOI 10.1038/nchembio.80; Vindigni A, 1996, BIOCHEMISTRY-US, V35, P4417, DOI 10.1021/bi952834d; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Xu H, 2005, J BIOL CHEM, V280, P7956, DOI 10.1074/jbc.M412869200	59	34	40	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19145	19152		10.1074/jbc.M110.119875	http://dx.doi.org/10.1074/jbc.M110.119875			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404340	Green Published, hybrid			2022-12-25	WOS:000278727800024
J	Mukhopadhyay, B; Liu, J; Osei-Hyiaman, D; Godlewski, G; Mukhopadhyay, P; Wang, L; Jeong, WI; Gao, B; Duester, G; Mackie, K; Kojima, S; Kunos, G				Mukhopadhyay, Bani; Liu, Jie; Osei-Hyiaman, Douglas; Godlewski, Grzegorz; Mukhopadhyay, Partha; Wang, Lei; Jeong, Won-Il; Gao, Bin; Duester, Gregg; Mackie, Ken; Kojima, Soichi; Kunos, George			Transcriptional Regulation of Cannabinoid Receptor-1 Expression in the Liver by Retinoic Acid Acting via Retinoic Acid Receptor-gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC CB1 RECEPTORS; DIET-INDUCED OBESITY; METABOLIC SYNDROME; RESPONSE ELEMENTS; RISK-FACTORS; CELLS; GENE; RIMONABANT; MICE; ACTIVATION	Alcoholism can result in fatty liver that can progress to steatohepatitis, cirrhosis, and liver cancer. Mice fed alcohol develop fatty liver through endocannabinoid activation of hepatic CB1 cannabinoid receptors (CB1R), which increases lipogenesis and decreases fatty acid oxidation. Chronic alcohol feeding also up-regulates CB1R in hepatocytes in vivo, which could be replicated in vitro by co-culturing control hepatocytes with hepatic stellate cells (HSC) isolated from ethanol-fed mice, implicating HSC-derived mediator(s) in the regulation of hepatic CB1R (Jeong, W. I., Osei-Hyiaman, D., Park, O., Liu, J., Batkai, S., Mukhopadhyay, P., Horiguchi, N., Harvey-White, J., Marsicano, G., Lutz, B., Gao, B., and Kunos, G. (2008) Cell Metab. 7, 227-235). HSC being a rich source of retinoic acid (RA), we tested whether RA and its receptors may regulate CB1R expression in cultured mouse hepatocytes. Incubation of hepatocytes with RA or RA receptor (RAR) agonists increased CB1R mRNA and protein, the most efficacious being the RAR gamma agonist CD437 and the pan-RAR agonist TTNPB. The endocannabinoid 2-arachidonoylglycerol (2-AG) also increased hepatic CB1R expression, which was mediated indirectly via RA, because it was absent in hepatocytes from mice lacking retinaldehyde dehydrogenase 1, the enzyme catalyzing the generation of RA from retinaldehyde. The binding of RAR gamma to the CB1R gene 5' upstream domain in hepatocytes treated with RAR agonists or 2-AG was confirmed by chromatin immunoprecipitation and electrophoretic mobility shift and antibody supershift assays. Finally, TTNPB-induced CB1R expression was attenuated by small interfering RNA knockdown of RAR gamma in hepatocytes. We conclude that RAR gamma regulates CB1R expression and is thus involved in the control of hepatic fat metabolism by endocannabinoids.	[Mukhopadhyay, Bani; Liu, Jie; Osei-Hyiaman, Douglas; Godlewski, Grzegorz; Mukhopadhyay, Partha; Wang, Lei; Jeong, Won-Il; Gao, Bin; Kunos, George] NIAAA, Lab Physiol Studies, NIH, Bethesda, MD 20892 USA; [Duester, Gregg] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Mackie, Ken] Indiana Univ, Gill Ctr Biomol Sci, Bloomington, IN 47405 USA; [Kojima, Soichi] RIKEN, Adv Sci Inst, Dept Biol Chem, Mol Ligand Biol Res Team,Chem Genom Res Grp, Wako, Saitama 3510198, Japan	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Sanford Burnham Prebys Medical Discovery Institute; Indiana University System; Indiana University Bloomington; RIKEN	Mukhopadhyay, B (corresponding author), NIAAA, Lab Physiol Studies, NIH, 5625 Fishers Ln,MSC 9413, Bethesda, MD 20892 USA.	mukhopadhyayb@mail.nih.gov; gkunos@mail.nih.gov	Kojima, Soichi/N-7104-2015; Mackie, Kenneth P/B-7358-2011; Mackie, Ken/E-3715-2013; MUKHOPADHYAY, PARTHA/G-3890-2010; JEONG, WON IL/B-6615-2011	Kojima, Soichi/0000-0002-5252-1612; Mackie, Ken/0000-0001-8501-6199; MUKHOPADHYAY, PARTHA/0000-0002-1178-1274; Duester, Gregg/0000-0003-4335-3650; Osei-Hyiaman, Douglas/0000-0002-2725-5519	National Institute on Alcohol Abuse and Alcoholism; National Institute on Drug Abuse [DA11322, DA21696]; RIKEN; NATIONAL EYE INSTITUTE [R01EY013969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000350, ZIAAA000368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA021696, R01DA011322] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); RIKEN; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health intramural funds from the National Institute on Alcohol Abuse and Alcoholism (to G. K.) and National Institute on Drug Abuse Grants DA11322 and DA21696 (to K. M.). This work was also supported by the Chemical Genomics Research Program from RIKEN (to S. K.).	Alique M, 2007, PHARMACOLOGY, V79, P57, DOI 10.1159/000097785; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; Borner C, 2008, MOL PHARMACOL, V73, P1013, DOI 10.1124/mol.107.042945; Borner C, 2007, J LEUKOCYTE BIOL, V81, P336, DOI 10.1189/jlb.0306224; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Falanga A, 1998, BLOOD, V92, P143, DOI 10.1182/blood.V92.1.143.413k18_143_151; Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Gillespie RF, 2007, J BIOL CHEM, V282, P33421, DOI 10.1074/jbc.M704845200; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; GUDAS LJ, 1994, J BIOL CHEM, V269, P15399; Hauksdottir H, 2003, MOL ENDOCRINOL, V17, P373, DOI 10.1210/me.2002-0340; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Jourdan T, 2010, DIABETES, V59, P926, DOI 10.2337/db09-1482; Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; McCaw EA, 2004, EUR J BIOCHEM, V271, P4909, DOI 10.1111/j.1432-1033.2004.04460.x; Mukhopadhyay B, 2003, MOL MICROBIOL, V47, P171, DOI 10.1046/j.1365-2958.2003.03286.x; Osei-Hyiaman D, 2005, NEUROENDOCRINOLOGY, V81, P273, DOI 10.1159/000087925; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Poirier B, 2005, DIABETES OBES METAB, V7, P65, DOI 10.1111/j.1463-1326.2004.00374.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shimada T, 1997, ARCH BIOCHEM BIOPHYS, V344, P220, DOI 10.1006/abbi.1997.0209; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Sun R, 2005, BIOCHEM BIOPH RES CO, V338, P1943, DOI 10.1016/j.bbrc.2005.10.171; Svensson AC, 2006, J NEUROSCI RES, V83, P1128, DOI 10.1002/jnr.20792; Taneja R, 1996, P NATL ACAD SCI USA, V93, P6197, DOI 10.1073/pnas.93.12.6197; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	42	76	80	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19002	19011		10.1074/jbc.M109.068460	http://dx.doi.org/10.1074/jbc.M109.068460			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410309	Green Published, hybrid			2022-12-25	WOS:000278727800008
J	Tabatabaian, F; Dougherty, K; Di Fulvio, M; Gomez-Cambronero, J				Tabatabaian, Farnaz; Dougherty, Kevin; Di Fulvio, Mauricio; Gomez-Cambronero, Julian			Mammalian Target of Rapamycin (mTOR) and S6 Kinase Down-regulate Phospholipase D2 Basal Expression and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; ACTIVATION; BINDING; PLD1; INTERLEUKIN-8; TRANSLATION; INVOLVEMENT; DOMAIN	The mammalian target of rapamycin (mTOR) and S6 kinase (S6K) pathway is essential for cell differentiation, growth, and survival. Phospholipase D2 (PLD2) plays a key role in mTOR/S6K mitogenic signaling. However, the impact of PLD on mTOR/S6K gene expression is not known. Here we show that interleukin-8 (IL-8) increases mRNA expression levels for PLD2, mTOR, and S6K, with PLD2 preceding mTOR/S6K in time. Silencing of PLD2 gene expression abrogated IL-8-induced mTOR/S6K mRNA expression, whereas silencing of mTOR or S6K gene expression resulted in large (>3-fold and >5-fold, respectively) increased levels of PLD2 RNA, which was paralleled by increases in protein expression and lipase activity. Treatment of cells with 0.5 nM rapamycin induced a similar trend. These results suggest that, under basal conditions, PLD2 expression and concomitant activity is negatively regulated by the mTOR/S6K signaling pathway. Down-regulation of PLD2 was confirmed in differentiated HL-60 leukocytes overexpressing an mTOR-wild type, but not an mTOR kinase-dead construct. At the cellular level, overexpression of mTOR-wild type resulted in lower basal cell migration, which was reversed by treatment with IL-8. We propose that IL-8 reverses an mTOR/S6K-led down-regulation of PLD2 expression and enables PLD2 to fully function as a facilitator for cell migration.	[Gomez-Cambronero, Julian] Wright State Univ, Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Di Fulvio, Mauricio] Wright State Univ, Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA	Wright State University Dayton; Wright State University Dayton	Gomez-Cambronero, J (corresponding author), Wright State Univ, Sch Med, Dept Biochem & Mol Biol, 3640 Colonel Glenn Highway, Dayton, OH 45435 USA.	julian.cambronero@wright.edu		Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health [HL056653]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056653, R29HL056653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL056653 (to J.G.-C.).	BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Bautista MV, 2009, J IMMUNOL, V183, P2159, DOI 10.4049/jimmunol.0803022; Berven LA, 2004, EXP CELL RES, V296, P183, DOI 10.1016/j.yexer.2003.12.032; Beyer A, 2004, MOL CELL PROTEOMICS, V3, P1083, DOI 10.1074/mcp.M400099-MCP200; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Di Fulvio M, 2006, ONCOGENE, V25, P3032, DOI 10.1038/sj.onc.1209340; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; English D, 1996, CHEM PHYS LIPIDS, V80, P117, DOI 10.1016/0009-3084(96)02549-2; Exton JH, 2002, REV PHYSIOL BIOCH P, V144, P1, DOI 10.1007/BFb0116585; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Fox R, 2007, EMBO J, V26, P505, DOI 10.1038/sj.emboj.7601522; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Gomez-Cambronero J, 2003, FEBS LETT, V550, P94, DOI 10.1016/S0014-5793(03)00828-7; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kikuchi R, 2007, ONCOGENE, V26, P1802, DOI 10.1038/sj.onc.1209973; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; LARSEN CG, 1989, SCIENCE, V243, P1464, DOI 10.1126/science.2648569; Lee CS, 2009, BBA-MOL CELL BIOL L, V1791, P862, DOI 10.1016/j.bbalip.2009.04.007; LEE J, 1992, J BIOL CHEM, V267, P16283; Lehman JA, 2001, AM J PHYSIOL-CELL PH, V280, pC183, DOI 10.1152/ajpcell.2001.280.1.C183; Lehman N, 2007, FASEB J, V21, P1075, DOI 10.1096/fj.06-6652com; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Makam M, 2009, P NATL ACAD SCI USA, V106, P5779, DOI 10.1073/pnas.0813410106; Martinez FO, 2004, EUR J IMMUNOL, V34, P2286, DOI 10.1002/eji.200324481; Murooka TT, 2008, BLOOD, V111, P4892, DOI 10.1182/blood-2007-11-125039; SEBOK K, 1993, J IMMUNOL, V150, P1524; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; Vilella-Bach M, 1999, J BIOL CHEM, V274, P4266, DOI 10.1074/jbc.274.7.4266; Zhang YQ, 2009, BBA-MOL CELL BIOL L, V1791, P850, DOI 10.1016/j.bbalip.2009.05.013; Zheng JC, 2008, J NEUROIMMUNOL, V200, P100, DOI 10.1016/j.jneuroim.2008.06.015	33	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					18991	19001		10.1074/jbc.M110.111542	http://dx.doi.org/10.1074/jbc.M110.111542			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410302	Green Published, hybrid			2022-12-25	WOS:000278727800007
J	Wen, KW; Damania, B				Wen, K. W.; Damania, B.			Hsp90 and Hsp40/Erdj3 are required for the expression and anti-apoptotic function of KSHV K1	ONCOGENE			English	Article						KSHV; K1; heat shock proteins; Hsp90; Hsp40; lytic replication	SARCOMA-ASSOCIATED HERPESVIRUS; MULTICENTRIC CASTLEMANS-DISEASE; HEAT-SHOCK PROTEINS; KAPOSIS-SARCOMA; DNA-SEQUENCES; SIGNALING PATHWAY; STEROID-RECEPTOR; GENE-PRODUCT; IN-VIVO; GELDANAMYCIN	Kaposi sarcoma-associated herpesvirus (KSHV) is a member of the gammaherpesvirus family. It is the etiological agent of three different human cancers, Kaposi sarcoma (KS), primary effusion lymphoma (PEL) and multicentric Castleman disease. The far left end of the KSHV genome encodes a unique transmembrane glycoprotein called K1. K1 possesses the ability to transform rodent fibroblasts and block apoptosis. K1 has also been shown to activate the PI3K/Akt/mTOR pathway in different cells. Using tandem affinity purification, we identified heat shock protein 90 beta (Hsp90 beta) and endoplasmic reticulum-associated Hsp40 (Erdj3/DnaJB11), as cellular binding partners of K1. Interactions of K1 with Hsp90 beta and Hsp40 were confirmed by co-immunoprecipitation in both directions. Furthermore, K1 also interacted with the Hsp90 alpha isoform. We report that small-interfering RNAs directed against Hsp90 and Hsp40/Erdj3, as well as pharmacological inhibitors of Hsp90, dramatically reduced K1 expression, suggesting that K1 is a client protein of these chaperones. In addition, both Hsp90 and Hsp40/Erdj3 were essential for K1's antiapoptotic function. Finally, we report that the Hsp90 inhibitors, 17-AAG and 17-DMAG, can suppress the proliferation of KSHV-positive PEL cell lines and exhibited IC(50) values of 50 nM and below. Oncogene (2010) 29, 3532-3544; doi:10.1038/onc.2010.124; published online 26 April 2010	[Wen, K. W.; Damania, B.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wen, K. W.; Damania, B.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Damania, B (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, CB 7295, Chapel Hill, NC 27599 USA.	damania@med.unc.edu			NIH [CA096500]; University of Pennsylvania [P30-AI045008]; NIAID [T32-AI007001]; MSTP [T32-GM008719]; NATIONAL CANCER INSTITUTE [R01CA096500] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007001, P30AI045008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MSTP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Prasanna Bhende for help with immunohistochemistry and cell-cycle analysis and Stuart Krall for technical assistance. We thank Dr Jae Jung for providing us with the anti-K1 antibody and members of the Damania and Dittmer lab for informative discussions. We also thank the UNC Proteomics Center for processing of the protein samples and subsequent mass spectroscopy analysis. BD is a Leukemia & Lymphoma Society Scholar, American Heart Association established investigator, and a Burroughs Wellcome Fund Investigator in Infectious Disease. This work was supported by grant CA096500 from NIH and a University of Pennsylvania CFAR pilot project grant (P30-AI045008) to BD. KWW was supported in part by NIAID training Grant T32-AI007001 and MSTP Grant T32-GM008719. BD is a Leukemia & Lymphoma Society Scholar and Burroughs Welcome Fund Investigator in Infectious Disease.	Berkova Z, 2009, JNCI-J NATL CANCER I, V101, P399, DOI 10.1093/jnci/djn516; Bowser BS, 2002, J VIROL, V76, P12574, DOI 10.1128/JVI.76.24.12574-12583.2002; Burch AD, 2005, J VIROL, V79, P10740, DOI 10.1128/JVI.79.16.10740-10749.2005; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANDRIANI S, 2010, J VIROL MAR; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Damania B, 1999, J VIROL, V73, P5123, DOI 10.1128/JVI.73.6.5123-5131.1999; Damania B, 2000, J VIROL, V74, P2721, DOI 10.1128/JVI.74.6.2721-2730.2000; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Gessain A, 1996, BLOOD, V87, P414; Goetz MP, 2005, J CLIN ONCOL, V23, P1078, DOI 10.1200/JCO.2005.09.119; Hollingshead M, 2005, CANCER CHEMOTH PHARM, V56, P115, DOI 10.1007/s00280-004-0939-2; Ivy P. S., 2004, ONCOLOGY HUNTINGT, V18, P619; Ivy PS, 2004, ONCOLOGY-NY, V18, P610; Lagunoff M, 1997, VIROLOGY, V236, P147, DOI 10.1006/viro.1997.8713; Lagunoff M, 1999, P NATL ACAD SCI USA, V96, P5704, DOI 10.1073/pnas.96.10.5704; Le Boeuf F, 2004, J BIOL CHEM, V279, P39175, DOI 10.1074/jbc.M405493200; Lee BS, 2000, J EXP MED, V192, P11, DOI 10.1084/jem.192.1.11; Lee BS, 2005, J VIROL, V79, P12173, DOI 10.1128/JVI.79.19.12173-12184.2005; Lee BS, 2003, J VIROL, V77, P8072, DOI 10.1128/JVI.77.14.8072-8086.2003; Lee H, 1998, NAT MED, V4, P435, DOI 10.1038/nm0498-435; Lee H, 1998, MOL CELL BIOL, V18, P5219, DOI 10.1128/MCB.18.9.5219; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Livingston CM, 2008, J VIROL, V82, P6324, DOI 10.1128/JVI.00455-08; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Ohji G, 2006, J BIOCHEM, V139, P129, DOI 10.1093/jb/mvj008; Pang QS, 2001, EMBO J, V20, P4478, DOI 10.1093/emboj/20.16.4478; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pedersen CB, 2003, J BIOL CHEM, V278, P47449, DOI 10.1074/jbc.M309514200; Picard D, 2004, NAT CELL BIOL, V6, P479, DOI 10.1038/ncb0604-479; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Prakash O, 2005, BLOOD, V105, P3987, DOI 10.1182/blood-2004-07-2781; Prakash O, 2002, JNCI-J NATL CANCER I, V94, P926; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Samaniego F, 2001, J Natl Cancer Inst Monogr, P15; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Shinozaki F, 2006, J BIOL CHEM, V281, P16361, DOI 10.1074/jbc.M600891200; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; SMITH DF, 1995, MOL CELL BIOL, V15, P6804; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Tomlinson CC, 2004, J VIROL, V78, P1918, DOI 10.1128/JVI.78.4.1918-1927.2004; Tomlinson CC, 2008, J VIROL, V82, P6514, DOI 10.1128/JVI.02637-07; Trentin L, 2008, BLOOD, V112, P4665, DOI 10.1182/blood-2008-02-139139; Wang L, 2006, CANCER RES, V66, P3658, DOI 10.1158/0008-5472.CAN-05-3680; Wang L, 2004, CANCER RES, V64, P2774, DOI 10.1158/0008-5472.CAN-03-3653; Wang SZ, 2007, BLOOD, V109, P2174, DOI 10.1182/blood-2006-02-003178; Whitesell L, 1997, ONCOGENE, V14, P2809, DOI 10.1038/sj.onc.1201120; Xu WP, 2003, CANCER RES, V63, P7777; Zhang C, 2005, PLANT PHYSIOL BIOCH, V43, P13, DOI 10.1016/j.plaphy.2004.10.006	55	50	52	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 17	2010	29	24					3532	3544		10.1038/onc.2010.124	http://dx.doi.org/10.1038/onc.2010.124			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	611QN	20418907	Green Accepted, Green Submitted			2022-12-25	WOS:000278835400008
J	Wu, T; Zhang, XL; Huang, XH; Yang, YQ; Hua, XX				Wu, Ting; Zhang, Xiuli; Huang, Xiaohua; Yang, Yuqing; Hua, Xianxin			Regulation of Cyclin B2 Expression and Cell Cycle G(2)/M Transition by Menin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR MENIN; MITOSIS-SPECIFIC PHOSPHORYLATION; HISTONE H3; NF-Y; DNA-REPLICATION; PROTEIN-KINASE; GENE; TRANSCRIPTION; CDC2; IDENTIFICATION	Multiple endocrine neoplasia type 1 (MEN1) results from mutations in tumor suppressor gene Men1, which encodes nuclear protein menin. Menin up-regulates certain cyclin-dependent kinase inhibitors through increasing histone H3 lysine 4 (H3K4) methylation and inhibits G(0)/G(1) to S phase transition. However, little is known as to whether menin controls G(2)/M-phase transition, another important cell cycle checkpoint. Here, we show that menin expression delays G(2)/M phase transition and reduces expression of Ccnb2 (encoding cyclin B2). Menin associates with the promoter of Ccnb2 and reduces histone H3 acetylation, a positive chromatin marker for gene transcription, at the Ccnb2 locus. Moreover, Men1 ablation leads to an increase in cyclin B2 expression, histone H3 acetylation at the Ccnb2 locus, and G(2)/Mtransition. In contrast, knockdown of cyclin B2 diminishes the number of cells at M phase and reduces cell proliferation. Furthermore, menin interferes with binding of certain positive transcriptional regulators, such as nuclear factor Y (NF-Y), E2 factors (E2Fs), and histone acetyltransferase CREB (cAMP-response element-binding protein)binding protein (CBP) to the Ccnb2 locus. Notably, MEN1 disease-related mutations, A242V and L22R, abrogate the ability of menin to repress cyclin B2 expression and G(2)/M transition. Both of the mutants fail to reduce the acetylated level of the Ccnb2 locus. Together, these results suggest that menin-mediated repression of cyclin B2 is crucial for inhibiting G(2)/M transition and cell proliferation through a previously unrecognized molecular mechanism for menin-induced suppression of MEN1 tumorigenesis.	[Yang, Yuqing; Hua, Xianxin] Univ Penn, Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Wu, Ting] Xiamen Univ, Dept Biomed Sci, Sch Life Sci, Xiamen 361005, Peoples R China; [Zhang, Xiuli; Huang, Xiaohua] Xiamen Univ, Dept Basic Med Sci, Coll Med, Xiamen 361005, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; Xiamen University; Xiamen University	Hua, XX (corresponding author), Univ Penn, Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, 421 Curie Blvd, Philadelphia, PA 19104 USA.	huax@mail.med.upenn.edu	Yang, YQ/G-4122-2010	Huang, Xiaohua/0000-0003-4150-0477	National Institutes of Health [R01-CA-100912, R01-CA-113962]; American Diabetes Association [7-07-RA-60]; NATIONAL CANCER INSTITUTE [R01CA100912, R01CA113962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097555] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA-100912 and R01-CA-113962 (to Xianxin H.). This work was also supported by American Diabetes Association Grant 7-07-RA-60 (to Xianxin H.).	Agarwal SK, 1999, CELL, V96, P143, DOI 10.1016/S0092-8674(00)80967-8; Agarwal SK, 1997, HUM MOL GENET, V6, P1169, DOI 10.1093/hmg/6.7.1169; Balogh K, 2006, TRENDS ENDOCRIN MET, V17, P357, DOI 10.1016/j.tem.2006.09.004; Bolognese F, 1999, ONCOGENE, V18, P1845, DOI 10.1038/sj.onc.1202494; Brandi ML, 2001, J CLIN ENDOCR METAB, V86, P5658, DOI 10.1210/jc.86.12.5658; Caretti G, 2003, J BIOL CHEM, V278, P30435, DOI 10.1074/jbc.M304606200; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen YX, 2006, P NATL ACAD SCI USA, V103, P1018, DOI 10.1073/pnas.0510347103; DAGLE JM, 1990, NUCLEIC ACIDS RES, V18, P4751, DOI 10.1093/nar/18.16.4751; Dohna CLZ, 2000, FEBS LETT, V484, P77, DOI 10.1016/S0014-5793(00)02133-5; DRAETTA G, 1989, CELL, V56, P829, DOI 10.1016/0092-8674(89)90687-9; Fajas L, 2000, FEBS LETT, V471, P29, DOI 10.1016/S0014-5793(00)01363-6; FISHER D, 1995, SEMIN CELL BIOL, V6, P73, DOI 10.1016/1043-4682(95)90003-9; Fontaniere S, 2006, ENDOCR-RELAT CANCER, V13, P1223, DOI 10.1677/erc.1.01294; Gao SB, 2009, ONCOGENE, V28, P4095, DOI 10.1038/onc.2009.273; Gardner DG, 1997, ADV INTERNAL MED, V42, P597; GAUTIER J, 1989, NATURE, V339, P626, DOI 10.1038/339626a0; GAUTIER J, 1990, CELL, V60, P487, DOI 10.1016/0092-8674(90)90599-A; Gobl AE, 1999, BBA-GENE STRUCT EXPR, V1447, P51, DOI 10.1016/S0167-4781(99)00132-3; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Harper Jane V., 2004, V296, P157; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Heppner C, 2001, ONCOGENE, V20, P4917, DOI 10.1038/sj.onc.1204529; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Jin SH, 2003, CANCER RES, V63, P4204; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Kim H, 2003, CANCER RES, V63, P6135; La P, 2006, ONCOGENE, V25, P3537, DOI 10.1038/sj.onc.1209400; La P, 2004, J BIOL CHEM, V279, P49045, DOI 10.1074/jbc.M409358200; La P, 2004, ENDOCRINOLOGY, V145, P3443, DOI 10.1210/en.2004-0124; La P, 2007, J BIOL CHEM, V282, P31332, DOI 10.1074/jbc.M609555200; LABBE JC, 1989, EMBO J, V8, P3053, DOI 10.1002/j.1460-2075.1989.tb08456.x; Lemos MC, 2008, HUM MUTAT, V29, P22, DOI 10.1002/humu.20605; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Myslinski E, 2007, NUCLEIC ACIDS RES, V35, P3453, DOI 10.1093/nar/gkm239; Nasmyth K, 1996, SCIENCE, V274, P1643, DOI 10.1126/science.274.5293.1643; NEVINS JR, 1992, SCIENCE, V258, P424; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; Salsi V, 2003, J BIOL CHEM, V278, P6642, DOI 10.1074/jbc.M210065200; Schnepp RW, 2006, CANCER RES, V66, P5707, DOI 10.1158/0008-5472.CAN-05-4518; Schnepp RW, 2004, J BIOL CHEM, V279, P10685, DOI 10.1074/jbc.M308073200; Song NM, 2009, SCI CHINA SER C, V52, P551, DOI 10.1007/s11427-009-0077-5; TOMMASI S, 1995, MOL CELL BIOL, V15, P6901; Tschop K, 2007, FEBS J, V274, P5235, DOI 10.1111/j.1742-4658.2007.06045.x; Wasner M, 2003, GENE, V312, P225, DOI 10.1016/S0378-1119(03)00618-8; Yang YQ, 2007, MOL CELL ENDOCRINOL, V265, P34, DOI 10.1016/j.mce.2006.12.032; Zerfass K, 1996, J VIROL, V70, P2637, DOI 10.1128/JVI.70.4.2637-2642.1996; ZWICKER J, 1995, EMBO J, V14, P4514, DOI 10.1002/j.1460-2075.1995.tb00130.x	50	47	50	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18291	18300		10.1074/jbc.M110.106575	http://dx.doi.org/10.1074/jbc.M110.106575			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20404349	hybrid, Green Published			2022-12-25	WOS:000278453900022
J	Kawaguchi, H; Yamanaka, A; Uchida, K; Shibasaki, K; Sokabe, T; Maruyama, Y; Yanagawa, Y; Murakami, S; Tominaga, M				Kawaguchi, Hitoshi; Yamanaka, Akihiro; Uchida, Kunitoshi; Shibasaki, Koji; Sokabe, Takaaki; Maruyama, Yutaka; Yanagawa, Yuchio; Murakami, Shingo; Tominaga, Makoto			Activation of Polycystic Kidney Disease-2-like 1 (PKD2L1)-PKD1L3 Complex by Acid in Mouse Taste Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOUR TASTE; RECEPTOR; CHANNELS; PKD2L1	Five basic tastes (bitter, sweet, umami, salty, and sour) are detected in the four taste areas where taste buds reside. Although molecular mechanisms for detecting bitter, sweet, and umami have been well clarified, those for sour and salty remain poorly understood. Several channels including acid-sensing ion channels have been proposed as candidate sour receptors, but they do not encompass all sour-sensing abilities in vivo. We recently reported a novel candidate for sour sensing, the polycystic kidney disease-2-like 1 (PKD2L1)-PKD1L3 channel complex. This channel is not a traditional ligand-gated channel and is gated open only after removal of an acid stimulus, called an off response. Here we show that off responses upon acid stimulus are clearly observed in native taste cells from circumvallate, but not fungiform papillae, of glutamate decarboxylase 67-green fluorescent protein (GAD67-GFP) knock-in mice, from which Type III taste cells can be visualized, using Ca2+ imaging and patch clamp methods. Off responses were detected in most cells where PKD2L1 immunoreactivity was observed. Interestingly, the pH threshold for acid-evoked intracellular Ca2+ increase was around 5.0, a value much higher than that observed in HEK293 cells expressing the PKD2L1-PKD1L3 complex. Thus, PKD2L1-PKD1L3-mediated acid-evoked off responses occurred both in HEK293 cells and in native taste cells, suggesting the involvement of the PKD2L1-PKD1L3 complex in acid sensing in vivo.	[Kawaguchi, Hitoshi; Yamanaka, Akihiro; Uchida, Kunitoshi; Shibasaki, Koji; Sokabe, Takaaki; Tominaga, Makoto] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Kawaguchi, Hitoshi; Murakami, Shingo] Nagoya City Univ, Grad Sch Med Sci, Dept Otorhinolaryngol, Nagoya, Aichi 4678601, Japan; [Yamanaka, Akihiro; Uchida, Kunitoshi; Shibasaki, Koji; Sokabe, Takaaki; Tominaga, Makoto] Grad Univ Adv Studies, Okazaki, Aichi 4448585, Japan; [Shibasaki, Koji] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurol, Maebashi, Gunma 3718511, Japan; [Maruyama, Yutaka] Ajinomoto Co Inc, Kawasaki, Kanagawa 2108681, Japan; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma 3718511, Japan; [Yanagawa, Yuchio] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Nagoya City University; Graduate University for Advanced Studies - Japan; Gunma University; Ajinomoto Co Inc; Gunma University; Japan Science & Technology Agency (JST)	Tominaga, M (corresponding author), Higashiyama 5-1, Okazaki, Aichi 4448787, Japan.	tominaga@nips.ac.jp	Shibasaki, Koji/U-8674-2018; Yamanaka, Akihiro/AAD-8641-2021	Shibasaki, Koji/0000-0003-2330-1749; Yamanaka, Akihiro/0000-0001-6099-7306; Sokabe, Takaaki/0000-0003-1280-9424	Ministry of Education, Culture, Sports, Science and Technology in Japan	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology in Japan (to M. T.).	Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; Herness MS, 1999, ANNU REV PHYSIOL, V61, P873, DOI 10.1146/annurev.physiol.61.1.873; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huque T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007347; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Kim S, 2006, J NEUROSCI, V26, P2403, DOI 10.1523/JNEUROSCI.4691-05.2006; Medler KF, 2003, J NEUROSCI, V23, P2608; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; *NIH, 1985, PUBL NIH, V8523; Richter TA, 2004, J NEUROPHYSIOL, V92, P1928, DOI 10.1152/jn.00273.2004; Richter TA, 2004, J NEUROSCI, V24, P4088, DOI 10.1523/JNEUROSCI.0653-04.2004; ROPER SD, 1989, ANNU REV NEUROSCI, V12, P329, DOI 10.1146/annurev.ne.12.030189.001553; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; Stevens JC, 1997, PHYSIOL BEHAV, V62, P1137, DOI 10.1016/S0031-9384(97)00270-9; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Ugawa S, 1998, NATURE, V395, P555, DOI 10.1038/26882; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Yang RB, 2000, J COMP NEUROL, V425, P139, DOI 10.1002/1096-9861(20000911)425:1<139::AID-CNE12>3.0.CO;2-#; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Yoshida R, 2009, J PHYSIOL-LONDON, V587, P4425, DOI 10.1113/jphysiol.2009.175075	27	35	38	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17277	17281		10.1074/jbc.C110.132944	http://dx.doi.org/10.1074/jbc.C110.132944			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20406802	Green Published, hybrid			2022-12-25	WOS:000278133400002
J	Espina, V; Mariani, BD; Gallagher, RI; Tran, K; Banks, S; Wiedemann, J; Huryk, H; Mueller, C; Adamo, L; Deng, JH; Petricoin, EF; Pastore, L; Zaman, S; Menezes, G; Mize, J; Johal, J; Edmiston, K; Liotta, LA				Espina, Virginia; Mariani, Brian D.; Gallagher, Rosa I.; Tran, Khoa; Banks, Stacey; Wiedemann, Joy; Huryk, Heather; Mueller, Claudius; Adamo, Luana; Deng, Jianghong; Petricoin, Emanuel F., III; Pastore, Lucia; Zaman, Syed; Menezes, Geetha; Mize, James; Johal, Jasbir; Edmiston, Kirsten; Liotta, Lance A.			Malignant Precursor Cells Pre-Exist in Human Breast DCIS and Require Autophagy for Survival	PLOS ONE			English	Article							CARCINOMA IN-SITU; DUCTAL CARCINOMA; STEM-CELL; CANCER PROGRESSION; STAGA COMPLEX; HUMAN GENOME; COPY NUMBER; RESISTANCE; THERAPY; MICROENVIRONMENT	Background: While it is accepted that a majority of invasive breast cancer progresses from a ductal carcinoma in situ ( DCIS) precursor stage, very little is known about the factors that promote survival of DCIS neoplastic cells within the hypoxic, nutrient deprived intraductal microenvironment. Methodology and Principal Findings: We examined the hypothesis that fresh human DCIS lesions contain pre-existing carcinoma precursor cells. We characterized these cells by full genome molecular cytogenetics (Illumina HumanCytoSNP profile), and signal pathway profiling ( Reverse Phase Protein Microarray, 59 endpoints), and demonstrated that autophagy is required for survival and anchorage independent growth of the cytogenetically abnormal tumorigenic DCIS cells. Ex vivo organoid culture of fresh human DCIS lesions, without enzymatic treatment or sorting, induced the emergence of neoplastic epithelial cells exhibiting the following characteristics: a) spontaneous generation of hundreds of spheroids and duct-like 3D structures in culture within 2-4 weeks; b) tumorigenicity in NOD/SCID mice; c) cytogenetically abnormal ( copy number loss or gain in chromosomes including 1, 5, 6, 8, 13, 17) compared to the normal karyotype of the non-neoplastic cells in the source patient's breast tissue; d) in vitro migration and invasion of autologous breast stroma; and e) up-regulation of signal pathways linked to, and components of, cellular autophagy. Multiple autophagy markers were present in the patient's original DCIS lesion and the mouse xenograft. We tested whether autophagy was necessary for survival of cytogenetically abnormal DCIS cells. The lysosomotropic inhibitor ( chloroquine phosphate) of autophagy completely suppressed the generation of DCIS spheroids/3-D structures, suppressed ex vivo invasion of autologous stroma, induced apoptosis, suppressed autophagy associated proteins including Atg5, AKT/PI3 Kinase and mTOR, eliminated cytogenetically abnormal spheroid forming cells from the organ culture, and abrogated xenograft tumor formation. Conclusions: Cytogenetically abnormal spheroid forming, tumorigenic, and invasive neoplastic epithelial cells pre-exist in human DCIS and require cellular autophagy for survival.	[Espina, Virginia; Gallagher, Rosa I.; Mueller, Claudius; Adamo, Luana; Deng, Jianghong; Petricoin, Emanuel F., III; Liotta, Lance A.] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA; [Mariani, Brian D.; Tran, Khoa] AGTCtr Genet, Fairfax, VA USA; [Mariani, Brian D.; Tran, Khoa] IVF Inst, Fairfax, VA USA; [Banks, Stacey; Wiedemann, Joy; Huryk, Heather; Edmiston, Kirsten] Inova Fairfax Hosp, Canc Translat Res Ctr, Inova Hlth Syst, Falls Church, VA USA; [Adamo, Luana] Ist Oncol Mediterraneo, Dept Pathol, Catania, Italy; [Pastore, Lucia; Zaman, Syed; Menezes, Geetha; Mize, James; Johal, Jasbir] Inova Fairfax Hosp, Inova Hlth Syst, Dept Pathol, Falls Church, VA USA	George Mason University; Inova Fairfax Hospital; Inova Health System; Mediterranean Institute of Oncology; Inova Fairfax Hospital; Inova Health System	Espina, V (corresponding author), George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA.	vespina@gmu.edu	Mueller, Claudius/A-4459-2012	Mueller, Claudius/0000-0003-4499-4724; Gallagher, Rosa Isela/0000-0003-3887-8399; Espina, Virginia/0000-0001-5080-5972				Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Beckhove P, 2003, INT J CANCER, V105, P444, DOI 10.1002/ijc.11125; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Castro NP, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2157; Collins LC, 2005, CANCER-AM CANCER SOC, V103, P1778, DOI 10.1002/cncr.20979; Damonte P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2104; de Roos MA, 2007, ANN SURG ONCOL, V14, P2097, DOI 10.1245/s10434-007-9395-7; Espina V, 2008, MOL CELL PROTEOMICS, V7, P1998, DOI 10.1074/mcp.M700596-MCP200; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gamper AM, 2008, MOL CELL BIOL, V28, P2517, DOI 10.1128/MCB.01461-07; GAO W, 2009, J BIOL CHEM; Gao WT, 2008, AUTOPHAGY, V4, P754, DOI 10.4161/auto.6360; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Gudjonsson T, 2005, J MAMMARY GLAND BIOL, V10, P261, DOI 10.1007/s10911-005-9586-4; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Huang J, 2007, CELL CYCLE, V6, P1837, DOI 10.4161/cc.6.15.4511; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Iyengar P, 2005, J CLIN INVEST, V115, P1163, DOI 10.1172/JCI200523424; Jedeszko C, 2009, CANCER RES, V69, P9148, DOI 10.1158/0008-5472.CAN-09-1043; Jin SK, 2008, AUTOPHAGY, V4, P563, DOI 10.4161/auto.5830; Kalirai H, 2006, J PATHOL, V208, P7, DOI 10.1002/path.1881; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kondo Y, 2006, AUTOPHAGY, V2, P85, DOI 10.4161/auto.2.2.2463; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; LAGIOS MD, 1995, CANCER LETT, V90, P97, DOI 10.1016/0304-3835(94)03683-A; Li CI, 2006, CANCER-AM CANCER SOC, V106, P2104, DOI 10.1002/cncr.21864; Li CI, 2005, CANCER EPIDEM BIOMAR, V14, P1008, DOI 10.1158/1055-9965.EPI-04-0849; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Liu XH, 2008, MOL CELL BIOL, V28, P108, DOI 10.1128/MCB.01402-07; Lock R, 2008, CURR OPIN CELL BIOL, V20, P583, DOI 10.1016/j.ceb.2008.05.002; Loehberg CR, 2007, CANCER RES, V67, P12026, DOI 10.1158/0008-5472.CAN-07-3058; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; RAO SK, 2009, J NEUROONCOL; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Scarlatti F, 2009, CELL DEATH DIFFER, V16, P12, DOI 10.1038/cdd.2008.101; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schoenlein PV, 2009, AUTOPHAGY, V5, P400, DOI 10.4161/auto.5.3.7784; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Simpson PT, 2005, J PATHOL, V205, P248, DOI 10.1002/path.1691; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Tlsty T, 2008, NATURE, V453, P604, DOI 10.1038/453604a; VanMeter AJ, 2008, MOL CELL PROTEOMICS, V7, P1902, DOI 10.1074/mcp.M800204-MCP200; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Witkiewicz AK, 2009, AM J PATHOL, V174, P2023, DOI 10.2353/ajpath.2009.080873; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855	52	93	95	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10240	10.1371/journal.pone.0010240	http://dx.doi.org/10.1371/journal.pone.0010240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20421921	Green Submitted, Green Published, gold			2022-12-25	WOS:000276854300007
J	Green, S; Studholme, DJ; Laue, BE; Dorati, F; Lovell, H; Arnold, D; Cottrell, JE; Bridgett, S; Blaxter, M; Huitema, E; Thwaites, R; Sharp, PM; Jackson, RW; Kamoun, S				Green, Sarah; Studholme, David J.; Laue, Bridget E.; Dorati, Federico; Lovell, Helen; Arnold, Dawn; Cottrell, Joan E.; Bridgett, Stephen; Blaxter, Mark; Huitema, Edgar; Thwaites, Richard; Sharp, Paul M.; Jackson, Robert W.; Kamoun, Sophien			Comparative Genome Analysis Provides Insights into the Evolution and Adaptation of Pseudomonas syringae pv. aesculi on Aesculus hippocastanum	PLOS ONE			English	Article							FILAMENTOUS HEMAGGLUTININ; ESCHERICHIA-COLI; PLANT-DISEASE; SEQUENCE; VIRULENCE; REVEALS; GENES; IDENTIFICATION; RECOMBINATION; COLONIZATION	A recently emerging bleeding canker disease, caused by Pseudomonas syringae pathovar aesculi (Pae), is threatening European horse chestnut in northwest Europe. Very little is known about the origin and biology of this new disease. We used the nucleotide sequences of seven commonly used marker genes to investigate the phylogeny of three strains isolated recently from bleeding stem cankers on European horse chestnut in Britain (E-Pae). On the basis of these sequences alone, the E-Pae strains were identical to the Pae type-strain (I-Pae), isolated from leaf spots on Indian horse chestnut in India in 1969. The phylogenetic analyses also showed that Pae belongs to a distinct clade of P. syringae pathovars adapted to woody hosts. We generated genome-wide Illumina sequence data from the three E-Pae strains and one strain of I-Pae. Comparative genomic analyses revealed pathovar-specific genomic regions in Pae potentially implicated in virulence on a tree host, including genes for the catabolism of plant-derived aromatic compounds and enterobactin synthesis. Several gene clusters displayed intra-pathovar variation, including those encoding type IV secretion, a novel fatty acid biosynthesis pathway and a sucrose uptake pathway. Rates of single nucleotide polymorphisms in the four Pae genomes indicate that the three E-Pae strains diverged from each other much more recently than they diverged from I-Pae. The very low genetic diversity among the three geographically distinct E-Pae strains suggests that they originate from a single, recent introduction into Britain, thus highlighting the serious environmental risks posed by the spread of an exotic plant pathogenic bacterium to a new geographic location. The genomic regions in Pae that are absent from other P. syringae pathovars that infect herbaceous hosts may represent candidate genetic adaptations to infection of the woody parts of the tree.	[Green, Sarah; Laue, Bridget E.] Ctr Forestry & Climate Change, Roslin, Midlothian, Scotland; [Studholme, David J.; Huitema, Edgar; Kamoun, Sophien] Sainsbury Lab, Norwich, Norfolk, England; [Dorati, Federico; Jackson, Robert W.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Lovell, Helen; Arnold, Dawn] Univ W England, Ctr Res Plant Sci, Bristol BS16 1QY, Avon, England; [Lovell, Helen; Arnold, Dawn] Univ W England, Ctr Res Plant Sci, Bristol, Somerset, England; [Cottrell, Joan E.] Ctr Human & Ecol Sci, Roslin, Midlothian, Scotland; [Bridgett, Stephen; Blaxter, Mark] Univ Edinburgh, GenePool Genom Facil, Edinburgh, Lothian Borders, Scotland; [Blaxter, Mark; Sharp, Paul M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Lothian Borders, Scotland; [Thwaites, Richard] Food & Environm Res Agcy, Sand Hutton, Yorks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Reading; University of West England; University of West England; University of Edinburgh; University of Edinburgh; Food & Environment Research Agency	Green, S (corresponding author), Ctr Forestry & Climate Change, Roslin, Midlothian, Scotland.	sarah.green@forestry.gsi.gov.uk	Sharp, Paul M/F-5783-2010; Sharp, Paul M/GPX-1497-2022; Kamoun, Sophien/B-3529-2009; Studholme, David/H-6790-2019; Arnold, Dawn/AAF-3484-2021; Huitema, Edgar/G-3760-2011; Blaxter, Mark/O-2535-2019; Sharp, Paul/Y-3787-2019; Jackson, Robert W/C-2973-2009; Blaxter, Mark/B-4113-2010	Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; Kamoun, Sophien/0000-0002-0290-0315; Studholme, David/0000-0002-3010-6637; Huitema, Edgar/0000-0002-5766-0830; Jackson, Robert W/0000-0002-2042-4105; Arnold, Donald/0000-0003-0943-8853; Blaxter, Mark/0000-0003-2861-949X; Bridgett, Stephen/0000-0001-9330-5820	'Forest Research CEO Innovation fund'; Gatsby Charitable Foundation; MRC [G0900740] Funding Source: UKRI; Medical Research Council [G0900740] Funding Source: researchfish	'Forest Research CEO Innovation fund'; Gatsby Charitable Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The 'Forest Research CEO Innovation fund' supported the sequencing and analysis of E-Pae strain 2250. The sequencing and analysis of the three other Pae strains were funded by the Gatsby Charitable Foundation (http://www.gatsby.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005831; Almeida NF, 2009, MOL PLANT MICROBE IN, V22, P52, DOI 10.1094/MPMI-22-1-0052; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Bultreys A., 2008, PSEUDOMONAS SYRINGAE, P283; D'Autreaux B, 2008, METHOD ENZYMOL, V437, P235, DOI 10.1016/S0076-6879(07)37013-4; Das A, 2009, MOL PLANT MICROBE IN, V22, P73, DOI 10.1094/MPMI-22-1-0073; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; DURGAPAL J C, 1971, Indian Phytopathology, V24, P392; Durgapal J. C., 1980, Indian Phytopathology, V33, P533; ESAU K, 1965, PLANT ANATOMY, P270; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Farrer RA, 2009, FEMS MICROBIOL LETT, V291, P103, DOI 10.1111/j.1574-6968.2008.01441.x; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Forestry Commission, 2008, REP NAT SURV ASS PRE; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Green S, 2009, PLANT PATHOL, V58, P731, DOI 10.1111/j.1365-3059.2009.02065.x; Guilhabert MR, 2005, MOL PLANT MICROBE IN, V18, P856, DOI 10.1094/MPMI-18-0856; GUNASEKARAN P, 1990, J BACTERIOL, V172, P6727, DOI 10.1128/jb.172.12.6727-6735.1990; HARDESTY C, 1991, J BACTERIOL, V173, P449, DOI 10.1128/jb.173.2.449-456.1991; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Helmick RA, 2005, ANTIMICROB AGENTS CH, V49, P1837, DOI 10.1128/AAC.49.5.1837-1843.2005; Inatsuka CS, 2005, P NATL ACAD SCI USA, V102, P18578, DOI 10.1073/pnas.0507910102; Jackson RW, 1999, P NATL ACAD SCI USA, V96, P10875, DOI 10.1073/pnas.96.19.10875; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Kasai D, 2007, FEMS MICROBIOL LETT, V274, P323, DOI 10.1111/j.1574-6968.2007.00855.x; KAZEMPOUR MN, 2006, IRAN J AGR SCI, V37, P849; Kennelly MM, 2007, PLANT DIS, V91, P4, DOI 10.1094/PD-91-0004; Killiny N, 2009, APPL ENVIRON MICROB, V75, P521, DOI 10.1128/AEM.01921-08; KING EO, 1954, J LAB CLIN MED, V44, P301; KOZLOWSKI TT, 1997, PHYSL WOODY PLANTS, P160; Landgraf A, 2006, MOL PLANT PATHOL, V7, P355, DOI 10.1111/j.1364-3703.2006.00343.x; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; McGuirk P, 2000, J INFECT DIS, V182, P1286, DOI 10.1086/315838; McGuirk P, 2002, TRENDS IMMUNOL, V23, P450, DOI 10.1016/S1471-4906(02)02288-3; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; NICHOLS NN, 1995, J BACTERIOL, V177, P7033, DOI 10.1128/jb.177.24.7033-7040.1995; OGIMI C, 1981, Annals of the Phytopathological Society of Japan, V47, P443, DOI 10.3186/jjphytopath.47.443; Perez-Losada M, 2007, INFECT GENET EVOL, V7, P271, DOI 10.1016/j.meegid.2006.11.003; Perez-Martinez I, 2008, J BACTERIOL, V190, P625, DOI 10.1128/JB.01067-07; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Rojas CM, 2002, P NATL ACAD SCI USA, V99, P13142, DOI 10.1073/pnas.202358699; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrook J.E.F., 1989, MOL CLONING LAB MANU, P1659; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Schmidt O, 2008, FOREST PATHOL, V38, P124, DOI 10.1111/j.1439-0329.2007.00539.x; Schwarzenbacher R, 2004, J BIOL CHEM, V279, P29320, DOI 10.1074/jbc.M401268200; Snyder LAS, 2009, MICROB ECOL, V57, P1, DOI 10.1007/s00248-008-9465-9; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Studholme DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-395; Sundin GW, 2007, ANNU REV PHYTOPATHOL, V45, P129, DOI 10.1146/annurev.phyto.45.062806.094317; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; WEBBER JF, 2008, PLANT PATHOL NEW DIS, V15, P1; Wilson DJ, 2009, MOL BIOL EVOL, V26, P385, DOI 10.1093/molbev/msn264; Wilson LA, 2006, MOL BIOL EVOL, V23, P1156, DOI 10.1093/molbev/msj125; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	62	83	85	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10224	10.1371/journal.pone.0010224	http://dx.doi.org/10.1371/journal.pone.0010224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419105	Green Published, gold, Green Submitted			2022-12-25	WOS:000276853800014
J	Zheng, LQ; Cheng, ZQ; Ai, CX; Jiang, XH; Bei, XS; Zheng, Y; Glahn, RP; Welch, RM; Miller, DD; Lei, XG; Shou, HX				Zheng, Luqing; Cheng, Zhiqiang; Ai, Chunxiang; Jiang, Xinhang; Bei, Xiaoshu; Zheng, Ye; Glahn, Raymond P.; Welch, Ross M.; Miller, Dennis D.; Lei, Xin Gen; Shou, Huixia			Nicotianamine, a Novel Enhancer of Rice Iron Bioavailability to Humans	PLOS ONE			English	Article							FORTIFICATION; EXPRESSION; AVAILABILITY; ACCUMULATION; FERRITIN; IDENTIFICATION; ABSORPTION; GENOTYPES; CITRATE; GENES	Background: Polished rice is a staple food for over 50% of the world's population, but contains little bioavailable iron (Fe) to meet human needs. Thus, biofortifying the rice grain with novel promoters or enhancers of Fe utilization would be one of the most effective strategies to prevent the high prevalence of Fe deficiency and iron deficiency anemia in the developing world. Methodology/Principal Findings: We transformed an elite rice line cultivated in Southern China with the rice nicotianamine synthase gene (OsNAS1) fused to a rice glutelin promoter. Endosperm overexpression of OsNAS1 resulted in a significant increase in nicotianamine (NA) concentrations in both unpolished and polished grain. Bioavailability of Fe from the high NA grain, as measured by ferritin synthesis in an in vitro Caco-2 cell model that simulates the human digestive system, was twice as much as that of the control line. When added at 1: 1 molar ratio to ferrous Fe in the cell system, NA was twice as effective when compared to ascorbic acid (one of the most potent known enhancers of Fe bioavailability) in promoting more ferritin synthesis. Conclusions: Our data demonstrated that NA is a novel and effective promoter of iron utilization. Biofortifying polished rice with this compound has great potential in combating global human iron deficiency in people dependent on rice for their sustenance.	[Zheng, Luqing; Jiang, Xinhang; Bei, Xiaoshu; Zheng, Ye; Shou, Huixia] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China; [Cheng, Zhiqiang; Ai, Chunxiang; Bei, Xiaoshu; Miller, Dennis D.; Lei, Xin Gen] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Cheng, Zhiqiang; Ai, Chunxiang; Bei, Xiaoshu; Miller, Dennis D.; Lei, Xin Gen] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Glahn, Raymond P.; Welch, Ross M.] Cornell Univ, USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA	Zhejiang University; Cornell University; Cornell University; Cornell University; United States Department of Agriculture (USDA)	Zheng, LQ (corresponding author), Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China.	xl20@cornell.edu; huixia@zju.edu.cn	Shou, Huixia/I-3052-2015	Bei, Xiaoshu/0000-0003-1772-7161; Zheng, Luqing/0000-0003-2711-780X	HarvestPlus-China [8019]; National Natural Science Foundation of China [30770191, 30871585]; Ministry of Agriculture [2009ZX08010-013B, 2009ZX08009-123B]	HarvestPlus-China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	This work was supported by HarvestPlus-China (Project No. 8019), the National Natural Science Foundation of China (30770191 and 30871585), and the Ministry of Agriculture (2009ZX08010-013B and 2009ZX08009-123B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CANDELA E, 1984, J NUTR, V114, P2204, DOI 10.1093/jn/114.12.2204; Chen SY, 2003, PLANT J, V36, P105, DOI 10.1046/j.1365-313X.2003.01860.x; Cheng LJ, 2007, PLANT PHYSIOL, V145, P1647, DOI 10.1104/pp.107.107912; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; COOK JD, 1983, AM J CLIN NUTR, V38, P648, DOI 10.1093/ajcn/38.4.648; Douchkov D, 2005, PLANT CELL ENVIRON, V28, P365, DOI 10.1111/j.1365-3040.2005.01273.x; Glahn RP, 1998, J NUTR, V128, P1555, DOI 10.1093/jn/128.9.1555; Glahn RP, 1998, J NUTR, V128, P257, DOI 10.1093/jn/128.2.257; Glahn RP, 2002, J AGR FOOD CHEM, V50, P3586, DOI 10.1021/jf0116496; Hayashi A, 2007, J NUTR SCI VITAMINOL, V53, P331, DOI 10.3177/jnsv.53.331; HAZELL T, 1987, BRIT J NUTR, V57, P223, DOI 10.1079/BJN19870028; Higuchi K, 2001, PLANT J, V25, P159, DOI 10.1046/j.1365-313x.2001.00951.x; Higuchi K, 1996, J PLANT NUTR, V19, P1235, DOI 10.1080/01904169609365194; Hurrell RF, 2004, INT J VITAM NUTR RES, V74, P387, DOI 10.1024/0300-9831.74.6.387; KINOSHITA E, 1993, BIOSCI BIOTECH BIOCH, V57, P1107, DOI 10.1271/bbb.57.1107; Lee S, 2009, P NATL ACAD SCI USA, V106, P22014, DOI 10.1073/pnas.0910950106; Lynch SR, 2003, J NUTR, V133, p2978S; Mayer JE, 2008, CURR OPIN PLANT BIOL, V11, P166, DOI 10.1016/j.pbi.2008.01.007; Paz MM, 2004, EUPHYTICA, V136, P167, DOI 10.1023/B:EUPH.0000030670.36730.a4; PICH A, 1994, PLANT SOIL, V165, P189, DOI 10.1007/BF00008061; Poletti S, 2004, CURR OPIN BIOTECH, V15, P162, DOI 10.1016/j.copbio.2004.03.002; Qu LQ, 2004, PLANT BIOTECHNOL J, V2, P113, DOI 10.1111/j.1467-7652.2004.00055.x; Qu LQ, 2005, PLANTA, V222, P225, DOI 10.1007/s00425-005-1530-8; Shojima S, 1989, BIOL METALS, V2, P142; TANAKA K, 1974, SOIL SCI PLANT NUTR, V20, P87; Usuda K, 2009, PLANT BIOTECHNOL J, V7, P87, DOI 10.1111/j.1467-7652.2008.00374.x; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107; Wada Y, 2007, BIOSCI BIOTECH BIOCH, V71, P435, DOI 10.1271/bbb.60496; Welch RM, 2002, J NUTR, V132, p495S, DOI 10.1093/jn/132.3.495S; Xuan Y, 2006, J CHROMATOGR A, V1136, P73, DOI 10.1016/j.chroma.2006.09.060; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	34	105	108	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10190	10.1371/journal.pone.0010190	http://dx.doi.org/10.1371/journal.pone.0010190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419136	Green Published, gold, Green Submitted			2022-12-25	WOS:000276743500003
J	Valley, JK; Swinton, P; Boscardin, WJ; Lue, TF; Rinaudo, PF; Wu, MC; Garcia, MM				Valley, Justin K.; Swinton, Paul; Boscardin, W. John; Lue, Tom F.; Rinaudo, Paolo F.; Wu, Ming C.; Garcia, Maurice M.			Preimplantation Mouse Embryo Selection Guided by Light-Induced Dielectrophoresis	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; ASSISTED REPRODUCTIVE TECHNOLOGY; FIELD-FLOW FRACTIONATION; UNITED-STATES; SINGLE CELLS; MANIPULATION; SEPARATION; CULTURE; PARAMETERS; TWEEZERS	Selection of optimal quality embryos for in vitro fertilization (IVF) transfer is critical to successful live birth outcomes. Currently, embryos are chosen based on subjective assessment of morphologic developmental maturity. A non-invasive means to quantitatively measure an embryo's developmental maturity would reduce the variability introduced by the current standard. We present a method that exploits the scaling electrical properties of pre-transfer embryos to quantitatively discern embryo developmental maturity using light-induced dielectrophoresis (DEP). We show that an embryo's DEP response is highly correlated with its developmental stage. Uniquely, this technique allows one to select, in sequence and under blinded conditions, the most developmentally mature embryos among a mixed cohort of morphologically indistinguishable embryos cultured in optimized and sub-optimal culture media. Following assay, embryos continue to develop normally in vitro. Light-induced dielectrophoresis provides a non-invasive, quantitative, and reproducible means to select embryos for applications including IVF transfer and embryonic stem cell harvest.	[Valley, Justin K.; Wu, Ming C.] Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Berkeley, CA 94720 USA; [Swinton, Paul] Univ Calif San Francisco, Gladstone Transgen Gene Targeting Core Lab, San Francisco, CA 94143 USA; [Boscardin, W. John] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Lue, Tom F.; Garcia, Maurice M.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Rinaudo, Paolo F.] Univ Calif San Francisco, Dept Obstet & Gynaecol, Div Reprod Endocrinol, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Valley, JK (corresponding author), Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Berkeley, CA 94720 USA.	mgarcia@urology.ucsf.edu	Wu, Ming C/J-9906-2012	Wu, Ming C/0000-0003-4808-6686	NIH/NCRR UCSF-CTSI [UL1 RR024131]; NIH [K-12, PN2 EY018228]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018228] Funding Source: NIH RePORTER	NIH/NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	M. G. acknowledges funding and publication support from NIH/NCRR UCSF-CTSI Grant Number UL1 RR024131, and NIH K-12 Men's Reproductive Health Research (MRHR) Grant. J.V. and M. W. acknowledge funding and publication support from NIH Grant Number PN2 EY018228. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; *ASRM, 2009, FREQ ASK QUEST INF; BECKER FF, 1995, P NATL ACAD SCI USA, V92, P860, DOI 10.1073/pnas.92.3.860; BENOS DJ, 1981, J PHYSIOL-LONDON, V316, P191, DOI 10.1113/jphysiol.1981.sp013782; Bergh T, 1999, LANCET, V354, P1579, DOI 10.1016/S0140-6736(99)04345-7; Biggers JD, 1998, INT J DEV BIOL, V42, P879; *CDC, 2009, ASS REPR TECHN; Chiou PY, 2005, NATURE, V436, P370, DOI 10.1038/nature0383l; Choi W, 2008, BIOMED MICRODEVICES, V10, P337, DOI 10.1007/s10544-007-9141-8; Creasy RK., 2009, CREASY RESNIKS MATER; Dessie SW, 2007, REPRODUCTION, V133, P931, DOI 10.1530/REP-06-0277; Fiedler S, 1998, ANAL CHEM, V70, P1909, DOI 10.1021/ac971063b; GASCOYNE PRC, 1992, MEAS SCI TECHNOL, V3, P439, DOI 10.1088/0957-0233/3/5/001; Grigorenko AN, 2008, NAT PHOTONICS, V2, P365, DOI 10.1038/nphoton.2008.78; Gurgan T, 2004, REPROD BIOMED ONLINE, V9, P237, DOI 10.1016/S1472-6483(10)62136-0; Hsu HY, 2010, LAB CHIP, V10, P165, DOI 10.1039/b906593h; Huang Y, 1997, BIOPHYS J, V73, P1118, DOI 10.1016/S0006-3495(97)78144-X; Jamshidi A, 2008, NAT PHOTONICS, V2, P85, DOI 10.1038/nphoton.2007.277; Jones T. B., 1995, ELECTROMECHANICS PAR; Kjellberg AT, 2006, HUM REPROD, V21, P210, DOI 10.1093/humrep/dei298; Kovalevsky G, 2005, FERTIL STERIL, V84, P325, DOI 10.1016/j.fertnstert.2005.04.020; Lei U, 2009, LAB CHIP, V9, P1349, DOI 10.1039/b822809d; Ludwig AK, 2005, SEMIN REPROD MED, V23, P348, DOI 10.1055/s-2005-923392; Manaresi N, 2003, IEEE J SOLID-ST CIRC, V38, P2297, DOI 10.1109/JSSC.2003.819171; Nagy ZP, 2008, REPROD BIOMED ONLINE, V17, P502, DOI 10.1016/S1472-6483(10)60236-2; Ohta AT, 2007, J MICROELECTROMECH S, V16, P491, DOI 10.1109/JMEMS.2007.896717; PALMER JF, 1970, J EMBRYOL EXP MORPH, V24, P535; Reefhuis J, 2009, HUM REPROD, V24, P360, DOI 10.1093/humrep/den387; *SART, 2007, ASS REPR SUCC RAT NA; Schoolcraft WB, 1999, FERTIL STERIL, V72, P604, DOI 10.1016/S0015-0282(99)00311-8; Smith PA, 2000, APPL PHYS LETT, V77, P1399, DOI 10.1063/1.1290272; STEPTOE PC, 1978, LANCET, V2, P366; WANG XB, 1993, J PHYS D APPL PHYS, V26, P1278, DOI 10.1088/0022-3727/26/8/019; Warner CM, 2008, REPROD BIOMED ONLINE, V17, P470, DOI 10.1016/S1472-6483(10)60233-7; Yang J, 1999, ANAL CHEM, V71, P911, DOI 10.1021/ac981250p; YING H, 1992, PHYS MED BIOL, V37, P1499, DOI 10.1088/0031-9155/37/7/003	36	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10160	10.1371/journal.pone.0010160	http://dx.doi.org/10.1371/journal.pone.0010160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405021	gold, Green Published			2022-12-25	WOS:000276706300015
J	Kuznetsova, E; Xu, LD; Singer, A; Brown, G; Dong, AP; Flick, R; Cui, H; Cuff, M; Joachimiak, A; Savchenko, A; Yakunin, AF				Kuznetsova, Ekaterina; Xu, Linda; Singer, Alexander; Brown, Greg; Dong, Aiping; Flick, Robert; Cui, Hong; Cuff, Marianne; Joachimiak, Andrzej; Savchenko, Alexei; Yakunin, Alexander F.			Structure and Activity of the Metal-independent Fructose-1,6-bisphosphatase YK23 from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRUCTOSE 1,6-BISPHOSPHATASE; CRYSTAL-STRUCTURE; BACILLUS-STEAROTHERMOPHILUS; FUNCTIONAL-ANALYSIS; ACID-PHOSPHATASE; INTRACELLULAR PH; PROTEIN; ENZYME; DEGRADATION; MODEL	Fructose-1,6-bisphosphatase (FBPase), a key enzyme of gluconeogenesis and photosynthetic CO2 fixation, catalyzes the hydrolysis of fructose 1,6-bisphosphate (FBP) to produce fructose 6-phosphate, an important precursor in various bio-synthetic pathways. All known FBPases are metal-dependent enzymes, which are classified into five different classes based on their amino acid sequences. Eukaryotes are known to contain only the type-I FBPases, whereas all five types exist in various combinations in prokaryotes. Here we demonstrate that the uncharacterized protein YK23 from Saccharomyces cerevisiae efficiently hydrolyzes FBP in a metal-independent reaction. YK23 is a member of the histidine phosphatase (phosphoglyceromutase) superfamily with homologues found in all organisms. The crystal structure of the YK23 apo-form was solved at 1.75-angstrom resolution and revealed the core domain with the alpha/beta/alpha-fold covered by two small cap domains. Two liganded structures of this protein show the presence of two phosphate molecules (an inhibitor) or FBP (a substrate) bound to the active site. FBP is bound in its linear, open conformation with the cleavable C1-phosphate positioned deep in the active site. Alanine replacement mutagenesis of YK23 identified six conserved residues absolutely required for activity and suggested that His(13) and Glu(99) are the primary catalytic residues. Thus, YK23 represents the first family of metal-independent FBPases and a second FBPase family in eukaryotes.	[Kuznetsova, Ekaterina; Xu, Linda; Singer, Alexander; Brown, Greg; Flick, Robert; Cui, Hong; Savchenko, Alexei; Yakunin, Alexander F.] Univ Toronto, Banting & Best Dept Med Res, Ctr Struct Prote Toronto, Toronto, ON M5G 1L6, Canada; [Kuznetsova, Ekaterina; Xu, Linda; Singer, Alexander; Brown, Greg; Flick, Robert; Cui, Hong; Savchenko, Alexei; Yakunin, Alexander F.] Max Bell Res Ctr, Ontario Canc Inst, Toronto, ON M5G 2C4, Canada; [Dong, Aiping] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; [Cuff, Marianne; Joachimiak, Andrzej] Midwest Ctr Struct Genom, Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Structural Genomics Consortium; United States Department of Energy (DOE); Argonne National Laboratory	Yakunin, AF (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Ctr Struct Prote Toronto, 112 Coll St, Toronto, ON M5G 1L6, Canada.	a.iakounine@utoronto.ca	Yakunin, Alexander/J-1519-2014	Yakunin, Alexander/0000-0003-0813-6490	National Institutes of Health [GM074942]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Genome Canada through Ontario Genomics Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, U54GM074942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Genome Canada through Ontario Genomics Institute(Genome Canada); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074942, United States Department of Energy, Office of Biological and Environmental Research contract DE-AC02-06CH11357, and Genome Canada (through the Ontario Genomics Institute).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BABUL J, 1983, ARCH BIOCHEM BIOPHYS, V225, P944, DOI 10.1016/0003-9861(83)90109-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Becker J, 2005, APPL ENVIRON MICROB, V71, P8587, DOI 10.1128/AEM.71.12.8587-8596.2005; BENKOVIC SJ, 1982, ADV ENZYMOL RAMB, V53, P45; Bond CS, 2001, J BIOL CHEM, V276, P3247, DOI 10.1074/jbc.M007318200; Brown G, 2009, J BIOL CHEM, V284, P3784, DOI 10.1074/jbc.M808186200; CAMPBELL JW, 1974, NATURE, V250, P301, DOI 10.1038/250301a0; CHIANG HL, 1991, NATURE, V350, P313, DOI 10.1038/350313a0; Choi KH, 2004, J AM CHEM SOC, V126, P3402, DOI 10.1021/ja038540u; DAIE J, 1993, PHOTOSYNTH RES, V38, P5, DOI 10.1007/BF00015056; Dang Q, 2007, J AM CHEM SOC, V129, P15491, DOI 10.1021/ja074871l; Donahue JL, 2000, J BACTERIOL, V182, P5624, DOI 10.1128/JB.182.19.5624-5627.2000; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENTIAN KD, 1988, FEBS LETT, V236, P195, DOI 10.1016/0014-5793(88)80313-2; FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13651, DOI 10.1021/bi00212a033; FUNAYAMA S, 1979, ARCH BIOCHEM BIOPHYS, V197, P170, DOI 10.1016/0003-9861(79)90233-9; Grazulis S, 2005, P NATL ACAD SCI USA, V102, P15797, DOI 10.1073/pnas.0507949102; Hamada K, 2005, GENES CELLS, V10, P1, DOI 10.1111/j.1365-2443.2005.00817.x; Heering HA, 1997, J AM CHEM SOC, V119, P11628, DOI 10.1021/ja9723242; Hines JK, 2007, J BIOL CHEM, V282, P36121, DOI 10.1074/jbc.M707302200; Hines JK, 2006, J BIOL CHEM, V281, P18386, DOI 10.1074/jbc.M602553200; Ho CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006993; Hoffman M, 1996, GENETICS, V143, P1555; Horak J, 2002, J BIOL CHEM, V277, P8248, DOI 10.1074/jbc.M107255200; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; IMAI T, 1995, J BIOTECHNOL, V38, P165, DOI 10.1016/0168-1656(94)00130-5; Jardon R, 2008, EUKARYOT CELL, V7, P1742, DOI 10.1128/EC.00169-08; Jedrzejas MJ, 2000, PROG BIOPHYS MOL BIO, V73, P263, DOI 10.1016/S0079-6107(00)00007-9; Johnson KA, 2001, BIOCHEMISTRY-US, V40, P618, DOI 10.1021/bi0016422; Kimber MS, 2003, PROTEINS, V51, P562, DOI 10.1002/prot.10340; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee YH, 1996, BIOCHEMISTRY-US, V35, P6010, DOI 10.1021/bi9600613; Li H, 2009, J BIOL CHEM, V284, P1748, DOI 10.1074/jbc.M807821200; Li L, 1997, BIOCHEM J, V328, P751, DOI 10.1042/bj3280751; LIANG JY, 1993, P NATL ACAD SCI USA, V90, P2132, DOI 10.1073/pnas.90.6.2132; Lorentzen E, 2005, BIOCHEMISTRY-US, V44, P4222, DOI 10.1021/bi048192o; MARCUS F, 1982, METHOD ENZYMOL, V90, P352; MARCUS F, 1984, BIOCHEM BIOPH RES CO, V119, P1103, DOI 10.1016/0006-291X(84)90888-X; Meyerhof O, 1935, BIOCHEM Z, V276, P239; MIDELFORT CF, 1976, BIOCHEMISTRY-US, V15, P2178, DOI 10.1021/bi00655a023; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; Nishimasu H, 2004, STRUCTURE, V12, P949, DOI 10.1016/j.str.2004.03.026; Nobeli I, 2006, BIOESSAYS, V28, P534, DOI 10.1002/bies.20414; Patel S, 2002, J MOL BIOL, V320, P1087, DOI 10.1016/S0022-2836(02)00564-8; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PILKIS SJ, 1988, ANNU REV BIOCHEM, V57, P755, DOI 10.1146/annurev.bi.57.070188.003543; Proudfoot Michael, 2008, V426, P331, DOI 10.1007/978-1-60327-058-8_21; Qin CB, 2002, PLANT PHYSIOL, V128, P1057, DOI 10.1104/pp.010928; Raines CA, 1999, J EXP BOT, V50, P1, DOI 10.1093/jexbot/50.330.1; Rashid N, 2002, J BIOL CHEM, V277, P30649, DOI 10.1074/jbc.M202868200; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Rigden DJ, 2001, PROTEIN SCI, V10, P1835, DOI 10.1110/ps.15701; Rigden DJ, 2003, J MOL BIOL, V325, P411, DOI 10.1016/S0022-2836(02)01229-9; SAHEKI S, 1985, ANAL BIOCHEM, V148, P277, DOI 10.1016/0003-2697(85)90229-5; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SEDIVY JM, 1985, J MOL BIOL, V186, P307, DOI 10.1016/0022-2836(85)90107-X; Singh H, 2009, J MOL BIOL, V394, P893, DOI 10.1016/j.jmb.2009.10.009; Tamoi M, 1996, ARCH BIOCHEM BIOPHYS, V334, P27, DOI 10.1006/abbi.1996.0425; Valli M, 2005, APPL ENVIRON MICROB, V71, P1515, DOI 10.1128/AEM.71.3.1515-1521.2005; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P2861; VINCENT JB, 1992, TRENDS BIOCHEM SCI, V17, P105, DOI 10.1016/0968-0004(92)90246-6; Wajngot A, 2001, METABOLISM, V50, P47, DOI 10.1053/meta.2001.19422; Walter RA, 1999, BIOCHEM J, V337, P89, DOI 10.1042/0264-6021:3370089; Wang YL, 2006, J BIOL CHEM, V281, P39642, DOI 10.1074/jbc.M606421200; Watkins HA, 2006, J BACTERIOL, V188, P3589, DOI 10.1128/JB.188.10.3589-3599.2006; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WOODROW IE, 1988, ANNU REV PLANT PHYS, V39, P533, DOI 10.1146/annurev.pp.39.060188.002533; YORK JD, 1995, P NATL ACAD SCI USA, V92, P5149, DOI 10.1073/pnas.92.11.5149; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X; ZHANG YP, 1993, BIOCHEM BIOPH RES CO, V190, P1080, DOI 10.1006/bbrc.1993.1159	77	17	19	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21049	21059		10.1074/jbc.M110.118315	http://dx.doi.org/10.1074/jbc.M110.118315			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20427268	Green Published, hybrid			2022-12-25	WOS:000279228600068
J	Chandak, PG; Radovic, B; Aflaki, E; Kolb, D; Buchebner, M; Frohlich, E; Magnes, C; Sinner, F; Haemmerle, G; Zechner, R; Tabas, I; Levak-Frank, S; Kratky, D				Chandak, Prakash G.; Radovic, Branislav; Aflaki, Elma; Kolb, Dagmar; Buchebner, Marlene; Froehlich, Eleonore; Magnes, Christoph; Sinner, Frank; Haemmerle, Guenter; Zechner, Rudolf; Tabas, Ira; Levak-Frank, Sanja; Kratky, Dagmar			Efficient Phagocytosis Requires Triacylglycerol Hydrolysis by Adipose Triglyceride Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; LOW-DENSITY-LIPOPROTEIN; FOAM CELL-FORMATION; LIPID DROPLETS; CHOLESTEROL ACCUMULATION; RICH LIPOPROTEINS; ENERGY-METABOLISM; J774 MACROPHAGES; ATHEROSCLEROSIS; LIPOLYSIS	Macrophage phagocytosis is an essential biological process in host defense and requires large amounts of energy. To date, glucose is believed to represent the prime substrate for ATP production in macrophages. To investigate the relative contribution of free fatty acids (FFAs) in this process, we determined the phagocytosis rates in normal mouse macrophages and macrophages of adipose triglyceride lipase (ATGL)-deficient mice. ATGL was shown to be the rate-limiting enzyme for the hydrolysis of lipid droplet-associated triacylglycerol (TG) in many tissues. Here, we demonstrate that Atgl(-/-) macrophages fail to efficiently hydrolyze cellular TG stores leading to decreased cellular FFA concentrations and concomitant accumulation of lipid droplets, even in the absence of exogenous lipid loading. The reduced availability of FFAs results in decreased cellular ATP concentrations and impaired phagocytosis suggesting that fatty acids must first go through a cycle of esterification and re-hydrolysis before they are available as energy substrate. Exogenously added glucose cannot fully compensate for the phagocytotic defect in Atgl(-/-) macrophages. Hence, phagocytosis was also decreased in vivo when Atgl(-/-) mice were challenged with bacterial particles. These findings imply that phagocytosis in macrophages depends on the availability of FFAs and that ATGL is required for their hydrolytic release from cellular TG stores. This novel mechanism links ATGL-mediated lipolysis to macrophage function in host defense and opens the way to explore possible roles of ATGL in immune response, inflammation, and atherosclerosis.	[Levak-Frank, Sanja] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Kolb, Dagmar; Haemmerle, Guenter; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Froehlich, Eleonore] Med Univ Graz, Med Res Ctr, A-8010 Graz, Austria; [Magnes, Christoph; Sinner, Frank] Inst Med Technol & Hlth Management, A-8010 Graz, Austria; [Tabas, Ira] Columbia Univ, Dept Med, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Medical University of Graz; University of Graz; Medical University of Graz; Columbia University; Columbia University; Columbia University		dagmar.kratky@medunigraz.at	Kratky, Dagmar/ABF-5699-2021; Fröhlich, Eleonore/M-8943-2014	Fröhlich, Eleonore/0000-0002-6056-6829; Zechner, Rudolf/0000-0001-5483-1182; Haemmerle, Guenter/0000-0001-9900-5896; Kratky, Dagmar/0000-0003-1357-7573; Sinner, Frank Michael/0000-0002-9292-4512; Magnes, Christoph/0000-0002-5153-7444	National Institutes of Health [HL54591, HL75662]; Austrian Science Fund FWF [SFB-LIPOTOX F30, P19186]; Austrian Federal Ministry of Science and Research; Medical University of Graz; Austrian Science Fund (FWF) [F 3002, F 3004, Z 136] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075662, P01HL054591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Federal Ministry of Science and Research; Medical University of Graz; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL54591 and HL75662. This work was also supported by the Austrian Science Fund FWF SFB-LIPOTOX F30 and P19186, the Austrian Federal Ministry of Science and Research GEN-AU Project Genomics of Lipid-associated Disorders, and the Medical University of Graz (Ph.D. Program for Molecular Medicine).	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Babaev VR, 1999, J CLIN INVEST, V103, P1697, DOI 10.1172/JCI6117; Babaev VR, 2000, J BIOL CHEM, V275, P26293, DOI 10.1074/jbc.M002423200; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; BATES SR, 1984, ARTERIOSCLEROSIS, V4, P103, DOI 10.1161/01.ATV.4.2.103; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; BROWN MS, 1980, J BIOL CHEM, V255, P9344; Contreras JA, 2002, BIOCHEM BIOPH RES CO, V292, P900, DOI 10.1006/bbrc.2002.6757; Escary JL, 1999, J LIPID RES, V40, P397; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; Galluhn D, 2004, J BIOL CHEM, V279, P38338, DOI 10.1074/jbc.M405871200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Holm C, 1999, METH MOL B, V109, P109; HUFF MW, 1991, ARTERIOSCLER THROMB, V11, P221, DOI 10.1161/01.ATV.11.2.221; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jong MC, 2000, ARTERIOSCL THROM VAS, V20, P144, DOI 10.1161/01.ATV.20.1.144; Kruth HS, 2005, J BIOL CHEM, V280, P2352, DOI 10.1074/jbc.M407167200; LINDQVIST P, 1983, J BIOL CHEM, V258, P9086; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Magnes C, 2008, ANAL CHEM, V80, P5736, DOI 10.1021/ac800031u; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; RENIER G, 1993, ARTERIOSCLER THROMB, V13, P190, DOI 10.1161/01.ATV.13.2.190; Schrijvers DM, 2007, CARDIOVASC RES, V73, P470, DOI 10.1016/j.cardiores.2006.09.005; Sekiya M, 2009, CELL METAB, V10, P219, DOI 10.1016/j.cmet.2009.08.004; SIMON LM, 1973, J EXP MED, V138, P1413, DOI 10.1084/jem.138.6.1413; SPEERT DP, 1992, J CLIN INVEST, V90, P1085, DOI 10.1172/JCI115924; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tabas I, 2007, CURR DRUG TARGETS, V8, P1288, DOI 10.2174/138945007783220623; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Van Eck M, 2000, ARTERIOSCL THROM VAS, V20, pE53, DOI 10.1161/01.ATV.20.9.e53; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; WARNER GJ, 1995, J BIOL CHEM, V270, P5772, DOI 10.1074/jbc.270.11.5772; XU XX, 1991, J BIOL CHEM, V266, P24849; Yin BY, 1997, J CLIN INVEST, V100, P649, DOI 10.1172/JCI119576; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	42	105	108	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20192	20201		10.1074/jbc.M110.107854	http://dx.doi.org/10.1074/jbc.M110.107854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20424161	Green Published, hybrid			2022-12-25	WOS:000279012000054
J	Brault, JJ; Jespersen, JG; Goldberg, AL				Brault, Jeffrey J.; Jespersen, Jakob G.; Goldberg, Alfred L.			Peroxisome Proliferator-activated Receptor gamma Coactivator 1 alpha or 1 beta Overexpression Inhibits Muscle Protein Degradation, Induction of Ubiquitin Ligases, and Disuse Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; SKELETAL-MUSCLE; MITOCHONDRIAL BIOGENESIS; METABOLIC-CONTROL; PGC-1-ALPHA; EXERCISE; EXPRESSION; KINASE; DENERVATION; PGC-1	Overexpression of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha), like exercise, increases mitochondrial content and inhibits muscle atrophy. To understand these actions, we tested whether PGC-1 alpha or its close homolog, PGC-1 alpha, influences muscle protein turnover. In myotubes, overexpression of either coactivator increased protein content by decreasing overall protein degradation without altering protein synthesis rates. Elevated PGC-1 alpha or PGC-1 alpha also prevented the acceleration of proteolysis induced by starvation or FoxO transcription factors and prevented the induction of autophagy and atrophy-specific ubiquitin ligases by a constitutively active FoxO3. In mouse muscles, overexpression of PGC-1 alpha (like PGC-1 alpha) inhibited denervation atrophy, ubiquitin ligase induction, and transcription by NF kappa B. However, increasing muscle PGC-1 alpha levels pharmacologically by treatment of mice with 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside failed to block loss of muscle mass or induction of ubiquitin ligases upon denervation atrophy, although it prevented loss of mitochondria. This capacity of PGC-1 alpha and PGC-1 alpha to inhibit FoxO3 and NF kappa B actions and proteolysis helps explain how exercise prevents muscle atrophy.	[Brault, Jeffrey J.; Jespersen, Jakob G.; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	alfred_goldberg@hms.harvard.edu	Brault, Jeffrey/AAH-3293-2021	Brault, Jeffrey/0000-0003-3503-0528	National Institutes of Health [AR055255, F32AR054699]; Muscular Dystrophy Association; Copenhagen Graduate School of Health Sciences; A. P. Moeller Foundation for the Advancement of Medical Science; Knud Hoejgaard Foundation; Lundbeck Foundation; Augustinus Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR054699, R01AR055255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Copenhagen Graduate School of Health Sciences; A. P. Moeller Foundation for the Advancement of Medical Science; Knud Hoejgaard Foundation; Lundbeck Foundation(Lundbeckfonden); Augustinus Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR055255 (to A. L. G.). This work was also supported by the Muscular Dystrophy Association (to A. L. G.).; Supported by a Kirschstein National Research Service Award from the National Institutes of Health (F32AR054699).; Supported by the Copenhagen Graduate School of Health Sciences, The A. P. Moeller Foundation for the Advancement of Medical Science, the Knud Hoejgaard Foundation, a Christian & Otilla Brorson's Travel Grant for Young Scientists, the Lundbeck Foundation, and the Augustinus Foundation.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Adams GR, 2007, J APPL PHYSIOL, V103, P1644, DOI 10.1152/japplphysiol.00669.2007; Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006; Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bdolah Y, 2007, AM J PHYSIOL-REG I, V292, pR971, DOI 10.1152/ajpregu.00617.2006; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Coussens LM, 2008, CURR OPIN GENET DEV, V18, P1, DOI 10.1016/j.gde.2008.04.001; Cuthbertson DJ, 2007, DIABETES, V56, P2078, DOI 10.2337/db06-1716; Dodd SL, 2009, FASEB J, V23, P3415, DOI 10.1096/fj.08-124602; FURUNO K, 1990, J BIOL CHEM, V265, P8550; GOLDBERG AL, 1969, J BIOL CHEM, V244, P3223; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Goodyear LJ, 2008, NEW ENGL J MED, V359, P1842, DOI 10.1056/NEJMcibr0806723; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; GREEN JD, 1980, J HISTOCHEM CYTOCHEM, V28, P408, DOI 10.1177/28.5.6966645; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Irrcher I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003614; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Krawiec BJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1555, DOI 10.1152/ajpendo.00622.2006; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Meirhaeghe A, 2003, BIOCHEM J, V373, P155, DOI 10.1042/BJ20030200; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Murakami T, 1998, BBA-GEN SUBJECTS, V1381, P113, DOI 10.1016/S0304-4165(98)00018-X; Nakashima K, 2007, BIOSCI BIOTECH BIOCH, V71, P1650, DOI 10.1271/bbb.70057; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; O'Leary MFN, 2008, J APPL PHYSIOL, V105, P114, DOI 10.1152/japplphysiol.00724.2007; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; Patterson MF, 2006, AM J PHYSIOL-CELL PH, V291, pC518, DOI 10.1152/ajpcell.00013.2006; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Richter EA, 2008, CELL METAB, V8, P96, DOI 10.1016/j.cmet.2008.07.004; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Suwa M, 2003, J APPL PHYSIOL, V95, P960, DOI 10.1152/japplphysiol.00349.2003; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; Taylor EB, 2005, AM J PHYSIOL-ENDOC M, V289, pE960, DOI 10.1152/ajpendo.00237.2005; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Van Gammeren D, 2009, FASEB J, V23, P362, DOI 10.1096/fj.08-114249; Wehling M, 2000, FASEB J, V14, P103, DOI 10.1096/fasebj.14.1.103; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; WICKS KL, 1991, AM J PHYSIOL, V260, pC841, DOI 10.1152/ajpcell.1991.260.4.C841; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zinna EM, 2003, CURR OPIN CLIN NUTR, V6, P87, DOI 10.1097/00075197-200301000-00013	71	162	169	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19460	19471		10.1074/jbc.M110.113092	http://dx.doi.org/10.1074/jbc.M110.113092			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404331	hybrid, Green Published			2022-12-25	WOS:000278727800056
J	Guezou, A; Trueman, M; Buddenhagen, CE; Chamorro, S; Guerrero, AM; Pozo, P; Atkinson, R				Guezou, Anne; Trueman, Mandy; Buddenhagen, Christopher Evan; Chamorro, Susana; Mireya Guerrero, Ana; Pozo, Paola; Atkinson, Rachel			An Extensive Alien Plant Inventory from the Inhabited Areas of Galapagos	PLOS ONE			English	Article							SANTA-CRUZ; INVASIONS; PACIFIC; HOMOGENIZATION; ERADICATION; PATTERNS; IMPACTS; ISLAND; FLORA	Background: Plant invasions are causing habitat degradation in Galapagos. Problems are concentrated on the four inhabited islands. Plants introduced to rural areas in the humid highlands and urban areas on the arid coast act as foci for invasion of the surrounding Galapagos National Park. Methodology/Principal Findings: Here we present results of the most comprehensive inventory to date of alien vascular plants in the inhabited areas of Galapagos. The survey was conducted between 2002 and 2007, in 6031 properties (97% of the total) on Floreana, Isabela, San Cristobal and Santa Cruz Islands. In total 754 alien vascular plant taxa were recorded, representing 468 genera in 123 families. Dicotyledons represented 554 taxa, monocotyledons 183, there were 7 gymnosperms and 10 pteridophytes. Almost half (363) of the taxa were herbaceous. The most represented families were Fabaceae (sensu lato), Asteraceae and Poaceae. The three most recorded species in the humid rural areas were Psidium guajava, Passiflora edulis and Bryophyllum pinnatum, and in the dry urban areas, Aloe vera, Portulaca oleracea and Carica papaya. In total, 264 (35%) taxa were recorded as naturalized. The most common use for taxa was ornamental (52%). Conclusions/Significance: This extensive survey has increased the known alien vascular flora of Galapagos by 257 species, giving a ratio of alien to native taxa of 1.57:1. It provides a crucial baseline for plant invasion management in the archipelago and contributes data for meta analyses of invasion processes worldwide. A repeat of the survey in the future would act as an effective early detection tool to help avoid further invasion of the Galapagos National Park.	[Guezou, Anne; Trueman, Mandy; Mireya Guerrero, Ana; Pozo, Paola; Atkinson, Rachel] Charles Darwin Fdn, Puerto Ayora, Galapagos, Ecuador; [Trueman, Mandy] Univ Western Australia, Crawley, WA, Australia; [Buddenhagen, Christopher Evan] SWCA Environm Consultants, Honolulu, HI USA; [Chamorro, Susana] Inst Mediterraneo Estudios Avanzados, Islas Baleares, Spain	University of Western Australia; Consejo Superior de Investigaciones Cientificas (CSIC)	Guezou, A (corresponding author), Charles Darwin Fdn, Puerto Ayora, Galapagos, Ecuador.	anne.guezou@fcdarwin.org.ec	Trueman, Mandy/E-7093-2013; Buddenhagen, Christopher/J-3942-2019	Buddenhagen, Christopher/0000-0002-3016-1054; Chamorro, Susana/0000-0002-2574-8424	Global Environment Facility (GEF) [ECU/00/G31]; Ministry of Environment; TAME Airlines; Galapagos Conservation Trust; Galapagos Conservancy	Global Environment Facility (GEF); Ministry of Environment(Ministry of Environment (ME), Republic of Korea); TAME Airlines; Galapagos Conservation Trust; Galapagos Conservancy	This work was accomplished with the support of Project ECU/00/G31 "Control of Invasive Species in the Galapagos Archipelago'', a donation from the Global Environment Facility (GEF) to the Ecuadorian Government, represented by the Ministry of Environment. The Project was implemented by the United Nations Development Programme (UNDP) and was executed by the Galapagos National Park Service (GNPS), Charles Darwin Foundation (CDF), National Institute for Galapagos (INGALA) and Ecuadorian Service for Agriculture and Livestock Sanitation-Galapagos (SESA-Galapagos). Additional financial support was provided by TAME Airlines, Galapagos Conservation Trust and Galapagos Conservancy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SWCA is included in the article because it relates to Christopher Buddenhagen's current place of employment, but SWCA did not fund any of the work and does not have any relation with the submitted article. C. Buddenhagen was employed by the Charles Darwin Foundation at the time of the inventory, and any subsequent work in relation with the submitted article was done on his own personal time.	Bensted-Smith, 2002, BIODIVERSITY VISION; Burt JW, 2007, BIOL INVASIONS, V9, P909, DOI 10.1007/s10530-007-9090-4; BUSTAMENTE R, ENV ENCOUNTERS SERIE; Castro SA, 2008, BIOL INVASIONS, V10, P1299, DOI 10.1007/s10530-007-9204-z; Castro SA, 2007, J BIOGEOGR, V34, P213, DOI 10.1111/j.1365-2699.2006.01605.x; Caujape-Castells J, 2010, PERSPECT PLANT ECOL, V12, P107, DOI 10.1016/j.ppees.2009.10.001; *CDB, 2002, 6 C PART HAG NETH 7; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Dehnen-Schmutz K, 2007, CONSERV BIOL, V21, P224, DOI 10.1111/j.1523-1739.2006.00538.x; Denslow JS, 2009, BIOTROPICA, V41, P162, DOI 10.1111/j.1744-7429.2008.00469.x; DIAZPJAZ P, 2010, LIST ALL KNOWN SPECI; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; ELREDGE LG, 2003, BISHOP MUSEUM OCCASI, V76, P1; Gardener MR, 2010, RESTOR ECOL, V18, P20, DOI 10.1111/j.1526-100X.2009.00614.x; Guerrero A. M., 2008, Pacific Conservation Biology, V14, P93; Guezou A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001042; Hickman J, 1985, ENCHANTED ISLANDS GA; HOSKINS JR, 14 AUSTR WEEDS C, P68; INEC, 2007, DIF RES DEF CENS POB; Jager H, 2007, BIOL CONSERV, V140, P297, DOI 10.1016/j.biocon.2007.08.014; Jager H, 2009, J ECOL, V97, P1252, DOI 10.1111/j.1365-2745.2009.01578.x; JORGENSEN PM, 1999, MONOGRAPHS MISSOURI, V75; Lambdon PW, 2008, PRESLIA, V80, P101; LAWESSON JE, 1987, ANNOTATED CHECKLIST; Lundh J. P., 2006, Galapagos Research, V64, P12; MACK RN, 2000, ISSUES ECOL, V5, P1; MACK RN, 2000, TURNING TIDE ERADICA, P164; Meyer JY, 2004, DIVERS DISTRIB, V10, P333, DOI 10.1111/j.1366-9516.2004.00094.x; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Panetta F. D., 2004, Plant Protection Quarterly, V19, P5; Porter D. M., 1983, PATTERNS EVOLUTION G, P33; PROANO ME, 2007, INFORM GALAPAGOS 200, P31; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Pysek P, 1998, OIKOS, V82, P282, DOI 10.2307/3546968; R Development Core Team, 2007, R LANG ENV STAT COMP; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Snell H. L., 2002, BIODIVERSITY VISION, P30; SOUBEYRAN Y, 2008, ESPECES EXOTIQUES EN; SOUBEYRAN Y, 2007, CONSERVATOIRE BOT NA; Timmins SM, 2004, WEED TECHNOL, V18, P1292, DOI 10.1614/0890-037X(2004)018[1292:HWLHPN]2.0.CO;2; TRUEMAN M, RESIDENCE T IN PRESS; Tye A, 2006, BIOL INVASIONS, V8, P201, DOI 10.1007/s10530-004-3574-2; Tye A., 2001, Weed risk assessment, P153; TYE A., 2002, BIODIVERSITY VISION; Tye Alan, 2007, Plant Protection Quarterly, V22, P33; Villasenor JL, 2004, DIVERS DISTRIB, V10, P113, DOI 10.1111/j.1366-9516.2004.00059.x; WATKINS G, 2009, 2 SIDES COIN; WATKINS G, 2007, INFORM GALAPAGOS 200, P7; Watson J, 2010, ORYX, V44, P79, DOI 10.1017/S0030605309990226; Wu SH, 2004, DIVERS DISTRIB, V10, P349, DOI 10.1111/j.1366-9516.2004.00121.x	50	65	68	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10276	10.1371/journal.pone.0010276	http://dx.doi.org/10.1371/journal.pone.0010276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20421999	gold, Green Published, Green Submitted			2022-12-25	WOS:000276952500021
J	Miranda, LS; Collins, AG; Marques, AC				Miranda, Lucilia S.; Collins, Allen G.; Marques, Antonio C.			Molecules Clarify a Cnidarian Life Cycle - The "Hydrozoan'' Microhydrula limopsicola Is an Early Life Stage of the Staurozoan Haliclystus antarcticus	PLOS ONE			English	Article							STAUROMEDUSA; SCYPHOZOA; EVOLUTION; AURICULA; AURELIA; PHYLOGENETICS; NEMATOCYSTS; MEDUSOZOA; PACIFIC; UTILITY	Background: Life cycles of medusozoan cnidarians vary widely, and have been difficult to document, especially in the most recently proposed class Staurozoa. However, molecular data can be a useful tool to elucidate medusozoan life cycles by tying together different life history stages. Methodology/Principal Findings: Genetic data from fast-evolving molecular markers (mitochondrial 16S, nuclear ITS1, and nuclear ITS2) show that animals that were presumed to be a hydrozoan, Microhydrula limopsicola (Limnomedusae, Microhydrulidae), are actually an early stage of the life cycle of the staurozoan Haliclystus antarcticus (Stauromedusae, Lucernariidae). Conclusions/Significance: Similarity between the haplotypes of three markers of Microhydrula limopsicola and Haliclystus antarcticus settles the identity of these taxa, expanding our understanding of the staurozoan life cycle, which was thought to be more straightforward and simple. A synthetic discussion of prior observations makes sense of the morphological, histological and behavioral similarities/congruence between Microhydrula and Haliclystus. The consequences are likely to be replicated in other medusozoan groups. For instance we hypothesize that other species of Microhydrulidae are likely to represent life stages of other species of Staurozoa.45	[Miranda, Lucilia S.; Marques, Antonio C.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [Collins, Allen G.] Smithsonian Inst, Natl Museum Nat Hist, Natl Marine Fisheries Serv, Natl Systemat Lab, Washington, DC 20560 USA	Universidade de Sao Paulo; National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History	Miranda, LS (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil.	mirandals@ib.usp.br	Miranda, Lucília Souza/L-4930-2015; Collins, Allen G/A-7944-2008; Marques, Antonio Carlos/E-8049-2011	Miranda, Lucília Souza/0000-0003-4121-8340; Collins, Allen G/0000-0002-3664-9691; Marques, Antonio Carlos/0000-0002-2884-0541	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2004/09961-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [55.7333/2005-9, 490348/2006-8, 305735/2006-3, 474672/2007-7]; National Science Foundation [0531779]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Science Foundation(National Science Foundation (NSF))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) ( research grant 2004/09961-4), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (55.7333/2005-9, 490348/2006-8, 305735/2006-3, 474672/2007-7), and the National Science Foundation through Assembling the Tree of Life Grant (0531779). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boero F, 2002, REPRO BIOL, V11, P141; BOUILLON J, 1967, CAH BIOL MAR, V8, P253; CALDER DR, 1973, MAR BIOL, V21, P109, DOI 10.1007/BF00354606; CALDER DR, 1971, T AM MICROSC SOC, V90, P269, DOI 10.2307/3225186; CALDER DR, 1983, CAN J ZOOL, V61, P1185, DOI 10.1139/z83-161; CARLGREN OSKAR, 1930, FURTHER ZOOL RESULTS SWEDISH ANTARCTIC EXPED 1901 1908, V2, P1; Chen SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008116; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Collins AG, 2005, BIOL BULL-US, V208, P221, DOI 10.2307/3593154; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Collins AG, 2008, J MAR BIOL ASSOC UK, V88, P1673, DOI 10.1017/S0025315408001732; CUNNINGHAM CW, 1993, BIOCHEM SYST ECOL, V21, P57, DOI 10.1016/0305-1978(93)90009-G; Davenport J, 1998, J MAR BIOL ASSOC UK, V78, P663, DOI 10.1017/S0025315400041709; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; Dawson MN, 2004, HYDROBIOLOGIA, V530, P249, DOI 10.1007/s10750-004-2659-3; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galea HR, 2007, ZOOTAXA, P39; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HARTOG JC, 1976, TRAV STAT BIOL ROSCO, V23, P3; Hirano Y.M., 1986, Journal of the Faculty of Science Hokkaido University Series VI Zoology, V24, P182; Jarms G, 1996, SCI MAR, V60, P109; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; KIKINGER R, 1995, J MAR BIOL ASSOC UK, V75, P899, DOI 10.1017/S0025315400038236; Kramp PL, 1961, J MAR BIOL ASSOC UK, V40, P292, DOI [10.1017/S0025315400007438, DOI 10.1017/S0025315400007438]; LARSON RJ, 1989, CAN J ZOOL, V67, P1543, DOI 10.1139/z89-219; LARSON RJ, 1988, CAN J ZOOL, V66, P2301, DOI 10.1139/z88-341; LARSON RJ, 1980, B MAR SCI, V30, P102; LESHLAURIE GE, 1991, MICROSCOPIC ANATOMY, V2, P195; Marques AC, 2004, INVERTEBR BIOL, V123, P23; MIANZAN H W, 1989, Investigaciones Marinas CICIMAR, V4, P15; Miglietta MP, 2007, J ZOOL SYST EVOL RES, V45, P11, DOI 10.1111/j.1439-0469.2006.00379.x; Miglietta MP, 2009, BIOL INVASIONS, V11, P825, DOI 10.1007/s10530-008-9296-0; Mills Claudia E., 2007, P168; Miranda LS, 2009, POLAR BIOL, V32, P1507, DOI 10.1007/s00300-009-0648-8; Morandini AC, 2009, J MAR BIOL ASSOC UK, V89, P67, DOI 10.1017/S0025315408002968; Muhlenhardt-Siegel U., 1989, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V86, P153; Otto J.J., 1978, P13; Otto JJ, 1976, COELENTERATE ECOLOGY, P319; Pfeffer G., 1889, JAHRB HAMBURG WISS A, V6, P37; Puce S, 2005, MAR ECOL-EVOL PERSP, V26, P73, DOI 10.1111/j.1439-0485.2005.00050.x; SALVINI-PLAWEN L V, 1987, Journal of the Marine Biological Association of the United Kingdom, V67, P623; Schroth W, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-1; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; UCHIDA TOHRU, 1929, JAPANESE JOUR ZOOL, V2, P103; Van Iten H, 2006, J SYST PALAEONTOL, V4, P109, DOI 10.1017/S1477201905001793; WEILL ROBERT, 1934, TRAV STAT ZOOL WIMEREUX, V10, P1; Wietrzykowski W., 1912, Archives de Zoologie Paris (Ser 5), V10; Wietrzykowski W, 1910, ARCH ZOOL EXP, V2, P10; Zagal CJ, 2008, J MAR BIOL ASSOC UK, V88, P259, DOI 10.1017/S0025315408000179; Zagal CJ, 2004, J MAR BIOL ASSOC UK, V84, P331, DOI 10.1017/S0025315404009233h; Zagal CJ, 2004, J MAR BIOL ASSOC UK, V84, P337, DOI 10.1017/S0025315404009245h	51	43	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10182	10.1371/journal.pone.0010182	http://dx.doi.org/10.1371/journal.pone.0010182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418959	Green Published, gold, Green Submitted			2022-12-25	WOS:000276706800019
J	Hale, JS; Frock, RL; Mamman, SA; Fink, PJ; Kennedy, BK				Hale, J. Scott; Frock, Richard L.; Mamman, Sara A.; Fink, Pamela J.; Kennedy, Brian K.			Cell-Extrinsic Defective Lymphocyte Development in Lmna(-/-) Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; LAMIN-A; NUCLEAR-ENVELOPE; T-CELLS; A/C; EXPRESSION; DISEASE; DIFFERENTIATION; EMERIN; MEMORY	Background: Mutations in the LMNA gene, which encodes all A-type lamins, result in a variety of human diseases termed laminopathies. Lmna(-/-) mice appear normal at birth but become runted as early as 2 weeks of age and develop multiple tissue defects that mimic some aspects of human laminopathies. Lmna(-/-) mice also display smaller spleens and thymuses. In this study, we investigated whether altered lymphoid organ sizes are correlated with specific defects in lymphocyte development. Principal Findings: Lmna(-/-) mice displayed severe age-dependent defects in T and B cell development which coincided with runting. Lmna(-/-) bone marrow reconstituted normal T and B cell development in irradiated wild-type recipients, driving generation of functional and self-MHC restricted CD4(+) and CD8(+) T cells. Transplantation of Lmna(-/-) neonatal thymus lobes into syngeneic wild-type recipients resulted in good engraftment of thymic tissue and normal thymocyte development. Conclusions: Collectively, these data demonstrate that the severe defects in lymphocyte development that characterize Lmna(-/-) mice do not result directly from the loss of A-type lamin function in lymphocytes or thymic stroma. Instead, the immune defects in Lmna(-/-) mice likely reflect indirect damage, perhaps resulting from prolonged stress due to the striated muscle dystrophies that occur in these mice.	[Hale, J. Scott; Fink, Pamela J.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Frock, Richard L.; Mamman, Sara A.; Kennedy, Brian K.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hale, JS (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	bkenn@u.washington.edu	Frock, Richard/I-6934-2019	Frock, Richard/0000-0001-6963-4931; Kennedy, Brian/0000-0002-5754-1874	National Institute on Aging (NIA) [R01 AG024287]; National Institutes of Health (NIH) [R01 AG13078]; Cardiovascular and Pathology Training [5T32HL007312-32]; National Cancer Institute Basic and Cancer Immunology [T32CA09537]; NATIONAL CANCER INSTITUTE [T32CA009537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013078, R01AG024287] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cardiovascular and Pathology Training; National Cancer Institute Basic and Cancer Immunology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging (NIA) grant R01 AG024287 to B. K. K. and National Institutes of Health (NIH) grant R01 AG13078 to P.J.F. R. L. F. is supported by the Cardiovascular and Pathology Training Grant (5T32HL007312-32). J.S.H. is supported by the National Cancer Institute Basic and Cancer Immunology Grant (T32CA09537). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsheimer M, 2004, J CELL SCI, V117, P1173, DOI 10.1242/jcs.00975; BLADON T, 1988, BIOCHEM CELL BIOL, V66, P40, DOI 10.1139/o88-006; Broers JLV, 1997, HISTOCHEM CELL BIOL, V107, P505, DOI 10.1007/s004180050138; Cohen TV, 2008, BIOCHEM SOC T, V36, P1329, DOI 10.1042/BST0361329; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; GUILLY MN, 1990, EXP CELL RES, V189, P145, DOI 10.1016/0014-4827(90)90267-E; GUILLY MN, 1987, EMBO J, V6, P3795, DOI 10.1002/j.1460-2075.1987.tb02715.x; Hendricks DW, 2009, J IMMUNOL, V182, P4267, DOI 10.4049/jimmunol.0804180; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Jansen MPHM, 1997, HISTOPATHOLOGY, V31, P304, DOI 10.1046/j.1365-2559.1997.2820881.x; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lee DC, 2009, EXP CELL RES, V315, P996, DOI 10.1016/j.yexcr.2009.01.003; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; OZAKI T, 1994, ONCOGENE, V9, P2649; ROBER RA, 1990, J CELL SCI, V95, P587; ROBER RA, 1989, DEVELOPMENT, V105, P365; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; STADELMANN B, 1990, LEUKEMIA RES, V14, P815, DOI 10.1016/0145-2126(90)90076-L; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742	26	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10127	10.1371/journal.pone.0010127	http://dx.doi.org/10.1371/journal.pone.0010127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405040	Green Published, gold, Green Submitted			2022-12-25	WOS:000276705900011
J	Arendrup, MC; Mavridou, E; Mortensen, KL; Snelders, E; Frimodt-Moller, N; Khan, H; Melchers, WJG; Verweij, PE				Arendrup, Maiken Cavling; Mavridou, Eleftheria; Mortensen, Klaus Leth; Snelders, Eveline; Frimodt-Moller, Niels; Khan, Humara; Melchers, Willem J. G.; Verweij, Paul E.			Development of Azole Resistance in Aspergillus fumigatus during Azole Therapy Associated with Change in Virulence	PLOS ONE			English	Article							14-ALPHA-STEROL DEMETHYLASE CYP51A; IN-VITRO; ITRACONAZOLE RESISTANCE; 14-ALPHA-DEMETHYLASE GENE; FUNGICIDE RESISTANCE; CROSS-RESISTANCE; SUSCEPTIBILITY; MECHANISMS; MUTATIONS; EVOLUTION	Four sequential Aspergillus fumigatus isolates from a patient with chronic granulomatous disease (CGD) eventually failing azole-echinocandin combination therapy were investigated. The first two isolates (1 and 2) were susceptible to antifungal azoles, but increased itraconazole, voriconazole and posaconazole MICs were found for the last two isolates (3 and 4). Microsatellite typing showed that the 4 isolates were isogenic, suggesting that resistance had been acquired during azole treatment of the patient. An immunocompromised mouse model confirmed that the in vitro resistance corresponded with treatment failure. Mice challenged with the resistant isolate 4 failed to respond to posaconazole therapy, while those infected by susceptible isolate 2 responded. Posaconazole-anidulafungin combination therapy was effective in mice challenged with isolate 4. No mutations were found in the Cyp51A gene of the four isolates. However, expression experiments of the Cyp51A showed that the expression was increased in the resistant isolates, compared to the azole-susceptible isolates. The microscopic morphology of the four isolates was similar, but a clear alteration in radial growth and a significantly reduced growth rate of the resistant isolates on solid and in broth medium was observed compared to isolates 1 and 2 and to unrelated wild-type controls. In the mouse model the virulence of isolates 3 and 4 was reduced compared to the susceptible ones and to wild-type controls. For the first time, the acquisition of azole resistance despite azole-echinocandin combination therapy is described in a CGD patient and the resistance demonstrated to be directly associated with significant change of virulence.	[Arendrup, Maiken Cavling; Mortensen, Klaus Leth] Statens Serum Inst, Unit Mycol & Parasitol, DK-2300 Copenhagen, Denmark; [Mavridou, Eleftheria; Snelders, Eveline; Melchers, Willem J. G.] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Frimodt-Moller, Niels] Statens Serum Inst, Natl Ctr Antimicrobials & Infect Control, DK-2300 Copenhagen, Denmark; [Khan, Humara; Verweij, Paul E.] Sydvestjysk Sygehus, Dept Internal Med, Esbjerg, Denmark	Statens Serum Institut; Radboud University Nijmegen; Statens Serum Institut	Arendrup, MC (corresponding author), Statens Serum Inst, Unit Mycol & Parasitol, DK-2300 Copenhagen, Denmark.	mad@ssi.dk	Melchers, Willem/C-8819-2015; Frimodt-Moller, Niels/G-1187-2018; Snelders, Eveline/HHS-5284-2022; Mortensen, Klaus Leth/AAS-3059-2021; Verweij, P.E./H-8108-2014	Melchers, Willem/0000-0002-5446-2230; Frimodt-Moller, Niels/0000-0003-1966-8302; Verweij, P.E./0000-0002-8600-9860; Mortensen, Klaus Leth/0000-0003-2719-5154; Snelders, Eveline/0000-0002-7868-7928; Arendrup, Maiken Cavling/0000-0002-4747-0144	Netherlands Organization for Health Research and Development [50-50800-98-030]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	This work was funded in part by The Netherlands Organization for Health Research and Development (ZonMW; grant 50-50800-98-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendrup MC, 2008, ANTIMICROB AGENTS CH, V52, P3504, DOI 10.1128/AAC.00190-08; Arendrup MC, 2009, ANTIMICROB AGENTS CH, V53, P1185, DOI 10.1128/AAC.01292-08; Chen J, 2005, J ANTIMICROB CHEMOTH, V55, P31, DOI 10.1093/jac/dkh507; CLSI Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI NCCLS; de Valk HA, 2009, CLIN MICROBIOL INFEC, V15, P180, DOI 10.1111/j.1469-0691.2008.02656.x; Denning DW, 1997, ANTIMICROB AGENTS CH, V41, P1364, DOI 10.1128/AAC.41.6.1364; Denning DW, 1997, J ANTIMICROB CHEMOTH, V40, P401, DOI 10.1093/jac/40.3.401; Diaz-Guerra TM, 2003, ANTIMICROB AGENTS CH, V47, P1120, DOI 10.1128/AAC.47.3.1120-1124.2003; Ferreira MED, 2004, ANTIMICROB AGENTS CH, V48, P4405, DOI [10.1128/AAC-.48.11.4405-4413.2004, 10.1128/AAC.48.11.4405-4413.2004]; Hamamoto H, 2000, APPL ENVIRON MICROB, V66, P3421, DOI 10.1128/AEM.66.8.3421-3426.2000; HARRISON E, 2009, P 49 INT C ANT AG CH; Hope WW, 2005, MED MYCOL, V43, pS207, DOI 10.1080/13693780400025179; Howard SJ, 2006, INT J ANTIMICROB AG, V28, P450, DOI 10.1016/j.ijantimicag.2006.08.017; Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043; Rodriguez-Tudela JL, 2008, ANTIMICROB AGENTS CH, V52, P2468, DOI 10.1128/AAC.00156-08; Luo CX, 2008, APPL ENVIRON MICROB, V74, P359, DOI 10.1128/AEM.02159-07; Ma ZH, 2006, APPL ENVIRON MICROB, V72, P2581, DOI 10.1128/AEM.72.4.2581-2585.2006; MANAVATHU EK, 2003, P 43 INT C ANT AG CH; Mann PA, 2003, ANTIMICROB AGENTS CH, V47, P577, DOI 10.1128/AAC.47.2.577-581.2003; Marichal P, 1997, ANTIMICROB AGENTS CH, V41, P2229, DOI 10.1128/AAC.41.10.2229; MAVRIDOU E, 2009, ANTIMICROB AGENTS CH; Meletiadis J, 2003, J CLIN MICROBIOL, V41, P4718, DOI 10.1128/JCM.41.10.4718-4725.2003; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P3402, DOI 10.1128/JCM.39.9.3402-3408.2001; Mellado E, 2007, ANTIMICROB AGENTS CH, V51, P1897, DOI 10.1128/AAC.01092-06; Mellado E, 2005, ANTIMICROB AGENTS CH, V49, P2536, DOI 10.1128/AAC.49.6.2536-2538.2005; Mellado E, 2004, ANTIMICROB AGENTS CH, V48, P2747, DOI 10.1128/AAC.48.7.2747-2750.2004; Nascimento AM, 2003, ANTIMICROB AGENTS CH, V47, P1719, DOI 10.1128/AAC.47.5.1719-1726.2003; REESLEV M, 1995, APPL ENVIRON MICROB, V61, P4236, DOI 10.1128/AEM.61.12.4236-4239.1995; Samson RA, 2007, STUD MYCOL, P147, DOI 10.3114/sim.2007.59.14; Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219; Snelders E, 2009, APPL ENVIRON MICROB, V75, P4053, DOI 10.1128/AEM.00231-09; Tudela JLR, 2008, CLIN MICROBIOL INFEC, V14, P982, DOI 10.1111/j.1469-0691.2008.02086.x; van der Linden JWM, 2009, CLIN INFECT DIS, V48, P1111, DOI 10.1086/597465; Verweij PE, 2007, NEW ENGL J MED, V356, P1481, DOI 10.1056/NEJMc061720; Verweij PE, 2009, DRUG RESIST UPDATE, V12, P141, DOI 10.1016/j.drup.2009.09.002; Verweij PE, 2009, LANCET INFECT DIS, V9, P789, DOI 10.1016/S1473-3099(09)70265-8; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258	37	127	129	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10080	10.1371/journal.pone.0010080	http://dx.doi.org/10.1371/journal.pone.0010080			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404915	Green Published, Green Submitted, gold			2022-12-25	WOS:000276482100007
J	Ohnishi, M; Razzaque, MS				Ohnishi, Mutsuko; Razzaque, M. Shawkat			Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging	FASEB JOURNAL			English	Article						klotho; NaPi2a; survival; fertility; emphysema; calcification	SOFT-TISSUE CALCIFICATION; AGE-ASSOCIATED INCREASES; KLOTHO MUTANT MICE; OXIDATIVE STRESS; VITAMIN-D; HOMEOSTASIS; PROTEIN; LEADS; COTRANSPORTER; TRANSCRIPTION	Identifying factors that accelerate the aging process can provide important therapeutic targets for slowing down this process. Misregulation of phosphate homeostasis has been noted in various skeletal, cardiac, and renal diseases, but the exact role of phosphate toxicity in mammalian aging is not clearly defined. Phosphate is widely distributed in the body and is involved in cell signaling, energy metabolism, nucleic acid synthesis, and the maintenance of acid-base balance by urinary buffering. In this study, we used an in vivo genetic approach to determine the role of phosphate toxicity in mammalian aging. Klotho-knockout mice (klotho(-/-)) have a short life span and show numerous physical, biochemical, and morphological features consistent with premature aging, including kyphosis, uncoordinated movement, hypogonadism, infertility, severe skeletal muscle wasting, emphysema, and osteopenia, as well as generalized atrophy of the skin, intestine, thymus, and spleen. Molecular and biochemical analyses suggest that increased renal activity of sodium-phosphate cotransporters (NaPi2a) leads to severe hyperphosphatemia in klotho(-/-) mice. Genetically reducing serum phosphate levels in klotho(-/-) mice by generating a NaPi2a and klotho double-knockout (NaPi2a(-/-)/klotho(-/-)) strain resulted in amelioration of premature aging-like features. The NaPi2a(-/-)/klotho(-/-) double-knockout mice regained reproductive ability, recovered their body weight, reduced their organ atrophy, and suppressed ectopic calcifications, with the resulting effect being prolonged survival. More important, when hyperphosphatemia was induced in NaPi2a(-/-)/klotho(-/-) mice by feeding with a high-phosphate diet, premature aging-like features reappeared, clearly suggesting that phosphate toxicity is the main cause of premature aging in klotho(-/-) mice. The results of our dietary and genetic manipulation studies provide in vivo evidence for phosphate toxicity accelerating the aging process and suggest a novel role for phosphate in mammalian aging.-Ohnishi, M., Razzaque, M. S. Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB J. 24, 3562-3571 (2010). www.fasebj.org	[Ohnishi, Mutsuko; Razzaque, M. Shawkat] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Razzaque, M. Shawkat] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pathol, Nagasaki 852, Japan	Harvard University; Harvard School of Dental Medicine; Nagasaki University	Razzaque, MS (corresponding author), Harvard Univ, Sch Dent Med, Dept Med Infect & Immun, Res & Educ Bldg,Rm 304,190 Longwood Ave, Boston, MA 02115 USA.	mrazzaque@hms.harvard.edu	Razzaque, Mohammed S./K-4282-2019		National Institute of Diabetes and Digestive and Kidney Disease [R01-DK-077276]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077276] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Parts of this research were supported by National Institute of Diabetes and Digestive and Kidney Disease grant R01-DK-077276 (to M. S. R.).	Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431; Edwards MG, 2003, PHYSIOL GENOMICS, V13, P119, DOI 10.1152/physiolgenomics.00172.2002; EVERS BM, 1994, SURG CLIN N AM, V74, P23; Gaasbeek A, 2005, AM J MED, V118, P1094, DOI 10.1016/j.amjmed.2005.02.014; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje; Kato Y, 2000, BIOCHEM BIOPH RES CO, V267, P597, DOI 10.1006/bbrc.1999.2009; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lanske B, 2007, AGEING RES REV, V6, P73, DOI 10.1016/j.arr.2007.02.002; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; MARTIN CJ, 1977, AM REV RESPIR DIS, V115, P981; Nakatani T, 2009, FASEB J, V23, P3702, DOI 10.1096/fj.08-123992; Nakatani T, 2009, FASEB J, V23, P433, DOI 10.1096/fj.08-114397; Ohnishi M, 2009, CIRC-CARDIOVASC GENE, V2, P583, DOI 10.1161/CIRCGENETICS.108.847814; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Radak Z, 2004, FASEB J, V18, P749, DOI 10.1096/fj.03-0509fje; Rauser CL, 2003, EXP GERONTOL, V38, P27, DOI 10.1016/S0531-5565(02)00148-1; Razzaque MS, 2007, AGEING RES REV, V6, P211, DOI 10.1016/j.arr.2007.06.001; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Razzaque MS, 2009, AM J PHYSIOL-RENAL, V296, pF470, DOI 10.1152/ajprenal.90538.2008; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; Razzaque MS, 2006, TRENDS MOL MED, V12, P298, DOI 10.1016/j.molmed.2006.05.002; Razzaque MS, 1998, NEPHRON, V80, P434, DOI 10.1159/000045217; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; Razzaque MS, 2005, J PATHOL, V207, P453, DOI 10.1002/path.1870; Razzaque MS, 2005, NEPHROL DIAL TRANSPL, V20, P2032, DOI 10.1093/ndt/gfh991; Razzaque MS, 1997, J PATHOL, V183, P24; Razzaque MS, 1999, HISTOCHEM CELL BIOL, V111, P359, DOI 10.1007/s004180050368; Salmon AB, 2009, FASEB J, V23, P3601, DOI 10.1096/fj.08-127415; Segawa H, 2007, AM J PHYSIOL-RENAL, V292, pF769, DOI 10.1152/ajprenal.00248.2006; Sitara D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000154; Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796; Tenenhouse HS, 2005, ANNU REV NUTR, V25, P197, DOI 10.1146/annurev.nutr.25.050304.092642; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Zha Y, 2006, ENDOCRINOLOGY, V147, P5690, DOI 10.1210/en.2006-0302	39	185	191	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3562	3571		10.1096/fj.09-152488	http://dx.doi.org/10.1096/fj.09-152488			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20418498	Green Published			2022-12-25	WOS:000281446400043
J	Yang, CB; Yang, Y; Brennan, L; Bouhassira, EE; Kantorow, M; Cvekl, A				Yang, Chunbo; Yang, Ying; Brennan, Lisa; Bouhassira, Eric E.; Kantorow, Marc; Cvekl, Ales			Efficient generation of lens progenitor cells and lentoid bodies from human embryonic stem cells in chemically defined conditions	FASEB JOURNAL			English	Article						cataract; crystallins; growth factors; Pax6	ALPHA-B-CRYSTALLIN; DIRECTED DIFFERENTIATION; A-CRYSTALLIN; INDUCTION; FGF; MOUSE; GENE; EXPRESSION; CATARACT; NETWORKS	The eye lens is an encapsulated avascular organ whose function is to focus light on the retina. Lens comprises a single progenitor cell lineage in multiple states of differentiation. Disruption of lens function leading to protein aggregation and opacity results in age-onset cataract. Cataract is a complex disease involving genetic and environmental factors. Here, we report the development of a new 3-stage system that differentiates human embryonic stem cells (hESCs) into large quantities of lens progenitor-like cells and differentiated 3-dimensional lentoid bodies. Inhibition of BMP signaling by noggin triggered differentiation of hESCs toward neuroectoderm. Subsequent reactivation of BMP and activation of FGF signaling stimulated formation of lens progenitor cells marked by the expression of PAX6 and alpha-crystallins. The formation of lentoid bodies was most efficient in the presence of FGF2 and Wnt-3a, yielding similar to 1000 lentoid bodies/30-mm well. Lentoid bodies expressed and accumulated lens-specific markers including alpha A-, alpha B-, beta-, and gamma-crystallins, filensin, CP49, and MIP/aquaporin 0. Collectively, these studies identify a novel procedure to generate lens cells from hESCs that can be applied for studies of lens differentiation and cataractogenesis using induced pluripotent stem (iPS) cells derived from various cataract patients.-Yang, C., Yang, Y., Brennan, L., Bouhassira, E. E., Kantorow, M., and Cvekl, A. Efficient generation of lens progenitor cells and lentoid bodies from human embryonic stem cells in chemically defined conditions. FASEB J. 24, 3274-3283 (2010). www.fasebj.org	[Yang, Chunbo; Yang, Ying; Cvekl, Ales] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10461 USA; [Yang, Ying; Cvekl, Ales] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Bouhassira, Eric E.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Bouhassira, Eric E.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Brennan, Lisa; Kantorow, Marc] Florida Atlantic Univ, Dept Biomed Sci, Boca Raton, FL 33431 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; State University System of Florida; Florida Atlantic University	Cvekl, A (corresponding author), Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	ales.cvekl@einstein.yu.edu	Cvekl, Ales/B-2427-2013; Bouhassira, Eric/AAZ-4184-2021		National Institutes of Health [EY012200, EY014237, EY013022]; Department of Ophthalmology and Visual Sciences of the Albert Einstein College of Medicine; New York State Stem Cell Science (NYSTEM) [N08S-001, N08T-006]; Einstein Human Pluripotent Stem Cell Center [N08S-001]; NATIONAL EYE INSTITUTE [R01EY012200, R01EY013022, R01EY014237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Ophthalmology and Visual Sciences of the Albert Einstein College of Medicine; New York State Stem Cell Science (NYSTEM); Einstein Human Pluripotent Stem Cell Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research for use of their core services. The authors are grateful to Dr. Roy Quinlan for filensin and CP49 antibodies. The authors also thank the West Virginia Eye Bank and Lions Eye Bank of Oregon for providing the human lenses used in this study. This work was supported by National Institutes of Health grants EY012200 (A. C.), EY014237 (A. C.), and EY013022 (M. K.) and the Sisenwein Family Endowment to the Department of Ophthalmology and Visual Sciences of the Albert Einstein College of Medicine. E. E. B. is supported in part by New York State Stem Cell Science (NYSTEM) grants N08S-001 and N08T-006. ESCs were produced by the NSTEM-supported Einstein Human Pluripotent Stem Cell Center (N08S-001).	Bassnett S, 2009, EXP EYE RES, V88, P133, DOI 10.1016/j.exer.2008.08.017; Boswell BA, 2008, DEV BIOL, V324, P202, DOI 10.1016/j.ydbio.2008.09.003; Brennan LA, 2009, EXP EYE RES, V88, P195, DOI 10.1016/j.exer.2008.05.018; Chen YJ, 2008, DEV BIOL, V324, P161, DOI 10.1016/j.ydbio.2008.09.002; Cvekl A, 2007, PROG RETIN EYE RES, V26, P555, DOI 10.1016/j.preteyeres.2007.07.002; Dai B, 2007, STEM CELLS, V25, P2567, DOI 10.1634/stemcells.2007-0131; de Longh RU, 2001, DEVELOPMENT, V128, P3995; De Maria A, 2007, INVEST OPHTH VIS SCI, V48, P5638, DOI 10.1167/iovs.07-0782; Faber SC, 2002, DEVELOPMENT, V129, P3727; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Golebiewska A, 2009, STEM CELLS, V27, P1298, DOI 10.1002/stem.59; Haynes JI, 1996, DEV DYNAM, V207, P75, DOI 10.1002/(SICI)1097-0177(199609)207:1<75::AID-AJA8>3.3.CO;2-O; Hutchins AP, 2009, CELL STEM CELL, V5, P126, DOI 10.1016/j.stem.2009.07.007; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KUWABARA T, 1974, INVEST OPHTH VISUAL, V13, P973; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lang RA, 2004, INT J DEV BIOL, V48, P783, DOI 10.1387/ijdb.041903rl; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Litsiou A, 2005, DEVELOPMENT, V132, P4051, DOI 10.1242/dev.01964; Liu Chenglong, 2006, AIDS Res Ther, V3, P6, DOI 10.1186/1742-6405-3-6; Lovicu FJ, 2005, DEV BIOL, V280, P1, DOI 10.1016/j.ydbio.2005.01.020; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Lyu J, 2004, DEVELOPMENT, V131, P1813, DOI 10.1242/dev.01060; MCAVOY JW, 1989, DEVELOPMENT, V107, P221; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; O'Connor MD, 2007, INVEST OPHTH VIS SCI, V48, P1245, DOI 10.1167/iovs.06-0949; Ooto S, 2003, INVEST OPHTH VIS SCI, V44, P2689, DOI 10.1167/iovs.02-1168; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Rajagopal R, 2009, DEV BIOL, V335, P305, DOI 10.1016/j.ydbio.2009.08.027; Robinson ML, 2006, SEMIN CELL DEV BIOL, V17, P726, DOI 10.1016/j.semcdb.2006.10.002; Robinson ML, 1996, INVEST OPHTH VIS SCI, V37, P2276; SANDILANDS A, 1995, J CELL SCI, V108, P1397; SCHULZ MW, 1993, DEVELOPMENT, V118, P117; Shiels A, 2007, ARCH OPHTHALMOL-CHIC, V125, P165, DOI 10.1001/archopht.125.2.165; Smith AN, 2010, DEV BIOL, V337, P195, DOI 10.1016/j.ydbio.2009.11.009; Stark MR, 2000, MECH DEVELOP, V93, P195, DOI 10.1016/S0925-4773(00)00263-X; Streit A, 2004, DEV BIOL, V276, P1, DOI 10.1016/j.ydbio.2004.08.037; Stump RJW, 2003, DEV BIOL, V259, P48, DOI 10.1016/S0012-1606(03)00179-9; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; VALENZUELA DM, 1995, J NEUROSCI, V15, P6077; VRENSEN GFJM, 1991, EXP EYE RES, V52, P647, DOI 10.1016/0014-4835(91)90017-9; Wagner LM, 2001, MOL VIS, V7, P57; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Wolf L, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-88; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao HT, 2008, DEV BIOL, V318, P276, DOI 10.1016/j.ydbio.2008.03.028	50	77	87	2	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3274	3283		10.1096/fj.10-157255	http://dx.doi.org/10.1096/fj.10-157255			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20410439	Green Published			2022-12-25	WOS:000281446400016
J	Asim, M; Chaturvedi, R; Hoge, S; Lewis, ND; Singh, K; Barry, DP; Algood, HS; de Sablet, T; Gobert, AP; Wilson, KT				Asim, Mohammad; Chaturvedi, Rupesh; Hoge, Svea; Lewis, Nuruddeen D.; Singh, Kshipra; Barry, Daniel P.; Algood, Holly S.; de Sablet, Thibaut; Gobert, Alain P.; Wilson, Keith T.			Helicobacter pylori Induces ERK-dependent Formation of a Phospho-c-Fos.c-Jun Activator Protein-1 Complex That Causes Apoptosis in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; KAPPA-B ACTIVATION; GROWTH-FACTOR; HOST-DEFENSE; DNA-BINDING; SIGNAL-TRANSDUCTION; IMMUNE-RESPONSE; AP-1 COMPLEX; ARGINASE-II; MAP KINASE	Macrophages are essential components of innate immunity, and apoptosis of these cells impairs mucosal defense to microbes. Helicobacter pylori is a gastric pathogen that infects half of the world population and causes peptic ulcer disease and gastric cancer. The host inflammatory response fails to eradicate the organism. We have reported that H. pylori induces apoptosis of macrophages by generation of polyamines from ornithine decarboxylase (ODC), which is dependent on c-Myc as a transcriptional enhancer. We have now demonstrated that expression of c-Myc requires phosphorylation and nuclear translocation of ERK,which results in phosphorylation of c-Fos and formation of a specific activator protein (AP)-1 complex. Electromobility shift assay and immunoprecipitation revealed a previously unrecognized complex of phospho-c-Fos (pc-Fos) and c-Jun in the nucleus. Fluorescence resonance energy transfer demonstrated the interaction of pc-Fos and c-Jun. The capacity of this AP-1 complex to bind to putative AP-1 sequences was demonstrated by oligonucleotide pulldown and fluorescence polarization. Binding of the pc-Fos center dot c-Jun complex to the c-Myc promoter was demonstrated by chromatin immunoprecipitation. A dominant-negative c-Fos inhibited H. pylori-induced expression of c-Myc and ODC and apoptosis. H. pylori infection of mice induced a rapid infiltration of macrophages into the stomach. Concomitant apoptosis depleted these cells, and this was associated with formation of a pc-Fos center dot c-Jun complex. Treatment of mice with an inhibitor of ERK phosphorylation attenuated phosphorylation of c-Fos, expression of ODC, and apoptosis in gastric macrophages. A unique AP-1 complex in gastric macrophages contributes to the immune escape of H. pylori.	[Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Sch Med, Div Gastroenterol, Nashville, TN 37232 USA; [Algood, Holly S.] Vanderbilt Univ, Med Ctr, Dept Med, Dept Infect Dis, Nashville, TN 37232 USA; [Lewis, Nuruddeen D.; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA; [Asim, Mohammad; Chaturvedi, Rupesh; Singh, Kshipra; Algood, Holly S.; de Sablet, Thibaut; Wilson, Keith T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA; [Hoge, Svea] Otto Von Guericke Univ, Dept Gen Abdominal & Vasc Surg, D-39120 Magdeburg, Germany; [Gobert, Alain P.] INRA, Unite Microbiol UR454, F-63122 St Genes Champanelle, France	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Otto von Guericke University; INRAE	Wilson, KT (corresponding author), Vanderbilt Univ, Med Ctr, Sch Med, Div Gastroenterol, 1030C MRB 4,2215B Garland Ave, Nashville, TN 37232 USA.	keith.wilson@vanderbilt.edu	Gobert, Alain P/AHB-1368-2022; Barry, Daniel P/B-5647-2008; de Sablet, Thibaut/AAI-4513-2020	Barry, Daniel P/0000-0002-3972-3914; Lewis, Nuruddeen/0000-0002-1233-6607; Wilson, Keith/0000-0003-4421-1830	National Institutes of Health [R01DK053620, R01AT004821, P01CA116087, P01CA028842, F31GM083500, T32CA009592, T32DK007673, P30DK058404]; Vanderbilt University Digestive Disease Research Center; Office of Medical Research, Department of Veterans Affairs; Philippe Foundation; NATIONAL CANCER INSTITUTE [P01CA116087, P01CA028842, T32CA009592] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007673, P30DK034854, P30DK058404, R01DK053620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM083500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Digestive Disease Research Center; Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); Philippe Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK053620 and R01AT004821 (to K. T. W.), P01CA116087 (to K. T. W.), P01CA028842 (to K. T. W.), F31GM083500 (to N. D. L.), T32CA009592 (to N. D. L.), and T32DK007673 (D. P. B.). This work was also supported by the Flow Cytometry Core and the Cell Imaging Core of the Vanderbilt University Digestive Disease Research Center, which was supported by National Institutes of Health Grant P30DK058404, a Merit Review Grant from the Office of Medical Research, Department of Veterans Affairs (to K. T. W.), and the Philippe Foundation (to T. d. S. and A. P. G.).	Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Algood HMS, 2007, FEMS IMMUNOL MED MIC, V51, P577, DOI 10.1111/j.1574-695X.2007.00338.x; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Aspholm M, 2006, PLOS PATHOG, V2, P989, DOI 10.1371/journal.ppat.0020110; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Bhattacharyya A, 2002, BIOCHEM J, V368, P121, DOI 10.1042/BJ20020555; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; Bussiere FI, 2006, CANCER RES, V66, P6834, DOI 10.1158/0008-5472.CAN-05-4197; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chaturvedi R, 2004, J BIOL CHEM, V279, P40161, DOI 10.1074/jbc.M401370200; Chaturvedi R, 2007, INFECT IMMUN, V75, P4305, DOI 10.1128/IAI.00578-07; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chen RH, 1996, ONCOGENE, V12, P1493; Cheng Y, 2005, J BIOL CHEM, V280, P22492, DOI 10.1074/jbc.C500122200; COLOTTA F, 1992, J BIOL CHEM, V267, P18278; Delyria ES, 2009, GASTROENTEROLOGY, V136, P247, DOI 10.1053/j.gastro.2008.09.017; DENG TL, 1994, NATURE, V371, P171, DOI 10.1038/371171a0; Ding SZ, 2008, FEMS IMMUNOL MED MIC, V53, P385, DOI 10.1111/j.1574-695X.2008.00439.x; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Gobert AP, 2002, J IMMUNOL, V168, P4692, DOI 10.4049/jimmunol.168.9.4692; Grill C, 2004, BIOCHEM J, V381, P635, DOI 10.1042/BJ20031688; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Hisatsune J, 2008, J IMMUNOL, V180, P5017, DOI 10.4049/jimmunol.180.7.5017; HOLT JT, 1986, P NATL ACAD SCI USA, V83, P4794, DOI 10.1073/pnas.83.13.4794; Iavarone C, 2003, J BIOL CHEM, V278, P50024, DOI 10.1074/jbc.M308617200; Kao JY, 2006, AM J PHYSIOL-GASTR L, V291, pG73, DOI 10.1152/ajpgi.00139.2005; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Keates S, 1999, J IMMUNOL, V163, P5552; Kudo T, 2007, GASTROENTEROLOGY, V132, P1024, DOI 10.1053/j.gastro.2007.01.009; Kyriakis JM, 2001, NATURE, V414, P265, DOI 10.1038/35104735; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Lewis ND, 2010, J IMMUNOL, V184, P2572, DOI 10.4049/jimmunol.0902436; Lu H, 2005, MOL BIOL CELL, V16, P4954, DOI 10.1091/mbc.E05-05-0426; Matsubayashi Y, 2001, J BIOL CHEM, V276, P41755, DOI 10.1074/jbc.M106012200; Mera R, 2005, GUT, V54, P1536, DOI 10.1136/gut.2005.072009; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Naumann M, 1999, J BIOL CHEM, V274, P31655, DOI 10.1074/jbc.274.44.31655; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; Niklinski J, 2000, MOL CELL BIOL, V20, P5276, DOI 10.1128/MCB.20.14.5276-5284.2000; Oh JD, 2005, P NATL ACAD SCI USA, V102, P5186, DOI 10.1073/pnas.0407657102; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Preston GA, 1996, MOL CELL BIOL, V16, P211; Rishi V, 2005, ANAL BIOCHEM, V340, P259, DOI 10.1016/j.ab.2005.02.012; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rusinova E, 2002, ANAL BIOCHEM, V308, P18, DOI 10.1016/S0003-2697(02)00325-1; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Singh K, 2008, J BIOL CHEM, V283, P16752, DOI 10.1074/jbc.M710530200; SMEAL T, 1992, MOL CELL BIOL, V12, P3507, DOI 10.1128/MCB.12.8.3507; SZABO E, 1991, CELL GROWTH DIFFER, V2, P475; Teixeiro E, 2010, FEBS J, V277, P30, DOI 10.1111/j.1742-4658.2009.07368.x; Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155; Weston CR, 2001, SCIENCE, V292, P2439, DOI 10.1126/science.1063279; Wilson KT, 2007, GASTROENTEROLOGY, V133, P288, DOI 10.1053/j.gastro.2007.05.008; Wilson KT, 1996, GASTROENTEROLOGY, V111, P1524, DOI 10.1016/S0016-5085(96)70014-8; Xu HX, 2004, CANCER RES, V64, P8521, DOI 10.1158/0008-5472.CAN-04-3511; Yamamura Y, 2000, J BIOL CHEM, V275, P36295, DOI 10.1074/jbc.M006023200; Yamauchi K, 2008, J IMMUNOL, V180, P1207, DOI 10.4049/jimmunol.180.2.1207; Zhao J, 2003, MOL CELL, V11, P405, DOI 10.1016/S1097-2765(03)00036-4	62	58	63	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20343	20357		10.1074/jbc.M110.116988	http://dx.doi.org/10.1074/jbc.M110.116988			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20410304	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000279012000068
J	Dridi, L; Ouameur, AA; Ouellette, M				Dridi, Larbi; Ouameur, Amin Ahmed; Ouellette, Marc			High Affinity S-Adenosylmethionine Plasma Membrane Transporter of Leishmania Is a Member of the Folate Biopterin Transporter (FBT) Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOZOAN PARASITE LEISHMANIA; METHOTREXATE-RESISTANT LEISHMANIA; TRYPANOSOMA-BRUCEI-RHODESIENSE; AMPLIFIED H-CIRCLE; GENE-EXPRESSION; METHIONINE ADENOSYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-CHARACTERIZATION; PLASMODIUM-FALCIPARUM; MITOCHONDRIAL CARRIER	S-Adenosylmethionine (AdoMet) is an important methyl group donor that plays a central role in many essential biochemical processes. The parasite Leishmania can both synthesize and transport AdoMet. Leishmania cells resistant to the antifolate methotrexate due to a rearrangement in folate biopterin transporter (FBT) genes were cross-resistant to sinefungin, an AdoMet analogue. FBT gene rearrangements were also observed in Leishmania major cells selected for sinefungin resistance. One of the rearranged FBT genes corresponded to the main AdoMet transporter (AdoMetT1) of Leishmania as determined by gene transfection and gene inactivation experiments. AdoMetT1 was determined to be a high affinity plasma membrane transporter expressed constitutively throughout the growth phases of the parasite. Leishmania cells selected for resistance or naturally insensitive to sinefungin had lower expression of AdoMetT1. A new function in one carbon metabolism, also a pathway of interest for chemotherapeutic interventions, is described for a novel class of membrane proteins found in diverse organisms.	[Dridi, Larbi; Ouameur, Amin Ahmed; Ouellette, Marc] Univ Laval, Ctr Rech Infectiol, CHUL, Quebec City, PQ G1V 4G2, Canada	Laval University	Ouellette, M (corresponding author), Univ Laval, Ctr Rech Infectiol, CHUL, 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	marc.ouellette@crchul.ulaval.ca	Ouellette, Marc/K-8694-2017	Ouellette, Marc/0000-0002-6743-9646	Canadian Institutes of Health	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research group and operating grants (to M.O.).; Recipient of a Canadian Institutes of Health Research studentship.	Agrimi G, 2004, BIOCHEM J, V379, P183, DOI 10.1042/BJ20031664; Al-Salabi MI, 2003, MOL PHARMACOL, V63, P814, DOI 10.1124/mol.63.4.814; AVILA JL, 1987, MOL BIOCHEM PARASIT, V26, P69, DOI 10.1016/0166-6851(87)90131-9; AVILA JL, 1993, MOL BIOCHEM PARASIT, V58, P123, DOI 10.1016/0166-6851(93)90096-G; Bacchi CJ, 2009, ANTIMICROB AGENTS CH, V53, P3269, DOI 10.1128/AAC.00076-09; BACHRACH U, 1980, FEBS LETT, V121, P287, DOI 10.1016/0014-5793(80)80364-4; Barker RH, 2009, ANTIMICROB AGENTS CH, V53, P2052, DOI 10.1128/AAC.01674-08; Bouvier F, 2006, PLANT CELL, V18, P3088, DOI 10.1105/tpc.105.040741; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Colasante C, 2009, MOL BIOCHEM PARASIT, V167, P104, DOI 10.1016/j.molbiopara.2009.05.004; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Cunningham ML, 2001, MOL BIOCHEM PARASIT, V113, P199, DOI 10.1016/S0166-6851(01)00213-4; Dridi L, 2010, BIOCHEM PHARMACOL, V79, P30, DOI 10.1016/j.bcp.2009.07.019; Drummelsmith J, 2004, J BIOL CHEM, V279, P33273, DOI 10.1074/jbc.M405183200; DUBE DK, 1983, AM J TROP MED HYG, V32, P31, DOI 10.4269/ajtmh.1983.32.31; El Fadili A, 2002, MOL BIOCHEM PARASIT, V124, P63, DOI 10.1016/S0166-6851(02)00163-9; ELLENBERGER TE, 1987, J BIOL CHEM, V262, P10053; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; Foucher AL, 2006, J PROTEOME RES, V5, P1741, DOI 10.1021/pr060081j; Gagnon D, 2006, MOL BIOCHEM PARASIT, V150, P63, DOI 10.1016/j.molbiopara.2006.06.009; Goldberg B, 1997, FASEB J, V11, P256, DOI 10.1096/fasebj.11.4.9068614; Goldberg B, 1998, BIOCHEM PHARMACOL, V56, P95, DOI 10.1016/S0006-2952(98)00118-X; Goldberg B, 1999, ARCH BIOCHEM BIOPHYS, V364, P13, DOI 10.1006/abbi.1999.1098; Guimond C, 2003, NUCLEIC ACIDS RES, V31, P5886, DOI 10.1093/nar/gkg806; Haferkamp I, 2007, FEBS LETT, V581, P2375, DOI 10.1016/j.febslet.2007.02.020; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Hirth B, 2009, BIOORG MED CHEM LETT, V19, P2916, DOI 10.1016/j.bmcl.2009.04.096; Klaus SMJ, 2005, J BIOL CHEM, V280, P38457, DOI 10.1074/jbc.M507432200; Kundig C, 1999, EMBO J, V18, P2342, DOI 10.1093/emboj/18.9.2342; Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004; Lemley C, 1999, MOL BIOCHEM PARASIT, V104, P93, DOI 10.1016/S0166-6851(99)00132-2; Leprohon P, 2009, NUCLEIC ACIDS RES, V37, P1387, DOI 10.1093/nar/gkn1069; Lu SC, 2008, J GASTROEN HEPATOL, V23, pS73, DOI 10.1111/j.1440-1746.2007.05289.x; Marobbio CMT, 2003, EMBO J, V22, P5975, DOI 10.1093/emboj/cdg574; Marquis N, 2005, MOL MICROBIOL, V57, P1690, DOI 10.1111/j.1365-2958.2005.04782.x; Massimine KM, 2005, MOL BIOCHEM PARASIT, V144, P44, DOI 10.1016/j.molbiopara.2005.07.006; Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev; Merali S, 2000, J BIOL CHEM, V275, P14958, DOI 10.1074/jbc.275.20.14958; Merali S, 2004, FEMS MICROBIOL LETT, V237, P179, DOI 10.1016/j.femsle.2004.06.039; Moreira W, 2009, FREE RADICAL BIO MED, V46, P367, DOI 10.1016/j.freeradbiomed.2008.10.034; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; NOLAN LL, 1987, ANTIMICROB AGENTS CH, V31, P1542, DOI 10.1128/AAC.31.10.1542; Ouameur AA, 2008, MOL BIOCHEM PARASIT, V162, P155, DOI 10.1016/j.molbiopara.2008.08.007; Ouellette M, 2004, DRUG RESIST UPDATE, V7, P257, DOI 10.1016/j.drup.2004.07.002; OUELLETTE M, 1990, EMBO J, V9, P1027, DOI 10.1002/j.1460-2075.1990.tb08206.x; Palmieri L, 2006, PLANT PHYSIOL, V142, P855, DOI 10.1104/pp.106.086975; PAOLANTONACCI P, 1985, ANTIMICROB AGENTS CH, V28, P528, DOI 10.1128/AAC.28.4.528; PAPADOPOULOU B, 1992, EMBO J, V11, P3601, DOI 10.1002/j.1460-2075.1992.tb05444.x; PAPADOPOULOU B, 1993, NUCLEIC ACIDS RES, V21, P4305, DOI 10.1093/nar/21.18.4305; Perez-Pertejo Y, 2006, BBA-GEN SUBJECTS, V1760, P10, DOI 10.1016/j.bbagen.2005.09.003; PHELOUZAT MA, 1995, BIOCHEM J, V305, P133, DOI 10.1042/bj3050133; Reguera RM, 2002, J BIOL CHEM, V277, P3158, DOI 10.1074/jbc.M105512200; Reguera RM, 2007, MOL BIOCHEM PARASIT, V152, P1, DOI 10.1016/j.molbiopara.2006.11.013; Richard D, 2004, J BIOL CHEM, V279, P54494, DOI 10.1074/jbc.M409264200; Richard D, 2002, J BIOL CHEM, V277, P29460, DOI 10.1074/jbc.M204796200; Rouillon A, 1999, J BIOL CHEM, V274, P28096, DOI 10.1074/jbc.274.40.28096; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Sambrook J., 2002, MOL CLONING LAB MANU; TRAGER W, 1980, EXP PARASITOL, V50, P83, DOI 10.1016/0014-4894(80)90010-7; Tucker AM, 2003, J BACTERIOL, V185, P3031, DOI 10.1128/JB.185.10.3031-3035.2003; Ubeda JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r115; Uemura T, 2007, J BIOL CHEM, V282, P7733, DOI 10.1074/jbc.M611105200; Wang P, 2007, MOL BIOCHEM PARASIT, V154, P40, DOI 10.1016/j.molbiopara.2007.04.002; Zheng S, 2007, NUCLEIC ACIDS RES, V35, P6895, DOI 10.1093/nar/gkm817	65	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19767	19775		10.1074/jbc.M110.114520	http://dx.doi.org/10.1074/jbc.M110.114520			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20406813	Green Published, hybrid			2022-12-25	WOS:000279012000009
J	Hanzelmann, P; Stingele, J; Hofmann, K; Schindelin, H; Raasi, S				Haenzelmann, Petra; Stingele, Julian; Hofmann, Kay; Schindelin, Hermann; Raasi, Shahri			The Yeast E4 Ubiquitin Ligase Ufd2 Interacts with the Ubiquitin-like Domains of Rad23 and Dsk2 via a Novel and Distinct Ubiquitin-like Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							63-LINKED POLYUBIQUITIN CHAINS; STRUCTURAL BASIS; UBA DOMAIN; PROTEASOME PATHWAY; PROTEIN-STRUCTURE; SUBUNIT S5A; RECOGNITION; DETERMINANTS; DEGRADATION; MULTIUBIQUITYLATION	Proteins containing ubiquitin-like (UBL) and ubiquitin-associated (UBA) domains interact with various binding partners and function as hubs during ubiquitin-mediated protein degradation. A common interaction of the budding yeast UBL-UBA proteins Rad23 and Dsk2 with the E4 ubiquitin ligase Ufd2 has been described in endoplasmic reticulum-associated degradation among other pathways. The UBL domains of Rad23 and Dsk2 play a prominent role in this process by interacting with Ufd2 and different subunits of the 26 S proteasome. Here, we report crystal structures of Ufd2 in complex with the UBL domains of Rad23 and Dsk2. The N-terminal UBL-interacting region of Ufd2 exhibits a unique sequence pattern, which is distinct from any known ubiquitin-or UBL-binding domain identified so far. Residue-specific differences exist in the interactions of these UBL domains with Ufd2, which are coupled to subtle differences in their binding affinities. The molecular details of their differential interactions point to a role for adaptive evolution in shaping these interfaces.	[Haenzelmann, Petra; Schindelin, Hermann] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Stingele, Julian; Raasi, Shahri] Univ Konstanz, Dept Biol, Lab Cellular Biochem, D-78457 Constance, Germany; [Hofmann, Kay] Miltenyi Biotec GmbH, Bioinformat Grp, D-51429 Bergisch Gladbach, Germany	University of Wurzburg; University of Konstanz; Miltenyi Biotec	Schindelin, H (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	hermann.schindelin@virchow.uni-wuerzburg.de; shahri.raasi@uni-konstanz.de	Schindelin, Hermann/Q-2697-2019; Hofmann, Kay/D-6714-2011; Stingele, Julian/K-7490-2012	Hofmann, Kay/0000-0002-2289-9083; Stingele, Julian/0000-0001-6020-2075	Deutsche Forschungsgemeinschaft [RA1643/2-1]; Rudolf Virchow Center for Experimental Biomedicine [FZ 82]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rudolf Virchow Center for Experimental Biomedicine	This work was supported by Deutsche Forschungsgemeinschaft Grant RA1643/2-1 (to S. R.) and Rudolf Virchow Center for Experimental Biomedicine Grant FZ 82 (to H. S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grabbe C, 2009, CHEM REV, V109, P1481, DOI 10.1021/cr800413p; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hara T, 2005, MOL CELL BIOL, V25, P9292, DOI 10.1128/MCB.25.21.9292-9303.2005; Harper JW, 2006, CELL, V124, P1133, DOI 10.1016/j.cell.2006.03.009; Hartmann-Petersen R, 2003, FEBS LETT, V535, P77, DOI 10.1016/S0014-5793(02)03874-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; Hunter CA, 2003, CHEM BIOL, V10, P1023, DOI 10.1016/j.chembiol.2003.10.009; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ishii T, 2006, EMBO J, V25, P5492, DOI 10.1038/sj.emboj.7601418; Ivantsiv Y, 2006, MOL CELL BIOL, V26, P1579, DOI 10.1128/MCB.26.5.1579-1588.2006; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Liu C, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-75; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777; Matiuhin Y, 2008, MOL CELL, V32, P415, DOI 10.1016/j.molcel.2008.10.011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Pazos F, 2008, EMBO J, V27, P2648, DOI 10.1038/emboj.2008.189; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rape M, 2004, BBA-MOL CELL RES, V1695, P209, DOI 10.1016/j.bbamcr.2004.09.022; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Sato Y, 2009, EMBO J, V28, P3903, DOI 10.1038/emboj.2009.345; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Tu D, 2007, P NATL ACAD SCI USA, V104, P15599, DOI 10.1073/pnas.0701369104; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Velthuis AJWT, 2008, CURR GENOMICS, V9, P88, DOI 10.2174/138920208784139537; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Walters KJ, 2003, P NATL ACAD SCI USA, V100, P12694, DOI 10.1073/pnas.1634989100; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhang DN, 2009, MOL CELL, V36, P1018, DOI 10.1016/j.molcel.2009.11.012	65	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20390	20398		10.1074/jbc.M110.112532	http://dx.doi.org/10.1074/jbc.M110.112532			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427284	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000279012000072
J	Tsutsumi, R; Mistry, D; Webster, NJG				Tsutsumi, Rie; Mistry, Devendra; Webster, Nicholas J. G.			Signaling Responses to Pulsatile Gonadotropin-releasing Hormone in L beta T2 Gonadotrope Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ADENYLYL-CYCLASE; GNRH RECEPTOR; DEPENDENT PHOSPHORYLATION; BETA-PROMOTER; LIVING CELLS; ACTIVATION; EXPRESSION; INDUCTION; PATHWAYS	The hypothalamic neuropeptide gonadotropin-releasing hormone ( GnRH) is secreted in a pulsatile fashion by hypothalamic neurons, and alterations in pulse frequency and amplitude differentially regulate gonadotropin synthesis and release. In this study, we investigated the kinetics of G(s) and G(q) signaling in response to continuous or pulsatile GnRH using fluorescence resonance energy transfer reporters in live mouse L beta T2 gonadotrope cells. cAMP and protein kinase A-dependent reporters showed a rapid but transient increase in fluorescence resonance energy transfer signal with increasing doses of constant GnRH, and in contrast diacylglycerol (DAG) and calcium reporters showed a rapid and sustained signal. Multiple pulses of GnRH caused multiple pulses of cAMP and protein kinase A activation without desensitization, but the DAG and calcium reporters were rapidly desensitized resulting in inhibition of calcium and DAG responses. At the transcriptional level, both a cAMP-dependent cAMP-response element reporter and a DAG/calcium-dependent AP-1 reporter showed a pulse frequency-dependent increase in luciferase activity. However, constant GnRH stimulation gave very little cAMP-response element activation but very strong AP-1 activation. Based on these data, we propose that both the GnRH-R-G(s) and G(q) pathways are responsive to pulses of GnRH, but only the G(q) pathway is responsive to constant GnRH. Furthermore, the G(q) pathway is subject to desensitization with multiple GnRH pulses, but the G(s) pathway is not.	[Webster, Nicholas J. G.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Mistry, Devendra; Webster, Nicholas J. G.] Univ Calif San Diego, Program Biomed Sci, La Jolla, CA 92093 USA; [Mistry, Devendra] Univ Calif San Diego, Interfaces Grad Program, La Jolla, CA 92093 USA; Vet Affairs San Diego Healthcare Syst, Med Res Serv, San Diego, CA 92161 USA; [Tsutsumi, Rie] Univ Tokushima, Tokushima 7708503, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Tokushima University	Webster, NJG (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr,M-C 0673, La Jolla, CA 92093 USA.	nwebster@ucsd.edu	Webster, Nick/AAI-8410-2021	Tsutsumi, Rie/0000-0001-6362-5823	National Institutes of Health [R01 HD047400, SCCPIR U54 HD012303]; Ruth L. Kirschstein National Research Service Award [T32 EB009380]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303, P50HD012303] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047400] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HD047400 and SCCPIR U54 HD012303 ( to N. J. G. W.). This work was also supported by Ruth L. Kirschstein National Research Service Award T32 EB009380 ( to D. M.).	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Armstrong SP, 2009, J BIOL CHEM, V284, P35746, DOI 10.1074/jbc.M109.063917; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Caunt CJ, 2004, ENDOCRINOLOGY, V145, P3594, DOI 10.1210/en.2004-0092; Ciccone NA, 2008, MOL ENDOCRINOL, V22, P1908, DOI 10.1210/me.2007-0455; Clark MA, 2006, MOL PHARMACOL, V69, P1280, DOI 10.1124/mol.105.019059; CONN PM, 1994, ANNU REV MED, V45, P391, DOI 10.1146/annurev.med.45.1.391; Coss D, 2004, J BIOL CHEM, V279, P152, DOI 10.1074/jbc.M304697200; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Ferris HA, 2007, BIOL REPROD, V77, P1073, DOI 10.1095/biolreprod.107.064139; Grosse R, 2000, J BIOL CHEM, V275, P9193, DOI 10.1074/jbc.275.13.9193; Han XB, 1999, ENDOCRINOLOGY, V140, P2241, DOI 10.1210/en.140.5.2241; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Huang HC, 2010, J BONE MINER RES, V25, P819, DOI 10.1359/jbmr.091019; Kaiser UB, 1997, ENDOCR REV, V18, P46, DOI 10.1210/er.18.1.46; Kaufmann K, 2001, BIOL CHEM, V382, P1077, DOI 10.1515/BC.2001.135; Komi N, 2007, BBA-BIOMEMBRANES, V1768, P3001, DOI 10.1016/j.bbamem.2007.10.015; Kraus S, 2001, ARCH MED RES, V32, P499, DOI 10.1016/S0188-4409(01)00331-9; Krsmanovic LZ, 2001, MOL ENDOCRINOL, V15, P429, DOI 10.1210/me.15.3.429; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Lawson MA, 2007, MOL ENDOCRINOL, V21, P1175, DOI 10.1210/me.2006-0392; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Litosch I, 1997, BIOCHEM J, V326, P701, DOI 10.1042/bj3260701; Liu FJ, 2003, ENDOCRINOLOGY, V144, P4354, DOI 10.1210/en.2003-0204; Liu FJ, 2002, J BIOL CHEM, V277, P32099, DOI 10.1074/jbc.M203639200; Liu FJ, 2002, MOL ENDOCRINOL, V16, P419, DOI 10.1210/me.16.3.419; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Marshall JC, 2001, MOL CELL ENDOCRINOL, V183, P29, DOI 10.1016/S0303-7207(01)00611-6; Morel E, 2005, CIRC RES, V97, P1296, DOI 10.1161/01.RES.0000194325.31359.86; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Shacham S, 2005, J BIOL CHEM, V280, P28981, DOI 10.1074/jbc.M500312200; SHAH BH, 1995, P NATL ACAD SCI USA, V92, P1886, DOI 10.1073/pnas.92.6.1886; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Washington Talitha M, 2004, Theor Biol Med Model, V1, P9, DOI 10.1186/1742-4682-1-9; Willars GB, 1999, J BIOL CHEM, V274, P30146, DOI 10.1074/jbc.274.42.30146; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140	37	35	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20262	20272		10.1074/jbc.M110.132662	http://dx.doi.org/10.1074/jbc.M110.132662			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20406815	hybrid, Green Published			2022-12-25	WOS:000279012000061
J	Zhao, CH; Coughlin, JM; Ju, JH; Zhu, DQ; Wendt-Pienkowski, E; Zhou, XF; Wang, ZJ; Shen, B; Deng, ZX				Zhao, Chunhua; Coughlin, Jane M.; Ju, Jianhua; Zhu, Dongqing; Wendt-Pienkowski, Evelyn; Zhou, Xiufen; Wang, Zhijun; Shen, Ben; Deng, Zixin			Oxazolomycin Biosynthesis in Streptomyces albus JA3453 Featuring an "Acyltransferase-less" Type I Polyketide Synthase That Incorporates Two Distinct Extender Units	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; NONRIBOSOMAL PEPTIDE SYNTHETASE; SITE-DIRECTED MUTAGENESIS; GENE-CLUSTER; CRYSTAL-STRUCTURE; BETA-KETOACYL; SORANGIUM-CELLULOSUM; BOND FORMATION; STARTER UNIT; SORAPHEN-A	The oxazolomycins (OZMs) are a growing family of antibiotics produced by several Streptomyces species that show diverse and important antibacterial, antitumor, and anti-human immunodeficiency virus activity. Oxazolomycin A is a peptide-polyketide hybrid compound containing a unique spiro-linked beta-lactone/gamma-lactam, a 5-substituted oxazole ring. The oxazolomycin biosynthetic gene cluster (ozm) was identified from Streptomyces albus JA3453 and localized to 79.5-kb DNA, consisting of 20 open reading frames that encode non-ribosomal peptide synthases, polyketide synthases (PKSs), hybrid non-ribosomal peptide synthase-PKS, trans-acyltransferases (trans-ATs), enzymes for methoxymalonyl-acyl carrier protein (ACP) synthesis, putative resistance genes, and hypothetical regulation genes. In contrast to classical type I polyketide or fatty acid biosynthases, all 10 PKS modules in the gene cluster lack cognate ATs. Instead, discrete ATs OzmM (with tandem domains OzmM-AT1 and OzmM-AT2) and OzmC were equipped to carry out all of the loading functions of both malonyl-CoA and methoxymalonyl-ACP extender units. Strikingly, only OzmM-AT2 is required for OzmM activity for OZM biosynthesis, whereas OzmM-AT1 seemed to be a cryptic AT domain. The above findings, together with previous results using isotope-labeled precursor feeding assays, are assembled for the OZM biosynthesis model to be proposed. The incorporation of both malonyl-CoA (by OzmM-AT2) and methoxymalonyl-ACP (by OzmC) extender units seemed to be unprecedented for this class of trans-AT type I PKSs, which might be fruitfully manipulated to create structurally diverse novel compounds.	[Coughlin, Jane M.; Shen, Ben] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; [Ju, Jianhua; Wendt-Pienkowski, Evelyn; Shen, Ben] Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Natl Cooperat Drug Discovery Grp, Madison, WI 53705 USA; [Zhao, Chunhua; Zhu, Dongqing; Zhou, Xiufen; Wang, Zhijun; Deng, Zixin] Shanghai Jiao Tong Univ, Lab Microbial Metab, Shanghai 200030, Peoples R China; [Zhao, Chunhua; Zhu, Dongqing; Zhou, Xiufen; Wang, Zhijun; Deng, Zixin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, B (corresponding author), Univ Wisconsin, Dept Chem, Madison, WI 53705 USA.	bshen@pharmacy.wisc.edu; zxdeng@sjtu.edu.cn			National Institutes of Health [CA113297]; Ministry of Science and Technology of China 973 and 863 [2003CB114205]; National Science Foundation of China; Chinese Ministry of Education; Shanghai Municipal Council of Science and Technology; NATIONAL CANCER INSTITUTE [U19CA113297, R01CA106150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China 973 and 863; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Shanghai Municipal Council of Science and Technology(Shanghai Leading Academic Discipline Project); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA113297 (to B.S.). This work was also supported by the Ministry of Science and Technology of China 973 (2003CB114205) and 863 programs, the National Science Foundation of China, the Chinese Ministry of Education, and the Shanghai Municipal Council of Science and Technology (to Z.D.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bagwell CL, 2008, BIOORG MED CHEM LETT, V18, P4081, DOI 10.1016/j.bmcl.2008.05.105; Bao WL, 1999, BIOCHEMISTRY-US, V38, P9752, DOI 10.1021/bi990751h; Calderone CT, 2007, CHEM BIOL, V14, P835, DOI 10.1016/j.chembiol.2007.06.008; Carroll BJ, 2002, J AM CHEM SOC, V124, P4176, DOI 10.1021/ja0124764; Chan YA, 2006, P NATL ACAD SCI USA, V103, P14349, DOI 10.1073/pnas.0603748103; Cheng YQ, 2009, METHOD ENZYMOL, V459, P165, DOI 10.1016/S0076-6879(09)04608-4; Cheng YQ, 2003, P NATL ACAD SCI USA, V100, P3149, DOI 10.1073/pnas.0537286100; Dorrestein PC, 2006, J AM CHEM SOC, V128, P10386, DOI 10.1021/ja0639362; El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Floriano B, 1996, MOL MICROBIOL, V21, P385, DOI 10.1046/j.1365-2958.1996.6491364.x; GRAFE U, 1992, LIEBIGS ANN CHEM, P429; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; He M, 2000, J BACTERIOL, V182, P2619, DOI 10.1128/JB.182.9.2619-2623.2000; Ishikawa J, 1999, FEMS MICROBIOL LETT, V174, P251, DOI 10.1111/j.1574-6968.1999.tb13576.x; Jakobi K, 2004, J AM CHEM SOC, V126, P2298, DOI 10.1021/ja0390698; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Klauck E, 1997, MOL MICROBIOL, V25, P559, DOI 10.1046/j.1365-2958.1997.4911852.x; Kumar P, 2003, J AM CHEM SOC, V125, P14307, DOI 10.1021/ja037429l; Li TL, 2004, CHEM BIOL, V11, P107, DOI 10.1016/j.chembiol.2004.01.001; Li WL, 2006, J BACTERIOL, V188, P4148, DOI 10.1128/JB.00172-06; Li WL, 2008, J BIOL CHEM, V283, P28607, DOI 10.1074/jbc.M804279200; Ligon J, 2002, GENE, V285, P257, DOI 10.1016/S0378-1119(02)00396-7; Lim SK, 2009, J BIOL CHEM, V284, P29746, DOI 10.1074/jbc.M109.046805; Lin SJ, 2009, P NATL ACAD SCI USA, V106, P4183, DOI 10.1073/pnas.0808880106; Liu W, 2002, SCIENCE, V297, P1170, DOI 10.1126/science.1072110; Nguyen T, 2008, NAT BIOTECHNOL, V26, P225, DOI 10.1038/nbt1379; O'Keeffe T, 1999, APPL ENVIRON MICROB, V65, P1506; Olsen JG, 1999, FEBS LETT, V460, P46, DOI 10.1016/S0014-5793(99)01303-4; Perlova O, 2006, J BIOTECHNOL, V121, P174, DOI 10.1016/j.jbiotec.2005.10.011; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Rajgarhia VB, 2001, METAB ENG, V3, P49, DOI 10.1006/mben.2000.0173; Rascher A, 2003, FEMS MICROBIOL LETT, V218, P223, DOI 10.1016/S0378-1097(02)01148-5; Reeves CD, 2001, BIOCHEMISTRY-US, V40, P15464, DOI 10.1021/bi015864r; Rouhiainen L, 2000, MOL MICROBIOL, V37, P156, DOI 10.1046/j.1365-2958.2000.01982.x; Savage H, 1997, STRUCTURE, V5, P895, DOI 10.1016/S0969-2126(97)00244-X; Schoenafinger G, 2006, J AM CHEM SOC, V128, P7406, DOI 10.1021/ja0611240; Song DF, 2008, ACTA BIOCH BIOPH SIN, V40, P319, DOI 10.1111/j.1745-7270.2008.00408.x; Stachelhaus T, 1998, J BIOL CHEM, V273, P22773, DOI 10.1074/jbc.273.35.22773; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Tang GL, 2004, CHEM BIOL, V11, P33, DOI 10.1016/j.chembiol.2003.12.014; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Vrljic M, 1996, MOL MICROBIOL, V22, P815, DOI 10.1046/j.1365-2958.1996.01527.x; Weber T, 2008, CHEM BIOL, V15, P175, DOI 10.1016/j.chembiol.2007.12.009; Wenzel SC, 2006, J AM CHEM SOC, V128, P14325, DOI 10.1021/ja064408t; Wu K, 2000, GENE, V251, P81, DOI 10.1016/S0378-1119(00)00171-2; Yu TW, 2002, P NATL ACAD SCI USA, V99, P7968, DOI 10.1073/pnas.092697199; Zaleta-Rivera K, 2006, BIOCHEMISTRY-US, V45, P2561, DOI 10.1021/bi052085s; Zhao CH, 2006, J BACTERIOL, V188, P4142, DOI 10.1128/JB.00173-06	52	60	62	2	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20097	20108		10.1074/jbc.M109.090092	http://dx.doi.org/10.1074/jbc.M109.090092			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20406823	hybrid, Green Published			2022-12-25	WOS:000279012000044
J	Deshpande, AS; Fang, PA; Simmer, JP; Margolis, HC; Beniash, E				Deshpande, Atul S.; Fang, Ping-An; Simmer, James P.; Margolis, Henry C.; Beniash, Elia			Amelogenin-Collagen Interactions Regulate Calcium Phosphate Mineralization in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTIN-ENAMEL JUNCTION; DENTINOENAMEL JUNCTION; HUMAN TEETH; MECHANICAL-PROPERTIES; PORCINE AMELOGENIN; HYDROXYAPATITE CRYSTALS; IMPERFECTA PHENOTYPE; SECONDARY STRUCTURE; BONE SIALOPROTEIN; PROTEIN	Collagen and amelogenin are two major extracellular organic matrix proteins of dentin and enamel, the mineralized tissues comprising a tooth crown. They both are present at the dentin-enamel boundary (DEB), a remarkably robust interface holding dentin and enamel together. It is believed that interactions of dentin and enamel protein assemblies regulate growth and structural organization of mineral crystals at the DEB, leading to a continuum at the molecular level between dentin and enamel organic and mineral phases. To gain insight into the mechanisms of the DEB formation and structural basis of its mechanical resiliency we have studied the interactions between collagen fibrils, amelogenin assemblies, and forming mineral in vitro, using electron microscopy. Our data indicate that collagen fibrils guide assembly of amelogenin into elongated chain or filament-like structures oriented along the long axes of the fibrils. We also show that the interactions between collagen fibrils and amelogenin-calcium phosphate mineral complexes lead to oriented deposition of elongated amorphous mineral particles along the fibril axes, triggering mineralization of the bulk of collagen fibril. The resulting structure was similar to the mineralized collagen fibrils found at the DEB, with arrays of smaller well organized crystals inside the collagen fibrils and bundles of larger crystals on the outside of the fibrils. These data suggest that interactions between collagen and amelogenin might play an important role in the formation of the DEB providing structural continuity between dentin and enamel.	[Beniash, Elia] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial Regenerat, Pittsburgh, PA 15261 USA; [Simmer, James P.] Univ Michigan, Dept Biol & Mat Sci, Sch Dent, Ann Arbor, MI 48109 USA; [Margolis, Henry C.] Forsyth Inst, Dept Biomineralizat, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; Harvard University; Forsyth Institute	Beniash, E (corresponding author), Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial Regenerat, 589 Salk Hall,3501 Terrace St, Pittsburgh, PA 15261 USA.	ebeniash@pitt.edu	Deshpande, Atul S./G-4568-2015; Deshpande, Atul S./AAQ-8330-2020; Fang, PINGAN/A-2461-2009; Deshpande, Atul/B-2993-2008	Deshpande, Atul S./0000-0003-0874-9502; Simmer, James/0000-0002-7192-6105	National Institutes of Health NIDCR [DE016703]; UPSOM Department of Structural Biology [SAP 4100031302]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R56DE016703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016703] Funding Source: NIH RePORTER	National Institutes of Health NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); UPSOM Department of Structural Biology; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health NIDCR Grant DE016703 (to E.B.).; We thank Dr. Peijun Zhang for her help in the analysis of the tomographic data. Electron microscopy studies were conducted at the Center for Biological Imaging, the Department of Structural Biology at the University of Pittsburgh and the Department of Materials Science and Engineering, Carnegie Mellon University, Pittsburgh. Support for electron tomography studies was provided by Dr. James Conway of the UPSOM Department of Structural Biology, including Commonwealth of Pennsylvania Grant SAP 4100031302, with assistance from Drs. Peijun Zhang and Alexander Makhov.	ARSENAULT AL, 1989, CALCIFIED TISSUE INT, V45, P111, DOI 10.1007/BF02561410; Begue-Kirn C, 1998, EUR J ORAL SCI, V106, P963, DOI 10.1046/j.0909-8836.1998.eos106510.x; Beniash E, 2005, J STRUCT BIOL, V149, P182, DOI 10.1016/j.jsb.2004.11.001; Beniash E, 2000, J STRUCT BIOL, V132, P212, DOI 10.1006/jsbi.2000.4320; Beniash E, 2006, EUR J ORAL SCI, V114, P24, DOI 10.1111/j.1600-0722.2006.00293.x; Beniash E, 2009, J STRUCT BIOL, V166, P133, DOI 10.1016/j.jsb.2009.02.001; Bleicher F, 1999, MATRIX BIOL, V18, P133, DOI 10.1016/S0945-053X(99)00007-4; Bodier-Houlle P, 2000, CELL TISSUE RES, V301, P389, DOI 10.1007/s004410000241; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; Brodsky B, 1995, FASEB J, V9, P1537, DOI 10.1096/fasebj.9.15.8529832; Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5; CHAPMAN JA, 1974, CONNECT TISSUE RES, V2, P137, DOI 10.3109/03008207409152099; Dahl T, 1998, J STRUCT BIOL, V123, P162, DOI 10.1006/jsbi.1998.4025; Delak K, 2009, BIOCHEMISTRY-US, V48, P2272, DOI 10.1021/bi802175a; Deshpande AS, 2008, CRYST GROWTH DES, V8, P3084, DOI 10.1021/cg800252f; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; Dong XD, 2003, J BIOMED MATER RES A, V66A, P103, DOI 10.1002/jbm.a.10541; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; GOTO Y, 1993, J BIOCHEM-TOKYO, V113, P55, DOI 10.1093/oxfordjournals.jbchem.a124003; Hart PS, 2002, ARCH ORAL BIOL, V47, P261, DOI 10.1016/S0003-9969(02)00003-1; HAYASHI Y, 1992, J ELECTRON MICROSC, V41, P387; He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200; Hoang AM, 2002, J DENT RES, V81, P497, DOI 10.1177/154405910208100713; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; Hunter GK, 2001, J BIOMED MATER RES, V55, P496, DOI 10.1002/1097-4636(20010615)55:4<496::AID-JBM1042>3.0.CO;2-2; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Imbeni V, 2005, NAT MATER, V4, P229, DOI 10.1038/nmat1323; Kadler KE, 1996, BIOCHEM J, V316, P1; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Kim JW, 2004, HUM GENET, V115, P248, DOI 10.1007/s00439-004-1143-5; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kwak SY, 2009, J BIOL CHEM, V284, P18972, DOI 10.1074/jbc.M109.020370; Lakshminarayanan R, 2007, BIOPHYS J, V93, P3664, DOI 10.1529/biophysj.107.113936; Lakshminarayanan R, 2009, PROTEINS, V76, P560, DOI 10.1002/prot.22369; Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192; LESTER KS, 1967, CALCIFIED TISSUE INT, V1, P273; LIN CP, 1994, J DENT RES, V73, P1072, DOI 10.1177/00220345940730050901; Margolis HC, 2006, J DENT RES, V85, P775, DOI 10.1177/154405910608500902; Marshall GW, 2001, J BIOMED MATER RES, V54, P87, DOI 10.1002/1097-4636(200101)54:1<87::AID-JBM10>3.0.CO;2-Z; Matsushima N, 1998, J BIOCHEM, V123, P150; MCCROSKERY PA, 1973, SCIENCE, V182, P70, DOI 10.1126/science.182.4107.70; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; Moradian-Oldak J, 2000, J STRUCT BIOL, V131, P27, DOI 10.1006/jsbi.2000.4237; Moradian-Oldak J, 1998, BIOPOLYMERS, V46, P225, DOI 10.1002/(SICI)1097-0282(19981005)46:4<225::AID-BIP4>3.0.CO;2-R; Moradian-Oldak J, 2006, EUR J ORAL SCI, V114, P289, DOI 10.1111/j.1600-0722.2006.00285.x; Nanci A, 1998, J HISTOCHEM CYTOCHEM, V46, P911, DOI 10.1177/002215549804600806; Nanci A, 2007, 10 CATES ORAL HISTOL; Papagerakis P, 2003, BONE, V32, P228, DOI 10.1016/S8756-3282(02)00978-X; Papagerakis P, 2008, J DENT RES, V87, P56, DOI 10.1177/154405910808700109; Saito T, 1997, BONE, V21, P305, DOI 10.1016/S8756-3282(97)00149-X; Silverman L, 2004, CALCIFIED TISSUE INT, V75, P494, DOI 10.1007/s00223-004-0019-y; SIMMER JP, 1994, CALCIFIED TISSUE INT, V54, P312, DOI 10.1007/BF00295956; TUCKWELL DS, 1994, J CELL SCI, V107, P993; Veis A, 2005, SCIENCE, V307, P1419, DOI 10.1126/science.1109440; VEIS A, 1960, NATURE, V186, P720, DOI 10.1038/186720a0; Wang RZ, 1998, J BIOMECH, V31, P135, DOI 10.1016/S0021-9290(97)00131-0; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; WEINER S, 1992, FASEB J, V6, P879, DOI 10.1096/fasebj.6.3.1740237; Wiedemann-Bidlack FB, 2007, J STRUCT BIOL, V160, P57, DOI 10.1016/j.jsb.2007.06.007; Xu HHK, 1998, J DENT RES, V77, P472, DOI 10.1177/00220345980770030601; Zaman MH, 2007, BIOPHYS J, V92, pL17, DOI 10.1529/biophysj.106.097519; Zaslansky P, 2006, J STRUCT BIOL, V153, P188, DOI 10.1016/j.jsb.2005.10.010	65	41	45	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19277	19287		10.1074/jbc.M109.079939	http://dx.doi.org/10.1074/jbc.M109.079939			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404336	Green Published, hybrid			2022-12-25	WOS:000278727800037
J	He, DY; Neasta, J; Ron, D				He, Dao-Yao; Neasta, Jeremie; Ron, Dorit			Epigenetic Regulation of BDNF Expression via the Scaffolding Protein RACK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIC FACTOR EXPRESSION; RECEPTOR-INTERACTING PROTEIN; ANTI-ADDICTION DRUG; DNA METHYLATION; WD REPEAT; TRANSCRIPTION; MECP2; PHOSPHORYLATION; PROMOTERS; RIBOSOME	Scaffolding proteins are major contributors to the spatial and temporal orchestration of signaling cascades and hence cellular functions. RACK1 is a scaffolding protein that plays an important role in the regulation of, and cross-talk between, various signaling pathways. Here we report that RACK1 is a mediator of chromatin remodeling, resulting in an exon-specific expression of the brain-derived neurotrophic factor (BDNF) gene. Specifically, we found that following the activation of the cAMP pathway, nuclear RACK1 localizes at the promoter IV region of the BDNF gene by its association with histones H3 and H4, leading to the dissociation of the transcription repressor methyl-CpG-binding protein 2 (MeCP2) from the promoter, resulting in the acetylation of histone H4. These chromatin modifications lead to the activation of the promoter and to the subsequent promoter-controlled transcription of BDNF exon IV. Our findings expand our knowledge regarding the function of scaffolding proteins such as RACK1. Furthermore, this novel mechanism for the regulation of exon-specific expression of the BDNF gene by RACK1 could have implications on the neuronal functions of the growth factor including synaptic plasticity, learning, and memory.	Univ Calif, Ernest Gallo Res Ctr, Oakland, CA 94608 USA; [Ron, Dorit] Univ Calif, Dept Neurol, Oakland, CA 94608 USA	University of California System; University of California Berkeley; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California Berkeley	Ron, D (corresponding author), 5858 Horton St,Ste 200, Emeryville, CA 94608 USA.	dron@gallo.ucsf.edu		Neasta, Jeremie/0000-0002-7801-4176	National Institutes of Health through the National Institute on Alcohol Abuse and Alcoholism [R01 AA016848]; Department of the Army through the United States Army Medical Research Acquisition Activity [W81XWH-05-1-0212]; U.S. Army Medical Research Acquisition Activity; State of California for Medical Research on Alcohol and Substance Abuse through the University of California, San Francisco; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016848] Funding Source: NIH RePORTER	National Institutes of Health through the National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Department of the Army through the United States Army Medical Research Acquisition Activity; U.S. Army Medical Research Acquisition Activity; State of California for Medical Research on Alcohol and Substance Abuse through the University of California, San Francisco(University of California System); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AA016848 (to D. R.) through the National Institute on Alcohol Abuse and Alcoholism. This work was also supported by the Department of the Army, Grant W81XWH-05-1-0212 through the United States Army Medical Research Acquisition Activity (to D. R.), for which the U.S. Army Medical Research Acquisition Activity is the awarding and administering acquisition office, and a grant from the State of California for Medical Research on Alcohol and Substance Abuse through the University of California, San Francisco (to D.R).	Ai E, 2009, MOL BIOL CELL, V20, P1629, DOI 10.1091/mbc.E08-09-0917; Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chern YJ, 2000, CELL SIGNAL, V12, P195, DOI 10.1016/S0898-6568(99)00084-4; *CLONT LAB, 2003, AD X EXPR SYST 1 US; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Dell EJ, 2002, J BIOL CHEM, V277, P49888, DOI 10.1074/jbc.M202755200; Dwivedi Yogesh, 2008, Neuropsychiatr Dis Treat, V4, P161; GHITZA UE, 2009, NEUROSCI BIOBEH 1113, DOI DOI 10.1016/J.NEUBIOREV.2009.1011.1009; He DY, 2006, FASEB J, V20, P2420, DOI 10.1096/fj.06-6394fje; He DY, 2005, J NEUROSCI, V25, P619, DOI 10.1523/JNEUROSCI.3959-04.2005; He DY, 2002, MOL PHARMACOL, V62, P272, DOI 10.1124/mol.62.2.272; Hennig L, 2005, TRENDS CELL BIOL, V15, P295, DOI 10.1016/j.tcb.2005.04.004; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jeanblanc J, 2009, J NEUROSCI, V29, P13494, DOI 10.1523/JNEUROSCI.2243-09.2009; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kiely PA, 2002, J BIOL CHEM, V277, P22581, DOI 10.1074/jbc.M201758200; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; Kuczewski N, 2009, MOL NEUROBIOL, V39, P37, DOI 10.1007/s12035-009-8050-7; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Liu QR, 2005, AM J MED GENET B, V134B, P93, DOI 10.1002/ajmg.b.30109; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; McGough NNH, 2004, J NEUROSCI, V24, P10542, DOI 10.1523/JNEUROSCI.3714-04.2004; METSIS M, 1993, P NATL ACAD SCI USA, V90, P8802, DOI 10.1073/pnas.90.19.8802; Moonat S, 2010, CELL MOL LIFE SCI, V67, P73, DOI 10.1007/s00018-009-0135-y; Mourton T, 2001, J BIOL CHEM, V276, P14896, DOI 10.1074/jbc.M010823200; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ou LC, 2007, MOL PHARMACOL, V72, P350, DOI 10.1124/mol.107.034934; Patterson RL, 2004, P NATL ACAD SCI USA, V101, P2328, DOI 10.1073/pnas.0308567100; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Ptasznik A, 2004, NAT MED, V10, P1187, DOI 10.1038/nm1127; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Thornton C, 2004, J BIOL CHEM, V279, P31357, DOI 10.1074/jbc.M402316200; Tian F, 2009, J NEUROCHEM, V109, P1375, DOI 10.1111/j.1471-4159.2009.06058.x; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Wong J, 2009, EUR J NEUROSCI, V29, P1311, DOI 10.1111/j.1460-9568.2009.06669.x; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yaka R, 2003, J BIOL CHEM, V278, P9630, DOI 10.1074/jbc.M209141200; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909	64	47	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19043	19050		10.1074/jbc.M110.100693	http://dx.doi.org/10.1074/jbc.M110.100693			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410295	hybrid, Green Published			2022-12-25	WOS:000278727800013
J	Jani, TS; DeVecchio, J; Mazumdar, T; Agyeman, A; Houghton, JA				Jani, Tanvi S.; DeVecchio, Jennifer; Mazumdar, Tapati; Agyeman, Akwasi; Houghton, Janet A.			Inhibition of NF-kappa B Signaling by Quinacrine Is Cytotoxic to Human Colon Carcinoma Cell Lines and Is Synergistic in Combination with Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) or Oxaliplatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADVANCED SOLID TUMORS; METASTATIC COLORECTAL-CANCER; FADD-DEPENDENT APOPTOSIS; MULTIPLE-MYELOMA CELLS; PHASE-I; MEDIATED APOPTOSIS; CONSTITUTIVE ACTIVATION; TRANSCRIPTION FACTOR; ANTITUMOR-ACTIVITY; BREAST-CANCER	Colorectal cancer is the third most common malignancy in the United States. Modest advances with therapeutic approaches that include oxaliplatin (L-OHP) have brought the median survival rate to 22 months, with drug resistance remaining a significant barrier. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is undergoing clinical evaluation. Although human colon carcinomas express TRAIL receptors, they can also demonstrate TRAIL resistance. Constitutive NF-kappa B activation has been implicated in resistance to TRAIL and to cytotoxic agents. We have demonstrated constitutive NF-kappa B activation in five of six human colon carcinoma cell lines; this activation is inhibited by quinacrine. Quinacrine induced apoptosis in colon carcinomas and potentiated the cytotoxic activity of TRAIL in RKO and HT29 cells and that of L-OHP in HT29 cells. Similarly, overexpression of I kappa B alpha mutant (I kappa B alpha M) or treatment with the IKK inhibitor, BMS-345541, also sensitized these cells to TRAIL and l-OHP. Importantly, 2 h of quinacrine pretreatment resulted in decreased expression of c-FLIP and Mcl-1, which were determined to be transcriptional targets of NF-kappa B. Extended exposure for 24 h to quinacrine did not further sensitize these cells to TRAIL- or L-OHP-induced cell death; however, exposure caused the down-regulation of additional NF-kappa B-dependent survival factors. Short hairpin RNA-mediated knockdown of c-FLIP or Mcl-1 significantly sensitized these cells to TRAIL andL-OHP. Taken together, data demonstrate that NF-kappa B is constitutively active in colon cancer cell lines and NF-kappa B, and its downstream targets may constitute an important target for the development of therapeutic approaches against this disease	[Jani, Tanvi S.; DeVecchio, Jennifer; Mazumdar, Tapati; Agyeman, Akwasi; Houghton, Janet A.] Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Houghton, JA (corresponding author), Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, 9500 Euclid Ave,NB40, Cleveland, OH 44195 USA.	houghtj@ccf.org						Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; *AM CANC SOC, 2008, CANC FACTS FIG 2008, P1; *AM CANC SOC, 2009, CANC FACTS FIG 2009, P3; Ammann JU, 2009, INT J CANCER, V124, P1301, DOI 10.1002/ijc.24068; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Assef Y, 2009, LEUKEMIA RES, V33, P710, DOI 10.1016/j.leukres.2008.09.024; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Ballestrero A, 2004, CLIN CANCER RES, V10, P1463, DOI 10.1158/1078-0432.CCR-1365-02; Banerjee S, 2009, CANCER RES, V69, P5575, DOI 10.1158/0008-5472.CAN-08-4235; BEG AA, 1996, SCIENCE, V274, P784; Braeuer SJ, 2006, MOL CANCER RES, V4, P715, DOI 10.1158/1541-7786.MCR-05-0231; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Cohen SJ, 2008, AM J CLIN ONCOL-CANC, V31, P1, DOI 10.1097/COC.0b013e31805c142f; Culy CR, 2000, DRUGS, V60, P895, DOI 10.2165/00003495-200060040-00005; Cusack JC, 2006, CLIN CANCER RES, V12, P6758, DOI 10.1158/1078-0432.CCR-06-1151; Cusack JC, 2001, CANCER RES, V61, P3535; Cusack JC, 1999, DRUG RESIST UPDATE, V2, P271, DOI 10.1054/drup.1999.0094; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; Diaz-Rubio E, 1998, ANN ONCOL, V9, P105, DOI 10.1023/A:1008200825886; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Ganten TM, 2006, CLIN CANCER RES, V12, P2640, DOI 10.1158/1078-0432.CCR-05-2635; Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482; Gliniak B, 1999, CANCER RES, V59, P6153; Goldberg R, 2000, ONCOLOGY-NY, V14, P42; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Hall MA, 2007, CANCER CELL, V12, P4, DOI 10.1016/j.ccr.2007.06.011; Haller DG, 2000, ONCOLOGY-NY, V14, P15; Harwood FG, 2000, J BIOL CHEM, V275, P10023, DOI 10.1074/jbc.275.14.10023; HAVELL EA, 1988, J EXP MED, V167, P1067, DOI 10.1084/jem.167.3.1067; Hernandez A, 2001, J GASTROINTEST SURG, V5, P56, DOI 10.1016/S1091-255X(01)80014-7; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Hind D, 2008, Health Technol Assess, V12, piii; Houghton JA, 1997, P NATL ACAD SCI USA, V94, P8144, DOI 10.1073/pnas.94.15.8144; Houghton JA, 1997, CLIN CANCER RES, V3, P2205; Huang S, 2000, CLIN CANCER RES, V6, P2573; Jin H, 2004, CANCER RES, V64, P4900, DOI 10.1158/0008-5472.CAN-04-0408; Keane MM, 2000, BREAST CANCER RES TR, V64, P211, DOI 10.1023/A:1006458407515; Kim YS, 2002, HEPATOLOGY, V36, P1498, DOI 10.1053/jhep.2002.36942; Koschny R, 2010, J NEURO-ONCOL, V97, P171, DOI 10.1007/s11060-009-0010-6; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Lagunas Vilma Maldonado, 2008, Metal-Based Drugs, P576104, DOI 10.1155/2008/576104; Lee CH, 2007, BIOFACTORS, V29, P19, DOI 10.1002/biof.5520290103; Li XX, 2002, EXP HEMATOL, V30, P285, DOI 10.1016/S0301-472X(02)00777-4; Lind DS, 2001, SURGERY, V130, P363, DOI 10.1067/msy.2001.116672; Louvet Christophe, 2003, Curr Treat Options Oncol, V4, P405, DOI 10.1007/s11864-003-0041-8; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; McConkey DJ, 2009, BLOOD, V114, P931, DOI 10.1182/blood-2009-06-223230; Menoret E, 2006, BLOOD, V108, P1346, DOI 10.1182/blood-2005-12-007971; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Mitsiades CS, 2001, BLOOD, V98, P795, DOI 10.1182/blood.V98.3.795; Mitsiades N, 2001, EXPERT OPIN INV DRUG, V10, P1521, DOI 10.1517/13543784.10.8.1521; Morales JC, 2007, MOL IMMUNOL, V44, P2587, DOI 10.1016/j.molimm.2006.12.015; Mori N, 1999, BLOOD, V93, P2360; Mufti AR, 2006, MOL CELL, V21, P775, DOI 10.1016/j.molcel.2006.01.033; Nagy K, 2006, PATHOL ONCOL RES, V12, P133, DOI 10.1007/BF02893359; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; NORTH RJ, 1988, J EXP MED, V167, P1086, DOI 10.1084/jem.167.3.1086; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Petak I, 2003, CELL DEATH DIFFER, V10, P729, DOI 10.1038/sj.cdd.4401232; Petak I, 2000, CLIN CANCER RES, V6, P4432; Petak I, 2000, CANCER RES, V60, P2643; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Pukac L, 2005, BRIT J CANCER, V92, P1430, DOI 10.1038/sj.bjc.6602487; Ragnhammar P, 2001, ACTA ONCOL, V40, P282, DOI 10.1080/02841860151116367; Rakitina TV, 2003, CANCER RES, V63, P8600; Ren YG, 2004, MOL BIOL CELL, V15, P5064, DOI 10.1091/mbc.e04-03-0184; Rieger J, 1998, FEBS LETT, V427, P124, DOI 10.1016/S0014-5793(98)00409-8; Roue G, 2007, J IMMUNOL, V178, P1923, DOI 10.4049/jimmunol.178.3.1923; Rowinsky EK, 2005, J CLIN ONCOL, V23, P9394, DOI 10.1200/JCO.2005.02.2889; Russo SM, 2001, INT J RADIAT ONCOL, V50, P183, DOI 10.1016/S0360-3016(01)01446-8; Ryan DP, 2006, CANCER-AM CANCER SOC, V107, P2482, DOI 10.1002/cncr.22264; Ryan DR, 2006, CANCER, V107, P2688, DOI 10.1002/cncr.22280; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; SCHWARTZBERG L, 2008, 99 ANN M AM ASS CANC; Schwartzberg LS, 2002, CLIN CANCER RES, V8, P2488; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Simpson D, 2003, DRUGS, V63, P2127, DOI 10.2165/00003495-200363190-00013; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Strater J, 2002, CLIN CANCER RES, V8, P3734; Tai DI, 2000, CANCER, V89, P2274, DOI 10.1002/1097-0142(20001201)89:11<2274::AID-CNCR16>3.0.CO;2-2; Tillman DM, 1998, CELL DEATH DIFFER, V5, P450, DOI 10.1038/sj.cdd.4400369; Tillman DM, 1999, CLIN CANCER RES, V5, P425; Tolcher AW, 2007, J CLIN ONCOL, V25, P1390, DOI 10.1200/JCO.2006.08.8898; Toscano F, 2008, ONCOGENE, V27, P4161, DOI 10.1038/onc.2008.52; VAN AD, 1996, SCIENCE, V274, P787; van Geelen CMM, 2003, BRIT J CANCER, V89, P363, DOI 10.1038/sj.bjc.6601065; Wakelee HA, 2010, ANN ONCOL, V21, P376, DOI 10.1093/annonc/mdp292; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang WX, 1999, CLIN CANCER RES, V5, P119; Watanabe M, 2005, INT J CANCER, V114, P32, DOI 10.1002/ijc.20688; Weaver KD, 2003, J NEURO-ONCOL, V61, P187, DOI 10.1023/A:1022554824129; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wilson C, 2008, J PHARMACOL EXP THER, V327, P746, DOI 10.1124/jpet.108.143826; Wilson TR, 2009, ONCOGENE, V28, P63, DOI 10.1038/onc.2008.366; Wilson TR, 2007, CANCER RES, V67, P5754, DOI 10.1158/0008-5472.CAN-06-3585; Xu L, 2009, FEBS LETT, V583, P943, DOI 10.1016/j.febslet.2009.02.014; Xu Y, 2002, ANN ONCOL, V13, P1841, DOI 10.1093/annonc/mdf337; Yeh PY, 2002, BIOCHEM PHARMACOL, V63, P1423, DOI 10.1016/S0006-2952(02)00908-5; Yoshimura FK, 2008, P NATL ACAD SCI USA, V105, P5543, DOI 10.1073/pnas.0710526105; Zisman A, 2001, J IMMUNOTHER, V24, P459, DOI 10.1097/00002371-200111000-00003	108	80	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19162	19172		10.1074/jbc.M109.091645	http://dx.doi.org/10.1074/jbc.M109.091645			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20424169	Green Published, hybrid			2022-12-25	WOS:000278727800026
J	Kannan-Thulasiraman, P; Seachrist, DD; Mahabeleshwar, GH; Jain, MK; Noy, N				Kannan-Thulasiraman, Padmamalini; Seachrist, Darcie D.; Mahabeleshwar, Ganapati H.; Jain, Mukesh K.; Noy, Noa			Fatty Acid-binding Protein 5 and PPAR beta/delta Are Critical Mediators of Epidermal Growth Factor Receptor-induced Carcinoma Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST-CANCER; NF-KAPPA-B; RETINOIC ACID; TRANSGENIC MICE; MAMMARY-CARCINOMA; TYROSINE PHOSPHORYLATION; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; TUMOR-SUPPRESSOR; PROSTATE-CANCER	Epidermal growth factors and their receptors (EGFRs) promote breast cancer cell proliferation and can drive tumorigenesis. However, the molecular mechanisms that mediate these effects are incompletely understood. We previously showed that mammary tumor development in the mouse model of breast cancer MMTV-neu, a model characterized by amplification of the EGFR ErbB2 in mammary tissue, correlates with a marked up-regulation of fatty acid-binding protein 5 (FABP5). FABP5 functions to deliver ligands to and enhance the transcriptional activity of the nuclear receptor peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta), a receptor whose target genes include genes involved in cell growth and survival. We show here that in MCF-7 mammary carcinoma cells, EGFR signaling directly up-regulates the expression of FABP5. The data demonstrate that treatment of these cells with the EGFR ligand heregulin-beta 1 signals through the ERK and the phophatidylinositol-3-kinase cascades, resulting in activation of the transcription factor NF-kappa B. In turn, NF-kappa B induces the expression of FABP5 through two cognate response elements in the promoter of this gene. The observations further demonstrate that FABP5 and PPAR beta/delta are critical mediators of the ability of EGFR to enhance cell proliferation, indicating that this transcriptional pathway plays a key role in EGFR-induced tumorigenesis. Additional observations indicate that the expression of FABP5 is down-regulated by the Kruppel-like factor KLF2, suggesting a tumor suppressor activity for this factor.	[Kannan-Thulasiraman, Padmamalini; Seachrist, Darcie D.; Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Mahabeleshwar, Ganapati H.; Jain, Mukesh K.] Case Western Reserve Univ, Sch Med, Case Cardiovasc Res Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Noy, N (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, W333 10900 Euclid Ave, Cleveland, OH 44106 USA.	noa.noy@case.edu			National Institutes of Health [DK060684, CA068150]; NATIONAL CANCER INSTITUTE [R01CA068150] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK060684 and CA068150 (to N. N.).	Adamson J, 2003, ONCOGENE, V22, P2739, DOI 10.1038/sj.onc.1206341; ALIMANDI M, 1995, ONCOGENE, V10, P1813; Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Biswas DK, 2006, J CELL PHYSIOL, V209, P645, DOI 10.1002/jcp.20785; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Chen F, 2007, CANCER RES, V67, P11093, DOI 10.1158/0008-5472.CAN-07-1576; DI FP, 1987, CELL, V51, P1063; Di-Poi N, 2003, J STEROID BIOCHEM, V85, P257, DOI 10.1016/S0960-0760(03)00215-2; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Frigo DE, 2009, MOL ENDOCRINOL, V23, P1385, DOI 10.1210/me.2009-0010; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; HUNG MC, 1995, GENE, V159, P65, DOI 10.1016/0378-1119(94)00459-6; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jing C, 2000, CANCER RES, V60, P2390; Jing C, 2001, CANCER RES, V61, P4357; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; KOKAI Y, 1989, CELL, V58, P287, DOI 10.1016/0092-8674(89)90843-X; Kumar A, 2005, MOL CELL BIOL, V25, P5893, DOI 10.1128/MCB.25.14.5893-5903.2005; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; Lewis GD, 1996, CANCER RES, V56, P1457; Li BL, 1997, MOL CELL BIOL, V17, P3155, DOI 10.1128/MCB.17.6.3155; Lorusso V, 2008, BIOL-TARGETS THER, V2, P813; Lupu R, 1996, BREAST CANCER RES TR, V38, P57, DOI 10.1007/BF01803784; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Manor D, 2003, CANCER RES, V63, P4426; Mariani G, 2009, NAT CLIN PRACT ONCOL, V6, P93, DOI 10.1038/ncponc1298; Mazumdar A, 2001, CANCER RES, V61, P400; Menard S, 2000, J CELL PHYSIOL, V182, P150, DOI 10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E; Morgan EA, 2008, INT J ONCOL, V32, P767; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Reese DM, 1997, STEM CELLS, V15, P1, DOI 10.1002/stem.150001; ROBBINS DJ, 1993, J AM SOC NEPHROL, V4, P1104; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Shultz DB, 2007, J INTERF CYTOK RES, V27, P875, DOI 10.1089/jir.2007.0031; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Simmen RCM, 2010, J ENDOCRINOL, V204, P223, DOI 10.1677/JOE-09-0329; Singh S, 2007, MOL CANCER THER, V6, P1973, DOI 10.1158/1535-7163.MCT-07-0063; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sledge GW, 2003, EUR J CANCER, V39, P1668, DOI 10.1016/S0959-8049(03)00273-9; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Tan NS, 2007, MOL CELL BIOL, V27, P7161, DOI 10.1128/MCB.00436-07; Tan NS, 2004, EXPERT OPIN THER TAR, V8, P39, DOI 10.1517/eott.8.1.39.26404; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Tsai PW, 2003, J BIOL CHEM, V278, P5750, DOI 10.1074/jbc.M204863200; VANDEVIJVER MJ, 1988, NEW ENGL J MED, V319, P1239, DOI 10.1056/NEJM198811103191902; VEERKAMP JH, 1995, PROG LIPID RES, V34, P17, DOI 10.1016/0163-7827(94)00005-7; Wang DZ, 2006, P NATL ACAD SCI USA, V103, P19069, DOI 10.1073/pnas.0607948103; Wang F, 2005, ONCOGENE, V24, P3875, DOI 10.1038/sj.onc.1208546; Wu JH, 2004, ONCOGENE, V23, P8088, DOI 10.1038/sj.onc.1207996; Yao J, 2001, ONCOGENE, V20, P8066, DOI 10.1038/sj.onc.1204944	73	71	73	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19106	19115		10.1074/jbc.M109.099770	http://dx.doi.org/10.1074/jbc.M109.099770			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20424164	Green Published, hybrid			2022-12-25	WOS:000278727800020
J	Koh, WWL; Steffensen, S; Gonzalez-Pajuelo, M; Hoorelbeke, B; Gorlani, A; Szynol, A; Forsman, A; Aasa-Chapman, MMI; de Haard, H; Verrips, T; Weiss, RA				Koh, Willie W. L.; Steffensen, Soren; Gonzalez-Pajuelo, Maria; Hoorelbeke, Bart; Gorlani, Andrea; Szynol, Agnieszka; Forsman, Anna; Aasa-Chapman, Marlen M. I.; de Haard, Hans; Verrips, Theo; Weiss, Robin A.			Generation of a Family-specific Phage Library of Llama Single Chain Antibody Fragments That Neutralize HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODY; FUSION INHIBITOR T-20; SUBTYPE-B; PASSIVE-IMMUNIZATION; TYPE-1 INFECTION; DOMAIN ANTIBODY; HIGH-AFFINITY; ENV CLONES; RECEPTOR	Recently, we described llama antibody fragments (VHH) that can neutralize human immunodeficiency virus, type 1 (HIV-1). These VHH were obtained after selective elution of phages carrying an immune library raised against gp120 of HIV-1 subtype B/C CN54 with soluble CD4. We describe here a new, family-specific approach to obtain the largest possible diversity of related VHH that compete with soluble CD4 for binding to the HIV-1 envelope glycoprotein. The creation of this family-specific library of homologous VHH has enabled us to isolate phages carrying similar nucleotide sequences as the parental VHH. These VHH displayed varying binding affinities and neutralization phenotypes to a panel of different strains and subtypes of HIV-1. Sequence analysis of the homologs showed that the C-terminal three amino acids of the CDR3 loop were crucial in determining the specificity of these VHH for different subtype C HIV-1 strains. There was a positive correlation between affinity of VHH binding to gp120 of HIV-1 IIIB and the breadth of neutralization of diverse HIV-1 envelopes. The family-specific approach has therefore allowed us to better understand the interaction of the CD4-binding site antibodies with virus strain specificity and has potential use for the bioengineering of antibodies and HIV-1 vaccine development.	[Gorlani, Andrea; Szynol, Agnieszka; de Haard, Hans; Verrips, Theo] Univ Utrecht, Dept Mol & Cellular Biol Cellular Architecture &, NL-3584 CH Utrecht, Netherlands; [Forsman, Anna; Aasa-Chapman, Marlen M. I.; Weiss, Robin A.] UCL, Div Infect & Immun, Ctr Med Mol Virol, MRC, London W1T 4JF, England; [Steffensen, Soren; Gonzalez-Pajuelo, Maria; Hoorelbeke, Bart] Ablynx NV, B-9052 Ghent, Belgium	Utrecht University; University of London; University College London	Verrips, T (corresponding author), Univ Utrecht, Dept Mol & Cellular Biol Cellular Architecture &, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	c.t.verrips@bio.uu.nl; r.weiss@ucl.ac.uk	gorlani, andrea/C-5678-2014		University College London Graduate School; Overseas Research Student Award Scheme; European Union; Bill and Melinda Gates Foundation [38637]; United Kingdom Medical Research Council; MRC [G0801176] Funding Source: UKRI; Medical Research Council [G0801176] Funding Source: researchfish	University College London Graduate School; Overseas Research Student Award Scheme; European Union(European Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the University College London Graduate School, Overseas Research Student Award Scheme, European Microbicides Project (European Union Framework 6), Collaboration for AIDS Vaccine Discovery Grant 38637 of the Bill and Melinda Gates Foundation, and the United Kingdom Medical Research Council.	Aasa-Chapman MMI, 2004, AIDS, V18, P371, DOI 10.1097/00002030-200402200-00002; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; BARBAS CF, 1993, J MOL BIOL, V230, P812, DOI 10.1006/jmbi.1993.1203; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Brodie SJ, 1999, NAT MED, V5, P34, DOI 10.1038/4716; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 1997, AIDS, V11, pS87; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; De Haard HJW, 2005, J BACTERIOL, V187, P4531, DOI 10.1128/JB.187.13.4531-4541.2005; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Desmyter A, 2001, J BIOL CHEM, V276, P26285, DOI 10.1074/jbc.M102107200; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Ferrantelli F, 2004, J INFECT DIS, V189, P2167, DOI 10.1086/420833; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Forsman A, 2008, J VIROL, V82, P12069, DOI 10.1128/JVI.01379-08; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gao F, 1998, J VIROL, V72, P5680, DOI 10.1128/JVI.72.7.5680-5698.1998; GAO F, 1994, AIDS RES HUM RETROV, V10, P1359, DOI 10.1089/aid.1994.10.1359; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, VET MICROBIOL, V120, P193, DOI 10.1016/j.vetmic.2006.10.029; Hinz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010482; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; McKeating JA, 1996, VIROLOGY, V220, P450, DOI 10.1006/viro.1996.0332; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Muyldermans S, 2001, J Biotechnol, V74, P277; Nuttall S. D., 2000, Current Pharmaceutical Biotechnology, V1, P253, DOI 10.2174/1389201003378906; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; PUTKONEN P, 1991, NATURE, V352, P436, DOI 10.1038/352436a0; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; Vu KB, 1997, MOL IMMUNOL, V34, P1121, DOI 10.1016/S0161-5890(97)00146-6; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Willey S, 2008, TRENDS MICROBIOL, V16, P596, DOI 10.1016/j.tim.2008.08.008; Yamamoto H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000540; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	57	34	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19116	19124		10.1074/jbc.M110.116699	http://dx.doi.org/10.1074/jbc.M110.116699			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20400507	Green Published, hybrid			2022-12-25	WOS:000278727800021
J	Motiani, RK; Abdullaev, IF; Trebak, M				Motiani, Rajender K.; Abdullaev, Iskandar F.; Trebak, Mohamed			A Novel Native Store-operated Calcium Channel Encoded by Orai3 SELECTIVE REQUIREMENT OF Orai3 VERSUS Orai1 IN ESTROGEN RECEPTOR-POSITIVE VERSUS ESTROGEN RECEPTOR-NEGATIVE BREAST CANCER CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER INCIDENCE; CURRENT I-CRAC; 2-AMINOETHOXYDIPHENYL BORATE; TRPC3 CHANNELS; 2-AMINOETHYLDIPHENYL BORATE; ESTROGEN-RECEPTOR; PORE SUBUNIT; MICE LACKING; CA2+ INFLUX; ENTRY	Store-operated calcium (Ca2+) entry (SOCE) mediated by STIM/Orai proteins is a ubiquitous pathway that controls many important cell functions including proliferation and migration. STIM proteins are Ca2+ sensors in the endoplasmic reticulum and Orai proteins are channels expressed at the plasma membrane. The fall in endoplasmic reticulum Ca2+ causes translocation of STIM1 to subplasmalemmal puncta where they activate Orai1 channels that mediate the highly Ca2+-selective Ca2+ release-activated Ca2+ current (I-CRAC). Whereas Orai1 has been clearly shown to encode SOCE channels in many cell types, the role of Orai2 and Orai3 in native SOCE pathways remains elusive. Here we analyzed SOCE in ten breast cell lines picked in an unbiased way. We used a combination of Ca2+ imaging, pharmacology, patch clamp electrophysiology, and molecular knockdown to show that native SOCE and I-CRAC in estrogen receptor-positive (ER+) breast cancer cell lines are mediated by STIM1/2 and Orai3 while estrogen receptor-negative (ER-) breast cancer cells use the canonical STIM1/Orai1 pathway. The ER+ breast cancer cells represent the first example where the native SOCE pathway and I-CRAC are mediated by Orai3. Future studies implicating Orai3 in ER+ breast cancer progression might establish Orai3 as a selective target in therapy of ER+ breast tumors.	[Motiani, Rajender K.; Abdullaev, Iskandar F.; Trebak, Mohamed] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	Albany Medical College	Trebak, M (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, 47 New Scotland Ave,MC8, Albany, NY 12208 USA.	trebakm@mail.amc.edu	Abdullaev, Iskandar/AAH-2478-2021; Trebak, Mohamed/E-7405-2014		National Institutes of Health [5K22 ES014729]; American Recovery and Reinvestment Act (ARRA) [3K22ES014729-03S1, 3K22ES014729-03S2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES014729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act (ARRA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by an early career National Institutes of Health Grant 5K22 ES014729 and funds allocated through the American Recovery and Reinvestment Act (ARRA) supplements 3K22ES014729-03S1 and 3K22ES014729-03S2 (to M. T.).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Bai ZL, 2009, ARCH PHARM, V342, P133, DOI 10.1002/ardp.200800174; Bakowski D, 2002, CELL CALCIUM, V32, P379, DOI 10.1016/S0143416002001914; Bakowski D, 2002, PFLUG ARCH EUR J PHY, V443, P892, DOI 10.1007/s00424-001-0775-8; BISAILLON JM, AM J PHYSL CELL PHYS, V298, P993; Braun A, 2009, BLOOD, V113, P2056, DOI 10.1182/blood-2008-07-171611; Braun FJ, 2003, MOL PHARMACOL, V63, P1304, DOI 10.1124/mol.63.6.1304; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Colton C. K., 2007, V179, P173; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Glass AG, 2007, JNCI-J NATL CANCER I, V99, P1152, DOI 10.1093/jnci/djm059; Gross SA, 2007, J BIOL CHEM, V282, P19375, DOI 10.1074/jbc.M701962200; Gu QH, 2005, AM J PHYSIOL-LUNG C, V288, pL932, DOI 10.1152/ajplung.00439.2004; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hurvitz SA, 2009, FUTURE ONCOL, V5, P1015, DOI 10.2217/FON.09.68; Jemal A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1672; Jones BF, 2008, HEPATOLOGY, V48, P1273, DOI 10.1002/hep.22461; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Ohana L, 2009, CHANNELS, V3, P129, DOI 10.4161/chan.3.2.8609; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Potier M, 2008, PFLUG ARCH EUR J PHY, V457, P405, DOI 10.1007/s00424-008-0533-2; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; RITCHIE MF, J BIOL CHEM, V285, P10591; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Schonherr R, 2005, J MEMBRANE BIOL, V205, P175, DOI 10.1007/s00232-005-0782-3; Trebak M, 2005, MOL PHARMACOL, V67, P558, DOI 10.1124/mol.104.007252; Trebak M, 2003, J BIOL CHEM, V278, P16244, DOI 10.1074/jbc.M300544200; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Trebak M, 2009, PFLUG ARCH EUR J PHY, V457, P757, DOI 10.1007/s00424-008-0550-1; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yu F, 2009, P NATL ACAD SCI USA, V106, P17401, DOI 10.1073/pnas.0904651106; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	49	232	238	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19173	19183		10.1074/jbc.M110.102582	http://dx.doi.org/10.1074/jbc.M110.102582			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20395295	Green Published, hybrid			2022-12-25	WOS:000278727800027
J	Yin, G; Chen, R; Alvero, AB; Fu, HH; Holmberg, J; Glackin, C; Rutherford, T; Mor, G				Yin, G.; Chen, R.; Alvero, A. B.; Fu, H-H; Holmberg, J.; Glackin, C.; Rutherford, T.; Mor, G.			TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214	ONCOGENE			English	Article						ovarian CSCs; Twist1; miR-199a/214 cluster; IKK beta	KAPPA-B ACTIVITY; SURFACE EPITHELIUM; IN-VIVO; DIFFERENTIATION; MICRORNAS; ONCOGENESIS; ACTIVATION; EXPRESSION; RESISTANCE; SURVIVAL	Cancer stem cells are responsible for sustaining the tumor and giving rise to proliferating and progressively differentiating cells. However, the molecular mechanisms regulating the process of cancer stem cell (CSC) differentiation is not clearly understood. Recently, we reported the isolation of the epithelial ovarian cancer (EOC) stem cells (type I/CD44+). In this study, we show that type I/CD44+ cells are characterized by low levels of both miR-199a and miR-214, whereas mature EOC cells (type II/CD44-) have higher levels of miR-199a and miR-214. Moreover, these two micro RNAs (miRNAs) are regulated as a cluster on pri-miR-199a2 within the human Dnm3os gene (GenBank FJ623959). This study identify Twist1 as a regulator of this unique miRNA cluster responsible for the regulation of the IKK beta/NF-kappa beta and PTEN/AKT pathways and its association of ovarian CSC differentiation. Our data suggest that Twist1 may be an important regulator of 'stemness' in EOC cells. The regulation of MIR199A2/214 expression may be used as a potential therapeutic approach in EOC patients. Oncogene (2010) 29, 3545-3553; doi:10.1038/onc.2010.111; published online 19 April 2010	[Mor, G.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Reprod Immunol Unit, New Haven, CT 06520 USA; [Glackin, C.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA USA	Yale University; City of Hope; Beckman Research Institute of City of Hope	Mor, G (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Reprod Immunol Unit, 333 Cedar St,LSOG 305A, New Haven, CT 06520 USA.	gil.mor@yale.edu	Yin, Gang/H-3289-2011	Holmberg, Jennie/0000-0002-1106-4718; Alvero, Ayesha/0000-0002-6593-3595	NCI/NIH [RO1CA127913, RO1CA118678]; Janet Burros Memorial Foundation; Sands Family Foundation; Discovery To Cure Research Program; NATIONAL CANCER INSTITUTE [R01CA118678, R01CA127913] Funding Source: NIH RePORTER	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Janet Burros Memorial Foundation; Sands Family Foundation; Discovery To Cure Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by grants from NCI/NIH RO1CA127913, RO1CA118678, the Janet Burros Memorial Foundation, the Sands Family Foundation and the Discovery To Cure Research Program.	Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Alison MR, 2008, CELL TISSUE RES, V331, P109, DOI 10.1007/s00441-007-0510-7; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Alvero AB, 2009, STEM CELLS, V27, P2405, DOI 10.1002/stem.191; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Chen R, 2007, AM J REPROD IMMUNOL, V57, P93, DOI 10.1111/j.1600-0897.2006.00441.x; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Cheng GZ, 2008, CURR CANCER DRUG TAR, V8, P2; Cheng GZ, 2008, CANCER RES, V68, P957, DOI 10.1158/0008-5472.CAN-07-5067; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clarke-Pearson DL, 2009, NEW ENGL J MED, V361, P170, DOI 10.1056/NEJMcp0901926; Entz-Werle N, 2005, INT J CANCER, V117, P349, DOI 10.1002/ijc.21068; Espey DK, 2007, CANCER-AM CANCER SOC, V110, P2119, DOI 10.1002/cncr.23044; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kamsteeg M, 2003, ONCOGENE, V22, P2611, DOI 10.1038/sj.onc.1206422; Koga K, 2009, AM J REPROD IMMUNOL, V61, P196, DOI 10.1111/j.1600-0897.2008.00682.x; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Lee MS, 1999, J CELL BIOCHEM, V75, P566, DOI 10.1002/(SICI)1097-4644(19991215)75:4<566::AID-JCB3>3.0.CO;2-0; Lee MS, 2000, BONE, V27, P591, DOI 10.1016/S8756-3282(00)00380-X; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Loebel DAF, 2002, GENESIS, V33, P103, DOI 10.1002/gene.10091; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; ODWYER PJ, 1994, CANCER RES, V54, P724; Ota MS, 2004, DEV DYNAM, V230, P216, DOI 10.1002/dvdy.20047; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Papagiannakopoulos T, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-15; Salamanca CM, 2004, J SOC GYNECOL INVEST, V11, P241, DOI 10.1016/j.jsgi.2003.10.010; Schwartz Peter E, 2002, Cancer Treat Res, V107, P99; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; WOOLAS RP, 1993, JNCI-J NATL CANCER I, V85, P1748, DOI 10.1093/jnci/85.21.1748; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	42	170	186	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 17	2010	29	24					3545	3553		10.1038/onc.2010.111	http://dx.doi.org/10.1038/onc.2010.111			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	611QN	20400975	Green Accepted			2022-12-25	WOS:000278835400009
J	Kraus, A; Groenendyk, J; Bedard, K; Baldwin, TA; Krause, KH; Dubois-Dauphin, M; Dyck, J; Rosenbaum, EE; Korngut, L; Colley, NJ; Gosgnach, S; Zochodne, D; Todd, K; Agellon, LB; Michalak, M				Kraus, Allison; Groenendyk, Jody; Bedard, Karen; Baldwin, Troy A.; Krause, Karl-Heinz; Dubois-Dauphin, Michel; Dyck, Jason; Rosenbaum, Erica E.; Korngut, Lawrence; Colley, Nansi J.; Gosgnach, Simon; Zochodne, Douglas; Todd, Kathryn; Agellon, Luis B.; Michalak, Marek			Calnexin Deficiency Leads to Dysmyelination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; CALRETICULIN; CHAPERONE; ASSOCIATION; BINDING; OPSIN; DEATH; MICE; ER	Calnexin is a molecular chaperone and a component of the quality control of the secretory pathway. We have generated calnexin gene-deficient mice (cnx(-/)) and showed that calnexin deficiency leads to myelinopathy. Calnexin-deficient mice were viable with no discernible effects on other systems, including immune function, and instead they demonstrated dysmyelination as documented by reduced conductive velocity of nerve fibers and electron microscopy analysis of sciatic nerve and spinal cord. Myelin of the peripheral and central nervous systems of cnx(-/-) mice was disorganized and decompacted. There were no abnormalities in neuronal growth, no loss of neuronal fibers, and no change in fictive locomotor pattern in the absence of calnexin. This work reveals a previously unrecognized and important function of calnexin in myelination and provides new insights into the mechanisms responsible for myelin diseases.	[Kraus, Allison; Groenendyk, Jody; Bedard, Karen; Michalak, Marek] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Dyck, Jason; Gosgnach, Simon] Univ Alberta, Dept Physiol, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada; [Baldwin, Troy A.] Univ Alberta, Dept Med Microbiol & Immunol, Sch Clin & Lab Sci, Edmonton, AB T6G 2H7, Canada; [Todd, Kathryn] Univ Alberta, Dept Psychiat, Ctr Neurosci, Edmonton, AB T6G 2H7, Canada; [Krause, Karl-Heinz; Dubois-Dauphin, Michel] Univ Geneva, Dept Pathol, CH-1211 Geneva 4, Switzerland; [Krause, Karl-Heinz; Dubois-Dauphin, Michel] Univ Geneva, Dept Immunol, CH-1211 Geneva 4, Switzerland; [Krause, Karl-Heinz; Dubois-Dauphin, Michel] Univ Geneva, Dept Clin Pathol, CH-1211 Geneva 4, Switzerland; [Rosenbaum, Erica E.; Colley, Nansi J.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Dept Genet & Neurosci, Madison, WI 53792 USA; [Rosenbaum, Erica E.; Colley, Nansi J.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53792 USA; [Korngut, Lawrence; Zochodne, Douglas] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Agellon, Luis B.] McGill Univ, Sch Dietet & Human Nutr, Ste Anne De Bellevue, PQ H9X 3V9, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Geneva; University of Geneva; University of Geneva; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Calgary; McGill University	Michalak, M (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	marek.michalak@ualberta.ca	Krause, Karl-Heinz/E-8030-2011	Krause, Karl-Heinz/0000-0002-9033-6768; Bedard, Karen/0000-0001-5864-5344	National Institutes of Health [EYEY008768, F31AG032176]; Canadian Institutes of Health Research [MOP-15291, MOP-8659, MOP-86470]; Swiss National Science Foundation; Retina Research Foundation; Alberta Innovates-Health Solutions; March of Dimes; Davey Fund for Brain Research; Multiple Sclerosis Society of Canada; Heart and Stroke Foundation of Canada; Membrane Protein Cardiovascular Disease Training Program; NATIONAL EYE INSTITUTE [R01EY008768, R03EY014378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG032176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Retina Research Foundation; Alberta Innovates-Health Solutions; March of Dimes(March of Dimes); Davey Fund for Brain Research; Multiple Sclerosis Society of Canada; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Membrane Protein Cardiovascular Disease Training Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants EYEY008768 (to N.J.C.) and F31AG032176 (to E. E. R.). This work was also supported by Grants MOP-15291 (to M. M.), MOP-8659 (to T. A. B.), and MOP-86470 (to S. G.) and other grants (to D.Z. and K. T.) from the Canadian Institutes of Health Research and grants from the Swiss National Science Foundation (to K.-H. K.), the Retina Research Foundation (to N.J.C.), Alberta Innovates-Health Solutions (to S. G.), the March of Dimes (to S. G.), and the Davey Fund for Brain Research (to K. T.).; Supported by a fellowship from the Multiple Sclerosis Society of Canada and by Alberta Innovates-Health Solutions.; Supported by the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada Membrane Protein and the Cardiovascular Disease Training Program.	Bennett MK, 1998, J BIOL CHEM, V273, P23674, DOI 10.1074/jbc.273.37.23674; Berger P, 2006, GLIA, V54, P243, DOI 10.1002/glia.20386; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; Fajardo M, 2004, MICROBIOL-SGM, V150, P2825, DOI 10.1099/mic.0.27111-0; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Jantzie LL, 2005, J CEREBR BLOOD F MET, V25, P314, DOI 10.1038/sj.jcbfm.9600025; Kosmaoglou M, 2008, MOL VIS, V14, P2466; Lee W, 2006, PROTEOMICS, V6, P1329, DOI 10.1002/pmic.200500320; Lozyk MD, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-54; MacInnis BL, 2002, SCIENCE, V295, P1536, DOI 10.1126/science.1064913; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Muller-Taubenberger A, 2001, EMBO J, V20, P6772, DOI 10.1093/emboj/20.23.6772; Nakamura K, 2001, J CLIN INVEST, V107, P1245, DOI 10.1172/JCI12412; PARLATI F, 1995, EMBO J, V14, P3064, DOI 10.1002/j.1460-2075.1995.tb07309.x; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Quarles RH, 2007, J NEUROCHEM, V100, P1431, DOI 10.1111/j.1471-4159.2006.04319.x; Rosenbaum EE, 2006, NEURON, V49, P229, DOI 10.1016/j.neuron.2005.12.011; Toth C, 2008, NEUROSCIENCE, V154, P767, DOI 10.1016/j.neuroscience.2008.03.052; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; WIEST DL, 1995, EMBO J, V14, P3425, DOI 10.1002/j.1460-2075.1995.tb07348.x; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	30	51	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18928	18938		10.1074/jbc.M110.107201	http://dx.doi.org/10.1074/jbc.M110.107201			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400506	Green Published, hybrid			2022-12-25	WOS:000278453900083
J	Khan, M; De Sevilla, L; Mahesh, VB; Brann, DW				Khan, Mohammad; De Sevilla, Liesl; Mahesh, Virendra B.; Brann, Darrell W.			Enhanced Glutamatergic and Decreased Gabaergic Synaptic Appositions to GnRH Neurons on Proestrus in the Rat: Modulatory Effect of Aging	PLOS ONE			English	Article							HORMONE-RELEASING HORMONE; MIDDLE-AGED RATS; MEDIAL PREOPTIC AREA; FEMALE RATS; GENE-EXPRESSION; LHRH NEURONS; FOS PROTEIN; SECRETION; SURGE; GABA	Background: Previous work by our lab and others has implicated glutamate as a major excitatory signal to gonadotropin hormone releasing hormone (GnRH) neurons, with gamma amino butyric acid (GABA) serving as a potential major inhibitory signal. However, it is unknown whether GABAergic and/or glutamatergic synaptic appositions to GnRH neurons changes on the day of the proestrous LH surge or is affected by aging. Methodology/Principal Findings: To examine this question, synaptic terminal appositions on GnRH neurons for VGAT (vesicular GABA transporter) and VGLUT2 (vesicular glutamate transporter-2), markers of GABAergic and glutamatergic synaptic terminals, respectively, was examined by immunohistochemistry and confocal microscopic analysis in young and middle-aged diestrous and proestrous rats. The results show that in young proestrous rats at the time of LH surge, we observed reciprocal changes in the VGAT and VGLUT2 positive terminals apposing GnRH neurons, where VGAT terminal appositions were decreased and VGLUT2 terminal appositions were significantly increased, as compared to young diestrus control animals. Interestingly, in middle-aged cycling animals this divergent modulation of VGAT and VGLUT2 terminal apposition was greatly impaired, as no significant differences were observed between VGAT and VGLUT2 terminals apposing GnRH neurons at proestrous. However, the density of VGAT and VGLUT2 terminals apposing GnRH neurons were both significantly increased in the middle-aged animals. Conclusions/Significance: In conclusion, there is an increase in glutamatergic and decrease in GABAergic synaptic terminal appositions on GnRH neurons on proestrus in young animals, which may serve to facilitate activation of GnRH neurons. In contrast, middle-aged diestrous and proestrous animals show a significant increase in both VGAT and VGLUT synaptic terminal appositions on GnRH neurons as compared to young animals, and the cycle-related change in these appositions between diestrus and proestrus that is observed in young animals is lost.	[Khan, Mohammad; De Sevilla, Liesl; Mahesh, Virendra B.; Brann, Darrell W.] Med Coll Georgia, Dev Neurobiol Program, Inst Mol Med & Genet, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Khan, M (corresponding author), Med Coll Georgia, Dev Neurobiol Program, Inst Mol Med & Genet, Augusta, GA 30912 USA.	dbrann@mcg.edu		Khan, Mohammad Badruzzaman/0000-0001-8231-1256	National Institutes of Aging (NIA), National Institutes of Health [17186, 29864]; National Institute of Child Health and Human Development (NICHD), National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028964] Funding Source: NIH RePORTER	National Institutes of Aging (NIA), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Child Health and Human Development (NICHD), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by Research Grants (#17186 and 29864) from the National Institutes of Aging (NIA), and National Institute of Child Health and Human Development (NICHD), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjan V, 2008, J NEUROENDOCRINOL, V20, P1147, DOI 10.1111/j.1365-2826.2008.01775.x; Beltran-Parrazal L, 2001, ENDOCRINE, V14, P189, DOI 10.1385/ENDO:14:2:189; Bilger M, 2001, ENDOCRINOLOGY, V142, P2102, DOI 10.1210/en.142.5.2102; BRANN DW, 1993, MOL CELL NEUROSCI, V4, P292, DOI 10.1006/mcne.1993.1037; Brann DW, 2005, STEROIDS, V70, P273, DOI 10.1016/j.steroids.2004.12.008; Brann DW, 1997, ENDOCR REV, V18, P678, DOI 10.1210/er.18.5.678; Cashion AB, 2004, J NEUROENDOCRINOL, V16, P711, DOI 10.1111/j.1365-2826.2004.01225.x; Cashion AB, 2003, ENDOCRINOLOGY, V144, P274, DOI 10.1210/en.2002-220711; COOPER RL, 1980, BIOL REPROD, V23, P611, DOI 10.1095/biolreprod23.3.611; DeFazio RA, 2002, MOL ENDOCRINOL, V16, P2872, DOI 10.1210/me.2002-0163; DELAESCALERA GM, 1994, NEUROENDOCRINOLOGY, V59, P420, DOI 10.1159/000126687; Funabashi T, 1997, NEUROREPORT, V8, P771, DOI 10.1097/00001756-199702100-00038; HALES TG, 1994, NEUROENDOCRINOLOGY, V59, P297, DOI 10.1159/000126671; Han SK, 2004, ENDOCRINOLOGY, V145, P495, DOI 10.1210/en.2003-1333; HERBISON AE, 1991, NEUROENDOCRINOLOGY, V53, P317, DOI 10.1159/000125735; Khan MM, 2005, ENDOCRINOLOGY, V146, P5215, DOI 10.1210/en.2005-0276; Le WW, 2001, ENDOCRINOLOGY, V142, P4976, DOI 10.1210/en.142.11.4976; LLOYD JM, 1994, ENDOCRINOLOGY, V134, P1800, DOI 10.1210/en.134.4.1800; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Neal-Perry GS, 2008, BIOL REPROD, V79, P878, DOI 10.1095/biolreprod.108.069831; Neal-Perry GS, 2005, ENDOCRINOLOGY, V146, P4331, DOI 10.1210/en.2005-0575; Ottem EN, 2004, J NEUROSCI, V24, P8097, DOI 10.1523/JNEUROSCI.2267-04.2004; Petersen SL, 2003, BIOL REPROD, V69, P1771, DOI 10.1095/biolreprod.103.019745; Ramos SD, 2001, J APPL PHYSIOL, V91, P667, DOI 10.1152/jappl.2001.91.2.667; RUBIN BS, 1994, BIOL REPROD, V51, P1264, DOI 10.1095/biolreprod51.6.1264; RUBIN BS, 1995, ENDOCRINOLOGY, V136, P3823, DOI 10.1210/en.136.9.3823; Rubin BS, 2000, BIOL REPROD, V63, P968, DOI 10.1095/biolreprod63.4.968; RUBIN BS, 1992, BIOL REPROD, V47, P254, DOI 10.1095/biolreprod47.2.254; RUBIN BS, 1989, NEUROENDOCRINOLOGY, V49, P225, DOI 10.1159/000125121; RUBIN BS, 1995, NEUROENDOCRINOLOGY, V62, P259, DOI 10.1159/000127012; RUBIN BS, 1993, BRAIN RES, V601, P246, DOI 10.1016/0006-8993(93)91717-7; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Tersawa E, 2001, VITAM HORM, V63, P91; URBANSKI HF, 1990, ENDOCRINOLOGY, V126, P1774, DOI 10.1210/endo-126-3-1774; Watanabe M, 2009, BIOL REPROD, V81, P327, DOI 10.1095/biolreprod.108.074583; WIEGAND SJ, 1980, NEUROENDOCRINOLOGY, V31, P147, DOI 10.1159/000123066; WISE PM, 1982, P SOC EXP BIOL MED, V169, P348, DOI 10.3181/00379727-169-41356; WITKIN JW, 1987, NEUROSCIENCE, V22, P1003, DOI 10.1016/0306-4522(87)92976-9; Zhang C, 2009, ENDOCRINOLOGY, V150, P2388, DOI 10.1210/en.2008-1313; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zuo Z, 1996, ENDOCRINOLOGY, V137, P2334, DOI 10.1210/en.137.6.2334	41	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10172	10.1371/journal.pone.0010172	http://dx.doi.org/10.1371/journal.pone.0010172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418960	Green Published, Green Submitted, gold			2022-12-25	WOS:000276706800014
J	Phillips, AJ; Arauco-Brown, R; Oceguera-Figueroa, A; Gomez, GP; Beltran, M; Lai, YT; Siddall, ME				Phillips, Anna J.; Arauco-Brown, Renzo; Oceguera-Figueroa, Alejandro; Gomez, Gloria P.; Beltran, Maria; Lai, Yi-Te; Siddall, Mark E.			Tyrannobdella rex N. Gen. N. Sp and the Evolutionary Origins of Mucosal Leech Infestations	PLOS ONE			English	Article							MEDICINAL LEECH; SEQUENCES; PRIMERS; MODEL	Background: Leeches have gained a fearsome reputation by feeding externally on blood, often from human hosts. Orificial hirudiniasis is a condition in which a leech enters a body orifice, most often the nasopharyngeal region, but there are many cases of leeches infesting the eyes, urethra, vagina, or rectum. Several leech species particularly in Africa and Asia are well-known for their propensity to afflict humans. Because there has not previously been any data suggesting a close relationship for such geographically disparate species, this unnerving tendency to be invasive has been regarded only as a loathsome oddity and not a unifying character for a group of related organisms. Principal Findings: A new genus and species of leech from Peru was found feeding from the nasopharynx of humans. Unlike any other leech previously described, this new taxon has but a single jaw with very large teeth. Phylogenetic analyses of nuclear and mitochondrial genes using parsimony and Bayesian inference demonstrate that the new species belongs among a larger, global clade of leeches, all of which feed from the mucosal surfaces of mammals. Conclusions: This new species, found feeding from the upper respiratory tract of humans in Peru, clarifies an expansion of the family Praobdellidae to include the new species Tyrannobdella rex n. gen. n.sp., along with others in the genera Dinobdella, Myxobdella, Praobdella and Pintobdella. Moreover, the results clarify a single evolutionary origin of a group of leeches that specializes on mucous membranes, thus, posing a distinct threat to human health.	[Phillips, Anna J.; Oceguera-Figueroa, Alejandro] CUNY, Grad Ctr, Dept Biol, New York, NY 10021 USA; [Phillips, Anna J.; Oceguera-Figueroa, Alejandro; Siddall, Mark E.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Arauco-Brown, Renzo] Univ Peruana Cayetano Heredia, Sch Med, Lima, Peru; [Gomez, Gloria P.] Univ Peruana Cayetano Heredia, Dept Microbiol, Lima, Peru; [Beltran, Maria] Peruvian Hlth Inst, Peruvian Publ Hlth Ctr, Enteroparasitol Lab, Lima, Peru; [Lai, Yi-Te] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan	City University of New York (CUNY) System; American Museum of Natural History (AMNH); Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Instituto Nacional de Salud - Peru; Academia Sinica - Taiwan; National Taiwan University	Phillips, AJ (corresponding author), CUNY, Grad Ctr, Dept Biol, New York, NY 10021 USA.	siddall@amnh.org	Phillips, Anna J/H-6141-2019; Gómez-Pérez, Gloria Patricia/AAS-8208-2021	Phillips, Anna J/0000-0003-4883-0022; Gómez-Pérez, Gloria Patricia/0000-0001-8555-8596; Gomez-Perez, Gloria Patricia/0000-0002-8927-7297	National Science Foundation [DEB-0640463]; Stavros Niarchos fund for Expeditionary Research; Theodore Roosevelt Memorial Grant; CUNY	National Science Foundation(National Science Foundation (NSF)); Stavros Niarchos fund for Expeditionary Research; Theodore Roosevelt Memorial Grant; CUNY	This work was financially supported by the National Science Foundation (DEB-0640463), the Stavros Niarchos fund for Expeditionary Research, a Theodore Roosevelt Memorial Grant, and a CUNY Science Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam Shadrul, 2008, J Pediatr Urol, V4, P70, DOI 10.1016/j.jpurol.2007.02.004; ALMALLAH Z, 1968, J PARASITOL, V54, P637, DOI 10.2307/3277105; Apakupakul K, 1999, MOL PHYLOGENET EVOL, V12, P350, DOI 10.1006/mpev.1999.0639; Beltran M, 1997, REV MED EXP INS, V14, P42; BLANCHARD R, 1896, ARCH NATURGESCH, V63, P49; Borda E, 2008, MOL PHYLOGENET EVOL, V46, P142, DOI 10.1016/j.ympev.2007.09.006; Caballero CE, 1957, ANA I BIOL U NAC AUT, V28, P241; CABELLERO CE, 1932, AN I BIOL U MEX, V3, P43; CUNDALL DB, 1986, T ROY SOC TROP MED H, V80, P940, DOI 10.1016/0035-9203(86)90265-8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Goloboff PA, 2003, CLADISTICS, V19, P324, DOI 10.1016/S0748-3007(03)00060-4; Hamid MSA, 1996, BRIT J UROL, V77, P164, DOI 10.1046/j.1464-410X.1996.87237.x; Harding WA, 1927, FAUNA BRIT INDIA HIR; KOSE A, 2008, AM J EMERG MED, V26, pE6; Laufer AS, 2008, APPL ENVIRON MICROB, V74, P6151, DOI 10.1128/AEM.00795-08; Lukin EI, 1976, FAUNA USSR, V1; Masterman E. W. G., 1908, Parasitology Cambridge, V1; Montazeri F, 2009, EUR J PEDIATR, V168, P39, DOI 10.1007/s00431-008-0706-1; MOORE JP, 1958, ANN NAT MUS, V14, P327; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Phillips AJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-246; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PREDINI L, 2005, CAN J ZOOL, V83, P498; Raza Syed Nusrat, 2006, J Coll Physicians Surg Pak, V16, P175; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAWYER R.T., 1986, LEECH BIOL BEHAV, VII; Siddall ME, 2007, APPL ENVIRON MICROB, V73, P655, DOI 10.1128/AEM.01282-06; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SINGH M, 1979, LANCET, V2, P1374; TURNER FM, 1969, LANCET, V2, P1400; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x	33	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10057	10.1371/journal.pone.0010057	http://dx.doi.org/10.1371/journal.pone.0010057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418947	Green Published, gold, Green Submitted			2022-12-25	WOS:000276706800005
J	Bain, MB; Cornwell, ER; Hope, KM; Eckerlin, GE; Casey, RN; Groocock, GH; Getchell, RG; Bowser, PR; Winton, JR; Batts, WN; Cangelosi, A; Casey, JW				Bain, Mark B.; Cornwell, Emily R.; Hope, Kristine M.; Eckerlin, Geofrey E.; Casey, Rufina N.; Groocock, Geoffrey H.; Getchell, Rodman G.; Bowser, Paul R.; Winton, James R.; Batts, William N.; Cangelosi, Allegra; Casey, James W.			Distribution of an Invasive Aquatic Pathogen (Viral Hemorrhagic Septicemia Virus) in the Great Lakes and Its Relationship to Shipping	PLOS ONE			English	Article							BALLAST-WATER; BIOLOGICAL INVASIONS; NORTH-SEA; CANADA; INTRODUCTIONS; ONTARIO; TROUT; OCEAN	Viral hemorrhagic septicemia virus (VHSV) is a rhabdovirus found in fish from oceans of the northern hemisphere and freshwaters of Europe. It has caused extensive losses of cultured and wild fish and has become established in the North American Great Lakes. Large die-offs of wild fish in the Great Lakes due to VHSV have alarmed the public and provoked government attention on the introduction and spread of aquatic animal pathogens in freshwaters. We investigated the relations between VHSV dispersion and shipping and boating activity in the Great Lakes by sampling fish and water at sites that were commercial shipping harbors, recreational boating centers, and open shorelines. Fish and water samples were individually analyzed for VHSV using quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and cell culture assays. Of 1,221 fish of 17 species, 55 were VHSV positive with highly varied qRT-PCR titers (1 to 5,950,000 N gene copies). The detections of VHSV in fish and water samples were closely associated and the virus was detected in 21 of 30 sites sampled. The occurrence of VHSV was not related to type of site or shipping related invasion hotspots. Our results indicate that VHSV is widely dispersed in the Great Lakes and is both an enzootic and epizootic pathogen. We demonstrate that pathogen distribution information could be developed quickly and is clearly needed for aquatic ecosystem conservation, management of affected populations, and informed regulation of the worldwide trade of aquatic organisms.	[Bain, Mark B.; Eckerlin, Geofrey E.] Cornell Univ, Dept Nat Resources, Ithaca, NY 14853 USA; [Cornwell, Emily R.; Hope, Kristine M.; Casey, Rufina N.; Groocock, Geoffrey H.; Getchell, Rodman G.; Bowser, Paul R.; Casey, James W.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Winton, James R.; Batts, William N.] US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA; [Cangelosi, Allegra] NE Midwest Inst, Washington, DC USA	Cornell University; Cornell University; United States Department of the Interior; United States Geological Survey	Bain, MB (corresponding author), Cornell Univ, Dept Nat Resources, Fernow Hall, Ithaca, NY 14853 USA.	Mark.Bain@Cornell.edu		Getchell, Rodman/0000-0003-4063-4668	Great Lakes Protection Fund through the The Northeast-Midwest Institute; U.S. Department of Agriculture [NYC-147446]	Great Lakes Protection Fund through the The Northeast-Midwest Institute; U.S. Department of Agriculture(United States Department of Agriculture (USDA))	Primary funding for this study was provided by The Great Lakes Protection Fund through the The Northeast-Midwest Institute. Additional funding came from the Great Lakes Research Consortium and the Cornell University Agricultural Experiment Station project No. NYC-147446 (U.S. Department of Agriculture). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM FISH SOC, 2007, SUGG PROC DET ID CER; BASURCO B, 1995, VET RES, V26, P460; BATTS WN, 1993, DIS AQUAT ORGAN, V17, P61; *CAN COOP WILDL HL, 2005, WILDL HLTH CTR NEWSL, V11, P10; CANGELOSI A, 2006, GREAT SHIPS GREAT LA; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Chico V, 2006, J VIROL METHODS, V132, P154, DOI 10.1016/j.jviromet.2005.10.005; *CORN U COOP EXT, 2009, VIR HEM SEPT VHS NEW; *CTR FOOD SEC PUBL, 2009, VHS VIR HEMM SEPT AM; Doblin MA, 2007, HARMFUL ALGAE, V6, P519, DOI 10.1016/j.hal.2006.05.007; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Drake LA, 2007, MAR POLLUT BULL, V55, P333, DOI 10.1016/j.marpolbul.2006.11.007; Drake Lisa A., 2001, Biological Invasions, V3, P193, DOI 10.1023/A:1014561102724; Einer-Jensen K, 2005, VET MICROBIOL, V106, P167, DOI 10.1016/j.vetmic.2004.12.008; Elsayed E, 2006, J FISH DIS, V29, P611, DOI 10.1111/j.1365-2761.2006.00755.x; FIJAN N, 1983, ANN INST PASTEUR VIR, V134, P207, DOI 10.1016/S0769-2617(83)80060-4; Gagne N, 2007, J FISH DIS, V30, P213, DOI 10.1111/j.1365-2761.2007.00802.x; Grigorovich IA, 2003, CAN J FISH AQUAT SCI, V60, P740, DOI 10.1139/F03-053; Groocockl GH, 2007, DIS AQUAT ORGAN, V76, P187, DOI 10.3354/dao076187; Holeck KT, 2004, BIOSCIENCE, V54, P919, DOI 10.1641/0006-3568(2004)054[0919:BTWBIT]2.0.CO;2; HOPE KM, 2010, J AQUAT ANI IN PRESS; Kent ML, 1998, J AQUAT ANIM HEALTH, V10, P211, DOI 10.1577/1548-8667(1998)010&lt;0211:SOSPIO&gt;2.0.CO;2; King JA, 2001, DIS AQUAT ORGAN, V47, P81, DOI 10.3354/dao047081; *LAK SUP BAS NAT P, 2008, EM PREV RESP PLAN VI; Lumsden JS, 2007, DIS AQUAT ORGAN, V76, P99, DOI 10.3354/dao076099; Ma Y, 2009, PROG NAT SCI-MATER, V19, P947, DOI 10.1016/j.pnsc.2008.09.007; Meyers Theodore R., 1995, Annual Review of Fish Diseases, V5, P3, DOI 10.1016/0959-8030(95)00002-X; MILLS EL, 1993, J GREAT LAKES RES, V19, P1, DOI 10.1016/S0380-1330(93)71197-1; MIURA L, 2009, INVASIVE SPECIES PRE; MURPHY E, 2007, GREAT LAKES FISH MON; National Research Council, 1996, STEMM TID CONTR INTR, DOI 10.17226/5294; O'Gorman R., 2007, GREAT LAKES PREY FIS, V1001, P48105; Ricciardi A, 2000, TRENDS ECOL EVOL, V15, P62, DOI 10.1016/S0169-5347(99)01745-0; Ricciardi A, 2001, CAN J FISH AQUAT SCI, V58, P2513, DOI 10.1139/cjfas-58-12-2513; Said T, 1998, J GEN VIROL, V79, P47, DOI 10.1099/0022-1317-79-1-47; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Stewart C.J, 2002, REVISED GEOMORPHIC S; Stewart C.J, 2001, OPEN COAST REACH DEL; Stone DM, 1997, J GEN VIROL, V78, P1319, DOI 10.1099/0022-1317-78-6-1319; Vanderploeg HA, 2002, CAN J FISH AQUAT SCI, V59, P1209, DOI 10.1139/F02-087; Whelan GE, 2009, VIRAL HEMORRHAGIC SE; WINTON JR, 1989, AM FISH SOC FISH HLT, V17, P2; Wolf K., 1988, FISH VIRUSES FISH VI, P217, DOI [10.7591/9781501746383, DOI 10.7591/9781501746383]	43	73	73	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10156	10.1371/journal.pone.0010156	http://dx.doi.org/10.1371/journal.pone.0010156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405014	Green Submitted, gold, Green Published			2022-12-25	WOS:000276706300012
J	Frachon, I; Etienne, Y; Jobic, Y; Le Gal, G; Humbert, M; Leroyer, C				Frachon, Irene; Etienne, Yves; Jobic, Yannick; Le Gal, Gregoire; Humbert, Marc; Leroyer, Christophe			Benfluorex and Unexplained Valvular Heart Disease: A Case-Control Study	PLOS ONE			English	Article							APPETITE-SUPPRESSANT DRUGS; CARDIAC-VALVE REGURGITATION; DOPAMINE AGONISTS; OBESE-PATIENTS; FENFLURAMINE; RISK; PREVALENCE	Background: Recent case reports suggest that benfluorex, a fenfluramine derivative used in the management of overweight diabetic patients and dyslipidemia, is associated with cardiac valve regurgitation. Methods: We conducted a case-control study. Eligible patients were those admitted in the cardiology or the cardiac surgery units of our hospital between January, 1(st) 2003 and June 30(th) 2009, with mitral insufficiency diagnostic codes (ICD-10 I340 and I051). Patients with either a primary cause ( degenerative, known rheumatic heart disease, infectious endocarditis, congenital, radiation-induced valvular disease, associated connective and/or vasculitis disease, trauma, tumor) or a secondary ( functional) cause were considered as having an "explained'' mitral regurgitation. Other patients were considered as having an "unexplained'' mitral regurgitation and were included as cases. For each case, two controls were matched for gender and for the closest date of birth, among a list of patients with an "explained'' mitral regurgitation. Drug exposures were assessed blindly regarding the case or control status, through contacts with patients, their family and/or their physicians. Results: Out of the 682 eligible patients, 27 cases and 54 matched controls were identified. The use of benfluorex was reported in 22 patients: 19 of the 27 cases, versus 3 of the 54 controls, odds-ratio 17.1 (3.5 to 83), adjusted for body mass index, diabetes and dexfenfluramine use. Conclusion: The use of benfluorex is associated with unexplained mitral regurgitation.	[Frachon, Irene; Le Gal, Gregoire; Leroyer, Christophe] Univ Europeenne Bretagne, Brest, France; [Frachon, Irene; Leroyer, Christophe] Univ Brest, EA3878, IFR 148, GETBO, Brest, France; [Frachon, Irene; Leroyer, Christophe] CHU Cavale Blanche, Grp HTAP Bretagne Occidentale, Dept Med Interne & Pneumol, Brest, France; [Etienne, Yves; Jobic, Yannick] CHU Cavale Blanche, Dept Cardiol, Grp HTAP Bretagne Occidentale, Brest, France; [Le Gal, Gregoire] Univ Brest, INSERM, CIC 05 02, IFR148, Brest, France; [Humbert, Marc] Univ Paris Sud, Fac Med, Le Kremlin Bicetre, France; [Humbert, Marc] Hop Antoine Beclere, AP HP, Ctr Natl Reference Hypertens Pulm Severe, Serv Pneumol & Reanimat Resp, Clamart, France; [Humbert, Marc] INSERM, U999, Le Plessis Robinson, France	Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Frachon, I (corresponding author), Univ Europeenne Bretagne, Brest, France.	irene.frachon@chu-brest.fr	LE GAL, Gregoire/K-1077-2012; Humbert, Marc/AAC-8459-2019; Humbert, Marc/ABD-5112-2021	Humbert, Marc/0000-0003-0703-2892; Frachon, Irene/0000-0001-6666-9709; LE GAL, Gregoire/0000-0002-9253-248X; leroyer, christophe/0000-0002-7601-1692	 [GETBO EA3878 Brest]		This study was funded by the authors' institution (GETBO EA3878 Brest). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901; *AFSSAPS, 2009, SUSP AUT MIS MARCH M; Bhattacharyya S, 2009, LANCET, V374, P577, DOI 10.1016/S0140-6736(09)60252-X; Boutet K, 2009, EUR RESPIR J, V33, P684, DOI 10.1183/09031936.00086308; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Dahl CF, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-34; DUHAULT J, 1970, AMPHETAMINES RELATED, P619; Enriquez-Sarano M, 2009, LANCET, V373, P1382, DOI 10.1016/S0140-6736(09)60692-9; Jick H, 1998, NEW ENGL J MED, V339, P719, DOI 10.1056/NEJM199809103391102; Khan MA, 1998, NEW ENGL J MED, V339, P713, DOI 10.1056/NEJM199809103391101; Noize P, 2006, FUND CLIN PHARMACOL, V20, P577, DOI 10.1111/j.1472-8206.2006.00441.x; Pritchett AM, 2002, MAYO CLIN PROC, V77, P1280, DOI 10.4065/77.12.1280; Ribera JR, 2003, REV ESP CARDIOL, V56, P215; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Rothman RB, 2000, CIRCULATION, V102, P2836; Schade R, 2007, NEW ENGL J MED, V356, P29, DOI 10.1056/NEJMoa062222; Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9; Weissman NJ, 1998, NEW ENGL J MED, V339, P725, DOI 10.1056/NEJM199809103391103; Zanettini R, 2007, NEW ENGL J MED, V356, P39, DOI 10.1056/NEJMoa054830	19	61	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10128	10.1371/journal.pone.0010128	http://dx.doi.org/10.1371/journal.pone.0010128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405030	Green Published, gold, Green Submitted			2022-12-25	WOS:000276705900012
J	Foller, M; Mahmud, H; Qadri, SM; Gu, SC; Braun, M; Bobbala, D; Hocher, B; Lang, F				Foeller, Michael; Mahmud, Hasan; Qadri, Syed M.; Gu, Shuchen; Braun, Manuel; Bobbala, Diwakar; Hocher, Berthold; Lang, Florian			Endothelin B receptor stimulation inhibits suicidal erythrocyte death	FASEB JOURNAL			English	Article						anemia; cell membrane scrambling; splenomegaly; ETB receptor; Ca2+; sarafotoxin 6c	PROGRAMMED CELL-DEATH; RED-BLOOD-CELLS; PHOSPHATIDYLSERINE EXPOSURE; PLASMODIUM-FALCIPARUM; INFECTED ERYTHROCYTES; CATION CONDUCTANCE; BETA-THALASSEMIA; NITRIC-OXIDE; SURVIVAL; HEMOGLOBIN	Endothelins (ETs), potent endothelium-derived mediators, stimulate formation of nitric oxide, which, in turn, protects against suicidal erythrocyte death or eryptosis, characterized by phosphatidylserine exposure at the erythrocyte surface and triggered by increase in cytosolic Ca2+ ([Ca2+](i)). The present study explored whether the ET1-receptor ETB influences suicidal erythrocyte death. To this end, [Ca2+](i) (Fluo3-fluorescence) and phosphatidylserine exposure (annexin V-binding) were determined utilizing FACS analysis. Energy depletion increased [Ca2+]i and phosphatidylserine-exposure, effects significantly blunted by ET1 (IC50 approximate to 100 nM) and the ETB receptor-agonist sarafotoxin 6c (IC50 approximate to 10 nM) but not by ET2 and ET3. ET1 and sarafotoxin significantly delayed the kinetics of suicidal erythrocyte death following energy depletion. ETB stimulation did not blunt the effect of Ca2+-ionophore ionomycin (1 mu M) on phosphatidylserine exposure. The in vivo significance was tested using rescued ETB-knockout (etb(-/-)) and wild-type (etb(+/+)) mice. The number of phosphatidylserine-exposing erythrocytes, of reticulocytes and spleen size were significantly larger in etb(-/-) mice than in etb(+/+)-mice. The etb(-/-) erythrocytes were more susceptible to the eryptotic effect of oxidative stress and more rapidly cleared from circulating blood than etb(+/+) erythrocytes. Finally, the spleens from etb(-/-) mice were enlarged and contained markedly more phosphatidylserine- exposing erythrocytes than spleens from etb(+/+) mice. The observations disclose a novel function of ET1, i. e., protection from suicidal erythrocyte death.-Foller, M., Mahmud, H., Qadri, S. M., Gu, S., Braun, M., Bobbala, D., Hocher, B., Lang, F. Endothelin B receptor stimulation inhibits suicidal erythrocyte death. FASEB J. 24, 3351-3359 (2010). www.fasebj.org	[Lang, Florian] Univ Tubingen, Inst Physiol, Dept Physiol, D-72076 Tubingen, Germany; [Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Hocher, Berthold] Charite, Dept Pharmacol & Toxicol, Cardiovasc Res Ctr, Berlin, Germany	Eberhard Karls University of Tubingen; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lang, F (corresponding author), Univ Tubingen, Inst Physiol, Dept Physiol, Gmelinstr 5, D-72076 Tubingen, Germany.	florian.lang@uni-tuebingen.de	Hocher, Berthold/AAC-3510-2020	Hocher, Berthold/0000-0001-8143-0579	Carl-Zeiss-Stiftung; Deutsche Forschungsgemeinschaft [La 315/4-3, La 315/6-1]	Carl-Zeiss-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors acknowledge the technical assistance of E. Faber and the meticulous preparation of the manuscript by Tanja Loch. This study was supported by the Carl-Zeiss-Stiftung and the Deutsche Forschungsgemeinschaft, Nr. La 315/4-3 and La 315/6-1.	Andrews D A, 1999, Curr Opin Hematol, V6, P76, DOI 10.1097/00062752-199903000-00004; Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; Basu S, 2010, GLYCOCONJUGATE J, V27, P717, DOI 10.1007/s10719-009-9257-6; Berg CP, 2001, CELL DEATH DIFFER, V8, P1197, DOI 10.1038/sj.cdd.4400905; Birka C, 2004, PFLUG ARCH EUR J PHY, V448, P471, DOI 10.1007/s00424-004-1289-y; Boas FE, 1998, P NATL ACAD SCI USA, V95, P3077, DOI 10.1073/pnas.95.6.3077; Bookchin R M, 1987, Prog Clin Biol Res, V240, P193; Bosman GJCGM, 2005, CELL PHYSIOL BIOCHEM, V16, P1, DOI 10.1159/000087725; Brand VB, 2003, CELL PHYSIOL BIOCHEM, V13, P347, DOI 10.1159/000075122; Brand V, 2008, CELL PHYSIOL BIOCHEM, V22, P405, DOI 10.1159/000185482; Bratosin D, 2001, CELL DEATH DIFFER, V8, P1143, DOI 10.1038/sj.cdd.4400946; Browning JA, 2007, CELL PHYSIOL BIOCHEM, V19, P165, DOI 10.1159/000099204; BRUGNARA C, 1993, J CLIN INVEST, V92, P520, DOI 10.1172/JCI116597; Cappadoro M, 1998, BLOOD, V92, P2527, DOI 10.1182/blood.V92.7.2527.2527_2527_2534; Chadebech P, 2009, TRANSFUSION, V49, P1785, DOI 10.1111/j.1537-2995.2009.02199.x; Chung SM, 2007, ARTERIOSCL THROM VAS, V27, P414, DOI 10.1161/01.ATV.0000252898.48084.6a; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Davenport AP, 2004, J CARDIOVASC PHARM, V44, pS276, DOI 10.1097/01.fjc.0000166284.08657.64; de Jong K, 2001, BLOOD, V98, P1577, DOI 10.1182/blood.V98.5.1577; Dejam A, 2005, BLOOD, V106, P734, DOI 10.1182/blood-2005-02-0567; Diesen D, 2007, J MOL CELL CARDIOL, V42, P921, DOI 10.1016/j.yjmcc.2007.03.739; Duranton C, 2002, J PHYSIOL-LONDON, V539, P847, DOI 10.1113/jphysiol.2001.013040; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Foller M, 2008, P NATL ACAD SCI USA, V105, P6771, DOI 10.1073/pnas.0708940105; Foeller M, 2008, EUR J PHARMACOL, V581, P13, DOI 10.1016/j.ejphar.2007.11.051; Foller M, 2007, CELL PHYSIOL BIOCHEM, V20, P1051, DOI 10.1159/000110715; Foller M, 2009, CELL PHYSIOL BIOCHEM, V24, P133, DOI 10.1159/000233238; Foller M, 2009, FASEB J, V23, P1072, DOI 10.1096/fj.08-121772; Gatidis S, 2009, ANN HEMATOL, V88, P721, DOI 10.1007/s00277-009-0697-7; Grimshaw MJ, 2007, ENDOCR-RELAT CANCER, V14, P233, DOI 10.1677/ERC-07-0057; Grubina R, 2007, J BIOL CHEM, V282, P12916, DOI 10.1074/jbc.M700546200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Huber SM, 2001, PFLUG ARCH EUR J PHY, V441, P551, DOI 10.1007/s004240000456; Kean LS, 2002, EXP HEMATOL, V30, P394, DOI 10.1016/S0301-472X(02)00780-4; Kempe DS, 2007, J MOL MED-JMM, V85, P269, DOI 10.1007/s00109-006-0123-8; Kempe DS, 2006, FASEB J, V20, P368, DOI 10.1096/fj.05-4872fje; Klarl BA, 2006, AM J PHYSIOL-CELL PH, V290, pC244, DOI 10.1152/ajpcell.00283.2005; Koka S, 2008, CELL PHYSIOL BIOCHEM, V21, P481, DOI 10.1159/000129641; Koka S, 2009, CELL PHYSIOL BIOCHEM, V23, P191, DOI 10.1159/000204107; Kriebardis AG, 2007, J CELL MOL MED, V11, P148, DOI 10.1111/j.1582-4934.2007.00008.x; Kuypers FA, 1998, BLOOD, V91, P3044, DOI 10.1182/blood.V91.8.3044.3044_3044_3051; Lang F, 2008, CELL PHYSIOL BIOCHEM, V22, P373, DOI 10.1159/000185448; Lang KS, 2005, CELL PHYSIOL BIOCHEM, V15, P195, DOI 10.1159/000086406; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; Lang KS, 2002, CELL PHYSIOL BIOCHEM, V12, P365, DOI 10.1159/000067907; Lang PA, 2003, CELL PHYSIOL BIOCHEM, V13, P337, DOI 10.1159/000075121; Lang PA, 2003, AM J PHYSIOL-CELL PH, V285, pC1553, DOI 10.1152/ajpcell.00186.2003; Lang PA, 2007, NAT MED, V13, P164, DOI 10.1038/nm1539; Lang PA, 2006, CELL PHYSIOL BIOCHEM, V18, P151, DOI 10.1159/000095190; Lang PA, 2006, J MOL MED, V84, P378, DOI 10.1007/s00109-006-0058-0; Lang PA, 2009, CELL PHYSIOL BIOCHEM, V24, P415, DOI 10.1159/000257529; Lion N, 2010, J PROTEOMICS, V73, P374, DOI 10.1016/j.jprot.2009.11.001; Mahmud H, 2009, CELL PHYSIOL BIOCHEM, V24, P263, DOI 10.1159/000233251; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; Nicolay JP, 2008, PFLUG ARCH EUR J PHY, V456, P293, DOI 10.1007/s00424-007-0393-1; Niemoeller OM, 2008, CELL PHYSIOL BIOCHEM, V21, P193, DOI 10.1159/000113761; Pandolfi A, 2007, J CELL PHYSIOL, V213, P699, DOI 10.1002/jcp.21138; Pollock JS, 2008, CURR OPIN NEPHROL HY, V17, P70, DOI 10.1097/MNH.0b013e3282f34b02; Power GG, 2007, J APPL PHYSIOL, V103, P1359, DOI 10.1152/japplphysiol.00443.2007; Quaschning T, 2005, J HYPERTENS, V23, P979, DOI 10.1097/01.hjh.0000166838.55688.7e; Reynolds JD, 2007, P NATL ACAD SCI USA, V104, P17058, DOI 10.1073/pnas.0707958104; Rivera A, 2002, BLOOD, V99, P357, DOI 10.1182/blood.V99.1.357; Rivera A, 2007, AM J PHYSIOL-CELL PH, V293, pC960, DOI 10.1152/ajpcell.00530.2006; RIVERS DB, 1999, TRENDS ENTOMOL, V2, P1; Sampaio ALF, 2004, J LEUKOCYTE BIOL, V76, P210, DOI 10.1189/jlb.1003504; Sarafidis PA, 2007, J CLIN ENDOCR METAB, V92, P379, DOI 10.1210/jc.2006-1819; Schneider J, 2007, CELL PHYSIOL BIOCHEM, V20, P35, DOI 10.1159/000104151; Shaw Sidney G., 2005, Current Vascular Pharmacology, V3, P359, DOI 10.2174/157016105774329471; Villeneuve A, 2000, J CARDIOVASC PHARM, V36, pS238, DOI 10.1097/00005344-200036001-00070; Wood BL, 1996, BLOOD, V88, P1873; Yang, 1996, J Cardiovasc Pharmacol Ther, V1, P297; Zappulla Donatella, 2008, J Cardiometab Syndr, V3, P30, DOI 10.1111/j.1559-4572.2008.07263.x	74	20	21	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3351	3359		10.1096/fj.10-159483	http://dx.doi.org/10.1096/fj.10-159483			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20427706				2022-12-25	WOS:000281446400023
J	Li, YJ; Stark, JM; Chen, DJ; Ann, DK; Chen, Y				Li, Y-J; Stark, J. M.; Chen, D. J.; Ann, D. K.; Chen, Y.			Role of SUMO:SIM-mediated protein-protein interaction in non-homologous end joining	ONCOGENE			English	Article						SUMO; NHEJ; SUMO-interacting motif; SBM; inhibitor; DNA repair	STRAND BREAK REPAIR; UBIQUITIN-LIKE PROTEINS; DNA-DAMAGE; BINDING MOTIF; LIGASE; XRCC4; IDENTIFICATION; RECOMBINATION; LOCALIZATION; NUCLEUS	Although post-translational modi. cations by the small ubiquitin-like modifiers (SUMO) are known to be important in DNA damage response, it is unclear whether they have a role in double-strand break (DSB) repair by non-homologous end joining (NHEJ). Here, we analyzed various DSB repair pathways upon inhibition of SUMO-mediated protein-protein interactions using peptides that contain the SUMO-interaction motif (SIM) and discriminate between mono-and SUMO-chain modi. cations. The SIM peptides specifically inhibit NHEJ as shown by in vivo repair assays and radio-sensitivity of cell lines deficient in different DSB repair pathways. Furthermore, mono-SUMO, instead of SUMO-chain, modi. cations appear to be involved in NHEJ. Immunoprecipitation experiments also showed that the SIM peptide interacted with SUMOylated Ku70 after radiation. This study is the first to show an important role for SUMO: SIM-mediated protein-protein interactions in NHEJ, and provides a mechanistic basis for the role of SIM peptide in sensitizing genotoxic stress of cancer cells. Oncogene (2010) 29, 3509-3518; doi:10.1038/onc.2010.108; published online 19 April 2010	[Li, Y-J; Chen, Y.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Stark, J. M.] City Hope Natl Med Ctr, Beckman Res Inst, Div Radiat Biol, Duarte, CA 91010 USA; [Chen, D. J.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Ann, D. K.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Clin & Mol Pharmacol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of Texas System; University of Texas Southwestern Medical Center Dallas; City of Hope; Beckman Research Institute of City of Hope	Chen, Y (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, 1500 E Duarte Rd, Duarte, CA 91010 USA.	ychen@coh.org		Li, Yi-Jia/0000-0002-8791-8097	NIH [R01GM074748, R01GM-086171, RO1CA120954, R37CA050519-20, F32CA134180]; NATIONAL CANCER INSTITUTE [F32CA134180, R01CA120954, R37CA050519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086171, R01GM074748] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is funded by NIH Grants R01GM074748 and R01GM-086171 to Y Chen, RO1CA120954 to JM Stark, R37CA050519-20 to DJ Chen and R01DE14183 to DK Ann. Y-J Li is a recipient of the NIH National Research Service Award (F32CA134180).	Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Carson JP, 2004, CANCER RES, V64, P2096, DOI 10.1158/0008-5472.CAN-03-2029; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Krebber H, 2000, METHOD ENZYMOL, V327, P283, DOI 10.1016/S0076-6879(00)27284-4; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Pastink A, 2001, MUTAT RES-FUND MOL M, V480, P37, DOI 10.1016/S0027-5107(01)00167-1; Pastwa E, 2003, ACTA BIOCHIM POL, V50, P891; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Shayeghi M, 1997, NUCLEIC ACIDS RES, V25, P1162, DOI 10.1093/nar/25.6.1162; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; TATHAM MH, 2001, J BIOL CHEM, V12, P12; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Weinstock DM, 2006, MOL CELL BIOL, V26, P131, DOI 10.1128/MCB.26.1.131-139.2006; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Yano K, 2008, CELL CYCLE, V7, P1321, DOI 10.4161/cc.7.10.5898; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Yurchenko V, 2006, MOL CELL BIOL, V26, P1786, DOI 10.1128/MCB.26.5.1786-1794.2006; Yurchenko V, 2008, BIOCHEM BIOPH RES CO, V366, P263, DOI 10.1016/j.bbrc.2007.11.136; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	35	23	24	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 17	2010	29	24					3509	3518		10.1038/onc.2010.108	http://dx.doi.org/10.1038/onc.2010.108			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	611QN	20400978	Green Accepted			2022-12-25	WOS:000278835400006
J	Hu, DQ; Liu, SW; Shi, L; Li, C; Wu, LF; Fan, ZS				Hu, Deqing; Liu, Shengwu; Shi, Lei; Li, Chong; Wu, Lianfeng; Fan, Zusen			Cleavage of Survivin by Granzyme M Triggers Degradation of the Survivin-X-linked Inhibitor of Apoptosis Protein (XIAP) Complex to Free Caspase Activity Leading to Cytolysis of Target Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NK-CELL; T-CELL; MEDIATED APOPTOSIS; NATURAL-KILLER; LYMPHOCYTES; ACTIVATION; DEATH; IAP; EXPRESSION; INDUCTION	Granzyme M (GzmM) is a chymotrypsin-like serine protease that preferentially cuts its substrates after Met or Leu. GzmM is constitutively expressed in activated innate effector natural killer (NK) cells. GzmM-induced cell death is consistent with the kinetics of cytotoxicity of NK cells. These suggest that GzmM may play an important role in innate immunity. Our previous work demonstrated that GzmM induces caspase-dependent apoptosis. However, it is unknown about how GzmM causes caspase activation. Here, we showed that the inhibitor of the apoptosis gene family member Survivin is a physiological substrate for GzmM. GzmM hydrolyzes Survivin at Leu-138 to remove the last four C-terminal residues. The truncated form (sur-TF) is more rapidly hydrolyzed through proteasome-mediated degradation. In addition, Survivin is in complex with X-linked inhibitor of apoptosis protein (XIAP) to inhibit caspase activation as an endogenous inhibitor. Survivin cleavage by GzmM abolishes the stability of the Survivin-XIAP complex and enhances XIAP hydrolysis, which amplifies caspase-9 and 3 activation of target tumor cells. The noncleavable L138A Survivin overexpression can significantly inhibit GzmM-mediated XIAP degradation, caspase activation, and GzmM- and NK cell-induced cytotoxicity. Moreover, Survivin silencing promotes XIAP degradation and enhances GzmM-induced caspase activation as well as GzmM- and NK cell-induced cytolysis of target tumor cells.	[Fan, Zusen] Chinese Acad Sci, Natl Lab Biomacromol, Beijing 100101, Peoples R China; Chinese Acad Sci, Ctr Infect & Immun, Inst Biophys, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Biophysics, CAS	Fan, ZS (corresponding author), Chinese Acad Sci, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	fanz@moon.ibp.ac.cn			National Natural Science Foundation of China [30830030, 30972676, 30772496]; 973 Program [2010CB911902, 2006CB910901]; Chinese Academy of Sciences [KSCX2-YW-R-42, KSCX1-YW-22]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 30830030, 30972676, and 30772496, 973 Program Grants 2010CB911902 and 2006CB910901, and the Innovative Program Grants KSCX2-YW-R-42 and KSCX1-YW-22 from the Chinese Academy of Sciences.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2006, CURR OPIN CELL BIOL, V18, P609, DOI 10.1016/j.ceb.2006.08.015; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cuvillier O, 1998, J BIOL CHEM, V273, P2910, DOI 10.1074/jbc.273.5.2910; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Fan ZS, 2006, BLOOD, V107, P1342, DOI 10.1182/blood-2005-08-3485; Hua GQ, 2007, J BIOL CHEM, V282, P20553, DOI 10.1074/jbc.M703196200; Kang BH, 2006, J BIOL CHEM, V281, P24721, DOI 10.1074/jbc.M603175200; Kelly JM, 2004, J BIOL CHEM, V279, P22236, DOI 10.1074/jbc.M401670200; Kelly JM, 2002, NAT IMMUNOL, V3, P83, DOI 10.1038/ni746; Krenacs L, 2003, BLOOD, V101, P3590, DOI 10.1182/blood-2002-09-2908; Lu HX, 2006, J IMMUNOL, V177, P1171, DOI 10.4049/jimmunol.177.2.1171; Mahrus S, 2004, J BIOL CHEM, V279, P54275, DOI 10.1074/jbc.M411482200; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; PILAT D, 1994, GENOMICS, V24, P445, DOI 10.1006/geno.1994.1651; Plesca D, 2008, J BIOL CHEM, V283, P30796, DOI 10.1074/jbc.M804642200; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sayers TJ, 2001, J IMMUNOL, V166, P765, DOI 10.4049/jimmunol.166.2.765; SHRESTA S, 1995, P NATL ACAD SCI USA, V92, P5679, DOI 10.1073/pnas.92.12.5679; Song ZY, 2003, J BIOL CHEM, V278, P23130, DOI 10.1074/jbc.M300957200; Suck G, 2005, EXP HEMATOL, V33, P1160, DOI 10.1016/j.exphem.2005.06.024; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Wu LF, 2009, J IMMUNOL, V183, P421, DOI 10.4049/jimmunol.0803088; Zhao T, 2007, CELL DEATH DIFFER, V14, P489, DOI 10.1038/sj.cdd.4402040	29	38	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18326	18335		10.1074/jbc.M109.083170	http://dx.doi.org/10.1074/jbc.M109.083170			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20406824	Green Published, hybrid			2022-12-25	WOS:000278453900026
J	Tanegashima, K; Okamoto, S; Nakayama, Y; Taya, C; Shitara, H; Ishii, R; Yonekawa, H; Minokoshi, Y; Hara, T				Tanegashima, Kosuke; Okamoto, Shiki; Nakayama, Yuki; Taya, Choji; Shitara, Hiroshi; Ishii, Rie; Yonekawa, Hiromichi; Minokoshi, Yasuhiko; Hara, Takahiko			CXCL14 Deficiency in Mice Attenuates Obesity and Inhibits Feeding Behavior in a Novel Environment	PLOS ONE			English	Article							FOOD-INTAKE; RECEPTOR; HORMONE; CELLS	Background: CXCL14 is a chemoattractant for macrophages and immature dendritic cells. We recently reported that CXCL14-deficient (CXCL14(-/-)) female mice in the mixed background are protected from obesity-induced hyperglycemia and insulin resistance. The decreased macrophage infiltration into visceral adipose tissues and the increased insulin sensitivity of skeletal muscle contributed to these phenotypes. Methodology/Principal Findings: In this study, we performed a comprehensive study for the body weight control of CXCL14(-/-) mice in the C57BL/6 background. We show that both male and female CXCL14(-/-) mice have a 7-11% lower body weight compared to CXCL14(+/-) and CXCL14(+/+) mice in adulthood. This is mainly caused by decreased food intake, and not by increased energy expenditure or locomotor activity. Reduced body weight resulting from the CXCL14 deficiency was more pronounced in double mutant CXCL14(-/-) ob/ob and CXCL14(-/-) A(y) mice. In the case of CXCL14(-/-) A(y) mice, oxygen consumption was increased compared to CXCL14(+/-) A(y) mice, in addition to the reduced food intake. In CXCL14(-/-) mice, fasting-induced up-regulation of Npy and Agrp mRNAs in the hypothalamus was blunted. As intracerebroventricular injection of recombinant CXCL14 did not change the food intake of CXCL14(-/-) mice, CXCL14 could indirectly regulate appetite. Intriguingly, the food intake of CXCL14(-/-) mice was significantly repressed when mice were transferred to a novel environment. Conclusions/Significance: We demonstrated that CXCL14 is involved in the body weight control leading to the fully obese phenotype in leptin-deficient or A(y) mutant mice. In addition, we obtained evidence indicating that CXCL14 may play an important role in central nervous system regulation of feeding behavior.	[Tanegashima, Kosuke; Nakayama, Yuki; Hara, Takahiko] Tokyo Metropolitan Inst Med Sci, Tokyo Metropolitan Org Med Res, Stem Cell Project Grp, Setagaya Ku, Tokyo, Japan; [Okamoto, Shiki; Minokoshi, Yasuhiko] Natl Inst Physiol Sci, Div Endocrinol & Metab, Aichi, Japan; [Nakayama, Yuki] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto, Japan; [Taya, Choji; Shitara, Hiroshi; Ishii, Rie; Yonekawa, Hiromichi] Tokyo Metropolitan Inst Med Sci, Tokyo Metropolitan Org Med Res, Lab Mouse Model Human Heritable Dis, Setagaya Ku, Tokyo 113, Japan	Tokyo Metropolitan Institute of Medical Science; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Kumamoto University; Tokyo Metropolitan Institute of Medical Science	Tanegashima, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Tokyo Metropolitan Org Med Res, Stem Cell Project Grp, Setagaya Ku, Tokyo, Japan.	hara-tk@igakuken.or.jp	Okamoto, Shiki/X-7274-2018	Okamoto, Shiki/0000-0002-2802-0527; Minokoshi, Yasuhiko/0000-0002-7119-4805	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Pharmaceutical Company Limited	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a research grant from Takeda Pharmaceutical Company Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagri A, 2002, DEVELOPMENT, V129, P4249; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Hara T, 2009, VITAM HORM, V80, P107, DOI 10.1016/S0083-6729(08)00605-5; Hromas R, 1999, BIOCHEM BIOPH RES CO, V255, P703, DOI 10.1006/bbrc.1999.0257; Huising MO, 2004, EUR J BIOCHEM, V271, P4094, DOI 10.1111/j.1432-1033.2004.04347.x; LARSON BA, 1976, ENDOCRINOLOGY, V98, P139, DOI 10.1210/endo-98-1-139; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Lu M, 2002, P NATL ACAD SCI USA, V99, P7090, DOI 10.1073/pnas.092013799; Meuter S, 2007, MOL CELL BIOL, V27, P983, DOI 10.1128/MCB.01648-06; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881	14	37	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10321	10.1371/journal.pone.0010321	http://dx.doi.org/10.1371/journal.pone.0010321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428232	Green Published, Green Submitted, gold			2022-12-25	WOS:000277079300011
J	Weisenhaus, M; Allen, ML; Yang, LH; Lu, Y; Nichols, CB; Su, T; Hell, JW; McKnight, GS				Weisenhaus, Michael; Allen, Margaret L.; Yang, Linghai; Lu, Yuan; Nichols, C. Blake; Su, Thomas; Hell, Johannes W.; McKnight, G. Stanley			Mutations in AKAP5 Disrupt Dendritic Signaling Complexes and Lead to Electrophysiological and Behavioral Phenotypes in Mice	PLOS ONE			English	Article							PROTEIN-KINASE-A; LONG-TERM POTENTIATION; MICROTUBULE-ASSOCIATED PROTEIN-2; AMPA RECEPTOR TRAFFICKING; ANCHORING PROTEIN; REGULATORY SUBUNIT; DEFICIENT MICE; GENE-EXPRESSION; SPATIAL MEMORY; GLUR1 SUBUNIT	AKAP5 (also referred to as AKAP150 in rodents and AKAP79 in humans) is a scaffolding protein that is highly expressed in neurons and targets a variety of signaling molecules to dendritic membranes. AKAP5 interacts with PKA holoenzymes containing RII alpha or RII beta as well as calcineurin (PP2B), PKC, calmodulin, adenylyl cyclase type V/VI, L-type calcium channels, and beta-adrenergic receptors. AKAP5 has also been shown to interact with members of the MAGUK family of PSD-scaffolding proteins including PSD95 and SAP97 and target signaling molecules to receptors and ion channels in the postsynaptic density (PSD). We created two lines of AKAP5 mutant mice: a knockout of AKAP5 (KO) and a mutant that lacks the PKA binding domain of AKAP5 (D36). We find that PKA is delocalized in both the hippocampus and striatum of KO and D36 mice indicating that other neural AKAPs cannot compensate for the loss of PKA binding to AKAP5. In AKAP5 mutant mice, a significant fraction of PKA becomes localized to dendritic shafts and this correlates with increased binding to microtubule associated protein-2 (MAP2). Electrophysiological and behavioral analysis demonstrated more severe deficits in both synaptic plasticity and operant learning in the D36 mice compared with the complete KO animals. Our results indicate that the targeting of calcineurin or other binding partners of AKAP5 in the absence of the balancing kinase, PKA, leads to a disruption of synaptic plasticity and results in learning and memory defects.	[Weisenhaus, Michael; Allen, Margaret L.; Yang, Linghai; Nichols, C. Blake; Su, Thomas; McKnight, G. Stanley] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Lu, Yuan; Hell, Johannes W.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	University of Washington; University of Washington Seattle; University of California System; University of California Davis	Weisenhaus, M (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA.	mcknight@u.washington.edu	Yang, Linghai/C-2773-2012; Hell, Johannes W./P-5085-2019		National Institutes of Health [GM 032875, NS035563]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant GM 032875 (G.S.M.) and NS035563 (J.W.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MR, 1997, P NATL ACAD SCI USA, V94, P12157, DOI 10.1073/pnas.94.22.12157; Bannerman DM, 2003, BEHAV NEUROSCI, V117, P866, DOI 10.1037/0735-7044.117.4.866; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Brandon EP, 1998, J NEUROSCI, V18, P3639; Burton KA, 1999, J BIOL CHEM, V274, P24131, DOI 10.1074/jbc.274.34.24131; CADD G, 1989, NEURON, V3, P71, DOI 10.1016/0896-6273(89)90116-5; Chai SH, 2007, J BIOL CHEM, V282, P22668, DOI 10.1074/jbc.M703624200; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Clark RE, 2000, J NEUROSCI, V20, P8853; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Dart C, 2001, J BIOL CHEM, V276, P20499, DOI 10.1074/jbc.M101425200; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Dodge K, 2000, FEBS LETT, V476, P58, DOI 10.1016/S0014-5793(00)01671-9; Ehninger D, 2006, GENES BRAIN BEHAV, V5, P29, DOI 10.1111/j.1601-183X.2005.00129.x; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Faux MC, 1997, J BIOL CHEM, V272, P17038, DOI 10.1074/jbc.272.27.17038; Few WP, 2007, P NATL ACAD SCI USA, V104, P5187, DOI 10.1073/pnas.0611619104; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; GLANTZ SB, 1993, J BIOL CHEM, V268, P12796; GLANTZ SB, 1992, MOL BIOL CELL, V3, P1215, DOI 10.1091/mbc.3.11.1215; Gorski JA, 2005, MOL BIOL CELL, V16, P3574, DOI 10.1091/mbc.E05-02-0134; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Herberg FW, 2000, J MOL BIOL, V298, P329, DOI 10.1006/jmbi.2000.3662; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Huang T, 2006, EUR J CELL BIOL, V85, P635, DOI 10.1016/j.ejcb.2006.02.005; Kashishian A, 1998, J BIOL CHEM, V273, P27412, DOI 10.1074/jbc.273.42.27412; Khuchua Z, 2003, NEUROSCIENCE, V119, P101, DOI 10.1016/S0306-4522(03)00094-0; Kim KS, 2008, J NEUROCHEM, V107, P105, DOI 10.1111/j.1471-4159.2008.05592.x; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Lee HK, 2007, MOL CELL NEUROSCI, V36, P86, DOI 10.1016/j.mcn.2007.06.003; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lu Y, 2008, J PHYSIOL-LONDON, V586, P4155, DOI 10.1113/jphysiol.2008.151662; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; LUDVIG N, 1990, BRAIN RES, V520, P90, DOI 10.1016/0006-8993(90)91694-C; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Metzler M, 2003, EMBO J, V22, P3254, DOI 10.1093/emboj/cdg334; Mok H, 2002, J NEUROSCI, V22, P5253; MORALES M, 1989, CELL TISSUE RES, V256, P447; Namekata K, 2006, MOL VIS, V12, P1586; Navedo MF, 2008, CIRC RES, V102, pE1, DOI 10.1161/CIRCRESAHA.107.167809; Nie T, 2007, J NEUROSCI, V27, P10278, DOI 10.1523/JNEUROSCI.1602-07.2007; Nolan MA, 2004, MOL ENDOCRINOL, V18, P2302, DOI 10.1210/me.2004-0194; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Ostroveanu A, 2007, BRAIN RES, V1145, P97, DOI 10.1016/j.brainres.2007.01.117; Phillips KG, 2008, J NEUROSCI, V28, P14031, DOI 10.1523/JNEUROSCI.3984-08.2008; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Robertson HR, 2009, J NEUROSCI, V29, P7929, DOI 10.1523/JNEUROSCI.6093-08.2009; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sandoz G, 2006, EMBO J, V25, P5864, DOI 10.1038/sj.emboj.7601437; SARKAR D, 1984, J BIOL CHEM, V259, P9840; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Sharifzadeh M, 2005, J NEUROSCI RES, V79, P392, DOI 10.1002/jnr.20358; Suen P, 1998, MOL BRAIN RES, V59, P215, DOI 10.1016/S0169-328X(98)00157-0; Tao YM, 2005, J NEUROCHEM, V94, P1512, DOI 10.1111/j.1471-4159.2005.03297.x; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; THEURKAUF WE, 1982, J BIOL CHEM, V257, P3284; Tibbs VC, 1998, J BIOL CHEM, V273, P25783, DOI 10.1074/jbc.273.40.25783; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Vinade L, 2003, J NEUROCHEM, V87, P1255, DOI 10.1046/j.1471-4159.2003.02091.x; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	72	65	65	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10325	10.1371/journal.pone.0010325	http://dx.doi.org/10.1371/journal.pone.0010325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428246	Green Published, Green Submitted, gold			2022-12-25	WOS:000277079300015
J	Puri, S; Faulkes, Z				Puri, Sakshi; Faulkes, Zen			Do Decapod Crustaceans Have Nociceptors for Extreme pH?	PLOS ONE			English	Article							PAIN EXPERIENCE; CRAYFISH; DROSOPHILA; NEURONS; EVOLUTIONARY; INNERVATION; MORPHOLOGY; PHYLOGENY; RECEPTORS; BEHAVIOR	Background: Nociception is the physiological detection of noxious stimuli. Because of its obvious importance, nociception is expected to be widespread across animal taxa and to trigger robust behaviours reliably. Nociception in invertebrates, such as crustaceans, is poorly studied. Methodology/Principal Findings: Three decapod crustacean species were tested for nociceptive behaviour: Louisiana red swamp crayfish (Procambarus clarkii), white shrimp (Litopenaeus setiferus), and grass shrimp (Palaemonetes sp.). Applying sodium hydroxide, hydrochloric acid, or benzocaine to the antennae caused no change in behaviour in the three species compared to controls. Animals did not groom the stimulated antenna, and there was no difference in movement of treated individuals and controls. Extracellular recordings of antennal nerves in P. clarkii revealed continual spontaneous activity, but no neurons that were reliably excited by the application of concentrated sodium hydroxide or hydrochloric acid. Conclusions/Significance: Previously reported responses to extreme pH are either not consistently evoked across species or were mischaracterized as nociception. There was no behavioural or physiological evidence that the antennae contained specialized nociceptors that responded to pH.	[Puri, Sakshi; Faulkes, Zen] Univ Texas Pan Amer, Dept Biol, Edinburg, TX 78541 USA	University of Texas System; University of Texas Rio Grande Valley	Puri, S (corresponding author), Univ Texas Pan Amer, Dept Biol, Edinburg, TX 78541 USA.	zfaulkes@utpa.edu	Faulkes, Zen/A-5777-2009	Faulkes, Zen/0000-0003-4049-7034	Howard Hughes Medical Undergraduate Science Education Program [52006321]; University of Texas-Pan American	Howard Hughes Medical Undergraduate Science Education Program; University of Texas-Pan American	S. P. was supported by Howard Hughes Medical Undergraduate Science Education Program grant (#52006321) and an Undergraduate Research Initiative grant from The University of Texas-Pan American. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahyong ST, 2004, RAFFLES B ZOOL, V52, P673; Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Appel M, 2009, ANIM BEHAV, V78, P1373, DOI 10.1016/j.anbehav.2009.09.008; Appel M, 2009, APPL ANIM BEHAV SCI, V119, P120, DOI 10.1016/j.applanim.2009.03.013; Ashley PJ, 2007, BRAIN RES, V1166, P47, DOI 10.1016/j.brainres.2007.07.011; Atwood HL, 1982, BIOL CRUSTACEA, V3; Barr S, 2008, ANIM BEHAV, V75, P745, DOI 10.1016/j.anbehav.2007.07.004; Basil J, 2000, ETHOLOGY, V106, P247, DOI 10.1046/j.1439-0310.2000.00524.x; BAUER R T, 1981, Journal of Crustacean Biology, V1, P153, DOI 10.2307/1548154; BAUER RT, 1978, MAR BIOL, V49, P69, DOI 10.1007/BF00390731; Bauer RT, 2002, AQUACULTURE, V208, P39, DOI 10.1016/S0044-8486(01)00794-3; BAUER RT, 1975, ZOOL J LINN SOC-LOND, V56, P45, DOI 10.1111/j.1096-3642.1975.tb00810.x; Elwood RW, 2009, APPL ANIM BEHAV SCI, V118, P128, DOI 10.1016/j.applanim.2009.02.018; Elwood RW, 2009, ANIM BEHAV, V77, P1243, DOI 10.1016/j.anbehav.2009.01.028; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Illich PA, 1997, J NEUROSCI, V17, P459, DOI 10.1523/JNEUROSCI.17-01-00459.1997; Immke DC, 2006, SEMIN CELL DEV BIOL, V17, P582, DOI 10.1016/j.semcdb.2006.09.004; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; KAVALIERS M, 1988, BRAIN RES BULL, V21, P923, DOI 10.1016/0361-9230(88)90030-5; Kawai N, 2004, BEHAV BRAIN RES, V150, P229, DOI 10.1016/S0166-4328(03)00261-4; KOCH LM, 2006, J EXPT BIOL, V209; LAMOTTE RH, 1992, J PHYSIOL-LONDON, V448, P749, DOI 10.1113/jphysiol.1992.sp019068; Le Bars D, 2001, PHARMACOL REV, V53, P597; Lewin GR, 2004, CURR OPIN NEUROBIOL, V14, P443, DOI 10.1016/j.conb.2004.07.009; Matsuura H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-228; Merskey H, 1994, CLASSIFICATION CHRON, DOI DOI 10.1016/0304-3959(86)90113-2; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Park TJ, 2003, J COMP NEUROL, V465, P104, DOI 10.1002/cne.10824; Pastor J, 1996, J NEUROPHYSIOL, V75, P2268, DOI 10.1152/jn.1996.75.6.2268; PAUL DH, 1986, J COMP PHYSIOL A, V158, P215, DOI 10.1007/BF01338564; Porter ML, 2005, MOL PHYLOGENET EVOL, V37, P355, DOI 10.1016/j.ympev.2005.06.021; Puri S, 2009, INTEGR COMP BIOL, V49, pE139; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; SANDEMAN D, 1992, BIOL BULL, V183, P304, DOI 10.2307/1542217; SANDEMAN DC, 1989, J EXP BIOL, V141, P197; Schmelz M, 2000, BRAIN, V123, P560, DOI 10.1093/brain/123.3.560; SCHOLTZ G, 1995, ZOOL J LINN SOC-LOND, V113, P289, DOI 10.1006/zjls.1995.0011; Smith ESJ, 2009, J COMP PHYSIOL A, V195, P1089, DOI 10.1007/s00359-009-0482-z; Sneddon LU, 2003, P ROY SOC B-BIOL SCI, V270, P1115, DOI 10.1098/rspb.2003.2349; Sneddon LU, 2003, BRAIN RES, V972, P44, DOI 10.1016/S0006-8993(03)02483-1; Sneddon LU, 2004, BRAIN RES REV, V46, P123, DOI 10.1016/j.brainresrev.2004.07.007; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; WESTON KM, 1984, J PHARMACOL METHOD, V12, P285, DOI 10.1016/0160-5402(84)90014-7; Wittenburg N, 1999, P NATL ACAD SCI USA, V96, P10477, DOI 10.1073/pnas.96.18.10477	45	21	21	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10244	10.1371/journal.pone.0010244	http://dx.doi.org/10.1371/journal.pone.0010244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422026	Green Published, gold, Green Submitted			2022-12-25	WOS:000276854300010
J	Arciero, JC; Ermentrout, GB; Upperman, JS; Vodovotz, Y; Rubin, JE				Arciero, Julia C.; Ermentrout, G. Bard; Upperman, Jeffrey S.; Vodovotz, Yoram; Rubin, Jonathan E.			Using a Mathematical Model to Analyze the Role of Probiotics and Inflammation in Necrotizing Enterocolitis	PLOS ONE			English	Article							BARRIER FUNCTION; PRETERM INFANTS; PATHOPHYSIOLOGY; DANGER; SEPSIS; MILK	Background: Necrotizing enterocolitis (NEC) is a severe disease of the gastrointestinal tract of pre-term babies and is thought to be related to the physiological immaturity of the intestine and altered levels of normal flora in the gut. Understanding the factors that contribute to the pathology of NEC may lead to the development of treatment strategies aimed at re-establishing the integrity of the epithelial wall and preventing the propagation of inflammation in NEC. Several studies have shown a reduced incidence and severity of NEC in neonates treated with probiotics ( beneficial bacteria species). Methodology/Principal Findings: The objective of this study is to use a mathematical model to predict the conditions under which probiotics may be successful in promoting the health of infants suffering from NEC. An ordinary differential equation model is developed that tracks the populations of pathogenic and probiotic bacteria in the intestinal lumen and in the blood/tissue region. The permeability of the intestinal epithelial layer is treated as a variable, and the role of the inflammatory response is included. The model predicts that in the presence of probiotics health is restored in many cases that would have been otherwise pathogenic. The timing of probiotic administration is also shown to determine whether or not health is restored. Finally, the model predicts that probiotics may be harmful to the NEC patient under very specific conditions, perhaps explaining the detrimental effects of probiotics observed in some clinical studies. Conclusions/Significance: The reduced, experimentally motivated mathematical model that we have developed suggests how a certain general set of characteristics of probiotics can lead to beneficial or detrimental outcomes for infants suffering from NEC, depending on the influences of probiotics on defined features of the inflammatory response.	[Arciero, Julia C.; Ermentrout, G. Bard; Rubin, Jonathan E.] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA; [Upperman, Jeffrey S.] Univ So Calif, Dept Surg, Los Angeles, CA USA; [Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Southern California; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Arciero, JC (corresponding author), Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA.	jarciero@pitt.edu	RUBIN, JONATHAN/AAD-9071-2019	Rubin, Jonathan/0000-0002-1513-1551	National Science Foundation [EMSW21-RTG 0739261]; National Institutes of Health [P50-GM-53789]; Division Of Mathematical Sciences [0739261] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM053789] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant EMSW21-RTG 0739261 (http://www.nsf.gov/) and National Institutes of Health Grant P50-GM-53789 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlFaleh K, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005496.pub2, 10.1097/AOG.0b013e3181726f2f]; AN G, 2009, WIRES IN PRESS; An G, 2008, J BURN CARE RES, V29, P277, DOI 10.1097/BCR.0b013e31816677c8; Barclay AR, 2007, J PEDIATR GASTR NUTR, V45, P569, DOI 10.1097/MPG.0b013e3181344694; Bewick S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008112; Bin-Nun A, 2005, J PEDIATR-US, V147, P192, DOI 10.1016/j.jpeds.2005.03.054; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; Claud EC, 2008, J CLIN GASTROENTEROL, V42, pS46, DOI 10.1097/MCG.0b013e31815a57a8; Dani C, 2002, BIOL NEONATE, V82, P103, DOI 10.1159/000063096; Day J, 2006, J THEOR BIOL, V242, P237, DOI 10.1016/j.jtbi.2006.02.015; Edelson MB, 1999, PEDIATRICS, V103, P766, DOI 10.1542/peds.103.4.766; Garcia-Lafuente A, 2001, GUT, V48, P503, DOI 10.1136/gut.48.4.503; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Guner YS, 2009, J SURG RES, V157, P21, DOI 10.1016/j.jss.2008.11.008; Hammerman C, 2006, CURR OPIN INFECT DIS, V19, P277, DOI 10.1097/01.qco.0000224823.73223.29; Han XN, 2004, SHOCK, V21, P261, DOI 10.1097/01.shk.0000112346.38599.10; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hoyos A B, 1999, Int J Infect Dis, V3, P197, DOI 10.1016/S1201-9712(99)90024-3; Hunter CJ, 2008, PEDIATR RES, V63, P117, DOI 10.1203/PDR.0b013e31815ed64c; Hunter CJ, 2009, INFECT IMMUN, V77, P1031, DOI 10.1128/IAI.01192-08; Kennedy RJ, 2002, GUT, V50, P441, DOI 10.1136/gut.50.3.441; Koffeman GI, 2003, BEST PRACT RES CL GA, V17, P879, DOI 10.1016/S1521-6918(03)00099-4; KOSLOSKE AM, 1980, ANN SURG, V192, P202, DOI 10.1097/00000658-198008000-00013; Kumar R, 2004, J THEOR BIOL, V230, P145, DOI 10.1016/j.jtbi.2004.04.044; Kumar R, 2008, SHOCK, V29, P104, DOI 10.1097/SHK.0b013e318067da56; Land MH, 2005, PEDIATRICS, V115, P178, DOI 10.1542/peds.2004-2137; Lin HC, 2008, PEDIATRICS, V122, P693, DOI 10.1542/peds.2007-3007; Lin PW, 2008, SEMIN PERINATOL, V32, P70, DOI 10.1053/j.semperi.2008.01.004; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; Markel TA, 2006, SHOCK, V25, P329, DOI 10.1097/01.shk.0000192126.33823.87; Mattar AF, 2001, PEDIATR SURG INT, V17, P265, DOI 10.1007/s003830100591; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Millar M, 2003, ARCH DIS CHILD-FETAL, V88, pF354, DOI 10.1136/fn.88.5.F354; Petty John K, 2005, Semin Pediatr Surg, V14, P191, DOI 10.1053/j.sempedsurg.2005.05.009; Reynolds A, 2006, J THEOR BIOL, V242, P220, DOI 10.1016/j.jtbi.2006.02.016; RICKETTS RR, 1990, WORLD J SURG, V14, P600, DOI 10.1007/BF01658800; Schanler RJ, 2001, PEDIATR CLIN N AM, V48, P207, DOI 10.1016/S0031-3955(05)70295-9; Szajewska H, 2006, J PEDIATR GASTR NUTR, V42, P454, DOI 10.1097/01.mpg.0000221913.88511.72; VODOVOTZ Y, 2009, IMMUNOTOXIC IN PRESS; Vodovotz Y, 2009, MATH BIOSCI, V217, P1, DOI 10.1016/j.mbs.2008.07.013; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014	42	38	39	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10066	10.1371/journal.pone.0010066	http://dx.doi.org/10.1371/journal.pone.0010066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419099	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000276853800004
J	Elnaccash, TW; Tonsor, SJ				Elnaccash, Tarek W.; Tonsor, Stephen J.			Something Old and Something New: Wedding Recombinant Inbred Lines with Traditional Line Cross Analysis Increases Power to Describe Gene Interactions	PLOS ONE			English	Article							BEETLE TRIBOLIUM-CASTANEUM; POPULATION DIFFERENTIATION; EPISTASIS; EVOLUTION; SELECTION; SUSCEPTIBILITY; SPECIATION; ADAPTATION; COMPONENTS; PATTERNS	In this paper we present a novel approach to quantifying genetic architecture that combines recombinant inbred lines (RIL) with line cross analysis (LCA). LCA is a method of quantifying directional genetic effects (i.e. summed effects of all loci) that differentiate two parental lines. Directional genetic effects are thought to be critical components of genetic architecture for the long term response to selection and as a cause of inbreeding depression. LCA typically begins with two inbred parental lines that are crossed to produce several generations such as F1, F2, and backcrosses to each parent. When a RIL population (founded from the same P1 and P2 as was used to found the line cross population) is added to the LCA, the sampling variance of several nonadditive genetic effect estimates is greatly reduced. Specifically, estimates of directional dominance, additive x additive, and dominance x dominance epistatic effects are reduced by 92%, 94%, and 56% respectively. The RIL population can be simultaneously used for QTL identification, thus uncovering the effects of specific loci or genomic regions as elements of genetic architecture. LCA and QTL mapping with RIL provide two qualitatively different measures of genetic architecture with the potential to overcome weaknesses of each approach alone. This approach provides cross-validation of the estimates of additive and additive x additive effects, much smaller confidence intervals on dominance, additive x additive and dominance x dominance estimates, qualitatively different measures of genetic architecture, and the potential when used together to balance the weaknesses of LCA or RIL QTL analyses when used alone.	[Elnaccash, Tarek W.; Tonsor, Stephen J.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Elnaccash, TW (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	Tarek.Elnaccash@gmail.com		Elnaccash, Tarek/0000-0002-2129-9529	National Science Foundation [DEB-0130347, IOS-0809171, K-12 038135]; Leroy K. Irvis Fund of the University of Pittsburgh	National Science Foundation(National Science Foundation (NSF)); Leroy K. Irvis Fund of the University of Pittsburgh	The work was supported by National Science Foundation grants DEB-0130347 and IOS-0809171 to SJT, the Leroy K. Irvis Fund of the University of Pittsburgh and an National Science Foundation Grade K-12 038135 Fellowship to TWE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankra-Badu GA, 2009, INT J OBESITY, V33, P89, DOI 10.1038/ijo.2008.215; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Beavis William D., 1998, P145; BRADSHAW WE, 2000, EPISTASIS EVOLUTIONA; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Carter AJR, 2005, THEOR POPUL BIOL, V68, P179, DOI 10.1016/j.tpb.2005.05.002; COCKERHAM CC, 1954, GENETICS, V39, P859; Combarros O, 2009, NEUROBIOL AGING, V30, P1333, DOI 10.1016/j.neurobiolaging.2007.11.027; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Coyne JA, 1997, EVOLUTION, V51, P295, DOI 10.1111/j.1558-5646.1997.tb02412.x; Demuth JP, 2007, EVOLUTION, V61, P494, DOI 10.1111/j.1558-5646.2007.00048.x; Demuth JP, 2006, ANNU REV ECOL EVOL S, V37, P289, DOI 10.1146/annurev.ecolsys.37.091305.110124; Demuth JP, 2007, EVOLUTION, V61, P694, DOI 10.1111/j.1558-5646.2007.00049.x; Demuth JP, 2005, AM NAT, V165, P524, DOI 10.1086/429276; Dobzhansky T., 1937; Dudley JW, 2007, CROP SCI, V47, pS20, DOI 10.2135/cropsci2007.04.0003IPBS; Dudley JW, 2008, CROP SCI, V48, P59, DOI 10.2135/cropsci2007.04.0242; Edmands S, 2002, TRENDS ECOL EVOL, V17, P520, DOI 10.1016/S0169-5347(02)02585-5; Erickson DL, 2006, EVOLUTION, V60, P225, DOI 10.1111/j.0014-3820.2006.tb01101.x; Fenster CB, 2000, EVOLUTION, V54, P1157, DOI 10.1111/j.0014-3820.2000.tb00551.x; FITSPATRICK BAM, 2008, AM NAT, V171, P491; Gavrilets S, 1997, TRENDS ECOL EVOL, V12, P307, DOI 10.1016/S0169-5347(97)01098-7; Hallander J, 2007, HEREDITY, V98, P349, DOI 10.1038/sj.hdy.6800946; Hansen TF, 2006, ANNU REV ECOL EVOL S, V37, P123, DOI 10.1146/annurev.ecolsys.37.091305.110224; HAYMAN BI, 1955, BIOMETRICS, V11, P69, DOI 10.2307/3001481; Keightley P. D., 2004, Plant Breeding Reviews, V24, P227; Kelly JK, 2005, GENETICS, V171, P1917, DOI 10.1534/genetics.105.041525; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Kusterer B, 2007, GENETICS, V175, P2009, DOI 10.1534/genetics.106.069005; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; LANDE R, 1980, EVOLUTION, V34, P292, DOI 10.1111/j.1558-5646.1980.tb04817.x; Lim U, 2005, J NUTR, V135, P1989, DOI 10.1093/jn/135.8.1989; Lopez-Fernandez H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001294; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Lynch M., 1998, GENETICS ANAL QUANTI; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Porter AH, 2002, EVOLUTION, V56, P2103; Presgraves DC, 2002, EVOLUTION, V56, P1168, DOI 10.1111/j.0014-3820.2002.tb01430.x; Qin SY, 2005, EUR J HUM GENET, V13, P807, DOI 10.1038/sj.ejhg.5201418; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Roff DA, 2006, EVOLUTION, V60, P1981, DOI 10.1111/j.0014-3820.2006.tb01836.x; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; Sun Z, 2006, PLANT BREEDING, V125, P277, DOI 10.1111/j.1439-0523.2006.01224.x; Tonsor SJ, 2005, PLANT CELL ENVIRON, V28, P2, DOI 10.1111/j.1365-3040.2004.01264.x; Wade MJ, 2000, EPISTASIS EVOLUTIONA, P213; Wagner GP, 1996, EVOLUTION, V50, P967, DOI 10.1111/j.1558-5646.1996.tb02339.x; Wegner KM, 2008, EVOLUTION, V62, P2381, DOI 10.1111/j.1558-5646.2008.00444.x; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; Wiltshire S, 2006, ANN HUM GENET, V70, P726, DOI 10.1111/j.1469-1809.2006.00289.x; *WOLFR RES INC, MATH VERS 6 0; Xu SZ, 2003, GENETICS, V165, P2259; Zeng ZB, 1999, GENET RES, V74, P279, DOI 10.1017/S0016672399004255	54	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10200	10.1371/journal.pone.0010200	http://dx.doi.org/10.1371/journal.pone.0010200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419131	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000276743500013
J	Molins, CR; Delorey, MJ; Yockey, BM; Young, JW; Sheldon, SW; Reese, SM; Schriefer, ME; Petersen, JM				Molins, Claudia R.; Delorey, Mark J.; Yockey, Brook M.; Young, John W.; Sheldon, Sarah W.; Reese, Sara M.; Schriefer, Martin E.; Petersen, Jeannine M.			Virulence Differences Among Francisella tularensis Subsp tularensis Clades in Mice	PLOS ONE			English	Article							TULAREMIA; STRAINS	Francisella tularensis subspecies tularensis (type A) and holarctica (type B) are of clinical importance in causing tularemia. Molecular typing methods have further separated type A strains into three genetically distinct clades, A1a, A1b and A2. Epidemiological analyses of human infections in the United States suggest that A1b infections are associated with a significantly higher mortality rate as compared to infections caused by A1a, A2 and type B. To determine if genetic differences as defined by molecular typing directly correlate with differences in virulence, A1a, A1b, A2 and type B strains were compared in C57BL/6 mice. Here we demonstrate significant differences between survival curves for infections caused by A1b versus A1a, A2 and type B, with A1b infected mice dying earlier than mice infected with A1a, A2 or type B; these results were conserved among multiple strains. Differences were also detected among type A clades as well as between type A clades and type B with respect to bacterial burdens, and gross anatomy in infected mice. Our results indicate that clades defined within F. tularensis subsp. tularensis by molecular typing methods correlate with virulence differences, with A1b strains more virulent than A1a, A2 and type B strains. These findings indicate type A strains are not equivalent with respect to virulence and have important implications for public health as well as basic research programs.	[Molins, Claudia R.; Delorey, Mark J.; Yockey, Brook M.; Young, John W.; Sheldon, Sarah W.; Reese, Sara M.; Schriefer, Martin E.; Petersen, Jeannine M.] Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO USA	Centers for Disease Control & Prevention - USA	Molins, CR (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO USA.	JPetersen@cdc.gov			American Society for Microbiology and Coordinating Center; Association of Public Health Laboratories	American Society for Microbiology and Coordinating Center; Association of Public Health Laboratories	Claudia R. Molins was funded by the American Society for Microbiology and Coordinating Center for Infectious Diseases as a postdoctoral fellow. Sara M. Reese is an Emerging Infectious Disease Research Fellow funded by the Association of Public Health Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckstrom-Sternberg SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000947; Broekhuijsen M, 2003, J CLIN MICROBIOL, V41, P2924, DOI 10.1128/JCM.41.7.2924-2931.2003; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; Del Blanco NG, 2002, J CLIN MICROBIOL, V40, P2964, DOI 10.1128/JCM.40.8.2964-2972.2002; DOWNS CM, 1949, J IMMUNOL, V63, P147; DOWNS CM, 1947, J IMMUNOL, V56, P217; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Farlow J, 2005, EMERG INFECT DIS, V11, P1835, DOI 10.3201/eid1112.050728; Jellison WL, 1961, WILDLIFE DISEASE, V17, P1; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Johansson A, 2000, J CLIN MICROBIOL, V38, P4180, DOI 10.1128/JCM.38.11.4180-4185.2000; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lee E, 2013, STAT METHODS SURVIVA; Molins-Schneekloth CR, 2008, APPL ENVIRON MICROB, V74, P336, DOI 10.1128/AEM.01522-07; National Research Council, 1996, GUIDE CARE USE LAB A, P1; OLSUFIEV N. G., 1959, JOUR HYG EPIDEMIOL MICROBIOL AND IMMUNOL, V3, P138; OLSUFJEV NG, 1982, J HYG EPID MICROB IM, V26, P291; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Pandya GA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-213; SJOSTEDT AB, 2005, PROTEOBACTERIA B, V2, P200; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Svensson K, 2005, J BACTERIOL, V187, P3903, DOI 10.1128/JB.187.11.3903-3908.2005; Twine SM, 2006, MICROB PATHOGENESIS, V40, P133, DOI 10.1016/j.micpath.2005.12.004	24	43	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10205	10.1371/journal.pone.0010205	http://dx.doi.org/10.1371/journal.pone.0010205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419133	Green Submitted, gold, Green Published			2022-12-25	WOS:000276743500015
J	Rodriguez-Rojas, A; Macia, MD; Couce, A; Gomez, C; Castaneda-Garcia, A; Oliver, A; Blazquez, J				Rodriguez-Rojas, Alexandro; Macia, Maria D.; Couce, Alejandro; Gomez, Cristina; Castaneda-Garcia, Alfredo; Oliver, Antonio; Blazquez, Jesus			Assessing the Emergence of Resistance: The Absence of Biological Cost In Vivo May Compromise Fosfomycin Treatments for P. aeruginosa Infections	PLOS ONE			English	Article							BETA-LACTAM ANTIBIOTICS; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; PLANKTONIC CULTURES; URINARY-TRACT; MULTIPLE; STRAINS; IMMUNIZATION; CEFTAZIDIME; EXPRESSION	Background: Fosfomycin is a cell wall inhibitor used efficiently to treat uncomplicated urinary tract and gastrointestinal infections. A very convenient feature of fosfomycin, among others, is that although the expected frequency of resistant mutants is high, the biological cost associated with mutation impedes an effective growth rate, and bacteria cannot offset the obstacles posed by host defenses or compete with sensitive bacteria. Due to the current scarcity of new antibiotics, fosfomycin has been proposed as an alternative treatment for other infections caused by a wide variety of bacteria, particularly Pseudomonas aeruginosa. However, whether fosfomycin resistance in P. aeruginosa provides a fitness cost still remains unknown. Principal Findings: We herein present experimental evidence to show that fosfomycin resistance cannot only emerge easily during treatment, but that it is also cost-free for P. aeruginosa. We also tested if, as has been reported for other species such as Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis, fosfomycin resistant strains are somewhat compromised in their virulence. As concerns colonization, persistence, lung damage, and lethality, we found no differences between the fosfomycin resistant mutant and its sensitive parental strain. The probability of acquisition in vitro of resistance to the combination of fosfomycin with other antibiotics ( tobramycin and imipenem) has also been studied. While the combination of fosfomycin with tobramycin makes improbable the emergence of resistance to both antibiotics when administered together, the combination of fosfomycin plus imipenem does not avoid the appearance of mutants resistant to both antibiotics. Conclusions: We have reached the conclusion that the use of fosfomycin for P. aeruginosa infections, even in combined therapy, might not be as promising as expected. This study should encourage the scientific community to assess the in vivo cost of resistance for specific antibiotic-bacterial species combinations, and therefore avoid reaching universal conclusions from single model organisms.	[Rodriguez-Rojas, Alexandro; Couce, Alejandro; Castaneda-Garcia, Alfredo; Blazquez, Jesus] CSIC, CNB, Madrid, Spain; [Macia, Maria D.; Oliver, Antonio] IUNICS, Hosp Son Dureta, Microbiol Serv, Palma de Mallorca, Spain; [Macia, Maria D.; Oliver, Antonio] IUNICS, Hosp Son Dureta, Unidad Invest, Palma de Mallorca, Spain; [Gomez, Cristina] Hosp Son Dureta, Serv Anat Patol, Palma de Mallorca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Universitat de les Illes Balears; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Universitat de les Illes Balears; Hospital Universitari Son Espases; Hospital Universitari Son Dureta	Rodriguez-Rojas, A (corresponding author), CSIC, CNB, Madrid, Spain.	arrojas@cnb.csic.es; blazquez@cnb.csic.es	Oliver, Antonio/V-5541-2019; IBIS, EVOLUCION/O-1921-2015; Rodríguez-Rojas, Alexandro/AAO-6084-2021; CastaÃeda, Alfredo/AAQ-5815-2020; Blazquez, Jesus/T-4680-2017; Castaneda, Alfredo/ABF-5497-2020; Oliver, Antonio/E-4048-2012	Oliver, Antonio/0000-0001-9327-1894; Rodríguez-Rojas, Alexandro/0000-0002-4119-8127; CastaÃeda, Alfredo/0000-0002-1441-6125; Blazquez, Jesus/0000-0003-0495-3848; Oliver, Antonio/0000-0001-9327-1894; Couce, Alejandro/0000-0002-4153-6018; Macia, Maria Dolores/0000-0001-5038-1356	Spanish Network for Research in Infectious Diseases [REIPI RD06/0008]; Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III;  [PI070215]	Spanish Network for Research in Infectious Diseases; Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III(Instituto de Salud Carlos III); 	Grants PI070215 and the Spanish Network for Research in Infectious Diseases (REIPI RD06/0008), both from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alos JI, 2007, REV ESP QUIM, V20, P211; Andersson DI, 2006, CURR OPIN MICROBIOL, V9, P461, DOI 10.1016/j.mib.2006.07.002; Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Bjorkman J, 2000, SCIENCE, V287, P1479, DOI 10.1126/science.287.5457.1479; Blanc Dominique S., 1998, Clin Microbiol Infect, V4, P242; Castaneda-Garcia A, 2009, J BACTERIOL, V191, P6968, DOI 10.1128/JB.00748-09; CHIN NX, 1986, DRUG EXP CLIN RES, V12, P943; *CLSI, 2006, CLSI METH DIL ANT SU; CORDARO JC, 1976, J BACTERIOL, V128, P785, DOI 10.1128/JB.128.3.785-793.1976; DiGiandomenico A, 2007, P NATL ACAD SCI USA, V104, P4624, DOI 10.1073/pnas.0608657104; Falagas ME, 2008, EXPERT REV ANTI-INFE, V6, P593, DOI 10.1586/14787210.6.5.593; Falagas ME, 2008, CLIN INFECT DIS, V46, P1069, DOI 10.1086/527442; Falagas ME, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.10.021; Foster PL, 2006, METHOD ENZYMOL, V409, P195, DOI 10.1016/S0076-6879(05)09012-9; GISMONDO MR, 1994, J CHEMOTHERAPY, V6, P167; HAAG R, 1981, IMMUN INFEKT, V9, P177; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; JOHANSEN HK, 1994, INFECT IMMUN, V62, P3146, DOI 10.1128/IAI.62.8.3146-3155.1994; JONES ME, 1994, GENETICS, V136, P1209; KADNER RJ, 1973, J BACTERIOL, V113, P895, DOI 10.1128/JB.113.2.895-900.1973; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Kawaguchi K, 2002, BIOL PHARM BULL, V25, P1658, DOI 10.1248/bpb.25.1658; KLEIN U, 1985, CHEMOTHERAPY, V31, P138, DOI 10.1159/000238326; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lemieux MJ, 2004, RES MICROBIOL, V155, P623, DOI 10.1016/j.resmic.2004.05.016; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Macia MD, 2005, ANTIMICROB AGENTS CH, V49, P3382, DOI 10.1128/AAC.49.8.3382-3386.2005; Marchese A, 2003, INT J ANTIMICROB AG, V22, pS53, DOI 10.1016/S0924-8579(03)00230-9; Mena A, 2008, J BACTERIOL, V190, P7910, DOI 10.1128/JB.01147-08; Moya B, 2008, ANTIMICROB AGENTS CH, V52, P3694, DOI 10.1128/AAC.00172-08; Mueller-Ortiz SL, 2004, INFECT IMMUN, V72, P2899, DOI 10.1128/IAI.72.5.2899-2906.2004; Nilsson AI, 2003, ANTIMICROB AGENTS CH, V47, P2850, DOI 10.1128/AAC.47.9.2850-2858.2003; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; OLAY T, 1978, J ANTIMICROB CHEMOTH, V4, P569, DOI 10.1093/jac/4.6.569; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Oteo J, 2009, J ANTIMICROB CHEMOTH, V64, P712, DOI 10.1093/jac/dkp288; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Rodriguez-Rojas A, 2009, J BACTERIOL, V191, P844, DOI 10.1128/JB.01081-08; SCHINDLER J, 1979, ZBL BAKT-INT J MED M, V243, P136; Schweizer HP, 1996, J BACTERIOL, V178, P5215, DOI 10.1128/jb.178.17.5215-5221.1996; Shorr AF, 2009, CRIT CARE MED, V37, P1463, DOI 10.1097/CCM.0b013e31819ced02; STRATEVA T, 2009, J MED MICROBIOL; SUAREZ JE, 1991, ANTIMICROB AGENTS CH, V35, P791, DOI 10.1128/AAC.35.5.791; Takahata S, 2010, INT J ANTIMICROB AG, V35, P333, DOI 10.1016/j.ijantimicag.2009.11.011; Tessier F, 1997, EUR J CLIN MICROBIOL, V16, P159, DOI 10.1007/BF01709477; TSURUOKA T, 1978, J ANTIBIOT, V31, P192, DOI 10.7164/antibiotics.31.192; Visalli MA, 1998, ANTIMICROB AGENTS CH, V42, P953, DOI 10.1128/AAC.42.4.953; Waite RD, 2005, J BACTERIOL, V187, P6571, DOI 10.1128/JB.187.18.6571-6576.2005; Waite RD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-162; Ward H, 2009, J EVOLUTION BIOL, V22, P997, DOI 10.1111/j.1420-9101.2009.01712.x; Yonezawa M, 2000, J Infect Chemother, V6, P155, DOI 10.1007/s101560070015; ZENGEL JM, 1977, J BACTERIOL, V129, P1320, DOI 10.1128/JB.129.3.1320-1329.1977	52	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10193	10.1371/journal.pone.0010193	http://dx.doi.org/10.1371/journal.pone.0010193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419114	Green Submitted, gold, Green Published			2022-12-25	WOS:000276707100010
J	Sauguet, L; Klinge, S; Perera, RL; Maman, JD; Pellegrini, L				Sauguet, Ludovic; Klinge, Sebastian; Perera, Rajika L.; Maman, Joseph D.; Pellegrini, Luca			Shared Active Site Architecture between the Large Subunit of Eukaryotic Primase and DNA Photolyase	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; P58 SUBUNIT; INITIATION; REFINEMENT; MECHANISM; BINDING; REPAIR; DOMAIN	Background: DNA synthesis during replication relies on RNA primers synthesised by the primase, a specialised DNA-dependent RNA polymerase that can initiate nucleic acid synthesis de novo. In archaeal and eukaryotic organisms, the primase is a heterodimeric enzyme resulting from the constitutive association of a small (PriS) and large (PriL) subunit. The ability of the primase to initiate synthesis of an RNA primer depends on a conserved Fe-S domain at the C-terminus of PriL (PriL-CTD). However, the critical role of the PriL-CTD in the catalytic mechanism of initiation is not understood. Methodology/Principal Findings: Here we report the crystal structure of the yeast PriL-CTD at 1.55 angstrom resolution. The structure reveals that the PriL-CTD folds in two largely independent alpha-helical domains joined at their interface by a [4F-e4S] cluster. The larger N-terminal domain represents the most conserved portion of the PriL-CTD, whereas the smaller C-terminal domain is largely absent in archaeal PriL. Unexpectedly, the N-terminal domain reveals a striking structural similarity with the active site region of the DNA photolyase/cryptochrome family of flavoproteins. The region of similarity includes PriL-CTD residues that are known to be essential for initiation of RNA primer synthesis by the primase. Conclusion/Significance: Our study reports the first crystallographic model of the conserved Fe-S domain of the archaeal/eukaryotic primase. The structural comparison with a cryptochrome protein bound to flavin adenine dinucleotide and single-stranded DNA provides important insight into the mechanism of RNA primer synthesis by the primase.	[Sauguet, Ludovic; Klinge, Sebastian; Perera, Rajika L.; Maman, Joseph D.; Pellegrini, Luca] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge	Sauguet, L (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	lp212@cam.ac.uk	Pellegrini, Luca/AAE-2312-2022	Pellegrini, Luca/0000-0002-9300-497X; Perera, Rajika/0000-0002-4932-8168	Wellcome Trust; Gates Cambridge Trust scholarship; Medical Research Council	Wellcome Trust(Wellcome Trust); Gates Cambridge Trust scholarship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wellcome Trust senior research fellowship award in basic biomedical science to LP. SK was funded by a Gates Cambridge Trust scholarship and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arezi B, 1999, BIOCHEMISTRY-US, V38, P12899, DOI 10.1021/bi9908991; Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; BADARACCO G, 1986, EUR J BIOCHEM, V161, P435, DOI 10.1111/j.1432-1033.1986.tb10463.x; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essen LO, 2006, CURR OPIN STRUC BIOL, V16, P51, DOI 10.1016/j.sbi.2006.01.004; FOIANI M, 1989, MOL CELL BIOL, V9, P3081, DOI 10.1128/MCB.9.7.3081; FOIANI M, 1989, J BIOL CHEM, V264, P2189; FRANCESCONI S, 1991, P NATL ACAD SCI USA, V88, P3877, DOI 10.1073/pnas.88.9.3877; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lao-Sirieix SH, 2005, NAT STRUCT MOL BIOL, V12, P1137, DOI 10.1038/nsmb1013; Muller M, 2009, CURR OPIN STRUC BIOL, V19, P277, DOI 10.1016/j.sbi.2009.05.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pokorny R, 2008, P NATL ACAD SCI USA, V105, P21023, DOI 10.1073/pnas.0805830106; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Stillman B, 2008, MOL CELL, V30, P259, DOI 10.1016/j.molcel.2008.04.011; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	29	47	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10083	10.1371/journal.pone.0010083	http://dx.doi.org/10.1371/journal.pone.0010083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404922	gold, Green Published, Green Submitted			2022-12-25	WOS:000276482100009
J	Chi, CW; Zhu, HH; Han, M; Zhuang, YA; Wu, XH; Xu, TA				Chi, Congwu; Zhu, Huanhu; Han, Min; Zhuang, Yuan; Wu, Xiaohui; Xu, Tian			Disruption of Lysosome Function Promotes Tumor Growth and Metastasis in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEEP-ORANGE; PROTEIN-DEGRADATION; MOLECULAR CHARACTERIZATION; VACUOLAR BIOGENESIS; ASCITES HEPATOMA; RAT HEPATOCYTES; GENETIC SCREEN; CATHEPSIN-D; FAT-BODY; AUTOPHAGY	Lysosome function is essential to many physiological processes. It has been suggested that deregulation of lysosome function could contribute to cancer. Through a genetic screen in Drosophila, we have discovered that mutations disrupting lysosomal degradation pathway components contribute to tumor development and progression. Loss-of-function mutations in the Class C vacuolar protein sorting (VPS) gene, deep orange (dor), dramatically promote tumor overgrowth and invasion of the Ras(V12) cells. Knocking down either of the two other components of the Class C VPS complex, carnation (car) and vps16A, also renders Ras(V12) cells capable for uncontrolled growth and metastatic behavior. Finally, chemical disruption of the lysosomal function by feeding animals with antimalarial drugs, chloroquine or monensin, leads to malignant tumor growth of the Ras(V12) cells. Taken together, our data provide evidence for a causative role of lysosome dysfunction in tumor growth and invasion and indicate that members of the Class C VPS complex behave as tumor suppressors.	Fudan Univ, Sch Life Sci, Fudan Yale Ctr Biomed Res, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China; [Han, Min] Univ Colorado, Howard Hughes Med Inst, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Zhuang, Yuan] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27701 USA; [Xu, Tian] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06536 USA	Fudan University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Duke University; Howard Hughes Medical Institute; Yale University		xiaohui_wu@fudan.edu.cn; tian.xu@yale.edu		zhuang, yuan/0000-0002-2964-3654	National Natural Science Foundation of China [30270694]; Chinese Key Projects for Basic Research [2006CB806702]; Hi-tech Research and Development Project [2007AA022101]; Chinese Ministry of Education [05PJ14024]; Shanghai Rising-Star Program [06QA14006]; National Institutes of Health NCI [R01 CA069408]; NATIONAL CANCER INSTITUTE [R01CA069408] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Key Projects for Basic Research; Hi-tech Research and Development Project(National High Technology Research and Development Program of China); Chinese Ministry of Education(Ministry of Education, China); Shanghai Rising-Star Program; National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Natural Science Foundation of China (Grant 30270694), Chinese Key Projects for Basic Research (973) (Grant 2006CB806702), Hi-tech Research and Development Project (863) (Grant 2007AA022101), 211 and 985 projects of Chinese Ministry of Education, Shanghai Pujiang Program (Grant 05PJ14024), and Shanghai Rising-Star Program (Grant 06QA14006). This work was also supported in part by National Institutes of Health NCI Grant R01 CA069408 (to T. X.).	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; BRADLEY MO, 1977, J BIOL CHEM, V252, P5310; Brouillet JP, 1997, CANCER, V79, P2132, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2132::AID-CNCR10>3.3.CO;2-L; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; DUTTA P, 1994, CANCER LETT, V76, P113, DOI 10.1016/0304-3835(94)90386-7; GRINDE B, 1983, EXP CELL RES, V149, P27, DOI 10.1016/0014-4827(83)90377-4; HIRANO T, 1993, CANCER LETT, V70, P41, DOI 10.1016/0304-3835(93)90072-H; Huizing M, 2001, GENE, V264, P241, DOI 10.1016/S0378-1119(01)00333-X; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Kim BY, 2001, J BIOL CHEM, V276, P29393, DOI 10.1074/jbc.M101778200; KISEN GO, 1993, CARCINOGENESIS, V14, P2501, DOI 10.1093/carcin/14.12.2501; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lindmo K, 2006, EXP CELL RES, V312, P2018, DOI 10.1016/j.yexcr.2006.03.002; Lloyd V, 1998, TRENDS CELL BIOL, V8, P257, DOI 10.1016/S0962-8924(98)01270-7; Maldonado E, 2006, PIGM CELL RES, V19, P315, DOI 10.1111/j.1600-0749.2006.00320.x; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Poupon V, 2003, MOL BIOL CELL, V14, P4015, DOI 10.1091/mbc.E03-01-0040; PRESTON RA, 1991, MOL CELL BIOL, V11, P5801, DOI 10.1128/MCB.11.12.5801; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Rieder SE, 1997, MOL BIOL CELL, V8, P2307, DOI 10.1091/mbc.8.11.2307; ROCHEFORT H, 1990, CANCER METAST REV, V9, P321, DOI 10.1007/BF00049522; Sadler KC, 2005, DEVELOPMENT, V132, P3561, DOI 10.1242/dev.01918; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; Sevrioukov EA, 1999, MOL CELL, V4, P479, DOI 10.1016/S1097-2765(00)80199-9; Shestopal SA, 1997, MOL GEN GENET, V253, P642; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Sriram V, 2003, J CELL BIOL, V161, P593, DOI 10.1083/jcb.200210166; Suzuki T, 2003, P NATL ACAD SCI USA, V100, P1146, DOI 10.1073/pnas.0237292100; TESSITORE L, 1988, BIOCHEM J, V251, P483, DOI 10.1042/bj2510483; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; Yogosawa S, 2005, J BIOL CHEM, V280, P41619, DOI 10.1074/jbc.M508397200; Yu JF, 2006, PIGM CELL RES, V19, P628, DOI 10.1111/j.1600-0749.2006.00346.x	43	37	38	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21817	21823		10.1074/jbc.M110.131714	http://dx.doi.org/10.1074/jbc.M110.131714			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20418542	hybrid, Green Published			2022-12-25	WOS:000279516100066
J	Koike, M; Fukushi, J; Ichinohe, Y; Higashimae, N; Fujishiro, M; Sasaki, C; Yamaguchi, M; Uchihara, T; Yagishita, S; Ohizumi, H; Hori, S; Kakizuka, A				Koike, Masaaki; Fukushi, Junpei; Ichinohe, Yuzuru; Higashimae, Naoki; Fujishiro, Masahiko; Sasaki, Chiyomi; Yamaguchi, Masahiro; Uchihara, Toshiki; Yagishita, Saburo; Ohizumi, Hiroshi; Hori, Seiji; Kakizuka, Akira			Valosin-containing Protein (VCP) in Novel Feedback Machinery between Abnormal Protein Accumulation and Transcriptional Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY MYOPATHY; AMYOTROPHIC-LATERAL-SCLEROSIS; MACHADO-JOSEPH-DISEASE; CREB-BINDING PROTEIN; NEURONAL CELL-DEATH; FRONTOTEMPORAL DEMENTIA; PAGET-DISEASE; P97/VALOSIN-CONTAINING PROTEIN; NEURODEGENERATIVE DISORDERS; EXPANDED POLYGLUTAMINE	Abnormal protein accumulation is often observed in human neurodegenerative disorders such as polyglutamine diseases and Parkinson disease. Genetic and biochemical analyses indicate that valosin-containing protein (VCP) is a crucial molecule in the pathogenesis of human neurodegenerative disorders. We report here that VCP was specifically modified in neuronal cells with abnormal protein accumulation; this modification caused the translocation of VCP into the nucleus. Modification-mimic forms of VCP induced transcriptional suppression with deacetylation of core histones, leading to cell atrophy and the decrease of de novo protein synthesis. Preventing VCP nuclear translocation in polyglutamine-expressing neuronal cells and Drosophila eyes mitigated neurite retraction and eye degenerations, respectively, concomitant with the recovery of core histone acetylation. This represents a novel feedback mechanism that regulates abnormal protein levels in the cytoplasm during physiological processes, as well as in pathological conditions such as abnormal protein accumulation in neurodegenerations.	[Koike, Masaaki; Fukushi, Junpei; Ichinohe, Yuzuru; Higashimae, Naoki; Fujishiro, Masahiko; Sasaki, Chiyomi; Ohizumi, Hiroshi; Hori, Seiji; Kakizuka, Akira] Kyoto Univ, Grad Sch Biostudies & Solut Oriented Res Sci & Te, Lab Funct Biol, Kyoto 6068501, Japan; [Yamaguchi, Masahiro] Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo 1130033, Japan; [Uchihara, Toshiki] Tokyo Metropolitan Inst Neurosci, Dept Neurol, Tokyo 1838526, Japan; [Yagishita, Saburo] Kanagawa Rehabil Ctr, Dept Pathol, Atsugi, Kanagawa 2430121, Japan	Kyoto University; University of Tokyo; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Kakizuka, A (corresponding author), Kyoto Univ, Grad Sch Biostudies & Solut Oriented Res Sci & Te, Lab Funct Biol, Kyoto 6068501, Japan.	kakizuka@lif.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Braun RJ, 2008, BBA-MOL CELL RES, V1783, P1418, DOI 10.1016/j.bbamcr.2008.01.015; Djamshidian A, 2009, MUSCLE NERVE, V39, P389, DOI 10.1002/mus.21225; Edmondson DG, 2002, J BIOL CHEM, V277, P29496, DOI 10.1074/jbc.M200651200; Forman MS, 2006, J NEUROPATH EXP NEUR, V65, P571, DOI 10.1097/00005072-200606000-00005; Gaertig J, 2008, CURR TOP DEV BIOL, V85, P83, DOI 10.1016/S0070-2153(08)00804-1; Giuliano P, 2003, HUM MOL GENET, V12, P2301, DOI 10.1093/hmg/ddg242; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Haubenberger D, 2005, NEUROLOGY, V65, P1304, DOI 10.1212/01.wnl.0000180407.15369.92; Higashiyama H, 2002, CELL DEATH DIFFER, V9, P264, DOI 10.1038/sj.cdd.4400955; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Ishigaki S, 2004, J BIOL CHEM, V279, P51376, DOI 10.1074/jbc.M406683200; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Kakizuka A, 1998, TRENDS GENET, V14, P396, DOI 10.1016/S0168-9525(98)01559-5; Kakizuka A, 2008, BIOCHEM SOC T, V36, P105, DOI 10.1042/BST0360105; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kimonis VE, 2008, BBA-MOL BASIS DIS, V1782, P744, DOI 10.1016/j.bbadis.2008.09.003; Klein JB, 2005, J BIOL CHEM, V280, P31870, DOI 10.1074/jbc.M501802200; Kobayashi T, 2003, CYTOGENET GENOME RES, V100, P261, DOI 10.1159/000072862; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Livingstone M, 2005, CANCER RES, V65, P7533, DOI 10.1158/0008-5472.CAN-04-3729; Mizuno Y, 2003, NEUROSCI LETT, V343, P77, DOI 10.1016/S0304-3940(03)00280-5; Mori S, 2006, MOL CELL BIOCHEM, V288, P47, DOI 10.1007/s11010-006-9117-7; Mori-Konya C, 2009, GENES CELLS, V14, P483, DOI 10.1111/j.1365-2443.2009.01286.x; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Noguchi M, 2005, J BIOL CHEM, V280, P41332, DOI 10.1074/jbc.M509700200; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Reina CP, 2010, HUM MOL GENET, V19, P235, DOI 10.1093/hmg/ddp482; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Rouaux C, 2007, J NEUROSCI, V27, P5535, DOI 10.1523/JNEUROSCI.1139-07.2007; Saha RN, 2006, CELL DEATH DIFFER, V13, P539, DOI 10.1038/sj.cdd.4401769; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Whiteheart SW, 2004, J STRUCT BIOL, V146, P32, DOI 10.1016/j.jsb.2003.09.015; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Yasuda S, 1999, GENES CELLS, V4, P743, DOI 10.1046/j.1365-2443.1999.00294.x; Yu ZX, 2002, HUM MOL GENET, V11, P905, DOI 10.1093/hmg/11.8.905	50	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21736	21749		10.1074/jbc.M109.099283	http://dx.doi.org/10.1074/jbc.M109.099283			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20410307	hybrid, Green Published			2022-12-25	WOS:000279516100060
J	Clausen, JD; Andersen, JP				Clausen, Johannes D.; Andersen, Jens Peter			Glutamate 90 at the Luminal Ion Gate of Sarcoplasmic Reticulum Ca2+-ATPase Is Critical for Ca2+ Binding on Both Sides of the Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL CONSEQUENCES; CALCIUM-PUMP; ADENOSINE-TRIPHOSPHATASE; INORGANIC-PHOSPHATE; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURES; AMINO-ACIDS; PHOSPHORYLATION; TRANSPORT; DOMAIN	The roles of Ser(72), Glu(90), and Lys(297) at the luminal ends of transmembrane helices M1, M2, and M4 of sarcoplasmic reticulum Ca2+-ATPase were examined by transient and steady-state kinetic analysis of mutants. The dependence on the luminal Ca2+ concentration of phosphorylation by P-i ("Ca2+ gradient-dependent E2P formation") showed a reduction of the apparent affinity for luminal Ca2+ in mutants with alanine or leucine replacement of Glu(90), whereas arginine replacement of Glu(90) or Ser(72) allowed E2P formation from P-i even at luminal Ca2+ concentrations much too small to support phosphorylation in wild type. The latter mutants further displayed a blocked dephosphorylation of E2P and an increased rate of conversion of the ADP-sensitive E1P phosphoenzyme intermediate to ADP-insensitive E2P as well as insensitivity of the E2.BeF3- complex to luminal Ca2+. Altogether, these findings, supported by structural modeling, indicate that the E2P intermediate is stabilized in the mutants with arginine replacement of Glu(90) or Ser(72), because the positive charge of the arginine side chain mimics Ca2+ occupying a luminally exposed low affinity Ca2+ site of E2P, thus identifying an essential locus (a "leaving site") on the luminal Ca2+ exit pathway. Mutants with alanine or leucine replacement of Glu(90) further displayed a marked slowing of the Ca2+ binding transition as well as slowing of the dissociation of Ca2+ from Ca(2)E1 back toward the cytoplasm, thus demonstrating that Glu(90) is also critical for the function of the cytoplasmically exposed Ca2+ sites on the opposite side of the membrane relative to where Glu(90) is located.	[Clausen, Johannes D.; Andersen, Jens Peter] Aarhus Univ, Dept Physiol & Biophys, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Disease PUMPKIN, DK-8000 Aarhus C, Denmark	Aarhus University; Danmarks Grundforskningsfond	Andersen, JP (corresponding author), Aarhus Univ, Dept Physiol & Biophys, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Disease PUMPKIN, Ole Worms Alle 6,Bldg 1180, DK-8000 Aarhus C, Denmark.	jpa@fi.au.dk		Andersen, Jens Peter/0000-0003-0654-4300	Danish Medical Research Council; Danish National Research Foundation (PUMPKIN Centre); Novo Nordisk Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Research Foundation (PUMPKIN Centre)(Danmarks Grundforskningsfond); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported in part by grants from the Danish Medical Research Council, the Danish National Research Foundation (PUMPKIN Centre), and the Novo Nordisk Foundation.	ANDERSEN JP, 1992, J BIOL CHEM, V267, P19383; Andersen JP, 1995, BIOSCIENCE REP, V15, P243, DOI 10.1007/BF01788358; Andersen JP, 2001, J BIOL CHEM, V276, P23312, DOI 10.1074/jbc.M102384200; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; BEIL FU, 1977, EUR J BIOCHEM, V81, P151, DOI 10.1111/j.1432-1033.1977.tb11936.x; BISHOP JE, 1988, J BIOL CHEM, V263, P1886; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen L, 1996, J BIOL CHEM, V271, P10745, DOI 10.1074/jbc.271.18.10745; Clausen JD, 2006, J BIOL CHEM, V281, P9471, DOI 10.1074/jbc.M512371200; Clausen JD, 2004, J BIOL CHEM, V279, P54426, DOI 10.1074/jbc.M410204200; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2009, J BIOL CHEM, V284, P22722, DOI 10.1074/jbc.M109.029702; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; GUILLAIN F, 1981, J BIOL CHEM, V256, P6140; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; Marchand A, 2008, J BIOL CHEM, V283, P14867, DOI 10.1074/jbc.M710165200; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PETITHORY JR, 1988, BIOCHEMISTRY-US, V27, P5553, DOI 10.1021/bi00415a025; PICK U, 1982, J BIOL CHEM, V257, P6111; PUNZENGRUBER C, 1978, EUR J BIOCHEM, V92, P349, DOI 10.1111/j.1432-1033.1978.tb12754.x; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2000, J BIOL CHEM, V275, P5400, DOI 10.1074/jbc.275.8.5400; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; TROULLIER A, 1992, J BIOL CHEM, V267, P22821; VILSEN B, 1991, J BIOL CHEM, V266, P16157; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925; VILSEN B, 1989, J BIOL CHEM, V264, P21024	41	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20780	20792		10.1074/jbc.M110.116459	http://dx.doi.org/10.1074/jbc.M110.116459			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20421308	Green Published, hybrid			2022-12-25	WOS:000279228600042
J	Cobucci-Ponzano, B; Aurilia, V; Riccio, G; Henrissat, B; Coutinho, PM; Strazzulli, A; Padula, A; Corsaro, MM; Pieretti, G; Pocsfalvi, G; Fiume, I; Cannio, R; Rossi, M; Moracci, M				Cobucci-Ponzano, Beatrice; Aurilia, Vincenzo; Riccio, Gennaro; Henrissat, Bernard; Coutinho, Pedro M.; Strazzulli, Andrea; Padula, Anna; Corsaro, Maria Michela; Pieretti, Giuseppina; Pocsfalvi, Gabriella; Fiume, Immacolata; Cannio, Raffaele; Rossi, Mose; Moracci, Marco			A New Archaeal beta-Glycosidase from Sulfolobus solfataricus SEEDING A NOVEL RETAINING beta-GLYCAN-SPECIFIC GLYCOSIDE HYDROLASE FAMILY ALONG WITH THE HUMAN NON-LYSOSOMAL GLUCOSYLCERAMIDASE GBA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NONLYSOSOMAL GLUCOSYLCERAMIDASE; CATALYTIC NUCLEOPHILE; GAUCHER DISEASE; IDENTIFICATION; GLUCOSIDASE; MECHANISMS; GENERATION; MIGLUSTAT; BINDING	Carbohydrate active enzymes (CAZymes) are a large class of enzymes, which build and breakdown the complex carbohydrates of the cell. On the basis of their amino acid sequences they are classified in families and clans that show conserved catalytic mechanism, structure, and active site residues, but may vary in substrate specificity. We report here the identification and the detailed molecular characterization of a novel glycoside hydrolase encoded from the gene sso1353 of the hyperthermophilic archaeon Sulfolobus solfataricus. This enzyme hydrolyzes aryl beta-gluco- and beta-xylosides and the observation of transxylosylation reactions products demonstrates that SSO1353 operates via a retaining reaction mechanism. The catalytic nucleophile (Glu-335) was identified through trapping of the 2-deoxy-2-fluoroglucosyl enzyme intermediate and subsequent peptide mapping, while the general acid/base was identified as Asp-462 through detailed mechanistic analysis of a mutant at that position, including azide rescue experiments. SSO1353 has detectable homologs of unknown specificity among Archaea, Bacteria, and Eukarya and shows distant similarity to the non-lysosomal bile acid beta-glucosidase GBA2 also known as glucocerebrosidase. On the basis of our findings we propose that SSO1353 and its homologs are classified in a new CAZy family, named GH116, which so far includes beta-glucosidases (EC 3.2.1.21), beta-xylosidases (EC 3.2.1.37), and glucocerebrosidases (EC 3.2.1.45) as known enzyme activities.	[Strazzulli, Andrea; Padula, Anna; Pocsfalvi, Gabriella; Fiume, Immacolata; Cannio, Raffaele; Rossi, Mose; Moracci, Marco] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Henrissat, Bernard; Coutinho, Pedro M.] Univ Aix Marseille 1, CNRS, UMR6098, F-13288 Marseille, France; [Henrissat, Bernard; Coutinho, Pedro M.] Univ Aix Marseille 2, CNRS, UMR6098, F-13288 Marseille, France; [Corsaro, Maria Michela; Pieretti, Giuseppina] Univ Naples Federico II, Dipartimento Chim Organ & Biochim, I-80126 Naples, Italy; [Rossi, Mose] Univ Naples Federico II, Dipartimento Biol Strut & Funz, I-80126 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Naples Federico II; University of Naples Federico II	Moracci, M (corresponding author), CNR, Inst Prot Biochem, Via P Castellino 111, I-80131 Naples, Italy.	m.moracci@ibp.cnr.it	Cobucci-Ponzano, Beatrice/B-7654-2015; Pocsfalvi, Gabriella/K-3753-2013; Corsaro, Maria Michela/T-6190-2019; Pocsfalvi, Gabriella/C-4948-2015; Fiume, Immacolata/D-9018-2013; Aurilia, Vincenzo/C-1969-2015; Cobucci-Ponzano, Beatrice/AAX-7630-2020; Fiume, Immacolata/W-7951-2019; Strazzulli, Andrea/E-1343-2017; Henrissat, Bernard/J-2475-2012; Riccio, Gennaro/AAH-6275-2020; Moracci, Marco/B-8444-2015; Strazzulli, Andrea/P-5145-2016	Corsaro, Maria Michela/0000-0002-6834-8682; Pocsfalvi, Gabriella/0000-0001-6065-3853; Fiume, Immacolata/0000-0002-4160-528X; Aurilia, Vincenzo/0000-0002-4858-6616; Cobucci-Ponzano, Beatrice/0000-0002-8211-2297; Fiume, Immacolata/0000-0002-4160-528X; Henrissat, Bernard/0000-0002-3434-8588; Moracci, Marco/0000-0002-9846-2531; Padula, Anna/0000-0002-4779-9660; Riccio, Gennaro/0000-0003-2541-5790; Strazzulli, Andrea/0000-0002-9690-149X	Agenzia Spaziale Italiana [MoMa 1/014/06/0]	Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI))	This work was supported by Project MoMa 1/014/06/0 of the Agenzia Spaziale Italiana.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amory JK, 2007, HUM REPROD, V22, P702, DOI 10.1093/humrep/del414; BOCK K, 1983, ADV CARBOHYD CHEM BI, V41, P27, DOI 10.1016/S0065-2318(08)60055-4; Bone W, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-1; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caramelo JJ, 2007, SEMIN CELL DEV BIOL, V18, P732, DOI 10.1016/j.semcdb.2007.09.006; DeMarco ML, 2008, GLYCOBIOLOGY, V18, P426, DOI 10.1093/glycob/cwn026; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elferink MGL, 2001, MOL MICROBIOL, V39, P1494, DOI 10.1046/j.1365-2958.2001.02336.x; GRABOWSKI GA, 1990, CRIT REV BIOCHEM MOL, V25, P385, DOI 10.3109/10409239009090616; Grabowski GA, 2008, LANCET, V372, P1263, DOI 10.1016/S0140-6736(08)61522-6; Huang YW, 2005, BIOCHEM J, V385, P581, DOI 10.1042/BJ20041388; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Ly HD, 1999, ANNU REV BIOCHEM, V68, P487, DOI 10.1146/annurev.biochem.68.1.487; Mackenzie LF, 1997, J BIOL CHEM, V272, P3161, DOI 10.1074/jbc.272.6.3161; Matern H, 2001, J BIOL CHEM, V276, P37929; Maurelli L, 2008, EXTREMOPHILES, V12, P689, DOI 10.1007/s00792-008-0175-5; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Moracci M, 2001, METHOD ENZYMOL, V330, P201; NICOLAUS B, 1993, FEMS MICROBIOL LETT, V109, P203, DOI 10.1111/j.1574-6968.1993.tb06168.x; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Perugino G, 2006, BIOCATAL BIOTRANSFOR, V24, P23, DOI 10.1080/10242420500518581; Saxon E, 2001, ANNU REV CELL DEV BI, V17, P1, DOI 10.1146/annurev.cellbio.17.1.1; Shaikh FA, 2007, FEBS LETT, V581, P2441, DOI 10.1016/j.febslet.2007.04.053; Stam MR, 2005, CARBOHYD RES, V340, P2728, DOI 10.1016/j.carres.2005.09.018; Torarinsson E, 2005, ENVIRON MICROBIOL, V7, P47, DOI 10.1111/j.1462-2920.2004.00674.x; van der Spoel AC, 2002, P NATL ACAD SCI USA, V99, P17173, DOI 10.1073/pnas.262586099; VANWEELY S, 1993, BIOCHIM BIOPHYS ACTA, V1181, P55, DOI 10.1016/0925-4439(93)90090-N; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Williams SJ, 2000, CARBOHYD RES, V327, P27, DOI 10.1016/S0008-6215(00)00041-0; WITHERS SG, 1995, PROTEIN SCI, V4, P361; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zolghadr B, 2010, J BACTERIOL, V192, P104, DOI 10.1128/JB.01061-09	39	34	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20691	20703		10.1074/jbc.M109.086470	http://dx.doi.org/10.1074/jbc.M109.086470			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20427274	Green Published, hybrid			2022-12-25	WOS:000279228600033
J	Gomez, V; Sese, M; Santamaria, A; Martinez, JD; Castellanos, E; Soler, M; Thomson, TM; Paciucci, R				Gomez, Valenti; Sese, Marta; Santamaria, Anna; Martinez, Juan D.; Castellanos, Elisabet; Soler, Marta; Thomson, Timothy M.; Paciucci, Rosanna			Regulation of Aurora B Kinase by the Lipid Raft Protein Flotillin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3 PHOSPHORYLATION; CHROMOSOMAL PASSENGERS; REGGIE/FLOTILLIN PROTEINS; MEMBRANE MICRODOMAINS; CELL-DIVISION; SPINDLE; INCENP; REGGIE-1/FLOTILLIN-2; PROHIBITINS; CYTOKINESIS	The lipid raft protein Flotillin-1 was previously shown to be required for cell proliferation. Here we show that it is critical for the maintenance of the levels of the mitotic regulator Aurora B. Knock-down of Flotillin-1 induced aberrant mitotic events similar to those produced by Aurora B depletion and led to a marked decline in Aurora B levels and activity. Transfection of wild-type full-length Flotillin-1 or forms directed to the nucleus increased Aurora B levels and activity. Flotillin-1 interacted with Aurora B directly through its SPFH domain in a complex distinct from the chromosomal passenger protein complex, and the two proteins co-purified in nuclear, non-raft fractions. These observations are the first evidence for a function of Flotillin-1 outside of lipid rafts and suggest its critical role in the maintenance of a pool of active Aurora B.	[Paciucci, Rosanna] Hosp Valle De Hebron, Inst Recerca, Unitat Recerca Biomed, Barcelona 08035, Spain; [Martinez, Juan D.; Soler, Marta; Thomson, Timothy M.] CSIC, Inst Biol Mol Barcelona, Dept Biol Celular, ES-08034 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Paciucci, R (corresponding author), Hosp Valle De Hebron, Inst Recerca, Unitat Recerca Biomed, Pg Vall Hebron 119-129, Barcelona 08035, Spain.	rpaciucci@ir.vhebron.net	Sese, Marta/AAH-9749-2021; Castellanos, Elisabeth/F-9609-2016; Paciucci, Rosanna/AGP-3844-2022	Sese, Marta/0000-0003-1473-4833; Castellanos, Elisabeth/0000-0002-8133-5325; Paciucci, Rosanna/0000-0001-5651-5933; Gomez, Valenti/0000-0002-2162-6462	Ministry of Science and Education [SAF2005-05848, SAF2008-03936, SAF2008-04136-C02-01]; Ministry of Science and Technology [SAF2005-05109-C02-01]; Fundacio Marato TV3 [052610, 053130]; Institut de Recerca Vall d'Hebron; Centre de Referencia en Biotecnologia de Catalunya	Ministry of Science and Education; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Fundacio Marato TV3; Institut de Recerca Vall d'Hebron; Centre de Referencia en Biotecnologia de Catalunya	This work was supported by the Ministry of Science and Education (Grants SAF2005-05848, SAF2008-03936, and SAF2008-04136-C02-01), the Ministry of Science and Technology (Grant SAF2005-05109-C02-01), the Fundacio Marato TV3 (Grants 052610 and 053130), the Institut de Recerca Vall d'Hebron, and the Centre de Referencia en Biotecnologia de Catalunya.	Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Carvajal RD, 2006, CLIN CANCER RES, V12, P6869, DOI 10.1158/1078-0432.CCR-06-1405; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lange BMH, 2002, EMBO J, V21, P5364, DOI 10.1093/emboj/cdf531; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Limpert AS, 2007, MOL CELL BIOL, V27, P5686, DOI 10.1128/MCB.01109-06; Liu J, 2005, J BIOL CHEM, V280, P16125, DOI 10.1074/jbc.M500940200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Santamaria A, 2005, MOL CELL BIOL, V25, P1900, DOI 10.1128/MCB.25.5.1900-1911.2005; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Song JX, 2007, NAT IMMUNOL, V8, P64, DOI 10.1038/ni1413; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Sun L, 2008, P NATL ACAD SCI USA, V105, P7153, DOI 10.1073/pnas.0710018105; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Winter A, 2007, PROTEINS, V68, P353, DOI 10.1002/prot.21355	31	28	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20683	20690		10.1074/jbc.M110.130591	http://dx.doi.org/10.1074/jbc.M110.130591			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430883	hybrid, Green Published			2022-12-25	WOS:000279228600032
J	Maio, N; Polticelli, F; De Francesco, G; Rizzo, G; di Patti, MCB; Musci, G				Maio, Nunziata; Polticelli, Fabio; De Francesco, Giovanni; Rizzo, Gianluca; di Patti, Maria Carmela Bonaccorsi; Musci, Giovanni			Role of External Loops of Human Ceruloplasmin in Copper Loading by ATP7B and Ccc2p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PICHIA-PASTORIS; ACERULOPLASMINEMIA; EXPRESSION; DISORDER; ATPASES; PROTEIN; SYSTEM	Ceruloplasmin is a multicopper oxidase required for correct iron homeostasis. Previously, we have identified a ceruloplasmin mutant associated with the iron overload disease aceruloplasminemia, which was unable to acquire copper from themammalian pump ATP7B but could be produced in an enzymatically active form in yeast. Here, we report the expression of recombinant ceruloplasmin in the yeast Pichia pastoris and the study of the role of five surface-exposed loops in copper incorporation by comparing the efficiencies of mammalian ATP7B and yeast Ccc2p. The possibility to "mix and match" mammalian and yeast multicopper oxidases and copper ATPases can provide clues on the molecular features underlying the process of copper loading in multicopper oxidases.	[De Francesco, Giovanni; di Patti, Maria Carmela Bonaccorsi] Univ Roma La Sapienza, Dept Sci Biochim, I-00185 Rome, Italy; [Musci, Giovanni] Univ ROMA TRE, Dipartimento Biol, I-00146 Rome, Italy; [Musci, Giovanni] Univ Molise, Dipartimento Sci & Tecnol Agroalimentari, I-86100 Campobasso, Italy	Sapienza University Rome; Roma Tre University; University of Molise	di Patti, MCB (corresponding author), Univ Roma La Sapienza, Dept Sci Biochim, Ple A Moro 5, I-00185 Rome, Italy.	mariacarmela.bonaccorsi@uniroma1.it; musci@unimol.it	Rizzo, Gianluca/J-6540-2019; Bonaccorsi di Patti, Maria Carmela/F-1198-2011; Musci, Giovanni/H-2862-2012; Polticelli, Fabio/A-4573-2009	Rizzo, Gianluca/0000-0002-5540-0621; Bonaccorsi di Patti, Maria Carmela/0000-0002-4794-7037; Musci, Giovanni/0000-0002-5196-709X; Polticelli, Fabio/0000-0002-7657-2019; Maio, Nunziata/0000-0002-6225-6058	Telethon-Italy [GGP06173]	Telethon-Italy(Fondazione Telethon)	This work was supported by Telethon-Italy Grant GGP06173 (to G.M.).	Bielli P, 2001, J BIOL CHEM, V276, P2678, DOI 10.1074/jbc.M007176200; di Patti MC, 2009, J BIOL CHEM, V284, P4545, DOI 10.1074/jbc.M805688200; Cereghino GPL, 2001, GENE, V263, P159, DOI 10.1016/S0378-1119(00)00576-X; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; di Patti MCB, 1999, ARCH BIOCHEM BIOPHYS, V372, P295, DOI 10.1006/abbi.1999.1493; Hsi G, 2008, HUM MUTAT, V29, P491, DOI 10.1002/humu.20674; Hung IH, 1997, J BIOL CHEM, V272, P21461, DOI 10.1074/jbc.272.34.21461; Kuhn J, 2005, J NEUROL, V252, P111, DOI 10.1007/s00415-005-0608-3; Lutsenko S, 2008, ARCH BIOCHEM BIOPHYS, V476, P22, DOI 10.1016/j.abb.2008.05.005; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Miyajima H, 2003, NEUROPATHOLOGY, V23, P345, DOI 10.1046/j.1440-1789.2003.00521.x; Patel BN, 1997, J BIOL CHEM, V272, P20185, DOI 10.1074/jbc.272.32.20185; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SCHOSINSKY KH, 1975, CLIN CHEM, V21, P757; Sears IB, 1998, YEAST, V14, P783, DOI 10.1002/(SICI)1097-0061(19980615)14:8<783::AID-YEA272>3.0.CO;2-Y; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02	17	7	8	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20507	20513		10.1074/jbc.M109.090027	http://dx.doi.org/10.1074/jbc.M109.090027			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430895	Green Published, hybrid			2022-12-25	WOS:000279228600011
J	Tselnicker, I; Tsemakhovich, VA; Dessauer, CW; Dascal, N				Tselnicker, Isabella; Tsemakhovich, Vladimir A.; Dessauer, Carmen W.; Dascal, Nathan			Stargazin Modulates Neuronal Voltage-dependent Ca2+ Channel Ca(v)2.2 by a G beta gamma-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNELS; ACTIVATED K+ CHANNELS; G-PROTEIN INHIBITION; XENOPUS OOCYTES; POTASSIUM CHANNEL; ADENYLYL-CYCLASE; SUBUNITS; MOUSE; EXPRESSION; RECEPTORS	Loss of neuronal protein stargazin (gamma(2)) is associated with recurrent epileptic seizures and ataxia in mice. Initially, due to homology to the skeletal muscle calcium channel gamma(1) subunit, stargazin and other family members (gamma(3-8)) were classified as gamma subunits of neuronal voltage-gated calcium channels (such as Ca(V)2.1-Ca(V)2.3). Here, we report that stargazin interferes with G protein modulation of Ca(V)2.2 (N-type) channels expressed in Xenopus oocytes. Stargazin counteracted the G beta gamma-induced inhibition of Ca(V)2.2 channel currents, caused either by coexpression of the G beta gamma dimer or by activation of a G protein-coupled receptor. Expression of high doses of G beta gamma overcame the effects of stargazin. High affinity G beta gamma scavenger proteins m-c beta ARK and m-phosducin produced effects similar to stargazin. The effects of stargazin and m-c beta ARK were not additive, suggesting a common mechanism of action, and generally independent of the presence of the Ca-V beta(3) subunit. However, in some cases, coexpression of Ca-V beta(3) blunted the modulation by stargazin. Finally, the G beta gamma-opposing action of stargazin was not unique to Ca(V)2.2, as stargazin also inhibited the G beta gamma-mediated activation of the G protein-activated K+ channel. Purified cytosolic C-terminal part of stargazin bound G beta gamma in vitro. Our results suggest that the regulation by stargazin of biophysical properties of Ca(V)2.2 are not exerted by direct modulation of the channel but via a G beta gamma-dependent mechanism.	[Tselnicker, Isabella; Tsemakhovich, Vladimir A.; Dascal, Nathan] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Dessauer, Carmen W.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Tel Aviv University; Sackler Faculty of Medicine; University of Texas System; University of Texas Health Science Center Houston	Tselnicker, I (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	isabell1@post.tau.ac.il; dascaln@post.tau.ac.il	Farhy, Isabella/P-1367-2018; Dascal, Nathan/O-3915-2015; Dessauer, Carmen/N-6933-2018	Dascal, Nathan/0000-0002-5397-4146; Dessauer, Carmen/0000-0003-1210-4280	Israeli Ministry of Health [3-4879]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419] Funding Source: NIH RePORTER	Israeli Ministry of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Israeli Ministry of Health Grant 3-4879.	Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bauer PH, 1998, J BIOL CHEM, V273, P9465, DOI 10.1074/jbc.273.16.9465; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Berlin S, 2010, J BIOL CHEM, V285, P6179, DOI 10.1074/jbc.M109.085944; Blumenstein Y, 2004, J PHYSIOL-LONDON, V556, P121, DOI 10.1113/jphysiol.2003.056168; Bourinet E, 1996, P NATL ACAD SCI USA, V93, P1486, DOI 10.1073/pnas.93.4.1486; Canti C, 2001, BIOPHYS J, V81, P1439, DOI 10.1016/S0006-3495(01)75799-2; Canti C, 2000, J PHYSIOL-LONDON, V527, P419, DOI 10.1111/j.1469-7793.2000.t01-1-00419.x; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; Dascal N., 1992, METHODS MOL BIOL VOL, VVolume 13, P205; De Waard M, 2005, TRENDS PHARMACOL SCI, V26, P427, DOI 10.1016/j.tips.2005.06.008; Deng F, 2006, J NEUROSCI, V26, P7875, DOI 10.1523/JNEUROSCI.1851-06.2006; Dessauer CW, 1998, J BIOL CHEM, V273, P25831, DOI 10.1074/jbc.273.40.25831; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; Ferron L, 2008, J NEUROSCI, V28, P10604, DOI 10.1523/JNEUROSCI.2709-08.2008; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; IKEDA SR, 1996, NATURE, V380, P258; Kang MG, 2001, J BIOL CHEM, V276, P32917, DOI 10.1074/jbc.M100787200; Khosravani H, 2006, PHYSIOL REV, V86, P941, DOI 10.1152/physrev.00002.2006; KIM CM, 1993, J BIOL CHEM, V268, P15412; Klugbauer N, 2000, FEBS LETT, V470, P189, DOI 10.1016/S0014-5793(00)01306-5; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Meir A, 2000, BIOPHYS J, V79, P731, DOI 10.1016/S0006-3495(00)76331-4; Meir A, 2002, PFLUG ARCH EUR J PHY, V444, P263, DOI 10.1007/s00424-002-0803-3; Moss FJ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-23; Moss FJ, 2002, EMBO J, V21, P1514, DOI 10.1093/emboj/21.7.1514; Osten P, 2006, CURR OPIN NEUROBIOL, V16, P275, DOI 10.1016/j.conb.2006.04.002; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rishal I, 2005, J BIOL CHEM, V280, P16685, DOI 10.1074/jbc.M412196200; Rishal I, 2003, J BIOL CHEM, V278, P3840, DOI 10.1074/jbc.C200605200; ROCHE JP, 1995, FEBS LETT, V371, P43, DOI 10.1016/0014-5793(95)00860-C; Roche JP, 1998, J NEUROSCI, V18, P4883; Roche JP, 1998, J NEUROSCI, V18, P878; Rousset M, 2001, J PHYSIOL-LONDON, V532, P583, DOI 10.1111/j.1469-7793.2001.0583e.x; Rubinstein M, 2007, J PHYSIOL-LONDON, V581, P17, DOI 10.1113/jphysiol.2006.125864; Rubinstein M, 2009, J PHYSIOL-LONDON, V587, P3473, DOI 10.1113/jphysiol.2009.173229; Sandoval A, 2007, J NEUROSCI, V27, P3317, DOI 10.1523/JNEUROSCI.4566-06.2007; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; Sharp AH, 2001, NEUROSCIENCE, V105, P599, DOI 10.1016/S0306-4522(01)00220-2; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Wakamori M, 1998, J NEUROPHYSIOL, V79, P622, DOI 10.1152/jn.1998.79.2.622; Wakamori M, 1999, J PHYSIOL-LONDON, V517, P659, DOI 10.1111/j.1469-7793.1999.0659s.x; Zamponi GW, 1998, CURR OPIN NEUROBIOL, V8, P351, DOI 10.1016/S0959-4388(98)80060-3; Zhang Y, 2008, J NEUROSCI, V28, P14176, DOI 10.1523/JNEUROSCI.1350-08.2008	54	16	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20462	20471		10.1074/jbc.M110.121277	http://dx.doi.org/10.1074/jbc.M110.121277			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20435886	hybrid, Green Published			2022-12-25	WOS:000279228600006
J	Genkov, T; Meyer, M; Griffiths, H; Spreitzer, RJ				Genkov, Todor; Meyer, Moritz; Griffiths, Howard; Spreitzer, Robert J.			Functional Hybrid Rubisco Enzymes with Plant Small Subunits and Algal Large Subunits ENGINEERED rbcS cDNA FOR EXPRESSION IN CHLAMYDOMONAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; CHLOROPLAST RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; THERMAL-STABILITY; CATALYTIC-PROPERTIES; SPECIFICITY FACTOR; CRYSTAL-STRUCTURE; 1,5-BISPHOSPHATE CARBOXYLASE; CONCENTRATING MECHANISMS; SUPPRESSOR MUTATIONS; CO2/O-2 SPECIFICITY	There has been much interest in the chloroplast-encoded large subunit of ribulose-1,5-bisphosphate carboxylase/oxygenase ( Rubisco) as a target for engineering an increase in net CO2 fixation in photosynthesis. Improvements in the enzyme would lead to an increase in the production of food, fiber, and renewable energy. Although the large subunit contains the active site, a family of rbcS nuclear genes encodes the Rubisco small subunits, which can also influence the carboxylation catalytic efficiency and CO2/O-2 specificity of the enzyme. To further define the role of the small subunit in Rubisco function, small subunits from spinach, Arabidopsis, and sunflower were assembled with algal large subunits by transformation of a Chlamydomonas reinhardtii mutant that lacks the rbcS gene family. Foreign rbcS cDNAs were successfully expressed in Chlamydomonas by fusing them to a Chlamydomonas rbcS transit peptide sequence engineered to contain rbcS introns. Although plant Rubisco generally has greater CO2/O-2 specificity but a lower carboxylation V-max than Chlamydomonas Rubisco, the hybrid enzymes have 3-11% increases in CO2/O-2 specificity and retain near normal Vmax values. Thus, small subunits may make a significant contribution to the overall catalytic performance of Rubisco. Despite having normal amounts of catalytically proficient Rubisco, the hybrid mutant strains display reduced levels of photosynthetic growth and lack chloroplast pyrenoids. It appears that small subunits contain the structural elements responsible for targeting Rubisco to the algal pyrenoid, which is the site where CO2 is concentrated for optimal photosynthesis.	[Genkov, Todor; Spreitzer, Robert J.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Meyer, Moritz; Griffiths, Howard] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	University of Nebraska System; University of Nebraska Lincoln; University of Cambridge	Spreitzer, RJ (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	rspreitzer1@unl.edu	Meyer, Moritz/K-6540-2012; Meyer, Moritz Thomas/AAP-2161-2021		United States Department of Energy [DE-FG02-00ER15044]	United States Department of Energy(United States Department of Energy (DOE))	This work was supported in part by Grant DE-FG02-00ER15044 from the United States Department of Energy.	Andersson I, 1996, J MOL BIOL, V259, P160, DOI 10.1006/jmbi.1996.0310; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; ANDREWS TJ, 1985, J BIOL CHEM, V260, P4632; Borkhsenious ON, 1998, PLANT PHYSIOL, V116, P1585, DOI 10.1104/pp.116.4.1585; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN Z, 1988, P NATL ACAD SCI USA, V85, P4696, DOI 10.1073/pnas.85.13.4696; CHEN ZX, 1992, PHOTOSYNTH RES, V31, P157, DOI 10.1007/BF00028792; CHEN ZX, 1993, PLANT PHYSIOL, V101, P1189, DOI 10.1104/pp.101.4.1189; Chua N. H, 1980, METHOD ENZYMOL, V69, P434; CHUA NH, 1978, P NATL ACAD SCI USA, V75, P6110, DOI 10.1073/pnas.75.12.6110; CLONEY LP, 1993, PLANT MOL BIOL, V23, P1285, DOI 10.1007/BF00042362; Dhingra A, 2004, P NATL ACAD SCI USA, V101, P6315, DOI 10.1073/pnas.0400981101; DOBBERSTEIN B, 1977, P NATL ACAD SCI USA, V74, P1082, DOI 10.1073/pnas.74.3.1082; Du YC, 2000, P NATL ACAD SCI USA, V97, P14206, DOI 10.1073/pnas.260503997; Du YC, 2000, J BIOL CHEM, V275, P19844, DOI 10.1074/jbc.M002321200; FLUHR R, 1986, P NATL ACAD SCI USA, V83, P2358, DOI 10.1073/pnas.83.8.2358; Genkov T, 2006, ARCH BIOCHEM BIOPHYS, V451, P167, DOI 10.1016/j.abb.2006.04.012; Genkov T, 2009, J BIOL CHEM, V284, P30105, DOI 10.1074/jbc.M109.044081; Getzoff TP, 1998, PLANT PHYSIOL, V116, P695, DOI 10.1104/pp.116.2.695; GOLDSCHMIDTCLERMONT M, 1986, J MOL BIOL, V191, P421, DOI 10.1016/0022-2836(86)90137-3; Grimm R, 1997, FEBS LETT, V408, P350, DOI 10.1016/S0014-5793(97)00462-6; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Invernizzi C, 2002, BIOCHEM J, V366, P989, DOI 10.1042/BJ20020378; JORDAN DB, 1981, NATURE, V291, P513, DOI 10.1038/291513a0; JORDAN DB, 1981, PLANT PHYSIOL, V67, P237, DOI 10.1104/pp.67.2.237; Kanevski I, 1999, PLANT PHYSIOL, V119, P133, DOI 10.1104/pp.119.1.133; Karkehabadi S, 2005, BIOCHEMISTRY-US, V44, P9851, DOI 10.1021/bi050537v; Khrebtukova I, 1996, P NATL ACAD SCI USA, V93, P13689, DOI 10.1073/pnas.93.24.13689; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; Kostov RV, 1997, PHOTOSYNTH RES, V54, P127, DOI 10.1023/A:1005967106993; KREBBERS E, 1988, PLANT MOL BIOL, V11, P745, DOI 10.1007/BF00019515; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUEHN GD, 1978, BIOCHEM J, V175, P909, DOI 10.1042/bj1750909; LAING WA, 1974, PLANT PHYSIOL, V54, P678, DOI 10.1104/pp.54.5.678; Larson EM, 1997, J BIOL CHEM, V272, P17033, DOI 10.1074/jbc.272.27.17033; LEE BG, 1991, ARCH BIOCHEM BIOPHYS, V291, P263, DOI 10.1016/0003-9861(91)90133-4; Lumbreras V, 1998, PLANT J, V14, P441, DOI 10.1046/j.1365-313X.1998.00145.x; MARTIN PG, 1979, AUST J PLANT PHYSIOL, V6, P401; Martin W, 1996, PLANT MOL BIOL, V32, P485, DOI 10.1007/BF00019100; MAZUR BJ, 1985, NUCLEIC ACIDS RES, V13, P2373, DOI 10.1093/nar/13.7.2373; Meyer M, 2008, PHILOS T R SOC B, V363, P2767, DOI 10.1098/rstb.2008.0039; Moroney JV, 2007, EUKARYOT CELL, V6, P1251, DOI 10.1128/EC.00064-07; Ott CM, 2000, J BIOL CHEM, V275, P26241, DOI 10.1074/jbc.M004580200; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; PARRY MAJ, 1989, J EXP BOT, V40, P317, DOI 10.1093/jxb/40.3.317; Pollock SV, 2003, PLANT PHYSIOL, V133, P1854, DOI 10.1104/pp.103.032078; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; PRICE GD, 1989, PLANT PHYSIOL, V91, P505, DOI 10.1104/pp.91.2.505; Raven JA, 2008, PHILOS T R SOC B, V363, P2641, DOI 10.1098/rstb.2008.0020; Rawat M, 1996, PLANTA, V198, P263; READ BA, 1992, BIOCHEMISTRY-US, V31, P5553, DOI 10.1021/bi00139a018; READ BA, 1994, ARCH BIOCHEM BIOPHYS, V312, P210, DOI 10.1006/abbi.1994.1301; Satagopan S, 2004, J BIOL CHEM, V279, P14240, DOI 10.1074/jbc.M313215200; Sharwood RE, 2008, PLANT PHYSIOL, V146, P83, DOI 10.1104/pp.107.109058; Shimogawara K, 1998, GENETICS, V148, P1821; Silflow Carolyn D., 1998, Advances in Photosynthesis, V7, P25; SMRCKA AV, 1991, ARCH BIOCHEM BIOPHYS, V286, P6, DOI 10.1016/0003-9861(91)90002-Z; Spalding MH, 2008, J EXP BOT, V59, P1463, DOI 10.1093/jxb/erm128; SPALDING MH, 1983, PLANT PHYSIOL, V73, P273, DOI 10.1104/pp.73.2.273; SPALDING MH, 1983, PLANT PHYSIOL, V73, P268, DOI 10.1104/pp.73.2.268; Spreitzer RJ, 2005, P NATL ACAD SCI USA, V102, P17225, DOI 10.1073/pnas.0508042102; SPREITZER RJ, 1981, PLANT PHYSIOL, V67, P565, DOI 10.1104/pp.67.3.565; Spreitzer RJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P141, DOI 10.1016/S0003-9861(03)00171-1; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Spreitzer RJ, 2001, BIOCHEMISTRY-US, V40, P5615, DOI 10.1021/bi002943e; SPREITZER RJ, 1982, FEBS LETT, V148, P117, DOI 10.1016/0014-5793(82)81255-6; SPREITZER RJ, 1987, CURR GENET, V11, P611, DOI 10.1007/BF00393924; SPREITZER RJ, 1993, ANNU REV PLANT PHYS, V44, P411, DOI 10.1146/annurev.pp.44.060193.002211; SU QX, 1994, BIOCHEM J, V300, P787, DOI 10.1042/bj3000787; Su QX, 1999, BIOCHEM J, V344, P391, DOI 10.1042/0264-6021:3440391; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; Taylor TC, 2001, J BIOL CHEM, V276, P48159, DOI 10.1074/jbc.M107765200; Uemura K, 1997, BIOCHEM BIOPH RES CO, V233, P568, DOI 10.1006/bbrc.1997.6497; VANDERVIES SM, 1986, EMBO J, V5, P2439, DOI 10.1002/j.1460-2075.1986.tb04519.x; WAKSMAN G, 1987, NUCLEIC ACIDS RES, V15, P7181, DOI 10.1093/nar/15.17.7181; Wang YL, 2001, ARCH BIOCHEM BIOPHYS, V396, P35, DOI 10.1006/abbi.2001.2555; Whitney SM, 2007, J BIOL CHEM, V282, P3809, DOI 10.1074/jbc.M610479200; Whitney SM, 2009, PLANT PHYSIOL, V149, P1887, DOI 10.1104/pp.109.135210; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Young L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh058	81	98	101	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19833	19841		10.1074/jbc.M110.124230	http://dx.doi.org/10.1074/jbc.M110.124230			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20424165	Green Published, hybrid			2022-12-25	WOS:000279012000016
J	Tatematsu, M; Ishii, A; Oshiumi, H; Horiuchi, M; Inagaki, F; Seya, T; Matsumoto, M				Tatematsu, Megumi; Ishii, Akihiro; Oshiumi, Hiroyuki; Horiuchi, Masataka; Inagaki, Fuyuhiko; Seya, Tsukasa; Matsumoto, Misako			A Molecular Mechanism for Toll-IL-1 Receptor Domain-containing Adaptor Molecule-1-mediated IRF-3 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTOR-3; REGULATORY FACTOR-3 ACTIVATION; DENDRITIC CELLS; INTERFERON-BETA; ANTIVIRAL RESPONSE; SIGNALING PATHWAY; TRIF; INDUCTION; TOLL-LIKE-RECEPTOR-4	The Toll-IL-1 receptor (TIR) domain-containing adaptor molecule-1 (TICAM-1, also called TRIF) is a signaling adaptor for TLR3 and TLR4 that activates the transcription factors IRF-3, NF-kappa B, and AP-1, leading to induction of type I interferon and cytokines. The N-terminal region of TICAM-1 participates in IRF-3 activation, although the C-terminal region is involved in NF-kappa B activation. However, the mechanism by which TICAM-1 is activated and transmits signals is largely unknown. In this study, we identified Leu(194) as a critical amino acid for TICAM-1-mediated IRF-3 activation. When Leu(194) was substituted with Ala, the mutant TICAM-1 failed to recruit the IRF-3 kinase TBK1, resulting in lack of IRF-3 phosphorylation, although TRAF3 and NAP1 appeared to be recruited. The N-terminal 176 amino acids of TICAM-1 (N-terminal domain (NTD)) form a protease-resistant structural domain. A TICAM-1 mutant lacking the N-terminal 180 amino acids showed greater interferon-beta promoter activation than wildtype TICAM-1. Furthermore, immunoprecipitation and protein-protein interaction analysis revealed that the NTD interacted with the N terminus of TICAM-1-TIR. These results suggest that the NTD folds into the TIR domain structure to maintain the naive conformation of TICAM-1. Upon stimulation of TLR3/4, TICAM-1 oligomerizes through the TIR domain and the C-terminal region, which may break the intramolecular association and induce a conformational change that allows TBK1 access to TICAM-1.	[Tatematsu, Megumi; Ishii, Akihiro; Oshiumi, Hiroyuki; Seya, Tsukasa; Matsumoto, Misako] Hokkaido Univ, Dept Microbiol & Immunol, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Horiuchi, Masataka; Inagaki, Fuyuhiko] Hokkaido Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0010021, Japan	Hokkaido University; Hokkaido University	Matsumoto, M (corresponding author), Hokkaido Univ, Dept Microbiol & Immunol, Grad Sch Med, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	matumoto@pop.med.hokudai.ac.jp	Funami, Kenji/A-4284-2012; 美佐子, 松本/A-4497-2012; Oshiumi, Hiroyuki/G-1645-2012; Horiuchi, Masataka/D-5491-2012; Ishii, Akihiro/F-6878-2012; Seya, Tsukasa/A-4336-2012	Ishii, Akihiro/0000-0003-4032-3691; Oshiumi, Hiroyuki/0000-0003-1567-8722	Ministry of Education, Science, and Culture; The North Tec Foundation; The Akiyama Life Science Foundation; Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The North Tec Foundation; The Akiyama Life Science Foundation; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid from the Ministry of Education, Science, and Culture, the Ministry of Health, Labor, and Welfare of Japan, The North Tec Foundation, The Akiyama Life Science Foundation, Sapporo Biocluster "Bio-S" (Knowledge Cluster Initiative of Ministry of Education, Culture, Sports, Science and Technology), and the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology.	Akazawa T, 2007, P NATL ACAD SCI USA, V104, P252, DOI 10.1073/pnas.0605978104; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Funami K, 2004, INT IMMUNOL, V16, P1143, DOI 10.1093/intimm/dxh115; Funami K, 2008, J BIOL CHEM, V283, P18283, DOI 10.1074/jbc.M801013200; Funami K, 2007, J IMMUNOL, V179, P6867, DOI 10.4049/jimmunol.179.10.6867; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; HORIUCHI M, 2008, BIOCH MOL BIOL ABSTR, V31, P533; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Salem ML, 2005, J IMMUNOTHER, V28, P220, DOI 10.1097/01.cji.0000156828.75196.0d; Sasai M, 2005, J IMMUNOL, V174, P27, DOI 10.4049/jimmunol.174.1.27; Sasai M, 2010, MOL IMMUNOL, V47, P1283, DOI 10.1016/j.molimm.2009.12.002; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Seya T, 2009, CANCER IMMUNOL IMMUN, V58, P1175, DOI 10.1007/s00262-008-0652-9; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	33	38	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20128	20136		10.1074/jbc.M109.099101	http://dx.doi.org/10.1074/jbc.M109.099101			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20418377	hybrid, Green Published			2022-12-25	WOS:000279012000047
J	Blanc, V; Sessa, KJ; Kennedy, S; Luo, JY; Davidson, NO				Blanc, Valerie; Sessa, Kimberly J.; Kennedy, Susan; Luo, Jianyang; Davidson, Nicholas O.			Apobec-1 Complementation Factor Modulates Liver Regeneration by Post-transcriptional Regulation of Interleukin-6 mRNA Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; BINDING PROTEIN; HEPATOCYTE PROLIFERATION; PARTIAL-HEPATECTOMY; STEM-LOOP; IDENTIFICATION; IL-6; GENE; DOMAINS; ELEMENT	Apobec-1 complementation factor (ACF) is the RNA binding subunit of a core complex that mediates C to U RNA editing of apolipoprotein B (apoB) mRNA. Targeted deletion of the murine Acf gene is early embryonic lethal and Acf(-/-) blastocysts fail to implant and proliferate, suggesting that ACF plays a key role in cell growth and differentiation. Here we demonstrate that heterozygous Acf(+/-) mice exhibit decreased proliferation and impaired liver mass restitution following partial hepatectomy (PH). To pursue the mechanism of impaired liver regeneration we examined activation of interleukin-6 (IL-6) a key cytokine required for induction of hepatocyte proliferation following PH. Peak induction of hepatic IL-6 mRNA abundance post PH was attenuated >80% in heterozygous Acf(+/-) mice, along with decreased serum IL-6 levels. IL-6 secretion from isolated Kupffer cells (KC) was 2-fold greater in wild-type compared with heterozygous Acf(+/-) mice. Recombinant ACF bound an AU-rich region in the IL-6 3'-untranslated region with high affinity and IL-6 mRNA half-life was significantly shorter in KC isolated from Acf(+/-) mice compared with wild-type controls. These findings suggest that ACF regulates liver regeneration following PH at least in part by controlling the stability of IL-6 mRNA. The results further suggest a new RNA target and an unanticipated physiological function for ACF beyond apoB RNA editing.	[Davidson, Nicholas O.] Washington Univ, Sch Med, Div Gastroenterol, Dept Med, St Louis, MO 63110 USA; [Davidson, Nicholas O.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Davidson, NO (corresponding author), Washington Univ, Sch Med, Div Gastroenterol, Dept Med, Box 8124,660 Euclid Ave, St Louis, MO 63110 USA.	nod@wustl.edu			National Institutes of Health [HL-38180, DK-56260, DK-52574]; American Heart Association [910115]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038180, R37HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056260, P30DK052574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-38180, DK-56260, and DK-52574 (to N.O.D.) and American Heart Association Graduate Student Fellowship 910115 (to K.J.S.).	Anant S, 2000, MOL CELL BIOL, V20, P1982, DOI 10.1128/MCB.20.6.1982-1992.2000; Bihl MP, 2002, AM J RESP CELL MOL, V27, P48, DOI 10.1165/ajrcmb.27.1.4637; Blanc V, 2005, MOL CELL BIOL, V25, P7260, DOI 10.1128/MCB.25.16.7260-7269.2005; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; Blanc V, 2001, J BIOL CHEM, V276, P46386, DOI 10.1074/jbc.M107654200; Blanc V, 2001, J BIOL CHEM, V276, P10272, DOI 10.1074/jbc.M006435200; Blindenbacher A, 2003, HEPATOLOGY, V38, P674, DOI 10.1053/jhep.2003.50378; Bultinck J, 2006, CYTOKINE, V36, P160, DOI 10.1016/j.cyto.2006.11.010; Chester A, 2004, RNA, V10, P1399, DOI 10.1261/rna.7490704; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; GIANNONI F, 1994, J BIOL CHEM, V269, P5932; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; GREEVE J, 1993, J LIPID RES, V34, P1367; Henderson JO, 2001, BBA-GENE STRUCT EXPR, V1522, P22, DOI 10.1016/S0167-4781(01)00295-0; HOYLE GW, 1991, J BIOL CHEM, V266, P1850; Lellek H, 2000, J BIOL CHEM, V275, P19848, DOI 10.1074/jbc.M001786200; Maris C, 2005, RNA, V11, P173, DOI 10.1261/rna.7190705; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Mehta A, 2002, RNA, V8, P69, DOI 10.1017/S1355838202015649; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Nakamura K, 2004, HEPATOLOGY, V39, P635, DOI 10.1002/hep.20086; Newberry EP, 2008, HEPATOLOGY, V48, P1097, DOI 10.1002/hep.22473; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Ren XD, 2003, J CLIN INVEST, V112, P1407, DOI 10.1172/JCI200317391; SMEDSROD B, 1985, J LEUKOCYTE BIOL, V38, P213, DOI 10.1002/jlb.38.2.213; Sowden MP, 2004, J BIOL CHEM, V279, P197, DOI 10.1074/jbc.M307920200; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tumanov AV, 2009, GASTROENTEROLOGY, V136, P694, DOI 10.1053/j.gastro.2008.09.015; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Wuestefeld T, 2003, J BIOL CHEM, V278, P11281, DOI 10.1074/jbc.M208470200; Yatsenko OP, 2004, B EXP BIOL MED+, V138, P73, DOI 10.1023/B:BEBM.0000046944.85314.bf; Zimmers TA, 2003, HEPATOLOGY, V38, P1590, DOI 10.1016/j.hep.2003.09.021	36	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19184	19192		10.1074/jbc.M110.115147	http://dx.doi.org/10.1074/jbc.M110.115147			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20406809	Green Published, hybrid			2022-12-25	WOS:000278727800028
J	Courville, P; Quick, M; Reimer, RJ				Courville, Pascal; Quick, Matthias; Reimer, Richard J.			Structure-Function Studies of the SLC17 Transporter Sialin Identify Crucial Residues and Substrate-induced Conformational Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID STORAGE DISEASES; VESICULAR GLUTAMATE TRANSPORTER; ESCHERICHIA-COLI; LACTOSE PERMEASE; TRANSLOCATION PATHWAY; MISSENSE MUTATIONS; SODIUM SYMPORTER; CHARGED RESIDUES; BINDING-SITE; MEMBRANE	Salla disease and infantile sialic acid storage disorder are human diseases caused by loss of function of sialin, a lysosomal transporter that mediates H+-coupled symport of acidic sugars N-acetylneuraminic acid and glucuronic acid out of lysosomes. Along with the closely related vesicular glutamate transporters, sialin belongs to the SLC17 transporter family. Despite their critical role in health and disease, these proteins remain poorly understood both structurally and mechanistically. Here, we use substituted cysteine accessibility screening and radiotracer flux assays to evaluate experimentally a computationally generated three-dimensional structure model of sialin. According to this model, sialin consists of 12 transmembrane helices (TMs) with an overall architecture similar to that of the distantly related glycerol 3-phosphate transporter GlpT. We show that TM4 in sialin lines a large aqueous cavity that forms a part of the substrate permeation pathway and demonstrate substrate-induced alterations in accessibility of substituted cysteine residues in TM4. In addition, we demonstrate that one mutant, F179C, has a dramatically different effect on the apparent affinity and transport rate for N-acetylneuraminic acid and glucuronic acid, suggesting that it may be directly involved in substrate recognition and/or translocation. These findings offer a basis for further defining the transport mechanism of sialin and other SLC17 family members.	[Courville, Pascal; Reimer, Richard J.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Quick, Matthias] Columbia Univ Coll Phys & Surg, Dept Psychiat, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA	Stanford University; Columbia University; New York State Psychiatry Institute	Reimer, RJ (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, 1201 Welch Rd, Stanford, CA 94305 USA.	rjreimer@stanford.edu	courville, pascal/A-5170-2009		National Institutes of Health [NS050417, NS045634]; Fonds de la Recherche en Sante du Quebec; Stanford University School of Medicine Dean Fellowship Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS045634, R01NS050417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Stanford University School of Medicine Dean Fellowship Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS050417 and NS045634 (to R.J.R.). This work was also supported by the Fonds de la Recherche en Sante du Quebec and the Stanford University School of Medicine Dean Fellowship Program (to P.C.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Almqvist J, 2007, PROTEIN SCI, V16, P1819, DOI 10.1110/ps.072944707; Angelow S, 2009, J BIOL CHEM, V284, P29205, DOI 10.1074/jbc.M109.043752; BRANDL CJ, 1986, P NATL ACAD SCI USA, V83, P917, DOI 10.1073/pnas.83.4.917; Edgar R, 1999, EMBO J, V18, P822, DOI 10.1093/emboj/18.4.822; Eswar N., 2006, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0506-15; Fann MC, 1998, J MEMBRANE BIOL, V164, P187, DOI 10.1007/s002329900404; Fei H, 2007, J NEUROCHEM, V101, P1662, DOI 10.1111/j.1471-4159.2007.04518.x; Furuhata K, 2004, TRENDS GLYCOSCI GLYC, V16, P143, DOI 10.4052/tigg.16.143; Guan L, 2003, BIOCHEMISTRY-US, V42, P1377, DOI 10.1021/bi027152m; Guan L, 2001, J BACTERIOL, V183, P1734, DOI 10.1128/JB.183.5.1734-1739.2001; Guan L, 2007, NAT PROTOC, V2, P2012, DOI 10.1038/nprot.2007.275; Havelaar AC, 1998, J BIOL CHEM, V273, P34568, DOI 10.1074/jbc.273.51.34568; Holm L., 2006, CURR PROTOC BIOINFOR; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Javitch JA, 1998, METHOD ENZYMOL, V296, P331; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; Jung SK, 2006, BIOL PHARM BULL, V29, P547, DOI 10.1248/bpb.29.547; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; MANCINI GMS, 1989, J BIOL CHEM, V264, P15247; MANCINI GMS, 1991, J CLIN INVEST, V87, P1329, DOI 10.1172/JCI115136; Matos M, 1996, J BIOL CHEM, V271, P18571, DOI 10.1074/jbc.271.31.18571; Miyaji T, 2008, P NATL ACAD SCI USA, V105, P11720, DOI 10.1073/pnas.0804015105; Morin P, 2004, EMBO J, V23, P4560, DOI 10.1038/sj.emboj.7600464; Myall NJ, 2007, MOL GENET METAB, V92, P371, DOI 10.1016/j.ymgme.2007.08.121; NI BH, 1994, P NATL ACAD SCI USA, V91, P5607, DOI 10.1073/pnas.91.12.5607; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; Ruel J, 2008, AM J HUM GENET, V83, P278, DOI 10.1016/j.ajhg.2008.07.008; Ruivo R, 2008, BIOL CELL, V100, P551, DOI 10.1042/BC20070166; Sahin-Toth M, 2000, P NATL ACAD SCI USA, V97, P10729, DOI 10.1073/pnas.200351797; Schenck S, 2009, NAT NEUROSCI, V12, P156, DOI 10.1038/nn.2248; Schmitt KC, 2010, J NEUROCHEM, V112, P1605, DOI 10.1111/j.1471-4159.2010.06583.x; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WANG HM, 1991, BIOCHEM J, V278, P689, DOI 10.1042/bj2780689; WERNER A, 1991, P NATL ACAD SCI USA, V88, P9608, DOI 10.1073/pnas.88.21.9608; Wreden CC, 2005, J BIOL CHEM, V280, P1408, DOI 10.1074/jbc.M411295200; YAN RT, 1995, P NATL ACAD SCI USA, V92, P5973, DOI 10.1073/pnas.92.13.5973; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264	46	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19316	19323		10.1074/jbc.M110.130716	http://dx.doi.org/10.1074/jbc.M110.130716			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20424173	Green Published, hybrid			2022-12-25	WOS:000278727800041
J	Marq, JB; Kolakofsky, D; Garcin, D				Marq, Jean-Baptiste; Kolakofsky, Daniel; Garcin, Dominique			Unpaired 5 ' ppp-Nucleotides, as Found in Arenavirus Double-stranded RNA Panhandles, Are Not Recognized by RIG-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5'-TRIPHOSPHATE RNA; DNA-REPLICATION; BACK MECHANISM; VIRUS; INITIATION; PROTEIN; GENOME; POLYMERASE; HELICASE; VITRO	Arenavirus and bunyavirus RNA genomes are unusual in that they are found in circular nucleocapsids, presumably due to the annealing of their complementary terminal sequences. Moreover, arenavirus genome synthesis initiates with GTP at position +2 of the template rather than at the precise 3' end (position +1). After formation of a dinucleotide, 5' pppGpC(OH) is then realigned on the template before this primer is extended. The net result of this "prime and realign" mechanism of genome initiation is that 5' pppG is found as an unpaired 5' nucleotide when the complementary genome ends anneal to form a double-stranded (dsRNA) panhandle. Using 5' pppRNA made in vitro and purified so that all dsRNA side products are absent, we have determined that both this 5' nucleotide overhang, as well as mismatches within the dsRNA (as found in some arenavirus genomes), clearly reduce the ability of these model dsRNAs to induce interferon upon transfection into cells. The presence of this unpaired 5' ppp-nucleotide is thus another way that some viruses appear to use to avoid detection by cytoplasmic pattern recognition receptors.	[Marq, Jean-Baptiste; Kolakofsky, Daniel; Garcin, Dominique] Univ Geneva, Dept Microbiol & Mol Med, Sch Med, CMU, CH-1211 Geneva, Switzerland	University of Geneva	Kolakofsky, D (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, Sch Med, CMU, 9 Ave Champel, CH-1211 Geneva, Switzerland.	daniel.kolakofsky@unige.ch			Swiss National Science Fund	Swiss National Science Fund(Swiss National Science Foundation (SNSF))	This work was supported by a grant from the Swiss National Science Fund.	Albarino CG, 2009, J VIROL, V83, P5606, DOI 10.1128/JVI.00276-09; CALDENTEY J, 1993, NUCLEIC ACIDS RES, V21, P3725, DOI 10.1093/nar/21.16.3725; CAZENAVE C, 1994, P NATL ACAD SCI USA, V91, P6972, DOI 10.1073/pnas.91.15.6972; Chen M, 2008, J GEN VIROL, V89, P1421, DOI 10.1099/vir.0.83464-0; COLBY C, 1969, P NATL ACAD SCI USA, V63, P160, DOI 10.1073/pnas.63.1.160; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Flatz L, 2006, P NATL ACAD SCI USA, V103, P4663, DOI 10.1073/pnas.0600652103; GARCIN D, 1990, J VIROL, V64, P6196, DOI 10.1128/JVI.64.12.6196-6203.1990; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hausmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003965; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; IAPALUCCI S, 1989, VIROLOGY, V173, P357, DOI 10.1016/0042-6822(89)90257-2; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; KING AJ, 1994, EMBO J, V13, P5786, DOI 10.1002/j.1460-2075.1994.tb06917.x; KING P, 1994, J BIOL CHEM, V269, P30609; KOLAKOFSKY D, 1976, CELL, V8, P547, DOI 10.1016/0092-8674(76)90223-3; Lukashevich IS, 2005, J VIROL, V79, P13934, DOI 10.1128/JVI.79.22.13934-13942.2005; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; Marq JB, 2009, J BIOL CHEM, V284, P25471, DOI 10.1074/jbc.M109.018895; MENDEZ J, 1992, P NATL ACAD SCI USA, V89, P9579, DOI 10.1073/pnas.89.20.9579; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; OBIJESKI JF, 1976, J VIROL, V20, P664, DOI 10.1128/JVI.20.3.664-675.1976; PALMER EL, 1977, J GEN VIROL, V36, P541, DOI 10.1099/0022-1317-36-3-541; Paul AV, 2003, J BIOL CHEM, V278, P43951, DOI 10.1074/jbc.M307441200; PETTERSSON RF, 1975, J VIROL, V15, P386, DOI 10.1128/JVI.15.2.386-392.1975; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Prehaud C, 1997, VIROLOGY, V227, P189, DOI 10.1006/viro.1996.8324; RAJU R, 1989, J VIROL, V63, P122, DOI 10.1128/JVI.63.1.122-128.1989; ROBERTSON HD, 1982, CELL, V30, P669, DOI 10.1016/0092-8674(82)90270-7; SALVATO M, 1988, VIROLOGY, V164, P517, DOI 10.1016/0042-6822(88)90566-1; SALVATO MS, 1989, VIROLOGY, V173, P1, DOI 10.1016/0042-6822(89)90216-X; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Steil BP, 2009, VIRUS RES, V139, P240, DOI 10.1016/j.virusres.2008.07.027; Straehle L, 2007, J VIROL, V81, P12227, DOI 10.1128/JVI.01300-07; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P6298, DOI 10.1074/jbc.270.11.6298; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	41	45	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18208	18216		10.1074/jbc.M109.089425	http://dx.doi.org/10.1074/jbc.M109.089425			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400512	Green Published, hybrid			2022-12-25	WOS:000278453900012
J	Hovatta, O; Jaconi, M; Tohonen, V; Bena, F; Gimelli, S; Bosman, A; Holm, F; Wyder, S; Zdobnov, EM; Irion, O; Andrews, PW; Antonarakis, SE; Zucchelli, M; Kere, J; Feki, A				Hovatta, Outi; Jaconi, Marisa; Tohonen, Virpi; Bena, Frederique; Gimelli, Stefania; Bosman, Alexis; Holm, Frida; Wyder, Stefan; Zdobnov, Evgeny M.; Irion, Olivier; Andrews, Peter W.; Antonarakis, Stylianos E.; Zucchelli, Marco; Kere, Juha; Feki, Anis			A Teratocarcinoma-Like Human Embryonic Stem Cell (hESC) Line and Four hESC Lines Reveal Potentially Oncogenic Genomic Changes	PLOS ONE			English	Article							RAW COPY NUMBERS; GENOTYPING ARRAYS; FEEDER CELLS; CULTURE; DERIVATION; DIFFERENTIATION; FIBROBLASTS; BLASTOCYSTS; ADAPTATION; HISTORY	The first Swiss human embryonic stem cell (hESC) line, CH-ES1, has shown features of a malignant cell line. It originated from the only single blastomere that survived cryopreservation of an embryo, and it more closely resembles teratocarcinoma lines than other hESC lines with respect to its abnormal karyotype and its formation of invasive tumors when injected into SCID mice. The aim of this study was to characterize the molecular basis of the oncogenicity of CH-ES1 cells, we looked for abnormal chromosomal copy number (by array Comparative Genomic Hybridization, aCGH) and single nucleotide polymorphisms (SNPs). To see how unique these changes were, we compared these results to data collected from the 2102Ep teratocarcinoma line and four hESC lines (H1, HS293, HS401 and SIVF-02) which displayed normal G-banding result. We identified genomic gains and losses in CH-ES1, including gains in areas containing several oncogenes. These features are similar to those observed in teratocarcinomas, and this explains the high malignancy. The CH-ES1 line was trisomic for chromosomes 1, 9, 12, 17, 19, 20 and X. Also the karyotypically (based on G-banding) normal hESC lines were also found to have several genomic changes that involved genes with known roles in cancer. The largest changes were found in the H1 line at passage number 56, when large 5 Mb duplications in chromosomes 1q32.2 and 22q12.2 were detected, but the losses and gains were seen already at passage 22. These changes found in the other lines highlight the importance of assessing the acquisition of genetic changes by hESCs before their use in regenerative medicine applications. They also point to the possibility that the acquisition of genetic changes by ESCs in culture may be used to explore certain aspects of the mechanisms regulating oncogenesis.	[Hovatta, Outi; Holm, Frida] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Obstet & Gynecol, Stockholm, Sweden; [Jaconi, Marisa; Bosman, Alexis] Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Tohonen, Virpi; Zucchelli, Marco; Kere, Juha] Karolinska Inst, Dept Biosci, Stockholm, Sweden; [Bena, Frederique; Gimelli, Stefania; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Irion, Olivier; Feki, Anis] Univ Hosp Geneva, Dept Obstet & Gynecol, Geneva, Switzerland; [Wyder, Stefan; Zdobnov, Evgeny M.] Swiss Inst Bioinformat, Geneva, Switzerland; [Andrews, Peter W.] Univ Sheffield, Ctr Stem Cell Biol, Sheffield, S Yorkshire, England; [Andrews, Peter W.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	Karolinska Institutet; University of Geneva; Karolinska Institutet; University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; University of Sheffield; University of Sheffield	Hovatta, O (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Obstet & Gynecol, Stockholm, Sweden.	Outi.hovatta@ki.se	Antonarakis, Stylianos E/N-8866-2014; Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008; Zdobnov, Evgeny M/K-1133-2012; Zdobnov, Evgeny/AAB-2745-2022; Jaconi, Marisa EE/J-4392-2013	Antonarakis, Stylianos E/0000-0001-8907-5823; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Zdobnov, Evgeny/0000-0002-5178-1498; Feki, Anis/0000-0002-9817-9445; Andrews, Peter/0000-0001-7215-4410; Wyder, Stefan/0000-0002-3412-0292; Jaconi, Marisa/0000-0002-2004-8226	Swiss National Foundation; Medical Research Council UK; Roche Research Foundation; Ernst & Lucie Schmidheiny Foundation; Geneva University Hospitals; Geneva Faculty of Medicine, Genico; EU; Swedish Research Council; Stockholm County; Karolinska Institutet; Medical Research Council [G0700785] Funding Source: researchfish; MRC [G0700785] Funding Source: UKRI	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Roche Research Foundation; Ernst & Lucie Schmidheiny Foundation; Geneva University Hospitals; Geneva Faculty of Medicine, Genico; EU(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Swiss National Foundation, Medical Research Council UK, Roche Research Foundation, the Ernst & Lucie Schmidheiny Foundation, the Geneva University Hospitals, the Geneva Faculty of Medicine, Genico, the EU for ESTOOLS, the Swedish Research Council and RD grants from Stockholm County and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Ambartsumyan G, 2008, HUM MOL GENET, V17, pR10, DOI 10.1093/hmg/ddn170; ANDREWS PW, 1982, INT J CANCER, V29, P523, DOI 10.1002/ijc.2910290507; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Bruce S, 2005, J MED GENET, V42, P847, DOI 10.1136/jmg.2005.032367; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; Damjanov I, 2005, STEM CELL REV, V1, P273, DOI 10.1385/SCR:1:3:273; Draper JS, 2004, STEM CELLS DEV, V13, P325, DOI 10.1089/1547328041797525; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB; Feki A, 2008, SWISS MED WKLY, V138, P540, DOI 2008/37/smw-12385; Geens M, 2009, HUM REPROD, V24, P2709, DOI 10.1093/humrep/dep262; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hardarson T, 2003, HUM REPROD, V18, P399, DOI 10.1093/humrep/deg092; Harrison NJ, 2007, INT J ANDROL, V30, P275, DOI 10.1111/j.1365-2605.2007.00762.x; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; *NIH, 2009, HUM DIS DAT DAV BIOI; *NIH, 2009, OMIM DAT; OLIVER RTD, 1990, CANCER SURV, V9, P333; Oosterhuis JW, 2003, APMIS, V111, P32, DOI 10.1034/j.1600-0463.2003.11101061.x; Solter D, 2006, NAT REV GENET, V7, P319, DOI 10.1038/nrg1827; Strelchenko N, 2004, REPROD BIOMED ONLINE, V9, P623, DOI 10.1016/S1472-6483(10)61772-5; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Weksberg R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-180; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; 2010, DATABASE GENOMIC VAR	34	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10263	10.1371/journal.pone.0010263	http://dx.doi.org/10.1371/journal.pone.0010263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428235	Green Published, gold, Green Accepted			2022-12-25	WOS:000277079300003
J	Tremblay, KL; Inoue, K; McClannahan, K; Ross, B				Tremblay, Kelly L.; Inoue, Kayo; McClannahan, Katrina; Ross, Bernhard			Repeated Stimulus Exposure Alters the Way Sound Is Encoded in the Human Brain	PLOS ONE			English	Article							AUDITORY-EVOKED POTENTIALS; PARTIAL LEAST-SQUARES; EVENT-RELATED POTENTIALS; SPEECH SOUNDS; TIME-COURSE; PLASTICITY; IDENTIFICATION; RESPONSES; CHILDREN; CORTEX	Auditory training programs are being developed to remediate various types of communication disorders. Biological changes have been shown to coincide with improved perception following auditory training so there is interest in determining if these changes represent biologic markers of auditory learning. Here we examine the role of stimulus exposure and listening tasks, in the absence of training, on the modulation of evoked brain activity. Twenty adults were divided into two groups and exposed to two similar sounding speech syllables during four electrophysiological recording sessions (24 hours, one week, and up to one year later). In between each session, members of one group were asked to identify each stimulus. Both groups showed enhanced neural activity from session-to-session, in the same P2 latency range previously identified as being responsive to auditory training. The enhancement effect was most pronounced over temporal-occipital scalp regions and largest for the group who participated in the identification task. The effects were rapid and long-lasting with enhanced synchronous activity persisting months after the last auditory experience. Physiological changes did not coincide with perceptual changes so results are interpreted to mean stimulus exposure, with and without being paired with an identification task, alters the way sound is processed in the brain. The cumulative effect likely involves auditory memory; however, in the absence of training, the observed physiological changes are insufficient to result in changes in learned behavior.	[Tremblay, Kelly L.; Inoue, Kayo; McClannahan, Katrina] Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA; [Ross, Bernhard] Rotman Res Inst, Toronto, ON, Canada	University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; Baycrest	Tremblay, KL (corresponding author), Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA.	tremblay@uw.edu	/AIE-5811-2022; McClannahan, Katrina S/AAO-5617-2021	McClannahan, Katrina S/0000-0002-7840-4262; Ross, Bernhard/0000-0001-7290-631X	National Institutes of Health [R01-DC007705, P30-DC04661]; National Institute on Deafness and Communication Disorders; Virginia Merrill Bloedel Hearing Research Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004661, R01DC007705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Virginia Merrill Bloedel Hearing Research Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by National Institutes of Health Grants (R01-DC007705 and P30-DC04661) from the National Institute on Deafness and Communication Disorders. Support from the Virginia Merrill Bloedel Hearing Research Center is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2010, J COGNITIVE NEUROSCI, V22, P392, DOI 10.1162/jocn.2009.21279; Amitay S, 2006, NAT NEUROSCI, V9, P1446, DOI 10.1038/nn1787; Atienza M, 2002, LEARN MEMORY, V9, P138, DOI 10.1101/lm.46502; Baumann S, 2008, J COGNITIVE NEUROSCI, V20, P2238, DOI 10.1162/jocn.2008.20157; Bradlow AR, 1999, PERCEPT PSYCHOPHYS, V61, P977, DOI 10.3758/BF03206911; Brattico E, 2003, NEUROREPORT, V14, P2489, DOI 10.1097/00001756-200312190-00039; Clarke CM, 2004, J ACOUST SOC AM, V116, P3647, DOI 10.1121/1.1815131; Dahmen JC, 2007, CURR OPIN NEUROBIOL, V17, P456, DOI 10.1016/j.conb.2007.07.004; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; ESCERA C, 1997, ELECTROENCEPHALOGRAP, V100, P549; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; Gourevitch B, 2008, EUR J NEUROSCI, V27, P3310, DOI 10.1111/j.1460-9568.2008.06265.x; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hayes EA, 2003, CLIN NEUROPHYSIOL, V114, P673, DOI 10.1016/S1388-2457(02)00414-5; KILENY PR, 1987, EAR HEARING, V8, P110, DOI 10.1097/00003446-198704000-00008; Kinoshita S, 1996, PHYSIOL BEHAV, V60, P1087, DOI 10.1016/0031-9384(96)00130-8; KLATT DH, 1980, J ACOUST SOC AM, V67, P971, DOI 10.1121/1.383940; Kuhl PK, 2007, DEVELOPMENTAL SCI, V10, P110, DOI 10.1111/j.1467-7687.2007.00572.x; Kuriki S, 2007, CEREB CORTEX, V17, P2725, DOI 10.1093/cercor/bhl182; Lobaugh NJ, 2001, PSYCHOPHYSIOLOGY, V38, P517, DOI 10.1017/S0048577201991681; MCCLASKEY CL, 1983, PERCEPT PSYCHOPHYS, V34, P323, DOI 10.3758/BF03203044; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Menning H, 2000, NEUROREPORT, V11, P817, DOI 10.1097/00001756-200003200-00032; Moucha R, 2006, PROG BRAIN RES, V157, P111, DOI 10.1016/S0079-6123(06)57007-4; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Nikjeh DA, 2009, EAR HEARING, V30, P432, DOI 10.1097/AUD.0b013e3181a61bf2; Norena AJ, 2006, NAT NEUROSCI, V9, P932, DOI 10.1038/nn1720; Pienkowski M, 2009, HEARING RES, V257, P24, DOI 10.1016/j.heares.2009.07.011; ROGERS RL, 1990, ELECTROEN CLIN NEURO, V77, P237, DOI 10.1016/0168-5597(90)90043-D; Ross B, 2009, HEARING RES, V248, P48, DOI 10.1016/j.heares.2008.11.012; Roth DAE, 2005, LEARN MEMORY, V12, P159, DOI 10.1101/87505; Shahin A, 2003, J NEUROSCI, V23, P5545; Shahin A, 2005, NEUROREPORT, V16, P1781, DOI 10.1097/01.wnr.0000185017.29316.63; Sheehan KA, 2005, COGNITIVE BRAIN RES, V25, P547, DOI 10.1016/j.cogbrainres.2005.08.007; Szpunar KK, 2004, J EXP PSYCHOL LEARN, V30, P370, DOI 10.1037/0278-7393.30.2.370; Tremblay K, 2001, EAR HEARING, V22, P79, DOI 10.1097/00003446-200104000-00001; Tremblay K, 1998, NEUROREPORT, V9, P3557, DOI 10.1097/00001756-199811160-00003; Tremblay K, 1997, J ACOUST SOC AM, V102, P3762, DOI 10.1121/1.420139; Tremblay Kelly L., 2007, Seminars in Hearing, V28, P120, DOI 10.1055/s-2007-973438; Tremblay KL, 2009, CLIN NEUROPHYSIOL, V120, P128, DOI 10.1016/j.clinph.2008.10.005; Tremblay KL, 2002, J SPEECH LANG HEAR R, V45, P564, DOI 10.1044/1092-4388(2002/045); Uwer R, 2000, CLIN NEUROPHYSIOL, V111, P45, DOI 10.1016/S1388-2457(99)00204-7; van Wassenhove V, 2007, J NEUROSCI, V27, P2663, DOI 10.1523/JNEUROSCI.4844-06.2007; WOODS DL, 1986, ELECTROEN CLIN NEURO, V65, P447, DOI 10.1016/0168-5597(86)90024-9; Yonan CA, 2000, PSYCHOL AGING, V15, P88, DOI 10.1037/0882-7974.15.1.88; Zouridakis G, 1998, BRAIN TOPOGR, V10, P183, DOI 10.1023/A:1022246825461	48	45	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10283	10.1371/journal.pone.0010283	http://dx.doi.org/10.1371/journal.pone.0010283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586YT	20421969	Green Submitted, Green Published, gold			2022-12-25	WOS:000276952600007
J	Xu, JY; Chen, RQ; Zhang, J; Chen, C				Xu, Jian-Yi; Chen, Rongqing; Zhang, Jian; Chen, Chu			Endocannabinoids Differentially Modulate Synaptic Plasticity in Rat Hippocampal CA1 Pyramidal Neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DEPOLARIZATION-INDUCED SUPPRESSION; METABOTROPIC GLUTAMATE; ENDOGENOUS CANNABINOIDS; EXCITATORY SYNAPSES; DISTAL DENDRITES; CORTICAL INPUT; TRANSMISSION; INHIBITION; RECEPTOR	Background: Hippocampal CA1 pyramidal neurons receive two excitatory glutamatergic synaptic inputs: their most distal dendritic regions in the stratum lacunosum-moleculare (SLM) are innervated by the perforant path (PP), originating from layer III of the entorhinal cortex, while their more proximal regions of the apical dendrites in the stratum adiatum (SR) are innervated by the Schaffer-collaterals (SC), originating from hippocampal CA3 neurons. Endocannabinoids (eCBs) are naturally occurring mediators capable of modulating both GABAergic and glutamatergic synaptic transmission and plasticity via the CB1 receptor. Previous work on eCB modulation of excitatory synapses in the CA1 region largely focuses on the SC pathway. However, little information is available on whether and how eCBs modulate glutamatergic synaptic transmission and plasticity at PP synapses. Methodology/Principal Findings: By employing somatic and dendritic patch-clamp recordings, Ca2+ uncaging, and immunostaining, we demonstrate that there are significant differences in low-frequency stimulation (LFS)- or DHPG-, an agonist of group I metabotropic glutamate receptors (mGluRs), induced long-term depression (LTD) of excitatory synaptic transmission between SC and PP synapses in the same pyramidal neurons. These differences are eliminated by pharmacological inhibition with selective CB1 receptor antagonists or genetic deletion of the CB1 receptor, indicating that these differences likely result from differential modulation via a CB1 receptor-dependent mechanism. We also revealed that depolarization-induced suppression of excitation (DSE), a form of short-term synaptic plasticity, and photolysis of caged Ca2+-induced suppression of Excitatory postsynaptic currents (EPSCs) were less at the PP than that at the SC. In addition, application of WIN55212 (WIN) induced a more pronounced inhibition of EPSCs at the SC when compared to that at the PP. Conclusions/Significance: Our results suggest that CB1 dependent LTD and DSE are differentially expressed at the PP versus SC synapses in the same neurons, which may have an impact on synaptic scaling, integration and plasticity of hippocampal CA1 pyramidal neurons.	[Xu, Jian-Yi; Chen, Rongqing; Zhang, Jian; Chen, Chu] Louisiana State Univ, Neurosci Ctr Excellence, Sch Med, Hlth Sci Ctr, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Xu, JY (corresponding author), Louisiana State Univ, Neurosci Ctr Excellence, Sch Med, Hlth Sci Ctr, New Orleans, LA USA.	cchen@lsuhsc.edu		Chen, Rongqing/0000-0002-1668-8554	National Institutes of Health [NS054886, DA025971]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA025971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grant NS054886 and DA025971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MS, 2009, NEURON, V63, P372, DOI 10.1016/j.neuron.2009.07.013; Alger BE, 2002, PROG NEUROBIOL, V68, P247; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; Arrigoni E, 2004, BRIT J PHARMACOL, V142, P317, DOI 10.1038/sj.bjp.0705744; Bellone C, 2008, CELL MOL LIFE SCI, V65, P2913, DOI 10.1007/s00018-008-8263-3; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Chen C, 2005, BIOCHEM BIOPH RES CO, V338, P1913, DOI 10.1016/j.bbrc.2005.10.169; Chen C, 2005, J NEUROPHYSIOL, V93, P929, DOI 10.1152/jn.00696.2004; Chen C, 2002, J NEUROPHYSIOL, V87, P2851, DOI 10.1152/jn.2002.87.6.2851; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Chiu CYQ, 2008, NEUROPHARMACOLOGY, V54, P68, DOI 10.1016/j.neuropharm.2007.06.026; COLBERT CM, 1993, BRAIN RES, V606, P87, DOI 10.1016/0006-8993(93)91573-B; Diana MA, 2004, BRIT J PHARMACOL, V142, P9, DOI 10.1038/sj.bjp.0705726; Dudman JT, 2007, NEURON, V56, P866, DOI 10.1016/j.neuron.2007.10.020; Dvorak-Carbone H, 1999, J NEUROPHYSIOL, V81, P1036, DOI 10.1152/jn.1999.81.3.1036; Edwards DA, 2008, P NATL ACAD SCI USA, V105, P8142, DOI 10.1073/pnas.0803558105; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gloveli T, 1997, J NEUROPHYSIOL, V78, P3444, DOI 10.1152/jn.1997.78.6.3444; Hajos N, 2002, NEUROPHARMACOLOGY, V43, P503, DOI 10.1016/S0028-3908(02)00157-0; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Hill MN, 2009, TRENDS PHARMACOL SCI, V30, P484, DOI 10.1016/j.tips.2009.06.006; HILL MN, 2009, JAMA-J AM MED ASSOC, V310, P1165; Izumi Y, 2008, J NEUROSCI, V28, P9557, DOI 10.1523/JNEUROSCI.3346-08.2008; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Kellogg R, 2009, J NEUROPHYSIOL, V102, P1160, DOI 10.1152/jn.00266.2009; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Lovinger David M., 2008, V184, P435; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Nicholson DA, 2006, NEURON, V50, P431, DOI 10.1016/j.neuron.2006.03.022; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Nosyreva ED, 2005, J NEUROSCI, V25, P2992, DOI 10.1523/JNEUROSCI.3652-04.2005; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Otmakhova NA, 1999, J NEUROSCI, V19, P1437; Otmakhova NA, 2005, J NEUROPHYSIOL, V94, P1413, DOI 10.1152/jn.00217.2005; Otmakhova NA, 2002, J NEUROSCI, V22, P1199, DOI 10.1523/JNEUROSCI.22-04-01199.2002; Otmakhova NA, 2000, ANN NY ACAD SCI, V911, P462; PITLER TA, 1994, NEURON, V13, P1447; Rammes G, 2003, J PHYSIOL-LONDON, V546, P455, DOI 10.1113/jphysiol.2002.033514; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Remondes M, 2003, LEARN MEMORY, V10, P247, DOI 10.1101/lm.59103; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; ROMANO C, 1995, J COMP NEUROL, V355, P455, DOI 10.1002/cne.903550310; Rouach N, 2003, EUR J NEUROSCI, V18, P1017, DOI 10.1046/j.1460-9568.2003.02823.x; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Sang N, 2005, J NEUROSCI, V25, P9858, DOI 10.1523/JNEUROSCI.2392-05.2005; Sergeeva OA, 2007, EUR J NEUROSCI, V26, P1889, DOI 10.1111/j.1460-9568.2007.05815.x; Slanina KA, 2005, NEUROPHARMACOLOGY, V49, P660, DOI 10.1016/j.neuropharm.2005.04.021; Spruston N, 2008, NAT NEUROSCI, V11, P733, DOI 10.1038/nn0708-733; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Volk LJ, 2006, J NEUROPHYSIOL, V95, P2427, DOI 10.1152/jn.00383.2005; Wang J, 2001, J PHYSIOL-LONDON, V533, P757, DOI 10.1111/j.1469-7793.2001.t01-1-00757.x; Watabe AM, 2002, J NEUROPHYSIOL, V87, P1395, DOI 10.1152/jn.00723.2001; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Zhu PJ, 2007, J NEUROPHYSIOL, V97, P4386, DOI 10.1152/jn.01228.2006	71	43	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10306	10.1371/journal.pone.0010306	http://dx.doi.org/10.1371/journal.pone.0010306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421986	Green Published, gold, Green Submitted			2022-12-25	WOS:000276952600023
J	Deng, JY; Wang, W; Lu, LJ; Ma, J				Deng, Jingyuan; Wang, Wei; Lu, Long Jason; Ma, Jun			A Two-Dimensional Simulation Model of the Bicoid Gradient in Drosophila	PLOS ONE			English	Article							MORPHOGEN GRADIENT; POSITIONAL INFORMATION; MESSENGER-RNA; DEVELOPMENTAL BIOLOGY; DEPENDENT MANNER; NUCLEAR; PATTERN; EMBRYO; PROTEIN; SEGMENTATION	Background: Bicoid (Bcd) is a Drosophila morphogenetic protein responsible for patterning the anterior structures in embryos. Recent experimental studies have revealed important insights into the behavior of this morphogen gradient, making it necessary to develop a model that can recapitulate the biological features of the system, including its dynamic and scaling properties. Methodology/Principal Findings: We present a biologically realistic 2-D model of the dynamics of the Bcd gradient in Drosophila embryos. This model is based on equilibrium binding of Bcd molecules to non-specific, low affinity DNA sites throughout the Drosophila genome. It considers both the diffusion media within which the Bcd gradient is formed and the dynamic and other relevant properties of bcd mRNA from which Bcd protein is produced. Our model recapitulates key features of the Bcd protein gradient observed experimentally, including its scaling properties and the stability of its nuclear concentrations during development. Our simulation model also allows us to evaluate the effects of other biological activities on Bcd gradient formation, including the dynamic redistribution of bcd mRNA in early embryos. Our simulation results suggest that, in our model, Bcd protein diffusion is important for the formation of an exponential gradient in embryos. Conclusions/Significance: The 2-D model described in this report is a simple and versatile simulation procedure, providing a quantitative evaluation of the Bcd gradient system. Our results suggest an important role of Bcd binding to non-specific, low-affinity DNA sites in proper formation of the Bcd gradient in our model. They demonstrate that highly complex biological systems can be effectively modeled with relatively few parameters.	[Deng, Jingyuan; Wang, Wei; Lu, Long Jason; Ma, Jun] Cincinnati Childrens Hosp Res Fdn, Div Biomed Informat, Cincinnati, OH USA; [Ma, Jun] Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH USA; [Deng, Jingyuan; Lu, Long Jason] Univ Cincinnati, Dept Biomed Engn, Cincinnati, OH USA; [Wang, Wei] Univ Cincinnati, Dept Chem Engn, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Deng, JY (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Biomed Informat, Cincinnati, OH USA.	jun.ma@cchmc.org	lu, lu/HGA-0894-2022; Ma, Jun/GLT-4809-2022; lu, lu/HII-7530-2022	Ma, Jun/0000-0002-1609-3294; 	National Science Foundation [IOS-0843424]; National Institutes of Health [GM072812, GM78381]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072812, R01GM078381] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by grants from the National Science Foundation (IOS-0843424) and the National Institutes of Health (GM072812, GM78381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aegerter-Wilmsen T, 2005, J THEOR BIOL, V234, P13, DOI 10.1016/j.jtbi.2004.11.002; AFFOLTER M, 1990, P NATL ACAD SCI USA, V87, P4093, DOI 10.1073/pnas.87.11.4093; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; BREUER HP, 1992, CHEM PHYS LETT, V190, P199, DOI 10.1016/0009-2614(92)85326-6; Coppey M, 2007, DEV BIOL, V312, P623, DOI 10.1016/j.ydbio.2007.09.058; Crauk O, 2005, CURR BIOL, V15, P1888, DOI 10.1016/j.cub.2005.09.046; DAMANTE G, 1993, BIOCHEM BIOPH RES CO, V197, P632, DOI 10.1006/bbrc.1993.2526; Day SJ, 2000, DEVELOPMENT, V127, P2977; DeLotto R, 2007, DEVELOPMENT, V134, P4233, DOI 10.1242/dev.010934; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; FOE VE, 1983, J CELL SCI, V61, P31; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; Ghaffari M, 1997, BIOCHEM J, V328, P757, DOI 10.1042/bj3280757; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Gregor T, 2008, DEV BIOL, V316, P350, DOI 10.1016/j.ydbio.2008.01.039; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; He F, 2008, DEV CELL, V15, P558, DOI 10.1016/j.devcel.2008.09.004; Hecht I, 2009, P NATL ACAD SCI USA, V106, P1710, DOI 10.1073/pnas.0807655106; Holloway DM, 2006, DEV DYNAM, V235, P2949, DOI 10.1002/dvdy.20940; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Howard M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208103; Ishihara S, 2006, J THEOR BIOL, V238, P683, DOI 10.1016/j.jtbi.2005.06.016; Kerszberg M, 2007, CELL, V130, P205, DOI 10.1016/j.cell.2007.06.038; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Lattin J., 2003, ANAL MULTIVARIATE DA; Lewis J, 2008, SCIENCE, V322, P399, DOI 10.1126/science.1166154; Lipshitz HD, 2009, NAT REV MOL CELL BIO, V10, P509, DOI 10.1038/nrm2730; Lott SE, 2007, P NATL ACAD SCI USA, V104, P10926, DOI 10.1073/pnas.0701359104; Lucchetta EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003651; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Manu, 2009, PLOS BIOL, V7, P591, DOI 10.1371/journal.pbio.1000049; Mavrakis Manos, 2009, Commun Integr Biol, V2, P313; Miura S, 2008, BIOSYSTEMS, V93, P133, DOI 10.1016/j.biosystems.2008.05.002; Morishita Y, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061905; Okabe-Oho Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000486; Patel NH, 2002, NATURE, V415, P748, DOI 10.1038/415748a; Quimby BB, 2001, CELL MOL LIFE SCI, V58, P1766, DOI 10.1007/PL00000816; Spirov A, 2009, DEVELOPMENT, V136, P605, DOI 10.1242/dev.031195; STJOHNSTON D, 1989, DEVELOPMENT S, P13; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Tostevin F, 2007, PLOS COMPUT BIOL, V3, P763, DOI 10.1371/journal.pcbi.0030078; Wilkie J, 2008, CHEM PHYS, V353, P132, DOI 10.1016/j.chemphys.2008.08.001; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wu YF, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-52	55	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10275	10.1371/journal.pone.0010275	http://dx.doi.org/10.1371/journal.pone.0010275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422054	Green Published, gold			2022-12-25	WOS:000276952500030
J	Nguyen, HH; Tumpey, TM; Park, HJ; Byun, YH; Tran, LD; Nguyen, VD; Kilgore, PE; Czerkinsky, C; Katz, JM; Seong, BL; Song, JM; Kim, YB; Do, HT; Nguyen, T; Nguyen, CV				Nguyen, Huan H.; Tumpey, Terrence M.; Park, Hae-Jung; Byun, Young-Ho; Tran, Linh D.; Nguyen, Van D.; Kilgore, Paul E.; Czerkinsky, Cecil; Katz, Jacqueline M.; Seong, Baik Lin; Song, Jae Min; Kim, Young Bong; Do, Hoa T.; Nguyen, Tung; Nguyen, Cam V.			Prophylactic and Therapeutic Efficacy of Avian Antibodies Against Influenza Virus H5N1 and H1N1 in Mice	PLOS ONE			English	Article							YOLK ANTIBODIES; CHICKEN ANTIBODIES; EGG-YOLK; MONOCLONAL-ANTIBODY; HELICOBACTER-PYLORI; ISOLATED WORLDWIDE; IMMUNOGLOBULIN-Y; INFECTIONS; RESISTANCE; HUMANS	Background: Pandemic influenza poses a serious threat to global health and the world economy. While vaccines are currently under development, passive immunization could offer an alternative strategy to prevent and treat influenza virus infection. Attempts to develop monoclonal antibodies (mAbs) have been made. However, passive immunization based on mAbs may require a cocktail of mAbs with broader specificity in order to provide full protection since mAbs are generally specific for single epitopes. Chicken immunoglobulins (IgY) found in egg yolk have been used mainly for treatment of infectious diseases of the gastrointestinal tract. Because the recent epidemic of highly pathogenic avian influenza virus (HPAIV) strain H5N1 has resulted in serious economic losses to the poultry industry, many countries including Vietnam have introduced mass vaccination of poultry with H5N1 virus vaccines. We reasoned that IgY from consumable eggs available in supermarkets in Vietnam could provide protection against infections with HPAIV H5N1. Methods and Findings: We found that H5N1-specific IgY that are prepared from eggs available in supermarkets in Vietnam by a rapid and simple water dilution method cross-protect against infections with HPAIV H5N1 and related H5N2 strains in mice. When administered intranasally before or after lethal infection, the IgY prevent the infection or significantly reduce viral replication resulting in complete recovery from the disease, respectively. We further generated H1N1 virus-specific IgY by immunization of hens with inactivated H1N1 A/PR/8/34 as a model virus for the current pandemic H1N1/09 and found that such H1N1-specific IgY protect mice from lethal influenza virus infection. Conclusions: The findings suggest that readily available H5N1-specific IgY offer an enormous source of valuable biological material to combat a potential H5N1 pandemic. In addition, our study provides a proof-of-concept for the approach using virus-specific IgY as affordable, safe, and effective alternative for the control of influenza outbreaks, including the current H1N1 pandemic.	[Nguyen, Huan H.; Park, Hae-Jung; Kilgore, Paul E.; Czerkinsky, Cecil] Int Vaccine Inst, Seoul, South Korea; [Tumpey, Terrence M.; Katz, Jacqueline M.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA USA; [Byun, Young-Ho; Seong, Baik Lin; Song, Jae Min] Yonsei Univ, Coll Engn, Dept Biotechnol, Seoul 120749, South Korea; [Tran, Linh D.; Nguyen, Van D.; Kim, Young Bong] Konkuk Univ, Coll Anim Biosci & Technol, Dept Anim Biotechnol, Seoul, South Korea; [Do, Hoa T.; Nguyen, Tung; Nguyen, Cam V.] Natl Ctr Vet Diagnost, Dept Anim Hlth, Hanoi, Vietnam; [Nguyen, Huan H.] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA	International Vaccine Institute; Centers for Disease Control & Prevention - USA; Yonsei University; Konkuk University; University of Alabama System; University of Alabama Birmingham	Nguyen, HH (corresponding author), Int Vaccine Inst, Seoul, South Korea.	hhnguyen@ivi.int	CZERKINSKY, CECIL/G-6520-2015; Kilgore, Paul/AAD-2869-2019; Kilgore, Paul E/L-1462-2013	Kilgore, Paul/0000-0003-3214-4482; Kilgore, Paul E/0000-0003-3214-4482	government of the Republic of Korea; government of Sweden; government of the Netherlands; government of Kuwait; Bill & Melinda Gates Foundation; Korean Healthcare Technology [A085105]; Ministry of Health and Welfare Family Affairs, Republic of Korea; Korea Research Council of Fundamental Science Technology [KGM3110912]	government of the Republic of Korea(Korean Government); government of Sweden; government of the Netherlands(Netherlands Government); government of Kuwait; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Korean Healthcare Technology; Ministry of Health and Welfare Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Research Council of Fundamental Science Technology	The International Vaccine Institute is supported by the governments of the Republic of Korea, Sweden, the Netherlands, and Kuwait. This work was supported in part by the Bill & Melinda Gates Foundation (to HHN), the Korean Healthcare Technology R&D Project (A085105), the Ministry of Health and Welfare Family Affairs, Republic of Korea (to BLS), and the Top Brand Project grant, Korea Research Council of Fundamental Science & Technology and KRIBB Initiative program (KGM3110912 to YBK). The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKITA EM, 1992, J FOOD SCI, V57, P629, DOI 10.1111/j.1365-2621.1992.tb08058.x; AKITA EM, 1993, J IMMUNOL METHODS, V160, P207, DOI 10.1016/0022-1759(93)90179-B; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Carlander D, 2000, IMMUNOL RES, V21, P1, DOI 10.1385/IR:21:1:1; Carlander D, 1999, UPSALA J MED SCI, V104, P179, DOI 10.3109/03009739909178961; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; Cooper H.M., 2009, CURR PROTOC NEUROSCI, DOI [10.1002/0471142301.ns0505s48, DOI 10.1002/0471142301.NS0505S48]; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; Gubareva LV, 1998, J INFECT DIS, V178, P1592, DOI 10.1086/314515; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Hanson BJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-126; Hatta H, 1997, CARIES RES, V31, P268, DOI 10.1159/000262410; Horie K, 2004, J DAIRY SCI, V87, P4073, DOI 10.3168/jds.S0022-0302(04)73549-3; Keller MA, 2000, CLIN MICROBIOL REV, V13, P602, DOI 10.1128/CMR.13.4.602-614.2000; Kollberg H, 2003, PEDIATR PULM, V35, P433, DOI 10.1002/ppul.10290; Kong L K, 2006, Hong Kong Med J, V12, P489; Kovacs-Nolan J, 2005, J AGR FOOD CHEM, V53, P8421, DOI 10.1021/jf050964f; Larsson A, 2003, UPSALA J MED SCI, V108, P129; LARSSON A, 1993, POULTRY SCI, V72, P1807, DOI 10.3382/ps.0721807; LARSSON A, 1991, CLIN CHEM, V37, P411; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Lim APC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-130; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Nguyen HH, 2001, J INFECT DIS, V183, P368, DOI 10.1086/318084; Nilsson E, 2008, J AGR FOOD CHEM, V56, P11638, DOI 10.1021/jf802626t; Nilsson E, 2008, PEDIATR PULM, V43, P892, DOI 10.1002/ppul.20875; Peyre M, 2009, EPIDEMIOL INFECT, V137, P1, DOI 10.1017/S0950268808001039; REED LJ, 1938, AM J HYG, V27; RICHMOND JY, 2007, LAB BIOSAFETY LEVEL; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; RUSSELL MW, 1986, J CLIN IMMUNOL, V6, P74, DOI 10.1007/BF00915367; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Suzuki H, 2004, ALIMENT PHARM THER, V20, P185, DOI 10.1111/j.1365-2036.2004.02027.x; Szretter KJ, 2009, J VIROL, V83, P5825, DOI 10.1128/JVI.02144-08; The World Health Organization Global Influenza Program Surveillance Network, 2005, EMERG INFECT DIS, V11, P1515; Tominack R L, 1987, Infect Dis Clin North Am, V1, P459; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Walsh WE, 2000, IMMUNOLOGY, V101, P467, DOI 10.1046/j.1365-2567.2000.00136.x; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5	43	51	56	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10152	10.1371/journal.pone.0010152	http://dx.doi.org/10.1371/journal.pone.0010152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405007	gold, Green Published			2022-12-25	WOS:000276706300008
J	Ayoub, MA; Trinquet, E; Pfleger, KDG; Pin, JP				Ayoub, Mohammed Akli; Trinquet, Eric; Pfleger, Kevin D. G.; Pin, Jean-Philippe			Differential association modes of the thrombin receptor PAR(1) with G alpha i1, G alpha 12, and beta-arrestin 1	FASEB JOURNAL			English	Article						BRET; GPCRs; G proteins; TR-FRET	PROTEIN-COUPLED RECEPTORS; HETEROTRIMERIC G-PROTEINS; RESONANCE ENERGY-TRANSFER; LIVING CELLS; ACTIVATED RECEPTOR-1; G(12) FAMILY; COMPLEXES; INTERNALIZATION; PHOSPHORYLATION; BETA-ARRESTIN-2	Although many G protein-coupled receptors (GPCRs) are known to activate multiple signaling pathways by coupling to different types of G proteins or by promoting G protein-independent events, how this occurs remains unclear. Using bioluminescence resonance energy transfer and time-resolved fluorescence resonance energy transfer, we provide evidence for protease-activated receptor 1 (PAR(1)) forming preassembled complexes with G alpha i1 but not G alpha 12. PAR(1) activation appears to rapidly induce transient G alpha i1 activation (t(1/2) = 4.13 s) but late and stable recruitment of G alpha 12 (t(1/2) = 8.8 min) in parallel with beta-arrestin 1 (t(1/2) = 7.5 min). However, there is no significant difference in the potency of the agonist-dependent response between G alpha i1, G alpha 12, and beta-arrestin 1 (EC50 values 0.48, 0.30, and 0.15 nM, respectively). Although it seems beta-arrestin 1 is recruited to preassembled PAR(1)-G alpha i1 complexes, this appears unlikely with G alpha 12, suggesting 2 distinct receptor populations. Of note, we observed a different G alpha 12 association mode with other GPCRs, indicating that preassembly and association dynamics may be specific properties of a receptor-G protein pair. Furthermore, the G alpha C terminus appears to play different roles in the distinct association modes. Consequently, G protein preassembly or recruitment may constitute novel mechanisms for controlling the kinetics and multitude of GPCR signaling pathways.-Ayoub, M. A., Trinquet, E., Pfleger K. D. G., Pin, J.-P. Differential association modes of the thrombin receptor PAR(1) with G alpha i1, G alpha 12, and beta-arrestin 1. FASEB J. 24, 3522-3535 (2010). www.fasebj.org	[Ayoub, Mohammed Akli; Pin, Jean-Philippe] Univ Montpellier 2, Inst Genom Fonct, Dept Mol Pharmacol, F-34094 Montpellier 5, France; [Ayoub, Mohammed Akli; Pin, Jean-Philippe] Univ Montpellier I, CNRS, INSERM, UMR5203,U661, Montpellier, France; [Ayoub, Mohammed Akli; Pfleger, Kevin D. G.] Univ Western Australia, Lab Mol Endocrinol GPCRs, Western Australian Inst Med Res, Perth, WA 6009, Australia; [Ayoub, Mohammed Akli; Pfleger, Kevin D. G.] Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia; [Trinquet, Eric] Cisbio Bioassays, Bagnols Sur Ceze, France	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Western Australia; University of Western Australia	Pin, JP (corresponding author), Univ Montpellier 2, Inst Genom Fonct, Dept Mol Pharmacol, 141 Rue Cardonille, F-34094 Montpellier 5, France.	jppin@igf.cnrs.fr	Pin, Jean-Philippe/Y-6668-2019; Pfleger, Kevin/H-5629-2014	Pin, Jean-Philippe/0000-0002-1423-345X; Pfleger, Kevin/0000-0001-8261-9189; AYOUB, Mohammed Akli/0000-0003-0022-578X	CNRS; INSERM; French Ministry of Research; Cisbio International; Agence Nationale pour la Recherche [ANR-05-PRIB-02502]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Cisbio International; Agence Nationale pour la Recherche(French National Research Agency (ANR))	The authors thank Cisbio Bioassays for continuous strong support of this work. The authors also thank Drs. Laurent Prezeau, Sebastien Granier, and Thierry Durroux (IGF, Montpellier, France) for helpful discussions and Montpellier RIO imaging for confocal analysis. The authors thank Claire Vol, Isabelle Brabet, and the medium screening facilities of the IGF (Plate-forme Pharmacologie Criblage Interactome, Montpellier, France). This work was supported by grants from the CNRS, INSERM, French Ministry of Research, Cisbio International, and the Agence Nationale pour la Recherche (contract ANR-05-PRIB-02502).	Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Ayoub MA, 2010, CURR OPIN PHARMACOL, V10, P44, DOI 10.1016/j.coph.2009.09.012; Ayoub MA, 2009, J BIOL CHEM, V284, P29136, DOI 10.1074/jbc.M109.042333; Bockaert J, 1991, Curr Opin Neurobiol, V1, P32, DOI 10.1016/0959-4388(91)90008-U; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Chen CH, 2004, J BIOL CHEM, V279, P10020, DOI 10.1074/jbc.M310590200; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Dhanasekaran N, 1996, CELL SIGNAL, V8, P235, DOI 10.1016/0898-6568(96)00048-4; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Even-Ram SC, 2001, J BIOL CHEM, V276, P10952, DOI 10.1074/jbc.M007027200; Firth TA, 2001, NEUROPHARMACOLOGY, V40, P358, DOI 10.1016/S0028-3908(00)00161-1; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gohla A, 1999, J BIOL CHEM, V274, P17901, DOI 10.1074/jbc.274.25.17901; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hammes SR, 1999, BIOCHEMISTRY-US, V38, P9308, DOI 10.1021/bi9902236; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hermans E, 2003, PHARMACOL THERAPEUT, V99, P25, DOI 10.1016/S0163-7258(03)00051-2; JEFFERY DR, 1980, J BIOL CHEM, V255, P5015; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kuo FT, 2006, CELL SIGNAL, V18, P1914, DOI 10.1016/j.cellsig.2006.02.009; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LIMBIRD LE, 1980, P NATL ACAD SCI-BIOL, V77, P775, DOI 10.1073/pnas.77.2.775; Limbird LE, 2004, MOL INTERV, V4, P326, DOI 10.1124/mi.4.6.6; Lohse MJ, 2008, TRENDS PHARMACOL SCI, V29, P159, DOI 10.1016/j.tips.2007.12.002; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; McGrew L, 2002, MOL PHARMACOL, V62, P1339, DOI 10.1124/mol.62.6.1339; Meyer BH, 2008, J CELL BIOCHEM, V104, P1660, DOI 10.1002/jcb.21732; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Pfleger KDG, 2005, BIOCHEM J, V385, P625, DOI 10.1042/BJ20041361; Prevost GP, 2006, CANCER RES, V66, P9227, DOI 10.1158/0008-5472.CAN-05-4205; Qin K, 2008, FASEB J, V22, P2920, DOI 10.1096/fj.08-105775; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SCHULSTER D, 1978, J BIOL CHEM, V253, P1201; Shea LD, 2000, LIFE SCI, V68, P647, DOI 10.1016/S0024-3205(00)00977-2; Shi CS, 2000, J BIOL CHEM, V275, P24470, DOI 10.1074/jbc.M908449199; Tanabe S, 2004, METHOD ENZYMOL, V390, P285; Vanderbeld B, 2000, BIOCHEM CELL BIOL, V78, P537, DOI 10.1139/o00-075; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Yamaguchi Y, 2003, J BIOL CHEM, V278, P14936, DOI 10.1074/jbc.M301409200; Yamaguchi Y, 2002, CURR BIOL, V12, P1353, DOI 10.1016/S0960-9822(02)01034-5	54	53	56	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3522	3535		10.1096/fj.10-154997	http://dx.doi.org/10.1096/fj.10-154997			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20410441				2022-12-25	WOS:000281446400039
J	Gora, S; Maouche, S; Atout, R; Wanherdrick, K; Lambeau, G; Cambien, F; Ninio, E; Karabina, SA				Gora, Sarah; Maouche, Seraya; Atout, Rajai; Wanherdrick, Kristell; Lambeau, Gerard; Cambien, Francois; Ninio, Ewa; Karabina, Sonia-Athina			Phospholipolyzed LDL induces an inflammatory response in endothelial cells through endoplasmic reticulum stress signaling	FASEB JOURNAL			English	Article						unfolded protein response; inflammation; secreted phospholipase A2 group X; hGX sPLA2; modified LDL; atherosclerosis	UNFOLDED PROTEIN RESPONSE; LOW-DENSITY-LIPOPROTEIN; GROUP-X; GROUP-V; SECRETORY PHOSPHOLIPASE-A(2); GROUP-IIA; A(2); ATHEROSCLEROSIS; HYDROLYSIS; PATHWAYS	Secreted phospholipases A2 (sPLA2s) are present in atherosclerotic plaques and are now considered novel attractive therapeutic targets and potential biomarkers as they contribute to the development of atherosclerosis through lipoprotein-dependent and independent mechanisms. We have previously shown that hGX-sPLA2-phospholipolyzed LDL (LDL-X) induces proinflammatory responses in human umbilical endothelial cells (HUVECs); here we explore the molecular mechanisms involved. Global transcriptional gene expression profiling of the response of endothelial cells exposed to either LDL or LDL-X revealed that LDL-X activates multiple distinct cellular pathways including the unfolded protein response (UPR). Mechanistic insight showed that LDL-X activates UPR through calcium depletion of intracellular stores, which in turn disturbs cytoskeleton organization. Treatment of HUVECs and aortic endothelial cells (HAECs) with LDL-X led to activation of all 3 proximal initiators of UPR: eIF-2 alpha, IRE1 alpha, and ATF6. In parallel, we observed a sustained phosphorylation of the p38 pathway resulting in the phosphorylation of AP-1 downstream targets. This was accompanied by significant production of the proinflammatory cytokines IL-6 and IL-8. Our study demonstrates that phospholipolyzed LDL uses a range of molecular pathways including UPR to initiate endothelial cell perturbation and thus provides an LDL oxidation-independent mechanism for the initiation of vascular inflammation in atherosclerosis.- Gora, S., Maouche, S., Atout, R., Wanherdrick, K., Lambeau, G., Cambien, F., Ninio, E., Karabina, S.-A. Phospholipolyzed LDL induces an inflammatory response in endothelial cells through endoplasmic reticulum stress signaling. FASEB J. 24, 3284-3297 (2010). www.fasebj.org	[Gora, Sarah; Maouche, Seraya; Atout, Rajai; Cambien, Francois; Ninio, Ewa; Karabina, Sonia-Athina] INSERM, UMRS 937, F-75634 Paris 13, France; [Wanherdrick, Kristell] Univ Paris 06, Fac Med Pierre & Marie Curie, Paris, France; [Lambeau, Gerard] Univ Nice Sophia Antipolis, CNRS, UMR 6097, Inst Pharmacol Mol & Cellulaire, Valbonne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Karabina, SA (corresponding author), INSERM, U937, Fac Med Pitie Salpetriere, 91 Blvd Hop, F-75634 Paris 13, France.	sonia.karabina@upmc.fr	Lambeau, Gerard/GRJ-5624-2022; Cambien, Francois/AAP-9751-2020	Maouche, Seraya/0000-0001-8186-1635; Lambeau, Gerard/0000-0002-9239-518X	Institut National de la Sante Et de la Recherche Medicale; Fondation pour la Recherche Medicale [SPF20080512033, FDT200910244, FDT20070910166]; European Union; ANR; Centre National de la Recherche Scientifique (CNRS); Association pour la Recherche sur le Cancer	Institut National de la Sante Et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Union(European Commission); ANR(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This study was supported by the Institut National de la Sante Et de la Recherche Medicale and by fellowships from the Fondation pour la Recherche Medicale (SPF20080512033) to S. A. K., (FDT200910244) to S. G., and (FDT20070910166) to S. M. The study was also supported by the European Union STREP Programme CVDIMMUNE (2006-2009) to E.N., by an ANR program (ANR 2006 Physio-pathologie des maladies humaines: sPLA2/ATHEROSCLEROSE) to G. L. and E.N., and by the Centre National de la Recherche Scientifique (CNRS) and the Association pour la Recherche sur le Cancer to G. L. E.N. and G. L. are Directors of Research at CNRS. The authors acknowledge the excellent technical assistance of Monique Agrapart and Herve Durand.	Asatryan L, 2005, J LIPID RES, V46, P115, DOI 10.1194/jlr.M400306-JLR200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chadjichristos CE, 2006, ADV CARDIOL, V42, P255, DOI 10.1159/000092574; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cho W, 2000, BBA-MOL CELL BIOL L, V1488, P48, DOI 10.1016/S1388-1981(00)00109-8; Corbett EF, 2000, TRENDS BIOCHEM SCI, V25, P307, DOI 10.1016/S0968-0004(00)01588-7; Curfs DMJ, 2008, J BIOL CHEM, V283, P21640, DOI 10.1074/jbc.M710584200; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fujioka D, 2008, CIRCULATION, V117, P2977, DOI 10.1161/CIRCULATIONAHA.107.743997; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Glembotski CC, 2008, J MOL CELL CARDIOL, V44, P453, DOI 10.1016/j.yjmcc.2007.10.017; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hanasaki K, 2002, J BIOL CHEM, V277, P29116, DOI 10.1074/jbc.M202867200; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jagavelu K, 2007, CIRC RES, V101, P1104, DOI 10.1161/CIRCRESAHA.107.156075; Karabina SA, 2006, FASEB J, V20, P2547, DOI 10.1096/fj.06-6018fje; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Matsumoto T, 2007, CURR MED CHEM, V14, P3209, DOI 10.2174/092986707782793899; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Oskolkova OV, 2008, BLOOD, V112, P330, DOI 10.1182/blood-2007-09-112870; Pan YH, 2002, J BIOL CHEM, V277, P29086, DOI 10.1074/jbc.M202531200; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Pruzanski W, 2005, BBA-MOL CELL BIOL L, V1736, P38, DOI 10.1016/j.bbalip.2005.07.005; PUHL H, 1994, METHOD ENZYMOL, V233, P425; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosengren B, 2006, BBA-MOL CELL BIOL L, V1761, P1301, DOI 10.1016/j.bbalip.2006.06.008; Sanson M, 2009, CIRC RES, V104, P328, DOI 10.1161/CIRCRESAHA.108.183749; SANTANAM N, 1995, J CLIN INVEST, V95, P2594, DOI 10.1172/JCI117961; Sato H, 2008, J BIOL CHEM, V283, P33483, DOI 10.1074/jbc.M804628200; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Seimon TA, 2009, J CLIN INVEST, V119, P886, DOI 10.1172/JCI37262; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Smyth G, 2005, LIMMA LINEAR MODELS; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Tabas I, 1999, ANNU REV NUTR, V19, P123, DOI 10.1146/annurev.nutr.19.1.123; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Treiman M, 2002, TRENDS CARDIOVAS MED, V12, P57, DOI 10.1016/S1050-1738(01)00147-5; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wooton-Kee CR, 2004, ARTERIOSCL THROM VAS, V24, P762, DOI 10.1161/01.ATV.0000122363.02961.c1; Yamamoto K, 2003, J BIOL CHEM, V278, P34525, DOI 10.1074/jbc.M304188200; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhou J, 2004, CIRCULATION, V110, P207, DOI 10.1161/01.CIR.0000134487.51510.97	56	42	45	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3284	3297		10.1096/fj.09-146852	http://dx.doi.org/10.1096/fj.09-146852			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20430794				2022-12-25	WOS:000281446400017
J	Hutnick, LK; Huang, XH; Loo, TC; Ma, ZC; Fan, GP				Hutnick, Leah K.; Huang, Xinhua; Loo, Tao-Chuan; Ma, Zhicheng; Fan, Guoping			Repression of Retrotransposal Elements in Mouse Embryonic Stem Cells Is Primarily Mediated by a DNA Methylation-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACISTERNAL-A-PARTICLE; GENE-EXPRESSION; ENDOGENOUS RETROVIRUSES; PRE-IMPLANTATION; IAP-LTR; GENOME; TRANSCRIPTION; SEQUENCE; TISSUE	In defense of deleterious retrotransposition of intracisternal A particle (IAP) elements, IAP loci are heavily methylated and silenced in mouse somatic cells. To determine whether IAP is also repressed in pluripotent stem cells by DNA methylation, we examined IAP expression in demethylated mouse embryonic stem cells (mESCs) and epiblast-derived stem cells. Surprisingly, in demethylated ESC cultures carrying mutations of DNA methyltransferase I (Dnmt1), no IAP transcripts and proteins are detectable in undifferentiated Oct4(+) ESCs. In contrast, similar to 3.6% of IAP-positive cells are detected in Oct4(-) Dnmt1(-/-) cells, suggesting that the previously observed increase in IAP transcripts in the population of Dnmt1(-/-) ESCs could be accounted for by this subset of Oct4(-) Dnmt1(-/-) ESCs undergoing spontaneous differentiation. Consistent with this possibility, a dramatic increase of IAP mRNA (>100-fold) and protein expression was observed in Dnmt1(-/-) ESC cultures upon induction of differentiation through the withdrawal of leukemia-inhibitory factor for 6 or more days. Interestingly, both mRNAs and proteins of IAP can be readily detected in demethylated Oct4(+) epiblast-derived stem cells as well as differentiated mouse embryo fibroblasts, neurons, and glia upon conditional Dnmt1 gene deletion. These data suggest that mESCs are a unique stem cell type possessing a DNA methylation-independent IAP repression mechanism. This methylation-independent mechanism does not involve Dicer-mediated action of microRNAs or RNA interference because IAP expression remains repressed in Dnmt1(-/-); Dicer(-/-) double mutant ESCs. We suggest that mESCs possess a unique DNA methylation-independent mechanism to silence retrotransposons to safeguard genome stability while undergoing rapid cell proliferation for self-renewal.	[Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Hutnick, Leah K.] Univ Calif Los Angeles, David Geffen Sch Med, Neurosci Interdept Program, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fan, GP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, 695 Charles Young Dr S, Los Angeles, CA 90095 USA.	gfan@mednet.ucla.edu	Albertini, David/AAD-3856-2021	Albertini, David/0000-0001-6536-2828; Fan, Guoping/0000-0001-5235-6410	National Institutes of Health [RO1 NS051411, P01 GM081621]; California Institute of Regenerative Medicine [RC1-0111]; National Research Service Award [5F31NS051]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 NS051411 and P01 GM081621 (to G. F.). This work was also supported by California Institute of Regenerative Medicine Grant RC1-0111 (to G. F.) and National Research Service Award 5F31NS051 (to L. K. H.).	Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Biniszkiewicz D, 2002, MOL CELL BIOL, V22, P2124, DOI 10.1128/MCB.22.7.2124-2135.2002; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; CALARCO PG, 1979, INTERVIROLOGY, V11, P321, DOI 10.1159/000149053; CONNELLY MA, 1994, P NATL ACAD SCI USA, V91, P1337, DOI 10.1073/pnas.91.4.1337; Dewannieux M, 2004, NAT GENET, V36, P534, DOI 10.1038/ng1353; Dupressoir A, 1996, MOL CELL BIOL, V16, P4495; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Feng JA, 2007, PEDIATR RES, V61, p58R, DOI 10.1203/pdr.0b013e3180457635; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; HEIDMANN O, 1991, CELL, V64, P159, DOI 10.1016/0092-8674(91)90217-M; Hutnick LK, 2009, HUM MOL GENET, V18, P2875, DOI 10.1093/hmg/ddp222; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; KUFF EL, 1980, J VIROL, V33, P1211, DOI 10.1128/JVI.33.3.1211-1214.1980; KUFF EL, 1968, CANCER RES, V28, P2137; KUFF EL, 1985, MOL CELL BIOL, V5, P474, DOI 10.1128/MCB.5.3.474; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lee JS, 1999, J VIROL, V73, P5166, DOI 10.1128/JVI.73.6.5166-5171.1999; Lees-Murdock DJ, 2003, GENOMICS, V82, P230, DOI 10.1016/S0888-7543(03)00105-8; Lei H, 1996, DEVELOPMENT, V122, P3195; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; MIETZ JA, 1987, J VIROL, V61, P3020, DOI 10.1128/JVI.61.10.3020-3029.1987; Morita S, 2007, GENOMICS, V89, P687, DOI 10.1016/j.ygeno.2007.01.004; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; POZNANSKI AA, 1991, DEV BIOL, V143, P271, DOI 10.1016/0012-1606(91)90077-G; Ramirez MA, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-55; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sugino H, 2004, GENE, V337, P91, DOI 10.1016/j.gene.2004.04.011; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Ukai H, 2003, MOL CARCINOGEN, V37, P110, DOI 10.1002/mc.10128; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850	45	61	62	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21082	21091		10.1074/jbc.M110.125674	http://dx.doi.org/10.1074/jbc.M110.125674			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20404320	Green Published, hybrid			2022-12-25	WOS:000279228600071
J	Olson, BJSC; Wang, QA; Osteryoung, KW				Olson, Bradley J. S. C.; Wang, Qiang; Osteryoung, Katherine W.			GTP-dependent Heteropolymer Formation and Bundling of Chloroplast FtsZ1 and FtsZ2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVISION PROTEIN FTSZ; BACTERIAL-CELL-DIVISION; PLASTID DIVISION; ESCHERICHIA-COLI; Z-RING; IN-VITRO; ASSEMBLY DYNAMICS; FORCE GENERATION; GENE FAMILIES; HIGHER-PLANTS	Bacteria and chloroplasts require the ring-forming cytoskeletal protein FtsZ for division. Although bacteria accomplish division with a single FtsZ, plant chloroplasts require two FtsZ types for division, FtsZ1 and FtsZ2. These proteins colocalize to a mid-plastid Z ring, but their biochemical relationship is poorly understood. We investigated the in vitro behavior of recombinant FtsZ1 and FtsZ2 separately and together. Both proteins bind and hydrolyze GTP, although GTPase activities are low compared with the activity of Escherichia coli FtsZ. Each protein undergoes GTP-dependent assembly into thin protofilaments in the presence of calcium as a stabilizing agent, similar to bacterial FtsZ. In contrast, when mixed without calcium, FtsZ1 and FtsZ2 exhibit slightly elevated GTPase activity and coassembly into extensively bundled protofilaments. Coassembly is enhanced by FtsZ1, suggesting that it promotes lateral interactions between protofilaments. Experiments with GTPase-deficient mutants reveal that FtsZ1 and FtsZ2 form heteropolymers. Maximum coassembly occurs in reactions containing equimolar FtsZ1 and FtsZ2, but significant coassembly occurs at other stoichiometries. The FtsZ1: FtsZ2 ratio in coassembled structures mirrors their input ratio, suggesting plasticity in protofilament and/or bundle composition. This behavior contrasts with that of alpha- and beta-tubulin and the bacterial tubulin-like proteins BtubA and BtubB, which coassemble in a strict 1:1 stoichiometry. Our findings raise the possibility that plasticity in FtsZ filament composition and heteropolymerization-induced bundling could have been a driving force for the coevolution of FtsZ1 and FtsZ2 in the green lineage, perhaps arising from an enhanced capacity for the regulation of Z ring composition and activity in vivo.	[Wang, Qiang; Osteryoung, Katherine W.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; Michigan State Univ, Biochem & Mol Biol Grad Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Osteryoung, KW (corresponding author), Michigan State Univ, Dept Plant Biol, 166 Plant Biol Bldg, E Lansing, MI 48824 USA.	osteryou@msu.edu	Olson, Bradley J S C/A-4532-2013; Wang, Qiang/P-7806-2016	Olson, Bradley J S C/0000-0002-4751-8347; Wang, Qiang/0000-0002-7388-4703	Michigan State University Plant Sciences; National Science Foundation [0544676]	Michigan State University Plant Sciences; National Science Foundation(National Science Foundation (NSF))	This work was supported by Michigan State University Plant Sciences and N. E. Tolbert Memorial Fellowships (to B. J. S. C. O.) and by National Science Foundation Grant 0544676 (to K. W. O.).	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Allard JF, 2009, P NATL ACAD SCI USA, V106, P145, DOI 10.1073/pnas.0808657106; Bendezu FO, 2009, EMBO J, V28, P193, DOI 10.1038/emboj.2008.264; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; El-Kafafi ES, 2008, BIOCHEM J, V409, P87, DOI 10.1042/BJ20070543; El-Kafafi ES, 2005, BIOCHEM J, V387, P669, DOI 10.1042/BJ20041281; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; Erickson HP, 2009, P NATL ACAD SCI USA, V106, P9238, DOI 10.1073/pnas.0902258106; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Glynn JM, 2007, TRAFFIC, V8, P451, DOI 10.1111/j.1600-0854.2007.00545.x; Huecas S, 2004, FEBS LETT, V569, P43, DOI 10.1016/j.febslet.2004.05.048; Huecas S, 2008, BIOPHYS J, V94, P1796, DOI 10.1529/biophysj.107.115493; Jeong KJ, 2003, APPL ENVIRON MICROB, V69, P1295, DOI 10.1128/AEM.69.2.1295-1298.2003; Lan GH, 2009, P NATL ACAD SCI USA, V106, P121, DOI 10.1073/pnas.0807963106; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Lohse S, 2006, PLANT CELL PHYSIOL, V47, P1124, DOI 10.1093/pcp/pcj083; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; Lu CL, 1998, METHOD ENZYMOL, V298, P305, DOI 10.1016/S0076-6879(98)98027-2; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Maple J, 2005, PLANT J, V43, P811, DOI 10.1111/j.1365-313X.2005.02493.x; Maple J, 2007, EMBO REP, V8, P293, DOI 10.1038/sj.embor.7400902; Marrington R, 2004, J BIOL CHEM, V279, P48821, DOI 10.1074/jbc.M404944200; McAndrew RS, 2008, BIOCHEM J, V412, P367, DOI 10.1042/BJ20071354; McAndrew RS, 2001, PLANT PHYSIOL, V127, P1656, DOI 10.1104/pp.010542; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Mohammadi T, 2009, BIOCHEMISTRY-US, V48, P11056, DOI 10.1021/bi901461p; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754, DOI 10.1128/JB.176.9.2754-2758.1994; Mukherjee A, 2001, J BACTERIOL, V183, P7190, DOI 10.1128/JB.183.24.7190-7197.2001; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Osawa M, 2009, EMBO J, V28, P3476, DOI 10.1038/emboj.2009.277; Osteryoung KW, 1998, PLANT CELL, V10, P1991, DOI 10.1105/tpc.10.12.1991; OSTERYOUNG KW, 1995, NATURE, V376, P473, DOI 10.1038/376473b0; Osteryoung KW, 2001, ANNU REV PLANT PHYS, V52, P315, DOI 10.1146/annurev.arplant.52.1.315; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Rensing SA, 2004, J MOL EVOL, V58, P154, DOI 10.1007/s00239-003-2535-1; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; Scheffers DJ, 2002, BIOCHEMISTRY-US, V41, P521, DOI 10.1021/bi011370i; Scheffers DJ, 2000, MOL MICROBIOL, V35, P1211, DOI 10.1046/j.1365-2958.2000.01791.x; Schlieper D, 2005, P NATL ACAD SCI USA, V102, P9170, DOI 10.1073/pnas.0502859102; Schmitz AJ, 2009, MOL PLANT, V2, P1211, DOI 10.1093/mp/ssp077; Smith AG, 2010, FEBS LETT, V584, P166, DOI 10.1016/j.febslet.2009.11.044; Sontag CA, 2005, J CELL BIOL, V169, P233, DOI 10.1083/jcb.200410027; Sontag CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007253; Stokes KD, 2003, GENE, V320, P97, DOI 10.1016/S0378-1119(03)00814-X; Stokes KD, 2000, PLANT PHYSIOL, V124, P1668, DOI 10.1104/pp.124.4.1668; Strepp R, 1998, P NATL ACAD SCI USA, V95, P4368, DOI 10.1073/pnas.95.8.4368; Vitha S, 2003, PLANT CELL, V15, P1918, DOI 10.1105/tpc.013292; Vitha S, 2001, J CELL BIOL, V153, P111, DOI 10.1083/jcb.153.1.111; Wang X, 1996, MOL MICROBIOL, V21, P313, DOI 10.1046/j.1365-2958.1996.6421360.x; Yang Y, 2008, CURR OPIN PLANT BIOL, V11, P577, DOI 10.1016/j.pbi.2008.10.001; Yoder DW, 2007, PLANT CELL PHYSIOL, V48, P775, DOI 10.1093/pcp/pcm049; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	64	51	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20634	20643		10.1074/jbc.M110.122614	http://dx.doi.org/10.1074/jbc.M110.122614			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20421292	Green Published, hybrid			2022-12-25	WOS:000279228600027
J	Cavanaugh, A; McKenna, J; Stepanchick, A; Breitwieser, GE				Cavanaugh, Alice; McKenna, Jennifer; Stepanchick, Ann; Breitwieser, Gerda E.			Calcium-sensing Receptor Biosynthesis Includes a Cotranslational Conformational Checkpoint and Endoplasmic Reticulum Retention	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; PROTEIN-COUPLED RECEPTORS; KAPPA-OPIOID-RECEPTOR; HUMAN CA2+ RECEPTOR; SIGNAL-TRANSDUCTION; PHARMACOLOGICAL CHAPERONES; EXTRACELLULAR DOMAIN; CALCIMIMETIC R-568; DOWN-REGULATION; QUALITY-CONTROL	Metabolic labeling with [S-35] cysteine was used to characterize early events in CaSR biosynthesis. [S-35] CaSR is relatively stable (half-life similar to 8 h), but maturation to the final glycosylated form is slow and incomplete. Incorporation of [S-35] cysteine is linear over 60 min, and the rate of [S-35] CaSR biosynthesis is significantly increased by the membrane-permeant allosteric agonist NPS R-568, which acts as a cotranslational pharmacochaperone. The [S-35] CaSR biosynthetic rate also varies as a function of conformational bias induced by loss- or gain-of-function mutations. In contrast, [S-35] CaSR maturation to the plasma membrane was not significantly altered by exposure to the pharmacochaperone NPS R-568, the allosteric agonist neomycin, or the orthosteric agonist Ca2+ (0.5 or 5 mM), suggesting that CaSR does not control its own release from the endoplasmic reticulum. A CaSR chimera containing the mGluR1 alpha carboxyl terminus matures completely (half-time of similar to 8 h) and without a lag period, as does the truncation mutant CaSR Delta 868 (half-time of similar to 16 h). CaSR Delta 898 exhibits maturation comparable with full-length CaSR, suggesting that the CaSR carboxyl terminus between residues Thr(868) and Arg(898) limits maturation. Overall, these results suggest that CaSR is subject to cotranslational quality control, which includes a pharmacochaperone-sensitive conformational checkpoint. The CaSR carboxyl terminus is the chief determinant of intracellular retention of a significant fraction of total CaSR. Intracellular CaSR may reflect a rapidly mobilizable "storage form" of CaSR and/or may subserve distinct intracellular signaling roles that are sensitive to signaling-dependent changes in endoplasmic reticulum Ca2+ and/or glutathione.	[Cavanaugh, Alice; McKenna, Jennifer; Stepanchick, Ann; Breitwieser, Gerda E.] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA		Breitwieser, GE (corresponding author), Weis Ctr Res, Geisinger Clin, 100 N Acad Ave, Danville, PA 17822 USA.	gebreitwieser@geisinger.edu		Breitwieser, Gerda/0000-0001-9081-0362	National Institutes of Health [R01 GM077563]; Geisinger Clinic; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geisinger Clinic; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM077563. This work was also supported by funds from the Geisinger Clinic (to G.E.B.).	Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Blaukat A, 2003, AM J PHYSIOL-HEART C, V284, pH1909, DOI 10.1152/ajpheart.00034.2003; Bradbury FA, 1997, J BIOL CHEM, V272, P5921, DOI 10.1074/jbc.272.9.5921; Breitwieser GE, 2004, CELL CALCIUM, V35, P209, DOI 10.1016/j.ceca.2003.10.013; Breitwieser GE, 2001, AM J PHYSIOL-CELL PH, V280, pC1412, DOI 10.1152/ajpcell.2001.280.6.C1412; Brennan SC, 2009, CURR PHARM BIOTECHNO, V10, P270, DOI 10.2174/138920109787847484; Brown E. M., 2007, V45, P139; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Chattopadhyay N, 1997, DEV BRAIN RES, V100, P13, DOI 10.1016/S0165-3806(97)00009-6; Chen Y, 2006, J PHARMACOL EXP THER, V319, P765, DOI 10.1124/jpet.106.107987; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Conn PM, 2006, MOL ENDOCRINOL, V20, P3035, DOI 10.1210/me.2006-0066; Csala M, 2006, FEBS LETT, V580, P2160, DOI 10.1016/j.febslet.2006.03.050; Dewire SM, 2008, J BIOL CHEM, V283, P10611, DOI 10.1074/jbc.M710515200; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Fan GF, 1998, FEBS LETT, V436, P353, DOI 10.1016/S0014-5793(98)01165-X; Felder CB, 1999, AAPS PHARMSCI, V1; Gama L, 1998, J BIOL CHEM, V273, P29712, DOI 10.1074/jbc.273.45.29712; Gama Lucio, 2002, Methods Mol Biol, V182, P77; Huang Y, 2006, J BIOL CHEM, V281, P11610, DOI 10.1074/jbc.M513552200; Huang Y, 2007, J BIOL CHEM, V282, P9517, DOI 10.1074/jbc.M609045200; Janovick JA, 2007, MOL CELL ENDOCRINOL, V272, P77, DOI 10.1016/j.mce.2007.04.012; Janovick JA, 2009, MOL ENDOCRINOL, V23, P157, DOI 10.1210/me.2008-0384; Jiang YF, 2004, J BIOL CHEM, V279, P14147, DOI 10.1074/jbc.M307422200; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Jong YJI, 2009, J BIOL CHEM, V284, P35827, DOI 10.1074/jbc.M109.046276; KATZ CL, 1992, ENDOCRINOLOGY, V131, P903, DOI 10.1210/en.131.2.903; Kawata T, 2008, KIDNEY INT, V74, P1270, DOI 10.1038/ki.2008.407; Koleganova N, 2009, KIDNEY INT, V75, P60, DOI 10.1038/ki.2008.490; Kumar V, 2008, J BIOL CHEM, V283, P14072, DOI 10.1074/jbc.M708551200; Landolfi B, 1998, J CELL BIOL, V142, P1235, DOI 10.1083/jcb.142.5.1235; Lee DK, 2004, J BIOL CHEM, V279, P7901, DOI 10.1074/jbc.M306377200; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Li JG, 2007, BIOCHEMISTRY-US, V46, P10960, DOI 10.1021/bi700443j; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Markkanen PMH, 2008, J BIOL CHEM, V283, P29086, DOI 10.1074/jbc.M801880200; Mauro TM, 2007, J INVEST DERMATOL, V127, P991, DOI 10.1038/sj.jid.5700696; Mendoza FJ, 2009, AM J PHYSIOL-RENAL, V296, pF605, DOI 10.1152/ajprenal.90272.2008; Miedlich SU, 2004, J BIOL CHEM, V279, P7254, DOI 10.1074/jbc.M307191200; Mizobuchi M, 2004, J AM SOC NEPHROL, V15, P2579, DOI 10.1097/01.ASN.0000141016.20133.33; Park MK, 2000, EMBO J, V19, P5729, DOI 10.1093/emboj/19.21.5729; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Piecha G, 2008, AM J PHYSIOL-RENAL, V294, pF748, DOI 10.1152/ajprenal.00220.2007; Pietila EM, 2005, J BIOL CHEM, V280, P26622, DOI 10.1074/jbc.M413815200; Ray K, 1998, J BIOL CHEM, V273, P34558, DOI 10.1074/jbc.273.51.34558; Ray K, 1999, J BIOL CHEM, V274, P27642, DOI 10.1074/jbc.274.39.27642; Ray K, 1997, J BIOL CHEM, V272, P31355, DOI 10.1074/jbc.272.50.31355; Revankar CM, 2007, ACS CHEM BIOL, V2, P536, DOI 10.1021/cb700072n; Riccardi D, 1998, AM J PHYSIOL-RENAL, V274, pF611, DOI 10.1152/ajprenal.1998.274.3.F611; Riccardi D, 2000, PFLUG ARCH EUR J PHY, V441, P379, DOI 10.1007/s004240000436; Robben JH, 2007, AM J PHYSIOL-RENAL, V292, pF253, DOI 10.1152/ajprenal.00247.2006; Robert J, 2005, J BIOL CHEM, V280, P42198, DOI 10.1074/jbc.M510180200; Schwieger I, 2008, MOL PHARMACOL, V73, P697, DOI 10.1124/mol.107.040931; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; Tu CL, 2007, J INVEST DERMATOL, V127, P1074, DOI 10.1038/sj.jid.5700633; Tu CL, 2004, CELL CALCIUM, V35, P265, DOI 10.1016/j.ceca.2003.10.019; Vizard TN, 2008, NAT NEUROSCI, V11, P285, DOI 10.1038/nn2044; Wang MH, 2006, J BIOL CHEM, V281, P8864, DOI 10.1074/jbc.M512865200; Ward DT, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015623.73739.B8; White E, 2009, MOL ENDOCRINOL, V23, P1115, DOI 10.1210/me.2009-0041; Wright CD, 2008, CIRC RES, V103, P992, DOI 10.1161/CIRCRESAHA.108.176024; Wuller S, 2004, J BIOL CHEM, V279, P47254, DOI 10.1074/jbc.M408154200	64	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19854	19864		10.1074/jbc.M110.124792	http://dx.doi.org/10.1074/jbc.M110.124792			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20421307	Green Published, hybrid			2022-12-25	WOS:000279012000018
J	Galvin, KE; Travis, ED; Yee, D; Magnuson, T; Vivian, JL				Galvin, Katherine E.; Travis, Emily D.; Yee, Della; Magnuson, Terry; Vivian, Jay L.			Nodal Signaling Regulates the Bone Morphogenic Protein Pluripotency Pathway in Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; SELF-RENEWAL; DEFINITIVE ENDODERM; DIRECT BINDING; SMAD PROTEINS; ID PROTEINS; DIFFERENTIATION; TROPHOBLAST; INHIBITOR	Members of the transforming growth factor-beta superfamily play essential roles in both the pluripotency and differentiation of embryonic stem (ES) cells. Although bone morphogenic proteins (BMPs) maintain pluripotency of undifferentiated mouse ES cells, the role of autocrine Nodal signaling is less clear. Pharmacological, molecular, and genetic methods were used to further understand the roles and potential interactions of these pathways. Treatment of undifferentiated ES cells with SB431542, a pharmacological inhibitor of Smad2 signaling, resulted in a rapid reduction of phosphorylated Smad2 and altered the expression of several putative downstream targets. Unexpectedly, inhibition of the Nodal signaling pathway resulted in enhanced BMP signaling, as assessed by Smad1/5 phosphorylation. SB431542-treated cells also demonstrated significant induction of the Id genes, which are known direct targets of BMP signaling and important factors in ES cell pluripotency. Inhibition of BMP signaling decreased the SB431542-mediated phosphorylation of Smad1/5 and induction of Id genes, suggesting that BMP signaling is necessary for some Smad2-mediated activity. Because Smad7, a known inhibitory factor to both Nodal and BMP signaling, was down-regulated following inhibition of Nodal-Smad2 signaling, the contribution of Smad7 to the cross-talk between the transforming growth factor-beta pathways in ES cells was examined. Biochemical manipulation of Smad7 expression, through shRNA knockdown or inducible gene expression, significantly reduced the SB431542-mediated phosphorylation of Smad1/5 and induction of the Id genes. We conclude that autocrine Nodal signaling in undifferentiated mouse ES cells modulates the vital pluripotency pathway of BMP signaling.	[Galvin, Katherine E.; Travis, Emily D.; Vivian, Jay L.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Galvin, Katherine E.; Travis, Emily D.; Vivian, Jay L.] Univ Kansas, Med Ctr, Div Canc & Dev Biol, Kansas City, KS 66160 USA; [Galvin, Katherine E.; Travis, Emily D.; Vivian, Jay L.] Univ Kansas, Med Ctr, Inst Maternal Fetal Biol, Kansas City, KS 66160 USA; [Yee, Della; Magnuson, Terry] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of North Carolina; University of North Carolina Chapel Hill	Vivian, JL (corresponding author), 3901 Rainbow Blvd,Mail Stop 3045, Kansas City, KS 66160 USA.	jvivian@kumc.edu			National Institutes of Health [RR022888]; COBRE [P20RR024214]; NIH [T32HD007455]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007455] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024214, R21RR022888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COBRE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant RR022888 and COBRE P20RR024214 (to J.L.V.) and by NIH postdoctoral training grant T32HD007455 (to K. E. G.).	Amthor H, 2002, DEV BIOL, V243, P115, DOI 10.1006/dbio.2001.0555; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Blake, 2007, SCI STKE, DOI DOI 10.1126/STKE.3992007CM1; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Guzman-Ayala M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004268; Hanyu A, 2001, J CELL BIOL, V155, P1017, DOI 10.1083/jcb.200106023; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Hayashi Y, 2010, IN VITRO CELL DEV-AN, V46, P416, DOI 10.1007/s11626-009-9266-6; He SY, 2008, STEM CELLS, V26, P842, DOI 10.1634/stemcells.2007-0356; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Ishisaki A, 1999, J BIOL CHEM, V274, P13637, DOI 10.1074/jbc.274.19.13637; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ma GT, 2001, DEV BIOL, V236, P124, DOI 10.1006/dbio.2001.0334; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; MIYAZONO K, 2002, SCI STKE, pPE40; Nagy A., 2003, MANIPULATING MOUSE E; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Park C, 2004, DEVELOPMENT, V131, P2749, DOI 10.1242/dev.01130; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pierre A, 2005, REPROD NUTR DEV, V45, P419, DOI 10.1051/rnd:2005031; Puceat M, 2007, CARDIOVASC RES, V74, P256, DOI 10.1016/j.cardiores.2006.12.012; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Ro S, 2005, BIOTECHNIQUES, V38, P625, DOI 10.2144/05384RN01; SEIFINEJAD A, 2010, STEM CELL R IN PRESS; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sikder HA, 2003, CANCER CELL, V3, P525, DOI 10.1016/S1535-6108(03)00141-7; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Tabibzadeh S, 2006, STEM CELLS, V24, P1998, DOI 10.1634/stemcells.2006-0075; Takaoka K, 2006, DEV CELL, V10, P451, DOI 10.1016/j.devcel.2006.02.017; Takenaga M, 2007, J CELL SCI, V120, P2078, DOI 10.1242/jcs.004127; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Tournay O, 1996, MOL CELL BIOL, V16, P2418; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vivian JL, 1999, BIOTECHNIQUES, V27, P154, DOI 10.2144/99271rr04; Vivian JL, 2002, P NATL ACAD SCI USA, V99, P15542, DOI 10.1073/pnas.242474199; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wu Z, 2008, J BIOL CHEM, V283, P24991, DOI 10.1074/jbc.M803893200; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yoshikawa T, 2006, GENE EXPR PATTERNS, V6, P213, DOI 10.1016/j.modgep.2005.06.003; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhao X, 2008, J BIOL CHEM, V283, P3272, DOI 10.1074/jbc.M708033200; Zhong W, 2006, MOL REPROD DEV, V73, P540, DOI 10.1002/mrd.20417	72	46	47	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19747	19756		10.1074/jbc.M109.077347	http://dx.doi.org/10.1074/jbc.M109.077347			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427282	Green Published, hybrid			2022-12-25	WOS:000279012000007
J	Gurzov, EN; Germano, CM; Cunha, DA; Ortis, F; Vanderwinden, JM; Marchetti, P; Zhang, L; Eizirik, DL				Gurzov, Esteban N.; Germano, Carla M.; Cunha, Daniel A.; Ortis, Fernanda; Vanderwinden, Jean-Marie; Marchetti, Piero; Zhang, Lin; Eizirik, Decio L.			p53 Up-regulated Modulator of Apoptosis (PUMA) Activation Contributes to Pancreatic beta-Cell Apoptosis Induced by Proinflammatory Cytokines and Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ER STRESS; MEMBRANE PERMEABILIZATION; BAX; DEATH; FAMILY; TYPE-1; GENE; DYSFUNCTION; INHIBITION	Type 1 diabetes is an autoimmune disorder characterized by chronic inflammation and pancreatic beta-cell loss. Here, we demonstrate that the proinflammatory cytokine interleukin-1 beta, combined with interferon-gamma, induces the expression of the Bcl-2 homology 3 ( BH3)-only activator PUMA (p53 up-regulated modulator of apoptosis) in beta-cells. Transcriptional activation of PUMA is regulated by nuclear factor-kappa B and endoplasmic reticulum stress but is independent of p53. PUMA activation leads to mitochondrial Bax translocation, cytochrome c release, and caspase-3 cleavage resulting in beta-cell demise. The antiapoptotic Bcl-XL protein is localized mainly at the mitochondria of the beta-cells and antagonizes PUMA action, but Bcl-XL is inactivated by the BH3-only sensitizer DP5/Hrk in cytokine-exposed beta-cells. Moreover, a pharmacological mimic of the BH3-only sensitizer Bad, which inhibits Bcl-XL and Bcl-2, induces PUMA-dependent beta-cell death and potentiates cytokine-induced apoptosis. Our data support a hierarchical activation of BH3-only proteins controlling the intrinsic pathway of beta-cell apoptosis in the context of inflammation and type 1 diabetes.	[Gurzov, Esteban N.; Germano, Carla M.; Cunha, Daniel A.; Ortis, Fernanda; Eizirik, Decio L.] Univ Libre Bruxelles, Expt Med Lab, B-1070 Brussels, Belgium; [Vanderwinden, Jean-Marie] Univ Libre Bruxelles, Neurophysiol Lab, B-1070 Brussels, Belgium; [Marchetti, Piero] Univ Pisa, Metab Unit, Dept Endocrinol & Metab, I-5610 Pisa, Italy; [Zhang, Lin] Univ Pittsburgh, Inst Canc, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15232 USA	Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Pisa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gurzov, EN (corresponding author), Univ Libre Bruxelles, Expt Med Lab, Route Lennik 808,CP 618, B-1070 Brussels, Belgium.	egurzov@ulb.ac.be	GERMANO, CARLA MARIA RAMOS/S-5312-2019; Zhang, Lin/A-7389-2009; Ortis, Fernanda/K-7917-2014; Marchetti, Piero/J-7439-2013; germano, carla/N-1736-2015; Ortis, Fernanda/M-7190-2019	GERMANO, CARLA MARIA RAMOS/0000-0001-5030-7164; Zhang, Lin/0000-0003-0018-3903; Marchetti, Piero/0000-0003-4907-0635; Gurzov, Esteban/0000-0003-4642-0273; Ortis, Fernanda/0000-0002-9551-2839	Communaute Francaise de Belgique; Actions de Recherche Concertees; National de la Recherche Scientifique Belgium; Fonds National de la Recherche Scientifique Belgium; Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State [IUAP P6/40]; Juvenile Diabetes Research Foundation [17-2009-106]; European Union; European Community; Naimit; Belgian Federal Science Policy Office; European Molecular Biology Organization (EMBO)	Communaute Francaise de Belgique(Australian Research Council); Actions de Recherche Concertees(University of Liege); National de la Recherche Scientifique Belgium; Fonds National de la Recherche Scientifique Belgium(Fonds de la Recherche Scientifique - FNRS); Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission); European Community(European Commission); Naimit; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This work was supported by grants from the Communaute Francaise de Belgique, Actions de Recherche Concertees and the Fonds National de la Recherche Scientifique Belgium; Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State, Grant IUAP P6/40, Juvenile Diabetes Research Foundation International Grant 17-2009-106, and the European Union projects Eurodia, in the Framework Programme 6 of the European Community, and Naimit, in the Framework Programme 7 of the European Community.; Supported by a research fellowship of the Belgian Federal Science Policy Office and by an European Molecular Biology Organization (EMBO) long term fellowship. To whom correspondence should be addressed: Laboratory of Experimental Medicine, Universite Libre de Bruxelles, Route de Lennik, 808, CP-618, 1070 Brussels, Belgium. Tel.: 32 2 555 6092; Fax: 32 2 555 6239; E-mail: egurzov@ulb.ac.be.; Supported by a postdoctoral fellowship from the National Council for Scientific and Technological Development, Brazil.	Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Bardwell PD, 2009, J IMMUNOL, V182, P7482, DOI 10.4049/jimmunol.0802813; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Carrington EM, 2009, DIABETES, V58, P2316, DOI 10.2337/db08-1602; Cazanave SC, 2009, J BIOL CHEM, V284, P26591, DOI 10.1074/jbc.M109.022491; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; GOEGER DE, 1988, BIOCHEM PHARMACOL, V37, P978, DOI 10.1016/0006-2952(88)90195-5; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gurzov EN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003030; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Holohan C, 2008, J CELL MOL MED, V12, P591, DOI 10.1111/j.1582-4934.2007.00191.x; Hostens K, 1999, J CLIN INVEST, V104, P67, DOI 10.1172/JCI6438; Kieran D, 2007, P NATL ACAD SCI USA, V104, P20606, DOI 10.1073/pnas.0707906105; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2009, J CELL BIOL, V185, P189, DOI 10.1083/jcb.200903134; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; McKenzie MD, 2008, DIABETES, V57, P1284, DOI 10.2337/db07-1692; McKenzie MD, 2010, DIABETES, V59, P644, DOI 10.2337/db09-1151; Melloul D, 2008, BIOCHEM SOC T, V36, P334, DOI 10.1042/BST0360334; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Ohara-Imaizumi M, 2004, J BIOL CHEM, V279, P41271, DOI 10.1074/jbc.C400360200; OLDEN K, 1978, CELL, V13, P461, DOI 10.1016/0092-8674(78)90320-3; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Smith MI, 2007, CELL DEATH DIFFER, V14, P1011, DOI 10.1038/sj.cdd.4402089; Wang P, 2009, CELL DEATH DIFFER, V16, P1192, DOI 10.1038/cdd.2009.51; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	43	99	105	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19910	19920		10.1074/jbc.M110.122374	http://dx.doi.org/10.1074/jbc.M110.122374			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20421300	hybrid, Green Published			2022-12-25	WOS:000279012000024
J	Yi, L; Morgan, JT; Ragsdale, SW				Yi, Li; Morgan, Jeffrey T.; Ragsdale, Stephen W.			Identification of a Thiol/Disulfide Redox Switch in the Human BK Channel That Controls Its Affinity for Heme and CO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; CA2+-ACTIVATED K+-CHANNELS; CARBON-MONOXIDE; LARGE-CONDUCTANCE; REGULATORY MOTIFS; CAROTID-BODY; RCK DOMAIN; CA2+; SENSITIVITY; BINDING	Heme is a required prosthetic group in many electron transfer proteins and redox enzymes. The human BK channel, which is a large-conductance Ca2+ and voltage-activated K+ channel, is involved in the hypoxic response in the carotid body. The BK channel has been shown to bind and undergo inhibition by heme and activation by CO. Furthermore, evidence suggests that human heme oxygenase-2 (HO2) acts as an oxygen sensor and CO donor that can form a protein complex with the BK channel. Here we describe a thiol/disulfide redox switch in the human BK channel and biochemical experiments of heme, CO, and HO2 binding to a 134-residue region within the cytoplasmic domain of the channel. This region, called the heme binding domain (HBD) forms a linker segment between two Ca2+-sensing domains (called RCK1 and RCK2) of the BK channel. The HBD includes a CXXCH motif in which histidine serves as the axial heme ligand and the two cysteine residues can form a reversible thiol/disulfide redox switch that regulates affinity of the HBD for heme. The reduced dithiol state binds heme (K-d = 210 nM) 14-fold more tightly than the oxidized disulfide state. Furthermore, the HBD is shown to tightly bindCO(K-d = 50 nM) with the Cys residues in the CXXCH motif regulating affinity of the HBD for CO. This HBD is also shown to interact with heme oxygenase-2. We propose that the thiol/disulfide switch in the HBD is a mechanism by which activity of the BK channel can respond quickly and reversibly to changes in the redox state of the cell, especially as it switches between hypoxic and normoxic conditions.	[Ragsdale, Stephen W.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ragsdale, SW (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu	Yi, Li/A-3967-2013		National Institutes of Health [R21HL089837]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089837, R01HL102662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R21HL089837.	ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; Baranano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298; Benda R, 2003, J BIOL INORG CHEM, V8, P787, DOI 10.1007/s00775-003-0472-5; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Boehning D, 2002, SCIENCE, V298, P2339, DOI 10.1126/science.1080339; Brazier SP, 2009, ADV EXP MED BIOL, V648, P49, DOI 10.1007/978-90-481-2259-2_5; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Dong DL, 2007, HYPERTENSION, V50, P643, DOI 10.1161/HYPERTENSIONAHA.107.096057; Dong JB, 2005, J BIOL CHEM, V280, P41716, DOI 10.1074/jbc.M508144200; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; FrancoObregon A, 1996, ADV EXP MED BIOL, V410, P97; Garrick MD, 1999, BBA-MOL CELL RES, V1449, P125, DOI 10.1016/S0167-4889(99)00006-3; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Horrigan FT, 2005, J GEN PHYSIOL, V126, P7, DOI 10.1085/jgp.200509262; Hou SW, 2008, NAT STRUCT MOL BIOL, V15, P403, DOI 10.1038/nsmb.1398; Hou SW, 2008, P NATL ACAD SCI USA, V105, P4039, DOI 10.1073/pnas.0800304105; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; IKEDASAITO M, 1992, J BIOL CHEM, V267, P22843; Jaggar JH, 2005, CIRC RES, V97, P805, DOI 10.1161/01.RES.0000186180.47148.7b; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; KUBISTA M, 1994, ANALYST, V119, P417, DOI 10.1039/an9941900417; Kumar P, 2007, ESSAYS BIOCHEM, V43, P43, DOI 10.1042/bse0430043; Lewis A, 2002, J PHYSIOL-LONDON, V540, P771, DOI 10.1113/jphysiol.2001.013888; Liu HJ, 1999, J CLIN INVEST, V104, P577, DOI 10.1172/JCI7291; LIU SC, 1988, BLOOD, V71, P1755; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; LOPEZBARNEO J, 1988, SCIENCE, V241, P580, DOI 10.1126/science.2456613; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; MacAuley SR, 2009, BIOCHEMISTRY-US, V48, P817, DOI 10.1021/bi802246s; Maines MD, 2005, ANTIOXID REDOX SIGN, V7, P1761, DOI 10.1089/ars.2005.7.1761; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Qiu Y, 1998, J BIOL CHEM, V273, P23426, DOI 10.1074/jbc.273.36.23426; Roach PL, 1997, NATURE, V387, P827, DOI 10.1038/42990; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sassa S, 2004, ANTIOXID REDOX SIGN, V6, P819, DOI 10.1089/ars.2004.6.819; Sassa S, 2006, J CLIN BIOCHEM NUTR, V38, P138, DOI 10.3164/jcbn.38.138; Tang XD, 2003, NATURE, V425, P531, DOI 10.1038/nature02003; Tang XD, 2001, J GEN PHYSIOL, V117, P253, DOI 10.1085/jgp.117.3.253; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yamashita T, 2004, J BIOL CHEM, V279, P21394, DOI 10.1074/jbc.M400512200; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; Yi L, 2009, J BIOL CHEM, V284, P20556, DOI 10.1074/jbc.M109.015651; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105	52	70	75	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20117	20127		10.1074/jbc.M110.116483	http://dx.doi.org/10.1074/jbc.M110.116483			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427280	Green Published, hybrid			2022-12-25	WOS:000279012000046
J	Guo, RF; Chen, J; Zhu, F; Biswas, AK; Berton, TR; Mitchell, DL; Johnson, DG				Guo, Ruifeng; Chen, Jie; Zhu, Feng; Biswas, Anup K.; Berton, Thomas R.; Mitchell, David L.; Johnson, David G.			E2F1 Localizes to Sites of UV-induced DNA Damage to Enhance Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIGMENTOSUM VARIANT CELLS; ATAXIA-TELANGIECTASIA; TRANSCRIPTION FACTOR; RNA-POLYMERASE; ATR KINASE; IN-VIVO; GROUP-A; TOPBP1; PROTEIN; IRRADIATION	The E2F1 transcription factor is a well known regulator of cell proliferation and apoptosis, but its role in the DNA damage response is less clear. Using a local UV irradiation technique and immunofluorescence staining, E2F1 is shown to accumulate at sites of DNA damage. Localization of E2F1 to UV-damaged DNA requires the ATM and Rad3-related (ATR) kinase and serine 31 of E2F1 but not an intact DNA binding domain. E2F1 deficiency does not appear to affect the expression of nucleotide excision repair (NER) factors, such as XPC and XPA. However, E2F1 depletion does impair the recruitment of NER factors to sites of damage and reduces the efficiency of DNA repair. E2F1 mutants unable to bindDNAor activate transcription retain the ability to stimulate NER. These findings demonstrate that E2F1 has a direct, non-transcriptional role in DNA repair involving increased recruitment of NER factors to sites of damage.	Univ Texas MD Anderson Canc Ctr, Div Sci Pk Res, Dept Carcinogenesis, Smithville, TX 78957 USA; [Guo, Ruifeng; Chen, Jie; Mitchell, David L.; Johnson, David G.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Johnson, DG (corresponding author), POB 389, Smithville, TX 78957 USA.	djohnson@mdanderson.org	Guo, Ruifeng/AAK-2072-2020	Johnson, David/0000-0002-6223-1790	National Institutes of Health through Anderson Cancer Center [CA016672, CA079648, K01-CA106603, CA105345, ES007784, ES007247]; The University of Texas Graduate School of Biomedical Sciences at Houston; University of Texas M. D. Anderson Cancer Center, Houston, TX; NATIONAL CANCER INSTITUTE [U01CA105345, K01CA106603, R01CA079648, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784, T32ES007247] Funding Source: NIH RePORTER	National Institutes of Health through Anderson Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The University of Texas Graduate School of Biomedical Sciences at Houston; University of Texas M. D. Anderson Cancer Center, Houston, TX; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA016672 and CA079648 (to D.G.J.) K01-CA106603 (to T. R. B.) and CA105345, ES007784, and ES007247 through the M. D. Anderson Cancer Center. This research was performed in partial fulfillment of the requirements for the Ph.D. degree from The University of Texas Graduate School of Biomedical Sciences at Houston; University of Texas M. D. Anderson Cancer Center, Houston, TX.	Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; Berton TR, 2005, ONCOGENE, V24, P2449, DOI 10.1038/sj.onc.1208462; Blattner C, 1999, MOL CELL BIOL, V19, P3704; Bosco EE, 2005, NUCLEIC ACIDS RES, V33, P1581, DOI 10.1093/nar/gki283; CRESS WD, 1993, MOL CELL BIOL, V13, P6314, DOI 10.1128/MCB.13.10.6314; DeGregori J, 2006, CURR MOL MED, V6, P739; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Greer DA, 2003, CANCER RES, V63, P4829; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Hayes S, 1998, MOL CELL BIOL, V18, P240, DOI 10.1128/MCB.18.1.240; Hofferer M, 1999, NUCLEIC ACIDS RES, V27, P491, DOI 10.1093/nar/27.2.491; Ianari A, 2009, CANCER CELL, V15, P184, DOI 10.1016/j.ccr.2009.01.026; Johnson DG, 2006, CURR MOL MED, V6, P731; Katsumi S, 2001, J INVEST DERMATOL, V117, P1156, DOI 10.1046/j.0022-202x.2001.01540.x; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lin PS, 2009, DNA REPAIR, V8, P795, DOI 10.1016/j.dnarep.2009.03.003; Lin WC, 2001, GENE DEV, V15, P1833; Lindsey-Boltz LA, 2007, P NATL ACAD SCI USA, V104, P13213, DOI 10.1073/pnas.0706316104; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Marini F, 2006, P NATL ACAD SCI USA, V103, P17325, DOI 10.1073/pnas.0605446103; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MITCHELL DL, 1995, MUTAT RES-DNA REPAIR, V337, P161, DOI 10.1016/0921-8777(95)00020-K; Mone MJ, 2001, EMBO REP, V2, P1013, DOI 10.1093/embo-reports/kve224; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; O'Connor DJ, 2000, ONCOGENE, V19, P2369, DOI 10.1038/sj.onc.1203540; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Prost S, 2007, ONCOGENE, V26, P3572, DOI 10.1038/sj.onc.1210151; Rounbehler RJ, 2002, CANCER RES, V62, P3276; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Stiff T, 2008, HUM MOL GENET, V17, P3247, DOI 10.1093/hmg/ddn220; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; WANG YC, 1993, MOL CELL BIOL, V13, P4276, DOI 10.1128/MCB.13.7.4276; WANI AA, 1987, PHOTOCHEM PHOTOBIOL, V46, P477, DOI 10.1111/j.1751-1097.1987.tb04798.x; Wikonkal NM, 2003, NAT CELL BIOL, V5, P655, DOI 10.1038/ncb1001; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Yoshida K, 2004, ONCOGENE, V23, P6250, DOI 10.1038/sj.onc.1207829; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	44	45	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19308	19315		10.1074/jbc.M110.121939	http://dx.doi.org/10.1074/jbc.M110.121939			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20413589	Green Published, hybrid			2022-12-25	WOS:000278727800040
J	Abbatecola, AM; Lattanzio, F; Spazzafumo, L; Molinari, AM; Cioffi, M; Canonico, R; DiCioccio, L; Paolisso, G				Abbatecola, Angela Marie; Lattanzio, Fabrizia; Spazzafumo, Liana; Molinari, Anna Maria; Cioffi, Michele; Canonico, Raffaele; DiCioccio, Luigi; Paolisso, Giuseppe			Adiposity Predicts Cognitive Decline in Older Persons with Diabetes: A 2-Year Follow-Up	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE; PLASMA-GLUCOSE; DEMENTIA; OBESITY; RISK; HYPERTENSION; INFLAMMATION; ADIPONECTIN	Background: The mechanisms related to cognitive impairment in older persons with Type 2 diabetes (DM) remains unclear. We tested if adiposity parameters and body fat distribution could predict cognitive decline in older persons with DM vs. normal glucose tolerance (NGT). Methodology: 693 older persons with no dementia were enrolled: 253 with DM in good metabolic control; 440 with NGT (age range: 65-85 years). Longitudinal study comparing DM and NGT individuals according to the association of baseline adiposity parameters (body mass index (BMI), waist-hip-ratio (WHR), waist circumference (WC) and total body fat mass) to cognitive change (Mini Mental State Examination (MMSE), a composite score of executive and attention functioning (CCS) over time. Findings: At baseline, in DM participants, MMSE correlated with WHR (beta = -0.240; p = 0.043), WC (beta = -0.264; p = 0.041) while CCS correlated with WHR (beta = -0.238; p = 0.041), WC (beta = -0.326; p = 0.013) after adjusting for confounders. In NGT subjects, no significant correlations were found among any adiposity parameters and MMSE, while CCS was associated with WHR (beta = -0.194; p = 0.036) and WC (beta = -0.210; p = 0.024). Participants with DM in the 3(rd) tertile of total fat mass showed the greatest decline in cognitive performance compared to those in 1(st) tertile (tests for trend: MMSE(p = 0.007), CCS(p = 0.003)). Logistic regression models showed that 3(rd) vs. 1(st) tertile of total fat mass, WHR, and WC predicted an almost two-fold decline in cognitive function in DM subjects at 2(nd) yr (OR 1.68, 95% IC 1.08-3.52). Conclusions: Total fat mass and central adiposity predict an increased risk for cognitive decline in older person with DM.	[Abbatecola, Angela Marie; Lattanzio, Fabrizia] Italian Natl Res Ctr Aging, Sci Direct, Ancona, Italy; [Spazzafumo, Liana] Italian Natl Inst Aging, Dept Gerontol Res, Stat & Biometry Ctr, Ancona, Italy; [Molinari, Anna Maria; Cioffi, Michele] Univ Naples 2, Dept Gen Pathol, Naples, Italy; [Canonico, Raffaele; Paolisso, Giuseppe] Univ Naples 2, Dept Geriatr Med & Metab Dis, Naples, Italy; [DiCioccio, Luigi] Santa Scolast Hosp, Dept Geriatr Med, Cassino, Italy	IRCCS INRCA; IRCCS INRCA; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Abbatecola, AM (corresponding author), Italian Natl Res Ctr Aging, Sci Direct, Ancona, Italy.	giuseppe.paolisso@unina2.it	paolisso, giuseppe/AAP-8516-2020; Spazzafumo, Liana/E-5488-2015; Lattanzio, Fabrizia/D-2896-2018	paolisso, giuseppe/0000-0002-2137-455X; Lattanzio, Fabrizia/0000-0003-4051-1289; Spazzafumo, Liana/0000-0002-9718-1658; CIOFFI, Michele/0000-0003-3883-111X; MOLINARI, Anna Maria/0000-0002-6503-432X				Abbatecola AM, 2006, NEUROLOGY, V67, P235, DOI 10.1212/01.wnl.0000224760.22802.e8; Beydoun MA, 2008, AM J EPIDEMIOL, V168, P1179, DOI 10.1093/aje/kwn229; Chen B, 2009, BRAIN RES, V1273, P129, DOI 10.1016/j.brainres.2009.04.002; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; Cukierman-Yaffe T, 2009, DIABETES CARE, V32, P221, DOI 10.2337/dc08-1153; Dore GA, 2008, ANN BEHAV MED, V35, P341, DOI 10.1007/s12160-008-9038-7; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; Fontbonne A, 2001, DIABETES CARE, V24, P366, DOI 10.2337/diacare.24.2.366; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gallagher D, 2000, AM J PHYSIOL-ENDOC M, V279, pE366, DOI 10.1152/ajpendo.2000.279.2.E366; Geroldi C, 2005, ARCH NEUROL-CHICAGO, V62, P1067, DOI 10.1001/archneur.62.7.1067; Han Changsu, 2009, Arch Gerontol Geriatr, V49, pe133, DOI 10.1016/j.archger.2008.11.005; Holden KF, 2009, NEUROBIOL AGING, V30, P1483, DOI 10.1016/j.neurobiolaging.2007.11.024; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; LAMBERTY GJ, 1994, NEUROPSY NEUROPSY BE, V7, P230; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P392, DOI 10.1001/archneur.64.3.392; Lyon CJ, 2003, ENDOCRINOLOGY, V144, P2195, DOI 10.1210/en.2003-0285; Muggeo M, 1997, CIRCULATION, V96, P1750, DOI 10.1161/01.CIR.96.6.1750; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ritchie JD, 2005, J AM DIET ASSOC, V105, P1617, DOI 10.1016/j.jada.2005.07.011; Ryan CM, 2006, DIABETES CARE, V29, P345, DOI 10.2337/diacare.29.02.06.dc05-1626; Sam S, 2009, DIABETES CARE, V32, P932, DOI 10.2337/dc08-1856; Thomson R, 2007, CLIN NUTR, V26, P771, DOI 10.1016/j.clnu.2007.08.003; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Wolf PA, 2007, CURR ALZHEIMER RES, V4, P111, DOI 10.2174/156720507780362263; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0	29	22	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10333	10.1371/journal.pone.0010333	http://dx.doi.org/10.1371/journal.pone.0010333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428239	Green Published, Green Submitted, gold			2022-12-25	WOS:000277079300017
J	Wheldon, LM; Haines, BP; Rajappa, R; Mason, I; Rigby, PW; Heath, JK				Wheldon, Lee M.; Haines, Bryan P.; Rajappa, Rajit; Mason, Ivor; Rigby, Peter W.; Heath, John K.			Critical Role of FLRT1 Phosphorylation in the Interdependent Regulation of FLRT1 Function and FGF Receptor Signalling	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTORS; PROMOTES NEURITE OUTGROWTH; SENSORY NEURONS; CELL-ADHESION; FUTILE CYCLES; EXPRESSION; PROTEINS; FAMILY; DOMAIN; SRC	Background: Fibronectin leucine rich transmembrane (FLRT) proteins have dual properties as regulators of cell adhesion and potentiators of fibroblast growth factor (FGF) mediated signalling. The mechanism by which the latter is achieved is still unknown and is the subject of this investigation. Principal Findings: Here we show that FLRT1 is a target for tyrosine phosphorylation mediated by FGFR1 and implicate a non-receptor Src family kinase (SFK). We identify the target tyrosine residues in the cytoplasmic domain of FLRT1 and show that these are not direct substrates for Src kinase suggesting that the SFK may exert effects via potentiation of FGFR1 kinase activity. We show that whilst FLRT1 expression results in a ligand-dependent elevation of MAP kinase activity, a mutant version of FLRT1, defective as an FGFR1 kinase substrate (Y3F-FLRT1), has the property of eliciting ligand-independent chronic activation of the MAP kinase pathway which is suppressed by pharmacological inhibition of either FGFR1 or Src kinase. Functional investigation of FGFR1 and FLRT1 signalling in SH-SY5Y neuroblastoma cells reveals that FLRT1 alone acts to induce a multi-polar phenotype whereas the combination of FLRT1 and FGFR activation, or expression of Y3F-FLRT1, acts to induce neurite outgrowth via MAPK activation. Similar results were obtained in a dendrite outgrowth assay in primary hippocampal neurons. We also show that FGFR1, FLRT1 and activated Src are co-localized and this complex is trafficked toward the soma of the cell. The presence of Y3F-FLRT1 rather than FLRT1 resulted in prolonged localization of this complex within the neuritic arbour. Conclusions: This study shows that the phosphorylation state of FLRT1, which is itself FGFR1 dependent, may play a critical role in the potentiation of FGFR1 signalling and may also depend on a SFK-dependent phosphorylation mechanism acting via the FGFR. This is consistent with an 'in vivo' role for FLRT1 regulation of FGF signalling via SFKs. Furthermore, the phosphorylation-dependent futile cycle mechanism controlling FGFR1 signalling is concurrently crucial for regulation of FLRT1-mediated neurite outgrowth.	[Wheldon, Lee M.] Univ Nottingham, MBIG, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Haines, Bryan P.; Rigby, Peter W.] Inst Canc Res, Chester Beatty Labs, Sect Gene Funct & Regulat, London SW3 6JB, England; [Rajappa, Rajit; Mason, Ivor] Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England; [Heath, John K.] Univ Birmingham, Canc Res UK Growth Factor Grp, Sch Biosci, Birmingham, W Midlands, England	University of Nottingham; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; King's College London; University of Birmingham	Wheldon, LM (corresponding author), Univ Nottingham, MBIG, Ctr Biomol Sci, Nottingham NG7 2RD, England.	j.k.heath@bham.ac.uk	Mason, Ivor/B-1859-2008	Mason, Ivor/0000-0001-8390-3050; Heath, John/0000-0003-4886-4070	Cancer Research UK; Medical Research Council; Wellcome Trust; Fp6 Endotrack; MRC [G0401199] Funding Source: UKRI; Cancer Research UK [10171] Funding Source: researchfish; Medical Research Council [G0401199] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Fp6 Endotrack; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Cancer Research UK (www.cancer.org.uk), the Medical Research Council (www.mrc.ac.uk), the Wellcome Trust (www.wellcome.ac.uk), and Fp6 Endotrack (www.endotrack.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bottcher RT, 2004, NAT CELL BIOL, V6, P38, DOI 10.1038/ncb1082; Buchanan SGS, 1996, PROG BIOPHYS MOL BIO, V65, P1, DOI 10.1016/S0079-6107(96)00003-X; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Haines BP, 2006, DEV BIOL, V297, P14, DOI 10.1016/j.ydbio.2006.04.004; Hansen SM, 2008, CELL MOL LIFE SCI, V65, P3809, DOI 10.1007/s00018-008-8290-0; Hausott B, 2008, NEUROSCIENCE, V153, P461, DOI 10.1016/j.neuroscience.2008.01.083; Huang P, 2005, CYTOKINE GROWTH F R, V16, P151, DOI 10.1016/j.cytogfr.2005.03.002; JANET T, 1995, J NEUROSCI RES, V40, P707, DOI 10.1002/jnr.490400602; Kesti T, 2007, J IMMUNOL, V179, P878, DOI 10.4049/jimmunol.179.2.878; Krause C, 2006, DEV BIOL, V296, P253, DOI 10.1016/j.ydbio.2006.04.462; Lacy SE, 1999, GENOMICS, V62, P417, DOI 10.1006/geno.1999.6033; Maretto S, 2008, DEV BIOL, V318, P184, DOI 10.1016/j.ydbio.2008.03.021; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Ogata S, 2007, GENE DEV, V21, P1817, DOI 10.1101/gad.1541807; Pruss T, 2006, MOL CELL NEUROSCI, V31, P354, DOI 10.1016/j.mcn.2005.10.009; Qian H, 2006, IEE P SYST BIOL, V153, P192, DOI 10.1049/ip-syb:20050086; Raguenez G, 1999, BIOCHEM BIOPH RES CO, V258, P745, DOI 10.1006/bbrc.1999.0613; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Robinson M, 2004, MOL CELL NEUROSCI, V27, P202, DOI 10.1016/j.mcn.2004.06.008; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Sandilands E, 2007, EMBO REP, V8, P1162, DOI 10.1038/sj.embor.7401097; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; SHOLL DA, 1953, J ANAT, V87, P387; Smith TG, 2006, INT J DEV BIOL, V50, P701, DOI 10.1387/ijdb.062192ts; Tanabe K, 2003, J NEUROSCI, V23, P9675; Tsuji L, 2004, BIOCHEM BIOPH RES CO, V313, P1086, DOI 10.1016/j.bbrc.2003.12.047; Vecchione A, 2007, PROTEOMICS, V7, P4565, DOI 10.1002/pmic.200700615	30	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10264	10.1371/journal.pone.0010264	http://dx.doi.org/10.1371/journal.pone.0010264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421966	Green Published, Green Submitted, gold			2022-12-25	WOS:000276952600004
J	Hioe, CE; Wrin, T; Seaman, MS; Yu, XS; Wood, B; Self, S; Williams, C; Gorny, MK; Zolla-Pazner, S				Hioe, Catarina E.; Wrin, Terri; Seaman, Michael S.; Yu, Xuesong; Wood, Blake; Self, Steve; Williams, Constance; Gorny, Miroslaw K.; Zolla-Pazner, Susan			Anti-V3 Monoclonal Antibodies Display Broad Neutralizing Activities against Multiple HIV-1 Subtypes	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; V3 DOMAIN; TYPE-1 INFECTION; CLADE-B; CORECEPTOR SELECTIVITY; ENVELOPE GLYCOPROTEIN; CROSS-REACTIVITY; STRUCTURAL BASIS; BINDING MODE; ENV CLONES	Background: The V3 loop of the HIV-1 envelope (Env) glycoprotein gp120 was identified as the "principal neutralizing domain'' of HIV-1, but has been considered too variable to serve as a neutralizing antibody (Ab) target. Structural and immunochemical data suggest, however, that V3 contains conserved elements which explain its role in binding to virus co-receptors despite its sequence variability. Despite this evidence of V3 conservation, the ability of anti-V3 Abs to neutralize a significant proportion of HIV-1 isolates from different subtypes (clades) has remained controversial. Methods: HIV-1 neutralization experiments were conducted in two independent laboratories to test human anti-V3 monoclonal Abs (mAbs) against pseudoviruses (psVs) expressing Envs of diverse HIV-1 subtypes from subjects with acute and chronic infections. Neutralization was defined by 50% inhibitory concentrations (IC(50)), and was statistically assessed based on the area under the neutralization titration curves (AUC). Results: Using AUC analyses, statistically significant neutralization was observed by >= 1 anti-V3 mAbs against 56/98 (57%) psVs expressing Envs of diverse subtypes, including subtypes A, AG, B, C and D. Even when the 10 Tier 1 psVs tested were excluded from the analysis, significant neutralization was detected by >= 1 anti-V3 mAbs against 46/88 (52%) psVs from diverse HIV-1 subtypes. Furthermore, 9/24 (37.5%) Tier 2 viruses from the clade B and C standard reference panels were neutralized by >= 1 anti-V3 mAbs. Each anti-V3 mAb tested was able to neutralize 28-42% of the psVs tested. By IC(50) criteria, 40/98 (41%) psVs were neutralized by >= 1 anti-V3 mAbs. Conclusions: Using standard and new statistical methods of data analysis, 6/7 anti-V3 human mAbs displayed cross-clade neutralizing activity and revealed that a significant proportion of viruses can be neutralized by anti-V3 Abs. The new statistical method for analysis of neutralization data provides many advantages to previously used analyses.	[Hioe, Catarina E.; Williams, Constance; Gorny, Miroslaw K.; Zolla-Pazner, Susan] NYU, Dept Pathol, Langone Sch Med, New York, NY 10016 USA; [Hioe, Catarina E.; Zolla-Pazner, Susan] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA; [Wrin, Terri] Monogram Biosci Inc, San Francisco, CA USA; [Seaman, Michael S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Viral Pathogenesis, Boston, MA 02215 USA; [Yu, Xuesong; Wood, Blake; Self, Steve] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA	New York University; NYU Langone Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Fred Hutchinson Cancer Center	Hioe, CE (corresponding author), NYU, Dept Pathol, Langone Sch Med, 550 1St Ave, New York, NY 10016 USA.	catarina.hioe@nyumc.org	Zolla-Pazner, Susan/S-1864-2019	Zolla-Pazner, Susan/0000-0002-0750-2666; Gorny, Miroslaw/0000-0002-2714-8780	Bill and Melinda Gates Foundation; National Institutes of Health [HL59725, AI36085]; New York University Center for AIDS Research [AI27742]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036085, P30AI027742] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Center for AIDS Research; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by grants from the Bill and Melinda Gates Foundation, National Institutes of Health grants (HL59725 and AI36085), the Immunology Core of the New York University Center for AIDS Research (AI27742), and by research funds from the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOND D, AIDS RES HU IN PRESS; Bell CH, 2008, J MOL BIOL, V375, P969, DOI 10.1016/j.jmb.2007.11.013; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Burke V, 2009, STRUCTURE, V17, P1538, DOI 10.1016/j.str.2009.09.012; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Cardozo T, 2009, AIDS RES HUM RETROV, V25, P441, DOI 10.1089/aid.2008.0188; Cocchi F, 1996, NAT MED, V2, P1244, DOI 10.1038/nm1196-1244; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; CORTI D, PLOS ONE, V5, pE8805; Davis KL, 2009, VIROLOGY, V387, P414, DOI 10.1016/j.virol.2009.02.022; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gigler A, 1999, J VIROL, V73, P1974, DOI 10.1128/JVI.73.3.1974-1979.1999; Gorny MK, 2006, J VIROL, V80, P6865, DOI 10.1128/JVI.02202-05; Gorny MK, 2009, MOL IMMUNOL, V46, P917, DOI 10.1016/j.molimm.2008.09.005; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; GORNY MK, 1993, J IMMUNOL, V150, P635; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; GOUDSMIT J, 1988, P NATL ACAD SCI USA, V85, P4478, DOI 10.1073/pnas.85.12.4478; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hill CM, 1997, J VIROL, V71, P6296, DOI 10.1128/JVI.71.9.6296-6304.1997; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; JAVAHERIAN K, 1990, SCIENCE, V250, P1590, DOI 10.1126/science.1703322; KAYMAN SC, 1994, J VIROL, V68, P400, DOI 10.1128/JVI.68.1.400-410.1994; Krachmarov C, 2005, J VIROL, V79, P780, DOI 10.1128/JVI.79.2.780-790.2005; Krachmarov CP, 2006, J VIROL, V80, P7127, DOI 10.1128/JVI.02619-05; Krachmarov CP, 2001, AIDS RES HUM RETROV, V17, P1737, DOI 10.1089/08892220152741432; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Losman B, 2001, AIDS RES HUM RETROV, V17, P1067, DOI 10.1089/088922201300343753; Lusso P, 2005, J VIROL, V79, P6957, DOI 10.1128/JVI.79.11.6957-6968.2005; McCaffrey RA, 2004, J VIROL, V78, P3279, DOI 10.1128/JVI.78.7.3279-3295.2004; MOORE JP, 1995, J VIROL, V69, P122, DOI 10.1128/JVI.69.1.122-130.1995; NANDI A, VIROLOGY, V396, P339; Nolan KM, 2009, J VIROL, V83, P3798, DOI 10.1128/JVI.01751-08; PALKER TJ, 1988, P NATL ACAD SCI USA, V85, P1932, DOI 10.1073/pnas.85.6.1932; Pantophlet R, 2007, VIROLOGY, V364, P441, DOI 10.1016/j.virol.2007.03.007; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Schweighardt B, 2007, JAIDS-J ACQ IMM DEF, V46, P1, DOI 10.1097/01.qai.0000286594.11191.91; Seaman MS, 2007, VIROLOGY, V367, P175, DOI 10.1016/j.virol.2007.05.024; Seaman MS, J VIROL, V84, P1439; Sharon M, 2003, STRUCTURE, V11, P225, DOI 10.1016/S0969-2126(03)00011-X; SHIODA T, 1992, P NATL ACAD SCI USA, V89, P9434, DOI 10.1073/pnas.89.20.9434; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Xiang SH, 2003, VIROLOGY, V315, P124, DOI 10.1016/S0042-6822(03)00521-X; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zolla-Pazner S, 2004, AIDS RES HUM RETROV, V20, P1254, DOI 10.1089/aid.2004.20.1254; Zolla-Pazner S, 2009, VIROLOGY, V392, P82, DOI 10.1016/j.virol.2009.05.039; ZWART G, 1991, VIROLOGY, V181, P481, DOI 10.1016/0042-6822(91)90880-K	63	95	102	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10254	10.1371/journal.pone.0010254	http://dx.doi.org/10.1371/journal.pone.0010254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20421997	Green Submitted, Green Published, gold			2022-12-25	WOS:000276952500015
J	Bianchi, L; Diez-Sampedro, A				Bianchi, Laura; Diez-Sampedro, Ana			A Single Amino Acid Change Converts the Sugar Sensor SGLT3 into a Sugar Transporter	PLOS ONE			English	Article							GLUCOSE-GALACTOSE MALABSORPTION; RABBIT SMALL-INTESTINE; NA+/GLUCOSE COTRANSPORTER; CAENORHABDITIS-ELEGANS; C-ELEGANS; CHEMOSENSORY NEURONS; VOLTAGE-CLAMP; CLC PROTEINS; CHANNELS; GENETICS	Background: Sodium-glucose cotransporter proteins ( SGLT) belong to the SLC5A family, characterized by the cotransport of Na(+) with solute. SGLT1 is responsible for intestinal glucose absorption. Until recently the only role described for SGLT proteins was to transport sugar with Na+. However, human SGLT3 (hSGLT3) does not transport sugar but causes depolarization of the plasma membrane when expressed in Xenopus oocytes. For this reason SGLT3 was suggested to be a sugar sensor rather than a transporter. Despite 70% amino acid identity between hSGLT3 and hSGLT1, their sugar transport, apparent sugar affinities, and sugar specificity differ greatly. Residue 457 is important for the function of SGLT1 and mutation at this position in hSGLT1 causes glucose-galactose malabsorption. Moreover, the crystal structure of vibrio SGLT reveals that the residue corresponding to 457 interacts directly with the sugar molecule. We thus wondered if this residue could account for some of the functional differences between SGLT1 and SGLT3. Methodology/Principal Findings: We mutated the glutamate at position 457 in hSGLT3 to glutamine, the amino acid present in all SGLT1 proteins, and characterized the mutant. Surprisingly, we found that E457Q-hSGLT3 transported sugar, had the same stoichiometry as SGLT1, and that the sugar specificity and apparent affinities for most sugars were similar to hSGLT1. We also show that SGLT3 functions as a sugar sensor in a living organism. We expressed hSGLT3 and E457Q-hSGLT3 in C. elegans sensory neurons and found that animals sensed glucose in an hSGLT3-dependent manner. Conclusions/Significance: In summary, we demonstrate that hSGLT3 functions as a sugar sensor in vivo and that mutating a single amino acid converts this sugar sensor into a sugar transporter similar to SGLT1.	[Bianchi, Laura; Diez-Sampedro, Ana] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA	University of Miami	Bianchi, L (corresponding author), Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA.	adiezsampedro@med.miami.edu	Alshali, Rasha A/K-8051-2012		Florida Biomedical Research Program [08KN-02-17217]; American Cancer Society [RGS-09-043-01-DDC]	Florida Biomedical Research Program; American Cancer Society(American Cancer Society)	This work was supported by a Florida Biomedical Research Program grant to ADS (08KN-02-17217, www.floridabiomed.com) and an American Cancer Society grant to LB (RGS-09-043-01-DDC, www.cancer.org/docroot/home/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Ashcroft F, 2009, PHILOS T R SOC B, V364, P145, DOI 10.1098/rstb.2008.0245; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BIRNIR B, 1991, PFLUG ARCH EUR J PHY, V418, P79, DOI 10.1007/BF00370455; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; DEAN PM, 1968, NATURE, V219, P389, DOI 10.1038/219389a0; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Diez-Sampedro A, 2001, J BIOL CHEM, V276, P49188, DOI 10.1074/jbc.M108286200; Diez-Sampedro A, 2001, AM J PHYSIOL-RENAL, V280, pF278, DOI 10.1152/ajprenal.2001.280.2.F278; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Freeman SL, 2006, AM J PHYSIOL-GASTR L, V291, pG439, DOI 10.1152/ajpgi.00079.2006; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Hevener AL, 1997, DIABETES, V46, P1521, DOI 10.2337/diabetes.46.9.1521; Hirayama BA, 2001, BRIT J PHARMACOL, V134, P484, DOI 10.1038/sj.bjp.0704274; IKEDA TS, 1989, J MEMBRANE BIOL, V110, P87, DOI 10.1007/BF01870995; Lam JT, 1999, BBA-MOL BASIS DIS, V1453, P297, DOI 10.1016/S0925-4439(98)00109-4; Levin BE, 2004, DIABETES, V53, P2521, DOI 10.2337/diabetes.53.10.2521; Lisal J, 2009, PHILOS T R SOC B, V364, P181, DOI 10.1098/rstb.2008.0123; Mackenzie B, 1998, J MEMBRANE BIOL, V162, P101, DOI 10.1007/s002329900347; O'Malley D, 2006, DIABETES, V55, P3381, DOI 10.2337/db06-0531; OOMURA Y, 1964, SCIENCE, V143, P484, DOI 10.1126/science.143.3605.484; Pardal R, 2002, NAT NEUROSCI, V5, P197, DOI 10.1038/nn812; PARENT L, 1992, J MEMBRANE BIOL, V125, P49; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Sambongi Y, 2000, NEUROREPORT, V11, P2229, DOI 10.1097/00001756-200007140-00033; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Voss AA, 2007, MOL PHARMACOL, V71, P628, DOI 10.1124/mol.106.030288; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Wang Y, 2008, EMBO J, V27, P2388, DOI 10.1038/emboj.2008.161; Wright EM, 2002, CELL BIOCHEM BIOPHYS, V36, P115, DOI 10.1385/CBB:36:2-3:115	32	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10241	10.1371/journal.pone.0010241	http://dx.doi.org/10.1371/journal.pone.0010241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20421923	Green Published, gold, Green Submitted			2022-12-25	WOS:000276854300008
J	von Groll, A; Martin, A; Stehr, M; Singh, M; Portaels, F; da Silva, PEA; Palomino, JC				von Groll, Andrea; Martin, Anandi; Stehr, Matthias; Singh, Mahavir; Portaels, Francoise; Almeida da Silva, Pedro Eduardo; Palomino, Juan Carlos			Fitness of Mycobacterium tuberculosis Strains of the W-Beijing and Non-W-Beijing Genotype	PLOS ONE			English	Article							ISONIAZID RESISTANCE MUTATIONS; RIFAMPIN RESISTANCE; DRUG-RESISTANCE; RPOB GENE; KATG; COST; TRANSMISSION; VIRULENCE; FAMILY; INHA	Background: Multidrug resistant tuberculosis (MDR-TB) is a major threat for global tuberculosis control. The W-Beijing Mycobacterium tuberculosis genotype has been associated with drug resistance. Elucidation of the mechanisms underlying this epidemiological finding may have an important role in the control of MDR-TB. The aim of this study was to evaluate the fitness of drug-susceptible and MDR M. tuberculosis strains of the W-Beijing genotype compared with that of Non-W-Beijing strains. Methodology/Principal Findings: Fitness of M. tuberculosis strains was determined by evaluating the difference in the growth curves obtained in the MGIT960 automated system and assessing the competitive growth capacity between W-Beijing and non-W-Beijing strains. The W-Beijing MDR strains had a significant longer lag phase duration compared to the other strains but did not present a significant fitness cost. When grown in competition they had an advantage only in medium containing 0.1% Tween 80. Conclusions/Significance: It was not possible to confirm a selective advantage of W-Beijing strains to grow, except for differences in their resistance to Tween 80. Further studies are needed to elucidate the putative advantage of W-Beijing strains compared to other genotypes.	[von Groll, Andrea; Martin, Anandi; Portaels, Francoise; Palomino, Juan Carlos] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Stehr, Matthias; Singh, Mahavir] Helmholtz Ctr Infect Res, Dept Genome Anal, Braunswcheig, Germany; [Almeida da Silva, Pedro Eduardo] Univ Fed Rio Grande, Lab Mycobacteriol, Rio Grande, Brazil	Institute of Tropical Medicine (ITM); Helmholtz Association; Helmholtz-Center for Infection Research; Universidade Federal do Rio Grande	von Groll, A (corresponding author), Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium.	avongrol@hotmail.com	da Silva, Pedro Almeida/B-6926-2012	da Silva, Pedro Almeida/0000-0003-1666-1295	UNESCO; Belgium Federal Government [BL/09/BR2]; EC [HEALTH-F3-2007-201690]; Brazilian Health Ministry; CNPq [410468/2006-1]	UNESCO; Belgium Federal Government; EC(European CommissionEuropean Commission Joint Research Centre); Brazilian Health Ministry; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	A. von Groll was partially supported by UNESCO-L'Oreal Co-Sponsored Fellowship for Young Women in Life Science and Belgium Federal Government Grant Programmatorische Federale Overheidsdienst Wetenschapsbeleid contract No. BL/09/BR2. This study was partially funded by EC project HEALTH-F3-2007-201690 (FAST-XDR-DETECT) and the Brazilian Health Ministry and CNPq grant MCT-CNPq/MS-SCTIE-DECIT (project 410468/2006-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caws M, 2006, J CLIN MICROBIOL, V44, P3934, DOI 10.1128/JCM.01181-06; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Gagneux S, 2009, CLIN MICROBIOL INFEC, V15, P66, DOI 10.1111/j.1469-0691.2008.02685.x; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; Hillemann D, 2005, INT J TUBERC LUNG D, V9, P1161; Hillemann D, 2006, J CLIN MICROBIOL, V44, P302, DOI 10.1128/JCM.44.2.302-306.2006; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kiepiela P, 2000, TUBERCLE LUNG DIS, V80, P47, DOI 10.1054/tuld.1999.0231; Kruuner A, 2001, J CLIN MICROBIOL, V39, P3339, DOI 10.1128/JCM.39.9.3339-3345.2001; Kubica T, 2005, INT J TUBERC LUNG D, V9, P646; Lipsitch M, 1998, INT J TUBERC LUNG D, V2, P187; Mani C, 2001, J CLIN MICROBIOL, V39, P2987, DOI 10.1128/JCM.39.8.2987-2990.2001; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; MASAKI S, 1991, J CLIN MICROBIOL, V29, P1453, DOI 10.1128/JCM.29.7.1453-1456.1991; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; National Committee for Clinical Laboratory Standards, 2003, M24A NCCLS; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Rad ME, 2003, EMERG INFECT DIS, V9, P838, DOI 10.3201/eid0907.020803; Rigouts L, 2007, J CLIN MICROBIOL, V45, P252, DOI 10.1128/JCM.01489-06; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Toungoussova OS, 2004, FEMS IMMUNOL MED MIC, V42, P281, DOI 10.1016/j.femsim.2004.05.012; van Soolingen D, 2000, J INFECT DIS, V182, P1788, DOI 10.1086/317598; Von Groll A, 2010, FEMS IMMUNOL MED MIC, V58, P119, DOI 10.1111/j.1574-695X.2009.00611.x; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; Werngren J, 2003, J CLIN MICROBIOL, V41, P1520, DOI 10.1128/JCM.41.4.1520-1524.2003; WHO, 2020, WHO REPORT; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	33	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10191	10.1371/journal.pone.0010191	http://dx.doi.org/10.1371/journal.pone.0010191			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419138	gold, Green Published, Green Submitted			2022-12-25	WOS:000276743500011
J	Carnevali, O; Tosti, L; Speciale, C; Peng, C; Zhu, Y; Maradonna, F				Carnevali, Oliana; Tosti, Luca; Speciale, Claudia; Peng, Chun; Zhu, Yong; Maradonna, Francesca			DEHP Impairs Zebrafish Reproduction by Affecting Critical Factors in Oogenesis	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-15; MEMBRANE PROGESTIN RECEPTOR; IN-UTERO EXPOSURE; OOCYTE MATURATION; GENE-EXPRESSION; PHTHALATE; BETA; GROWTH; CYCLOOXYGENASE-2; CLONING	Public concerns on phthalates distributions in the environment have been increasing since they can cause liver cancer, structural abnormalities and reduce sperm counts in male reproductive system. However, few data are actually available on the effects of Di-(2-ethylhexyl)-phthalate ( DEHP) in female reproductive system. The aim of this study was to assess the impacts of DEHP on zebrafish oogenesis and embryo production. Female Danio rerio were exposed to environmentally relevant doses of DEHP and a significant decrease in ovulation and embryo production was observed. The effects of DEHP on several key regulators of oocyte maturation and ovulation including bone morphogenetic protein-15 (BMP15), luteinizing hormone receptor (LHR), membrane progesterone receptors (mPRs) and cyclooxygenase (COX)-2 (ptgs2) were determined by real time PCR. The expressions of BMP15 and mPR proteins were further determined by Western analyses to strengthen molecular findings. Moreover, plasma vitellogenin (vtg) titers were assayed by an ELISA procedure to determine the estrogenic effects of DEHP and its effects on oocyte growth. A significant reduction of fecundity in fish exposed to DEHP was observed. The reduced reproductive capacity was associated with an increase in ovarian BMP15 levels. This rise, in turn, was concomitant with a significant reduction in LHR and mPRb levels. Finally, ptgs2 expression, the final trigger of ovulation, was also decreased by DEHP. By an in vitro maturation assay, the inhibitory effect of DEHP on germinal vesicle breakdown was further confirmed. In conclusion, DEHP affecting signals involved in oocyte growth ( vtg), maturation ( BMP15, LHR, mPRs,) and ovulation ( ptgs2), deeply impairs ovarian functions with serious consequences on embryo production. Since there is a significant genetic similarity between D. rerio and humans, the harmful effects observed at oocyte level may be relevant for further molecular studies on humans.	[Carnevali, Oliana; Tosti, Luca; Speciale, Claudia; Maradonna, Francesca] Polytech Univ Marche, Dept Marine Sci, Ancona, Italy; [Carnevali, Oliana; Maradonna, Francesca] Natl Inst Biostruct & Biosyst, Rome, Italy; [Peng, Chun] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Zhu, Yong] E Carolina Univ, Dept Biol, Greenville, NC USA	Marche Polytechnic University; York University - Canada; University of North Carolina; East Carolina University	Carnevali, O (corresponding author), Polytech Univ Marche, Dept Marine Sci, Ancona, Italy.	o.carnevali@univpm.it	Maradonna, Francesca/AAU-3017-2021; Maradonna, Francesca/AAU-5167-2021; Carnevali, Oliana/P-2751-2015	Maradonna, Francesca/0000-0001-6677-1017; Carnevali, Oliana/0000-0001-5994-0572; Zhu, Yong/0000-0003-0374-485X	Fondi di Ateneo Universita Politecnica delle Marche; INBB	Fondi di Ateneo Universita Politecnica delle Marche; INBB	This study was supported by Fondi di Ateneo 2004, 2007 Universita Politecnica delle Marche grant awarded to O.C. and by INBB for the fellowship grant to Dr. Maradonna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann GE, 2003, FRONT BIOSCI-LANDMRK, V8, pD1227, DOI 10.2741/1092; ARMSTRONG DT, 1981, J REPROD FERTIL, V62, P283; Arukwe A, 2001, ENVIRON TOXICOL PHAR, V10, P5, DOI 10.1016/S1382-6689(01)00063-1; Bauer MJ, 1997, SCI TOTAL ENVIRON, V208, P49, DOI 10.1016/S0048-9697(97)00272-6; Ben-Yehoshua LJ, 2007, MOL ENDOCRINOL, V21, P664, DOI 10.1210/me.2006-0256; Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015; Clark K, 2003, HANDB ENVIRON CHEM, V3, P227; Clelland E, 2006, ENDOCRINOLOGY, V147, P201, DOI 10.1210/en.2005-1017; Clelland ES, 2007, ENDOCRINOLOGY, V148, P5451, DOI 10.1210/en.2007-0674; Culty M, 2008, BIOL REPROD, V78, P1018, DOI 10.1095/biolreprod.107.065649; Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231; Hanna R, 2006, J ENDOCRINOL, V190, P247, DOI 10.1677/joe.1.06694; Hokanson R, 2006, HUM EXP TOXICOL, V25, P687, DOI 10.1177/0960327106071977; Kazeto Y, 2005, GEN COMP ENDOCR, V142, P204, DOI 10.1016/j.ygcen.2005.01.017; Khan I. A, 1999, ENCY REPROD, V3, P552; Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300; Kortner TM, 2007, GEN COMP ENDOCR, V150, P419, DOI 10.1016/j.ygcen.2006.10.008; Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202; Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278; Lister AL, 2009, MOL REPROD DEV, V76, P1064, DOI 10.1002/mrd.21072; Maia H, 2006, GYNECOL ENDOCRINOL, V22, P547, DOI 10.1080/09513590601005375; Migliarini B, 2008, MOL CELL ENDOCRINOL, V286, pS12, DOI 10.1016/j.mce.2008.01.021; Mosconi G, 1998, GEN COMP ENDOCR, V110, P252, DOI 10.1006/gcen.1998.7075; NAGAHAMA Y, 1995, CURR TOP DEV BIOL, V30, P103, DOI 10.1016/S0070-2153(08)60565-7; Nagahama Y, 2008, DEV GROWTH DIFFER, V50, pS195, DOI 10.1111/j.1440-169X.2008.01019.x; Patino R, 2001, COMP BIOCHEM PHYS B, V129, P427, DOI 10.1016/S1096-4959(01)00344-X; Peng C, 2009, COMP BIOCHEM PHYS A, V153, P83, DOI 10.1016/j.cbpa.2008.09.034; Pyati UJ, 2007, SEMIN CANCER BIOL, V17, P154, DOI 10.1016/j.semcancer.2006.11.007; Qiu HB, 2008, STEROIDS, V73, P1416, DOI 10.1016/j.steroids.2008.07.007; SELMAN K, 1993, J MORPHOL, V218, P203, DOI 10.1002/jmor.1052180209; Sirois J, 2004, HUM REPROD UPDATE, V10, P373, DOI 10.1093/humupd/dmh032; Tan Q, 2009, MOL CELL ENDOCRINOL, V312, P72, DOI 10.1016/j.mce.2009.03.011; Tan Q, 2009, COMP BIOCHEM PHYS A, V153, P18, DOI 10.1016/j.cbpa.2008.09.016; Thomas P, 2004, STEROIDS, V69, P567, DOI 10.1016/j.steroids.2004.05.004; Thomas P, 2002, STEROIDS, V67, P511, DOI 10.1016/S0039-128X(01)00180-5; Tokumoto M, 2006, GEN COMP ENDOCR, V145, P101, DOI 10.1016/j.ygcen.2005.07.002	36	101	109	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10201	10.1371/journal.pone.0010201	http://dx.doi.org/10.1371/journal.pone.0010201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419165	gold, Green Published, Green Submitted			2022-12-25	WOS:000276707100015
J	Grabowski, JH; Clesceri, EJ; Baukus, AJ; Gaudette, J; Weber, M; Yund, PO				Grabowski, Jonathan H.; Clesceri, Erika J.; Baukus, Adam J.; Gaudette, Julien; Weber, Matthew; Yund, Philip O.			Use of Herring Bait to Farm Lobsters in the Gulf of Maine	PLOS ONE			English	Article							HOMARUS-AMERICANUS; NEW-BRUNSWICK; LONG-TERM; COD; PSEUDOREPLICATION; POPULATION; BEHAVIOR; GROWTH	Background: Ecologists, fisheries scientists, and coastal managers have all called for an ecosystem approach to fisheries management, yet many species such as the American lobster ( Homarus americanus) are still largely managed individually. One hypothesis that has yet to be tested suggests that human augmentation of lobster diets via the use of Atlantic herring (Clupea harengus) as bait may contribute to recent increases in lobster landings. Currently 70% of Atlantic herring landings in the Gulf of Maine are used as bait to catch lobsters in traps throughout coastal New England. Methodology/Principal Findings: We examined the effects of this herring bait on the diet composition and growth rate of lobsters at heavily baited vs. seasonally closed (i.e., bait free) sites in coastal Maine. Our results suggest that human use of herring bait may be subsidizing juvenile lobster diets, thereby enhancing lobster growth and the overall economic value and yield of one of the most valuable fisheries in the U. S. Conclusions/Significance: Our study illustrates that shifting to an ecosystem approach to fisheries management should require consideration of cross-fishery interactions.	[Grabowski, Jonathan H.; Gaudette, Julien] Gulf Maine Res Inst, Portland, ME USA; [Clesceri, Erika J.] US Agcy Int Dev, Washington, DC 20523 USA; [Baukus, Adam J.] Univ So Maine, Portland, ME 04103 USA; [Yund, Philip O.] Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA	Gulf of Maine Research Institute; United States Agency for International Development (USAID); University of Maine System; University of Southern Maine; University of Maine System; University of Maine Orono	Grabowski, JH (corresponding author), Gulf Maine Res Inst, Portland, ME USA.	jgrabowski@gmri.org		Yund, Philip/0000-0003-0474-5205; Grabowski, Jonathan/0000-0003-4711-5481	The Northeast Consortium; The Davis Foundation; The Lobster Advisory Council, Maine Sea; NSF [OCE-01-22031, OCE-07-09527]	The Northeast Consortium; The Davis Foundation; The Lobster Advisory Council, Maine Sea; NSF(National Science Foundation (NSF))	The Northeast Consortium, The Davis Foundation, The Lobster Advisory Council, Maine Sea Grant Program, and NSF (OCE-01-22031; OCE-07-09527). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames EP, 2004, FISHERIES, V29, P10, DOI 10.1577/1548-8446(2004)29[10:ACSSIT]2.0.CO;2; *ATL STAT MAR FISH, 2000, AM LOBST STOCK ASS R; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; Brandt S, 2006, MAR POLICY, V30, P659, DOI 10.1016/j.marpol.2005.09.007; CAMPBELL A, 1983, CAN J FISH AQUAT SCI, V40, P1667, DOI 10.1139/f83-193; Castro KM, 2001, MAR FRESHWATER RES, V52, P1253, DOI 10.1071/MF01095; CHRISTIANSEN R, 2006, 2005 REV FISHERY MAN; COBB JS, 1970, ECOLOGY, V52, P108; Cottenie K, 2003, OIKOS, V100, P394, DOI 10.1034/j.1600-0706.2003.11953.x; DAY RW, 1989, ECOL MONOGR, V59, P433, DOI 10.2307/1943075; Drinkwater KF, 1996, FISH OCEANOGR, V5, P176, DOI 10.1111/j.1365-2419.1996.tb00116.x; Dutil JD, 2003, FISH OCEANOGR, V12, P502, DOI 10.1046/j.1365-2419.2003.00243.x; ELNER RW, 1987, MAR ECOL PROG SER, V37, P131, DOI 10.3354/meps037131; ENNIS GP, 1973, J FISH RES BOARD CAN, V34, P2203; FAO, 2003, FISH MAN; Grabowski JH, 2009, NEW ZEAL J MAR FRESH, V43, P185, DOI 10.1080/00288330909509992; HUDON C, 1989, MAR ECOL PROG SER, V52, P155, DOI 10.3354/meps052155; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Incze LS, 2003, FISH RES, V65, P33, DOI 10.1016/j.fishres.2003.09.005; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JAMIESON GS, 1981, CANADIAN J FISHERIES, V39, P499; Janowicz M, 2001, ICES J MAR SCI, V58, P453, DOI 10.1006/jmsc.2000.1024; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jury SH, 2001, MAR FRESHWATER RES, V52, P1125, DOI 10.1071/MF01096; LAWTON P, 1987, CAN J FISH AQUAT SCI, V44, P1195, DOI 10.1139/f87-142; Lawton Peter, 1995, P47, DOI 10.1016/B978-012247570-2/50026-8; *MAR DEP MAR RES, 2010, DAT MAIN LOBST LAND; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Myers RA, 2007, CURR BIOL, V17, pR10, DOI 10.1016/j.cub.2006.11.045; *NAT MAR FISH SERV, 2010, COMM FISH LAND; NOAA (National Oceanic and Atmospheric Administration), 1999, EC BAS FISH MAN REP; Oksanen L, 2001, OIKOS, V94, P27, DOI 10.1034/j.1600-0706.2001.11311.x; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Rose GA, 2002, ICES J MAR SCI, V59, P1018, DOI 10.1006/jmsc.2002.1252; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Saila SB, 2002, N AM J FISH MANAGE, V22, P602, DOI 10.1577/1548-8675(2002)022<0602:DLTBIT>2.0.CO;2; SHERWOOD GD, 2007, DEEP SEA 2 IN PRESS, V2; Sinclair M., 2003, RESPONSIBLE FISHERIE; SLOBODKIN LAWRENCE B., 1961; Steneck RS, 2001, MAR FRESHWATER RES, V52, P1303, DOI 10.1071/MF01173; Steneck RS, 1997, P GULF MAIN EC DYN S, P91; Suring E, 2009, J EXP MAR BIOL ECOL, V370, P56, DOI 10.1016/j.jembe.2008.11.014; Swain DP, 2000, CAN J FISH AQUAT SCI, V57, P1321, DOI 10.1139/cjfas-57-7-1321; *TRANSB RES ASS CO, 2006, 200601 TRANSB RES AS; Underwood A.J., 1981, Oceanography and Marine Biology an Annual Review, V19, P513; Waddington KI, 2009, FISH RES, V99, P1, DOI 10.1016/j.fishres.2009.04.002; Waddy S.L., 1995, P217, DOI 10.1016/B978-012247570-2/50032-3; WAINRIGHT SC, 1993, MAR BIOL, V115, P481, DOI 10.1007/BF00349847; WITMAN JD, 1992, OECOLOGIA, V90, P305, DOI 10.1007/BF00317686; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2	50	48	50	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10188	10.1371/journal.pone.0010188	http://dx.doi.org/10.1371/journal.pone.0010188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419167	Green Published, gold, Green Submitted			2022-12-25	WOS:000276707100009
J	Bonnet, E; Tatari, M; Joshi, A; Michoel, T; Marchal, K; Berx, G; Van de Peer, Y				Bonnet, Eric; Tatari, Marianthi; Joshi, Anagha; Michoel, Tom; Marchal, Kathleen; Berx, Geert; Van de Peer, Yves			Module Network Inference from a Cancer Gene Expression Data Set Identifies MicroRNA Regulated Modules	PLOS ONE			English	Article							C-FOS TRANSCRIPTION; MESENCHYMAL TRANSITION; MIR-200 FAMILY; MASTER REGULATOR; PROSTATE-CANCER; CHEMOKINE BRAK; CELLS; REPRESSION; RECEPTOR; BREAST	Background: MicroRNAs (miRNAs) are small RNAs that recognize and regulate mRNA target genes. Multiple lines of evidence indicate that they are key regulators of numerous critical functions in development and disease, including cancer. However, defining the place and function of miRNAs in complex regulatory networks is not straightforward. Systems approaches, like the inference of a module network from expression data, can help to achieve this goal. Methodology/Principal Findings: During the last decade, much progress has been made in the development of robust and powerful module network inference algorithms. In this study, we analyze and assess experimentally a module network inferred from both miRNA and mRNA expression data, using our recently developed module network inference algorithm based on probabilistic optimization techniques. We show that several miRNAs are predicted as statistically significant regulators for various modules of tightly co-expressed genes. A detailed analysis of three of those modules demonstrates that the specific assignment of miRNAs is functionally coherent and supported by literature. We further designed a set of experiments to test the assignment of miR-200a as the top regulator of a small module of nine genes. The results strongly suggest that miR-200a is regulating the module genes via the transcription factor ZEB1. Interestingly, this module is most likely involved in epithelial homeostasis and its dysregulation might contribute to the malignant process in cancer cells. Conclusions/Significance: Our results show that a robust module network analysis of expression data can provide novel insights of miRNA function in important cellular processes. Such a computational approach, starting from expression data alone, can be helpful in the process of identifying the function of miRNAs by suggesting modules of co-expressed genes in which they play a regulatory role. As shown in this study, those modules can then be tested experimentally to further investigate and refine the function of the miRNA in the regulatory network.	[Bonnet, Eric; Joshi, Anagha; Michoel, Tom; Van de Peer, Yves] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Bonnet, Eric; Joshi, Anagha; Michoel, Tom; Van de Peer, Yves] Univ Ghent, Dept Mol Genet, B-9000 Ghent, Belgium; [Tatari, Marianthi; Berx, Geert] VIB, Dept Mol Biomed Res, Unit Mol & Cellular Oncol, Ghent, Belgium; [Tatari, Marianthi; Berx, Geert] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Marchal, Kathleen] KULeuven, Dept Microbial & Mol Syst, CMPG, Louvain, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; KU Leuven	Bonnet, E (corresponding author), VIB, Dept Plant Syst Biol, Ghent, Belgium.	yves.vandepeer@psb.vib-ugent.be	Van de Peer, Yves/D-4388-2009; Marchal, Kathleen/B-5001-2013; Marchal, Kathleen/O-7936-2017; Van de Peer, Yves/AAE-7666-2019	Van de Peer, Yves/0000-0003-4327-3730; Marchal, Kathleen/0000-0002-2169-4588; Marchal, Kathleen/0000-0002-2169-4588; Van de Peer, Yves/0000-0003-4327-3730; Berx, Geert/0000-0001-5770-2458; Joshi, Anagha/0000-0003-1184-3305; Michoel, Tom/0000-0003-4749-4725; Tatari, Marianthi/0000-0002-6309-5057; Bonnet, Eric/0000-0002-8468-2867	Innovatie door Wetenschap en Technologie (IWT); Interuniversity Attraction Pole (IUAP) [p6/25]	Innovatie door Wetenschap en Technologie (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Interuniversity Attraction Pole (IUAP)(Belgian Federal Science Policy Office)	This work is supported by an Innovatie door Wetenschap en Technologie (IWT) grant for the Strategisch BasisOnderzoek (SBO) Bioframe project and by an Interuniversity Attraction Pole (IUAP) grant for the BioMaGNet project (Bioinformatics and Modelling: from Genomes to Networks, ref. p6/25). The funders had no role in study design, datacollection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Beckler A, 2003, CANCER, V98, P1547, DOI 10.1002/cncr.11654; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen MQ, 2007, BBA-MOL CELL RES, V1773, P1133, DOI 10.1016/j.bbamcr.2007.04.013; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Crambert G, 2005, MOL BIOL CELL, V16, P2363, DOI 10.1091/mbc.E04-10-0878; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Frederick MJ, 2000, AM J PATHOL, V156, P1937, DOI 10.1016/S0002-9440(10)65067-5; FRIEDMAN RC, 2008, GENOME RES; Gires O, 2003, ANTICANCER RES, V23, P3255; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grzmil M, 2004, INT J ONCOL, V24, P97; Herrgard MJ, 2003, GENOME RES, V13, P2423, DOI 10.1101/gr.1330003; Hooghe B, 2008, NUCLEIC ACIDS RES, V36, pW128, DOI 10.1093/nar/gkn195; Joshi A, 2008, BIOINFORMATICS, V24, P176, DOI 10.1093/bioinformatics/btm562; Joshi A, 2009, BIOINFORMATICS, V25, P490, DOI 10.1093/bioinformatics/btn658; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Kurth I, 2001, J EXP MED, V194, P855, DOI 10.1084/jem.194.6.855; Liao RX, 2008, J CELL BIOCHEM, V104, P805, DOI 10.1002/jcb.21668; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-408; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maghazachi AA, 1996, EUR J IMMUNOL, V26, P315, DOI 10.1002/eji.1830260207; McCarthy KM, 2003, J BIOL CHEM, V278, P42106, DOI 10.1074/jbc.M308586200; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Michoel T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-49; OBRYAN JP, 1995, J BIOL CHEM, V270, P551, DOI 10.1074/jbc.270.2.551; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; RIVERA VM, 1990, GENE DEV, V4, P255, DOI 10.1101/gad.4.2.255; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; SHAW PE, 1989, EMBO J, V8, P2567, DOI 10.1002/j.1460-2075.1989.tb08395.x; Stritt C, 2009, NAT NEUROSCI, V12, P418, DOI 10.1038/nn.2280; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Turesson C, 2006, MAYO CLIN PROC, V81, P94, DOI 10.4065/81.1.94; VANDEWALLE C, 2008, CELL MOL LIFE SCI; Walhout AJM, 2006, GENOME RES, V16, P1445, DOI 10.1101/gr.5321506; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Yoon SR, 2005, BIOINFORMATICS, V21, P93, DOI 10.1093/bioinformatics/bti1116; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898	56	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10162	10.1371/journal.pone.0010162	http://dx.doi.org/10.1371/journal.pone.0010162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418949	Green Published, Green Submitted, gold			2022-12-25	WOS:000276706800011
J	Huang, LQ; Jin, R; Li, JR; Luo, K; Huang, T; Wu, D; Wang, WX; Chen, R; Xiao, GF				Huang, Liqin; Jin, Rui; Li, Jiarui; Luo, Kan; Huang, Tao; Wu, Di; Wang, Wenxi; Chen, Rui; Xiao, Gengfu			Macromolecular crowding converts the human recombinant PrPC to the soluble neurotoxic beta-oligomers	FASEB JOURNAL			English	Article						prion protein; thermodynamic stability; neurotoxicity; crowded environment; oligomerization	PRION PROTEIN; INSERTION MUTATIONS; ALPHA-SYNUCLEIN; CONFORMATION; AGGREGATION; FIBRILLIZATION; TRANSITION; STABILITY; VOLUME; FORM	Prion diseases are fatal neurodegenerative disorders and are linked with the conversion of the cellular isoform of the prion protein (PrPC) into the abnormal beta-sheet-rich isoform. It is widely accepted that the soluble oligomers of beta-PrP are neurotoxic and that they are more pathologically significant. To unravel the molecular mechanism under the conversion process, it is critical to identify the factors that can promote the conversion from PrPC to the beta-oligomers. By recording circular dichroism spectra and performing a size-exclusion HPLC assay, we found that the conformation of the recombinant human prion protein (rPrP(C)) was converted from an alpha-helical conformation into beta-sheet oligomers under a macromolecular crowding condition. The soluble beta-oligomers of rPrP were resistant to proteinase K digestion and could bind to the dyes thioflavin T and 8-anilino-1-naphthalene sulfonate. Furthermore, by the 3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium assay, we showed that the soluble beta-oligomers were neurotoxic. These results suggest that macromolecular crowding, which has not been considered before, is a key intracellular factor in the formation of soluble neurotoxic beta-oligomers in prion diseases.-Huang, L., Jin, R., Li, J., Luo, K., Huang, T., Wu, D., Wang, W., Chen, R., Xiao, G. Macromolecular crowding converts the human recombinant PrPC to the soluble neurotoxic beta-oligomers. FASEB J. 24, 3536-3543 (2010). www.fasebj.org	[Jin, Rui; Xiao, Gengfu] Wuhan Univ, Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan 430071, Hubei, Peoples R China; [Huang, Liqin; Li, Jiarui; Luo, Kan; Huang, Tao; Wu, Di; Wang, Wenxi; Chen, Rui; Xiao, Gengfu] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430071, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Wuhan University; Wuhan University	Xiao, GF (corresponding author), Wuhan Univ, Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan 430071, Hubei, Peoples R China.	xiaogf@wh.iov.cn			National Key Scientific Program (973)-Nanoscience and Nanotechnology [2006CB933100]; National Natural Science Foundation of China [30970150]; Program for New Century Excellent Talents in University [NCET-06-0620]; Program for Changjiang Scholars and Innovative Research Team in University [IRT 0745]	National Key Scientific Program (973)-Nanoscience and Nanotechnology(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This study was supported by National Key Scientific Program (973)-Nanoscience and Nanotechnology (2006CB933100), a grant from the National Natural Science Foundation of China (30970150), the Program for New Century Excellent Talents in University (NCET-06-0620), and the Program for Changjiang Scholars and Innovative Research Team in University (IRT 0745).	Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chesebro B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000800; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Grasbon-Frodl E, 2004, NEUROGENETICS, V5, P249, DOI 10.1007/s10048-004-0196-x; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Huang Z, 1996, CURR TOP MICROBIOL, V207, P49; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Kazlauskaite J, 2005, BIOCHEM BIOPH RES CO, V328, P292, DOI 10.1016/j.bbrc.2004.12.172; Leffers KW, 2004, J MOL BIOL, V344, P839, DOI 10.1016/j.jmb.2004.09.071; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Minton AP, 1997, CURR OPIN BIOTECH, V8, P65, DOI 10.1016/S0958-1669(97)80159-0; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; MINTON AP, 1983, MOL CELL BIOCHEM, V55, P119, DOI 10.1007/BF00673707; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Mukherjee S, 2009, J MOL BIOL, V393, P227, DOI 10.1016/j.jmb.2009.08.016; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Nandi PK, 2006, J MOL BIOL, V362, P810, DOI 10.1016/j.jmb.2006.07.060; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Perham M, 2007, FEBS LETT, V581, P5065, DOI 10.1016/j.febslet.2007.09.049; Peters PJ, 2003, J CELL BIOL, V162, P703, DOI 10.1083/jcb.200304140; Polyakova O, 2009, EUR BIOPHYS J BIOPHY, V38, P209, DOI 10.1007/s00249-008-0371-3; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rezaei H, 2005, J MOL BIOL, V347, P665, DOI 10.1016/j.jmb.2005.01.043; Rivas German, 2004, EMBO Reports, V5, P23, DOI 10.1038/sj.embor.7400056; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Sasahara K, 2003, J MOL BIOL, V326, P1227, DOI 10.1016/S0022-2836(02)01443-2; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Stagg L, 2007, P NATL ACAD SCI USA, V104, P18976, DOI 10.1073/pnas.0705127104; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; Tokuriki N, 2004, PROTEIN SCI, V13, P125, DOI 10.1110/ps.03288104; Uversky VN, 2002, FEBS LETT, V515, P99, DOI 10.1016/S0014-5793(02)02446-8; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; Yin SM, 2006, J BIOL CHEM, V281, P10698, DOI 10.1074/jbc.M511819200; Yu SL, 2007, BIOCHEM J, V403, P343, DOI 10.1042/BJ20061592; Yu SL, 2004, EUR J HUM GENET, V12, P867, DOI 10.1038/sj.ejhg.5201245; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832	42	34	35	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3536	3543		10.1096/fj.09-150987	http://dx.doi.org/10.1096/fj.09-150987			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20400537				2022-12-25	WOS:000281446400040
J	Lopez-Ramos, M; Prudent, R; Moucadel, V; Sautel, CF; Barette, C; Lafanechere, L; Mouawad, L; Grierson, D; Schmidt, F; Florent, JC; Filippakopoulos, P; Bullock, AN; Knapp, S; Reiser, JB; Cochet, C				Lopez-Ramos, Miriam; Prudent, Renaud; Moucadel, Virginie; Sautel, Celine F.; Barette, Caroline; Lafanechere, Laurence; Mouawad, Liliane; Grierson, David; Schmidt, Frederic; Florent, Jean-Claude; Filippakopoulos, Panagis; Bullock, Alex N.; Knapp, Stefan; Reiser, Jean-Baptiste; Cochet, Claude			New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights	FASEB JOURNAL			English	Article						X-ray crystallography; binding mode; comparative structural study; high-throughput screening; selective inhibition	FACTOR-KAPPA-B; CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; CONSTITUTIVE ACTIVITY; PROTOONCOGENE PIM-1; PHOSPHORYLATES BAD; PROGNOSTIC MARKER; CASEIN KINASE-2; ALPHA-SUBUNIT; PROTEIN	Protein kinase casein kinase 2 (CK2) is a serine/threonine kinase with evidence of implication in growth dysregulation and apoptosis resistance, making it a relevant target for cancer therapy. Several CK2 inhibitors have been developed showing variable efficiency, emphasizing the need to expand the chemical diversity of those inhibitors. We report the identification and characterization of 2,8-difurandicarboxylic acid derivatives as a new class of nanomolar ATP-competitive inhibitors. Selectivity profiling pointed out proviral insertion Moloney virus kinases (Pim kinases) as the only other kinases that are significantly inhibited. By combining structure-activity relationship analysis with structural determination, we were able to determine the binding mode of these inhibitors for both kinases and to explain their strong inhibitory potency. Essential chemical features necessary for activity on both kinases were then identified. The described compounds are not cell permeable: however, they could provide a lead for developing novel inhibitors usable also in vivo. Given the similar but not redundant pathophysiological functions of CK2 and Pim family members, such inhibitors would provide new attractive leads for targeted cancer therapy. This work highlights that 2 functionally related kinases from different kinome branches display exquisite sensitivity to a common inhibitor.-Lopez-Ramos, M., Prudent, R., Moucadel, V., Sautel, C. F., Barette, C., Lafanechere, L., Mouawad, L., Grierson, D., Schmidt, F., Florent, J.-C., Filippakopoulos, P., Bullock, A. N., Knapp, S., Reiser, J.-B., Cochet, C. New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights. FASEB J. 24, 3171-3185 (2010). www.fasebj.org	[Prudent, Renaud; Moucadel, Virginie; Sautel, Celine F.; Cochet, Claude] INSERM, U873, F-38054 Grenoble, France; [Lopez-Ramos, Miriam; Grierson, David; Schmidt, Frederic; Florent, Jean-Claude] Inst Curie, Ctr Rech, Paris, France; [Lopez-Ramos, Miriam; Grierson, David; Schmidt, Frederic; Florent, Jean-Claude] CNRS, UMR 176, Paris, France; [Lopez-Ramos, Miriam; Mouawad, Liliane] Univ Paris 11, Inst Curie, Ctr Rech, Orsay, France; [Lopez-Ramos, Miriam; Mouawad, Liliane] Univ Paris 11, INSERM, U759, F-91405 Orsay, France; [Prudent, Renaud; Moucadel, Virginie; Sautel, Celine F.; Cochet, Claude] CEA, iRTSV, Lab Transduct Signal, Grenoble, France; [Barette, Caroline; Lafanechere, Laurence] CEA, DSV, iRTSV, Ctr Criblage Mol Bioact, Grenoble, France; [Barette, Caroline; Lafanechere, Laurence] CEA, DSV, iRTSV, CMBA,CNRS,UMR 5168, Grenoble, France; [Filippakopoulos, Panagis; Bullock, Alex N.; Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Knapp, Stefan] Univ Oxford, Dept Clin Pharmacol, Oxford, England; [Reiser, Jean-Baptiste] UJF, CNRS, CEA, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; CEA; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; University of Oxford; University of Oxford; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Cochet, C (corresponding author), INSERM, U873, F-38054 Grenoble, France.	jean-baptiste.reiser@ibs.fr; ccochet1@cea.fr	Knapp, Stefan/AAG-2347-2019; Schmidt, Frederic/F-8946-2016; Reiser, Jean-Baptiste/W-7683-2019; Lafanechère, Laurence MP/N-7474-2013; Mouawad, Liliane/N-1945-2018	Knapp, Stefan/0000-0001-5995-6494; Schmidt, Frederic/0000-0002-1537-3585; Reiser, Jean-Baptiste/0000-0001-6926-9137; Lafanechère, Laurence MP/0000-0002-7902-7630; Mouawad, Liliane/0000-0002-7155-9712; florent, jean-claude/0000-0001-9837-5094; BARETTE, Caroline/0000-0003-0999-7751; Filippakopoulos, Panagis/0000-0002-1515-1317; Cochet, Claude/0000-0002-1772-4270	INSERM; CNRS; CEA; Institut Curie; Ligue Nationale Contre le Cancer; Institut National du Cancer; Fondation pour la Recherche Medicale; Structural Genomics Consortium [1097737]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); CEA(French Atomic Energy Commission); Institut Curie; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Structural Genomics Consortium(University of Toronto); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome Trust)	This work was supported by INSERM, CNRS, CEA, the Institut Curie, the Ligue Nationale Contre le Cancer (equipe labelisee 2007), the Institut National du Cancer (grant 57). R. P. is the recipient of a fellowship from the Fondation pour la Recherche Medicale. The authors thank Sylvie Dubruille for assessing the purity of all synthesized compounds by HPLC. The authors also thank the ChemAxon company (http://www.chemaxon.com) that has allowed the academic TAMIS software team (especially S. Wieczorek, S. Aci, C. Charavay, and S. Roy) to freely use the MarvinView package, a helpful graphic user interface for viewing structure files and query results. The authors are also indebted to Dr. J. Schwaller and S. Ehret for cellular Pim-1 kinase assays and to Dr. Michael Lilly (Loma Linda University School of Medicine, Loma Linda, CA, USA) for providing us with BaF3/Pim-1 cells. The authors thank Juan-Carlos Fontecilla-Camps and his group (Laboratoire de Cristallogenese et Cristallographie des Proteines, Institut de Biologie Structurale Jean-Pierre Ebel, Grenoble, France) for laboratory technical support. The authors thank the SLS and ESRF MX team and local contacts for support during diffraction data collections on beamlines. The Structural Genomics Consortium is a registered charity (No. 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.	Ahmad KA, 2005, ANTI-CANCER DRUG, V16, P1037, DOI 10.1097/00001813-200511000-00001; Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Aho TL, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-21; ANDERES K, 2009, AM ASS CANC RES AACR; Arrault A, 1999, SYNTHESIS-STUTTGART, P1241; AUGUSTIN S, 2005, FLEXX; Ayala GE, 2004, CANCER RES, V64, P6082, DOI 10.1158/0008-5472.CAN-04-0838; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Azam M, 2010, CHEM BIOL DRUG DES, V75, P223, DOI 10.1111/j.1747-0285.2009.00911.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battistutta R, 2000, J BIOL CHEM, V275, P29618, DOI 10.1074/jbc.M004257200; Battistutta R, 2005, CHEM BIOL, V12, P1211, DOI 10.1016/j.chembiol.2005.08.015; Battistutta R, 2009, CELL MOL LIFE SCI, V66, P1868, DOI 10.1007/s00018-009-9155-x; Battistutta R, 2001, PROTEIN SCI, V10, P2200, DOI 10.1110/ps.19601; Bibby AC, 2005, INT J BIOL SCI, V1, P67; BILGER C, 1987, EUR J MED CHEM, V22, P213, DOI 10.1016/0223-5234(87)90052-3; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Chen J, 2009, ONCOGENE, V28, P2581, DOI 10.1038/onc.2009.124; Cheney IW, 2007, BIOORG MED CHEM LETT, V17, P1679, DOI 10.1016/j.bmcl.2006.12.086; Cibull TL, 2006, J CLIN PATHOL, V59, P285, DOI 10.1136/jcp.2005.027672; COZZA G, 2009, MED RES REV IN PRESS, DOI DOI 10.1002/MED.20164; Debreczeni JE, 2006, ANGEW CHEM INT EDIT, V45, P1580, DOI 10.1002/anie.200503468; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ermakova I, 2003, J MOL BIOL, V330, P925, DOI 10.1016/S0022-2836(03)00638-7; Evans P., 2007, SCALA SCALE TOGETHER; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; FILHOL O, 1991, BIOCHEMISTRY-US, V30, P11133, DOI 10.1021/bi00110a016; Frisch M. J., 2004, GAUSSIAN 03W; Gerber DA, 2000, J BIOL CHEM, V275, P23919, DOI 10.1074/jbc.M002697200; Hammerman PS, 2004, CANCER RES, V64, P8341, DOI 10.1158/0008-5472.CAN-04-2284; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Hubert A, 2006, J CELL SCI, V119, P3351, DOI 10.1242/jcs.03069; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kallergi G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2452; Kim JS, 2007, CLIN CANCER RES, V13, P1019, DOI 10.1158/1078-0432.CCR-06-1602; Klumpp S, 2004, NEUROCHEM INT, V45, P747, DOI 10.1016/j.neuint.2004.02.006; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Landesman-Bollag E, 2001, MOL CELL BIOCHEM, V227, P153, DOI 10.1023/A:1013108822847; Laramas M, 2007, EUR J CANCER, V43, P928, DOI 10.1016/j.ejca.2006.11.021; LESLIE AGW, 2007, MOSFLM; Liao JJL, 2007, J MED CHEM, V50, P409, DOI 10.1021/jm0608107; Lilly M, 1999, ONCOGENE, V18, P4022, DOI 10.1038/sj.onc.1202741; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mazzorana M, 2008, MOL CELL BIOCHEM, V316, P57, DOI 10.1007/s11010-008-9822-5; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Mottet D, 2005, INT J CANCER, V117, P764, DOI 10.1002/ijc.21268; Moustakas DT, 2006, J COMPUT AID MOL DES, V20, P601, DOI 10.1007/s10822-006-9060-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Niefind K, 2009, CELL MOL LIFE SCI, V66, P1800, DOI 10.1007/s00018-009-9149-8; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; Niefind K, 1998, EMBO J, V17, P2451, DOI 10.1093/emboj/17.9.2451; Niefind K, 2007, J MOL BIOL, V370, P427, DOI 10.1016/j.jmb.2007.04.068; O-charoenrat P, 2004, CLIN CANCER RES, V10, P5792, DOI 10.1158/1078-0432.CCR-03-0317; Pagano MA, 2006, BIOCHEM SOC T, V34, P1303, DOI 10.1042/BST0341303; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pierce AC, 2008, J MED CHEM, V51, P1972, DOI 10.1021/jm701248t; Pogacic V, 2007, CANCER RES, V67, P6916, DOI 10.1158/0008-5472.CAN-07-0320; Prudent R, 2008, BBA-GEN SUBJECTS, V1780, P1412, DOI 10.1016/j.bbagen.2008.06.010; Prudent R, 2008, MOL CELL BIOCHEM, V316, P71, DOI 10.1007/s11010-008-9828-z; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; Raaf J, 2008, MOL CELL BIOCHEM, V316, P15, DOI 10.1007/s11010-008-9826-1; Raaf J, 2008, CHEM BIOL, V15, P111, DOI 10.1016/j.chembiol.2007.12.012; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Reiser-Erkan C, 2008, CANCER BIOL THER, V7, P1352, DOI 10.4161/cbt.7.9.6418; Romieu-Mourez R, 2001, CANCER RES, V61, P3810; RUZZENE M, 2009, BIOCHIM BIOPHYS ACTA, V1804, P499; Ryan AJ, 2003, J MED CHEM, V46, P3448, DOI 10.1021/jm0340896; Sarno S, 2005, MOL CELL BIOCHEM, V274, P69, DOI 10.1007/s11010-005-3079-z; Sarno S, 2002, J BIOL CHEM, V277, P22509, DOI 10.1074/jbc.M200486200; Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r; Shoichet BK, 2006, J MED CHEM, V49, P7274, DOI 10.1021/jm061103g; Slaton JW, 2004, MOL CANCER RES, V2, P712; SYBYL Tripos Inc, SYBYL, P63144; Valdman A, 2004, PROSTATE, V60, P367, DOI 10.1002/pros.20064; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Xie Y, 2006, ONCOGENE, V25, P70, DOI 10.1038/sj.onc.1209058; Xu Y, 2005, J SURG ONCOL, V92, P326, DOI 10.1002/jso.20325; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Zemskova M, 2008, J BIOL CHEM, V283, P20635, DOI 10.1074/jbc.M709479200	88	51	55	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3171	3185		10.1096/fj.09-143743	http://dx.doi.org/10.1096/fj.09-143743			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20400536				2022-12-25	WOS:000281446400007
J	Guang, W; Ding, H; Czinn, SJ; Kim, KC; Blanchard, TG; Lillehoj, EP				Guang, Wei; Ding, Hua; Czinn, Steven J.; Kim, K. Chul; Blanchard, Thomas G.; Lillehoj, Erik P.			Muc1 Cell Surface Mucin Attenuates Epithelial Inflammation in Response to a Common Mucosal Pathogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICOBACTER-PYLORI INFECTION; SPLICE VARIANTS; H-DNA; EXPRESSION; GENE; PHOSPHORYLATION; IDENTIFICATION; COLONIZATION; ACTIVATION; INHIBITION	Helicobacter pylori infection of the gastric mucosa causes an active-chronic inflammation that is strongly linked to the development of duodenal and gastric ulcers and stomach cancer. However, greater than 80% of individuals infected with H. pylori are asymptomatic beyond histologic inflammation, and it is unknown what factors influence the incidence and character of bacterial-associated gastritis and related disorders. Because previous studies demonstrated that the Muc1 epithelial glycoprotein inhibited inflammation during acute lung infection by Pseudomonas aeruginosa, we asked whether Muc1 might also counter-regulate gastric inflammation in response to H. pylori infection. Muc1(-/-) mice displayed increased bacterial colonization of the stomach and greater TNF-alpha and keratinocyte chemoattractant transcript levels compared with Muc1(+/+) mice after experimental H. pylori infection. Knockdown of Muc1 expression in AGS human gastric epithelial cells by RNA interference was associated with increased phosphorylation of I kappa B alpha, augmented activation and nuclear translocation of NF-kappa B, and enhanced production of interleulin-8 compared with Muc1-expressing cells. Conversely, Muc1 overexpression was correlated with decreased NF-kappa B activation, reduced interleulin-8 production, and diminished I kappa B kinase beta (IKK beta)/IKK gamma coimmunoprecipitation compared with cells expressing Muc1 endogenously. Cotransfection of AGS cells with Muc1 plus IKK beta, but not a catalytically inactive IKK beta mutant, reversed the Muc1 inhibitory effect. Finally, Muc1 formed a coimmunoprecipitation complex with IKK gamma but not with IKK beta. These results are consistent with the hypothesis that Muc1 binds to IKK gamma, thereby inhibiting formation of the catalytically active IKK complex and blocking the ability of H. pylori to stimulate I kappa B alpha phosphorylation, NF-kappa B activation, and downstream inflammatory responses.	[Lillehoj, Erik P.] Univ Maryland, Dept Pediat, Sch Med, Baltimore, MD 21201 USA; [Kim, K. Chul] Temple Univ Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Kim, K. Chul] Temple Univ Sch Med, Lung Ctr, Philadelphia, PA 19140 USA	University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Lillehoj, EP (corresponding author), Univ Maryland, Dept Pediat, Sch Med, 655 W Baltimore St,BRB 13-029, Baltimore, MD 21201 USA.	elillehoj@peds.umaryland.edu		Lillehoj, Erik/0000-0002-2710-1704; , Erik/0000-0003-0910-6074	United States Public Health Service [AI072291, AI083463, AI055710]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083463, R56AI055710, R01AI055710, R21AI072291] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United States Public Health Service Grants AI072291 (to E.P.L.), AI083463 (to E.P.L.), and AI055710 (to T.G.B.).	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Beswick EJ, 2005, INFECT IMMUN, V73, P2736, DOI 10.1128/IAI.73.5.2736-2743.2005; BICKLEY J, 1993, J MED MICROBIOL, V39, P338, DOI 10.1099/00222615-39-5-338; Burgel PR, 2004, THORAX, V59, P992, DOI 10.1136/thx.2003.018879; Byrd JC, 2000, GASTROENTEROLOGY, V118, P1072, DOI 10.1016/S0016-5085(00)70360-X; Carraway KL, 2003, BIOESSAYS, V25, P66, DOI 10.1002/bies.10201; CORREA P, 1988, CANCER RES, V48, P3554; Ding H, 2009, INFECT IMMUN, V77, P5543, DOI 10.1128/IAI.00532-09; Eaton KA, 2001, INFECT IMMUN, V69, P2902, DOI 10.1128/IAI.69.5.2902-2908.2001; Fox JG, 2001, NEW ENGL J MED, V345, P829, DOI 10.1056/NEJM200109133451111; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Gottwein JM, 2001, J INFECT DIS, V184, P308, DOI 10.1086/322032; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hinojosa-Kurtzberg AM, 2003, AM J PHYSIOL-GASTR L, V284, pG853, DOI 10.1152/ajpgi.00326.2002; Imbert Y, 2006, EXP EYE RES, V83, P493, DOI 10.1016/j.exer.2006.01.031; Kardon R, 1999, INVEST OPHTH VIS SCI, V40, P1328; KOVARIK A, 1993, J BIOL CHEM, V268, P9917; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lee IJ, 2003, AM J PHYSIOL-LUNG C, V284, pL160, DOI 10.1152/ajplung.00342.2000; LEVINE SJ, 1995, J INVEST MED, V43, P241; Lillehoj EP, 2003, BIOCHEM BIOPH RES CO, V307, P743, DOI 10.1016/S0006-291X(03)01260-9; Linden S, 2004, BIOCHEM J, V384, P263, DOI 10.1042/BJ20040402; Linden SK, 2008, HELICOBACTER, V13, P81, DOI 10.1111/j.1523-5378.2008.00587.x; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; Lu WJ, 2006, J IMMUNOL, V176, P3890, DOI 10.4049/jimmunol.176.7.3890; MacFarlane AJ, 2007, NUTR REV, V65, pS157, DOI [10.1111/j.1753-4887.2007.tb00355.x, 10.1301/nr.2007.dec.S157-S166]; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Marshall B, 2002, CLIN MED, V2, P147, DOI 10.7861/clinmedicine.2-2-147; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mcguckin MA, 2007, GASTROENTEROLOGY, V133, P1210, DOI 10.1053/j.gastro.2007.07.003; McNamara D, 2008, DIGEST LIVER DIS, V40, P504, DOI 10.1016/j.dld.2008.02.031; Nelson KL, 1996, J BIOL CHEM, V271, P18061, DOI 10.1074/jbc.271.30.18061; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Pahwa GS, 1996, J BIOL CHEM, V271, P26543, DOI 10.1074/jbc.271.43.26543; Panchal PC, 2003, CURR OPIN GASTROEN, V19, P4, DOI 10.1097/00001574-200301000-00002; Peleteiro B, 2007, WORLD J GASTROENTERO, V13, P1885, DOI 10.3748/wjg.v13.i12.1885; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; Radziejewska I, 2008, HEPATO-GASTROENTEROL, V55, P1887; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Schmitz JM, 2009, J HISTOCHEM CYTOCHEM, V57, P457, DOI 10.1369/jhc.2009.952473; SPICER AP, 1995, J BIOL CHEM, V270, P30093; Sujanuma M, 2008, INT J CANCER, V123, P117, DOI 10.1002/ijc.23484; Talarico S, 2009, J CLIN MICROBIOL, V47, P1680, DOI 10.1128/JCM.00273-09; Tsuji S, 2003, ALIMENT PHARM THER, V18, P82, DOI 10.1046/j.1365-2036.18.s1.22.x; Vinall LE, 2002, GASTROENTEROLOGY, V123, P41, DOI 10.1053/gast.2002.34157; Wang HH, 2004, BIOCHEM BIOPH RES CO, V321, P448, DOI 10.1016/j.bbrc.2004.06.167; Wang RQ, 2006, J GASTROEN HEPATOL, V21, P425, DOI 10.1111/j.1440-1746.2005.04006.x; Wilson KT, 2007, GASTROENTEROLOGY, V133, P288, DOI 10.1053/j.gastro.2007.05.008; ZRIHANLICHT S, 1995, INT J CANCER, V62, P245, DOI 10.1002/ijc.2910620303	54	66	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20547	20557		10.1074/jbc.M110.121319	http://dx.doi.org/10.1074/jbc.M110.121319			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430889	Green Published, hybrid			2022-12-25	WOS:000279228600017
J	Mollinedo, F; de la Iglesia-Vicente, J; Gajate, C; de Mendoza, AEH; Villa-Pulgarin, JA; Campanero, MA; Blanco-Prieto, MJ				Mollinedo, F.; de la Iglesia-Vicente, J.; Gajate, C.; Estella-Hermoso de Mendoza, A.; Villa-Pulgarin, J. A.; Campanero, M. A.; Blanco-Prieto, M. J.			Lipid raft-targeted therapy in multiple myeloma	ONCOGENE			English	Article						lipid raft; cholesterol; phospholipid ether; edelfosine; apoptosis; MM	ETHER PHOSPHOLIPID EDELFOSINE; ET-18-OCH3 EDELFOSINE; CANCER-CELLS; DEATH RECEPTOR; TUMOR-TISSUES; APOPTOSIS; CHOLESTEROL; FAS/CD95; FAS; INVOLVEMENT	Despite recent advances in treatment, multiple myeloma (MM) remains an incurable malignancy. By using in vitro, ex vivo and in vivo approaches, we have identified here that lipid rafts constitute a new target in MM. We have found that the phospholipid ether edelfosine targets and accumulates in MM cell membrane rafts, inducing apoptosis through co-clustering of rafts and death receptors. Raft disruption by cholesterol depletion inhibited drug uptake by tumor cells as well as cell killing. Cholesterol replenishment restored MM cell ability to take up edelfosine and to undergo drug-induced apoptosis. Ceramide addition displaced cholesterol from rafts, and inhibited edelfosine-induced apoptosis. In an MM animal model, edelfosine oral administration showed a potent in vivo antimyeloma activity, and the drug accumulated preferentially and dramatically in the tumor. A decrease in tumor cell cholesterol, a major raft component, inhibited the in vivo antimyeloma action of edelfosine and reduced drug uptake by the tumor. The results reported here provide the proof-of-principle and rationale for further clinical evaluation of edelfosine and for this raft-targeted therapy to improve patient outcome in MM. Our data reveal cholesterol-containing lipid rafts as a novel and efficient therapeutic target in MM, opening a new avenue in cancer treatment. Oncogene (2010) 29, 3748-3757; doi: 10.1038/onc.2010.131; published online 26 April 2010	[Mollinedo, F.; de la Iglesia-Vicente, J.; Gajate, C.; Villa-Pulgarin, J. A.] Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc, E-37007 Salamanca, Spain; [Gajate, C.] Hosp Univ Salamanca, Unidad Invest, E-37007 Salamanca, Spain; [Estella-Hermoso de Mendoza, A.; Blanco-Prieto, M. J.] Univ Navarra, Fac Farm, Dept Farm & Tecnol Farmaceut, E-31080 Pamplona, Spain; [Campanero, M. A.] Clin Univ, Serv Farmacol Clin, Pamplona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; University of Navarra; University of Navarra	Mollinedo, F (corresponding author), Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc, Campus Miguel Unamuno, E-37007 Salamanca, Spain.	fmollin@usal.es; cgajate@usal.es	IBSAL, Secretaría/H-3719-2011; Estella-Hermoso de Mendoza, Ander/E-9201-2011; Maria, Blanco-Prieto/E-6665-2017; Estella-Hermoso de Mendoza, Ander/M-7194-2016; Villa-Pulgarin, Janny A/AAW-4592-2020	Maria, Blanco-Prieto/0000-0003-0710-899X; Estella-Hermoso de Mendoza, Ander/0000-0001-9855-4527; Villa-Pulgarin, Janny A/0000-0002-9916-5977; Gajate, Consuelo/0000-0003-0604-6459	Ministerio de Ciencia e Innovacion [SAF2007-61261, SAF2008-02251, PCT-0901002007-27, RD06/0020/1037]; Fondo de Investigacion Sanitaria; European Commission [FIS-FEDER 06/0813, PS09/01915]; Junta de Castilla y Leon; Caja Navarra Foundation; Department of Health of the Navarra Government; Department of Education of the Basque Government [BF106.37]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); European Commission(European CommissionEuropean Commission Joint Research Centre); Junta de Castilla y Leon(Junta de Castilla y Leon); Caja Navarra Foundation; Department of Health of the Navarra Government; Department of Education of the Basque Government	This work was supported by grants from Ministerio de Ciencia e Innovacion (SAF2007-61261, SAF2008-02251, PCT-0901002007-27, RD06/0020/1037 from Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III), Fondo de Investigacion Sanitaria and European Commission (FIS-FEDER 06/0813, PS09/01915), Junta de Castilla y Leon (GR15-Experimental Therapeutics and Translational Oncology Program, and Biomedicine Project 2009) and Caja Navarra Foundation, Department of Health of the Navarra Government ('Ortiz de Landazuri, 2009' project). CG is supported by the Ramon y Cajal Program from the Ministerio de Ciencia e Innovacion of Spain. AEHdM is supported by a research grant (BF106.37) from the Department of Education of the Basque Government.	Auer J, 2002, CURR MED CHEM, V9, P1831, DOI 10.2174/0929867023369024; Ausili A, 2008, J PHYS CHEM B, V112, P11643, DOI 10.1021/jp802165n; Barnes K, 2004, BIOCHEM J, V378, P343, DOI 10.1042/BJ20031186; Blanco-Prieto MJ, 2004, J CHROMATOGR B, V810, P85, DOI 10.1016/j.jchromb.2004.07.013; Busto Jon V, 2008, J Chem Biol, V1, P89, DOI 10.1007/s12154-008-0009-z; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Christian AE, 1997, J LIPID RES, V38, P2264; DESSI S, 1994, CANCER, V73, P253, DOI 10.1002/1097-0142(19940115)73:2<253::AID-CNCR2820730204>3.0.CO;2-F; Dimberg LY, 2005, BLOOD, V106, P1346, DOI 10.1182/blood-2004-04-1322; Elahi MM, 2008, HYPERTENSION, V51, P939, DOI 10.1161/HYPERTENSIONAHA.107.100982; de Mendoza AEH, 2009, CLIN CANCER RES, V15, P858, DOI 10.1158/1078-0432.CCR-08-1654; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; Gajate C, 2000, INT J CANCER, V85, P674, DOI 10.1002/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z; Gajate C, 2005, J BIOL CHEM, V280, P11641, DOI 10.1074/jbc.M411781200; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; Gajate C, 2000, INT J CANCER, V86, P208, DOI 10.1002/(SICI)1097-0215(20000415)86:2<208::AID-IJC10>3.0.CO;2-E; Gajate C, 2002, CURR DRUG METAB, V3, P491, DOI 10.2174/1389200023337225; Gajate C, 2001, BLOOD, V98, P3860, DOI 10.1182/blood.V98.13.3860; Gajate C, 2007, BLOOD, V109, P711, DOI 10.1182/blood-2006-04-016824; Gajate C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005044; Gajate C, 2009, BIOCHEM BIOPH RES CO, V380, P780, DOI 10.1016/j.bbrc.2009.01.147; Grassme H, 2003, ONCOGENE, V22, P5457, DOI 10.1038/sj.onc.1206540; Hanson PK, 2003, J BIOL CHEM, V278, P36041, DOI 10.1074/jbc.M305263200; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hope HR, 1996, MOL BIOL CELL, V7, P843, DOI 10.1091/mbc.7.6.843; Hussein MA, 2002, CURR OPIN ONCOL, V14, P31, DOI 10.1097/00001622-200201000-00006; Jasinska M, 2007, PHARMACOL REP, V59, P483; Karasavvas N, 1996, EUR J BIOCHEM, V236, P729, DOI 10.1111/j.1432-1033.1996.00729.x; KOGA T, 1990, BIOCHIM BIOPHYS ACTA, V1045, P115, DOI 10.1016/0005-2760(90)90139-O; Kolanjiappan K, 2003, CLIN BIOCHEM, V36, P61, DOI 10.1016/S0009-9120(02)00421-6; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; MEGHA LE, 2004, J BIOL CHEM, V279, P9997; Mihelic R, 2007, LEUKEMIA, V21, P1150, DOI 10.1038/sj.leu.2404633; Mollinedo F, 1997, CANCER RES, V57, P1320; Mollinedo F, 2004, CURR MED CHEM, V11, P3163, DOI 10.2174/0929867043363703; Mollinedo F, 2007, EXPERT OPIN THER PAT, V17, P385, DOI 10.1517/13543776.17.4.385; Mollinedo F, 2006, DRUG RESIST UPDATE, V9, P51, DOI 10.1016/j.drup.2006.04.002; Mollinedo F, 2008, CONTEMP HEMATOL, P393; Mollinedo F, 2009, J PHARMACOL EXP THER, V329, P439, DOI 10.1124/jpet.108.148254; Mollinedo Faustino, 2006, P13; Nieto-Miguel T, 2006, J BIOL CHEM, V281, P14833, DOI 10.1074/jbc.M511251200; Nybond S, 2005, BBA-BIOMEMBRANES, V1718, P61, DOI 10.1016/j.bbamem.2005.10.009; PEREZSALA D, 1994, BIOCHEM BIOPH RES CO, V199, P1209, DOI 10.1006/bbrc.1994.1359; PEREZSALA D, 1995, J BIOL CHEM, V270, P6235, DOI 10.1074/jbc.270.11.6235; Quesada E, 2004, J MED CHEM, V47, P5333, DOI 10.1021/jm049808a; Rouquette-Jazdanian AK, 2007, CELL SIGNAL, V19, P1404, DOI 10.1016/j.cellsig.2007.01.015; SCHON A, 1989, BIOCHEMISTRY-US, V28, P5019, DOI 10.1021/bi00438a017; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Tosi MR, 2005, CLIN CHIM ACTA, V359, P27, DOI 10.1016/j.cccn.2005.04.003; Zerp SF, 2008, ANTI-CANCER DRUG, V19, P65, DOI 10.1097/CAD.0b013e3282f16d36; Zhuang LY, 2005, J CLIN INVEST, V115, P959	51	95	97	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 1	2010	29	26					3748	3757		10.1038/onc.2010.131	http://dx.doi.org/10.1038/onc.2010.131			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	618VW	20418917				2022-12-25	WOS:000279385200003
J	Zuntini, M; Pedrini, E; Parra, A; Sgariglia, F; Gentile, FV; Pandolfi, M; Alberghini, M; Sangiorgi, L				Zuntini, M.; Pedrini, E.; Parra, A.; Sgariglia, F.; Gentile, F. V.; Pandolfi, M.; Alberghini, M.; Sangiorgi, L.			Genetic models of osteochondroma onset and neoplastic progression: evidence for mechanisms alternative to EXT genes inactivation	ONCOGENE			English	Article						solitary osteochondroma; multiple osteochondroma; chondrosarcoma; EXT genes; tumor suppressor; mutation screening	MULTIPLE EXOSTOSES; NATURAL-HISTORY; MUTATIONS; HETEROZYGOSITY; POINT; LOCI	Osteochondroma, the most common benign bone tumor, may occur as a sporadic lesion or as multiple neoplasms in the context of multiple osteochondromas syndrome. The most severe complication is malignant transformation into peripheral secondary chondrosarcoma. Although both benign conditions have been linked to defects in EXT1 or EXT2 genes, contradictory reports are present in the literature regarding the requirement of their biallelic inactivation for osteochondroma development. A major limitation of these studies is represented by the small number of samples available for the screening. Taking advantage of a large series of tissues, our aim was to contribute to the definition of a genetic model for osteochondromas onset and transformation. EXT genes point mutations and big deletions were analyzed in 64 tissue samples. A double hit was found in 5 out of 35 hereditary cases, 6 out of 16 chondrosarcomas and 2 recurrences; none of the 11 sporadic osteochondromas showed two somatic mutations. Our results clearly indicate that, in most cases, biallelic inactivation of EXT genes does not account for osteochondromas formation; this mechanism should be regarded as a common feature for hereditary osteochondromas transformation and as an event that occurs later in tumor progression of solitary cases. These findings suggest that mechanisms alternative to EXT genetic alteration likely have a role in osteochondromas pathogenesis. Oncogene (2010) 29, 3827-3834; doi: 10.1038/onc.2010.135; published online 26 April 2010	[Zuntini, M.; Pedrini, E.; Parra, A.; Sgariglia, F.; Gentile, F. V.; Pandolfi, M.; Sangiorgi, L.] Ist Ortoped Rizzoli, Dept Med Genet & Skeletal Rare Dis, I-40136 Bologna, Italy; [Alberghini, M.] Ist Ortoped Rizzoli, Dept Anat Pathol & Histol, I-40136 Bologna, Italy	IRCCS Istituto Ortopedico Rizzoli; IRCCS Istituto Ortopedico Rizzoli	Sangiorgi, L (corresponding author), Ist Ortoped Rizzoli, Dept Med Genet & Skeletal Rare Dis, Via Barbiano 1-10, I-40136 Bologna, Italy.	luca.sangiorgi@ior.it	Sangiorgi, Luca/AHI-1694-2022; Parra, Alessandro/C-7967-2019; Pandolfi, Margareth/H-7616-2016; PEDRINI, ELENA/E-6340-2019	Parra, Alessandro/0000-0002-4482-0612; PEDRINI, ELENA/0000-0001-9980-7741; Sangiorgi, Luca/0000-0003-3658-1209	European Project EuroBoNeT	European Project EuroBoNeT	This research was supported by the European Project EuroBoNeT.	Bernard MA, 2001, CELL MOTIL CYTOSKEL, V48, P149, DOI 10.1002/1097-0169(200102)48:2<149::AID-CM1005>3.0.CO;2-3; Bovee JVMG, 1999, GENE CHROMOSOME CANC, V26, P237; Bovee JVMG, 1999, AM J HUM GENET, V65, P689, DOI 10.1086/302532; Bridge JA, 1998, CANCER-AM CANCER SOC, V82, P1657, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1657::AID-CNCR10>3.0.CO;2-3; Cheung PK, 2001, AM J HUM GENET, V69, P55, DOI 10.1086/321278; Essadki B, 2000, Acta Orthop Belg, V66, P146; Farach-Carson MC, 2005, CRIT REV EUKAR GENE, V15, P29, DOI 10.1615/CritRevEukaryotGeneExpr.v15.i1.30; Hall CR, 2002, AM J MED GENET, V112, P1, DOI 10.1002/ajmg.10635; Hameetman L, 2007, JNCI-J NATL CANCER I, V99, P396, DOI 10.1093/jnci/djk067; HECHT JT, 1995, AM J HUM GENET, V56, P1125; HENNEKAM RCM, 1991, J MED GENET, V28, P262, DOI 10.1136/jmg.28.4.262; Huvos A, 1991, BONE TUMORS DIAGNOSI; Jennes I, 2009, HUM MUTAT, V30, P1620, DOI 10.1002/humu.21123; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lonie Lorne, 2006, Hum Mutat, V27, P1160, DOI 10.1002/humu.9467; Ludecke HJ, 1997, GENOMICS, V40, P351, DOI 10.1006/geno.1996.4577; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; MERTENS F, 1994, GENE CHROMOSOME CANC, V9, P8, DOI 10.1002/gcc.2870090103; Pedrini E, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9359; Porter DE, 1999, J PATHOL, V188, P119; RASKIND WH, 1995, AM J HUM GENET, V56, P1132; Rohlin A, 2009, HUM MUTAT, V30, P1012, DOI 10.1002/humu.20980; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; SOLOMON L, 1964, AM J HUM GENET, V16, P351; Springfield DS, 1996, AAOS INSTR COURS LEC, V45, P417; Traeger-Synodinos Joanne, 2006, Molecular Aspects of Medicine, V27, P176, DOI 10.1016/j.mam.2005.12.004; Trebicz-Geffen M, 2008, INT J EXP PATHOL, V89, P321, DOI 10.1111/j.1365-2613.2008.00589.x; WICKLUND CL, 1995, AM J MED GENET, V55, P43, DOI 10.1002/ajmg.1320550113; WU YQ, 1994, HUM MOL GENET, V3, P167, DOI 10.1093/hmg/3.1.167; Wuyts W, 2000, HUM MUTAT, V15, P220, DOI 10.1002/(SICI)1098-1004(200003)15:3<220::AID-HUMU2>3.0.CO;2-K; Wuyts W, 1998, AM J HUM GENET, V62, P346, DOI 10.1086/301726; WUYTS W, 1995, AM J HUM GENET, V57, P382	33	32	32	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 1	2010	29	26					3827	3834		10.1038/onc.2010.135	http://dx.doi.org/10.1038/onc.2010.135			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	618VW	20418910				2022-12-25	WOS:000279385200010
J	Silkstone, G; Kapetanaki, SM; Husu, I; Vos, MH; Wilson, MT				Silkstone, Gary; Kapetanaki, Sofia M.; Husu, Ivan; Vos, Marten H.; Wilson, Michael T.			Nitric Oxide Binds to the Proximal Heme Coordination Site of the Ferrocytochrome c/Cardiolipin Complex FORMATION MECHANISM AND DYNAMICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE GUANYLATE-CYCLASE; XYLOSOXIDANS CYTOCHROME C'; CARBON-MONOXIDE; CARDIOLIPIN COMPLEX; PEROXIDASE-ACTIVITY; MOLECULAR-BASIS; APOPTOSIS; PROTEIN; NO; MITOCHONDRIA	Mammalian mitochondrial cytochrome c interacts with cardiolipin to form a complex (cyt. c/CL) important in apoptosis. Here we show that this interaction leads to structural changes in ferrocytochrome c that leads to an open coordinate site on the central iron, resulting from the dissociation of the intrinsic methionine residue, where NO can rapidly bind (k = 1.2 x 10(7) M-1 s(-1)). Accompanying NO binding, the proximal histidine dissociates leaving the heme pentacoordinate, in contrast to the hexacoordinate nitrosyl adducts of native ferrocytochrome c or of the protein in which the coordinating methionine is removed by chemical modification or mutation. We present the results of stopped-flow and photolysis experiments that show that following initial NO binding to the heme, there ensues an unusually complex set of kinetic steps. The spectral changes associated with these kinetic transitions, together with their dependence on NO concentration, have been determined and lead us to conclude that NO binding to cyt. c/CL takes place via an overall scheme comparable to that described for cytochrome c' and guanylate cyclase, the final product being one in which NO resides on the proximal side of the heme. In addition, novel features not observed before in other heme proteins forming pentacoordinate nitrosyl species, include a high yield of NO escape after dissociation, rapid (< 1 ms) dissociation of proximal histidine upon NO binding and its very fast binding (60 ps) after NO dissociation, and the formation of a hexacoordinate intermediate. These features all point at a remarkable mobility of the proximal heme environment induced by cardiolipin.	[Silkstone, Gary; Husu, Ivan; Wilson, Michael T.] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England; [Kapetanaki, Sofia M.; Vos, Marten H.] Ecole Polytech, CNRS, Lab Opt Biosci, F-91128 Palaiseau, France; [Kapetanaki, Sofia M.; Vos, Marten H.] INSERM, U696, F-91128 Palaiseau, France	University of Essex; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Wilson, MT (corresponding author), Univ Essex, Dept Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	wilsmt@essex.ac.uk	Kapetanaki, Sofia Maria/W-5156-2019	Kapetanaki, Sofia Maria/0000-0003-1286-9929; Vos, Marten/0000-0003-0493-4831	Region Ile-de-France; Italian Government; BBSRC, UK	Region Ile-de-France(Region Ile-de-France); Italian Government; BBSRC, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants from the Region Ile-de-France (to S. M. K.), from the Italian Government (to I. H.), and from BBSRC, UK (to M. T. W. and G. S.).	Andrew CR, 2003, J AM CHEM SOC, V125, P9548, DOI 10.1021/ja035105r; Andrew CR, 2002, BIOCHEMISTRY-US, V41, P2353, DOI 10.1021/bi011419k; Andrew CR, 2001, BIOCHEMISTRY-US, V40, P4115, DOI 10.1021/bi0023652; ANTONINI E, 1978, FEBS LETT, V86, P209, DOI 10.1016/0014-5793(78)80564-X; Basova LV, 2007, BIOCHEMISTRY-US, V46, P3423, DOI 10.1021/bi061854k; Choi BM, 2002, J BIOCHEM MOL BIOL, V35, P116; Chung HT, 2001, BIOCHEM BIOPH RES CO, V282, P1075, DOI 10.1006/bbrc.2001.4670; COLETTA M, 1988, FEBS LETT, V236, P127, DOI 10.1016/0014-5793(88)80299-0; Franzen S, 2001, BIOPHYS J, V80, P2372, DOI 10.1016/S0006-3495(01)76207-8; Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005; Giuffre A, 2005, FEBS LETT, V579, P2528, DOI 10.1016/j.febslet.2005.03.067; Godoy LC, 2009, P NATL ACAD SCI USA, V106, P2653, DOI 10.1073/pnas.0809279106; Haynes V, 2004, J BIOENERG BIOMEMBR, V36, P341, DOI 10.1023/B:JOBB.0000041765.27145.08; IGNARRO LJ, 1990, PHARMACOL TOXICOL, V67, P1, DOI 10.1111/j.1600-0773.1990.tb00772.x; Iverson SL, 2004, ARCH BIOCHEM BIOPHYS, V423, P37, DOI 10.1016/j.abb.2003.12.002; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kalanxhi E, 2007, BIOCHEM J, V407, P179, DOI 10.1042/BJ20070459; Kapetanaki SM, 2009, BIOCHEMISTRY-US, V48, P1613, DOI 10.1021/bi801817v; Kruglik SG, 2007, J BIOL CHEM, V282, P5053, DOI 10.1074/jbc.M604327200; Lawson DM, 2000, EMBO J, V19, P5661, DOI 10.1093/emboj/19.21.5661; Mannick JB, 2004, FREE RADICAL RES, V38, P1, DOI 10.1080/10715760310001629065; Negrerie M, 2006, J BIOL CHEM, V281, P10389, DOI 10.1074/jbc.M513375200; Negrerie M, 2001, J BIOL CHEM, V276, P46815, DOI 10.1074/jbc.M102224200; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; PERUTZ MF, 1976, BIOCHEMISTRY-US, V15, P378, DOI 10.1021/bi00647a022; PETRICH JW, 1988, BIOCHEMISTRY-US, V27, P4049, DOI 10.1021/bi00411a022; Pixton DA, 2009, J AM CHEM SOC, V131, P4846, DOI 10.1021/ja809587q; Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Schonhoff CM, 2003, J BIOL CHEM, V278, P18265, DOI 10.1074/jbc.M212459200; Silkstone G, 2005, DALTON T, P3489, DOI 10.1039/b508183c; Silkstone G, 2007, J BIOL CHEM, V282, P1638, DOI 10.1074/jbc.M605760200; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Vlasova II, 2006, J BIOL CHEM, V281, P14554, DOI 10.1074/jbc.M509507200; Vos MH, 2008, BBA-BIOENERGETICS, V1777, P15, DOI 10.1016/j.bbabio.2007.10.004; Ye X, 2002, J AM CHEM SOC, V124, P5914, DOI 10.1021/ja017359n; YOO BK, 2010, ULTRAFAST PHENOMENA, V16; YOSHIMURA T, 1986, BIOCHEMISTRY-US, V25, P2436, DOI 10.1021/bi00357a021; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753	39	35	36	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19785	19792		10.1074/jbc.M109.067736	http://dx.doi.org/10.1074/jbc.M109.067736			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20395293	Green Published, hybrid			2022-12-25	WOS:000279012000011
J	Ventrella-Lucente, LF; Unnikrishnan, A; Pilling, AB; Patel, HV; Kushwaha, D; Dombkowski, AA; Schmelz, EM; Cabelof, DC; Heydari, AR				Ventrella-Lucente, Lisa F.; Unnikrishnan, Archana; Pilling, Amanda B.; Patel, Hiral V.; Kushwaha, Deepa; Dombkowski, Alan A.; Schmelz, Eva M.; Cabelof, Diane C.; Heydari, Ahmad R.			Folate Deficiency Provides Protection against Colon Carcinogenesis in DNA Polymerase beta Haploinsufficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; HAMSTER OVARY CELLS; ABERRANT CRYPT FOCI; FOLIC-ACID DEFICIENCY; URACIL MISINCORPORATION; IN-VITRO; DIETARY-FOLATE; STRAND BREAKS; ALKYLATING-AGENTS; OXIDATIVE STRESS	Aging and DNA polymerase beta deficiency (beta-pol(+/)-) interact to accelerate the development of malignant lymphomas and adenocarcinoma and increase tumor bearing load in mice. Folate deficiency (FD) has been shown to induce DNA damage repaired via the base excision repair (BER) pathway. We anticipated that FD and BER deficiency would interact to accelerate aberrant crypt foci (ACF) formation and tumor development in beta-pol haploinsufficient animals. FD resulted in a significant increase in ACF formation in wild type (WT) animals exposed to 1,2-dimethylhydrazine, a known colon and liver carcinogen; however, FD reduced development of ACF in beta-pol haploinsufficient mice. Prolonged feeding of the FD diet resulted in advanced ACF formation and liver tumors in wild type mice. However, FD attenuated onset and progression of ACF and prevented liver tumorigenesis in beta-pol haploinsufficient mice, i.e. FD provided protection against tumorigenesis in a BER-deficient environment in all tissues where 1,2-dimethylhydrazine exerts its damage. Here we show a distinct down-regulation in DNA repair pathways, e.g. BER, nucleotide excision repair, and mismatch repair, and decline in cell proliferation, as well as an up-regulation in poly(ADP-ribose) polymerase, proapoptotic genes, and apoptosis in colons of FD beta-pol haploinsufficient mice.	[Heydari, Ahmad R.] Wayne State Univ, Dept Nutr & Food Sci, Sch Med, Barbara Ann Karmanos Canc Inst, Detroit, MI 48202 USA; [Cabelof, Diane C.; Heydari, Ahmad R.] Wayne State Univ, Dept Nutr & Food, Sch Med, Sci Coll Liberal Arts & Sci, Detroit, MI 48202 USA; [Dombkowski, Alan A.] Wayne State Univ, Sch Med, Inst Environm Hlth Sci, Detroit, MI 48202 USA; [Schmelz, Eva M.] Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; Virginia Polytechnic Institute & State University	Heydari, AR (corresponding author), Wayne State Univ, Dept Nutr & Food Sci, Sch Med, Barbara Ann Karmanos Canc Inst, 3009 Sci Hall, Detroit, MI 48202 USA.	ahmad.heydari@wayne.edu	Schmelz, Eva M/E-6579-2012	Dombkowski, Alan/0000-0002-0312-8750	National Institutes of Health [R01 CA121298]; American Institute for Cancer Research [03A061]; NATIONAL CANCER INSTITUTE [R01CA121298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA121298 (to A.R.H.).This work was also supported by American Institute for Cancer Research Grant 03A061 (to A.R.H.).	BIRD RP, 1995, CANCER LETT, V93, P55, DOI 10.1016/0304-3835(95)03788-X; Branda RF, 1999, MUTAT RES-FUND MOL M, V427, P79, DOI 10.1016/S0027-5107(99)00095-0; Branda RF, 1998, ENVIRON MOL MUTAGEN, V32, P33, DOI 10.1002/(SICI)1098-2280(1998)32:1&lt;33::AID-EM4&gt;3.0.CO;2-C; Branda RF, 2007, MUTAT RES-FUND MOL M, V615, P12, DOI 10.1016/j.mrfmmm.2006.09.007; Cabelof DC, 2004, J BIOL CHEM, V279, P36504, DOI 10.1074/jbc.M405185200; Cabelof DC, 2003, CANCER RES, V63, P5799; Cabelof DC, 2006, CANCER RES, V66, P7460, DOI 10.1158/0008-5472.CAN-06-1177; Chapkin RS, 2009, J NUTR BIOCHEM, V20, P649, DOI 10.1016/j.jnutbio.2008.07.001; Choi SW, 1998, GUT, V43, P93, DOI 10.1136/gut.43.1.93; CRAVO ML, 1992, CANCER RES, V52, P5002; Crott JW, 2008, J NUTR BIOCHEM, V19, P328, DOI 10.1016/j.jnutbio.2007.05.003; Duthie SJ, 2000, BRIT J CANCER, V83, P1532, DOI 10.1054/bjoc.2000.1481; Duthie SJ, 2002, J NUTR, V132, p2444S, DOI 10.1093/jn/132.8.2444S; Duthie SJ, 2000, NUTR CANCER, V37, P245, DOI 10.1207/S15327914NC372_18; Duthie SJ, 1998, FASEB J, V12, P1491, DOI 10.1096/fasebj.12.14.1491; Duthie SJ, 2008, J PROTEOME RES, V7, P3254, DOI 10.1021/pr700751y; EVERSON RB, 1988, JNCI-J NATL CANCER I, V80, P525, DOI 10.1093/jnci/80.7.525; Fenoglio-Preiser CM, 1999, TOXICOL PATHOL, V27, P632, DOI 10.1177/019262339902700604; Fishel ML, 2007, CLIN CANCER RES, V13, P260, DOI 10.1158/1078-0432.CCR-06-1920; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Holmquist GP, 1998, MUTAT RES-FUND MOL M, V400, P59, DOI 10.1016/S0027-5107(98)00051-7; Huang Q, 2009, CELL DEATH DIFFER, V16, P264, DOI 10.1038/cdd.2008.151; Jaiswal AS, 2008, CANCER LETT, V271, P272, DOI 10.1016/j.canlet.2008.06.024; KIM YI, 1995, AM J CLIN NUTR, V61, P1083, DOI 10.1093/ajcn/61.5.1083; Kim YI, 1996, GUT, V39, P732, DOI 10.1136/gut.39.5.732; Kim YI, 2000, GASTROENTEROLOGY, V119, P151, DOI 10.1053/gast.2000.8518; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; Lawrance AK, 2009, GUT, V58, P805, DOI 10.1136/gut.2007.143107; LIBBUS BL, 1990, CANCER GENET CYTOGEN, V46, P231, DOI 10.1016/0165-4608(90)90108-M; Lindahl T, 2000, MUTAT RES-REV MUTAT, V462, P129, DOI 10.1016/S1383-5742(00)00024-7; MacGregor JT, 1997, MUTAT RES-FUND MOL M, V377, P125, DOI 10.1016/S0027-5107(97)00070-5; MCLELLAN EA, 1991, CANCER RES, V51, P5270; Melnyk S, 1999, CANCER LETT, V146, P35, DOI 10.1016/S0304-3835(99)00213-X; Miknyoczki S, 2007, MOL CANCER THER, V6, P2290, DOI 10.1158/1535-7163.MCT-07-0062; No HN, 2007, NUTR RES, V27, P659, DOI 10.1016/j.nutres.2007.08.001; Ochs K, 2002, CANCER RES, V62, P1524; Peralta-Leal A, 2009, FREE RADICAL BIO MED, V47, P13, DOI 10.1016/j.freeradbiomed.2009.04.008; Peterson QP, 2009, J MOL BIOL, V388, P144, DOI 10.1016/j.jmb.2009.03.003; Rime M, 2004, MOL CANCER THER, V3, P955; SOKAL RR, 1981, BIOMETRY, P169; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Taverna P, 2001, MUTAT RES-DNA REPAIR, V485, P269, DOI 10.1016/S0921-8777(01)00076-3; Trivedi RN, 2008, MOL PHARMACOL, V74, P505, DOI 10.1124/mol.108.045112; Unnikrishnan A, 2009, FREE RADICAL BIO MED, V46, P1488, DOI 10.1016/j.freeradbiomed.2009.02.021; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zhu HP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-128	46	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19246	19258		10.1074/jbc.M109.069807	http://dx.doi.org/10.1074/jbc.M109.069807			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404327	Green Published, hybrid			2022-12-25	WOS:000278727800034
J	Wang, GX; Gao, XA; Huang, Y; Yao, Z; Shi, QH; Wu, MA				Wang, Guoxing; Gao, Xiang; Huang, Yun; Yao, Zhan; Shi, Qinghua; Wu, Mian			Nucleophosmin/B23 Inhibits Eg5-mediated Microtubule Depolymerization by Inactivating Its ATPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; CENTROSOME DUPLICATION; DOWN-REGULATION; CELLS; EXPRESSION; PROTEINS; NUCLEUS; SHUTTLE; TUBULIN; BINDING	Nucleophosmin/B23, an abundant nucleolar protein, plays multiple roles in cell growth and proliferation, and yet, little has been studied about its function in regulating dynamics of microtubules. Here, we report that B23 directly interacts with Eg5, a member of the kinesin family, in the cytosol. The DNA/RNA binding domain of B23 and the motor domain of Eg5 were found to be involved in their interaction. Both in vivo and in vitro evidences showed that B23 acts as an upstream regulator of Eg5 in promoting microtubule polymerization. Moreover, we further demonstrated that B23 regulates microtubule dynamics by directly inhibiting Eg5 ATPase activity.	[Wu, Mian] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, MA (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China.	wumian@ustc.edu.cn	Yao, Zhan/K-1839-2013; Wu, Mian/H-2494-2018; XIANG, GAO/ABH-4277-2020; Yao, Zhan/AAK-6756-2020; Huang, Yun/AGX-8953-2022	Huang, Yun/0000-0001-5987-1319; YAO, ZHAN/0000-0001-5391-5691; Wu, Mian/0000-0002-2714-0500	National Natural Science Foundation of China [30530200, 30871290, 30728003]; Ministry of Science and Technology of China [2006CB910300, 2010CB912804]; Chinese Academy of Sciences [KSCX1-YW-R-57]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Natural Science Foundation of China (30530200, 30871290, and 30728003), the Ministry of Science and Technology of China (2006CB910300 and 2010CB912804), and the Chinese Academy of Sciences (KSCX1-YW-R-57).	Alcalay M, 2005, BLOOD, V106, P899, DOI 10.1182/blood-2005-02-0560; Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; ANDERSON DF, 2002, INT J COMMUTATIVE RI, V1, P11; Belmont L, 1996, TRENDS BIOCHEM SCI, V21, P197, DOI 10.1016/S0968-0004(96)80013-2; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Cochran JC, 2009, CELL, V136, P110, DOI 10.1016/j.cell.2008.11.048; Daire V, 2009, J BIOL CHEM, V284, P31992, DOI 10.1074/jbc.M109.007906; den Besten W, 2005, CELL CYCLE, V4, P1593; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Inder KL, 2009, J BIOL CHEM, V284, P28410, DOI 10.1074/jbc.M109.001537; Jiang PS, 1999, BIOCHEM BIOPH RES CO, V257, P865, DOI 10.1006/bbrc.1999.0551; Koller E, 2006, CANCER RES, V66, P2059, DOI 10.1158/0008-5472.CAN-05-1531; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; Myers KA, 2007, J CELL BIOL, V178, P1081, DOI 10.1083/jcb.200702074; Neben K, 2003, BLOOD, V101, P289, DOI 10.1182/blood-2002-04-1188; Nishimura Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2239, DOI 10.1271/bbb.66.2239; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuda M, 2002, ONCOGENE, V21, P6170, DOI 10.1038/sj.onc.1205708; Runge M S, 1982, Cold Spring Harb Symp Quant Biol, V46 Pt 1, P483; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Vulevic B, 1997, BIOPHYS J, V72, P1357, DOI 10.1016/S0006-3495(97)78782-4; Walczak CE, 1996, CELL, V85, P943, DOI 10.1016/S0092-8674(00)81295-7; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Wordeman L, 2009, DEV CELL, V17, P437, DOI 10.1016/j.devcel.2009.10.002; Wu HL, 1999, INT J CANCER, V81, P923, DOI 10.1002/(SICI)1097-0215(19990611)81:6<923::AID-IJC14>3.0.CO;2-D; Yao Z, 2007, EMBO J, V26, P1068, DOI 10.1038/sj.emboj.7601571; Yun JP, 2003, J CELL BIOCHEM, V90, P1140, DOI 10.1002/jcb.10706	33	14	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19060	19067		10.1074/jbc.M110.100396	http://dx.doi.org/10.1074/jbc.M110.100396			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404347	Green Published, hybrid			2022-12-25	WOS:000278727800015
J	Fletcher, TC; DiGiandomenico, A; Hawiger, J				Fletcher, Tynetta C.; DiGiandomenico, Antonio; Hawiger, Jacek			Extended Anti-inflammatory Action of a Degradation-resistant Mutant of Cell-penetrating Suppressor of Cytokine Signaling 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR DELIVERY; FUNCTIONAL PEPTIDES; UBIQUITIN LIGASE; PEST SEQUENCES; SOCS PROTEINS; SH2 DOMAIN; RECEPTOR; INFLAMMATION; IMMUNITY; BINDING	Suppressor of cytokine signaling 3 (SOCS3) regulates the proinflammatory cytokine signaling mediated by the JAK/STAT signaling pathway. SOCS3 is rapidly induced and then targeted to the ubiquitin-proteasome pathway via a mechanism that requires the C-terminal SOCS box. Due to its rapid turnover, the intracellular stores of SOCS3 seem insufficient to control acute or protracted inflammatory diseases. Previously, we developed an intracellular protein therapy that uses a recombinant cell-penetrating form of SOCS3 (CP-SOCS3) to inhibit the JAK/STAT pathway and prevent cytokine-mediated lethal inflammation and apoptosis of the liver (Jo, D., Liu, D., Yao, S., Collins, R. D., and Hawiger, J. (2005) Nat. Med. 11, 892-898). The potent anti-inflammatory and cytoprotective activity of CP-SOCS3 prompted us to analyze its intracellular turnover, as compared with that of endogenous SOCS3 protein induced in macrophages by the proinflammatory agonists, interferon-gamma and lipopolysaccharide. We found that the half-life (t(1/2)) of endogenous SOCS3 is 0.7 h in activated macrophages, compared with a t(1/2) of 6.2 h for recombinant CP-SOCS3. Deletion of the SOCS box in CP-SOCS3 renders it more resistant to proteasomal degradation, extending its t(1/2) to 29 h. Consequently, this SOCS box-deleted form of CP-SOCS3 displays persistent inhibitory activity for 24 h toward interferon-gamma-and lipopolysaccharide-induced cytokine and chemokine production. Compared with the wild-type suppressor, this gain-of-function CP-SOCS3 mutant provides a longer acting inhibitor of cytokine signaling, a feature that offers a clear advantage for the intracellular delivery of proteins to treat acute or protracted inflammatory diseases.	[DiGiandomenico, Antonio; Hawiger, Jacek] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Fletcher, Tynetta C.] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA	Vanderbilt University; Meharry Medical College	Hawiger, J (corresponding author), Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, A-5321 MCN,1161 21st Ave S, Nashville, TN 37232 USA.	jacek.hawiger@vanderbilt.edu		DiGiandomenico, Antonio/0000-0003-1745-647X	National Institutes of Health, United States Public Health Service [HL069452, AA015752, T32 AI007281, T32 HL069765]; Kirschstein National Research Service Award Individual Fellowship [F31-GM077030]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069452, T32HL069765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, U24DK059637, P30DK020593, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM077030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015752] Funding Source: NIH RePORTER	National Institutes of Health, United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Kirschstein National Research Service Award Individual Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL069452 and AA015752 from the United States Public Health Service, and Training Grants T32 AI007281 and T32 HL069765.; Supported by Ruth L. Kirschstein National Research Service Award Individual Fellowship F31-GM077030. Submitted as partial fulfillment of the requirements for the degree of Doctor of Philosophy, Meharry Medical College.	Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Babon JJ, 2008, J MOL BIOL, V381, P928, DOI 10.1016/j.jmb.2008.06.038; Babon JJ, 2009, J MOL BIOL, V387, P162, DOI 10.1016/j.jmb.2009.01.024; Babon JJ, 2006, MOL CELL, V22, P205, DOI 10.1016/j.molcel.2006.03.024; Badi I, 2009, FEBS LETT, V583, P2486, DOI 10.1016/j.febslet.2009.07.001; BARNES JA, 1995, MOL CELL BIOCHEM, V149, P17, DOI 10.1007/BF01076559; Chen BB, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706472200; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; DiGiandomenico A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.1162191; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dunn SL, 2005, MOL ENDOCRINOL, V19, P925, DOI 10.1210/me.2004-0353; Hawiger J, 1999, CURR OPIN CHEM BIOL, V3, P89, DOI 10.1016/S1367-5931(99)80016-7; Hawiger J, 2001, IMMUNOL RES, V23, P99, DOI 10.1385/IR:23:2-3:099; Hortner M, 2002, J IMMUNOL, V169, P1219, DOI 10.4049/jimmunol.169.3.1219; Hortner M, 2002, EUR J BIOCHEM, V269, P2516, DOI 10.1046/j.1432-1033.2002.02916.x; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kiu H, 2009, GROWTH FACTORS, V27, P384, DOI 10.3109/08977190903210954; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; MOLINARI M, 1995, J BIOL CHEM, V270, P2032, DOI 10.1074/jbc.270.5.2032; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Rakesh K, 2005, BIOCHEM PHARMACOL, V70, P649, DOI 10.1016/j.bcp.2005.04.042; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Sasaki A, 2003, J BIOL CHEM, V278, P2432, DOI 10.1074/jbc.C200608200; Siewert E, 1999, EUR J BIOCHEM, V265, P251, DOI 10.1046/j.1432-1327.1999.00719.x; Veach RA, 2004, J BIOL CHEM, V279, P11425, DOI 10.1074/jbc.M311089200	33	19	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18727	18736		10.1074/jbc.M109.095216	http://dx.doi.org/10.1074/jbc.M109.095216			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400504	Green Published, hybrid			2022-12-25	WOS:000278453900064
J	Green, SM; Coyne, HJ; McIntosh, LP; Graves, BJ				Green, Sean M.; Coyne, H. Jerome, III; McIntosh, Lawrence P.; Graves, Barbara J.			DNA Binding by the ETS Protein TEL (ETV6) Is Regulated by Autoinhibition and Self-association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE TUMOR-SUPPRESSOR; TRANSCRIPTION FACTOR; COMPLEX-FORMATION; MULTIPLE DOMAINS; AUTO-INHIBITION; NUCLEAR EXPORT; FAMILY; GENE; YAN; ACTIVATION	The ETS protein TEL, a transcriptional repressor, contains a PNT domain that, as an isolated fragment in vitro, self-associates to form a head-to-tail polymer. How such polymerization might affect the DNA-binding properties of full-length TEL is unclear. Here we report that monomeric TEL binds to a consensus ETS site with unusually low affinity (K-d = 2.8 x 10(-8) M). A deletion analysis demonstrated that the low affinity was caused by a C-terminal inhibitory domain (CID) that attenuates DNA binding by similar to 10-fold. An NMR spectroscopically derived structure of a TEL fragment, deposited in the Protein Data Bank, revealed that the CID consists of two alpha-helices, one of which appears to block the DNA binding surface of the TEL ETS domain. Based on this structure, we substituted two conserved glutamic acids (Glu-431 and Glu-434) with alanines and found that this activated DNA binding and enhanced trypsin sensitivity in the CID. We propose that TEL displays a conformational equilibrium between inhibited and activated states and that electrostatic interactions involving these negatively charged residues play a role in stabilizing the inhibited conformation. Using a TEL dimer as a model polymer, we show that self-association facilitates cooperative binding to DNA. Cooperativity was observed on DNA duplexes containing tandem consensus ETS sites at variable spacing and orientations, suggesting flexibility in the region of TEL linking its self-associating PNT domain and DNA-binding ETS domain. We speculate that TEL compensates for the low affinity, which is caused by autoinhibition, by binding to DNA as a cooperative polymer.	[Green, Sean M.; Graves, Barbara J.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Sch Med, Salt Lake City, UT 84112 USA; [Coyne, H. Jerome, III; McIntosh, Lawrence P.] Univ British Columbia, Dept Biochem & Mol Biol, Dept Chem, Vancouver, BC V6T 1Z3, Canada; [Coyne, H. Jerome, III; McIntosh, Lawrence P.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z3, Canada	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of British Columbia; University of British Columbia	Graves, BJ (corresponding author), Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Sch Med, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	barbara.graves@hci.utah.edu			National Institutes of Health [R01GM38663, P50CA42014]; Canadian Cancer Society Research Institute; Canadian Institutes for Health Research; Canadian Foundation for Innovation; British Columbia Knowledge Development Fund; UBC Blusson Fund; Michael Smith Foundation for Health Research; Huntsman Cancer Institute/Huntsman Cancer Foundation; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; UBC Blusson Fund; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Huntsman Cancer Institute/Huntsman Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM38663 (to B. J. G.) and P50CA42014 (to the Huntsman Cancer Institute for support of shared resources). This work was also supported by funds from the Canadian Cancer Society Research Institute (to L. P. M.). Received instrument support from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, the British Columbia Knowledge Development Fund, the UBC Blusson Fund, and the Michael Smith Foundation for Health Research. Supported by the Huntsman Cancer Institute/Huntsman Cancer Foundation. To whom correspondence should be addressed: Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112-5550. Tel.: 801-581-7308; Fax: 801-585-6410; E-mail: barbara. graves@hci.utah.edu.	Agarkar VB, 2010, J MOL BIOL, V397, P278, DOI 10.1016/j.jmb.2010.01.017; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Bojovic BB, 2001, J BIOL CHEM, V276, P4509, DOI 10.1074/jbc.M005509200; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Chakrabarti SR, 1999, BIOCHEM BIOPH RES CO, V264, P871, DOI 10.1006/bbrc.1999.1605; Fenrick R, 2000, MOL CELL BIOL, V20, P5828, DOI 10.1128/MCB.20.16.5828-5839.2000; Fenrick R, 1999, MOL CELL BIOL, V19, P6566; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Golub TR, 1997, CURR TOP MICROBIOL, V220, P67; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Gu TL, 2000, MOL CELL BIOL, V20, P91, DOI 10.1128/MCB.20.1.91-103.2000; HAGMAN J, 1992, P NATL ACAD SCI USA, V89, P8889, DOI 10.1073/pnas.89.19.8889; Hiebert SW, 1996, MOL CELL BIOL, V16, P1349; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Irvin BJ, 2003, J BIOL CHEM, V278, P46378, DOI 10.1074/jbc.M305189200; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Kopp JL, 2007, J BIOL CHEM, V282, P3027, DOI 10.1074/jbc.M609907200; Kwiatkowski BA, 1998, J BIOL CHEM, V273, P17525, DOI 10.1074/jbc.273.28.17525; Lee GM, 2008, J MOL BIOL, V382, P1014, DOI 10.1016/j.jmb.2008.07.064; LIM F, 1992, EMBO J, V11, P643, DOI 10.1002/j.1460-2075.1992.tb05096.x; Ling Y, 1997, EMBO J, V16, P2431, DOI 10.1093/emboj/16.9.2431; Lopez R, 1999, J BIOL CHEM, V274, P30132, DOI 10.1074/jbc.274.42.30132; Mackereth CD, 2004, J MOL BIOL, V342, P1249, DOI 10.1016/j.jmb.2004.07.094; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Mo Y, 2000, NAT STRUCT BIOL, V7, P292; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; Poirel H, 2000, ONCOGENE, V19, P4802, DOI 10.1038/sj.onc.1203830; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Qiao F, 2006, EMBO J, V25, P70, DOI 10.1038/sj.emboj.7600924; Qiao F, 2004, CELL, V118, P163, DOI 10.1016/j.cell.2004.07.010; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Roukens MG, 2008, MOL CELL BIOL, V28, P4394, DOI 10.1128/MCB.01914-07; Roukens MG, 2008, MOL CELL BIOL, V28, P2342, DOI 10.1128/MCB.01159-07; Seidel JJ, 2002, GENE DEV, V16, P127, DOI 10.1101/gad.950902; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Song HY, 2005, GENE DEV, V19, P1767, DOI 10.1101/gad.1327405; Szymczyna BR, 2000, J BIOL CHEM, V275, P28363, DOI 10.1074/jbc.M004294200; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tran Hoang H, 2002, BMC Struct Biol, V2, P5, DOI 10.1186/1472-6807-2-5; Uchida H, 1999, ONCOGENE, V18, P1015, DOI 10.1038/sj.onc.1202383; Wang H, 2002, J BIOL CHEM, V277, P2225, DOI 10.1074/jbc.M109430200; Wang LL, 2001, ONCOGENE, V20, P3716, DOI 10.1038/sj.onc.1204479; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; Wood LD, 2003, P NATL ACAD SCI USA, V100, P3257, DOI 10.1073/pnas.0637114100; Yang SH, 1999, EMBO J, V18, P5666, DOI 10.1093/emboj/18.20.5666; Yang SH, 2002, MOL CELL BIOL, V22, P5036, DOI 10.1128/MCB.22.14.5036-5046.2002; Zhang J, 2010, MOL CELL BIOL, V30, P1158, DOI 10.1128/MCB.01225-09	56	44	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18496	18504		10.1074/jbc.M109.096958	http://dx.doi.org/10.1074/jbc.M109.096958			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400516	Green Published, hybrid			2022-12-25	WOS:000278453900043
J	Sliedrecht, T; Zhang, C; Shokat, KM; Kops, GJPL				Sliedrecht, Tale; Zhang, Chao; Shokat, Kevan M.; Kops, Geert J. P. L.			Chemical Genetic Inhibition of Mps1 in Stable Human Cell Lines Reveals Novel Aspects of Mps1 Function in Mitosis	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; CHROMOSOME BI-ORIENTATION; SMALL-MOLECULE INHIBITOR; POLE BODY DUPLICATION; MITOTIC CHECKPOINT; AURORA-B; CENTROSOME DUPLICATION; PROTEIN-KINASES; KINETOCHORE; ANAPHASE	Background: Proper execution of chromosome segregation relies on tight control of attachment of chromosomes to spindle microtubules. This is monitored by the mitotic checkpoint that allows chromosome segregation only when all chromosomes are stably attached. Proper functioning of the attachment and checkpoint processes is thus important to prevent chromosomal instability. Both processes rely on the mitotic kinase Mps1. Principal Finding: We present here two cell lines in which endogenous Mps1 has been stably replaced with a mutant kinase (Mps1-as) that is specifically inhibited by bulky PP1 analogs. Mps1 inhibition in these cell lines is highly penetrant and reversible. Timed inhibition during bipolar spindle assembly shows that Mps1 is critical for attachment error-correction and confirms its role in Aurora B regulation. We furthermore show that Mps1 has multiple controls over mitotic checkpoint activity. Mps1 inhibition precludes Mad1 localization to unattached kinetochores but also accelerates mitosis. This acceleration correlates with absence of detectable mitotic checkpoint complex after Mps1 inhibition. Finally, we show that short-term inhibition of Mps1 catalytic activity is sufficient to kill cells. Conclusions/Significance: Mps1 is involved in the regulation of multiple key processes that ensure correct chromosome segregation and is a promising target for inhibition in anti-cancer strategies. We report here two cell lines that allow specific and highly penetrant inhibition of Mps1 in a reproducible manner through the use of chemical genetics. Using these cell lines we confirm previously suggested roles for Mps1 activity in mitosis, present evidence for novel functions and examine cell viability after short and prolonged Mps1 inhibition. These cell lines present the best cellular model system to date for investigations into Mps1 biology and the effects of penetrance and duration of Mps1 inhibition on cell viability.	[Sliedrecht, Tale; Kops, Geert J. P. L.] Univ Med Ctr Utrecht, Dept Physiol Chem, Canc Genom Ctr, Utrecht, Netherlands; [Sliedrecht, Tale; Kops, Geert J. P. L.] Netherlands Prote Ctr, Utrecht, Netherlands; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Utrecht University; Utrecht University Medical Center; University of California System; University of California San Francisco	Sliedrecht, T (corresponding author), Univ Med Ctr Utrecht, Dept Physiol Chem, Canc Genom Ctr, Utrecht, Netherlands.	g.j.p.l.kops@umcutrecht.nl		Kops, Geert/0000-0003-3555-5295	Netherlands Organization for Scientific Research;  [ERC-StG-242617]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); 	This work was supported by the Netherlands Genomics Initiative of the Netherlands Organization for Scientific Research and ERC-StG-242617 to GJPLK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; Bourhis E, 2009, BIOCHEMISTRY-US, V48, P6783, DOI 10.1021/bi900530v; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dorer RK, 2005, CURR BIOL, V15, P1070, DOI 10.1016/j.cub.2005.05.020; Fischer MG, 2004, CURR BIOL, V14, P2019, DOI 10.1016/j.cub.2004.11.008; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; He XW, 1998, J CELL SCI, V111, P1635; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Jelluma N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002415; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; KANG J, 2007, P NATL ACAD SCI; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Khodjakov A, 2004, CURR BIOL, V14, P1330, DOI 10.1016/j.cub.2004.07.028; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kops GJPL, 2009, BIOCHEM SOC T, V37, P971, DOI 10.1042/BST0370971; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; Maure JF, 2007, CURR BIOL, V17, P2175, DOI 10.1016/j.cub.2007.11.032; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745	41	74	75	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10251	10.1371/journal.pone.0010251	http://dx.doi.org/10.1371/journal.pone.0010251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20422024	Green Published, gold, Green Submitted			2022-12-25	WOS:000276952600003
J	Anas, AA; Hovius, JWR; van't Veer, C; van der Poll, T; de Vos, AF				Anas, Adam A.; Hovius, Joppe W. R.; van't Veer, Cornelis; van der Poll, Tom; de Vos, Alex F.			Role of CD14 in a Mouse Model of Acute Lung Inflammation Induced by Different Lipopolysaccharide Chemotypes	PLOS ONE			English	Article							ESCHERICHIA-COLI PNEUMONIA; TOLL-LIKE RECEPTORS; SOLUBLE CD14; INHALED ENDOTOXIN; EPITHELIAL-CELLS; GENE-EXPRESSION; LPS; COMPLEX; BINDING; INJURY	Background: Recognition of lipopolysaccharide (LPS) is required for effective defense against invading gram-negative bacteria. Recently, in vitro studies revealed that CD14 is required for activation of the myeloid differentiation factor (MyD)88-dependent Toll-like receptor (TLR)4 signaling pathway by smooth (S)-LPS, but not by rough (R)-LPS. The present study investigated the role of CD14 in induction of lung inflammation in mice by these different LPS chemotypes. Methodology/Results: Neutrophil accumulation and tumor necrosis factor (TNF) release in bronchoalveolar lavage fluid were determined 6 hours after intranasal treatment of wild type (WT) and CD14 knock-out (KO) mice with different doses S-LPS or R-LPS. The contribution of CD14 to lung inflammation induced by S-LPS or R-LPS depended on the LPS dose. At low doses, S-LPS and R-LPS induced neutrophil influx in a CD14-dependent manner. Low dose S-LPS-induced cytokine release also depended on CD14. Strikingly, neutrophil influx and TNF release induced by high dose S-LPS or R-LPS was diminished in the presence of CD14. Intranasal administration of sCD14 to CD14 KO mice treated with S-LPS partially reversed the inflammatory response to the response observed in WT mice. Conclusions: In conclusion, CD14 modulates effects of both S-LPS and R-LPS within the lung in a similar way. Except for R-LPS-induced TNF release, S-LPS and R-LPS at low dose induced acute lung inflammation in a CD14-dependent manner, while the inflammatory response triggered by high dose S-LPS or R-LPS was diminished by CD14.	[Anas, Adam A.] Univ Amsterdam, Ctr Infect & Immun Amsterdam, Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Anas, AA (corresponding author), Univ Amsterdam, Ctr Infect & Immun Amsterdam, Amsterdam, Netherlands.	a.f.devos@amc.uva.nl	Hovius, Joppe/GZL-6894-2022	Hovius, Joppe/0000-0003-0066-2437	Academic Medical Center, Amsterdam, The Netherlands	Academic Medical Center, Amsterdam, The Netherlands(Netherlands Government)	This work was funded by the Academic Medical Center, Amsterdam, The Netherlands. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Brass DM, 2007, AM J PHYSIOL-LUNG C, V293, pL77, DOI 10.1152/ajplung.00282.2006; Cai S, 2009, AM J RESP CELL MOL, V40, P701, DOI 10.1165/rcmb.2008-0152OC; Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Gangloff SC, 2005, J IMMUNOL, V175, P3940, DOI 10.4049/jimmunol.175.6.3940; HAZIOT A, 1994, J IMMUNOL, V152, P5868; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hovius JWR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040031; Huber M, 2006, EUR J IMMUNOL, V36, P701, DOI 10.1002/eji.200535593; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Jeyaseelan S, 2005, INFECT IMMUN, V73, P1754, DOI 10.1128/IAI.73.3.1754-1763.2005; Jeyaseelan S, 2007, J IMMUNOL, V178, P3153, DOI 10.4049/jimmunol.178.5.3153; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Knapp S, 2006, AM J RESP CRIT CARE, V173, P122, DOI 10.1164/rccm.200505-730OC; Knapp S, 2006, J IMMUNOL, V176, P3189, DOI 10.4049/jimmunol.176.5.3189; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Noulin N, 2005, J IMMUNOL, V175, P6861, DOI 10.4049/jimmunol.175.10.6861; Oshikawa K, 2003, BIOCHEM BIOPH RES CO, V305, P649, DOI 10.1016/S0006-291X(03)00837-4; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Saito T, 2005, CELL TISSUE RES, V321, P75, DOI 10.1007/s00441-005-1113-9; Skerrett SJ, 2004, AM J PHYSIOL-LUNG C, V287, pL143, DOI 10.1152/ajplung.00030.2004; Stelter F, 1998, EUR J CLIN INVEST, V28, P205; Tasaka S, 2003, AM J RESP CELL MOL, V29, P252, DOI 10.1165/rcmb.2002-0132OC; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777	31	11	11	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10183	10.1371/journal.pone.0010183	http://dx.doi.org/10.1371/journal.pone.0010183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419140	Green Published, Green Submitted, gold			2022-12-25	WOS:000276743500010
J	Tossidou, I; Teng, BN; Menne, J; Shushakova, N; Park, JK; Becker, JU; Modde, F; Leitges, M; Haller, H; Schiffer, M				Tossidou, Irini; Teng, Beina; Menne, Jan; Shushakova, Nelli; Park, Joon-Keun; Becker, Jan U.; Modde, Friedrich; Leitges, Michael; Haller, Hermann; Schiffer, Mario			Podocytic PKC-Alpha Is Regulated in Murine and Human Diabetes and Mediates Nephrin Endocytosis	PLOS ONE			English	Article							PROTEIN-KINASE-C; SLIT DIAPHRAGM; GENE; NEPHROPATHY; ALBUMIN	Background: Microalbuminuria is an early lesion during the development of diabetic nephropathy. The loss of high molecular weight proteins in the urine is usually associated with decreased expression of slit diaphragm proteins. Nephrin, is the major component of the glomerular slit diaphragm and loss of nephrin has been well described in rodent models of experimental diabetes as well as in human diabetic nephropathy. Methodology/Principal Findings: In this manuscript we analyzed the role of PKC-alpha (PKC alpha) on endocytosis of nephrin in podocytes. We found that treatment of diabetic mice with a PKC alpha-inhibitor (GO6976) leads to preserved nephrin expression and reduced proteinuria. In vitro, we found that high glucose stimulation would induce PKC alpha protein expression in murine and human podocytes. We can demonstrate that PKC alpha mediates nephrin endocytosis in podocytes and that overexpression of PKC alpha leads to an augmented endocytosis response. After PKC-activation, we demonstrate an inducible association of PKC alpha, PICK1 and nephrin in podocytes. Moreover, we can demonstrate a strong induction of PKC alpha in podocytes of patients with diabetic nephropathy. Conclusions/Significance: We therefore conclude that activation of PKC alpha is a pathomechanistic key event during the development of diabetic nephropathy. PKC alpha is involved in reduction of nephrin surface expression and therefore PKC alpha inhibition might be a novel target molecule for anti-proteinuric therapy.	[Tossidou, Irini; Teng, Beina; Menne, Jan; Shushakova, Nelli; Park, Joon-Keun; Leitges, Michael; Haller, Hermann; Schiffer, Mario] Hannover Med Sch, Dept Med, Div Nephrol, D-3000 Hannover, Germany; [Becker, Jan U.; Modde, Friedrich] Hannover Med Sch, Dept Pathol, D-3000 Hannover, Germany; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway	Hannover Medical School; Hannover Medical School; University of Oslo	Tossidou, I (corresponding author), Hannover Med Sch, Dept Med, Div Nephrol, D-3000 Hannover, Germany.	schiffer.mario@mh-hannover.de	Schiffer, Mario/U-7050-2019; Leitges, Michael/AAN-1953-2021	Schiffer, Mario/0000-0002-8414-1470; Leitges, Michael/0000-0003-4203-6995; Becker, Jan Ulrich/0000-0003-2929-8085	DFG [SCHI 587/2-2, ME3143/1-1]; SFB [566-B16]	DFG(German Research Foundation (DFG)); SFB(Austrian Science Fund (FWF))	This work was supported by a DFG-Emmy Noether Fellowship (SCHI 587/2-2) and SFB 566-B16 to M. S., and DFG-grant ME3143/1-1 to J.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Dev KK, 2004, J BIOL CHEM, V279, P41393, DOI 10.1074/jbc.M404499200; Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023; Hanley JG, 2006, BIOCHEM SOC T, V34, P931, DOI 10.1042/BST0340931; Huber TB, 2009, J AM SOC NEPHROL, V20, P798, DOI 10.1681/ASN.2008080871; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Le Lay S, 2006, TRAFFIC, V7, P549, DOI 10.1111/j.1600-0854.2006.00406.x; Lee-Kwon W, 2003, AM J PHYSIOL-CELL PH, V285, pC1527, DOI 10.1152/ajpcell.00017.2003; Leitges M, 2007, BIOCHEM SOC T, V35, P1018, DOI 10.1042/BST0351018; Letiges M, 2002, MOL ENDOCRINOL, V16, P847, DOI 10.1210/me.16.4.847; Menne J, 2006, KIDNEY INT, V70, P1456, DOI 10.1038/sj.ki.5001830; Menne J, 2004, DIABETES, V53, P2101, DOI 10.2337/diabetes.53.8.2101; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Mundel P, 1996, EXP NEPHROL, V4, P263; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Ranganathan S, 2004, J BIOL CHEM, V279, P40536, DOI 10.1074/jbc.M407592200; Rastaldi MP, 2006, KIDNEY INT, V70, P477, DOI 10.1038/sj.ki.5001563; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Tossidou I, 2009, CELL PHYSIOL BIOCHEM, V24, P627, DOI 10.1159/000257518; Tryggvason K, 1999, INT J DEV BIOL, V43, P445	28	57	59	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10185	10.1371/journal.pone.0010185	http://dx.doi.org/10.1371/journal.pone.0010185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419132	Green Published, gold, Green Submitted			2022-12-25	WOS:000276743500002
J	Potter, CJ; Luo, LQ				Potter, Christopher J.; Luo, Liqun			Splinkerette PCR for Mapping Transposable Elements in Drosophila	PLOS ONE			English	Article							GERM-LINE; P-ELEMENTS; HYBRID DYSGENESIS; MELANOGASTER; TRANSFORMATION; PIGGYBAC; VECTOR; GENOME; MUTAGENESIS; EXPRESSION	Transposable elements (such as the P-element and piggyBac) have been used to introduce thousands of transgenic constructs into the Drosophila genome. These transgenic constructs serve many roles, from assaying gene/cell function, to controlling chromosome arm rearrangement. Knowing the precise genomic insertion site for the transposable element is often desired. This enables identification of genomic enhancer regions trapped by an enhancer trap, identification of the gene mutated by a transposon insertion, or simplifying recombination experiments. The most commonly used transgene mapping method is inverse PCR (iPCR). Although usually effective, limitations with iPCR hinder its ability to isolate flanking genomic DNA in complex genomic loci, such as those that contain natural transposons. Here we report the adaptation of the splinkerette PCR (spPCR) method for the isolation of flanking genomic DNA of any P-element or piggyBac. We report a simple and detailed protocol for spPCR. We use spPCR to 1) map a GAL4 enhancer trap located inside a natural transposon, pinpointing a master regulatory region for olfactory neuron expression in the brain; and 2) map all commonly used centromeric FRT insertion sites. The ease, efficiency, and efficacy of spPCR could make it a favored choice for the mapping of transposable element in Drosophila.	[Potter, Christopher J.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Ctr Sensory Biol, Baltimore, MD 21218 USA; [Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA	Johns Hopkins University; Howard Hughes Medical Institute; Stanford University	Potter, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Ctr Sensory Biol, Baltimore, MD 21218 USA.	cpotter@jhmi.edu	Potter, Christopher John/H-5884-2019	Potter, Christopher John/0000-0002-5223-8112	National Institutes of Health [R01-DC005982]; Human Frontiers Science Program; Damon Runyon Cancer Research Foundation [DRG-1766-03]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Institutes of Health [R01-DC005982]; the Human Frontiers Science Program; and the Damon Runyon Cancer Research Foundation [DRG-1766-03 to C.J.P.]. L. L. is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdnik D, 2008, CURR BIOL, V18, P1754, DOI 10.1016/j.cub.2008.09.045; Bharathi V, 2004, J CELL SCI, V117, P1911, DOI 10.1242/jcs.01034; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BLACK DM, 1987, EMBO J, V6, P4125, DOI 10.1002/j.1460-2075.1987.tb02758.x; BLACKMAN RK, 1989, EMBO J, V8, P211, DOI 10.1002/j.1460-2075.1989.tb03366.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chou TB, 1996, GENETICS, V144, P1673; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; DEVON RS, 1995, NUCLEIC ACIDS RES, V23, P1644, DOI 10.1093/nar/23.9.1644; DING D, 1994, GENET RES, V64, P167, DOI 10.1017/S0016672300032833; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Horn C, 2007, NAT GENET, V39, P933, DOI 10.1038/ng0807-933; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Kaminker JS, 2002, GENOME BIOL, V3, P0084, DOI DOI 10.1186/GB-2002-3-12-RFESEARCH84; Laissue PP, 1999, J COMP NEUROL, V405, P543; LIDHOLM DA, 1993, GENETICS, V134, P859; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; LOUKERIS TG, 1995, P NATL ACAD SCI USA, V92, P9485, DOI 10.1073/pnas.92.21.9485; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; O'Malley RC, 2007, NAT PROTOC, V2, P2910, DOI 10.1038/nprot.2007.425; OBrochta DA, 1996, GENETICS, V142, P907; OCHMAN H, 1988, GENETICS, V120, P621; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Quinones-Coello AT, 2007, GENETICS, V175, P1089, DOI 10.1534/genetics.106.065995; RASMUSSON KE, 1993, GENETICS, V133, P605; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; SENTRY JW, 1994, NUCLEIC ACIDS RES, V22, P3429, DOI 10.1093/nar/22.16.3429; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; XU T, 1993, DEVELOPMENT, V117, P1223	38	82	86	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10168	10.1371/journal.pone.0010168	http://dx.doi.org/10.1371/journal.pone.0010168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405015	gold, Green Submitted, Green Published			2022-12-25	WOS:000276706300021
J	Desgranges, B; Ramirez-Amaya, V; Ricano-Cornejo, I; Levy, F; Ferreira, G				Desgranges, Bertrand; Ramirez-Amaya, Victor; Ricano-Cornejo, Itzel; Levy, Frederic; Ferreira, Guillaume			Flavor Preference Learning Increases Olfactory and Gustatory Convergence onto Single Neurons in the Basolateral Amygdala but Not in the Insular Cortex in Rats	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; LONG-TERM POTENTIATION; STIMULUS CONVERGENCE; SYNAPTIC PLASTICITY; PROTEIN EXPRESSION; LATERAL AMYGDALA; ARC; TASTE; CONSOLIDATION; HIPPOCAMPAL	The basolateral amygdala (BLA) and the insular cortex (IC) represent two major areas for odor-taste associations, i.e. flavor integration. This learning may require the development of convergent odor and taste neuronal activation allowing the memory representation of such association. Yet identification of neurons that respond to such coincident input and the effect of flavor experience on odor-taste convergence remain unclear. In the present study we used the compartmental analysis of temporal activity using fluorescence in situ hybridization for Arc (catFISH) to visualize odor-taste convergence onto single neurons in the BLA and in the IC to assess the number of cells that were co-activated by both stimuli after odor-taste association. We used a sucrose conditioned odor preference as a flavor experience in rats, in which 9 odor-sucrose pairings induce a reliable odor-taste association. The results show that flavor experience induced a four-fold increase in the percentage of cells activated by both taste and odor stimulations in the BLA, but not in the IC. Because conditioned odor preference did not modify the number of cells responding selectively to one stimulus, this greater odor-taste convergence into individual BLA neurons suggests the recruitment of a neuronal population that can be activated by both odor and taste only after the association. We conclude that the development of convergent activation in amygdala neurons after odor-taste associative learning may provide a cellular basis of flavor memory.	[Desgranges, Bertrand; Levy, Frederic; Ferreira, Guillaume] Univ Tours, Lab Comportement Neurobiol & Adaptat, CNRS, INRA,UMR 6175,UMR 85, Nouzilly, France; [Ramirez-Amaya, Victor; Ricano-Cornejo, Itzel] Univ Nacl Autonoma Mexico, Inst Neurol, Dept Neurobiol Conductual & Cognit, Queretaro, Mexico	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Universidad Nacional Autonoma de Mexico	Desgranges, B (corresponding author), Univ Tours, Lab Comportement Neurobiol & Adaptat, CNRS, INRA,UMR 6175,UMR 85, Nouzilly, France.	vramirez@unam.mx; guillaume.ferreira@bordeaux.inra.fr	Desgranges, Béatrice/L-7739-2015	Ferreira, Guillaume/0000-0001-5984-8143; Desgranges, Beatrice/0000-0002-3657-9996	AROMALIM Grant Agence National de la Recherche [ANR-05-PNRA-002]; CONACyT Mexico [51028]; PAPIIT UNAM [IN213907]; INRegion Centre	AROMALIM Grant Agence National de la Recherche(French National Research Agency (ANR)); CONACyT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); INRegion Centre	This work was supported by AROMALIM Grant Agence National de la Recherche ANR-05-PNRA-002 (GF), CONACyT Mexico 51028 and PAPIIT UNAM IN213907 (VRA). BD was supported by a PhD grant from INRegion Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton J. P., 2000, AMYGDALA FUNCTIONAL, P1; Barot SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006156; Barot SK, 2008, P NATL ACAD SCI USA, V105, P20959, DOI 10.1073/pnas.0808996106; Blair HT, 2003, ANN NY ACAD SCI, V985, P485; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Burke SN, 2005, NEURON, V45, P667, DOI 10.1016/j.neuron.2005.01.042; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Desgranges B, 2008, BRAIN RES, V1236, P166, DOI 10.1016/j.brainres.2008.07.123; Gilbert PE, 2003, NEUROBIOL LEARN MEM, V79, P118, DOI 10.1016/S1074-7427(02)00013-8; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; LAMPRECHT R, 2000, AMYGDALA, P310; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Reilly S, 2005, NEUROSCI BIOBEHAV R, V29, P1067, DOI 10.1016/j.neubiorev.2005.03.025; Sakai N, 2001, NEUROBIOL LEARN MEM, V75, P128, DOI 10.1006/nlme.2000.3969; Sevelinges Y, 2009, LEARN MEMORY, V16, P235, DOI 10.1101/lm.1247609; Sewards TV, 2001, NEUROSCI BIOBEHAV R, V25, P395, DOI 10.1016/S0149-7634(01)00021-5; Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405; Shionoya K, 2009, NEUROBIOL LEARN MEM, V92, P590, DOI 10.1016/j.nlm.2009.07.008; Shipley MT, 1996, J NEUROBIOL, V30, P123; Slotnick BM, 1997, ANIM LEARN BEHAV, V25, P357, DOI 10.3758/BF03199093; Small DM, 2005, EXP BRAIN RES, V166, P345, DOI 10.1007/s00221-005-2376-9; Touzani K, 2005, EUR J NEUROSCI, V22, P1767, DOI 10.1111/j.1460-9568.2005.04360.x; Touzani K, 2007, EUR J NEUROSCI, V26, P1692, DOI 10.1111/j.1460-9568.2007.05798.x; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Voronin LL, 1996, NEUROSCIENCE, V74, P323, DOI 10.1016/0306-4522(96)00207-2	34	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10097	10.1371/journal.pone.0010097	http://dx.doi.org/10.1371/journal.pone.0010097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	580WU	20404918	Green Submitted, Green Published, gold			2022-12-25	WOS:000276482100014
J	Podhraski, V; Campo-Fernandez, B; Worle, H; Piatti, P; Niederegger, H; Bock, G; Fyodorov, DV; Lusser, A				Podhraski, Valerie; Campo-Fernandez, Beatriz; Woerle, Hildegard; Piatti, Paolo; Niederegger, Harald; Boeck, Guenther; Fyodorov, Dmitry V.; Lusser, Alexandra			CenH3/CID Incorporation Is Not Dependent on the Chromatin Assembly Factor CHD1 in Drosophila	PLOS ONE			English	Article							CENTROMERE-SPECIFIC HISTONE; CENP-A; PROTEIN; HJURP; LOCALIZATION; MELANOGASTER; ASSOCIATION; PROPAGATION; DEPOSITION; ARREST	CHD1 is a SNF2-related ATPase that is required for the genome-wide incorporation of variant histone H3.3 in the paternal pronucleus as well as in transcriptionally active nuclei in Drosophila embryos. The S. pombe and vertebrate orthologs of CHD1 have been implicated in the assembly of the centromeric histone H3 variant CenH3(CENP-A), which occurs in a DNA replication-independent manner. Here, we examined whether CHD1 participates in the assembly of CenH3(CID) in Drosophila. In contrast to the findings in fission yeast and vertebrate cells, our evidence clearly argues against such a role for CHD1 in Drosophila. CHD1 does not localize to centromeres in either S2 cells or developing fly embryos. Down-regulation of CHD1 in S2 cells by RNAi reveals unchanged levels of CenH3 CID at the centromeres. Most notably, ablation of functional CHD1 in Chd1 mutant fly embryos does not interfere with centromere and kinetochore assembly, as the levels and localization of CenH3(CID), CENP-C and BubR1 in the mutant embryos remain similar to those seen in wild-type embryos. These results indicate that Drosophila CHD1 has no direct function in the incorporation of the centromeric H3 variant CenH3(CID) into chromatin. Therefore, centromeric chromatin assembly may involve different mechanisms in different organisms.	[Podhraski, Valerie; Campo-Fernandez, Beatriz; Woerle, Hildegard; Piatti, Paolo; Lusser, Alexandra] Innsbruck Med Univ, Div Mol Biol, Innsbruck, Austria; [Niederegger, Harald] Tyrolean Canc Res Inst, Innsbruck, Austria; [Boeck, Guenther] Innsbruck Med Univ, Div Expt Pathophysiol & Immunol, Bioctr, Innsbruck, Austria; [Fyodorov, Dmitry V.] Albert Einstein Coll Med, Dept Cell Biol, New York, NY USA	Medical University of Innsbruck; Medical University of Innsbruck; Yeshiva University	Podhraski, V (corresponding author), Innsbruck Med Univ, Div Mol Biol, Innsbruck, Austria.	alexandra.lusser@i-med.ac.at		Lusser, Alexandra/0000-0002-2226-9081; Piatti, Paolo/0000-0002-4863-5887	Austrian Science Foundation [START Y275-B12]; National Institutes of Health [GM74233]; Austrian Science Fund (FWF) [Y 275] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074233] Funding Source: NIH RePORTER	Austrian Science Foundation(Austrian Science Fund (FWF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the Austrian Science Foundation (START Y275-B12) to A. L. and the National Institutes of Health (GM74233) to D. V. F. D. V. F. was a Scholar of the Sidney Kimmel Foundation for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Blower MD, 2006, PLOS GENET, V2, P1025, DOI 10.1371/journal.pgen.0020110; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Erhardt S, 2008, J CELL BIOL, V183, P805, DOI 10.1083/jcb.200806038; Foe Victoria E., 1993, P149; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Hanai K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000011; Haushalter KA, 2003, NAT REV MOL CELL BIO, V4, P613, DOI 10.1038/nrm1177; Heeger S, 2005, GENE DEV, V19, P2041, DOI 10.1101/gad.347805; Henikoff S, 2005, CURR OPIN GENET DEV, V15, P177, DOI 10.1016/j.gde.2005.01.004; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kelley DE, 1999, CHROMOSOMA, V108, P10, DOI 10.1007/s004120050347; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Loppin B, 2005, NATURE, V437, P1386, DOI 10.1038/nature04059; Loppin B, 2001, CHROMOSOMA, V110, P430, DOI 10.1007/s004120100161; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Malik HS, 2001, GENETICS, V157, P1293; OKADA M, 2009, MOL BIOL CELL; Perez-Mongiovi D, 2005, DEVELOPMENT, V132, P4509, DOI 10.1242/dev.02028; Perpelescu M, 2009, J CELL BIOL, V185, P397, DOI 10.1083/jcb.200903088; Polo SE, 2006, CURR OPIN GENET DEV, V16, P104, DOI 10.1016/j.gde.2006.02.011; Sanchez-Pulido L, 2009, CELL, V137, P1173, DOI 10.1016/j.cell.2009.06.010; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Stokes DG, 1996, P NATL ACAD SCI USA, V93, P7137, DOI 10.1073/pnas.93.14.7137; STOKES DG, 1995, MOL CELL BIOL, V15, P2745; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Talbert Paul B, 2004, J Biol, V3, P18, DOI 10.1186/jbiol11; Torras-Llort M, 2009, EMBO J, V28, P2337, DOI 10.1038/emboj.2009.174; Vermaak D, 2002, MOL CELL BIOL, V22, P7553, DOI 10.1128/MCB.22.21.7553-7561.2002; Walfridsson J, 2005, NUCLEIC ACIDS RES, V33, P2868, DOI 10.1093/nar/gki579; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001	35	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10120	10.1371/journal.pone.0010120	http://dx.doi.org/10.1371/journal.pone.0010120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20396651	Green Submitted, Green Published, gold			2022-12-25	WOS:000276482100026
J	Wiederhold, K; Kloepper, TH; Walter, AM; Stein, A; Kienle, N; Sorensen, JB; Fasshauer, D				Wiederhold, Katrin; Kloepper, Tobias H.; Walter, Alexander M.; Stein, Alexander; Kienle, Nickias; Sorensen, Jakob B.; Fasshauer, Dirk			A Coiled Coil Trigger Site Is Essential for Rapid Binding of Synaptobrevin to the SNARE Acceptor Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE FUSION; MEMBRANE-FUSION; REGULATED EXOCYTOSIS; SECRETORY VESICLES; CRYSTAL-STRUCTURE; PROTEINS; SEQUENCE; CONSERVATION; MECHANISMS; PRINCIPLES	Exocytosis from synaptic vesicles is driven by stepwise formation of a tight alpha-helical complex between the fusing membranes. The complex is composed of the three SNAREs: synaptobrevin 2, SNAP-25, and syntaxin 1a. An important step in complex formation is fast binding of vesicular synaptobrevin to the preformed syntaxin 1.SNAP-25 dimer. Exactly how this step relates to neurotransmitter release is not well understood. Here, we combined different approaches to gain insights into this reaction. Using computational methods, we identified a stretch in synaptobrevin 2 that may function as a coiled coil "trigger site." This site is also present in many synaptobrevin homologs functioning in other trafficking steps. Point mutations in this stretch inhibited binding to the syntaxin 1.SNAP-25 dimer and slowed fusion of liposomes. Moreover, the point mutations severely inhibited secretion from chromaffin cells. Altogether, this demonstrates that the trigger site in synaptobrevin is crucial for productive SNARE zippering.	[Fasshauer, Dirk] Max Planck Inst Biophys Chem, Res Grp Struct Biochem, D-37077 Gottingen, Germany; [Kloepper, Tobias H.; Stein, Alexander] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Walter, Alexander M.; Sorensen, Jakob B.] Max Planck Inst Biophys Chem, Res Grp Mol Mech Exocytosis, D-37077 Gottingen, Germany; [Sorensen, Jakob B.] Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Fasshauer, Dirk] Univ Lausanne, Dept Cellular Biol & Morphol, CH-1005 Lausanne, Switzerland	Max Planck Society; Max Planck Society; Max Planck Society; University of Copenhagen; University of Lausanne	Fasshauer, D (corresponding author), Max Planck Inst Biophys Chem, Res Grp Struct Biochem, D-37077 Gottingen, Germany.	dfassha@gwdg.de	Stein, Alexander/I-4950-2012; Walter, Alexander M/O-1824-2015; Fasshauer, Dirk/B-1563-2013	Stein, Alexander/0000-0002-2696-0611; Walter, Alexander M/0000-0001-5646-4750; Fasshauer, Dirk/0000-0002-1040-4282; Sorensen, Jakob/0000-0001-5465-3769	Deutsche Forschungsgemeinschaft [SFB523-B11, SFB523-B16]; Lundbeck Foundation; Lundbeck Foundation [R28-2008-1976] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB523-B11 (to D. F.) and SFB523-B16 (to J.B.S.) and by a Lundbeck Foundation Junior Group Leader Fellowship (to J.B.S.).	Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 2007, NAT STRUCT MOL BIOL, V14, P360, DOI 10.1038/nsmb0507-360; Frank S, 2000, J BIOL CHEM, V275, P11672, DOI 10.1074/jbc.275.16.11672; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; Hannenhalli SS, 2000, J MOL BIOL, V303, P61, DOI 10.1006/jmbi.2000.4036; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Holt M, 2008, CURR BIOL, V18, P715, DOI 10.1016/j.cub.2008.04.069; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kesavan J, 2007, CELL, V131, P351, DOI 10.1016/j.cell.2007.09.025; Kienle N, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-19; Kloepper TH, 2008, MOL BIOL EVOL, V25, P2055, DOI 10.1093/molbev/msn151; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Lee DL, 2001, J MOL BIOL, V306, P539, DOI 10.1006/jmbi.2000.4351; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Neher E, 2006, PFLUG ARCH EUR J PHY, V453, P261, DOI 10.1007/s00424-006-0143-9; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Siddiqui TJ, 2007, MOL BIOL CELL, V18, P2037, DOI 10.1091/mbc.E07-01-0049; Sorensen JB, 2009, ANNU REV CELL DEV BI, V25, P513, DOI 10.1146/annurev.cellbio.24.110707.175239; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Sorensen JB, 2004, PFLUG ARCH EUR J PHY, V448, P347, DOI 10.1007/s00424-004-1247-8; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Walter AM, 2010, J CELL BIOL, V188, P401, DOI 10.1083/jcb.200907018; Wiederhold K, 2009, J BIOL CHEM, V284, P13143, DOI 10.1074/jbc.M900703200; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Yang CM, 2001, MOL CELL BIOL, V21, P1573, DOI 10.1128/MCB.21.5.1573-1580.2001; Zwilling D, 2007, EMBO J, V26, P9, DOI 10.1038/sj.emboj.7601467	47	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21549	21559		10.1074/jbc.M110.105148	http://dx.doi.org/10.1074/jbc.M110.105148			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20406821	Green Published, hybrid			2022-12-25	WOS:000279516100041
J	Thoms, BL; Murphy, CL				Thoms, Brendan L.; Murphy, Christopher L.			Inhibition of Hypoxia-inducible Factor-targeting Prolyl Hydroxylase Domain-containing Protein 2 (PHD2) Enhances Matrix Synthesis by Human Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-TENSION; ARTICULAR CHONDROCYTES; TRANSCRIPTIONAL ACTIVITY; PROLINE HYDROXYLATION; HIF-ALPHA; EXPRESSION; CARTILAGE; 4-HYDROXYLASES; HIF-1-ALPHA; PHENOTYPE	Human articular cartilage is an avascular tissue, and therefore it functions in a hypoxic environment. Cartilage cells, the chondrocytes, have adapted to this and actually use hypoxia to drive tissue-specific functions. We have previously shown that human chondrocytes enhance cartilage matrix synthesis in response to hypoxia specifically through hypoxia-inducible factor 2 alpha (HIF-2 alpha)-mediated up-regulation of master regulator transcription factor SOX9, which in turn drives expression of the main cartilage-specific extracellular matrix genes. HIF-alpha isoforms are themselves regulated by specific prolyl hydroxylase domain-containing proteins, which target them for proteosomal degradation. In fact, prolyl hydroxylase domains are the direct oxygen sensors because they require molecular oxygen as a co-substrate. Here, we have identified PHD2 as the dominant isoenzyme regulating HIF-2 alpha stability in human chondrocytes. Moreover, specific inhibition of PHD2 using RNA interference-mediated depletion caused an up-regulation of SOX9 and enhanced extracellular matrix protein production. Depletion of PHD2 resulted in greater HIF-2 alpha levels and therefore enhanced SOX9-induced cartilage matrix production compared with the levels normally found in hypoxia (1% oxygen) implying that PHD2 inhibition offers a novel means to enhance cartilage repair in vivo. The need for HIF-specific hydroxylase inhibition was highlighted because treatment with the 2-oxoglutarate analogue dimethyloxalylglycine (which also inhibits the collagen prolyl 4-hydroxylases) prevented secretion of type II collagen, a critical cartilage matrix component.	[Thoms, Brendan L.; Murphy, Christopher L.] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, Fac Med, London W6 8LH, England	Imperial College London; University of Oxford	Murphy, CL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, Fac Med, 65 Aspenlea Rd, London W6 8LH, England.	c.murphy@imperial.ac.uk			Arthritis Research United Kingdom	Arthritis Research United Kingdom(Versus Arthritis)	This work was supported by Arthritis Research United Kingdom.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; BRIGHTON CT, 1971, J BONE JOINT SURG AM, VA 53, P719, DOI 10.2106/00004623-197153040-00011; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Gelse K, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2508; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hofbauer KH, 2003, EUR J BIOCHEM, V270, P4515, DOI 10.1046/j.1432-1033.2003.03846.x; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Katopodi T, 2009, BIOMATERIALS, V30, P535, DOI 10.1016/j.biomaterials.2008.09.064; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Lafont JE, 2008, J BIOL CHEM, V283, P4778, DOI 10.1074/jbc.M707729200; Lafont JE, 2007, ARTHRITIS RHEUM, V56, P3297, DOI 10.1002/art.22878; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Milner PJ, 2006, ARTHRITIS RHEUM-US, V54, P3523, DOI 10.1002/art.22209; Murphy CL, 2001, TISSUE ENG, V7, P791, DOI 10.1089/107632701753337735; Murphy CL, 2004, J CELL PHYSIOL, V199, P451, DOI 10.1002/jcp.10481; MURPHY CL, 2009, GENE DEV, V11, P213; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Poole AR, 2002, ANN RHEUM DIS, V61, P78, DOI 10.1136/ard.61.suppl_2.ii78; Semenza GL, 2000, GENE DEV, V14, P1983; SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Terkhorn SP, 2007, J CELL PHYSIOL, V210, P257, DOI 10.1002/jcp.20873; Willam C, 2006, J MOL CELL CARDIOL, V41, P68, DOI 10.1016/j.yjmcc.2006.04.009; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	38	29	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20472	20480		10.1074/jbc.M110.115238	http://dx.doi.org/10.1074/jbc.M110.115238			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20404338	hybrid, Green Published			2022-12-25	WOS:000279228600007
J	Hong, C; Duit, S; Jalonen, P; Out, R; Scheer, L; Sorrentino, V; Boyadjian, R; Rodenburg, KW; Foley, E; Korhonen, L; Lindholm, D; Nimpf, J; van Berkel, TJC; Tontonoz, P; Zelcer, N				Hong, Cynthia; Duit, Sarah; Jalonen, Pilvi; Out, Ruud; Scheer, Lilith; Sorrentino, Vincenzo; Boyadjian, Rima; Rodenburg, Kees W.; Foley, Edan; Korhonen, Laura; Lindholm, Dan; Nimpf, Johannes; van Berkel, Theo J. C.; Tontonoz, Peter; Zelcer, Noam			The E3 Ubiquitin Ligase IDOL Induces the Degradation of the Low Density Lipoprotein Receptor Family Members VLDLR and ApoER2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X-RECEPTORS; LEUCINE ZIPPER PROTEIN; LDL RECEPTOR; BRAIN; HYPERCHOLESTEROLEMIA; REELIN; PCSK9; MICE; GENE; MUTATIONS	We have previously identified the E3 ubiquitin ligase-inducible degrader of the low density lipoprotein receptor ( LDLR) ( Idol) as a post-translational modulator of LDLR levels. Idol is a direct target for regulation by liver X receptors (LXRs), and its expression is responsive to cellular sterol status independent of the sterol-response element-binding proteins. Here we demonstrate that Idol also targets two closely related LDLR family members, VLDLR and ApoE receptor 2 (ApoER2), proteins implicated in both neuronal development and lipid metabolism. Idol triggers ubiquitination of the VLDLR and ApoER2 on their cytoplasmic tails, leading to their degradation. We further show that the level of endogenous VLDLR is sensitive to cellular sterol content, Idol expression, and activation of the LXR pathway. Pharmacological activation of the LXR pathway in mice leads to increased Idol expression and to decreased Vldlr levels in vivo. Finally, we establish an unexpected functional link between LXR and Reelin signaling. We demonstrate that LXR activation results in decreased Reelin binding to VLDLR and reduced Dab1 phosphorylation. The identification of VLDLR and ApoER2 as Idol targets suggests potential roles for this LXR-inducible E3 ligase in the central nervous system in addition to lipid metabolism.	[Hong, Cynthia; Boyadjian, Rima; Tontonoz, Peter] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Hong, Cynthia; Boyadjian, Rima; Tontonoz, Peter] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Duit, Sarah; Nimpf, Johannes] Med Univ Vienna, Max F Perutz Lab, Dept Med Biochem, A-1030 Vienna, Austria; [Jalonen, Pilvi; Korhonen, Laura; Lindholm, Dan] Minerva Med Res Inst, Helsinki 00290, Finland; [Out, Ruud; van Berkel, Theo J. C.; Zelcer, Noam] Leiden Univ, Div Biopharmaceut, Leiden Amsterdam Ctr Drug Res, NL-2300 RA Leiden, Netherlands; [Foley, Edan] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada; [Rodenburg, Kees W.] Univ Utrecht, Dept Biol, Div Endocrinol & Metab, NL-3584 CH Utrecht, Netherlands; [Lindholm, Dan] Univ Helsinki, Inst Biomed Biochem, FIN-00014 Helsinki, Finland; [Scheer, Lilith; Sorrentino, Vincenzo; Zelcer, Noam] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Medical University of Vienna; Leiden University; Leiden University - Excl LUMC; University of Alberta; Utrecht University; University of Helsinki; University of Amsterdam; Academic Medical Center Amsterdam	Zelcer, N (corresponding author), Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	n.zelcer@amc.uva.nl	Korhonen, Laura/AAW-3256-2020; Van Berkel, Theo/ABD-7677-2021; Lindholm, Dan/B-3777-2014; Sorrentino, Vincenzo/R-4403-2018	Zelcer, Noam/0000-0001-6935-7532; Sorrentino, Vincenzo/0000-0002-7212-370X; Nimpf, Johannes/0000-0002-9273-3492; Korhonen, Laura/0000-0002-1837-5930	National Institutes of Health [HL066088, HL090553]; Canadian Institutes of Health Research; Alberta Heritage Foundation; Canada Research Chair in Innate Immunity; Academy of Finland; Sigrid Juselius Foundation; Fonds zur Forderung der Wissenschaftlichen Forschung; Herzfelder'sche Familienstiftung; Human Frontier Science Program Organization; Netherlands Organization for Scientific Research (NWO); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066088, P01HL090553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation(Alberta Heritage Foundation for Medical Research); Canada Research Chair in Innate Immunity; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Herzfelder'sche Familienstiftung; Human Frontier Science Program Organization(Human Frontier Science Program); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL066088 and HL090553 (to P.T.).; Supported by the Canadian Institutes of Health Research. Alberta Heritage Foundation for Medical Research Scholar. Canada Research Chair in Innate Immunity.; Supported by grants from the Academy of Finland and the Sigrid Juselius Foundation.; Supported by the Fonds zur Forderung der Wissenschaftlichen Forschung and the Herzfelder'sche Familienstiftung.; Supported by a Career Development Award from the Human Frontier Science Program Organization and by a VIDI grant from the Netherlands Organization for Scientific Research (NWO). To whom correspondence should be addressed: Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands. Tel.: 31-20-566-5131; Fax: 31-20-6915519; E-mail: n.zelcer@amc.uva.nl.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; Fan X, 2008, P NATL ACAD SCI USA, V105, P13445, DOI 10.1073/pnas.0806974105; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Hartfuss E, 2003, DEVELOPMENT, V130, P4597, DOI 10.1242/dev.00654; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer H, 2006, MOL CELL BIOL, V26, P19, DOI 10.1128/MCB.26.1.19-27.2006; Morales JR, 2008, CIRCULATION, V118, P1450, DOI 10.1161/CIRCULATIONAHA.108.782300; Olsson PA, 1999, J BIOL CHEM, V274, P36288, DOI 10.1074/jbc.274.51.36288; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Primrose DA, 2007, J CELL SCI, V120, P1189, DOI 10.1242/jcs.03417; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; RUSSELL DW, 1984, CELL, V37, P577, DOI 10.1016/0092-8674(84)90388-X; Sakai K, 2009, BRAIN RES, V1276, P11, DOI 10.1016/j.brainres.2009.04.030; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Sironi L, 2008, FEBS LETT, V582, P3396, DOI 10.1016/j.febslet.2008.08.035; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Tacken PJ, 2001, CURR OPIN LIPIDOL, V12, P275, DOI 10.1097/00041433-200106000-00006; TOLLESHAUG H, 1983, CELL, V32, P941, DOI 10.1016/0092-8674(83)90079-X; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Van Hoof D, 2002, J CELL SCI, V115, P4001, DOI 10.1242/jcs.00113; Yang XV, 2009, P NATL ACAD SCI USA, V106, P274, DOI 10.1073/pnas.0807594106; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	43	99	108	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19720	19726		10.1074/jbc.M110.123729	http://dx.doi.org/10.1074/jbc.M110.123729			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427281	Green Published, hybrid			2022-12-25	WOS:000279012000004
J	Huang, X; Dementiev, A; Olson, ST; Gettins, PGW				Huang, Xin; Dementiev, Alexey; Olson, Steven T.; Gettins, Peter G. W.			Basis for the Specificity and Activation of the Serpin Protein Z-dependent Proteinase Inhibitor (ZPI) as an Inhibitor of Membrane-associated Factor Xa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TICK ANTICOAGULANT PEPTIDE; COAGULATION FACTOR-XA; AMINO-ACID-SEQUENCE; ACTIVE-SITE; ALPHA(1)-PROTEINASE INHIBITOR; BINDING; PROTHROMBIN; SUBSTRATE; EXOSITE; COMPLEX	The serpin ZPI is a protein Z (PZ)-dependent specific inhibitor of membrane-associated factor Xa (fXa) despite having an unfavorable P1 Tyr. PZ accelerates the inhibition reaction similar to 2000-fold in the presence of phospholipid and Ca2+. To elucidate the role of PZ, we determined the x-ray structure of Gladomainless PZ (PZ(Delta GD)) complexed with protein Z-dependent proteinase inhibitor (ZPI). The PZ pseudocatalytic domain bound ZPI at a novel site through ionic and polar interactions. Mutation of four ZPI contact residues eliminated PZ binding and membrane-dependent PZ acceleration of fXa inhibition. Modeling of the ternary Michaelis complex implicated ZPI residues Glu-313 and Glu-383 in fXa binding. Mutagenesis established that only Glu-313 is important, contributing similar to 5-10-fold to rate acceleration of fXa and fXIa inhibition. Limited conformational change in ZPI resulted from PZ binding, which contributed only similar to 2-fold to rate enhancement. Instead, template bridging from membrane association, together with previously demonstrated interaction of the fXa and ZPI Gla domains, resulted in an additional similar to 1000-fold rate enhancement. To understand why ZPI has P1 tyrosine, we examined a P1 Arg variant. This reacted at a diffusion-limited rate with fXa, even without PZ, and predominantly as substrate, reflecting both rapid acylation and deacylation. P1 tyrosine thus ensures that reaction with fXa or most other arginine-specific proteinases is insignificant unless PZ binds and localizes ZPI and fXa on the membrane, where the combined effects of Gla-Gla interaction, template bridging, and interaction of fXa with Glu-313 overcome the unfavorability of P1 Tyr and ensure a high rate of reaction as an inhibitor.	[Huang, Xin; Olson, Steven T.; Gettins, Peter G. W.] Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60607 USA; [Dementiev, Alexey; Gettins, Peter G. W.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Olson, Steven T.; Gettins, Peter G. W.] Univ Illinois, Struct Biol Ctr, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Olson, ST (corresponding author), Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60607 USA.	stolson@uic.edu; pgettins@uic.edu		Huang, Xin/0000-0002-4730-9318	National Institutes of Health [HL49234, HL79430, HL78827]; American Heart Association [0920029G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888, R37HL049234, R01HL078827, R01HL079430, R01HL049234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL49234 and HL79430 ( to P. G. W. G.) and HL78827 ( to S. T. O.). This work was also supported by American Heart Association Fellowship 0920029G ( to X. H.).	Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; Bianchini EP, 2002, J BIOL CHEM, V277, P20527, DOI 10.1074/jbc.M201139200; BRANDSTETTER H, 1995, P NATL ACAD SCI USA, V92, P9796, DOI 10.1073/pnas.92.21.9796; BROZE GJ, 1984, J CLIN INVEST, V73, P933, DOI 10.1172/JCI111317; Calugaru SV, 2001, J BIOL CHEM, V276, P32446, DOI 10.1074/jbc.M104731200; Chandrasekaran V, 2008, PROTEIN SCI, V17, P1354, DOI 10.1110/ps.034801.108; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Futamura A, 1998, BIOCHEMISTRY-US, V37, P13110, DOI 10.1021/bi981234m; Gettins PGW, 2009, FEBS LETT, V583, P3397, DOI 10.1016/j.febslet.2009.10.005; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Han X, 1999, BIOCHEMISTRY-US, V38, P11073, DOI 10.1021/bi990641a; Han X, 2000, BLOOD, V96, P3049; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; HEEB MJ, 1993, J BIOL CHEM, V268, P2872; HOOD DB, 1994, BIOCHEMISTRY-US, V33, P8538, DOI 10.1021/bi00194a020; Huang X, 2008, J BIOL CHEM, V283, P29770, DOI 10.1074/jbc.M805214200; Huntington JA, 1998, BIOCHEMISTRY-US, V37, P3272, DOI 10.1021/bi972182o; ICHINOSE A, 1990, BIOCHEM BIOPH RES CO, V172, P1139, DOI 10.1016/0006-291X(90)91566-B; JORDAN SP, 1992, BIOCHEMISTRY-US, V31, P5374, DOI 10.1021/bi00138a019; Lee CJ, 2007, J THROMB HAEMOST, V5, P1558, DOI 10.1111/j.1538-7836.2007.02597.x; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSESTUEN GL, 1977, BIOCHEMISTRY-US, V16, P4164, DOI 10.1021/bi00638a005; NGAI PK, 1991, BIOCHEM J, V280, P805, DOI 10.1042/bj2800805; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; Olson Steven T., 1994, Perspectives in Drug Discovery and Design, V1, P479, DOI 10.1007/BF02171861; Rezaie AR, 2008, J BIOL CHEM, V283, P19922, DOI 10.1074/jbc.M802639200; Rezaie AR, 2006, BIOCHEMISTRY-US, V45, P9427, DOI 10.1021/bi060820+; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Rezaie AR, 2005, J BIOL CHEM, V280, P32722, DOI 10.1074/jbc.M505517200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Swanson R, 2007, J BIOL CHEM, V282, P2305, DOI 10.1074/jbc.M609546200; Wei AZ, 1998, J MOL BIOL, V283, P147, DOI 10.1006/jmbi.1998.2069; Wei ZQ, 2009, BLOOD, V114, P3662, DOI 10.1182/blood-2009-04-210021	39	37	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20399	20409		10.1074/jbc.M110.112748	http://dx.doi.org/10.1074/jbc.M110.112748			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427285	hybrid, Green Published			2022-12-25	WOS:000279012000073
J	Ye, Y; Pringle, LM; Lau, AW; Riquelme, DN; Wang, H; Jiang, T; Lev, D; Welman, A; Blobel, GA; Oliveira, AM; Chou, MM				Ye, Y.; Pringle, L. M.; Lau, A. W.; Riquelme, D. N.; Wang, H.; Jiang, T.; Lev, D.; Welman, A.; Blobel, G. A.; Oliveira, A. M.; Chou, M. M.			TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappa B	ONCOGENE			English	Article						TRE17/USP6; aneurysmal bone cyst; MMP-9; Arf6; NF-kappa B; RhoA	ENDOTHELIAL GROWTH-FACTOR; IN-SITU HYBRIDIZATION; DEUBIQUITINATING ENZYME; MATRIX-METALLOPROTEINASE-9 EXPRESSION; STROMELYSIN-2 MMP-10; UBIQUITIN LIGASE; CARCINOMA CELLS; CDC42 GTPASES; RHO-GTPASES; PATHWAY	Aneurysmal bone cyst (ABC) is an aggressive, pediatric bone tumor characterized by extensive destruction of the surrounding bone. Although first described over 60 years ago, its molecular etiology remains poorly understood. Recent work revealed that ABCs harbor translocation of TRE17/USP6, leading to its transcriptional upregulation. TRE17 encodes a ubiquitin-specific protease (USP), and a TBC domain that mediates binding to the Arf6 GTPase. However, the mechanisms by which TRE17 overexpression contributes to tumor pathogenesis, and the role of its USP and TBC domains, are unknown. ABCs are characterized by osteolysis, inflammatory recruitment and extensive vascularization, the processes in which matrix proteases have a prominent role. This led us to explore whether TRE17 regulates the production of matrix metalloproteinases ( MMPs). In this study we show that TRE17 is sufficient to induce expression of MMP-9 and MMP-10, in a manner requiring its USP activity, but not its ability to bind Arf6. TRE17 induces transcription of MMP-9 through activation of nuclear factor-kappa B (NF-kappa B), mediated in part by the GTPase RhoA and its effector kinase, ROCK. Furthermore, xenograft studies show that TRE17 induces formation of tumors that reproduce multiple features of ABC, including a high degree of vascularization, with an essential role for the USP domain. In sum, these studies reveal that TRE17 is sufficient to initiate tumorigenesis, identify MMPs as novel TRE17 effectors that likely contribute to ABC pathogenesis and define the underlying signaling mechanism of their induction. Oncogene ( 2010) 29, 3619-3629; doi: 10.1038/onc.2010.116; published online 26 April 2010	[Ye, Y.; Pringle, L. M.; Lau, A. W.; Riquelme, D. N.; Chou, M. M.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wang, H.; Blobel, G. A.] Univ Penn, Childrens Hosp Philadelphia, Div Pediat, Sch Med, Philadelphia, PA 19104 USA; [Jiang, T.] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Lev, D.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Welman, A.] Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland; [Oliveira, A. M.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Edinburgh; Mayo Clinic	Chou, MM (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Sch Med, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	mmc@mail.med.upenn.edu			NIH [CA081415, DK58044, P30 AR050950]; Mayo Foundation; Pennsylvania Muscle Institute; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R01CA081415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058044, R01DK058044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Pennsylvania Muscle Institute; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIH Grants CA081415 (MMC), DK58044 (GAB) and P30 AR050950 (Penn Center for Musculoskeletal Disorders). Additional support was from the Mayo Foundation CR20 Program (AMO), the Pennsylvania Muscle Institute Pilot Project Grant (MMC) and the Pennsylvania Department of Health (MMC), which specifically disclaims responsibility for any analysis, interpretations or conclusions. We thank Yvette Liu for invaluable assistance with bioluminescence imaging.	Althof PA, 2004, MODERN PATHOL, V17, P518, DOI 10.1038/modpathol.3800090; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965; Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P3244, DOI 10.1002/art.22167; Benitah SA, 2003, MOL BIOL CELL, V14, P3041, DOI 10.1091/mbc.E03-01-0016; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bizimungu C, 2005, BIOCHEM BIOPH RES CO, V335, P883, DOI 10.1016/j.bbrc.2005.07.159; Bizimungu C, 2007, BIOTECHNOL LETT, V29, P1927, DOI 10.1007/s10529-007-9475-6; Bord S, 1998, BONE, V23, P7, DOI 10.1016/S8756-3282(98)00064-7; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Bryan B, 2005, FEBS LETT, V579, P1015, DOI 10.1016/j.febslet.2004.12.074; Cho A, 2000, ARTERIOSCL THROM VAS, V20, P2527, DOI 10.1161/01.ATV.20.12.2527; Cottalorda J, 2007, ARCH ORTHOP TRAUM SU, V127, P105, DOI 10.1007/s00402-006-0223-5; Cui RW, 2006, CIRC RES, V99, P723, DOI 10.1161/01.RES.0000244015.10655.3f; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Genersch E, 2000, J CELL SCI, V113, P4319; Ghajar CM, 2008, CRIT REV EUKAR GENE, V18, P251, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.30; Giambernardi TA, 1998, MATRIX BIOL, V16, P483, DOI 10.1016/S0945-053X(98)90019-1; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Haeusler G, 2005, CALCIFIED TISSUE INT, V76, P326, DOI 10.1007/s00223-004-0161-6; Han SW, 2006, J BIOL CHEM, V281, P29614, DOI 10.1074/jbc.M604013200; John Anitha, 2001, Pathology and Oncology Research, V7, P14; Kanangat S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2086; Kim KC, 2005, ARCH PHARM RES, V28, P1257, DOI 10.1007/BF02978209; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Krampert M, 2004, MOL BIOL CELL, V15, P5242, DOI 10.1091/mbc.E04-02-0109; Kumta SM, 2003, LIFE SCI, V73, P1427, DOI 10.1016/S0024-3205(03)00434-X; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Liu J, 2006, MOL CANCER RES, V4, P803, DOI 10.1158/1541-7786.MCR-06-0201; Martinu L, 2004, MOL CELL BIOL, V24, P9752, DOI 10.1128/MCB.24.22.9752-9762.2004; Masuda-Robens JM, 2003, MOL CELL BIOL, V23, P2151, DOI 10.1128/MCB.23.6.2151-2161.2003; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Nakakuki T, 2005, ARTERIOSCL THROM VAS, V25, P2088, DOI 10.1161/01.ATV.0000183607.50230.9f; NAKAMURA T, 1992, ONCOGENE, V7, P733; Nielsen GP, 2002, AM J SURG PATHOL, V26, P64, DOI 10.1097/00000478-200201000-00007; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Oliveira AM, 2005, ONCOGENE, V24, P3419, DOI 10.1038/sj.onc.1208506; Oliveira AM, 2004, CANCER RES, V64, P1920, DOI 10.1158/0008-5472.CAN-03-2827; Oliveira AM, 2004, AM J PATHOL, V165, P1773, DOI 10.1016/S0002-9440(10)63432-3; Onodera S, 2002, J BIOL CHEM, V277, P7865, DOI 10.1074/jbc.M106020200; Panoutsakopoulos G, 1999, GENE CHROMOSOME CANC, V26, P265, DOI 10.1002/(SICI)1098-2264(199911)26:3<265::AID-GCC12>3.0.CO;2-#; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Paulding CA, 2003, P NATL ACAD SCI USA, V100, P2507, DOI 10.1073/pnas.0437015100; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Saccomanni B, 2008, ARCH ORTHOP TRAUM SU, V128, P1145, DOI 10.1007/s00402-007-0477-6; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; Shen CL, 2005, J BIOL CHEM, V280, P35967, DOI 10.1074/jbc.M505220200; Shinde A, 2006, PEDIATR DEVEL PATHOL, V9, P38, DOI 10.2350/06-05-0070.1; Singhal S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S3; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Subramaniam M, 2002, J CELL BIOCHEM, V87, P9, DOI 10.1002/jcb.10259; Sukov WR, 2008, SKELETAL RADIOL, V37, P321, DOI 10.1007/s00256-007-0442-z; Tolboom TCA, 2002, ANN RHEUM DIS, V61, P975, DOI 10.1136/ard.61.11.975; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang HR, 2006, METHOD ENZYMOL, V406, P437, DOI 10.1016/S0076-6879(06)06032-0; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Welman A, 2006, NEOPLASIA, V8, P905, DOI 10.1593/neo.06475; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yamaguchi T, 2007, J BIOL CHEM, V282, P33943, DOI 10.1074/jbc.M706282200; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	67	102	107	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 24	2010	29	25					3619	3629		10.1038/onc.2010.116	http://dx.doi.org/10.1038/onc.2010.116			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	615CG	20418905	Green Accepted			2022-12-25	WOS:000279108600003
J	Kos, V; Whitfield, C				Kos, Veronica; Whitfield, Chris			A Membrane-located Glycosyltransferase Complex Required for Biosynthesis of the D-Galactan I Lipopolysaccharide O Antigen in Klebsiella pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE-ASSOCIATED COMPLEX; SIGNAL RECOGNITION PARTICLE; LARGE RIBOSOMAL-SUBUNIT; NASCENT CHAINS; ENDOPLASMIC-RETICULUM; TRANSLATING RIBOSOME; TRANSCRIPTION FACTOR; PROTEIN IMPORT; ALPHA-SUBUNIT; BETA-NAC	D-Galactan I is a polysaccharide with the disaccharide repeat unit structure [-> 3-beta-D-Galf-(1-3)-alpha-D-Galp-(1 ->]. This glycan represents the lipopolysaccharide O antigen found in many Gram-negative bacteria, including several Klebsiella pneumoniae O serotypes. The polysaccharide is synthesized in the cytoplasm prior to its export via an ATP-binding cassette transporter. Sequence analysis predicts three galactosyltransferases in the D-galactan I genetic locus. They are WbbO (belonging to glycosyltransferase (GT) family 4), WbbM (GT-family 8), and WbbN (GT-family 2). The WbbO and WbbM proteins are each predicted to contain two domains, with the GT modules located toward their C termini. The N-terminal domains of WbbO and WbbM exhibit no similarity to proteins with known function. In vivo complementation assays suggest that all three glycosyltransferases are required for D-galactan I biosynthesis. Using a bacterial two-hybrid system and confirmatory co-purification strategies, evidence is provided for protein-protein interactions among the glycosyltransferases, creating a membrane-located enzyme complex dedicated to D-galactan I biosynthesis.	[Kos, Veronica; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca						Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beatrix B, 2000, J BIOL CHEM, V275, P37838, DOI 10.1074/jbc.M006368200; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Bingel-Erlenmeyer R, 2008, NATURE, V452, P108, DOI 10.1038/nature06683; Blau M, 2005, NAT STRUCT MOL BIOL, V12, P1015, DOI 10.1038/nsmb998; Bloss TA, 2003, NATURE, V424, P1066, DOI 10.1038/nature01920; Creagh EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005055; DENG JM, 1995, TRANSGENIC RES, V4, P264, DOI 10.1007/BF01969120; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Franke J, 2001, J CELL SCI, V114, P2641; Funfschilling U, 1999, MOL BIOL CELL, V10, P3289, DOI 10.1091/mbc.10.10.3289; George R, 2002, FEBS LETT, V516, P213, DOI 10.1016/S0014-5793(02)02528-0; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hotokezaka Y, 2009, CELL DEATH DIFFER, V16, P1505, DOI 10.1038/cdd.2009.90; Kim SH, 2002, J INVEST MED, V50, P293, DOI 10.2310/6650.2002.33287; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Kroes RA, 2000, CANCER LETT, V156, P191, DOI 10.1016/S0304-3835(00)00462-6; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Lauring B, 1995, COLD SPRING HARB SYM, V60, P47, DOI 10.1101/SQB.1995.060.01.008; LAURING B, 1995, P NATL ACAD SCI USA, V92, P5411, DOI 10.1073/pnas.92.12.5411; LAURING B, 1995, P NATL ACAD SCI USA, V92, P9435, DOI 10.1073/pnas.92.21.9435; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; Lithgow T, 2000, FEBS LETT, V476, P22, DOI 10.1016/S0014-5793(00)01663-X; Makarova KS, 1999, GENOME RES, V9, P608; Markesich DC, 2000, DEVELOPMENT, V127, P559; Moller I, 1998, P NATL ACAD SCI USA, V95, P13425, DOI 10.1073/pnas.95.23.13425; Peisker K, 2008, MOL BIOL CELL, V19, P5279, DOI 10.1091/mbc.E08-06-0661; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; Reimann B, 1999, YEAST, V15, P397, DOI 10.1002/(SICI)1097-0061(19990330)15:5<397::AID-YEA384>3.3.CO;2-L; Rospert S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-208; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Sambrook J., 2002, MOL CLONING LAB MANU; Scheuring UJ, 1998, AIDS, V12, P563, DOI 10.1097/00002030-199806000-00004; Spreter T, 2005, J BIOL CHEM, V280, P15849, DOI 10.1074/jbc.M500160200; WANG S, 1995, J CELL BIOL, V130, P519, DOI 10.1083/jcb.130.3.519; Wegrzyn RD, 2006, J BIOL CHEM, V281, P2847, DOI 10.1074/jbc.M511420200; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Yogev O, 2007, J BIOL CHEM, V282, P29222, DOI 10.1074/jbc.M704201200; Yotov WV, 1998, MOL CELL BIOL, V18, P1303, DOI 10.1128/MCB.18.3.1303; Yotov WV, 1996, GENE DEV, V10, P1763, DOI 10.1101/gad.10.14.1763	48	22	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19668	19687		10.1074/jbc.M110.122598	http://dx.doi.org/10.1074/jbc.M110.122598			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410291	Green Published, hybrid			2022-12-25	WOS:000278727800076
J	Orlichenko, L; Geyer, R; Yanagisawa, M; Khauv, D; Radisky, ES; Anastasiadis, PZ; Radisky, DC				Orlichenko, Lidiya; Geyer, Rory; Yanagisawa, Masahiro; Khauv, Davitte; Radisky, Evette S.; Anastasiadis, Panos Z.; Radisky, Derek C.			The 19-Amino Acid Insertion in the Tumor-associated Splice Isoform Rac1b Confers Specific Binding to p120 Catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; COLORECTAL-CANCER CELLS; HUMAN P120(CTN) CATENIN; NUCLEAR-LOCALIZATION; BETA-CATENIN; RHO-GTPASES; CRYSTALLOGRAPHIC ANALYSIS; ELECTROPHORETIC TRANSFER; POLYACRYLAMIDE GELS; INTRINSIC DISORDER	The Rac1b splice isoform contains a 19-amino acid insertion not found in Rac1; this insertion leads to decreased GTPase activity and reduced affinity for GDP, resulting in the intracellular predominance of GTP-bound Rac1b. Here, using co-precipitation and proteomic methods, we find that Rac1b does not bind to many common regulators of Rho family GTPases but that it does display enhanced binding to SmgGDS, RACK1, and p120 catenin (p120(ctn)), proteins involved in cell-cell adhesion, motility, and transcriptional regulation. We use molecular modeling and structure analysis approaches to determine that the interaction between Rac1b and p120(ctn) is dependent upon protein regions that are predicted to be unstructured in the absence of molecular complex formation, suggesting that the interaction between these two proteins involves coupled folding and binding. We also find that directed cell movement initiated by Rac1b is dependent upon p120. These results define a distinct binding functionality of Rac1b and provide insight into how the distinct phenotypic program activated by this protein may be implemented through molecular recognition of effectors distinct from those of Rac1.	[Orlichenko, Lidiya; Geyer, Rory; Yanagisawa, Masahiro; Khauv, Davitte; Radisky, Evette S.; Anastasiadis, Panos Z.; Radisky, Derek C.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Radisky, DC (corresponding author), Mayo Clin, Dept Canc Biol, Griffin 331,4500 San Pablo Rd S, Jacksonville, FL 32224 USA.	radisky.derek@mayo.edu	Radisky, Evette S/C-8526-2012; Radisky, Derek/B-6569-2018	Radisky, Evette S/0000-0003-3121-109X; Radisky, Derek/0000-0002-1962-8784	National Institutes of Health [CA122086, CA128660, CA100467]; Susan B. Komen Foundation [FAS0703855]; Mayo Clinic [CA116201]; NATIONAL CANCER INSTITUTE [P50CA116201, R01CA100467, R21CA128660, R01CA122086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan B. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Mayo Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA122086 (to D. C. R.), CA128660 (to Celeste M. Nelson and D. C. R.), and CA100467 (to P. Z. A.). This work was also supported by Susan B. Komen Foundation Grant FAS0703855 (to Celeste M. Nelson and D. C. R.) and by the Mayo Clinic Breast Cancer Specialized Program of Research Excellence (SPORE) Grant CA116201 (to James Ingle).	Aho S, 1999, J CELL BIOCHEM, V73, P390, DOI 10.1002/(SICI)1097-4644(19990601)73:3<390::AID-JCB10>3.3.CO;2-T; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Biou V, 2004, BIOCHEMISTRY-US, V43, P6833, DOI 10.1021/bi049630u; Boguslavsky S, 2007, P NATL ACAD SCI USA, V104, P10882, DOI 10.1073/pnas.0702731104; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Chattopadhyay N, 2003, J CELL BIOL, V163, P1351, DOI 10.1083/jcb.200306067; Choi HJ, 2005, J MOL BIOL, V346, P367, DOI 10.1016/j.jmb.2004.11.048; CHUANG TH, 1994, BIOCHEM J, V303, P761, DOI 10.1042/bj3030761; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Corbett KD, 2001, TRENDS BIOCHEM SCI, V26, P710, DOI 10.1016/S0968-0004(01)01974-0; Cozzolino M, 2003, MOL BIOL CELL, V14, P1964, DOI 10.1091/mbc.E02-08-0469; Dachsel JC, 2007, PARKINSONISM RELAT D, V13, P382, DOI 10.1016/j.parkreldis.2007.01.008; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Esufali S, 2007, FEBS LETT, V581, P4850, DOI 10.1016/j.febslet.2007.09.013; Esufali S, 2007, CANCER RES, V67, P2469, DOI 10.1158/0008-5472.CAN-06-2843; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Graham TA, 2002, MOL CELL, V10, P563, DOI 10.1016/S1097-2765(02)00637-8; Graham TA, 2001, NAT STRUCT BIOL, V8, P1048, DOI 10.1038/nsb718; Grosheva I, 2001, J CELL SCI, V114, P695; Hirai Y, 2007, BLOOD, V110, P3082, DOI 10.1182/blood-2007-06-095372; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lozano E, 2008, J CELL SCI, V121, P933, DOI 10.1242/jcs.016121; Mamidipudi V, 2007, ONCOGENE, V26, P2914, DOI 10.1038/sj.onc.1210091; Matos P, 2006, J BIOL CHEM, V281, P13724, DOI 10.1074/jbc.M513243200; Matos P, 2005, EXP CELL RES, V305, P292, DOI 10.1016/j.yexcr.2004.12.029; Matos P, 2003, J BIOL CHEM, V278, P50442, DOI 10.1074/jbc.M308215200; Matos P, 2008, GASTROENTEROLOGY, V135, P899, DOI 10.1053/j.gastro.2008.05.052; Matos P, 2008, MOL CANCER RES, V6, P1178, DOI 10.1158/1541-7786.MCR-08-0008; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Miller LD, 2004, ONCOGENE, V23, P5682, DOI 10.1038/sj.onc.1207735; Nelson CM, 2008, J CELL BIOCHEM, V105, P25, DOI 10.1002/jcb.21821; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Orlichenko L, 2006, J BIOL CHEM, V281, P4570, DOI 10.1074/jbc.M512088200; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Sprang S R, 2000, Sci STKE, V2000, ppe1; Stallings-Mann M, 2007, CELLS TISSUES ORGANS, V185, P104, DOI 10.1159/000101310; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vikis HG, 2002, ONCOGENE, V21, P2425, DOI 10.1038/sj.onc.1205306; YAMAMOTO T, 1990, J BIOL CHEM, V265, P16626; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022	68	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19153	19161		10.1074/jbc.M109.099382	http://dx.doi.org/10.1074/jbc.M109.099382			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20395297	Green Published, hybrid			2022-12-25	WOS:000278727800025
J	Sadre, R; Frentzen, M; Saeed, M; Hawkes, T				Sadre, Radin; Frentzen, Margrit; Saeed, Mansoor; Hawkes, Tim			Catalytic Reactions of the Homogentisate Prenyl Transferase Involved in Plastoquinone-9 Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUINONE BIOSYNTHESIS; POLYPRENYLTRANSFERASE	Homogentisate solanesyl transferase (HST) catalyzes the prenylation and decarboxylation of homogentisate to form 2-methyl6-solanesyl-1,4-benzoquinol, the first intermediate in plastoquinone-9 biosynthesis. In vitro, HST from Spinacia oleracea L., Arabidopsis thaliana, and Chlamydomonas reinhardtii were all found to use not only solanesyl diphosphate but also short chain prenyl diphosphates of 10-20 carbon atoms as prenyl donors. Surprisingly, with these donors, prenyl transfer was largely decoupled from decarboxylation, and thus the major products were 6-prenyl-1,4-benzoquinol-2-methylcarboxylates rather than the expected 2-methyl-6-prenyl-1,4-benzoquinols. The 6-prenyl-1,4-benzoquinol-2-methylcarboxylates were not substrates for HST-catalyzed decarboxylation, and the enzyme kinetics associated with forming these products appeared quite distinct from those for 2-methyl-6-prenyl-1,4-benzoquinol formation in respect of catalytic rate, substrate K-m value, and the pattern of inhibition by haloxydine, a molecule that appeared to act as a dead end mimic of homogentisate. These observations were reconciled into a simple model for the HST mechanism. Here, prenyl diphosphate binds to HST to form at least two alternative complexes that go on to react differently with homogentisate and prenylate it either with or without it first being decarboxylated. It is supposed that solanesyl diphosphate binds tightly and preferentially in the mode that compels prenylation with decarboxylation.	[Sadre, Radin; Frentzen, Margrit] Rhein Westfal TH Aachen, Inst Biol 1, D-52056 Aachen, Germany; [Saeed, Mansoor; Hawkes, Tim] Syngenta Ltd, Dept Biosci, Jealotts Hill Res Stn, Bracknell RG42 6EY, Berks, England	RWTH Aachen University; Syngenta	Sadre, R (corresponding author), Rhein Westfal TH Aachen, Inst Biol 1, Worringerweg 1, D-52056 Aachen, Germany.	rsadre@bio1.rwth-aachen.de		Sadre, Radin/0000-0002-8412-2579				[Anonymous], METHODS CHLOROPLAST; Brauer L, 2008, CHEMBIOCHEM, V9, P982, DOI 10.1002/cbic.200700575; Cheng ZG, 2003, PLANT CELL, V15, P2343, DOI 10.1105/tpc.013656; CLELAND WW, 1982, CRC CR REV BIOCH MOL, V13, P385; FISHER KJ, 1995, Patent No. 5728650; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; HAWKES TR, 2007, MODERN CROP PROTECTI, P211; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; KAWAHARA K, 1991, AGR BIOL CHEM TOKYO, V55, P2307, DOI 10.1080/00021369.1991.10870951; MELZER M, 1994, BBA-LIPID LIPID MET, V1212, P93, DOI 10.1016/0005-2760(94)90193-7; MISITI D, 1965, J AM CHEM SOC, V87, P1402, DOI 10.1021/ja01084a058; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Ohara K, 2006, PLANT CELL PHYSIOL, V47, P581, DOI 10.1093/pcp/pcj025; Sadre R, 2006, FEBS LETT, V580, P5357, DOI 10.1016/j.febslet.2006.09.002; SOLL J, 1985, ARCH BIOCHEM BIOPHYS, V238, P290, DOI 10.1016/0003-9861(85)90167-5; Tian L, 2007, PLANTA, V226, P1067, DOI 10.1007/s00425-007-0564-5; TOMLIN CDS, 1969, Patent No. 1161491	17	23	25	7	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18191	18198		10.1074/jbc.M110.117929	http://dx.doi.org/10.1074/jbc.M110.117929			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400515	Green Published, hybrid			2022-12-25	WOS:000278453900010
J	Majava, V; Polverini, E; Mazzini, A; Nanekar, R; Knoll, W; Peters, J; Natali, F; Baumgartel, P; Kursula, I; Kursula, P				Majava, Viivi; Polverini, Eugenia; Mazzini, Alberto; Nanekar, Rahul; Knoll, Wiebke; Peters, Judith; Natali, Francesca; Baumgaertel, Peter; Kursula, Inari; Kursula, Petri			Structural and Functional Characterization of Human Peripheral Nervous System Myelin Protein P2	PLOS ONE			English	Article							LIPID-BINDING PROTEINS; T-CELL EPITOPE; FATTY-ACID; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; P-2 PROTEIN; FAMILY; P2-PROTEIN; TRANSPORT; MODEL	The myelin sheath is a tightly packed multilayered membrane structure insulating selected axons in the central and the peripheral nervous systems. Myelin is a biochemically unique membrane, containing a specific set of proteins. In this study, we expressed and purified recombinant human myelin P2 protein and determined its crystal structure to a resolution of 1.85 angstrom. A fatty acid molecule, modeled as palmitate based on the electron density, was bound inside the barrel-shaped protein. Solution studies using synchrotron radiation indicate that the crystal structure is similar to the structure of the protein in solution. Docking experiments using the high-resolution crystal structure identified cholesterol, one of the most abundant lipids in myelin, as a possible ligand for P2, a hypothesis that was proven by fluorescence spectroscopy. In addition, electrostatic potential surface calculations supported a structural role for P2 inside the myelin membrane. The potential membrane-binding properties of P2 and a peptide derived from its N terminus were studied. Our results provide an enhanced view into the structure and function of the P2 protein from human myelin, which is able to bind both monomeric lipids inside its cavity and membrane surfaces.	[Majava, Viivi; Nanekar, Rahul; Kursula, Petri] Univ Oulu, Dept Biochem, Oulu, Finland; [Polverini, Eugenia; Mazzini, Alberto] Univ Parma, Dept Phys, I-43100 Parma, Italy; [Knoll, Wiebke; Peters, Judith; Natali, Francesca] Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France; [Knoll, Wiebke; Peters, Judith] Univ Grenoble 1, Grenoble, France; [Peters, Judith] Inst Biol Struct, Grenoble, France; [Natali, Francesca] Operat Grp Grenoble, Consiglio Nazl Ric, Grenoble, France; [Baumgaertel, Peter] Helmholtz Zentrum Berlin, BESSY 2, Berlin, Germany; [Kursula, Inari; Kursula, Petri] Helmholtz Ctr Infect Res, Ctr Struct Syst Biol, Braunschweig, Germany; [Kursula, Inari; Kursula, Petri] Univ Hamburg, Hamburg, Germany	Finland National Institute for Health & Welfare; University of Oulu; University of Parma; Institut Laue-Langevin (ILL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Helmholtz Association; Helmholtz-Center for Infection Research; University of Hamburg	Majava, V (corresponding author), Univ Oulu, Dept Biochem, Oulu, Finland.	petri.kursula@oulu.fi	Peters, Judith/M-3817-2019; Kursula, Petri/AAF-4563-2020; Kursula, Petri/K-1058-2012; Kursula, Inari/AHB-9980-2022; Kursula, Inari/F-7140-2013	Peters, Judith/0000-0001-5151-7710; Kursula, Petri/0000-0001-8529-3751; Kursula, Petri/0000-0001-8529-3751; Kursula, Inari/0000-0001-5236-7056; Kursula, Inari/0000-0001-5236-7056	Academy of Finland; Multiple Sclerosis Foundation of Finland; Sigrid Juselius Foundation (Finland); Department of Biochemistry, University of Oulu (Finland); European Community [RII3-CT-2004-506008]	Academy of Finland(Academy of Finland); Multiple Sclerosis Foundation of Finland; Sigrid Juselius Foundation (Finland)(Sigrid Juselius Foundation); Department of Biochemistry, University of Oulu (Finland); European Community(European Commission)	This study has been financially supported by the Academy of Finland, the Multiple Sclerosis Foundation of Finland, the Sigrid Juselius Foundation (Finland), the Department of Biochemistry, University of Oulu (Finland), and the European Community (Research Infrastructure Action under the FP6 "Structuring the European Research Area" Programme, contract RII3-CT-2004-506008 (IA-SFS)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BANASZAK L, 1994, ADV PROTEIN CHEM, V45, P89; BROSTOFF SW, 1980, NATURE, V285, P103, DOI 10.1038/285103a0; Bulheller BM, 2009, BIOINFORMATICS, V25, P539, DOI 10.1093/bioinformatics/btp016; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; COWAN SW, 1993, J MOL BIOL, V230, P1225, DOI 10.1006/jmbi.1993.1238; DEARMOND SJ, 1980, J HISTOCHEM CYTOCHEM, V28, P1275, DOI 10.1177/28.12.6785343; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GREENFIELD S, 1973, J NEUROCHEM, V20, P1207, DOI 10.1111/j.1471-4159.1973.tb00089.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hammarstrom Martin, 2006, Journal of Structural and Functional Genomics, V7, P1, DOI 10.1007/s10969-005-9003-7; Hohoff C, 1999, BIOCHEMISTRY-US, V38, P12229, DOI 10.1021/bi990305u; HORROCKS LA, 1967, J LIPID RES, V8, P569; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter DJB, 2005, ACTA CRYSTALLOGR D, V61, P1067, DOI 10.1107/S0907444905014162; Inglis HR, 2007, J NEUROL NEUROSUR PS, V78, P419, DOI 10.1136/jnnp.2006.106617; JONES TA, 1988, EMBO J, V7, P1597, DOI 10.1002/j.1460-2075.1988.tb02985.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KHALILISHIRAZI A, 1993, J NEUROIMMUNOL, V46, P245, DOI 10.1016/0165-5728(93)90255-W; KNOLL W, 2010, SPECTROSCOPY; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kursula P, 2008, AMINO ACIDS, V34, P175, DOI 10.1007/s00726-006-0479-7; Kursula P., 2004, J APPL CRYSTALLOGR, V37, P347; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Likic VA, 2000, PROTEIN SCI, V9, P497; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; MAJAVA V, 2010, AMINO ACIDS; Makowska A, 2008, J NEUROL NEUROSUR PS, V79, P664, DOI 10.1136/jnnp.2007.123943; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nesgaard LW, 2008, BIOPOLYMERS, V89, P779, DOI 10.1002/bip.21011; OLEE T, 1990, J NEUROIMMUNOL, V27, P187, DOI 10.1016/0165-5728(90)90068-X; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Polverini E, 2006, J STRUCT BIOL, V153, P253, DOI 10.1016/j.jsb.2005.11.010; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rich MR, 1996, BIOCHEMISTRY-US, V35, P1506, DOI 10.1021/bi951574x; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; ROSTAMI A, 1991, CELL IMMUNOL, V132, P433, DOI 10.1016/0008-8749(91)90040-I; Sanvito L, 2009, J NEUROL NEUROSUR PS, V80, P333, DOI 10.1136/jnnp.2008.159798; Sapay N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-255; Schaap FG, 2002, MOL CELL BIOCHEM, V239, P69, DOI 10.1023/A:1020519011939; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sedzik J, 2003, J STRUCT BIOL, V142, P292, DOI 10.1016/S1047-8477(03)00031-5; SHAW MK, 1965, J BACTERIOL, V90, P141, DOI 10.1128/JB.90.1.141-146.1965; Stienekemeier M, 2001, P NATL ACAD SCI USA, V98, P13872, DOI 10.1073/pnas.241504598; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Thompson J, 1999, MOL CELL BIOCHEM, V192, P9, DOI 10.1023/A:1006806616963; TRAPP BD, 1983, J NEUROCHEM, V40, P47, DOI 10.1111/j.1471-4159.1983.tb12651.x; TRAPP BD, 1979, P NATL ACAD SCI USA, V76, P3552, DOI 10.1073/pnas.76.7.3552; TRAPP BD, 1984, J NEUROCHEM, V43, P944, DOI 10.1111/j.1471-4159.1984.tb12828.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; UYEMURA K, 1982, J NEUROCHEM, V39, P895, DOI 10.1111/j.1471-4159.1982.tb07979.x; Uyemura K, 1978, Adv Exp Med Biol, V100, P95; UYEMURA K, 1984, NEUROCHEM RES, V9, P1509, DOI 10.1007/BF00964676; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WAKSMAN BH, 1955, J EXP MED, V102, P213, DOI 10.1084/jem.102.2.213; WINTER J, 1982, J NEUROCYTOL, V11, P351, DOI 10.1007/BF01257982; Xu Z, 2008, BIOCHEMISTRY-US, V47, P11134, DOI 10.1021/bi801328u	67	45	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10300	10.1371/journal.pone.0010300	http://dx.doi.org/10.1371/journal.pone.0010300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421974	Green Published, Green Submitted, gold			2022-12-25	WOS:000276952600017
J	Gutierrez-Reyes, G; de Leon, MDG; Varela-Fascinetto, G; Valencia, P; Tamayo, RP; Rosado, CG; Labonne, BF; Rochilin, NM; Garcia, RM; Valadez, JA; Latour, GT; Corona, DL; Diaz, GR; Zlotnik, A; Kershenobich, D				Gutierrez-Reyes, Gabriela; del Carmen Garcia de Leon, Maria; Varela-Fascinetto, Gustavo; Valencia, Pedro; Perez Tamayo, Ruy; Gonzalez Rosado, Claudia; Farfan Labonne, Blanca; Morales Rochilin, Norma; Martinez Garcia, Rosalinda; Aguirre Valadez, Jonathan; Togno Latour, Gabriela; Lau Corona, Dana; Robles Diaz, Guillermo; Zlotnik, Albert; Kershenobich, David			Cellular Senescence in Livers from Children with End Stage Liver Disease	PLOS ONE			English	Article							REPLICATIVE SENESCENCE; DNA-DAMAGE; HEPATITIS-C; CELLS; EXPRESSION; HEPATOCYTES; P16(INK4A); BIOMARKER; MARKERS; REPAIR	Background: Senescent cells occur in adults with cirrhotic livers independent of the etiology. Aim: Investigate the presence rate of cellular senescence and expression of cell cycle check points in livers from children with end stage disease. Methodology/Principal Findings: Livers of five children aged three years or less undergoing liver transplantation due to tyrosinemia (n = 1), biliary atresia (n = 2), or fulminant hepatitis (n = 2) were analyzed for senescence associated beta-galactosidase (SA-beta gal) activity and p16INK4a, p21cip1 and p53. All livers displayed positive cellular staining for SA-beta gal in the canals of Hering and interlobular biliary ducts. In the presence of cirrhosis (3/5 cases) SA-beta gal was found at the cholangioles and hepatocytes surrounding the regenerative nodules. Children with fulminant hepatic failure without cirrhosis had significant ductular transformation with intense SA-beta gal activity. No SA-beta gal activity was evident in the fibrous septa. Staining for p53 had a similar distribution to that observed for SA-beta gal. Staining for p16(INK4a) and p21(cip1) was positive in the explanted liver of the patient with tyrosinemia, in the hepatocytes, the canals of Hering, cholangioles and interlobular bile ducts. In the livers with fulminant hepatitis, p21(cip1) staining occurred in the areas of ductular transformation and in the interlobular bile ducts. Conclusions/Significance: Cellular senescence in livers of children with end stage disease is associated with damage rather than corresponding to an age dependent phenomenon. Further studies are needed to support the hypothesis that these senescence markers correlate with disease progression.	[Gutierrez-Reyes, Gabriela; del Carmen Garcia de Leon, Maria; Perez Tamayo, Ruy; Gonzalez Rosado, Claudia; Farfan Labonne, Blanca; Morales Rochilin, Norma; Martinez Garcia, Rosalinda; Aguirre Valadez, Jonathan; Togno Latour, Gabriela; Lau Corona, Dana; Robles Diaz, Guillermo; Kershenobich, David] Univ Nacl Autonoma Mexico, Sch Med, Dept Expt Med, Mexico City 04510, DF, Mexico; [Varela-Fascinetto, Gustavo; Valencia, Pedro] Hosp Infantil Mexico Dr Federico Gomez, Dept Surg & Pathol, Mexico City, DF, Mexico; [Zlotnik, Albert] Univ Calif Irvine, Irvine, CA USA	Universidad Nacional Autonoma de Mexico; Hospital Infantil de Mexico Federico Gomez; University of California System; University of California Irvine	Gutierrez-Reyes, G (corresponding author), Univ Nacl Autonoma Mexico, Sch Med, Dept Expt Med, Mexico City 04510, DF, Mexico.	kesdhipa@yahoo.com	Zlotnik, Albert/C-3791-2011	Varela-Fascinetto, Gustavo/0000-0001-8836-8448; Lau Corona, Dana/0000-0002-8743-6346	CONACYT-SALUD (Mexico) [2004-C01-175]; Universidad Nacional Autonoma de Mexico (UNAM) [SDI.PTID.05.6.]	CONACYT-SALUD (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico)	This study was supported by CONACYT-SALUD (Mexico), grant (2004-C01-175) and Universidad Nacional Autonoma de Mexico (UNAM) grant (NEEGPSP SDI.PTID.05.6.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Campisi J, 2000, IN VIVO, V14, P183; Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1575, DOI 10.1152/ajpheart.00364.2005; Chen Jian-Hua, 2007, Methods Mol Biol, V371, P179; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hong Z, 2007, J CELL PHYSIOL, V210, P567, DOI 10.1002/jcp.20919; Ju YJ, 2006, EXP MOL MED, V38, P686, DOI 10.1038/emm.2006.81; Kenyon J, 2007, NUCLEIC ACIDS RES, V35, P7557, DOI 10.1093/nar/gkm1064; Kiss A, 2001, LIVER, V21, P237, DOI 10.1034/j.1600-0676.2001.021004237.x; Kuhlmann WD, 2006, INT J EXP PATHOL, V87, P343, DOI 10.1111/j.1365-2613.2006.00485.x; Maier AB, 2007, ANN NY ACAD SCI, V1100, P323, DOI 10.1196/annals.1395.035; Martien S, 2007, ANN NY ACAD SCI, V1119, P51, DOI 10.1196/annals.1404.010; Obata M, 2001, MOL CARCINOGEN, V32, P9, DOI 10.1002/mc.1059; Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Seki S, 2003, HEPATOL RES, V25, P149, DOI 10.1016/S1386-6346(02)00205-X; Shawi M, 2008, MECH AGEING DEV, V129, P3, DOI 10.1016/j.mad.2007.11.007; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Trak-Smayra V, 2004, TRANSPLANTATION, V77, P1755, DOI 10.1097/01.TP.0000131172.75294.A9; Watanabe H, 2008, PATHOLOGY, V40, P272, DOI 10.1080/00313020801911546; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; Yang SQ, 2004, HEPATOLOGY, V39, P403, DOI 10.1002/hep.20082; Zwerschke W, 2003, BIOCHEM J, V376, P403, DOI 10.1042/BJ20030816	26	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10231	10.1371/journal.pone.0010231	http://dx.doi.org/10.1371/journal.pone.0010231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422055	gold, Green Published			2022-12-25	WOS:000276952500009
J	Ong, JBS; Chen, MIC; Cook, AR; Lee, HC; Lee, VJ; Lin, RTP; Tambyah, PA; Goh, LG				Ong, Jimmy Boon Som; Chen, Mark I-Cheng; Cook, Alex R.; Lee, Huey Chyi; Lee, Vernon J.; Lin, Raymond Tzer Pin; Tambyah, Paul Ananth; Goh, Lee Gan			Real-Time Epidemic Monitoring and Forecasting of H1N1-2009 Using Influenza-Like Illness from General Practice and Family Doctor Clinics in Singapore	PLOS ONE			English	Article							A H1N1 VIRUS; PANDEMIC INFLUENZA; SURVEILLANCE; IMPACT; TRANSMISSION; VACCINATION; MODELS	Background: Reporting of influenza-like illness (ILI) from general practice/family doctor (GPFD) clinics is an accurate indicator of real-time epidemic activity and requires little effort to set up, making it suitable for developing countries currently experiencing the influenza A (H1N1-2009) pandemic or preparing for subsequent epidemic waves. Methodology/Principal Findings: We established a network of GPFDs in Singapore. Participating GPFDs submitted returns via facsimile or e-mail on their work days using a simple, standard data collection format, capturing: gender; year of birth; "ethnicity''; residential status; body temperature (degrees C); and treatment (antiviral or not); for all cases with a clinical diagnosis of an acute respiratory illness (ARI). The operational definition of ILI in this study was an ARI with fever of 37.8 degrees C or more. The data were processed daily by the study co-ordinator and fed into a stochastic model of disease dynamics, which was refitted daily using particle filtering, with data and forecasts uploaded to a website which could be publicly accessed. Twenty-three GPFD clinics agreed to participate. Data collection started on 2009-06-26 and lasted for the duration of the epidemic. The epidemic appeared to have peaked around 2009-08-03 and the ILI rates had returned to baseline levels by the time of writing. Conclusions/Significance: This real-time surveillance system is able to show the progress of an epidemic and indicates when the peak is reached. The resulting information can be used to form forecasts, including how soon the epidemic wave will end and when a second wave will appear if at all.	[Ong, Jimmy Boon Som; Chen, Mark I-Cheng] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore; [Chen, Mark I-Cheng] Duke NUS Grad Med Sch, Singapore, Singapore; [Chen, Mark I-Cheng; Lee, Vernon J.] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Cook, Alex R.; Lee, Huey Chyi] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Lee, Vernon J.] Minist Def, Biodef Ctr, Singapore, Singapore; [Lee, Vernon J.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Lin, Raymond Tzer Pin] Minist Hlth, Natl Publ Hlth Lab, Singapore, Singapore; [Tambyah, Paul Ananth; Goh, Lee Gan] Natl Univ Singapore Hosp, Dept Med, Singapore 117548, Singapore; [Goh, Lee Gan] Coll Family Phys, Singapore, Singapore	Tan Tock Seng Hospital; National University of Singapore; National University of Singapore; National University of Singapore; Australian National University; Ministry of Health-Singapore; National University of Singapore	Ong, JBS (corresponding author), Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore.	stacar@nus.edu.sg	Cook, Alex/S-3576-2019; Chen, Mark/CAG-2949-2022; Cook, Alex/B-5941-2011; Chen, Mark/AGC-5338-2022	Chen, Mark/0000-0001-9369-5830; Cook, Alex/0000-0002-6271-5832; Chen, Mark/0000-0001-9369-5830	National University of Singapore; National Medical Research Council, Singapore	National University of Singapore(National University of Singapore); National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The National University of Singapore provided research funding to ARC and a scholarship to HCL. Staff time for JBSO and MI-CC was partially funded by the National Medical Research Council, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL:http://www.nus.edu.sg/ and https://www.nmrc.gov.sg/	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], INFECT DIS HUMANS; Bailey NTJ, 1975, MATH THEORY INFECT D; Baker MG, 2009, EUROSURVEILLANCE, V14, P6; Berger J. O., 1988, LIKELIHOOD PRINCIPLE; Carrat F, 1998, J EPIDEMIOL COMMUN H, V52, p32S; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2006, EMERG INFECT DIS, V12, P110; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; Clothier HJ, 2005, COMMUN DIS INTELL, V29, P231; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; DEFINETTI B, 1974, THEORY PROBABILITY; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; DORAISINGHAM S, 1988, B WORLD HEALTH ORGAN, V66, P57; Doucet A, 2000, STAT COMPUT, V10, P197, DOI 10.1023/A:1008935410038; Doucet A., 2001, SEQUENTIAL MONTE CAR; Emmanuel S. C., 2004, SMJ Singapore Medical Journal, V45, P199; Falcao IM, 1998, J EPIDEMIOL COMMUN H, V52, p39S; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Gates P, 2009, VACCINE, V27, P6669, DOI 10.1016/j.vaccine.2009.08.094; Gordon A, 2009, EMERG INFECT DIS, V15, P408, DOI 10.3201/eid1503.080238; Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084; Hsieh YH, 2006, EMERG INFECT DIS, V12, P122, DOI 10.3201/eid1201.050396; Huang Q. S., 2009, Morbidity and Mortality Weekly Report, V58, P918; Jegat C, 2008, QUANT GEO G, V15, P23; KANAGARATNAM K, 1958, Public Health, V72, P143, DOI 10.1016/S0033-3506(58)80032-3; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kelly Heath, 2004, Aust Fam Physician, V33, P305; KEYFITZ N, 1972, J AM STAT ASSOC, V67, P347, DOI 10.2307/2284381; Lee PM, 2009, BAYESIAN STAT INTRO; Lee VJ, 2008, ANN ACAD MED SINGAP, V37, P470; Lee VJ, 2007, EMERG INFECT DIS, V13, P1052, DOI 10.3201/eid1307.061313; Lindley D.V., 2006, UNDERSTANDING UNCERT; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380; Magnus D, 2009, ARCH DIS CHILD, V94, P997, DOI 10.1136/adc.2009.171603; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Mukherjee P, 2010, EMERG INFECT DIS, V16, P21, DOI 10.3201/eid1601.091376; Newman KB, 2006, ECOL APPL, V16, P74, DOI 10.1890/04-0592; Nishiura Hiroshi, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P1075; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Roberts MG, 2007, J R SOC INTERFACE, V4, P949, DOI 10.1098/rsif.2007.1031; Taleb N., 2008, BLACK SWAN; Thomas L, 2005, AUST NZ J STAT, V47, P19, DOI 10.1111/j.1467-842X.2005.00369.x; Trenkel VM, 2000, J AM STAT ASSOC, V95, P363, DOI 10.2307/2669373; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P166, DOI 10.1017/S0950268807008369; Vynnycky E, 2008, VACCINE, V26, P5321, DOI 10.1016/j.vaccine.2008.06.101; Vynnycky E, 2007, INT J EPIDEMIOL, V36, P881, DOI 10.1093/ije/dym071; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	66	112	113	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10036	10.1371/journal.pone.0010036	http://dx.doi.org/10.1371/journal.pone.0010036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418945	Green Submitted, Green Published, gold			2022-12-25	WOS:000276706800004
J	Verdu, JR; Casas, JL; Lobo, JM; Numa, C				Verdu, Jose R.; Casas, Jose L.; Lobo, Jorge M.; Numa, Catherine			Dung Beetles Eat Acorns to Increase Their Ovarian Development and Thermal Tolerance	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; SELF-SELECTION; THORECTES-LUSITANICUS; COLD-HARDINESS; ANTIFREEZE; COLEOPTERA; INSECTS; BODY; GEOTRUPIDAE; ENDOTHERMY	Animals eat different foods in proportions that yield a more favorable balance of nutrients. Despite known examples of these behaviors across different taxa, their ecological and physiological benefits remain unclear. We identified a surprising dietary shift that confers ecophysiological advantages in a dung beetle species. Thorectes lusitanicus, a Mediterranean ecosystem species adapted to eat semi-dry and dry dung (dung-fiber consumers) is also actively attracted to oak acorns, consuming and burying them. Acorn consumption appears to confer potential advantages over beetles that do not eat acorns: acorn-fed beetles showed important improvements in the fat body mass, hemolymph composition, and ovary development. During the reproductive period (October-December) beetles incorporating acorns into their diets should have greatly improved resistance to low-temperature conditions and improved ovarian development. In addition to enhancing the understanding of the relevance of dietary plasticity to the evolutionary biology of dung beetles, these results open the way to a more general understanding of the ecophysiological implications of differential dietary selection on the ecology and biogeography of these insects.	[Verdu, Jose R.; Casas, Jose L.; Numa, Catherine] Univ Alicante, IU CIBIO, E-03080 Alicante, Spain; [Lobo, Jorge M.] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain	Universitat d'Alacant; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Verdu, JR (corresponding author), Univ Alicante, IU CIBIO, E-03080 Alicante, Spain.	jr.verdu@ua.es	Numa, Catherine/H-7486-2015; Casas, Jose Luis/L-9869-2014; Verdú, José/F-8269-2010; Lobo, Jorge M/E-2309-2013	Numa, Catherine/0000-0003-3213-1980; Casas, Jose Luis/0000-0001-8929-1331; Verdú, José/0000-0002-0805-8341; Lobo, Jorge M/0000-0002-3152-4769	Ministerio de Ciencia e Innovacion-Spain [CGL2008-03878]	Ministerio de Ciencia e Innovacion-Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by the Ministerio de Ciencia e Innovacion-Spain (CGL2008-03878). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; ATAPUR M, 2009, CHANGES COLD HARDINE; AVILA J M, 1988, Elytron (Barcelona), V2, P41; AVILA JM, 1988, ACT 3 C IB ENT, P707; BALE JS, 1993, FUNCT ECOL, V7, P751; BARTHOLOMEW GA, 1978, J EXP BIOL, V73, P65; BAUST JG, 1982, COMP BIOCHEM PHYS A, V73, P563, DOI 10.1016/0300-9629(82)90263-8; BEENAKKERS AMT, 1985, PROG LIPID RES, V24, P19; Beucke K, 2009, COLEOPTS BULL, V63, P228, DOI 10.1649/1168.1; Bouderoua K, 2003, ANIM RES, V52, P377, DOI 10.1051/animres:2003027; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cambefort Y., 1991, P22; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; CANGUSSU JA, 1995, J INSECT PHYSIOL, V41, P223, DOI 10.1016/0022-1910(94)00099-3; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Chown SL, 1998, CAN J ZOOL, V76, P1123, DOI 10.1139/cjz-76-6-1123; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Dadd R.H., 1985, COMPREHENSIVE INSECT; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; DENLINGER DL, INSECTS APPL INTEGRA, P55; Duman JG, 2004, J INSECT PHYSIOL, V50, P259, DOI 10.1016/j.jinsphys.2003.12.003; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; Emlen DJ, 2007, P NATL ACAD SCI USA, V104, P8661, DOI 10.1073/pnas.0701209104; Fielding DJ, 2008, PHYSIOL ENTOMOL, V33, P264, DOI 10.1111/j.1365-3032.2008.00619.x; *FLIR SYST LTD, 2007, THERMACAM RES V 2 9; FRIEDMAN S, 1991, J INSECT PHYSIOL, V37, P919, DOI 10.1016/0022-1910(91)90007-M; Grigg GC, 2004, PHYSIOL BIOCHEM ZOOL, V77, P982, DOI 10.1086/425188; HALFFTER G, 1982, ANALES ESCUELA NACL, V25, P117; HALFFTER G, 1966, FOLIA ENTOMOL MEX, V12, P14; HANSEN TN, 1988, BIOCHIM BIOPHYS ACTA, V957, P217, DOI 10.1016/0167-4838(88)90275-0; Hidalgo J.M., 1998, Boletin de la Asociacion Espanola de Entomologia, V22, P203; Hidalgo Juan M., 1994, Nouvelle Revue d'Entomologie, V11, P217; Lavy D, 1997, COMP BIOCHEM PHYS A, V118, P699, DOI 10.1016/S0300-9629(97)00019-4; Lee R.E. Jr, 1991, P17; LOBL I., CATALOGUE PALAEARCTI, V3; Lobo JM, 2006, DIVERS DISTRIB, V12, P179, DOI 10.1111/j.1366-9516.2005.00214.x; Lopes IMG, 2005, EUR J LIPID SCI TECH, V107, P12, DOI 10.1002/ejlt.200401039; Lu M, 2002, J THERM ANAL CALORIM, V67, P689, DOI 10.1023/A:1014369208229; Martin-Piera F., 2000, Fauna Iberica, V14; Meyer-Fernandes JR, 2000, INSECT BIOCHEM MOLEC, V30, P473, DOI 10.1016/S0965-1748(00)00016-3; Michaud MR, 2006, J INSECT PHYSIOL, V52, P1073, DOI 10.1016/j.jinsphys.2006.07.005; Negro JJ, 2002, NATURE, V416, P807, DOI 10.1038/416807a; Perez-Ramos IM, 2007, ECOL ENTOMOL, V32, P349, DOI 10.1111/j.1365-2311.2007.00874.x; Romero-Alcaraz E., 1998, Zoologica Baetica, V9, P47; SANCHEZ-PINERO F, 1991, EOS-Revista Espanola de Entomologia, V67, P23; Sayah F, 2008, ENTOMOL SCI, V11, P55, DOI 10.1111/j.1479-8298.2007.00254.x; Shimada T, 2003, POPUL ECOL, V45, P7, DOI 10.1007/s10144-002-0134-4; Sinclair BJ, 2002, POLAR BIOL, V25, P928, DOI 10.1007/s00300-002-0433-4; SOMME L, 1982, OIKOS, V38, P168, DOI 10.2307/3544016; StatsDirect Ltd, 2005, STATSDIRECT STAT SOF; Storey KB, 1996, ANNU REV ECOL SYST, V27, P365, DOI 10.1146/annurev.ecolsys.27.1.365; Storey Kenneth B., 1992, V1, P101; TYNDALEBISCOE M, 1984, B ENTOMOL RES, V74, P341, DOI 10.1017/S0007485300015637; Van der Horst D.J., 2005, P225; Verdu JR, 2007, ANIM BEHAV, V74, P1697, DOI 10.1016/j.anbehav.2007.03.016; Verdu JR, 2004, SYST ENTOMOL, V29, P509, DOI 10.1111/j.0307-6970.2004.00256.x; Verdu JR, 2004, J NAT HIST, V38, P705, DOI 10.1080/0022293021000041707; WALDBAUER GP, 1991, ANNU REV ENTOMOL, V36, P43, DOI 10.1146/annurev.en.36.010191.000355; Wolfe GR, 1998, J INSECT PHYSIOL, V44, P597, DOI 10.1016/S0022-1910(98)00035-3; XU L, 1991, J EXP ZOOL, V258, P288, DOI 10.1002/jez.1402580303	60	31	33	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10114	10.1371/journal.pone.0010114	http://dx.doi.org/10.1371/journal.pone.0010114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404931	Green Published, gold			2022-12-25	WOS:000276482100024
J	Verma, S; Kumar, R; Katara, GK; Singh, LC; Negi, NS; Ramesh, V; Salotra, P				Verma, Sandeep; Kumar, Rajesh; Katara, Gajendra Kumar; Singh, Laishram Chandreshwor; Negi, Narender Singh; Ramesh, V.; Salotra, Poonam			Quantification of Parasite Load in Clinical Samples of Leishmaniasis Patients: IL-10 Level Correlates with Parasite Load in Visceral Leishmaniasis	PLOS ONE			English	Article							REAL-TIME PCR; AZAR DERMAL LEISHMANIASIS; POLYMERASE-CHAIN-REACTION; KALA-AZAR; INTERFERON-GAMMA; IFN-GAMMA; CUTANEOUS-LEISHMANIASIS; CYTOKINE PROFILES; OXIDE PRODUCTION; MOUSE-TISSUES	A rapid and accurate method to detect and quantify Leishmania parasite is urgently needed to facilitate early diagnosis of Leishmaniasis and monitoring of antileishmania therapy. In this study, real-time assay was applied to estimate parasite load in clinical samples of visceral leishmaniasis (VL) and post kala-azar dermal leishmaniasis (PKDL) patients. The mean parasite load in blood of VL patients (n = 31) was 8,372 parasites/ml, while the mean parasite load in bone marrow aspirate (BMA) was 194,962 parasites/million nucleated cells (n = 12). Parasite load was undetectable after treatment with amphotericin B (n = 9) in VL, while a residual parasite burden was detected in 2 of 6 patients following treatment with sodium antimony gluconate. Further, circulating levels of IFN-gamma, TNF-alpha, IL-10, IL-6, IL-4 and IL-2 were analysed in VL patients (n = 29) by Cytometric Bead Array to evaluate correlation with parasitic load. Interestingly, IL-10 levels correlated significantly with parasite load (r = 0.82, P < 0.0001). The mean parasite load in dermal lesions of PKDL patients was 9,502 parasites/mu g tissue DNA at pre-treatment stage (n = 25), with no detectable parasites after therapy (n = 5). Parasite burden was distinctly higher (P < 0.0001) in nodular lesions (n = 12) (19,586 parasites/mu g tissue DNA) compared to papular/macular lesions (n = 13, 193 parasites/mu g tissue DNA). Further, chronic PKDL lesions showed significantly (P = 0.0166) higher parasite load in comparison with acute lesions. Results indicate that chronic, nodular cases constitute the major parasite reservoir for anthroponotic transmission. Our results establish that the high parasite load in VL is strongly correlated with a high level of IL-10, implicating IL-10 as a marker of disease severity. The assay is applicable for diagnosis as well as prognosis of both VL and PKDL, providing a simple molecular tool to monitor the efficacy of antileishmanial drugs or vaccines.	[Verma, Sandeep; Kumar, Rajesh; Katara, Gajendra Kumar; Singh, Laishram Chandreshwor; Salotra, Poonam] ICMR, Inst Pathol, New Delhi, India; [Ramesh, V.] Safdarjang Hosp, Dept Dermatol, New Delhi, India; [Negi, Narender Singh] Safdarjang Hosp, Dept Med, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Pathology (IOP); Vardhman Mahavir Medical College & Safdarjung Hospital; Vardhman Mahavir Medical College & Safdarjung Hospital	Verma, S (corresponding author), ICMR, Inst Pathol, Safdarjung Hosp Campus, New Delhi, India.	salotra@vsnl.com		Salotra, Poonam/0000-0002-4057-4872	Indian Council of Medical Research; Council of Scientific and Industrial Research (CSIR), India	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	Financial assistance provided by the Indian Council of Medical Research is gratefully acknowledged. SV and GKK thank Council of Scientific and Industrial Research (CSIR), India, for providing research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA S, 2002, T R SOC TROP MED S1, V96, P179; Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020; Ansari NA, 2006, J INFECT DIS, V194, P958, DOI 10.1086/506624; Ansari NA, 2006, CLIN IMMUNOL, V119, P339, DOI 10.1016/j.clim.2006.01.017; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Bossolasco S, 2003, J CLIN MICROBIOL, V41, P5080, DOI 10.1128/JCM.41.11.5080-5084.2003; Bretagne S, 2001, CLIN DIAGN LAB IMMUN, V8, P828, DOI 10.1128/CDLI.8.4.828-831.2001; Caldas A, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-113; CENINI P, 1993, J INFECT DIS, V168, P986, DOI 10.1093/infdis/168.4.986; CILLARI E, 1995, CYTOKINE, V7, P740, DOI 10.1006/cyto.1995.0088; DEMADEIROS IM, 1998, REV INST MED TROP SP, V40, P31; DENIS M, 1993, J IMMUNOL, V151, P5425; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; FERNANDES DM, 1995, INFECT IMMUN, V63, P1130, DOI 10.1128/IAI.63.3.1130-1133.1995; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; GHALIB HW, 1993, J CLIN INVEST, V92, P324, DOI 10.1172/JCI116570; GRADONI L, 1993, T ROY SOC TROP MED H, V87, P94, DOI 10.1016/0035-9203(93)90441-R; GREENBERGER MJ, 1995, J IMMUNOL, V155, P722; Hailu A, 2004, AM J TROP MED HYG, V71, P561, DOI 10.4269/ajtmh.2004.71.561; Harris E, 1998, J CLIN MICROBIOL, V36, P1989, DOI 10.1128/JCM.36.7.1989-1995.1998; Jauregui LH, 2001, J CLIN MICROBIOL, V39, P2065, DOI 10.1128/JCM.39.6.2065-2071.2001; KARP CL, 1993, J CLIN INVEST, V91, P1644, DOI 10.1172/JCI116372; Kumar R, 2007, AM J TROP MED HYG, V76, P896, DOI 10.4269/ajtmh.2007.76.896; Kumar R, 2009, FEMS IMMUNOL MED MIC, V57, P239, DOI 10.1111/j.1574-695X.2009.00607.x; Manna L, 2008, CYTOKINE, V44, P288, DOI 10.1016/j.cyto.2008.08.017; Manna L, 2009, RES VET SCI, V87, P76, DOI 10.1016/j.rvsc.2008.12.009; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; MIRALLES GD, 1994, INFECT IMMUN, V62, P1058, DOI 10.1128/IAI.62.3.1058-1063.1994; MITRA RS, 1995, J IMMUNOL, V154, P2668; Nicolas L, 2002, J CLIN MICROBIOL, V40, P1666, DOI 10.1128/JCM.40.5.1666-1669.2002; Perandin F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004; Peruhype-Magalhaes V, 2006, CLIN EXP IMMUNOL, V146, P124, DOI 10.1111/j.1365-2249.2006.03171.x; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; Ramesh V, 2007, TROP MED INT HEALTH, V12, P848, DOI 10.1111/j.1365-3156.2007.01854.x; REED SG, 1994, J IMMUNOL, V153, P3135; Rolao N, 2004, J PARASITOL, V90, P1150, DOI 10.1645/GE-264R1; ROMANI L, 1994, J IMMUNOL, V152, P3514; Salotra P, 2003, J CLIN PATHOL, V56, P840, DOI 10.1136/jcp.56.11.840; Salotra P, 2001, J CLIN MICROBIOL, V39, P849, DOI 10.1128/JCM.39.3.849-854.2001; SCOTT P, 1991, J IMMUNOL, V147, P3149; Selvapandiyan A, 2005, J MOL DIAGN, V7, P268, DOI 10.1016/S1525-1578(10)60554-5; Selvapandiyan A, 2008, TRANSFUSION, V48, P1787, DOI 10.1111/j.1537-2995.2008.01798.x; Sundar S, 2000, T ROY SOC TROP MED H, V94, P200, DOI 10.1016/S0035-9203(00)90277-3; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; TAGA K, 1992, J IMMUNOL, V148, P1143; THAKUR CP, 1992, ANN TROP MED PARASIT, V86, P355, DOI 10.1080/00034983.1992.11812678; VANDERPOLL T, 1995, CLIN IMMUNOL IMMUNOP, V77, P111, DOI 10.1016/0090-1229(95)90144-2; Wortman G, 2007, AM J TROP MED HYG, V73, P999; Zijlstra EE, 2000, BRIT J DERMATOL, V143, P136, DOI 10.1046/j.1365-2133.2000.03603.x	49	105	107	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10107	10.1371/journal.pone.0010107	http://dx.doi.org/10.1371/journal.pone.0010107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404924	Green Published, Green Submitted, gold			2022-12-25	WOS:000276482100020
J	Jao, CC; Hegde, BG; Gallop, JL; Hegde, PB; McMahon, HT; Haworth, IS; Langen, R				Jao, Christine C.; Hegde, Balachandra G.; Gallop, Jennifer L.; Hegde, Prabhavati B.; McMahon, Harvey T.; Haworth, Ian S.; Langen, Ralf			Roles of Amphipathic Helices and the Bin/Amphiphysin/Rvs (BAR) Domain of Endophilin in Membrane Curvature Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS; DISTANCE; SIMULATIONS; REFINEMENT; MECHANISMS; INSIGHTS; MUTANTS	Control of membrane curvature is required in many important cellular processes, including endocytosis and vesicular trafficking. Endophilin is a bin/amphiphysin/rvs (BAR) domain protein that induces vesicle formation by promotion of membrane curvature through membrane binding as a dimer. Using site-directed spin labeling and EPR spectroscopy, we show that the overall BAR domain structure of the rat endophilin A1 dimer determined crystallographically is maintained under predominantly vesiculating conditions. Spin-labeled side chains on the concave surface of the BAR domain do not penetrate into the acyl chain interior, indicating that the BAR domain interacts only peripherally with the surface of a curved bilayer. Using a combination of EPR data and computational refinement, we determined the structure of residues 63-86, a region that is disordered in the crystal structure of rat endophilin A1. Upon membrane binding, residues 63-75 in each subunit of the endophilin dimer form a slightly tilted, amphipathic alpha-helix that directly interacts with the membrane. In their predominant conformation, these helices are located orthogonal to the long axis of the BAR domain. In this conformation, the amphipathic helices are positioned to act as molecular wedges that induce membrane curvature along the concave surface of the BAR domain.	[Jao, Christine C.; Hegde, Balachandra G.; Hegde, Prabhavati B.; Langen, Ralf] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Gallop, Jennifer L.; McMahon, Harvey T.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Haworth, Ian S.] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA	University of Southern California; MRC Laboratory Molecular Biology; University of Southern California	Langen, R (corresponding author), Univ So Calif, Zilkha Neurogenet Inst, 1501 San Pablo St, Los Angeles, CA 90033 USA.	langen@usc.edu	Hegde, Balachandra/GPS-6028-2022	Gallop, Jennifer Louise/0000-0002-9978-1382	National Institutes of Health [GM063915, T32 GM067587]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067587, R01GM063915] Funding Source: NIH RePORTER; MRC [MC_U105178795] Funding Source: UKRI; Medical Research Council [MC_U105178795] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant GM063915 ( to R. L.).; Recipient of National Institutes of Health Predoctoral Training Grant T32 GM067587.	ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Arkhipov A, 2008, BIOPHYS J, V95, P2806, DOI 10.1529/biophysj.108.132563; Ayton GS, 2007, BIOPHYS J, V92, P3595, DOI 10.1529/biophysj.106.101709; Ayton GS, 2009, BIOPHYS J, V97, P1616, DOI 10.1016/j.bpj.2009.06.036; Bhatnagar J, 2007, METHOD ENZYMOL, V423, P117, DOI 10.1016/S0076-6879(07)23004-6; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; CASE DA, 2004, AMBER 8; Cui HS, 2009, BIOPHYS J, V97, P2746, DOI 10.1016/j.bpj.2009.08.043; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fischer T, 2007, J BIOL CHEM, V282, P9996, DOI 10.1074/jbc.M611180200; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Frazier AA, 2002, BIOCHEMISTRY-US, V41, P6282, DOI 10.1021/bi0160821; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2007, STRUCTURE, V15, P751, DOI 10.1016/j.str.2007.06.006; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; JUNG AG, PLOS ONE, V5, pE9492; Langen R, 2000, BIOCHEMISTRY-US, V39, P8396, DOI 10.1021/bi000604f; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Yin Y, 2009, STRUCTURE, V17, P882, DOI 10.1016/j.str.2009.03.016; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	32	59	59	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20164	20170		10.1074/jbc.M110.127811	http://dx.doi.org/10.1074/jbc.M110.127811			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20418375	hybrid, Green Published			2022-12-25	WOS:000279012000051
J	Linke, C; Young, PG; Kang, HJ; Bunker, RD; Middleditch, MJ; Caradoc-Davies, TT; Proft, T; Baker, EN				Linke, Christian; Young, Paul G.; Kang, Hae Joo; Bunker, Richard D.; Middleditch, Martin J.; Caradoc-Davies, Tom T.; Proft, Thomas; Baker, Edward N.			Crystal Structure of the Minor Pilin FctB Reveals Determinants of Group A Streptococcal Pilus Anchoring	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; ISOPEPTIDE BONDS; CORYNEBACTERIUM-DIPHTHERIAE; STABILIZING ISOPEPTIDE; SURFACE-PROTEINS; CELL-ADHESION; PYOGENES; SOFTWARE; SORTASE; REGION	Cell surface pili are polymeric protein assemblies that enable bacteria to adhere to surfaces and to specific host tissues. The pili expressed by Gram-positive bacteria constitute a unique paradigm in which sortase-mediated covalent linkages join successive pilin subunits like beads on a string. These pili are formed from two or three distinct types of pilin subunit, typically encoded in small gene clusters, often with their cognate sortases. In Group A streptococci (GAS), a major pilin forms the polymeric backbone, whereas two minor pilins are located at the tip and the base. Here, we report the 1.9-angstrom resolution crystal structure of the GAS basal pilin FctB, revealing an immunoglobulin (Ig)-like N-terminal domain with an extended proline-rich tail. Unexpected structural homology between the FctB Ig-like domain and the N-terminal domain of the GAS shaft pilin helps explain the use of the same sortase for polymerization of the shaft and its attachment to FctB. It also enabled the identification, from mass spectral data, of the lysine residue involved in the covalent linkage of FctB to the shaft. The proline-rich tail forms a polyproline-II helix that appears to be a common feature of the basal (cell wall-anchoring) pilins. Together, our results indicate distinct structural elements in the pilin proteins that play a role in selecting for the appropriate sortases and thereby help orchestrate the ordered assembly of the pilus.	[Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland Mail Ctr, Auckland 1142, New Zealand; [Linke, Christian; Young, Paul G.; Kang, Hae Joo; Bunker, Richard D.; Middleditch, Martin J.; Proft, Thomas; Baker, Edward N.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand; [Proft, Thomas] Univ Auckland, Sch Med Sci, Auckland 1142, New Zealand; [Caradoc-Davies, Tom T.] Australian Synchrotron, Clayton, Vic 3168, Australia	University of Auckland; University of Auckland; University of Auckland	Baker, EN (corresponding author), Univ Auckland, Sch Biol Sci, Auckland Mail Ctr, Private Bag 92019, Auckland 1142, New Zealand.	ted.baker@auckland.ac.nz	Linke-Winnebeck, Christian/F-4091-2010; Proft, Thomas/H-4686-2019; Linke-Winnebeck, Christian/P-1585-2019	Linke-Winnebeck, Christian/0000-0002-2306-247X; Proft, Thomas/0000-0002-9275-5042; Linke-Winnebeck, Christian/0000-0002-2306-247X; Bunker, Richard/0000-0001-8866-5290; Baker, Edward/0000-0003-2456-7661	Marsden Fund of New Zealand; Health Research Council of New Zealand; Tertiary Education Commission; Maurice Wilkins Centre for Molecular Biodiscovery; New Zealand International Doctoral Research Scholarship (Education New Zealand); University of Auckland New Zealand	Marsden Fund of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand); Tertiary Education Commission; Maurice Wilkins Centre for Molecular Biodiscovery; New Zealand International Doctoral Research Scholarship (Education New Zealand); University of Auckland New Zealand	This work was supported in part by the Marsden Fund of New Zealand, the Health Research Council of New Zealand, and the Tertiary Education Commission through funding of the Maurice Wilkins Centre for Molecular Biodiscovery.; Supported by a New Zealand International Doctoral Research Scholarship (Education New Zealand) and a University of Auckland New Zealand International Doctoral Research Scholarship Plus Scholarship.; Supported by a University of Auckland Doctoral Scholarship.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; Barnett TC, 2004, J BACTERIOL, V186, P5865, DOI 10.1128/JB.186.17.5865-5875.2004; Barnett TC, 2002, J BACTERIOL, V184, P2181, DOI 10.1128/JB.184.8.2181-2191.2002; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Falugi F, 2008, J INFECT DIS, V198, P1834, DOI 10.1086/593176; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Hollingsworth SA, 2009, PROTEIN SCI, V18, P1321, DOI 10.1002/pro.133; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Linke C, 2010, ACTA CRYSTALLOGR F, V66, P177, DOI 10.1107/S1744309109051951; Mandlik A, 2008, P NATL ACAD SCI USA, V105, P14147, DOI 10.1073/pnas.0806350105; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Oh SY, 2008, P NATL ACAD SCI USA, V105, P13703, DOI 10.1073/pnas.0807334105; Okuyama K, 2007, BIOPOLYMERS, V86, P212, DOI 10.1002/bip.20724; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Quigley BR, 2009, MOL MICROBIOL, V72, P1379, DOI 10.1111/j.1365-2958.2009.06727.x; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0; Scott JR, 2006, ANNU REV MICROBIOL, V60, P397, DOI 10.1146/annurev.micro.60.080805.142256; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Solovyova AS, 2010, EUR BIOPHYS J BIOPHY, V39, P469, DOI 10.1007/s00249-009-0432-2; Stapley BJ, 1999, PROTEIN SCI, V8, P587; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Yeates TO, 2007, SCIENCE, V318, P1558, DOI 10.1126/science.1151398	54	55	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20381	20389		10.1074/jbc.M109.089680	http://dx.doi.org/10.1074/jbc.M109.089680			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427291	hybrid, Green Published			2022-12-25	WOS:000279012000071
J	Bidinosti, M; Martineau, Y; Frank, F; Sonenberg, N				Bidinosti, Michael; Martineau, Yvan; Frank, Filipp; Sonenberg, Nahum			Repair of Isoaspartate Formation Modulates the Interaction of Deamidated 4E-BP2 with mTORC1 in Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CARBOXYL METHYLTRANSFERASE; CAP-DEPENDENT TRANSLATION; DAMAGED PROTEINS; INITIATION; PEPTIDES; RAPTOR; GROWTH; TOR; METHYLATION; BINDING	In eukaryotes, a rate-limiting step of translation initiation is recognition of the mRNA 5' m(7)GpppN cap structure by the eukaryotic initiation factor 4F (eIF4F), a heterotrimeric complex consisting of the cap-binding protein, eIF4E, along with eIF4G, and eIF4A. The eIF4E-binding proteins (4E-BPs) repress translation by disrupting eIF4F formation, thereby preventing ribosome recruitment to the mRNA. Of the three 4E-BPs, 4E-BP2 is the predominant paralog expressed in the mammalian brain and plays an important role in synaptic plasticity and learning and memory. 4E-BP2 undergoes asparagine deamidation, solely in the brain, during early postnatal development. Deamidation spontaneously converts asparagines into a mixture of aspartates or isoaspartates, the latter of which may be destabilizing to proteins. The enzyme protein L-isoaspartyl methyltransferase (PIMT) prevents isoaspartate accumulation by catalyzing the conversion of isoaspartates to aspartates. PIMTexhibits high activity in the brain, relative to other tissues. We report here that 4E-BP2 is a substrate for PIMT. In vitro deamidated 4E-BP2 accrues isoapartyl residues and is methylated by recombinant PIMT. Using an antibody that recognizes 4E-BP2, which harbors isoaspartates at the deamidation sites, Asn(99) and Asn(102), we demonstrate that 4E-BP2 in PIMT-/- brain lysates contains isoaspartate residues. Further, we show that 4E-BP2 containing isoaspartates lacks the augmented association with raptor that is a feature of deamidated 4E-BP2.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Goodman Canc Ctr, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University	Sonenberg, N (corresponding author), 1160 Pine Ave W, Montreal, PQ H3A 1A3, Canada.	nahum.sonenberg@mcgill.ca	Martineau, Yvan/G-2387-2017	Martineau, Yvan/0000-0002-0575-4085; Frank, Filipp/0000-0001-8680-2757	Canadian Institutes of Health Research (CIHR); Howard Hughes Medical Institute; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Canadian Institutes of Health Research (CIHR) Team grant and a Howard Hughes Medical Institute grant (to N.S.).; Recipient of a postgraduate doctoral scholarship from the Natural Sciences and Engineering Research Council of Canada.	ASWAD DW, 1984, J BIOL CHEM, V259, P714; Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Bidinosti M, 2010, MOL CELL, V37, P797, DOI 10.1016/j.molcel.2010.02.022; Bohme L, 2008, BIOL CHEM, V389, P1043, DOI 10.1515/BC.2008.123; BRENNAN TV, 1994, J BIOL CHEM, V269, P24586; Chavous DA, 2001, P NATL ACAD SCI USA, V98, P14814, DOI 10.1073/pnas.251446498; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; FLATMARK T, 1967, J BIOL CHEM, V242, P2454; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1996, P NATL ACAD SCI USA, V93, P5578, DOI 10.1073/pnas.93.11.5578; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; HALEY EE, 1966, BIOCHEMISTRY-US, V5, P3229, DOI 10.1021/bi00874a024; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; JOHNSON BA, 1990, BIOCHEMISTRY-US, V29, P4373, DOI 10.1021/bi00470a017; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Lee VHY, 2008, FEBS J, V275, P2185, DOI 10.1111/j.1742-4658.2008.06372.x; Lindner H, 1999, J CANCER RES CLIN, V125, P182, DOI 10.1007/s004320050261; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lowenson JD, 2001, J BIOL CHEM, V276, P20695, DOI 10.1074/jbc.M100987200; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MADER S, 1995, MOL CELL BIOL, V15, P4990; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; MIDELFORT CF, 1972, P NATL ACAD SCI USA, V69, P1816, DOI 10.1073/pnas.69.7.1816; MURRAY ED, 1984, J BIOL CHEM, V259, P722; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; PATEL K, 1990, PHARMACEUT RES, V7, P703, DOI 10.1023/A:1015807303766; Pepperkok R, 2000, J CELL BIOL, V148, P715, DOI 10.1083/jcb.148.4.715; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Proud CG, 2009, BIOCHEM SOC T, V37, P227, DOI 10.1042/BST0370227; Radkiewicz JL, 2001, J AM CHEM SOC, V123, P3499, DOI 10.1021/ja0026814; Reissner KJ, 2006, J BIOL CHEM, V281, P8389, DOI 10.1074/jbc.M510716200; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; ROBINSON AB, 1970, P NATL ACAD SCI USA, V66, P753, DOI 10.1073/pnas.66.3.753; ROBINSON AB, 1991, P NATL ACAD SCI USA, V88, P8880, DOI 10.1073/pnas.88.20.8880; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P12409, DOI 10.1073/pnas.221463198; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Shimizu T, 2002, J NEUROSCI RES, V70, P451, DOI 10.1002/jnr.10350; SHIRASAWA T, 1995, NEUROSCI LETT, V188, P37, DOI 10.1016/0304-3940(95)11389-E; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tarcsa E, 2000, J BIOL CHEM, V275, P20295, DOI 10.1074/jbc.M001555200; Vigneswara V, 2006, J BIOL CHEM, V281, P32619, DOI 10.1074/jbc.M605421200; WEINTRAUB SJ, 2007, SCI STKE, pRE7; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie ML, 1999, J PHARM SCI, V88, P8, DOI 10.1021/js9802493; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Yonezawa K, 2003, CURR TOP MICROBIOL, V279, P271; Zhao R, 2007, PLOS BIOL, V5, P39, DOI 10.1371/journal.pbio.0050001; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200	60	13	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19402	19408		10.1074/jbc.M110.120774	http://dx.doi.org/10.1074/jbc.M110.120774			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20424163	Green Published, hybrid			2022-12-25	WOS:000278727800051
J	Li, M; Wang, W; Soroka, CJ; Mennone, A; Harry, K; Weinman, EJ; Boyer, JL				Li, Man; Wang, Wei; Soroka, Carol J.; Mennone, Albert; Harry, Kathy; Weinman, Edward J.; Boyer, James L.			NHERF-1 Binds to Mrp2 and Regulates Hepatic Mrp2 Expression and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; MULTIDRUG-RESISTANCE PROTEIN-2; APICAL MEMBRANE LOCALIZATION; DOMAIN INTERACTION CONTROLS; RAT HEPATOCYTE COUPLETS; DUBIN-JOHNSON SYNDROME; HEPATOCELLULAR TRANSPORTERS; OXIDIZED GLUTATHIONE; TARGETED DISRUPTION; ADAPTER PROTEINS	Multidrug resistance-associated protein 2 (Mrp2, Abcc2) is an ATP-binding cassette transporter localized at the canalicular membrane of hepatocytes that plays an important role in bile formation and detoxification. Prior in vitro studies suggest that Mrp2 can bind to Na+/H+ exchanger regulatory factor 1 (NHERF-1), a PDZ protein that cross-links membrane proteins to actin filaments. However the role of NHERF-1 in the expression and functional regulation of Mrp2 remains largely unknown. Here we examine the interaction of Mrp2 and NHERF-1 and its physiological significance in HEK293 cells and NHERF-1 knock-out mice. Mrp2 co-precipitated with NHERF-1 in co-transfected HEK293 cells, an interaction that required the PDZ-binding motif of Mrp2. In NHERF-1(-/-) mouse liver, Mrp2 mRNA was unchanged but Mrp2 protein was reduced in whole cell lysates and membrane-enriched fractions to similar to 50% (p < 1 x 10(-6)) and similar to 70% (p < 0.05), respectively, compared with wild-type mice, suggesting that the down-regulation of Mrp2 expression was caused by post-transcriptional events. Mrp2 remained localized at the apical/canalicular membrane of NHERF-1(-/-) mouse hepatocytes, although its immunofluorescent labeling was noticeably weaker. Bile flow in NHERF-1(-/-) mice was reduced to similar to 70% (p < 0.001) in association with a 50% reduction in glutathione excretion (p < 0.05) and a 60% reduction in glutathione-methylfluorescein (GS-MF) excretion in isolated mouse hepatocyte (p < 0.01). Bile acid and bilirubin excretion remained unchanged compared with wild-type mice. These findings strongly suggest that NHERF-1 binds to Mrp2, and plays a critical role in the canalicular expression of Mrp2 and its function as a determinant of glutathione-dependent, bile acid-independent bile flow.	[Boyer, James L.] Yale Univ, Sch Med, Dept Med, Ctr Liver, New Haven, CT 06520 USA; [Weinman, Edward J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Weinman, Edward J.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	Yale University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Boyer, JL (corresponding author), Yale Univ, Sch Med, Dept Med, Ctr Liver, 333 Cedar St,1080 LMP,POB 208019, New Haven, CT 06520 USA.	james.boyer@yale.edu			National Institutes of Health [DK34989, DK25636, DK55881]; Research Service, Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055881, R37DK025636, P30DK034989, R01DK025636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK34989 and DK25636 (to J.L.B.) and DK55881 (to E.J.W.). This work was also supported by a grant from the Research Service, Department of Veterans Affairs (to E.J.W.).	BALLATORI N, 1992, AM J PHYSIOL, V263, pG617, DOI 10.1152/ajpgi.1992.263.5.G617; Ballatori N, 2005, HEPATOLOGY, V42, P1270, DOI 10.1002/hep.20961; Bandler PE, 2008, MOL PHARMACOL, V74, P9, DOI 10.1124/mol.108.045674; Borst P, 2006, CANCER LETT, V234, P51, DOI 10.1016/j.canlet.2005.05.051; BOYER JL, 1995, GASTROENTEROLOGY, V109, P1600, DOI 10.1016/0016-5085(95)90649-5; Broere N, 2007, J BIOL CHEM, V282, P37575, DOI 10.1074/jbc.M704878200; Brone B, 2005, AM J PHYSIOL-CELL PH, V288, pC20, DOI 10.1152/ajpcell.00368.2004; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cunningham R, 2007, J AM SOC NEPHROL, V18, P1419, DOI 10.1681/ASN.2006090980; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Fouassier L, 2001, HEPATOLOGY, V33, P166, DOI 10.1053/jhep.2001.21143; Fouassier L, 2009, AM J PATHOL, V174, P869, DOI 10.2353/ajpath.2009.080079; Geier A, 2007, BBA-MOL CELL RES, V1773, P283, DOI 10.1016/J.BBAMCR.2006.04.014; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Harris MJ, 2001, J BIOL CHEM, V276, P20876, DOI 10.1074/jbc.M010566200; Hegedus T, 2003, BIOCHEM BIOPH RES CO, V302, P454, DOI 10.1016/S0006-291X(03)00196-7; Hoque MT, 2009, BIOCHEM BIOPH RES CO, V379, P60, DOI 10.1016/j.bbrc.2008.12.014; Hoque MT, 2008, CANCER RES, V68, P4802, DOI 10.1158/0008-5472.CAN-07-6778; Jedlitschky G, 2006, EXPERT OPIN DRUG MET, V2, P351, DOI 10.1517/17425255.2.3.351; Kartenbeck J, 1996, HEPATOLOGY, V23, P1061; Kikuchi S, 2002, NAT GENET, V31, P320, DOI 10.1038/ng905; Kipp H, 2001, J BIOL CHEM, V276, P7218, DOI 10.1074/jbc.M007794200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Kocher O, 1999, LAB INVEST, V79, P1161; Kojima H, 2003, J HEPATOL, V39, P693, DOI 10.1016/S0168-8278(03)00410-0; Kojima H, 2008, J GASTROEN HEPATOL, V23, pE120, DOI 10.1111/j.1440-1746.2007.05109.x; Konno T, 2003, J BIOL CHEM, V278, P22908, DOI 10.1074/jbc.M302868200; Kubitz R, 1999, GASTROENTEROLOGY, V116, P401, DOI 10.1016/S0016-5085(99)70138-1; Lamprecht G, 2006, AM J PHYSIOL-GASTR L, V291, pG766, DOI 10.1152/ajpgi.00135.2006; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Mottino AD, 2002, HEPATOLOGY, V35, P1409, DOI 10.1053/jhep.2002.33327; Mottino AD, 2008, WORLD J GASTROENTERO, V14, P7068, DOI 10.3748/wjg.14.7068; Nies AT, 2007, PFLUG ARCH EUR J PHY, V453, P643, DOI 10.1007/s00424-006-0109-y; Nies AT, 2002, EUR J BIOCHEM, V269, P1866, DOI 10.1046/j.1432-1033.2002.02832.x; Paulusma CC, 1997, HEPATOLOGY, V25, P1539, DOI 10.1002/hep.510250635; Paulusma CC, 2000, HEPATOLOGY, V31, P684, DOI 10.1002/hep.510310319; Pietrement C, 2008, J BIOL CHEM, V283, P2986, DOI 10.1074/jbc.M704678200; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Roelofsen H, 1998, J CELL SCI, V111, P1137; Roma MG, 2008, WORLD J GASTROENTERO, V14, P6786, DOI 10.3748/wjg.14.6786; Roma MG, 2000, HEPATOLOGY, V32, P1342, DOI 10.1053/jhep.2000.20519; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Sekine S, 2006, FREE RADICAL BIO MED, V40, P2166, DOI 10.1016/j.freeradbiomed.2006.02.015; Shaik IH, 2006, ANAL BIOANAL CHEM, V385, P105, DOI 10.1007/s00216-006-0375-8; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Sun F, 2000, J BIOL CHEM, V275, P14360, DOI 10.1074/jbc.275.19.14360; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Wade JB, 2001, AM J PHYSIOL-CELL PH, V280, pC192, DOI 10.1152/ajpcell.2001.280.1.C192; Wang W, 2006, GASTROENTEROLOGY, V131, P878, DOI 10.1053/j.gastro.2006.06.013; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Weinman EJ, 2005, J PHYSIOL-LONDON, V567, P27, DOI 10.1113/jphysiol.2005.086777; Weinman EJ, 2003, FEBS LETT, V536, P141, DOI 10.1016/S0014-5793(03)00043-7; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903	57	45	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19299	19307		10.1074/jbc.M109.096081	http://dx.doi.org/10.1074/jbc.M109.096081			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404332	hybrid, Green Published			2022-12-25	WOS:000278727800039
J	Yagi, H; Ozawa, D; Sakurai, K; Kawakami, T; Kuyama, H; Nishimura, O; Shimanouchi, T; Kuboi, R; Naiki, H; Goto, Y				Yagi, Hisashi; Ozawa, Daisaku; Sakurai, Kazumasa; Kawakami, Toru; Kuyama, Hiroki; Nishimura, Osamu; Shimanouchi, Toshinori; Kuboi, Ryoichi; Naiki, Hironobu; Goto, Yuji			Laser-induced Propagation and Destruction of Amyloid beta Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOFLAVIN-T; PHOTODYNAMIC THERAPY; DISEASE; GROWTH; INSULIN; FIBRILLOGENESIS; FLUORESCENCE; ASSEMBLIES; NUCLEATION; MECHANISM	The amyloid deposition of amyloid beta (A beta) peptides is a critical pathological event in Alzheimer disease (AD). Preventing the formation of amyloid deposits and removing preformed fibrils in tissues are important therapeutic strategies against AD. Previously, we reported the destruction of amyloid fibrils of beta 2-microglobulin K3 fragments by laser irradiation coupled with the binding of amyloid-specific thioflavin T. Here, we studied the effects of a laser beam on A beta fibrils. As was the case for K3 fibrils, extensive irradiation destroyed the preformed A beta fibrils. However, irradiation during spontaneous fibril formation resulted in only the partial destruction of growing fibrils and a subsequent explosive propagation of fibrils. The explosive propagation was caused by an increase in the number of active ends due to breakage. The results not only reveal a case of fragmentation-induced propagation of fibrils but also provide insights into therapeutic strategies for AD.	[Yagi, Hisashi; Ozawa, Daisaku; Sakurai, Kazumasa; Kawakami, Toru; Kuyama, Hiroki; Nishimura, Osamu; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Shimanouchi, Toshinori; Kuboi, Ryoichi] Osaka Univ, Grad Sch Chem Sci & Engn, Dept Engn Sci, Osaka 5608531, Japan; [Naiki, Hironobu] Univ Fukui, Fac Med Sci, Dept Pathol Sci, Fukui 9101193, Japan	Osaka University; Osaka University; University of Fukui	Goto, Y (corresponding author), Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp	Kuyama, Hiroki/B-4687-2012; Naiki, Hironobu/G-5599-2014; Kuyama, Hiroki/W-8450-2019; Kuyama, Hiroki/D-1297-2009					Allsop D, 2008, BIOCHEM SOC T, V36, P1293, DOI 10.1042/BST0361293; Andersen CB, 2009, BIOPHYS J, V96, P1529, DOI 10.1016/j.bpj.2008.11.024; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Ban T, 2006, J BIOL CHEM, V281, P33677, DOI 10.1074/jbc.M606072200; Ban T, 2006, ACCOUNTS CHEM RES, V39, P663, DOI 10.1021/ar050074l; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Dahlgren PR, 2005, NANOMED-NANOTECHNOL, V1, P52, DOI 10.1016/j.nano.2004.11.004; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Giuliano EA, 2007, VET OPHTHALMOL, V10, P337, DOI 10.1111/j.1463-5224.2007.00578.x; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Higurashi T, 2008, P NATL ACAD SCI USA, V105, P16596, DOI 10.1073/pnas.0808934105; Krebs MRH, 2004, P NATL ACAD SCI USA, V101, P14420, DOI 10.1073/pnas.0405933101; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Librizzi F, 2005, PROTEIN SCI, V14, P3129, DOI 10.1110/ps.051692305; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mauro M, 2007, J MOL BIOL, V366, P258, DOI 10.1016/j.jmb.2006.11.008; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Narimoto T, 2004, FEBS LETT, V576, P313, DOI 10.1016/j.febslet.2004.09.024; Olteanu A, 2004, PROTEIN SCI, V13, P2852, DOI 10.1110/ps.04947204; Ono K, 2006, BBA-MOL BASIS DIS, V1762, P575, DOI 10.1016/j.bbadis.2006.03.002; Ozawa D, 2009, J BIOL CHEM, V284, P1009, DOI 10.1074/jbc.M805118200; Padrick SB, 2002, BIOCHEMISTRY-US, V41, P4694, DOI 10.1021/bi0160462; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Ruschak AM, 2007, P NATL ACAD SCI USA, V104, P12341, DOI 10.1073/pnas.0703306104; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Stsiapura VI, 2007, J PHYS CHEM A, V111, P4829, DOI 10.1021/jp070590o; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; Wazawa T, 2005, ADV BIOCHEM ENG BIOT, V95, P77, DOI 10.1007/b102211; Yagi H, 2007, BIOCHEMISTRY-US, V46, P15009, DOI 10.1021/bi701842n	37	44	48	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19660	19667		10.1074/jbc.M109.076505	http://dx.doi.org/10.1074/jbc.M109.076505			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20406822	Green Published, hybrid			2022-12-25	WOS:000278727800075
J	Xu, XA; Vatsyayan, J; Gao, CX; Bakkenist, CJ; Hu, J				Xu, Xiang; Vatsyayan, Jaya; Gao, Chenxi; Bakkenist, Christopher J.; Hu, Jing			HDAC2 Promotes eIF4E Sumoylation and Activates mRNA Translation Gene Specifically	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; EXPRESSION; INITIATION; PHOSPHORYLATION; MEF2; SUMO	Histone deacetylases (HDACs) are best known as transcription corepressors through deacetylating histone tails. Here we show that HDAC2 is also involved in cap-dependent mRNA translation by promoting sumoylation of eukaryotic translation initiation factor 4E (eIF4E), which is independent of its deacetylase activity. By stimulating eIF4E sumoylation, HDAC2 induces the formation of the active eukaryotic initiation factor 4F (eIF4F) complex and induces the protein synthesis of a subset of eIF4E-responsive genes that are essential for cell proliferation and preventing apoptosis. These data demonstrate that HDAC2 has an unexpected sumoylation-promoting activity and regulates cap-dependent mRNA translation.	[Xu, Xiang; Vatsyayan, Jaya; Gao, Chenxi; Bakkenist, Christopher J.; Hu, Jing] Univ Pittsburgh, Sch Med, Inst Canc, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Bakkenist, Christopher J.] Univ Pittsburgh, Sch Med, Inst Canc, Dept Radiat Oncol, Pittsburgh, PA 15213 USA; [Xu, Xiang] Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Inst Surg Res, Daping Hosp, Chongqing 400042, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Army Medical University	Hu, J (corresponding author), 2-42D Hillman Canc Ctr Res Pavil,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	huj3@upmc.edu	Hu, Jing/M-3130-2014; xu, xiang/L-2579-2014	xu, xiang/0000-0002-1026-2210	National Institutes of Health through the United States Public Health Service [CA128681]; Hillman Foundation; Pittsburgh Foundation; NATIONAL CANCER INSTITUTE [R21CA128681] Funding Source: NIH RePORTER	National Institutes of Health through the United States Public Health Service; Hillman Foundation; Pittsburgh Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA128681 through the United States Public Health Service (to J. H.). This work was also supported in part by grants from the Hillman Foundation fellowship and The Pittsburgh Foundation (to J. H.).	Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Cullen BR, 2009, CELL, V136, P592, DOI 10.1016/j.cell.2009.01.048; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Di Bacco A, 2006, CELL CYCLE, V5, P2310, DOI 10.4161/cc.5.20.3367; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Graff JR, 2007, J CLIN INVEST, V117, P2638, DOI 10.1172/JCI32044; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Kee HJ, 2008, CIRC RES, V103, P1259, DOI 10.1161/01.RES.0000338570.27156.84; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Nie M, 2006, NUCLEIC ACIDS RES, V34, P5528, DOI 10.1093/nar/gkl584; Nie MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005905; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Vatsyayan J, 2008, EMBO REP, V9, P885, DOI 10.1038/embor.2008.122; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Xu X, 2010, EMBO REP, V11, P299, DOI 10.1038/embor.2010.18; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X; Zimmermann S, 2007, CANCER RES, V67, P9047, DOI 10.1158/0008-5472.CAN-07-0312	22	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18139	18143		10.1074/jbc.C110.131599	http://dx.doi.org/10.1074/jbc.C110.131599			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20421305	hybrid, Green Published			2022-12-25	WOS:000278453900004
J	Kim, YS; Ke, F; Lei, XY; Zhu, R; Zhang, QY				Kim, Yu-Sin; Ke, Fei; Lei, Xiao-Ying; Zhu, Rong; Zhang, Qi-Ya			Viral Envelope Protein 53R Gene Highly Specific Silencing and Iridovirus Resistance in Fish Cells by AmiRNA	PLOS ONE			English	Article							RANA-GRYLIO-VIRUS; RNA INTERFERENCE; PARALICHTHYS-OLIVACEUS; FUNCTIONAL-CHARACTERIZATION; EXPRESSION; LINE; INHIBITION; SYSTEM; SIRNA; REPLICATION	Background: Envelope protein 53R was identified from frog Rana grylio virus (RGV), a member of the family Iridoviridae, and it plays an important role in the virus assembly. Although inhibition of iridovirus major capsid protein (MCP) by small hairpin RNAs (shRNAs) has been shown to cause resistance to viral infection in vitro, RNA interference (RNAi) to inhibit aquatic animal virus envelope protein gene product has not been reported. Methodology: We devised artificial microRNAs (amiRNAs) that target a viral envelope protein gene RGV 53R. By incorporating sequences encoding amiRNAs specific to 53R of RGV into pre-miRNA155 (pSM155) vectors, which use the backbone of natural miR-155 sequence and could intracellularly express 53R-targeted pre-amiRNAs. The pre-amiRNAs could be processed by the RNase III-like enzyme Dicer into 21-25 nt amiRNAs (amiR-53Rs) in fish cell lines. The levels of 53R expression were analyzed through real-time PCR and RGV virions assembly were observed by electronic microscopy in fish cells transfected with or without amiR-53Rs at 72 h of RGV infection. Conclusion/Significance: The results argue that viral envelope protein RGV 53R can be silenced and the virions assembly was deficient by amiR-53R-1, and further identified the first amiRNA of envelope protein gene from iridovirus that was able to cause resistance to virus infection in fish cells. The data demonstrate that the viral infection is efficiently suppressed (58%) by amiR-53R-1 targeting positon 36-57 of RGV 53R. Moreover, electron microscopic observations revealed virion assembly defect or reduced virions assembly capacity was closely correlated to expression of amiR-53R-1. Based on real time PCR of the Mx gene, we found no evidence of activation of IFN by amiR-53R-1.	[Kim, Yu-Sin; Ke, Fei; Lei, Xiao-Ying; Zhu, Rong; Zhang, Qi-Ya] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Kim, Yu-Sin] Kim II Sung Univ, Coll Life Sci, Pyongyang, North Korea	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Kim, YS (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	zhangqy@ihb.ac.cn			National Major Basic Research Program [2009CB118704, 2010CB126303]; National Natural Science Foundation of China [30871938, 30800854]; Agriculture Commonweal Scientific Research Plan [200803013]; China Postdoctoral Science Foundation [20080440975]	National Major Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture Commonweal Scientific Research Plan; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Major Basic Research Program (2009CB118704, 2010CB126303), the National Natural Science Foundation of China (30871938, 30800854), Agriculture Commonweal Scientific Research Plan (200803013) and China Postdoctoral Science Foundation (20080440975). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Dang LT, 2008, ANTIVIR RES, V77, P142, DOI 10.1016/j.antiviral.2007.10.007; Dang LT, 2008, ANTIVIR RES, V80, P316, DOI 10.1016/j.antiviral.2008.07.005; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Du GW, 2006, FEBS J, V273, P5421, DOI 10.1111/j.1742-4658.2006.05534.x; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Eaton HE, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-11; FIJAN N, 1983, ANN INST PASTEUR VIR, V134, P207, DOI 10.1016/S0769-2617(83)80060-4; Huang XH, 2006, J VIROL METHODS, V133, P117, DOI 10.1016/j.jviromet.2005.10.029; Jiang J, 2009, MOL IMMUNOL, V46, P3131, DOI 10.1016/j.molimm.2009.05.183; Ke F, 2009, MOL BIOL REP, V36, P1651, DOI 10.1007/s11033-008-9365-6; MAGEE WE, 1972, LIFE SCI 2-BIOCH GEN, V11, P1081, DOI 10.1016/0024-3205(72)90216-0; MANETTI R, 1995, EUR J IMMUNOL, V25, P2656, DOI 10.1002/eji.1830250938; Ooi EL, 2006, FISH SHELLFISH IMMUN, V21, P293, DOI 10.1016/j.fsi.2005.12.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Robertsen B, 2006, FISH SHELLFISH IMMUN, V20, P172, DOI 10.1016/j.fsi.2005.01.010; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; *SINONSAM, 2009, THESIS WUNAN U; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Sui HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005671; Sun W, 2006, BIOCHEM BIOPH RES CO, V351, P44, DOI 10.1016/j.bbrc.2006.09.169; Williams T, 1996, ADV VIRUS RES, V46, P345, DOI 10.1016/S0065-3527(08)60076-7; Xie JF, 2005, VIROLOGY, V338, P43, DOI 10.1016/j.virol.2005.04.040; Yeung ML, 2005, CELL RES, V15, P935, DOI 10.1038/sj.cr.7290371; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zhang QY, 1999, AQUACULTURE, V175, P185, DOI 10.1016/S0044-8486(99)00041-1; Zhang QY, 2006, AQUACULTURE, V251, P1, DOI 10.1016/j.aquaculture.2005.05.012; Zhang QY, 2003, DIS AQUAT ORGAN, V57, P27, DOI 10.3354/dao057027; Zhang QY, 2001, DIS AQUAT ORGAN, V48, P27, DOI 10.3354/dao048027; Zhao Z, 2008, J GEN VIROL, V89, P1866, DOI 10.1099/vir.0.2008/000810-0; Zhao Z, 2007, VIRUS RES, V123, P128, DOI 10.1016/j.virusres.2006.08.007; Zhao Z, 2009, VIRUS GENES, V38, P345, DOI 10.1007/s11262-008-0318-x	33	31	38	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10308	10.1371/journal.pone.0010308	http://dx.doi.org/10.1371/journal.pone.0010308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428238	gold, Green Published, Green Submitted			2022-12-25	WOS:000277079300007
J	Pause, BM; Lubke, K; Laudien, JH; Ferstl, R				Pause, Bettina M.; Luebke, Katrin; Laudien, Joachim H.; Ferstl, Roman			Intensified Neuronal Investment in the Processing of Chemosensory Anxiety Signals in Non-Socially Anxious and Socially Anxious Individuals	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; STRESS-INDUCED HYPERTHERMIA; ALARM PHEROMONE; EMOTIONAL EXPRESSIONS; GENDER-DIFFERENCES; MALE RATS; PHOBIA; FACES; PERCEPTION; DISORDER	Background: The ability to communicate anxiety through chemosensory signals has been documented in humans by behavioral, perceptual and brain imaging studies. Here, we investigate in a time-sensitive manner how chemosensory anxiety signals, donated by humans awaiting an academic examination, are processed by the human brain, by analyzing chemosensory event-related potentials (CSERPs, 64-channel recording with current source density analysis). Methodology/Principal Findings: In the first study cerebral stimulus processing was recorded from 28 non-socially anxious participants and in the second study from 16 socially anxious individuals. Each individual participated in two sessions, smelling sweat samples donated from either female or male donors (88 sessions; balanced session order). Most of the participants of both studies were unable to detect the stimuli olfactorily. In non-socially anxious females, CSERPs demonstrate an increased magnitude of the P3 component in response to chemosensory anxiety signals. The source of this P3 activity was allocated to medial frontal brain areas. In socially anxious females chemosensory anxiety signals require more neuronal resources during early pre-attentive stimulus processing (N1). The neocortical sources of this activity were located within medial and lateral frontal brain areas. In general, the event-related neuronal brain activity in males was much weaker than in females. However, socially anxious males processed chemosensory anxiety signals earlier (N1 latency) than the control stimuli collected during an ergometer training. Conclusions/Significance: It is concluded that the processing of chemosensory anxiety signals requires enhanced neuronal energy. Socially anxious individuals show an early processing bias towards social fear signals, resulting in a repression of late attentional stimulus processing.	[Pause, Bettina M.; Luebke, Katrin] Univ Dusseldorf, Dept Expt Psychol, Dusseldorf, Germany; [Laudien, Joachim H.; Ferstl, Roman] Univ Kiel, Dept Psychol, Kiel, Germany	Heinrich Heine University Dusseldorf; University of Kiel	Pause, BM (corresponding author), Univ Dusseldorf, Dept Expt Psychol, Dusseldorf, Germany.	bettina.pause@uni-duesseldorf.de			German Research Foundation (DFG) [PA 937/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The study was supported by a grant from the German Research Foundation to BMP (DFG, PA 937/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerl K, 2002, NEUROENDOCRINOL LETT, V23, P79; [Anonymous], 2014, PHEROMONES ANIMAL BE; Birbaumer N, 1998, NEUROREPORT, V9, P1223, DOI 10.1097/00001756-199804200-00048; Blair K, 2008, AM J PSYCHIAT, V165, P1193, DOI 10.1176/appi.ajp.2008.07071060; Borkenau P., 1993, NEO FUNF FAKTOREN IN; Brechbuhl J, 2008, SCIENCE, V321, P1092, DOI 10.1126/science.1160770; Chen D, 2000, PERCEPT MOTOR SKILL, V91, P771, DOI 10.2466/pms.2000.91.3.771; Damasio A.R., 1994, DESCARTES ERROR EMOT; FANSELOW MS, 1985, BEHAV NEUROSCI, V99, P589, DOI 10.1037/0735-7044.99.3.589; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hautzinger M., 1995, BECK DEPRESSIONS INV; Hirsch CR, 2004, CLIN PSYCHOL REV, V24, P799, DOI 10.1016/j.cpr.2004.07.005; Hideaki IA, 2008, PHYSIOL BEHAV, V93, P606, DOI 10.1016/j.physbeh.2007.10.021; Inagaki H, 2009, PHYSIOL BEHAV, V96, P749, DOI 10.1016/j.physbeh.2008.12.006; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kikusui T, 2001, PHYSIOL BEHAV, V72, P45, DOI 10.1016/S0031-9384(00)00370-X; Kiyokawa Y, 2005, BRAIN RES, V1043, P145, DOI 10.1016/j.brainres.2005.02.061; Kiyokawa Y, 2007, CHEM SENSES, V32, P57, DOI 10.1093/chemse/bjl036; Kobal G., 2003, HDB OLFACTION GUSTAT, P229; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Kolassa IT, 2006, BRAIN RES, V1118, P130, DOI 10.1016/j.brainres.2006.08.019; Kolassa IT, 2009, COGNITION EMOTION, V23, P69, DOI 10.1080/02699930801940461; Laudien JH, 2008, NEUROIMAGE, V41, P1426, DOI 10.1016/j.neuroimage.2008.03.046; Li H, 2008, NEUROIMAGE, V40, P1921, DOI 10.1016/j.neuroimage.2008.01.033; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; McClintock Martha K., 2002, P797; Morgan CD, 1997, EVOKED POTENTIAL, V104, P351, DOI 10.1016/S0168-5597(97)00020-8; Moser JS, 2008, BIOL PSYCHOL, V78, P93, DOI 10.1016/j.biopsycho.2008.01.005; Moynihan JA, 2000, J NEUROIMMUNOL, V102, P145, DOI 10.1016/S0165-5728(99)00173-3; Mueller EM, 2009, PSYCHOL MED, V39, P1141, DOI 10.1017/S0033291708004820; Mujica-Parodi LR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006415; Olofsson JK, 2004, CHEM SENSES, V29, P629, DOI 10.1093/chemse/bjh066; Orozco S, 1998, BIOL PSYCHIAT, V44, P281, DOI 10.1016/S0006-3223(97)00487-3; Page MC, 2003, LEVINES GUIDE SPSS A; Pause BM, 2009, INT J PSYCHOPHYSIOL, V74, P88, DOI 10.1016/j.ijpsycho.2009.07.008; Pause BM, 2000, INT J PSYCHOPHYSIOL, V36, P105, DOI 10.1016/S0167-8760(99)00105-1; Pause BM, 2004, CHEM SENSES, V29, P797, DOI 10.1093/chemse/bjh245; Pause BM, 1999, INT J PSYCHOPHYSIOL, V32, P251, DOI 10.1016/S0167-8760(99)00020-3; Pause BM, 1998, GENETICA, V104, P285, DOI 10.1023/A:1026462701154; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phan KL, 2006, BIOL PSYCHIAT, V59, P424, DOI 10.1016/j.biopsych.2005.08.012; Prehn A, 2006, NEUROSCI LETT, V394, P127, DOI 10.1016/j.neulet.2005.10.012; Prehn-Kristensen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005987; Proverbio AM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-56; ROLLS ET, 1999, BRAIN EMOTION; Rozenkrants B, 2008, CLIN NEUROPHYSIOL, V119, P2260, DOI 10.1016/j.clinph.2008.07.213; Schirmer A, 2005, NEUROREPORT, V16, P635, DOI 10.1097/00001756-200504250-00024; Stangier U, 1999, Z KLIN PSYCHOL-FORSC, V28, P28, DOI 10.1026//0084-5345.28.1.28; Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2; Straube T, 2004, BIOL PSYCHIAT, V56, P921, DOI 10.1016/j.biopsych.2004.09.024; Stuck BA, 2006, CLIN NEUROPHYSIOL, V117, P1367, DOI 10.1016/j.clinph.2006.03.004; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Wittchen H.U., 1997, SKID STRUKTURIERTES; ZALAQUETT C, 1991, PHYSIOL BEHAV, V50, P221, DOI 10.1016/0031-9384(91)90524-R; Zhou W, 2009, PSYCHOL SCI, V20, P177, DOI 10.1111/j.1467-9280.2009.02263.x	56	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10342	10.1371/journal.pone.0010342	http://dx.doi.org/10.1371/journal.pone.0010342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	588NU	20428249	gold, Green Submitted, Green Published			2022-12-25	WOS:000277079300022
J	Viadas, C; Rodriguez, MC; Sangari, FJ; Gorvel, JP; Garcia-Lobo, JM; Lopez-Goni, I				Viadas, Cristina; Rodriguez, Maria C.; Sangari, Felix J.; Gorvel, Jean-Pierre; Garcia-Lobo, Juan M.; Lopez-Goni, Ignacio			Transcriptome Analysis of the Brucella abortus BvrR/BvrS Two-Component Regulatory System	PLOS ONE			English	Article							SINORHIZOBIUM-MELILOTI EXOR; OUTER-MEMBRANE PROTEINS; IV SECRETION SYSTEM; AGROBACTERIUM-TUMEFACIENS; VIRULENCE; MELITENSIS; GENES; PHOSPHORYLATION; SUCCINOGLYCAN; EXPRESSION	Background: The two-component BvrR/BvrS system is essential for Brucella abortus virulence. It was shown previously that its dysfunction alters the expression of some major outer membrane proteins and the pattern of lipid A acylation. To determine the genes regulated by BvrR/BvrS, we performed a whole-genome microarray analysis using B. abortus RNA obtained from wild type and bvrR mutant cells grown in the same conditions. Methodology/Principal Findings: A total of 127 differentially expressed genes were found: 83 were over expressed and 44 were less expressed in the bvrR mutant. Two operons, the phosphotransferase system and the maltose transport system, were down-regulated. Several genes involved in cell envelope or outer membrane biogenesis were differentially expressed: genes for outer membrane proteins (omp25a, omp25d), lipoproteins, LPS and fatty acid biosynthesis, stress response proteins, chaperones, flagellar genes, and twelve genes encoding ABC transport systems. Ten genes related with carbon metabolism (pckA and fumB among others) were up-regulated in the bvrR mutant, and denitrification genes (nirK, norC and nosZ) were also regulated. Notably, seven transcriptional regulators were affected, including VjbR, ExoR and OmpR that were less expressed in the bvrR mutant. Finally, the expression of eleven genes which have been previously related with Brucella virulence was also altered. Conclusions/Significance: All these data corroborate the impact of BvrR/BvrS on cell envelope modulation, confirm that this system controls the carbon and nitrogen metabolism, and suggest a cross-talk among some regulators to adjust the Brucella physiology to the shift expected to occur during the transit from the extracellular to the intracellular niche.	[Viadas, Cristina; Lopez-Goni, Ignacio] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain; [Rodriguez, Maria C.; Sangari, Felix J.; Garcia-Lobo, Juan M.] Univ Cantabria, Dept Biol Mol, E-39005 Santander, Spain; [Rodriguez, Maria C.; Sangari, Felix J.; Garcia-Lobo, Juan M.] UC CSIC IDICAN, Inst Biomed & Biotecnol Cantabria IBBTEC, Santander, Spain; [Gorvel, Jean-Pierre] Aix Marseille Univ, CIML, UMR6546, Fac Sci Luminy, Marseille, France; [Gorvel, Jean-Pierre] INSERM, U631, F-13258 Marseille, France; [Gorvel, Jean-Pierre] INSERM, UMR6102, F-13258 Marseille, France	University of Navarra; Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Viadas, C (corresponding author), Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain.	ilgoni@unav.es	Sangari, Félix J/K-9104-2014; López-Goñi, Ignacio/K-2572-2017; Gorvel, Jean-Pierre/O-1332-2018; Rodriguez, Maria-Cruz/K-6533-2014; Lobo, Juan M Garcia/K-2727-2014	Sangari, Félix J/0000-0002-3298-6076; López-Goñi, Ignacio/0000-0002-3873-8743; Gorvel, Jean-Pierre/0000-0002-2829-9804; Rodriguez, Maria-Cruz/0000-0001-6778-1663; Lobo, Juan M Garcia/0000-0002-9187-0671	Ministerio de Ciencia y Tecnolog-ia of Spain [AGL2008-04514, BIO2007-63656]; Instituto de Salud Carlos III [PI050894]; Fundacion Marques de Valdecilla-IFIMAV	Ministerio de Ciencia y Tecnolog-ia of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Marques de Valdecilla-IFIMAV	This work was supported by the Ministerio de Ciencia y Tecnolog-ia of Spain (AGL2008-04514 to ILG, and BIO2007-63656 to FJS) and Instituto de Salud Carlos III (PI050894 to JMG-L). Fellowship support to CV for the Gobierno Vasco and to MCR for Fundacion Marques de Valdecilla-IFIMAV are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belanger L, 2009, MOL MICROBIOL, V74, P1223, DOI 10.1111/j.1365-2958.2009.06931.x; Boel G, 2003, J MOL MICROB BIOTECH, V5, P206, DOI 10.1159/000071072; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; CHARLES TC, 1993, J BACTERIOL, V175, P6614, DOI 10.1128/jb.175.20.6614-6625.1993; CHAVESOLARTE E, 2003, BRUC 2003 INT RES C; Chen EJ, 2008, MOL MICROBIOL, V69, P1290, DOI 10.1111/j.1365-2958.2008.06362.x; Cheng HP, 1998, J BACTERIOL, V180, P20, DOI 10.1128/JB.180.1.20-26.1998; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Delrue RM, 2005, CELL MICROBIOL, V7, P1151, DOI 10.1111/j.1462-5822.2005.00543.x; Delrue RM, 2004, FEMS MICROBIOL LETT, V231, P1, DOI 10.1016/S0378-1097(03)00963-7; DEUTSCHER J, 2005, BIOCHIM BIOPHYS ACTA, V754, P118; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dricot A, 2004, GENOME RES, V14, P2201, DOI 10.1101/gr.2456204; Eskra L, 2001, INFECT IMMUN, V69, P7736, DOI 10.1128/IAI.69.12.7736-7742.2001; FUGIER E, PLOS PATHOG, V5; GERHARDT P, 1958, BACTERIOL REV, V22, P81, DOI 10.1128/MMBR.22.2.81-98.1958; Guzman-Verri C, 2002, P NATL ACAD SCI USA, V99, P12375, DOI 10.1073/pnas.192439399; Haine V, 2006, J BACTERIOL, V188, P1615, DOI 10.1128/JB.188.4.1615-1619.2006; Hoch JA, 1995, 2 COMPONENT SIGNAL T; Keating DH, 2007, FEMS MICROBIOL LETT, V267, P23, DOI 10.1111/j.1574-6968.2006.00498.x; Lamontagne J, 2007, J PROTEOME RES, V6, P1519, DOI 10.1021/pr060636a; Leonard S, 2007, J BACTERIOL, V189, P131, DOI 10.1128/JB.00712-06; Lestrate P, 2000, MOL MICROBIOL, V38, P543, DOI 10.1046/j.1365-2958.2000.02150.x; Letesson J. J., 2004, Brucella: molecular and cellular biology, P117; Li LP, 2002, P NATL ACAD SCI USA, V99, P12369, DOI 10.1073/pnas.192439499; Liu P, 2005, J BACTERIOL, V187, P6039, DOI 10.1128/JB.187.17.6039-6045.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loisel-Meyer S, 2006, INFECT IMMUN, V74, P1973, DOI 10.1128/IAI.74.3.1973-1976.2006; Lopez-Goni I, 2002, VET MICROBIOL, V90, P329, DOI 10.1016/S0378-1135(02)00218-3; Manterola L, 2007, INFECT IMMUN, V75, P4867, DOI 10.1128/IAI.00439-07; MIZUNO T, 1990, MOL MICROBIOL, V4, P1077, DOI 10.1111/j.1365-2958.1990.tb00681.x; Oshima T, 2002, MOL MICROBIOL, V46, P281, DOI 10.1046/j.1365-2958.2002.03170.x; REIZER J, 1992, PROTEIN SCI, V1, P722, DOI 10.1002/pro.5560010604; Sola-Landa A, 1998, MOL MICROBIOL, V29, P125, DOI 10.1046/j.1365-2958.1998.00913.x; Uzureau S, 2007, J BACTERIOL, V189, P6035, DOI 10.1128/JB.00265-07; Viadas C, 2009, MICROB PATHOGENESIS, V47, P189, DOI 10.1016/j.micpath.2009.06.002; Wells DH, 2007, MOL MICROBIOL, V64, P647, DOI 10.1111/j.1365-2958.2007.05680.x; Yao SY, 2004, J BACTERIOL, V186, P6042, DOI [10.1128/JB.186.18.6042-6049.2004, 10.1128/jb.186.18.6042-6049.2004]; YUZBASIOGLU A, 2010, EXP MOL PATHOL	40	65	70	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10216	10.1371/journal.pone.0010216	http://dx.doi.org/10.1371/journal.pone.0010216			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422049	Green Published, gold, Green Submitted			2022-12-25	WOS:000276952500008
J	Brown, KC; Witte, TR; Hardman, WE; Luo, HT; Chen, YC; Carpenter, AB; Lau, JK; Dasgupta, P				Brown, Kathleen C.; Witte, Ted R.; Hardman, W. Elaine; Luo, Haitao; Chen, Yi C.; Carpenter, A. Betts; Lau, Jamie K.; Dasgupta, Piyali			Capsaicin Displays Anti-Proliferative Activity against Human Small Cell Lung Cancer in Cell Culture and Nude Mice Models via the E2F Pathway	PLOS ONE			English	Article							INDUCED APOPTOSIS; TRANSCRIPTION FACTOR; VANILLOID RECEPTOR; TUMOR-GROWTH; PROLIFERATION; ANGIOGENESIS; ACTIVATION; CARCINOMA; RB; CARCINOGENESIS	Background: Small cell lung cancer (SCLC) is characterized by rapid progression and low survival rates. Therefore, novel therapeutic agents are urgently needed for this disease. Capsaicin, the active ingredient of chilli peppers, displays anti-proliferative activity in prostate and epidermoid cancer in vitro. However, the anti-proliferative activity of capsaicin has not been studied in human SCLCs. The present manuscript fills this void of knowledge and explores the anti-proliferative effect of capsaicin in SCLC in vitro and in vivo. Methodology/Principal Findings: BrdU assays and PCNA ELISAs showed that capsaicin displays robust anti-proliferative activity in four human SCLC cell lines. Furthermore, capsaicin potently suppressed the growth of H69 human SCLC tumors in vivo as ascertained by CAM assays and nude mice models. The second part of our study attempted to provide insight into molecular mechanisms underlying the anti-proliferative activity of capsaicin. We found that the anti-proliferative activity of capsaicin is correlated with a decrease in the expression of E2F-responsive proliferative genes like cyclin E, thymidylate synthase, cdc25A and cdc6, both at mRNA and protein levels. The transcription factor E2F4 mediated the anti-proliferative activity of capsaicin. Ablation of E2F4 levels by siRNA methodology suppressed capsaicin-induced G1 arrest. ChIP assays demonstrated that capsaicin caused the recruitment of E2F4 and p130 on E2F-responsive proliferative promoters, thereby inhibiting cell proliferation. Conclusions/Significance: Our findings suggest that the anti-proliferative effects of capsaicin could be useful in the therapy of human SCLCs.	[Brown, Kathleen C.; Lau, Jamie K.; Dasgupta, Piyali] Marshall Univ, Dept Pharmacol Physiol & Toxicol, Joan C Edwards Sch Med, Huntington, WV 25755 USA; [Witte, Ted R.; Hardman, W. Elaine] Marshall Univ, Dept Biochem & Microbiol, Joan C Edwards Sch Med, Huntington, WV USA; [Luo, Haitao; Chen, Yi C.] Alderson Broaddus Coll, Dept Biol, Phillipi, WV USA; [Carpenter, A. Betts] Marshall Univ, Dept Anat & Pathol, Joan C Edwards Sch Med, Huntington, WV USA	Marshall University; Marshall University; Marshall University	Brown, KC (corresponding author), Marshall Univ, Dept Pharmacol Physiol & Toxicol, Joan C Edwards Sch Med, Huntington, WV 25755 USA.	dasgupta@marshall.edu	Wang, Weili/D-1546-2011		National Institutes of Health [5P20RR020180]; Pharmaceutical Manufacturers Association Foundation Research Starter; Marshall University ADVANCE fellowship; National Aeronautics and Space Administration; Young Clinical Scientist Award from the Flight Attendant Medical Research Institute [82115]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020180] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmaceutical Manufacturers Association Foundation Research Starter; Marshall University ADVANCE fellowship; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Young Clinical Scientist Award from the Flight Attendant Medical Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a Center of Biochemical Research Excellence Pilot Research Grant from the National Institutes of Health (grant number 5P20RR020180); the Pharmaceutical Manufacturers Association Foundation Research Starter Grant; the Marshall University ADVANCE fellowship; a Grant-in-Aid undergraduate research grant from National Aeronautics and Space Administration; and a Young Clinical Scientist Award from the Flight Attendant Medical Research Institute (grant number 82115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantini C, 2007, J NEUROCHEM, V102, P977, DOI 10.1111/j.1471-4159.2007.04582.x; Anandakumar P., 2007, BIOMED PHARMACOTHER; Athanasiou A, 2007, BIOCHEM BIOPH RES CO, V354, P50, DOI 10.1016/j.bbrc.2006.12.179; BANKOVIC J, 2009, LUNG CANC; Bhutani M, 2007, CLIN CANCER RES, V13, P3024, DOI 10.1158/1078-0432.CCR-06-2575; Biro T, 1997, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, P56, DOI 10.1038/jidsymp.1997.12; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chow J, 2007, BBA-MOL CELL RES, V1773, P565, DOI 10.1016/j.bbamcr.2007.01.001; Claudio PP, 2000, CLIN CANCER RES, V6, P754; Danielian PS, 2007, DEV BIOL, V305, P564, DOI 10.1016/j.ydbio.2007.02.037; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Dasgupta P, 2004, MOL CELL BIOL, V24, P9527, DOI 10.1128/MCB.24.21.9527-9541.2004; Dasgupta P, 2004, J BIOL CHEM, V279, P38762, DOI 10.1074/jbc.M312273200; Dasgupta P, 2006, J CLIN INVEST, V116, P3083, DOI 10.1172/JCI28164C1; Dasgupta P, 2006, CELL CYCLE, V5, P2324, DOI 10.4161/cc.5.20.3366; DeGregori J, 2006, CURR MOL MED, V6, P739; Gabellini C, 2006, ONCOGENE, V25, P5326, DOI 10.1038/sj.onc.1209631; GAZDAR AF, 1980, CANCER RES, V40, P3502; GAZDAR AF, 1985, CANCER RES, V45, P2924; Gil YG, 2008, LIFE SCI, V82, P997, DOI 10.1016/j.lfs.2008.02.020; Gu JW, 2005, CANCER-AM CANCER SOC, V103, P422, DOI 10.1002/cncr.20781; HEO DS, 1990, CANCER RES, V50, P3681; Ho VM, 2009, ONCOGENE, V28, P1393, DOI 10.1038/onc.2008.491; Jang J J, 1989, In Vivo, V3, P49; Johnson DG, 2006, CURR MOL MED, V6, P731; Kinkade R, 2008, CANCER RES, V68, P3810, DOI 10.1158/0008-5472.CAN-07-6672; Knudsen Erik S, 2003, Methods Mol Biol, V218, P3; KRUG LM, 2008, SMALL CELL OTHER NEU; Lehen'kyi V, 2007, ONCOGENE, V26, P7380, DOI 10.1038/sj.onc.1210545; Metro G, 2009, EXPERT OPIN EMERG DR, V14, P591, DOI 10.1517/14728210903206983; Min JK, 2004, CANCER RES, V64, P644, DOI 10.1158/0008-5472.CAN-03-3250; Minna JD, 2003, CANCER CELL, V4, P163, DOI 10.1016/S1535-6108(03)00221-6; MINNA JD, 1993, CHEST, V103, pS449, DOI 10.1378/chest.103.4_Supplement.449S; Mori A, 2006, CANCER RES, V66, P3222, DOI 10.1158/0008-5472.CAN-05-0087; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; NEVINS JR, 1991, COLD SPRING HARB SYM, V56, P157; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Parisi T, 2009, ONCOGENE, V28, P500, DOI 10.1038/onc.2008.406; Park KK, 1997, CANCER LETT, V114, P183, DOI 10.1016/S0304-3835(97)04657-0; PETTENGILL OS, 1980, CANCER-AM CANCER SOC, V45, P906, DOI 10.1002/1097-0142(19800301)45:5<906::AID-CNCR2820450513>3.0.CO;2-H; Potemski P, 2006, JPN J CLIN ONCOL, V36, P142, DOI 10.1093/jjco/hyi246; Pyun BJ, 2008, CANCER RES, V68, P227, DOI 10.1158/0008-5472.CAN-07-2799; Rastogi S, 2006, MOL CELL BIOL, V26, P4161, DOI 10.1128/MCB.02142-05; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Salgia R, 1998, J CLIN ONCOL, V16, P1207, DOI 10.1200/JCO.1998.16.3.1207; Sanchez AM, 2006, APOPTOSIS, V11, P89, DOI 10.1007/s10495-005-3275-z; Shabbir M, 2003, EUR UROL SUPPL, V2, P24; Simpson DS, 2009, CANCER RES, V69, P8733, DOI 10.1158/0008-5472.CAN-09-1359; Song PF, 2008, CANCER RES, V68, P4693, DOI 10.1158/0008-5472.CAN-08-0183; SWISS VA, 2009, GLIA; Tanaka T, 2002, CARCINOGENESIS, V23, P1361, DOI 10.1093/carcin/23.8.1361; THOENNISSEN NH, 2009, ONCOGENE; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tsou MF, 2006, ANTICANCER RES, V26, P1965; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Wu CC, 2006, MUTAT RES-FUND MOL M, V601, P71, DOI 10.1016/j.mrfmmm.2006.06.015	58	65	72	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10243	10.1371/journal.pone.0010243	http://dx.doi.org/10.1371/journal.pone.0010243			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20421925	gold, Green Published, Green Submitted			2022-12-25	WOS:000276854300009
J	Garcia-Nieto, S; Johal, RK; Shakesheff, KM; Emara, M; Royer, PJ; Chau, DYS; Shakib, F; Ghaemmaghami, AM				Garcia-Nieto, Samuel; Johal, Ramneek K.; Shakesheff, Kevin M.; Emara, Mohamed; Royer, Pierre-Joseph; Chau, David Y. S.; Shakib, Farouk; Ghaemmaghami, Amir M.			Laminin and Fibronectin Treatment Leads to Generation of Dendritic Cells with Superior Endocytic Capacity	PLOS ONE			English	Article							LYMPH-NODE; T-CELLS; ANTIGEN PRESENTATION; EXTRACELLULAR-MATRIX; PROTEOLYTIC ACTIVITY; MANNOSE RECEPTOR; INFORMATION; INTEGRINS; PROTEINS; ADHESION	Background: Sampling the microenvironment at sites of microbial exposure by dendritic cells ( DC) and their subsequent interaction with T cells in the paracortical area of lymph nodes are key events for initiating immune responses. Most of our knowledge of such events in human is based on in vitro studies performed in the absence of extracellular matrix (ECM) proteins. ECM in basement membranes and interstitial spaces of different tissues, including lymphoid organs, plays an important role in controlling specific cellular functions such as migration, intracellular signalling and differentiation. The aim of this study was, therefore, to investigate the impact of two abundant ECM components, fibronectin and laminin, on the phenotypical and functional properties of DC and how that might influence DC induced T-cell differentiation. Methodology/Principal Findings: Human monocyte derived DC were treated with laminin and fibronectin for up to 48 hours and their morphology and phenotype was analyzed using scanning electron microscopy, flow cytometry and real time PCR. The endocytic ability of DC was determined using flow cytometry. Furthermore, co-culture of DC and T cells were established and T cell proliferation and cytokine profile was measured using H-3-thymidine incorporation and ELISA respectively. Finally, we assessed formation of DC-T cell conjugates using different cell trackers and flow cytometry. Our data show that in the presence of ECM, DC maintain a 'more immature' phenotype and express higher levels of key endocytic receptors, and as a result become significantly better endocytic cells, but still fully able to mature in response to stimulation as evidenced by their superior ability to induce antigen-specific T cell differentiation. Conclusion: These studies underline the importance of including ECM components in in vitro studies investigating DC biology and DC-T cell interaction. Within the context of antigen specific DC induced T cell proliferation, inclusion of ECM proteins could lead to development of more sensitive assays.	[Garcia-Nieto, Samuel; Johal, Ramneek K.; Emara, Mohamed; Royer, Pierre-Joseph; Chau, David Y. S.; Shakib, Farouk; Ghaemmaghami, Amir M.] Univ Nottingham, Allergy Res Grp, Sch Mol Med Sci, Nottingham NG7 2RD, England; [Garcia-Nieto, Samuel; Johal, Ramneek K.; Emara, Mohamed; Royer, Pierre-Joseph; Chau, David Y. S.; Shakib, Farouk; Ghaemmaghami, Amir M.] Univ Nottingham, Resp Biomed Res Unit, Nottingham NG7 2RD, England; [Shakesheff, Kevin M.] Univ Nottingham, Sch Pharm, Tissue Engn Grp, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham; University of Nottingham	Garcia-Nieto, S (corresponding author), Univ Nottingham, Allergy Res Grp, Sch Mol Med Sci, Nottingham NG7 2RD, England.	Amir.Ghaemmaghami@nottingham.ac.uk	Chau, David YS/U-2911-2019; Emara, Mohamed M./C-8220-2013; Shakesheff, Kevin M/O-6371-2018; Ghaemmaghami, Amir/AAP-2968-2020; Ghaemmaghami, Amir/S-2627-2019; Shakesheff, Kevin/AAR-6603-2021; Royer, Pierre-Joseph/D-4768-2015	Emara, Mohamed M./0000-0001-7708-9435; Shakesheff, Kevin M/0000-0003-3236-2439; Ghaemmaghami, Amir/0000-0003-3160-8759; Royer, Pierre-Joseph/0000-0001-5534-7982; Chau, David/0000-0001-9200-6749	UK Biotechnology and Biological Sciences Research Council [BB/F001142/1]; CONACYT-Mexico; BBSRC [BB/F001142/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F001142/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partly funded by a research grant from the UK Biotechnology and Biological Sciences Research Council (bbsrc.ac.uk) Grant Number BB/F001142/1. S.G.N. is a recipient of a CONACYT-Mexico PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CAS, 2006, INT IMMUNOL, V18, P1295, DOI 10.1093/intimm/dxl062; Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Ardouin L, 2003, EUR J IMMUNOL, V33, P790, DOI 10.1002/eji.200323858; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Birdsall HH, 2005, J IMMUNOL, V175, P3347, DOI 10.4049/jimmunol.175.5.3347; Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Brand U, 1998, EUR J IMMUNOL, V28, P1673, DOI 10.1002/(SICI)1521-4141(199805)28:05<1673::AID-IMMU1673>3.0.CO;2-J; Ebnet K, 1996, ANNU REV IMMUNOL, V14, P155, DOI 10.1146/annurev.immunol.14.1.155; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; Frison N, 2003, J BIOL CHEM, V278, P23922, DOI 10.1074/jbc.M302483200; Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P1468, DOI 10.1046/j.1365-2745.2002.01504.x; Ghaemmaghami AM, 2001, EUR J IMMUNOL, V31, P1211, DOI 10.1002/1521-4141(200104)31:4&lt;1211::AID-IMMU1211&gt;3.0.CO;2-R; Gorfu G, 2008, J LEUKOCYTE BIOL, V84, P701, DOI 10.1189/jlb.0108048; Grashoff C, 2004, CURR OPIN CELL BIOL, V16, P565, DOI 10.1016/j.ceb.2004.07.004; Gretz JE, 1996, J IMMUNOL, V157, P495; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Gunzer M, 2004, BLOOD, V104, P2801, DOI 10.1182/blood-2004-03-1193; HARA M, 1994, J CELL SCI, V107, P2739; HAYAKAWA M, 1988, ARCH HISTOL CYTOL, V51, P233, DOI 10.1679/aohc.51.233; Horlock C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r30; Kaldjian EP, 2001, INT IMMUNOL, V13, P1243, DOI 10.1093/intimm/13.10.1243; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Kato M, 2000, INT IMMUNOL, V12, P1511, DOI 10.1093/intimm/12.11.1511; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lauvau G, 2004, EUR J IMMUNOL, V34, P913, DOI 10.1002/eji.200424944; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Sallusto F, 2002, ARTHRITIS RES THER, V4, pS127, DOI 10.1186/ar567; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Staquet MJ, 1997, J INVEST DERMATOL, V109, P738, DOI 10.1111/1523-1747.ep12340748; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Unsworth JM, 2003, J BIOMED MATER RES A, V66A, P425, DOI 10.1002/jbm.a.10592; Willard-Mack CL, 2006, TOXICOL PATHOL, V34, P409, DOI 10.1080/01926230600867727	41	35	36	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10123	10.1371/journal.pone.0010123	http://dx.doi.org/10.1371/journal.pone.0010123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419094	Green Published, gold, Green Submitted			2022-12-25	WOS:000276853800006
J	Filippi, M; Ceccarelli, A; Pagani, E; Gatti, R; Rossi, A; Stefanelli, L; Falini, A; Comi, G; Rocca, MA				Filippi, Massimo; Ceccarelli, Antonia; Pagani, Elisabetta; Gatti, Roberto; Rossi, Alice; Stefanelli, Laura; Falini, Andrea; Comi, Giancarlo; Rocca, Maria Assunta			Motor Learning in Healthy Humans Is Associated to Gray Matter Changes: A Tensor-Based Morphometry Study	PLOS ONE			English	Article							BRAIN ABNORMALITIES; 3D PATTERN; PLASTICITY; NEUROGENESIS; CONTRACTION; PROGRESSION; MOVEMENT; STROKE; CORTEX; SKILLS	We used tensor-based morphometry (TBM) to: 1) map gray matter ( GM) volume changes associated with motor learning in young healthy individuals; 2) evaluate if GM changes persist three months after cessation of motor training; and 3) assess whether the use of different schemes of motor training during the learning phase could lead to volume modifications of specific GM structures. From 31 healthy subjects, motor functional assessment and brain 3D T1-weighted sequence were obtained: before motor training ( time 0), at the end of training ( two weeks) ( time 2), and three months later ( time 3). Fifteen subjects ( group A) were trained with goal-directed motor sequences, and 16 ( group B) with non purposeful motor actions of the right hand. At time 1 vs. time 0, the whole sample of subjects had GM volume increase in regions of the temporooccipital lobes, inferior parietal lobule (IPL) and middle frontal gyrus, while at time 2 vs. time 1, an increased GM volume in the middle temporal gyrus was seen. At time 1 vs. time 0, compared to group B, group A had a GM volume increase of the hippocampi, while the opposite comparison showed greater GM volume increase in the IPL and insula in group B vs. group A. Motor learning results in structural GM changes of different brain areas which are part of specific neuronal networks and tend to persist after training is stopped. The scheme applied during the learning phase influences the pattern of such structural changes.	[Filippi, Massimo; Ceccarelli, Antonia; Pagani, Elisabetta; Rocca, Maria Assunta] Ist Sci San Raffaele, Div Neurosci, Inst Expt Neurol, Neuroimaging Res Unit, I-20132 Milan, Italy; [Filippi, Massimo; Ceccarelli, Antonia; Pagani, Elisabetta; Gatti, Roberto; Rossi, Alice; Stefanelli, Laura; Falini, Andrea; Comi, Giancarlo; Rocca, Maria Assunta] Univ Hosp San Raffaele, Milan, Italy; [Filippi, Massimo; Comi, Giancarlo; Rocca, Maria Assunta] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy; [Gatti, Roberto; Rossi, Alice; Stefanelli, Laura] Ist Sci San Raffaele, Sch Physiotherapy, Lab Movement Anal, I-20132 Milan, Italy; [Falini, Andrea] Ist Sci San Raffaele, Dept Neuroradiol, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Filippi, M (corresponding author), Ist Sci San Raffaele, Div Neurosci, Inst Expt Neurol, Neuroimaging Res Unit, I-20132 Milan, Italy.	m.filippi@hsr.it	ceccarelli, antonia/N-9563-2019; Filippi, Massimo/K-1755-2018; stefanelli, laura/AAA-8203-2020; Rocca, Maria Assunta/K-1619-2018; Gatti, Roberto/J-6452-2018	ceccarelli, antonia/0000-0002-1628-5667; Filippi, Massimo/0000-0002-5485-0479; Rocca, Maria Assunta/0000-0003-2358-4320; Gatti, Roberto/0000-0002-4669-1287; stefanelli, laura/0000-0002-3263-4791; Pagani, Elisabetta/0000-0002-1850-1175; falini, andrea/0000-0002-1461-8755				Agosta F, 2009, AMYOTROPH LATERAL SC, V10, P168, DOI 10.1080/17482960802603841; Ashburner J, 2003, LANCET NEUROL, V2, P79, DOI 10.1016/S1474-4422(03)00304-1; Ashburner J, 2000, HUM BRAIN MAPP, V9, P212, DOI 10.1002/(SICI)1097-0193(200004)9:4<212::AID-HBM3>3.0.CO;2-#; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Brambati SM, 2009, NEUROBIOL AGING, V30, P103, DOI 10.1016/j.neurobiolaging.2007.05.014; Brambati SM, 2007, NEUROIMAGE, V35, P998, DOI 10.1016/j.neuroimage.2007.01.028; Ceccarelli A, 2009, NEUROIMAGE, V48, P585, DOI 10.1016/j.neuroimage.2009.07.009; Chiang MC, 2007, NEUROIMAGE, V36, P1096, DOI 10.1016/j.neuroimage.2007.04.024; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Doyon J, 2008, CURR OPIN NEUROL, V21, P478, DOI 10.1097/WCO.0b013e328304b6a3; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Halsband U, 2006, J PHYSIOL-PARIS, V99, P414, DOI 10.1016/j.jphysparis.2006.03.007; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Kipps CM, 2005, J NEUROL NEUROSUR PS, V76, P650, DOI 10.1136/jnnp.2004.047993; Koski L, 2002, CEREB CORTEX, V12, P847, DOI 10.1093/cercor/12.8.847; Lee AD, 2007, NEUROIMAGE, V34, P924, DOI 10.1016/j.neuroimage.2006.09.043; Leow AD, 2006, NEUROIMAGE, V31, P627, DOI 10.1016/j.neuroimage.2005.12.013; Lepore N, 2006, LECT NOTES COMPUT SC, V4190, P191; Lepper M, 2008, ACTA PSYCHOL, V128, P139, DOI 10.1016/j.actpsy.2007.12.001; MANDELL RJ, 1984, AM J OCCUP THER, V38, P114, DOI 10.5014/ajot.38.2.114; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Salmond CH, 2002, NEUROIMAGE, V17, P1027, DOI 10.1006/nimg.2002.1153; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Trombly CA, 1999, AM J OCCUP THER, V53, P333, DOI 10.5014/ajot.53.4.333; Tunik E, 2008, J NEUROSCI, V28, P13615, DOI 10.1523/JNEUROSCI.3303-08.2008; Wu CY, 2000, ARCH PHYS MED REHAB, V81, P95, DOI 10.1053/apmr.2000.0810095	36	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10198	10.1371/journal.pone.0010198	http://dx.doi.org/10.1371/journal.pone.0010198			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419166	Green Published, Green Submitted, gold			2022-12-25	WOS:000276707100014
J	Ohnuki, S; Oka, S; Nogami, S; Ohya, Y				Ohnuki, Shinsuke; Oka, Satomi; Nogami, Satoru; Ohya, Yoshikazu			High-Content, Image-Based Screening for Drug Targets in Yeast	PLOS ONE			English	Article							MODE-OF-ACTION; RIBONUCLEOTIDE REDUCTASE; SACCHAROMYCES-CEREVISIAE; 1,3-BETA-D-GLUCAN SYNTHASE; GENE ONTOLOGY; V-ATPASES; H+-ATPASE; SUBUNIT; ENCODES; INHIBITION	Background: Drug discovery and development are predicated on elucidation of the potential mechanisms of action and cellular targets of candidate chemical compounds. Recent advances in high-content imaging techniques allow simultaneous analysis of a range of cellular events. In this study, we propose a novel strategy to identify drug targets by combining genetic screening and high-content imaging in yeast. Methodology: In this approach, we infer the cellular functions affected by candidate drugs by comparing morphologic changes induced by the compounds with the phenotypes of yeast mutants. Conclusions: Using this method and four well-characterized reagents, we successfully identified previously known target genes of the compounds as well as other genes involved with functionally related cellular pathways. This is the first demonstration of a genetic high-content assay that can be used to identify drug targets based on morphologic phenotypes of a reference mutant panel.	[Ohnuki, Shinsuke; Oka, Satomi; Nogami, Satoru; Ohya, Yoshikazu] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan	University of Tokyo	Ohnuki, S (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan.	ohya@k.u-tokyo.ac.jp	Ohya, Yoshikazu/AAW-2200-2021; Nogami, Satoru/G-6061-2014	Ohya, Yoshikazu/0000-0003-0837-1239; Nogami, Satoru/0000-0002-4517-0180; Ohnuki, Shinsuke/0000-0001-6254-081X	Ministry of Education, Culture, Sports, Science and Technology of Japan [21310127]; New Energy and Industrial Technology Development Organization [P06008]; Japan Society for the Promotion of Science [209689]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 21310127, http://www.mext.go. jp/), and from the New Energy and Industrial Technology Development Organization (No. P06008, http://www.nedo.go.jp/), and from the Japan Society for the Promotion of Science (No. 209689, http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BASSON ME, 1986, P NATL ACAD SCI USA, V83, P5563, DOI 10.1073/pnas.83.15.5563; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Bowman EJ, 2004, J BIOL CHEM, V279, P33131, DOI 10.1074/jbc.M404638200; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; CHANG CH, 1978, BIOCHEM PHARMACOL, V27, P2297, DOI 10.1016/0006-2952(78)90134-X; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; deHart AKA, 2003, MOL BIOL CELL, V14, P4676, DOI 10.1091/mbc.E03-05-0323; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740; Feng Y, 2009, NAT REV DRUG DISCOV, V8, P567, DOI 10.1038/nrd2876; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; HANADA H, 1990, BIOCHEM BIOPH RES CO, V170, P873, DOI 10.1016/0006-291X(90)92172-V; HECTOR RF, 1993, CLIN MICROBIOL REV, V6, P1; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Hoon S, 2008, TRENDS PHARMACOL SCI, V29, P499, DOI 10.1016/j.tips.2008.07.006; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; INOUE SB, 1995, EUR J BIOCHEM, V231, P845, DOI 10.1111/j.1432-1033.1995.tb20770.x; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; KINASHI H, 1981, TETRAHEDRON LETT, V22, P3857, DOI 10.1016/S0040-4039(01)91328-0; Korn K, 2007, CURR OPIN CHEM BIOL, V11, P503, DOI 10.1016/j.cbpa.2007.08.030; KRAKOFF IH, 1968, CANCER RES, V28, P1559; LASSMANN G, 1992, BIOCHEM BIOPH RES CO, V188, P879, DOI 10.1016/0006-291X(92)91138-G; Luesch H, 2005, CHEM BIOL, V12, P55, DOI 10.1016/j.chembiol.2004.10.015; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Moriya H, 2006, PLOS GENET, V2, P1034, DOI 10.1371/journal.pgen.0020111; Negishi T, 2009, J BIOTECHNOL, V141, P109, DOI 10.1016/j.jbiotec.2009.03.014; Ohnuki S, 2007, EUKARYOT CELL, V6, P817, DOI 10.1128/EC.00012-07; Ohya Y, 2005, P NATL ACAD SCI USA, V102, P19015, DOI 10.1073/pnas.0509436102; OKADA H, 2010, GENETICS IN PRESS; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; SAWISTOWSKASCHRODER ET, 1984, FEBS LETT, V173, P134, DOI 10.1016/0014-5793(84)81032-7; Stolz J, 1999, J BIOL CHEM, V274, P18747, DOI 10.1074/jbc.274.26.18747; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Vizeacoumar FJ, 2009, FEBS LETT, V583, P1656, DOI 10.1016/j.febslet.2009.03.068; Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114; White WH, 2001, J BIOL CHEM, V276, P10794, DOI 10.1074/jbc.M009804200; Wuster A, 2008, TRENDS BIOTECHNOL, V26, P252, DOI 10.1016/j.tibtech.2008.01.004	46	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10177	10.1371/journal.pone.0010177	http://dx.doi.org/10.1371/journal.pone.0010177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418956	Green Published, Green Submitted, gold			2022-12-25	WOS:000276706800017
J	Dirks, RP; van Geel, R; Hensen, SMM; van Genesen, ST; Lubsen, NH				Dirks, Ron P.; van Geel, Remon; Hensen, Sanne M. M.; van Genesen, Siebe T.; Lubsen, Nicolette H.			Manipulating Heat Shock Factor-1 in Xenopus Tadpoles: Neuronal Tissues Are Refractory to Exogenous Expression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-1; HSF1; PROTEIN; CELLS; EMBRYOS; MICE; STRESS; VECTOR; LAEVIS; GENE	Background: The aging related decline of heat shock factor-1 (HSF1) signaling may be causally related to protein aggregation diseases. To model such disease, we tried to cripple HSF1 signaling in the Xenopus tadpole. Results: Over-expression of heat shock factor binding protein-1 did not inhibit the heat shock response in Xenopus. RNAi against HSF1 mRNA inhibited the heat shock response by 70% in Xenopus A6 cells, but failed in transgenic tadpoles. Expression of XHSF380, a dominant-negative HSF1 mutant, was embryonic lethal, which could be circumvented by delaying expression via a tetracycline inducible promoter. HSF1 signaling is thus essential for embryonic Xenopus development. Surprisingly, transgenic expression of the XHSF380 or of full length HSF1, whether driven by a ubiquitous or a neural specific promoter, was not detectable in the larval brain. Conclusions: Our finding that the majority of neurons, which have little endogenous HSF1, refused to accept transgene-driven expression of HSF1 or its mutant suggests that HSF1 levels are strictly controlled in neuronal tissue.	[Dirks, Ron P.; van Geel, Remon; Hensen, Sanne M. M.; van Genesen, Siebe T.; Lubsen, Nicolette H.] Radboud Univ Nijmegen, Dept Biomol Chem, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Dirks, RP (corresponding author), ZF Screens BV, Leiden, Netherlands.	n.lubsen@science.ru.nl	Lubsen, Nicolette H./B-8426-2011		Senter IOP Genomics programme [IGE03018]	Senter IOP Genomics programme	Senter IOP Genomics programme, grant nr. IGE03018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Das B, 2004, P NATL ACAD SCI USA, V101, P4839, DOI 10.1073/pnas.0401011101; Dirks Ron P. H., 2003, Current Genomics, V4, P699, DOI 10.2174/1389202033490132; Doerwald L, 2003, J BIOL CHEM, V278, P49743, DOI 10.1074/jbc.M302914200; Evans TG, 2007, COMP BIOCHEM PHYS A, V146, P131, DOI 10.1016/j.cbpa.2006.09.023; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Inouye S, 2004, J BIOL CHEM, V279, P38701, DOI 10.1074/jbc.M405986200; Izu H, 2004, BIOL REPROD, V70, P18, DOI 10.1095/biolreprod.103.020065; JOHNSON AD, 1994, GENE, V147, P223, DOI 10.1016/0378-1119(94)90070-1; Jurivich DA, 2005, EXP GERONTOL, V40, P948, DOI 10.1016/j.exger.2005.08.003; Klein SL, 2002, DEV DYNAM, V225, P384, DOI 10.1002/dvdy.10174; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Li M, 2006, CELL RES, V16, P99, DOI 10.1038/sj.cr.7310013; Mercier PA, 1997, J BIOL CHEM, V272, P14147, DOI 10.1074/jbc.272.22.14147; Nakai A, 2000, EMBO J, V19, P1545, DOI 10.1093/emboj/19.7.1545; Santos SD, 2004, NEUROSCIENCE, V126, P657, DOI 10.1016/j.neuroscience.2004.03.023; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Satyal SH, 1998, GENE DEV, V12, P1962, DOI 10.1101/gad.12.13.1962; Sparrow D B, 2000, Nucleic Acids Res, V28, pE12, DOI 10.1093/nar/28.4.e12; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tai LJ, 2002, J BIOL CHEM, V277, P735, DOI 10.1074/jbc.M108604200; Takaki E, 2006, J BIOL CHEM, V281, P4931, DOI 10.1074/jbc.M506911200; Tonkiss J, 2005, INT J HYPERTHER, V21, P433, DOI 10.1080/02656730500165514; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Tuttle AM, 2007, COMP BIOCHEM PHYS A, V147, P112, DOI 10.1016/j.cbpa.2006.12.003; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Voellmy R, 2005, METHODS, V35, P199, DOI 10.1016/j.ymeth.2004.08.010; Wang GH, 2001, GENESIS, V30, P195, DOI 10.1002/gene.1064; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232	34	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10158	10.1371/journal.pone.0010158	http://dx.doi.org/10.1371/journal.pone.0010158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405018	Green Published, gold, Green Submitted			2022-12-25	WOS:000276706300014
J	Hadwiger, G; Dour, S; Arur, S; Fox, P; Nonet, ML				Hadwiger, Gayla; Dour, Scott; Arur, Swathi; Fox, Paul; Nonet, Michael L.			A Monoclonal Antibody Toolkit for C. elegans	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; CAENORHABDITIS-ELEGANS; NUCLEAR-LOCALIZATION; FUNCTIONAL-ANALYSIS; GENETIC-ANALYSIS; L1CAM HOMOLOG; IN-VIVO; PROTEIN; IDENTIFICATION; DYNAMIN	Background: Antibodies are critical tools in many avenues of biological research. Though antibodies can be produced in the research laboratory setting, most research labs working with vertebrates avail themselves of the wide array of commercially available reagents. By contrast, few such reagents are available for work with model organisms. Methodology/Principal Findings: We report the production of monoclonal antibodies directed against a wide range of proteins that label specific subcellular and cellular components, and macromolecular complexes. Antibodies were made to synaptobrevin (SNB-1), a component of synaptic vesicles; to Rim (UNC-10), a protein localized to synaptic active zones; to transforming acidic coiled-coil protein (TAC-1), a component of centrosomes; to CENP-C (HCP-4), which in worms labels the entire length of their holocentric chromosomes; to ORC2 (ORC-2), a subunit of the DNA origin replication complex; to the nucleolar phosphoprotein NOPP140 (DAO-5); to the nuclear envelope protein lamin (LMN-1); to EHD1 (RME-1) a marker for recycling endosomes; to caveolin (CAV-1), a marker for caveolae; to the cytochrome P450 (CYP-33E1), a resident of the endoplasmic reticulum; to beta-1,3-glucuronyltransferase (SQV-8) that labels the Golgi; to a chaperonin (HSP-60) targeted to mitochondria; to LAMP (LMP-1), a resident protein of lysosomes; to the alpha subunit of the 20S subcomplex (PAS-7) of the 26S proteasome; to dynamin (DYN-1) and to the alpha-subunit of the adaptor complex 2 (APA-2) as markers for sites of clathrin-mediated endocytosis; to the MAGUK, protein disks large (DLG-1) and cadherin (HMR-1), both of which label adherens junctions; to a cytoskeletal linker of the ezrin-radixin-moesin family (ERM-1), which localized to apical membranes; to an ERBIN family protein (LET-413) which localizes to the basolateral membrane of epithelial cells and to an adhesion molecule (SAX-7) which localizes to the plasma membrane at cell-cell contacts. In addition to working in whole mount immunocytochemistry, most of these antibodies work on western blots and thus should be of use for biochemical fractionation studies. Conclusions/Significance: We have produced a set of monoclonal antibodies to subcellular components of the nematode C. elegans for the research community. These reagents are being made available through the Developmental Studies Hybridoma Bank (DSHB).	[Hadwiger, Gayla; Dour, Scott; Nonet, Michael L.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Arur, Swathi; Fox, Paul] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Hadwiger, G (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	nonetm@pcg.wustl.edu		Fox, Paul/0000-0002-5626-9637	National Center for Research Resources [R24 RR022234]; NIH [R01 GM63310, GM085150]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR022234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063310, R01GM085150] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project described was funded primarily by award number R24 RR022234 from the National Center for Research Resources. Work by S. A. and P. F. was conducted in Tim Schedl's laboratory under NIH R01 GM63310 and GM085150. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams B, 2008, DEV DYNAM, V237, P630, DOI 10.1002/dvdy.21446; Aono S, 2004, DEVELOPMENT, V131, P2865, DOI 10.1242/dev.01146; Arur S, 2009, P NATL ACAD SCI USA, V106, P4776, DOI 10.1073/pnas.0812285106; Bellanger JM, 2003, CURR BIOL, V13, P1488, DOI 10.1016/S0960-9822(03)00582-7; Bossinger O, 2001, DEV BIOL, V230, P29, DOI 10.1006/dbio.2000.0113; Broadbent ID, 2002, CURR BIOL, V12, P59, DOI 10.1016/S0960-9822(01)00624-8; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; CAIRNS C, 1995, J CELL SCI, V108, P3339; Chakrapani BPS, 2008, J BIOSCIENCES, V33, P269, DOI 10.1007/s12038-008-0044-5; Chen LS, 2001, J CELL BIOL, V154, P841, DOI 10.1083/jcb.200009004; Clark SG, 1997, P NATL ACAD SCI USA, V94, P10438, DOI 10.1073/pnas.94.19.10438; Cohen M, 2002, J STRUCT BIOL, V140, P232, DOI 10.1016/S1047-8477(02)00516-6; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Duerr JS, 2008, J COMP NEUROL, V506, P398, DOI 10.1002/cne.21551; Firestein BL, 2001, MOL BIOL CELL, V12, P3465, DOI 10.1091/mbc.12.11.3465; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; FRANCIS GR, 1985, J CELL BIOL, V101, P1532, DOI 10.1083/jcb.101.4.1532; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Gobel V, 2004, DEV CELL, V6, P865, DOI 10.1016/j.devcel.2004.05.018; GOSSEN M, 1995, SCIENCE, V270, P1674, DOI 10.1126/science.270.5242.1674; Gracheva EO, 2008, NEUROSCI LETT, V444, P137, DOI 10.1016/j.neulet.2008.08.026; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Han SM, 2006, DEVELOPMENT, V133, P3597, DOI 10.1242/dev.02534; Hao W, 2008, CLIN VACCINE IMMUNOL, V15, P194, DOI 10.1128/CVI.00362-07; Herman T, 1999, P NATL ACAD SCI USA, V96, P974, DOI 10.1073/pnas.96.3.974; Hofbauer A, 2009, J NEUROGENET, V23, P78, DOI 10.1080/01677060802471627; Inoue T, 2007, VET PARASITOL, V146, P281, DOI 10.1016/j.vetpar.2007.02.028; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; Kelly S, 2006, EUKARYOT CELL, V5, P876, DOI 10.1128/EC.5.5.876-879.2006; Kostich M, 2000, J CELL SCI, V113, P2595; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Kudron MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000181; Kuwahara T, 2008, HUM MOL GENET, V17, P2997, DOI 10.1093/hmg/ddn198; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Labrousse AM, 1998, MOL BIOL CELL, V9, P3227, DOI 10.1091/mbc.9.11.3227; Ladurner P, 2005, HISTOCHEM CELL BIOL, V123, P89, DOI 10.1007/s00418-004-0722-9; Le Bot N, 2003, CURR BIOL, V13, P1499, DOI 10.1016/S0960-9822(03)00577-3; Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089; Legouis R, 2000, NAT CELL BIOL, V2, P415, DOI 10.1038/35017046; Legouis R, 2003, EMBO REP, V4, P1096, DOI 10.1038/sj.embor.7400006; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; McCain J, 2006, CELL TISSUE RES, V323, P105, DOI 10.1007/s00441-005-0044-9; McMahon L, 2001, J CELL SCI, V114, P2265; Meier UT, 1996, J BIOL CHEM, V271, P19376; MEIER UT, 1990, J CELL BIOL, V111, P2235, DOI 10.1083/jcb.111.6.2235; Moore LL, 2001, J CELL BIOL, V153, P1199, DOI 10.1083/jcb.153.6.1199; Moore LL, 1999, J CELL BIOL, V147, P471, DOI 10.1083/jcb.147.3.471; Nakayama Y, 2009, DEV CELL, V16, P889, DOI 10.1016/j.devcel.2009.04.009; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; NEVESCARVALHO A, 2009, BIOCH BIOPHYS RES CO; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nonet ML, 1998, J NEUROSCI, V18, P70; Nunes F, 2005, BIOCHEM BIOPH RES CO, V338, P862, DOI 10.1016/j.bbrc.2005.10.023; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Ono K, 2006, MOL BIOL CELL, V17, P2722, DOI 10.1091/mbc.E06-02-0114; Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986; Parker Scott, 2007, Invertebrate Neuroscience, V7, P157, DOI 10.1007/s10158-007-0051-5; Parker S, 2009, MOL BIOL CELL, V20, P1763, DOI 10.1091/mbc.E08-08-0837; Pettitt J, 2003, J CELL BIOL, V162, P15, DOI 10.1083/jcb.200212136; Radichev I, 2006, J BIOL CHEM, V281, P23264, DOI 10.1074/jbc.M603873200; Rodrigues AJ, 2007, FASEB J, V21, P1126, DOI 10.1096/fj.06-7002com; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; Sasakura H, 2005, EMBO J, V24, P1477, DOI 10.1038/sj.emboj.7600621; Schaffer U, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1178; Scheel J, 1999, NAT CELL BIOL, V1, P127, DOI 10.1038/10100; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; Schuske K, 2007, NAT NEUROSCI, V10, P846, DOI 10.1038/nn1920; Segbert C, 2004, DEV BIOL, V266, P17, DOI 10.1016/j.ydbio.2003.10.019; Shim J, 2000, MOL CELLS, V10, P309; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Takeda K, 2008, GENES CELLS, V13, P653, DOI 10.1111/j.1365-2443.2008.01195.x; Tang ZL, 1997, J BIOL CHEM, V272, P2437, DOI 10.1074/jbc.272.4.2437; Thompson HM, 2002, CURR BIOL, V12, P2111, DOI 10.1016/S0960-9822(02)01390-8; van Furden D, 2004, DEV BIOL, V272, P262, DOI 10.1016/j.ydbio.2004.05.012; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Waggener JM, 2002, MOL BIOL CELL, V13, P362, DOI 10.1091/mbc.01-04-0162; Wang XL, 2005, DEV BIOL, V284, P273, DOI 10.1016/j.ydbio.2005.05.020; WARD S, 1986, J CELL BIOL, V102, P1778, DOI 10.1083/jcb.102.5.1778; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Weimer RM, 2006, J NEUROSCI, V26, P8040, DOI 10.1523/JNEUROSCI.2350-06.2006; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Zhou S, 2008, GENETICS, V180, P1429, DOI 10.1534/genetics.108.091272	86	63	84	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10161	10.1371/journal.pone.0010161	http://dx.doi.org/10.1371/journal.pone.0010161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405020	Green Published, gold, Green Submitted			2022-12-25	WOS:000276706300016
J	Sampaio, P; Santos, M; Correia, A; Amaral, FE; Chavez-Galarza, J; Costa-de-Oliveira, S; Castro, AG; Pedrosa, J; Pais, C				Sampaio, Paula; Santos, Marlene; Correia, Alexandra; Amaral, Fabio E.; Chavez-Galarza, Julio; Costa-de-Oliveira, Sofia; Castro, Antonio G.; Pedrosa, Jorge; Pais, Celia			Virulence Attenuation of Candida albicans Genetic Variants Isolated from a Patient with a Recurrent Bloodstream Infection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; IN-VITRO MODEL; TRANSCRIPTIONAL RESPONSE; INCREASED SUSCEPTIBILITY; INTERFERON-GAMMA; DEFICIENT MICE; HOST-DEFENSE; G-CSF; STRAIN; IMMUNITY	The incidence of Candida albicans infections and the relapse episodes after antifungal treatment have increased in recent decades. Recurrences are mainly due to the persistence of the original infecting strain that may present genetic and genomic rearrangements during interaction with the host, reflecting strain adaptation. In this study, four isolates recovered from a patient during recurrent candidemia episodes were genotyped by microsatellite length polymorphism (MLP) and by multilocus sequence typing (MLST) and found to be genetic variants of the same strain. Using experimental mouse infections, a progressive reduction in the virulence of the four isolates was observed, with the first two isolates more virulent than the third and fourth. Additionally, in the mouse model, the first isolate resisted host control more efficiently, resulting in higher kidney fungal burdens and necrosis as compared to the third isolate. The resolution of inflammation was delayed in mice challenged with the first isolate and the message for IFN-gamma and TNF-alpha in the spleen was lower within the first few hours post-infection. Original and recurrent isolates also displayed different phenotypes regarding activity of secreted enzymes and response to stress agents. Overall, the comparative analysis indicated that the virulence decrease of these isolates was related to a lower ability to resist to the host anticandida effector mechanisms. We showed for the first time that C. albicans genetic variants of the same strain, sequentially isolated from an immunocompromised patient, underwent adaptations in the human host that resulted in virulence attenuation when tested in mice.	[Sampaio, Paula; Santos, Marlene; Correia, Alexandra; Chavez-Galarza, Julio; Pais, Celia] Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal; [Amaral, Fabio E.; Castro, Antonio G.; Pedrosa, Jorge] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Chavez-Galarza, Julio] Univ Nacl Trujillo, Fac Ciencias Biol, Trujillo, Peru; [Costa-de-Oliveira, Sofia] Univ Porto, Fac Med Porto, Dept Microbiol, P-4100 Oporto, Portugal	Universidade do Minho; Universidade do Minho; Universidad Nacional de Trujillo; Universidade do Porto	Sampaio, P (corresponding author), Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal.	cpais@bio.uminho.pt	Sampaio, Paula/I-7566-2015; Castro, António/F-5863-2011; Correia, Alexandra/AID-6313-2022; Santos, Marlene/GZN-2124-2022; Correia, Alexandra/J-7926-2013; Oliveira, Sofia/K-2156-2013; Pais, Célia/A-9186-2010; Castro, Gil/T-7584-2018; Pedrosa, Jorge/H-4877-2011	Sampaio, Paula/0000-0002-1415-4428; Castro, António/0000-0002-4684-4183; Correia, Alexandra/0000-0003-0408-6262; Santos, Marlene/0000-0001-5020-5942; Correia, Alexandra/0000-0003-0408-6262; Oliveira, Sofia/0000-0003-2899-6615; Pais, Célia/0000-0001-5959-290X; Castro, Gil/0000-0002-4684-4183; Pedrosa, Jorge/0000-0002-8204-4888; Amaral, Fabio/0000-0002-1547-8213; Chavez Galarza, Julio Cesar/0000-0002-8899-2862	Fundacao para a Ciencia e Tecnologia (FCT) [POCI/SAU-IMI/58014/2004]; Health Services of Fundacao Calouste Gulbenkian; ALbAN scholarship [E06M103915PE];  [SFRH/BD/31354/2006]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Health Services of Fundacao Calouste Gulbenkian; ALbAN scholarship; 	This work was supported by Fundacao para a Ciencia e Tecnologia (FCT) through the project POCI/SAU-IMI/58014/2004 and by a Grant from the Health Services of Fundacao Calouste Gulbenkian. Julio Chavez-Galarza was supported by an ALbAN scholarship (N<SUP>o</SUP> E06M103915PE), and Alexandra Correia by SFRH/BD/31354/2006 fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bartie KL, 2004, ORAL MICROBIOL IMMUN, V19, P293, DOI 10.1111/j.1399-302X.2004.00155.x; Basu S, 2000, BLOOD, V95, P3725; BISTONI F, 1985, ANTIMICROB AGENTS CH, V27, P625, DOI 10.1128/AAC.27.4.625; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Botelho AS, 2007, EXP PARASITOL, V115, P68, DOI 10.1016/j.exppara.2006.06.004; Bougnoux ME, 2003, J CLIN MICROBIOL, V41, P5265, DOI 10.1128/JCM.41.11.5265-5266.2003; Bretagne S, 1997, J CLIN MICROBIOL, V35, P1777, DOI 10.1128/JCM.35.7.1777-1780.1997; Calera JA, 1999, INFECT IMMUN, V67, P4280, DOI 10.1128/IAI.67.8.4280-4284.1999; Campos PRA, 2009, EVOLUTION, V63, P950, DOI 10.1111/j.1558-5646.2008.00595.x; CENCI E, 1995, J INFECT DIS, V171, P1279, DOI 10.1093/infdis/171.5.1279; Cheng SJ, 2007, CELL MICROBIOL, V9, P492, DOI 10.1111/j.1462-5822.2006.00805.x; Diogo D, 2009, FUNGAL GENET BIOL, V46, P159, DOI 10.1016/j.fgb.2008.11.005; DJEU JY, 1986, J IMMUNOL, V137, P2980; DJEU JY, 1990, DIAGN MICR INFEC DIS, V13, P383, DOI 10.1016/0732-8893(90)90007-I; Enoch DA, 2006, J MED MICROBIOL, V55, P809, DOI 10.1099/jmm.0.46548-0; Forche A, 2009, GENETICS, V182, P799, DOI 10.1534/genetics.109.103325; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Hu Y, 2006, MICROBES INFECT, V8, P612, DOI 10.1016/j.micinf.2005.08.011; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Jacobsen MD, 2008, FEMS YEAST RES, V8, P1334, DOI 10.1111/j.1567-1364.2008.00438.x; Kaposzta R, 1998, INFECT IMMUN, V66, P1708; Kretschmar M, 1999, INFECT IMMUN, V67, P6637; KULLBERG BJ, 1993, J INFECT DIS, V168, P436, DOI 10.1093/infdis/168.2.436; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Lavigne LM, 1998, J IMMUNOL, V160, P284; Leigh JE, 1998, J ACQ IMMUN DEF SYND, V19, P373, DOI 10.1097/00042560-199812010-00008; Leigh JE, 2002, ORAL MICROBIOL IMMUN, V17, P311, DOI 10.1034/j.1399-302X.2002.170508.x; LOCKHART SR, 1995, J CLIN MICROBIOL, V33, P1501, DOI 10.1128/JCM.33.6.1501-1509.1995; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lorenz MC, 2002, EUKARYOT CELL, V1, P657, DOI 10.1128/EC.1.5.657-662.2002; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; Mansour MK, 2002, CURR OPIN MICROBIOL, V5, P359, DOI 10.1016/S1369-5274(02)00342-9; Mencacci A, 1998, INT IMMUNOL, V10, P37, DOI 10.1093/intimm/10.1.37; Monod M, 1998, MICROBIOL-UK, V144, P2731, DOI 10.1099/00221287-144-10-2731; Mullaly SC, 2007, EUR J IMMUNOL, V37, P224, DOI 10.1002/eji.200636405; Murciano C, 2006, MED MYCOL, V44, P149, DOI 10.1080/13693780500294733; Netea MG, 1999, J IMMUNOL, V163, P1498; Netea MG, 2006, CURR PHARM DESIGN, V12, P4195, DOI 10.2174/138161206778743538; Odds FC, 2006, J CLIN MICROBIOL, V44, P3647, DOI 10.1128/JCM.00934-06; Oliveira MS, 2005, INFECT IMMUN, V73, P6299, DOI 10.1128/IAI.73.10.6299-6310.2005; Ortega E, 2005, EUR J APPL PHYSIOL, V93, P714, DOI 10.1007/s00421-004-1245-8; Pappas PG, 2006, INFECT DIS CLIN N AM, V20, P485, DOI 10.1016/j.idc.2006.07.004; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Pirofski LA, 2009, J EXP MED, V206, P269, DOI 10.1084/jem.20090093; Richardson M, 2009, FRONT BIOSCI-LANDMRK, V14, P4363, DOI 10.2741/3533; Romani L, 1999, CURR OPIN MICROBIOL, V2, P363, DOI 10.1016/S1369-5274(99)80064-2; Romani L, 2003, CURR OPIN MICROBIOL, V6, P338, DOI 10.1016/S1369-5274(03)00081-X; Romani L, 2000, J LEUKOCYTE BIOL, V68, P175; Romani Luigina, 2004, Nat Rev Immunol, V4, P1, DOI 10.1038/nri2939; Rozell B, 2006, CURR DRUG TARGETS, V7, P483, DOI 10.2174/138945006776359449; SAMARANAYAKE LP, 1984, SABOURAUDIA, V22, P201; Sampaio P, 2005, J CLIN MICROBIOL, V43, P3869, DOI 10.1128/JCM.43.8.3869-3876.2005; Schaller M, 2004, MICROBIOL-SGM, V150, P2807, DOI 10.1099/mic.0.27169-0; Shin JH, 2004, J CLIN MICROBIOL, V42, P4025, DOI 10.1128/JCM.42.9.4025-4031.2004; Shin YK, 2005, MOL CELLS, V20, P271; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavanti A, 2004, J CLIN MICROBIOL, V42, P4726, DOI 10.1128/JCM.42.10.4726-4734.2004; Tavares D, 2003, MICROBIOL-SGM, V149, P333, DOI 10.1099/mic.0.25915-0; Terron MP, 2004, J COMP PHYSIOL B, V174, P421, DOI 10.1007/s00360-004-0429-1; Thewes S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-187; Zhang HH, 2007, J LEUKOCYTE BIOL, V82, P915, DOI 10.1189/jlb.0107023	64	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10155	10.1371/journal.pone.0010155	http://dx.doi.org/10.1371/journal.pone.0010155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405013	Green Submitted, Green Published, gold			2022-12-25	WOS:000276706300011
J	Li, N; Thompson, S; Schultz, DC; Zhu, WL; Jiang, HL; Luo, C; Lieberman, PM				Li, Ning; Thompson, Scott; Schultz, David C.; Zhu, Weiliang; Jiang, Hualiang; Luo, Cheng; Lieberman, Paul M.			Discovery of Selective Inhibitors Against EBNA1 via High Throughput In Silico Virtual Screening	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; ORIGIN-BINDING PROTEIN; SMALL-MOLECULE INHIBITORS; EBV NUCLEAR ANTIGEN-1; DNA-BINDING; TRANSCRIPTION FACTORS; CRYSTAL-STRUCTURE; REPLICATION; DOCKING; DATABASE	Background: Epstein-Barr Virus (EBV) latent infection is associated with several human malignancies and is a causal agent of lymphoproliferative diseases during immunosuppression. While inhibitors of herpesvirus DNA polymerases, like gancyclovir, reduce EBV lytic cycle infection, these treatments have limited efficacy for treating latent infection. EBNA1 is an EBV-encoded DNA-binding protein required for viral genome maintenance during latent infection. Methodology: Here, we report the identification of a new class of small molecules that inhibit EBNA1 DNA binding activity. These compounds were identified by virtual screening of 90,000 low molecular mass compounds using computational docking programs with the solved crystal structure of EBNA1. Four structurally related compounds were found to inhibit EBNA1-DNA binding in biochemical assays with purified EBNA1 protein. Compounds had a range of 20-100 mM inhibition of EBNA1 in fluorescence polarization assays and were further validated for inhibition using electrophoresis mobility shift assays. These compounds exhibited no significant inhibition of an unrelated DNA binding protein. Three of these compounds inhibited EBNA1 transcription activation function in cell-based assays and reduced EBV genome copy number when incubated with a Burkitt lymphoma cell line. Conclusions: These experiments provide a proof-of-principle that virtual screening can be used to identify specific inhibitors of EBNA1 that may have potential for treatment of EBV latent infection.	[Li, Ning; Zhu, Weiliang; Jiang, Hualiang; Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Thompson, Scott; Schultz, David C.; Lieberman, Paul M.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; The Wistar Institute	Li, N (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	cluo@mail.shcnc.ac.cn; lieberman@wistar.org		Thompson, Scott/0000-0001-8270-1983	NIH [R01CA093606, R21NS063906]; National Natural Science Foundation of China [20972174]; Shanghai Committee of Science and Technologyy [10410703900, 08431900800]; State Key Program of Basic Research of China [2009CB918502]; NATIONAL CANCER INSTITUTE [R01CA093606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063906] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technologyy; State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded in part by grants from NIH (R01CA093606 and R21NS063906) to PML and the National Natural Science Foundation of China (20972174), Shanghai Committee of Science and Technologyy grant (10410703900 and 08431900800) and the State Key Program of Basic Research of China grant (2009CB918502) to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann M, 2006, P NATL ACAD SCI USA, V103, P14188, DOI 10.1073/pnas.0605985103; AMBINDER RF, 1990, J VIROL, V64, P2369, DOI 10.1128/JVI.64.5.2369-2379.1990; Bochkarev A, 1996, CELL, V84, P791, DOI 10.1016/S0092-8674(00)81056-9; BOCHKAREV A, 1995, CELL, V83, P39, DOI 10.1016/0092-8674(95)90232-5; Bochkarev A, 1998, J MOL BIOL, V284, P1273, DOI 10.1006/jmbi.1998.2247; Bowser TE, 2007, BIOORG MED CHEM LETT, V17, P5652, DOI 10.1016/j.bmcl.2007.07.072; Ewing TJA, 1997, J COMPUT CHEM, V18, P1175, DOI 10.1002/(SICI)1096-987X(19970715)18:9<1175::AID-JCC6>3.0.CO;2-O; Garber AC, 2002, J BIOL CHEM, V277, P27401, DOI 10.1074/jbc.M203489200; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Humme S, 2003, P NATL ACAD SCI USA, V100, P10989, DOI 10.1073/pnas.1832776100; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; KENNEDY G, 2003, P NATL ACAD SCI US; Kieff E., 2007, FIELDS VIROLOGY; Kiessling A, 2006, CHEM BIOL, V13, P745, DOI 10.1016/j.chembiol.2006.05.011; KUNTZ ID, 1994, ACCOUNTS CHEM RES, V27, P117, DOI 10.1021/ar00041a001; Leight ER, 2000, REV MED VIROL, V10, P83, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;83::AID-RMV262&gt;3.0.CO;2-T; Mao C, 2008, J BIOL CHEM, V283, P12819, DOI 10.1074/jbc.M709936200; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MORRIS GM, 1999, AUTODOCK VERSION 3 0; RAWLINS DR, 1985, CELL, V42, P859, DOI 10.1016/0092-8674(85)90282-X; Rickinson A., 2007, EPSTEIN BARR VIRUS; Rishi V, 2005, ANAL BIOCHEM, V340, P259, DOI 10.1016/j.ab.2005.02.012; Schnecke V, 1998, PROTEINS, V33, P74, DOI 10.1002/(SICI)1097-0134(19981001)33:1<74::AID-PROT7>3.0.CO;2-L; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Vangrevelinghe E, 2003, J MED CHEM, V46, P2656, DOI 10.1021/jm030827e; Wang JD, 2006, MOL CELL BIOL, V26, P1124, DOI 10.1128/MCB.26.3.1124-1134.2006; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; Yin QY, 2006, VIROLOGY, V346, P385, DOI 10.1016/j.virol.2005.11.021; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zavodszky MI, 2002, J COMPUT AID MOL DES, V16, P883, DOI 10.1023/A:1023866311551; Zhou J, 2005, EMBO J, V24, P1406, DOI 10.1038/sj.emboj.7600609	33	44	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10126	10.1371/journal.pone.0010126	http://dx.doi.org/10.1371/journal.pone.0010126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405039	Green Published, gold			2022-12-25	WOS:000276705900010
J	Tan, JL; Peng, X; Luo, GX; Ma, B; Cao, C; He, WF; Yuan, SZ; Li, SR; Wilkins, JA; Wu, J				Tan, Jianglin; Peng, Xu; Luo, Gaoxing; Ma, Bing; Cao, Chuan; He, Weifeng; Yuan, Shunzong; Li, Shirong; Wilkins, John A.; Wu, Jun			Investigating the Role of P311 in the Hypertrophic Scar	PLOS ONE			English	Article							MYOFIBROBLAST PHENOTYPE; GRANULATION-TISSUE; WOUND CONTRACTION; FIBROBLASTS; EXPRESSION; PROLIFERATION; REGENERATION; MECHANISMS; GROWTH; HIC-5	The mechanisms of hypertrophic scar formation are not fully understood. We previously screened the differentially expressed genes of human hypertrophic scar tissue and identified P311 gene as upregulated. As the activities of P311 in human fibroblast function are unknown, we examined the distribution of it and the effects of forced expression or silencing of expression of P311. P311 expression was detected in fibroblast-like cells from the hypertrophic scar of burn injury patients but not in peripheral blood mononuclear cells, bone marrow mesenchymal stem cells, epidermal cells or normal skin dermal cells. Transfection of fibroblasts with P311 gene stimulated the expression of alpha-smooth muscle actin (alpha-SMA), TGF-beta 1 and alpha 1(I) collagen (COL1A1), and enhanced the contraction of fibroblast populated collagen lattices (FPCL). In contrast, interference of fibroblast P311 gene expression decreased the TGF-beta 1 mRNA expression and reduced the contraction of fibroblasts in FPCL. These results suggest that P311 may be involved in the pathogenesis of hypertrophic scar via induction of a myofibroblastic phenotype and of functions such as TGF-beta 1 expression. P311 could be a novel target for the control of hypertrophic scar development.	[Tan, Jianglin; Peng, Xu; Luo, Gaoxing; He, Weifeng; Yuan, Shunzong; Wu, Jun] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China; [Luo, Gaoxing; He, Weifeng; Wu, Jun] Chongqing Key Lab Dis Prote, Chongqing, Peoples R China; [Ma, Bing] Chengdu Med Coll, Affiliated Hosp 1, Dept Plast Surg, Chengdu, Sichuan Prov, Peoples R China; [Cao, Chuan; Li, Shirong] Third Mil Med Univ, Dept Plast Surg, Southwest Hosp, Chongqing, Peoples R China; [Wilkins, John A.] Univ Manitoba, Dept Internal Med, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada	Army Medical University; Chengdu Medical College; Army Medical University; University of Manitoba	Tan, JL (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China.	dmabing@hotmail.com; junwupro1@yahoo.com.cn	Yuan, Shunzong/AAO-3551-2020; Gaoxing, LUO/AAE-4505-2020	LUO, Gaoxing/0000-0003-4764-3209	NSFC [30872695, 30672174]; 863 project in China [2006AA02A121]; State Key Lab Funding in China [SKLZZ200808, SKLZZ200820]	NSFC(National Natural Science Foundation of China (NSFC)); 863 project in China(National High Technology Research and Development Program of China); State Key Lab Funding in China	This work was supported by NSFC (No: 30872695 and 30672174), and partly by "863" project in China (2006AA02A121), by State Key Lab Funding in China (SKLZZ200808 to J. W., SKLZZ200820 to G. L.). The relevant grant number is 5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baryza Mary Jo, 1995, Journal of Burn Care and Rehabilitation, V16, P535, DOI 10.1097/00004630-199509000-00013; Brown JJ, 2009, BRIT J DERMATOL, V161, P8, DOI 10.1111/j.1365-2133.2009.09258.x; Cheng B, 2008, BRIT J DERMATOL, V158, P713, DOI 10.1111/j.1365-2133.2008.08449.x; Ramos MLC, 2008, J BURN CARE RES, V29, P363, DOI 10.1097/BCR.0b013e3181667557; Dabiri G, 2008, J INVEST DERMATOL, V128, P2518, DOI 10.1038/jid.2008.90; Dabiri G, 2008, J INVEST DERMATOL, V128, P280, DOI 10.1038/sj.jid.5700975; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; English RS, 1999, DERMATOL SURG, V25, P631, DOI 10.1046/j.1524-4725.1999.98257.x; Fujitani M, 2004, J NEUROCHEM, V91, P737, DOI 10.1111/j.1471-4159.2004.02738.x; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Lee JYY, 2004, AM J DERMATOPATH, V26, P379, DOI 10.1097/00000372-200410000-00006; Li FF, 2009, BIOCHEM BIOPH RES CO, V382, P259, DOI 10.1016/j.bbrc.2009.02.165; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mutalik Sharad, 2005, Indian J Dermatol Venereol Leprol, V71, P3; Pan DS, 2002, J CLIN INVEST, V110, P1349, DOI 10.1172/JCI200215614; Phan TT, 2003, J TRAUMA, V54, P1212, DOI 10.1097/01.TA.0000030630.72836.32; Shin DM, 2004, PLAST RECONSTR SURG, V113, P633, DOI 10.1097/01.PRS.0000101530.33096.5B; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Taylor GA, 2000, J BIOL CHEM, V275, P4215, DOI 10.1074/jbc.275.6.4215; Taylor GA, 2008, GENES BRAIN BEHAV, V7, P786, DOI 10.1111/j.1601-183X.2008.00420.x; van der Veer WM, 2009, BURNS, V35, P15, DOI 10.1016/j.burns.2008.06.020; Wang JF, 2007, J INTERF CYTOK RES, V27, P921, DOI 10.1089/jir.2007.0008; Wu J, 2004, J TRAUMA, V57, P1276, DOI 10.1097/01.TA.0000108997.49513.DC; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	25	48	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e9995	10.1371/journal.pone.0009995	http://dx.doi.org/10.1371/journal.pone.0009995			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404911	Green Published, Green Submitted, gold			2022-12-25	WOS:000276482100002
J	Donato, DM; Ryzhova, LM; Meenderink, LM; Kaverina, I; Hanks, SK				Donato, Dominique M.; Ryzhova, Larisa M.; Meenderink, Leslie M.; Kaverina, Irina; Hanks, Steven K.			Dynamics and Mechanism of p130Cas Localization to Focal Adhesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRK-ASSOCIATED SUBSTRATE; BREAST-CANCER CELLS; PHOSPHOTYROSINE-CONTAINING PROTEINS; DOMAIN TYROSINE PHOSPHORYLATION; SRC-TRANSFORMED CELLS; V-CRK; ANTIESTROGEN RESISTANCE; EXTRACELLULAR-MATRIX; KINASE-ACTIVITY; P130(CAS)	The docking protein p130Cas is a major Src substrate involved in integrin signaling and mechanotransduction. Tyrosine phosphorylation of p130Cas in focal adhesions (FAs) has been linked to enhanced cell migration, invasion, proliferation, and survival. However, the mechanism of p130Cas targeting to FAs is uncertain, and dynamic aspects of its localization have not been explored. Using live cell microscopy, we show that fluorophore-tagged p130Cas is a component of FAs throughout the FA assembly and disassembly stages, although it resides transiently in FAs with a high mobile fraction. Deletion of either the N-terminal Src homology 3 (SH3) domain or the Cas-family C-terminal homology (CCH) domain significantly impaired p130Cas FA localization, and deletion of both domains resulted in full exclusion. Focal adhesion kinase was implicated in the FA targeting function of the p130Cas SH3 domain. Consistent with their roles in FA targeting, both the SH3 and CCH domains were found necessary for p130Cas to fully undergo tyrosine phosphorylation and promote cell migration. By revealing the capacity of p130Cas to function in FAs throughout their lifetime, clarifying FA targeting mechanism, and demonstrating the functional importance of the highly conserved CCH domain, our results advance the understanding of an important aspect of integrin signaling.	[Hanks, Steven K.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, MRBIII,Learned Lab U4206, Nashville, TN 37232 USA	Vanderbilt University	Hanks, SK (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, MRBIII,Learned Lab U4206, 1161 21st Ave S, Nashville, TN 37232 USA.	steve.hanks@vanderbilt.edu	Donato, Dominique/C-1058-2012	Donato, Dominique/0000-0002-0495-4376; Meenderink, Leslie/0000-0003-3943-4079	National Institutes of Health [R01-GM049882, R01-GM78373, T32-CA09592, T32-GM07347, P30-DK058404]; American Heart Association [0815136E]; NATIONAL CANCER INSTITUTE [T32CA009592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347, R01GM078373, R01GM049882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM049882, R01-GM78373, T32-CA09592, T32-GM07347, and P30-DK058404. This work was also supported by American Heart Association Predoctoral Fellowship 0815136E (to L. M. M.).	Arold ST, 2002, STRUCTURE, V10, P319, DOI 10.1016/S0969-2126(02)00717-7; Bertolucci CM, 2005, PROTEIN SCI, V14, P644, DOI 10.1110/ps.041107205; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Brabek J, 2004, ONCOGENE, V23, P7406, DOI 10.1038/sj.onc.1207965; Brinkman A, 2000, JNCI-J NATL CANCER I, V92, P112, DOI 10.1093/jnci/92.2.112; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; CANTLEY LC, 1994, J CELL SCI, P121; Cho SY, 2000, J CELL BIOL, V149, P223, DOI 10.1083/jcb.149.1.223; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Fonseca PM, 2004, CELL SIGNAL, V16, P621, DOI 10.1016/j.cellsig.2003.10.004; Garron ML, 2009, J MOL BIOL, V386, P190, DOI 10.1016/j.jmb.2008.12.010; Hamasaki K, 1996, BIOCHEM BIOPH RES CO, V222, P338, DOI 10.1006/bbrc.1996.0745; Harte MT, 2000, BBA-MOL CELL RES, V1499, P34, DOI 10.1016/S0167-4889(00)00104-X; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Huang JH, 2002, J BIOL CHEM, V277, P27265, DOI 10.1074/jbc.M203063200; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Law SF, 1999, EXP CELL RES, V252, P224, DOI 10.1006/excr.1999.4609; Law SF, 1996, MOL CELL BIOL, V16, P3327; Liu GH, 2002, MOL CELL BIOL, V22, P2751, DOI 10.1128/MCB.22.8.2751-2760.2002; Luo W, 2008, J PROTEOME RES, V7, P3447, DOI 10.1021/pr800187n; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; MATSUDA M, 1991, MOL CELL BIOL, V11, P1607, DOI 10.1128/MCB.11.3.1607; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakamoto T, 1997, MOL CELL BIOL, V17, P3884, DOI 10.1128/MCB.17.7.3884; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; NOJIMA Y, 1995, CELL IMMUNOL, V161, P8, DOI 10.1006/cimm.1995.1002; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Owen JD, 1999, MOL CELL BIOL, V19, P4806; PATCH LA, 1995, J CELL SCI, V108, P1371; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; Polte TR, 1997, J BIOL CHEM, V272, P5501, DOI 10.1074/jbc.272.9.5501; Pratt SJ, 2005, J CELL BIOL, V168, P813, DOI 10.1083/jcb.200406083; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P3951, DOI 10.1128/MCB.9.9.3951; Riggins RB, 2003, J BIOL CHEM, V278, P28264, DOI 10.1074/jbc.M303535200; Riggins RB, 2006, CANCER RES, V66, P7007, DOI 10.1158/0008-5472.CAN-05-3952; Rivera GM, 2006, P NATL ACAD SCI USA, V103, P9536, DOI 10.1073/pnas.0603786103; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sakai R, 1997, ONCOGENE, V14, P1419, DOI 10.1038/sj.onc.1200954; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Shin NY, 2004, J BIOL CHEM, V279, P38331, DOI 10.1074/jbc.M404675200; Singh MK, 2008, MOL BIOL CELL, V19, P1627, DOI 10.1091/mbc.E07-09-0953; Soni S, 2009, J CELL BIOCHEM, V107, P364, DOI 10.1002/jcb.22136; TACHIBANA K, 1995, J EXP MED, V182, P1089, DOI 10.1084/jem.182.4.1089; Vuori K, 1996, MOL CELL BIOL, V16, P2606; VUORI K, 1995, J BIOL CHEM, V270, P22259, DOI 10.1074/jbc.270.38.22259; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792	58	43	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20769	20779		10.1074/jbc.M109.091207	http://dx.doi.org/10.1074/jbc.M109.091207			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430882	Green Published, hybrid			2022-12-25	WOS:000279228600041
J	Shridas, P; Bailey, WM; Boyanovsky, BB; Oslund, RC; Gelb, MH; Webb, NR				Shridas, Preetha; Bailey, William M.; Boyanovsky, Boris B.; Oslund, Rob C.; Gelb, Michael H.; Webb, Nancy R.			Group X Secretory Phospholipase A(2) Regulates the Expression of Steroidogenic Acute Regulatory Protein (StAR) in Mouse Adrenal Glands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M-TYPE RECEPTOR; LOW-DENSITY-LIPOPROTEIN; FOAM CELL-FORMATION; ARACHIDONIC-ACID; GROUP-V; EICOSANOID PRODUCTION; BIOLOGICAL FUNCTIONS; MAMMALIAN-CELLS; GENE-EXPRESSION; ACTIVATION	We developed C57BL/6 mice with targeted deletion of group X secretory phospholipase A(2) (GX KO). These mice have similar to 80% higher plasma corticosterone concentrations compared with wild-type (WT) mice under both basal and adrenocorticotropic hormone (ACTH)-induced stress conditions. This increased corticosterone level was not associated with increased circulating ACTH or a defect in the hypothalamic-pituitary axis as evidenced by a normal response to dexamethasone challenge. Primary cultures of adrenal cells from GX KO mice exhibited significantly increased corticosteroid secretion compared with WT cells. Conversely, overexpression of GX secretory phospholipase A(2) (sPLA(2)), but not a catalytically inactive mutant form of GX sPLA(2), significantly reduced steroid production 30-40% in Y1 mouse adrenal cell line. This effect was reversed by the sPLA(2) inhibitor, indoxam. Silencing of endogenous M-type receptor expression did not restore steroid production in GX sPLA(2-)overexpressing Y1 cells, ruling out a role for this sPLA(2) receptor in this regulatory process. Expression of steroidogenic acute regulatory protein (StAR), the rate-limiting protein in corticosteroid production, was similar to 2-fold higher in adrenal glands of GX KO mice compared with WT mice, whereas StAR expression was suppressed in Y1 cells overexpressing GX sPLA(2). Results from StAR-promoter luciferase reporter gene assays indicated that GX sPLA(2) antagonizes StAR promoter activity and liver X receptor-mediated StAR promoter activation. In summary, GX sPLA(2) is expressed in mouse adrenal glands and functions to negatively regulate corticosteroid synthesis, most likely by negatively regulating StAR expression.	[Shridas, Preetha; Bailey, William M.; Boyanovsky, Boris B.; Webb, Nancy R.] Univ Kentucky, Med Ctr, Dept Internal Med, Lexington, KY 40536 USA; [Shridas, Preetha; Bailey, William M.; Boyanovsky, Boris B.; Webb, Nancy R.] Univ Kentucky, Med Ctr, Grad Ctr Nutr Sci, Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Webb, Nancy R.] Dept Vet Affairs Med Ctr, Lexington, KY 40536 USA; [Oslund, Rob C.; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Oslund, Rob C.; Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Kentucky; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Webb, NR (corresponding author), Univ Kentucky, Med Ctr, Dept Internal Med, 535 CT Wethington Bldg,900 S Limestone St, Lexington, KY 40536 USA.	nrwebb1@uky.edu	Webb, Nancy/AAL-7030-2021; Boyanovsky, Boris/AAQ-5194-2021	gelb, michael/0000-0001-7000-5219	National Institutes of Health [P01 HL080100]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080100, R37HL036235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL080100 (to N.R.W.). This paper is the result of work supported with resources and the use of facilities at the Lexington Veterans Affairs Medical Center.	Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Boilard E, 2006, BIOCHEMISTRY-US, V45, P13203, DOI 10.1021/bi061376d; Boyanovsky BB, 2009, CARDIOVASC DRUG THER, V23, P61, DOI 10.1007/s10557-008-6134-7; Cummins CL, 2006, J CLIN INVEST, V116, P1902, DOI 10.1172/JCI28400; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Curfs DMJ, 2008, J BIOL CHEM, V283, P21640, DOI 10.1074/jbc.M710584200; DALLMAN MF, 1993, FRONT NEUROENDOCRIN, V14, P303, DOI 10.1006/frne.1993.1010; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; Fujioka D, 2008, CIRCULATION, V117, P2977, DOI 10.1161/CIRCULATIONAHA.107.743997; Granata F, 2005, J IMMUNOL, V174, P464, DOI 10.4049/jimmunol.174.1.464; Hanasaki K, 2002, J BIOL CHEM, V277, P29116, DOI 10.1074/jbc.M202867200; Hanasaki K, 2002, PROSTAG OTH LIPID M, V68-9, P71, DOI 10.1016/S0090-6980(02)00022-9; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Karabina SA, 2006, FASEB J, V20, P2547, DOI 10.1096/fj.06-6018fje; Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200; Kolko M, 2006, J NEUROSCI RES, V83, P874, DOI 10.1002/jnr.20773; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Manna PR, 2003, STEROIDS, V68, P1125, DOI 10.1016/j.steroids.2003.07.009; Masuda S, 2005, J BIOL CHEM, V280, P23203, DOI 10.1074/jbc.M500985200; Masuda S, 2004, BBA-MOL CELL BIOL L, V1686, P61, DOI 10.1016/j.bbalip.2004.08.017; Matsumoto Y, 2009, MED VET ENTOMOL, V23, P47, DOI 10.1111/j.1365-2915.2008.00789.x; Mitsuishi M, 2006, BIOCHEM J, V393, P97, DOI 10.1042/BJ20050781; Morioka Y, 2000, ARCH BIOCHEM BIOPHYS, V381, P31, DOI 10.1006/abbi.2000.1977; Murakami M, 2003, CURR OPIN LIPIDOL, V14, P431, DOI 10.1097/00041433-200310000-00003; Nakashima S, 2003, BIOCHEM J, V376, P655, DOI 10.1042/BJ20030830; Nilsson M, 2007, MOL ENDOCRINOL, V21, P126, DOI 10.1210/me.2006-0187; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; PARKER KL, 1985, P NATL ACAD SCI USA, V82, P7860, DOI 10.1073/pnas.82.23.7860; Rigotti A, 1996, J BIOL CHEM, V271, P33545, DOI 10.1074/jbc.271.52.33545; Rouault M, 2007, BIOCHEMISTRY-US, V46, P1647, DOI 10.1021/bi062119b; Saiga A, 2005, PROSTAG OTH LIPID M, V75, P79, DOI 10.1016/j.prostaglandins.2004.10.001; Scott GA, 2006, J INVEST DERMATOL, V126, P855, DOI 10.1038/sj.jid.5700180; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Shea-Eaton W, 2002, MOL CELL ENDOCRINOL, V188, P161, DOI 10.1016/S0303-7207(01)00715-8; Steffensen KR, 2004, J MOL ENDOCRINOL, V33, P609, DOI 10.1677/jme.1.01508; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Suzuki N, 2000, J BIOL CHEM, V275, P5785, DOI 10.1074/jbc.275.8.5785; Triggiani M, 2006, BBA-MOL CELL BIOL L, V1761, P1289, DOI 10.1016/j.bbalip.2006.07.003; Wang XJ, 1999, MOL CELL ENDOCRINOL, V158, P7, DOI 10.1016/S0303-7207(99)00130-6; Wang XJ, 2003, ENDOCRINOLOGY, V144, P3368, DOI 10.1210/en.2002-0081; Wooton-Kee CR, 2004, ARTERIOSCL THROM VAS, V24, P762, DOI 10.1161/01.ATV.0000122363.02961.c1; Yamazaki T, 1996, ENDOCRINOLOGY, V137, P2670, DOI 10.1210/en.137.7.2670; Yokota Y, 2001, FEBS LETT, V509, P250, DOI 10.1016/S0014-5793(01)03173-8; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Zvaritch E, 1996, J BIOL CHEM, V271, P250, DOI 10.1074/jbc.271.1.250	45	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20031	20039		10.1074/jbc.M109.090423	http://dx.doi.org/10.1074/jbc.M109.090423			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20421306	hybrid, Green Published			2022-12-25	WOS:000279012000037
J	Pandey, RN; Rani, R; Yeo, EJ; Spencer, M; Hu, S; Lang, RA; Hegde, RS				Pandey, R. N.; Rani, R.; Yeo, E-J; Spencer, M.; Hu, S.; Lang, R. A.; Hegde, R. S.			The Eyes Absent phosphatase-transactivator proteins promote proliferation, transformation, migration, and invasion of tumor cells	ONCOGENE			English	Article						EYA; cell migration; cell invasion; metastasis; tyrosine phosphatase	EXTRASKELETAL MYXOID CHONDROSARCOMAS; FATE DETERMINATION FACTOR; TYROSINE-PHOSPHATASE; BREAST-CANCER; ENDOTHELIAL MIGRATION; SIX1 HOMEOPROTEIN; GENE-EXPRESSION; MATRIX ADHESION; GROWTH; DEPHOSPHORYLATION	The Eyes Absent (EYA) proteins combine transactivation, tyrosine phosphatase, and threonine phosphatase activities in their function as part of a conserved regulatory cascade involved in embryonic organ development. EYA tyrosine phosphatase activity contributes to fly eye development, and vertebrate EYA is involved in promoting DNA damage repair subsequent to genotoxic stress. EYAs are known to be expressed at elevated levels in ovarian and breast cancers. Here, we show that the tyrosine phosphatase activity of the EYAs promotes tumor cell migration, invasion, and transformation. These cellular effects are accompanied by alterations of the actin cytoskeleton and increased levels of active Rac and Cdc42. The invasiveness conferred by EYA is reflected in vivo by inhibition of metastasis seen when EYA3 expression is silenced in the invasive breast cancer cell line MDA-MB-231. Together, our data directly associate the tyrosine phosphatase activity of the EYAs with the oncogenesis-associated cellular properties of motility and invasiveness. Oncogene (2010) 29, 3715-3722; doi: 10.1038/onc.2010.122; published online 26 April 2010	[Hegde, R. S.] Cincinnati Childrens Hosp Res Fdn, Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Pandey, R. N.; Rani, R.; Yeo, E-J; Spencer, M.; Hu, S.; Hegde, R. S.] Univ Cincinnati, Dept Pediat, Sch Med, Cincinnati, OH 45221 USA; [Yeo, E-J; Lang, R. A.] Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp Med Ctr, Dept Ophthalmol,Div Pediat Ophthalmol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hegde, RS (corresponding author), Cincinnati Childrens Hosp Res Fdn, Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	rashmi.hegde@cchmc.org	Lang, Richard/E-5578-2011; Hu, Shengyong/C-2798-2012	Lang, Richard/0000-0002-5212-254X	NIH [RO1-EY014648, R21-EY19125]; NATIONAL EYE INSTITUTE [R01EY014648, R21EY019125] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Dr Steve Danzer for help with confocal microscopy. Viral vectors were produced by the Viral Vector Core at the Translational Core Laboratories, Cincinnati Children's Hospital Research Foundation. This study was supported by NIH grants RO1-EY014648 and R21-EY19125 to RSH.	Agazie YM, 2003, ONCOGENE, V22, P6909, DOI 10.1038/sj.onc.1206798; Bacac M, 2006, J PATHOL, V208, P543, DOI 10.1002/path.1915; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Castiglioni S, 2007, BIOCHEM BIOPH RES CO, V364, P534, DOI 10.1016/j.bbrc.2007.10.022; Christensen KL, 2007, ONCOGENE, V26, P3406, DOI 10.1038/sj.onc.1210122; Coletta RD, 2004, P NATL ACAD SCI USA, V101, P6478, DOI 10.1073/pnas.0401139101; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Ford HL, 1998, P NATL ACAD SCI USA, V95, P12608, DOI 10.1073/pnas.95.21.12608; Ford HL, 2000, J BIOL CHEM, V275, P22245, DOI 10.1074/jbc.M002446200; Hanson IM, 2001, SEMIN CELL DEV BIOL, V12, P475, DOI 10.1006/scdb.2001.0271; Hisaoka M, 2004, CANCER GENET CYTOGEN, V152, P101, DOI 10.1016/j.cancergencyto.2003.11.011; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; Jandt E, 2003, ONCOGENE, V22, P4175, DOI 10.1038/sj.onc.1206652; Jemc J, 2007, DEV BIOL, V310, P416, DOI 10.1016/j.ydbio.2007.07.024; Kriebel M, 2007, DEV DYNAM, V236, P1526, DOI 10.1002/dvdy.21170; Krishnan N, 2009, J BIOL CHEM, V284, P16066, DOI 10.1074/jbc.C900032200; Laflamme C, 2003, CANCER RES, V63, P449; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; Li CM, 2002, AM J PATHOL, V160, P2181, DOI 10.1016/S0002-9440(10)61166-2; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Liang FB, 2005, J BIOL CHEM, V280, P24857, DOI 10.1074/jbc.M502780200; Mariotti M, 2009, INT J BIOCHEM CELL B, V41, P687, DOI 10.1016/j.biocel.2008.08.005; Miller SJ, 2010, ONCOGENE, V29, P368, DOI 10.1038/onc.2009.360; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pauli T, 2005, DEVELOPMENT, V132, P2771, DOI 10.1242/dev.01841; Rayapureddi JP, 2006, FEBS LETT, V580, P3853, DOI 10.1016/j.febslet.2006.06.009; Rayapureddi JP, 2005, BIOCHEMISTRY-US, V44, P751, DOI 10.1021/bi0481794; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Reichenberger KJ, 2005, CANCER RES, V65, P2668, DOI 10.1158/0008-5472.CAN-04-4286; Richert MM, 2005, BREAST CANCER RES, V7, pR819, DOI 10.1186/bcr1292; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Takamatsu N, 1998, Nihon Ronen Igakkai Zasshi, V35, P535; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Winchester C, 2000, J CLIN PATHOL, V53, P212, DOI 10.1136/jcp.53.3.212; Wu KM, 2008, P NATL ACAD SCI USA, V105, P6924, DOI 10.1073/pnas.0802085105; Wu KM, 2007, MOL BIOL CELL, V18, P755, DOI 10.1091/mbc.E06-09-0793; Wu KM, 2006, MOL CELL BIOL, V26, P7116, DOI 10.1128/MCB.00268-06; Xiong WJ, 2009, DEV CELL, V16, P271, DOI 10.1016/j.devcel.2008.12.005; Yu YL, 2006, CANCER RES, V66, P1982, DOI 10.1158/0008-5472.CAN-05-2360; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zhang L, 2005, CANCER RES, V65, P925; Zhang TY, 2006, DEVELOPMENT, V133, P4881, DOI 10.1242/dev.02669	44	79	89	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 24	2010	29	25					3715	3722		10.1038/onc.2010.122	http://dx.doi.org/10.1038/onc.2010.122			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	615CG	20418914	Green Accepted			2022-12-25	WOS:000279108600011
J	Hardiville, S; Hoedt, E; Mariller, C; Benaissa, M; Pierce, A				Hardiville, Stephan; Hoedt, Esthelle; Mariller, Christophe; Benaissa, Monique; Pierce, Annick			O-GlcNAcylation/Phosphorylation Cycling at Ser(10) Controls Both Transcriptional Activity and Stability of Delta-Lactoferrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; ESTROGEN-RECEPTOR-BETA; GLCNAC TRANSFERASE; NUCLEOCYTOPLASMIC PROTEINS; MESSENGER-RNA; OKADAIC ACID; GLYCOSYLATION/O-PHOSPHORYLATION; TETRATRICOPEPTIDE REPEATS; CYTOSOLIC PROTEINS; GENE-EXPRESSION	Delta-Lactoferrin (Delta Lf) is a transcription factor that up-regulates DcpS, Skp1, and Bax genes, provoking cell cycle arrest and apoptosis. It is post-translationally modified either by O-GlcNAc or phosphate, but the effects of the O-GlcNAc/phosphorylation interplay on Delta Lf function are not yet understood. Here, using a series of glycosylation mutants, we showed that Ser(10) is O-GlcNAcylated and that this modification is associated with increased Delta Lf stability, achieved by blocking ubiquitin-dependent proteolysis, demonstrating that O-GlcNAcylation protects against polyubiquitination. We highlighted the 391KSQQSSDPDPNCVD404 sequence as a functional PEST motif responsible for Delta Lf degradation and defined Lys379 as the main polyubiquitin acceptor site. We next investigated the control of Delta Lf transcriptional activity by the O-GlcNAc/phosphorylation interplay. Reporter gene analyses using the Skp1 promoter fragment containing a Delta Lf response element showed that O-GlcNAcylation at Ser(10) negatively regulates Delta Lf transcriptional activity, whereas phosphorylation activates it. Using a chromatin immunoprecipitation assay, we showed that O-GlcNAcylation inhibits DNA binding. Deglycosylation leads to DNA binding and transactivation of the Skp1 promoter at a basal level. Basal transactivation was markedly enhanced by 23-fold when phosphorylation was mimicked at Ser(10) by aspartate. Moreover, using double chromatin immunoprecipitation assays, we showed that the Delta Lf transcriptional complex binds to the Delta Lf response element and is phosphorylated and/or ubiquitinated, suggesting that Delta Lf transcriptional activity and degradation are concomitant events. Collectively, our results indicate that reciprocal occupancy of Ser(10) by either O-phosphate or O-GlcNAc coordinately regulates Delta Lf stability and transcriptional activity.	[Hardiville, Stephan; Hoedt, Esthelle; Mariller, Christophe; Benaissa, Monique; Pierce, Annick] Univ Sci & Technol Lille, CNRS, Unite Glycobiol Struct & Fonct, UMR 8576,IFR 147, F-59655 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Pierce, A (corresponding author), Univ Sci & Technol Lille, CNRS, Unite Glycobiol Struct & Fonct, UMR 8576,IFR 147, F-59655 Villeneuve Dascq, France.	annick.pierce@univ-lille1.fr		Hardiville, Stephan/0000-0002-3554-277X	CNRS UMR 8576 (Unite de Glycobiologie Structurale et Fonctionnelle); Institut Federatif de Recherche 147; Universite des Sciences et Technologies de Lille I; Comite du Nord de la Ligue Nationale contre le Cancer; Association pour la Recherche sur le Cancer ("Etude du role de la delta-lactoferrine, des gangliosides et des neurotrophines dans le developpement et la progression du cancer du sein")	CNRS UMR 8576 (Unite de Glycobiologie Structurale et Fonctionnelle); Institut Federatif de Recherche 147; Universite des Sciences et Technologies de Lille I; Comite du Nord de la Ligue Nationale contre le Cancer; Association pour la Recherche sur le Cancer ("Etude du role de la delta-lactoferrine, des gangliosides et des neurotrophines dans le developpement et la progression du cancer du sein")(Fondation ARC pour la Recherche sur le Cancer)	This work was supported in part by the CNRS UMR 8576 (Unite de Glycobiologie Structurale et Fonctionnelle), the Institut Federatif de Recherche 147, the Universite des Sciences et Technologies de Lille I, the Comite du Nord de la Ligue Nationale contre le Cancer, and the Association pour la Recherche sur le Cancer ("Etude du role de la delta-lactoferrine, des gangliosides et des neurotrophines dans le developpement et la progression du cancer du sein").	Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Baker EN, 2005, CELL MOL LIFE SCI, V62, P2531, DOI 10.1007/s00018-005-5368-9; Baker EN, 2002, BIOCHEM CELL BIOL, V80, P27, DOI 10.1139/o01-153; Benaissa M, 2005, INT J CANCER, V114, P299, DOI 10.1002/ijc.20728; Breton M, 2004, BIOMETALS, V17, P325, DOI 10.1023/B:BIOM.0000027712.81056.13; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Cheng XG, 2001, J BIOL CHEM, V276, P10570, DOI 10.1074/jbc.M010411200; Comer FI, 1999, BBA-GEN SUBJECTS, V1473, P161, DOI 10.1016/S0304-4165(99)00176-2; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Datta R, 2003, BIOCHEMISTRY-US, V42, P5453, DOI 10.1021/bi020699g; Dauphinee SM, 2005, J CELL BIOCHEM, V96, P579, DOI 10.1002/jcb.20508; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; Fiordaliso F, 2001, DIABETES, V50, P2363, DOI 10.2337/diabetes.50.10.2363; Fu Y, 2007, J CELL BIOCHEM, V102, P704, DOI 10.1002/jcb.21323; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Guinez C, 2004, BIOCHEM BIOPH RES CO, V319, P21, DOI 10.1016/j.bbrc.2004.04.144; Guinez C, 2008, FASEB J, V22, P2901, DOI 10.1096/fj.07-102509; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; HARDIVILLE S, 2010, EUR J CELL IN PRESS; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; HART GW, 1989, CIBA F SYMP, V145, P102; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; Huynh-Dellerme C, 2003, ENVIRON TOXICOL, V18, P383, DOI 10.1002/tox.10140; James LR, 2002, DIABETES, V51, P1146, DOI 10.2337/diabetes.51.4.1146; Kamemura K, 2003, PROG NUCLEIC ACID RE, V73, P107, DOI 10.1016/S0079-6603(03)01004-3; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Krek W, 1998, CURR OPIN GENET DEV, V8, P36, DOI 10.1016/S0959-437X(98)80059-2; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kuo M, 2008, BIOCHIMIE, V90, P679, DOI 10.1016/j.biochi.2008.03.005; Lefebvre T, 2004, EUR J BIOCHEM, V271, P3843, DOI 10.1111/j.1432-1033.2004.04316.x; Lefebvre T, 1999, BBA-GEN SUBJECTS, V1472, P71, DOI 10.1016/S0304-4165(99)00105-1; Lefebvre T, 2003, BBA-GEN SUBJECTS, V1619, P167, DOI 10.1016/S0304-4165(02)00477-4; Lefebvre T, 2010, BBA-GEN SUBJECTS, V1800, P67, DOI 10.1016/j.bbagen.2009.08.008; Liu DX, 2003, BIOCHEM BIOPH RES CO, V301, P472, DOI 10.1016/S0006-291X(02)03077-2; Mariller C, 2007, FEBS J, V274, P2038, DOI 10.1111/j.1742-4658.2007.05747.x; Mariller C, 2009, BIOCHIMIE, V91, P109, DOI 10.1016/j.biochi.2008.07.009; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Querfurth HW, 1997, J NEUROCHEM, V69, P1580; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Roos MD, 2000, BIOCHEM BIOPH RES CO, V271, P275, DOI 10.1006/bbrc.2000.2600; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Shaw P, 1996, ONCOGENE, V12, P921; Siebert PD, 1997, P NATL ACAD SCI USA, V94, P2198, DOI 10.1073/pnas.94.6.2198; Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Sumegi M, 2003, BIOCHEM BIOPH RES CO, V312, P1284, DOI 10.1016/j.bbrc.2003.11.074; Teng C, 2004, BIOMETALS, V17, P317, DOI 10.1023/B:BIOM.0000027711.13818.8a; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Yang Y, 2003, CANCER LETT, V191, P155, DOI 10.1016/S0304-3835(02)00677-8; Yonashiro R, 2009, MOL BIOL CELL, V20, P4524, DOI 10.1091/mbc.E09-02-0112; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	69	25	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19205	19218		10.1074/jbc.M109.080572	http://dx.doi.org/10.1074/jbc.M109.080572			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404350	Green Published, hybrid			2022-12-25	WOS:000278727800030
J	Lv, XB; Xie, FY; Hu, KS; Wu, YZ; Cao, LL; Han, X; Sang, Y; Zeng, YX; Kang, TB				Lv, Xiao-Bin; Xie, Fangyun; Hu, Kaishun; Wu, Yuanzhong; Cao, Lin-Lin; Han, Xia; Sang, Yi; Zeng, Yi-Xin; Kang, Tiebang			Damaged DNA-binding Protein 1 (DDB1) Interacts with Cdh1 and Modulates the Function of APC/CCdh1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE PROGRESSION; S-PHASE ENTRY; UBIQUITIN LIGASE; GENOMIC STABILITY; COP9 SIGNALOSOME; MITOTIC CYCLINS; PROTEOLYSIS; DEGRADATION; INHIBITOR	APC/C-Cdh1 plays a key role in mitotic exit and has essential targets in the G(1) phase; however, these mechanisms are poorly understood. In this report, we provide evidence that damaged DNA-binding protein 1 (DDB1) is capable of binding the WD40 domains of Cdh1, but not of Cdc20, through its BPA and BPC domains. Moreover, cells lacking DDB1 exhibit markedly elevated levels of the protein substrates of APC/CCdh1. Depletion of DDB1 in mitotic cells significantly delays mitotic exit, which demonstrates that the interaction between DDB1 and Cdh1 plays a critical role in regulating APC/C-Cdh1 activity. However, cells depleted of Cdh1 demonstrated no change in the UV-induced degradation of Cdt1, the main function of DDB1 as an E3 ligase. Strikingly, the APC/CCdh1 substrate levels are normal in cell knockdowns of Cul4A and Cul4B, which, along with DDB1, form an E3 ligase complex. This finding indicates that DDB1 modulates the function of APC/C-Cdh1 in a manner independent on the Cul4-DDB1 complex. Our results suggest that DDB1 may functionally regulate mitotic exit by modulating APC/C-Cdh1 activity. This study reveals that there may be cross-talk among DDB1, Cdh1, and Skp2 in the control of cell cycle division.	[Lv, Xiao-Bin; Hu, Kaishun; Wu, Yuanzhong; Cao, Lin-Lin; Han, Xia; Sang, Yi; Zeng, Yi-Xin; Kang, Tiebang] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510060, Guangdong, Peoples R China; [Lv, Xiao-Bin; Xie, Fangyun; Hu, Kaishun; Wu, Yuanzhong; Cao, Lin-Lin; Han, Xia; Sang, Yi; Zeng, Yi-Xin; Kang, Tiebang] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510060, Guangdong, Peoples R China; [Xie, Fangyun] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510060, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Kang, TB (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, 651 DongFeng Rd E, Guangzhou 510060, Guangdong, Peoples R China.	kangtb@mail.sysu.edu.cn	Lv, Xiao-Bin/T-7607-2019	Kang, Tiebang/0000-0001-8805-4174; Sang, Yi/0000-0001-6534-0741; Wu, Yuanzhong/0000-0002-3577-7069	National Natural Science Foundation of China [30840005, 30930045, u0732005]; China's 973 project [2010CB912201]; China's 863 program [2006AA02A404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China's 973 project(National Basic Research Program of China); China's 863 program(National High Technology Research and Development Program of China)	This work was supported by grants from National Natural Science Foundation of China (30840005, 30930045), China's 973 project (2010CB912201) (to T. K.), China's 863 program (2006AA02A404), and the National Natural Science Foundation of China (u0732005) (to Y.-X.Z.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Benmaamar R, 2005, CELL CYCLE, V4, P1230, DOI 10.4161/cc.4.9.2048; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Blanco MA, 2000, EMBO J, V19, P3945, DOI 10.1093/emboj/19.15.3945; Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buschhorn BA, 2006, NAT CELL BIOL, V8, P209, DOI 10.1038/ncb0306-209; Cang Y, 2007, P NATL ACAD SCI USA, V104, P2733, DOI 10.1073/pnas.0611311104; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Clarke DJ, 2005, CELL CYCLE, V4, P1585, DOI 10.4161/cc.4.11.2143; Coster G, 2007, J BIOL CHEM, V282, P32053, DOI 10.1074/jbc.M705890200; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Hu J, 2008, GENE DEV, V22, P866, DOI 10.1101/gad.1624008; Jia XZ, 2009, BIOCHEM PHARMACOL, V77, P770, DOI 10.1016/j.bcp.2008.11.008; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Katiyar S, 2009, EMBO REP, V10, P866, DOI 10.1038/embor.2009.93; Kattan Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002002; Kitamura K, 1998, MOL BIOL CELL, V9, P1065, DOI 10.1091/mbc.9.5.1065; Kohn EA, 2003, CANCER RES, V63, P31; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Liu WJ, 2008, CARCINOGENESIS, V29, P263, DOI 10.1093/carcin/bgm251; Lovejoy CA, 2006, MOL CELL BIOL, V26, P7977, DOI 10.1128/MCB.00819-06; Nakayama K, 2001, BIOCHEM BIOPH RES CO, V282, P853, DOI 10.1006/bbrc.2001.4627; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P1759, DOI 10.1101/gad.897901; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; Smith KN, 1999, YEAST, V15, P1255, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1255::AID-YEA451>3.0.CO;2-L; Townsend K, 2009, J BIOL CHEM, V284, P33939, DOI 10.1074/jbc.M109.009191; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381	50	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18234	18240		10.1074/jbc.M109.094144	http://dx.doi.org/10.1074/jbc.M109.094144			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20395298	Green Published, hybrid			2022-12-25	WOS:000278453900015
J	Martin, P; Pardo, J; Schill, N; Jockel, L; Berg, M; Froelich, CJ; Wallich, R; Simon, MM				Martin, Praxedis; Pardo, Julian; Schill, Natalie; Joeckel, Lars; Berg, Matthias; Froelich, Christopher J.; Wallich, Reinhard; Simon, Markus M.			Granzyme B-induced and Caspase 3-dependent Cleavage of Gelsolin by Mouse Cytotoxic T Cells Modifies Cytoskeleton Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTE-MEDIATED CYTOTOXICITY; SMOOTH-MUSCLE-CELLS; IN-VIVO; ALPHA-TUBULIN; APOPTOSIS; ACTIN; DEATH; SUBSTRATE; PROTEASE; PERFORIN	Granule-associated perforin and granzymes (gzms) are key effector molecules of cytotoxic T lymphocytes (Tc cells) and natural killer cells and play a critical role in the control of intracellular pathogens and cancer. Based on the notion that many gzms, including A, B, C, K, H, and M exhibit cytotoxic activity in vitro, all gzms are believed to serve a similar function in vivo. However, more recent evidence supports the concept that gzms are not unidimensional but, rather, possess non-cytotoxic potential, including stimulation of pro-inflammatory cytokines and anti-viral activities. The present study shows that isolated mouse gzmB cleaves the actin-severing mouse protein, cytoplasmic gelsolin (c-gelsolin) in vitro. However, when delivered to intact target cells by ex vivo immune Tc cells, gzmB mediates c-gelsolin proteolysis via activation of caspases 3/7. The NH2-terminal c-gelsolin fragment generated by either gzmB or caspase 3 in vitro constitutively severs actin filaments without destroying the target cells. The observation that gzmB secreted by Tc cells initiates a caspase cascade that disintegrates the actin cytoskeleton in target cells suggests that this intracellular process may contribute to anti-viral host defense.	[Martin, Praxedis; Pardo, Julian; Schill, Natalie; Joeckel, Lars; Simon, Markus M.] Max Planck Inst Immunobiol, Metschnikoff Lab, D-79108 Freiburg, Germany; [Berg, Matthias] M Scan GmbH, Mass Spectrometry Consultants & Analysts, D-79108 Freiburg, Germany; [Froelich, Christopher J.] Univ Chicago, Sch Med, NorthShore Univ HealthSyst Res Inst, Evanston, IL 60201 USA; [Wallich, Reinhard] Univ Heidelberg, Inst Immunol, D-69120 Heidelberg, Germany	Max Planck Society; NorthShore University Health System; University of Chicago; Ruprecht Karls University Heidelberg	Simon, MM (corresponding author), Brombergstr 45, D-79102 Freiburg, Germany.	simon@immunbio.mpg.de	Pardo, Julián/K-6764-2014	Pardo, Julián/0000-0003-0154-0730	National Institutes of Health [R01AI044941]; Ministerio de Ciencia e Innovacion, Spain [SAF2008-02139]; Gobierno de Aragon and Fundacion Aragon I+D (ARAID) [PI076/08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044941] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Gobierno de Aragon and Fundacion Aragon I+D (ARAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI044941 (to C.J.F.).; Supported in part by Ministerio de Ciencia e Innovacion, Spain, Grant SAF2008-02139 and Gobierno de Aragon and Fundacion Aragon I+D (ARAID) Grant PI076/08. Present address: ARAID, Dept. of Biochemistry and Molecular and Cellular Biology, Faculty of Science, University of Zaragoza, Zaragoza 50009, Spain.	Adrain C, 2006, J BIOL CHEM, V281, P8118, DOI 10.1074/jbc.M509361200; Andrade F, 2007, EMBO J, V26, P2148, DOI 10.1038/sj.emboj.7601650; Bar S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000126; Balkow S, 2001, J VIROL, V75, P8781, DOI 10.1128/JVI.75.18.8781-8791.2001; BHAKDI S, 1985, INFECT IMMUN, V47, P52; Bredemeyer AJ, 2004, P NATL ACAD SCI USA, V101, P11785, DOI 10.1073/pnas.0402353101; Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; Choe H, 2002, J MOL BIOL, V324, P691, DOI 10.1016/S0022-2836(02)01131-2; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Cullen SP, 2007, J CELL BIOL, V176, P435, DOI 10.1083/jcb.200612025; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; De Corte V, 2002, EMBO J, V21, P6781, DOI 10.1093/emboj/cdf680; DIEFFENBACH CW, 1989, J BIOL CHEM, V264, P13281; Fackler OT, 2006, CURR OPIN MICROBIOL, V9, P409, DOI 10.1016/j.mib.2006.06.010; Froelich CJ, 2009, TRENDS IMMUNOL, V30, P117, DOI 10.1016/j.it.2009.01.002; Froelich CJ, 2004, CELL DEATH DIFFER, V11, P369, DOI 10.1038/sj.cdd.4401381; Geng YJ, 1998, EUR J CELL BIOL, V77, P294, DOI 10.1016/S0171-9335(98)80088-5; Goping IS, 2006, J CELL SCI, V119, P858, DOI 10.1242/jcs.02791; Harris JL, 1998, J BIOL CHEM, V273, P27364, DOI 10.1074/jbc.273.42.27364; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; Khaitlina S, 2002, FEBS LETT, V521, P14, DOI 10.1016/S0014-5793(02)02657-1; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kurschus FC, 2008, P NATL ACAD SCI USA, V105, P13799, DOI 10.1073/pnas.0801724105; Kwiatkowski DJ, 1999, CURR OPIN CELL BIOL, V11, P103, DOI 10.1016/S0955-0674(99)80012-X; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Li GH, 2009, CIRC RES, V104, P896, DOI 10.1161/CIRCRESAHA.108.172882; Lin KM, 2000, J BIOL CHEM, V275, P27746; LJUNGGREN HG, 1986, J IMMUNOGENET, V13, P141; Lord SJ, 2003, IMMUNOL REV, V193, P31, DOI 10.1034/j.1600-065X.2003.00044.x; Martin P, 2005, BLOOD, V106, P2871, DOI 10.1182/blood-2005-04-1522; Metkar SS, 2003, J CELL BIOL, V160, P875, DOI 10.1083/jcb.200210158; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Pardo J, 2008, CELL DEATH DIFFER, V15, P567, DOI 10.1038/sj.cdd.4402289; Pardo J, 2007, CELL DEATH DIFFER, V14, P1768, DOI 10.1038/sj.cdd.4402183; Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115; Pardo J, 2009, MICROBES INFECT, V11, P452, DOI 10.1016/j.micinf.2009.02.004; Quan LT, 1996, P NATL ACAD SCI USA, V93, P1972, DOI 10.1073/pnas.93.5.1972; Revell PA, 2005, J IMMUNOL, V174, P2124, DOI 10.4049/jimmunol.174.4.2124; Romero V, 2008, TISSUE ANTIGENS, V71, P409, DOI 10.1111/j.1399-0039.2008.01013.x; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Spinardi L., 2007, V45, P55; Stegh AH, 2000, MOL CELL BIOL, V20, P5665, DOI 10.1128/MCB.20.15.5665-5679.2000; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Trapani JA, 2008, IMMUNITY, V29, P665, DOI 10.1016/j.immuni.2008.10.002; Ulanet DB, 2004, ARTHRITIS RHEUM, V50, P233, DOI 10.1002/art.11485; Van Damme P, 2009, MOL CELL PROTEOMICS, V8, P258, DOI 10.1074/mcp.M800060-MCP200; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; Waterhouse NJ, 2006, CELL DEATH DIFFER, V13, P1839, DOI 10.1038/sj.cdd.4402023; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Yang XH, 1998, J BIOL CHEM, V273, P34278, DOI 10.1074/jbc.273.51.34278	54	15	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18918	18927		10.1074/jbc.M109.056028	http://dx.doi.org/10.1074/jbc.M109.056028			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20395300	Green Published, hybrid			2022-12-25	WOS:000278453900082
J	Sokabe, T; Fukumi-Tominaga, T; Yonemura, S; Mizuno, A; Tominaga, M				Sokabe, Takaaki; Fukumi-Tominaga, Tomoko; Yonemura, Shigenobu; Mizuno, Atsuko; Tominaga, Makoto			The TRPV4 Channel Contributes to Intercellular Junction Formation in Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-SENSING RECEPTOR; CELL-CELL ADHESION; CATION CHANNEL; INDUCED DIFFERENTIATION; EPIDERMAL BARRIER; E-CADHERIN; RHO; TEMPERATURE; ACTIVATION; MEMBRANE	Transient receptor potential vanilloid 4 (TRPV4) channel is a physiological sensor for hypo-osmolarity, mechanical deformation, and warm temperature. The channel activation leads to various cellular effects involving Ca2+ dynamics. We found that TRPV4 interacts with beta-catenin, a crucial component linking adherens junctions and the actin cytoskeleton, thereby enhancing cell-cell junction development and formation of the tight barrier between skin keratinocytes. TRPV4-deficient mice displayed impairment of the intercellular junction-dependent barrier function in the skin. In TRPV4-deficient keratinocytes, extracellular Ca2+-induced actin rearrangement and stratification were delayed following significant reduction in cytosolic Ca2+ increase and small GTPase Rho activation. TRPV4 protein located where the cell-cell junctions are formed, and the channel deficiency caused abnormal cell-cell junction structures, resulting in higher intercellular permeability in vitro. Our results suggest a novel role for TRPV4 in the development and maturation of cell-cell junctions in epithelia of the skin.	[Sokabe, Takaaki; Fukumi-Tominaga, Tomoko; Tominaga, Makoto] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Natl Inst Physiol Sci, Okazaki, Aichi 4448787, Japan; [Sokabe, Takaaki; Fukumi-Tominaga, Tomoko; Tominaga, Makoto] Grad Univ Adv Studies Sokendai, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan; [Yonemura, Shigenobu] RIKEN Ctr Dev Biol, Lab Cellular Morphogenesis, Kobe, Hyogo 6500047, Japan; [Mizuno, Atsuko] Jichi Med Sch, Dept Pharmacol, Minami Kawachi, Tochigi 3290498, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; RIKEN; Jichi Medical University	Sokabe, T (corresponding author), Higashiyama 5-1, Okazaki, Aichi 4448787, Japan.	sokabe@nips.ac.jp; tominaga@nips.ac.jp		Sokabe, Takaaki/0000-0003-1280-9424	Ministry of Education, Culture, Sport, Science and Technology in Japan; Nakatomi Foundation	Ministry of Education, Culture, Sport, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakatomi Foundation	This work was supported by grants from the Ministry of Education, Culture, Sport, Science and Technology in Japan (to T. S., T. F.-T., and M. T.) and from The Nakatomi Foundation (to M. T.).	Alvarez DF, 2006, CIRC RES, V99, P988, DOI 10.1161/01.RES.0000247065.11756.19; Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Becker D, 2009, EUR J CELL BIOL, V88, P141, DOI 10.1016/j.ejcb.2008.10.002; Bershadsky A, 2004, TRENDS CELL BIOL, V14, P589, DOI 10.1016/j.tcb.2004.09.009; Bikle DD, 2004, J STEROID BIOCHEM, V89-90, P355, DOI 10.1016/j.jsbmb.2004.03.020; Braga VMM, 1999, J CLIN PATHOL-MOL PA, V52, P197, DOI 10.1136/mp.52.4.197; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; Cai SW, 2006, PFLUG ARCH EUR J PHY, V452, P43, DOI 10.1007/s00424-005-0001-1; Calautti E, 2002, J CELL BIOL, V156, P137, DOI 10.1083/jcb.200105140; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Denda M, 2007, J INVEST DERMATOL, V127, P654, DOI 10.1038/sj.jid.5700590; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guler AD, 2002, J NEUROSCI, V22, P6408; Hadj-Rabia S, 2004, GASTROENTEROLOGY, V127, P1386, DOI 10.1053/j.gastro.2004.07.022; Hakuno M, 2000, BRIT J DERMATOL, V142, P702, DOI 10.1046/j.1365-2133.2000.03415.x; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Komuves L, 2002, J CELL PHYSIOL, V192, P45, DOI 10.1002/jcp.10107; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; Lehen'kyi V, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M611398200; Liebig T, 2009, MOL BIOL CELL, V20, P452, DOI 10.1091/mbc.E07-11-1197; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Mandadi S, 2009, PFLUG ARCH EUR J PHY, V458, P1093, DOI 10.1007/s00424-009-0703-x; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Meng WX, 2004, EMBO J, V23, P760, DOI 10.1038/sj.emboj.7600095; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Plant T. D., 2007, V179, P189; Popoff MR, 2009, BBA-BIOMEMBRANES, V1788, P797, DOI 10.1016/j.bbamem.2009.01.011; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Ramadass R, 2007, ARCH BIOCHEM BIOPHYS, V463, P27, DOI 10.1016/j.abb.2007.01.036; Reiter B, 2006, FASEB J, V20, P1802, DOI 10.1096/fj.06-5772com; Sakurada S, 2003, CIRC RES, V93, P548, DOI 10.1161/01.RES.0000090998.08629.60; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; SHUTTLEWORTH TJ, 1991, J BIOL CHEM, V266, P1410; Smith PL, 2006, J BIOL CHEM, V281, P29897, DOI 10.1074/jbc.M605394200; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Troy TC, 2004, METH MOL B, V289, P121; Tsukita S, 2002, CURR OPIN CELL BIOL, V14, P531, DOI 10.1016/S0955-0674(02)00362-9; Tu CL, 2001, J BIOL CHEM, V276, P41079, DOI 10.1074/jbc.M107122200; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Turksen K, 2003, MECH DEVELOP, V120, P733, DOI 10.1016/S0925-4773(03)00045-5; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Yoshioka T, 2009, J INVEST DERMATOL, V129, P714, DOI 10.1038/jid.2008.245	60	114	123	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18749	18758		10.1074/jbc.M110.103606	http://dx.doi.org/10.1074/jbc.M110.103606			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20413591	hybrid, Green Published			2022-12-25	WOS:000278453900066
J	Nilsen, IW; Overbo, K; Havdalen, LJ; Elde, M; Gjellesvik, DR; Lanes, O				Nilsen, Inge W.; Overbo, Kersti; Havdalen, Linda Jensen; Elde, Morten; Gjellesvik, Dag Rune; Lanes, Olav			The Enzyme and the cDNA Sequence of a Thermolabile and Double-Strand Specific DNase from Northern Shrimps (Pandalus borealis)	PLOS ONE			English	Article							DUPLEX-SPECIFIC NUCLEASE; ALKALINE-PHOSPHATASE; SERRATIA-MARCESCENS; PYLORIC CECA; ACTIVE-SITE; HEPATOPANCREAS; ENDONUCLEASE; PROTEIN; CRAB; DEOXYRIBONUCLEASE	Background: We have previously isolated a thermolabile nuclease specific for double-stranded DNA from industrial processing water of Northern shrimps (Pandalus borealis) and developed an application of the enzyme in removal of contaminating DNA in PCR-related technologies. Methodology/Principal Findings: A 43 kDa nuclease with a high specific activity of hydrolysing linear as well as circular forms of DNA was purified from hepatopancreas of Northern shrimp (Pandalus borealis). The enzyme displayed a substrate preference that was shifted from exclusively double-stranded DNA in the presence of magnesium to also encompass significant activity against single-stranded DNA when calcium was added. No activity against RNA was detected. Although originating from a cold-environment animal, the shrimp DNase has only minor low-temperature activity. Still, the enzyme was irreversibly inactivated by moderate heating with a half-life of 1 min at 65 degrees C. The purified protein was partly sequenced and derived oligonucleotides were used to prime amplification of the encoding cDNA. This cDNA sequence revealed an open reading frame encoding a 404 amino acid protein containing a signal peptide. By sequence similarity the enzyme is predicted to belong to a family of DNA/RNA non-specific nucleases even though this shrimp DNase lacks RNase activity and is highly double-strand specific in some respects. These features are in agreement with those previously established for endonucleases classified as similar to the Kamchatka crab duplex-specific nuclease (Par_DSN). Sequence comparisons and phylogenetic analyses confirmed that the Northern shrimp nuclease resembles the Par_DSN-like nucleases and displays a more distant relationship to the Serratia family of nucleases. Conclusions/Significance: The shrimp nuclease contains enzyme activity that may be controlled by temperature or buffer compositions. The double-stranded DNA specificity, as well as the thermolabile feature, strengthens its potential for in vitro applications.	[Nilsen, Inge W.; Overbo, Kersti] Nofima Marin, Tromso, Norway; [Havdalen, Linda Jensen; Elde, Morten; Gjellesvik, Dag Rune; Lanes, Olav] Marine Biochem, Tromso, Norway	Nofima	Nilsen, IW (corresponding author), Nofima Marin, Tromso, Norway.	ol@marinebiochem.com			Research council of Norway [138822/130]; Nofima Marin; Biotec Marine Biochemicals	Research council of Norway(Research Council of Norway); Nofima Marin(Nofima); Biotec Marine Biochemicals	This work was supported by the Research council of Norway, project number 138822/130, Nofima Marin and Biotec Marine Biochemicals. Since IWN and KO are employees at Nofima Marin and LJH, ME, DRG and OL are employees at Marine Biochemicals the funders played a role in the design, data analysis and the decision to publish.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova VE, 2008, GENE, V418, P41, DOI 10.1016/j.gene.2008.04.005; Anisimova VE, 2009, BIOTECHNOL LETT, V31, P251, DOI 10.1007/s10529-008-9850-y; Anisimova Veronika E., 2008, BMC Biochemistry, V9, P14, DOI 10.1186/1471-2091-9-14; BALL TK, 1987, GENE, V57, P183, DOI 10.1016/0378-1119(87)90121-1; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Calvo E, 2006, J EXP BIOL, V209, P2651, DOI 10.1242/jeb.02267; CHIEN A, 1976, J BACTERIOL, V127, P1550, DOI 10.1128/JB.127.3.1550-1557.1976; EDMAN P, 1956, ACTA CHEM SCAND, V10, P761, DOI 10.3891/acta.chem.scand.10-0761; FRIEDHOFF P, 1994, NUCLEIC ACIDS RES, V22, P3280, DOI 10.1093/nar/22.16.3280; Friedhoff P, 1996, NUCLEIC ACIDS RES, V24, P2632, DOI 10.1093/nar/24.14.2632; FULLER CW, 1998, Patent No. 5756285; KUNITZ M, 1950, J GEN PHYSIOL, V33, P349, DOI 10.1085/jgp.33.4.349; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Menzorova N.I., 1993, Biokhimiya, V58, P681; Miller MD, 1999, J MOL BIOL, V288, P975, DOI 10.1006/jmbi.1999.2729; MOORE S, 1981, ENZYMES A, V14, P281; Nilsen IW, 2001, COMP BIOCHEM PHYS B, V129, P853, DOI 10.1016/S1096-4959(01)00391-8; Nilsen IW, 2003, US patent, Patent No. [6,541,204, 6541204]; OLSEN RL, 1991, COMP BIOCHEM PHYS B, V99, P755, DOI 10.1016/0305-0491(91)90139-5; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 2001, MOL CLONING LAB MANU; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shagin DA, 2002, GENOME RES, V12, P1935, DOI 10.1101/gr.547002; STRAETKVERN KO, 1990, FISH PHYSIOL BIOCHEM, V8, P529, DOI 10.1007/BF00003411; STRAETKVERN KO, 1992, FISH PHYSIOL BIOCHEM, V9, P439, DOI 10.1007/BF02274225; Wang WY, 2000, BIOCHEM J, V346, P799, DOI 10.1042/0264-6021:3460799; YAMAMOTO M, 1971, BIOCHIM BIOPHYS ACTA, V228, P95, DOI 10.1016/0005-2787(71)90549-1	29	19	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10295	10.1371/journal.pone.0010295	http://dx.doi.org/10.1371/journal.pone.0010295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421970	Green Published, gold, Green Submitted			2022-12-25	WOS:000276952600012
J	Arnold, DH; Tear, M; Schindel, R; Roseboom, W				Arnold, Derek H.; Tear, Morgan; Schindel, Ryan; Roseboom, Warrick			Audio-Visual Speech Cue Combination	PLOS ONE			English	Article							VISUAL-MOTION SIGNALS; INTEGRATION; INFORMATION	Background: Different sources of sensory information can interact, often shaping what we think we have seen or heard. This can enhance the precision of perceptual decisions relative to those made on the basis of a single source of information. From a computational perspective, there are multiple reasons why this might happen, and each predicts a different degree of enhanced precision. Relatively slight improvements can arise when perceptual decisions are made on the basis of multiple independent sensory estimates, as opposed to just one. These improvements can arise as a consequence of probability summation. Greater improvements can occur if two initially independent estimates are summated to form a single integrated code, especially if the summation is weighted in accordance with the variance associated with each independent estimate. This form of combination is often described as a Bayesian maximum likelihood estimate. Still greater improvements are possible if the two sources of information are encoded via a common physiological process. Principal Findings: Here we show that the provision of simultaneous audio and visual speech cues can result in substantial sensitivity improvements, relative to single sensory modality based decisions. The magnitude of the improvements is greater than can be predicted on the basis of either a Bayesian maximum likelihood estimate or a probability summation. Conclusion: Our data suggest that primary estimates of speech content are determined by a physiological process that takes input from both visual and auditory processing, resulting in greater sensitivity than would be possible if initially independent audio and visual estimates were formed and then subsequently combined.	[Arnold, Derek H.; Tear, Morgan; Schindel, Ryan; Roseboom, Warrick] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia	University of Queensland	Arnold, DH (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.	d.arnold@psy.uq.edu.au		Arnold, Derek/0000-0003-1027-6222	Australian Research Council [DP0878140]	Australian Research Council(Australian Research Council)	Australian Research Council Discovery Grant DP0878140 http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Arrighi R, 2009, J VISION, V9, DOI 10.1167/9.4.25; Bresciani JP, 2005, EXP BRAIN RES, V162, P172, DOI 10.1007/s00221-004-2128-2; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fujisaki W, 2006, P ROY SOC B-BIOL SCI, V273, P865, DOI 10.1098/rspb.2005.3327; Graham N.V.S, 1989, VISUAL PATTERN ANAL; Green DM, 1966, SIGNAL DETECTION THE; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Koene A, 2007, J VISION, V7, DOI 10.1167/7.11.14; Lopez-Moliner J, 2007, J VISION, V7, DOI 10.1167/7.13.11; Ma WJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004638; Macmillan N. A., 2005, DETECTION THEORY USE; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Meese TS, 2001, PERCEPTION, V30, P1189, DOI 10.1068/p3196; Meyer GF, 2005, EXP BRAIN RES, V166, P538, DOI 10.1007/s00221-005-2394-7; MORRONE MC, 1995, NATURE, V376, P507, DOI 10.1038/376507a0; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Soto-Faraco S, 2004, COGNITION, V92, pB13, DOI 10.1016/j.cognition.2003.10.005; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Treisman M, 1998, PSYCHOL METHODS, V3, P252, DOI 10.1037/1082-989X.3.2.252; Wuerger SM, 2003, PERCEPT PSYCHOPHYS, V65, P1188, DOI 10.3758/BF03194844; Yuille AL, 1996, PERCEPTION BAYESIAN, P123, DOI DOI 10.1017/CBO9780511984037.006	25	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10217	10.1371/journal.pone.0010217	http://dx.doi.org/10.1371/journal.pone.0010217			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	584HZ	20419130	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000276743500018
J	Bitan, M; Weiss, L; Zeira, M; Zcharia, E; Slavin, S; Nagler, A; Vlodavsky, I				Bitan, Menachem; Weiss, Lola; Zeira, Michael; Zcharia, Eyal; Slavin, Shimon; Nagler, Arnon; Vlodavsky, Israel			Heparanase Promotes Engraftment and Prevents Graft versus Host Disease in Stem Cell Transplantation	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; NECROSIS-FACTOR-ALPHA; SULFATE PROTEOGLYCANS; MAMMALIAN HEPARANASE; CYTOKINE PRODUCTION; CANCER METASTASIS; TUMOR-GROWTH; T-CELLS; ANGIOGENESIS; EXPRESSION	Background: Heparanase, endoglycosidase that cleaves heparan sulfate side chains of heparan sulfate proteoglycans, plays important roles in cancer metastasis, angiogenesis and inflammation. Design and Methods: Applying a mouse model of bone marrow transplantation and transgenic mice over-expressing heparanase, we evaluated the effect of heparanase on the engraftment process and the development of graft-versus-host disease. Results: Analysis of F1 mice undergoing allogeneic bone marrow transplantation from C57BL/6 mice demonstrated a better and faster engraftment in mice receiving cells from donors that were pretreated with heparanase. Moreover, heparanase treated recipient F1 mice showed only a mild appearance of graft-versus-host disease and died 27 days post transplantation while control mice rapidly developed signs of graft-versus-host disease (i.e., weight loss, hair loss, diarrhea) and died after 12 days, indicating a protective effect of heparanase against graft-versus-host disease. Similarly, we applied transgenic mice over-expressing heparanase in most tissues as the recipients of BMT from C57BL/6 mice. Monitoring clinical parameters of graft-versus-host disease, the transgenic mice showed 100% survival on day 40 post transplantation, compared to only 50% survival on day 14, in the control group. In vitro and in vivo studies revealed that heparanase inhibited T cell function and activation through modulation of their cytokine repertoire, indicated by a marked increase in the levels of Interleukin-4, Interleukin-6 and Interleukin-10, and a parallel decrease in Interleukin-12, tumor necrosis factor-alfa and interferon-gamma. Using point mutated inactive enzyme, we found that the shift in cytokine profile was independent of heparanase enzymatic activity. Conclusions: Our results indicate a significant role of heparanase in bone marrow transplantation biology, facilitating engraftment and suppressing graft-versus-host disease, apparently through an effect on T cell activation and cytokine production pattern.	[Bitan, Menachem; Weiss, Lola; Zeira, Michael; Slavin, Shimon] Hadassah Hebrew Univ, Med Ctr, Dept Bone Marrow Transplantat, Jerusalem, Israel; [Zcharia, Eyal] Hadassah Hebrew Univ, Med Ctr, Dept Oncol, Jerusalem, Israel; [Nagler, Arnon] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, IL-52621 Tel Hashomer, Israel; [Vlodavsky, Israel] Technion Israel Inst Technol, Canc & Vasc Biol Res Ctr, Bruce Rappaport Fac Med, Haifa, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Chaim Sheba Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Bitan, M (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Bone Marrow Transplantat, Jerusalem, Israel.	Vlodavsk@cc.huji.ac.il			Israel Science Foundation [549/06]; National Cancer Institute [RO1-CA106456]; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Israel Science Foundation (grant 549/06); National Cancer Institute (RO1-CA106456). I. Vlodavsky is a Research Professor of the ICRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud-Jarrous G, 2005, J BIOL CHEM, V280, P13568, DOI 10.1074/jbc.M413370200; ABBOUDJARROUS G, 2008, J BIOL CHEM; ANTIN JH, 1992, BLOOD, V80, P2964; Barrett AJ, 1997, STEM CELLS, V15, P248, DOI 10.1002/stem.150248; Ben-Zaken O, 2008, INT J BIOCHEM CELL B, V40, P530, DOI 10.1016/j.biocel.2007.09.003; Ben-Zaken O, 2007, BIOCHEM BIOPH RES CO, V361, P829, DOI 10.1016/j.bbrc.2007.06.188; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bitan M, 2008, DIABETES-METAB RES, V24, P413, DOI 10.1002/dmrr.868; BORTIN MM, 1973, SCIENCE, V179, P811, DOI 10.1126/science.179.4075.811; Casu B, 2002, BIOCHEMISTRY-US, V41, P10519, DOI 10.1021/bi020118n; Cohen-Kaplan V, 2008, INT J CANCER, V123, P2566, DOI 10.1002/ijc.23898; Cohen-Kaplan V, 2008, CANCER RES, V68, P10077, DOI 10.1158/0008-5472.CAN-08-2910; Dempsey LA, 2000, GLYCOBIOLOGY, V10, P467, DOI 10.1093/glycob/10.5.467; Edovitsky E, 2006, BLOOD, V107, P3609, DOI 10.1182/blood-2005-08-3301; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; FERRARA JLM, 1991, NEW ENGL J MED, V324, P667; Ferro V, 2004, MINI-REV MED CHEM, V4, P693, DOI 10.2174/1389557043403729; FOWLER DH, 1994, BLOOD, V84, P3540; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Goker H, 2001, EXP HEMATOL, V29, P259, DOI 10.1016/S0301-472X(00)00677-9; Goldshmidt O, 2002, P NATL ACAD SCI USA, V99, P10031, DOI 10.1073/pnas.152070599; HOLLER E, 1990, BLOOD, V75, P1011; Hulett MD, 2000, BIOCHEMISTRY-US, V39, P15659, DOI 10.1021/bi002080p; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Ilan Y, 2000, BLOOD, V95, P3613, DOI 10.1182/blood.V95.11.3613.011k31_3613_3619; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Kappel LW, 2009, BLOOD, V113, P945, DOI 10.1182/blood-2008-08-172155; Kim DH, 2008, BIOL BLOOD MARROW TR, V14, P1408, DOI 10.1016/j.bbmt.2008.09.022; Korngold R, 2003, BIOL BLOOD MARROW TR, V9, P292, DOI 10.1016/S1083-8791(03)00087-9; Levy-Adam F, 2003, BIOCHEM BIOPH RES CO, V308, P885, DOI 10.1016/S0006-291X(03)01478-5; Li RW, 2008, ARTHRITIS RHEUM, V58, P1590, DOI 10.1002/art.23489; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; McKenzie E, 2003, BIOCHEM J, V373, P423, DOI 10.1042/BJ20030318; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Mielcarek M, 2003, BLOOD, V102, P756, DOI 10.1182/blood-2002-08-2628; Nagler A, 1998, CYTOKINES CELL MOL T, V4, P161; NAPARSTEK Y, 1984, NATURE, V310, P241, DOI 10.1038/310241a0; Nardella C, 2004, BIOCHEMISTRY-US, V43, P1862, DOI 10.1021/bi030203a; Ostrovsky O, BLOOD, V115, P2319; PAN LY, 1995, BLOOD, V86, P4422, DOI 10.1182/blood.V86.12.4422.bloodjournal86124422; Parish CR, 2001, BIOCHIM BIOPHYS ACTA, V1471, P99, DOI DOI 10.1016/S0304-419X(01)00017-8; Porgador A, 1997, P NATL ACAD SCI USA, V94, P13140, DOI 10.1073/pnas.94.24.13140; Pugatsch T, 1996, BONE MARROW TRANSPL, V17, P273; ROMAGNANI S, 1991, INT J CLIN LAB RES, V21, P152; Rops AL, 2007, KIDNEY INT, V72, P1204, DOI 10.1038/sj.ki.5002514; ROY J, 1995, TRANSPLANTATION, V60, P343; RUS V, 1995, J IMMUNOL, V155, P2396; Sanderson RD, 2004, MATRIX BIOL, V23, P341, DOI 10.1016/j.matbio.2004.08.004; SLAVIN S, 1977, J EXP MED, V146, P34, DOI 10.1084/jem.146.1.34; Spiegel A, 2008, BLOOD, V111, P4934, DOI 10.1182/blood-2007-10-116145; Tanaka J, 1997, BONE MARROW TRANSPL, V19, P571, DOI 10.1038/sj.bmt.1700708; TRINCHIERI G, 1993, IMMUNOL TODAY, V14, P335, DOI 10.1016/0167-5699(93)90230-I; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; VLODAVSKY I, 1992, INVAS METAST, V12, P112; VLODAVSKY I, 1993, BASEMENT MEMBRANES C, P327; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Weiss L, 2002, CYTOKINE, V19, P85, DOI 10.1006/cyto.2002.1956; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Zecchina G, 2001, J HEMATOTH STEM CELL, V10, P769, DOI 10.1089/152581601317210863; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2003, CANCER RES, V63, P7733	67	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10135	10.1371/journal.pone.0010135	http://dx.doi.org/10.1371/journal.pone.0010135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419162	Green Published, Green Submitted, gold			2022-12-25	WOS:000276707100004
J	Gu, A; Zhang, ZF; Zhang, N; Tsark, W; Shively, JE				Gu, Angel; Zhang, Zhifang; Zhang, Nan; Tsark, Walter; Shively, John E.			Generation of Human CEACAM1 Transgenic Mice and Binding of Neisseria Opa Protein to Their Neutrophils	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; SHORT CYTOPLASMIC DOMAIN; CARCINOEMBRYONIC ANTIGEN; BILIARY GLYCOPROTEIN; EPITHELIAL-CELLS; MUTATIONAL ANALYSIS; LUMEN FORMATION; KEY RESIDUES; GROWTH-FACTOR; IN-VIVO	Background: Human CEACAM1 is a cell-cell adhesion molecule with multiple functions including insulin clearance in the liver, vasculogenesis in endothelial cells, lumen formation in the mammary gland, and binding of certain human pathogens. Principal Findings: Three genomic BAC clones containing the human CEACAM1 gene were microinjected into pronuclei of fertilized FVB mouse oocytes. The embryos were implanted in the oviducts of pseudopregnant females and allowed to develop to term. DNA from newborn mice was evaluated by PCR for the presence of the human CEACAM1 gene. Feces of the PCR positive offspring screened for expression of human CEACAM1. Using this assay, one out of five PCR positive lines was positive for human CEACAM1 expression and showed stable transmission to the F1 generation with the expected transmission frequency (0.5) for heterozygotes. Liver, lung, intestine, kidney, mammary gland, and prostate were strongly positive for the dual expression of both murine and human CEACAM1 and mimic that seen in human tissue. Peripheral blood and bone marrow granulocytes stained strongly for human CEACAM1 and bound Neisseria Opa proteins similar to that in human neutrophils. Conclusion: These transgenic animals may serve as a model for the binding of human pathogens to human CEACAM1.	[Gu, Angel; Zhang, Zhifang; Zhang, Nan; Shively, John E.] Beckman Res Inst City Hope, Dept Immunol, Duarte, CA USA; [Tsark, Walter] Beckman Res Inst City Hope, Dept Biol, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Gu, A (corresponding author), Beckman Res Inst City Hope, Dept Immunol, Duarte, CA USA.	jshively@coh.org		Montoro, Daniel/0000-0002-6222-2149	National Institutes of Health (NIH) [CA84202]; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) CA84202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Rjaily GA, 2004, J CLIN INVEST, V114, P944, DOI 10.1172/JCI200421786; Beauchemin N, 1997, ONCOGENE, V14, P783, DOI 10.1038/sj.onc.1200888; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; Chen DH, 2004, J IMMUNOL, V172, P3535, DOI 10.4049/jimmunol.172.6.3535; Chen ZG, 2008, J IMMUNOL, V180, P6085, DOI 10.4049/jimmunol.180.9.6085; Clarke P, 1998, CANCER RES, V58, P1469; COUTELIER JP, 1994, EUR J IMMUNOL, V24, P1383, DOI 10.1002/eji.1830240622; Daniels E, 1996, DEV DYNAM, V206, P272, DOI 10.1002/(SICI)1097-0177(199607)206:3<272::AID-AJA5>3.3.CO;2-U; Ergun S, 2000, MOL CELL, V5, P311, DOI 10.1016/S1097-2765(00)80426-8; Gaur S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-46; Godfraind C, 1998, ADV EXP MED BIOL, V440, P569; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; GrayOwen SD, 1997, EMBO J, V16, P3435, DOI 10.1093/emboj/16.12.3435; Greicius G, 2003, J LEUKOCYTE BIOL, V74, P126, DOI 10.1189/jlb.1202594; Han E, 2001, BIOCHEM J, V355, P417, DOI 10.1042/0264-6021:3550417; Hauck CR, 1998, EMBO J, V17, P443, DOI 10.1093/emboj/17.2.443; HINODA Y, 1990, INT J CANCER, V45, P875, DOI 10.1002/ijc.2910450516; Horst AK, 2006, J CLIN INVEST, V116, P1596, DOI 10.1172/JCI24340; Huang J, 1999, J CELL SCI, V112, P4193; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Izzi L, 1999, ONCOGENE, V18, P5563, DOI 10.1038/sj.onc.1202935; Jin L, 2008, EXP BIOL MED, V233, P849, DOI 10.3181/0712-RM-352; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Klaile E, 2005, J CELL SCI, V118, P5513, DOI 10.1242/jcs.02660; Li CX, 2009, EXP CELL RES, V315, P1225, DOI 10.1016/j.yexcr.2008.12.015; Lobo EO, 2009, J LEUKOCYTE BIOL, V86, P205, DOI 10.1189/jlb.0109037; Nagaishi T, 2008, MUCOSAL IMMUNOL, V1, pS39, DOI 10.1038/mi.2008.50; Nagaishi T, 2006, ANN NY ACAD SCI, V1072, P155, DOI 10.1196/annals.1326.004; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Najjar SM, 2002, TRENDS ENDOCRIN MET, V13, P240, DOI 10.1016/S1043-2760(02)00608-2; Obrink B, 2008, LUNG CANCER, V60, P309, DOI 10.1016/j.lungcan.2008.03.020; Pantelic M, 2005, INFECT IMMUN, V73, P4171, DOI 10.1128/IAI.73.7.4171-4179.2005; Phan D, 2004, CANCER RES, V64, P3072, DOI 10.1158/0008-5472.CAN-03-3730; Phan D, 2001, MOL CELL ENDOCRINOL, V184, P115, DOI 10.1016/S0303-7207(01)00638-4; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; ROBBINS J, 1991, GENOMICS, V10, P583, DOI 10.1016/0888-7543(91)90439-L; Robitaille J, 1999, EUR J BIOCHEM, V264, P534, DOI 10.1046/j.1432-1327.1999.00660.x; Sadekova S, 2000, MOL BIOL CELL, V11, P65, DOI 10.1091/mbc.11.1.65; SCHEDL A, 1993, NUCLEIC ACIDS RES, V21, P4783, DOI 10.1093/nar/21.20.4783; Schumann D, 2001, J BIOL CHEM, V276, P47421, DOI 10.1074/jbc.M109110200; Singer BB, 2005, EUR J IMMUNOL, V35, P1949, DOI 10.1002/eji.200425691; Skubitz KM, 1996, J LEUKOCYTE BIOL, V60, P106, DOI 10.1002/jlb.60.1.106; Slevogt H, 2008, NAT IMMUNOL, V9, P1270, DOI 10.1038/ni.1661; SVENBERG T, 1979, CLIN EXP IMMUNOL, V36, P436; Villullas S, 2007, CELL MICROBIOL, V9, P329, DOI 10.1111/j.1462-5822.2006.00789.x; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; WAGENER C, 1983, J IMMUNOL, V130, P2308; Yokoyama S, 2007, ONCOGENE, V26, P7637, DOI 10.1038/sj.onc.1210577; Zhang ZF, 2008, J LEUKOCYTE BIOL, V84, P780, DOI 10.1189/jlb.0208086	51	205	208	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10067	10.1371/journal.pone.0010067	http://dx.doi.org/10.1371/journal.pone.0010067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404914	gold, Green Published, Green Submitted			2022-12-25	WOS:000276482100004
J	Li, K; Wang, R; Lozada, E; Fan, W; Orren, DK; Luo, JY				Li, Kai; Wang, Rui; Lozada, Enerlyn; Fan, Wei; Orren, David K.; Luo, Jianyuan			Acetylation of WRN Protein Regulates Its Stability by Inhibiting Ubiquitination	PLOS ONE			English	Article							WERNER-SYNDROME PROTEIN; DNA-REPAIR; RECQ HELICASES; SYNDROME GENE; TRANSCRIPTION; DAMAGE; DEACETYLATION; LOCALIZATION; COACTIVATOR; MUTATIONS	Background: WRN is a multi-functional protein involving DNA replication, recombination and repair. WRN acetylation has been demonstrated playing an important role in response to DNA damage. We previously found that WRN acetylation can regulate its enzymatic activities and nuclear distribution. Methodology/Principal Finding: Here, we investigated the factors involved in WRN acetylation and found that CBP and p300 are the only major acetyltransferases for WRN acetylation. We further identified 6 lysine residues in WRN that are subject to acetylation. Interestingly, WRN acetylation can increase its protein stability. SIRT1-mediated deacetylation of WRN reverses this effect. CBP dramatically increases the half-life of wild type WRN, while mutation of these 6 lysine residues (WRN-6KR) abrogates this increase. We further found that WRN stability is regulated by the ubiquitination pathway and WRN acetylation by CBP significantly reduces its ubiquitination. Importantly, we found that WRN is strongly acetylated and stabilized in response to mitomycin C (MMC) treatment. H1299 cells stably expressing WRN-6KR, which mimics unacetylated WRN, display significantly higher MMC sensitivity compared with the cells expressing wild-type WRN. Conclusion/Significance: Taken together, these data demonstrate that WRN acetylation regulates its stability and has significant implications regarding the role of acetylation on WRN function in response to DNA damage.	[Li, Kai; Wang, Rui; Fan, Wei; Luo, Jianyuan] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Li, Kai; Wang, Rui; Fan, Wei; Luo, Jianyuan] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA USA; [Lozada, Enerlyn; Orren, David K.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Kentucky	Li, K (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA.	Jianyuan.luo@umassmed.edu	Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914	National Institutes of Health National Institute on Aging (NIH/NIA) [R01AG026534, R01AG027258]; NATIONAL CANCER INSTITUTE [R01CA113371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026534, R01AG027258] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Aging (NIH/NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health National Institute on Aging (NIH/NIA) grant R01AG026534 to J. Luo and R01AG027258 to D. Orren. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blander G, 2002, J BIOL CHEM, V277, P50934, DOI 10.1074/jbc.M210479200; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Ge XJ, 2009, MOL BIOL CELL, V20, P419, DOI 10.1091/mbc.E08-08-0792; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Kahyo T, 2008, FEBS LETT, V582, P2479, DOI 10.1016/j.febslet.2008.06.031; Karmakar P, 2005, MECH AGEING DEV, V126, P1146, DOI 10.1016/j.mad.2005.06.004; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kusumoto R, 2007, MECH AGEING DEV, V128, P50, DOI 10.1016/j.mad.2006.11.010; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lee JW, 2005, MECH AGEING DEV, V126, P79, DOI 10.1016/j.mad.2004.09.011; Li K, 2008, J BIOL CHEM, V283, P7590, DOI 10.1074/jbc.M709707200; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; MARTIN GM, 1970, LAB INVEST, V23, P86; Muftuoglu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001918; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; Ogburn CE, 1997, HUM GENET, V101, P121, DOI 10.1007/s004390050599; Poot M, 2001, FASEB J, V15, P1224, DOI 10.1096/fj.00-0611fje; Rausa FM, 2004, J BIOL CHEM, V279, P43070, DOI 10.1074/jbc.M407472200; Singh DK, 2009, BIOGERONTOLOGY, V10, P235, DOI 10.1007/s10522-008-9205-z; STEFANINI M, 1989, MUTAT RES, V219, P179, DOI 10.1016/0921-8734(89)90013-1; Vaitiekunaite R, 2007, MECH AGEING DEV, V128, P650, DOI 10.1016/j.mad.2007.09.004; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	27	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10341	10.1371/journal.pone.0010341	http://dx.doi.org/10.1371/journal.pone.0010341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20808827	Green Published, Green Submitted, gold			2022-12-25	WOS:000277079300021
